Citrus Sinensis ID: 015734

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-
Protein Sequence
MLLAVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEEVRQQEVSLLPHQFAWGEDSSIDQEAIQLSNAR
Secondary Structure (PSIPRED)
cccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccccEEEEEccccEEEEEEccccccccHHHHHHHHHHHHHHccccccccEEcEEcccccEEEEEcccccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccEEEcccccccccccHHHcccccccccccccHHHHHHHHHHcccccccccccccccHHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccHHEEEHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccEcHHHHHHHHccccccccccccccccEEEEEcccccEEEEEEcccccccccHHHHHHHHHHHHHHHHHHHHHHHcEEcccccEEEEEEccccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHccccEEccccccHHHEEEEHHHEEEEccccHHHHcccccccEEEEEEEcEccccHHHHHccccccHHHHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHHHcccHHHHcccccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHcccccccccccccccccccccccccccccccccccccccccEEEccccc
Coil and Loop (DISEMBL)
mllavstsrTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKhdvffdvageddckVSLTQLRRFSCRELQLatdnfsesniigqggfgkvykgvlsdNTKVAVKRLQDyyspggeaafQREVHLISVAIHKNLLQLIGYcttsserilvYPFMQNLSVAYRlrdlkpgekgldwptrkrVAFGTAYGLEYLheqcnpkiiHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQirgtmghiapeylstgkssektdvFGYGITLLELVTgqraidfsrleeEEDVLLLDHIRKLLREDRLndivdrnlntydskEVETMVQVALLCtqstpedrppMAQVVKMLQGEDLAERWAEWEELEEVRQQEVSllphqfawgedssiDQEAIQLSNAR
Flexible Loop (DISEMBL)
mllavstsrtklRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLAtdnfsesniigqggFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKpgekgldwptrkRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVttqirgtmghIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKllredrlndivdrnlntydskevETMVQVALLCTqstpedrppMAQVVKMLQGEDLAERWAEWEELEEVRQQEVSLLPHQFawgedssidqeaiqlsnar
Low Complexity Region (SEG)
MLLAVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRleeeedvllldHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDlaerwaeweeleevrqqevSLLPHQFAWGEDSSIDQEAIQLSNAR
Disordered region (IsUnstruct)
*********TKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID**********LLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCT*************VKMLQGEDLAERWAEWEELEEVRQQEVSLLPHQFAW*****************
Disordered Region (DISOPRED)
***************VASASCGAFVLLSLGALFACRYQ**********************LTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ******GE**FQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF*RLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDL********************************************
Disordered Region (DISEMBL)
********RTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEEVRQQEVSLLPHQFAWGEDSSIDQEAIQLSNAR
Disordered Region (DISPRO)
*******SRTKLRIVVASASCGAFVLLSLGALFACRYQKLR*****VFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP*AQVVKMLQ************************************************
Transmembrane Helix (TMHMM)
iiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSiiHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLLAVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEEVRQQEVSLLPHQFAWGEDSSIDQEAIQLSNAR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	401	2.2.26 [Sep-21-2011]
Q8W4S5	614	Probable LRR receptor-lik	yes	no	0.995	0.649	0.753	1e-174
C0LGT1	613	Probable LRR receptor-lik	no	no	0.982	0.642	0.659	1e-153
C0LGX1	607	Probable LRR receptor-lik	no	no	0.972	0.642	0.670	1e-152
Q94AG2	625	Somatic embryogenesis rec	no	no	0.897	0.576	0.597	1e-126
Q9XIC7	628	Somatic embryogenesis rec	no	no	0.897	0.573	0.589	1e-121
Q94F62	615	BRASSINOSTEROID INSENSITI	no	no	0.827	0.539	0.621	1e-120
Q9SKG5	620	Somatic embryogenesis rec	no	no	0.820	0.530	0.587	1e-114
Q8RY65	635	Protein NSP-INTERACTING K	no	no	0.960	0.606	0.517	1e-109
Q93ZS4	632	Protein NSP-INTERACTING K	no	no	0.912	0.579	0.532	1e-108
Q8LPS5	601	Somatic embryogenesis rec	no	no	0.815	0.544	0.571	1e-107

>sp|Q8W4S5|Y5371_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g63710 OS=Arabidopsis thaliana GN=At5g63710 PE=2 SV=1

 Score =  610 bits (1573), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 303/402 (75%), Positives = 353/402 (87%), Gaps = 3/402 (0%)

Query: 3   LAVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLT 62
           L V++S+ KLR +  +ASC A ++L LGA+    + ++R+ K+D+FFDVAGEDD K+S  
Sbjct: 213 LPVTSSKKKLRDITLTASCVASIILFLGAMVMYHHHRVRRTKYDIFFDVAGEDDRKISFG 272

Query: 63  QLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQ 122
           QL+RFS RE+QLATD+F+ESN+IGQGGFGKVY+G+L D TKVAVKRL DY+SPGGEAAFQ
Sbjct: 273 QLKRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLPDKTKVAVKRLADYFSPGGEAAFQ 332

Query: 123 REVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR 182
           RE+ LISVA+HKNLL+LIG+CTTSSERILVYP+M+NLSVAYRLRDLK GE+GLDWPTRKR
Sbjct: 333 REIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENLSVAYRLRDLKAGEEGLDWPTRKR 392

Query: 183 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 242
           VAFG+A+GLEYLHE CNPKIIHRDLKAANILLD+NFE VL DFGLAKLVD  LTHVTTQ+
Sbjct: 393 VAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNNFEPVLGDFGLAKLVDTSLTHVTTQV 452

Query: 243 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL 302
           RGTMGHIAPEYL TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE++LLLDHI+KL
Sbjct: 453 RGTMGHIAPEYLCTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEENILLLDHIKKL 512

Query: 303 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE-DLAERW 361
           LRE RL DIVD NL TYDSKEVET+VQVALLCTQ +PEDRP M++VVKMLQG   LAE+W
Sbjct: 513 LREQRLRDIVDSNLTTYDSKEVETIVQVALLCTQGSPEDRPAMSEVVKMLQGTGGLAEKW 572

Query: 362 AEWEELEEVRQQEVSLLPHQFA-WG-EDSSIDQEAIQLSNAR 401
            EWE+LEEVR +E  LLP   A W  E++++DQE+I+LS AR
Sbjct: 573 TEWEQLEEVRNKEALLLPTLPATWDEEETTVDQESIRLSTAR 614

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT1|Y5129_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g10290 OS=Arabidopsis thaliana GN=At5g10290 PE=1 SV=1

 Score =  540 bits (1392), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 261/396 (65%), Positives = 320/396 (80%), Gaps = 2/396 (0%)

Query: 7   TSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRR 66
           +S+ K  I+    +    VL  +     C+  + +  + DVF DVAGE D +++  QL+R
Sbjct: 219 SSKPKTGIIAGVVAGVTVVLFGILLFLFCK-DRHKGYRRDVFVDVAGEVDRRIAFGQLKR 277

Query: 67  FSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVH 126
           F+ RELQLATDNFSE N++GQGGFGKVYKGVL DNTKVAVKRL D+ SPGG+AAFQREV 
Sbjct: 278 FAWRELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVAVKRLTDFESPGGDAAFQREVE 337

Query: 127 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +ISVA+H+NLL+LIG+CTT +ER+LVYPFMQNLS+A+RLR++K G+  LDW TRKR+A G
Sbjct: 338 MISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRLREIKAGDPVLDWETRKRIALG 397

Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
            A G EYLHE CNPKIIHRD+KAAN+LLD++FEAV+ DFGLAKLVD + T+VTTQ+RGTM
Sbjct: 398 AARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVTTQVRGTM 457

Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 306
           GHIAPEYLSTGKSSE+TDVFGYGI LLELVTGQRAIDFSRLEEE+DVLLLDH++KL RE 
Sbjct: 458 GHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREK 517

Query: 307 RLNDIVDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWE 365
           RL  IVD+NL+  Y  +EVE M+QVALLCTQ +PEDRP M++VV+ML+GE LAERW EW+
Sbjct: 518 RLGAIVDKNLDGEYIKEEVEMMIQVALLCTQGSPEDRPVMSEVVRMLEGEGLAERWEEWQ 577

Query: 366 ELEEVRQQEVSLLPHQFAWGEDSSIDQEAIQLSNAR 401
            +E  R+ E   L  +F WGEDS  +Q+AI+LS  R
Sbjct: 578 NVEVTRRHEFERLQRRFDWGEDSMHNQDAIELSGGR 613

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGX1|Y5524_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g65240 OS=Arabidopsis thaliana GN=At5g65240 PE=2 SV=1

 Score =  536 bits (1382), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 263/392 (67%), Positives = 316/392 (80%), Gaps = 2/392 (0%)

Query: 11  KLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCR 70
           K  I+    S  A +LL     F C+  K +  K DVF DVAGE D +++  QLRRF+ R
Sbjct: 217 KTGIIAGVVSGIAVILLGFFFFFFCK-DKHKGYKRDVFVDVAGEVDRRIAFGQLRRFAWR 275

Query: 71  ELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISV 130
           ELQLATD FSE N++GQGGFGKVYKG+LSD TKVAVKRL D+  PGG+ AFQREV +ISV
Sbjct: 276 ELQLATDEFSEKNVLGQGGFGKVYKGLLSDGTKVAVKRLTDFERPGGDEAFQREVEMISV 335

Query: 131 AIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG 190
           A+H+NLL+LIG+CTT +ER+LVYPFMQNLSVAY LR++KPG+  LDW  RK++A G A G
Sbjct: 336 AVHRNLLRLIGFCTTQTERLLVYPFMQNLSVAYCLREIKPGDPVLDWFRRKQIALGAARG 395

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
           LEYLHE CNPKIIHRD+KAAN+LLD++FEAV+ DFGLAKLVD + T+VTTQ+RGTMGHIA
Sbjct: 396 LEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIA 455

Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 310
           PE +STGKSSEKTDVFGYGI LLELVTGQRAIDFSRLEEE+DVLLLDH++KL RE RL D
Sbjct: 456 PECISTGKSSEKTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLED 515

Query: 311 IVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEE 369
           IVD+ L+  Y  +EVE M+QVALLCTQ+ PE+RP M++VV+ML+GE LAERW EW+ LE 
Sbjct: 516 IVDKKLDEDYIKEEVEMMIQVALLCTQAAPEERPAMSEVVRMLEGEGLAERWEEWQNLEV 575

Query: 370 VRQQEVSLLPHQFAWGEDSSIDQEAIQLSNAR 401
            RQ+E   L  +F WGEDS  +Q+AI+LS  R
Sbjct: 576 TRQEEFQRLQRRFDWGEDSINNQDAIELSGGR 607

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2

 Score =  452 bits (1163), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 217/363 (59%), Positives = 287/363 (79%), Gaps = 3/363 (0%)

Query: 41  RKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSD 100
           R+   D+FFDV  E+D +V L QL+RFS RELQ+A+D FS  NI+G+GGFGKVYKG L+D
Sbjct: 264 RRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKVYKGRLAD 323

Query: 101 NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS 160
            T VAVKRL++  +PGGE  FQ EV +IS+A+H+NLL+L G+C T +ER+LVYP+M N S
Sbjct: 324 GTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 383

Query: 161 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA 220
           VA  LR+  P +  LDWPTRKR+A G+A GL YLH+ C+PKIIHRD+KAANILLD+ FEA
Sbjct: 384 VASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 443

Query: 221 VLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 280
           V+ DFGLAKL+D K THVTT +RGT+GHIAPEYLSTGKSSEKTDVFGYGI LLEL+TGQR
Sbjct: 444 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQR 503

Query: 281 AIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTP 339
           A D +RL  ++DV+LLD ++ LL+E +L  +VD +L T Y+ +E+E ++QVALLCTQ +P
Sbjct: 504 AFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLCTQGSP 563

Query: 340 EDRPPMAQVVKMLQGEDLAERWAEWEELEEVRQQEVSLLPHQFA-WGEDSSIDQEAIQLS 398
            +RP M++VV+ML+G+ LAE+W EW+++E +R +E+ L P+  + W  DS+ +  A++LS
Sbjct: 564 MERPKMSEVVRMLEGDGLAEKWDEWQKVEILR-EEIDLSPNPNSDWILDSTYNLHAVELS 622

Query: 399 NAR 401
             R
Sbjct: 623 GPR 625

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XIC7|SERK2_ARATH Somatic embryogenesis receptor kinase 2 OS=Arabidopsis thaliana GN=SERK2 PE=1 SV=1

 Score =  436 bits (1122), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 214/363 (58%), Positives = 282/363 (77%), Gaps = 3/363 (0%)

Query: 41  RKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSD 100
           R+   + FFDV  E+D +V L QL+RFS RELQ+ATD+FS  NI+G+GGFGKVYKG L+D
Sbjct: 267 RRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLAD 326

Query: 101 NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS 160
            T VAVKRL++  +PGGE  FQ EV +IS+A+H+NLL+L G+C T +ER+LVYP+M N S
Sbjct: 327 GTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 386

Query: 161 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA 220
           VA  LR+  P +  L W  R+++A G+A GL YLH+ C+PKIIHRD+KAANILLD+ FEA
Sbjct: 387 VASCLRERPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEA 446

Query: 221 VLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 280
           V+ DFGLA+L+D K THVTT +RGT+GHIAPEYLSTGKSSEKTDVFGYGI LLEL+TGQR
Sbjct: 447 VVGDFGLARLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQR 506

Query: 281 AIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTP 339
           A D +RL  ++DV+LLD ++ LL+E +L  +VD +L + Y   EVE ++QVALLCTQS+P
Sbjct: 507 AFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQSNYTEAEVEQLIQVALLCTQSSP 566

Query: 340 EDRPPMAQVVKMLQGEDLAERWAEWEELEEVRQQEVSLLPHQFA-WGEDSSIDQEAIQLS 398
            +RP M++VV+ML+G+ LAE+W EW+++E +R QEV L  H  + W  DS+ +  A++LS
Sbjct: 567 MERPKMSEVVRMLEGDGLAEKWDEWQKVEVLR-QEVELSSHPTSDWILDSTDNLHAMELS 625

Query: 399 NAR 401
             R
Sbjct: 626 GPR 628

Serine/threonine-kinase involved in brassinosteroid-dependent and -independent signaling pathways. Acts redundantly with SERK1 as a control point for sporophytic development controlling male gametophyte production.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2

 Score =  433 bits (1113), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 207/333 (62%), Positives = 264/333 (79%), Gaps = 1/333 (0%)

Query: 41  RKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSD 100
           RK   D FFDV  E+D +V L QL+RFS RELQ+A+DNFS  NI+G+GGFGKVYKG L+D
Sbjct: 251 RKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD 310

Query: 101 NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS 160
            T VAVKRL++  + GGE  FQ EV +IS+A+H+NLL+L G+C T +ER+LVYP+M N S
Sbjct: 311 GTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 370

Query: 161 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA 220
           VA  LR+    +  LDWP R+R+A G+A GL YLH+ C+PKIIHRD+KAANILLD+ FEA
Sbjct: 371 VASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 430

Query: 221 VLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 280
           V+ DFGLAKL+D K THVTT +RGT+GHIAPEYLSTGKSSEKTDVFGYG+ LLEL+TGQR
Sbjct: 431 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 490

Query: 281 AIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL-NTYDSKEVETMVQVALLCTQSTP 339
           A D +RL  ++DV+LLD ++ LL+E +L  +VD +L   Y  +EVE ++QVALLCTQS+P
Sbjct: 491 AFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSP 550

Query: 340 EDRPPMAQVVKMLQGEDLAERWAEWEELEEVRQ 372
            +RP M++VV+ML+G+ LAERW EW++ E  RQ
Sbjct: 551 MERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQ 583

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2

 Score =  410 bits (1055), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 194/330 (58%), Positives = 256/330 (77%), Gaps = 1/330 (0%)

Query: 40  LRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLS 99
           LR+   D FFDV  E+D +V L QL+RF+ REL +ATDNFS  N++G+GGFGKVYKG L+
Sbjct: 255 LRRKPQDHFFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLA 314

Query: 100 DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 159
           D   VAVKRL++  + GGE  FQ EV +IS+A+H+NLL+L G+C T +ER+LVYP+M N 
Sbjct: 315 DGNLVAVKRLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 374

Query: 160 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 219
           SVA  LR+   G   LDWP RK +A G+A GL YLH+ C+ KIIHRD+KAANILLD+ FE
Sbjct: 375 SVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFE 434

Query: 220 AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           AV+ DFGLAKL++   +HVTT +RGT+GHIAPEYLSTGKSSEKTDVFGYG+ LLEL+TGQ
Sbjct: 435 AVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 494

Query: 280 RAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL-NTYDSKEVETMVQVALLCTQST 338
           +A D +RL  ++D++LLD ++++L+E +L  +VD  L   Y   EVE ++Q+ALLCTQS+
Sbjct: 495 KAFDLARLANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSS 554

Query: 339 PEDRPPMAQVVKMLQGEDLAERWAEWEELE 368
             +RP M++VV+ML+G+ LAERW EW++ E
Sbjct: 555 AMERPKMSEVVRMLEGDGLAERWEEWQKEE 584

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1

 Score =  397 bits (1019), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 209/404 (51%), Positives = 281/404 (69%), Gaps = 19/404 (4%)

Query: 7   TSRTKLRIVVA-SASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLR 65
           T   K+ +V   S +C   +++  G L    + + R  K  +FFD+  ++  ++ L  LR
Sbjct: 242 TKNRKIAVVFGVSLTCVCLLIIGFGFLL---WWRRRHNKQVLFFDINEQNKEEMCLGNLR 298

Query: 66  RFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREV 125
           RF+ +ELQ AT NFS  N++G+GGFG VYKG L D + +AVKRL+D  + GGE  FQ E+
Sbjct: 299 RFNFKELQSATSNFSSKNLVGKGGFGNVYKGCLHDGSIIAVKRLKDINNGGGEVQFQTEL 358

Query: 126 HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF 185
            +IS+A+H+NLL+L G+CTTSSER+LVYP+M N SVA RL+  KP    LDW TRKR+A 
Sbjct: 359 EMISLAVHRNLLRLYGFCTTSSERLLVYPYMSNGSVASRLK-AKPV---LDWGTRKRIAL 414

Query: 186 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 245
           G   GL YLHEQC+PKIIHRD+KAANILLDD FEAV+ DFGLAKL+D + +HVTT +RGT
Sbjct: 415 GAGRGLLYLHEQCDPKIIHRDVKAANILLDDYFEAVVGDFGLAKLLDHEESHVTTAVRGT 474

Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 305
           +GHIAPEYLSTG+SSEKTDVFG+GI LLEL+TG RA++F +   +    +LD ++KL +E
Sbjct: 475 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGKAANQRGA-ILDWVKKLQQE 533

Query: 306 DRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEW 364
            +L  IVD++L + YD  EVE MVQVALLCTQ  P  RP M++VV+ML+G+ L E+W   
Sbjct: 534 KKLEQIVDKDLKSNYDRIEVEEMVQVALLCTQYLPIHRPKMSEVVRMLEGDGLVEKWEAS 593

Query: 365 EELEEVRQQEVSLLPHQFAWGE-------DSSIDQEAIQLSNAR 401
            +  E  +      P++F+  E       DSS+  +A++LS  R
Sbjct: 594 SQRAETNRSYSK--PNEFSSSERYSDLTDDSSVLVQAMELSGPR 635

Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1

 Score =  393 bits (1010), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 204/383 (53%), Positives = 277/383 (72%), Gaps = 17/383 (4%)

Query: 30  GALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGG 89
           G     RY++ ++    +FFDV  + D +VSL  L+R++ +EL+ AT++F+  NI+G+GG
Sbjct: 256 GMFLWWRYRRNKQ----IFFDVNEQYDPEVSLGHLKRYTFKELRSATNHFNSKNILGRGG 311

Query: 90  FGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 149
           +G VYKG L+D T VAVKRL+D    GGE  FQ EV  IS+A+H+NLL+L G+C+++ ER
Sbjct: 312 YGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSNQER 371

Query: 150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKA 209
           ILVYP+M N SVA RL+D   GE  LDW  RK++A GTA GL YLHEQC+PKIIHRD+KA
Sbjct: 372 ILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKA 431

Query: 210 ANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYG 269
           ANILLD++FEAV+ DFGLAKL+D + +HVTT +RGT+GHIAPEYLSTG+SSEKTDVFG+G
Sbjct: 432 ANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG 491

Query: 270 ITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN-TYDSKEVETMV 328
           I LLEL+TGQ+A+DF R   ++ V +LD ++KL +E +L  ++D++LN  +D  E+E +V
Sbjct: 492 ILLLELITGQKALDFGRSAHQKGV-MLDWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIV 550

Query: 329 QVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEEVRQQEVSLLPHQFA----- 383
           QVALLCTQ  P  RP M++V+KML+G+ LAERW E  +      Q   L P   +     
Sbjct: 551 QVALLCTQFNPSHRPKMSEVMKMLEGDGLAERW-EATQNGTGEHQPPPLPPGMVSSSPRV 609

Query: 384 -----WGEDSSIDQEAIQLSNAR 401
                + ++SS+  EAI+LS  R
Sbjct: 610 RYYSDYIQESSLVVEAIELSGPR 632

Involved in defense response to geminivirus infection.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8LPS5|SERK5_ARATH Somatic embryogenesis receptor kinase 5 OS=Arabidopsis thaliana GN=SERK5 PE=1 SV=2

 Score =  390 bits (1001), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 188/329 (57%), Positives = 252/329 (76%), Gaps = 2/329 (0%)

Query: 41  RKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSD 100
           RKL+   F DV  E+D +V L Q +RFS REL +AT+ FS+ N++G+G FG +YKG L+D
Sbjct: 238 RKLQGH-FLDVPAEEDPEVYLGQFKRFSLRELLVATEKFSKRNVLGKGRFGILYKGRLAD 296

Query: 101 NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS 160
           +T VAVKRL +  + GGE  FQ EV +IS+A+H+NLL+L G+C T +ER+LVYP+M N S
Sbjct: 297 DTLVAVKRLNEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 356

Query: 161 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA 220
           VA  LR+   G   LDWP RK +A G+A GL YLH+ C+ KIIH D+KAANILLD+ FEA
Sbjct: 357 VASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHLDVKAANILLDEEFEA 416

Query: 221 VLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 280
           V+ DFGLAKL++   +HVTT +RGT+GHIAPEYLSTGKSSEKTDVFGYG+ LLEL+TGQ+
Sbjct: 417 VVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQK 476

Query: 281 AIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL-NTYDSKEVETMVQVALLCTQSTP 339
           A D +RL  ++D++LLD ++++L+E +L  +VD  L   Y   EVE ++Q+ALLCTQS+ 
Sbjct: 477 AFDLARLANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSA 536

Query: 340 EDRPPMAQVVKMLQGEDLAERWAEWEELE 368
            +RP M++VV+ML+G+ LAERW EW++ E
Sbjct: 537 MERPKMSEVVRMLEGDGLAERWEEWQKEE 565

Serine/threonine-kinase of unknown function.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	401
356527105	595	PREDICTED: probable LRR receptor-like se	0.987	0.665	0.775	0.0
356512884	596	PREDICTED: probable LRR receptor-like se	0.987	0.664	0.773	0.0
357520193	597	Plasma membrane receptor-like kinase [Me	0.987	0.663	0.763	0.0
359480667	621	PREDICTED: probable LRR receptor-like se	0.995	0.642	0.794	1e-180
224126743	595	predicted protein [Populus trichocarpa]	0.995	0.670	0.79	1e-179
255568877	598	ATP binding protein, putative [Ricinus c	0.985	0.660	0.765	1e-179
224060473	594	predicted protein [Populus trichocarpa]	0.995	0.671	0.791	1e-178
10177052	579	receptor-like protein kinase [Arabidopsi	0.995	0.689	0.753	1e-172
297793957	614	hypothetical protein ARALYDRAFT_496559 [	0.995	0.649	0.756	1e-172
18424740	614	Leucine-rich repeat protein kinase famil	0.995	0.649	0.753	1e-172

>gi|356527105|ref|XP_003532154.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g63710-like [Glycine max]

 Score =  645 bits (1665), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 307/396 (77%), Positives = 352/396 (88%)

Query: 6   STSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLR 65
           S  ++KL  +V  ASCGAF LL LGA+F  R  +  + K DVF DV+GED+ K+S  QLR
Sbjct: 200 SAHKSKLAKIVRYASCGAFALLCLGAIFTYRQHQKHRRKIDVFVDVSGEDERKISFGQLR 259

Query: 66  RFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREV 125
           RFS RELQLAT NFSE N+IGQGGFGKVYKGVLSDNTKVAVKRL DY++PGGEAAF+REV
Sbjct: 260 RFSWRELQLATKNFSEGNVIGQGGFGKVYKGVLSDNTKVAVKRLIDYHNPGGEAAFEREV 319

Query: 126 HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF 185
            LISVA+H+NLL+LIG+CTT++ERILVYPFM+NLSVAYRLRDLKPGEKGLDWPTRKRVAF
Sbjct: 320 QLISVAVHRNLLRLIGFCTTTTERILVYPFMENLSVAYRLRDLKPGEKGLDWPTRKRVAF 379

Query: 186 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 245
           GTA+GLEYLHEQCNPKIIHRDLKAANILLDD FEAVL DFGLAKLVDA++THVTTQ+RGT
Sbjct: 380 GTAHGLEYLHEQCNPKIIHRDLKAANILLDDEFEAVLGDFGLAKLVDARMTHVTTQVRGT 439

Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 305
           MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG+RA+D SRLEE+EDVLL+D+++KLLRE
Sbjct: 440 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGERALDLSRLEEDEDVLLIDYVKKLLRE 499

Query: 306 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWE 365
            RL DIVDRNL +YD KEVET++QVALLCTQ  PEDRP M++VVKMLQG  LA+RWA+W+
Sbjct: 500 KRLEDIVDRNLESYDPKEVETILQVALLCTQGYPEDRPTMSEVVKMLQGVGLADRWADWQ 559

Query: 366 ELEEVRQQEVSLLPHQFAWGEDSSIDQEAIQLSNAR 401
           +LEE R QE SL+ HQF W ++S++DQEAIQLS AR
Sbjct: 560 QLEEARNQEFSLMTHQFVWNDESTLDQEAIQLSRAR 595

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356512884|ref|XP_003525144.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g63710-like [Glycine max]

 Score =  642 bits (1656), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 307/397 (77%), Positives = 351/397 (88%), Gaps = 1/397 (0%)

Query: 6   STSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHD-VFFDVAGEDDCKVSLTQL 64
           S  ++KL  +V  ASCGAF LL LGA+F  R+ +    K D VF DV+GED+ K+   QL
Sbjct: 200 SAHKSKLAKIVRYASCGAFALLCLGAIFTYRHHRKHWRKSDDVFVDVSGEDESKIFFGQL 259

Query: 65  RRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQRE 124
           RRFS RELQLAT NFSE N+IGQGGFGKVYKGVLSDNTKVAVKRL DY++PGGEAAF+RE
Sbjct: 260 RRFSWRELQLATKNFSEGNVIGQGGFGKVYKGVLSDNTKVAVKRLIDYHNPGGEAAFERE 319

Query: 125 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVA 184
           V LISVA+H+NLL+LIG+CTT++ERILVYPFM+NLSVAYRLRDLKPGEKGLDWPTRKRVA
Sbjct: 320 VQLISVAVHRNLLRLIGFCTTTTERILVYPFMENLSVAYRLRDLKPGEKGLDWPTRKRVA 379

Query: 185 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG 244
           FGTA+GLEYLHEQCNPKIIHRDLKAANILLDD FEAVL DFGLAKLVDA++THVTTQ+RG
Sbjct: 380 FGTAHGLEYLHEQCNPKIIHRDLKAANILLDDEFEAVLGDFGLAKLVDARMTHVTTQVRG 439

Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 304
           TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG+RAID SRLEE+EDVLL+D+++KLLR
Sbjct: 440 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGERAIDLSRLEEDEDVLLIDYVKKLLR 499

Query: 305 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEW 364
           E RL DIVDRNL +YD KEVET++QVALLCTQ  PEDRP M++VVKMLQG  LA+RWA+W
Sbjct: 500 EKRLEDIVDRNLESYDPKEVETILQVALLCTQGYPEDRPTMSEVVKMLQGVGLADRWADW 559

Query: 365 EELEEVRQQEVSLLPHQFAWGEDSSIDQEAIQLSNAR 401
           ++LEE R QE SL+ HQF W ++S++DQEAIQLS AR
Sbjct: 560 QQLEEARNQEFSLMTHQFVWNDESTLDQEAIQLSRAR 596

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357520193|ref|XP_003630385.1| Plasma membrane receptor-like kinase [Medicago truncatula] gi|194441092|gb|ACF70844.1| plasma membrane receptor-like kinase [Medicago truncatula] gi|355524407|gb|AET04861.1| Plasma membrane receptor-like kinase [Medicago truncatula]

 Score =  639 bits (1648), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 304/398 (76%), Positives = 351/398 (88%), Gaps = 2/398 (0%)

Query: 6   STSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLR 65
           ST+++KL   +  ASCGAFVLL LGA+F  R+ +  + K DVF DV GED+ K+S  QLR
Sbjct: 200 STNKSKLAKAMPYASCGAFVLLCLGAIFTYRHHQKIRHKSDVFVDVLGEDESKISFGQLR 259

Query: 66  RFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREV 125
           RFS RELQLAT +FSESN+IGQGGFGKVYKGVLSDNTK+AVKRL DY++PGGEAAF+REV
Sbjct: 260 RFSLRELQLATKSFSESNVIGQGGFGKVYKGVLSDNTKIAVKRLTDYHNPGGEAAFEREV 319

Query: 126 HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF 185
            LISVA+H+NLL+LIG+CTTS+ERILVYPFM+NLSVAY+LRDLK  EKGLDWPTRKRVAF
Sbjct: 320 DLISVAVHRNLLRLIGFCTTSTERILVYPFMENLSVAYQLRDLKSDEKGLDWPTRKRVAF 379

Query: 186 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 245
           GTA+GLEYLHEQCNPKIIHRDLKAANILLDD FE VL DFGLAKLVDA++THVTTQ+RGT
Sbjct: 380 GTAHGLEYLHEQCNPKIIHRDLKAANILLDDEFEPVLGDFGLAKLVDARMTHVTTQVRGT 439

Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 305
           MGHIAPEYLSTGKSSEKTDVFGYGITLLEL+TGQRAID SRLEEEEDVLL+DH++ L+RE
Sbjct: 440 MGHIAPEYLSTGKSSEKTDVFGYGITLLELITGQRAIDLSRLEEEEDVLLIDHVKNLIRE 499

Query: 306 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWE 365
           +RL DIVD NL TYD KE ET++QVALLCTQ  PEDRP M++VVKMLQG  LA+RWA+W+
Sbjct: 500 NRLEDIVDNNLETYDPKEAETILQVALLCTQGYPEDRPTMSEVVKMLQGVGLADRWADWK 559

Query: 366 ELEEVRQQEV--SLLPHQFAWGEDSSIDQEAIQLSNAR 401
           +LEE R QE+  SL+ HQF W ++S++DQEAIQLS AR
Sbjct: 560 QLEEARNQEIELSLMTHQFPWSDESTLDQEAIQLSRAR 597

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359480667|ref|XP_002272767.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At5g63710-like [Vitis vinifera]

 Score =  638 bits (1646), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 317/399 (79%), Positives = 351/399 (87%)

Query: 3   LAVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLT 62
           + VST ++KLR+V   A C AF+LLSLGA+FA RY    K+K DVF DV GED+CK+S  
Sbjct: 223 IPVSTKKSKLRVVTPVAICAAFILLSLGAIFAYRYCYAHKIKRDVFHDVTGEDECKISFG 282

Query: 63  QLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQ 122
           Q+RRFS  ELQLATD FSESNIIGQGGFGKVY+GVL + TKVAVKRL DY++PGGEAAFQ
Sbjct: 283 QVRRFSWHELQLATDEFSESNIIGQGGFGKVYRGVLPNGTKVAVKRLSDYHNPGGEAAFQ 342

Query: 123 REVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR 182
           REV LISVA+HKNLL+LIG+CTT +ERILVYPFMQNLSVAYRLRDLKPGE+GLDWPTR++
Sbjct: 343 REVQLISVAVHKNLLRLIGFCTTFNERILVYPFMQNLSVAYRLRDLKPGERGLDWPTRRK 402

Query: 183 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 242
           VAFG A+GLEYLHE CNPKIIHRDLKAANILLDD+FE VL DFGLAKL+D KLTHVTTQ+
Sbjct: 403 VAFGAAHGLEYLHEHCNPKIIHRDLKAANILLDDDFEPVLGDFGLAKLLDTKLTHVTTQV 462

Query: 243 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL 302
           RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL
Sbjct: 463 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL 522

Query: 303 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWA 362
            RE RL+ IVDRNL T+D+KEVET+VQVALLCTQS+PEDRP MA+VV MLQGE LA RW 
Sbjct: 523 QREKRLDAIVDRNLKTFDAKEVETIVQVALLCTQSSPEDRPKMAEVVSMLQGEGLAARWV 582

Query: 363 EWEELEEVRQQEVSLLPHQFAWGEDSSIDQEAIQLSNAR 401
           EWE LEEVR Q  SLL HQF W ++S+ DQEAIQLS AR
Sbjct: 583 EWERLEEVRNQHFSLLSHQFPWADESTHDQEAIQLSKAR 621

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224126743|ref|XP_002329462.1| predicted protein [Populus trichocarpa] gi|222870142|gb|EEF07273.1| predicted protein [Populus trichocarpa]

 Score =  633 bits (1633), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 316/400 (79%), Positives = 355/400 (88%), Gaps = 1/400 (0%)

Query: 3   LAVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLT 62
           L VSTS+++L+++  SASCGAF+LL L A+ A RY +  K K+D+F DVAGEDD K++  
Sbjct: 196 LRVSTSKSRLKVIATSASCGAFILLILVAVLAYRYHQFHKEKNDIFVDVAGEDDRKITFG 255

Query: 63  QLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQ 122
           QLRRFS RELQLATDNFSESNIIGQGG GKVYKG+LSDN KVAVKRL DYYSPGGEAAFQ
Sbjct: 256 QLRRFSWRELQLATDNFSESNIIGQGGCGKVYKGILSDNMKVAVKRLADYYSPGGEAAFQ 315

Query: 123 REVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR 182
           REV LISVA HKNLL+L+G+CTTSSERILVYP+MQNLSVAYRLR+LKPGEKGLDWPTRK+
Sbjct: 316 REVQLISVAFHKNLLKLVGFCTTSSERILVYPYMQNLSVAYRLRELKPGEKGLDWPTRKK 375

Query: 183 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 242
           +AFG A+GLEYLHE CNPKIIHRDLKAANILLDDNFEAVL DFGLAKLVD K THVTTQ+
Sbjct: 376 IAFGAAHGLEYLHEHCNPKIIHRDLKAANILLDDNFEAVLGDFGLAKLVDTKFTHVTTQV 435

Query: 243 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL 302
           RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID SRLEEEE+VLLLDHI+KL
Sbjct: 436 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDLSRLEEEEEVLLLDHIKKL 495

Query: 303 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWA 362
           LRE+RL+DIVD NL TYD KEVET+VQVALLCT S+PE RP M +VVKML+G  LAERWA
Sbjct: 496 LRENRLDDIVDGNLKTYDRKEVETIVQVALLCTNSSPEGRPKMEEVVKMLRGIGLAERWA 555

Query: 363 EWEELEEVRQQEVS-LLPHQFAWGEDSSIDQEAIQLSNAR 401
           +WE+LE+   Q+++ L+  Q+ W EDSSIDQEAIQLS AR
Sbjct: 556 KWEQLEDAMNQDLAVLMSQQYIWAEDSSIDQEAIQLSRAR 595

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255568877|ref|XP_002525409.1| ATP binding protein, putative [Ricinus communis] gi|223535300|gb|EEF36976.1| ATP binding protein, putative [Ricinus communis]

 Score =  633 bits (1632), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 304/397 (76%), Positives = 348/397 (87%), Gaps = 2/397 (0%)

Query: 5   VSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQL 64
           VS ++++L I+V +ASCGAF+L  LG  FA R+ +LR+LK+DVF DVAGEDD K+SL Q+
Sbjct: 204 VSPNKSRLSIIVIAASCGAFILFLLG--FAYRHHRLRRLKNDVFVDVAGEDDRKISLGQI 261

Query: 65  RRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQRE 124
           +RFS RE+QLATDNFS+SNIIGQGGFGKVYKGVLSDNTKVAVKRL D Y PGGEAAF RE
Sbjct: 262 KRFSWREIQLATDNFSDSNIIGQGGFGKVYKGVLSDNTKVAVKRLSDCYIPGGEAAFHRE 321

Query: 125 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVA 184
           V +ISVA+H+NLL+LIG+CTTSSERILVYP+MQNLSVA+ LR+LKPGE GLDW TR+RVA
Sbjct: 322 VQIISVAVHRNLLRLIGFCTTSSERILVYPYMQNLSVAFHLRELKPGETGLDWQTRRRVA 381

Query: 185 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG 244
           FG A+GLEYLHE CNPKIIHRDLKAANILLDDNFEAVL DFGLA+LVD KLTHVTTQIRG
Sbjct: 382 FGAAHGLEYLHEHCNPKIIHRDLKAANILLDDNFEAVLGDFGLARLVDTKLTHVTTQIRG 441

Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 304
           TMGHIAPEYLSTGKSSEKTDVFGYG+TLLELV G+RAID SRL EEEDVLLLDH +KLLR
Sbjct: 442 TMGHIAPEYLSTGKSSEKTDVFGYGVTLLELVNGKRAIDLSRLAEEEDVLLLDHAKKLLR 501

Query: 305 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEW 364
           E+RL+DIVD NL TYD KEVET+V+VALLCTQS+PE RP M++VVK+L G  L ERW EW
Sbjct: 502 ENRLDDIVDGNLKTYDRKEVETLVKVALLCTQSSPECRPRMSEVVKLLHGVGLTERWIEW 561

Query: 365 EELEEVRQQEVSLLPHQFAWGEDSSIDQEAIQLSNAR 401
           E LE+ R Q+ SL+  Q+ W EDS++DQEAI LS AR
Sbjct: 562 ERLEDARNQDFSLMSCQYLWAEDSTVDQEAIHLSKAR 598

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224060473|ref|XP_002300217.1| predicted protein [Populus trichocarpa] gi|222847475|gb|EEE85022.1| predicted protein [Populus trichocarpa]

 Score =  629 bits (1622), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 316/399 (79%), Positives = 350/399 (87%)

Query: 3   LAVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLT 62
           L VST + +L+++ ASASCGAF LL L  + A RYQ+  K K+D+F DV+GEDD K+S  
Sbjct: 196 LPVSTRKLRLKVIAASASCGAFGLLILLVVLAYRYQQFHKEKNDIFVDVSGEDDRKISFG 255

Query: 63  QLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQ 122
           QLRRFS RELQLATDNFSESNIIGQGGFGKVYKG++SDN KVAVKRL+DYYSPGG+AAF 
Sbjct: 256 QLRRFSWRELQLATDNFSESNIIGQGGFGKVYKGIISDNMKVAVKRLEDYYSPGGKAAFL 315

Query: 123 REVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR 182
           REV LISVA HKNLL+LIG+CTTSSERILVYP+MQNLSVAY LRDLKPGEKGLDWPTRKR
Sbjct: 316 REVQLISVAAHKNLLRLIGFCTTSSERILVYPYMQNLSVAYHLRDLKPGEKGLDWPTRKR 375

Query: 183 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 242
           +AFG A+GLEYLHE CNPKIIHRDLKAANILLDDNFE VL DFGLAKLVD K TH+TTQ+
Sbjct: 376 IAFGAAHGLEYLHEHCNPKIIHRDLKAANILLDDNFEPVLGDFGLAKLVDTKFTHITTQV 435

Query: 243 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL 302
           RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID SRLEEEEDVLLLD+I+KL
Sbjct: 436 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDLSRLEEEEDVLLLDYIKKL 495

Query: 303 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWA 362
           LRE+RL+D+VD NL TYD KEVET+VQVALLCTQS+PE RP MA VVKMLQG  LAERWA
Sbjct: 496 LRENRLDDVVDGNLETYDRKEVETIVQVALLCTQSSPEGRPTMAGVVKMLQGIGLAERWA 555

Query: 363 EWEELEEVRQQEVSLLPHQFAWGEDSSIDQEAIQLSNAR 401
           + E+  + R QE SL+  Q+ W EDSSIDQEAIQLS AR
Sbjct: 556 KREQHGDARNQEFSLMSQQYIWSEDSSIDQEAIQLSKAR 594

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|10177052|dbj|BAB10464.1| receptor-like protein kinase [Arabidopsis thaliana]

 Score =  611 bits (1576), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 303/402 (75%), Positives = 353/402 (87%), Gaps = 3/402 (0%)

Query: 3   LAVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLT 62
           L V++S+ KLR +  +ASC A ++L LGA+    + ++R+ K+D+FFDVAGEDD K+S  
Sbjct: 178 LPVTSSKKKLRDITLTASCVASIILFLGAMVMYHHHRVRRTKYDIFFDVAGEDDRKISFG 237

Query: 63  QLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQ 122
           QL+RFS RE+QLATD+F+ESN+IGQGGFGKVY+G+L D TKVAVKRL DY+SPGGEAAFQ
Sbjct: 238 QLKRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLPDKTKVAVKRLADYFSPGGEAAFQ 297

Query: 123 REVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR 182
           RE+ LISVA+HKNLL+LIG+CTTSSERILVYP+M+NLSVAYRLRDLK GE+GLDWPTRKR
Sbjct: 298 REIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENLSVAYRLRDLKAGEEGLDWPTRKR 357

Query: 183 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 242
           VAFG+A+GLEYLHE CNPKIIHRDLKAANILLD+NFE VL DFGLAKLVD  LTHVTTQ+
Sbjct: 358 VAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNNFEPVLGDFGLAKLVDTSLTHVTTQV 417

Query: 243 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL 302
           RGTMGHIAPEYL TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE++LLLDHI+KL
Sbjct: 418 RGTMGHIAPEYLCTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEENILLLDHIKKL 477

Query: 303 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE-DLAERW 361
           LRE RL DIVD NL TYDSKEVET+VQVALLCTQ +PEDRP M++VVKMLQG   LAE+W
Sbjct: 478 LREQRLRDIVDSNLTTYDSKEVETIVQVALLCTQGSPEDRPAMSEVVKMLQGTGGLAEKW 537

Query: 362 AEWEELEEVRQQEVSLLPHQFA-WG-EDSSIDQEAIQLSNAR 401
            EWE+LEEVR +E  LLP   A W  E++++DQE+I+LS AR
Sbjct: 538 TEWEQLEEVRNKEALLLPTLPATWDEEETTVDQESIRLSTAR 579

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297793957|ref|XP_002864863.1| hypothetical protein ARALYDRAFT_496559 [Arabidopsis lyrata subsp. lyrata] gi|297310698|gb|EFH41122.1| hypothetical protein ARALYDRAFT_496559 [Arabidopsis lyrata subsp. lyrata]

 Score =  610 bits (1573), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 304/402 (75%), Positives = 353/402 (87%), Gaps = 3/402 (0%)

Query: 3   LAVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLT 62
           L V++S+ KLR +  +ASC A ++L LGA+    + ++R+ K+D+FFDVAGEDD K+S  
Sbjct: 213 LPVTSSKKKLRDITLTASCVASIILFLGAMVMYHHHRVRQTKYDIFFDVAGEDDRKISFG 272

Query: 63  QLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQ 122
           QLRRFS RE+QLATD+F+ESN+IGQGGFGKVY+G+L D TKVAVKRL DY+SPGGEAAFQ
Sbjct: 273 QLRRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLPDKTKVAVKRLADYFSPGGEAAFQ 332

Query: 123 REVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR 182
           RE+ LISVA+HKNLL+LIG+CTTSSERILVYP+M+NLSVAYRLRDLK GE+GLDWPTRKR
Sbjct: 333 REIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENLSVAYRLRDLKAGEEGLDWPTRKR 392

Query: 183 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 242
           VAFG+A+GLEYLHE CNPKIIHRDLKAANILLD+NFE VL DFGLAKLVD  LTHVTTQ+
Sbjct: 393 VAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNNFEPVLGDFGLAKLVDTSLTHVTTQV 452

Query: 243 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL 302
           RGTMGHIAPEYL TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE++LLLDHI+KL
Sbjct: 453 RGTMGHIAPEYLCTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEENILLLDHIKKL 512

Query: 303 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE-DLAERW 361
           LRE RL DIVD NL TYDSKEVET+VQVALLCTQ +PEDRP M++VVKMLQG   LAE+W
Sbjct: 513 LREQRLRDIVDSNLTTYDSKEVETIVQVALLCTQGSPEDRPAMSEVVKMLQGTGGLAEKW 572

Query: 362 AEWEELEEVRQQEVSLLPHQFA-WG-EDSSIDQEAIQLSNAR 401
            EWE+LEEVR +E  LLP   A W  E++++DQE+I+LS AR
Sbjct: 573 TEWEQLEEVRNKEALLLPTLPATWDEEETTVDQESIRLSAAR 614

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|18424740|ref|NP_568977.1| Leucine-rich repeat protein kinase family protein [Arabidopsis thaliana] gi|75331406|sp|Q8W4S5.1|Y5371_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At5g63710; Flags: Precursor gi|16974577|gb|AAL31184.1| AT5g63710/MBK5_19 [Arabidopsis thaliana] gi|22655394|gb|AAM98289.1| At5g63710/MBK5_19 [Arabidopsis thaliana] gi|224589745|gb|ACN59404.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332010405|gb|AED97788.1| Leucine-rich repeat protein kinase family protein [Arabidopsis thaliana]

 Score =  610 bits (1573), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 303/402 (75%), Positives = 353/402 (87%), Gaps = 3/402 (0%)

Query: 3   LAVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLT 62
           L V++S+ KLR +  +ASC A ++L LGA+    + ++R+ K+D+FFDVAGEDD K+S  
Sbjct: 213 LPVTSSKKKLRDITLTASCVASIILFLGAMVMYHHHRVRRTKYDIFFDVAGEDDRKISFG 272

Query: 63  QLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQ 122
           QL+RFS RE+QLATD+F+ESN+IGQGGFGKVY+G+L D TKVAVKRL DY+SPGGEAAFQ
Sbjct: 273 QLKRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLPDKTKVAVKRLADYFSPGGEAAFQ 332

Query: 123 REVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR 182
           RE+ LISVA+HKNLL+LIG+CTTSSERILVYP+M+NLSVAYRLRDLK GE+GLDWPTRKR
Sbjct: 333 REIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENLSVAYRLRDLKAGEEGLDWPTRKR 392

Query: 183 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 242
           VAFG+A+GLEYLHE CNPKIIHRDLKAANILLD+NFE VL DFGLAKLVD  LTHVTTQ+
Sbjct: 393 VAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNNFEPVLGDFGLAKLVDTSLTHVTTQV 452

Query: 243 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL 302
           RGTMGHIAPEYL TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE++LLLDHI+KL
Sbjct: 453 RGTMGHIAPEYLCTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEENILLLDHIKKL 512

Query: 303 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE-DLAERW 361
           LRE RL DIVD NL TYDSKEVET+VQVALLCTQ +PEDRP M++VVKMLQG   LAE+W
Sbjct: 513 LREQRLRDIVDSNLTTYDSKEVETIVQVALLCTQGSPEDRPAMSEVVKMLQGTGGLAEKW 572

Query: 362 AEWEELEEVRQQEVSLLPHQFA-WG-EDSSIDQEAIQLSNAR 401
            EWE+LEEVR +E  LLP   A W  E++++DQE+I+LS AR
Sbjct: 573 TEWEQLEEVRNKEALLLPTLPATWDEEETTVDQESIRLSTAR 614

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	401
TAIR|locus:2160644	614	AT5G63710 [Arabidopsis thalian	0.995	0.649	0.699	5.1e-145
TAIR|locus:2145407	613	AT5G10290 [Arabidopsis thalian	0.965	0.631	0.621	6.3e-124
TAIR|locus:2013021	625	SERK1 "somatic embryogenesis r	0.957	0.614	0.532	7.7e-103
TAIR|locus:2026097	628	SERK2 "somatic embryogenesis r	0.957	0.611	0.526	1e-98
TAIR|locus:2040461	620	SERK4 "somatic embryogenesis r	0.845	0.546	0.540	1.1e-94
TAIR|locus:2036636	632	NIK3 "NSP-interacting kinase 3	0.832	0.528	0.555	1.4e-94
TAIR|locus:2146102	638	NIK1 "NSP-interacting kinase 1	0.860	0.540	0.540	2.5e-90
TAIR|locus:2040471	601	SERK5 "somatic embryogenesis r	0.840	0.560	0.535	3.1e-90
TAIR|locus:2118811	648	SARK "SENESCENCE-ASSOCIATED RE	0.865	0.535	0.532	5.9e-89
TAIR|locus:2061466	634	AT2G23950 [Arabidopsis thalian	0.860	0.544	0.535	7.5e-89

TAIR|locus:2160644 AT5G63710 [Arabidopsis thaliana (taxid:3702)]

 Score = 1417 (503.9 bits), Expect = 5.1e-145, P = 5.1e-145
 Identities = 281/402 (69%), Positives = 327/402 (81%)

Query:     3 LAVSTSRTKLRIVVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLT 62
             L V++S+ KLR +  +ASC A ++L LGA+    + ++R+ K+D+FFDVAGEDD K+S  
Sbjct:   213 LPVTSSKKKLRDITLTASCVASIILFLGAMVMYHHHRVRRTKYDIFFDVAGEDDRKISFG 272

Query:    63 QLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQ 122
             QL+RFS RE+QLATD+F+ESN+IGQGGFGKVY+G+L D TKVAVKRL DY+SPGGEAAFQ
Sbjct:   273 QLKRFSLREIQLATDSFNESNLIGQGGFGKVYRGLLPDKTKVAVKRLADYFSPGGEAAFQ 332

Query:   123 REVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR 182
             RE+ LISVA+HKNLL+LIG+CTTSSERILVYP+M+NLSVAYRLRDLK GE+GLDWPTRKR
Sbjct:   333 REIQLISVAVHKNLLRLIGFCTTSSERILVYPYMENLSVAYRLRDLKAGEEGLDWPTRKR 392

Query:   183 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 242
             VAFG+A+GLEYLHE CNPKIIHRDLKAANILLD+NFE VL DFGLAKLVD  LTHVTTQ+
Sbjct:   393 VAFGSAHGLEYLHEHCNPKIIHRDLKAANILLDNNFEPVLGDFGLAKLVDTSLTHVTTQV 452

Query:   243 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKL 302
             RGTMGHIAPEYL TGKSSEKTDVFGYGITLLELVTGQRAIDFSR           HI+KL
Sbjct:   453 RGTMGHIAPEYLCTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEENILLLDHIKKL 512

Query:   303 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDXXXXXX 362
             LRE RL DIVD NL TYDSKEVET+VQVALLCTQ +PEDRP M++VVKMLQG        
Sbjct:   513 LREQRLRDIVDSNLTTYDSKEVETIVQVALLCTQGSPEDRPAMSEVVKMLQGTGGLAEKW 572

Query:   363 XXXXXXXXXXXXXSLL-PHQFA-WGED-SSIDQEAIQLSNAR 401
                          +LL P   A W E+ +++DQE+I+LS AR
Sbjct:   573 TEWEQLEEVRNKEALLLPTLPATWDEEETTVDQESIRLSTAR 614

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

TAIR|locus:2145407 AT5G10290 [Arabidopsis thaliana (taxid:3702)]

 Score = 1218 (433.8 bits), Expect = 6.3e-124, P = 6.3e-124
 Identities = 241/388 (62%), Positives = 293/388 (75%)

Query:    15 VVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQL 74
             ++A    G  V+L    LF     + +  + DVF DVAGE D +++  QL+RF+ RELQL
Sbjct:   226 IIAGVVAGVTVVLFGILLFLFCKDRHKGYRRDVFVDVAGEVDRRIAFGQLKRFAWRELQL 285

Query:    75 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 134
             ATDNFSE N++GQGGFGKVYKGVL DNTKVAVKRL D+ SPGG+AAFQREV +ISVA+H+
Sbjct:   286 ATDNFSEKNVLGQGGFGKVYKGVLPDNTKVAVKRLTDFESPGGDAAFQREVEMISVAVHR 345

Query:   135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
             NLL+LIG+CTT +ER+LVYPFMQNLS+A+RLR++K G+  LDW TRKR+A G A G EYL
Sbjct:   346 NLLRLIGFCTTQTERLLVYPFMQNLSLAHRLREIKAGDPVLDWETRKRIALGAARGFEYL 405

Query:   195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 254
             HE CNPKIIHRD+KAAN+LLD++FEAV+ DFGLAKLVD + T+VTTQ+RGTMGHIAPEYL
Sbjct:   406 HEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPEYL 465

Query:   255 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDR 314
             STGKSSE+TDVFGYGI LLELVTGQRAIDFSR           H++KL RE RL  IVD+
Sbjct:   466 STGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLGAIVDK 525

Query:   315 NLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDXXXXXXXXXXXXXXXXX 373
             NL+  Y  +EVE M+QVALLCTQ +PEDRP M++VV+ML+GE                  
Sbjct:   526 NLDGEYIKEEVEMMIQVALLCTQGSPEDRPVMSEVVRMLEGEGLAERWEEWQNVEVTRRH 585

Query:   374 XXSLLPHQFAWGEDSSIDQEAIQLSNAR 401
                 L  +F WGEDS  +Q+AI+LS  R
Sbjct:   586 EFERLQRRFDWGEDSMHNQDAIELSGGR 613

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1019 (363.8 bits), Expect = 7.7e-103, P = 7.7e-103
 Identities = 207/389 (53%), Positives = 274/389 (70%)

Query:    15 VVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQL 74
             +    + GA +L +  A+    +++ + L  D+FFDV  E+D +V L QL+RFS RELQ+
Sbjct:   240 IAGGVAAGAALLFAAPAIAFAWWRRRKPL--DIFFDVPAEEDPEVHLGQLKRFSLRELQV 297

Query:    75 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 134
             A+D FS  NI+G+GGFGKVYKG L+D T VAVKRL++  +PGGE  FQ EV +IS+A+H+
Sbjct:   298 ASDGFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 357

Query:   135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
             NLL+L G+C T +ER+LVYP+M N SVA  LR+  P +  LDWPTRKR+A G+A GL YL
Sbjct:   358 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYL 417

Query:   195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 254
             H+ C+PKIIHRD+KAANILLD+ FEAV+ DFGLAKL+D K THVTT +RGT+GHIAPEYL
Sbjct:   418 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL 477

Query:   255 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDR 314
             STGKSSEKTDVFGYGI LLEL+TGQRA D +R            ++ LL+E +L  +VD 
Sbjct:   478 STGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 537

Query:   315 NLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDXXXXXXXXXXXXXXXXX 373
             +L T Y+ +E+E ++QVALLCTQ +P +RP M++VV+ML+G D                 
Sbjct:   538 DLQTNYEERELEQVIQVALLCTQGSPMERPKMSEVVRMLEG-DGLAEKWDEWQKVEILRE 596

Query:   374 XXSLLPHQFA-WGEDSSIDQEAIQLSNAR 401
                L P+  + W  DS+ +  A++LS  R
Sbjct:   597 EIDLSPNPNSDWILDSTYNLHAVELSGPR 625

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0042802 "identical protein binding" evidence=IPI

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=IDA

GO:0009793 "embryo development ending in seed dormancy" evidence=RCA;IMP

GO:0005515 "protein binding" evidence=IPI

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=TAS

GO:0009556 "microsporogenesis" evidence=IGI;IMP

GO:0010152 "pollen maturation" evidence=IMP

GO:0043234 "protein complex" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI;IMP

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0007030 "Golgi organization" evidence=IGI

GO:0010227 "floral organ abscission" evidence=IGI

GO:0000226 "microtubule cytoskeleton organization" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0007062 "sister chromatid cohesion" evidence=RCA

GO:0009880 "embryonic pattern specification" evidence=RCA

GO:0010072 "primary shoot apical meristem specification" evidence=RCA

GO:0010228 "vegetative to reproductive phase transition of meristem" evidence=RCA

GO:0010431 "seed maturation" evidence=RCA

GO:0016310 "phosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0045595 "regulation of cell differentiation" evidence=RCA

GO:0051301 "cell division" evidence=RCA

TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 980 (350.0 bits), Expect = 1.0e-98, P = 1.0e-98
 Identities = 205/389 (52%), Positives = 269/389 (69%)

Query:    15 VVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQL 74
             +    + GA +L +  AL A  + + RK   + FFDV  E+D +V L QL+RFS RELQ+
Sbjct:   243 IAGGVAAGAALLFAAPAL-AFAWWRRRK-PQEFFFDVPAEEDPEVHLGQLKRFSLRELQV 300

Query:    75 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 134
             ATD+FS  NI+G+GGFGKVYKG L+D T VAVKRL++  +PGGE  FQ EV +IS+A+H+
Sbjct:   301 ATDSFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 360

Query:   135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
             NLL+L G+C T +ER+LVYP+M N SVA  LR+  P +  L W  R+++A G+A GL YL
Sbjct:   361 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLAWSIRQQIALGSARGLSYL 420

Query:   195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 254
             H+ C+PKIIHRD+KAANILLD+ FEAV+ DFGLA+L+D K THVTT +RGT+GHIAPEYL
Sbjct:   421 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLARLMDYKDTHVTTAVRGTIGHIAPEYL 480

Query:   255 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDR 314
             STGKSSEKTDVFGYGI LLEL+TGQRA D +R            ++ LL+E +L  +VD 
Sbjct:   481 STGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDP 540

Query:   315 NLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDXXXXXXXXXXXXXXXXX 373
             +L + Y   EVE ++QVALLCTQS+P +RP M++VV+ML+G D                 
Sbjct:   541 DLQSNYTEAEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG-DGLAEKWDEWQKVEVLRQ 599

Query:   374 XXSLLPHQFA-WGEDSSIDQEAIQLSNAR 401
                L  H  + W  DS+ +  A++LS  R
Sbjct:   600 EVELSSHPTSDWILDSTDNLHAMELSGPR 628

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009556 "microsporogenesis" evidence=IGI;IMP

GO:0010152 "pollen maturation" evidence=IMP

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 942 (336.7 bits), Expect = 1.1e-94, P = 1.1e-94
 Identities = 185/342 (54%), Positives = 248/342 (72%)

Query:    15 VVASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQL 74
             +    + GA +L ++ A+    +  LR+   D FFDV  E+D +V L QL+RF+ REL +
Sbjct:   232 IAGGVAAGAALLFAVPAIAFAWW--LRRKPQDHFFDVPAEEDPEVHLGQLKRFTLRELLV 289

Query:    75 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 134
             ATDNFS  N++G+GGFGKVYKG L+D   VAVKRL++  + GGE  FQ EV +IS+A+H+
Sbjct:   290 ATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVKRLKEERTKGGELQFQTEVEMISMAVHR 349

Query:   135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
             NLL+L G+C T +ER+LVYP+M N SVA  LR+   G   LDWP RK +A G+A GL YL
Sbjct:   350 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYL 409

Query:   195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 254
             H+ C+ KIIHRD+KAANILLD+ FEAV+ DFGLAKL++   +HVTT +RGT+GHIAPEYL
Sbjct:   410 HDHCDQKIIHRDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYL 469

Query:   255 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDR 314
             STGKSSEKTDVFGYG+ LLEL+TGQ+A D +R            ++++L+E +L  +VD 
Sbjct:   470 STGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWVKEVLKEKKLESLVDA 529

Query:   315 NLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 355
              L   Y   EVE ++Q+ALLCTQS+  +RP M++VV+ML+G+
Sbjct:   530 ELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRMLEGD 571

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0060548 "negative regulation of cell death" evidence=IMP

GO:1900140 "regulation of seedling development" evidence=IMP

GO:0010200 "response to chitin" evidence=IEP;RCA

GO:0008219 "cell death" evidence=IGI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI

GO:0010150 "leaf senescence" evidence=IGI

GO:0000165 "MAPK cascade" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 941 (336.3 bits), Expect = 1.4e-94, P = 1.4e-94
 Identities = 189/340 (55%), Positives = 253/340 (74%)

Query:    17 ASASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLAT 76
             AS S   FV  + G     RY++ ++    +FFDV  + D +VSL  L+R++ +EL+ AT
Sbjct:   243 ASFSAAFFVFFTSGMFLWWRYRRNKQ----IFFDVNEQYDPEVSLGHLKRYTFKELRSAT 298

Query:    77 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 136
             ++F+  NI+G+GG+G VYKG L+D T VAVKRL+D    GGE  FQ EV  IS+A+H+NL
Sbjct:   299 NHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNL 358

Query:   137 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 196
             L+L G+C+++ ERILVYP+M N SVA RL+D   GE  LDW  RK++A GTA GL YLHE
Sbjct:   359 LRLRGFCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHE 418

Query:   197 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST 256
             QC+PKIIHRD+KAANILLD++FEAV+ DFGLAKL+D + +HVTT +RGT+GHIAPEYLST
Sbjct:   419 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 478

Query:   257 GKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNL 316
             G+SSEKTDVFG+GI LLEL+TGQ+A+DF R            ++KL +E +L  ++D++L
Sbjct:   479 GQSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVMLDW-VKKLHQEGKLKQLIDKDL 537

Query:   317 NT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 355
             N  +D  E+E +VQVALLCTQ  P  RP M++V+KML+G+
Sbjct:   538 NDKFDRVELEEIVQVALLCTQFNPSHRPKMSEVMKMLEGD 577

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0048653 "anther development" evidence=RCA

TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 901 (322.2 bits), Expect = 2.5e-90, P = 2.5e-90
 Identities = 194/359 (54%), Positives = 253/359 (70%)

Query:     2 LLAVSTSRTKLRIVVASASCGAFVLLSLGA-LFACRYQKLRKLKHDVFFDVA-GEDDCKV 59
             L A  +   K+ I V S S G   L+ +   LF    Q+  +   + FFDV  G    +V
Sbjct:   237 LYAGGSRNHKMAIAVGS-SVGTVSLIFIAVGLFLWWRQRHNQ---NTFFDVKDGNHHEEV 292

Query:    60 SLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA 119
             SL  LRRF  RELQ+AT+NFS  N++G+GG+G VYKG+L D+T VAVKRL+D  + GGE 
Sbjct:   293 SLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYKGILGDSTVVAVKRLKDGGALGGEI 352

Query:   120 AFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPT 179
              FQ EV +IS+A+H+NLL+L G+C T +E++LVYP+M N SVA R++  KP    LDW  
Sbjct:   353 QFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYMSNGSVASRMK-AKPV---LDWSI 408

Query:   180 RKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 239
             RKR+A G A GL YLHEQC+PKIIHRD+KAANILLDD  EAV+ DFGLAKL+D + +HVT
Sbjct:   409 RKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVT 468

Query:   240 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHI 299
             T +RGT+GHIAPEYLSTG+SSEKTDVFG+GI LLELVTGQRA +F +            +
Sbjct:   469 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVTGQRAFEFGKAANQKGVMLDW-V 527

Query:   300 RKLLREDRLNDIVDRNL---NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 355
             +K+ +E +L  +VD+ L    +YD  E++ MV+VALLCTQ  P  RP M++VV+ML+G+
Sbjct:   528 KKIHQEKKLELLVDKELLKKKSYDEIELDEMVRVALLCTQYLPGHRPKMSEVVRMLEGD 586

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0051607 "defense response to virus" evidence=IMP

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0009736 "cytokinin mediated signaling pathway" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2040471 SERK5 "somatic embryogenesis receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 900 (321.9 bits), Expect = 3.1e-90, P = 3.1e-90
 Identities = 183/342 (53%), Positives = 246/342 (71%)

Query:    18 SASCGAFVL-LSLGA--LFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQL 74
             S +  A V+ ++ GA  LFA  +   RKL+   F DV  E+D +V L Q +RFS REL +
Sbjct:   212 SGTSAAIVVGVAAGAALLFALAWWLRRKLQGH-FLDVPAEEDPEVYLGQFKRFSLRELLV 270

Query:    75 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 134
             AT+ FS+ N++G+G FG +YKG L+D+T VAVKRL +  + GGE  FQ EV +IS+A+H+
Sbjct:   271 ATEKFSKRNVLGKGRFGILYKGRLADDTLVAVKRLNEERTKGGELQFQTEVEMISMAVHR 330

Query:   135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
             NLL+L G+C T +ER+LVYP+M N SVA  LR+   G   LDWP RK +A G+A GL YL
Sbjct:   331 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYL 390

Query:   195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 254
             H+ C+ KIIH D+KAANILLD+ FEAV+ DFGLAKL++   +HVTT +RGT+GHIAPEYL
Sbjct:   391 HDHCDQKIIHLDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYL 450

Query:   255 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDR 314
             STGKSSEKTDVFGYG+ LLEL+TGQ+A D +R            ++++L+E +L  +VD 
Sbjct:   451 STGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWVKEVLKEKKLESLVDA 510

Query:   315 NLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 355
              L   Y   EVE ++Q+ALLCTQS+  +RP M++VV+ML+G+
Sbjct:   511 ELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRMLEGD 552

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2118811 SARK "SENESCENCE-ASSOCIATED RECEPTOR-LIKE KINASE" [Arabidopsis thaliana (taxid:3702)]

 Score = 888 (317.7 bits), Expect = 5.9e-89, P = 5.9e-89
 Identities = 189/355 (53%), Positives = 246/355 (69%)

Query:     3 LAVSTSRTKLRIVVA-SASCGAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSL 61
             L+ S+ R   R+ +A S S G+ V+L L     C Y+K ++    +  +   E+  +  L
Sbjct:   227 LSSSSGRRSNRLAIALSVSLGSVVILVLALGSFCWYRKKQRRLLILNLNDKQEEGLQ-GL 285

Query:    62 TQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAF 121
               LR F+ REL + TD FS  NI+G GGFG VY+G L D T VAVKRL+D     G++ F
Sbjct:   286 GNLRSFTFRELHVYTDGFSSKNILGAGGFGNVYRGKLGDGTMVAVKRLKDINGTSGDSQF 345

Query:   122 QREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK 181
             + E+ +IS+A+HKNLL+LIGYC TS ER+LVYP+M N SVA +L+  KP    LDW  RK
Sbjct:   346 RMELEMISLAVHKNLLRLIGYCATSGERLLVYPYMPNGSVASKLKS-KPA---LDWNMRK 401

Query:   182 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 241
             R+A G A GL YLHEQC+PKIIHRD+KAANILLD+ FEAV+ DFGLAKL++   +HVTT 
Sbjct:   402 RIAIGAARGLLYLHEQCDPKIIHRDVKAANILLDECFEAVVGDFGLAKLLNHADSHVTTA 461

Query:   242 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRK 301
             +RGT+GHIAPEYLSTG+SSEKTDVFG+GI LLEL+TG RA++F +            +RK
Sbjct:   462 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGKTVSQKGAMLEW-VRK 520

Query:   302 LLREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 355
             L  E ++ +++DR L T YD  EV  M+QVALLCTQ  P  RP M++VV ML+G+
Sbjct:   521 LHEEMKVEELLDRELGTNYDKIEVGEMLQVALLCTQYLPAHRPKMSEVVLMLEGD 575

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010150 "leaf senescence" evidence=IMP

GO:0007267 "cell-cell signaling" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0009616 "virus induced gene silencing" evidence=RCA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009887 "organ morphogenesis" evidence=RCA

GO:0009944 "polarity specification of adaxial/abaxial axis" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010051 "xylem and phloem pattern formation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010267 "production of ta-siRNAs involved in RNA interference" evidence=RCA

GO:0035196 "production of miRNAs involved in gene silencing by miRNA" evidence=RCA

GO:0048438 "floral whorl development" evidence=RCA

GO:0048439 "flower morphogenesis" evidence=RCA

GO:0048519 "negative regulation of biological process" evidence=RCA

TAIR|locus:2061466 AT2G23950 [Arabidopsis thaliana (taxid:3702)]

 Score = 887 (317.3 bits), Expect = 7.5e-89, P = 7.5e-89
 Identities = 191/357 (53%), Positives = 248/357 (69%)

Query:     2 LLAVSTSRTKLRIVVASASCG--AFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKV 59
             L + S  RT +  V    S G    V+LSLG  F    +K R+L      D   +++  +
Sbjct:   224 LRSSSGRRTNILAVALGVSLGFAVSVILSLG--FIWYRKKQRRLTMLRISDK--QEEGLL 279

Query:    60 SLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA 119
              L  LR F+ REL +ATD FS  +I+G GGFG VY+G   D T VAVKRL+D     G +
Sbjct:   280 GLGNLRSFTFRELHVATDGFSSKSILGAGGFGNVYRGKFGDGTVVAVKRLKDVNGTSGNS 339

Query:   120 AFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPT 179
              F+ E+ +IS+A+H+NLL+LIGYC +SSER+LVYP+M N SVA RL+  KP    LDW T
Sbjct:   340 QFRTELEMISLAVHRNLLRLIGYCASSSERLLVYPYMSNGSVASRLK-AKPA---LDWNT 395

Query:   180 RKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 239
             RK++A G A GL YLHEQC+PKIIHRD+KAANILLD+ FEAV+ DFGLAKL++ + +HVT
Sbjct:   396 RKKIAIGAARGLFYLHEQCDPKIIHRDVKAANILLDEYFEAVVGDFGLAKLLNHEDSHVT 455

Query:   240 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHI 299
             T +RGT+GHIAPEYLSTG+SSEKTDVFG+GI LLEL+TG RA++F +            +
Sbjct:   456 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSVSQKGAMLEW-V 514

Query:   300 RKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 355
             RKL +E ++ ++VDR L T YD  EV  M+QVALLCTQ  P  RP M++VV+ML+G+
Sbjct:   515 RKLHKEMKVEELVDRELGTTYDRIEVGEMLQVALLCTQFLPAHRPKMSEVVQMLEGD 571

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q8W4S5	Y5371_ARATH	2, ., 7, ., 1, 1, ., 1	0.7537	0.9950	0.6498	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	401
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-48
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	8e-48
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-47
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	9e-47
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-46
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	7e-44
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-40
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-34
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-32
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-30
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-28
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-26
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-26
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-26
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-25
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-25
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-24
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-24
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-24
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	8e-24
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-23
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-22
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-22
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-22
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-22
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-21
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-21
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-21
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-21
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-20
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-20
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-20
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-20
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-20
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-20
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-20
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-20
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-20
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	9e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-19
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-19
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-18
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-18
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-18
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-18
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	7e-18
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	7e-18
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-17
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-17
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-17
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-17
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-17
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-17
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	8e-17
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	9e-17
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-16
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-16
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-16
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-16
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-16
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	8e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-15
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-15
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-15
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-15
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-15
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-15
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-15
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-15
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	9e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-14
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-14
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-14
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-14
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-14
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-14
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-14
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	9e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-13
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-13
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-13
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-13
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-13
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-13
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-13
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-13
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-13
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-13
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-13
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-13
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-13
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-13
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-13
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-13
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-13
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	7e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-13
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-12
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-12
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-12
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-12
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-12
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-11
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-11
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-11
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-11
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-11
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-11
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	8e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	9e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-10
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-10
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-10
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-10
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-10
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-10
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-10
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-10
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-10
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	7e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-10
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-09
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-09
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-09
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-09
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-09
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-09
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	6e-09
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	6e-09
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-09
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-09
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	7e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-08
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-08
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-08
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-08
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-08
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-08
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-08
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-08
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	6e-08
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	7e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	9e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	9e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-07
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-07
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-07
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-07
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-07
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	6e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	6e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	7e-07
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	8e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	8e-07
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	8e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-06
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-06
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-05
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	7e-05
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-04
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-04
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	7e-04
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	0.002
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	0.003
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	0.004

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  163 bits (415), Expect = 6e-48
 Identities = 78/278 (28%), Positives = 124/278 (44%), Gaps = 34/278 (12%)

Query: 84  IIGQGGFGKVYKGVLSDN-----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
            +G+G FG+VYKG L         +VAVK L++  S      F RE  ++    H N+++
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
           L+G CT     ++V  +M    +   LR  +P  K L        A   A G+EYL  + 
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK- 122

Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ----IRGTMGHIAPEYL 254
               IHRDL A N L+ +N    + DFGL++ +     +        IR      APE L
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM----APESL 176

Query: 255 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 314
             GK + K+DV+ +G+ L E+        F+  EE    +    + + L++         
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEI--------FTLGEEPYPGMSNAEVLEYLKKGYRLPKPP- 227

Query: 315 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
                   E   + ++ L C    PEDRP  +++V++L
Sbjct: 228 ----NCPPE---LYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  163 bits (414), Expect = 8e-48
 Identities = 81/280 (28%), Positives = 127/280 (45%), Gaps = 40/280 (14%)

Query: 85  IGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +G+G FG+VYKG L        TKVAVK L++  S      F  E  ++    H N+++L
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
           +G CT      +V  +M    +   LR        L      ++A   A G+EYL  +  
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLESK-- 121

Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-----IRGTMGHIAPEYL 254
              +HRDL A N L+ +N    + DFGL++ +     +         I+      APE L
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM----APESL 176

Query: 255 STGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 313
             GK + K+DV+ +G+ L E+ T G+    +  +  EE + LL+   +L R +       
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGE--QPYPGMSNEEVLELLEDGYRLPRPE------- 227

Query: 314 RNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKML 352
                    E+ E M+Q    C    PEDRP  +++V+ L
Sbjct: 228 -----NCPDELYELMLQ----CWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  160 bits (407), Expect = 2e-47
 Identities = 71/195 (36%), Positives = 98/195 (50%), Gaps = 12/195 (6%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G+GGFG VY         KVA+K ++   S        RE+ ++    H N+++L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 144 TTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 202
              +   LV  + +  S    L+D LK  E  L      R+      GLEYLH      I
Sbjct: 61  EDENHLYLVMEYCEGGS----LKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GI 113

Query: 203 IHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-STGKSS 260
           IHRDLK  NILLD DN +  L DFGL+KL+ +    +   I GT  ++APE L   G  S
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSD-KSLLKTIVGTPAYMAPEVLLGKGYYS 172

Query: 261 EKTDVFGYGITLLEL 275
           EK+D++  G+ L EL
Sbjct: 173 EKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  160 bits (407), Expect = 9e-47
 Identities = 76/279 (27%), Positives = 123/279 (44%), Gaps = 37/279 (13%)

Query: 84  IIGQGGFGKVYKGVLSDN-----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
            +G+G FG+VYKG L         +VAVK L++  S      F RE  ++    H N+++
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
           L+G CT      +V  +M+   +   LR  +P    L        A   A G+EYL  + 
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIARGMEYLESK- 121

Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI-----APEY 253
               IHRDL A N L+ +N    + DFGL++ +     +     R   G +     APE 
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDL-----YDDDYYRKRGGKLPIRWMAPES 174

Query: 254 LSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 313
           L  GK + K+DV+ +G+ L E+        F+  E+    +  + + + L+         
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEI--------FTLGEQPYPGMSNEEVLEYLKNGYRLPQPP 226

Query: 314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
                    E   +  + L C    PEDRP  +++V++L
Sbjct: 227 -----NCPPE---LYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  158 bits (403), Expect = 5e-46
 Identities = 85/287 (29%), Positives = 132/287 (45%), Gaps = 41/287 (14%)

Query: 83  NIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
             +G+G FG+VYKG L       T+VAVK L++  S      F +E  ++    H N+++
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 139 LIGYCTTSSERILVYPFMQN---LSV--AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
           L+G CT      LV  +M+    L      R     P +  L        A   A G+EY
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---A 250
           L  +   K +HRDL A N L+ ++    + DFGL++ V     +      G    I   A
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK--TGGKLPIRWMA 175

Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRK---LLRED 306
           PE L  G  + K+DV+ +G+ L E+ T G  A  +  L  EE   +L+++RK   L + +
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLG--ATPYPGLSNEE---VLEYLRKGYRLPKPE 230

Query: 307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
              D +      Y+         + L C Q  PEDRP  +++V+ L+
Sbjct: 231 YCPDEL------YE---------LMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  153 bits (388), Expect = 7e-44
 Identities = 67/199 (33%), Positives = 93/199 (46%), Gaps = 11/199 (5%)

Query: 84  IIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
            +G G FG VYK         VAVK L+        +   +RE+ ++    H N+++LI 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 142 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 201
                    LV  + +   +   L         L     K++A     GLEYLH      
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSR----GGPLSEDEAKKIALQILRGLEYLHSN---G 118

Query: 202 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK-SS 260
           IIHRDLK  NILLD+N    + DFGLAK +    + +TT   GT  ++APE L  G    
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGNGYG 177

Query: 261 EKTDVFGYGITLLELVTGQ 279
            K DV+  G+ L EL+TG+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  143 bits (364), Expect = 2e-40
 Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 10/198 (5%)

Query: 83  NIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
             +G+G FGKVY          VA+K ++            RE+ ++    H N+++L  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 142 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 201
                 +  LV  + +   +   L+        L     +         LEYLH +    
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLLKK----RGRLSEDEARFYLRQILSALEYLHSK---G 117

Query: 202 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSE 261
           I+HRDLK  NILLD++    L DFGLA+ +D     +TT + GT  ++APE L      +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFV-GTPEYMAPEVLLGKGYGK 175

Query: 262 KTDVFGYGITLLELVTGQ 279
             D++  G+ L EL+TG+
Sbjct: 176 AVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  127 bits (321), Expect = 3e-34
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 16/224 (7%)

Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEA-AFQREVHLISVAIHKN 135
            ++   ++G+G FG VY  +  D  + +AVK ++       E  A +RE+ ++S   H N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 136 LLQLIGYCTTSSERILVYPFMQNL---SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 192
           +++  G      E+  +  F++ +   S++  L+        L  P  ++       GL 
Sbjct: 61  IVRYYG-SERDEEKNTLNIFLEYVSGGSLSSLLKKFGK----LPEPVIRKYTRQILEGLA 115

Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHIAP 251
           YLH      I+HRD+K ANIL+D +    L DFG AK + D +    T  +RGT   +AP
Sbjct: 116 YLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172

Query: 252 EYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 295
           E +   +     D++  G T++E+ TG+    +S L      L 
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGKPP--WSELGNPMAALY 214

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  124 bits (312), Expect = 4e-32
 Identities = 72/278 (25%), Positives = 110/278 (39%), Gaps = 23/278 (8%)

Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAA--FQREVH-LISVAIHKNLLQLIG 141
           +G+G FG+VY     D   VA+K L        +    F RE+  L S+    N+++L  
Sbjct: 8   LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65

Query: 142 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 201
           +        LV  ++   S+   L      +  L       +       LEYLH +    
Sbjct: 66  FFQDEGSLYLVMEYVDGGSL-EDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121

Query: 202 IIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQIR-----GTMGHIAPEYL- 254
           IIHRD+K  NILLD D     L DFGLAKL+    +  +         GT G++APE L 
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 255 --STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 312
             S   +S  +D++  GITL EL+TG    +  +         L  I +L      + + 
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS-QTLKIILELPTPSLASPLS 240

Query: 313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
             N              +        P++R   +  + 
Sbjct: 241 PSNPELISKA----ASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  116 bits (294), Expect = 2e-30
 Identities = 66/202 (32%), Positives = 93/202 (46%), Gaps = 22/202 (10%)

Query: 85  IGQGGFGKVYKG-VLSDNTKVAVKRL----QDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           IG+GGFG+VYK        +VA+K +    ++            E+ ++    H N+++ 
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEK-----IINEIQILKKCKHPNIVKY 62

Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
            G      E  +V  F    S    L+D LK   + L       V      GLEYLH   
Sbjct: 63  YGSYLKKDELWIVMEFCSGGS----LKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN- 117

Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAPEYLSTG 257
              IIHRD+KAANILL  + E  L DFGL+  L D K  +      GT   +APE ++  
Sbjct: 118 --GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVINGK 172

Query: 258 KSSEKTDVFGYGITLLELVTGQ 279
               K D++  GIT +EL  G+
Sbjct: 173 PYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  111 bits (279), Expect = 2e-28
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 18/218 (8%)

Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA-AFQREVHLISVAIHKNLLQLIGYC 143
           IG+G FG V  G      KVAVK L+D       A AF  E  +++   H NL+QL+G  
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCLKDD---STAAQAFLAEASVMTTLRHPNLVQLLGVV 69

Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
              +   +V  +M   S+   LR    G   +    +   A     G+EYL E+     +
Sbjct: 70  LQGNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGFALDVCEGMEYLEEK---NFV 124

Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N+L+ ++  A + DFGLAK            ++ T    APE L   K S K+
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKS 180

Query: 264 DVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK 301
           DV+ +GI L E+ +  R   + R+  ++   ++ H+ K
Sbjct: 181 DVWSFGILLWEIYSFGRV-PYPRIPLKD---VVPHVEK 214

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  107 bits (268), Expect = 1e-26
 Identities = 67/199 (33%), Positives = 98/199 (49%), Gaps = 19/199 (9%)

Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 142
           +G G FG+V+ G  +  TKVAVK L+    PG     AF +E  ++    H  L+QL   
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLK----PGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69

Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 202
           C+      +V  +M   S+   L+      K L  P    +A   A G+ YL  +     
Sbjct: 70  CSEEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESR---NY 124

Query: 203 IHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQ--IRGTMGHIAPEYLSTGK 258
           IHRDL A NIL+ +N    + DFGLA+L+  D        +  I+ T    APE  + G+
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAANYGR 180

Query: 259 SSEKTDVFGYGITLLELVT 277
            + K+DV+ +GI L E+VT
Sbjct: 181 FTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  104 bits (262), Expect = 7e-26
 Identities = 66/203 (32%), Positives = 101/203 (49%), Gaps = 15/203 (7%)

Query: 79  FSESNIIGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLL 137
           F+    +G G FG+V++G+  +  +VA+K L  D      +  FQ+EV  +    HK+L+
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD--FQKEVQALKRLRHKHLI 65

Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
            L   C+      ++   M+  S+   LR   P  + L   +   +A   A G+ YL EQ
Sbjct: 66  SLFAVCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEEQ 123

Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTT-QIRGTMGHIAPEYL 254
                IHRDL A NIL+ ++    + DFGLA+L+  D  L+       + T    APE  
Sbjct: 124 ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT----APEAA 176

Query: 255 STGKSSEKTDVFGYGITLLELVT 277
           S G  S K+DV+ +GI L E+ T
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  109 bits (274), Expect = 9e-26
 Identities = 95/362 (26%), Positives = 165/362 (45%), Gaps = 53/362 (14%)

Query: 9   RTKLRIVVASASCGAFVLLSLGALFACRYQKLRK---LKHDVFFDVAGED--------DC 57
           +T       + + GAF++L+L A F   + + R    LK      V  ED        D 
Sbjct: 624 KTPSWWFYITCTLGAFLVLALVA-FGFVFIRGRNNLELKR-----VENEDGTWELQFFDS 677

Query: 58  KVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDN-TKVAVKRLQDYYS-P 115
           KVS    +  +  ++  +     E N+I +G  G  YKG    N  +  VK + D  S P
Sbjct: 678 KVS----KSITINDILSSL---KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP 730

Query: 116 GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL 175
             E A   ++       H N+++LIG C +     L++ +++  +++  LR        L
Sbjct: 731 SSEIADMGKLQ------HPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-------NL 777

Query: 176 DWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 235
            W  R+++A G A  L +LH +C+P ++  +L    I++D   E  L    L  L+    
Sbjct: 778 SWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL---C 833

Query: 236 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 295
           T     I  +  ++APE   T   +EK+D++G+G+ L+EL+TG+   D    E      +
Sbjct: 834 TDTKCFI--SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD---AEFGVHGSI 888

Query: 296 LDHIRKLLREDRLNDIVD----RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 351
           ++  R    +  L+  +D     +++   ++ VE M  +AL CT + P  RP    V+K 
Sbjct: 889 VEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVM-NLALHCTATDPTARPCANDVLKT 947

Query: 352 LQ 353
           L+
Sbjct: 948 LE 949

Length = 968

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  103 bits (260), Expect = 1e-25
 Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 10/204 (4%)

Query: 78  NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGE-AAFQREVHLISVAIHKN 135
           N+   ++IG+G FG VYKG+ L     VA+K++           +  +E+ L+    H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
           +++ IG   TS    ++  + +N S    LR +                +    GL YLH
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGS----LRQIIKKFGPFPESLVAVYVYQVLQGLAYLH 116

Query: 196 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 255
           EQ    +IHRD+KAANIL   +    L DFG+A  ++  ++     + GT   +APE + 
Sbjct: 117 EQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLND-VSKDDASVVGTPYWMAPEVIE 172

Query: 256 TGKSSEKTDVFGYGITLLELVTGQ 279
              +S  +D++  G T++EL+TG 
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  102 bits (257), Expect = 5e-25
 Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 22/220 (10%)

Query: 67  FSCRELQLATDNFSESNIIGQGGFGKVYKG---VLSDNT--KVAVKRLQDYYSPGGEAAF 121
           F  R L+           +G+G FGKV       L DNT  +VAVK L         + F
Sbjct: 1   FEKRHLKF-------IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDF 53

Query: 122 QREVHLISVAIHKNLLQLIGYCTTSSERI--LVYPFMQNLSVAYRLRDLKPGEKGLDWPT 179
           +RE+ ++    H+N+++  G C     R   L+  ++ + S+   L+  +     ++   
Sbjct: 54  EREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ---INLKR 110

Query: 180 RKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 239
               +     G++YL  Q   + IHRDL A NIL++      + DFGLAK++     +  
Sbjct: 111 LLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYY 167

Query: 240 TQIRGT--MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
            +  G   +   APE L T K S  +DV+ +G+TL EL T
Sbjct: 168 VKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 99.8 bits (249), Expect = 4e-24
 Identities = 63/201 (31%), Positives = 98/201 (48%), Gaps = 19/201 (9%)

Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           IG+G FG VYKGVL  NT+VAVK  +    P  +  F +E  ++    H N+++LIG C 
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62

Query: 145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG--TAYGLEYLHEQCNPKI 202
                 +V   +   S+   LR     +K      +K +      A G+EYL  +     
Sbjct: 63  QKQPIYIVMELVPGGSLLTFLR-----KKKNRLTVKKLLQMSLDAAAGMEYLESKN---C 114

Query: 203 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI-----APEYLSTG 257
           IHRDL A N L+ +N    + DFG+++  +  +  V+      +  I     APE L+ G
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS----DGLKQIPIKWTAPEALNYG 170

Query: 258 KSSEKTDVFGYGITLLELVTG 278
           + + ++DV+ YGI L E  + 
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 99.7 bits (249), Expect = 5e-24
 Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 20/208 (9%)

Query: 83  NIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
            +IG G FG+V +G L    K    VA+K L+   S      F  E  ++    H N+++
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
           L G  T S   +++  +M+N S+   LR+    +          +  G A G++YL E  
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEMN 126

Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-----IRGTMGHIAPEY 253
               +HRDL A NIL++ N    + DFGL++ ++      TT+     IR T    APE 
Sbjct: 127 ---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEA 179

Query: 254 LSTGKSSEKTDVFGYGITLLELVT-GQR 280
           ++  K +  +DV+ +GI + E+++ G+R
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 99.5 bits (248), Expect = 7e-24
 Identities = 81/282 (28%), Positives = 132/282 (46%), Gaps = 36/282 (12%)

Query: 83  NIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
            +IG+G FG VY G L D+       AVK L           F +E  ++    H N+L 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 139 LIGYC-TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR-VAFG--TAYGLEYL 194
           L+G C  +    ++V P+M++  +   +R           PT K  + FG   A G+EYL
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHN------PTVKDLIGFGLQVAKGMEYL 114

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK---LTHVTTQIRGTMGHIAP 251
             +   K +HRDL A N +LD++F   + DFGLA+ +  K     H  T  +  +  +A 
Sbjct: 115 ASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171

Query: 252 EYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 311
           E L T K + K+DV+ +G+ L EL+T + A  +  ++  +  + L   R+LL+ +   D 
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVDSFDITVYLLQGRRLLQPEYCPD- 229

Query: 312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                          + +V L C    PE RP  +++V  ++
Sbjct: 230 --------------PLYEVMLSCWHPKPEMRPTFSELVSRIE 257

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 99.1 bits (248), Expect = 8e-24
 Identities = 77/279 (27%), Positives = 125/279 (44%), Gaps = 43/279 (15%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           IG+G FGKVY     SD     +K +     S         EV ++    H N+   I Y
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI---IKY 64

Query: 143 CTTSSERILVYPFMQ-----NLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYGLEY 193
             +  E+  +   M+     +LS   + +  +    P E+ LDW  +          L+Y
Sbjct: 65  YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ------LCLALKY 118

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH +   KI+HRD+K  NI L  N    L DFG++K++ + +    T + GT  +++PE 
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE- 173

Query: 254 LSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 312
           L   K  + K+D++  G  L EL T +   +   L E    L      K+L+        
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE----L----ALKILKGQY----- 220

Query: 313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 351
              + +  S E+  +V  +LL  Q  PE+RP +AQ+++ 
Sbjct: 221 -PPIPSQYSSELRNLVS-SLL--QKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 98.7 bits (246), Expect = 1e-23
 Identities = 61/195 (31%), Positives = 94/195 (48%), Gaps = 11/195 (5%)

Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 142
           +G G FG+V++G+ ++ T VAVK L+    PG      F  E  ++    H  L+QL   
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLK----PGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 202
           CT      +V   M+  S+   L+      + L  P    +A   A G+ YL  Q     
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYLQ--GGAGRALKLPQLIDMAAQVASGMAYLEAQ---NY 124

Query: 203 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 262
           IHRDL A N+L+ +N    + DFGLA+++   +       +  +   APE     + S K
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184

Query: 263 TDVFGYGITLLELVT 277
           +DV+ +GI L E+VT
Sbjct: 185 SDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 97.4 bits (243), Expect = 4e-23
 Identities = 70/221 (31%), Positives = 100/221 (45%), Gaps = 25/221 (11%)

Query: 82  SNIIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQ---REVHLISVAIHKN 135
            N IG G FGKVY  V L     +AVK  R+QD          +    E+ ++ +  H N
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD----NDPKTIKEIADEMKVLELLKHPN 60

Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
           L   + Y      R  VY FM+  S    L +L    + LD    +        GL YLH
Sbjct: 61  L---VKYYGVEVHREKVYIFMEYCSGG-TLEELLEHGRILDEHVIRVYTLQLLEGLAYLH 116

Query: 196 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG---HIAPE 252
                 I+HRD+K ANI LD N    L DFG A  +    T +  +++   G   ++APE
Sbjct: 117 SH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173

Query: 253 YLSTGKSSEK---TDVFGYGITLLELVTGQRAIDFSRLEEE 290
            ++ GK        D++  G  +LE+ TG+R   +S L+ E
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRP--WSELDNE 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 96.0 bits (239), Expect = 1e-22
 Identities = 83/278 (29%), Positives = 127/278 (45%), Gaps = 43/278 (15%)

Query: 85  IGQGGFGKVYKGVLSDNTK-VAVKR--LQDYYSPGGEAAFQ--REVHLISVAIHKNLLQL 139
           +G G FG VY+G+  D+    AVK   L D    G EA  Q  +E+ L+S   H N++Q 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 140 IGYCTTSSERILVY-PFMQNLSVAYRLRDLKPGEKGLDWP-----TRKRVAFGTAYGLEY 193
           +G      + + ++   +   S+A  L+           P     TR+ +      GLEY
Sbjct: 68  LG-TEREEDNLYIFLELVPGGSLAKLLKKYGS----FPEPVIRLYTRQILL-----GLEY 117

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH++     +HRD+K ANIL+D N    L DFG+AK V           +G+   +APE 
Sbjct: 118 LHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEV 172

Query: 254 L-STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 312
           +   G      D++  G T+LE+ TG+    +S+LE    V       K+ R   L  I 
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGK--PPWSQLEGVAAVF------KIGRSKELPPIP 224

Query: 313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
           D     + S E +  +   L C Q  P  RP  A++++
Sbjct: 225 D-----HLSDEAKDFI---LKCLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 95.5 bits (238), Expect = 1e-22
 Identities = 75/277 (27%), Positives = 123/277 (44%), Gaps = 36/277 (12%)

Query: 85  IGQGGFGKVYKGV-LSDNTK---VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLI 140
           +G G FG V KGV L  + K   VAVK L+  +   G+  F RE  +++   H  +++LI
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 141 GYCTTSSERILVYPFM--QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
           G C          P M    L+    L       + +     K +A   A G+ YL  + 
Sbjct: 63  GVC-------KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK- 114

Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT--MGHIAPEYLST 256
               +HRDL A N+LL +  +A + DFG+++ + A   +      G   +   APE ++ 
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172

Query: 257 GKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 315
           GK S K+DV+ YG+TL E  + G +   +  ++  E + +L+   +L R +         
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKP--YGEMKGAEVIAMLESGERLPRPEECPQ----- 225

Query: 316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
              Y          + L C +  PEDRP  +++    
Sbjct: 226 -EIYS---------IMLSCWKYRPEDRPTFSELESTF 252

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 95.5 bits (237), Expect = 2e-22
 Identities = 73/200 (36%), Positives = 104/200 (52%), Gaps = 16/200 (8%)

Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 142
           +G G FG+V+ G  + NTKVAVK L+    PG     +F  E  ++    H  L+QL  Y
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLK----PGTMSPESFLEEAQIMKKLRHDKLVQL--Y 67

Query: 143 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGE-KGLDWPTRKRVAFGTAYGLEYLHEQCNP 200
              S E I +V  +M   S+   L  LK GE + L  P    +A   A G+ Y+ E+ N 
Sbjct: 68  AVVSEEPIYIVTEYMSKGSL---LDFLKDGEGRALKLPNLVDMAAQVAAGMAYI-ERMN- 122

Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 260
             IHRDL++ANIL+ D     + DFGLA+L++          +  +   APE    G+ +
Sbjct: 123 -YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 261 EKTDVFGYGITLLELVTGQR 280
            K+DV+ +GI L ELVT  R
Sbjct: 182 IKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 94.1 bits (234), Expect = 5e-22
 Identities = 80/269 (29%), Positives = 129/269 (47%), Gaps = 44/269 (16%)

Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G FG+V+ G  + +TKVA+K L Q   SP    AF  E +L+    H  L++L  Y 
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP---EAFLAEANLMKQLQHPRLVRL--YA 68

Query: 144 TTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV--AFGTAYGLEYLHEQCNP 200
             + E I ++  +M+N S    L D     +G+     K +  A   A G+ ++  +   
Sbjct: 69  VVTQEPIYIITEYMENGS----LVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK--- 121

Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGHIAPEYL 254
             IHRDL+AANIL+ +     + DFGLA+L+  +    T +      I+ T    APE +
Sbjct: 122 NYIHRDLRAANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWT----APEAI 175

Query: 255 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 314
           + G  + K+DV+ +GI L E+VT  R I +  +   E +  L+   ++ R D        
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGR-IPYPGMTNPEVIQNLERGYRMPRPDNCP----- 229

Query: 315 NLNTYDSKEVETMVQVALLCTQSTPEDRP 343
                     E + ++  LC +  PE+RP
Sbjct: 230 ----------EELYELMRLCWKEKPEERP 248

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 93.3 bits (232), Expect = 1e-21
 Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 32/216 (14%)

Query: 85  IGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G+G FGKV+ G         D   VAVK L++  S      F+RE  L++   H+N+++
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK----------RVAFGTA 188
             G CT     I+V+ +M++  +   LR   P    L  P             ++A   A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 248
            G+ YL  Q     +HRDL   N L+  +    + DFG+++ V       TT      GH
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDV------YTTDYYRVGGH 183

Query: 249 -------IAPEYLSTGKSSEKTDVFGYGITLLELVT 277
                  + PE +   K + ++DV+ +G+ L E+ T
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 92.4 bits (230), Expect = 2e-21
 Identities = 82/274 (29%), Positives = 119/274 (43%), Gaps = 23/274 (8%)

Query: 83  NIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
            +IG G    VY  + L +N KVA+KR+            ++EV  +S   H N+++   
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 142 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 201
                 E  LV P++   S+   ++   P   GLD      V      GLEYLH      
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---G 122

Query: 202 IIHRDLKAANILLDDNFEAVLCDFG----LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 257
            IHRD+KA NILL ++    + DFG    LA   D       T   GT   +APE +   
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT-FVGTPCWMAPEVMEQV 181

Query: 258 KS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 316
                K D++ +GIT +EL TG  A  +S+    + VL+L      L+ D  +     + 
Sbjct: 182 HGYDFKADIWSFGITAIELATG--AAPYSKYPPMK-VLML-----TLQNDPPSLETGADY 233

Query: 317 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
             Y SK    M+    LC Q  P  RP   +++K
Sbjct: 234 KKY-SKSFRKMIS---LCLQKDPSKRPTAEELLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 92.5 bits (230), Expect = 2e-21
 Identities = 66/224 (29%), Positives = 107/224 (47%), Gaps = 26/224 (11%)

Query: 84  IIGQGGFGKVYKGV---LSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           ++G G FG VYKGV     +  K  VA+K L++  SP        E ++++   H ++++
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG----LDWPTRKRVAFGTAYGLEYL 194
           L+G C +S    L+   M    +   +R+ K    G    L+W  +       A G+ YL
Sbjct: 74  LLGICLSSQ-VQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQ------IAKGMSYL 125

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---AP 251
            E+   +++HRDL A N+L+       + DFGLAKL+D           G    I   A 
Sbjct: 126 EEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVPIKWMAL 180

Query: 252 EYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVL 294
           E +     + K+DV+ YG+T+ EL+T G +  +     E  D+L
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 91.5 bits (227), Expect = 5e-21
 Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 24/204 (11%)

Query: 83  NIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPG----GEAAFQREVHLISVAIHKNLL 137
           + +G G +G+VY+GV    +  VAVK L++          EAA  +E+       H NL+
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK------HPNLV 65

Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
           QL+G CT      ++  FM   ++   LR+     + ++      +A   +  +EYL ++
Sbjct: 66  QLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK 123

Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQ--IRGTMGHIAPEY 253
                IHRDL A N L+ +N    + DFGL++L+  D    H   +  I+ T    APE 
Sbjct: 124 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APES 176

Query: 254 LSTGKSSEKTDVFGYGITLLELVT 277
           L+  K S K+DV+ +G+ L E+ T
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 91.2 bits (226), Expect = 7e-21
 Identities = 61/210 (29%), Positives = 113/210 (53%), Gaps = 17/210 (8%)

Query: 80  SESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           ++  +IG G FG+V++G+L         VA+K L+  Y+      F  E  ++    H N
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67

Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--GTAYGLEY 193
           +++L G  T     +++  +M+N ++   LRD   GE    + + + V    G A G++Y
Sbjct: 68  IIRLEGVVTKFKPAMIITEYMENGALDKYLRD-HDGE----FSSYQLVGMLRGIAAGMKY 122

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAP 251
           L +      +HRDL A NIL++ N E  + DFGL++++  D + T+ T+  +  +   AP
Sbjct: 123 LSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179

Query: 252 EYLSTGKSSEKTDVFGYGITLLELVT-GQR 280
           E ++  K +  +DV+ +GI + E+++ G+R
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGER 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 90.5 bits (225), Expect = 1e-20
 Identities = 70/289 (24%), Positives = 124/289 (42%), Gaps = 46/289 (15%)

Query: 85  IGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL-- 136
           +GQG FG VY+G+          T+VA+K + +  S      F     L   ++ K    
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEF-----LNEASVMKEFNC 68

Query: 137 ---LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEK---GLDWPTRKRV---AFGT 187
              ++L+G  +T    ++V   M    +   LR  +P  +   GL  PT ++    A   
Sbjct: 69  HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128

Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 247
           A G+ YL  +   K +HRDL A N ++ ++    + DFG+ +  D   T    +    + 
Sbjct: 129 ADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTR--DIYETDYYRKGGKGLL 183

Query: 248 HI---APEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 304
            +   APE L  G  + K+DV+ +G+ L E+ T         L E+         + L  
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT---------LAEQP-------YQGLSN 227

Query: 305 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
           E+ L  ++D           + ++++  +C Q  P+ RP   ++V  L+
Sbjct: 228 EEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 89.7 bits (222), Expect = 2e-20
 Identities = 71/201 (35%), Positives = 104/201 (51%), Gaps = 18/201 (8%)

Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 142
           +GQG FG+V+ G  +  T+VA+K L+    PG     AF +E  ++    H+ L+QL  Y
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLK----PGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 67

Query: 143 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKG--LDWPTRKRVAFGTAYGLEYLHEQCN 199
              S E I +V  +M   S    L D   GE G  L  P    +A   A G+ Y+ E+ N
Sbjct: 68  AVVSEEPIYIVTEYMSKGS----LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMN 122

Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 259
              +HRDL+AANIL+ +N    + DFGLA+L++          +  +   APE    G+ 
Sbjct: 123 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180

Query: 260 SEKTDVFGYGITLLELVTGQR 280
           + K+DV+ +GI L EL T  R
Sbjct: 181 TIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 89.6 bits (222), Expect = 2e-20
 Identities = 76/275 (27%), Positives = 120/275 (43%), Gaps = 38/275 (13%)

Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           IG G FG V+ G   +  KVA+K +++      E  F  E  ++    H  L+QL G CT
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 145 TSSERILVYPFMQNLSVAYRLRDLKPGEKG-LDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
             S   LV+ FM++  ++  LR     ++G     T   +      G+ YL       +I
Sbjct: 70  ERSPICLVFEFMEHGCLSDYLR----AQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122

Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 262
           HRDL A N L+ +N    + DFG+ + V D + T  +T  +  +   +PE  S  K S K
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSPEVFSFSKYSSK 181

Query: 263 TDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT---- 318
           +DV+ +G+ + E+        FS               K   E+R N  V   +N     
Sbjct: 182 SDVWSFGVLMWEV--------FSE-------------GKTPYENRSNSEVVETINAGFRL 220

Query: 319 YDSKEVETMV-QVALLCTQSTPEDRPPMAQVVKML 352
           Y  +     V ++   C +  PEDRP  + ++  L
Sbjct: 221 YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 89.3 bits (221), Expect = 2e-20
 Identities = 60/191 (31%), Positives = 97/191 (50%), Gaps = 6/191 (3%)

Query: 84  IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           ++G+G FG+V+KG L D T VAVK  ++      +  F  E  ++    H N+++LIG C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           T   +R  +Y  M+ +     L  L+  +  L      + A   A G+ YL  +     I
Sbjct: 62  T---QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCI 115

Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N L+ +N    + DFG+++  D  +   +   +  +   APE L+ G+ S ++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175

Query: 264 DVFGYGITLLE 274
           DV+ YGI L E
Sbjct: 176 DVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 89.3 bits (221), Expect = 2e-20
 Identities = 75/200 (37%), Positives = 105/200 (52%), Gaps = 16/200 (8%)

Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 142
           +GQG FG+V+ G  +  TKVA+K L+    PG     AF +E  ++    H  L+ L  Y
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLK----PGTMMPEAFLQEAQIMKKLRHDKLVPL--Y 67

Query: 143 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGE-KGLDWPTRKRVAFGTAYGLEYLHEQCNP 200
              S E I +V  FM   S+   L  LK G+ K L  P    +A   A G+ Y+ E+ N 
Sbjct: 68  AVVSEEPIYIVTEFMGKGSL---LDFLKEGDGKYLKLPQLVDMAAQIADGMAYI-ERMN- 122

Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 260
             IHRDL+AANIL+ DN    + DFGLA+L++          +  +   APE    G+ +
Sbjct: 123 -YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 261 EKTDVFGYGITLLELVTGQR 280
            K+DV+ +GI L ELVT  R
Sbjct: 182 IKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 89.3 bits (221), Expect = 2e-20
 Identities = 72/273 (26%), Positives = 127/273 (46%), Gaps = 32/273 (11%)

Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA--AFQREVHLISVAIHKNLLQLIGY 142
           +G G FG+V+    + +TKVAVK ++    PG  +  AF  E +++    H  L++L   
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMK----PGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69

Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--AYGLEYLHEQCNP 200
            T     I+   FM   S    L D    ++G   P  K + F    A G+ ++ ++   
Sbjct: 70  VTKEPIYIIT-EFMAKGS----LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR--- 121

Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 260
             IHRDL+AANIL+  +    + DFGLA++++          +  +   APE ++ G  +
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 181

Query: 261 EKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYD 320
            K+DV+ +GI L+E+VT  R I +  +   E +  L+   ++ R +              
Sbjct: 182 IKSDVWSFGILLMEIVTYGR-IPYPGMSNPEVIRALERGYRMPRPENCP----------- 229

Query: 321 SKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
               E +  + + C ++ PE+RP    +  +L 
Sbjct: 230 ----EELYNIMMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 89.3 bits (221), Expect = 2e-20
 Identities = 64/196 (32%), Positives = 97/196 (49%), Gaps = 16/196 (8%)

Query: 85  IGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           IG+G FG+V+ G L +DNT VAVK  ++   P  +A F +E  ++    H N+++LIG C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           T      +V   +Q       LR   P    L      ++    A G+EYL  +     I
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGP---RLKVKELIQMVENAAAGMEYLESKH---CI 116

Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI-----APEYLSTGK 258
           HRDL A N L+ +     + DFG+++  +  +   T    G M  I     APE L+ G+
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST----GGMKQIPVKWTAPEALNYGR 172

Query: 259 SSEKTDVFGYGITLLE 274
            S ++DV+ +GI L E
Sbjct: 173 YSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 89.6 bits (223), Expect = 3e-20
 Identities = 67/202 (33%), Positives = 93/202 (46%), Gaps = 24/202 (11%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAF-QREVHLISVAIHKNLLQLIGY 142
           IG+G FG+VYK +    N  VA+K + D      E    Q+E+  +S      + +  G 
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 143 CTTSSERILVYPFMQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 201
               S+  ++  +    S      DL KPG   LD      +      GLEYLHE+    
Sbjct: 68  FLKGSKLWIIMEYCGGGSC----LDLLKPG--KLDETYIAFILREVLLGLEYLHEE---G 118

Query: 202 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR-----GTMGHIAPEYLST 256
            IHRD+KAANILL +  +  L DFG    V  +LT   T  +     GT   +APE +  
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFG----VSGQLTS--TMSKRNTFVGTPFWMAPEVIKQ 172

Query: 257 GKSSEKTDVFGYGITLLELVTG 278
               EK D++  GIT +EL  G
Sbjct: 173 SGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 89.5 bits (222), Expect = 3e-20
 Identities = 82/286 (28%), Positives = 135/286 (47%), Gaps = 37/286 (12%)

Query: 84  IIGQGGFGKVYKGVLS--DNT--KVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           I+G+G FG V +G LS  D +  KVAVK ++ D ++      F  E   +    H N+++
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 139 LIGYCTTSSER------ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--GTAYG 190
           LIG C  +S        +++ PFM++  +   L   + G      P +  + F    A G
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI-RGTMGHI 249
           +EYL    N   IHRDL A N +L ++    + DFGL+K + +   +   +I +  +  I
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182

Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLRE-DR 307
           A E L+    + K+DV+ +G+T+ E+ T GQ    +  +E  E       I   LR  +R
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTP--YPGVENHE-------IYDYLRHGNR 233

Query: 308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
           L    D     YD      M      C ++ P+DRP   ++ ++L+
Sbjct: 234 LKQPEDCLDELYDL-----MYS----CWRADPKDRPTFTKLREVLE 270

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 88.8 bits (220), Expect = 5e-20
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 17/211 (8%)

Query: 79  FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA-----AFQREVHLISVAIH 133
           +++  ++G+G +G VY G+ +    +AVK+++   S    A       Q EV L+    H
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
            N++Q +G C   +   +   F+   S++  L    P    L  P   +       G+ Y
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP----LPEPVFCKYTKQILDGVAY 117

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK---LVDAKLTH--VTTQIRGTMGH 248
           LH  C   ++HRD+K  N++L  N    L DFG A+    V    TH  +   + GT   
Sbjct: 118 LHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174

Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           +APE ++      K+D++  G T+ E+ TG+
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 88.4 bits (220), Expect = 9e-20
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 24/207 (11%)

Query: 83  NIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLI 140
             IG+G +G+VYK         VA+K+++ +    G      RE+ L+    H N+++L 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 141 GYCT--TSSERILVYPFMQNLSVAYRLRDL-----KPGEKGLDWPTRKRVAFGTAYGLEY 193
              T        +V+ +M +        DL      P  K       K        GL+Y
Sbjct: 65  EIVTSKGKGSIYMVFEYMDH--------DLTGLLDSPEVK-FTESQIKCYMKQLLEGLQY 115

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH      I+HRD+K +NIL++++    L DFGLA+    + +   T    T+ +  PE 
Sbjct: 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172

Query: 254 L--STGKSSEKTDVFGYGITLLELVTG 278
           L  +T +   + D++  G  L EL  G
Sbjct: 173 LLGAT-RYGPEVDMWSVGCILAELFLG 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 57/213 (26%), Positives = 88/213 (41%), Gaps = 45/213 (21%)

Query: 84  IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLI-------------S 129
            +G+G +G VYK +       VA+K +             +E+ ++             S
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVP---VEEDLQEIIKEISILKQCDSPYIVKYYGS 66

Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTA 188
              + +L  ++ YC   S                 + D+ K   K L       + + T 
Sbjct: 67  YFKNTDLWIVMEYCGAGS-----------------VSDIMKITNKTLTEEEIAAILYQTL 109

Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR---GT 245
            GLEYLH     K IHRD+KA NILL++  +A L DFG    V  +LT    +     GT
Sbjct: 110 KGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFG----VSGQLTDTMAKRNTVIGT 162

Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
              +APE +     + K D++  GIT +E+  G
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEG 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 45/134 (33%), Positives = 72/134 (53%), Gaps = 9/134 (6%)

Query: 168 LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 227
           LK  +  +      ++A     GL YLHE+   KIIHRD+K +NIL++   +  LCDFG+
Sbjct: 90  LKEVQGRIPERILGKIAVAVLKGLTYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGV 147

Query: 228 A-KLVDAK-LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 285
           + +LV++   T V     GT  ++APE +     S K+D++  G++L+EL TG+      
Sbjct: 148 SGQLVNSLAKTFV-----GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202

Query: 286 RLEEEEDVLLLDHI 299
               +    LL +I
Sbjct: 203 NDPPDGIFELLQYI 216

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 87.1 bits (216), Expect = 2e-19
 Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 24/224 (10%)

Query: 71  ELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQRE 124
           E+ L+   F E   +G+G FGKVYKG L         T VA+K L++   P  +  F++E
Sbjct: 1   EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58

Query: 125 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV-AYRLR-----------DLKPGE 172
             L+S   H N++ L+G CT      +++ ++ +  +  + +R             +  +
Sbjct: 59  AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118

Query: 173 KGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV- 231
             LD      +A   A G+EYL        +HRDL A N L+ +     + DFGL++ + 
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175

Query: 232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLEL 275
            A    V ++    +  + PE +  GK + ++D++ +G+ L E+
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 86.7 bits (215), Expect = 3e-19
 Identities = 75/280 (26%), Positives = 132/280 (47%), Gaps = 34/280 (12%)

Query: 79  FSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIH-- 133
           +    +IG+G +G VY+G  V +    VA+K + +  +P  + +  QREV L+S      
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRV-VALKII-NLDTPDDDVSDIQREVALLSQLRQSQ 60

Query: 134 -KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 192
             N+ +  G         ++  + +  SV   ++     EK +    R+         L+
Sbjct: 61  PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIRE-----VLVALK 115

Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 252
           Y+H+     +IHRD+KAANIL+ +     LCDFG+A L++   +  +T + GT   +APE
Sbjct: 116 YIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPE 171

Query: 253 YLSTGKSSE-KTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 311
            ++ GK  + K D++  GIT+ E+ TG     +S ++    ++L+   +      RL D 
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPP--YSDVDAFRAMMLIPKSKP----PRLED- 224

Query: 312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 351
                N Y SK +   V     C    P++R    +++K 
Sbjct: 225 -----NGY-SKLLREFVA---ACLDEEPKERLSAEELLKS 255

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 84.5 bits (209), Expect = 1e-18
 Identities = 60/210 (28%), Positives = 105/210 (50%), Gaps = 23/210 (10%)

Query: 84  IIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEA-------AFQREVHLISVAIHK 134
           +IG G FG VY G+  S    +AVK+++    S   +        A  RE+ L+    H+
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 135 NLLQLIGYCTTSSERILVY-PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
           N++Q +G  +  ++ + ++  ++   SVA  L +    E+ L     +        GL Y
Sbjct: 67  NIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFVRQILKGLNY 121

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-----IRGTMGH 248
           LH   N  IIHRD+K ANIL+D+     + DFG++K ++A      T      ++G++  
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178

Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           +APE +     + K D++  G  ++E++TG
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 84.7 bits (210), Expect = 1e-18
 Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 13/199 (6%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           IG+G +G VYK         VA+K++   + S G      RE+ L+    H N+++L+  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 143 CTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 201
                +  LV+ FM  +L   Y+L  +K  ++GL     K   +    GL + H      
Sbjct: 67  FRHKGDLYLVFEFMDTDL---YKL--IKDRQRGLPESLIKSYLYQLLQGLAFCHSH---G 118

Query: 202 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS-S 260
           I+HRDLK  N+L++      L DFGLA+   + +   T  +  T  + APE L   K  S
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAPELLLGDKGYS 177

Query: 261 EKTDVFGYGITLLELVTGQ 279
              D++  G    EL++ +
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 84.7 bits (209), Expect = 2e-18
 Identities = 78/283 (27%), Positives = 132/283 (46%), Gaps = 34/283 (12%)

Query: 85  IGQGGFGKVYKGVLSDNT---KVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           +G+G FG V +G L+ +    KVAVK ++       E   F  E   +    H N+++LI
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 141 GYCTTSSER------ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--AYGLE 192
           G C  + E       +++ PFM++  +   L   + G+     PT+  V F T  A G+E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI-RGTMGHIAP 251
           YL  +     IHRDL A N +L++N    + DFGL+K +     +   +I +  +  IA 
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 252 EYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 310
           E L+    + K+DV+ +G+T+ E+ T GQ    +  +E  E   + D++R+  R  +  D
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP--YPGVENSE---IYDYLRQGNRLKQPPD 238

Query: 311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
            +D             +  +   C    P+DRP    +   L+
Sbjct: 239 CLD------------GLYSLMSSCWLLNPKDRPSFETLRCELE 269

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 83.9 bits (207), Expect = 2e-18
 Identities = 60/197 (30%), Positives = 100/197 (50%), Gaps = 15/197 (7%)

Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA--AFQREVHLISVAIHKNLLQLIGY 142
           +G G FG+V+ G  +++TKVAVK L+    PG  +  AF  E +L+    H  L++L   
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLK----PGTMSVQAFLEEANLMKTLQHDKLVRLYAV 69

Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--AYGLEYLHEQCNP 200
            T      ++  +M   S    L D    ++G      K + F    A G+ Y+  +   
Sbjct: 70  VTKEEPIYIITEYMAKGS----LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK--- 122

Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 260
             IHRDL+AAN+L+ ++    + DFGLA++++          +  +   APE ++ G  +
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182

Query: 261 EKTDVFGYGITLLELVT 277
            K+DV+ +GI L E+VT
Sbjct: 183 IKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 83.3 bits (206), Expect = 3e-18
 Identities = 71/271 (26%), Positives = 115/271 (42%), Gaps = 30/271 (11%)

Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           +G G FG V+ G       VA+K +++      E  F  E  ++    H NL+QL G CT
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIRE--GAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 204
                 +V  +M N  +   LR+ + G+ G +W     +       +EYL        IH
Sbjct: 70  KQRPIFIVTEYMANGCLLNYLRE-RKGKLGTEWLLD--MCSDVCEAMEYLESNG---FIH 123

Query: 205 RDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---APEYLSTGKSSE 261
           RDL A N L+ ++    + DFGLA+ V   L    T  +GT   +    PE     + S 
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYV---LDDQYTSSQGTKFPVKWAPPEVFDYSRFSS 180

Query: 262 KTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS 321
           K+DV+ +G+ + E+ +  + + + R    E   +++ +    R  R              
Sbjct: 181 KSDVWSFGVLMWEVFSEGK-MPYERFSNSE---VVESVSAGYRLYR---------PKLAP 227

Query: 322 KEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
            EV T   +   C    PEDRP   +++  L
Sbjct: 228 TEVYT---IMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 82.6 bits (205), Expect = 5e-18
 Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 25/205 (12%)

Query: 85  IGQGGFGKVY--KGVLSDNT---KVAVKR-LQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G+G FGKV   +   +      KV  K+ +              E +++S   H  +++
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR---KEVEHTLTERNILSRINHPFIVK 57

Query: 139 LIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA---YGLEYL 194
           L  Y   + E++ LV  +     +   L      E        +R  F  A     LEYL
Sbjct: 58  LH-YAFQTEEKLYLVLEYAPGGELFSHLSK----EGRFS---EERARFYAAEIVLALEYL 109

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 254
           H      II+RDLK  NILLD +    L DFGLAK + ++ +   T   GT  ++APE L
Sbjct: 110 HSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVL 165

Query: 255 STGKSSEKTDVFGYGITLLELVTGQ 279
                 +  D +  G+ L E++TG+
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 82.8 bits (205), Expect = 7e-18
 Identities = 77/291 (26%), Positives = 131/291 (45%), Gaps = 43/291 (14%)

Query: 84  IIGQGGFGKVYKG--VLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLI-SVAIHKNL 136
            +G+G FG+V K   V  DN      VAVK L+D  +    +    E+ ++  +  HKN+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 137 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGE----KGLDWPTRKRV--------A 184
           + L+G CT      +V  +  + ++   LR  +P           P  + +        A
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 185 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIR 243
           +  A G+E+L  +   K IHRDL A N+L+ ++    + DFGLA+ +        TT  R
Sbjct: 139 YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 244 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKL 302
             +  +APE L     + ++DV+ +G+ L E+ T G        +EE         + KL
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---------LFKL 246

Query: 303 LRE-DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
           L+E  R+    ++  N   ++E+  ++     C    P  RP   Q+V+ L
Sbjct: 247 LKEGYRM----EKPQNC--TQELYHLM---RDCWHEVPSQRPTFKQLVEDL 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 82.8 bits (205), Expect = 7e-18
 Identities = 77/290 (26%), Positives = 128/290 (44%), Gaps = 38/290 (13%)

Query: 84  IIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQ---REVHLISVAIHKNLLQL 139
           ++G+G +G V K    +  + VA+K+     S   +   +   RE+ ++    H+NL+ L
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKF--LESEDDKMVKKIAMREIRMLKQLRHENLVNL 65

Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
           I          LV+ F+ +      L DL+    GLD    ++  F    G+E+ H   +
Sbjct: 66  IEVFRRKKRLYLVFEFVDHTV----LDDLEKYPNGLDESRVRKYLFQILRGIEFCH---S 118

Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-STGK 258
             IIHRD+K  NIL+  +    LCDFG A+ + A    V T    T  + APE L    K
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-GEVYTDYVATRWYRAPELLVGDTK 177

Query: 259 SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE--DRLNDIVDRN- 315
                D++  G  + E++TG+          + D+  L HI K L     R  +I  +N 
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGE-----PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232

Query: 316 ----LNTYDSKEVETM-----------VQVALLCTQSTPEDRPPMAQVVK 350
               +   + KE+E +           + +A  C +  P+DRP  +Q++ 
Sbjct: 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 64/217 (29%), Positives = 95/217 (43%), Gaps = 17/217 (7%)

Query: 75  ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVH-LISVAIH 133
            T  F    +IG+G +GKVYK       ++   ++ D      E   + E + L   + H
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI-IEDEEEEIKEEYNILRKYSNH 62

Query: 134 KNLLQLIGYCTTSSERI------LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 187
            N+    G     +         LV       SV   ++ L+   K L       +   T
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122

Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 247
             GL YLHE    K+IHRD+K  NILL  N E  L DFG++  +D+ L    T I GT  
Sbjct: 123 LRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPY 178

Query: 248 HIAPEYLSTGKSSEKT-----DVFGYGITLLELVTGQ 279
            +APE ++  +  + +     DV+  GIT +EL  G+
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 81.7 bits (202), Expect = 1e-17
 Identities = 75/276 (27%), Positives = 112/276 (40%), Gaps = 31/276 (11%)

Query: 85  IGQGGFGKVYKG----VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLI 140
           +G G FG V +G           VAVK L+          F +E  ++    H+NL++L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 141 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 200
           G   T    ++V       S+  RLR    G   +   T    A   A G+ YL  +   
Sbjct: 63  GVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLI--STLCDYAVQIANGMRYLESK--- 116

Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--IRGTMGHIAPEYLSTGK 258
           + IHRDL A NILL  + +  + DFGL + +     H   +  ++      APE L T  
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176

Query: 259 SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 318
            S  +DV+ +G+TL E+        F+  EE    L    I K          +D+    
Sbjct: 177 FSHASDVWMFGVTLWEM--------FTYGEEPWAGLSGSQILKK---------IDKEGER 219

Query: 319 YDSKEV--ETMVQVALLCTQSTPEDRPPMAQVVKML 352
            +  E   + +  V L C    P DRP  A + + L
Sbjct: 220 LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 81.7 bits (202), Expect = 1e-17
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 21/211 (9%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           +   E + +G+G  G V K  L +   + A+K +    +P  +    RE+ +        
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 136 LLQLIGYCT---TSSERILV-YPFMQNLSVAY---RLRDLKPGEKGLDWPTRKRVAFGTA 188
           +++  G      +SS  I + Y    +L   Y   + R  + GEK L      ++A    
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESVL 115

Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMG 247
            GL YLH +   KIIHRD+K +NILL    +  LCDFG++ +LV++     T    GT  
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSF 168

Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           ++APE +     S  +DV+  G+TLLE+   
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQN 199

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 81.5 bits (201), Expect = 2e-17
 Identities = 81/285 (28%), Positives = 129/285 (45%), Gaps = 46/285 (16%)

Query: 84  IIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +IG G FG+V +G L    K    VA+K L+  Y+      F  E  ++    H N++ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--GTAYGLEYLHEQ 197
            G  T S   +++  FM+N ++   LR    G+    +   + V    G A G++YL E 
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLR-QNDGQ----FTVIQLVGMLRGIAAGMKYLSEM 125

Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT--------TQIRGTMGHI 249
                +HRDL A NIL++ N    + DFGL++ ++   +  T          IR T    
Sbjct: 126 ---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT---- 178

Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVT-GQRAI-DFSRLEEEEDVLLLDHIRKLLREDR 307
           APE ++  K +  +DV+ YGI + E+++ G+R   D S     +DV     I  + ++ R
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS----NQDV-----INAIEQDYR 229

Query: 308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
           L   +D             + Q+ L C Q     RP   Q+V  L
Sbjct: 230 LPPPMDCP---------TALHQLMLDCWQKDRNARPKFGQIVSTL 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 56/218 (25%), Positives = 101/218 (46%), Gaps = 22/218 (10%)

Query: 84  IIGQGGFGKVYKGVLSDNTKV-AVKRLQ---------DYYSPGGEAAFQREVHLISVAIH 133
           +IG+G +G+VY  +     ++ AVK+++         D        A + E+  +    H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
            N++Q +G+ TT     +   ++   S+   LR    G    +    +        GL Y
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR--TYGR--FEEQLVRFFTEQVLEGLAY 123

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPE 252
           LH +    I+HRDLKA N+L+D +    + DFG++K  D    +     ++G++  +APE
Sbjct: 124 LHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180

Query: 253 YLSTGKS--SEKTDVFGYGITLLELVTGQRAIDFSRLE 288
            + +     S K D++  G  +LE+  G+R   +S  E
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP--WSDEE 216

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 78/299 (26%), Positives = 133/299 (44%), Gaps = 54/299 (18%)

Query: 85  IGQGGFGKVYK----GVLS--DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           IGQG FG+V++    G+L     T VAVK L++  S   +A FQRE  L++   H N+++
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP------------------GEKGLDWPTR 180
           L+G C       L++ +M    +   LR   P                      L    +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 181 KRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT 240
             +A   A G+ YL E+   K +HRDL   N L+ +N    + DFGL++ + +   +  +
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 241 Q-----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 295
           +     IR     + PE +   + + ++DV+ YG+ L E+ +      +    EE    +
Sbjct: 190 ENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE----V 241

Query: 296 LDHIRKLLREDRLNDIVDRN-LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
           + ++R            D N L+  D+  +E +  +  LC    P DRP  A + ++LQ
Sbjct: 242 IYYVR------------DGNVLSCPDNCPLE-LYNLMRLCWSKLPSDRPSFASINRILQ 287

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 80.8 bits (200), Expect = 2e-17
 Identities = 67/235 (28%), Positives = 98/235 (41%), Gaps = 42/235 (17%)

Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 136
           +F    +IG+G FGKV      D  K+ A+K    Y +       Q+ V   SV    N 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMK----YMNK------QKCVEKGSVRNVLNE 50

Query: 137 LQLIGYCTTSSERILVYPFMQNLSVA-------YRLRDLKPGEKGLDWPTRKRVAFGT-- 187
            +++       E  L +PF+ NL  +       Y + DL  G   L +   ++V F    
Sbjct: 51  RRIL------QE--LNHPFLVNLWYSFQDEENMYLVVDLLLGGD-LRYHLSQKVKFSEEQ 101

Query: 188 --------AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 239
                      LEYLH +    IIHRD+K  NILLD+     + DF +A  V      +T
Sbjct: 102 VKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD--TLT 156

Query: 240 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 294
           T   GT G++APE L     S   D +  G+T  E + G+R          + + 
Sbjct: 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR 211

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 80.4 bits (198), Expect = 3e-17
 Identities = 65/199 (32%), Positives = 102/199 (51%), Gaps = 16/199 (8%)

Query: 84  IIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           IIG+G FG V +G  +   KVAVK ++ D  +     AF  E  +++   HKNL++L+G 
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA----QAFLEETAVMTKLHHKNLVRLLGV 67

Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 202
              +   I V   M   ++   LR    G   +      + +   A G+EYL  +   K+
Sbjct: 68  ILHNGLYI-VMELMSKGNLVNFLR--TRGRALVSVIQLLQFSLDVAEGMEYLESK---KL 121

Query: 203 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 262
           +HRDL A NIL+ ++  A + DFGLA++    + +    ++ T    APE L   K S K
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSK 177

Query: 263 TDVFGYGITLLELVTGQRA 281
           +DV+ YG+ L E+ +  RA
Sbjct: 178 SDVWSYGVLLWEVFSYGRA 196

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 79.9 bits (197), Expect = 6e-17
 Identities = 60/202 (29%), Positives = 92/202 (45%), Gaps = 18/202 (8%)

Query: 85  IGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
           +G+GGFG+V    +    K+ A K+L  +      GE     E  ++   +    +  + 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILE-KVSSRFIVSLA 59

Query: 142 YC-TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY---GLEYLHEQ 197
           Y   T  +  LV   M    + Y + ++  GE G       R  F  A    GLE+LH++
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFPEA---RAIFYAAQIICGLEHLHQR 114

Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 257
              +I++RDLK  N+LLDD+    + D GLA  V+ K         GT G++APE L   
Sbjct: 115 ---RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGE 169

Query: 258 KSSEKTDVFGYGITLLELVTGQ 279
                 D F  G TL E++ G+
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 79.8 bits (197), Expect = 8e-17
 Identities = 61/200 (30%), Positives = 91/200 (45%), Gaps = 20/200 (10%)

Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           +G G FGKVYK    +    A  ++    S      F  E+ ++S   H N++ L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 204
             ++  ++  F    ++   + +L   E+GL  P  + V       L +LH     K+IH
Sbjct: 73  YENKLWILIEFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIH 126

Query: 205 RDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR----GTMGHIAPEYLSTGKSS 260
           RDLKA NILL  + +  L DFG    V AK    T Q R    GT   +APE ++     
Sbjct: 127 RDLKAGNILLTLDGDVKLADFG----VSAKNKS-TLQKRDTFIGTPYWMAPEVVACETFK 181

Query: 261 E-----KTDVFGYGITLLEL 275
           +     K D++  GITL+EL
Sbjct: 182 DNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 79.1 bits (195), Expect = 9e-17
 Identities = 62/221 (28%), Positives = 111/221 (50%), Gaps = 26/221 (11%)

Query: 71  ELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS 129
           E +   D   E  ++G+G +G VY    LS   ++A+K + +  S   +     E+ L S
Sbjct: 2   EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP-LHEEIALHS 60

Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNL---SVAYRLRD----LKPGEKGLDWPTRKR 182
              H+N++Q +G     SE      FM+ +   S++  LR     LK  E+ + + T++ 
Sbjct: 61  YLKHRNIVQYLGSD---SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI 117

Query: 183 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL--CDFGLAKLVDAKLTHVTT 240
           +      GL+YLH+    +I+HRD+K  N+L+ + +  V+   DFG +K + A +   T 
Sbjct: 118 LE-----GLKYLHDN---QIVHRDIKGDNVLV-NTYSGVVKISDFGTSKRL-AGINPCTE 167

Query: 241 QIRGTMGHIAPEYLSTGKS--SEKTDVFGYGITLLELVTGQ 279
              GT+ ++APE +  G        D++  G T++E+ TG+
Sbjct: 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.7 bits (194), Expect = 1e-16
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 16/208 (7%)

Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQ-DYYSPGGE---AAFQREVHLISVAI 132
           N+    ++GQG FG+VY     D  + +AVK++  D  SP  +    A + E+ L+    
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 133 HKNLLQLIGYCTTSSERILVY-PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL 191
           H+ ++Q  G C    E + ++  +M   SV  +L+      + +   TRK        G+
Sbjct: 63  HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETV---TRK-YTRQILEGV 117

Query: 192 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTMGHI 249
           EYLH      I+HRD+K ANIL D      L DFG +K +    +  T    + GT   +
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174

Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVT 277
           +PE +S      K DV+  G T++E++T
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 22/204 (10%)

Query: 85  IGQGGFGKVYKG-VLSDNTKVAVKRLQDYYSPGGEAA---FQREVHLISVAIHKNLLQLI 140
           +G+G +G V K    +    VA+K+ ++  S   E       REV ++    H+N++ L 
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKE--SEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 141 GYCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
                     LV+ ++ + L     L  L+    GL     +   +     + Y H    
Sbjct: 67  EAFRRKGRLYLVFEYVERTL-----LELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH-- 119

Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL----S 255
             IIHRD+K  NIL+ ++    LCDFG A+ + A+     T    T  + APE L    +
Sbjct: 120 -NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178

Query: 256 TGKSSEKTDVFGYGITLLELVTGQ 279
            GK     DV+  G  + EL+ G+
Sbjct: 179 YGKP---VDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 78.7 bits (195), Expect = 2e-16
 Identities = 58/213 (27%), Positives = 88/213 (41%), Gaps = 39/213 (18%)

Query: 84  IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ----REVHLISVAIHKNLLQ 138
            +G+G +G VYK         VA+K+++      G         RE+ L+    H N+++
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG---IPSTALREISLLKELKHPNIVK 62

Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
           L+    T  +  LV+ +         L+  L      L     K + +    GL Y H  
Sbjct: 63  LLDVIHTERKLYLVFEYCD-----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117

Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTH--VTTQIRGTMGHIAPE 252
              +I+HRDLK  NIL++ +    L DFGLA+         TH  VT   R      APE
Sbjct: 118 ---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYR------APE 168

Query: 253 YL------STGKSSEKTDVFGYGITLLELVTGQ 279
            L      ST       D++  G    E++TG+
Sbjct: 169 ILLGSKHYSTA-----VDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 78.3 bits (193), Expect = 2e-16
 Identities = 71/287 (24%), Positives = 122/287 (42%), Gaps = 31/287 (10%)

Query: 78  NFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA 131
           N  E   +G+G FG+V+             T V VK LQ       ++ F+RE+ +    
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 132 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWP---TRKRVAFGT- 187
            HKN+++L+G C  +    ++  +     +   LR  K  ++ L  P   T+++VA  T 
Sbjct: 66  SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 188 -AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
            A G+++L    N + +HRDL A N L+    E  +    L+K V     +        +
Sbjct: 126 IALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182

Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 306
             +APE +     S K+DV+ +G+ + E+ T Q  + F  L +EE               
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-QGELPFYGLSDEE--------------- 226

Query: 307 RLNDIVDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
            LN +    L           + ++   C    P+DRP  +++V  L
Sbjct: 227 VLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 61/221 (27%), Positives = 95/221 (42%), Gaps = 40/221 (18%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAF-QREVHLISVAIHK 134
           +++     IG G +G VYK   ++    VA+K ++    PG +    Q+E+ ++    H 
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK--LEPGDDFEIIQQEISMLKECRHP 60

Query: 135 NLLQLIG-------------YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK 181
           N++   G             YC   S           L   Y++      E  + +  R+
Sbjct: 61  NIVAYFGSYLRRDKLWIVMEYCGGGS-----------LQDIYQVTRGPLSELQIAYVCRE 109

Query: 182 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 241
                T  GL YLHE      IHRD+K ANILL ++ +  L DFG++  + A +    + 
Sbjct: 110 -----TLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF 161

Query: 242 IRGTMGHIAPEYL---STGKSSEKTDVFGYGITLLELVTGQ 279
           I GT   +APE       G    K D++  GIT +EL   Q
Sbjct: 162 I-GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQ 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 30/221 (13%)

Query: 84  IIGQGGFGKVYKGV------LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
            +G+G FGKV K         +  T VAVK L++  S         E +L+    H +++
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLR--------------------DLKPGEKGLDW 177
           +L G C+     +L+  + +  S+   LR                       P E+ L  
Sbjct: 67  KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 178 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 237
                 A+  + G++YL E    K++HRDL A N+L+ +  +  + DFGL++ V  + ++
Sbjct: 127 GDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183

Query: 238 VT-TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
           V  ++ R  +  +A E L     + ++DV+ +G+ L E+VT
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 77.6 bits (192), Expect = 4e-16
 Identities = 70/281 (24%), Positives = 110/281 (39%), Gaps = 65/281 (23%)

Query: 77  DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRL----------QDYYSPGGEAAFQREV 125
           D+F    IIG+G F  V        N + A+K L            Y         ++EV
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKY------VKIEKEV 54

Query: 126 HLISVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 183
            L  +  H  +++L  Y T   E  L  V  +  N  +   +R        LD    +  
Sbjct: 55  -LTRLNGHPGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYG----SLDEKCTRFY 107

Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 243
           A      LEYLH +    IIHRDLK  NILLD +    + DFG AK++D   +  + +  
Sbjct: 108 AAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGD 164

Query: 244 -------------------GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID- 283
                              GT  +++PE L+   + + +D++  G  + +++TG+     
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224

Query: 284 ------FSRLEEEE-------DVLLLDHIRKLLR---EDRL 308
                 F ++ + E            D I KLL    +DRL
Sbjct: 225 SNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRL 265

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 78.1 bits (192), Expect = 4e-16
 Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 19/213 (8%)

Query: 74  LATDNFSESNIIGQGGFGKVYKGVL---SDNTK--VAVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++G G FG VYKG+     +  K  VA+K L++  SP        E +++
Sbjct: 4   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 63

Query: 129 SVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ +++  + PF   L      +D    +  L+W  +      
Sbjct: 64  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------ 117

Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRG 244
            A G+ YL E+   +++HRDL A N+L+       + DFGLAKL+  D K  H     + 
Sbjct: 118 IAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG-KV 173

Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
            +  +A E +     + ++DV+ YG+T+ EL+T
Sbjct: 174 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 77.1 bits (190), Expect = 7e-16
 Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 18/203 (8%)

Query: 85  IGQGGFGKVYK---GVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +G+G FG V       L DNT   VAVK+LQ + +      F+RE+ ++    H N+++ 
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ-HSTAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 140 IGYCTTSSER--ILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHE 196
            G C ++  R   LV  ++   S    LRD L+   + LD       A     G+EYL  
Sbjct: 71  KGVCYSAGRRNLRLVMEYLPYGS----LRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126

Query: 197 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYL 254
           +   + +HRDL   NIL++      + DFGL K++  D +   V       +   APE L
Sbjct: 127 K---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183

Query: 255 STGKSSEKTDVFGYGITLLELVT 277
           +  K S  +DV+ +G+ L EL T
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 76.7 bits (188), Expect = 7e-16
 Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 12/203 (5%)

Query: 79  FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLL 137
           F++   IG+G FG+V+KG+ +   KV   ++ D      E    Q+E+ ++S      + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
           +  G     ++   ++  M+ L     L  L+PG   LD      +      GL+YLH +
Sbjct: 66  KYYGSYLKDTK---LWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSE 120

Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYLST 256
              K IHRD+KAAN+LL ++ E  L DFG+A +L D ++        GT   +APE +  
Sbjct: 121 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQ 175

Query: 257 GKSSEKTDVFGYGITLLELVTGQ 279
                K D++  GIT +EL  G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 76.5 bits (189), Expect = 8e-16
 Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 14/199 (7%)

Query: 85  IGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG-Y 142
           +GQG  G VYK          A+K++             RE+  +       +++  G +
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68

Query: 143 CTTSSERI-LVYPFMQNLSVAYRLRDLKP-GEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 200
                  I +V  +M   S+A  L+ +    E  L       +A     GL+YLH +   
Sbjct: 69  Y--KEGEISIVLEYMDGGSLADLLKKVGKIPEPVL-----AYIARQILKGLDYLHTK--R 119

Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 260
            IIHRD+K +N+L++   E  + DFG++K+++  L    T + GT+ +++PE +     S
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYS 178

Query: 261 EKTDVFGYGITLLELVTGQ 279
              D++  G+TLLE   G+
Sbjct: 179 YAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 76.5 bits (188), Expect = 1e-15
 Identities = 77/277 (27%), Positives = 127/277 (45%), Gaps = 32/277 (11%)

Query: 84  IIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +IG G FG+V  G L    K    VA+K L+  Y+      F  E  ++    H N++ L
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
            G  T S   ++V  +M+N S+   LR        +      R   G A G++YL +   
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---GIASGMKYLSDM-- 125

Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLSTG 257
              +HRDL A NIL++ N    + DFGL++++  D +  + T   +  +   APE ++  
Sbjct: 126 -GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184

Query: 258 KSSEKTDVFGYGITLLELVT-GQRAI-DFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 315
           K +  +DV+ YGI + E+++ G+R   + S     +DV     I+ +    RL   +D  
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERPYWEMS----NQDV-----IKAIEEGYRLPAPMDCP 235

Query: 316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
              +         Q+ L C Q    +RP   Q+V +L
Sbjct: 236 AALH---------QLMLDCWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 12/203 (5%)

Query: 79  FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLL 137
           F++   IG+G FG+VYKG+ +   +V   ++ D      E    Q+E+ ++S      + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
           +  G     ++   ++  M+ L     L  LKPG   L+      +      GL+YLH +
Sbjct: 66  RYYGSYLKGTK---LWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLHSE 120

Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYLST 256
              + IHRD+KAAN+LL +  +  L DFG+A +L D ++   T    GT   +APE +  
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 175

Query: 257 GKSSEKTDVFGYGITLLELVTGQ 279
                K D++  GIT +EL  G+
Sbjct: 176 SAYDFKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 76.4 bits (189), Expect = 1e-15
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 17/201 (8%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVH-LISVAIHKNLLQLIG 141
           +G G FG VY          VA+K++ + +YS   E    REV  L  +  H N+++L  
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKE 65

Query: 142 YCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 200
               + E   V+ +M  NL    + R  KP          + + +    GL ++H+    
Sbjct: 66  VFRENDELYFVFEYMEGNLYQLMKDRKGKP----FSESVIRSIIYQILQGLAHIHKH--- 118

Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL--STGK 258
              HRDLK  N+L+       + DFGLA+ + ++  + T  +  T  + APE L  ST  
Sbjct: 119 GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYV-STRWYRAPEILLRSTSY 176

Query: 259 SSEKTDVFGYGITLLELVTGQ 279
           SS   D++  G  + EL T +
Sbjct: 177 SS-PVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 76.0 bits (187), Expect = 1e-15
 Identities = 65/203 (32%), Positives = 95/203 (46%), Gaps = 23/203 (11%)

Query: 85  IGQGGFGKVY------KGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G+GGFG+V        G L    K+  KRL+     G E A   +  L  V  H   + 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK--RKGYEGAMVEKRILAKV--HSRFIV 56

Query: 139 LIGYC-TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY---GLEYL 194
            + Y   T ++  LV   M    + Y + ++     G   P   R  F TA    GLE+L
Sbjct: 57  SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEP---RACFYTAQIISGLEHL 113

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEY 253
           H++   +II+RDLK  N+LLD++    + D GLA +L D +    T    GT G +APE 
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTKGYAGTPGFMAPEL 168

Query: 254 LSTGKSSEKTDVFGYGITLLELV 276
           L   +     D F  G+TL E++
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMI 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 76.1 bits (187), Expect = 1e-15
 Identities = 63/224 (28%), Positives = 114/224 (50%), Gaps = 26/224 (11%)

Query: 84  IIGQGGFGKVYKGVL---SDNTK--VAVKRLQDYYSPGGEAAFQREV-HLISVAI--HKN 135
           ++G G FG V+KG+     D+ K  VA+K +QD     G   FQ    H++++    H  
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR---SGRQTFQEITDHMLAMGSLDHAY 70

Query: 136 LLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
           +++L+G C  +S +++  + P    L    + RD    ++ L+W  +       A G+ Y
Sbjct: 71  IVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYY 124

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAP 251
           L E     ++HR+L A NILL  +    + DFG+A L+  D K  +  ++ +  +  +A 
Sbjct: 125 LEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK-KYFYSEHKTPIKWMAL 180

Query: 252 EYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVL 294
           E +  G+ + ++DV+ YG+T+ E+++ G       R  E  D+L
Sbjct: 181 ESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL 224

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 75.3 bits (185), Expect = 2e-15
 Identities = 67/273 (24%), Positives = 113/273 (41%), Gaps = 32/273 (11%)

Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           +G G FG V  G       VA+K +++      E  F  E  ++    H+ L+QL G CT
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 204
                 +V  +M N  +   LR+     K         +      G+ YL  +   + IH
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLESK---QFIH 123

Query: 205 RDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQ--IRGTMGHIAPEYLSTGKSS 260
           RDL A N L+DD     + DFGL++ V  D   + V ++  +R +     PE L   K S
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLLYSKFS 179

Query: 261 EKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYD 320
            K+DV+ +G+ + E+ +  + + + R    E V  +    +L R    +           
Sbjct: 180 SKSDVWAFGVLMWEVYSLGK-MPYERFNNSETVEKVSQGLRLYRPHLAS----------- 227

Query: 321 SKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
               E +  +   C     E+RP   Q++  ++
Sbjct: 228 ----EKVYAIMYSCWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 52/175 (29%), Positives = 87/175 (49%), Gaps = 20/175 (11%)

Query: 182 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTT 240
           ++A     GL YL+     +I+HRD+K +NIL++   +  LCDFG++ +L+++    +  
Sbjct: 107 KIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IAD 160

Query: 241 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 300
              GT  +++PE +  GK + K+DV+  GI+++EL  G+    FS      D    D   
Sbjct: 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS----NIDDDGQDDPM 216

Query: 301 KLLREDRLNDIVDR---NLNTYD-SKEVETMVQVALLCTQSTPEDRPPMAQVVKM 351
            +L  D L  IV      L + D  +++   V   LL     P +RP   Q+  M
Sbjct: 217 GIL--DLLQQIVQEPPPRLPSSDFPEDLRDFVDACLL---KDPTERPTPQQLCAM 266

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 78/307 (25%), Positives = 125/307 (40%), Gaps = 58/307 (18%)

Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLS----DNTK--VAVKRLQDYYSPGGEAAFQREVH 126
           ++  D+ +    +G G FG+VY+G+      D  +  VAVK L +  S   E+ F  E  
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 127 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR---- 182
           ++S   H+N+++LIG       R ++   M    +   LR+ +P     + P+       
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRP---RPERPSSLTMKDL 118

Query: 183 --VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE---AVLCDFGLAKLVDAKLTH 237
              A   A G +YL E      IHRD+ A N LL        A + DFG+A+  D     
Sbjct: 119 LFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--DIYRAS 173

Query: 238 VTTQIRGTMGHIA---PEYLSTGKSSEKTDVFGYGITLLELV-------TGQRAIDFSRL 287
              +    M  I    PE    G  + KTDV+ +G+ L E+         G+        
Sbjct: 174 YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT------- 226

Query: 288 EEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMV-QVALLCTQSTPEDRPPMA 346
              ++V+       +    RL+            K     V ++   C Q TPEDRP  A
Sbjct: 227 --NQEVMEF-----VTGGGRLD----------PPKGCPGPVYRIMTDCWQHTPEDRPNFA 269

Query: 347 QVVKMLQ 353
            +++ +Q
Sbjct: 270 TILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 75.3 bits (186), Expect = 4e-15
 Identities = 63/226 (27%), Positives = 99/226 (43%), Gaps = 58/226 (25%)

Query: 83  NIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REVHLISVAI 132
             IG G +G V   V      KVA+K++ +         F          RE+ L+    
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISN--------VFDDLIDAKRILREIKLLRHLR 57

Query: 133 HKNLLQLI-----GYCTTSSERILVYPFMQ-NL-SVAYRLRDLKPGEKGLDWPTRKRVAF 185
           H+N++ L+           ++  +V   M+ +L  V    + L          T   + +
Sbjct: 58  HENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPL----------TDDHIQY 107

Query: 186 GTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK------L 235
              Y    GL+YLH   N  +IHRDLK +NIL++ N +  +CDFGLA+ VD        L
Sbjct: 108 FL-YQILRGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163

Query: 236 T-HVTTQ-IRGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELVTG 278
           T +V T+  R      APE  LS+ + ++  D++  G    EL+T 
Sbjct: 164 TEYVVTRWYR------APELLLSSSRYTKAIDIWSVGCIFAELLTR 203

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 74.3 bits (182), Expect = 6e-15
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 24/226 (10%)

Query: 71  ELQLATDNFSESNIIGQGGFGKVYKGVL----SDNTK-VAVKRLQDYYSPGGEAAFQREV 125
           EL L+   F E   +G+  FGK+YKG L     D+ + VA+K L+D  +P     FQ+E 
Sbjct: 1   ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58

Query: 126 HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP--------GEKG--- 174
            L++   H N++ L+G  T      +++ ++    +   L    P         E G   
Sbjct: 59  SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118

Query: 175 --LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LV 231
             LD      +A   A G+EYL        +H+DL A NIL+ +     + D GL++ + 
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIY 175

Query: 232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
            A    V  +    +  + PE +  GK S  +D++ +G+ L E+ +
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 74.3 bits (182), Expect = 7e-15
 Identities = 61/221 (27%), Positives = 107/221 (48%), Gaps = 20/221 (9%)

Query: 84  IIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           ++G G FG VYKG+      +    VA+K L +   P     F  E  +++   H +L++
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 139 LIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 196
           L+G C + + +++  + P    L   +  +D    +  L+W  +       A G+ YL E
Sbjct: 74  LLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127

Query: 197 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM--GHIAPEYL 254
           +   +++HRDL A N+L+       + DFGLA+L++           G M    +A E +
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD-GGKMPIKWMALECI 183

Query: 255 STGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVL 294
              K + ++DV+ YG+T+ EL+T G +  D     E  D+L
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 73.6 bits (181), Expect = 9e-15
 Identities = 74/299 (24%), Positives = 126/299 (42%), Gaps = 52/299 (17%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNT-----KVAVKRLQDYYSPGGEAAFQREVHLISVA 131
           D  + S+++ +G FG+++ G+L D       +V VK ++D+ S        +E  L+   
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65

Query: 132 IHKNLLQLIGYCTTSSERILV-YPFMQ--NLSVAYRLRDLKPGEKGLDWPTRKRVAFGT- 187
            H+N+L ++  C    E   V YP+M   NL +  +   L          T++ V     
Sbjct: 66  SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125

Query: 188 -AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
            A G+ YLH      +IH+D+ A N ++D+  +  + D  L++ +     H        +
Sbjct: 126 IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH-------CL 175

Query: 247 GH--------IAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRA---IDFSRLEEEEDVL 294
           G         +A E L   + S  +DV+ +G+ L EL+T GQ     ID      E    
Sbjct: 176 GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID----PFEMAAY 231

Query: 295 LLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
           L D  R           + + +N  D      +  V   C    PE+RP  +Q+V+ L 
Sbjct: 232 LKDGYR-----------LAQPINCPDE-----LFAVMACCWALDPEERPSFSQLVQCLT 274

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 73.4 bits (180), Expect = 1e-14
 Identities = 65/221 (29%), Positives = 100/221 (45%), Gaps = 25/221 (11%)

Query: 85  IGQGGFGKVYKGVLSDNT-------KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
           +G+GGFG+V   V   NT       K+  KRL+      GE     E  ++       ++
Sbjct: 1   LGKGGFGEVC-AVQVKNTGKMYACKKLDKKRLK---KKSGEKMALLEKEILEKVNSPFIV 56

Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY---GLEYL 194
            L     + +   LV   M    + Y + ++  GE+GL+    +RV   +A    G+ +L
Sbjct: 57  NLAYAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEM---ERVIHYSAQITCGILHL 111

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 254
           H      I++RD+K  N+LLDD     L D GLA  V+ K     TQ  GT G++APE L
Sbjct: 112 HSM---DIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEIL 166

Query: 255 STGKSSEKTDVFGYGITLLELVTGQRAI-DFSRLEEEEDVL 294
                S   D F  G ++ E+V G+    D      +E++ 
Sbjct: 167 KEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 72/296 (24%), Positives = 129/296 (43%), Gaps = 41/296 (13%)

Query: 85  IGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +GQG FG VY+G   D       T+VAVK + +  S      F  E  ++      ++++
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEK---GLDWPTRK---RVAFGTAYGLE 192
           L+G  +     ++V   M +  +   LR L+P  +   G   PT +   ++A   A G+ 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG----- 247
           YL+ +   K +HRDL A N ++  +F   + DFG+ +     +       +G  G     
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 186

Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 307
            +APE L  G  +  +D++ +G+ L E+         + L E+         + L  E  
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEI---------TSLAEQP-------YQGLSNEQV 230

Query: 308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAE 363
           L  ++D           E +  +  +C Q  P+ RP   ++V +L+ +DL   + E
Sbjct: 231 LKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK-DDLHPSFPE 285

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 73.0 bits (179), Expect = 1e-14
 Identities = 72/300 (24%), Positives = 123/300 (41%), Gaps = 64/300 (21%)

Query: 78  NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEA-----AFQREVHLISVA 131
            + +   +G G F   Y+   +   T +AVK++    +   E      A ++E+ L++  
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 132 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY-- 189
            H ++++++G     S   L   +M   SV++ L      ++          A    Y  
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE----------AVIINYTE 110

Query: 190 ----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLT---HVTTQ 241
               GL YLHE    +IIHRD+K AN+L+D   + + + DFG A  + AK T       Q
Sbjct: 111 QLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ 167

Query: 242 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR-----------AIDFSRLEEE 290
           + GT+  +APE L   +     DV+  G  ++E+ T +            A+ F      
Sbjct: 168 LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT 227

Query: 291 EDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
               + +H+   LR+                        V L C +  PEDRPP  +++K
Sbjct: 228 TAPSIPEHLSPGLRD------------------------VTLRCLELQPEDRPPSRELLK 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 48/176 (27%), Positives = 74/176 (42%), Gaps = 33/176 (18%)

Query: 75  ATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKR-LQDYYSPGGEAAFQREVHLISVAI 132
              ++     +G+G FG+VYK   +     VA+K+ L      G      RE+ ++    
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65

Query: 133 HKNLLQLIGYCTTSSERI--------LVYPFM--------QNLSVAYRLRDLKPGEKGLD 176
           H N++ LI       ++         +V P+M        +N SV      +K     L 
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL- 124

Query: 177 WPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 232
                        G+ YLHE     I+HRD+KAANIL+D+     + DFGLA+  D
Sbjct: 125 -----------LEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYD 166

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 73.0 bits (179), Expect = 1e-14
 Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 19/203 (9%)

Query: 85  IGQGGFGKV----YKGVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G+G FGKV    Y    +D T   VAVK L+        + +++E++++    H+N+++
Sbjct: 12  LGEGHFGKVSLYCYDPA-NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70

Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
             G C+    + L    M+ + +   LRD  P  K L+       A     G+ YLH Q 
Sbjct: 71  YKGCCSEQGGKGLQL-IMEYVPLG-SLRDYLPKHK-LNLAQLLLFAQQICEGMAYLHSQ- 126

Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR----GTMGHIAPEYL 254
               IHRDL A N+LLD++    + DFGLAK V     H   ++R      +   A E L
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG--HEYYRVREDGDSPVFWYAVECL 182

Query: 255 STGKSSEKTDVFGYGITLLELVT 277
              K S  +DV+ +G+TL EL+T
Sbjct: 183 KENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 52/301 (17%)

Query: 83  NIIGQGGFGKVYKGVLSDN---TKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQ 138
           ++IG+G FG+V K  +  +      A+KR+++Y S      F  E+  L  +  H N++ 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVA------------FG 186
           L+G C       L   +  + ++   LR  +  E    +      A              
Sbjct: 73  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
            A G++YL ++   + IHRDL A NIL+ +N+ A + DFGL++  +         ++ TM
Sbjct: 133 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTM 182

Query: 247 GHI-----APEYLSTGKSSEKTDVFGYGITLLELVT--GQRAIDFSRLEEEEDVLLLDHI 299
           G +     A E L+    +  +DV+ YG+ L E+V+  G      +  E  E        
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE-------- 234

Query: 300 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAE 359
            KL +  RL    ++ LN  D +  + M Q    C +  P +RP  AQ++  L    L E
Sbjct: 235 -KLPQGYRL----EKPLNC-DDEVYDLMRQ----CWREKPYERPSFAQILVSL-NRMLEE 283

Query: 360 R 360
           R
Sbjct: 284 R 284

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 18/216 (8%)

Query: 79  FSESNIIGQGGFGKVYKGVL--SDNT--KVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 133
           F+   ++G+G FG V +  L   D +  KVAVK L+ D +S      F RE   +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 134 KNLLQLIGYCTTSSER------ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF-- 185
            N+++LIG    S  +      +++ PFM++  +   L   + GE+    P +  V F  
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 186 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRG 244
             A G+EYL    +   IHRDL A N +L++N    + DFGL+ K+            + 
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQ 279
            +  +A E L+    +  +DV+ +G+T+ E++T GQ
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 25/206 (12%)

Query: 84  IIGQGGFGKVYKGVL---SDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           ++G G FG VYKG+     +N K  VA+K L++  SP        E ++++      + +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 139 LIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 196
           L+G C TS+ +++  + P+   L      +D    +  L+W  +       A G+ YL E
Sbjct: 74  LLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127

Query: 197 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI-----AP 251
               +++HRDL A N+L+       + DFGLA+L+D       T+     G +     A 
Sbjct: 128 V---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDID----ETEYHADGGKVPIKWMAL 180

Query: 252 EYLSTGKSSEKTDVFGYGITLLELVT 277
           E +   + + ++DV+ YG+T+ EL+T
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 72.2 bits (177), Expect = 3e-14
 Identities = 63/232 (27%), Positives = 103/232 (44%), Gaps = 22/232 (9%)

Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTKV-AVKR--LQDYYSPGGEAAFQREVHLISVAIHK 134
           +F   N IG+G FG V+K V   + +V A+K+  L        E A   E  +++     
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAKLDSS 59

Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--RVAFGTAYGLE 192
               +I Y  +  ++  +   M+       L  L   ++G   P  +  R       GL 
Sbjct: 60  ---YIIRYYESFLDKGKLNIVMEYAENG-DLHKLLKMQRGRPLPEDQVWRFFIQILLGLA 115

Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 252
           +LH +   KI+HRD+K+ N+ LD      + D G+AKL+    T+    I GT  +++PE
Sbjct: 116 HLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN-TNFANTIVGTPYYLSPE 171

Query: 253 YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 304
                  +EK+DV+  G+ L E  TG+   D       +  L    I K++R
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFD----ANNQGAL----ILKIIR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 72.1 bits (177), Expect = 3e-14
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 13/209 (6%)

Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKN 135
           NF +   IG+G +G VYK       + VA+K+++ D  + G  +   RE+ L+    H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 136 LLQLIGYCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           +++L+    T ++  LV+ F+ Q+L    +  D  P   G+  P  K   F    GL + 
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLHQDLK---KFMDASPLS-GIPLPLIKSYLFQLLQGLAFC 116

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 254
           H     +++HRDLK  N+L++      L DFGLA+     +   T ++  T+ + APE L
Sbjct: 117 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 172

Query: 255 STGK-SSEKTDVFGYGITLLELVTGQRAI 282
              K  S   D++  G    E+VT +RA+
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 72.0 bits (177), Expect = 4e-14
 Identities = 39/94 (41%), Positives = 56/94 (59%), Gaps = 10/94 (10%)

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHI 249
           L YL E+    +IHRD+K +NILLD +    LCDFG++ +LVD+K     T+  G   ++
Sbjct: 127 LHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK---AKTRSAGCAAYM 181

Query: 250 APEYLSTGKSSEK----TDVFGYGITLLELVTGQ 279
           APE +     + K     DV+  GI+L+EL TGQ
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 71.9 bits (177), Expect = 4e-14
 Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 12/206 (5%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 134
            + +     IG+G  G+VYK    +   +VA+K++        E     E+ ++    H 
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIIN-EILIMKDCKHP 75

Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           N++          E  +V  +M   S+   +         ++ P    V      GLEYL
Sbjct: 76  NIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT---QNFVRMNEPQIAYVCREVLQGLEYL 132

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL-AKLVDAKLTHVTTQIRGTMGHIAPEY 253
           H Q    +IHRD+K+ NILL  +    L DFG  A+L   K    +  + GT   +APE 
Sbjct: 133 HSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEV 187

Query: 254 LSTGKSSEKTDVFGYGITLLELVTGQ 279
           +       K D++  GI  +E+  G+
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 71.6 bits (176), Expect = 5e-14
 Identities = 43/102 (42%), Positives = 57/102 (55%), Gaps = 13/102 (12%)

Query: 183 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVD--AKLTHVT 239
           +A  T   L YL E    KIIHRD+K +NILLD N    LCDFG++ +LVD  AK     
Sbjct: 112 IAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK----- 164

Query: 240 TQIRGTMGHIAPEYLSTGKSSE---KTDVFGYGITLLELVTG 278
           T+  G   ++APE +          ++DV+  GITL E+ TG
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 71.8 bits (176), Expect = 6e-14
 Identities = 57/209 (27%), Positives = 104/209 (49%), Gaps = 19/209 (9%)

Query: 76  TDNFSESNIIGQGGFGKV--YKGVLSDNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAI 132
           T+ + +   +G G FG V   +  L+    VA+K++   +S P       RE+ L+    
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67

Query: 133 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 192
           H+N++ L     +  E I     +    +  RL   +P EK       +   +    GL+
Sbjct: 68  HENIISLSDIFISPLEDIYFVTELLGTDLH-RLLTSRPLEKQF----IQYFLYQILRGLK 122

Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAP 251
           Y+H   +  ++HRDLK +NIL+++N +  +CDFGLA++ D ++T +V+T+      + AP
Sbjct: 123 YVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAP 174

Query: 252 EYLST-GKSSEKTDVFGYGITLLELVTGQ 279
           E + T  K   + D++  G    E++ G+
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 71.2 bits (174), Expect = 8e-14
 Identities = 65/200 (32%), Positives = 95/200 (47%), Gaps = 20/200 (10%)

Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           +G G FGKVYK    +   +A  ++ D  S      +  E+ +++   H N+++L+    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 204
             +   ++  F    +V   + +L   E+ L  P  + V   T   L YLHE    KIIH
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIH 126

Query: 205 RDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR----GTMGHIAPEYLSTGKSS 260
           RDLKA NIL   + +  L DFG    V AK T  T Q R    GT   +APE +    S 
Sbjct: 127 RDLKAGNILFTLDGDIKLADFG----VSAKNTR-TIQRRDSFIGTPYWMAPEVVMCETSK 181

Query: 261 E-----KTDVFGYGITLLEL 275
           +     K DV+  GITL+E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 71.2 bits (174), Expect = 8e-14
 Identities = 80/293 (27%), Positives = 131/293 (44%), Gaps = 51/293 (17%)

Query: 83  NIIGQGGFGKVYKGVL-SDNTKV--AVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQ 138
           ++IG+G FG+V + ++  D  K+  A+K L+++ S      F  E+  L  +  H N++ 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 139 LIGYCTTSSE---RILVYPFMQNLSVAYRLRDLKPG-----EKG----LDWPTRKRVAFG 186
           L+G C         I   P+   L    + R L+       E G    L      + A  
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
            A G++YL E+   + IHRDL A N+L+ +N  + + DFGL++  +         ++ TM
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEE-------VYVKKTM 177

Query: 247 GHI-----APEYLSTGKSSEKTDVFGYGITLLELVT--GQRAIDFSRLEEEEDVLLLDHI 299
           G +     A E L+    + K+DV+ +G+ L E+V+  G      +  E  E        
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE-------- 229

Query: 300 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
            KL +  R+     RN    D +  E M Q    C +  P +RPP AQ+   L
Sbjct: 230 -KLPQGYRMEK--PRNC---DDEVYELMRQ----CWRDRPYERPPFAQISVQL 272

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 71.0 bits (174), Expect = 8e-14
 Identities = 77/299 (25%), Positives = 128/299 (42%), Gaps = 56/299 (18%)

Query: 77  DNFSESNIIGQGGFGKVYKGV---LSDN---TKVAVKRLQDYYSPGGEAAFQREVHLIS- 129
           +N S    +G G FGKV +     LS +    KVAVK L+         A   E+ ++S 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT-- 187
           +  H+N++ L+G CT     +++  +           DL      L++  RKR +F T  
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYC-------CYGDL------LNFLRRKRESFLTLE 141

Query: 188 ---------AYGLEYL-HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 237
                    A G+ +L  + C    IHRDL A N+LL       +CDFGLA+ +     +
Sbjct: 142 DLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNY 197

Query: 238 VTT-QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR-LEEEEDVLL 295
           V     R  +  +APE +     + ++DV+ YGI L E+        FS        + +
Sbjct: 198 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI--------FSLGSNPYPGMPV 249

Query: 296 LDHIRKLLRED-RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                KL++E  R+          +   E+  +++    C  + P  RP   Q+V+++ 
Sbjct: 250 DSKFYKLIKEGYRMAQPE------HAPAEIYDIMKT---CWDADPLKRPTFKQIVQLIG 299

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 70.3 bits (172), Expect = 9e-14
 Identities = 71/270 (26%), Positives = 118/270 (43%), Gaps = 28/270 (10%)

Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           +G G FG V+ G      KVA+K + +      E  F  E  ++    H  L+QL G CT
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINE--GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 204
                 +V  FM+N  +   LR  + G+   D      +      G+EYL E+ +   IH
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLRQ-RQGKLSKD--MLLSMCQDVCEGMEYL-ERNS--FIH 123

Query: 205 RDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           RDL A N L+       + DFG+ + V D + T  ++  +  +    PE  +  K S K+
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS-SSGAKFPVKWSPPEVFNFSKYSSKS 182

Query: 264 DVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSK- 322
           DV+ +G+ + E+ T  +       E++ +    + +  + R  RL          Y  K 
Sbjct: 183 DVWSFGVLMWEVFTEGKM----PFEKKSN---YEVVEMISRGFRL----------YRPKL 225

Query: 323 EVETMVQVALLCTQSTPEDRPPMAQVVKML 352
              T+ +V   C    PE RP  A++++ +
Sbjct: 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 19/218 (8%)

Query: 68  SCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQ-DYYSPGGEAAFQREV 125
            CR +      F + N IG+G +G VY+   + + + VA+K+++ D    G   +  RE+
Sbjct: 2   RCRSVT----EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREI 57

Query: 126 HLISVAIHKNLLQLIGYCTTSS-ERI-LVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKR 182
            L+    H N+++L         + I LV  +  Q+L+    L D  P          K 
Sbjct: 58  TLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLA---SLLDNMP--TPFSESQVKC 112

Query: 183 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 242
           +      GL+YLHE     IIHRDLK +N+LL D     + DFGLA+        +T ++
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV 169

Query: 243 RGTMGHIAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 279
             T+ + APE L      +   D++  G  L EL+  +
Sbjct: 170 V-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 25/215 (11%)

Query: 85  IGQGGFGKVYK----GVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISV-AIHKN 135
           +G+G FG+V +    G+          VAVK L+D  +    A    E+ L+ +   HKN
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRV 183
           ++ L+G CT      ++  +    ++   LR  +P             E+ L +      
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQI 242
           A+  A G+EYL  +   + IHRDL A N+L+ ++    + DFGLA+ V D      T+  
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 243 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
           R  +  +APE L     + ++DV+ +GI + E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 69/298 (23%), Positives = 131/298 (43%), Gaps = 40/298 (13%)

Query: 73  QLATDNFSESNIIGQGGFGKVY----KGVLSDN--TKVAVKRLQDYYSPGGEAAFQREVH 126
           ++A +  + S  +GQG FG VY    KGV+ D   T+VA+K + +  S      F  E  
Sbjct: 2   EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61

Query: 127 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKRV 183
           ++      ++++L+G  +     +++   M    +   LR L+P          P+ K++
Sbjct: 62  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121

Query: 184 ---AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT 240
              A   A G+ YL+     K +HRDL A N ++ ++F   + DFG+ +     +     
Sbjct: 122 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDY 174

Query: 241 QIRGTMG-----HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 295
             +G  G      ++PE L  G  +  +DV+ +G+ L E+ T          E+    + 
Sbjct: 175 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT--------LAEQPYQGMS 226

Query: 296 LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
            + + + + E  L D  D   N  D      + ++  +C Q  P+ RP   +++  ++
Sbjct: 227 NEQVLRFVMEGGLLDKPD---NCPD-----MLFELMRMCWQYNPKMRPSFLEIISSIK 276

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 12/207 (5%)

Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQ-DYYSPGGE---AAFQREVHLISVAI 132
           N+    ++GQG FG+VY    +D  + +AVK++Q D  SP       A + E+ L+   +
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 133 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 192
           H+ ++Q  G      ER L   FM+       ++D       L     ++       G+ 
Sbjct: 63  HERIVQYYGCLRDPMERTLSI-FME-HMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS 120

Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTMGHIA 250
           YLH      I+HRD+K ANIL D      L DFG +K +       T    + GT   ++
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177

Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVT 277
           PE +S      K D++  G T++E++T
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 77/293 (26%), Positives = 124/293 (42%), Gaps = 51/293 (17%)

Query: 83  NIIGQGGFGKVYKGVLSDN---TKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQ 138
           ++IG+G FG+V K  +  +      A+KR+++Y S      F  E+  L  +  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 139 LIGYCTTSSE---RILVYPFMQNLSVAYRLRDLKPG-----EKG----LDWPTRKRVAFG 186
           L+G C         I   P    L    + R L+              L        A  
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
            A G++YL ++   + IHRDL A NIL+ +N+ A + DFGL++  +         ++ TM
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTM 170

Query: 247 GHI-----APEYLSTGKSSEKTDVFGYGITLLELVT--GQRAIDFSRLEEEEDVLLLDHI 299
           G +     A E L+    +  +DV+ YG+ L E+V+  G      +  E  E        
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE-------- 222

Query: 300 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
            KL +  RL      N    D +  + M Q    C +  P +RP  AQ++  L
Sbjct: 223 -KLPQGYRLEK--PLNC---DDEVYDLMRQ----CWREKPYERPSFAQILVSL 265

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 78/303 (25%), Positives = 135/303 (44%), Gaps = 43/303 (14%)

Query: 73  QLATDNFSESNIIGQGGFGKVYK----GVLSDNTK----VAVKRLQDYYSPGGEAAFQRE 124
           + + D  +    +G+G FG+V      G+  D  K    VAVK L+D  +    +    E
Sbjct: 11  EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70

Query: 125 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP------------G 171
           + ++  +  HKN++ L+G CT      ++  +    ++   LR  +P             
Sbjct: 71  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130

Query: 172 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 231
           ++ + +       +  A G+EYL  Q   K IHRDL A N+L+ +N    + DFGLA+ V
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDV 187

Query: 232 -DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEE 289
            +      TT  R  +  +APE L     + ++DV+ +G+ + E+ T G        +EE
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247

Query: 290 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 349
                    + KLL+E      +D+  N   + E+  M++    C  + P  RP   Q+V
Sbjct: 248 ---------LFKLLKEGHR---MDKPANC--TNELYMMMRD---CWHAIPSHRPTFKQLV 290

Query: 350 KML 352
           + L
Sbjct: 291 EDL 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 56/192 (29%), Positives = 91/192 (47%), Gaps = 30/192 (15%)

Query: 79  FSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEA----AFQREVHL---ISV 130
           + E   IG+G +G VYK   L+    VA+K+++    P  E     +  RE+ L   +  
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVR---VPLSEEGIPLSTLREIALLKQLES 57

Query: 131 AIHKNLLQLIGYCTTS-SERI----LVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVA 184
             H N+++L+  C    ++R     LV+  + Q+L+        K  + GL   T K + 
Sbjct: 58  FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLS----KCPKPGLPPETIKDLM 113

Query: 185 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD--AKLTHVTTQI 242
                G+++LH      I+HRDLK  NIL+  + +  + DFGLA++      LT V    
Sbjct: 114 RQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV-- 168

Query: 243 RGTMGHIAPEYL 254
             T+ + APE L
Sbjct: 169 --TLWYRAPEVL 178

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 67/262 (25%), Positives = 120/262 (45%), Gaps = 27/262 (10%)

Query: 104 VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAY 163
           VAVK L+   S      F +EV ++S     N+ +L+G CT      ++  +M+N  +  
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 164 RLRDLKPGEKGLDWPTRKRVAFGT--------AYGLEYLHEQCNPKIIHRDLKAANILLD 215
            L+       GL     K ++F T        A G+ YL E  N   +HRDL   N L+ 
Sbjct: 109 FLQKHVAETSGLAC-NSKSLSFSTLLYMATQIASGMRYL-ESLN--FVHRDLATRNCLVG 164

Query: 216 DNFEAVLCDFGLAKLVDAKLTHVTTQIRG-TMGHI---APEYLSTGKSSEKTDVFGYGIT 271
            N+   + DFG+++ + +       +++G     I   A E +  GK + K+DV+ +G+T
Sbjct: 165 KNYTIKIADFGMSRNLYSS---DYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVT 221

Query: 272 LLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVA 331
           L E++T  R   +  L +++   ++++     R+D     + R  N       + + ++ 
Sbjct: 222 LWEILTLCREQPYEHLTDQQ---VIENAGHFFRDDGRQIYLPRPPNC-----PKDIYELM 273

Query: 332 LLCTQSTPEDRPPMAQVVKMLQ 353
           L C +   EDRP   ++   LQ
Sbjct: 274 LECWRRDEEDRPTFREIHLFLQ 295

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 47/141 (33%), Positives = 59/141 (41%), Gaps = 28/141 (19%)

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVD-----AKLTHVTTQI 242
            LEYLH   +  IIHRDLK  NIL+D N    L DFGL+K  LV              +I
Sbjct: 105 ALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161

Query: 243 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG-----------------QRAIDFS 285
            GT  +IAPE +     S+  D +  G  L E + G                    I++ 
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWP 221

Query: 286 RLEEEEDVLLLDHIRKLLRED 306
              E  D   +D I KLL  D
Sbjct: 222 EDVEVSDE-AIDLISKLLVPD 241

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 29/217 (13%)

Query: 85  IGQGGFGKVYK----GVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKN 135
           +G+G FG+V      G+  D       VAVK L+D  +    +    E+ ++  +  HKN
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW-------PTRK------- 181
           ++ L+G CT      ++  +    ++   LR  +P   G+D+       P  +       
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRP--PGMDYSFDTCKLPEEQLTFKDLV 137

Query: 182 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTT 240
             A+  A G+EYL  Q   K IHRDL A N+L+ ++    + DFGLA+ V +      TT
Sbjct: 138 SCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194

Query: 241 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
             R  +  +APE L     + ++DV+ +G+ L E+ T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 12/203 (5%)

Query: 79  FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLL 137
           F++   IG+G FG+V+KG+ +   +V   ++ D      E    Q+E+ ++S      + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
           +  G     ++   ++  M+ L     L  L+ G    D      +      GL+YLH +
Sbjct: 66  KYYGSYLKGTK---LWIIMEYLGGGSALDLLRAGP--FDEFQIATMLKEILKGLDYLHSE 120

Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYLST 256
              K IHRD+KAAN+LL +  +  L DFG+A +L D ++   T    GT   +APE +  
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQ 175

Query: 257 GKSSEKTDVFGYGITLLELVTGQ 279
                K D++  GIT +EL  G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 69.2 bits (169), Expect = 2e-13
 Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 23/215 (10%)

Query: 84  IIGQGGFGKV----YKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
            IG+G FG V    Y+G      KVAVK +++        AF  E  +++   H NL+QL
Sbjct: 13  TIGKGEFGDVMLGDYRG-----NKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQL 64

Query: 140 IGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
           +G        + +V  +M   S+   LR    G   L      + +      +EYL    
Sbjct: 65  LGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEAN- 121

Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 258
               +HRDL A N+L+ ++  A + DFGL K   +        ++ T    APE L   K
Sbjct: 122 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKK 175

Query: 259 SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV 293
            S K+DV+ +GI L E+ +  R + + R+  ++ V
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGR-VPYPRIPLKDVV 209

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 69.0 bits (169), Expect = 2e-13
 Identities = 59/282 (20%), Positives = 111/282 (39%), Gaps = 47/282 (16%)

Query: 84  IIGQGGFGK--VYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLI 140
           ++G+G FG+  +Y+    D++ V  K +     S         E+ ++S+  H N++   
Sbjct: 7   VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 141 GYCTTSSERILVYPFMQNLSVAYRLRDLKPG--------EKGLDWPTRKRVA--FGTAYG 190
            +            FM + ++   +     G        +KG  +     +   F     
Sbjct: 66  NH------------FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA 113

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
           + Y+H+     I+HRD+K  NI L       L DFG++K++ ++ +   T + GT  +++
Sbjct: 114 VSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMS 169

Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 310
           PE     K + K+D++  G  L EL+T +R  D +                      +  
Sbjct: 170 PELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-----------------LVVK 212

Query: 311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
           IV  N     S     ++ +     Q  PE RP   +V+   
Sbjct: 213 IVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 18/215 (8%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 134
           TD +     IG+G +GKVYK     D +  AVK L        E   +  + L S+  H 
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI-LQSLPNHP 79

Query: 135 NLLQLIGYCTTSSERI-----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
           N+++  G    + + +     LV       SV   ++ L    + LD      + +G   
Sbjct: 80  NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL-AKLVDAKLTHVTTQIRGTMGH 248
           GL++LH   N +IIHRD+K  NILL       L DFG+ A+L   +L   T+   GT   
Sbjct: 140 GLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--GTPFW 194

Query: 249 IAPEYLSTGKSSE-----KTDVFGYGITLLELVTG 278
           +APE ++  +  +     + DV+  GIT +EL  G
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 69.2 bits (170), Expect = 3e-13
 Identities = 60/223 (26%), Positives = 89/223 (39%), Gaps = 47/223 (21%)

Query: 83  NIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQR---EVHLISVAIHKNLLQ 138
             IG+G FG V K    SD   +  K +   Y    E   Q+   EV+++    H N+++
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEID--YGNMTEKEKQQLVSEVNILRELKHPNIVR 63

Query: 139 LIGYCTTSSERIL------VYPFM---------QNLSVAYRLRDLKPGEKGLDWPTRKRV 183
                    +RI+      +Y  M         Q +    + R     E         R+
Sbjct: 64  YY-------DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW------RI 110

Query: 184 AFGTAYGLEYLH--EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD-----AKLT 236
                  L   H        ++HRDLK ANI LD N    L DFGLAK++      AK T
Sbjct: 111 LTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK-T 169

Query: 237 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           +V     GT  +++PE L+     EK+D++  G  + EL    
Sbjct: 170 YV-----GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 69.9 bits (171), Expect = 3e-13
 Identities = 82/334 (24%), Positives = 134/334 (40%), Gaps = 84/334 (25%)

Query: 85  IGQGGFGKVYKGVLSDNTK------VAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLL 137
           +G+G FGKV +       K      VAVK L++  +     A   E+  LI +  H N++
Sbjct: 15  LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74

Query: 138 QLIGYCTTSSERILV---YPFMQNLS----------VAYRLRDL-------KPGEKG-LD 176
            L+G CT     ++V   Y    NLS            YR +         K G+K  LD
Sbjct: 75  NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134

Query: 177 ------------WPTRKRV-------------------------AFGTAYGLEYLHEQCN 199
                       +   K +                         +F  A G+E+L  +  
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR-- 192

Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QIRGTMGHIAPEYLSTGK 258
            K IHRDL A NILL +N    +CDFGLA+ +     +V     R  +  +APE +    
Sbjct: 193 -KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKV 251

Query: 259 SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 318
            + ++DV+ +G+ L E+ +   A  +  ++ +E+       R+L    R+          
Sbjct: 252 YTTQSDVWSFGVLLWEIFS-LGASPYPGVQIDEEF-----CRRLKEGTRMRA-------- 297

Query: 319 YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
                   +  + L C  + PEDRP  +++V++L
Sbjct: 298 -PEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 12/209 (5%)

Query: 85  IGQGGFGKVYKG--VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           +G+G +  VYKG   L+DN  VA+K ++  +  G      REV L+    H N++ L   
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 202
             T     LV+ ++      Y    L      ++    K   F    GL Y H +   K+
Sbjct: 73  IHTEKSLTLVFEYLDKDLKQY----LDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KV 125

Query: 203 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE-YLSTGKSSE 261
           +HRDLK  N+L+++  E  L DFGLA+         + ++  T+ +  P+  L +   S 
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYST 184

Query: 262 KTDVFGYGITLLELVTGQRAIDFSRLEEE 290
           + D++G G    E+ TG+     S +EE+
Sbjct: 185 QIDMWGVGCIFYEMSTGRPLFPGSTVEEQ 213

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 69.1 bits (170), Expect = 4e-13
 Identities = 57/190 (30%), Positives = 79/190 (41%), Gaps = 43/190 (22%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQ--REVHLISVAIHKNLLQL 139
           +G+G +  VYK         VA+K  +L +         F   RE+ L+    H N++ L
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY---------- 189
           +      S   LV+ FM+         DL   EK +     K +    A           
Sbjct: 68  LDVFGHKSNINLVFEFMET--------DL---EKVIK---DKSIVLTPADIKSYMLMTLR 113

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTH--VTTQIRG 244
           GLEYLH      I+HRDLK  N+L+  +    L DFGLA+     + K+TH  VT   R 
Sbjct: 114 GLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYR- 169

Query: 245 TMGHIAPEYL 254
                APE L
Sbjct: 170 -----APELL 174

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 69.0 bits (169), Expect = 4e-13
 Identities = 39/104 (37%), Positives = 61/104 (58%), Gaps = 14/104 (13%)

Query: 182 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVD--AKLTHV 238
           ++A      LEYLH +    +IHRD+K +N+L++ N +  LCDFG++  LVD  AK    
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK---- 160

Query: 239 TTQIRGTMGHIAPEYLSTGKSSE----KTDVFGYGITLLELVTG 278
            T   G   ++APE ++   + +    K+DV+  GIT++EL TG
Sbjct: 161 -TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATG 203

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 69.1 bits (169), Expect = 4e-13
 Identities = 65/220 (29%), Positives = 90/220 (40%), Gaps = 52/220 (23%)

Query: 79  FSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQ---REVHLISVAIHK 134
           F++   IG G FG VY        + VA+K++  Y        +Q   +EV  +    H 
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKM-SYSGKQSNEKWQDIIKEVRFLQQLRHP 75

Query: 135 NLLQLIG-------------YCTTSSERIL-VY--PFMQNLSVAYRLRDLKPGEKGLDWP 178
           N ++  G             YC  S+  IL V+  P +Q + +A                
Sbjct: 76  NTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKP-LQEVEIA---------------- 118

Query: 179 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 238
               +  G   GL YLH       IHRD+KA NILL +     L DFG A LV    + V
Sbjct: 119 ---AICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV 172

Query: 239 TTQIRGTMGHIAPEY---LSTGKSSEKTDVFGYGITLLEL 275
                GT   +APE    +  G+   K DV+  GIT +EL
Sbjct: 173 -----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 69.2 bits (170), Expect = 5e-13
 Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 50/226 (22%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVH--------- 126
           D +   + +G G +G+V     +    KVA+K+L     P     FQ  +H         
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL---SRP-----FQSAIHAKRTYRELR 66

Query: 127 LISVAIHKNLLQLIGYCTTSSER------ILVYPFM-QNLSVAYRLRDLKPGEKGLDWPT 179
           L+    H+N++ L+   T +S         LV   M  +L+   + + L          +
Sbjct: 67  LLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKL----------S 116

Query: 180 RKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 235
              + F   Y    GL+Y+H   +  IIHRDLK +NI ++++ E  + DFGLA+  D ++
Sbjct: 117 DDHIQF-LVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM 172

Query: 236 T-HVTTQIRGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           T +V      T  + APE  L+    ++  D++  G  + EL+TG+
Sbjct: 173 TGYV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 69.0 bits (168), Expect = 5e-13
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 12/220 (5%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           D++ +   +G+G +  VYKG    N K VA+K ++     G      RE  L+    H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
           ++ L     T     LV+ ++      Y   D  PG  GL     K   F    GL Y+H
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVHTDLCQYM--DKHPG--GLHPENVKLFLFQLLRGLSYIH 120

Query: 196 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE-YL 254
           ++    I+HRDLK  N+L+ D  E  L DFGLA+   +  +H  +    T+ +  P+  L
Sbjct: 121 QR---YILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLL 176

Query: 255 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 294
            + + S   D++G G   +E++ G  A  F  +++ +D L
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAA--FPGMKDIQDQL 214

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 68.4 bits (167), Expect = 5e-13
 Identities = 57/206 (27%), Positives = 86/206 (41%), Gaps = 17/206 (8%)

Query: 85  IGQGGFGKVYKG---VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
           IG G FGKV  G         +V VK L+   +P  +  F +EV       H N+LQ +G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 142 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWP-TRKRVAFGTAYGLEYLHEQCNP 200
            C  S   +LV  F     +   LR  +     +      +R+A   A GL +LH+    
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119

Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT--QIRGTMGHIAPEY----- 253
             IH DL   N  L  +    + D+GLA L      +  T       +  +APE      
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178

Query: 254 --LSTGKSSEKTDVFGYGITLLELVT 277
             L     ++K++++  G+T+ EL T
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 68.3 bits (167), Expect = 5e-13
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 19/211 (9%)

Query: 83  NIIGQGGFGKVYKGVLSD-------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           N +G G FG+VY+G  +D         +VAVK L+   +   +  F +E HL+S   H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK---PGEKGLDWPTRKRVAFGTAYGLE 192
           +++L+G C  +  + ++   M+   +   LRD +    G   L       +    A G  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAV-----LCDFGLAK-LVDAKLTHVTTQIRGTM 246
           YL +      IHRDL A N L+ +          + DFGLA+ +  +       +    +
Sbjct: 121 YLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
             +APE L  GK + ++DV+ +G+ + E++T
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 68.5 bits (167), Expect = 5e-13
 Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 22/211 (10%)

Query: 85  IGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G+G FGKV+           D   VAVK L++  S      FQRE  L++V  H+++++
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVR 71

Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLD-----------WPTRKRVAFGT 187
             G CT     ++V+ +M++  +   LR   P  K L                  +A   
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTM 246
           A G+ YL    +   +HRDL   N L+       + DFG+++ +       V  +    +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
             + PE +   K + ++D++ +G+ L E+ T
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 68.0 bits (166), Expect = 7e-13
 Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 15/203 (7%)

Query: 85  IGQGGFGKVYKG-VLSD--NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
           IG G FGKV  G V S     +V VK L+   S   +  F  E        H NLLQ +G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 142 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEK-GLDWPTRKRVAFGTAYGLEYLHEQCNP 200
            CT  +  +LV  F     +   LR  +  E    D  T +R+A   A GL +LH+    
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119

Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QIRGTMGHIAPEYLSTGKS 259
             IH DL   N LL  +    + D+GL+     +  +VT  Q+   +  IAPE +     
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179

Query: 260 -------SEKTDVFGYGITLLEL 275
                  +++++V+  G+T+ EL
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 68.1 bits (166), Expect = 8e-13
 Identities = 79/307 (25%), Positives = 136/307 (44%), Gaps = 51/307 (16%)

Query: 73  QLATDNFSESNIIGQGGFGKVYK----GVLSDN----TKVAVKRLQDYYSPGGEAAFQRE 124
           ++  D       +G+G FG+V      G+  +     TKVAVK L+   +    +    E
Sbjct: 14  EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73

Query: 125 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG------------ 171
           + ++  +  HKN++ L+G CT      ++  +    ++   LR  +P             
Sbjct: 74  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133

Query: 172 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 231
           E+ L +      A+  A G+EYL  +   K IHRDL A N+L+ ++    + DFGLA+  
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR-- 188

Query: 232 DAKLTHV-----TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFS 285
              + H+     TT  R  +  +APE L     + ++DV+ +G+ L E+ T G       
Sbjct: 189 --DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246

Query: 286 RLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 345
            +EE         + KLL+E      +D+  N   + E+  M++    C  + P  RP  
Sbjct: 247 PVEE---------LFKLLKEGHR---MDKPSNC--TNELYMMMRD---CWHAVPSQRPTF 289

Query: 346 AQVVKML 352
            Q+V+ L
Sbjct: 290 KQLVEDL 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 19/208 (9%)

Query: 78  NFSESNIIGQGGFGKVY--KGVLSDNTKVAVKRLQDYYSPGGEA-AFQREVHLISVAIHK 134
            +     IG+G FGK+Y  K   SD+    +K +     P  E  A ++EV L++   H 
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59

Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD----LKPGEKGLDWPTRKRVAFGTAYG 190
           N++        +    +V  +     +  R+      L   ++ L W  +       + G
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ------ISLG 113

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           L+++H++   KI+HRD+K+ NI L  N   A L DFG+A+ ++  +    T + GT  ++
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYL 169

Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVT 277
           +PE       + KTD++  G  L EL T
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 66.7 bits (163), Expect = 1e-12
 Identities = 75/281 (26%), Positives = 111/281 (39%), Gaps = 41/281 (14%)

Query: 78  NFSESNIIGQGGFGKVYK-GVLSDNTKVAVKR--LQDYYSPGGEAAFQREVHLISVAIHK 134
           +F     +G+G +G VYK   LSDN   A+K   L        E A   E+ +++   H 
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHP 59

Query: 135 NLLQLIGYCTTSSE-RILV----YPFMQNLSVAYRLRDL--KPGEKGLDWPTRKRVAFGT 187
           N+   I Y     +   L     Y    +LS A   R    K   +   W    R+    
Sbjct: 60  NI---ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQL 112

Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 247
             GL+ LHEQ   KI+HRDLK+ANILL  N    + D G++K+   K     TQI GT  
Sbjct: 113 LRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKV--LKKNMAKTQI-GTPH 166

Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 307
           ++APE       S K+D++  G  L E+ T     +   +++             LR   
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-------------LRYKV 213

Query: 308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQV 348
                      Y     + +        Q  P+ RP   ++
Sbjct: 214 QRGKYPPIPPIYS----QDLQNFIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 67.1 bits (164), Expect = 1e-12
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 20/209 (9%)

Query: 78  NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 136
           NF +   +G+G +  VYKG   +    VA+K +      G  +   RE+ L+    H+N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 137 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP-----GEKG-LDWPTRKRVAFGTAYG 190
           ++L     T ++ +LV+ +M          DLK      G +G LD  T K   +    G
Sbjct: 61  VRLHDVIHTENKLMLVFEYMDK--------DLKKYMDTHGVRGALDPNTVKSFTYQLLKG 112

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
           + + HE    +++HRDLK  N+L++   E  L DFGLA+     +   + ++  T+ + A
Sbjct: 113 IAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRA 168

Query: 251 PEYLSTGKS-SEKTDVFGYGITLLELVTG 278
           P+ L   ++ S   D++  G  + E++TG
Sbjct: 169 PDVLLGSRTYSTSIDIWSVGCIMAEMITG 197

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 25/207 (12%)

Query: 85  IGQGGFGKVYKGVLSDNTKV--AVK--RLQDYYSPGGEAAFQ---REVHLISVAIHKNLL 137
           +G+G +G VYK VL   T V  A+K  RL+       E+ F     E+ ++  A+   ++
Sbjct: 9   LGKGNYGSVYK-VLHRPTGVTMAMKEIRLEL-----DESKFNQIIMELDILHKAVSPYIV 62

Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
              G         +   +M   S+  +L       +G+     +R+ +    GL++L E+
Sbjct: 63  DFYGAFFIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121

Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 257
            N  IIHRD+K  N+L++ N +  LCDFG++  + A L    T I G   ++APE + +G
Sbjct: 122 HN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA--KTNI-GCQSYMAPERIKSG 176

Query: 258 KSSE------KTDVFGYGITLLELVTG 278
             ++      ++DV+  G+++LE+  G
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALG 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 40/226 (17%)

Query: 84  IIGQGGFGKVYKG---VLSDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQ 138
           +IG+GG G+VY     V S   +VA+K++++  S  P  +  F RE  + +  IH  ++ 
Sbjct: 9   LIGKGGMGEVYLAYDPVCS--RRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66

Query: 139 LIGYCTTSSERILVY---PFMQNLSVAYRLRDL-------KPGEKGLDWPTRKRVAFGTA 188
           +   C   S+   VY   P+++  ++   L+ +       K   +         +     
Sbjct: 67  VYSIC---SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123

Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK-------------- 234
             +EY+H +    ++HRDLK  NILL    E V+ D+G A     +              
Sbjct: 124 ATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 235 LTHVTT---QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
                T   +I GT  ++APE L    +SE TD++  G+ L +++T
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 12/207 (5%)

Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQ-DYYSPGGE---AAFQREVHLISVAI 132
           N+    ++GQG FG+VY     D  + +A K++Q D  SP      +A + E+ L+    
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 133 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 192
           H+ ++Q  G     +E+ L   FM+ +     ++D       L     ++       G+ 
Sbjct: 63  HERIVQYYGCLRDRAEKTLTI-FMEYMP-GGSVKDQLKAYGALTESVTRKYTRQILEGMS 120

Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTMGHIA 250
           YLH      I+HRD+K ANIL D      L DFG +K +       T    + GT   ++
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177

Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVT 277
           PE +S      K DV+  G T++E++T
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 12/209 (5%)

Query: 85  IGQGGFGKVYKG--VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           +G+G +  V+KG   L++N  VA+K ++  +  G      REV L+    H N++ L   
Sbjct: 13  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 202
             T     LV+ ++ +    Y    L      +     K   F    GL Y H++   KI
Sbjct: 72  IHTERCLTLVFEYLDSDLKQY----LDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KI 124

Query: 203 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE-YLSTGKSSE 261
           +HRDLK  N+L+++  E  L DFGLA+         + ++  T+ +  P+  L + + S 
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYST 183

Query: 262 KTDVFGYGITLLELVTGQRAIDFSRLEEE 290
             D++G G  L E+ TG+     S ++EE
Sbjct: 184 PIDMWGVGCILYEMATGRPMFPGSTVKEE 212

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 66.3 bits (161), Expect = 3e-12
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 17/211 (8%)

Query: 79  FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           F    ++G G +G+VYKG      ++A  ++ D      E   Q    L   + H+N+  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 139 LIGYCTTSS------ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 192
             G     +      +  LV  F    SV   +++ K      +W     +      GL 
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLS 125

Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 252
           +LH+    K+IHRD+K  N+LL +N E  L DFG++  +D  +    T I GT   +APE
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPE 181

Query: 253 YLSTGKSSE-----KTDVFGYGITLLELVTG 278
            ++  ++ +     K+D++  GIT +E+  G
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 20/200 (10%)

Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           +G G FGKVYK    +   +A  ++ +  S      +  E+ +++   H  +++L+G   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 204
              +  ++  F    +V   + +L   ++GL  P  + +       L+YLH     KIIH
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIH 133

Query: 205 RDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR----GTMGHIAPEYL--STGK 258
           RDLKA N+LL  + +  L DFG    V AK    T Q R    GT   +APE +   T K
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFG----VSAKNVK-TLQRRDSFIGTPYWMAPEVVMCETMK 188

Query: 259 SSE---KTDVFGYGITLLEL 275
            +    K D++  GITL+E+
Sbjct: 189 DTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 27/214 (12%)

Query: 85  IGQGGFGKVYKG------VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G+G FGKV+           D   VAVK L+D  +      FQRE  L++   H+++++
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVK 71

Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP--------------GEKGLDWPTRKRVA 184
             G C      I+V+ +M++  +   LR   P              GE GL       +A
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS--QMLHIA 129

Query: 185 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHVTTQIR 243
              A G+ YL  Q     +HRDL   N L+  N    + DFG+++ +       V     
Sbjct: 130 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 244 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
             +  + PE +   K + ++DV+ +G+ L E+ T
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 66.5 bits (162), Expect = 4e-12
 Identities = 70/216 (32%), Positives = 96/216 (44%), Gaps = 45/216 (20%)

Query: 85  IGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREV-HLISVAIHKNLLQLIGY 142
           IG+G FG+VY+    D  ++ A+K L        E   ++EV H I     +N+L     
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSK-----KEIVAKKEVAHTIG---ERNILV---- 48

Query: 143 CTTSSERILVYPFM-------QNLSVAYRLRDLKPGEKGLDWPTRK-------RVAFGTA 188
            T   E     PF+       Q  S  Y + D   G + L W  +K       R  F  A
Sbjct: 49  RTLLDES----PFIVGLKFSFQTDSDLYLVTDYMSGGE-LFWHLQKEGRFSEDRAKFYIA 103

Query: 189 ---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIR 243
                LE+LH+     I++RDLK  NILLD      LCDFGL+K  L D K T+      
Sbjct: 104 ELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC--- 157

Query: 244 GTMGHIAPEYLSTGKSSEK-TDVFGYGITLLELVTG 278
           GT  ++APE L   K   K  D +  G+ + E+  G
Sbjct: 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 65.5 bits (160), Expect = 6e-12
 Identities = 46/148 (31%), Positives = 76/148 (51%), Gaps = 11/148 (7%)

Query: 85  IGQGGFGKVYKGVLSDNTK-VAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           IG+G +G V+K    +  + VA+KR++ D    G  ++  RE+ L+    HKN+++L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 143 CTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 201
             +  +  LV+ +  Q+L    +  D   G+  +D    K   F    GL + H      
Sbjct: 68  LHSDKKLTLVFEYCDQDLK---KYFDSCNGD--IDPEIVKSFMFQLLKGLAFCHSH---N 119

Query: 202 IIHRDLKAANILLDDNFEAVLCDFGLAK 229
           ++HRDLK  N+L++ N E  L DFGLA+
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 65.3 bits (159), Expect = 7e-12
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 23/206 (11%)

Query: 85  IGQGGFGKVY------KGVLSDNT--KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 136
           +G+G FGKV       +G   DNT  +VAVK L+        A  ++E+ ++    H+N+
Sbjct: 12  LGEGHFGKVELCRYDPEG---DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68

Query: 137 LQLIGYCTTSSER--ILVYPFMQNLSVAYRLRDLKPGEKG-LDWPTRKRVAFGTAYGLEY 193
           ++  G CT        L+  F+ + S    L++  P  K  ++   + + A     G++Y
Sbjct: 69  VKYKGICTEDGGNGIKLIMEFLPSGS----LKEYLPRNKNKINLKQQLKYAVQICKGMDY 124

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAP 251
           L  +   + +HRDL A N+L++   +  + DFGL K +  D +   V   +   +   AP
Sbjct: 125 LGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP 181

Query: 252 EYLSTGKSSEKTDVFGYGITLLELVT 277
           E L   K    +DV+ +G+TL EL+T
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 60/233 (25%), Positives = 108/233 (46%), Gaps = 21/233 (9%)

Query: 79  FSESNIIGQGGFGKV------YKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI 132
           F +  ++G+GGFG+V        G +    K+  KR++      GE+    E  ++    
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK---KRKGESMALNEKQILEKVN 58

Query: 133 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 192
            + ++ L     T     LV   M    + + +  +  GE G +       A     GLE
Sbjct: 59  SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLE 116

Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 252
            LH++   +I++RDLK  NILLDD+    + D GLA  V    T +  ++ GT+G++APE
Sbjct: 117 DLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPE 171

Query: 253 YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 305
            +   + +   D +  G  L E++ GQ     S  ++ +  +  + + +L++E
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQ-----SPFQQRKKKIKREEVERLVKE 219

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 16/201 (7%)

Query: 85  IGQGGFGKVYK-GVLSDNTKVAVKRLQDYYSPGGEAAFQ----REVHLISVAIHKNLLQL 139
           IG+G  G V+K         VA+K++        E        RE+  +    H  +++L
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKV---ALRRLEGGIPNQALREIKALQACQHPYVVKL 64

Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
           +      S  +LV  +M +  ++  LRD    E+ L     K        G+ Y+H    
Sbjct: 65  LDVFPHGSGFVLVMEYMPS-DLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN-- 118

Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-STGK 258
             I+HRDLK AN+L+  +    + DFGLA+L   +   + +    T  + APE L    K
Sbjct: 119 -GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177

Query: 259 SSEKTDVFGYGITLLELVTGQ 279
                D++  G    EL+ G 
Sbjct: 178 YDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 20/213 (9%)

Query: 85  IGQGGFGKVYKG--VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           +G+G +  V+KG   L++N  VA+K ++  +  G      REV L+    H N++ L   
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKG----LDWPTRKRVAFGTAYGLEYLHEQC 198
             T     LV+ ++         +DLK         +     K   +    GL Y H + 
Sbjct: 73  VHTDKSLTLVFEYLD--------KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR- 123

Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE-YLSTG 257
             K++HRDLK  N+L+++  E  L DFGLA+         + ++  T+ +  P+  L + 
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSS 180

Query: 258 KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE 290
           + S + D++G G    E+ +G+     S +E+E
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE 213

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 38/225 (16%)

Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHL-ISVA 131
           +L  D+F + + +G G  G V+K                 + P G    ++ +HL I  A
Sbjct: 1   ELKDDDFEKISELGAGNGGVVFKVS---------------HKPSGLIMARKLIHLEIKPA 45

Query: 132 IHKNL---LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------- 181
           I   +   LQ++  C +         F  +  ++  +  +  G   LD   +K       
Sbjct: 46  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPEQ 103

Query: 182 ---RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTH 237
              +V+     GL YL E+   KI+HRD+K +NIL++   E  LCDFG++ +L+D+    
Sbjct: 104 ILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 157

Query: 238 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 282
           +     GT  +++PE L     S ++D++  G++L+E+  G+  I
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 19/212 (8%)

Query: 79  FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLL 137
           F    ++G G +G+VYKG      ++A  ++ D  +   E   + E++++   + H+N+ 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TEDEEEEIKLEINMLKKYSHHRNIA 76

Query: 138 QLIGYCTTSS------ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL 191
              G     S      +  LV  F    SV   +++ K      DW     +      GL
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGL 134

Query: 192 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAP 251
            +LH     K+IHRD+K  N+LL +N E  L DFG++  +D  +    T I GT   +AP
Sbjct: 135 AHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAP 190

Query: 252 EYLSTGKSSEKT-----DVFGYGITLLELVTG 278
           E ++  ++ + T     D++  GIT +E+  G
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 35/102 (34%), Positives = 61/102 (59%), Gaps = 7/102 (6%)

Query: 182 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTT 240
           +V+     GL YL E+   +I+HRD+K +NIL++   E  LCDFG++ +L+D+    +  
Sbjct: 107 KVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 160

Query: 241 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 282
              GT  +++PE L     S ++D++  G++L+EL  G+  I
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 33/102 (32%), Positives = 60/102 (58%), Gaps = 7/102 (6%)

Query: 182 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTT 240
           +++     GL YL E    KI+HRD+K +NIL++   E  LCDFG++ +L+D+    +  
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 156

Query: 241 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 282
              GT  +++PE L     + ++D++  G++L+E+  G+  I
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 32/215 (14%)

Query: 85  IGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G+G FGKV+           D   VAVK L+D  S      F RE  L++   H+++++
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVK 71

Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL---DWPTR------KRVAFGTAY 189
             G C      I+V+ +M++  +   LR   P    +   + P          +A   A 
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH- 248
           G+ YL  Q     +HRDL   N L+ +N    + DFG+++ V       +T      GH 
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDV------YSTDYYRVGGHT 182

Query: 249 ------IAPEYLSTGKSSEKTDVFGYGITLLELVT 277
                 + PE +   K + ++DV+  G+ L E+ T
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 18/208 (8%)

Query: 79  FSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQD--YYSPGGEAAFQREVHLISVAIHKN 135
           F +  ++G+GGFG+V    +    K+ A KRL+        GE+    E  ++     + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY---GLE 192
           ++ L     T     LV   M    + + + ++  G  G +    +R  F  A    GLE
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFE---EERALFYAAEILCGLE 116

Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAP 251
            LH +     ++RDLK  NILLDD     + D GLA K+ + +         GT+G++AP
Sbjct: 117 DLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---GTVGYMAP 170

Query: 252 EYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           E L+  + +   D +G G  + E++ GQ
Sbjct: 171 EVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 11/198 (5%)

Query: 85  IGQGGFGKVYKGVLSDNTK-VAVKR-LQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           IG+G +G V+K    +  + VA+K+ ++    P  +    RE+ ++    H NL+ LI  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 202
                +  LV+ +  + +V   L +L+   +G+     K++ + T   + + H+      
Sbjct: 69  FRRKRKLHLVFEYCDH-TV---LNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NC 121

Query: 203 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-STGKSSE 261
           IHRD+K  NIL+    +  LCDFG A+++       T  +  T  + APE L    +   
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGDTQYGP 180

Query: 262 KTDVFGYGITLLELVTGQ 279
             DV+  G    EL+TGQ
Sbjct: 181 PVDVWAIGCVFAELLTGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 34/231 (14%)

Query: 85  IGQGGFGKVYKGV--LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           +G+G +  VYKG   L+    VA+K ++  +  G      RE  L+    H N++ L   
Sbjct: 13  LGEGSYATVYKGRSKLTGQL-VALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71

Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLK------PGEKGLDWPTRKRVAFGTAYGLEYLHE 196
             T     LV+ ++          DLK       G  GL     +   F    GL Y H+
Sbjct: 72  IHTKKTLTLVFEYLD--------TDLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQ 121

Query: 197 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL--THVTTQIRGTMGHIAPEYL 254
           +   +++HRDLK  N+L+ +  E  L DFGLA+   AK   +   +    T+ +  P+ L
Sbjct: 122 R---RVLHRDLKPQNLLISERGELKLADFGLAR---AKSVPSKTYSNEVVTLWYRPPDVL 175

Query: 255 --STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 303
             ST  S+   D++G G    E+ TG+     S   E++    L  I ++L
Sbjct: 176 LGSTEYSTS-LDMWGVGCIFYEMATGRPLFPGSTDVEDQ----LHKIFRVL 221

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 63.0 bits (153), Expect = 3e-11
 Identities = 65/280 (23%), Positives = 126/280 (45%), Gaps = 37/280 (13%)

Query: 78  NFSESNIIGQGGFGKVY--KGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 134
            + +  ++G+G FG V+  +   +D   V +K++  +  +     A Q E  ++ +  H 
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59

Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVA----YRLRDLKPGEKGLDWPTRKRVAFGTAYG 190
           N+++           ++V  +    ++A     R   L   +  L +  +  +A      
Sbjct: 60  NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------ 113

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           L ++H      I+HRDLK  NILLD +   V + DFG++K++ +K    T  + GT  +I
Sbjct: 114 LHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYI 168

Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 309
           +PE       ++K+D++  G  L EL + +RA + + L      L+L    K++      
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP----ALVL----KIMS-GTFA 219

Query: 310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 349
            I DR      S ++  ++   L      P  RP ++Q++
Sbjct: 220 PISDRY-----SPDLRQLILSML---NLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 45/211 (21%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGE-AAFQREVHLISVAIHKNLLQLIG- 141
           +G G +G VYK   L      AVK ++    PG + +  Q+E+ ++    H N++   G 
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74

Query: 142 ------------YCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 187
                       YC   S + +  V   +  L +AY  R+                   T
Sbjct: 75  YLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRE-------------------T 115

Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 247
             GL YLH +     +HRD+K ANILL DN +  L DFG+A  + A +    + I GT  
Sbjct: 116 LQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPY 171

Query: 248 HIAPEYLSTGKS---SEKTDVFGYGITLLEL 275
            +APE  +  K+   ++  D++  GIT +EL
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 53/172 (30%), Positives = 80/172 (46%), Gaps = 35/172 (20%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTK--VAVKR-LQDYYSPGGEAAFQREVHLISVAIH 133
             + +   IGQG FG+V+K      TK  VA+K+ L +    G      RE+ ++ +  H
Sbjct: 12  SKYEKLAKIGQGTFGEVFK-ARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKH 70

Query: 134 KNLLQLIGYCTTSSER--------ILVYPF--------MQNLSVAYRLRDLKPGEKGLDW 177
           +N++ LI  C T +           LV+ F        + N +V + L ++K   K L  
Sbjct: 71  ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKML-- 128

Query: 178 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 229
                       GL Y+H     KI+HRD+KAANIL+  +    L DFGLA+
Sbjct: 129 ----------LNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 61/230 (26%), Positives = 97/230 (42%), Gaps = 32/230 (13%)

Query: 71  ELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQRE 124
           E+ L+T  F E   +G+  FGKVYKG L           VA+K L+D         F+ E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 125 VHLISVAIHKNLLQLIGYCTTSS--ERILVYPFMQNLSVAYRLR----------DLKPGE 172
             + S   H N++ L+G  T       I  Y    +L     +R          D K  +
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 173 KGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 232
             L+      +    A G+E+L       ++H+DL   N+L+ D     + D GL + V 
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 233 AK-----LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
           A      + +    IR     ++PE +  GK S  +D++ YG+ L E+ +
Sbjct: 176 AADYYKLMGNSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 27/206 (13%)

Query: 85  IGQGGFGKVYKGVLSDNTK--VAVKRLQDYYSPGG-------EAAFQREVHLISVAIHKN 135
           IG+G +GKV+K     N    VA+KR++      G       E A  R +       H N
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE---HPN 65

Query: 136 LLQLIGYCTTS-----SERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
           +++L   CT S     ++  LV+  + Q+L+        K  E G+   T K + F    
Sbjct: 66  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD----KVPEPGVPTETIKDMMFQLLR 121

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL++LH     +++HRDLK  NIL+  + +  L DFGLA++   ++    T +  T+ + 
Sbjct: 122 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYR 176

Query: 250 APEYLSTGKSSEKTDVFGYGITLLEL 275
           APE L     +   D++  G    E+
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 61/277 (22%), Positives = 118/277 (42%), Gaps = 21/277 (7%)

Query: 78  NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ--DYYSPGGEAAFQREVHLISVAIHK 134
           NF     IG+G F +VY+   L D   VA+K++Q  D       A   +E+ L+    H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           N+++        +E  +V        ++  ++  K  ++ +   T  +        LE++
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 254
           H +   +++HRD+K AN+ +       L D GL +   +K T   + + GT  +++PE +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 178

Query: 255 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 314
                + K+D++  G  L E+   Q      ++          ++  L ++    D    
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----------NLYSLCKKIEQCDYPPL 228

Query: 315 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 351
             + Y S+E+  +V    +C    PE RP +  V  +
Sbjct: 229 PSDHY-SEELRQLVN---MCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 76/274 (27%), Positives = 111/274 (40%), Gaps = 38/274 (13%)

Query: 85  IGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQ---REVHLISVAIHKNLLQLI 140
           IG G FG VY    S  N  VAVK++  Y        +Q   +EV  +    H N ++  
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMS-YSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 141 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 200
           G         LV  +   L  A  L  L+  +K L       +  G   GL YLH     
Sbjct: 88  GCYLKEHTAWLVMEYC--LGSASDL--LEVHKKPLQEVEIAAITHGALQGLAYLHSHN-- 141

Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY---LSTG 257
            +IHRD+KA NILL +  +  L DFG A       + V     GT   +APE    +  G
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEG 195

Query: 258 KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN 317
           +   K DV+  GIT +EL            E +  +  ++ +  L        I   +  
Sbjct: 196 QYDGKVDVWSLGITCIELA-----------ERKPPLFNMNAMSALYH------IAQNDSP 238

Query: 318 TYDSKE-VETMVQVALLCTQSTPEDRPPMAQVVK 350
           T  S E  ++       C Q  P++RP  A++++
Sbjct: 239 TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 85/336 (25%), Positives = 141/336 (41%), Gaps = 75/336 (22%)

Query: 84  IIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           ++G+G FGKV+   L   N   A+K            A +++V L+   +          
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIK------------ALKKDVVLMDDDVE--------- 40

Query: 143 CTTSSERILV----YPFMQNLSVAYRLRD--------LKPGE--------KGLDWPTRKR 182
           CT   +R+L     +PF+ +L   ++ ++        L  G+           D P    
Sbjct: 41  CTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF 100

Query: 183 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK---LVDAKLTHVT 239
            A     GL++LH +    I++RDLK  NILLD +    + DFG+ K   L DAK    T
Sbjct: 101 YAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK----T 153

Query: 240 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI 299
               GT  +IAPE L   K +   D + +G+ L E++ GQ    F   +EEE        
Sbjct: 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP--FHGHDEEE-------- 203

Query: 300 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAE 359
             L +  R+++       T ++K++   + V        PE R  +   ++    +    
Sbjct: 204 --LFQSIRMDNPCYPRWLTREAKDILVKLFV------REPERRLGVKGDIR----QHPFF 251

Query: 360 RWAEWEELEEVRQQEVSLLPHQFAWGEDSSIDQEAI 395
           R  +W  LEE R+ E    P   +  + S+ D+E +
Sbjct: 252 REIDWSALEE-REIEPPFKPKVKSANDCSNFDKEFL 286

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 62.5 bits (152), Expect = 5e-11
 Identities = 48/203 (23%), Positives = 93/203 (45%), Gaps = 7/203 (3%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ--DYYSPGGEAAFQREVHLISVAI 132
             NF     IG+G F  VYK + L D   VA+K++Q  +           +E+ L+    
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 133 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 192
           H N+++ +     ++E  +V        ++  ++  K  ++ +   T  +        LE
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 252
           ++H +   +I+HRD+K AN+ +       L D GL +   +K T   + + GT  +++PE
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176

Query: 253 YLSTGKSSEKTDVFGYGITLLEL 275
            +     + K+D++  G  L E+
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 63.3 bits (154), Expect = 6e-11
 Identities = 53/161 (32%), Positives = 80/161 (49%), Gaps = 22/161 (13%)

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPE 252
           +H   +  +IHRD+K+ANILL  N    L DFG +K+  A ++  V     GT  ++APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215

Query: 253 YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL--REDRLND 310
                  S+K D+F  G+ L EL+T +R  D   +EE         + K L  R D L  
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV--------MHKTLAGRYDPLPP 267

Query: 311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 351
            +        S E++ +V  ALL   S P+ RP  ++++ M
Sbjct: 268 SI--------SPEMQEIVT-ALLS--SDPKRRPSSSKLLNM 297

Length = 496

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 63/238 (26%), Positives = 109/238 (45%), Gaps = 27/238 (11%)

Query: 79  FSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQD--YYSPGGEAAFQREVHLISVAIHKN 135
           F    ++G+GGFG+V    +    K+ A K+L+        GEA    E  ++     + 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY---GLE 192
           ++ L     T     LV   M    + + + ++  G  G D    +R  F  A    GLE
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFD---EQRAIFYAAELCCGLE 116

Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR---GTMGHI 249
            L  +   +I++RDLK  NILLDD     + D GLA  +    T     +R   GT+G++
Sbjct: 117 DLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-----VRGRVGTVGYM 168

Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 307
           APE ++  K +   D +G G  + E++ GQ     S   + ++ +  + + + ++ED+
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMIQGQ-----SPFRKRKERVKREEVDRRVKEDQ 221

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 62.1 bits (151), Expect = 7e-11
 Identities = 50/210 (23%), Positives = 106/210 (50%), Gaps = 17/210 (8%)

Query: 73  QLATDNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQREVHLI 128
           ++  ++ +    IG+G FG VY+GV     ++   VAVK  ++  SP     F +E +++
Sbjct: 2   EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61

Query: 129 SVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAF 185
               H ++++LIG  T +   I+  + P  +       LR  L+  +  LD  +    ++
Sbjct: 62  RQFDHPHIVKLIGVITENPVWIVMELAPLGE-------LRSYLQVNKYSLDLASLILYSY 114

Query: 186 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 245
             +  L YL  +   + +HRD+ A N+L+       L DFGL++ ++ +  +  ++ +  
Sbjct: 115 QLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP 171

Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLEL 275
           +  +APE ++  + +  +DV+ +G+ + E+
Sbjct: 172 IKWMAPESINFRRFTSASDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 62.0 bits (150), Expect = 8e-11
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 20/211 (9%)

Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEA------AFQREVHLISV 130
           N+    ++G+G FG+VY    +D  + +AVK++   + P  +       A + E+ L+  
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVP--FDPDSQETSKEVNALECEIQLLKN 60

Query: 131 AIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 188
             H  ++Q  G      E+ L     +M   S+  +L+        L     +R      
Sbjct: 61  LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQIL 116

Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTM 246
            G+ YLH      I+HRD+K ANIL D      L DFG +K +       T    + GT 
Sbjct: 117 QGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173

Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
             ++PE +S      K DV+    T++E++T
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 61.9 bits (150), Expect = 8e-11
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 23/206 (11%)

Query: 84  IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS---PGGEAAFQREVHLISVAIHKN--LLQ 138
           IIG+GGFG+VY    +D  K+   +  D        GE     E  ++S+    +   + 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 139 LIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA---YGLEYL 194
            + Y   + +++  +   M    + Y L      + G+   +   + F  A    GLE++
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVF--SEAEMRFYAAEIILGLEHM 113

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 254
           H   N  +++RDLK ANILLD++    + D GLA     K  H +    GT G++APE L
Sbjct: 114 H---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167

Query: 255 STGKSSEKT-DVFGYGITLLELVTGQ 279
             G + + + D F  G  L +L+ G 
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGH 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 62.1 bits (151), Expect = 8e-11
 Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 5/90 (5%)

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
           L++LH+     II+RD+K  NILLD     VL DFGL+K   A+         GT+ ++A
Sbjct: 118 LDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174

Query: 251 PEYLSTGKS--SEKTDVFGYGITLLELVTG 278
           PE +  G     +  D +  G+   EL+TG
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 61.5 bits (149), Expect = 9e-11
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 19/205 (9%)

Query: 85  IGQGGFGKVYKGVLSDNTK---VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
           +G G FG V KGV     K   VA+K L++           RE  ++    +  ++++IG
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 142 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVA---FGTAYGLEYLHEQC 198
            C   +  +++      ++    L     G+K  D  T   V       + G++YL  + 
Sbjct: 63  VCEAEALMLVM-----EMASGGPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK- 114

Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT--MGHIAPEYLST 256
               +HRDL A N+LL +   A + DFGL+K + A  ++   +  G   +   APE ++ 
Sbjct: 115 --NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172

Query: 257 GKSSEKTDVFGYGITLLELVT-GQR 280
            K S ++DV+ YGIT+ E  + GQ+
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 24/211 (11%)

Query: 85  IGQGGFGKVYKGVLSDN--TKVAVKRLQDYYSPGGEAAFQR---------EVHLISVAI- 132
           +G G FG VYK    +N    +A+K +  +    G+   +R         EV +I   + 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 133 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--RVAFGTAYG 190
           H N+++       +    +V   ++   +      LK  EK   +   +   +       
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLK--EKKQRFTEERIWNIFVQMVLA 125

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA--KLVDAKLTHVTTQIRGTMGH 248
           L YLH++   +I+HRDL   NI+L ++ +  + DFGLA  K  ++KLT V     GT+ +
Sbjct: 126 LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV----GTILY 179

Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
             PE +      EK DV+ +G  L ++ T Q
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQ 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 21/202 (10%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           IG+G +G VYKG        VA+K+++ +    G  +   RE+ L+    H N++ L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLK------PGEKGLDWPTRKRVAFGTAYGLEYLHE 196
               S   L++ F+          DLK      P  + +D    K   +    G+ + H 
Sbjct: 68  LMQESRLYLIFEFLS--------MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119

Query: 197 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-S 255
           +   +++HRDLK  N+L+D+     L DFGLA+     +   T ++  T+ + APE L  
Sbjct: 120 R---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLLG 175

Query: 256 TGKSSEKTDVFGYGITLLELVT 277
           + + S   D++  G    E+ T
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 61.4 bits (149), Expect = 1e-10
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 16/207 (7%)

Query: 79  FSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQD--YYSPGGEAAFQREVHLISVAIHKN 135
           F    ++G+GGFG+V    +    K+ A K+L+        GEA    E  ++     + 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA---YGLE 192
           ++ L     T     LV   M    + + + ++     G D    +R  F  A    GLE
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNP--GFD---EERAVFYAAEITCGLE 116

Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 252
            LH +   +I++RDLK  NILLDD     + D GLA  V+           GT+G++APE
Sbjct: 117 DLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAPE 171

Query: 253 YLSTGKSSEKTDVFGYGITLLELVTGQ 279
            +   + +   D +G G  + E++ G+
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 34/99 (34%), Positives = 58/99 (58%), Gaps = 8/99 (8%)

Query: 182 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTT 240
           R+A     GL YL    + KI+HRD+K +N+L++   +  LCDFG++ +LV++    +  
Sbjct: 99  RIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAK 151

Query: 241 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
              GT  ++APE +S  +    +DV+  GI+ +EL  G+
Sbjct: 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 57/269 (21%), Positives = 115/269 (42%), Gaps = 35/269 (13%)

Query: 104 VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN----- 158
           VAVK L+   +      F +EV ++S     N+++L+G C       ++  +M+N     
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 159 -LSVAYRLRDLKPGEKG---------LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLK 208
            LS  +     + G            + + +   VA   A G++YL    +   +HRDL 
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165

Query: 209 AANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG--HIAPEYLSTGKSSEKTDVF 266
             N L+ +N    + DFG+++ + A   +   Q R  +    +A E +  GK +  +DV+
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAG-DYYRIQGRAVLPIRWMAWECILMGKFTTASDVW 224

Query: 267 GYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEV-- 324
            +G+TL E++   +   +  L +E+   ++++  +  R        D+    Y  +    
Sbjct: 225 AFGVTLWEILMLCKEQPYGELTDEQ---VIENAGEFFR--------DQGRQVYLFRPPPC 273

Query: 325 -ETMVQVALLCTQSTPEDRPPMAQVVKML 352
            + + ++ L C      +RP  + +   L
Sbjct: 274 PQGLYELMLQCWSRDCRERPSFSDIHAFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 47/236 (19%)

Query: 84  IIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLI-----SVAIHKNLL 137
           ++G+G FGKV    L    +  A+K            A +++V L         + + +L
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIK------------ALKKDVVLEDDDVECTMVERRVL 49

Query: 138 QLIG--------YCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 187
            L          +CT  ++  L  V  ++    + + ++     ++        R  F  
Sbjct: 50  ALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDE-------ARARFYA 102

Query: 188 A---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG 244
           A    GL++LH++    II+RDLK  N+LLD +    + DFG+ K  +       +   G
Sbjct: 103 AEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKASTFCG 158

Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 300
           T  +IAPE L   K +E  D + +G+ L E++ GQ    F   +E+E   L D I 
Sbjct: 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP--FHGEDEDE---LFDSIL 209

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 23/206 (11%)

Query: 84  IIGQGGFGKVYKGVLSDNTKVAVKRLQDY----YSPGGEAAFQREVHLISVAIHK-NLLQ 138
           IIG+GGFG+VY    +D  K+   +  D        G   A    + L  V+      + 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 139 LIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA---YGLEYL 194
            + Y   + +++  +   M    + Y L      + G+   + K + F       GLE++
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHL-----SQHGVF--SEKEMRFYATEIILGLEHM 113

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 254
           H   N  +++RDLK ANILLD++    + D GLA     K  H +    GT G++APE L
Sbjct: 114 H---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167

Query: 255 STGKSSEKT-DVFGYGITLLELVTGQ 279
             G + + + D F  G  L +L+ G 
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGH 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 56/207 (27%), Positives = 104/207 (50%), Gaps = 29/207 (14%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIG 141
           +G G +G V   +      KVA+K+L   +      + A+ RE+ L+    H+N++ L+ 
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHMQHENVIGLLD 81

Query: 142 YCTTSS------ERILVYPFMQ-NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
             T++       +  LV P+MQ +L    ++      E  + +     + +    GL+Y+
Sbjct: 82  VFTSAVSGDEFQDFYLVMPYMQTDLQ---KIMGHPLSEDKVQY-----LVYQMLCGLKYI 133

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEY 253
           H      IIHRDLK  N+ ++++ E  + DFGLA+  DA++T +V T+      + APE 
Sbjct: 134 HSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEV 185

Query: 254 -LSTGKSSEKTDVFGYGITLLELVTGQ 279
            L+    ++  D++  G  + E++TG+
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 12/198 (6%)

Query: 85  IGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G+G +  VYKG+   N + VA+K +      G      RE  L+    H N++ L    
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72

Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
            T      V+ +M      Y ++   PG  GL     +   F    GL Y+H Q    I+
Sbjct: 73  HTKETLTFVFEYMHTDLAQYMIQ--HPG--GLHPYNVRLFMFQLLRGLAYIHGQ---HIL 125

Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL--STGKSSE 261
           HRDLK  N+L+    E  L DFGLA+         ++++  T+ +  P+ L  +T  SS 
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSA 184

Query: 262 KTDVFGYGITLLELVTGQ 279
             D++G G   +E++ GQ
Sbjct: 185 -LDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 59.9 bits (146), Expect = 3e-10
 Identities = 58/217 (26%), Positives = 89/217 (41%), Gaps = 52/217 (23%)

Query: 85  IGQGGFGKVYK-GVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G GGFG+V    V S N   A+K +             ++ H++     +++       
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCV-------------KKRHIVETGQQEHIFS----- 42

Query: 144 TTSSER----ILVYPFMQNLSVAYR-------LRDLKPG--------EKGL--DWPTRKR 182
               E+       +PF+  L   ++       L +   G        ++GL  ++  R  
Sbjct: 43  ----EKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFY 98

Query: 183 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHVTTQ 241
           +A       EYLH +    II+RDLK  N+LLD N    L DFG AK L   + T     
Sbjct: 99  IACVVL-AFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT--- 151

Query: 242 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
             GT  ++APE +         D +  GI L EL+TG
Sbjct: 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTG 188

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 61.8 bits (150), Expect = 3e-10
 Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 27/203 (13%)

Query: 103 KVAVKRLQDYYSPGGE---AAFQREVHLISVAIHKNLLQLIGYCTTSSERIL-VYPFMQN 158
           +VA+K L+   +P  E   A F+RE  L +   H N++ L+         +  V+ ++  
Sbjct: 5   EVAIKLLRTD-APEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPG 63

Query: 159 LSVAYRLRD---LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL- 214
            ++   L     L  GE G       R+       L   H Q    I+HRDLK  NI++ 
Sbjct: 64  RTLREVLAADGALPAGETG-------RLMLQVLDALACAHNQ---GIVHRDLKPQNIMVS 113

Query: 215 --DDNFEAVLCDFGLAKL------VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVF 266
                  A + DFG+  L       D      TT++ GT  + APE L     +  +D++
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173

Query: 267 GYGITLLELVTGQRAIDFSRLEE 289
            +G+  LE +TGQR +  + + E
Sbjct: 174 AWGLIFLECLTGQRVVQGASVAE 196

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 22/217 (10%)

Query: 76  TDNFSESNIIGQGGFGKVYKGVLS--DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH 133
           +D +     IG+G +GKV+K VL+  + +K AVK L   +    E   +  + L +++ H
Sbjct: 17  SDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDEEIEAEYNI-LKALSDH 74

Query: 134 KNLLQLIGY-----CTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGT 187
            N+++  G           +  LV       SV   ++  LK GE+ ++ P    +    
Sbjct: 75  PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER-MEEPIIAYILHEA 133

Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL-AKLVDAKLTHVTTQIRGTM 246
             GL++LH     K IHRD+K  NILL       L DFG+ A+L   +L   T+   GT 
Sbjct: 134 LMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--GTP 188

Query: 247 GHIAPEYLSTGKS-----SEKTDVFGYGITLLELVTG 278
             +APE ++  +        + DV+  GIT +EL  G
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 60.1 bits (145), Expect = 4e-10
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 15/204 (7%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGE-AAFQREVHLISVAIHK 134
           ++F     IG G +G VYK   ++     A+K ++    PG + A  Q+E+ ++    H 
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKDCKHS 66

Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           N++   G      +  +   F    S    L+D+      L       V+  T  GL YL
Sbjct: 67  NIVAYFGSYLRRDKLWICMEFCGGGS----LQDIYHVTGPLSESQIAYVSRETLQGLYYL 122

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 254
           H   +   +HRD+K ANILL DN    L DFG++  + A +    + I GT   +APE  
Sbjct: 123 H---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVA 178

Query: 255 ST---GKSSEKTDVFGYGITLLEL 275
           +    G  ++  D++  GIT +EL
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 60.1 bits (145), Expect = 4e-10
 Identities = 65/204 (31%), Positives = 90/204 (44%), Gaps = 20/204 (9%)

Query: 79  FSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---REVHLISVAIHK 134
           FS+   IG G FG VY    + ++  VA+K++  Y        +Q   +EV  +    H 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS-YSGKQSNEKWQDIIKEVRFLQKLRHP 75

Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           N +Q  G         LV  +   L  A  L  L+  +K L       V  G   GL YL
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYC--LGSASDL--LEVHKKPLQEVEIAAVTHGALQGLAYL 131

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY- 253
           H   +  +IHRD+KA NILL +     L DFG A ++      V     GT   +APE  
Sbjct: 132 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183

Query: 254 --LSTGKSSEKTDVFGYGITLLEL 275
             +  G+   K DV+  GIT +EL
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 59.3 bits (143), Expect = 5e-10
 Identities = 47/205 (22%), Positives = 95/205 (46%), Gaps = 7/205 (3%)

Query: 78  NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ--REVHLISVAIHK 134
           NF     IG+G F +VY+   L D   VA+K++Q +     +A     +E+ L+    H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           N+++ +      +E  +V        ++  ++  K  ++ +   T  +        +E++
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 254
           H +   +++HRD+K AN+ +       L D GL +   +K T   + + GT  +++PE +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 178

Query: 255 STGKSSEKTDVFGYGITLLELVTGQ 279
                + K+D++  G  L E+   Q
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQ 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 59.7 bits (144), Expect = 5e-10
 Identities = 60/203 (29%), Positives = 84/203 (41%), Gaps = 18/203 (8%)

Query: 79  FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQ---REVHLISVAIHKN 135
           F++   IG G FG VY        +V   +   Y        +Q   +EV  +    H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
            ++  G         LV  +   L  A  L  L+  +K L       +  G   GL YLH
Sbjct: 87  SIEYKGCYLREHTAWLVMEYC--LGSASDL--LEVHKKPLQEVEIAAITHGALQGLAYLH 142

Query: 196 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY-- 253
                 +IHRD+KA NILL +  +  L DFG A +     + V     GT   +APE   
Sbjct: 143 SH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVIL 194

Query: 254 -LSTGKSSEKTDVFGYGITLLEL 275
            +  G+   K DV+  GIT +EL
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 46/197 (23%), Positives = 96/197 (48%), Gaps = 12/197 (6%)

Query: 104 VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN--LSV 161
           VAVK L+   +      F +E+ ++S   + N+++L+G C +     ++  +M+N  L+ 
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106

Query: 162 AYRLRDLKPG-EKGLDWPTRKR-----VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD 215
               R+++       + P+        +A   A G++YL    +   +HRDL   N L+ 
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVG 163

Query: 216 DNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLE 274
           +++   + DFG+++ L       +  +    +  +A E +  GK +  +DV+ +G+TL E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223

Query: 275 LVTGQRAIDFSRLEEEE 291
           + T  +   +S L +E+
Sbjct: 224 MFTLCKEQPYSLLSDEQ 240

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 59.9 bits (145), Expect = 6e-10
 Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 9/89 (10%)

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGTMG 247
           GL YLH Q   +IIHRD+K  NI ++D  +  + D G A+  +V      +     GT+ 
Sbjct: 169 GLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA----GTVE 221

Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELV 276
             APE L+  K + K D++  GI L E++
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 28/215 (13%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ----REVHLISVA 131
           D + +   +G G +G V   +      KVA+K+L   Y P     F     RE+ L+   
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKL---YRPFQSELFAKRAYRELRLLKHM 71

Query: 132 IHKNLLQLIGYCT--TSSERI----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF 185
            H+N++ L+   T   S +R     LV PFM    +   ++  K  E  + +     + +
Sbjct: 72  KHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQF-----LVY 125

Query: 186 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 245
               GL+Y+H      IIHRDLK  N+ ++++ E  + DFGLA+  D+++T        T
Sbjct: 126 QMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV----T 178

Query: 246 MGHIAPEY-LSTGKSSEKTDVFGYGITLLELVTGQ 279
             + APE  L+    ++  D++  G  + E++TG+
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 59.4 bits (144), Expect = 7e-10
 Identities = 50/213 (23%), Positives = 90/213 (42%), Gaps = 14/213 (6%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTK-VAVKR-LQDYYSPGGEAAFQREVHL---ISVA 131
           D + +   IG+G +GKVYK    +  K VA+K+   +    G      RE+ L   +S +
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 132 IHKNLLQLIGYCTTSSERILVYPFMQNLSV---AYRLRDLKPGEKGLDWPTRKRVAFGTA 188
           I+   L  + +    + +  +Y   + L      +   + +   + L   T K   +   
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120

Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMG 247
            G+ + H+     ++HRDLK  N+L+D     + + D GL +     +   T +I  T+ 
Sbjct: 121 KGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLW 176

Query: 248 HIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 279
           + APE L      S   D++  G    E+   Q
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 58.8 bits (142), Expect = 7e-10
 Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 26/202 (12%)

Query: 85  IGQGGFGKVYKGVLS---DNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLI 140
           +G G FG V KG+         VAVK L+ D   P  +    RE +++    +  ++++I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 141 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWP---TRKRV---AFGTAYGLEYL 194
           G C             ++  +   L +L P  K L      T K +       + G++YL
Sbjct: 63  GICEA-----------ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYL 111

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT--MGHIAPE 252
            E      +HRDL A N+LL     A + DFGL+K + A   +   +  G   +   APE
Sbjct: 112 EET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE 168

Query: 253 YLSTGKSSEKTDVFGYGITLLE 274
            ++  K S K+DV+ +G+ + E
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 59.2 bits (143), Expect = 8e-10
 Identities = 36/88 (40%), Positives = 48/88 (54%), Gaps = 4/88 (4%)

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
           LE LH+     +I+RDLK  NILLD      LCDFGL KL + K    T    GT  ++A
Sbjct: 106 LENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLA 161

Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE L     ++  D +  G+ L E++TG
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 38/105 (36%), Positives = 57/105 (54%), Gaps = 9/105 (8%)

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGTMGH 248
           GL++LHE+    II+RDLK  N+LLD      + DFG+ K  +  L  VTT    GT  +
Sbjct: 108 GLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDY 162

Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV 293
           IAPE LS        D +  G+ L E++ GQ   +    ++E+++
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE---GDDEDEL 204

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 30/208 (14%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           IG+G +G VYK         VA+K+++ +    G  +   RE+ L+    H N+++L+  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLKP-----GEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
             + ++  LV+ F+          DLK         GLD P  K   +    G+ Y H  
Sbjct: 67  VHSENKLYLVFEFLD--------LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118

Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL---TH--VTTQIRGTMGHIAPE 252
              +++HRDLK  N+L+D      L DFGLA+     +   TH  VT   R      APE
Sbjct: 119 ---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYR------APE 169

Query: 253 YLSTGKS-SEKTDVFGYGITLLELVTGQ 279
            L   +  S   D++  G    E+V  +
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 62/244 (25%), Positives = 94/244 (38%), Gaps = 40/244 (16%)

Query: 50  DVAGEDDCKVSLTQLRRFSCRELQLATDNFS----ESNIIGQ---GGFGKVYKGVL---S 99
           D   +++     T + +  C E   ++D  S    + NI+     G  G+V+        
Sbjct: 59  DYDADEESLSPQTDVCQEPC-ETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKHGDE 117

Query: 100 DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 159
              KV VK +    +PG E    + +       H+ ++ LI      S   +V P  +  
Sbjct: 118 QRKKVIVKAVTGGKTPGREIDILKTIS------HRAIINLIHAYRWKSTVCMVMPKYKCD 171

Query: 160 SVAY-------RLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI 212
              Y        L      ++ L               L YLH +    IIHRD+K  NI
Sbjct: 172 LFTYVDRSGPLPLEQAITIQRRL------------LEALAYLHGR---GIIHRDVKTENI 216

Query: 213 LLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGIT 271
            LD+   AVL DFG A KL     T       GT+   +PE L+      KTD++  G+ 
Sbjct: 217 FLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLV 276

Query: 272 LLEL 275
           L E+
Sbjct: 277 LFEM 280

Length = 392

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 58.0 bits (140), Expect = 1e-09
 Identities = 51/198 (25%), Positives = 89/198 (44%), Gaps = 14/198 (7%)

Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQ-------DYYSPGGEAAFQREVHLISVAIHKNLL 137
           +G+G FG VY  ++ D   VA +RL+          +P       +E  L+S   H  ++
Sbjct: 8   LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
           +            ++  + +   +  +L +LK   K L              G+ Y+H++
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125

Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 257
              +I+HRDLKA NI L +N   +  DFG+++L+       TT   GT  +++PE L   
Sbjct: 126 ---RILHRDLKAKNIFLKNNLLKI-GDFGVSRLLMGSCDLATT-FTGTPYYMSPEALKHQ 180

Query: 258 KSSEKTDVFGYGITLLEL 275
               K+D++  G  L E+
Sbjct: 181 GYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 33/91 (36%), Positives = 48/91 (52%), Gaps = 5/91 (5%)

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            LE+LH+     II+RD+K  NILLD N   VL DFGL+K              GT+ ++
Sbjct: 117 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173

Query: 250 APEYLSTGKS--SEKTDVFGYGITLLELVTG 278
           AP+ +  G     +  D +  G+ + EL+TG
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 15/204 (7%)

Query: 84  IIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           I+G G FG++ +G L   +K    VA+  L+   S      F  E   +    H N+++L
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
            G  T  +  ++V  +M N ++   LR     E  L       +  G A G++YL E   
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEM-- 126

Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI--APEYLSTG 257
              +H+ L A  +L++ +    +  F   +L + K   + T + G    +  APE +   
Sbjct: 127 -GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183

Query: 258 KSSEKTDVFGYGITLLELVT-GQR 280
             S  +DV+ +GI + E+++ G+R
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 28/169 (16%)

Query: 85  IGQGGFGKVYKGVL---SDNTKVAVKRLQ---DYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           IG+G +G+VYK       D  + A+K+ +   + Y+ G   +  RE+ L+    H+N++ 
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYT-GISQSACREIALLRELKHENVVS 66

Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDL--------KPGEKGLDWPTRKRVAFGTAYG 190
           L+      +++  VY     L   Y   DL        +     +     K + +    G
Sbjct: 67  LVEVFLEHADK-SVY-----LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 191 LEYLHEQCNPKIIHRDLKAANILL--DDNFEAV--LCDFGLAKLVDAKL 235
           + YLH      ++HRDLK ANIL+  +     V  + D GLA+L +A L
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 48/200 (24%), Positives = 94/200 (47%), Gaps = 17/200 (8%)

Query: 84  IIGQGGFGK--VYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
           ++G+G FG+  + + V SD  K A+K ++   S       ++E  L++   H N++    
Sbjct: 7   VVGEGSFGRALLVQHVNSDQ-KYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65

Query: 142 YCTTSSERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
                    +V  +     +  +++  +    P +  L W  +         G++++HE+
Sbjct: 66  SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQHIHEK 119

Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 257
              +++HRD+K+ NI L  N +  L DFG A+L+ +   +  T + GT  ++ PE     
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENM 175

Query: 258 KSSEKTDVFGYGITLLELVT 277
             + K+D++  G  L EL T
Sbjct: 176 PYNNKSDIWSLGCILYELCT 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 50/171 (29%), Positives = 80/171 (46%), Gaps = 21/171 (12%)

Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QI 242
           +F  A G+E+L  +   K IHRDL A NILL +N    +CDFGLA+ +     +V     
Sbjct: 185 SFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241

Query: 243 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRK 301
           R  +  +APE +     + ++DV+ +G+ L E+ + G       +++EE         R+
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCRR 294

Query: 302 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
           L    R+          Y + E   M Q  L C    P  RP  +++V+ L
Sbjct: 295 LKEGTRM------RAPDYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 27/91 (29%), Positives = 44/91 (48%), Gaps = 8/91 (8%)

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           G+E LH++    IIHRD+K  N+L+D      L DFGL++           +  GT  ++
Sbjct: 109 GVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG-----LENKKFVGTPDYL 160

Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQR 280
           APE +      + +D +  G  + E + G  
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLFGYP 191

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 50/178 (28%), Positives = 85/178 (47%), Gaps = 20/178 (11%)

Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QI 242
           +F  A G+E+L  +   K IHRDL A NILL +N    +CDFGLA+ +     +V     
Sbjct: 180 SFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236

Query: 243 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL 302
           R  +  +APE +     + ++DV+ +G+ L E+ +   A  +  ++  E+          
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS-LGASPYPGVQINEEFC-------- 287

Query: 303 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAER 360
               RL D          + E+    ++ L C Q  P++RP  + +V++L G+ L E 
Sbjct: 288 ---QRLKDGTRMRAPENATPEIY---RIMLACWQGDPKERPTFSALVEIL-GDLLQEN 338

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 57/261 (21%), Positives = 120/261 (45%), Gaps = 25/261 (9%)

Query: 104 VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAY 163
           VAVK L++  +      F +E+ ++S     N+++L+  C TS    ++  +M+N  +  
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 164 RLRDLKPGEKGLD-------WPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD 216
            L   +P E           + T   +A   A G++YL    +   +HRDL   N L+  
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGK 165

Query: 217 NFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLEL 275
           N+   + DFG+++ L       +  +    +  ++ E +  GK +  +DV+ +G+TL E+
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225

Query: 276 VTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEV---ETMVQVAL 332
           +T  +   +S+L +E+   ++++  +  R        D+    Y  K     +++ ++ L
Sbjct: 226 LTLCKEQPYSQLSDEQ---VIENTGEFFR--------DQGRQVYLPKPALCPDSLYKLML 274

Query: 333 LCTQSTPEDRPPMAQVVKMLQ 353
            C +   ++RP   ++   L 
Sbjct: 275 SCWRRNAKERPSFQEIHATLL 295

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 61/200 (30%), Positives = 85/200 (42%), Gaps = 14/200 (7%)

Query: 84  IIGQGGFGKVYKGVLSDNTKV-AVKRLQDYY----SPGGEAAFQREVHLISVAIHKNLLQ 138
           +IG+G FGKV       + K  AVK LQ               +R V L +V  H  L+ 
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK-HPFLVG 60

Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
           L     T+ +   V  F+    + + L+     E+    P  +  A   A  L YLH   
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLH--- 113

Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 258
           +  I++RDLK  NILLD     VL DFGL K      +  TT   GT  ++APE +    
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQP 172

Query: 259 SSEKTDVFGYGITLLELVTG 278
                D +  G  L E++ G
Sbjct: 173 YDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 52/199 (26%), Positives = 92/199 (46%), Gaps = 17/199 (8%)

Query: 85  IGQGGFGKVYKG-VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLI-SVAIHKNLLQLIG- 141
           IG+G F +V K          A+K ++ ++    +    RE+  +  ++ H N+L+LI  
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66

Query: 142 -YCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
            +   +    LV+  M  NL   Y L  +K  ++ L     K   +     L+++H +  
Sbjct: 67  LFDRKTGRLALVFELMDMNL---YEL--IKGRKRPLPEKRVKSYMYQLLKSLDHMH-RNG 120

Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE-YLSTGK 258
             I HRD+K  NIL+ D+    L DFG  + + +K  +  T+   T  + APE  L+ G 
Sbjct: 121 --IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPY--TEYISTRWYRAPECLLTDGY 175

Query: 259 SSEKTDVFGYGITLLELVT 277
              K D++  G    E+++
Sbjct: 176 YGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 62/201 (30%), Positives = 88/201 (43%), Gaps = 16/201 (7%)

Query: 84  IIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY----SPGGEAAFQREVHLISVAIHKNLLQ 138
           +IG+G FGKV      SD +  AVK LQ               +R V L ++  H  L+ 
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK-HPFLVG 60

Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
           L     T+ +   V  ++    + + L+     E+    P  +  A   A  + YLH   
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL- 115

Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKL-VDAKLTHVTTQIRGTMGHIAPEYLSTG 257
              II+RDLK  NILLD     VL DFGL K  V+ + T  T+   GT  ++APE L   
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKE 171

Query: 258 KSSEKTDVFGYGITLLELVTG 278
                 D +  G  L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 66/213 (30%), Positives = 91/213 (42%), Gaps = 40/213 (18%)

Query: 84  IIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQR--EVHLI---SVAIHKNLL 137
           +IG+G FGKV       + K  AVK LQ       +A  ++  + H++   +V + KN+ 
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQK------KAILKKKEQKHIMAERNVLL-KNVK 54

Query: 138 Q--LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG---------EKGLDWPTRKRVAFG 186
              L+G         L Y F Q     Y + D   G         E+    P  +  A  
Sbjct: 55  HPFLVG---------LHYSF-QTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAE 104

Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL-VDAKLTHVTTQIRGT 245
            A  L YLH      II+RDLK  NILLD     VL DFGL K  ++   T  T+   GT
Sbjct: 105 IASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGT 159

Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
             ++APE L         D +  G  L E++ G
Sbjct: 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 57.3 bits (139), Expect = 4e-09
 Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 52/228 (22%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAF----QREVHLISVA 131
             +   + IG+G +G V          KVA+K++    SP     F     RE+ ++   
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI----SPFEHQTFCQRTLREIKILRRF 60

Query: 132 IHKNLLQLIGYCTTSS-----ERILVYPFM----------QNLS---VAYRLRDLKPGEK 173
            H+N++ ++      S     +  +V   M          Q+LS   + Y L        
Sbjct: 61  KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFL-------- 112

Query: 174 GLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 233
                      +    GL+Y+H   N  ++HRDLK +N+LL+ N +  +CDFGLA++ D 
Sbjct: 113 -----------YQILRGLKYIH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158

Query: 234 KLTH--VTTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELVTG 278
           +  H    T+   T  + APE +   K   K  D++  G  L E+++ 
Sbjct: 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 57.2 bits (139), Expect = 4e-09
 Identities = 63/259 (24%), Positives = 108/259 (41%), Gaps = 60/259 (23%)

Query: 69  CRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ----R 123
           CR +    D + + N I +G +G VY+         VA+K+L+       E  F     R
Sbjct: 1   CRSV----DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK--MEKEKEG-FPITSLR 53

Query: 124 EVHLISVAIHKNLLQL--IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK 181
           E++++    H N++ +  +   +   +  +V  ++++        DLK            
Sbjct: 54  EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH--------DLK------SLMETM 99

Query: 182 RVAFGTA----------YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 231
           +  F  +           G+ +LH+     I+HRDLK +N+LL++     +CDFGLA+  
Sbjct: 100 KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY 156

Query: 232 DAKLTHVTTQIRGTMGHIAPE-YLSTGKSSEKTDV------FGYGITLLELVTGQRAIDF 284
            + L    TQ+  T+ + APE  L   + S   D+      F   +T   L  G+  ID 
Sbjct: 157 GSPLKPY-TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID- 214

Query: 285 SRLEEEEDVLLLDHIRKLL 303
                      L+ I KLL
Sbjct: 215 ----------QLNKIFKLL 223

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 57/201 (28%), Positives = 87/201 (43%), Gaps = 18/201 (8%)

Query: 85  IGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQ----REVHLI---SVAIHKNL 136
           IG G +G VYK     +   VA+K ++       E        REV L+       H N+
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVR---VQTNEDGLPLSTVREVALLKRLEAFDHPNI 64

Query: 137 LQLIGYCTTS--SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           ++L+  C TS       V    +++    R    K    GL   T K +      GL++L
Sbjct: 65  VRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 254
           H  C   I+HRDLK  NIL+    +  L DFGLA++   ++    T +  T+ + APE L
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWYRAPEVL 179

Query: 255 STGKSSEKTDVFGYGITLLEL 275
                +   D++  G    E+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 57.1 bits (138), Expect = 5e-09
 Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 19/207 (9%)

Query: 84  IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLIG 141
           +IG+G +G V   +      KVA+K++ D +    +A    RE+ L+ +  H +++++  
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 142 YCTTSSERILVYPFMQNLSVAYRL--RDLKPGEKGLDWPTRKRVAF---GTAYGLEYLHE 196
                S R       +++ V + L   DL    K  D  T +   F        L+Y+H 
Sbjct: 67  IMLPPSRREF-----KDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH- 120

Query: 197 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGTMGHIAPEYL 254
                + HRDLK  NIL + + +  +CDFGLA+    D       T    T  + APE  
Sbjct: 121 --TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178

Query: 255 ST--GKSSEKTDVFGYGITLLELVTGQ 279
            +   K +   D++  G    E++TG+
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 56.7 bits (137), Expect = 5e-09
 Identities = 34/91 (37%), Positives = 49/91 (53%), Gaps = 8/91 (8%)

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGTMGH 248
           LE+LH+Q    II+RDLK  NILLD      L DFGL K  + +  +TH      GT+ +
Sbjct: 113 LEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---GTIEY 166

Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           +APE L      +  D +  G  + +++TG 
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGA 197

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 56.5 bits (136), Expect = 6e-09
 Identities = 38/109 (34%), Positives = 58/109 (53%), Gaps = 10/109 (9%)

Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR-GTM 246
           + GL +LH +    II+RDLK  N++LD      + DFG+ K  +  +  VTT+   GT 
Sbjct: 111 SVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTP 165

Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 295
            +IAPE ++     +  D + YG+ L E++ GQ   D     E+ED L 
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD----GEDEDELF 210

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 56.7 bits (137), Expect = 6e-09
 Identities = 63/220 (28%), Positives = 102/220 (46%), Gaps = 53/220 (24%)

Query: 84  IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           ++GQG FGKV+           V+++       G  A Q  ++ + V + K  L++    
Sbjct: 3   VLGQGSFGKVF----------LVRKIT------GPDAGQ--LYAMKV-LKKATLKVRDRV 43

Query: 144 TTSSER-ILV---YPFMQNLSVAYRLRDLKPGE--------KGLDWPTR--KRVAFGT-- 187
            T  ER IL    +PF+  L  A++      G+        +G D  TR  K V F    
Sbjct: 44  RTKMERDILAEVNHPFIVKLHYAFQ----TEGKLYLILDFLRGGDLFTRLSKEVMFTEED 99

Query: 188 --------AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHV 238
                   A  L++LH   +  II+RDLK  NILLD+     L DFGL+K  +D +    
Sbjct: 100 VKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KK 154

Query: 239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
                GT+ ++APE ++    ++  D + +G+ + E++TG
Sbjct: 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 56.4 bits (137), Expect = 6e-09
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 42/219 (19%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREV-HLISVAIHK 134
           D+F     +G G FG+V       + K  A+K L        +    ++V H+++    K
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKIL-----SKAKIVKLKQVEHVLN---EK 52

Query: 135 NLLQLIG--YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY--- 189
            +LQ I   +        L   F  + ++ Y + +  PG +      RK   F       
Sbjct: 53  RILQSIRHPFLVN-----LYGSFQDDSNL-YLVMEYVPGGELFSH-LRKSGRFPEPVARF 105

Query: 190 -------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 242
                   LEYLH   +  I++RDLK  N+LLD +    + DFG AK V  +    T  +
Sbjct: 106 YAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTL 158

Query: 243 RGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTG 278
            GT  ++APE + +   GK+    D +  GI + E++ G
Sbjct: 159 CGTPEYLAPEIILSKGYGKAV---DWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 56.6 bits (137), Expect = 7e-09
 Identities = 43/127 (33%), Positives = 63/127 (49%), Gaps = 11/127 (8%)

Query: 179 TRKRVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 235
           +  R  F  A    GL+YLHE    KI++RDLK  N+LLD      + DFGL K      
Sbjct: 99  SEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGF 154

Query: 236 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE--DV 293
              T+   GT   +APE L+    +   D +G G+ + E++ G+    F   +EEE  D 
Sbjct: 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP--FPGDDEEEVFDS 212

Query: 294 LLLDHIR 300
           ++ D +R
Sbjct: 213 IVNDEVR 219

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 56.1 bits (135), Expect = 7e-09
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 11/196 (5%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           IGQG  G VY  + ++   +VA+K++     P  E     E+ ++    H N++  +   
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKHPNIVNYLDSY 85

Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  +V  ++   S    L D+   E  +D      V       LE+LH     ++I
Sbjct: 86  LVGDELWVVMEYLAGGS----LTDVVT-ETCMDEGQIAAVCRECLQALEFLHSN---QVI 137

Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRD+K+ NILL  +    L DFG    +  + +  +T + GT   +APE ++      K 
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196

Query: 264 DVFGYGITLLELVTGQ 279
           D++  GI  +E+V G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 56.4 bits (136), Expect = 7e-09
 Identities = 49/216 (22%), Positives = 96/216 (44%), Gaps = 21/216 (9%)

Query: 73  QLATDNFSE---SNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLI 128
             A  + SE    N IG G  G VYK +     ++ A+K +   +         RE+ ++
Sbjct: 67  PSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEIL 126

Query: 129 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 188
               H N+++       + E  ++  FM   S+         G    D      VA    
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE--------GTHIADEQFLADVARQIL 178

Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 248
            G+ YLH +    I+HRD+K +N+L++      + DFG+++++   +    + + GT+ +
Sbjct: 179 SGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAY 234

Query: 249 IAPEYLSTGKSSEK-----TDVFGYGITLLELVTGQ 279
           ++PE ++T  +         D++  G+++LE   G+
Sbjct: 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 24/205 (11%)

Query: 84  IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQR--EVHLISV-------AIH 133
           +IG+G FGKV      ++    AVK LQ       +A  ++  E H++S          H
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQK------KAILKKKEEKHIMSERNVLLKNVKH 55

Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
             L+ L     T+ +   V  ++    + Y L+     E+    P  +  A   A  L Y
Sbjct: 56  PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGY 111

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH   +  I++RDLK  NILLD     VL DFGL K  + +    T+   GT  ++APE 
Sbjct: 112 LH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEV 167

Query: 254 LSTGKSSEKTDVFGYGITLLELVTG 278
           L         D +  G  L E++ G
Sbjct: 168 LHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 44/226 (19%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 134
           D F     IG+G +G+VYK    D    VA+K+++ D    G      RE+ ++    H+
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66

Query: 135 NLLQLIGYCTTSSERI----------LVYPFMQNLSVAYRLRDLKPG--EKGLDWPTRKR 182
           N++ L    T   + +          LV+ +M +        DL  G  E GL       
Sbjct: 67  NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH--------DLM-GLLESGL------- 110

Query: 183 VAFGTAY----------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 232
           V F   +          GL Y H       +HRD+K +NILL++  +  L DFGLA+L +
Sbjct: 111 VHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN 167

Query: 233 AKLTHVTTQIRGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELVT 277
           ++ +   T    T+ +  PE  L   +     DV+  G  L EL T
Sbjct: 168 SEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 51/210 (24%), Positives = 102/210 (48%), Gaps = 23/210 (10%)

Query: 84  IIGQGGFGKV----YKGVLSDNTKVAVKRLQDYYSPGGE-AAFQREVHLISVAIHKNLLQ 138
           ++G+G +G+V    ++   +D  +  +K+L    +   E  A ++E  L+S   H N++ 
Sbjct: 7   VVGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63

Query: 139 LI-GYCTTSSERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYGLEY 193
               +        +V  F +   + ++L++ K    P  + ++W  +       A  L+Y
Sbjct: 64  YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ------IAMALQY 117

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LHE+    I+HRDLK  N+ L       + D G+A++++ +    +T I GT  +++PE 
Sbjct: 118 LHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPEL 173

Query: 254 LSTGKSSEKTDVFGYGITLLELVTGQRAID 283
            S    + K+DV+  G  + E+ T + A +
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATLKHAFN 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 67/261 (25%), Positives = 106/261 (40%), Gaps = 54/261 (20%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTK--VAVKRLQ--DYYSPGGEAAFQREVHLISVAI 132
           D+      +G G FG+V+  V    ++   A+K +   +      E     E  ++    
Sbjct: 1   DDLERIKTVGTGTFGRVHL-VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS 59

Query: 133 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW-PTRKRVAFGTA--Y 189
           H  +++L  + T   +R L           Y L +  PG +   +     R +  T   Y
Sbjct: 60  HPFIIRL--FWTEHDQRFL-----------YMLMEYVPGGELFSYLRNSGRFSNSTGLFY 106

Query: 190 G------LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 243
                  LEYLH +   +I++RDLK  NILLD      L DFG AK    KL   T  + 
Sbjct: 107 ASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAK----KLRDRTWTLC 159

Query: 244 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG-----------------QRAIDFSR 286
           GT  ++APE + +   ++  D +  GI + E++ G                    ++F R
Sbjct: 160 GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR 219

Query: 287 LEEEEDVLLLDHIRKLLREDR 307
                D+   D I+KLL  DR
Sbjct: 220 ---HLDLYAKDLIKKLLVVDR 237

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 34/89 (38%), Positives = 50/89 (56%), Gaps = 4/89 (4%)

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
           LE+LH+     I++RD+K  NILLD     VL DFGL+K   ++    T    GT+ ++A
Sbjct: 118 LEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174

Query: 251 PEYL-STGKSSEKTDVFGYGITLLELVTG 278
           PE +   G   +  D +  GI + EL+TG
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 42/119 (35%), Positives = 60/119 (50%), Gaps = 21/119 (17%)

Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGT 245
           A GL +LH +    II+RDLK  N++LD      + DFG+ K  +   K T       GT
Sbjct: 111 AIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC---GT 164

Query: 246 MGHIAPE---YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL---LLDH 298
             +IAPE   Y   GKS    D + +G+ L E++ GQ   D     E+ED L   +++H
Sbjct: 165 PDYIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAGQPPFD----GEDEDELFQSIMEH 216

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 11/196 (5%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           IGQG  G VY  + ++   +VA+K++     P  E     E+ ++    + N++  +   
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 85

Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  +V  ++   S    L D+   E  +D      V       L++LH     ++I
Sbjct: 86  LVGDELWVVMEYLAGGS----LTDVVT-ETCMDEGQIAAVCRECLQALDFLHSN---QVI 137

Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRD+K+ NILL  +    L DFG    +  + +  +T + GT   +APE ++      K 
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196

Query: 264 DVFGYGITLLELVTGQ 279
           D++  GI  +E+V G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 55/222 (24%), Positives = 98/222 (44%), Gaps = 16/222 (7%)

Query: 84  IIGQGGFGKVYKGVLSDNTKV-AVKRLQD--YYSPGGEAAFQREVHLISVAIHKNLLQLI 140
           ++G+G FGKV    L ++ ++ AVK L+               E  ++S+A +   L  +
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 141 GYCTTSSERIL-VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
             C  + +R+  V  F+    + + ++      +  D    +  A      L +LH++  
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK-- 115

Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGTMGHIAPEYLSTG 257
             II+RDLK  N+LLD      L DFG+ K  + + K    T+   GT  +IAPE L   
Sbjct: 116 -GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT---TSTFCGTPDYIAPEILQEM 171

Query: 258 KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI 299
                 D +  G+ L E++ G    +    ++  + +L D +
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV 213

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 30/97 (30%), Positives = 54/97 (55%), Gaps = 8/97 (8%)

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT---TQIRGTM 246
           GL+Y+H      +IHRDLK +N+L++++ E  + DFG+A+ + +  T      T+   T 
Sbjct: 119 GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175

Query: 247 GHIAPE-YLSTGKSSEKTDVFGYGITLLELVTGQRAI 282
            + APE  LS  + +   D++  G    E++ G+R +
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 17/217 (7%)

Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDY--YSPGGEAAFQREVH 126
           R+LQ+  +++    +IG+G FG+V       + KV A+K L  +        A F  E  
Sbjct: 36  RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 127 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +++ A    ++QL  +C    ++ L Y  M+ +       DL       D P  K   F 
Sbjct: 96  IMAFANSPWVVQL--FCAFQDDKYL-YMVMEYMPGG----DLVNLMSNYDVP-EKWAKFY 147

Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGT 245
           TA  +  L    +  +IHRD+K  N+LLD +    L DFG   K+ +  +    T + GT
Sbjct: 148 TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GT 206

Query: 246 MGHIAPEYLST----GKSSEKTDVFGYGITLLELVTG 278
             +I+PE L +    G    + D +  G+ L E++ G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 38/115 (33%), Positives = 59/115 (51%), Gaps = 9/115 (7%)

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+YLH   +  I+HRD+K  N+L++ N    +CDFGLA++ +   +   TQ   T  + 
Sbjct: 115 GLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYR 171

Query: 250 APEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 303
           APE L   +  +   D++  G    EL+   R I F   + +  +  LD I  LL
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELL--GRRILF---QAQSPIQQLDLITDLL 221

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 54.7 bits (131), Expect = 4e-08
 Identities = 68/252 (26%), Positives = 115/252 (45%), Gaps = 45/252 (17%)

Query: 54  EDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNT-KVAVKR-LQD 111
           ED+ K+    + R   +  +L        NIIG G FG VY+ +  D + KVA+K+ LQD
Sbjct: 50  EDEEKMIDNDINRSPNKSYKLG-------NIIGNGSFGVVYEAICIDTSEKVAIKKVLQD 102

Query: 112 -YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER-----ILVYPFMQNL--SVAY 163
             Y         RE+ ++    H N++ L  Y  T   +     I +   M+ +  +V  
Sbjct: 103 PQYK-------NRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHK 155

Query: 164 RLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-L 222
            ++        L     K  ++     L Y+H +    I HRDLK  N+L+D N   + L
Sbjct: 156 YMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKL 212

Query: 223 CDFGLAKLVDA---KLTHVTTQIRGTMGHIAPEYLSTGKSSEKT--DVFGYGITLLELV- 276
           CDFG AK + A    ++++ ++      + APE L  G ++  T  D++  G  + E++ 
Sbjct: 213 CDFGSAKNLLAGQRSVSYICSRF-----YRAPE-LMLGATNYTTHIDLWSLGCIIAEMIL 266

Query: 277 -----TGQRAID 283
                +GQ ++D
Sbjct: 267 GYPIFSGQSSVD 278

Length = 440

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 54.3 bits (131), Expect = 4e-08
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 21/205 (10%)

Query: 85  IGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQ-REVHLISVAIHKNLLQLIGY 142
           IG+G +G V     S+ N KVA+K++ + +    +A    RE+ L+    H+N++ +   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 143 CTTSSERI-----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
                        +VY  M        L  +    + L     +   +    GL+Y+H  
Sbjct: 73  MPPPHREAFNDVYIVYELMDT-----DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH-- 125

Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 257
            +  ++HRDLK +N+LL+ N +  +CDFGLA+    K   +T  +  T  + APE L   
Sbjct: 126 -SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPELLLN- 182

Query: 258 KSSEKT---DVFGYGITLLELVTGQ 279
             SE T   DV+  G    EL+  +
Sbjct: 183 -CSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 31/87 (35%), Positives = 46/87 (52%), Gaps = 7/87 (8%)

Query: 192 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAP 251
           EYLH   +  II+RDLK  N+LLD+     + DFG AK    K+   T  + GT  ++AP
Sbjct: 132 EYLHS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAK----KVPDRTFTLCGTPEYLAP 184

Query: 252 EYLSTGKSSEKTDVFGYGITLLELVTG 278
           E + +    +  D +  G+ L E + G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 64/238 (26%), Positives = 101/238 (42%), Gaps = 51/238 (21%)

Query: 84  IIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           ++G+G FGKV    L       AVK            A +++V LI   +          
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVK------------ALKKDVVLIDDDVE--------- 40

Query: 143 CTTSSERILVY----PFMQNLSVAYRLRD--------LKPGEKGLDWPTRKRVAF--GTA 188
           CT   +R+L      PF+ +L   ++ ++        L  G+       + R      T 
Sbjct: 41  CTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF 100

Query: 189 Y------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 242
           Y      GL++LH +    II+RDLK  N++LD +    + DFG+ K         +T  
Sbjct: 101 YAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-F 156

Query: 243 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 300
            GT  +IAPE L   K +   D + +G+ L E++ GQ    F   +E+E   L + IR
Sbjct: 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP--FHGDDEDE---LFESIR 209

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 53.9 bits (130), Expect = 5e-08
 Identities = 67/285 (23%), Positives = 105/285 (36%), Gaps = 35/285 (12%)

Query: 86  GQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
                  + K     NT VAVK++  D  S       Q+E+       H N+L  +    
Sbjct: 11  EDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI 69

Query: 145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 204
             SE  +V P M   S    L+   P  +GL       +       L+Y+H   +   IH
Sbjct: 70  VDSELYVVSPLMAYGSCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIH---SKGFIH 124

Query: 205 RDLKAANILLDDNFEAVLCDFGLAKLVD------AKLTHVTTQIRGTMGHIAPEYLSTGK 258
           R +KA++ILL  + + VL     +  +         +          +  ++PE L    
Sbjct: 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNL 184

Query: 259 S--SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL---------LLDHIRKLLREDR 307
              +EK+D++  GIT  EL  G   + F  +   + +L         LLD     L ED 
Sbjct: 185 QGYNEKSDIYSVGITACELANGH--VPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS 242

Query: 308 LNDIVDRNLNTYDSKEVETMV---------QVALLCTQSTPEDRP 343
           ++     N +  +   V+            Q   LC Q  PE RP
Sbjct: 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRP 287

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 52.9 bits (127), Expect = 6e-08
 Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 28/211 (13%)

Query: 85  IGQGGFGKVYKGVL----SDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           IG+G FGK    +L     D  +  +K +     SP      ++EV ++S   H N++Q 
Sbjct: 8   IGEGSFGK---AILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ- 63

Query: 140 IGYCTTSSERILVYPFMQNLS-------VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 192
             Y  +  E   +Y  M           +  +   L P ++ LDW  +          L+
Sbjct: 64  --YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQ------ICLALK 115

Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 252
           ++H++   KI+HRD+K+ NI L  +    L DFG+A+++++ +    T I GT  +++PE
Sbjct: 116 HVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPE 171

Query: 253 YLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
                  + K+D++  G  L E+ T + A +
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 53.6 bits (128), Expect = 6e-08
 Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 11/196 (5%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           IGQG  G V+  + ++   +VA+K++     P  E     E+ ++    + N++  +   
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIIN-EILVMKELKNPNIVNFLDSF 85

Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  +V  ++   S    L D+   E  +D      V       LE+LH     ++I
Sbjct: 86  LVGDELFVVMEYLAGGS----LTDVVT-ETCMDEAQIAAVCRECLQALEFLHAN---QVI 137

Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRD+K+ N+LL  +    L DFG    +  + +  +T + GT   +APE ++      K 
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196

Query: 264 DVFGYGITLLELVTGQ 279
           D++  GI  +E+V G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 53.3 bits (128), Expect = 7e-08
 Identities = 59/219 (26%), Positives = 91/219 (41%), Gaps = 50/219 (22%)

Query: 84  IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY- 142
           ++G+G FGKV          +A  +  D            EV+ I V     +LQ     
Sbjct: 2   VLGKGSFGKVM---------LAELKGTD------------EVYAIKVLKKDVILQDDDVD 40

Query: 143 CTTSSERILV----YPFMQNLSVAYRLRD--------LKPGE--------KGLDWPTRKR 182
           CT + +RIL     +PF+  L   ++ +D        +  G+        +  D P  + 
Sbjct: 41  CTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF 100

Query: 183 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTT 240
            A      L +LH      +I+RDLK  NILLD      L DFG+ K  +++      TT
Sbjct: 101 YAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT---TT 154

Query: 241 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
              GT  +IAPE L   +     D +  G+ + E++ GQ
Sbjct: 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 53.2 bits (128), Expect = 9e-08
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 21/219 (9%)

Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQ--DYYSPGGEAAFQREVH 126
            +L++  ++F    +IG+G FG+V       + +V A+K L   +       A F  E  
Sbjct: 36  TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 127 LISVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVA 184
           +++ A  + ++QL  +     ++ L  V  +M    +   + +    EK   W       
Sbjct: 96  IMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK---W-----AR 145

Query: 185 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK-LTHVTTQIR 243
           F TA  +  L    +   IHRD+K  N+LLD +    L DFG    +DA  +    T + 
Sbjct: 146 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV- 204

Query: 244 GTMGHIAPEYLST----GKSSEKTDVFGYGITLLELVTG 278
           GT  +I+PE L +    G    + D +  G+ L E++ G
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 33/222 (14%)

Query: 70  RELQLATDNFSESNIIGQGGFGKV----YKGVLSDNTKVAVKRLQDYYSPGGEAAFQREV 125
           R+ ++  ++F+    +G G FG+V    YK    D   VA+KR +       +   Q++V
Sbjct: 23  RKNKMKYEDFNFIRTLGTGSFGRVILATYKN--EDFPPVAIKRFEK-----SKIIKQKQV 75

Query: 126 -------HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK--PGEKGLD 176
                   +++   H   + L G     S   LV  F+        LR  K  P + G  
Sbjct: 76  DHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF 135

Query: 177 WPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 236
           +  +  + F      EYL    +  I++RDLK  N+LLD +    + DFG AK+VD +  
Sbjct: 136 YAAQIVLIF------EYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184

Query: 237 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
             T  + GT  +IAPE L      +  D +  GI + E++ G
Sbjct: 185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 37/109 (33%), Positives = 57/109 (52%), Gaps = 10/109 (9%)

Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR-GTM 246
           A GL +LH +    II+RDLK  N++LD      + DFG+ K  +     VTT+   GT 
Sbjct: 111 AIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTP 165

Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 295
            +IAPE ++     +  D + +G+ L E++ GQ   +     E+ED L 
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE----GEDEDELF 210

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 56/239 (23%), Positives = 105/239 (43%), Gaps = 34/239 (14%)

Query: 85  IGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 136
           +GQG F K++KG+  +         T+V +K L   +    E+ F+    ++S   HK+L
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFE-AASMMSQLSHKHL 61

Query: 137 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEK-GLDWPTRKRVAFGTAYGLEYLH 195
           +   G C    E I+V  +++  S+   L+  K      + W  +  VA   A+ L +L 
Sbjct: 62  VLNYGVCVCGDESIMVQEYVKFGSLDTYLK--KNKNLINISW--KLEVAKQLAWALHFLE 117

Query: 196 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH----IAP 251
           ++    + H ++ A N+LL    +    +    KL D  ++ +T   +  +      + P
Sbjct: 118 DK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS-ITVLPKEILLERIPWVPP 173

Query: 252 EYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL-REDRL 308
           E +   ++ S   D + +G TL E+ +G           ++ +  LD  +KL   EDR 
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFSGG----------DKPLSALDSQKKLQFYEDRH 222

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 14/204 (6%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           DNF +   IG+G  G V    +  + K VAVK++        E  F  EV ++    H+N
Sbjct: 23  DNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHEN 78

Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
           ++++        E  +V  F++  ++   +   +  E+ +       V       L  LH
Sbjct: 79  VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLKALSVLH 133

Query: 196 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 255
            Q    +IHRD+K+ +ILL  +    L DFG    V  ++    + + GT   +APE +S
Sbjct: 134 AQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELIS 189

Query: 256 TGKSSEKTDVFGYGITLLELVTGQ 279
                 + D++  GI ++E+V G+
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 52.6 bits (127), Expect = 1e-07
 Identities = 44/165 (26%), Positives = 77/165 (46%), Gaps = 38/165 (23%)

Query: 85  IGQGGFGKVYKGVLSD---NTKVAVKRLQDYYSPGGEAAFQ---------REV-HLISVA 131
           +G+G +G V+K +  D      VA+K++ D        AF+         RE+  L  + 
Sbjct: 15  LGKGAYGIVWKAI--DRRTKEVVALKKIFD--------AFRNATDAQRTFREIMFLQELG 64

Query: 132 IHKNLLQLIGYCTTSSER--ILVYPFMQ-NLSVAYRLRDLKPGEKGLDWPTRKR-VAFGT 187
            H N+++L+      +++   LV+ +M+ +L    R          +     KR + +  
Sbjct: 65  DHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIR--------ANILEDVHKRYIMYQL 116

Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 232
              L+Y+H      +IHRDLK +NILL+ +    L DFGLA+ + 
Sbjct: 117 LKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 44/173 (25%), Positives = 70/173 (40%), Gaps = 36/173 (20%)

Query: 124 EVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 183
           E H++    H +++QL G  T +    L+ P  +     Y L              ++ +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCY-LAA------------KRNI 179

Query: 184 AF--------GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL-VDAK 234
           A              ++YLHE    +IIHRD+KA NI ++   +  L DFG A   VD  
Sbjct: 180 AICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD-- 234

Query: 235 LTHVTTQIR-----GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 282
                   +     GT+   APE L+        D++  GI L E+ T   ++
Sbjct: 235 ----INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 49/196 (25%), Positives = 89/196 (45%), Gaps = 11/196 (5%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           IGQG  G VY  + ++   +VA++++     P  E     E+ ++    + N++  +   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 86

Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  +V  ++   S    L D+   E  +D      V       LE+LH     ++I
Sbjct: 87  LVGDELWVVMEYLAGGS----LTDVVT-ETCMDEGQIAAVCRECLQALEFLHSN---QVI 138

Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRD+K+ NILL  +    L DFG    +  + +   + + GT   +APE ++      K 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKV 197

Query: 264 DVFGYGITLLELVTGQ 279
           D++  GI  +E++ G+
Sbjct: 198 DIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 55/227 (24%), Positives = 86/227 (37%), Gaps = 40/227 (17%)

Query: 83  NIIGQGGFGKVYKGV-LSDNTKVAVKRLQDY-YSPGGEAAFQ------------REVHLI 128
             +G+G +GKV K         VA+K+++    S       Q            RE+ ++
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 129 SVAIHKNLLQLIG-YCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   H+N++ L+  Y     + I LV   M     A  L+ +   +  L     K +   
Sbjct: 75  NEIKHENIMGLVDVYV--EGDFINLVMDIM-----ASDLKKVVDRKIRLTESQVKCILLQ 127

Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-------------KLVDA 233
              GL  LH       +HRDL  ANI ++      + DFGLA             K    
Sbjct: 128 ILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 234 KLTHVTTQIRGTMGHIAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 279
           +     T    T+ + APE L    K     D++  G    EL+TG+
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 27/89 (30%), Positives = 42/89 (47%), Gaps = 4/89 (4%)

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
           L YLH      +++RDLK  N++LD +    + DFGL K              GT  ++A
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLA 163

Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           PE L         D +G G+ + E++ G+
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 55/198 (27%), Positives = 84/198 (42%), Gaps = 36/198 (18%)

Query: 102 TKVAVKRLQDYYSPGGE--AAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL 159
           T V V R+ D  +   E   A Q EV L     H N++      TT S   ++ PFM   
Sbjct: 26  TLVTV-RITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84

Query: 160 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE 219
           S    L+   P  +G+       + FG   GL YLH+      IHR++KA++IL+  +  
Sbjct: 85  SANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGD-- 137

Query: 220 AVLCDFGLAKLVDAKLTHVTTQIRGTMGH----------------IAPEYLSTGKS--SE 261
                 GL  L  + L+H+ + +R                     ++PE L       + 
Sbjct: 138 ------GLVSL--SGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNV 189

Query: 262 KTDVFGYGITLLELVTGQ 279
           K+D++  GIT  EL TG+
Sbjct: 190 KSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 49/196 (25%), Positives = 86/196 (43%), Gaps = 25/196 (12%)

Query: 95  KGVLSDNTKV--AVKRLQDYYSPGGEAAFQREVHLISVAI--HKNLLQLIGYCTTSSERI 150
           +GV S N       + +      G  AA Q E  ++++    H+N+L++        E I
Sbjct: 180 RGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI--------EEI 231

Query: 151 LVYP---FMQNLSVAYRL------RDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 201
           L      +M      + L            ++ L   TR  +       +EY+H++   K
Sbjct: 232 LRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---K 287

Query: 202 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSE 261
           +IHRD+K  NI L+ + + VL DFG A   + +         GT+   +PE L+     E
Sbjct: 288 LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCE 347

Query: 262 KTDVFGYGITLLELVT 277
            TD++  G+ LL++++
Sbjct: 348 ITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 35/121 (28%), Positives = 58/121 (47%), Gaps = 4/121 (3%)

Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 247
           +  L YLHE+    II+RDLK  N+LLD      L D+G+ K    +    T+   GT  
Sbjct: 106 SLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPN 161

Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 307
           +IAPE L         D +  G+ + E++ G+   D     +  D    D++ +++ E +
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 221

Query: 308 L 308
           +
Sbjct: 222 I 222

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 41/142 (28%), Positives = 69/142 (48%), Gaps = 13/142 (9%)

Query: 141 GYCTTSSERIL-VYPFMQNLSVAYRLRDLKPGEKGLDWPTRK----RVAFGTAYGLEYL- 194
           G+ +  S+  + + P   + S +   +D +  E    WP       R +   A G+++L 
Sbjct: 172 GFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTED--SWPLDLDDLLRFSSQVAQGMDFLA 229

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QIRGTMGHIAPEY 253
            + C    IHRD+ A N+LL D   A +CDFGLA+ +     +V     R  +  +APE 
Sbjct: 230 SKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES 285

Query: 254 LSTGKSSEKTDVFGYGITLLEL 275
           +     + ++DV+ YGI L E+
Sbjct: 286 IFDCVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 50.5 bits (120), Expect = 6e-07
 Identities = 34/113 (30%), Positives = 58/113 (51%), Gaps = 8/113 (7%)

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGTMG 247
            L+YLH   + KI++RDLK  N++LD +    + DFGL K  + DA          GT  
Sbjct: 107 ALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC---GTPE 160

Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 300
           ++APE L         D +G G+ + E++ G+        E+  +++L++ I+
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK 213

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 51.2 bits (122), Expect = 6e-07
 Identities = 32/91 (35%), Positives = 49/91 (53%), Gaps = 4/91 (4%)

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHI 249
           L+ +H +    ++HRDLK+ANI L       L DFG +K   D+    V +   GT  ++
Sbjct: 182 LDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238

Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQR 280
           APE     + S+K D++  G+ L EL+T  R
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLTLHR 269

Length = 478

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 50.4 bits (120), Expect = 6e-07
 Identities = 49/209 (23%), Positives = 91/209 (43%), Gaps = 17/209 (8%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQ---REVHLISVAI 132
           + F    ++G+G +G V K    +    VA+K+ +D  S   E   +   RE+ ++    
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKD--SEENEEVKETTLRELKMLRTLK 58

Query: 133 HKNLLQLIGYCTTSSERILVYPFMQN--LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG 190
            +N+++L        +  LV+ +++   L +   + +  P EK       +   +     
Sbjct: 59  QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEK------VRSYIYQLIKA 112

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
           + + H+     I+HRD+K  N+L+  N    LCDFG A+ +        T+   T  + +
Sbjct: 113 IHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRS 169

Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           PE L      +  D++  G  L EL  GQ
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 12/204 (5%)

Query: 84  IIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAA--FQREVHLISVAIHKNLLQLI 140
           +IG+G + KV    L  N ++ A+K ++       E     Q E H+   A     L  +
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 141 GYC-TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
             C  T+S   LV  ++    + + ++     ++ L     +  A      L +LHE+  
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER-- 115

Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 259
             II+RDLK  N+LLD +    L D+G+ K         T+   GT  +IAPE L   + 
Sbjct: 116 -GIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEEY 173

Query: 260 SEKTDVFGYGITLLELVTGQRAID 283
               D +  G+ + E++ G+   D
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 49.8 bits (119), Expect = 8e-07
 Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 10/92 (10%)

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR---GTMG 247
           L +LH Q    +IHRD+K+ +ILL  +    L DFG      A+++    + +   GT  
Sbjct: 128 LSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFC----AQVSKEVPRRKSLVGTPY 180

Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
            +APE +S      + D++  GI ++E+V G+
Sbjct: 181 WMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 49.9 bits (119), Expect = 8e-07
 Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 30/210 (14%)

Query: 85  IGQGGFGKVYKGVLSDNTKVA---VKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
           IG G FGKV    +  +T VA   VK L+   S   +  F ++     +  H N+LQ +G
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 142 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR-------KRVAFGTAYGLEYL 194
            C  +   +LV+ + +       L DLK       W  R       +R+A   A G+ ++
Sbjct: 63  QCVEAIPYLLVFEYCE-------LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHM 115

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGH 248
           H+      +H DL   N  L  +    + D+G+      K  ++ T+      +R     
Sbjct: 116 HKH---NFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPE 171

Query: 249 IAPEY---LSTGKSSEKTDVFGYGITLLEL 275
           +  E+   L T + ++ ++V+  G+TL EL
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 50.0 bits (119), Expect = 8e-07
 Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 11/196 (5%)

Query: 85  IGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           IG+G  G V         K VAVK++        E  F  EV ++    H+N++ +    
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN-EVVIMRDYHHENVVDMYNSY 88

Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  +V  F++  ++   +   +  E+ +       V       L YLH Q    +I
Sbjct: 89  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLHNQ---GVI 140

Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRD+K+ +ILL  +    L DFG    V  ++    + + GT   +APE +S      + 
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEV 199

Query: 264 DVFGYGITLLELVTGQ 279
           D++  GI ++E++ G+
Sbjct: 200 DIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 49.7 bits (118), Expect = 1e-06
 Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 26/203 (12%)

Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAAFQ-REVHLISVAIHKNLLQLI 140
           IG G  G V   Y  VL  N  VA+K+L   +     A    RE+ L+    HKN++ L+
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 141 GYCT---TSSERILVYPFMQ----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
              T   +  E   VY  M+    NL    ++         LD      + +    G+++
Sbjct: 83  NVFTPQKSLEEFQDVYLVMELMDANLCQVIQME--------LDHERMSYLLYQMLCGIKH 134

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH   +  IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE 
Sbjct: 135 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 189

Query: 254 LSTGKSSEKTDVFGYGITLLELV 276
           +      E  D++  G  + E+V
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 49.7 bits (118), Expect = 1e-06
 Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 24/205 (11%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           +G G +G V          KVAVK+L + + S        RE+ L+    H+N++ L+  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFGTAYGLEYLH 195
            T ++        ++N +  Y + +L   +       + L     + + +    GL+Y+H
Sbjct: 83  FTPATS-------IENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH 135

Query: 196 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE-YL 254
              +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + APE  L
Sbjct: 136 ---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYV----ATRWYRAPEIML 188

Query: 255 STGKSSEKTDVFGYGITLLELVTGQ 279
           +    ++  D++  G  + EL+ G+
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 35/115 (30%), Positives = 58/115 (50%), Gaps = 14/115 (12%)

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--IRGTMGH 248
           LEYLH +    +++RD+K  N++LD +    + DFGL K     ++   T     GT  +
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEY 161

Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI---DFSRLEEEEDVLLLDHIR 300
           +APE L         D +G G+ + E++ G+      D  RL E   ++L++ IR
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE---LILMEEIR 213

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 33/111 (29%), Positives = 56/111 (50%), Gaps = 3/111 (2%)

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L+YLH + N  +++RDLK  N++LD +    + DFGL K    K         GT  ++
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYL 163

Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 300
           APE L         D +G G+ + E++ G+        E+  +++L++ IR
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 214

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 25/212 (11%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSD---NTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAI 132
           D + +   IG+G +G VYK    D   N  +A+K+++ +    G  +   RE+ L+    
Sbjct: 2   DQYEKVEKIGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ 59

Query: 133 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG-EKGLDWPTRKRVAFGTAY-- 189
           H N+++L       SE+ L   F       Y   DLK   +   D+    R+     Y  
Sbjct: 60  HGNIVRL--QDVVHSEKRLYLVF------EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQI 111

Query: 190 --GLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTM 246
             G+ Y H     +++HRDLK  N+L+D    A+ L DFGLA+     +   T ++  T+
Sbjct: 112 LRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TL 167

Query: 247 GHIAPEYLSTGKS-SEKTDVFGYGITLLELVT 277
            + APE L   +  S   D++  G    E+V 
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199

Length = 294

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 27/175 (15%)

Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QI 242
           ++  A G+ +L  +     IHRDL A NILL       +CDFGLA+ +     +V     
Sbjct: 220 SYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNA 276

Query: 243 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD-HIRK 301
           R  +  +APE +     + ++DV+ YGI L E+        FS        + +D    K
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEI--------FSLGSSPYPGMPVDSKFYK 328

Query: 302 LLRED-RLNDIVDRNLNTYDSKEVE--TMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
           +++E  R+            S E     M  +   C  + P  RP   Q+V++++
Sbjct: 329 MIKEGYRM-----------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 132 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 184

Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 57/201 (28%), Positives = 87/201 (43%), Gaps = 18/201 (8%)

Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAAFQ-REVHLISVAIHKNLLQLI 140
           IG G  G V   +  VL  N  VAVK+L   +     A    RE+ L+    HKN++ L+
Sbjct: 29  IGSGAQGIVCAAFDTVLGIN--VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86

Query: 141 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGE---KGLDWPTRKRVAFGTAYGLEYLHEQ 197
              T            Q++ +   L D    +     LD      + +    G+++LH  
Sbjct: 87  NVFTPQKS----LEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH-- 140

Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 257
            +  IIHRDLK +NI++  +    + DFGLA+   A    + T    T  + APE +   
Sbjct: 141 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGM 197

Query: 258 KSSEKTDVFGYGITLLELVTG 278
              E  D++  G  + ELV G
Sbjct: 198 GYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 72/290 (24%), Positives = 111/290 (38%), Gaps = 56/290 (19%)

Query: 85  IGQGGFGKVYKGVLSDN-----------TKVAVKRLQDYYSPGGEA--AFQREVHLISVA 131
           +GQG F  +YKGVL                V +K L            AF     L+S  
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG----SDHRDSLAFFETASLMSQL 58

Query: 132 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL 191
            HK+L++L G C    E I+V  +++   +   L   +     L W  +  VA   A  L
Sbjct: 59  SHKHLVKLYGVC-VRDENIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQLASAL 114

Query: 192 EYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDA--KLTHVTTQIR-GT 245
            YL ++   K++H ++   NIL+     N   V       KL D    +T ++ + R   
Sbjct: 115 HYLEDK---KLVHGNVCGKNILVARYGLNEGYVPF----IKLSDPGIPITVLSREERVER 167

Query: 246 MGHIAPEYLSTGKSS--EKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 303
           +  IAPE +  G++S     D + +G TLLE+         S    EE +  L    K  
Sbjct: 168 IPWIAPECIRNGQASLTIAADKWSFGTTLLEI--------CSN--GEEPLSTLSSSEKER 217

Query: 304 REDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKML 352
                +      L   D  E+   + Q    C    P  RP    +++ L
Sbjct: 218 FYQDQH-----RLPMPDCAELANLINQ----CWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 16/208 (7%)

Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           +G+G +G VYK    D        L+     G   +  RE+ L+    H N++ L     
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 145 TSSER--ILVYPFMQN--LSVAYRLRDLKPGEKGLDWPTR--KRVAFGTAYGLEYLHEQC 198
           + S+R   L++ + ++    +    R  K  +K +  P    K + +    G+ YLH   
Sbjct: 69  SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128

Query: 199 NPKIIHRDLKAANILL----DDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTMGHIAPE 252
              ++HRDLK ANIL+     +     + D G A+L ++ L  +     +  T  + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 253 YLSTGKSSEKT-DVFGYGITLLELVTGQ 279
            L   +   K  D++  G    EL+T +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 31/98 (31%), Positives = 48/98 (48%), Gaps = 15/98 (15%)

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-------KLVDAKLTHVTTQI 242
           GL+Y+H   +  ++HRDLK  N+L++ + E  +CDFGLA             +T      
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA-- 171

Query: 243 RGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
             T  + APE  LS    ++  DV+  G  L EL+  +
Sbjct: 172 --TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 35/122 (28%), Positives = 66/122 (54%), Gaps = 8/122 (6%)

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTH--VTTQIRGTM 246
           GL+Y+H   +  ++HRDLK AN+ ++ ++    + DFGLA++VD   +H    ++   T 
Sbjct: 126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182

Query: 247 GHIAPE-YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 305
            + +P   LS    ++  D++  G    E++TG+     +  E E+  L+L+ +  +  E
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH-ELEQMQLILESVPVVREE 241

Query: 306 DR 307
           DR
Sbjct: 242 DR 243

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 34/115 (29%), Positives = 56/115 (48%), Gaps = 4/115 (3%)

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
           L +LHE+    II+RDLK  N+LLD      L D+G+ K    +    T+   GT  +IA
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIA 164

Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 305
           PE L         D +  G+ + E++ G+   D   + +  D    D++ +++ E
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE 219

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 18/202 (8%)

Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAAFQ-REVHLISVAIHKNLLQLI 140
           IG G  G V   Y  +L  N  VA+K+L   +     A    RE+ L+    HKN++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89

Query: 141 GYCTTSSERILVYPFMQNLSVAYRLRD---LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
              T            Q++ +   L D    +  +  LD      + +    G+++LH  
Sbjct: 90  NVFTPQKS----LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH-- 143

Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 257
            +  IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE +   
Sbjct: 144 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200

Query: 258 KSSEKTDVFGYGITLLELVTGQ 279
              E  D++  G  + E++ G 
Sbjct: 201 GYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 47.1 bits (112), Expect = 6e-06
 Identities = 37/109 (33%), Positives = 49/109 (44%), Gaps = 23/109 (21%)

Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT------ 240
           T   LEYLH   N  I+HRDLK  N+L+       L DFGL+K+    L  +TT      
Sbjct: 110 TVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI---GLMSLTTNLYEGH 163

Query: 241 -----------QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
                      Q+ GT  +IAPE +      +  D +  GI L E + G
Sbjct: 164 IEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 16/208 (7%)

Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           +G+G +G VYK    D        L+     G   +  RE+ L+    H N++ L     
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 145 TSSER--ILVYPFMQN--LSVAYRLRDLKPGEKGLDWP--TRKRVAFGTAYGLEYLHEQC 198
           + ++R   L++ + ++    +    R  K  +K +  P    K + +    G+ YLH   
Sbjct: 69  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128

Query: 199 NPKIIHRDLKAANILL----DDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTMGHIAPE 252
              ++HRDLK ANIL+     +     + D G A+L ++ L  +     +  T  + APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 253 YLSTGKSSEKT-DVFGYGITLLELVTGQ 279
            L   +   K  D++  G    EL+T +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 4/90 (4%)

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L YLH Q    +IHRD+K+ +ILL  +    L DFG    +   +    + + GT   +
Sbjct: 129 ALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWM 184

Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE +S      + D++  GI ++E+V G+
Sbjct: 185 APEVISRTPYGTEVDIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 45.6 bits (109), Expect = 2e-05
 Identities = 30/109 (27%), Positives = 48/109 (44%), Gaps = 9/109 (8%)

Query: 172 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKL 230
           E  L     K++       L  LH      IIH D+K  N+L D   + + LCD+GL K+
Sbjct: 103 EGKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159

Query: 231 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           +     +      GT+ + +PE +         D +  G+   EL+TG+
Sbjct: 160 IGTPSCY-----DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 56/211 (26%), Positives = 87/211 (41%), Gaps = 36/211 (17%)

Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEA--AFQREVHLISVAIHKNLLQL 139
           IG G  G V   Y  V      VA+K+L   +     A  A+ RE+ L+ +  HKN++ L
Sbjct: 24  IGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAY-RELVLMKLVNHKNIIGL 80

Query: 140 IGYCT------TSSERILVYPFMQ-NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 192
           +   T         +  LV   M  NL    ++         LD      + +    G++
Sbjct: 81  LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD--------LDHERMSYLLYQMLCGIK 132

Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH----VTTQIRGTMGH 248
           +LH   +  IIHRDLK +NI++  +    + DFGLA+            VT   R     
Sbjct: 133 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR----- 184

Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
            APE +      E  D++  G  + E++ G 
Sbjct: 185 -APEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 51/241 (21%), Positives = 96/241 (39%), Gaps = 50/241 (20%)

Query: 141 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW-------PTRKRVA--------- 184
           GY   S +    Y  MQ++    +  D++       +       P R R           
Sbjct: 177 GYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPAL 236

Query: 185 ---------FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 235
                    +  A G+E+L  +     +HRDL A N+L+ +     +CDFGLA+ +    
Sbjct: 237 SYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDS 293

Query: 236 THVTTQIRGT----MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE 291
            +++   +G+    +  +APE +     +  +DV+ +GI L E+ T      +  L   E
Sbjct: 294 NYIS---KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT-LGGTPYPELPMNE 349

Query: 292 DVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 351
                + I++  R  +           + S E+  ++Q    C +   E RP  +Q+V +
Sbjct: 350 --QFYNAIKRGYRMAK---------PAHASDEIYEIMQ---KCWEEKFEIRPDFSQLVHL 395

Query: 352 L 352
           +
Sbjct: 396 V 396

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 44.7 bits (105), Expect = 5e-05
 Identities = 50/215 (23%), Positives = 89/215 (41%), Gaps = 22/215 (10%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHK 134
           ++F    +IG+G FG+V    L +  KV   ++ + +      E A  RE   + V    
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 135 NLLQLIGYCTTSSERILV----YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG 190
             +  + Y       + +    Y     L++  +  D  P +    +     +A  + + 
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG-LAKLVDAKLTHVTTQIRGTMGHI 249
           L Y         +HRD+K  NIL+D N    L DFG   KL++      +  + GT  +I
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYI 170

Query: 250 APEYLST-----GKSSEKTDVFGYGITLLELVTGQ 279
           +PE L       GK   + D +  G+ + E++ G+
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 44.6 bits (105), Expect = 6e-05
 Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 10/97 (10%)

Query: 185 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG 244
           +  A G+E+L  +     +HRDL A N+LL       +CDFGLA+ +     +V+   +G
Sbjct: 244 YQVARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS---KG 297

Query: 245 T----MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
           +    +  +APE +     +  +DV+ YGI L E+ +
Sbjct: 298 STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 44.2 bits (104), Expect = 6e-05
 Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 17/217 (7%)

Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDY--YSPGGEAAFQREVH 126
           R+L++  +++    +IG+G FG+V         KV A+K L  +        A F  E  
Sbjct: 36  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 127 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +++ A    ++QL           +V  +M    +   + +    EK   + T + V   
Sbjct: 96  IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVV--- 152

Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGT 245
               L+ +H       IHRD+K  N+LLD +    L DFG   K+    +    T + GT
Sbjct: 153 --LALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GT 206

Query: 246 MGHIAPEYLST----GKSSEKTDVFGYGITLLELVTG 278
             +I+PE L +    G    + D +  G+ L E++ G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 44.5 bits (105), Expect = 7e-05
 Identities = 42/160 (26%), Positives = 66/160 (41%), Gaps = 8/160 (5%)

Query: 116 GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL 175
           G  A+   E  L+    H  +L L+          LV P  ++    Y    L+P    L
Sbjct: 202 GWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRP----L 257

Query: 176 DWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD-AK 234
                  VA      ++Y+H +    IIHRD+K  N+L++   +  L DFG A     + 
Sbjct: 258 GLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314

Query: 235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLE 274
            T     I GT+   APE L+    +   D++  G+ + E
Sbjct: 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 26/83 (31%), Positives = 39/83 (46%), Gaps = 6/83 (7%)

Query: 203 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 262
           +HRD+K  N+L+D      L DFG A  + A     +    GT  +IAPE L+T     K
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183

Query: 263 T------DVFGYGITLLELVTGQ 279
                  D +  G+   E++ G+
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 20/56 (35%), Positives = 29/56 (51%), Gaps = 4/56 (7%)

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 245
            LEYLH      I++RDLK  NILL ++   +L DF L+K  D +     ++    
Sbjct: 115 ALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE-PPPVSKALRK 166

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 26/82 (31%), Positives = 42/82 (51%), Gaps = 5/82 (6%)

Query: 203 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-----G 257
           +HRD+K  N+LLD N    L DFG    ++   T  ++   GT  +I+PE L       G
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183

Query: 258 KSSEKTDVFGYGITLLELVTGQ 279
           K   + D +  G+ + E++ G+
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 31/109 (28%), Positives = 46/109 (42%), Gaps = 6/109 (5%)

Query: 202 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSE 261
            IHRDLK  N L+D +    L DFGL+K +      V     G+  ++APE L       
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV----GSPDYMAPEVLRGKGYDF 177

Query: 262 KTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 310
             D +  G  L E + G      S   E  + L   + ++ L+    +D
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK--YWKETLQRPVYDD 224

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 42.2 bits (99), Expect = 5e-04
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 28/158 (17%)

Query: 85  IGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           I +G FGKVY G   +N+K+ AVK ++       +   +  VH   V   ++ L L    
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKK-----ADMINKNMVH--QVQAERDALAL---- 60

Query: 144 TTSSERILVYPF--MQNLSVAYRLRDLKPGE--KGL-------DWPTRKRVAFGTAYGLE 192
             S    +V+ +  +Q+ +  Y + +   G   K L       D     +     A  L+
Sbjct: 61  --SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALD 118

Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 230
           YLH      IIHRDLK  N+L+ +     L DFGL+K+
Sbjct: 119 YLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 40.9 bits (96), Expect = 7e-04
 Identities = 26/82 (31%), Positives = 41/82 (50%), Gaps = 5/82 (6%)

Query: 203 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-----STG 257
           +HRD+K  N+LLD N    L DFG    + A  T  +    GT  +I+PE L       G
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183

Query: 258 KSSEKTDVFGYGITLLELVTGQ 279
           +   + D +  G+ + E++ G+
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 39.7 bits (93), Expect = 0.002
 Identities = 47/240 (19%), Positives = 105/240 (43%), Gaps = 20/240 (8%)

Query: 93  VYKGVLSDNTKVAVKRLQDYYSPGGEA---AFQREVHLISVAIHKNLLQLIGYCTTSSER 149
           +YKG+  +N +V ++  +  +  G +      + E+  +      N+L++ G+     + 
Sbjct: 36  IYKGIF-NNKEVIIRTFK-KFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKA 209
           +     +        LR++   EK L + T+  +A     GL  L++  N    +++L +
Sbjct: 94  LPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTS 151

Query: 210 ANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST--GKSSEKTDVFG 267
            + L+ +N++  +   GL K+    L+    +    M + + + L+    + + K D++ 
Sbjct: 152 VSFLVTENYKLKIICHGLEKI----LSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYS 207

Query: 268 YGITLLELVTGQRAIDFSRLEEEE--DVLLLDHIRKLLRED---RLNDIVDRNLNTYDSK 322
            G+ L E+ TG+  I F  L  +E  D+++  +    L  D    +  IV+   +    K
Sbjct: 208 LGVVLWEIFTGK--IPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIK 265

Length = 283

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 38.9 bits (91), Expect = 0.003
 Identities = 14/27 (51%), Positives = 16/27 (59%)

Query: 203 IHRDLKAANILLDDNFEAVLCDFGLAK 229
           IHRD+K  N+LLD      L DFGL  
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCT 149

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 38.3 bits (89), Expect = 0.004
 Identities = 49/162 (30%), Positives = 73/162 (45%), Gaps = 15/162 (9%)

Query: 120 AFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPT 179
           AF     L+S   H +L  + G C   SE I+V  F+++  +   LR  K G   + W  
Sbjct: 62  AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAW-- 118

Query: 180 RKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA--KLVD--AKL 235
           +  VA   A  L YL    +  ++H ++ A NILL       L +      KL D     
Sbjct: 119 KITVAQQLASALSYLE---DKNLVHGNVCAKNILLA---RLGLAEGTSPFIKLSDPGVSF 172

Query: 236 THVTTQIR-GTMGHIAPEYLSTGKS-SEKTDVFGYGITLLEL 275
           T ++ + R   +  IAPE +  G S S   D + +G TLLE+
Sbjct: 173 TALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	401
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.98
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.9
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.89
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.89
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.85
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.83
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.82
PRK10345	210	hypothetical protein; Provisional	99.8
smart00090	237	RIO RIO-like kinase.	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.77
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.76
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.75
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.68
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.65
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.63
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.56
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.52
KOG1243	690	consensus Protein kinase [General function predict	99.43
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.4
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.38
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.35
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.3
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.24
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.24
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.18
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.15
COG4248	637	Uncharacterized protein with protein kinase and he	99.15
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.15
KOG3087	229	consensus Serine/threonine protein kinase [General	99.14
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.03
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.96
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.89
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.8
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.7
PRK09902	216	hypothetical protein; Provisional	98.68
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.59
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.52
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.45
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.38
PF01636	239	APH: Phosphotransferase enzyme family This family	98.32
PLN02876	822	acyl-CoA dehydrogenase	98.21
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.2
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.17
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.17
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.16
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.11
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.06
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.86
PRK10593	297	hypothetical protein; Provisional	97.86
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.8
PRK05231	319	homoserine kinase; Provisional	97.75
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.67
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.64
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.56
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.56
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.5
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.44
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.34
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.28
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.13
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.08
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.03
KOG2270	520	consensus Serine/threonine protein kinase involved	96.93
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.84
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.57
PLN02236	344	choline kinase	96.39
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.37
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.36
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.27
COG2334	331	Putative homoserine kinase type II (protein kinase	96.23
PLN02756	418	S-methyl-5-thioribose kinase	96.21
PRK11768	325	serine/threonine protein kinase; Provisional	96.01
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.97
PRK06148	1013	hypothetical protein; Provisional	95.94
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.73
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.67
PRK12396	409	5-methylribose kinase; Reviewed	94.89
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	94.61
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.54
KOG1093	725	consensus Predicted protein kinase (contains TBC a	94.5
PF02439	38	Adeno_E3_CR2: Adenovirus E3 region protein CR2; In	94.37

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-56  Score=416.53  Aligned_cols=286  Identities=52%  Similarity=0.846  Sum_probs=250.8

Q ss_pred             cccccCHHHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeee
Q 015734           63 QLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY  142 (401)
Q Consensus        63 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~  142 (401)
                      ..+.|++.++..++++|+..+.||+|+||.||+|...++..||||++....... ..+|.+|+.++.+++|||+|+++||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence            678899999999999999999999999999999999888999999887543332 5669999999999999999999999


Q ss_pred             eecCC-eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEE
Q 015734          143 CTTSS-ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV  221 (401)
Q Consensus       143 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~k  221 (401)
                      |.+.+ +.++||||+++|+|.++|+.....  +++|..+.+|+.++|+||+|||..+.+.|+||||||+|||+|+++++|
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            99999 599999999999999999974332  799999999999999999999999888899999999999999999999


Q ss_pred             EeecCCccccCC-CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHH
Q 015734          222 LCDFGLAKLVDA-KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR  300 (401)
Q Consensus       222 l~Dfgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~  300 (401)
                      |+|||+++.... ........ .||.+|+|||++..+..+.++||||||++++||+||++|.+....  .....+.+|+.
T Consensus       218 lsDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~--~~~~~l~~w~~  294 (361)
T KOG1187|consen  218 LSDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP--RGELSLVEWAK  294 (361)
T ss_pred             ccCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC--cccccHHHHHH
Confidence            999999976554 22211111 699999999999999999999999999999999999998876542  22334888998


Q ss_pred             HHhccCccchhccCcCC--CCCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          301 KLLREDRLNDIVDRNLN--TYDS-KEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       301 ~~~~~~~~~~~~d~~~~--~~~~-~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ..+....+.+++|+.+.  .+.. .....+..++..|++.+|.+||+|.+|++.|+.
T Consensus       295 ~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~  351 (361)
T KOG1187|consen  295 PLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEG  351 (361)
T ss_pred             HHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence            88888899999999986  3443 678889999999999999999999999999954

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-51  Score=363.20  Aligned_cols=256  Identities=24%  Similarity=0.363  Sum_probs=216.2

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCC-eeEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-ERILV  152 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv  152 (401)
                      ..+++...+.||+|..|+||++.++ ++..+|+|.+.....+...+++.+|+++++..+||+||.++|.|...+ ...++
T Consensus        77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~  156 (364)
T KOG0581|consen   77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC  156 (364)
T ss_pred             CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence            3346677889999999999999975 688999999976667778899999999999999999999999999998 59999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      ||||++|||...+...    +.+++....+|+.+|++||.|||+..  +|+||||||+|||++..|+|||||||.+..+.
T Consensus       157 mEYMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv  230 (364)
T KOG0581|consen  157 MEYMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILV  230 (364)
T ss_pred             hhhcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence            9999999999999864    56999999999999999999999632  89999999999999999999999999998776


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      +.   ....+.||..|||||.+.+..|+.++||||||+.++|+.+|+.||............+...+.            
T Consensus       231 nS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv------------  295 (364)
T KOG0581|consen  231 NS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV------------  295 (364)
T ss_pred             hh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh------------
Confidence            54   445678999999999999999999999999999999999999999765222222222222222            


Q ss_pred             cCcCCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          313 DRNLNTYDSK-EVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       313 d~~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      +..-+..+.. .+.++..++..||++||.+|||++|++++
T Consensus       296 ~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  296 DEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             cCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            2222223333 67789999999999999999999999775

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.2e-52  Score=354.99  Aligned_cols=257  Identities=23%  Similarity=0.338  Sum_probs=214.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEE-ECCCCEEEEEEec-ccCCcchHHHHHHHHHHHHhccCCcccceee-eeecCCe-eEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIG-YCTTSSE-RIL  151 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~-~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~~-~~l  151 (401)
                      ..+|.++++||.|.||+||++. ..+|..+|.|.++ ...+.+..+.+..|+.+|++++|||||++++ .+.+.++ +++
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            3467788899999999999998 5689999999987 3345667788999999999999999999998 4555555 799


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP-KIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      |||+|..|+|...+..++.+.+.+++.++|+++.|++.||.++|++... -++||||||.||+++.+|.+||+|||+++.
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            9999999999999999999999999999999999999999999994321 399999999999999999999999999998


Q ss_pred             cCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccch
Q 015734          231 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND  310 (401)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      +... .......+|||.||+||.+.+.+|+.+|||||+||++|||+.-.+||.+...        .+.-.+. ...    
T Consensus       178 l~s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~--------~~L~~KI-~qg----  243 (375)
T KOG0591|consen  178 LSSK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL--------LSLCKKI-EQG----  243 (375)
T ss_pred             hcch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH--------HHHHHHH-HcC----
Confidence            8654 3345567899999999999999999999999999999999999999987532        1111111 111    


Q ss_pred             hccCcCCCCC-HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          311 IVDRNLNTYD-SKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       311 ~~d~~~~~~~-~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                          ..+..+ .-++.++.+++..|++.||+.||+.-.+++
T Consensus       244 ----d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~  280 (375)
T KOG0591|consen  244 ----DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQ  280 (375)
T ss_pred             ----CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence                222233 456788999999999999999998444433

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-50  Score=373.46  Aligned_cols=261  Identities=30%  Similarity=0.450  Sum_probs=212.9

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCC-eeE
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-ERI  150 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~  150 (401)
                      .+..+++...+.||+|+||+||+|.+.....||+|++.... +....+.|.+|+.+|.+++|||||+++|+|.+.. ..+
T Consensus        37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~  116 (362)
T KOG0192|consen   37 EIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC  116 (362)
T ss_pred             ecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence            33444555666799999999999999554459999997432 3333779999999999999999999999999988 799


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEEeCCCCCceEEcCCC-cEEEeecCCc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK-IIHRDLKAANILLDDNF-EAVLCDFGLA  228 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-i~H~dlkp~Nill~~~~-~~kl~Dfgl~  228 (401)
                      +||||+++|+|..+++..  ....+++..+..++.+||+||.|||++   + ||||||||+|||++.++ ++||+|||++
T Consensus       117 iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGls  191 (362)
T KOG0192|consen  117 IVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLS  191 (362)
T ss_pred             EEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccc
Confidence            999999999999999874  356799999999999999999999999   7 99999999999999997 9999999999


Q ss_pred             cccCCCCcceeccccCCcccccccccc--cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLS--TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED  306 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (401)
                      +...... ...+...||+.|||||++.  ...++.|+||||||+++|||+||+.||......        +.+...... 
T Consensus       192 r~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~--------~~~~~v~~~-  261 (362)
T KOG0192|consen  192 REKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV--------QVASAVVVG-  261 (362)
T ss_pred             eeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhc-
Confidence            8665432 2233367999999999999  568999999999999999999999999864431        111111111 


Q ss_pred             ccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       307 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                             ...+..+..+...+..++..||+.||..||++.+++..|+..
T Consensus       262 -------~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  262 -------GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI  303 (362)
T ss_pred             -------CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence                   111222333667888999999999999999999999999753

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-50  Score=375.78  Aligned_cols=264  Identities=30%  Similarity=0.422  Sum_probs=221.5

Q ss_pred             HHHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCe
Q 015734           69 CRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE  148 (401)
Q Consensus        69 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  148 (401)
                      .+.+.+..+.+...+.||+|-||.||.|.++....||+|.++..  ....+.|.+|+++|.+|+|+|||+++++|.....
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~--~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p  275 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG--SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP  275 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc--ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence            33444555556667889999999999999987889999999864  3456789999999999999999999999999999


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      .++|||||+.|+|.++|+.  ..+..+...+.+.++.|||.||+||+++   ++|||||.++||||+++..+||+|||++
T Consensus       276 iyIVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLA  350 (468)
T KOG0197|consen  276 IYIVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLA  350 (468)
T ss_pred             eEEEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccc
Confidence            9999999999999999997  3456789999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      +...++.........-+..|.|||.+..+.++.|||||||||+||||+| |+.||......        +.+....+..+
T Consensus       351 r~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~--------ev~~~le~GyR  422 (468)
T KOG0197|consen  351 RLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE--------EVLELLERGYR  422 (468)
T ss_pred             cccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH--------HHHHHHhccCc
Confidence            9666555544444445779999999999999999999999999999999 88887754432        22222222222


Q ss_pred             cchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 015734          308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED  356 (401)
Q Consensus       308 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  356 (401)
                      ++         .+..++.++.++|..||+.+|++|||++.+...|+...
T Consensus       423 lp---------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  423 LP---------RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             CC---------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence            22         35567788999999999999999999999988887543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-49  Score=371.50  Aligned_cols=249  Identities=24%  Similarity=0.389  Sum_probs=214.9

Q ss_pred             cCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecc--cCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQD--YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ..|...+.||+|||+.||.++. .+|..||+|++.+  ...+...+.+.+|+++.+.+.|||||+++++|.+.++.|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4688999999999999999997 7899999999974  235667788999999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      |+|.+++|..++..    .+++++++++.++.||+.||.|||+.   +|+|||||..|+|++++.++||+|||+|..+..
T Consensus        98 ELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence            99999999998885    46799999999999999999999999   999999999999999999999999999998865


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      ... .....+|||.|.|||++....++..+||||+||++|.||.|++||+.....        +...+....+       
T Consensus       171 ~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk--------ety~~Ik~~~-------  234 (592)
T KOG0575|consen  171 DGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK--------ETYNKIKLNE-------  234 (592)
T ss_pred             ccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH--------HHHHHHHhcC-------
Confidence            433 344578999999999999999999999999999999999999999865432        2222221111       


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                         ...+...+.+..+||.++|+.||.+|||+++|+.+
T Consensus       235 ---Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  235 ---YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             ---cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence               11234455678899999999999999999999864

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.7e-50  Score=358.61  Aligned_cols=255  Identities=24%  Similarity=0.324  Sum_probs=208.5

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCcc------hHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPG------GEAAFQREVHLISVAIHKNLLQLIGYCTTSS  147 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  147 (401)
                      ..+.|.+.+.||+|+||.|-+|.. ++|+.||||++.+.....      ......+|+++|.+++|||||++++++....
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            456788899999999999999994 579999999997533222      2234579999999999999999999999999


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCC---CcEEEee
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN---FEAVLCD  224 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~---~~~kl~D  224 (401)
                      ..|+||||++||+|.+++-.    .+.+.+...+.++.|++.|+.|||++   ||+||||||+|||+..+   ..+||+|
T Consensus       250 s~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD  322 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD  322 (475)
T ss_pred             ceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence            99999999999999999986    44577888899999999999999999   99999999999999766   8899999


Q ss_pred             cCCccccCCCCcceeccccCCcccccccccccCCC---CcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHH
Q 015734          225 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS---SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK  301 (401)
Q Consensus       225 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~  301 (401)
                      ||+++..+.  ...+...+|||.|.|||++.+...   ..+.||||+||+||-+++|.+||......    ..+.+.+.+
T Consensus       323 FGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~----~sl~eQI~~  396 (475)
T KOG0615|consen  323 FGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD----PSLKEQILK  396 (475)
T ss_pred             cchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC----ccHHHHHhc
Confidence            999998763  456777899999999999976653   34779999999999999999999853322    112222221


Q ss_pred             HhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          302 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       302 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                          +++.     -.+..+....++..+++.+||..||++|||+.|++++
T Consensus       397 ----G~y~-----f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  397 ----GRYA-----FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             ----Cccc-----ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence                1110     0112355667889999999999999999999999765

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.8e-49  Score=384.30  Aligned_cols=265  Identities=25%  Similarity=0.403  Sum_probs=223.7

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeec
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT  145 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  145 (401)
                      ..+...+....+.||+|.||.||+|...      +...||||.+++..+.+...+|++|+++++.++|||||+++|+|.+
T Consensus       481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~  560 (774)
T KOG1026|consen  481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE  560 (774)
T ss_pred             eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence            3445666777889999999999999843      3467999999987777788999999999999999999999999999


Q ss_pred             CCeeEEEEecccCCcHHHHhhhcCCC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEc
Q 015734          146 SSERILVYPFMQNLSVAYRLRDLKPG----------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD  215 (401)
Q Consensus       146 ~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~  215 (401)
                      ++..++|+|||..|+|.++|+...+.          ..+++..+.+.|+.|||.||.||.++   .++||||..+|+||.
T Consensus       561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVg  637 (774)
T KOG1026|consen  561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVG  637 (774)
T ss_pred             CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceec
Confidence            99999999999999999999854331          12388899999999999999999999   899999999999999


Q ss_pred             CCCcEEEeecCCccccCCCCcceec-cccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhh
Q 015734          216 DNFEAVLCDFGLAKLVDAKLTHVTT-QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDV  293 (401)
Q Consensus       216 ~~~~~kl~Dfgl~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~  293 (401)
                      ++..|||+|||+++.......+... ...-+.+|||||.+..++++.+||||||||+|||++| |+.||......+    
T Consensus       638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E----  713 (774)
T KOG1026|consen  638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE----  713 (774)
T ss_pred             cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH----
Confidence            9999999999999966554444333 4455789999999999999999999999999999999 899987654322    


Q ss_pred             hHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 015734          294 LLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED  356 (401)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  356 (401)
                           +...+++        ..+.+.+..++.++.+||..||+.+|.+||+++||-..|+...
T Consensus       714 -----VIe~i~~--------g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~  763 (774)
T KOG1026|consen  714 -----VIECIRA--------GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA  763 (774)
T ss_pred             -----HHHHHHc--------CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence                 2222222        2333456677889999999999999999999999999997643

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-48  Score=346.02  Aligned_cols=204  Identities=26%  Similarity=0.390  Sum_probs=184.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ..+|...+.||.|+||+||+|+++ ++..||||.+... ...+..+.+..|+.+|+.++|||||.+++++...+..++||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            357888899999999999999964 5899999998753 36667888999999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCC------CcEEEeecCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN------FEAVLCDFGL  227 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~------~~~kl~Dfgl  227 (401)
                      |||+||+|..+++..    +.+++.+.+.++.|+|.||++||++   +|+||||||+||||+.+      -.+||+|||+
T Consensus        89 EyC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             EeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            999999999999973    3699999999999999999999999   99999999999999765      5689999999


Q ss_pred             ccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcch
Q 015734          228 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLE  288 (401)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~  288 (401)
                      ++.+..  .......+|+|-|||||++...+|+.|+|+||+|+++|+|++|+.||+..+..
T Consensus       162 AR~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~  220 (429)
T KOG0595|consen  162 ARFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK  220 (429)
T ss_pred             hhhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence            998864  34456678999999999999999999999999999999999999999865543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-48  Score=343.81  Aligned_cols=245  Identities=26%  Similarity=0.312  Sum_probs=206.4

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      ..++|.+.++||+|+||.||.++. ++++.+|+|++++..  .....+....|..+|.+++||.||++...+++...+|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            467899999999999999999995 468999999997432  33457788999999999999999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      |++|+.||.|..+|.+    +..+++..++.++..|+.||.|||++   +|+||||||+|||+|++|+++|+|||+++..
T Consensus       103 Vld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             EEeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            9999999999999986    56699999999999999999999999   9999999999999999999999999999854


Q ss_pred             CCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      -.. ...+..++||+.|||||++.+..|+..+|+||||+++|||++|.+||...+..        .+..+....+     
T Consensus       176 ~~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~--------~~~~~I~~~k-----  241 (357)
T KOG0598|consen  176 LKD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK--------KMYDKILKGK-----  241 (357)
T ss_pred             ccC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH--------HHHHHHhcCc-----
Confidence            333 23345589999999999999999999999999999999999999999865432        2233333222     


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP  344 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  344 (401)
                          +...+.-...+..+++...++.||.+|..
T Consensus       242 ----~~~~p~~ls~~ardll~~LL~rdp~~RLg  270 (357)
T KOG0598|consen  242 ----LPLPPGYLSEEARDLLKKLLKRDPRQRLG  270 (357)
T ss_pred             ----CCCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence                11111223446778888999999999963

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=9.8e-47  Score=326.14  Aligned_cols=265  Identities=22%  Similarity=0.339  Sum_probs=207.7

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCC-cchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      +.|....++|+|+||+||+|+++ +|+.||||++.+... +...+..++|+++|+++.|+|+|.++.+|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            46778889999999999999976 599999999986544 4455678999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      ||+. ++.+.|..+.   ..++.....+++.|++.|+.|+|++   +++||||||+|||++.+|.+||||||+++.+...
T Consensus        82 ~~dh-TvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   82 YCDH-TVLHELERYP---NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             ecch-HHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence            9976 5555555543   3488899999999999999999999   9999999999999999999999999999988753


Q ss_pred             CcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHH--------HHHhcc
Q 015734          235 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI--------RKLLRE  305 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~~  305 (401)
                       ....+..+.|..|+|||.+.+ .+|+...||||+||++.||++|.+.|.+.+.-+.-  .+....        ...+..
T Consensus       155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQL--y~I~ktLG~L~prhq~iF~~  231 (396)
T KOG0593|consen  155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQL--YLIRKTLGNLIPRHQSIFSS  231 (396)
T ss_pred             -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHH--HHHHHHHcccCHHHHHHhcc
Confidence             334455678999999999987 68999999999999999999999999876543221  111111        111111


Q ss_pred             Cc-cchhccCcC------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          306 DR-LNDIVDRNL------NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       306 ~~-~~~~~d~~~------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .. +..+.-+..      ..-.+....-+.+++..|++.||.+|++-++++.+
T Consensus       232 N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  232 NPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             CCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            11 111100100      00123334568899999999999999999999764

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4e-48  Score=370.89  Aligned_cols=256  Identities=28%  Similarity=0.415  Sum_probs=218.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC----CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      .....+.++||.|.||.|++|.++-    ...||||.++..++++....|+.|..+|.+++||||+++.|+.+.....++
T Consensus       628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI  707 (996)
T KOG0196|consen  628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI  707 (996)
T ss_pred             hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence            4445678899999999999999753    457999999999999999999999999999999999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      |+|||++|+|..+|+..   ...+++.+...++++|+.||.||.++   +++||||..+|||++.+..+|++|||+++.+
T Consensus       708 iTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvl  781 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL  781 (996)
T ss_pred             EhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeec
Confidence            99999999999999974   34599999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCcceeccc--cCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          232 DAKLTHVTTQI--RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       232 ~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      .++.....+..  ..+.+|.|||.+...+++.+|||||||++|||.++ |.+||=..+..        +.+.......++
T Consensus       782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ--------dVIkaIe~gyRL  853 (996)
T KOG0196|consen  782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--------DVIKAIEQGYRL  853 (996)
T ss_pred             ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH--------HHHHHHHhccCC
Confidence            66553332222  23679999999999999999999999999999877 88997543321        112222223333


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      +.         +.+++..|.+||+.||++|...||.+.+++..|..
T Consensus       854 Pp---------PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDk  890 (996)
T KOG0196|consen  854 PP---------PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDK  890 (996)
T ss_pred             CC---------CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence            33         55667789999999999999999999999999864

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-46  Score=341.66  Aligned_cols=267  Identities=22%  Similarity=0.281  Sum_probs=213.7

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCcccceeeeeecCC-eeEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSS-ERIL  151 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~l  151 (401)
                      .-++|...++||.|.||.||+|+. .+|..||||+++...-......-.+|++.|++++ ||||+++.+++.+.+ .+++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            456889999999999999999994 4688999999986555445556679999999999 999999999998888 8999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      |||||+. +|.+.+.+.   +..+++..++.|+.||++||+|+|.+   |+.|||+||+|||+..+..+||+|||+++..
T Consensus        88 VfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence            9999965 899988873   67899999999999999999999999   9999999999999998889999999999977


Q ss_pred             CCCCcceeccccCCcccccccccc-cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhcc-----
Q 015734          232 DAKLTHVTTQIRGTMGHIAPEYLS-TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE-----  305 (401)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----  305 (401)
                      ....  ..+..+.|..|+|||++. ...|+.+.|||++||+++|+.+-++.|.+.+.-+.-...+ +.+.....+     
T Consensus       161 ~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc-~VLGtP~~~~~~eg  237 (538)
T KOG0661|consen  161 RSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKIC-EVLGTPDKDSWPEG  237 (538)
T ss_pred             ccCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHH-HHhCCCccccchhH
Confidence            5533  334556899999999974 5679999999999999999999999998766543322211 111100000     


Q ss_pred             --------CccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          306 --------DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       306 --------~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                              -.+.......+....+..+.+..+++.+|+++||.+||||++.+++
T Consensus       238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                    0111111122222334477889999999999999999999999885

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-45  Score=333.54  Aligned_cols=256  Identities=27%  Similarity=0.425  Sum_probs=205.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC-CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCC--eeEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS--ERILV  152 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv  152 (401)
                      ..++...+.||+|+||+||++...+ |...|||.+....+.. .+.+.+|+.+|.+++|||||+.+|......  .+++.
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~   94 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF   94 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence            3457778999999999999999654 8999999886432222 677999999999999999999999754444  58999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC-CCcEEEeecCCcccc
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFGLAKLV  231 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfgl~~~~  231 (401)
                      |||+++|+|.+++....  + .+++..++.++.|+++||+|||++   +++|+||||+|||++. ++.+||+|||++...
T Consensus        95 mEy~~~GsL~~~~~~~g--~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIKRYG--G-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKL  168 (313)
T ss_pred             eeccCCCcHHHHHHHcC--C-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence            99999999999999743  2 699999999999999999999999   9999999999999999 799999999999866


Q ss_pred             CC--CCcceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          232 DA--KLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       232 ~~--~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ..  ..........||+.|||||++..+ ....++|||||||++.||+||++||... .      ...++........  
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~------~~~~~~~~ig~~~--  239 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-F------EEAEALLLIGRED--  239 (313)
T ss_pred             ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-c------chHHHHHHHhccC--
Confidence            63  222234457799999999999853 3445999999999999999999999742 0      0111111121111  


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                            ..+.++...+.+..+++..|++.+|++||||.+++++.-
T Consensus       240 ------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  240 ------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             ------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence                  122344456678889999999999999999999988754

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.7e-45  Score=343.82  Aligned_cols=263  Identities=26%  Similarity=0.430  Sum_probs=206.9

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEE------CCCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeeec
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT  145 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  145 (401)
                      +++.++|.+.+.||+|+||.||+|..      .++..||+|++...........+.+|+.++..+ +||||+++++++..
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            45667899999999999999999974      235679999997544445567899999999999 89999999998876


Q ss_pred             CC-eeEEEEecccCCcHHHHhhhcCCC-----------------------------------------------------
Q 015734          146 SS-ERILVYPFMQNLSVAYRLRDLKPG-----------------------------------------------------  171 (401)
Q Consensus       146 ~~-~~~lv~e~~~~gsL~~~l~~~~~~-----------------------------------------------------  171 (401)
                      .+ ..+++|||+++|+|.+++......                                                     
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            54 578999999999999988753210                                                     


Q ss_pred             -----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcc-eeccccCC
Q 015734          172 -----EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGT  245 (401)
Q Consensus       172 -----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt  245 (401)
                           ..++++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++........ ......++
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence                 13578889999999999999999998   9999999999999999999999999999765332221 12233456


Q ss_pred             cccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHH
Q 015734          246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEV  324 (401)
Q Consensus       246 ~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  324 (401)
                      +.|+|||++.+..++.++|||||||++|||++ |..||......+.    ..    .....+.        ....+...+
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~----~~----~~~~~~~--------~~~~~~~~~  303 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE----FC----QRLKDGT--------RMRAPENAT  303 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH----HH----HHHhcCC--------CCCCCCCCC
Confidence            78999999998899999999999999999997 9999975432111    11    1111111        011122334


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          325 ETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       325 ~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ..+.+++.+||+.||.+|||+.++++.|+.
T Consensus       304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~  333 (338)
T cd05102         304 PEIYRIMLACWQGDPKERPTFSALVEILGD  333 (338)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-45  Score=337.56  Aligned_cols=254  Identities=22%  Similarity=0.318  Sum_probs=209.3

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccC--CcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCe
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSE  148 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  148 (401)
                      .....+|..++.||.|+|++|++|+. ++++.||||++.+..  .+........|-.+|.+| .||.|++++..|++...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            44667899999999999999999995 468999999986432  223345567788888888 79999999999999999


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      +|+|+||+++|+|.++|..+    +.+++...+.++.+|+.||+|||++   |||||||||+|||+|+|++++|+|||.+
T Consensus       149 LYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA  221 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA  221 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence            99999999999999999985    4589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcc----------e--eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHH
Q 015734          229 KLVDAKLTH----------V--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL  296 (401)
Q Consensus       229 ~~~~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~  296 (401)
                      +.+......          .  ...++||..|.+||++..+..+..+|||+|||++|+|+.|.+||.....-    . ..
T Consensus       222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney----l-iF  296 (604)
T KOG0592|consen  222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY----L-IF  296 (604)
T ss_pred             ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH----H-HH
Confidence            876543221          1  14478999999999999999999999999999999999999999864321    1 11


Q ss_pred             HHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          297 DHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       297 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      +.+..          ++-.   +++..++.+.+|+.+.|..||.+|+|.+++-++
T Consensus       297 qkI~~----------l~y~---fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  297 QKIQA----------LDYE---FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             HHHHH----------hccc---CCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            11111          1111   233334677888889999999999999998665

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-45  Score=337.84  Aligned_cols=268  Identities=22%  Similarity=0.357  Sum_probs=219.4

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      +.+.+...+.++||+|-||.|.++....+.+||||+++.........+|.+|+++|.+++||||+.++|+|..++.++++
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI  613 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI  613 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence            44667788899999999999999998778999999999877777789999999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      +||+++|+|.+++.....  ..+.-....+|+.||++||+||.+.   +++||||.++|+|++.++++||+|||+++.+.
T Consensus       614 ~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             HHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence            999999999999987422  1134455677999999999999998   99999999999999999999999999999554


Q ss_pred             CCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh--CCCCCCCCcchhhhhhhHHHHHHHHhccCccc
Q 015734          233 AKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT--GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN  309 (401)
Q Consensus       233 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ..... .....+-+.+|||||.+..++++.+||+|+||+++||+++  ...||....     +....+......+.....
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt-----~e~vven~~~~~~~~~~~  763 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT-----DEQVVENAGEFFRDQGRQ  763 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh-----HHHHHHhhhhhcCCCCcc
Confidence            44333 3344556789999999999999999999999999999876  567775322     222333333333332222


Q ss_pred             hhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       310 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                      ..+     ..+.-++..+.+++..||..+-.+||+++++...|++.
T Consensus       764 ~~l-----~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  764 VVL-----SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             eec-----cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            221     23455667889999999999999999999999998754

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-45  Score=335.35  Aligned_cols=268  Identities=24%  Similarity=0.310  Sum_probs=209.6

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEE-ECCCCEEEEEEec-ccCCcchHHHHHHHHHHHHhccCCcccceeeeeecC--CeeE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERI  150 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~-~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  150 (401)
                      ..+.|...++||+|.||.||+|+ ..+|..||+|+++ +...+.......+|+.+|++++||||+++.+...+.  +.+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            45567888999999999999999 4579999999997 334566778889999999999999999999998876  6899


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      +|+|||+. +|.-++..   ..-.++..+++.++.|++.||+|+|++   +++|||||.+|||||++|.+||+|||++++
T Consensus       195 lVFeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~  267 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARF  267 (560)
T ss_pred             EEEecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceee
Confidence            99999976 77776664   234589999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCcceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHH----Hhcc
Q 015734          231 VDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK----LLRE  305 (401)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~  305 (401)
                      +........+..+-|..|.|||++.+. .|+.+.|+||.|||+.||++|++.|++.+..+...... .....    .+..
T Consensus       268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIf-klcGSP~e~~W~~  346 (560)
T KOG0600|consen  268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIF-KLCGSPTEDYWPV  346 (560)
T ss_pred             ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHH-HHhCCCChhcccc
Confidence            877666656667789999999998775 59999999999999999999999998765433221111 00000    0000


Q ss_pred             Cccc--hhccCc------CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          306 DRLN--DIVDRN------LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       306 ~~~~--~~~d~~------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                      ..+.  ..+.+.      +.......+....+|+..+|..||.+|.|+.+.++
T Consensus       347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            0111  111110      00001112345678889999999999999999976

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=9.3e-45  Score=308.71  Aligned_cols=262  Identities=24%  Similarity=0.303  Sum_probs=210.9

Q ss_pred             cCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           77 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      ++|...++||+|.||.||+|++ .+|+.||||+++.. ..+.......+|++.|+.++|+||+.+++++...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4678889999999999999994 57999999999743 334445688999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |++. +|...+++   ....++..++..++.++++|++|||++   .|+||||||.|+|++.+|.+||+|||+++.+...
T Consensus        82 fm~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   82 FMPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             eccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            9976 88888886   345789999999999999999999999   8999999999999999999999999999988776


Q ss_pred             CcceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC---ccch
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED---RLND  310 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  310 (401)
                      ....... +-|..|.|||.+.+. .|+...||||.||++.||+.|.+-|.+.+.-+    ++...++ .+...   .+.+
T Consensus       155 ~~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid----QL~~If~-~LGTP~~~~WP~  228 (318)
T KOG0659|consen  155 NRIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID----QLSKIFR-ALGTPTPDQWPE  228 (318)
T ss_pred             Ccccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH----HHHHHHH-HcCCCCcccCcc
Confidence            5554443 579999999998765 59999999999999999999998887654322    2222222 22111   1111


Q ss_pred             ---hc---------cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          311 ---IV---------DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       311 ---~~---------d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                         +.         .+.....-+.+..+..+++..|+..||.+|+++.|.+++
T Consensus       229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence               11         111222334556677999999999999999999999764

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-44  Score=325.01  Aligned_cols=264  Identities=27%  Similarity=0.352  Sum_probs=210.1

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEE-ECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      ...+.|.+.++||.|..++||+|. .+.+..||||++.-.......+.+.+|+..++.++||||++++..|..++.+++|
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV  102 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV  102 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence            356789999999999999999999 5678999999997333333478999999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |+||.+||+.+.+.....  ..+++..+..|++++++||.|||.+   |.||||||+.||||+.+|.|||+|||.+..+.
T Consensus       103 mpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             ehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            999999999999987554  3489999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCcc---eeccccCCcccccccccc--cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          233 AKLTH---VTTQIRGTMGHIAPEYLS--TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       233 ~~~~~---~~~~~~gt~~y~aPE~~~--~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      .....   ....+.||++|||||++.  -..|+.|+||||||++.+||.+|..||....+.    ..+.   ........
T Consensus       178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm----kvLl---~tLqn~pp  250 (516)
T KOG0582|consen  178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM----KVLL---LTLQNDPP  250 (516)
T ss_pred             ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH----HHHH---HHhcCCCC
Confidence            43322   114568999999999953  345899999999999999999999999743321    1111   11111111


Q ss_pred             cchhccCcCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          308 LNDIVDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       308 ~~~~~d~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ...  -.... .........+.+++..||++||.+|||+++++++
T Consensus       251 ~~~--t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  251 TLL--TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             Ccc--cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            000  00000 0122334578899999999999999999999873

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-44  Score=312.15  Aligned_cols=238  Identities=24%  Similarity=0.302  Sum_probs=203.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecc--cCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQD--YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      .++|+..+.||.|+||.|.+++.+ +|..+|+|++..  ....++.+...+|..+|+.+.||+++++.+.+.+.+.+++|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            457888999999999999999965 588999999963  23345667888999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||.+||.|.++++.    .++++.+.++.++.||+.||+|||+.   ++++|||||+|||+|.+|.+||+|||.++.+.
T Consensus       123 meyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~  195 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS  195 (355)
T ss_pred             EeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence            999999999999997    44699999999999999999999999   99999999999999999999999999999775


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ..    +...+|||.|+|||.++...++.++|.|||||++|||+.|.+||.....        .+...++...+.     
T Consensus       196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~iY~KI~~~~v-----  258 (355)
T KOG0616|consen  196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQIYEKILEGKV-----  258 (355)
T ss_pred             Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHHHHHHHhCcc-----
Confidence            43    5567899999999999999999999999999999999999999986543        122222222111     


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDR  342 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~R  342 (401)
                           .+++-...++.+|+...|+.|-.+|
T Consensus       259 -----~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 -----KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             -----cCCcccCHHHHHHHHHHHhhhhHhh
Confidence                 1233444578888899999999999

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.1e-44  Score=333.93  Aligned_cols=255  Identities=20%  Similarity=0.233  Sum_probs=206.9

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCe
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE  148 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  148 (401)
                      .++..++|..+.+||+|+||.||+|+- ++|..+|+|++++.  ...........|-++|...++|+||+++..|++...
T Consensus       136 ~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~  215 (550)
T KOG0605|consen  136 TRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY  215 (550)
T ss_pred             ccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence            355778999999999999999999994 46999999999853  234567788999999999999999999999999999


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      +||||||++||++..+|..    ...+++..++.++.+++.|+..+|+.   |++||||||+|+|||..|++||+||||+
T Consensus       216 LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs  288 (550)
T KOG0605|consen  216 LYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLS  288 (550)
T ss_pred             eEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeecccccc
Confidence            9999999999999999986    45699999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCC-----------------------Cc-----c------------------eeccccCCcccccccccccCCCCcc
Q 015734          229 KLVDAK-----------------------LT-----H------------------VTTQIRGTMGHIAPEYLSTGKSSEK  262 (401)
Q Consensus       229 ~~~~~~-----------------------~~-----~------------------~~~~~~gt~~y~aPE~~~~~~~~~~  262 (401)
                      .-+...                       ..     .                  .....+|||.|+|||++.+..|+..
T Consensus       289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~  368 (550)
T KOG0605|consen  289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE  368 (550)
T ss_pred             chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc
Confidence            532110                       00     0                  0112459999999999999999999


Q ss_pred             cchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 015734          263 TDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDR  342 (401)
Q Consensus       263 sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~R  342 (401)
                      +|+||||||+||||.|.+||...++.+ ....+..|-......             .......+..+||.+|+. ||++|
T Consensus       369 cDwWSLG~ImyEmLvGyPPF~s~tp~~-T~rkI~nwr~~l~fP-------------~~~~~s~eA~DLI~rll~-d~~~R  433 (550)
T KOG0605|consen  369 CDWWSLGCIMYEMLVGYPPFCSETPQE-TYRKIVNWRETLKFP-------------EEVDLSDEAKDLITRLLC-DPENR  433 (550)
T ss_pred             ccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhhhccCC-------------CcCcccHHHHHHHHHHhc-CHHHh
Confidence            999999999999999999999766532 122222222211110             011223678899999999 99999


Q ss_pred             CC---HHHH
Q 015734          343 PP---MAQV  348 (401)
Q Consensus       343 Ps---~~~v  348 (401)
                      ..   ++||
T Consensus       434 LG~~G~~EI  442 (550)
T KOG0605|consen  434 LGSKGAEEI  442 (550)
T ss_pred             cCcccHHHH
Confidence            75   5555

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-44  Score=363.45  Aligned_cols=264  Identities=30%  Similarity=0.440  Sum_probs=219.8

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEECC--CC----EEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVLSD--NT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS  147 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  147 (401)
                      +..++....+.||+|.||.||.|...+  +.    .||+|.+....+.+....|.+|..+|+.++||||++++|+|.+..
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            345667778899999999999999643  33    499999998888888999999999999999999999999999999


Q ss_pred             eeEEEEecccCCcHHHHhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEee
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD  224 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D  224 (401)
                      ..++++|||++|+|..+|++.+.   +...++..+...++.+||+|+.||+++   ++|||||..+|+|++....|||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence            99999999999999999997533   245689999999999999999999999   899999999999999999999999


Q ss_pred             cCCccccCCCCcceeccc-cCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHH
Q 015734          225 FGLAKLVDAKLTHVTTQI-RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKL  302 (401)
Q Consensus       225 fgl~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  302 (401)
                      ||+++............. .-+..|||||.+..+.++.|+|||||||++||++| |..||......+        .....
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--------v~~~~  917 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--------VLLDV  917 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH--------HHHHH
Confidence            999995544443333322 34579999999999999999999999999999999 889987644321        11112


Q ss_pred             hccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCc
Q 015734          303 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDL  357 (401)
Q Consensus       303 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  357 (401)
                      ...+++         ..+..++..+.++|.+||+.+|++||++..+++.+.....
T Consensus       918 ~~ggRL---------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  918 LEGGRL---------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             HhCCcc---------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence            222222         1255667788999999999999999999999997765443

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-44  Score=339.14  Aligned_cols=268  Identities=28%  Similarity=0.420  Sum_probs=216.4

Q ss_pred             cCHHHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEec-ccCCcchHHHHHHHHHHHHhccCCcccceeeeeec
Q 015734           67 FSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT  145 (401)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~-~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  145 (401)
                      .+..++++..+.+.+.+.||+|.||+||+|.+..  .||||+++ ...+++..+.|.+|+.++++-+|.||+-+.|+|..
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            3347888999999999999999999999999843  69999998 44466788999999999999999999999999998


Q ss_pred             CCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeec
Q 015734          146 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF  225 (401)
Q Consensus       146 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  225 (401)
                      ++. .+|+.+|+|-+|..+++...   ..+...+...|+.|+++||.|||.+   +|||+|||..|||+.+++.|||+||
T Consensus       460 p~~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDF  532 (678)
T KOG0193|consen  460 PPL-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDF  532 (678)
T ss_pred             Cce-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecc
Confidence            887 99999999999999999743   4588999999999999999999999   9999999999999999999999999


Q ss_pred             CCccccCC-CCcceeccccCCcccccccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHH
Q 015734          226 GLAKLVDA-KLTHVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK  301 (401)
Q Consensus       226 gl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~  301 (401)
                      |++..-.. ..........|...|||||++.   ..+++.++||||||+++|||+||..||.. ...+..        .-
T Consensus       533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqI--------if  603 (678)
T KOG0193|consen  533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQI--------IF  603 (678)
T ss_pred             cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhhe--------EE
Confidence            99863321 1111223344677899999985   35689999999999999999999999983 221110        00


Q ss_pred             HhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 015734          302 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED  356 (401)
Q Consensus       302 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  356 (401)
                      ++..+.    +-+........+..++.+|+..||..++++||.+.+|+..|+...
T Consensus       604 mVGrG~----l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~  654 (678)
T KOG0193|consen  604 MVGRGY----LMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL  654 (678)
T ss_pred             Eecccc----cCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence            111110    111222234566778999999999999999999999999876543

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.2e-43  Score=327.45  Aligned_cols=266  Identities=21%  Similarity=0.324  Sum_probs=205.3

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECC-----------------CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCccc
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLSD-----------------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL  137 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv  137 (401)
                      ..++|.+.+.||+|+||.||+|.+.+                 +..||+|.+...........+.+|++++.+++||||+
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence            34678899999999999999997532                 2369999987654455567899999999999999999


Q ss_pred             ceeeeeecCCeeEEEEecccCCcHHHHhhhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 015734          138 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI  202 (401)
Q Consensus       138 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  202 (401)
                      ++++++...+..+++|||+.+++|.+++.....               ....+++.....++.|++.||.|||+.   ++
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i  159 (304)
T cd05096          83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NF  159 (304)
T ss_pred             EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence            999999999999999999999999998865321               113478889999999999999999998   99


Q ss_pred             EEeCCCCCceEEcCCCcEEEeecCCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhC--C
Q 015734          203 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG--Q  279 (401)
Q Consensus       203 ~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg--~  279 (401)
                      +|+||||+|||++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||+++  .
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence            99999999999999999999999999765433221 22233457899999999888899999999999999999974  4


Q ss_pred             CCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          280 RAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       280 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                      .||......     ..................     ...++..+..+.+++.+||+.+|.+|||+.+|.+.|+
T Consensus       240 ~p~~~~~~~-----~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         240 QPYGELTDE-----QVIENAGEFFRDQGRQVY-----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCCcCCHH-----HHHHHHHHHhhhcccccc-----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            555532211     111122211111110000     0112233467899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-43  Score=332.61  Aligned_cols=251  Identities=24%  Similarity=0.311  Sum_probs=206.8

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccC----CcchHHHHHHHHHHHHhcc-CCcccceeeeeecCC
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY----SPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSS  147 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  147 (401)
                      ...++|.+.+.||+|+||+|+.|.. .++..||+|++....    .......+.+|+.+++.+. ||||++++.+.....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3567899999999999999999985 468999999765421    1133456678999999999 999999999999999


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCC-CcEEEeecC
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFG  226 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfg  226 (401)
                      ..++||||+.+|+|.+++.+    ..++.+..++.++.|+++|++|||++   +|+||||||+|+|++.+ +++||+|||
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG  166 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG  166 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence            99999999999999999987    34588899999999999999999999   99999999999999999 999999999


Q ss_pred             CccccCCCCcceeccccCCcccccccccccCC-CC-cccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhc
Q 015734          227 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK-SS-EKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR  304 (401)
Q Consensus       227 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (401)
                      ++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||+.....        ........
T Consensus       167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~--------~l~~ki~~  237 (370)
T KOG0583|consen  167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP--------NLYRKIRK  237 (370)
T ss_pred             cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH--------HHHHHHhc
Confidence            998764 2233445678999999999999877 75 7899999999999999999999863321        11121111


Q ss_pred             cCccchhccCcCCCCCHHH-HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          305 EDRLNDIVDRNLNTYDSKE-VETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       305 ~~~~~~~~d~~~~~~~~~~-~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                                .-..++... +.++..++.+|+..||.+|+++.+++.
T Consensus       238 ----------~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  238 ----------GEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             ----------CCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence                      101112222 668889999999999999999999974

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5e-45  Score=338.63  Aligned_cols=249  Identities=27%  Similarity=0.409  Sum_probs=209.6

Q ss_pred             HHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeE
Q 015734           71 ELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI  150 (401)
Q Consensus        71 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  150 (401)
                      .++++.+....++-||+|+.|.||+|++ .++.||||+++..        -..+++.|++|+||||+.+.|+|....-+|
T Consensus       118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtqsPcyC  188 (904)
T KOG4721|consen  118 LWEIPFEEISELEWLGSGAQGAVFLGRL-HNETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQSPCYC  188 (904)
T ss_pred             hccCCHHHhhhhhhhccCcccceeeeec-cCceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecCCceeE
Confidence            3555566667788999999999999999 6789999987642        136789999999999999999999999999


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      +|||||..|-|...|+.    +.+++......+..+||.||.|||.+   .|||||||+-||||+.+..|||+|||-++.
T Consensus       189 IiMEfCa~GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e  261 (904)
T KOG4721|consen  189 IIMEFCAQGQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKE  261 (904)
T ss_pred             EeeeccccccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHh
Confidence            99999999999999986    55688899999999999999999999   899999999999999999999999999987


Q ss_pred             cCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccch
Q 015734          231 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND  310 (401)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ..+.  ...-.+.||..|||||++...+.+.|.|||||||+||||+||.-||...+....        ++ .+..     
T Consensus       262 ~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI--------Iw-GVGs-----  325 (904)
T KOG4721|consen  262 LSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI--------IW-GVGS-----  325 (904)
T ss_pred             hhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee--------EE-eccC-----
Confidence            7654  233457899999999999999999999999999999999999999974322100        00 0000     


Q ss_pred             hccCcCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          311 IVDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       311 ~~d~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                         ..+. ..+..++.-+.-|+++||+..|.+||++.+++.+|+-
T Consensus       326 ---NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  326 ---NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             ---CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence               1111 2456677788899999999999999999999999974

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-44  Score=333.66  Aligned_cols=251  Identities=22%  Similarity=0.322  Sum_probs=209.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEE-ECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      ...|..-.+||+|+.|.||.+. ..+++.||||++.... ....+-+.+|+.+|+..+|+|||++++.+...++++.|||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~-Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK-QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc-CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            4567888899999999999998 4568899999996433 3346778999999999999999999999998999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++|+|.+.+...     .+++.++..|+.++++||+|||.+   +|+|||||.+|||++.+|.+||+|||++..+...
T Consensus       351 ym~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  351 YMEGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             ecCCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence            99999998888753     389999999999999999999999   9999999999999999999999999999877665


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccC
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR  314 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  314 (401)
                      .. .....+|||.|||||++....|+++.||||||++++||+-|.+||=...+       +.. .. ........++   
T Consensus       423 ~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-------lrA-ly-LIa~ng~P~l---  489 (550)
T KOG0578|consen  423 QS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRA-LY-LIATNGTPKL---  489 (550)
T ss_pred             cC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-------HHH-HH-HHhhcCCCCc---
Confidence            44 34446799999999999999999999999999999999999999864332       100 11 1111111111   


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          315 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       315 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                         ..+...+..+.+++.+||+.|+++||++.++|++
T Consensus       490 ---k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  490 ---KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             ---CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence               1345566789999999999999999999999875

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-44  Score=340.51  Aligned_cols=268  Identities=27%  Similarity=0.382  Sum_probs=215.9

Q ss_pred             ccCHHHHHHHhcCCCCCCeeeecCcEEEEEEEECC--C---CEEEEEEecc--cCCcchHHHHHHHHHHHHhccCCcccc
Q 015734           66 RFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSD--N---TKVAVKRLQD--YYSPGGEAAFQREVHLISVAIHKNLLQ  138 (401)
Q Consensus        66 ~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~--~---~~vavK~~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~  138 (401)
                      ......+++..++....++||+|+||.||+|.++.  +   ..||+|..+.  ........+|++|.+++++++|||||+
T Consensus       146 PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr  225 (474)
T KOG0194|consen  146 PIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVR  225 (474)
T ss_pred             cccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence            33445567777788888999999999999999643  2   2389998873  355677889999999999999999999


Q ss_pred             eeeeeecCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC
Q 015734          139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF  218 (401)
Q Consensus       139 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~  218 (401)
                      ++|++......++|||+|.||+|.++|....   ..++..+...++.+.|.||+|||++   +++||||..+|+|++.++
T Consensus       226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~  299 (474)
T KOG0194|consen  226 FYGVAVLEEPLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKG  299 (474)
T ss_pred             EEEEEcCCCccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCC
Confidence            9999999999999999999999999999743   2599999999999999999999999   999999999999999999


Q ss_pred             cEEEeecCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHH
Q 015734          219 EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLD  297 (401)
Q Consensus       219 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~  297 (401)
                      .+||+|||+++......... ....-+..|+|||.+....++.++|||||||++||+++ |..||......     .+..
T Consensus       300 ~vKISDFGLs~~~~~~~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-----~v~~  373 (474)
T KOG0194|consen  300 VVKISDFGLSRAGSQYVMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-----EVKA  373 (474)
T ss_pred             eEEeCccccccCCcceeecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-----HHHH
Confidence            99999999987554111111 11234679999999999999999999999999999999 88898765432     1212


Q ss_pred             HHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 015734          298 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED  356 (401)
Q Consensus       298 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  356 (401)
                      ++.   ..+.        ....+...+.++..++.+||..+|++||+|.++.+.|+...
T Consensus       374 kI~---~~~~--------r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~  421 (474)
T KOG0194|consen  374 KIV---KNGY--------RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE  421 (474)
T ss_pred             HHH---hcCc--------cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence            221   1110        01123345667888888999999999999999999987543

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.2e-43  Score=322.14  Aligned_cols=256  Identities=22%  Similarity=0.307  Sum_probs=206.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC----CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      .++|++.+.||+|+||.||+|.++    .+..||+|.++...+......+.+|+.++.+++|||++++++++...+..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            457888999999999999999853    3568999999865555556789999999999999999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      ||||+++++|.+++...   ...+++..++.++.|++.||+|||++   +++|+||||+||+++.++.++++|||.+...
T Consensus        84 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          84 VTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            99999999999998753   24589999999999999999999998   9999999999999999999999999987654


Q ss_pred             CCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccch
Q 015734          232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND  310 (401)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ............++..|+|||.+.+..++.++|||||||++||+++ |..||......+     ....+    ....   
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-----~~~~~----~~~~---  225 (266)
T cd05064         158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-----VIKAV----EDGF---  225 (266)
T ss_pred             cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-----HHHHH----HCCC---
Confidence            3222111222335678999999999999999999999999999875 999997543211     11111    1110   


Q ss_pred             hccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       311 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                           ....+...+..+.+++..||+.+|.+||++.++.+.|..
T Consensus       226 -----~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         226 -----RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence                 011123345678899999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.6e-44  Score=333.91  Aligned_cols=248  Identities=25%  Similarity=0.399  Sum_probs=213.5

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecc-cCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQD-YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      ++|.+.+.||+|.||.||+|+.+ +.+.||+|.+.+ ...++....+.+|+++++.++||||+.+++++....+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46888899999999999999965 578899998864 3455677889999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+.| +|...|.+    ...+++..+..++.+++.||.|||+.   +|+|||+||.|||++.++.+|+||||+++.....
T Consensus        82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN  153 (808)
T ss_pred             hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence            9977 99999986    56799999999999999999999999   9999999999999999999999999999977654


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccC
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR  314 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  314 (401)
                       ....+...|||-|||||++.+.+|+..+|+||+||++||+++|++||....        ..+.+..+..++.       
T Consensus       154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--------i~~Lv~~I~~d~v-------  217 (808)
T KOG0597|consen  154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--------ITQLVKSILKDPV-------  217 (808)
T ss_pred             -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--------HHHHHHHHhcCCC-------
Confidence             334556789999999999999999999999999999999999999997432        2233333332221       


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          315 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       315 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                         ..++.....+..++...|.+||.+|.+-.+++.+
T Consensus       218 ---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  218 ---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             ---CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence               1244667788899999999999999999999764

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4.1e-43  Score=335.63  Aligned_cols=264  Identities=25%  Similarity=0.382  Sum_probs=207.9

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEE------CCCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeee
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT  144 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  144 (401)
                      +....++|++.+.||+|+||.||+|..      .++..||+|+++..........+.+|+.++..+ +||||+++++++.
T Consensus        30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            445567899999999999999999973      235689999997544444567789999999999 8999999999999


Q ss_pred             cCCeeEEEEecccCCcHHHHhhhcCC------------------------------------------------------
Q 015734          145 TSSERILVYPFMQNLSVAYRLRDLKP------------------------------------------------------  170 (401)
Q Consensus       145 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------  170 (401)
                      ..+..++||||+++|+|.+++.....                                                      
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            99999999999999999999865321                                                      


Q ss_pred             -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          171 -----------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       171 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                                       ....+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++.....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                             012578889999999999999999998   999999999999999999999999999986543


Q ss_pred             CCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          234 KLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       234 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      .... ......++..|+|||++.+..++.++|||||||++|||++ |..||.......    .......    ....   
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~----~~~~~~~----~~~~---  335 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS----KFYKMIK----EGYR---  335 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH----HHHHHHH----hCcc---
Confidence            3221 1222335668999999999999999999999999999998 888886432211    1111111    1100   


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                        .   ..+...+.++.+++.+||+.||++|||+.++++.|+.
T Consensus       336 --~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         336 --M---LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             --C---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence              0   0111223578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-44  Score=326.35  Aligned_cols=250  Identities=26%  Similarity=0.356  Sum_probs=212.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      ...|+..+.||+|.||.||+|.+ .+++.||+|++.-.......+.+.+|+.++.+++++||.++++.+..+..+.++||
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            34577788999999999999995 46889999999866677788899999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      ||.||++.+.|..    +..+.+..+..++.++..|+.|||++   +.+|||||+.|||+..+|.+|++|||.+-.....
T Consensus        92 y~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   92 YCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             HhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeech
Confidence            9999999988875    34457888888999999999999999   9999999999999999999999999999877665


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccC
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR  314 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  314 (401)
                      .... ..++|||.|||||++....|+.++||||||++.+||.+|.+|+....+.                  +..-++..
T Consensus       165 ~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm------------------rvlflIpk  225 (467)
T KOG0201|consen  165 VKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM------------------RVLFLIPK  225 (467)
T ss_pred             hhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc------------------eEEEeccC
Confidence            4444 6678999999999999889999999999999999999999998743320                  01111111


Q ss_pred             cCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          315 NLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       315 ~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..+ .........+.+++..||++||+.||+|.+++++
T Consensus       226 ~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  226 SAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             CCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            111 1233556678999999999999999999999875

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.3e-42  Score=318.13  Aligned_cols=246  Identities=17%  Similarity=0.268  Sum_probs=197.6

Q ss_pred             CCeeeecCcEEEEEEEECCCCEEEEEEecccCC--cchHHHHHHHHHHHHhccCCcccceeeeeec----CCeeEEEEec
Q 015734           82 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQLIGYCTT----SSERILVYPF  155 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~  155 (401)
                      ...||+|++|.||+|.+ +|+.||+|.+.....  ....+.+.+|+.++.+++||||+++++++.+    ....+++|||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999998 788999999874322  1224678899999999999999999999876    3467899999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +++|+|.+++..    ...+++.....++.+++.||.|||+..  +++||||||+||++++++.+||+|||+++......
T Consensus       104 ~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~  177 (283)
T PHA02988        104 CTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP  177 (283)
T ss_pred             CCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence            999999999875    345889999999999999999999742  68899999999999999999999999987654321


Q ss_pred             cceeccccCCccccccccccc--CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          236 THVTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                          ....++..|+|||++.+  ..++.++|||||||++|||++|..||......+     .   ......... .    
T Consensus       178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~-----~---~~~i~~~~~-~----  240 (283)
T PHA02988        178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE-----I---YDLIINKNN-S----  240 (283)
T ss_pred             ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH-----H---HHHHHhcCC-C----
Confidence                22357889999999976  678999999999999999999999997543211     1   111111110 0    


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      .   ..+...+..+.+++.+||+.||++|||++++++.|+.
T Consensus       241 ~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~  278 (283)
T PHA02988        241 L---KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL  278 (283)
T ss_pred             C---CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence            0   1122345678899999999999999999999998865

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.1e-42  Score=318.08  Aligned_cols=268  Identities=19%  Similarity=0.273  Sum_probs=203.2

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      ++|.+.+.||+|+||.||+|..+ ++..||+|++.... .......+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46889999999999999999975 57889999987432 23445678899999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |++++.+......    ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            9998776554332    34588999999999999999999998   9999999999999999999999999999866443


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhH-------HHHHHHHhccCc
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL-------LDHIRKLLREDR  307 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~  307 (401)
                      .........||+.|+|||++.+..++.++|||||||++|||++|+.||......+......       ............
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            3333334568999999999988889999999999999999999999997643221100000       000000000000


Q ss_pred             cchhccCcCCC-------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          308 LNDIVDRNLNT-------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       308 ~~~~~d~~~~~-------~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ......+....       .....+.++.+++.+||+.||++|||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00000000000       111234578999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-43  Score=329.09  Aligned_cols=252  Identities=23%  Similarity=0.344  Sum_probs=217.8

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEec-ccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCe-eEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE-RILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~-~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~  153 (401)
                      ++|..++++|+|+||.++++..+ ++..+++|.+. ...++...+....|+.+++++.|||||.+.+.+..++. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57888999999999999999865 57789999987 34455566789999999999999999999999999988 89999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      +||+||++.+.+...+  +..+++..+..++.|++.|+.|||++   .|+|||||+.|||++.+..|+|+|||+++....
T Consensus        84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            9999999999998755  45689999999999999999999988   899999999999999999999999999998876


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      .. .......||+.|+.||.+.+.+|..|+|||||||.+|||++-+++|...+....        +.+..         .
T Consensus       159 ~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L--------i~ki~---------~  220 (426)
T KOG0589|consen  159 ED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL--------ILKIN---------R  220 (426)
T ss_pred             ch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH--------HHHHh---------h
Confidence            54 234556799999999999999999999999999999999999999987654321        11111         1


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ....+.+..++.++..++..|+..+|..||++.+++.+
T Consensus       221 ~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  221 GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            12234567778899999999999999999999999886

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.5e-41  Score=362.37  Aligned_cols=259  Identities=27%  Similarity=0.481  Sum_probs=208.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      ...+...++||+|+||.||+|.. .++..||+|++......     ...|++.+++++||||++++++|.+.+..++|||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E  763 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE  763 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence            35678889999999999999996 47899999988643221     1346888999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++|+|.++++.       ++|..+..++.|++.||+|||..+.++++||||||+||+++.++.+++. ||........
T Consensus       764 y~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~  835 (968)
T PLN00113        764 YIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD  835 (968)
T ss_pred             CCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC
Confidence            9999999999863       7899999999999999999996656699999999999999999988876 6655432211


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccC
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR  314 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  314 (401)
                           ....+|+.|+|||++.+..++.++|||||||++|||+||+.||+....   ......+|.+...........+|+
T Consensus       836 -----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  907 (968)
T PLN00113        836 -----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG---VHGSIVEWARYCYSDCHLDMWIDP  907 (968)
T ss_pred             -----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC---CCCcHHHHHHHhcCccchhheeCc
Confidence                 122578999999999999999999999999999999999999864322   122344555544444444455555


Q ss_pred             cCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          315 NLNT---YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       315 ~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                      .+..   ....+..++.+++.+||+.+|++||||.++++.|+..
T Consensus       908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  951 (968)
T PLN00113        908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA  951 (968)
T ss_pred             cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence            4432   3456677889999999999999999999999999754

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.8e-42  Score=323.92  Aligned_cols=264  Identities=22%  Similarity=0.318  Sum_probs=207.4

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ..++|.+.+.||+|+||.||++... ++..+|+|.+.....+.....+.+|++++++++||||+++++++...+..++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence            3578999999999999999999965 578899998875444455678999999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+..  +++|+||||+||+++.++.+||+|||++.....
T Consensus        83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649          83 EHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence            99999999999876    335889999999999999999999852  599999999999999999999999999875533


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC--c----
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED--R----  307 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~----  307 (401)
                      .   ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..     ..+.......  .    
T Consensus       157 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  228 (331)
T cd06649         157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE-----AIFGRPVVDGEEGEPHS  228 (331)
T ss_pred             c---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHhcccccccccCCccc
Confidence            2   223346899999999999989999999999999999999999999754322110     0000000000  0    


Q ss_pred             ------------------------cchh----ccCcCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 015734          308 ------------------------LNDI----VDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML  352 (401)
Q Consensus       308 ------------------------~~~~----~d~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  352 (401)
                                              ....    .....+. .......++.+++.+||+.||++|||+++++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                                    0000    0000000 0112456789999999999999999999998764

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.6e-42  Score=319.29  Aligned_cols=259  Identities=25%  Similarity=0.440  Sum_probs=209.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC-C-----CEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCee
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSD-N-----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  149 (401)
                      .++|.+.+.||+|+||.||+|.... +     ..|++|.+...........+.+|+.++..++|||++++++++......
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            3478889999999999999998543 2     579999987555555567899999999999999999999999999999


Q ss_pred             EEEEecccCCcHHHHhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCC
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPG------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN  217 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~  217 (401)
                      +++|||+++++|.+++......            ...+++..+..++.|++.||+|||+.   +++|+||||+||+++++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEG  160 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCC
Confidence            9999999999999998754221            14588899999999999999999998   99999999999999999


Q ss_pred             CcEEEeecCCccccCCCCc-ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhH
Q 015734          218 FEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLL  295 (401)
Q Consensus       218 ~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~  295 (401)
                      +.++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+     .
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-----~  235 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-----V  235 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----H
Confidence            9999999999875533221 22233446788999999988889999999999999999998 999987543211     1


Q ss_pred             HHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          296 LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       296 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ...    +...        .....+...+.++.+++.+||+.||.+||++++|++.|+.
T Consensus       236 ~~~----i~~~--------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         236 IEM----IRSR--------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHH----HHcC--------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            111    1111        1112234456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.9e-42  Score=314.05  Aligned_cols=251  Identities=26%  Similarity=0.382  Sum_probs=203.3

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecc
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM  156 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  156 (401)
                      ++|.+.+.||+|+||.||++..+++..+|+|.+...  ......+.+|+.++++++|||++++++++...+..+++|||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG--AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC--CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            467888999999999999999888889999987642  234567889999999999999999999999999999999999


Q ss_pred             cCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCc
Q 015734          157 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT  236 (401)
Q Consensus       157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  236 (401)
                      ++|+|.+++....   ..+++..+..++.|++.||+|||++   +++|+||||+||++++++.++|+|||.+........
T Consensus        82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05114          82 ENGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY  155 (256)
T ss_pred             CCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence            9999999887532   3588999999999999999999998   999999999999999999999999999876543322


Q ss_pred             ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCc
Q 015734          237 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN  315 (401)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  315 (401)
                      .......++..|+|||.+.+..++.++|+||||+++|||++ |+.||.......     .   ..........       
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~-----~---~~~i~~~~~~-------  220 (256)
T cd05114         156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE-----V---VEMISRGFRL-------  220 (256)
T ss_pred             eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH-----H---HHHHHCCCCC-------
Confidence            22222335668999999988889999999999999999999 889986543211     1   1111111110       


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 015734          316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML  352 (401)
Q Consensus       316 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  352 (401)
                        ..+......+.+++.+||+.+|.+||+++++++.|
T Consensus       221 --~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         221 --YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             --CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence              01112235788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.4e-42  Score=317.53  Aligned_cols=252  Identities=25%  Similarity=0.364  Sum_probs=201.0

Q ss_pred             CCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           79 FSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        79 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      |...+.||+|+||.||+|.. .++..||+|.+....  .......+.+|++++..++|+|++++.+++.+.+..++++||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            66788999999999999995 478999999886322  222345678899999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +++|+|..++....  ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+|||++.......
T Consensus        82 ~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          82 MNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             cCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            99999988876432  34588999999999999999999999   99999999999999999999999999997653322


Q ss_pred             cceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCc
Q 015734          236 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN  315 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  315 (401)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........     ..+.......         
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-----~~~~~~~~~~---------  220 (285)
T cd05631         157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR-----EEVDRRVKED---------  220 (285)
T ss_pred             --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH-----HHHHHHhhcc---------
Confidence              223346899999999999999999999999999999999999999754321111     1111111100         


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 015734          316 LNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVKM  351 (401)
Q Consensus       316 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~~  351 (401)
                      ...++...+.++.+|+.+||+.||.+||+     +++++++
T Consensus       221 ~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         221 QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            01122334567889999999999999997     7777653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-42  Score=321.98  Aligned_cols=246  Identities=21%  Similarity=0.218  Sum_probs=201.4

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ++|.+.+.||+|+||.||+|..+ +++.||+|.+....  .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46888999999999999999965 68899999986321  2234567889999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++++|.+++..    ...+++.....++.|++.||+|||++   +++||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            99999999999875    34588999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      .    .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......     .   ........       
T Consensus       154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-----~---~~~i~~~~-------  214 (291)
T cd05612         154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-----I---YEKILAGK-------  214 (291)
T ss_pred             C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----H---HHHHHhCC-------
Confidence            2    223468999999999998889999999999999999999999997543211     1   11111110       


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVKM  351 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~~  351 (401)
                         ...+......+.+++.+||+.||.+||+     +++++++
T Consensus       215 ---~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         215 ---LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             ---cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence               0112222456889999999999999995     8888654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.2e-42  Score=332.22  Aligned_cols=265  Identities=25%  Similarity=0.401  Sum_probs=208.1

Q ss_pred             HHHHHhcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeee
Q 015734           71 ELQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYC  143 (401)
Q Consensus        71 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  143 (401)
                      .+....++|.+.+.||+|+||.||+|...      ++..||+|.+...........+.+|+++++.+ +|+||+++++++
T Consensus        32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~  111 (374)
T cd05106          32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC  111 (374)
T ss_pred             cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence            34556778999999999999999998842      23579999997554455567789999999999 899999999999


Q ss_pred             ecCCeeEEEEecccCCcHHHHhhhcCC-----------------------------------------------------
Q 015734          144 TTSSERILVYPFMQNLSVAYRLRDLKP-----------------------------------------------------  170 (401)
Q Consensus       144 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------------------------------------------------  170 (401)
                      ...+..++||||+++|+|.+++.....                                                     
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            999999999999999999998864210                                                     


Q ss_pred             -------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcc
Q 015734          171 -------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH  237 (401)
Q Consensus       171 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  237 (401)
                                   ...++++..+..++.|++.||.|||++   +++||||||+||++++++.+||+|||+++........
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence                         113578889999999999999999998   9999999999999999999999999998765433221


Q ss_pred             -eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCc
Q 015734          238 -VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN  315 (401)
Q Consensus       238 -~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  315 (401)
                       ......++..|+|||++.+..++.++|||||||++|||++ |..||.......    ...    ...... .    ...
T Consensus       269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~----~~~----~~~~~~-~----~~~  335 (374)
T cd05106         269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS----KFY----KMVKRG-Y----QMS  335 (374)
T ss_pred             eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH----HHH----HHHHcc-c----Ccc
Confidence             1222335668999999988889999999999999999997 999987533211    011    111110 0    000


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       316 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                         .+...+.++.+++..||+.||.+|||+.++++.|+.
T Consensus       336 ---~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~  371 (374)
T cd05106         336 ---RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR  371 (374)
T ss_pred             ---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence               111124578899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.8e-42  Score=318.57  Aligned_cols=262  Identities=23%  Similarity=0.313  Sum_probs=201.2

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      ++|...+.||+|+||+||+|..+ ++..||+|.+...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56889999999999999999965 68899999987543444456778999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +++ +|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++......
T Consensus        85 ~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          85 LDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             CCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence            975 888887652   33578899999999999999999998   99999999999999999999999999987543322


Q ss_pred             cceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhcc---------
Q 015734          236 THVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE---------  305 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------  305 (401)
                      . ......+++.|+|||.+.+ ..++.++||||+||++|+|+||+.||......+...     ........         
T Consensus       158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  231 (288)
T cd07871         158 K-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELH-----LIFRLLGTPTEETWPGI  231 (288)
T ss_pred             c-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHHHhCCCChHHhhcc
Confidence            1 1233457899999999865 568999999999999999999999997654322111     11110000         


Q ss_pred             ---CccchhccCcCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          306 ---DRLNDIVDRNLNT-----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       306 ---~~~~~~~d~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                         ........+....     .......+..+++.+||+.||.+|||++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence               0000000000000     011224567899999999999999999999754

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-43  Score=333.16  Aligned_cols=247  Identities=26%  Similarity=0.351  Sum_probs=207.9

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhcc-CCcccceeeeeecCC
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSS  147 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  147 (401)
                      ..+..++|.+.++||+|.||+|+++..+ +++.+|||.+++.  ...+..+..+.|-+++.... ||.++.++..++..+
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            3556788999999999999999999976 5789999999853  35667888999999888775 999999999999999


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCC
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL  227 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl  227 (401)
                      ++++||||+.||++..+.+     ...+++..++.++..|+.||.|||++   +||+||||.+|||+|.+|++||+|||+
T Consensus       443 ~l~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGl  514 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGL  514 (694)
T ss_pred             eEEEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccc
Confidence            9999999999999433332     35699999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          228 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      ++..-.. ...+..++|||.|+|||++.+..|+.+.|+|||||+||||+.|..||.+++..+.-+.        ++.++ 
T Consensus       515 cKe~m~~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fds--------I~~d~-  584 (694)
T KOG0694|consen  515 CKEGMGQ-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDS--------IVNDE-  584 (694)
T ss_pred             ccccCCC-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH--------HhcCC-
Confidence            9854322 2356778999999999999999999999999999999999999999997665432211        11111 


Q ss_pred             cchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 015734          308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM  345 (401)
Q Consensus       308 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  345 (401)
                               ..++...+.+...++.++|..+|++|..+
T Consensus       585 ---------~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  585 ---------VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ---------CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence                     12345566788899999999999999865

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.5e-42  Score=324.04  Aligned_cols=243  Identities=21%  Similarity=0.261  Sum_probs=197.3

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCC
Q 015734           83 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL  159 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  159 (401)
                      +.||+|+||.||++..+ +|+.||+|++....  .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999964 68899999987421  2334567788999999999999999999999999999999999999


Q ss_pred             cHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCccee
Q 015734          160 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT  239 (401)
Q Consensus       160 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  239 (401)
                      +|..++..    ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++...... ...
T Consensus        81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~  152 (323)
T cd05571          81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATM  152 (323)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccc
Confidence            99988875    34689999999999999999999999   99999999999999999999999999987532221 122


Q ss_pred             ccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCC
Q 015734          240 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTY  319 (401)
Q Consensus       240 ~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  319 (401)
                      ....||+.|+|||++.+..++.++|||||||++|||++|..||...+...     ...   ......          ...
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-----~~~---~~~~~~----------~~~  214 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----LFE---LILMEE----------IRF  214 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH-----HHH---HHHcCC----------CCC
Confidence            34568999999999999999999999999999999999999996533211     111   111100          011


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 015734          320 DSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM  351 (401)
Q Consensus       320 ~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  351 (401)
                      +.....++.+++.+||+.||++||     ++.+++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            223445788999999999999999     78888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2e-42  Score=325.47  Aligned_cols=247  Identities=21%  Similarity=0.258  Sum_probs=201.7

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      .++|.+.+.||+|+||.||+|..+ +++.||+|.+...  ........+.+|+.++..++||||+++++++...+..+++
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            357888999999999999999975 5889999998642  1233456788999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||+.+++|.+++..    ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++....
T Consensus        97 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  169 (329)
T PTZ00263         97 LEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP  169 (329)
T ss_pred             EcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence            999999999999876    34588899999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ...    ....||+.|+|||++.+..++.++|||||||++|+|++|..||......        ........ ...    
T Consensus       170 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~~~i~~-~~~----  232 (329)
T PTZ00263        170 DRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--------RIYEKILA-GRL----  232 (329)
T ss_pred             CCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH--------HHHHHHhc-CCc----
Confidence            322    2346899999999999999999999999999999999999999653321        11111111 110    


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVKM  351 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~~  351 (401)
                           ..+.....++.+++.+||+.||.+||+     +++++.+
T Consensus       233 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        233 -----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             -----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                 011123346789999999999999997     5777654

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.1e-42  Score=313.61  Aligned_cols=256  Identities=25%  Similarity=0.397  Sum_probs=208.0

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      ..++|.+.+.||+|+||.||+|...++..||+|.+...  ....+.+.+|+.+++.++|+|++++++.+...+..++++|
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG--TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE   81 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC--chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence            45678899999999999999999888889999987642  2345788999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++++|.+++....  ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        82 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          82 YMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             cCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            999999999987532  34578899999999999999999998   9999999999999999999999999999866543


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      .........++..|+|||.+.+..++.++|||||||++|+|+| |..||.......     ....+.   .....     
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-----~~~~~~---~~~~~-----  223 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-----VMSALQ---RGYRM-----  223 (261)
T ss_pred             ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-----HHHHHH---cCCCC-----
Confidence            3222223345678999999988889999999999999999998 999986433211     111111   11000     


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                          ......+.++.+++.+||+.+|++||+++++.+.|+.
T Consensus       224 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         224 ----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             ----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                0112234578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-42  Score=311.84  Aligned_cols=257  Identities=27%  Similarity=0.390  Sum_probs=208.2

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      +..++|++.+.||+|++|.||+|...++..||+|.+...  ......+.+|+.++++++|||++++++++...+..+++|
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG--TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT   80 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC--cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence            345678899999999999999999877888999998643  224567899999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++++|.+++....  ...+++..+..++.|++.|+.|||+.   +++|+||||+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          81 ELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             ecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            9999999999987633  34689999999999999999999998   999999999999999999999999999987653


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ...........+..|+|||.+.+..++.++|+||||+++|||+| |..||......     .....+.   ....     
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~~~---~~~~-----  222 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-----EVLQQVD---QGYR-----  222 (261)
T ss_pred             CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHH---cCCC-----
Confidence            32222222223457999999998899999999999999999999 99998643321     1111111   1100     


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                          ...+...+..+.+++.+||+.+|.+||++.++++.|++
T Consensus       223 ----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         223 ----MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             ----CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence                01122344678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-42  Score=323.74  Aligned_cols=254  Identities=19%  Similarity=0.221  Sum_probs=204.7

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ++|.+.+.||+|+||.||+|... +++.||+|++....  .......+.+|++++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888999999999999999975 58899999987422  2234567889999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            99999999999875    34588999999999999999999999   999999999999999999999999999875543


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                          ......||+.|+|||++.+..++.++|||||||++|||++|..||......+.     ...+....  ....   .
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-----~~~i~~~~--~~~~---~  219 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-----WENLKYWK--ETLQ---R  219 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-----HHHHHhcc--cccc---C
Confidence                22345689999999999988999999999999999999999999976443211     11111100  0000   0


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      +.........+.++.+++.+||+.+|.+||++.+++++
T Consensus       220 ~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         220 PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            00000012335678899999999999999999999876

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.7e-42  Score=315.13  Aligned_cols=250  Identities=30%  Similarity=0.472  Sum_probs=195.8

Q ss_pred             CCCeeeecCcEEEEEEEEC-----CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           81 ESNIIGQGGFGKVYKGVLS-----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        81 ~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      ..+.||.|.||.||+|.+.     .+..|+||.++........+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3568999999999999975     25789999997655555678999999999999999999999999988889999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +++|+|.++|...  ....+++..+..++.|++.||+|||++   +++|+||+++||+++.++.+||+|||++.......
T Consensus        83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999974  135689999999999999999999998   89999999999999999999999999998663222


Q ss_pred             c-ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          236 T-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       236 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      . ...........|+|||.+.+..++.++||||||+++|||++ |..||......        +..... .....     
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~--------~~~~~~-~~~~~-----  223 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE--------EIIEKL-KQGQR-----  223 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH--------HHHHHH-HTTEE-----
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------cccccc-ccccc-----
Confidence            2 22233446779999999999889999999999999999999 67887643221        111111 11111     


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML  352 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  352 (401)
                         ...+...+..+.+++..||+.+|++|||+.++++.|
T Consensus       224 ---~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 ---LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ---TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ---ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence               111223355788999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=293.27  Aligned_cols=266  Identities=24%  Similarity=0.319  Sum_probs=212.9

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEE-ECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCC---
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS---  147 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---  147 (401)
                      +.+..++|.+.+.||+|||+-||++. ..++..||+|++.-. +.+..+..++|++..++++|||++++++++..+.   
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~-~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~   94 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH-SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG   94 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc-chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence            34567889999999999999999999 567899999998743 3467788999999999999999999999875443   


Q ss_pred             --eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeec
Q 015734          148 --ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF  225 (401)
Q Consensus       148 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  225 (401)
                        ..+++++|...|+|.+.+...+..+..+++.+++.|+.++++||.+||+. .++++||||||.|||+.+++.++|.||
T Consensus        95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEec
Confidence              48999999999999999998877777899999999999999999999997 335999999999999999999999999


Q ss_pred             CCccccCCCCccee--------ccccCCcccccccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhh
Q 015734          226 GLAKLVDAKLTHVT--------TQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL  294 (401)
Q Consensus       226 gl~~~~~~~~~~~~--------~~~~gt~~y~aPE~~~---~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~  294 (401)
                      |.+....-......        ....-|..|+|||.+.   +...++++|||||||++|+|+.|..||+..-.       
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-------  246 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-------  246 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-------
Confidence            99875432211111        1123588999999985   34578999999999999999999999973211       


Q ss_pred             HHHHHHHHhccCcc-chhccCcCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          295 LLDHIRKLLREDRL-NDIVDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       295 ~~~~~~~~~~~~~~-~~~~d~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                               ..+.+ ..+....+. +..+..++.+.+++.+|++.||.+||++.+++..++..
T Consensus       247 ---------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  247 ---------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             ---------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                     11111 111111111 12334778899999999999999999999999988653

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.5e-41  Score=319.93  Aligned_cols=263  Identities=22%  Similarity=0.317  Sum_probs=204.8

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ..++|++.+.||+|+||.||++..+ ++..+|+|.+...........+.+|+++++.++||||+++++++...+..++||
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            4578999999999999999999975 578899998875444445677999999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++++|.+++..    ...+++.....++.|++.||.|||+..  +++|+||||+||+++.++.+||+|||++.....
T Consensus        83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          83 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            99999999999875    345888999999999999999999742  699999999999999999999999999875533


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCc------
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR------  307 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------  307 (401)
                      .   ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||..........     ..........      
T Consensus       157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~  228 (333)
T cd06650         157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL-----MFGCPVEGDPAESETS  228 (333)
T ss_pred             h---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHH-----HhcCcccCCccccccC
Confidence            2   1223458999999999998889999999999999999999999997543211100     0000000000      


Q ss_pred             ----------------------cchh----ccCcCCCC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          308 ----------------------LNDI----VDRNLNTY-DSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       308 ----------------------~~~~----~d~~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                                            ...+    .....+.. ......++.+++.+||+.||++|||+.+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         229 PRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             cccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                                  0000    00000000 01134568899999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.9e-42  Score=315.14  Aligned_cols=260  Identities=23%  Similarity=0.389  Sum_probs=205.5

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS  147 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  147 (401)
                      +..++|+..+.||+|+||.||+|...      ++..||+|.+...........+.+|+.+++.++|||++++++++....
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            45678999999999999999998753      246799998865433345567889999999999999999999999999


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEE
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPG------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV  221 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~k  221 (401)
                      ..++||||+++++|.+++......      ...+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence            999999999999999998764321      23467888999999999999999998   999999999999999999999


Q ss_pred             EeecCCccccCCCCcce-eccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHH
Q 015734          222 LCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHI  299 (401)
Q Consensus       222 l~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~  299 (401)
                      |+|||++.......... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.......     ...  
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-----~~~--  232 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-----VLR--  232 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHH--
Confidence            99999987554322211 122345778999999998889999999999999999999 688886433211     111  


Q ss_pred             HHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          300 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       300 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                        ........        ..+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       233 --~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         233 --FVMEGGLL--------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             --HHHcCCcC--------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence              11111111        112223457889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=324.95  Aligned_cols=281  Identities=22%  Similarity=0.371  Sum_probs=234.1

Q ss_pred             cCHHHHHHHhcCCCCCCeeeecCcEEEEEEEECC---C--CEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceee
Q 015734           67 FSCRELQLATDNFSESNIIGQGGFGKVYKGVLSD---N--TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG  141 (401)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~  141 (401)
                      .+..+.++..+.....+.||.|-||.||+|.+.+   |  -.||||..+....++..+.|..|..+++.++||||++++|
T Consensus       379 P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIG  458 (974)
T KOG4257|consen  379 PTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIG  458 (974)
T ss_pred             CCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheee
Confidence            3334455566667778899999999999999533   2  3589999988788888999999999999999999999999


Q ss_pred             eeecCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEE
Q 015734          142 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV  221 (401)
Q Consensus       142 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~k  221 (401)
                      +|.+. ..++|||.++-|.|..+|...+   ..++......++.||+.||+|||+.   +++||||..+|||+...-.+|
T Consensus       459 v~~e~-P~WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVK  531 (974)
T KOG4257|consen  459 VCVEQ-PMWIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVK  531 (974)
T ss_pred             eeecc-ceeEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceee
Confidence            99864 4689999999999999999743   4588999999999999999999999   999999999999999999999


Q ss_pred             EeecCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHH
Q 015734          222 LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIR  300 (401)
Q Consensus       222 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~  300 (401)
                      |+|||+++.+.+..........-+..|||||.++..+++.+||||.|||.+||+++ |..||.+-...+           
T Consensus       532 LaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-----------  600 (974)
T KOG4257|consen  532 LADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-----------  600 (974)
T ss_pred             ecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-----------
Confidence            99999999888776655554445779999999999999999999999999999987 899997543321           


Q ss_pred             HHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCchhhhhhHHHHHHHH
Q 015734          301 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEEVR  371 (401)
Q Consensus       301 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~~~~~  371 (401)
                            .+..+-.....+.++.++..+..++.+||+.+|.+||++.++...|.+....++...-|++...+
T Consensus       601 ------VI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~~~Eq~r~~R  665 (974)
T KOG4257|consen  601 ------VIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKINSSEQLRRQR  665 (974)
T ss_pred             ------eEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhhhHHHHHhhh
Confidence                  12222223334457778889999999999999999999999999999887777666666655543

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.5e-42  Score=339.22  Aligned_cols=258  Identities=24%  Similarity=0.288  Sum_probs=207.5

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecc-cCCcchHHHHHHHHHHHHhccCCcccceeeeeecCC----
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQD-YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS----  147 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  147 (401)
                      ...++|.+.+.||+|+||+||+|.. .+++.||+|.+.. ..+......+.+|+..+..++|+|+++++..+....    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            3456899999999999999999985 4689999999863 234455667889999999999999999887664332    


Q ss_pred             ----eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEe
Q 015734          148 ----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLC  223 (401)
Q Consensus       148 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~  223 (401)
                          ..++||||+++|+|.+++.........+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence                25799999999999999986554456789999999999999999999999   99999999999999999999999


Q ss_pred             ecCCccccCCCCc-ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHH
Q 015734          224 DFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL  302 (401)
Q Consensus       224 Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  302 (401)
                      |||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+        .+...
T Consensus       186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~--------~~~~~  257 (496)
T PTZ00283        186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE--------VMHKT  257 (496)
T ss_pred             ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHH
Confidence            9999986543322 22334568999999999999999999999999999999999999997543211        11111


Q ss_pred             hccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          303 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       303 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .. .        .....+...+.++.+++..||+.||.+||++.+++++
T Consensus       258 ~~-~--------~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        258 LA-G--------RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             hc-C--------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            11 1        1111223345678899999999999999999999864

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=9e-42  Score=313.71  Aligned_cols=258  Identities=26%  Similarity=0.400  Sum_probs=207.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC------CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCee
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  149 (401)
                      .++|.+.+.||+|+||.||+|...+      +..||+|.+...........+.+|++++..++|||++++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3568888999999999999998633      4789999987654444567899999999999999999999999999999


Q ss_pred             EEEEecccCCcHHHHhhhcC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCc
Q 015734          150 ILVYPFMQNLSVAYRLRDLK----------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE  219 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~  219 (401)
                      +++|||+++++|.+++....          .....+++..+..++.|++.|+.|||++   +++|+||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence            99999999999999997542          1234578899999999999999999998   9999999999999999999


Q ss_pred             EEEeecCCccccCCCCc-ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHH
Q 015734          220 AVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLD  297 (401)
Q Consensus       220 ~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~  297 (401)
                      ++|+|||++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||.......     ...
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-----~~~  235 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-----VIE  235 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----HHH
Confidence            99999999875433221 11223345778999999999999999999999999999999 999986433211     111


Q ss_pred             HHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          298 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       298 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                      ...    ...        ....+...+..+.+++.+||+.||++||++.++++.|+
T Consensus       236 ~~~----~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         236 CIT----QGR--------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHH----cCC--------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            111    111        11112234567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=7.8e-42  Score=311.38  Aligned_cols=255  Identities=27%  Similarity=0.402  Sum_probs=206.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      ..+|...+.||+|+||.||+|..+ ++..|++|.+..  +......+.+|+++++.++|||++++++++...+..+++||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   82 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecC--CchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence            456788899999999999999964 578899998864  23345678999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++++|.+++....  ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          83 FMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             eCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            999999999987532  34589999999999999999999998   9999999999999999999999999999866543


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      .........++..|+|||.+.+..++.++|||||||++|||++ |..||......+     .   .........      
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-----~---~~~~~~~~~------  223 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----V---YELLEKGYR------  223 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----H---HHHHHCCCC------
Confidence            3222222334668999999998999999999999999999998 889987543211     1   111111000      


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      .   ..+...+.++.+++.+||+.+|++||++.++++.|+.
T Consensus       224 ~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         224 M---ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             C---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence            0   1122334678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.4e-41  Score=316.21  Aligned_cols=264  Identities=24%  Similarity=0.320  Sum_probs=198.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      .++|.+.+.||+|+||.||+|..+ +++.||+|++...........+.+|+.+++.++||||+++++++......++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999975 6889999998754333444567889999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+. ++|.+++...   ...++...+..++.|++.||+|||++   +++||||||+||++++++.+||+|||++......
T Consensus        84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          84 YVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             CCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            995 5777777642   34588899999999999999999999   9999999999999999999999999998754332


Q ss_pred             CcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC---cc--
Q 015734          235 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED---RL--  308 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~--  308 (401)
                      .. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||........   .+ ..........   ..  
T Consensus       157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~-~~~~~~~~~~~~~~~~~  231 (303)
T cd07869         157 SH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD---QL-ERIFLVLGTPNEDTWPG  231 (303)
T ss_pred             Cc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH---HH-HHHHHHhCCCChhhccc
Confidence            21 2233457899999999865 4578899999999999999999999975322111   01 1111100000   00  


Q ss_pred             ----chhccCcCCCCC----------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          309 ----NDIVDRNLNTYD----------SKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       309 ----~~~~d~~~~~~~----------~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                          ............          ......+.+++..||+.||.+|||+.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence                000000000000          0112467789999999999999999999763

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-41  Score=309.84  Aligned_cols=256  Identities=27%  Similarity=0.388  Sum_probs=207.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC----CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      .++|++.+.||+|+||.||+|.++.    ...||+|.+...........+.+|+.+++.++|||++++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            4678999999999999999998642    457999998765555566789999999999999999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      +|||+++++|.+++...   ...+++..+..++.|++.||+|||++   +++|+||||+||++++++.++|+|||++...
T Consensus        83 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          83 ITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             EEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            99999999999998753   23689999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccc
Q 015734          232 DAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN  309 (401)
Q Consensus       232 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ...... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......     .......   ..... 
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-----~~~~~~~---~~~~~-  227 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-----DVIKAVE---DGYRL-  227 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-----HHHHHHH---cCCCC-
Confidence            522221 2222334678999999998899999999999999999998 99998543221     1111111   11000 


Q ss_pred             hhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       310 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                              ..+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       228 --------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~  264 (266)
T cd05033         228 --------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK  264 (266)
T ss_pred             --------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence                    1122334678899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1e-41  Score=321.25  Aligned_cols=253  Identities=22%  Similarity=0.272  Sum_probs=199.7

Q ss_pred             CCCCCCeeeecCcEEEEEEEE----CCCCEEEEEEecccC---CcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCee
Q 015734           78 NFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  149 (401)
                      +|.+.+.||+|+||.||++..    .++..||+|++....   .....+.+..|+.++..+ +||||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478889999999999999885    357899999986421   223445678899999999 499999999999999999


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ++||||+++|+|.+++..    ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            999999999999998875    34588999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCcceeccccCCcccccccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          230 LVDAKLTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ..............||+.|+|||++.+.. ++.++|||||||++|||+||..||..........    ........    
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~----~~~~~~~~----  225 (332)
T cd05614         154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS----EVSRRILK----  225 (332)
T ss_pred             cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH----HHHHHHhc----
Confidence            65443333334457899999999987654 7889999999999999999999997433211111    11111111    


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM  351 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  351 (401)
                         .++.   .+......+.+++.+||+.||++||     ++++++++
T Consensus       226 ---~~~~---~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         226 ---CDPP---FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             ---CCCC---CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence               0111   1222345678899999999999999     67777664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=325.05  Aligned_cols=271  Identities=24%  Similarity=0.365  Sum_probs=227.4

Q ss_pred             HHHHHHHhcCCCCCCeeeecCcEEEEEEEECC-CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 015734           69 CRELQLATDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS  147 (401)
Q Consensus        69 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  147 (401)
                      .++++....+....++||-|.||.||.|.++. ...||||.+++.  ....++|++|..+|+.+.|||+|+++|+|....
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED--tMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep  336 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP  336 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc--chhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence            36777777788889999999999999999875 567999999863  345789999999999999999999999999999


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCC
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL  227 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl  227 (401)
                      .+|+|+|||..|+|.++|+...  ...++....+.++.||++||.||..+   ++|||||..+|+|+.++..+|++|||+
T Consensus       337 PFYIiTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGL  411 (1157)
T KOG4278|consen  337 PFYIITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGL  411 (1157)
T ss_pred             CeEEEEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccch
Confidence            9999999999999999999754  34577788899999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccC
Q 015734          228 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLRED  306 (401)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (401)
                      ++++..+.........-+..|.|||-+..+.++.|+|||+|||+|||+.| |..||.+.+..     +..+...+..   
T Consensus       412 sRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-----qVY~LLEkgy---  483 (1157)
T KOG4278|consen  412 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYGLLEKGY---  483 (1157)
T ss_pred             hhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-----HHHHHHhccc---
Confidence            99887766555544445778999999999999999999999999999998 88998764431     1112121111   


Q ss_pred             ccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCchhhhhh
Q 015734          307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAE  363 (401)
Q Consensus       307 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~~~~  363 (401)
                      +    +     ..+..+++.+++||+.||+++|.+||++.++.+.|+...-......
T Consensus       484 R----M-----~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSisd  531 (1157)
T KOG4278|consen  484 R----M-----DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSISD  531 (1157)
T ss_pred             c----c-----cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccccH
Confidence            1    1     1255677889999999999999999999999999987655544444

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=9.9e-42  Score=327.41  Aligned_cols=264  Identities=24%  Similarity=0.385  Sum_probs=208.8

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEECC------CCEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCcccceeeeee
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCT  144 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~  144 (401)
                      +....++|.+.+.||+|+||.||+|....      +..||+|++.........+.+.+|+++++++. ||||+++++++.
T Consensus        32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~  111 (400)
T cd05105          32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT  111 (400)
T ss_pred             eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence            44567889999999999999999998521      34699999975545555678999999999996 999999999999


Q ss_pred             cCCeeEEEEecccCCcHHHHhhhcCC------------------------------------------------------
Q 015734          145 TSSERILVYPFMQNLSVAYRLRDLKP------------------------------------------------------  170 (401)
Q Consensus       145 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------  170 (401)
                      ..+..++||||+++|+|.+++.....                                                      
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence            99999999999999999998865311                                                      


Q ss_pred             --------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCce
Q 015734          171 --------------------------------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI  212 (401)
Q Consensus       171 --------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Ni  212 (401)
                                                            ....+++..+..++.|++.||+|||+.   +++|+||||+||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Ni  268 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNV  268 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhE
Confidence                                                  013478888999999999999999998   999999999999


Q ss_pred             EEcCCCcEEEeecCCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhh
Q 015734          213 LLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEE  290 (401)
Q Consensus       213 ll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~  290 (401)
                      ++++++.+||+|||++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||....... 
T Consensus       269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-  347 (400)
T cd05105         269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-  347 (400)
T ss_pred             EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-
Confidence            9999999999999998865432221 2223346788999999988889999999999999999997 889986432111 


Q ss_pred             hhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          291 EDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                         ...    .......        ....+...+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus       348 ---~~~----~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~  396 (400)
T cd05105         348 ---TFY----NKIKSGY--------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES  396 (400)
T ss_pred             ---HHH----HHHhcCC--------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence               011    1111110        001122345678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.4e-41  Score=314.08  Aligned_cols=261  Identities=24%  Similarity=0.344  Sum_probs=195.5

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC--CCCEEEEEEecccC-CcchHHHHHHHHHHHHhc---cCCcccceeeeee-----c
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS--DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVA---IHKNLLQLIGYCT-----T  145 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~-----~  145 (401)
                      .+|.+.+.||+|+||.||+|...  ++..||+|.+.... .......+.+|+.+++.+   .||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36889999999999999999863  46789999886432 223344566777777655   6999999999885     2


Q ss_pred             CCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeec
Q 015734          146 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF  225 (401)
Q Consensus       146 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  225 (401)
                      ....++||||+. ++|.+++....  ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence            346799999996 58888887532  34588999999999999999999998   9999999999999999999999999


Q ss_pred             CCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhc-
Q 015734          226 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR-  304 (401)
Q Consensus       226 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-  304 (401)
                      |++......  .......||+.|+|||.+.+..++.++|||||||++|||++|.+||......+..     ..+..... 
T Consensus       155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~-----~~i~~~~~~  227 (290)
T cd07862         155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL-----GKILDVIGL  227 (290)
T ss_pred             cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH-----HHHHHHhCC
Confidence            999765433  2233456899999999998888999999999999999999999999764432111     11111100 


Q ss_pred             --cCccc-------hhccCcCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          305 --EDRLN-------DIVDRNLN----TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       305 --~~~~~-------~~~d~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                        .....       ..+.....    ...+.....+.+++.+||+.||++|||+.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence              00000       00000000    011223456789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=8.1e-42  Score=322.28  Aligned_cols=248  Identities=23%  Similarity=0.243  Sum_probs=201.8

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECC--CCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLSD--NTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI  150 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  150 (401)
                      ..++|.+.+.||+|+||.||+|..+.  +..||+|.+...  ........+.+|+.++..++||||+++++++.+.+..+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            44578999999999999999998543  368999988632  22344567889999999999999999999999999999


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      +||||+.+|+|.+++..    ...+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++..
T Consensus       108 lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            99999999999999876    34588999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccch
Q 015734          231 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND  310 (401)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ....    .....||+.|+|||++.+..++.++|||||||++|||++|..||.......     .   ........    
T Consensus       181 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~---~~~i~~~~----  244 (340)
T PTZ00426        181 VDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-----I---YQKILEGI----  244 (340)
T ss_pred             cCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-----H---HHHHhcCC----
Confidence            5432    233568999999999998889999999999999999999999997543211     1   11111110    


Q ss_pred             hccCcCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 015734          311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM  351 (401)
Q Consensus       311 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  351 (401)
                            ...+......+.+++.+||+.||.+|+     ++++++++
T Consensus       245 ------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        245 ------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             ------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                  001122234677899999999999995     88888765

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-42  Score=325.04  Aligned_cols=249  Identities=22%  Similarity=0.276  Sum_probs=210.2

Q ss_pred             cCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      .-|.+++.||.|+-|.|-+|++ .+|+.+|||++...  .++.....+.+|+-+|+.+.|||++.+++++.+..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            3477889999999999999994 57999999999743  34445667889999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++|.|.+++..    .++++..++.+++.||+.|+.|+|..   +|+||||||+|+|+|..+++||+|||+|..-..
T Consensus        92 Eyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP  164 (786)
T ss_pred             EecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence            99999999999986    56799999999999999999999998   999999999999999999999999999986544


Q ss_pred             CCcceeccccCCcccccccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      .  ......+|+|.|.+||++.+.+| +.++||||.|||||.|+||+.||+.+...     .+...++    .+.     
T Consensus       165 g--klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir-----~LLlKV~----~G~-----  228 (786)
T KOG0588|consen  165 G--KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR-----VLLLKVQ----RGV-----  228 (786)
T ss_pred             C--ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH-----HHHHHHH----cCc-----
Confidence            3  33455689999999999999987 67899999999999999999999843321     1111111    111     


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML  352 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  352 (401)
                          -..+...+.+..+|+.+|+..||++|.|++||+++-
T Consensus       229 ----f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  229 ----FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             ----ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence                112345566888999999999999999999998863

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-41  Score=325.35  Aligned_cols=262  Identities=21%  Similarity=0.246  Sum_probs=198.0

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ...+|.+.+.||+|+||.||++... +++.||+|...       ...+.+|++++++++||||+++++++......++++
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~  162 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL  162 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence            4467999999999999999999964 68899999643       234678999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      |++. ++|..++..    ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.....
T Consensus       163 e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~  234 (391)
T PHA03212        163 PRYK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD  234 (391)
T ss_pred             ecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence            9995 688877765    34588999999999999999999998   999999999999999999999999999975433


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchh---hhhhhHHHHHHHHhc-cC---
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE---EEDVLLLDHIRKLLR-ED---  306 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~-~~---  306 (401)
                      ..........||+.|+|||++.+..++.++|||||||++|||++|..|+-......   .....+...+...-. ..   
T Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~  314 (391)
T PHA03212        235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP  314 (391)
T ss_pred             ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence            32233344579999999999999899999999999999999999998764321100   000011111100000 00   


Q ss_pred             -----ccchhc---------cCcCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          307 -----RLNDIV---------DRNLNT---YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       307 -----~~~~~~---------d~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                           .+....         .+....   .....+.++.+++.+||+.||.+|||+++++++
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence                 000000         000000   011335678899999999999999999999753

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=7.7e-42  Score=322.29  Aligned_cols=263  Identities=26%  Similarity=0.424  Sum_probs=205.7

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeeec
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT  145 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  145 (401)
                      +++.++|.+.+.||+|+||.||+|...      +++.||+|++...........+.+|+.++.++ +|+||++++++|..
T Consensus         3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~   82 (337)
T cd05054           3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK   82 (337)
T ss_pred             ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence            445678999999999999999999632      24789999987544444556788999999999 79999999998865


Q ss_pred             C-CeeEEEEecccCCcHHHHhhhcCCC-----------------------------------------------------
Q 015734          146 S-SERILVYPFMQNLSVAYRLRDLKPG-----------------------------------------------------  171 (401)
Q Consensus       146 ~-~~~~lv~e~~~~gsL~~~l~~~~~~-----------------------------------------------------  171 (401)
                      . ...++++||+++++|.+++......                                                     
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence            4 5678999999999999988643210                                                     


Q ss_pred             ----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcc-eeccccCCc
Q 015734          172 ----EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTM  246 (401)
Q Consensus       172 ----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~  246 (401)
                          ..++++..+..++.|++.||+|||++   +++||||||+||++++++.++|+|||++......... ......++.
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                13689999999999999999999998   9999999999999999999999999999865432221 122334567


Q ss_pred             ccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHH
Q 015734          247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVE  325 (401)
Q Consensus       247 ~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  325 (401)
                      .|+|||++.+..++.++|||||||++|||++ |..||......+.    +..    ...... .       ...+.....
T Consensus       240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~----~~~----~~~~~~-~-------~~~~~~~~~  303 (337)
T cd05054         240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE----FCR----RLKEGT-R-------MRAPEYATP  303 (337)
T ss_pred             cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH----HHH----HHhccC-C-------CCCCccCCH
Confidence            8999999999999999999999999999998 9999865332111    111    111110 0       011223345


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          326 TMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       326 ~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ++.+++.+||+.+|++||++.+++++|+.
T Consensus       304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~  332 (337)
T cd05054         304 EIYSIMLDCWHNNPEDRPTFSELVEILGD  332 (337)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            78899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.2e-41  Score=307.10  Aligned_cols=262  Identities=21%  Similarity=0.329  Sum_probs=211.2

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecc--cCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQD--YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+..  .........+.+|+.+++.++|||++++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57889999999999999999964 689999998763  223344567889999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++++|.+++.........++...+..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999998876554455688999999999999999999998   999999999999999999999999999886543


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      .... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||......      ........ .....     
T Consensus       159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~------~~~~~~~~-~~~~~-----  225 (267)
T cd08228         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LFSLCQKI-EQCDY-----  225 (267)
T ss_pred             hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc------HHHHHHHH-hcCCC-----
Confidence            3221 22345788999999998888999999999999999999999998643221      11111111 11110     


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED  356 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  356 (401)
                      +..  ........+.+++.+||+.+|++||++.++++.|++..
T Consensus       226 ~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         226 PPL--PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             CCC--ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            000  12234567899999999999999999999999998654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.2e-41  Score=308.87  Aligned_cols=252  Identities=25%  Similarity=0.363  Sum_probs=203.3

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecc
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM  156 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  156 (401)
                      ++|.+.+.||+|+||+||++...++..+|+|.+...  ......+.+|+.++..++||||+++++++...+..+++|||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC--cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            467888999999999999999877778999988642  223567899999999999999999999999888899999999


Q ss_pred             cCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCc
Q 015734          157 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT  236 (401)
Q Consensus       157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  236 (401)
                      .+++|.+++...   ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||.++.......
T Consensus        82 ~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05113          82 SNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY  155 (256)
T ss_pred             CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence            999999998753   23589999999999999999999998   999999999999999999999999999876544322


Q ss_pred             ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCc
Q 015734          237 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN  315 (401)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  315 (401)
                      .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......     ....   .......       
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-----~~~~---~~~~~~~-------  220 (256)
T cd05113         156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-----TVEK---VSQGLRL-------  220 (256)
T ss_pred             eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-----HHHH---HhcCCCC-------
Confidence            22222335678999999988889999999999999999999 999986433211     1111   1111110       


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       316 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                        ..+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus       221 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         221 --YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence              011123467889999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.4e-41  Score=334.65  Aligned_cols=253  Identities=19%  Similarity=0.264  Sum_probs=204.4

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-C-CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-D-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      .|.+.+.||+|+||.||+|... + +..||+|.+.. ........+.+|+.+++.++||||+++++++...+..++||||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~-~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML-NDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc-CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            4888999999999999999853 3 57788887643 2334456778899999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +++|+|.+++........++++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+++......
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            999999998876444455789999999999999999999998   99999999999999999999999999998664432


Q ss_pred             c-ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccC
Q 015734          236 T-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR  314 (401)
Q Consensus       236 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  314 (401)
                      . .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......        ........         
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~--------~~~~~~~~---------  286 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE--------IMQQVLYG---------  286 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhC---------
Confidence            2 12334568999999999999899999999999999999999999997543211        11111111         


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          315 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       315 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .....+...+.++.+++..||+.+|++||++.+++..
T Consensus       287 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        287 KYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            1111122334578899999999999999999999753

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.8e-41  Score=318.77  Aligned_cols=243  Identities=22%  Similarity=0.276  Sum_probs=197.2

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCC
Q 015734           83 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL  159 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  159 (401)
                      +.||+|+||.||++..+ ++..||+|++....  .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999964 68999999997432  2344567889999999999999999999999999999999999999


Q ss_pred             cHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCccee
Q 015734          160 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT  239 (401)
Q Consensus       160 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  239 (401)
                      +|..++..    ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~  152 (328)
T cd05593          81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM  152 (328)
T ss_pred             CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence            99888865    34589999999999999999999999   99999999999999999999999999987533221 122


Q ss_pred             ccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCC
Q 015734          240 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTY  319 (401)
Q Consensus       240 ~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  319 (401)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||.......     .   ........       .   ..
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-----~---~~~~~~~~-------~---~~  214 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----L---FELILMED-------I---KF  214 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH-----H---HHHhccCC-------c---cC
Confidence            34568999999999998899999999999999999999999997543211     1   11111000       0   11


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 015734          320 DSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM  351 (401)
Q Consensus       320 ~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  351 (401)
                      +.....++.+++.+||+.||.+||     ++.+++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            223345788999999999999997     88998765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.9e-42  Score=299.77  Aligned_cols=263  Identities=24%  Similarity=0.278  Sum_probs=204.7

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecC--CeeEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERIL  151 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  151 (401)
                      .++|..++.|++|+||.||+|+++ +++.||+|+++-. ....-...-.+|+.+|.+.+|||||.+..+....  +..++
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            456888999999999999999965 6899999999732 2333445678999999999999999999887544  57899


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      |||||+. +|...+....   +++...+.+-++.|+++|++|||.+   .|+|||||++|+|++..|.+||+|||+++.+
T Consensus       155 VMe~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             eHHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhh
Confidence            9999976 8888888754   5788999999999999999999999   8999999999999999999999999999988


Q ss_pred             CCCCcceeccccCCcccccccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC---c
Q 015734          232 DAKLTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED---R  307 (401)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~  307 (401)
                      +..... .+..+-|..|.|||.+.+.+ |+.+.|+||+|||+.||+++++.|.+.+.-+.-..     +...+...   -
T Consensus       228 gsp~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~-----If~llGtPte~i  301 (419)
T KOG0663|consen  228 GSPLKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDK-----IFKLLGTPSEAI  301 (419)
T ss_pred             cCCccc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHH-----HHHHhCCCcccc
Confidence            876443 34456799999999988765 89999999999999999999999987654322211     11111110   0


Q ss_pred             cchhcc------CcCCC---------CCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          308 LNDIVD------RNLNT---------YDSK-EVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       308 ~~~~~d------~~~~~---------~~~~-~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      +..+..      -....         +... ..+.-++|+...+..||.+|.|+.+.+++
T Consensus       302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            110000      00111         1111 33566788889999999999999998664

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.3e-41  Score=321.39  Aligned_cols=265  Identities=20%  Similarity=0.345  Sum_probs=196.1

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCC-----eeE
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-----ERI  150 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  150 (401)
                      +|++.+.||+|+||.||+|..+ ++..||+|++.... .......+.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4788899999999999999964 68999999987432 2334457889999999999999999999875432     479


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      +||||+. ++|.+++..    ...+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            9999995 688888765    34589999999999999999999999   999999999999999999999999999975


Q ss_pred             cCCCCc--ceeccccCCccccccccccc--CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHH-------H
Q 015734          231 VDAKLT--HVTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH-------I  299 (401)
Q Consensus       231 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~-------~  299 (401)
                      ......  .......||+.|+|||++.+  ..++.++|||||||++|||+||+.||.......... ...+.       .
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~-~~~~~~~~~~~~~  231 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD-LITDLLGTPSPET  231 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHH-HHHHHhCCCCHHH
Confidence            432221  12234568999999999865  578999999999999999999999997543211100 00000       0


Q ss_pred             HHHhccCccchhc---cCcCCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          300 RKLLREDRLNDIV---DRNLNT----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       300 ~~~~~~~~~~~~~---d~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ............+   ......    ..+.....+.+++.+||+.||++|||+++++++
T Consensus       232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0000000000000   000000    011223567899999999999999999999764

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.5e-41  Score=322.76  Aligned_cols=250  Identities=20%  Similarity=0.307  Sum_probs=196.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      .++|...+.||+|+||.||+|... +++.||+|++...........+.+|+++++.++|+||+++++++...+..++|||
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  152 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE  152 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence            345677889999999999999965 6899999998754444556789999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++++|...        ...+...+..++.|++.||.|||++   +++||||||+|||+++++.+||+|||++......
T Consensus       153 ~~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        153 FMDGGSLEGT--------HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             cCCCCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            9999987542        2245677889999999999999998   9999999999999999999999999999865432


Q ss_pred             CcceeccccCCccccccccccc-----CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccc
Q 015734          235 LTHVTTQIRGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN  309 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      .. ......||..|+|||.+..     ...+.++|||||||++|||++|+.||......+.  .   .........    
T Consensus       222 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~---~~~~~~~~~----  291 (353)
T PLN00034        222 MD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW--A---SLMCAICMS----  291 (353)
T ss_pred             cc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH--H---HHHHHHhcc----
Confidence            21 1233468999999998743     2345689999999999999999999974322111  0   011110000    


Q ss_pred             hhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       310 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                           ...........++.+++.+||+.||++||++.+++++
T Consensus       292 -----~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        292 -----QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             -----CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 0011123345678899999999999999999999775

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.5e-41  Score=318.64  Aligned_cols=243  Identities=21%  Similarity=0.265  Sum_probs=196.3

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCC
Q 015734           83 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL  159 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  159 (401)
                      +.||+|+||.||++..+ +|..||+|.+....  .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999964 68999999987421  2334567788999999999999999999999999999999999999


Q ss_pred             cHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCccee
Q 015734          160 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT  239 (401)
Q Consensus       160 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  239 (401)
                      +|..++..    ...+++..++.++.|++.||+|||++   +++||||||+|||++.++.+||+|||++....... ...
T Consensus        81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~  152 (323)
T cd05595          81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM  152 (323)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence            99888875    34589999999999999999999999   99999999999999999999999999987532221 122


Q ss_pred             ccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCC
Q 015734          240 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTY  319 (401)
Q Consensus       240 ~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  319 (401)
                      ....||+.|+|||++.+..++.++|||||||++|||++|..||...+...     .   ........       .   ..
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-----~---~~~~~~~~-------~---~~  214 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----L---FELILMEE-------I---RF  214 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-----H---HHHHhcCC-------C---CC
Confidence            33568999999999999899999999999999999999999997543211     1   11111000       0   11


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 015734          320 DSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM  351 (401)
Q Consensus       320 ~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  351 (401)
                      +.....++.+++..||+.||.+||     ++.+++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            223345788999999999999998     78888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-42  Score=311.57  Aligned_cols=250  Identities=19%  Similarity=0.315  Sum_probs=211.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEE-ECCCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      ..+|.+.+.||+|.||.|-++. ...|+.||||.+++.  .++.+.-.+.+|+++|+.++||||+.++.+|.+.+...+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            4568888999999999999999 478999999998743  3455566789999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||..+|.|.+++..    .+.+++.+++.+++||.+|+.|+|.+   +++|||||.+|||+|.|+++||+|||++..+.
T Consensus       132 MEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  132 MEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence            999999999999987    34599999999999999999999999   99999999999999999999999999998775


Q ss_pred             CCCcceeccccCCcccccccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ..  ...+.++|+|-|.+||++++.+| ++..|.||||++||.|..|.-||++.+...        .++.+- .+...  
T Consensus       205 ~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~--------lvrQIs-~GaYr--  271 (668)
T KOG0611|consen  205 DK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR--------LVRQIS-RGAYR--  271 (668)
T ss_pred             cc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH--------HHHHhh-ccccc--
Confidence            43  34566899999999999999987 678999999999999999999999755421        122111 11111  


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                              .+..+.+..-||++||-.||++|.|+.+|..+..
T Consensus       272 --------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  272 --------EPETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             --------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence                    1222335678899999999999999999988754

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-41  Score=316.65  Aligned_cols=243  Identities=24%  Similarity=0.274  Sum_probs=195.0

Q ss_pred             eeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCCcH
Q 015734           85 IGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV  161 (401)
Q Consensus        85 lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  161 (401)
                      ||+|+||.||+|... ++..||+|.+...  ........+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999965 5789999998642  2334556788999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcceecc
Q 015734          162 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ  241 (401)
Q Consensus       162 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  241 (401)
                      .+++..    ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.++|+|||+++...... .....
T Consensus        81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~  152 (312)
T cd05585          81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT  152 (312)
T ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence            998875    34589999999999999999999998   99999999999999999999999999987543222 22334


Q ss_pred             ccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCH
Q 015734          242 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS  321 (401)
Q Consensus       242 ~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  321 (401)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|..||......        ..........          ...+.
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~--------~~~~~~~~~~----------~~~~~  214 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN--------EMYRKILQEP----------LRFPD  214 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH--------HHHHHHHcCC----------CCCCC
Confidence            56899999999999999999999999999999999999999754321        1112111111          01122


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          322 KEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       322 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                      ....++.+++.+||+.||.+||++..+.+.|.
T Consensus       215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            33457889999999999999986544433333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.1e-41  Score=313.85  Aligned_cols=257  Identities=23%  Similarity=0.321  Sum_probs=204.0

Q ss_pred             CCCCCCeeeecCcEEEEEEEECC------CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           78 NFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      +|.+.+.||+|+||.||+|...+      +..||+|++...........+.+|+.++..++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            46677889999999999998532      468999998754444445678899999999999999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCc
Q 015734          152 VYPFMQNLSVAYRLRDLK------------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE  219 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~  219 (401)
                      ++||+.+++|.+++....            .....+++..+..++.|++.||.|||++   +++||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence            999999999999985321            1123588889999999999999999998   9999999999999999999


Q ss_pred             EEEeecCCccccCCCCc-ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHH
Q 015734          220 AVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLD  297 (401)
Q Consensus       220 ~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~  297 (401)
                      +||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......        +
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--------~  234 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--------D  234 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--------H
Confidence            99999999876533221 12233445789999999988889999999999999999998 77888643221        1


Q ss_pred             HHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          298 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       298 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ...... .        ......+...+..+.+++.+||+.+|.+||+++++++.|+.
T Consensus       235 ~~~~i~-~--------~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         235 VIEMIR-N--------RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHH-c--------CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            111111 1        11112233455678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.6e-41  Score=316.27  Aligned_cols=256  Identities=24%  Similarity=0.381  Sum_probs=203.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCC----EEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI  150 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  150 (401)
                      ..+|+..+.||+|+||.||+|.+. ++.    .||+|.+...........+.+|+.+++.++||||++++++|... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            457899999999999999999853 333    48999987544555667899999999999999999999998764 567


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      ++++|+++|+|.+++...   ...+++.....++.|++.||+|||++   +++||||||+||++++++.+||+|||+++.
T Consensus        85 ~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          85 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             eeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence            999999999999998863   23588899999999999999999998   999999999999999999999999999986


Q ss_pred             cCCCCccee-ccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          231 VDAKLTHVT-TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       231 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ......... ....++..|+|||.+.+..++.++||||||+++|||++ |..||.......     ...    .......
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-----~~~----~~~~~~~  229 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISS----ILEKGER  229 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-----HHH----HHhCCCC
Confidence            654332221 22234678999999999999999999999999999998 999987532211     111    1111100


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                              ...+.....++.+++..||+.+|.+||++.+++..|...
T Consensus       230 --------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~  268 (316)
T cd05108         230 --------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  268 (316)
T ss_pred             --------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                    011122345688999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-41  Score=306.02  Aligned_cols=251  Identities=24%  Similarity=0.355  Sum_probs=202.1

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecc
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM  156 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  156 (401)
                      .+|++.+.||+|+||.||++.++++..+|+|.+...  ......+.+|+++++.++|||++++++++...+..++++||+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG--AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM   81 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC--CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence            357888999999999999999877788999988642  223457889999999999999999999999999999999999


Q ss_pred             cCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCc
Q 015734          157 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT  236 (401)
Q Consensus       157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  236 (401)
                      ++++|.+++...   ...+++.....++.|++.||+|||+.   +++|+||||+||++++++.+||+|||+++.......
T Consensus        82 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~  155 (256)
T cd05059          82 ANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY  155 (256)
T ss_pred             CCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence            999999998753   23589999999999999999999999   999999999999999999999999999876543322


Q ss_pred             ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCc
Q 015734          237 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN  315 (401)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  315 (401)
                      .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+     ..   ........      . 
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~---~~~~~~~~------~-  220 (256)
T cd05059         156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-----VV---ESVSAGYR------L-  220 (256)
T ss_pred             cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-----HH---HHHHcCCc------C-
Confidence            22222223457999999998899999999999999999999 788887533211     11   11110000      0 


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 015734          316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML  352 (401)
Q Consensus       316 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  352 (401)
                        ..+...+.++.+++.+||+.+|++|||+.++++.|
T Consensus       221 --~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         221 --YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence              11222455788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=6.6e-41  Score=302.80  Aligned_cols=248  Identities=28%  Similarity=0.434  Sum_probs=200.7

Q ss_pred             CeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCCcHH
Q 015734           83 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVA  162 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  162 (401)
                      ++||+|+||.||+|...++..+|+|.+...........+.+|+++++.++|||++++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988889999999876544445567899999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcceeccc
Q 015734          163 YRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI  242 (401)
Q Consensus       163 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~  242 (401)
                      +++...   ...+++..+..++.+++.||.|||+.   +++|+||||+||++++++.++|+|||++..............
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (250)
T cd05085          81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK  154 (250)
T ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence            988652   23578999999999999999999998   999999999999999999999999999875443322222222


Q ss_pred             cCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCH
Q 015734          243 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS  321 (401)
Q Consensus       243 ~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  321 (401)
                      .++..|+|||++.+..++.++||||||+++|++++ |..||.......     ....+.   .....         ..+.
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-----~~~~~~---~~~~~---------~~~~  217 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-----AREQVE---KGYRM---------SCPQ  217 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-----HHHHHH---cCCCC---------CCCC
Confidence            34668999999998889999999999999999998 999987543211     111111   11000         1122


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          322 KEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       322 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                      ..+.++.+++.+||+.+|++||++.++++.|.
T Consensus       218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            23467889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.1e-41  Score=316.57  Aligned_cols=252  Identities=23%  Similarity=0.297  Sum_probs=196.5

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCeeEEEEecccC
Q 015734           83 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN  158 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  158 (401)
                      ++||+|+||.||++..+ ++..||+|+++...  .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999965 58899999997422  233456688899999888 699999999999999999999999999


Q ss_pred             CcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcce
Q 015734          159 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV  238 (401)
Q Consensus       159 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  238 (401)
                      ++|..++..    ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++...... ...
T Consensus        81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~  152 (329)
T cd05588          81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDT  152 (329)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCc
Confidence            999888865    34589999999999999999999999   9999999999999999999999999998743221 112


Q ss_pred             eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCC
Q 015734          239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT  318 (401)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  318 (401)
                      .....||+.|+|||++.+..++.++|+|||||++|+|++|+.||+.............++..........         .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------~  223 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI---------R  223 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC---------C
Confidence            2345689999999999999999999999999999999999999974332211111111122211111110         1


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCC------HHHHHHH
Q 015734          319 YDSKEVETMVQVALLCTQSTPEDRPP------MAQVVKM  351 (401)
Q Consensus       319 ~~~~~~~~l~~l~~~cl~~~p~~RPs------~~~vl~~  351 (401)
                      .+.....++.+++.+||+.||.+||+      +.+++++
T Consensus       224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            12223456888999999999999997      5676543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.8e-41  Score=306.32  Aligned_cols=256  Identities=28%  Similarity=0.423  Sum_probs=206.4

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      +..++|.+.++||+|+||.||+|..+++..||+|.+...  ......+.+|+.+++.++|+|++++++++. .+..++++
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG--SMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT   79 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCC--CCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence            456789999999999999999999888999999998643  234567899999999999999999998864 45689999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+.+++|.+++....  ...+++.....++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++.....
T Consensus        80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05067          80 EYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED  154 (260)
T ss_pred             EcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence            9999999999887532  34688999999999999999999998   999999999999999999999999999976653


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ..........++..|+|||.+....++.++||||||+++|||++ |..||.......     .   ..........    
T Consensus       155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~---~~~~~~~~~~----  222 (260)
T cd05067         155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-----V---IQNLERGYRM----  222 (260)
T ss_pred             CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-----H---HHHHHcCCCC----
Confidence            32222223345678999999988889999999999999999999 999997543211     1   1111111000    


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                           ..+...+.++.+++.+||+.+|++||+++++++.|+.
T Consensus       223 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         223 -----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                 1112234578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.7e-41  Score=306.34  Aligned_cols=256  Identities=29%  Similarity=0.432  Sum_probs=205.3

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      +..++|++.+.||+|+||.||+|...++..+|+|.+....  ...+.+.+|+.++++++|+|++++++++. .+..+++|
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~   79 (260)
T cd05070           3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT--MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT   79 (260)
T ss_pred             CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC--CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence            3456789999999999999999998888889999987532  23467899999999999999999999875 45678999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++++|.+++....  ...+++..+..++.+++.||+|||+.   +++|+||||+||++++++.++|+|||++.....
T Consensus        80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05070          80 EYMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIED  154 (260)
T ss_pred             EecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence            9999999999987532  34589999999999999999999998   999999999999999999999999999986544


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ..........++..|+|||.+.+..++.++||||||+++|+|++ |..||......+     ..+.   ......     
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-----~~~~---~~~~~~-----  221 (260)
T cd05070         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE-----VLEQ---VERGYR-----  221 (260)
T ss_pred             cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHH---HHcCCC-----
Confidence            33222222335668999999988889999999999999999999 888886432211     1111   111000     


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                          ...+...+..+.+++.+||+.+|++|||+.++.+.|++
T Consensus       222 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         222 ----MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ----CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                01123345678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.6e-41  Score=309.21  Aligned_cols=248  Identities=24%  Similarity=0.331  Sum_probs=196.7

Q ss_pred             eeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCCcH
Q 015734           85 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV  161 (401)
Q Consensus        85 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  161 (401)
                      ||+|+||+||++... +++.||+|.+....  .....+.+..|+++++.++|+|++++.+++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999964 68899999986422  122345678899999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcceecc
Q 015734          162 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ  241 (401)
Q Consensus       162 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  241 (401)
                      ...+.........+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++........ ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence            988865444456789999999999999999999998   999999999999999999999999999876543322 2233


Q ss_pred             ccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCH
Q 015734          242 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS  321 (401)
Q Consensus       242 ~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  321 (401)
                      ..||+.|+|||.+.+..++.++|||||||++|+|++|+.||..........    .......         ... ...+.
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~----~~~~~~~---------~~~-~~~~~  222 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK----ELKQRIL---------NDS-VTYPD  222 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH----HHHHhhc---------ccC-CCCcc
Confidence            468999999999999999999999999999999999999997543211100    0011110         000 11223


Q ss_pred             HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 015734          322 KEVETMVQVALLCTQSTPEDRP-----PMAQVVK  350 (401)
Q Consensus       322 ~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~  350 (401)
                      ..+..+.+++.+||+.||++||     +++++++
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            4456788999999999999999     5566654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.6e-41  Score=308.85  Aligned_cols=256  Identities=30%  Similarity=0.453  Sum_probs=209.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      +..+|++.+.||.|+||.||+|...++..+++|.+... .......+.+|+.+++.++|||++++++++...+..+++||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD-DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEecccc-chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            44578889999999999999999888999999998643 22345678899999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++++|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||||+||++++++.+||+|||.+......
T Consensus        83 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~  157 (261)
T cd05148          83 LMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED  157 (261)
T ss_pred             ecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence            999999999998643  34589999999999999999999998   9999999999999999999999999999766443


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      ... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+     ......   ....      
T Consensus       158 ~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~-----~~~~~~---~~~~------  222 (261)
T cd05148         158 VYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE-----VYDQIT---AGYR------  222 (261)
T ss_pred             ccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH-----HHHHHH---hCCc------
Confidence            222 223345678999999988889999999999999999998 889986543211     111111   1100      


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                         ...+...+..+.+++.+||+.+|.+|||++++++.|++
T Consensus       223 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         223 ---MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence               01123345678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-41  Score=310.71  Aligned_cols=260  Identities=23%  Similarity=0.378  Sum_probs=208.2

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEECC------CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS  147 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  147 (401)
                      +..++|.+.+.||+|+||.||+|..++      +..||+|.+...........+.+|+.++..++|||++++++++....
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            345688899999999999999998642      36899999875444455678889999999999999999999999999


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEE
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPG------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV  221 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~k  221 (401)
                      ..+++|||+++++|.+++......      ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+|
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence            999999999999999998754321      23478899999999999999999998   999999999999999999999


Q ss_pred             EeecCCccccCCCCc-ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHH
Q 015734          222 LCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHI  299 (401)
Q Consensus       222 l~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~  299 (401)
                      |+|||+++....... .......++..|+|||.+.+..++.++|||||||++||++| |..||.......     .....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-----~~~~~  234 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-----VLKFV  234 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-----HHHHH
Confidence            999999875543321 12223346788999999988889999999999999999998 889986433211     11111


Q ss_pred             HHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          300 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       300 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                          ....        ....+...+.++.+++..||+.+|++|||+.++++.|+
T Consensus       235 ----~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         235 ----IDGG--------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             ----hcCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence                1111        11112223567889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5.3e-41  Score=315.74  Aligned_cols=246  Identities=23%  Similarity=0.294  Sum_probs=192.0

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCeeEEEEecccC
Q 015734           83 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN  158 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  158 (401)
                      +.||+|+||.||++..+ +++.||+|.+....  .......+..|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 57899999987432  233455678888888776 799999999999999999999999999


Q ss_pred             CcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcce
Q 015734          159 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV  238 (401)
Q Consensus       159 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  238 (401)
                      ++|..++..    ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++....... ..
T Consensus        81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~  152 (329)
T cd05618          81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT  152 (329)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cc
Confidence            999888765    34589999999999999999999999   99999999999999999999999999987532221 12


Q ss_pred             eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCC
Q 015734          239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT  318 (401)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  318 (401)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||...............+..........         .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------~  223 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------R  223 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC---------C
Confidence            2345689999999999999999999999999999999999999964322111111111112111111110         1


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCH
Q 015734          319 YDSKEVETMVQVALLCTQSTPEDRPPM  345 (401)
Q Consensus       319 ~~~~~~~~l~~l~~~cl~~~p~~RPs~  345 (401)
                      .+.....++.+++.+||+.||.+||++
T Consensus       224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         224 IPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            222334567899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.9e-41  Score=321.44  Aligned_cols=266  Identities=23%  Similarity=0.295  Sum_probs=199.5

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCC-----eeE
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-----ERI  150 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  150 (401)
                      +|+..+.||+|+||.||++... +++.||+|++.... .......+.+|+.+++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4778899999999999999964 68999999986432 2334567889999999999999999999998776     789


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      +|+||+. ++|.+.+..    ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++..
T Consensus        81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence            9999996 577777654    34689999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCcceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhH--------------
Q 015734          231 VDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL--------------  295 (401)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~--------------  295 (401)
                      .............+++.|+|||.+.+. .++.++|||||||++|||++|+.||.............              
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            544333333344578999999998774 47899999999999999999999997654321110000              


Q ss_pred             HHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          296 LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       296 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..............................++.+++.+||+.||.+|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            00000000000000000000001112235678899999999999999999999875

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.2e-41  Score=315.13  Aligned_cols=243  Identities=25%  Similarity=0.299  Sum_probs=195.5

Q ss_pred             CeeeecCcEEEEEEEE----CCCCEEEEEEeccc---CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           83 NIIGQGGFGKVYKGVL----SDNTKVAVKRLQDY---YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      +.||+|+||.||++..    .+++.||+|.+...   ........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999985    35789999998642   1223345678899999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +.+++|.+++..    ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++......
T Consensus        82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            999999998875    34578888999999999999999998   99999999999999999999999999987443222


Q ss_pred             cceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCc
Q 015734          236 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN  315 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  315 (401)
                       .......||+.|+|||++.+..++.++|||||||++|||++|..||.......        ........ .        
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~--------~~~~~~~~-~--------  216 (323)
T cd05584         155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK--------TIDKILKG-K--------  216 (323)
T ss_pred             -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcC-C--------
Confidence             12233568999999999998889999999999999999999999997543211        11111111 0        


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 015734          316 LNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM  351 (401)
Q Consensus       316 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  351 (401)
                       ...+.....++.+++.+||+.+|++||     ++.+++++
T Consensus       217 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         217 -LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             -CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence             011222345788999999999999999     78888664

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.1e-41  Score=313.39  Aligned_cols=263  Identities=28%  Similarity=0.418  Sum_probs=209.9

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEECC------CCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeee
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT  144 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  144 (401)
                      +.+..++|+..+.||+|+||.||++....      ...+|+|.+...........+.+|++++.++ +|+|++++++++.
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            45566788999999999999999998632      3679999987554555566789999999999 7999999999999


Q ss_pred             cCCeeEEEEecccCCcHHHHhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCce
Q 015734          145 TSSERILVYPFMQNLSVAYRLRDLK------------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI  212 (401)
Q Consensus       145 ~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Ni  212 (401)
                      ..+..+++|||+++++|..++....            .....+++..+..++.|++.||+|||+.   +++|+||||+||
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni  163 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV  163 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence            9999999999999999999987532            2245689999999999999999999998   999999999999


Q ss_pred             EEcCCCcEEEeecCCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhh
Q 015734          213 LLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEE  290 (401)
Q Consensus       213 ll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~  290 (401)
                      ++++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... 
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-  242 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-  242 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-
Confidence            9999999999999999865443221 1222235678999999988889999999999999999998 888886433211 


Q ss_pred             hhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          291 EDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                          .   .. ......        ....+......+.+++.+||+.+|++|||+.++++.|+.
T Consensus       243 ----~---~~-~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~  290 (293)
T cd05053         243 ----L---FK-LLKEGY--------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR  290 (293)
T ss_pred             ----H---HH-HHHcCC--------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence                1   11 111110        011122335578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.5e-41  Score=305.67  Aligned_cols=255  Identities=27%  Similarity=0.392  Sum_probs=204.4

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      ..++|.+.+.||+|+||.||+|.++++..||+|.+....  .....+.+|+++++.++|||++++++++.. ...+++||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e   80 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE   80 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc--cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence            346799999999999999999998777789999987422  234678999999999999999999988754 55799999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++++|.+++....  ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||.+......
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          81 YMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             cCCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            999999999997532  34578999999999999999999998   9999999999999999999999999999766543


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      .........++..|+|||+..+..++.++||||||+++|+|+| |..||.......     ..   .......       
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-----~~---~~~~~~~-------  220 (262)
T cd05071         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VL---DQVERGY-------  220 (262)
T ss_pred             ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-----HH---HHHhcCC-------
Confidence            3222223345678999999988889999999999999999999 788886443211     11   1111000       


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                        ........+..+.+++.+||+.+|.+||+++++++.|+.
T Consensus       221 --~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         221 --RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             --CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence              011223455678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-41  Score=308.08  Aligned_cols=265  Identities=29%  Similarity=0.411  Sum_probs=197.3

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHh--ccCCcccceeeeeecCC----eeE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISV--AIHKNLLQLIGYCTTSS----ERI  150 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~~~  150 (401)
                      ...+..+++|+|.||.||+|.+ +++.||||++..    ...+.|.+|-++.+.  +.|+||+++++.-....    ++.
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc-cCceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            3456678899999999999999 569999999853    567788888888774  67999999999876555    789


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeEEeCCCCCceEEcCCCcEEEee
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ------CNPKIIHRDLKAANILLDDNFEAVLCD  224 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------~~~~i~H~dlkp~Nill~~~~~~kl~D  224 (401)
                      +|++|.+.|+|.++|...     .++|....+++..+++||+|||+.      .+++|+|||||+.|||+.+|+++.|+|
T Consensus       285 LVt~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             EEeeeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence            999999999999999863     489999999999999999999964      357899999999999999999999999


Q ss_pred             cCCccccCCCCcc-eeccccCCcccccccccccCC-C-----CcccchhHHHHHHHHHHhCCCCCCCCcch--------h
Q 015734          225 FGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGK-S-----SEKTDVFGYGITLLELVTGQRAIDFSRLE--------E  289 (401)
Q Consensus       225 fgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~-----~~~sDi~slG~ll~elltg~~p~~~~~~~--------~  289 (401)
                      ||++..+...... .....+||.+|||||++.+.- .     -.+.||||+|.++|||++...-++.....        +
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e  439 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE  439 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence            9999877543322 233367999999999997643 2     23689999999999999966544311110        0


Q ss_pred             hhhhhHHHHHHHHhccCcc-chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          290 EEDVLLLDHIRKLLREDRL-NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ....=..+.++..+-.++. +.+.+. ..  .-..+.-+.+.+..||..||+.|.|+.=+-+++..
T Consensus       440 vG~hPt~e~mq~~VV~kK~RP~~p~~-W~--~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~  502 (534)
T KOG3653|consen  440 VGNHPTLEEMQELVVRKKQRPKIPDA-WR--KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAE  502 (534)
T ss_pred             hcCCCCHHHHHHHHHhhccCCCChhh-hh--cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHH
Confidence            0000011222222211111 111111 11  11345678899999999999999999888766543

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-41  Score=321.74  Aligned_cols=254  Identities=22%  Similarity=0.261  Sum_probs=204.9

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ++|.+.+.||+|+||+||+|... +++.||+|++....  .......+..|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46888999999999999999965 68999999987421  2245567889999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            999999999998863    4589999999999999999999998   999999999999999999999999999886544


Q ss_pred             CC----------------------------cceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCC
Q 015734          234 KL----------------------------THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS  285 (401)
Q Consensus       234 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~  285 (401)
                      ..                            ........||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            32                            11223346899999999999999999999999999999999999999754


Q ss_pred             cchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHh
Q 015734          286 RLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-MAQVVKML  352 (401)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~~vl~~L  352 (401)
                      ....        ..........  ..   ..+. ....+.++.+++..|++ +|.+||+ +++++++.
T Consensus       234 ~~~~--------~~~~i~~~~~--~~---~~p~-~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp  286 (350)
T cd05573         234 TLQE--------TYNKIINWKE--SL---RFPP-DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP  286 (350)
T ss_pred             CHHH--------HHHHHhccCC--cc---cCCC-CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence            4211        1111111000  00   0000 11135678889999997 9999999 99998763

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.6e-40  Score=303.04  Aligned_cols=260  Identities=22%  Similarity=0.340  Sum_probs=211.9

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecc--cCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQD--YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ++|.+.+.||+|+||.||+|... +++.||+|.++.  .........+.+|++++++++|+|++++++++...+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57889999999999999999976 789999998863  223334678899999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++++|..++.........+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999999987655556689999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      .... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||......      ..+..... ...       
T Consensus       159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~-------  223 (267)
T cd08224         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKI-EKC-------  223 (267)
T ss_pred             CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc------HHHHHhhh-hcC-------
Confidence            3221 22345788999999998888999999999999999999999998643311      11111111 011       


Q ss_pred             CcCCCCC-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          314 RNLNTYD-SKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       314 ~~~~~~~-~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                       .....+ ......+.+++.+||+.+|++|||+.++++.|+..
T Consensus       224 -~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         224 -DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             -CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence             111111 24456788999999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=5.3e-41  Score=309.26  Aligned_cols=258  Identities=24%  Similarity=0.391  Sum_probs=204.5

Q ss_pred             cCCCCCCeeeecCcEEEEEEEE-----CCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      ++|++.+.||+|+||.||+|..     .++..+++|.+...........+.+|+.+++.++|||++++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4677889999999999999984     24578999998754444455788999999999999999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC
Q 015734          152 VYPFMQNLSVAYRLRDLKP-------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF  218 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~  218 (401)
                      +|||+++++|.+++.....             ....+++.....++.|++.||+|||++   +++|+||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence            9999999999998863221             123478889999999999999999998   999999999999999999


Q ss_pred             cEEEeecCCccccCCCCc-ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHH
Q 015734          219 EAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLL  296 (401)
Q Consensus       219 ~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~  296 (401)
                      .+||+|||++........ .......++..|+|||++.+..++.++|+||||+++|||++ |..||......     ...
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~-----~~~  236 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-----EVI  236 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-----HHH
Confidence            999999999976533221 12233345678999999988889999999999999999999 88888643221     111


Q ss_pred             HHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          297 DHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       297 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ..+.    ....        ...+...+.++.+++.+||+.+|.+||++.++.++|..
T Consensus       237 ~~~~----~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         237 EMVR----KRQL--------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHH----cCCc--------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            1111    1111        11122334578899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=7.6e-41  Score=302.83  Aligned_cols=248  Identities=28%  Similarity=0.403  Sum_probs=198.2

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCCcH
Q 015734           83 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV  161 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  161 (401)
                      +.||+|+||.||+|... +++.||+|.............+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46899999999999964 68899999886544555667899999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCccee-c
Q 015734          162 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT-T  240 (401)
Q Consensus       162 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~-~  240 (401)
                      .+++...   ...+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++........... .
T Consensus        81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            9998742   34588999999999999999999998   999999999999999999999999999875433211111 1


Q ss_pred             cccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCC
Q 015734          241 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTY  319 (401)
Q Consensus       241 ~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  319 (401)
                      ....+..|+|||.+.+..++.++||||||+++|||++ |..||.......         .........        ....
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---------~~~~~~~~~--------~~~~  217 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---------TREAIEQGV--------RLPC  217 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---------HHHHHHcCC--------CCCC
Confidence            1123457999999998889999999999999999998 888886432211         111111000        0011


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          320 DSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       320 ~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                      +...+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            2233567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.3e-41  Score=309.33  Aligned_cols=262  Identities=25%  Similarity=0.403  Sum_probs=210.0

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEECC-----CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeec-CC
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVLSD-----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SS  147 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~  147 (401)
                      +..++|.+.+.||+|+||.||+|...+     +..|++|++...........+.+|+.+++.++|||++++++++.. ..
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            456789999999999999999999755     688999998765556667788999999999999999999998766 46


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEe
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGE----KGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLC  223 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~  223 (401)
                      ..+++++|+.+++|.+++.......    ..+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence            7789999999999999987643321    5689999999999999999999998   99999999999999999999999


Q ss_pred             ecCCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHH
Q 015734          224 DFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRK  301 (401)
Q Consensus       224 Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  301 (401)
                      |||+++.+...... ......++..|+|||++.+..++.++||||||+++||+++ |..||......+     ...... 
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~-  233 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-----MAAYLK-  233 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-----HHHHHH-
Confidence            99999865433222 1222345678999999988889999999999999999999 999987533211     111111 


Q ss_pred             HhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          302 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       302 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                        .....         ......+.++.+++.+||+.+|++|||+.++++.|+..
T Consensus       234 --~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         234 --DGYRL---------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             --cCCCC---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence              11000         11122345788999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.4e-40  Score=308.40  Aligned_cols=265  Identities=24%  Similarity=0.376  Sum_probs=207.7

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC-----------------CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccc
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSD-----------------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ  138 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~  138 (401)
                      ..+|.+.+.||+|+||.||++...+                 +..||+|.+...........+.+|++++.+++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4678999999999999999988542                 24589999876555556778999999999999999999


Q ss_pred             eeeeeecCCeeEEEEecccCCcHHHHhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCc
Q 015734          139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP-------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN  211 (401)
Q Consensus       139 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N  211 (401)
                      +++++...+..++++|++++++|.+++.....       ....+++..+..++.|++.||+|||+.   +++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence            99999999999999999999999999976431       123589999999999999999999998   99999999999


Q ss_pred             eEEcCCCcEEEeecCCccccCCCCc-ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh--CCCCCCCCcch
Q 015734          212 ILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT--GQRAIDFSRLE  288 (401)
Q Consensus       212 ill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt--g~~p~~~~~~~  288 (401)
                      |++++++.++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999875543322 12233446778999999988889999999999999999998  56676532211


Q ss_pred             hhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          289 EEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                           ...................     ..+...+.++.+++.+||+.+|.+|||+.++++.|+
T Consensus       241 -----~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 -----QVIENAGHFFRDDGRQIYL-----PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             -----HHHHHHHhccccccccccC-----CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence                 1112222111111111111     112233467999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.5e-42  Score=304.55  Aligned_cols=258  Identities=22%  Similarity=0.345  Sum_probs=199.5

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCC-----eeEE
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-----ERIL  151 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~l  151 (401)
                      .|...+++|.|+||.||.|... ++..||||+.-....     .-.+|+.+|+.++|||||+++.++....     ...+
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            3566789999999999999954 578999998854222     1237999999999999999998875433     2358


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCC-CcEEEeecCCccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKL  230 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfgl~~~  230 (401)
                      ||||++. +|...++.+...+..++.-.++-++.|+.+||+|||+.   +|+||||||.|+|+|.+ |.+||||||.|+.
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            9999976 99999998766677899999999999999999999998   99999999999999976 8999999999998


Q ss_pred             cCCCCcceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccc
Q 015734          231 VDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN  309 (401)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      +.........  .-|..|+|||.+.+. .|+.+.||||.||++.||+-|++.|.+.+..+.    +...+ +.+......
T Consensus       176 L~~~epniSY--icSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ----L~eIi-k~lG~Pt~e  248 (364)
T KOG0658|consen  176 LVKGEPNISY--ICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ----LVEII-KVLGTPTRE  248 (364)
T ss_pred             eccCCCceeE--EEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH----HHHHH-HHhCCCCHH
Confidence            7665544333  357899999998765 599999999999999999999999987554322    22111 121111111


Q ss_pred             h----------hccCcCCC------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          310 D----------IVDRNLNT------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       310 ~----------~~d~~~~~------~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      +          ...+.+..      .......+..+++.++++.+|.+|.++.+++.+
T Consensus       249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence            1          11111111      233456788999999999999999999999764

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.8e-41  Score=310.35  Aligned_cols=263  Identities=22%  Similarity=0.383  Sum_probs=206.4

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEECC------CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecC
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS  146 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  146 (401)
                      ++..++|++.+.||+|+||.||+|..++      +..||+|.+...........+.+|+.+++.++|||++++++++...
T Consensus         2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            3457789999999999999999997532      4579999886544444455788999999999999999999999999


Q ss_pred             CeeEEEEecccCCcHHHHhhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcE
Q 015734          147 SERILVYPFMQNLSVAYRLRDLKPG------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA  220 (401)
Q Consensus       147 ~~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~  220 (401)
                      +..+++|||+++|+|.+++......      ....++..+..++.|++.||.|||++   +++|+||||+||++++++.+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~  158 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence            9999999999999999999764321      23456778899999999999999998   99999999999999999999


Q ss_pred             EEeecCCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHH
Q 015734          221 VLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDH  298 (401)
Q Consensus       221 kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~  298 (401)
                      +|+|||+++........ ......++..|+|||.+.+..++.++|+|||||++|||++ |..||......+     .   
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-----~---  230 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-----V---  230 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-----H---
Confidence            99999998755432221 1122235678999999988889999999999999999999 778886433211     1   


Q ss_pred             HHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          299 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       299 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                      ........         ....+...+..+.+++.+||+.+|++|||+.++++.|+..
T Consensus       231 ~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         231 LKFVMDGG---------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            11111111         1111122346799999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=8.2e-41  Score=320.78  Aligned_cols=253  Identities=20%  Similarity=0.222  Sum_probs=196.7

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      .|...+.||+|+||+||+|... ++..||+|++...  ........+.+|++++..++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788899999999999999864 5789999998642  223345678999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++++||+|||++......
T Consensus        82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            9999999999875    34588899999999999999999998   9999999999999999999999999997533110


Q ss_pred             Cc----------------------------------------------ceeccccCCcccccccccccCCCCcccchhHH
Q 015734          235 LT----------------------------------------------HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGY  268 (401)
Q Consensus       235 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  268 (401)
                      ..                                              .......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            00                                              00123468999999999998889999999999


Q ss_pred             HHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHH--cccCCCCCCCCHH
Q 015734          269 GITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALL--CTQSTPEDRPPMA  346 (401)
Q Consensus       269 G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~--cl~~~p~~RPs~~  346 (401)
                      ||++|||+||..||......+..        ..........     ..+ .......++.+++.+  |+..+|..||++.
T Consensus       235 G~il~elltG~~Pf~~~~~~~~~--------~~i~~~~~~~-----~~~-~~~~~s~~~~dli~~ll~~~~~~~~R~~~~  300 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPTETQ--------LKVINWENTL-----HIP-PQVKLSPEAVDLITKLCCSAEERLGRNGAD  300 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHHHHH--------HHHHcccccc-----CCC-CCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence            99999999999999754432111        1111000000     000 011223456677766  5566777799999


Q ss_pred             HHHHH
Q 015734          347 QVVKM  351 (401)
Q Consensus       347 ~vl~~  351 (401)
                      +++++
T Consensus       301 ~~l~h  305 (381)
T cd05626         301 DIKAH  305 (381)
T ss_pred             HHhcC
Confidence            99875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4e-41  Score=321.38  Aligned_cols=257  Identities=19%  Similarity=0.237  Sum_probs=203.5

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCee
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  149 (401)
                      ....++|.+.+.||+|+||.||++..+ ++..||+|.+...  ........+.+|+.+++.++||||+++++++.+.+..
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~  118 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL  118 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            345678999999999999999999965 5889999998632  1223345678899999999999999999999999999


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ++||||+++|+|.+++..     ..++...+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++.
T Consensus       119 ~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~  190 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEecccee
Confidence            999999999999998865     2478888999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCcceeccccCCcccccccccccC----CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhcc
Q 015734          230 LVDAKLTHVTTQIRGTMGHIAPEYLSTG----KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE  305 (401)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (401)
                      ..............||+.|+|||++.+.    .++.++|||||||++|||++|..||.......        ........
T Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~~~i~~~  262 (370)
T cd05596         191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--------TYSKIMDH  262 (370)
T ss_pred             eccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH--------HHHHHHcC
Confidence            6544322223345689999999998653    37889999999999999999999997543211        11111111


Q ss_pred             CccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 015734          306 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPED--RPPMAQVVKM  351 (401)
Q Consensus       306 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~vl~~  351 (401)
                      .....     .+ .....+.++.+++.+||+.+|.+  ||++.+++++
T Consensus       263 ~~~~~-----~~-~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         263 KNSLT-----FP-DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCcCC-----CC-CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            10000     00 11123567888999999999987  9999999776

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6e-41  Score=314.22  Aligned_cols=237  Identities=25%  Similarity=0.341  Sum_probs=191.4

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCeeEEEEecccC
Q 015734           83 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN  158 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  158 (401)
                      +.||+|+||+||+|..+ +++.||+|++...  ........+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 5789999998642  2334556777888888766 699999999999999999999999999


Q ss_pred             CcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcce
Q 015734          159 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV  238 (401)
Q Consensus       159 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  238 (401)
                      |+|..++..    ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++....... ..
T Consensus        81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~  152 (320)
T cd05590          81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT  152 (320)
T ss_pred             chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence            999988875    34588999999999999999999998   99999999999999999999999999987532221 12


Q ss_pred             eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCC
Q 015734          239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT  318 (401)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  318 (401)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......     .   ........          ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-----~---~~~i~~~~----------~~  214 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-----L---FEAILNDE----------VV  214 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-----H---HHHHhcCC----------CC
Confidence            234568999999999998899999999999999999999999997543211     1   11111110          01


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCH
Q 015734          319 YDSKEVETMVQVALLCTQSTPEDRPPM  345 (401)
Q Consensus       319 ~~~~~~~~l~~l~~~cl~~~p~~RPs~  345 (401)
                      .+.....++.+++.+||+.||.+||++
T Consensus       215 ~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         215 YPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            122234578899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-40  Score=307.23  Aligned_cols=264  Identities=25%  Similarity=0.352  Sum_probs=200.8

Q ss_pred             CCCCeeeecCcEEEEEEEE-----CCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecC--CeeEEE
Q 015734           80 SESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERILV  152 (401)
Q Consensus        80 ~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  152 (401)
                      ...+.||+|+||+||++..     .++..||+|.+...........+.+|+++++.++|||++++++++...  ...+++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            7889999999999988653     357789999987544444567888999999999999999999987654  357899


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||+++++|.+++..     ..+++..+..++.|++.||.|||++   +++|+||||+||++++++.++|+|||++....
T Consensus        87 ~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          87 MEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             ecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccC
Confidence            999999999999875     2489999999999999999999998   99999999999999999999999999988654


Q ss_pred             CCCcce--eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccch
Q 015734          233 AKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND  310 (401)
Q Consensus       233 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ......  .....++..|+|||.+.+..++.++||||||+++|||+||..|+.........   .............+.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~  235 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE---MIGPKQGQMTVVRLIE  235 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh---hhcccccccchhhhhh
Confidence            332211  11223566799999998888999999999999999999999998643221000   0000000000001111


Q ss_pred             hccCcC-CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          311 IVDRNL-NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       311 ~~d~~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ..+... ...+...+.++.+++..||+.+|++|||++++++.|+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~  280 (283)
T cd05080         236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE  280 (283)
T ss_pred             hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence            111111 11223345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1e-40  Score=303.55  Aligned_cols=255  Identities=29%  Similarity=0.427  Sum_probs=203.8

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      ..++|.+.+.||+|++|.||++..+++..+|+|.+...  ....+.+.+|+.+++.++|||++++++++. .+..+++||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG--TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTE   80 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC--CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEE
Confidence            34568889999999999999999877778999987642  234567889999999999999999998875 456789999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+.+++|.+++....  ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05069          81 FMGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDN  155 (260)
T ss_pred             cCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence            999999999997532  34578999999999999999999998   9999999999999999999999999999765443


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      .........++..|+|||...+..++.++||||||+++|+|+| |..||.......     ......   ....      
T Consensus       156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----~~~~~~---~~~~------  221 (260)
T cd05069         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-----VLEQVE---RGYR------  221 (260)
T ss_pred             cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHH---cCCC------
Confidence            2222223345678999999988889999999999999999999 888987532211     111111   1100      


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                         ...+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus       222 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         222 ---MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ---CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence               01122345678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3e-41  Score=317.05  Aligned_cols=243  Identities=21%  Similarity=0.260  Sum_probs=195.5

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCC
Q 015734           83 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL  159 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  159 (401)
                      +.||+|+||.||++... ++..||+|.+...  ........+..|++++..++||||+++.+++...+..++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999964 6889999998742  12334567788999999999999999999999999999999999999


Q ss_pred             cHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcce
Q 015734          160 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV  238 (401)
Q Consensus       160 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  238 (401)
                      +|..++..    ...+++..+..++.|++.||+|||+ .   +++||||||+|||++.++.+||+|||++........ .
T Consensus        81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~  152 (325)
T cd05594          81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T  152 (325)
T ss_pred             cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence            99888865    3458999999999999999999997 6   899999999999999999999999999875332211 2


Q ss_pred             eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCC
Q 015734          239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT  318 (401)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  318 (401)
                      .....||+.|+|||++.+..++.++|||||||++|+|+||..||.......     .   ...... ..         ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~-----~---~~~i~~-~~---------~~  214 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----L---FELILM-EE---------IR  214 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH-----H---HHHHhc-CC---------CC
Confidence            233468999999999999899999999999999999999999997543211     1   111100 00         01


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 015734          319 YDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM  351 (401)
Q Consensus       319 ~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  351 (401)
                      .+.....++.+++.+||+.||.+|+     ++.+++++
T Consensus       215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            1122345688899999999999996     89999765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=9.3e-41  Score=312.38  Aligned_cols=242  Identities=24%  Similarity=0.328  Sum_probs=191.2

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHh-ccCCcccceeeeeecCCeeEEEEecccC
Q 015734           83 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISV-AIHKNLLQLIGYCTTSSERILVYPFMQN  158 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~  158 (401)
                      ++||+|+||.||+|..+ ++..||+|.++...  .....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 57899999987421  22334555667776664 4899999999999999999999999999


Q ss_pred             CcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcce
Q 015734          159 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV  238 (401)
Q Consensus       159 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  238 (401)
                      |+|..++..    ...++...+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++....... ..
T Consensus        81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~  152 (316)
T cd05592          81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK  152 (316)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence            999988875    34588999999999999999999998   99999999999999999999999999987543322 22


Q ss_pred             eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCC
Q 015734          239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT  318 (401)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  318 (401)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|..||.......     .   .......          ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-----~---~~~i~~~----------~~~  214 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-----L---FDSILND----------RPH  214 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-----H---HHHHHcC----------CCC
Confidence            334568999999999998899999999999999999999999997543211     1   1111110          011


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 015734          319 YDSKEVETMVQVALLCTQSTPEDRPPMA-QVVK  350 (401)
Q Consensus       319 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~-~vl~  350 (401)
                      .+.....++.+++.+||+.+|.+||++. ++++
T Consensus       215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            1222345678899999999999999875 4544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6.6e-41  Score=307.67  Aligned_cols=259  Identities=27%  Similarity=0.386  Sum_probs=204.9

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECC------CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCe
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE  148 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  148 (401)
                      ..++|.+.+.||+|++|.||+|.+.+      +..|++|.............+..|+.+++.++|+||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            45678899999999999999999643      567899988654444455679999999999999999999999999999


Q ss_pred             eEEEEecccCCcHHHHhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC---cEEE
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPG---EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF---EAVL  222 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl  222 (401)
                      .+++|||+++++|.+++......   ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence            99999999999999998764321   23589999999999999999999998   999999999999998754   5999


Q ss_pred             eecCCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHH
Q 015734          223 CDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIR  300 (401)
Q Consensus       223 ~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~  300 (401)
                      +|||+++........ .......+..|+|||++.+..++.++|||||||++|||++ |..||+......     ....  
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-----~~~~--  233 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-----VMEF--  233 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHH--
Confidence            999999865332211 1112233568999999988899999999999999999997 999987543221     1111  


Q ss_pred             HHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          301 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       301 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                       ......         ...+...+..+.+++.+||+.+|++||++.+|+++|+
T Consensus       234 -~~~~~~---------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         234 -VTGGGR---------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -HHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence             111110         0112233467889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.2e-41  Score=300.49  Aligned_cols=266  Identities=24%  Similarity=0.289  Sum_probs=206.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCC-cchHHHHHHHHHHHHhccCCc-ccceeeeeecCC-----
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKN-LLQLIGYCTTSS-----  147 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~-----  147 (401)
                      ...|...+.||+|+||+||+|+. .+|+.||+|+++-... +.......+|+.+++.++|+| |+.+++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            34566678899999999999995 4689999999974333 445567889999999999999 999999998877     


Q ss_pred             -eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecC
Q 015734          148 -ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG  226 (401)
Q Consensus       148 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  226 (401)
                       .+++|+||++. +|..++.........++...++.++.|++.||+|||++   +|+||||||.|||++++|.+||+|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence             78899999954 99999998654324577789999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCcceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhcc
Q 015734          227 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE  305 (401)
Q Consensus       227 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (401)
                      +++...-+... ....++|..|.|||++.+. .|+...||||+||++.||+++++.|++....    .++...++ .+..
T Consensus       166 lAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~----~ql~~If~-~lGt  239 (323)
T KOG0594|consen  166 LARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI----DQLFRIFR-LLGT  239 (323)
T ss_pred             hHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH----HHHHHHHH-HcCC
Confidence            99966533332 3345679999999999877 6899999999999999999999999865542    12222222 1111


Q ss_pred             ---Cccchhc---cC--cCCC------C---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          306 ---DRLNDIV---DR--NLNT------Y---DSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       306 ---~~~~~~~---d~--~~~~------~---~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                         ..++...   +-  ....      .   .+....+..+++.+|++.+|.+|.|++..+++
T Consensus       240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence               1121111   10  0000      0   11112468899999999999999999999876

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=308.68  Aligned_cols=266  Identities=20%  Similarity=0.335  Sum_probs=203.8

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECC---------------CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccce
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLSD---------------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL  139 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~  139 (401)
                      ..++|.+.+.||+|+||.||++...+               ...||+|.+...........+.+|++++++++|+|++++
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            34678999999999999999987532               125899998765455556789999999999999999999


Q ss_pred             eeeeecCCeeEEEEecccCCcHHHHhhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCc
Q 015734          140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKP--------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN  211 (401)
Q Consensus       140 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N  211 (401)
                      ++++...+..++||||+++++|.+++.....        ....+++..+..++.|++.||+|||+.   +++|+||||+|
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N  159 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN  159 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence            9999999999999999999999999865321        112478889999999999999999998   99999999999


Q ss_pred             eEEcCCCcEEEeecCCccccCCCCc-ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh--CCCCCCCCcch
Q 015734          212 ILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT--GQRAIDFSRLE  288 (401)
Q Consensus       212 ill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt--g~~p~~~~~~~  288 (401)
                      |++++++.+||+|||++........ .......++..|+|||.+.+..++.++|||||||++|+|++  |..||......
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~  239 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE  239 (295)
T ss_pred             EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence            9999999999999999875533221 11222345678999999988889999999999999999998  55666543221


Q ss_pred             hhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          289 EEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                      .     .................     ...+...+..+.+++.+||+.+|++|||+++|++.|+
T Consensus       240 ~-----~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         240 Q-----VIENTGEFFRNQGRQIY-----LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             H-----HHHHHHHhhhhcccccc-----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            1     11111111111000000     0111223458999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-41  Score=320.21  Aligned_cols=253  Identities=19%  Similarity=0.230  Sum_probs=199.5

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ++|.+.+.||+|+||+||+|... +++.||+|++...  ........+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47888999999999999999965 6889999999642  12334567888999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++|+|||++.....
T Consensus        81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            99999999999875    34589999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCcc-------------------------------------eeccccCCcccccccccccCCCCcccchhHHHHHHHHHH
Q 015734          234 KLTH-------------------------------------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELV  276 (401)
Q Consensus       234 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ell  276 (401)
                      ....                                     ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence            1100                                     011245899999999999889999999999999999999


Q ss_pred             hCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 015734          277 TGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP---MAQVVKM  351 (401)
Q Consensus       277 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~~vl~~  351 (401)
                      +|..||.......        .............     .+ .......++.+++..|+. +|.+|++   +.+++++
T Consensus       234 ~G~~Pf~~~~~~~--------~~~~i~~~~~~~~-----~~-~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         234 VGYPPFCSDNPQE--------TYRKIINWKETLQ-----FP-DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             cCCCCCCCCCHHH--------HHHHHHcCCCccC-----CC-CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            9999997543211        1111111000000     00 011224467788888886 9999998   8888664

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.2e-41  Score=303.81  Aligned_cols=257  Identities=29%  Similarity=0.434  Sum_probs=208.1

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      +..++|.+.+.||+|+||.||++..+++..+++|.+...  ......+.+|+.++++++|+|++++++++......+++|
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG--TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT   80 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC--ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence            456789999999999999999999878889999998742  234567899999999999999999999999888999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++++|.+++....  ...+++..+..++.+++.|+.|||++   +++|+||||+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          81 EYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             eccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence            9999999999997632  34589999999999999999999999   999999999999999999999999999876643


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ..........++..|+|||.+.+..++.++|+||||+++|+|++ |+.||......     .....   ......     
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-----~~~~~---~~~~~~-----  222 (261)
T cd05034         156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-----EVLEQ---VERGYR-----  222 (261)
T ss_pred             hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHH---HHcCCC-----
Confidence            32222222234668999999998889999999999999999999 99998643221     11111   111100     


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                          ...+...+.++.+++.+||+.+|++||+++++.+.|+.
T Consensus       223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 ----MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                01112224578899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=8.6e-41  Score=308.67  Aligned_cols=260  Identities=26%  Similarity=0.383  Sum_probs=205.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCee
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  149 (401)
                      .++|.+.+.||+|+||.||++...      ++..+|+|.+... .......+.+|+.++.+++|||++++++++...+..
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            457888999999999999999842      2456899987643 334466789999999999999999999999999999


Q ss_pred             EEEEecccCCcHHHHhhhcCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcE
Q 015734          150 ILVYPFMQNLSVAYRLRDLKP---------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA  220 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~  220 (401)
                      ++++||+++++|.+++.....         ....+++..+..++.|++.||+|||++   +++||||||+||++++++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence            999999999999999875321         123589999999999999999999998   99999999999999999999


Q ss_pred             EEeecCCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHH
Q 015734          221 VLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDH  298 (401)
Q Consensus       221 kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~  298 (401)
                      +|+|||++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......     .   
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-----~---  231 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-----V---  231 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----H---
Confidence            99999998755432211 1222335778999999998889999999999999999998 889886443211     1   


Q ss_pred             HHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 015734          299 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED  356 (401)
Q Consensus       299 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  356 (401)
                      .... ......        ..+...+.++.+++.+||+.+|.+|||+.++++.|+...
T Consensus       232 ~~~i-~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         232 IECI-TQGRVL--------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             HHHH-HcCCcC--------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            1111 111111        011123357899999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=9.1e-41  Score=308.46  Aligned_cols=259  Identities=27%  Similarity=0.425  Sum_probs=206.2

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCe
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE  148 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  148 (401)
                      ..++|...+.||+|+||.||++..+      ++..||+|.+...........+.+|+.+++.++|||++++++++.....
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            3567889999999999999999863      4678999998755444556779999999999999999999999999999


Q ss_pred             eEEEEecccCCcHHHHhhhcCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 015734          149 RILVYPFMQNLSVAYRLRDLKP------------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAA  210 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~  210 (401)
                      .++++||+++++|.+++.....                  ....+++..+..++.|++.||+|||+.   +++|+||||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence            9999999999999999975321                  123578889999999999999999998   9999999999


Q ss_pred             ceEEcCCCcEEEeecCCccccCCCCc-ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcch
Q 015734          211 NILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLE  288 (401)
Q Consensus       211 Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~  288 (401)
                      ||++++++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999875433221 11122234667999999988899999999999999999998 87887543221


Q ss_pred             hhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          289 EEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                              +..... ....        ....+...+.++.+++.+||+.+|++|||+.|+++.|+
T Consensus       240 --------~~~~~~-~~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         240 --------EVIYYV-RDGN--------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             --------HHHHHH-hcCC--------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence                    111111 1111        11112234567889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7.9e-41  Score=314.09  Aligned_cols=242  Identities=24%  Similarity=0.309  Sum_probs=193.9

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCC-cccceeeeeecCCeeEEEE
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHK-NLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~  153 (401)
                      +|++.+.||+|+||.||+|..+ +++.||+|++....  .....+.+..|..++..+.|+ +++++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788899999999999999965 57899999987421  234556788899999988765 5888989999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++.....
T Consensus        81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            99999999988875    34588999999999999999999998   999999999999999999999999999864322


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      .. .......||+.|+|||++.+..++.++|||||||++|+|+||+.||.......     .   ........       
T Consensus       154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-----~---~~~i~~~~-------  217 (324)
T cd05587         154 GG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-----L---FQSIMEHN-------  217 (324)
T ss_pred             CC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-----H---HHHHHcCC-------
Confidence            11 12234568999999999999999999999999999999999999997543211     1   11111100       


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPM  345 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  345 (401)
                         ...+.....++.+++.+||+.||.+|++.
T Consensus       218 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         218 ---VSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             ---CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence               01122334578899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.4e-40  Score=317.09  Aligned_cols=203  Identities=21%  Similarity=0.269  Sum_probs=175.3

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ++|+..+.||+|+||+||++... +++.||+|++...  ........+..|+.++..++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47888999999999999999865 5889999998642  12334467888999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            99999999999875    34689999999999999999999998   999999999999999999999999999875432


Q ss_pred             CCc----------------------------------ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCC
Q 015734          234 KLT----------------------------------HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ  279 (401)
Q Consensus       234 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~  279 (401)
                      ...                                  .......||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence            110                                  0012346899999999999999999999999999999999999


Q ss_pred             CCCCCCc
Q 015734          280 RAIDFSR  286 (401)
Q Consensus       280 ~p~~~~~  286 (401)
                      .||....
T Consensus       234 ~Pf~~~~  240 (363)
T cd05628         234 PPFCSET  240 (363)
T ss_pred             CCCCCCC
Confidence            9997543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=9.9e-41  Score=313.43  Aligned_cols=246  Identities=24%  Similarity=0.319  Sum_probs=194.7

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHH---HhccCCcccceeeeeecCCeeEEE
Q 015734           79 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLI---SVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        79 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      |.+.+.||+|+||.||+|..+ +++.||+|.+....  .....+.+..|.+++   +.++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567889999999999999964 68899999987421  223345666676654   567899999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||+++++|...+..     ..+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++....
T Consensus        81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            999999999887753     3589999999999999999999998   99999999999999999999999999987432


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ... .......|++.|+|||.+.+..++.++|||||||++|+|++|..||.......     .   ........      
T Consensus       153 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-----~---~~~i~~~~------  217 (324)
T cd05589         153 GFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-----V---FDSIVNDE------  217 (324)
T ss_pred             CCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-----H---HHHHHhCC------
Confidence            221 22234568999999999999899999999999999999999999997543211     1   11111110      


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM  351 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  351 (401)
                          ...+...+..+.+++.+||+.||.+||     ++.+++++
T Consensus       218 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         218 ----VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             ----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence                011222345678999999999999999     56666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.8e-41  Score=317.11  Aligned_cols=254  Identities=19%  Similarity=0.231  Sum_probs=202.9

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ++|.+.+.||+|+||+||++..+ ++..||+|++....  .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46888999999999999999965 68899999987422  2334567889999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++++|.+++...   ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            999999999998763   24689999999999999999999999   999999999999999999999999999986654


Q ss_pred             CCcceeccccCCcccccccccc------cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLS------TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      ..........||+.|+|||++.      ...++.++|||||||++|||++|..||.......        ..........
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--------~~~~i~~~~~  226 (330)
T cd05601         155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK--------TYNNIMNFQR  226 (330)
T ss_pred             CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH--------HHHHHHcCCC
Confidence            4333334456899999999986      4557899999999999999999999997543211        1111111111


Q ss_pred             cchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       308 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ....      ........++.+++..|++ +|.+||++++++++
T Consensus       227 ~~~~------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         227 FLKF------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             ccCC------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            1100      0112234567888889997 99999999999754

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-40  Score=306.02  Aligned_cols=253  Identities=25%  Similarity=0.347  Sum_probs=201.5

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      +|+..++||+|+||+||++... +++.||+|.+....  .......+.+|+.+++.++|||++++++.+...+..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778899999999999999964 68899999986422  12233567789999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++++|..++...  ....+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            99999999888653  234589999999999999999999998   9999999999999999999999999998765432


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccC
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR  314 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  314 (401)
                      ..  .....|++.|+|||++.+..++.++||||+||++|||++|..||.......     ....+......         
T Consensus       156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-----~~~~~~~~~~~---------  219 (285)
T cd05605         156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-----KREEVERRVKE---------  219 (285)
T ss_pred             Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-----HHHHHHHHhhh---------
Confidence            21  123468999999999988889999999999999999999999997533211     10111111110         


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 015734          315 NLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM  351 (401)
Q Consensus       315 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  351 (401)
                      .....+...+..+.+++..||+.||.+||     ++.+++++
T Consensus       220 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         220 DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            01112233456788999999999999999     78888654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-40  Score=303.38  Aligned_cols=256  Identities=27%  Similarity=0.399  Sum_probs=201.3

Q ss_pred             CCCCCeeeecCcEEEEEEEECC----CCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCe-----
Q 015734           79 FSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE-----  148 (401)
Q Consensus        79 ~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  148 (401)
                      |.+.+.||+|+||.||+|....    +..||+|+++.. ........+.+|+..++.++|||++++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998642    367999998743 233445688999999999999999999998866554     


Q ss_pred             -eEEEEecccCCcHHHHhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeec
Q 015734          149 -RILVYPFMQNLSVAYRLRDLKP--GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF  225 (401)
Q Consensus       149 -~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  225 (401)
                       .++++||+++++|..++.....  ....+++.....++.|++.||+|||++   +++|+||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             6899999999999998865332  224689999999999999999999998   9999999999999999999999999


Q ss_pred             CCccccCCCCcce-eccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHh
Q 015734          226 GLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLL  303 (401)
Q Consensus       226 gl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  303 (401)
                      |+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......     ...+...   
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-----~~~~~~~---  229 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-----EIYDYLR---  229 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHH---
Confidence            9998654332221 112234678999999988889999999999999999999 88888643321     1111111   


Q ss_pred             ccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          304 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       304 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                       ...        ....+...+.++.+++.+||+.||.+||++.++++.|+.
T Consensus       230 -~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         230 -HGN--------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             -cCC--------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence             111        111223345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=8.5e-41  Score=320.82  Aligned_cols=265  Identities=24%  Similarity=0.376  Sum_probs=209.2

Q ss_pred             HHHHHhcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCcccceeeee
Q 015734           71 ELQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYC  143 (401)
Q Consensus        71 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~  143 (401)
                      ++++..++|.+.+.||+|+||.||+|.+.      .+..||+|++...........+.+|++++.++. ||||+++++++
T Consensus        31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~  110 (401)
T cd05107          31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC  110 (401)
T ss_pred             cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence            36667788999999999999999999853      245799999975444444567899999999997 99999999999


Q ss_pred             ecCCeeEEEEecccCCcHHHHhhhcCC-----------------------------------------------------
Q 015734          144 TTSSERILVYPFMQNLSVAYRLRDLKP-----------------------------------------------------  170 (401)
Q Consensus       144 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------------------------------------------------  170 (401)
                      ...+..++|+||+.+|+|.++++....                                                     
T Consensus       111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence            999999999999999999999875321                                                     


Q ss_pred             -----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 015734          171 -----------------------------------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKA  209 (401)
Q Consensus       171 -----------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp  209 (401)
                                                               ....+++.....++.|++.||+|||+.   +++|+||||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp  267 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAA  267 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCc
Confidence                                                     113467788899999999999999998   999999999


Q ss_pred             CceEEcCCCcEEEeecCCccccCCCCc-ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcc
Q 015734          210 ANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRL  287 (401)
Q Consensus       210 ~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~  287 (401)
                      +|||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            999999999999999999976432211 11222346788999999988889999999999999999998 8889864332


Q ss_pred             hhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          288 EEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      .+.    ....+   .....         ...+.....++.+++..||+.+|.+||+++++++.|+.
T Consensus       348 ~~~----~~~~~---~~~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~  398 (401)
T cd05107         348 NEQ----FYNAI---KRGYR---------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD  398 (401)
T ss_pred             hHH----HHHHH---HcCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            111    11111   11100         01122334678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2e-40  Score=301.03  Aligned_cols=246  Identities=26%  Similarity=0.381  Sum_probs=195.8

Q ss_pred             eeeecCcEEEEEEEE---CCCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCC
Q 015734           84 IIGQGGFGKVYKGVL---SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL  159 (401)
Q Consensus        84 ~lG~G~~g~V~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  159 (401)
                      .||+|+||.||+|.+   +++..+|+|++.... .....+.+.+|+.+++.++|||++++++++. ....+++|||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999974   357889999886332 2345678899999999999999999999875 45678999999999


Q ss_pred             cHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCccee
Q 015734          160 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT  239 (401)
Q Consensus       160 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  239 (401)
                      +|.+++..    ...+++.....++.|++.||+|||++   +++|+||||+||++++++.++|+|||++...........
T Consensus        81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            99999875    33588999999999999999999998   999999999999999999999999999986644332211


Q ss_pred             --ccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcC
Q 015734          240 --TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL  316 (401)
Q Consensus       240 --~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  316 (401)
                        ....++..|+|||.+....++.++|+|||||++|||++ |..||......+     ....+.    ....        
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----~~~~i~----~~~~--------  216 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-----VTQMIE----SGER--------  216 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHH----CCCC--------
Confidence              12234578999999988889999999999999999998 999997543211     111111    1110        


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          317 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       317 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ...+...+.++.+++.+||+.||++||++++|.+.|++
T Consensus       217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            11122345678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.2e-40  Score=303.20  Aligned_cols=256  Identities=25%  Similarity=0.372  Sum_probs=198.1

Q ss_pred             CCCCCeeeecCcEEEEEEEECCC-C--EEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecC------Ce
Q 015734           79 FSESNIIGQGGFGKVYKGVLSDN-T--KVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------SE  148 (401)
Q Consensus        79 ~~~~~~lG~G~~g~V~~~~~~~~-~--~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~  148 (401)
                      |.+.+.||+|+||.||+|.+.++ .  .+|+|.+... .+......+..|+.+++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            35678899999999999997543 2  5899988643 2344567889999999999999999999987432      24


Q ss_pred             eEEEEecccCCcHHHHhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecC
Q 015734          149 RILVYPFMQNLSVAYRLRDLK--PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG  226 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  226 (401)
                      .++++||+.+|+|.+++....  .....+++.....++.|++.||+|||++   +++|+||||+||++++++.++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence            689999999999998875322  1234588999999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCcce-eccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhc
Q 015734          227 LAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLR  304 (401)
Q Consensus       227 l~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (401)
                      ++.......... .....+++.|++||.+.+..++.++||||||+++|||++ |..||......     .....+    .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~~~~~~----~  228 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-----EIYDYL----R  228 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHH----H
Confidence            998664332211 122235678999999998899999999999999999999 78888643221     111111    1


Q ss_pred             cCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          305 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       305 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ....        ...+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       229 ~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         229 QGNR--------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             cCCC--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            1110        01122334568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.4e-40  Score=308.70  Aligned_cols=258  Identities=24%  Similarity=0.381  Sum_probs=202.3

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECC-C--CEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCeeEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLSD-N--TKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  152 (401)
                      ++|++.+.||+|+||.||+|..++ +  ..+++|.++........+.+.+|+.++.++ +|||++++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578899999999999999998653 3  247888887544444567789999999999 799999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcE
Q 015734          153 YPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA  220 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~  220 (401)
                      +||+++++|.+++.....            ....+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence            999999999999875321            113588999999999999999999998   99999999999999999999


Q ss_pred             EEeecCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHH
Q 015734          221 VLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHI  299 (401)
Q Consensus       221 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~  299 (401)
                      ||+|||++........  ......+..|+|||.+.+..++.++|||||||++|||++ |..||.......        ..
T Consensus       159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--------~~  228 (297)
T cd05089         159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--------LY  228 (297)
T ss_pred             EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------HH
Confidence            9999999864322111  111123557999999988889999999999999999998 999996543211        11


Q ss_pred             HHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 015734          300 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED  356 (401)
Q Consensus       300 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  356 (401)
                      .......         ....+...+..+.+++.+||+.+|.+||++.++++.|+...
T Consensus       229 ~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  276 (297)
T cd05089         229 EKLPQGY---------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML  276 (297)
T ss_pred             HHHhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1111100         00112223457889999999999999999999999886533

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.8e-41  Score=315.41  Aligned_cols=239  Identities=23%  Similarity=0.270  Sum_probs=193.3

Q ss_pred             CeeeecCcEEEEEEEE----CCCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEeccc
Q 015734           83 NIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQ  157 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  157 (401)
                      +.||+|+||.||++..    .+|+.||+|++.... .......+..|++++++++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    357899999987422 22234567789999999999999999999999999999999999


Q ss_pred             CCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcc
Q 015734          158 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH  237 (401)
Q Consensus       158 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  237 (401)
                      +++|.+++..    ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||++....... .
T Consensus        82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~  153 (318)
T cd05582          82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K  153 (318)
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-C
Confidence            9999998865    34589999999999999999999999   99999999999999999999999999987654332 2


Q ss_pred             eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCC
Q 015734          238 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN  317 (401)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  317 (401)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......     .   ........          .
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-----~---~~~i~~~~----------~  215 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE-----T---MTMILKAK----------L  215 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH-----H---HHHHHcCC----------C
Confidence            2334568999999999998889999999999999999999999997543211     1   11111110          0


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 015734          318 TYDSKEVETMVQVALLCTQSTPEDRPPMAQ  347 (401)
Q Consensus       318 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~  347 (401)
                      ..+.....++.+++.+||+.||.+||++.+
T Consensus       216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         216 GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            112223457789999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.3e-40  Score=305.99  Aligned_cols=265  Identities=21%  Similarity=0.352  Sum_probs=203.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-----------------CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccc
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-----------------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ  138 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~  138 (401)
                      .++|++.+.||+|+||.||++...                 ++..+|+|.+...........+.+|+.+++.++|+|+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            457899999999999999998532                 234689999875444455678999999999999999999


Q ss_pred             eeeeeecCCeeEEEEecccCCcHHHHhhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCc
Q 015734          139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG-------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN  211 (401)
Q Consensus       139 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N  211 (401)
                      +++++...+..+++|||+++++|.+++......       ...+++..+..++.|++.||+|||+.   +++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence            999999999999999999999999998764321       13477889999999999999999999   99999999999


Q ss_pred             eEEcCCCcEEEeecCCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh--CCCCCCCCcch
Q 015734          212 ILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT--GQRAIDFSRLE  288 (401)
Q Consensus       212 ill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt--g~~p~~~~~~~  288 (401)
                      |+++.++.++|+|||++......... ......++..|++||...++.++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            99999999999999998755332211 1222334678999999888889999999999999999998  66777543221


Q ss_pred             hhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          289 EEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                      .     ..................     ..+..++..+.+++.+||+.||.+||++.++++.|+
T Consensus       241 ~-----~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         241 Q-----VIENTGEFFRDQGRQVYL-----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             H-----HHHHHHHHHhhccccccC-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            1     111111111111000000     111223467889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.3e-40  Score=312.25  Aligned_cols=243  Identities=24%  Similarity=0.346  Sum_probs=194.9

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCeeEEEEecccC
Q 015734           83 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN  158 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  158 (401)
                      ++||+|+||.||+|..+ +++.||+|++...  ........+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46899999999999965 5789999998742  2234456677888888765 799999999999999999999999999


Q ss_pred             CcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcce
Q 015734          159 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV  238 (401)
Q Consensus       159 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  238 (401)
                      ++|...+..    ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++........ .
T Consensus        81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~  152 (321)
T cd05591          81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-T  152 (321)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-c
Confidence            999988875    34588999999999999999999999   999999999999999999999999999875432221 2


Q ss_pred             eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCC
Q 015734          239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT  318 (401)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  318 (401)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......     .   .........          .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-----~---~~~i~~~~~----------~  214 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-----L---FESILHDDV----------L  214 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-----H---HHHHHcCCC----------C
Confidence            234568999999999998899999999999999999999999997544211     1   111111110          0


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCC-------CHHHHHHH
Q 015734          319 YDSKEVETMVQVALLCTQSTPEDRP-------PMAQVVKM  351 (401)
Q Consensus       319 ~~~~~~~~l~~l~~~cl~~~p~~RP-------s~~~vl~~  351 (401)
                      .+.....++.+++..||+.||++||       ++++++++
T Consensus       215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            1122345788899999999999999       77777655

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.7e-40  Score=299.74  Aligned_cols=251  Identities=24%  Similarity=0.332  Sum_probs=206.0

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecc-cCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQD-YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      +|...+.||+|++|.||+|..+ ++..|++|.+.. .........+.+|+++++.++|||++++++++...+..++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4777889999999999999965 588999998863 23445677899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +++++|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            99999999998642  34688999999999999999999998   99999999999999999999999999988654432


Q ss_pred             cceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCc
Q 015734          236 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN  315 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  315 (401)
                      .. .....+++.|+|||++.+..++.++|+||||+++|+|++|..||.......     .   ......         ..
T Consensus       156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~---~~~~~~---------~~  217 (256)
T cd08529         156 NF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA-----L---ILKIIR---------GV  217 (256)
T ss_pred             ch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-----H---HHHHHc---------CC
Confidence            22 233457889999999998889999999999999999999999997543211     1   111111         11


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       316 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..........++.+++.+||+.+|++||++.++++.
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         218 FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            111222445678999999999999999999999764

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.4e-40  Score=317.25  Aligned_cols=258  Identities=20%  Similarity=0.253  Sum_probs=201.7

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCe
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE  148 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  148 (401)
                      +....++|++.+.||+|+||.||++..+ +++.||+|.+...  ........+.+|+.+++.++||||+++++++.+.+.
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            3445678999999999999999999975 5789999998632  223345568899999999999999999999999999


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      .++||||+++|+|.+++..     ..++...+..++.|++.||+|||++   +++||||||+|||+++++.+||+|||++
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a  189 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTC  189 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccc
Confidence            9999999999999998864     2478889999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcceeccccCCcccccccccccC----CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhc
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLSTG----KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR  304 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (401)
                      ...............||+.|+|||++.+.    .++.++|||||||++|+|++|..||.......        .......
T Consensus       190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~--------~~~~i~~  261 (370)
T cd05621         190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG--------TYSKIMD  261 (370)
T ss_pred             eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH--------HHHHHHh
Confidence            86644333233445699999999998654    37889999999999999999999997543211        1111111


Q ss_pred             cCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 015734          305 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPED--RPPMAQVVKM  351 (401)
Q Consensus       305 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~vl~~  351 (401)
                      ......     .+ .....+..+.+++..|++.++..  ||++.+++++
T Consensus       262 ~~~~~~-----~p-~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         262 HKNSLN-----FP-EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CCcccC-----CC-CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            110000     00 01123456778888898755543  8899999776

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-40  Score=299.06  Aligned_cols=252  Identities=24%  Similarity=0.315  Sum_probs=202.6

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCC----cchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS----PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      ++|...+.||+|++|.||++... ++..|++|.+.....    ......+.+|++++++++||||+++++++......++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57899999999999999999864 689999998864221    1234578899999999999999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      ++||+++++|.+++...    ..++......++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++...
T Consensus        82 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~  154 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL  154 (263)
T ss_pred             EEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            99999999999988762    3588899999999999999999998   9999999999999999999999999998755


Q ss_pred             CCCCccee--ccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccc
Q 015734          232 DAKLTHVT--TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN  309 (401)
Q Consensus       232 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ........  ....++..|+|||.+.+..++.++||||||+++|+|++|+.||.......        .........   
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~---  223 (263)
T cd06625         155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA--------AIFKIATQP---  223 (263)
T ss_pred             cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH--------HHHHHhccC---
Confidence            43222111  23457889999999999889999999999999999999999986432211        011111110   


Q ss_pred             hhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       310 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                           .....+......+.+++..||+.+|.+|||+.+++++
T Consensus       224 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         224 -----TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -----CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                 0011223345578899999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.1e-40  Score=309.17  Aligned_cols=267  Identities=21%  Similarity=0.318  Sum_probs=200.2

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      ++|...+.||+|+||.||+|..+ ++..||+|.+...........+.+|+.+++.++|||++++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            57888999999999999999965 57889999987544444455678999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +++ +|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.......
T Consensus        86 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          86 LDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            975 787777652   34578899999999999999999998   99999999999999999999999999987543322


Q ss_pred             cceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHH-------HHHHHHhccCc
Q 015734          236 THVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL-------DHIRKLLREDR  307 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~  307 (401)
                      . ......+|+.|+|||.+.+ ..++.++|||||||++|+|+||+.||...+..+.......       ...........
T Consensus       159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         159 K-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             c-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence            2 1223457889999998865 4588999999999999999999999976543221111000       00000000000


Q ss_pred             cchhccCcCC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          308 LNDIVDRNLN-----TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       308 ~~~~~d~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ....-.+...     ........++.+++.+||+.||.+|||+.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence            0000000000     0112234567899999999999999999999763

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.4e-40  Score=309.60  Aligned_cols=262  Identities=26%  Similarity=0.401  Sum_probs=208.0

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC--------CCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeee
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLS--------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYC  143 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  143 (401)
                      .+..++|.+.+.||+|+||.||++...        ++..||+|.+...........+.+|+.++..+ +||||+++++++
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   90 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC   90 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence            355678899999999999999999741        23579999887544445567899999999999 899999999999


Q ss_pred             ecCCeeEEEEecccCCcHHHHhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCc
Q 015734          144 TTSSERILVYPFMQNLSVAYRLRDLKPG------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN  211 (401)
Q Consensus       144 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N  211 (401)
                      ...+..+++|||+.+++|.+++......            ...+++..+..++.|++.||.|||++   +++|+||||+|
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N  167 (304)
T cd05101          91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN  167 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence            9999999999999999999999864321            23578889999999999999999998   99999999999


Q ss_pred             eEEcCCCcEEEeecCCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchh
Q 015734          212 ILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEE  289 (401)
Q Consensus       212 ill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~  289 (401)
                      |++++++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|+|++ |..||......+
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~  247 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  247 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence            99999999999999999866443222 1222345678999999988889999999999999999998 778886433211


Q ss_pred             hhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          290 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                              ..........         ...+...+..+.+++.+||+.+|.+|||+.++++.|+.
T Consensus       248 --------~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~  295 (304)
T cd05101         248 --------LFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR  295 (304)
T ss_pred             --------HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence                    1111111111         01122345678899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2e-40  Score=306.45  Aligned_cols=258  Identities=27%  Similarity=0.391  Sum_probs=204.1

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      +|++.+.||+|+||.||+|...      ....+++|.+...........+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999853      2356888888754444456789999999999999999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCc
Q 015734          152 VYPFMQNLSVAYRLRDLKP--------------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN  211 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N  211 (401)
                      ++||+.+++|.+++.....                    ....+++..+..++.|++.||.|||+.   +++|+||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence            9999999999998875321                    123588999999999999999999998   99999999999


Q ss_pred             eEEcCCCcEEEeecCCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchh
Q 015734          212 ILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEE  289 (401)
Q Consensus       212 ill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~  289 (401)
                      |++++++.++|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||...... 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            99999999999999998755332221 1122345678999999988889999999999999999999 99998643321 


Q ss_pred             hhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          290 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                          .+.....    ...     ..   ..+.....++.+++.+||+.+|++||++.++++.|+..
T Consensus       237 ----~~~~~~~----~~~-----~~---~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         237 ----RLFNLLK----TGY-----RM---ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             ----HHHHHHh----CCC-----CC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence                1111111    100     00   11223345788999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.1e-40  Score=309.97  Aligned_cols=242  Identities=26%  Similarity=0.352  Sum_probs=192.0

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHh-ccCCcccceeeeeecCCeeEEEEecccC
Q 015734           83 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISV-AIHKNLLQLIGYCTTSSERILVYPFMQN  158 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~  158 (401)
                      +.||+|+||.||+|... ++..||+|.+....  .......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 57899999987432  22344566677777775 5899999999999999999999999999


Q ss_pred             CcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcce
Q 015734          159 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV  238 (401)
Q Consensus       159 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  238 (401)
                      |+|.+++..    ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++....... ..
T Consensus        81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  152 (316)
T cd05619          81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AK  152 (316)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cc
Confidence            999998875    24588999999999999999999998   99999999999999999999999999987432221 12


Q ss_pred             eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCC
Q 015734          239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT  318 (401)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  318 (401)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..||.......     ....+..   ..       +   .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-----~~~~i~~---~~-------~---~  214 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE-----LFQSIRM---DN-------P---C  214 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHh---CC-------C---C
Confidence            234568999999999998899999999999999999999999997543211     1111110   00       0   1


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 015734          319 YDSKEVETMVQVALLCTQSTPEDRPPMA-QVVK  350 (401)
Q Consensus       319 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~-~vl~  350 (401)
                      .+.....++.+++.+||+.||.+||++. ++.+
T Consensus       215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         215 YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            1122345678899999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-41  Score=327.17  Aligned_cols=259  Identities=22%  Similarity=0.292  Sum_probs=208.9

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEECCC-CEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCcccceeee-eec---C
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLSDN-TKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGY-CTT---S  146 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~-~~~---~  146 (401)
                      .+...++++.++|.+|||+.||+|.+..+ ..||+|++... ++...+.+.+|+++|+.|. |+|||.+++. ...   .
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~  111 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN  111 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence            44556778889999999999999997655 99999998754 6778899999999999997 9999999993 221   1


Q ss_pred             ---CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEe
Q 015734          147 ---SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLC  223 (401)
Q Consensus       147 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~  223 (401)
                         -+.+++||||.||+|-+++......  .|++.++++|+.++++|+++||.. .+++||||||-+||||+.+++.|||
T Consensus       112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLC  188 (738)
T KOG1989|consen  112 NGVWEVLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLC  188 (738)
T ss_pred             CceeEEEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeC
Confidence               2568999999999999999875433  399999999999999999999996 6689999999999999999999999


Q ss_pred             ecCCccccCCCCcce--------eccccCCccccccccc---ccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhh
Q 015734          224 DFGLAKLVDAKLTHV--------TTQIRGTMGHIAPEYL---STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEED  292 (401)
Q Consensus       224 Dfgl~~~~~~~~~~~--------~~~~~gt~~y~aPE~~---~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~  292 (401)
                      |||.+..........        .-....|+.|+|||.+   .+..+++|+|||+|||+||-|+....||+....     
T Consensus       189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-----  263 (738)
T KOG1989|consen  189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-----  263 (738)
T ss_pred             cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----
Confidence            999987433222110        0112369999999987   577899999999999999999999999985421     


Q ss_pred             hhHHHHHHHHhccCccchhccCcCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 015734          293 VLLLDHIRKLLREDRLNDIVDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED  356 (401)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  356 (401)
                                      ..+++.... +..+.++..+.+||..||+.||++||++-+|+..+-.+.
T Consensus       264 ----------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~  312 (738)
T KOG1989|consen  264 ----------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA  312 (738)
T ss_pred             ----------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence                            111221111 123578889999999999999999999999998876533

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.9e-40  Score=301.55  Aligned_cols=260  Identities=22%  Similarity=0.342  Sum_probs=208.7

Q ss_pred             cCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ++|++.+.||+|+||.||++.. .++..+++|.+...  ........+.+|+.+++.++|||++++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688889999999999999995 47899999987642  22334567889999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++++|.+++.........+++.....++.|++.||+|||++   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999999886544456789999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      ... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......      ........ ...     ..
T Consensus       159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~-----~~  225 (267)
T cd08229         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKI-EQC-----DY  225 (267)
T ss_pred             CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch------HHHHhhhh-hcC-----CC
Confidence            322 122345788999999998888999999999999999999999998643221      00111111 000     00


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      +..  ........+.+++.+||+.+|++|||+.+|++.+..
T Consensus       226 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~  264 (267)
T cd08229         226 PPL--PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR  264 (267)
T ss_pred             CCC--CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence            111  112345678899999999999999999999888754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=319.63  Aligned_cols=253  Identities=19%  Similarity=0.205  Sum_probs=197.5

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ++|.+.+.||+|+||+||++... +++.||+|++...  ........+.+|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47888999999999999999864 6889999998632  22334567889999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++|+|.+++..    ...+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            99999999999875    34588999999999999999999999   999999999999999999999999999863321


Q ss_pred             CCcc----------------------------------------------eeccccCCcccccccccccCCCCcccchhH
Q 015734          234 KLTH----------------------------------------------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFG  267 (401)
Q Consensus       234 ~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~s  267 (401)
                      ....                                              ......||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  233 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence            0000                                              001246899999999999889999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCC---CC
Q 015734          268 YGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDR---PP  344 (401)
Q Consensus       268 lG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~R---Ps  344 (401)
                      |||++|||++|..||......+        .............     .+ .......++.+++.+|++ +|.+|   ++
T Consensus       234 lGvil~elltG~~Pf~~~~~~~--------~~~~i~~~~~~~~-----~p-~~~~~s~~~~dli~~lL~-~~~~r~~r~~  298 (377)
T cd05629         234 LGAIMFECLIGWPPFCSENSHE--------TYRKIINWRETLY-----FP-DDIHLSVEAEDLIRRLIT-NAENRLGRGG  298 (377)
T ss_pred             cchhhhhhhcCCCCCCCCCHHH--------HHHHHHccCCccC-----CC-CCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence            9999999999999997543211        1111111000000     00 011234567788889997 66665   59


Q ss_pred             HHHHHHH
Q 015734          345 MAQVVKM  351 (401)
Q Consensus       345 ~~~vl~~  351 (401)
                      +.+++++
T Consensus       299 ~~~~l~h  305 (377)
T cd05629         299 AHEIKSH  305 (377)
T ss_pred             HHHHhcC
Confidence            9998775

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=9.9e-40  Score=300.17  Aligned_cols=253  Identities=22%  Similarity=0.333  Sum_probs=199.9

Q ss_pred             cCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           77 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      ++|...++||+|+||.||+|.+ .++..||+|.+...........+.+|++++.+++|||++++++++...+..++++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3678889999999999999985 468899999987544445567799999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +++++|..+.        .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~  149 (279)
T cd06619          81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI  149 (279)
T ss_pred             CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence            9999986432        367888999999999999999998   99999999999999999999999999987554321


Q ss_pred             cceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCc
Q 015734          236 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN  315 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  315 (401)
                         .....+|..|+|||.+.+..++.++|+||||+++|+|++|+.||......... ........... ...     .+.
T Consensus       150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~-~~~-----~~~  219 (279)
T cd06619         150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS-LMPLQLLQCIV-DED-----PPV  219 (279)
T ss_pred             ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc-cchHHHHHHHh-ccC-----CCC
Confidence               22346899999999999888999999999999999999999999643211110 00011111110 000     001


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 015734          316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML  352 (401)
Q Consensus       316 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  352 (401)
                      .  .......++.+++.+||+.+|.+||++++++++-
T Consensus       220 ~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~  254 (279)
T cd06619         220 L--PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP  254 (279)
T ss_pred             C--CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence            1  0122345688999999999999999999998763

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.9e-40  Score=303.77  Aligned_cols=254  Identities=22%  Similarity=0.336  Sum_probs=198.9

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCC----EEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      ++|...+.||+|+||+||+|.+. ++.    .+++|.+...........+..|+..++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            56788899999999999999964 344    4788877543333345677888889999999999999998764 45788


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      ++||+++|+|.+++...   ...+++.....++.|++.||+|||++   +++|+||||+||++++++.+||+|||+++..
T Consensus        86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence            99999999999999752   34589999999999999999999998   9999999999999999999999999999865


Q ss_pred             CCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccc
Q 015734          232 DAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN  309 (401)
Q Consensus       232 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.......     ..+..    ......
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-----~~~~~----~~~~~~  230 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-----VPDLL----EKGERL  230 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHH----HCCCcC
Confidence            433221 2233446778999999998899999999999999999998 999987543211     11111    111100


Q ss_pred             hhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       310 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                              ..+.....++.+++.+||..+|.+|||+.++++.|..
T Consensus       231 --------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~  267 (279)
T cd05111         231 --------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTR  267 (279)
T ss_pred             --------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence                    0011123467889999999999999999999998865

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1e-40  Score=324.93  Aligned_cols=261  Identities=23%  Similarity=0.315  Sum_probs=194.5

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecC-------
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-------  146 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------  146 (401)
                      ...+|.+.+.||+|+||.||+|... +++.||+|++...     .....+|+.+++.++||||+++++++...       
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            4567999999999999999999964 6889999988542     12345799999999999999998876332       


Q ss_pred             -CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC-cEEEee
Q 015734          147 -SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCD  224 (401)
Q Consensus       147 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~D  224 (401)
                       ...++||||+++ +|.+++.........+++..++.++.|++.||+|||+.   +++||||||+|||++.++ .+||+|
T Consensus       139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence             135689999975 77777765544456799999999999999999999999   999999999999998665 699999


Q ss_pred             cCCccccCCCCcceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHh
Q 015734          225 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL  303 (401)
Q Consensus       225 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  303 (401)
                      ||+++.......  .....||+.|+|||++.+. .++.++|||||||++|||++|.+||......+.    +..... ..
T Consensus       215 FGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~----~~~i~~-~~  287 (440)
T PTZ00036        215 FGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ----LVRIIQ-VL  287 (440)
T ss_pred             cccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHH-Hh
Confidence            999986543222  2234579999999998654 689999999999999999999999976443211    111111 00


Q ss_pred             ccCc----------cchhccCcCC------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          304 REDR----------LNDIVDRNLN------TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       304 ~~~~----------~~~~~d~~~~------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ....          ...+.-+...      .++...+.++.+|+.+||+.||.+|||+.+++++
T Consensus       288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            0000          0000000000      0112234678899999999999999999999764

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.1e-40  Score=304.58  Aligned_cols=257  Identities=25%  Similarity=0.363  Sum_probs=203.5

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCC----EEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCee
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  149 (401)
                      ..++|...+.||+|+||+||+|.+. ++.    .||+|.+...........+.+|+.++..+.|||++++++++... ..
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~   83 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV   83 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence            3457888899999999999999853 443    48999987655555667889999999999999999999998754 56


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      +++++|+++|+|.+++...   ...+++..+..++.|++.||+|||++   +++|+||||+||++++++.+||+|||+++
T Consensus        84 ~l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~  157 (279)
T cd05109          84 QLVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCcee
Confidence            8999999999999988752   34589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcce-eccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          230 LVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       230 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      ......... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||+.....     .+...+.    ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~~~----~~~  228 (279)
T cd05109         158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-----EIPDLLE----KGE  228 (279)
T ss_pred             ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHH----CCC
Confidence            664332211 112234678999999988889999999999999999998 88998643221     1111111    110


Q ss_pred             cchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       308 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                      .        ...+...+.++.+++..||+.||++||++.++++.|+..
T Consensus       229 ~--------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~  268 (279)
T cd05109         229 R--------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM  268 (279)
T ss_pred             c--------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence            0        011223445788999999999999999999999888654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.7e-40  Score=311.74  Aligned_cols=242  Identities=24%  Similarity=0.305  Sum_probs=193.6

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCeeEEEE
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      +|.+.+.||+|+||.||+|... ++..||+|.+....  .......+..|..++..+ .|++++++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999965 57899999987432  223345567788887776 5899999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++|+|.+.+..    ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++.....
T Consensus        81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            99999999988875    24588999999999999999999998   999999999999999999999999999875432


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      .. .......||+.|+|||++.+..++.++|||||||++|||+||..||.......     +...+.   ...       
T Consensus       154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~-----~~~~i~---~~~-------  217 (323)
T cd05616         154 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-----LFQSIM---EHN-------  217 (323)
T ss_pred             CC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH-----HHHHHH---hCC-------
Confidence            21 12234568999999999999999999999999999999999999997543211     111111   100       


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPM  345 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  345 (401)
                         ...+.....++.+++.+||+.+|.+|++.
T Consensus       218 ---~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         218 ---VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ---CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence               01122344578899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.6e-40  Score=319.04  Aligned_cols=252  Identities=20%  Similarity=0.214  Sum_probs=194.4

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      .|...+.||+|+||+||+|... ++..||+|.+....  .......+.+|+++++.++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5788899999999999999964 57899999986421  23345678899999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++|+|.+++..    ...++...+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            9999999998875    23578899999999999999999999   9999999999999999999999999997532100


Q ss_pred             C----------------------------------------------cceeccccCCcccccccccccCCCCcccchhHH
Q 015734          235 L----------------------------------------------THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGY  268 (401)
Q Consensus       235 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~sl  268 (401)
                      .                                              ........||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            0                                              000122468999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCC---H
Q 015734          269 GITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP---M  345 (401)
Q Consensus       269 G~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~  345 (401)
                      ||++|||++|..||........        .........  ..   ..+ .......+..+++.+|+ .+|.+|++   +
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~--------~~~i~~~~~--~~---~~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~~~  299 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTPLET--------QMKVINWQT--SL---HIP-PQAKLSPEASDLIIKLC-RGPEDRLGKNGA  299 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCHHHH--------HHHHHccCC--Cc---CCC-CcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence            9999999999999975433111        111110000  00   000 01122345667776665 59999987   7


Q ss_pred             HHHHHH
Q 015734          346 AQVVKM  351 (401)
Q Consensus       346 ~~vl~~  351 (401)
                      .+++++
T Consensus       300 ~ei~~h  305 (382)
T cd05625         300 DEIKAH  305 (382)
T ss_pred             HHHhcC
Confidence            777653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2e-40  Score=310.55  Aligned_cols=243  Identities=26%  Similarity=0.349  Sum_probs=195.2

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCeeEEEEecccC
Q 015734           83 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN  158 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  158 (401)
                      +.||+|+||+||+|..+ ++..||+|.+...  ........+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 5789999998742  1234456677888888877 699999999999999999999999999


Q ss_pred             CcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcce
Q 015734          159 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV  238 (401)
Q Consensus       159 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  238 (401)
                      ++|..++..    ...+++..+..++.|++.||.|||++   +++|+||||+||++++++.++|+|||++....... ..
T Consensus        81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~  152 (318)
T cd05570          81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VT  152 (318)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cc
Confidence            999988875    33589999999999999999999998   99999999999999999999999999986432221 12


Q ss_pred             eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCC
Q 015734          239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT  318 (401)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  318 (401)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......     .   ........          ..
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-----~---~~~i~~~~----------~~  214 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-----L---FQSILEDE----------VR  214 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-----H---HHHHHcCC----------CC
Confidence            233468999999999999999999999999999999999999997543211     1   11111110          01


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 015734          319 YDSKEVETMVQVALLCTQSTPEDRPPM-----AQVVKM  351 (401)
Q Consensus       319 ~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~~vl~~  351 (401)
                      .+......+.+++.+||+.||.+||++     .+++++
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            122234578899999999999999999     888654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.9e-40  Score=308.58  Aligned_cols=257  Identities=27%  Similarity=0.417  Sum_probs=201.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCC--EEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCeeEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNT--KVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  151 (401)
                      .++|++.+.||+|+||.||+|.++ ++.  .+++|.+....+......+.+|++++.++ +|||++++++++...+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            457888999999999999999964 343  46777776544455567888999999999 89999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCc
Q 015734          152 VYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE  219 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~  219 (401)
                      ++||+++++|.+++.....            ....+++..+..++.|++.||+|||+.   +++||||||+||++++++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence            9999999999999875321            123588999999999999999999998   9999999999999999999


Q ss_pred             EEEeecCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHH
Q 015734          220 AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDH  298 (401)
Q Consensus       220 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~  298 (401)
                      +||+|||++.......  ......++..|+|||.+.+..++.++|||||||++|||+| |..||......+     .   
T Consensus       163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~---  232 (303)
T cd05088         163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----L---  232 (303)
T ss_pred             EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-----H---
Confidence            9999999986432111  1111224568999999988889999999999999999998 999986433211     1   


Q ss_pred             HHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          299 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       299 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ..........         ..+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       233 ~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~  279 (303)
T cd05088         233 YEKLPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  279 (303)
T ss_pred             HHHHhcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            1111100000         0112234568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.6e-40  Score=309.67  Aligned_cols=262  Identities=28%  Similarity=0.412  Sum_probs=206.5

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC--------CCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeee
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLS--------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYC  143 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  143 (401)
                      ++..++|.+.+.||+|+||.||++...        ++..+|+|.+...........+..|+.++..+ +|||++++++++
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            344578999999999999999999752        23569999987544444566788999999999 799999999999


Q ss_pred             ecCCeeEEEEecccCCcHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCc
Q 015734          144 TTSSERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN  211 (401)
Q Consensus       144 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N  211 (401)
                      ...+..++||||+++++|.+++.....            ....+++..+..++.|++.||+|||++   +++|+||||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N  170 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  170 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence            999999999999999999999976432            123588999999999999999999998   99999999999


Q ss_pred             eEEcCCCcEEEeecCCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchh
Q 015734          212 ILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEE  289 (401)
Q Consensus       212 ill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~  289 (401)
                      |+++.++.++|+|||++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~  250 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  250 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence            99999999999999998755432111 1112224568999999988889999999999999999998 888886433211


Q ss_pred             hhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          290 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                           .   .. ......        ....+.....++.+++.+||+.+|.+|||+.++++.|+.
T Consensus       251 -----~---~~-~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~  298 (307)
T cd05098         251 -----L---FK-LLKEGH--------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  298 (307)
T ss_pred             -----H---HH-HHHcCC--------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence                 1   11 111111        011122345678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.9e-40  Score=301.70  Aligned_cols=256  Identities=27%  Similarity=0.404  Sum_probs=205.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-C---CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-D---NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      .++|.+.+.||+|+||.||+|... +   +..+|+|.+...........+.+|+.++..++|||++++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            357888999999999999999863 2   347999988754445556789999999999999999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      +|||+++++|.+++...   ...+++.....++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++...
T Consensus        83 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          83 VTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            99999999999998753   24589999999999999999999998   9999999999999999999999999999866


Q ss_pred             CCCCcceec--cccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          232 DAKLTHVTT--QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       232 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      .........  ...++..|+|||.+.+..++.++|+||||+++||+++ |..||......+     ....+.   .... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-----~~~~~~---~~~~-  227 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD-----VIKAIE---EGYR-  227 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH-----HHHHHh---CCCc-
Confidence            543222211  1223568999999998889999999999999999887 999986433211     111111   1100 


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                              .......+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus       228 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         228 --------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             --------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence                    01122334578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2e-40  Score=310.15  Aligned_cols=242  Identities=24%  Similarity=0.309  Sum_probs=191.7

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHh-ccCCcccceeeeeecCCeeEEEEecccC
Q 015734           83 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISV-AIHKNLLQLIGYCTTSSERILVYPFMQN  158 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~  158 (401)
                      +.||+|+||.||+|..+ ++..||+|.+....  .......+..|..++.. .+|||++++++++.+.+..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999975 57899999987422  12344566777777765 4899999999999999999999999999


Q ss_pred             CcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcce
Q 015734          159 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV  238 (401)
Q Consensus       159 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  238 (401)
                      ++|..++..    ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.++|+|||++....... ..
T Consensus        81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  152 (316)
T cd05620          81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR  152 (316)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence            999988875    34588999999999999999999999   99999999999999999999999999987432211 12


Q ss_pred             eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCC
Q 015734          239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT  318 (401)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  318 (401)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..||......     .....+..    .      .+   .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-----~~~~~~~~----~------~~---~  214 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-----ELFESIRV----D------TP---H  214 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHHHh----C------CC---C
Confidence            33456899999999999999999999999999999999999999754321     11111110    0      01   1


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 015734          319 YDSKEVETMVQVALLCTQSTPEDRPPMA-QVVK  350 (401)
Q Consensus       319 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~-~vl~  350 (401)
                      .+.....++.+++.+||+.||.+||++. ++.+
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~  247 (316)
T cd05620         215 YPRWITKESKDILEKLFERDPTRRLGVVGNIRG  247 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            1122345678899999999999999984 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.4e-40  Score=316.04  Aligned_cols=262  Identities=19%  Similarity=0.248  Sum_probs=204.3

Q ss_pred             HHHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeec
Q 015734           69 CRELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT  145 (401)
Q Consensus        69 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  145 (401)
                      ..++....++|.+.+.||+|+||.||++..+ +++.||+|.+...  ........+.+|..+++.++||||+++++.+..
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            3445667789999999999999999999965 5789999998632  222344567889999999999999999999999


Q ss_pred             CCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeec
Q 015734          146 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF  225 (401)
Q Consensus       146 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  225 (401)
                      .+..++||||+++|+|.+++..     ..++...+..++.|++.||.|||++   +++||||||+|||++.++.+||+||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence            9999999999999999998865     2378888999999999999999999   9999999999999999999999999


Q ss_pred             CCccccCCCCcceeccccCCcccccccccccC----CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHH
Q 015734          226 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG----KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK  301 (401)
Q Consensus       226 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~  301 (401)
                      |++...............||+.|+|||++.+.    .++.++|||||||++|||++|..||......        .....
T Consensus       187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~  258 (371)
T cd05622         187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSK  258 (371)
T ss_pred             CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH--------HHHHH
Confidence            99986654333233445699999999998654    3788999999999999999999999754321        11111


Q ss_pred             HhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHh
Q 015734          302 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPED--RPPMAQVVKML  352 (401)
Q Consensus       302 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~vl~~L  352 (401)
                      ...........      .....+..+.+++..|++.++.+  ||++.+++++.
T Consensus       259 i~~~~~~~~~~------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         259 IMNHKNSLTFP------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             HHcCCCcccCC------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            11111100110      11234456778889999844433  78899888764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-41  Score=284.02  Aligned_cols=251  Identities=24%  Similarity=0.333  Sum_probs=209.0

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      +.++|.+++.||.|-||.||.|+.+ ++..||+|++.+..  ......++.+|+++-+.++||||+++++++.+....|+
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            4568899999999999999999954 57889999996422  23345688999999999999999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      ++||..+|++...|+...  ...++......++.|+|.||.|+|..   +++||||||+|+|++..+..||+|||-+..-
T Consensus       100 ilEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA  174 (281)
T ss_pred             EEEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence            999999999999999533  45588889999999999999999998   9999999999999999999999999998644


Q ss_pred             CCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      +.   ......+||..|.|||...+..++...|+|++|++.||++.|.+||......     .....+.+.       ++
T Consensus       175 p~---~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-----etYkrI~k~-------~~  239 (281)
T KOG0580|consen  175 PS---NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-----ETYKRIRKV-------DL  239 (281)
T ss_pred             CC---CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-----HHHHHHHHc-------cc
Confidence            32   2334567999999999999999999999999999999999999999754311     122222211       11


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                            .+++.......+++..|+..+|.+|.+..|++.+
T Consensus       240 ------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  240 ------KFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ------cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                  1234445578899999999999999999999765

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.3e-40  Score=307.83  Aligned_cols=262  Identities=26%  Similarity=0.398  Sum_probs=207.9

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeee
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT  144 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  144 (401)
                      .....++|.+.+.||+|+||.||++...      ++..||+|.+.........+.+.+|+++++++ +||||+++++++.
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            3455678999999999999999999742      24579999887544444567789999999999 7999999999999


Q ss_pred             cCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEee
Q 015734          145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD  224 (401)
Q Consensus       145 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D  224 (401)
                      ..+..+++|||+.+++|.+++....  ...+++.....++.|++.||.|||++   +++|+||||+||+++.++.++|+|
T Consensus       110 ~~~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~d  184 (302)
T cd05055         110 IGGPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICD  184 (302)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECC
Confidence            9999999999999999999987532  23489999999999999999999998   999999999999999999999999


Q ss_pred             cCCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHH
Q 015734          225 FGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKL  302 (401)
Q Consensus       225 fgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  302 (401)
                      ||++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+.    .    ...
T Consensus       185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~----~----~~~  256 (302)
T cd05055         185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK----F----YKL  256 (302)
T ss_pred             CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH----H----HHH
Confidence            9998765433221 1222345778999999988889999999999999999998 9999865432111    1    111


Q ss_pred             hccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          303 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       303 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ..... .       ...+.....++.+++.+||+.+|++|||+.++++.|+.
T Consensus       257 ~~~~~-~-------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         257 IKEGY-R-------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             HHcCC-c-------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence            11110 0       00111234578899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.6e-40  Score=309.30  Aligned_cols=263  Identities=29%  Similarity=0.427  Sum_probs=206.8

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEEC--------CCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeee
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVLS--------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGY  142 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~  142 (401)
                      +....++|.+.+.||+|+||.||++...        ....+|+|.+...........+..|+++++.+ +||||++++++
T Consensus         7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (314)
T cd05099           7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGV   86 (314)
T ss_pred             ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence            3445678899999999999999999742        24568999887544455567788999999999 69999999999


Q ss_pred             eecCCeeEEEEecccCCcHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 015734          143 CTTSSERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAA  210 (401)
Q Consensus       143 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~  210 (401)
                      +...+..++++||+++++|.+++.....            ....+++.....++.|++.||.|||++   +++|+||||+
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~  163 (314)
T cd05099          87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAAR  163 (314)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccce
Confidence            9998999999999999999999976432            124588999999999999999999998   9999999999


Q ss_pred             ceEEcCCCcEEEeecCCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcch
Q 015734          211 NILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLE  288 (401)
Q Consensus       211 Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~  288 (401)
                      ||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~  243 (314)
T cd05099         164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE  243 (314)
T ss_pred             eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999999865432211 1112224567999999988889999999999999999999 88888643321


Q ss_pred             hhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          289 EEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      +     .   .. .......        ...+...+.++.+++.+||+.+|++|||+.++++.|..
T Consensus       244 ~-----~---~~-~~~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~  292 (314)
T cd05099         244 E-----L---FK-LLREGHR--------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK  292 (314)
T ss_pred             H-----H---HH-HHHcCCC--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            1     1   11 1111110        01122334578899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.7e-40  Score=305.86  Aligned_cols=259  Identities=25%  Similarity=0.398  Sum_probs=205.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCee
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  149 (401)
                      ..+|.+.+.||+|+||.||+|...      ++..+++|.+... .......+.+|+.+++.++|||++++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL   82 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc-cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence            346778899999999999999742      3456888887542 233446789999999999999999999999999999


Q ss_pred             EEEEecccCCcHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCC
Q 015734          150 ILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN  217 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~  217 (401)
                      ++||||+++++|.+++.....            ....+++..++.++.|++.||+|||++   +++|+||||+||+++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGAN  159 (291)
T ss_pred             EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence            999999999999999975321            123488999999999999999999999   99999999999999999


Q ss_pred             CcEEEeecCCccccCCCCc-ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhH
Q 015734          218 FEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLL  295 (401)
Q Consensus       218 ~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~  295 (401)
                      +.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||+| |..||.......     .
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-----~  234 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-----V  234 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----H
Confidence            9999999999875543322 12233446788999999998899999999999999999999 999986433211     1


Q ss_pred             HHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          296 LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       296 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                      .+.    ......        .......+..+.+++.+||+.+|++||++.++++.|+..
T Consensus       235 ~~~----~~~~~~--------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~  282 (291)
T cd05094         235 IEC----ITQGRV--------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL  282 (291)
T ss_pred             HHH----HhCCCC--------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            111    111111        111222345788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.1e-40  Score=299.36  Aligned_cols=251  Identities=20%  Similarity=0.281  Sum_probs=204.0

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecc
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM  156 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  156 (401)
                      +|++.+.||+|+||.||++... ++..+|+|.+.........+.+.+|+.+++.++|+|++++++.+...+..++++||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999965 588999998864444455678889999999999999999999999999999999999


Q ss_pred             cCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCc
Q 015734          157 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT  236 (401)
Q Consensus       157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  236 (401)
                      ++++|.+++....  ...++......++.|++.||.|||++   +++|+||||+||++++++.++++|||++........
T Consensus        81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  155 (255)
T cd08219          81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA  155 (255)
T ss_pred             CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence            9999998887532  34578999999999999999999998   999999999999999999999999999876543222


Q ss_pred             ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcC
Q 015734          237 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL  316 (401)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  316 (401)
                       ......+++.|+|||++.+..++.++|+||||+++|+|++|..||.......        ..... .....        
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--------~~~~~-~~~~~--------  217 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN--------LILKV-CQGSY--------  217 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH--------HHHHH-hcCCC--------
Confidence             2223458889999999988889999999999999999999999997533211        11111 11111        


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          317 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       317 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ...+......+.+++.+||+.||++||++.+++..
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            11122334568899999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-40  Score=298.10  Aligned_cols=251  Identities=31%  Similarity=0.463  Sum_probs=204.8

Q ss_pred             CeeeecCcEEEEEEEECC----CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccC
Q 015734           83 NIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN  158 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  158 (401)
                      +.||+|+||.||+|....    +..|++|.+...........+.+|++.+..++|+|++++++++......+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            468999999999999653    7889999997654444578899999999999999999999999999999999999999


Q ss_pred             CcHHHHhhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          159 LSVAYRLRDLKPG-----EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       159 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ++|.+++......     ...+++..+..++.|++.||+|||++   +++|+||+|+||++++++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999875322     36689999999999999999999998   999999999999999999999999999986654


Q ss_pred             CCc-ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          234 KLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       234 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ... .......++..|+|||.+....++.++||||||+++|+|++ |..||......     ...+...   ..      
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~---~~------  223 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-----EVLEYLR---KG------  223 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHH---cC------
Confidence            321 12233456889999999988889999999999999999999 68998754221     1111111   10      


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                         .....+...+.++.+++.+||+.+|.+|||+.++++.|+
T Consensus       224 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 ---YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ---CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence               011122333568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.8e-40  Score=298.62  Aligned_cols=248  Identities=25%  Similarity=0.369  Sum_probs=196.2

Q ss_pred             eeeecCcEEEEEEEEC---CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCCc
Q 015734           84 IIGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS  160 (401)
Q Consensus        84 ~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  160 (401)
                      .||+|+||.||+|.+.   ++..||+|.+.........+.+.+|+.++++++|||++++++++. .+..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999753   355799999876544445677999999999999999999999885 456799999999999


Q ss_pred             HHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCccee-
Q 015734          161 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT-  239 (401)
Q Consensus       161 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~-  239 (401)
                      |.+++...   ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++........... 
T Consensus        81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            99988752   34589999999999999999999998   999999999999999999999999999976543322211 


Q ss_pred             -ccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCC
Q 015734          240 -TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN  317 (401)
Q Consensus       240 -~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  317 (401)
                       ....++..|+|||.+.+..++.++||||||+++|++++ |..||......+     .   . ........        .
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~---~-~~~~~~~~--------~  217 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-----V---M-SFIEQGKR--------L  217 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-----H---H-HHHHCCCC--------C
Confidence             11223578999999988889999999999999999996 999986433211     1   1 11111110        1


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          318 TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       318 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                      ..+...+.++.+++..||+.+|++||++.+|.+.|+..
T Consensus       218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            12233456888999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-41  Score=298.82  Aligned_cols=267  Identities=21%  Similarity=0.331  Sum_probs=203.3

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecc-cCCcchHHHHHHHHHHHHhccCCcccceeeeeec-----CC
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQD-YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-----SS  147 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~  147 (401)
                      ....|...+.||.|+||.|+.+..+ +|..||||++.+ ..+.-..+...+|+++|+.++|+||+.+.+.+..     -+
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3455666789999999999999964 689999999974 3344556788899999999999999999998865     34


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCC
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL  227 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl  227 (401)
                      ..|+|+|+| +-+|...++.    ++.++......++.|+++||.|+|+.   +++||||||+|+|++.+...||+|||+
T Consensus       100 DvYiV~elM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence            689999999 5588887775    45589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCC-cceeccccCCcccccccccc-cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhh-----------
Q 015734          228 AKLVDAKL-THVTTQIRGTMGHIAPEYLS-TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL-----------  294 (401)
Q Consensus       228 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~-----------  294 (401)
                      ++...... ....+..+.|..|.|||++. ...|+.+.||||.|||+.||++|++.|.+.+....-...           
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~  251 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED  251 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence            99775431 22335566799999999975 566999999999999999999999999865532211100           


Q ss_pred             ----HHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          295 ----LLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       295 ----~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                          -.+.++..+..-..  .........-+.......+|+.+||..||.+|+|++|.+++
T Consensus       252 l~~i~s~~ar~yi~slp~--~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  252 LQKIRSEKARPYIKSLPQ--IPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHhccHHHHHHHHhCCC--CCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                00111111111000  00000001122344567889999999999999999999765

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.2e-40  Score=301.54  Aligned_cols=256  Identities=25%  Similarity=0.430  Sum_probs=204.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC-C---CEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSD-N---TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      .++|+..+.||+|+||.||+|..+. +   ..+++|.+.........+.+..|+++++.++|||++++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            4578888999999999999999653 3   36999988755445556789999999999999999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      +|||+++++|..++...   ...+++..+..++.|++.|++|||+.   +++|+||||+||++++++.++|+|||++...
T Consensus        84 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          84 ITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence            99999999999998752   34589999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCccee--ccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          232 DAKLTHVT--TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       232 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ........  .....+..|+|||++.+..++.++|||||||++|||++ |..||......        +...........
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--------~~~~~i~~~~~~  229 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--------EVMKAINDGFRL  229 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--------HHHHHHhcCCCC
Confidence            43322211  11123457999999988889999999999999999998 99998643221        111111111000


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                               ......+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       230 ---------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~  266 (268)
T cd05063         230 ---------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK  266 (268)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence                     1112234578899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3.9e-40  Score=299.68  Aligned_cols=256  Identities=25%  Similarity=0.403  Sum_probs=206.0

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      +..++|.+.+.||+|+||.||++...++..+++|.+...  ......+.+|+.+++.++|+|++++.+.+.. ...+++|
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~   79 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT   79 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence            456789999999999999999999877888999987642  2345678999999999999999999999887 7789999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++++|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||.+.....
T Consensus        80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          80 EFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             EeCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            9999999999987632  34578889999999999999999998   999999999999999999999999999876544


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ..........++..|+|||++....++.++|+||||+++|+++| |..||.......     ......   ....     
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-----~~~~~~---~~~~-----  221 (260)
T cd05073         155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALE---RGYR-----  221 (260)
T ss_pred             CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHh---CCCC-----
Confidence            32222222345678999999988889999999999999999999 899987533211     111111   1000     


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                          .......+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus       222 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         222 ----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ----CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                01122334578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6.7e-40  Score=301.01  Aligned_cols=248  Identities=25%  Similarity=0.322  Sum_probs=194.5

Q ss_pred             eeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCCcH
Q 015734           85 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV  161 (401)
Q Consensus        85 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  161 (401)
                      ||+|+||.||++..+ +|+.||+|.+....  .......+..|++++++++||||+++.+++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999964 58999999986321  112234566799999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcceecc
Q 015734          162 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ  241 (401)
Q Consensus       162 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  241 (401)
                      .+++....  ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++.......  ....
T Consensus        81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~  153 (277)
T cd05607          81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ  153 (277)
T ss_pred             HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence            98886532  34588999999999999999999998   99999999999999999999999999987654322  2223


Q ss_pred             ccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCH
Q 015734          242 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS  321 (401)
Q Consensus       242 ~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  321 (401)
                      ..|++.|+|||++.+..++.++|||||||++|||++|..||.........    ..........         .......
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~----~~~~~~~~~~---------~~~~~~~  220 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK----EELKRRTLED---------EVKFEHQ  220 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH----HHHHHHhhcc---------ccccccc
Confidence            45899999999998888999999999999999999999999743221111    1111111111         0110112


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 015734          322 KEVETMVQVALLCTQSTPEDRPPMAQVVKML  352 (401)
Q Consensus       322 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  352 (401)
                      ....++.+++..||+.||++||+++++++.+
T Consensus       221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         221 NFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             cCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            2345788999999999999999998876544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.2e-40  Score=298.62  Aligned_cols=252  Identities=26%  Similarity=0.426  Sum_probs=202.2

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecc
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM  156 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  156 (401)
                      .+|++.+.||+|+||.||++.+.++..+|+|.+...  ......+.+|+++++.++|||++++++++......++++||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG--AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC--CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            467888999999999999999877889999988642  223567899999999999999999999999999999999999


Q ss_pred             cCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCc
Q 015734          157 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT  236 (401)
Q Consensus       157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  236 (401)
                      ++++|.+++...   ...+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  155 (256)
T cd05112          82 EHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY  155 (256)
T ss_pred             CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence            999999988752   23578999999999999999999998   999999999999999999999999999875543322


Q ss_pred             ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCc
Q 015734          237 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN  315 (401)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  315 (401)
                      .......++.+|+|||.+.+..++.++||||||+++|||++ |..||.......     ..   ... ...  .....  
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----~~---~~~-~~~--~~~~~--  222 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-----VV---ETI-NAG--FRLYK--  222 (256)
T ss_pred             cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-----HH---HHH-hCC--CCCCC--
Confidence            21222234678999999988889999999999999999998 899986433211     11   111 110  00011  


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       316 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                          +...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       223 ----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         223 ----PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             ----CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                1112457889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1e-40  Score=319.75  Aligned_cols=253  Identities=21%  Similarity=0.226  Sum_probs=196.6

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      .+|.+.+.||+|+||.||++... +++.||+|.+...  ........+.+|+++++.++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36889999999999999999964 5889999998632  12234567889999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++|+|.+++..    ...++...+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++..+..
T Consensus        81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            99999999999876    34578899999999999999999999   999999999999999999999999999753210


Q ss_pred             CC------------------------------------------cceeccccCCcccccccccccCCCCcccchhHHHHH
Q 015734          234 KL------------------------------------------THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGIT  271 (401)
Q Consensus       234 ~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~l  271 (401)
                      ..                                          ........||+.|+|||++.+..++.++|||||||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence            00                                          000123468999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCC---CHHHH
Q 015734          272 LLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP---PMAQV  348 (401)
Q Consensus       272 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP---s~~~v  348 (401)
                      +|||++|+.||......+..        ........  ...   .+ .......++.+++.+|+ .+|.+|+   ++.++
T Consensus       234 lyell~G~~Pf~~~~~~~~~--------~~i~~~~~--~~~---~~-~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el  298 (376)
T cd05598         234 LYEMLVGQPPFLADTPAETQ--------LKVINWET--TLH---IP-SQAKLSREASDLILRLC-CGAEDRLGKNGADEI  298 (376)
T ss_pred             eeehhhCCCCCCCCCHHHHH--------HHHhccCc--ccc---CC-CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence            99999999999765432110        11100000  000   00 01123345667777765 5999999   88998


Q ss_pred             HHH
Q 015734          349 VKM  351 (401)
Q Consensus       349 l~~  351 (401)
                      +++
T Consensus       299 l~h  301 (376)
T cd05598         299 KAH  301 (376)
T ss_pred             hCC
Confidence            766

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.6e-40  Score=311.25  Aligned_cols=262  Identities=26%  Similarity=0.400  Sum_probs=202.3

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEE------CCCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeeecC
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS  146 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  146 (401)
                      .+.++|.+.+.||+|+||.||+|..      .+++.||||+++..........+.+|+.++.++ +||||+++++++...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            4567899999999999999999973      246789999997544444566788999999999 689999999988654


Q ss_pred             -CeeEEEEecccCCcHHHHhhhcCCC------------------------------------------------------
Q 015734          147 -SERILVYPFMQNLSVAYRLRDLKPG------------------------------------------------------  171 (401)
Q Consensus       147 -~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------  171 (401)
                       ...+++|||+++|+|.+++......                                                      
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence             4578999999999999998753210                                                      


Q ss_pred             ---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCc-ceecc
Q 015734          172 ---------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQ  241 (401)
Q Consensus       172 ---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~  241 (401)
                               ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++........ .....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                     12467888899999999999999998   999999999999999999999999999876533221 11222


Q ss_pred             ccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCC
Q 015734          242 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYD  320 (401)
Q Consensus       242 ~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  320 (401)
                      ..+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......    ....    ........     .   .+
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~----~~~~~~~~-----~---~~  304 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----EFCR----RLKEGTRM-----R---AP  304 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH----HHHH----HHhccCCC-----C---CC
Confidence            335678999999988889999999999999999997 889986532211    0111    11111000     0   01


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          321 SKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       321 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      .....++.+++..||+.+|++|||+.+++++|+.
T Consensus       305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~  338 (343)
T cd05103         305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  338 (343)
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            1123468899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6.7e-40  Score=308.06  Aligned_cols=245  Identities=23%  Similarity=0.270  Sum_probs=191.6

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCeeEEEEecccC
Q 015734           83 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN  158 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  158 (401)
                      +.||+|+||.||+|... +++.||+|++....  .......+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999964 57899999997432  233456688899998887 699999999999999999999999999


Q ss_pred             CcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcce
Q 015734          159 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV  238 (401)
Q Consensus       159 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  238 (401)
                      ++|..++..    ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++....... ..
T Consensus        81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~  152 (327)
T cd05617          81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT  152 (327)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence            999888865    34589999999999999999999999   99999999999999999999999999987432221 12


Q ss_pred             eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCC
Q 015734          239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT  318 (401)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  318 (401)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.........  ...+..........      .   .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~------~---~  221 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM--NTEDYLFQVILEKP------I---R  221 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc--ccHHHHHHHHHhCC------C---C
Confidence            23456899999999999999999999999999999999999999643221110  01111111111110      0   1


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 015734          319 YDSKEVETMVQVALLCTQSTPEDRPPMA  346 (401)
Q Consensus       319 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~  346 (401)
                      .+...+..+.+++.+||+.||.+||++.
T Consensus       222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         222 IPRFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence            1222335678899999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.4e-40  Score=305.04  Aligned_cols=262  Identities=23%  Similarity=0.344  Sum_probs=202.7

Q ss_pred             CCCCCCeeeecCcEEEEEEEE-----CCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecC--CeeE
Q 015734           78 NFSESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERI  150 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  150 (401)
                      .|.+.+.||+|+||.||++..     .++..||+|.+...........+.+|+.+++.++|||++++.+++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            467889999999999999974     247789999987544455567899999999999999999999998775  5678


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      ++|||+++++|.+++...   ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||++..
T Consensus        85 lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence            999999999999998652   23589999999999999999999998   999999999999999999999999999986


Q ss_pred             cCCCCcc--eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchh-------hhhhhHHHHHHH
Q 015734          231 VDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE-------EEDVLLLDHIRK  301 (401)
Q Consensus       231 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~-------~~~~~~~~~~~~  301 (401)
                      .......  ......++..|+|||.+.+..++.++||||||+++|+|+|++.|........       ........... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  237 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR-  237 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH-
Confidence            5433221  1223446778999999988889999999999999999999877643211100       00000001111 


Q ss_pred             HhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          302 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       302 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      .....        .....+...+.++.+++.+||+.+|.+|||++++++.|+.
T Consensus       238 ~~~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         238 VLEEG--------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             HHHcC--------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            11111        0011123345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=8.9e-40  Score=298.39  Aligned_cols=256  Identities=23%  Similarity=0.295  Sum_probs=201.4

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ..++|.+.+.||+|+||.||+|.. .++..||+|++... .......+.+|+.++..++|||++++++++...+..++|+
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~   85 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE-PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM   85 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC-ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence            345799999999999999999996 46788999998643 2234567889999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        86 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          86 EYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITA  158 (267)
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence            99999999998875    34588999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCcceeccccCCcccccccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccch
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND  310 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ... ......+++.|+|||.+.   ...++.++|+|||||++|||++|+.||.........        ... ....   
T Consensus       159 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--------~~~-~~~~---  225 (267)
T cd06646         159 TIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--------FLM-SKSN---  225 (267)
T ss_pred             ccc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--------eee-ecCC---
Confidence            221 122345788999999884   344788999999999999999999998533211000        000 0000   


Q ss_pred             hccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 015734          311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML  352 (401)
Q Consensus       311 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  352 (401)
                      ...+.. ......+..+.+++.+||+.+|++|||+++++++|
T Consensus       226 ~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         226 FQPPKL-KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCCCC-ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            000111 11123346788999999999999999999998765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.4e-40  Score=309.66  Aligned_cols=238  Identities=27%  Similarity=0.294  Sum_probs=188.7

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHH-HHHhccCCcccceeeeeecCCeeEEEEecccC
Q 015734           83 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVH-LISVAIHKNLLQLIGYCTTSSERILVYPFMQN  158 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  158 (401)
                      +.||+|+||+||+|... +++.||+|++....  .......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999965 68999999986321  1223344555554 55789999999999999999999999999999


Q ss_pred             CcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcce
Q 015734          159 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV  238 (401)
Q Consensus       159 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  238 (401)
                      ++|..++..    ...+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++....... ..
T Consensus        81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~  152 (323)
T cd05575          81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT  152 (323)
T ss_pred             CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence            999988875    34688999999999999999999999   99999999999999999999999999987532221 22


Q ss_pred             eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCC
Q 015734          239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT  318 (401)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  318 (401)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......        .........         . .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~---------~-~  214 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE--------MYDNILNKP---------L-R  214 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH--------HHHHHHcCC---------C-C
Confidence            334568999999999999899999999999999999999999997543211        111111110         0 1


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 015734          319 YDSKEVETMVQVALLCTQSTPEDRPPMA  346 (401)
Q Consensus       319 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~  346 (401)
                      ..+.....+.+++.+||+.||.+||++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         215 LKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            1122345788999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1e-39  Score=304.37  Aligned_cols=261  Identities=22%  Similarity=0.333  Sum_probs=202.4

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      ++|.+.+.||+|+||.||++... ++..+|+|.+...........+.+|++++.+++||||+++++.+...+..++++||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46888999999999999999965 57889999886544444556788999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +++++|.+++...    ..+++.....++.|++.||.|||+..  +++|+||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (308)
T cd06615          81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  154 (308)
T ss_pred             cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence            9999999998762    45889999999999999999999732  79999999999999999999999999987543321


Q ss_pred             cceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCc--------
Q 015734          236 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR--------  307 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------  307 (401)
                         .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||........     ............        
T Consensus       155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~  226 (308)
T cd06615         155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-----EAMFGRPVSEGEAKESHRPV  226 (308)
T ss_pred             ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH-----HHhhcCccccccccCCcccc
Confidence               2334678999999999888899999999999999999999999864332110     000000000000        


Q ss_pred             ----------------cchhccCcCCCC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          308 ----------------LNDIVDRNLNTY-DSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       308 ----------------~~~~~d~~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                                      .........+.. ......++.+++.+||+.+|++||++.+++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                            000000000000 01234568899999999999999999999776

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.2e-40  Score=301.08  Aligned_cols=257  Identities=22%  Similarity=0.364  Sum_probs=204.0

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECC----CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI  150 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  150 (401)
                      ..++|.+.+.||+|+||.||+|...+    ...|++|...........+.+.+|+.+++.++|||++++++++.+ +..+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~   82 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW   82 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence            34568889999999999999998643    246899988754444566789999999999999999999998875 4578


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      ++|||+++++|.+++...   ...+++..+..++.+++.||.|||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus        83 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~  156 (270)
T cd05056          83 IVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY  156 (270)
T ss_pred             EEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence            999999999999998753   23589999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccc
Q 015734          231 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN  309 (401)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      .............++..|+|||.+....++.++||||||+++||+++ |..||......+     ....   ....... 
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-----~~~~---~~~~~~~-  227 (270)
T cd05056         157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-----VIGR---IENGERL-  227 (270)
T ss_pred             cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-----HHHH---HHcCCcC-
Confidence            54432222222334568999999988889999999999999999986 999997543211     1111   1111111 


Q ss_pred             hhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       310 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                              ..+...+..+.+++.+|+..+|++|||+.++++.|+..
T Consensus       228 --------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         228 --------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                    11223345788999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-40  Score=297.01  Aligned_cols=251  Identities=28%  Similarity=0.398  Sum_probs=205.3

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      ..++|.+.+.||+|+||.||+|.. .|+.||+|.+.....  ..+.+.+|+.+++.++|+|++++++++...+..++|||
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   80 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE   80 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence            356788899999999999999987 488999999875322  56789999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++++|.+++....  ...+++.....++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||.+......
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          81 YMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             ecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccc
Confidence            999999999987632  23589999999999999999999998   9999999999999999999999999999866332


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      ..    ....+..|+|||.+....++.++||||||+++|++++ |..||.......     +.....    ....     
T Consensus       156 ~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~~----~~~~-----  217 (256)
T cd05039         156 QD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPHVE----KGYR-----  217 (256)
T ss_pred             cc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHh----cCCC-----
Confidence            11    2234568999999988889999999999999999997 999986443211     111111    1100     


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                         ...+...+..+.+++.+||+.+|++|||+.+++..|+.
T Consensus       218 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         218 ---MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ---CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence               01122234678899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=5.4e-40  Score=302.12  Aligned_cols=257  Identities=24%  Similarity=0.361  Sum_probs=202.7

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCee
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  149 (401)
                      ..+|...++||+|+||.||++...      ++..+++|.+.. ........+.+|+++++.++|+||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL   82 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc-CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence            356788899999999999999742      356789998764 2344567899999999999999999999999999999


Q ss_pred             EEEEecccCCcHHHHhhhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPG-----------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF  218 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~  218 (401)
                      ++++||+++++|.+++......           ...+++..+..++.|++.|++|||+.   +++|+||||+||++++++
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCC
Confidence            9999999999999998764321           13588999999999999999999998   999999999999999999


Q ss_pred             cEEEeecCCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHH
Q 015734          219 EAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLL  296 (401)
Q Consensus       219 ~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~  296 (401)
                      .++|+|||++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.......       
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------  232 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-------  232 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-------
Confidence            9999999998755432221 1122335678999999999999999999999999999998 888886432211       


Q ss_pred             HHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          297 DHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       297 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                       ..........         ...+...+..+.+++.+||+.||.+||+++++++.|+
T Consensus       233 -~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         233 -AIECITQGRE---------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             -HHHHHHcCcc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence             1111111000         0111223456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=8.4e-40  Score=299.21  Aligned_cols=250  Identities=27%  Similarity=0.420  Sum_probs=196.1

Q ss_pred             CeeeecCcEEEEEEEECC-CC--EEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCeeEEEEecccC
Q 015734           83 NIIGQGGFGKVYKGVLSD-NT--KVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFMQN  158 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  158 (401)
                      +.||+|+||.||+|..++ +.  .+++|.+...........+.+|++++.++ +|||++++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999754 43  46888887544455567889999999999 799999999999999999999999999


Q ss_pred             CcHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecC
Q 015734          159 LSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG  226 (401)
Q Consensus       159 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  226 (401)
                      ++|.+++.....            ....+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            999999875321            123578999999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhcc
Q 015734          227 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLRE  305 (401)
Q Consensus       227 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (401)
                      ++........  ......+..|+|||++....++.++||||||+++|||++ |..||......+        ........
T Consensus       158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--------~~~~~~~~  227 (270)
T cd05047         158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------LYEKLPQG  227 (270)
T ss_pred             Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH--------HHHHHhCC
Confidence            9863321111  111223567999999988889999999999999999997 999986432211        11111111


Q ss_pred             CccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          306 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       306 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ...         ..+.....++.+++.+||+.+|.+|||+.+++..|+.
T Consensus       228 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~  267 (270)
T cd05047         228 YRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  267 (270)
T ss_pred             CCC---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence            000         0112234578899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.2e-39  Score=310.43  Aligned_cols=265  Identities=22%  Similarity=0.287  Sum_probs=197.4

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecCC-----
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-----  147 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  147 (401)
                      ..++|...+.||+|+||.||++... ++..||+|.+... ........+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999999999964 5889999998643 23344567889999999999999999999886443     


Q ss_pred             -eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecC
Q 015734          148 -ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG  226 (401)
Q Consensus       148 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  226 (401)
                       ..++||||+++ +|...+..      .++...+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence             46899999975 55555532      377888999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhh------------
Q 015734          227 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL------------  294 (401)
Q Consensus       227 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~------------  294 (401)
                      +++......  ......+|+.|+|||.+.+..++.++|||||||++|+|++|..||...+..+.-...            
T Consensus       169 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         169 LARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             CccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence            987543321  223346899999999999999999999999999999999999999754321110000            


Q ss_pred             --HHHHHHHHhccC-cc-----chhcc----CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          295 --LLDHIRKLLRED-RL-----NDIVD----RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       295 --~~~~~~~~~~~~-~~-----~~~~d----~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                        ....+....... ..     .+...    +...........++.+++.+||+.||++|||+.|++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence              000011110000 00     00000    00000111224568899999999999999999999775

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-40  Score=301.44  Aligned_cols=258  Identities=24%  Similarity=0.307  Sum_probs=201.6

Q ss_pred             HHHHHhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCC-------------cchHHHHHHHHHHHHhccCCcc
Q 015734           71 ELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS-------------PGGEAAFQREVHLISVAIHKNL  136 (401)
Q Consensus        71 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni  136 (401)
                      +-....++|.+...||+|.||.|-+|+. .+++.||||++.+..-             -...+...+|+.+|+++.||||
T Consensus        91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV  170 (576)
T KOG0585|consen   91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV  170 (576)
T ss_pred             ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence            3445667899999999999999999995 4689999999953210             0123578899999999999999


Q ss_pred             cceeeeeecC--CeeEEEEecccCCcHHHHhhhcCCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceE
Q 015734          137 LQLIGYCTTS--SERILVYPFMQNLSVAYRLRDLKPGEKG-LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANIL  213 (401)
Q Consensus       137 v~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil  213 (401)
                      |+++.+..+.  +.+|+|+|||..|.+...     ...++ ++..++++++.++..||.|||.+   +|+||||||+|+|
T Consensus       171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~-----p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLL  242 (576)
T KOG0585|consen  171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWC-----PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLL  242 (576)
T ss_pred             eEEEEeecCcccCceEEEEEeccCCccccC-----CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheE
Confidence            9999998765  478999999998875322     22344 89999999999999999999999   9999999999999


Q ss_pred             EcCCCcEEEeecCCccccCCCCc----ceeccccCCcccccccccccCC----CCcccchhHHHHHHHHHHhCCCCCCCC
Q 015734          214 LDDNFEAVLCDFGLAKLVDAKLT----HVTTQIRGTMGHIAPEYLSTGK----SSEKTDVFGYGITLLELVTGQRAIDFS  285 (401)
Q Consensus       214 l~~~~~~kl~Dfgl~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~~~~sDi~slG~ll~elltg~~p~~~~  285 (401)
                      ++++|++||+|||.+........    .......|||.|+|||...++.    .+.+.||||+||+||.|+.|+.||-..
T Consensus       243 l~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~  322 (576)
T KOG0585|consen  243 LSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD  322 (576)
T ss_pred             EcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence            99999999999999986632211    1123367999999999987633    366789999999999999999999643


Q ss_pred             cchhhhhhhHHHHHHHHhccCccchhccCcCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          286 RLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                      ..        .....++...         .+. +..++..+++.+|+.++|++||++|.+..+|..+.-
T Consensus       323 ~~--------~~l~~KIvn~---------pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw  374 (576)
T KOG0585|consen  323 FE--------LELFDKIVND---------PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW  374 (576)
T ss_pred             hH--------HHHHHHHhcC---------cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence            22        1222222211         111 122345678899999999999999999999977654

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.3e-39  Score=295.29  Aligned_cols=252  Identities=21%  Similarity=0.300  Sum_probs=206.2

Q ss_pred             CCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           78 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      +|+..+.||+|+||.||.+.. .++..+++|.+... .+......+.+|+.++++++|+|++++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            578899999999999999985 46889999988632 3455567889999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +++++|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            99999999987632  34588999999999999999999998   99999999999999999999999999987664433


Q ss_pred             cceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCc
Q 015734          236 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN  315 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  315 (401)
                      . ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......        +....... .        .
T Consensus       156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--------~~~~~~~~-~--------~  217 (256)
T cd08221         156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL--------NLVVKIVQ-G--------N  217 (256)
T ss_pred             c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHc-C--------C
Confidence            2 223345889999999998888999999999999999999999999753321        11111111 1        1


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 015734          316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML  352 (401)
Q Consensus       316 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  352 (401)
                      ..........++.+++.+||+.+|.+||++.++++++
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         218 YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            1111233456788999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=9.2e-40  Score=301.65  Aligned_cols=261  Identities=25%  Similarity=0.314  Sum_probs=193.6

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhc---cCCcccceeeeeecC-----C
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVA---IHKNLLQLIGYCTTS-----S  147 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~-----~  147 (401)
                      +|.+.+.||+|+||+||+|..+ +++.||+|.+.... .......+.+|+.++..+   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999965 68899999886432 222234556677766654   799999999987542     3


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCC
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL  227 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl  227 (401)
                      ..++++||+.+ +|..++....  ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence            57899999975 8888877532  24589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhcc--
Q 015734          228 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE--  305 (401)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--  305 (401)
                      +.......  ......+|+.|+|||++.+..++.++|||||||++|+|++|.+||.........    .. +......  
T Consensus       155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~----~~-~~~~~~~~~  227 (288)
T cd07863         155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL----GK-IFDLIGLPP  227 (288)
T ss_pred             cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHH----HH-HHHHhCCCC
Confidence            98654322  122345789999999998888999999999999999999999999754322111    11 1111100  


Q ss_pred             -Cccch-------hccCc----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          306 -DRLND-------IVDRN----LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       306 -~~~~~-------~~d~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                       ..+..       ...+.    .....+.....+.+++.+||+.||.+|||+.+++.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             hhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence             00000       00000    001112334567899999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.7e-40  Score=297.69  Aligned_cols=254  Identities=27%  Similarity=0.393  Sum_probs=198.6

Q ss_pred             CCCCCeeeecCcEEEEEEEECC-CCEEEEEEecccCCcch-HHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecc
Q 015734           79 FSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGG-EAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM  156 (401)
Q Consensus        79 ~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  156 (401)
                      |+..+.||+|+||+||++.... +..||+|.+........ .....+|+.++++++||||+++++++......+++||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            4567899999999999999765 56899999975432222 223456999999999999999999999999999999999


Q ss_pred             cCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCc
Q 015734          157 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT  236 (401)
Q Consensus       157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  236 (401)
                      ++++|.+++..    ...+++..+..++.|++.||++||+.   +++|+||||+||++++++.++|+|||.+..... ..
T Consensus        81 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NN  152 (260)
T ss_dssp             TTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TT
T ss_pred             ccccccccccc----cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cc
Confidence            99999999983    34589999999999999999999999   999999999999999999999999999875422 22


Q ss_pred             ceeccccCCcccccccccc-cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCc
Q 015734          237 HVTTQIRGTMGHIAPEYLS-TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN  315 (401)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  315 (401)
                      .......++..|+|||++. +...+.++||||+|+++|+|++|..||......... ..............         
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~---------  222 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQL-EIIEKILKRPLPSS---------  222 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHH-HHHHHHHHTHHHHH---------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhh-hhhhhccccccccc---------
Confidence            2344456899999999998 788999999999999999999999999855211111 11111111000000         


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       316 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .. ........+.+++..||+.||++||++.+++++
T Consensus       223 ~~-~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  223 SQ-QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             TT-SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             cc-ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00 000112688999999999999999999999763

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=306.46  Aligned_cols=256  Identities=20%  Similarity=0.247  Sum_probs=197.3

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ++|.+.+.||+|+||.||++... +++.||+|.+...  ........+.+|..++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47889999999999999999965 5889999998631  22334566888999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++++|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            999999999998752   34588999999999999999999999   999999999999999999999999999876544


Q ss_pred             CCcceeccccCCccccccccccc-----CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ..........||+.|+|||++..     ..++.++|||||||++|+|++|+.||......        +...........
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~--------~~~~~i~~~~~~  226 (331)
T cd05597         155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--------ETYGKIMNHKEH  226 (331)
T ss_pred             CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH--------HHHHHHHcCCCc
Confidence            33322233468999999999863     45788999999999999999999999754321        111111111110


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCC--CCCCCHHHHHHH
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTP--EDRPPMAQVVKM  351 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p--~~RPs~~~vl~~  351 (401)
                      ..     ++......+..+.+++.+|+..++  ..||++.+++++
T Consensus       227 ~~-----~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         227 FQ-----FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             cc-----CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            11     111112234566777777765433  347899999776

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6.7e-40  Score=309.13  Aligned_cols=266  Identities=27%  Similarity=0.373  Sum_probs=208.6

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEECC--------CCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeee
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGY  142 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~  142 (401)
                      +++...+|.+.+.||+|+||.||++....        +..||+|.+...........+.+|+++++++ +||||++++++
T Consensus         7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (334)
T cd05100           7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA   86 (334)
T ss_pred             cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence            34455678999999999999999997421        2368999887544455567899999999999 79999999999


Q ss_pred             eecCCeeEEEEecccCCcHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 015734          143 CTTSSERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAA  210 (401)
Q Consensus       143 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~  210 (401)
                      +...+..++++||+++++|.+++.....            ....+++..+..++.|++.||+|||++   +++|+||||+
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~  163 (334)
T cd05100          87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR  163 (334)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence            9999999999999999999999875321            124588899999999999999999998   9999999999


Q ss_pred             ceEEcCCCcEEEeecCCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcch
Q 015734          211 NILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLE  288 (401)
Q Consensus       211 Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~  288 (401)
                      ||+++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  243 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  243 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            999999999999999998765432211 1122234567999999999899999999999999999998 88888653321


Q ss_pred             hhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCc
Q 015734          289 EEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDL  357 (401)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  357 (401)
                      +        .........         ....+...+.++.+++.+||+.+|.+||++.++++.|+....
T Consensus       244 ~--------~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         244 E--------LFKLLKEGH---------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             H--------HHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            1        111111110         011122334578899999999999999999999999976543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=9.9e-40  Score=300.92  Aligned_cols=268  Identities=21%  Similarity=0.272  Sum_probs=199.5

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      +|++.+.||+|++|.||+|..+ ++..||+|.+.... .......+.+|+.+++.++|||++++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999965 68899999986322 233456788999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +. ++|.+++..... ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            97 688888875432 35689999999999999999999998   99999999999999999999999999987554322


Q ss_pred             cceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHH---HHHhc-------
Q 015734          236 THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI---RKLLR-------  304 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~-------  304 (401)
                      . ......+++.|+|||.+.+. .++.++|||||||++|+|+||+.||.................   ...+.       
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         156 R-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             c-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence            1 12223468899999988654 478999999999999999999999975432211111000000   00000       


Q ss_pred             -cCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          305 -EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       305 -~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                       .....................++.+++.+||+.||.+|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence             00000000000000111234577899999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-39  Score=299.98  Aligned_cols=255  Identities=22%  Similarity=0.395  Sum_probs=203.4

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      ++|++.+.||+|+||.||++..+ ++..||+|.+.....+.....+.+|++++.+++|||++++++.+...+..++++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            46888999999999999999975 68999999887544445567889999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +++++|..++.... ....+++..+..++.|++.||.|||+..  +++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            99999988887532 1346899999999999999999999632  89999999999999999999999999987553322


Q ss_pred             cceeccccCCcccccccccccCC------CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccc
Q 015734          236 THVTTQIRGTMGHIAPEYLSTGK------SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN  309 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                         .....+++.|+|||.+.+..      ++.++|+|||||++|+|++|..||.......     ........       
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~-------  222 (286)
T cd06622         158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-----IFAQLSAI-------  222 (286)
T ss_pred             ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-----HHHHHHHH-------
Confidence               22235788999999985543      4789999999999999999999996432211     11111111       


Q ss_pred             hhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       310 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                        .+......+.....++.+++.+||+.+|++||++.+++.+
T Consensus       223 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         223 --VDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             --hhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence              1111112334466788899999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=7.5e-40  Score=299.27  Aligned_cols=255  Identities=27%  Similarity=0.416  Sum_probs=202.9

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECC-C---CEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLSD-N---TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      .+|.+.+.||+|+||.||+|..+. +   ..||+|.+...........|..|+.+++.++|||++++++++......+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            357788999999999999999643 3   369999987655555677899999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||+++++|.+++...   ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence            9999999999988753   34588999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCCcce--ecccc--CCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          233 AKLTHV--TTQIR--GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       233 ~~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      ......  .....  .+..|+|||.+.+..++.++|||||||++||+++ |..||......     .....+.   ....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-----~~~~~i~---~~~~  229 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-----DVINAIE---QDYR  229 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-----HHHHHHH---cCCc
Confidence            322211  11111  2457999999998899999999999999999887 99998643221     1111111   1100


Q ss_pred             cchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       308 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      .         ..+...+..+.+++.+||+.+|.+||++.+++..|+.
T Consensus       230 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         230 L---------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             C---------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            0         0112334568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-39  Score=300.32  Aligned_cols=260  Identities=23%  Similarity=0.362  Sum_probs=206.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      .++|++.+.||+|+||+||++... ++..||+|++...........+.+|+++++.++|||++++++++...+..++|+|
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            457788899999999999999964 5889999988754445556789999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++++|..++..    ...+++.....++.+++.||.|||+..  +++|+||+|+||++++++.++|+|||++......
T Consensus        84 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          84 FMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             cCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            9999999988875    245899999999999999999999732  7999999999999999999999999998654322


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhh---hhhhHHHHHHHHhccCccchh
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE---EDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      .   .....|+..|+|||++.+..++.++|+|||||++|+|+||..||........   ......+.........     
T Consensus       158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  229 (284)
T cd06620         158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-----  229 (284)
T ss_pred             c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-----
Confidence            1   2234688999999999888899999999999999999999999975432111   0111112222211110     


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML  352 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  352 (401)
                       .+.+  .....+.++.+++.+||+.||++|||+.+++++.
T Consensus       230 -~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         230 -PPRL--PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             -CCCC--CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence             0011  1112456788999999999999999999998864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.4e-39  Score=295.93  Aligned_cols=255  Identities=28%  Similarity=0.362  Sum_probs=192.6

Q ss_pred             CeeeecCcEEEEEEEECC---CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCC
Q 015734           83 NIIGQGGFGKVYKGVLSD---NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL  159 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  159 (401)
                      +.||+|+||.||+|...+   +..+++|.+...........+.+|+.+++.++|||++++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999998643   45799998875444445567889999999999999999999999999999999999999


Q ss_pred             cHHHHhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcce
Q 015734          160 SVAYRLRDLKP-GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV  238 (401)
Q Consensus       160 sL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  238 (401)
                      +|.+++..... .....++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999976432 123466778889999999999999998   99999999999999999999999999987543322211


Q ss_pred             -eccccCCcccccccccccC-------CCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccc
Q 015734          239 -TTQIRGTMGHIAPEYLSTG-------KSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN  309 (401)
Q Consensus       239 -~~~~~gt~~y~aPE~~~~~-------~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                       .....++..|+|||++.+.       .++.++||||||+++|||++ |..||........     ....   .. ....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-----~~~~---~~-~~~~  228 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-----LTYT---VR-EQQL  228 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-----HHHH---hh-cccC
Confidence             1234467889999998642       35789999999999999996 9999975432111     0000   00 0111


Q ss_pred             hhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       310 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                      ...++.+.   ......+.+++..|| .+|++|||+++|+..|+
T Consensus       229 ~~~~~~~~---~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         229 KLPKPRLK---LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCCccC---CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11111111   122345677888998 68999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-39  Score=295.21  Aligned_cols=248  Identities=28%  Similarity=0.455  Sum_probs=196.6

Q ss_pred             CeeeecCcEEEEEEEECC----CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccC
Q 015734           83 NIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN  158 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  158 (401)
                      +.||+|+||.||+|.+..    +..+|+|.+.........+.+.+|+.+++.+.|||++++++++. .+..+++|||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            468999999999998532    26899999875444345678899999999999999999999876 4567999999999


Q ss_pred             CcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcce
Q 015734          159 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV  238 (401)
Q Consensus       159 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  238 (401)
                      ++|.+++...    ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++.........
T Consensus        80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            9999999763    3588999999999999999999998   99999999999999999999999999998664433221


Q ss_pred             ec--cccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCc
Q 015734          239 TT--QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN  315 (401)
Q Consensus       239 ~~--~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  315 (401)
                      ..  ...++..|+|||.+.+..++.++||||||+++|+|++ |..||......     .....+..   ....       
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-----~~~~~~~~---~~~~-------  217 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-----EVIAMLES---GERL-------  217 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-----HHHHHHHc---CCcC-------
Confidence            11  1123467999999988899999999999999999998 99998754321     11111111   1000       


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       316 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                        ..+...+..+.+++.+||+.+|++||++.++++.|++.
T Consensus       218 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         218 --PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence              11222345788999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=306.55  Aligned_cols=253  Identities=23%  Similarity=0.263  Sum_probs=213.3

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECC-CCEEEEEEecccCC--cchHHHHHHHHHHHHhcc-CCcccceeeeeecCCeeE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYS--PGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERI  150 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  150 (401)
                      ..+.|.+.+.||+|.||.||++..+. |+.+|+|.+.+...  ......+.+|+.+|+++. |||++.+.+.+.+....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            45678889999999999999999765 99999999975332  234578999999999998 999999999999999999


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC----CCcEEEeecC
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD----NFEAVLCDFG  226 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~----~~~~kl~Dfg  226 (401)
                      +|||++.||.|.+.+...     .+++..+..++.|++.++.|||+.   +++||||||+|+|+..    ++.+|++|||
T Consensus       113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            999999999999999874     289999999999999999999998   9999999999999953    3579999999


Q ss_pred             CccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC
Q 015734          227 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED  306 (401)
Q Consensus       227 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (401)
                      ++.....  .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||...+......        ... ..
T Consensus       185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~--------~i~-~~  253 (382)
T KOG0032|consen  185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL--------AIL-RG  253 (382)
T ss_pred             CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--------HHH-cC
Confidence            9998766  445566789999999999999999999999999999999999999998655322111        111 11


Q ss_pred             ccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       307 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .+ .+    -...++..+....+++..|+..||.+|+|+.+++++
T Consensus       254 ~~-~f----~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  254 DF-DF----TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             CC-CC----CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            11 11    112455667788899999999999999999999996

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=5.7e-40  Score=309.09  Aligned_cols=256  Identities=21%  Similarity=0.250  Sum_probs=198.7

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ++|.+.+.||+|+||.||++..+ +++.||+|.+...  ........+.+|..++..++|+||+++++++...+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47889999999999999999965 5788999998642  12234456788999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++|+|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.....
T Consensus        81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            999999999999763   24588999999999999999999998   999999999999999999999999999976654


Q ss_pred             CCcceeccccCCccccccccccc-----CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ..........||+.|+|||++.+     ..++.++|||||||++|+|++|+.||......+        ...........
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--------~~~~i~~~~~~  226 (331)
T cd05624         155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE--------TYGKIMNHEER  226 (331)
T ss_pred             CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH--------HHHHHHcCCCc
Confidence            33333334568999999999865     467889999999999999999999997543211        11111111100


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPED--RPPMAQVVKM  351 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~vl~~  351 (401)
                      .     ..+......+.++.+++.+|+..++.+  |+++++++++
T Consensus       227 ~-----~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         227 F-----QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             c-----cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            0     011112233457788888888865543  4678777654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-39  Score=292.95  Aligned_cols=248  Identities=29%  Similarity=0.445  Sum_probs=199.4

Q ss_pred             CeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCCcHH
Q 015734           83 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVA  162 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  162 (401)
                      ++||+|+||.||++...+++.|++|.+...........+.+|++++++++|+||+++++++......++++||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46899999999999976799999998875444445678999999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCccee-cc
Q 015734          163 YRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT-TQ  241 (401)
Q Consensus       163 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~-~~  241 (401)
                      +++...   ...+++.....++.+++.||+|||++   +++|+||+|+||+++.++.++|+|||++........... ..
T Consensus        81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            998752   23578899999999999999999998   999999999999999999999999999875542221111 11


Q ss_pred             ccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCC
Q 015734          242 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYD  320 (401)
Q Consensus       242 ~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  320 (401)
                      ...+..|+|||.+.+..++.++|+||||+++|+|+| |..||.......     ......    ...        ....+
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-----~~~~~~----~~~--------~~~~~  217 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-----TRERIE----SGY--------RMPAP  217 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-----HHHHHh----cCC--------CCCCC
Confidence            223567999999988889999999999999999999 788886543211     111111    000        00112


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          321 SKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       321 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                      ...+.++.+++.+||+.+|.+||++.++++.|+
T Consensus       218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            233557889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=6.2e-40  Score=308.16  Aligned_cols=243  Identities=26%  Similarity=0.284  Sum_probs=189.5

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHH-HHHhccCCcccceeeeeecCCeeEEEEecccC
Q 015734           83 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVH-LISVAIHKNLLQLIGYCTTSSERILVYPFMQN  158 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  158 (401)
                      +.||+|+||+||+|... +++.||+|++....  .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999965 57789999986421  1222334444444 56778999999999999999999999999999


Q ss_pred             CcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcce
Q 015734          159 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV  238 (401)
Q Consensus       159 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  238 (401)
                      ++|.+++..    ...++......++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++....... ..
T Consensus        81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~  152 (325)
T cd05602          81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT  152 (325)
T ss_pred             CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence            999998875    34578888899999999999999999   99999999999999999999999999987532221 12


Q ss_pred             eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCC
Q 015734          239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT  318 (401)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  318 (401)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......     .   ....... ..         .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~---~~~i~~~-~~---------~  214 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-----M---YDNILNK-PL---------Q  214 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH-----H---HHHHHhC-Cc---------C
Confidence            334568999999999999999999999999999999999999997543211     1   1111110 00         0


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          319 YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       319 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..+.....+.+++.+||+.+|.+||++.+.+..
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence            112334567889999999999999998754433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-39  Score=298.50  Aligned_cols=250  Identities=27%  Similarity=0.385  Sum_probs=204.2

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      ++|...+.||.|++|.||+|... ++..|++|.+....+......+.+|+++++.++|+|++++.+++.+....++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36888899999999999999965 58899999987544445567789999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +++++|.+++...     ++++..+..++.|++.||.|||++   +++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  152 (274)
T cd06609          81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM  152 (274)
T ss_pred             eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence            9999999988752     689999999999999999999998   99999999999999999999999999998765432


Q ss_pred             cceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCc
Q 015734          236 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN  315 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  315 (401)
                      . ......+++.|+|||.+.+..++.++||||||+++|+|+||..||.......     ....+.    ....     +.
T Consensus       153 ~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-----~~~~~~----~~~~-----~~  217 (274)
T cd06609         153 S-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-----VLFLIP----KNNP-----PS  217 (274)
T ss_pred             c-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-----HHHHhh----hcCC-----CC
Confidence            2 2233457889999999998889999999999999999999999996433210     000011    0100     11


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       316 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      +..  ...+.++.+++.+||+.+|++|||+++++++
T Consensus       218 ~~~--~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         218 LEG--NKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             Ccc--cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            110  1145578899999999999999999999774

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.6e-39  Score=298.08  Aligned_cols=264  Identities=23%  Similarity=0.335  Sum_probs=200.0

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-----CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecC--Cee
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SER  149 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  149 (401)
                      .+|.+.+.||+|+||+||++..+     ++..||+|.+... .......+.+|+++++.++|||++++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            46888899999999999999742     4788999998643 334456889999999999999999999987543  467


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ++|+||+++++|.+++...   ...+++..+..++.|++.||+|||++   +++|+||||+||++++++.++|+|||++.
T Consensus        83 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~  156 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK  156 (284)
T ss_pred             EEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence            8999999999999998753   23588999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCcce--eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhh-------hhhhHHHHHH
Q 015734          230 LVDAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE-------EDVLLLDHIR  300 (401)
Q Consensus       230 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~-------~~~~~~~~~~  300 (401)
                      .........  .....++..|+|||.+.+..++.++||||||+++|||++|..|+........       ..........
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            654332211  1112234569999999888899999999999999999998876543211000       0000000000


Q ss_pred             HHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          301 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       301 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                      .....        ..........+.++.+++.+||+.+|++|||++++++.|+..
T Consensus       237 ~~~~~--------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         237 ELLKN--------NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHhc--------CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            00000        000111223456789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.5e-39  Score=305.21  Aligned_cols=242  Identities=24%  Similarity=0.317  Sum_probs=193.0

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhcc-CCcccceeeeeecCCeeEEEE
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  153 (401)
                      +|+..+.||+|+||.||+|..+ +++.||+|++....  .......+..|..++..+. |++++++.+++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3677889999999999999965 58899999987421  2334566778888888876 577888999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++|+|.+++..    ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.....
T Consensus        81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            99999999988875    34589999999999999999999998   999999999999999999999999999875432


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      .. .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......     ..   .......       
T Consensus       154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-----~~---~~i~~~~-------  217 (323)
T cd05615         154 DG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE-----LF---QSIMEHN-------  217 (323)
T ss_pred             CC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH-----HH---HHHHhCC-------
Confidence            21 12233568999999999998889999999999999999999999997543211     11   1111100       


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPM  345 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  345 (401)
                         ...+.....++.+++.+||+.+|.+|++.
T Consensus       218 ---~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         218 ---VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ---CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence               01122234577889999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=320.75  Aligned_cols=252  Identities=27%  Similarity=0.433  Sum_probs=211.0

Q ss_pred             CCCCCeeeecCcEEEEEEEE-CCC----CEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           79 FSESNIIGQGGFGKVYKGVL-SDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        79 ~~~~~~lG~G~~g~V~~~~~-~~~----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ....++||+|+||+||+|.+ .+|    -+||+|++.+..+.+...++.+|+..|.+++|||+++++++|.... ..+|+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            34467899999999999984 443    4799999998888888999999999999999999999999998776 88999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      +|++.|+|.++++..   ...+.....+.|..|||+||.|||.+   +++||||..+|||++.-..+||+|||+++....
T Consensus       777 q~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HhcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence            999999999999974   45688899999999999999999999   999999999999999999999999999997765


Q ss_pred             CCcceecc-ccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          234 KLTHVTTQ-IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       234 ~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ........ ..-.+.|||-|.+....++.++|||||||++||++| |..|++.....+         +.+.++.+     
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e---------I~dlle~g-----  916 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE---------IPDLLEKG-----  916 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH---------hhHHHhcc-----
Confidence            54433322 223568999999999999999999999999999999 899998654432         22222221     


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                         .....++.+..++.-++.+||..|+..||+++++...+..
T Consensus       917 ---eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~  956 (1177)
T KOG1025|consen  917 ---ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR  956 (1177)
T ss_pred             ---ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence               1123456777899999999999999999999999887653

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1e-39  Score=303.36  Aligned_cols=262  Identities=25%  Similarity=0.348  Sum_probs=200.5

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      ++|...+.||+|+||.||+|..+ ++..||+|.+...........+.+|+.+++.++||||+++++++...+..++|+||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            57888999999999999999965 57899999987443444455678899999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +. ++|..++...   ...+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++.......
T Consensus        86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            97 5888887653   34588999999999999999999998   99999999999999999999999999987543322


Q ss_pred             cceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhc---cCccchh
Q 015734          236 THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR---EDRLNDI  311 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  311 (401)
                      .. .....+++.|+|||.+.+. .++.++|||||||++|+|+||+.||...+..+.     ...+.....   ...+...
T Consensus       159 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  232 (301)
T cd07873         159 KT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-----LHFIFRILGTPTEETWPGI  232 (301)
T ss_pred             Cc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHHcCCCChhhchhh
Confidence            21 2223468899999998654 478899999999999999999999976543211     111111100   0001110


Q ss_pred             cc------CcCC--------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          312 VD------RNLN--------TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       312 ~d------~~~~--------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ++      ...+        .........+.+++.+||+.||.+|||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            00      0000        0111234567899999999999999999999774

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=7.8e-40  Score=306.95  Aligned_cols=238  Identities=25%  Similarity=0.291  Sum_probs=188.1

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHH-HHHhccCCcccceeeeeecCCeeEEEEecccC
Q 015734           83 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVH-LISVAIHKNLLQLIGYCTTSSERILVYPFMQN  158 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  158 (401)
                      ++||+|+||.||+|... ++..||+|.+....  .......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 57899999986321  2223344555554 57789999999999999999999999999999


Q ss_pred             CcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcce
Q 015734          159 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV  238 (401)
Q Consensus       159 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  238 (401)
                      ++|...+..    ...++...+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++....... ..
T Consensus        81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~  152 (321)
T cd05603          81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET  152 (321)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence            999888865    34588889999999999999999998   99999999999999999999999999987532221 12


Q ss_pred             eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCC
Q 015734          239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT  318 (401)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  318 (401)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|..||...+...     .   ....... .         ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~---~~~i~~~-~---------~~  214 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ-----M---YDNILHK-P---------LQ  214 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH-----H---HHHHhcC-C---------CC
Confidence            334568999999999998889999999999999999999999997543211     1   1111111 0         01


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 015734          319 YDSKEVETMVQVALLCTQSTPEDRPPMA  346 (401)
Q Consensus       319 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~  346 (401)
                      .+......+.+++.+||+.+|.+||++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         215 LPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            1223445788999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.6e-39  Score=294.00  Aligned_cols=254  Identities=20%  Similarity=0.336  Sum_probs=190.4

Q ss_pred             eeeecCcEEEEEEEECCC---CEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCCc
Q 015734           84 IIGQGGFGKVYKGVLSDN---TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS  160 (401)
Q Consensus        84 ~lG~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  160 (401)
                      .||+|+||.||++...++   ..+++|.+...........+.+|+.+++.++|||++++++.+......+++|||+++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999975433   34667766544444556789999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC-ccee
Q 015734          161 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL-THVT  239 (401)
Q Consensus       161 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~  239 (401)
                      |.+++..........++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++....... ....
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            9999986433334567778889999999999999998   99999999999999999999999999976432211 1122


Q ss_pred             ccccCCccccccccccc-------CCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          240 TQIRGTMGHIAPEYLST-------GKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       240 ~~~~gt~~y~aPE~~~~-------~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ....++..|+|||++..       ..++.++||||||+++|||++ |..||......        +........ ....+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--------~~~~~~~~~-~~~~~  229 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR--------EVLNHVIKD-QQVKL  229 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHhh-ccccc
Confidence            33457889999998743       235789999999999999997 46677543221        111111111 11122


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                      .++.+..   .....+.+++..|| .+|++||+++++++.|.
T Consensus       230 ~~~~~~~---~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         230 FKPQLEL---PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCCccCC---CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            2222221   23346777888899 67999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6.6e-40  Score=307.95  Aligned_cols=243  Identities=27%  Similarity=0.300  Sum_probs=190.7

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHH-HHHhccCCcccceeeeeecCCeeEEEEecccC
Q 015734           83 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVH-LISVAIHKNLLQLIGYCTTSSERILVYPFMQN  158 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  158 (401)
                      +.||+|+||.||+|... +|+.||+|++....  .......+..|.. +++.++||||+++++++...+..++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46899999999999964 68899999986421  2233445556655 46778999999999999999999999999999


Q ss_pred             CcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcce
Q 015734          159 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV  238 (401)
Q Consensus       159 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  238 (401)
                      ++|..++..    ...+++..+..++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++....... ..
T Consensus        81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~  152 (325)
T cd05604          81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT  152 (325)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence            999888865    34689999999999999999999998   99999999999999999999999999987532221 12


Q ss_pred             eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCC
Q 015734          239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT  318 (401)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  318 (401)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......        .........         . .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--------~~~~~~~~~---------~-~  214 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE--------MYDNILHKP---------L-V  214 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH--------HHHHHHcCC---------c-c
Confidence            234568999999999999999999999999999999999999997543211        111111110         0 0


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          319 YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       319 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..+.....+.+++..|++.+|.+||++.+.++.
T Consensus       215 ~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~  247 (325)
T cd05604         215 LRPGASLTAWSILEELLEKDRQRRLGAKEDFLE  247 (325)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence            112234567789999999999999998644433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.9e-39  Score=329.28  Aligned_cols=260  Identities=22%  Similarity=0.325  Sum_probs=202.2

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCC--cchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ++|.+.++||+|+||.||+|.+. +++.||+|++.....  +.....+.+|+++++.++|||++++++++.+.+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            47889999999999999999965 588999999874322  234567899999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecC
Q 015734          154 PFMQNLSVAYRLRDLKP-------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG  226 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  226 (401)
                      ||+++++|.+++.....       .....++..+..++.|++.||+|||++   +++||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            99999999998875321       123456778899999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCc-----------------ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchh
Q 015734          227 LAKLVDAKLT-----------------HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE  289 (401)
Q Consensus       227 l~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~  289 (401)
                      ++........                 .......||+.|+|||.+.+..++.++|||||||++|||+||..||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986521110                 01123468999999999999999999999999999999999999997532211


Q ss_pred             hhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhcc
Q 015734          290 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-PMAQVVKMLQG  354 (401)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~~vl~~L~~  354 (401)
                      ..   .    ...     .   .++.-.......+..+.+++.+||+.||++|| +++++.+.|+.
T Consensus       239 i~---~----~~~-----i---~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~  289 (932)
T PRK13184        239 IS---Y----RDV-----I---LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP  289 (932)
T ss_pred             hh---h----hhh-----c---cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            00   0    000     0   00000000123345678899999999999996 56667666654

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.8e-39  Score=294.50  Aligned_cols=249  Identities=26%  Similarity=0.352  Sum_probs=199.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeee-cCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT-TSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e  154 (401)
                      .++|.+.+.||+|+||.||++.. .+..+++|.+...   ...+.+.+|+.+++.++|+|++++++++. ..+..++++|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   80 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC---chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence            45788899999999999999987 4788999988642   23567899999999999999999999764 4567899999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++++|.+++....  ...+++.....++.|++.||+|||++   +++|+||||+||++++++.+||+|||++......
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          81 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             CCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            999999999987532  33588999999999999999999998   9999999999999999999999999998754332


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      .    ....++..|+|||++.+..++.++|||||||++|+|++ |+.||.......        ..... .....     
T Consensus       156 ~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~--------~~~~~-~~~~~-----  217 (256)
T cd05082         156 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRV-EKGYK-----  217 (256)
T ss_pred             C----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHH-hcCCC-----
Confidence            1    12234568999999988889999999999999999998 999886433211        11111 11100     


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      .   ......+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       218 ~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         218 M---DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             C---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            0   1122334578899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.2e-39  Score=292.21  Aligned_cols=249  Identities=29%  Similarity=0.385  Sum_probs=199.1

Q ss_pred             CeeeecCcEEEEEEEECC--C--CEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccC
Q 015734           83 NIIGQGGFGKVYKGVLSD--N--TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN  158 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  158 (401)
                      +.||+|++|.||+|.+.+  +  ..||+|.+...........+.+|+.++++++|||++++++.+.. ...++++||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  3  36899998754433566789999999999999999999999988 888999999999


Q ss_pred             CcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcc-
Q 015734          159 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH-  237 (401)
Q Consensus       159 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-  237 (401)
                      ++|.+++.....  ..+++...+.++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++......... 
T Consensus        80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            999999986432  4689999999999999999999998   9999999999999999999999999999866443221 


Q ss_pred             -eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCc
Q 015734          238 -VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN  315 (401)
Q Consensus       238 -~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  315 (401)
                       ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+     .......   ..        .
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----~~~~~~~---~~--------~  218 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-----ILKKIDK---EG--------E  218 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHh---cC--------C
Confidence             1122346788999999998899999999999999999999 999986433211     1111110   00        0


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       316 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                      ....+...+..+.+++.+||+.+|.+||++.++++.|.
T Consensus       219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            00112233467889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.2e-39  Score=292.90  Aligned_cols=251  Identities=22%  Similarity=0.326  Sum_probs=201.4

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeec-CCeeEEEEe
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSERILVYP  154 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e  154 (401)
                      +|.+.+.||+|++|.||++..+ +++.|++|.+... ......+.+.+|++++++++|+|++++.+.+.. .+..+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788899999999999999965 5788999998642 233455678899999999999999999988764 445789999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++++|.+++....  ...+++..+..++.+++.|+++||+.   +++|+||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            999999999987632  34589999999999999999999999   9999999999999999999999999998765433


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccC
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR  314 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  314 (401)
                      .. ......+++.|+|||++.+..++.++|+||||+++++|++|+.||...+...        ....... .        
T Consensus       156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--------~~~~~~~-~--------  217 (257)
T cd08223         156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS--------LVYRIIE-G--------  217 (257)
T ss_pred             CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHh-c--------
Confidence            22 2233457889999999998889999999999999999999999987533211        1111111 1        


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          315 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       315 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .....+......+.+++.+||+.+|++||++.+++++
T Consensus       218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         218 KLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             CCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            1111223445678899999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=9.8e-40  Score=310.60  Aligned_cols=265  Identities=20%  Similarity=0.277  Sum_probs=198.2

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecC------
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------  146 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  146 (401)
                      ..++|...+.||+|+||.||++... .++.||+|++.... .......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578999999999999999999864 58899999987432 333456788899999999999999999987543      


Q ss_pred             CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecC
Q 015734          147 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG  226 (401)
Q Consensus       147 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  226 (401)
                      ...+++|||+++ ++...+..      .+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence            346899999965 56665542      378889999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhH-----------
Q 015734          227 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL-----------  295 (401)
Q Consensus       227 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~-----------  295 (401)
                      +++......  ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.............           
T Consensus       165 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             ccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            998654322  2233468999999999998899999999999999999999999997544221110000           


Q ss_pred             ---HHHHHHHhccC-ccc-----hhccCcCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          296 ---LDHIRKLLRED-RLN-----DIVDRNLN----TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       296 ---~~~~~~~~~~~-~~~-----~~~d~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                         ........... ...     ........    ........++.+++.+||+.||++|||+.+++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence               00011111000 000     00000000    0111234567899999999999999999999875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.4e-39  Score=294.24  Aligned_cols=251  Identities=22%  Similarity=0.354  Sum_probs=201.0

Q ss_pred             CCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCC-----cchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           78 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS-----PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      +|...+.||+|+||.||+|...+++.+|+|.+.....     ......+.+|+++++.++|+|++++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4778899999999999999987899999998863221     22345688999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      +||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          81 MEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            9999999999998752    3578999999999999999999998   89999999999999999999999999987543


Q ss_pred             CCC-----cceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          233 AKL-----THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       233 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      ...     ........++..|+|||.+.+..++.++|+||||+++|+|++|..||........       ..........
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~  226 (265)
T cd06631         154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-------MFYIGAHRGL  226 (265)
T ss_pred             hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-------HHHhhhccCC
Confidence            211     1112334578899999999988899999999999999999999999964322110       0000000000


Q ss_pred             cchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       308 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                              .+..+.....++.+++.+||+.+|.+||++.++++
T Consensus       227 --------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         227 --------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                    11122334567889999999999999999999965

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.8e-39  Score=297.24  Aligned_cols=251  Identities=24%  Similarity=0.350  Sum_probs=197.5

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           79 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        79 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      |+..+.||+|+||+||++... +++.||+|.+....  .......+.+|+++++.++|+|++++.+.+...+..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            566788999999999999964 68899999986422  222345678899999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +++++|..++....  ...+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          82 MNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             ccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            99999998886532  34689999999999999999999998   99999999999999999999999999987543321


Q ss_pred             cceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCc
Q 015734          236 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN  315 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  315 (401)
                        ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.........     ...........        
T Consensus       157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~-----~~~~~~~~~~~--------  221 (285)
T cd05632         157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR-----EEVDRRVLETE--------  221 (285)
T ss_pred             --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHHhhhccc--------
Confidence              122346899999999998888999999999999999999999999753321110     11111111100        


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 015734          316 LNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVK  350 (401)
Q Consensus       316 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~  350 (401)
                       ..........+.+++..||+.||++||+     +.+++.
T Consensus       222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         222 -EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             -cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence             0112233456788999999999999999     556544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.9e-39  Score=302.54  Aligned_cols=197  Identities=24%  Similarity=0.364  Sum_probs=160.2

Q ss_pred             CCeeeecCcEEEEEEEEC---CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeec--CCeeEEEEecc
Q 015734           82 SNIIGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--SSERILVYPFM  156 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~  156 (401)
                      .++||+|+||+||+|..+   ++..||+|.+...   .....+.+|+.++++++||||+++++++..  ....++++||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT---GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC---CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            468999999999999864   4678999988642   223457889999999999999999998854  44678999998


Q ss_pred             cCCcHHHHhhhcCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEE----cCCCcEEEeecCC
Q 015734          157 QNLSVAYRLRDLKP-----GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGL  227 (401)
Q Consensus       157 ~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfgl  227 (401)
                      . ++|..++.....     ....++...+..++.|++.||.|||++   +++||||||+|||+    +.++.+||+|||+
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            5 477777653221     123588999999999999999999999   99999999999999    4667899999999


Q ss_pred             ccccCCCCcc--eeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCC
Q 015734          228 AKLVDAKLTH--VTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFS  285 (401)
Q Consensus       228 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~  285 (401)
                      ++........  ......+|+.|+|||++.+. .++.++||||+||++|+|++|++||...
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            9866543221  22345689999999998764 5899999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=9.8e-40  Score=307.65  Aligned_cols=256  Identities=20%  Similarity=0.247  Sum_probs=198.0

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ++|.+.+.||+|+||.||++..+ ++..+|+|.+...  ........+..|..++..++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47888999999999999999965 4778999998631  12233456788999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++|+|.+++...   ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            999999999999763   34588999999999999999999998   999999999999999999999999999875543


Q ss_pred             CCcceeccccCCcccccccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ..........||+.|+|||++.     ...++.++|||||||++|||++|+.||.......        ...........
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~--------~~~~i~~~~~~  226 (332)
T cd05623         155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE--------TYGKIMNHKER  226 (332)
T ss_pred             CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH--------HHHHHhCCCcc
Confidence            3333333456899999999986     3457899999999999999999999997543211        11111111100


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPED--RPPMAQVVKM  351 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~vl~~  351 (401)
                      .     ..+........++.+++.+|+..++..  |+++.+++++
T Consensus       227 ~-----~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         227 F-----QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             c-----cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            0     011112233456778888887654443  6889998765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.6e-39  Score=299.71  Aligned_cols=252  Identities=24%  Similarity=0.341  Sum_probs=198.4

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           79 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        79 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      |+..+.||+|+||.||++... +++.||+|.+....  .......+..|+.+++.++|+|++++.+.+...+..+++|||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667789999999999999964 68899999886422  122335677899999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +++++|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        82 ~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          82 MNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             cCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            99999998886532  34588999999999999999999998   99999999999999999999999999987543322


Q ss_pred             cceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCc
Q 015734          236 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN  315 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  315 (401)
                      .  .....|+..|+|||++.+..++.++||||||+++|+|++|..||......... ..........      ..     
T Consensus       157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-~~~~~~~~~~------~~-----  222 (285)
T cd05630         157 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERLVKEV------QE-----  222 (285)
T ss_pred             c--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-HHHHhhhhhh------hh-----
Confidence            1  12346899999999999889999999999999999999999999753221100 0010000000      00     


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 015734          316 LNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVKM  351 (401)
Q Consensus       316 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~~  351 (401)
                        ........++.+++..||+.||++|||     +.+++++
T Consensus       223 --~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         223 --EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             --hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence              011223456889999999999999999     7788653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.1e-39  Score=295.43  Aligned_cols=254  Identities=23%  Similarity=0.364  Sum_probs=205.8

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      ++|...+.||+|++|.||++..+ +++.+++|.+...........+.+|++++++++|||++++++.+...+..++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35777889999999999999975 58899999987654455667889999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      +++++|.+++....   ..++......++.|++.||+|||+ .   +++|+||||+||++++++.++|+|||.+......
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~  154 (265)
T cd06605          81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS  154 (265)
T ss_pred             cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence            99999999988632   568899999999999999999999 7   9999999999999999999999999998755332


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccC
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR  314 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  314 (401)
                      ...   ...++..|+|||.+.+..++.++||||||+++|+|++|..||........   ...+........         
T Consensus       155 ~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~---------  219 (265)
T cd06605         155 LAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD---GIFELLQYIVNE---------  219 (265)
T ss_pred             Hhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc---cHHHHHHHHhcC---------
Confidence            211   15578899999999998999999999999999999999999975422111   111122221111         


Q ss_pred             cCCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          315 NLNTYDSK-EVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       315 ~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .....+.. ...++.+++.+||..+|++|||+.+++.+
T Consensus       220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         220 PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            11111122 45678899999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.7e-39  Score=296.77  Aligned_cols=252  Identities=28%  Similarity=0.439  Sum_probs=199.1

Q ss_pred             CeeeecCcEEEEEEEECC-------CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           83 NIIGQGGFGKVYKGVLSD-------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      +.||+|+||.||+|...+       +..+++|.+...........+.+|+.+++.++||||+++++++...+..+++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            358999999999998643       2579999886544445567889999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC-----cEEEeecCC
Q 015734          156 MQNLSVAYRLRDLKP---GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-----EAVLCDFGL  227 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-----~~kl~Dfgl  227 (401)
                      +++++|.+++.....   ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            999999999975322   124478899999999999999999998   899999999999999887     899999999


Q ss_pred             ccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhcc
Q 015734          228 AKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLRE  305 (401)
Q Consensus       228 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (401)
                      +......... ......++..|+|||.+.+..++.++|||||||++|+|+| |..||.......     ....+.   ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~-----~~~~~~---~~  229 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-----VLQHVT---AG  229 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH-----HHHHHh---cC
Confidence            8755332211 1122345678999999998899999999999999999998 999986433211     111111   00


Q ss_pred             CccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          306 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       306 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      .         ....+...+..+.+++.+||+.+|.+||+++++++.|+.
T Consensus       230 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         230 G---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             C---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            0         011123345678899999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.9e-39  Score=292.97  Aligned_cols=251  Identities=24%  Similarity=0.348  Sum_probs=204.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC-CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      .++|+..+.||+|+||.||+|...+ +..+++|.+....   ..+.+.+|+++++.++|||++++++++......++++|
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e   78 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME   78 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence            4678999999999999999999764 7899999986432   26789999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+.+++|.+++...   ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        79 ~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          79 YCGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             cCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            99999999998652   34689999999999999999999998   9999999999999999999999999998866443


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccC
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR  314 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  314 (401)
                      .. ......++..|+|||.+.+..++.++||||||+++|+|++|+.||........        ... .....     ..
T Consensus       153 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--------~~~-~~~~~-----~~  217 (256)
T cd06612         153 MA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--------IFM-IPNKP-----PP  217 (256)
T ss_pred             cc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--------hhh-hccCC-----CC
Confidence            22 22234478899999999888999999999999999999999999875332110        000 00000     00


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          315 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       315 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      . ...+.....++.+++.+||+.+|++|||+.+++++
T Consensus       218 ~-~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         218 T-LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             C-CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            0 01123344678899999999999999999999763

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-42  Score=287.49  Aligned_cols=253  Identities=21%  Similarity=0.254  Sum_probs=208.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEec-ccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~-~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      ..+.|++-++||+|.|+.|+++.. .+|+.+|+|++. +..+....+.+.+|+.+-+.++||||+++.......+-.++|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            356788889999999999999884 478999999886 344556788999999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEc---CCCcEEEeecCCcc
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---DNFEAVLCDFGLAK  229 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfgl~~  229 (401)
                      +|++.|++|...+-..    ...++..+-..++||+.+|.|+|.+   +|+|||+||+|+++-   ...-+||+|||++.
T Consensus        89 Fe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             EecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence            9999999998777652    3467788889999999999999999   999999999999994   44568999999999


Q ss_pred             ccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccc
Q 015734          230 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN  309 (401)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      .++  .........|||+|||||++...+|+..+|||+-|++||-|+.|.+||...+.     ..+.+.+..   ..   
T Consensus       162 ~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-----~rlye~I~~---g~---  228 (355)
T KOG0033|consen  162 EVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HRLYEQIKA---GA---  228 (355)
T ss_pred             EeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-----HHHHHHHhc---cc---
Confidence            887  34445567899999999999999999999999999999999999999975322     112222211   10   


Q ss_pred             hhccCcCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          310 DIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       310 ~~~d~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                          -..++ .++...++..+|+.+||..||.+|.|+.|.+++
T Consensus       229 ----yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  229 ----YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             ----cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence                11111 345556678899999999999999999998765

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5.8e-39  Score=294.34  Aligned_cols=259  Identities=24%  Similarity=0.355  Sum_probs=204.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCee
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  149 (401)
                      .++|...+.||+|+||.||+|..+      +...+++|.+...........+.+|++++++++|+|++++++++.+.+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            367888999999999999999964      24579999876533333567899999999999999999999999999999


Q ss_pred             EEEEecccCCcHHHHhhhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEee
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGE-----KGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD  224 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D  224 (401)
                      ++||||+++++|.+++.......     ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++++|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence            99999999999999998644221     2589999999999999999999998   999999999999999999999999


Q ss_pred             cCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHh
Q 015734          225 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLL  303 (401)
Q Consensus       225 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  303 (401)
                      ||++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||......     ..   .... 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-----~~---~~~~-  231 (275)
T cd05046         161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-----EV---LNRL-  231 (275)
T ss_pred             cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-----HH---HHHH-
Confidence            99987543332222333446778999999988889999999999999999999 77888532211     11   1111 


Q ss_pred             ccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          304 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       304 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                      .......       ......+..+.+++.+||+.+|.+||++.+++..|.
T Consensus       232 ~~~~~~~-------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         232 QAGKLEL-------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HcCCcCC-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            1111100       011223457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.2e-39  Score=292.03  Aligned_cols=252  Identities=29%  Similarity=0.474  Sum_probs=202.4

Q ss_pred             CCCCCeeeecCcEEEEEEEECC-----CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           79 FSESNIIGQGGFGKVYKGVLSD-----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        79 ~~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      +++.+.||.|+||.||++...+     +..||+|.+...........+..|+..+..++|+|++++++++...+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567889999999999999653     37899999976544446778999999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++++|.+++.....  ..+++..+..++.|++.||++||+.   +++|+||||+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            99999999999876321  1289999999999999999999999   999999999999999999999999999986654


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ..........+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......     .......   ...      
T Consensus       156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~-----~~~~~~~---~~~------  221 (258)
T smart00219      156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE-----EVLEYLK---KGY------  221 (258)
T ss_pred             ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHh---cCC------
Confidence            42222222336789999999988889999999999999999998 78887642221     1111111   111      


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML  352 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  352 (401)
                         ........+.++.+++.+||+.+|++|||+.++++.|
T Consensus       222 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 ---RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ---CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence               0111222456788999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=9.7e-40  Score=311.13  Aligned_cols=252  Identities=20%  Similarity=0.248  Sum_probs=195.7

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ++|+..+.||+|+||.||++..+ ++..||+|++...  ........+..|+.++..++|||++++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999965 5889999998632  22334567888999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++|+|.+++..    ...++...+..++.|++.||.|||+.   +++||||||+|||++.++.++|+|||++.....
T Consensus        81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            99999999999875    34588999999999999999999999   999999999999999999999999999874422


Q ss_pred             CCc----------------------------------ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCC
Q 015734          234 KLT----------------------------------HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ  279 (401)
Q Consensus       234 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~  279 (401)
                      ...                                  .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence            100                                  0112346899999999999999999999999999999999999


Q ss_pred             CCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 015734          280 RAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP---MAQVVK  350 (401)
Q Consensus       280 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~~vl~  350 (401)
                      .||.......        ............. +.+     ......++.+++.+|+ .+|.+|++   +.++++
T Consensus       234 ~Pf~~~~~~~--------~~~~i~~~~~~~~-~p~-----~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         234 PPFCSETPQE--------TYRKVMNWKETLV-FPP-----EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCCCCHHH--------HHHHHHcCCCcee-cCC-----CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            9997544321        1111111000000 000     0112346677777766 49999986   455544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4e-39  Score=313.11  Aligned_cols=262  Identities=22%  Similarity=0.257  Sum_probs=195.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      ..+|.+.+.||+|+||.||++.+. +++.||+|...       ...+.+|++++++++|+||+++++++...+..+++|+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            346889999999999999999975 47889999532       2345789999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      ++. ++|..++...   ...+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++.....
T Consensus       241 ~~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~  313 (461)
T PHA03211        241 KYR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS  313 (461)
T ss_pred             ccC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence            995 6888877642   23689999999999999999999999   9999999999999999999999999999865432


Q ss_pred             Ccc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCC-CCCcchh--hhhhhHHHHHHHHhc-cCccc
Q 015734          235 LTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI-DFSRLEE--EEDVLLLDHIRKLLR-EDRLN  309 (401)
Q Consensus       235 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~-~~~~~~~--~~~~~~~~~~~~~~~-~~~~~  309 (401)
                      ... ......||+.|+|||++.+..++.++|||||||++|||++|..|+ .......  .....+...+..... .....
T Consensus       314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~  393 (461)
T PHA03211        314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP  393 (461)
T ss_pred             cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence            221 223456899999999999999999999999999999999987654 2211100  001111111111100 00000


Q ss_pred             hhc---------c---C-cCCC----CCH---HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          310 DIV---------D---R-NLNT----YDS---KEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       310 ~~~---------d---~-~~~~----~~~---~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ...         .   . ....    .+.   ....++.+|+.+||+.||.+|||+.|++++
T Consensus       394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            000         0   0 0000    001   123467889999999999999999999875

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.1e-39  Score=293.93  Aligned_cols=250  Identities=24%  Similarity=0.369  Sum_probs=199.9

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCc--------chHHHHHHHHHHHHhccCCcccceeeeeecCCe
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP--------GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE  148 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  148 (401)
                      +|.+...||+|++|.||+|... ++..+|+|.+......        ...+.+.+|+.++++++|||++++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4778899999999999999864 5789999988643211        123568889999999999999999999999999


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      .++++||+++++|..++...    ..+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||.+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~  153 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS  153 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence            99999999999999999763    4578899999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCCcc-----eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHh
Q 015734          229 KLVDAKLTH-----VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL  303 (401)
Q Consensus       229 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  303 (401)
                      +........     ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......        ..+....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~  225 (267)
T cd06628         154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--------QAIFKIG  225 (267)
T ss_pred             cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--------HHHHHHh
Confidence            866432111     112235788999999998888999999999999999999999999743211        0011110


Q ss_pred             ccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          304 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       304 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .         ...+..+......+.+++.+||+.+|.+||++.+++++
T Consensus       226 ~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         226 E---------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             c---------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            0         00111223345678899999999999999999999763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.1e-39  Score=296.70  Aligned_cols=263  Identities=24%  Similarity=0.291  Sum_probs=204.9

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecC--CeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  153 (401)
                      ++|...+.||.|++|.||++... +++.+|+|.+...........+.+|+++++.++||||+++++++...  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36778889999999999999974 57899999987544445567899999999999999999999988654  4679999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++++|.+++.........++......++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999988775444456688999999999999999999998   999999999999999999999999999875433


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      ...   ....++..|+|||.+.+..++.++||||||+++|+|++|..||+..............+...    .....+.+
T Consensus       158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  230 (287)
T cd06621         158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPELKD  230 (287)
T ss_pred             ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhhcc
Confidence            221   23346889999999998899999999999999999999999997543211111111121111    00011100


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      . . .........+.+++.+||+.+|++|||+.|++++
T Consensus       231 ~-~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         231 E-P-GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             C-C-CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            0 0 0011235678899999999999999999999874

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.8e-40  Score=333.90  Aligned_cols=259  Identities=19%  Similarity=0.244  Sum_probs=200.9

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeec--CCe
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--SSE  148 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~  148 (401)
                      ....++|.+.+.||+|+||+||++... ++..+|+|.+... ........+..|+.++..++||||+++++++..  ...
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            345578999999999999999999965 4678999988632 234456788999999999999999999998754  346


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEEeCCCCCceEEcC--------
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN----PKIIHRDLKAANILLDD--------  216 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~i~H~dlkp~Nill~~--------  216 (401)
                      .++||||+++++|..+|.........+++..++.|+.||+.||+|||+...    .+|+|+||||+|||++.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            899999999999999998654444579999999999999999999998521    25999999999999964        


Q ss_pred             ---------CCcEEEeecCCccccCCCCcceeccccCCccccccccccc--CCCCcccchhHHHHHHHHHHhCCCCCCCC
Q 015734          217 ---------NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFS  285 (401)
Q Consensus       217 ---------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDi~slG~ll~elltg~~p~~~~  285 (401)
                               .+.+||+|||++.......  ......||+.|+|||++.+  ..++.++|||||||++|+|+||..||...
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                     3358999999998654322  2234568999999999854  45889999999999999999999999743


Q ss_pred             cchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          286 RLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                      ...       ...+.......        .++  ....+.++.+|+..||+.+|.+||++.+++.
T Consensus       247 ~~~-------~qli~~lk~~p--------~lp--i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        247 NNF-------SQLISELKRGP--------DLP--IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CcH-------HHHHHHHhcCC--------CCC--cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            221       11111111110        000  1123457889999999999999999999984

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.1e-39  Score=294.37  Aligned_cols=254  Identities=26%  Similarity=0.360  Sum_probs=190.2

Q ss_pred             eeeecCcEEEEEEEECC---CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCCc
Q 015734           84 IIGQGGFGKVYKGVLSD---NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS  160 (401)
Q Consensus        84 ~lG~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  160 (401)
                      .||+|+||.||+|...+   ...+++|.+...........+.+|+..++.++||||+++++.+......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997533   356888887654444456678899999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcc-e
Q 015734          161 VAYRLRDLKPG-EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH-V  238 (401)
Q Consensus       161 L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~  238 (401)
                      |.+++...... ....++.....++.|++.||+|||++   +++||||||+||++++++.+||+|||++......... .
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            99999864422 23356778899999999999999999   9999999999999999999999999998654322111 1


Q ss_pred             eccccCCccccccccccc-------CCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccch
Q 015734          239 TTQIRGTMGHIAPEYLST-------GKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND  310 (401)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      .....++..|+|||++..       ..++.++|||||||++|||++ |..||......+    .    ........ ...
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----~----~~~~~~~~-~~~  229 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ----V----LKQVVREQ-DIK  229 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH----H----HHHHhhcc-Ccc
Confidence            122345678999998743       356889999999999999999 778886432211    1    11111111 111


Q ss_pred             hccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       311 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                      +..+.   ........+.+++..|| .||++|||+++|++.|.
T Consensus       230 ~~~~~---~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         230 LPKPQ---LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCCc---ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            11111   12233455667777888 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-39  Score=297.12  Aligned_cols=256  Identities=25%  Similarity=0.381  Sum_probs=203.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC-CC----EEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSD-NT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI  150 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  150 (401)
                      ..+|.+.+.||+|+||.||+|..++ +.    .+|+|.+...........+.+|+.++..++|||++++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            4578888999999999999998643 32    5899988755444556788999999999999999999999987 7889


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      +++||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||+++.
T Consensus        85 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          85 LITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             EEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence            999999999999998763   23489999999999999999999998   999999999999999999999999999986


Q ss_pred             cCCCCccee-ccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          231 VDAKLTHVT-TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       231 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ......... ....++..|+|||.+....++.++|+||||+++||+++ |..||......+     +.+.+.    ... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~----~~~-  228 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-----IPDLLE----KGE-  228 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-----HHHHHh----CCC-
Confidence            643322211 11223568999999988889999999999999999999 999987543211     111111    110 


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                             ....+......+.+++.+||..+|.+||++.++++.|...
T Consensus       229 -------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         229 -------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                   0111122335688999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-39  Score=293.16  Aligned_cols=257  Identities=22%  Similarity=0.247  Sum_probs=205.9

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEECC-CCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCee
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  149 (401)
                      .+..+.|...+.||+|.-|+||++..++ +..+|+|++.+..  +.........|-++|+.++||.+..+++.+......
T Consensus        73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~  152 (459)
T KOG0610|consen   73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS  152 (459)
T ss_pred             ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence            3345567778899999999999999764 6899999996422  233456778899999999999999999999999999


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      |++||||+||+|...++...  ++.++...++.++..++.||+|||-.   |||+|||||+||||.++|++.|+||.++.
T Consensus       153 cl~meyCpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~  227 (459)
T KOG0610|consen  153 CLVMEYCPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSL  227 (459)
T ss_pred             EEEEecCCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccc
Confidence            99999999999999888643  56799999999999999999999999   99999999999999999999999999875


Q ss_pred             ccCC---------------------------------C-C---------------------cceeccccCCccccccccc
Q 015734          230 LVDA---------------------------------K-L---------------------THVTTQIRGTMGHIAPEYL  254 (401)
Q Consensus       230 ~~~~---------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~  254 (401)
                      ....                                 . .                     ......++||-.|+|||++
T Consensus       228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI  307 (459)
T KOG0610|consen  228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI  307 (459)
T ss_pred             cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence            3210                                 0 0                     0012235689999999999


Q ss_pred             ccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHc
Q 015734          255 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLC  334 (401)
Q Consensus       255 ~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~c  334 (401)
                      .+...+.+.|+|+|||++|||+.|.-||.+.+..+    .    +...+...       ..++. .+..+....+||+..
T Consensus       308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~----T----l~NIv~~~-------l~Fp~-~~~vs~~akDLIr~L  371 (459)
T KOG0610|consen  308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE----T----LRNIVGQP-------LKFPE-EPEVSSAAKDLIRKL  371 (459)
T ss_pred             ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh----h----HHHHhcCC-------CcCCC-CCcchhHHHHHHHHH
Confidence            99999999999999999999999999998765432    1    11111111       11111 224556788999999


Q ss_pred             ccCCCCCCCC----HHHHHH
Q 015734          335 TQSTPEDRPP----MAQVVK  350 (401)
Q Consensus       335 l~~~p~~RPs----~~~vl~  350 (401)
                      |.+||.+|..    +.||-+
T Consensus       372 LvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  372 LVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             hccChhhhhccccchHHhhc
Confidence            9999999998    666643

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.5e-39  Score=310.26  Aligned_cols=265  Identities=19%  Similarity=0.267  Sum_probs=197.7

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecC------
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------  146 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  146 (401)
                      ..++|...+.||+|+||.||++... .++.||+|++.... .......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3578999999999999999999964 58899999987432 334456788999999999999999999887543      


Q ss_pred             CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecC
Q 015734          147 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG  226 (401)
Q Consensus       147 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  226 (401)
                      ...++||||+++ +|...+..      .+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence            356999999965 66666642      377889999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHH----------
Q 015734          227 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL----------  296 (401)
Q Consensus       227 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~----------  296 (401)
                      +++......  ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.....+.          
T Consensus       172 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         172 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             CccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            998654322  22334689999999999999999999999999999999999999976543211110000          


Q ss_pred             ----HHHHHHhccCc-c-----chhccCcC----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          297 ----DHIRKLLREDR-L-----NDIVDRNL----NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       297 ----~~~~~~~~~~~-~-----~~~~d~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                          ........... .     ........    .........++.+++.+||+.||.+|||+.+++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                00000000000 0     00000000    00111123567899999999999999999999775

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.8e-39  Score=294.57  Aligned_cols=256  Identities=23%  Similarity=0.345  Sum_probs=203.2

Q ss_pred             CCCCCCeeeecCcEEEEEEEECC--CCEEEEEEeccc---------CCcchHHHHHHHHHHHHh-ccCCcccceeeeeec
Q 015734           78 NFSESNIIGQGGFGKVYKGVLSD--NTKVAVKRLQDY---------YSPGGEAAFQREVHLISV-AIHKNLLQLIGYCTT  145 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~---------~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~  145 (401)
                      +|++.+.||+|+||.||+|..+.  +..+|+|.+...         ........+..|+.++.+ ++|||++++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788899999999999999754  688999987521         122344567788888865 799999999999999


Q ss_pred             CCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeec
Q 015734          146 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF  225 (401)
Q Consensus       146 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  225 (401)
                      .+..+++|||+++++|.+++.........+++..++.++.|++.||.|||+..  +++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999988765444567899999999999999999999631  7999999999999999999999999


Q ss_pred             CCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhcc
Q 015734          226 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE  305 (401)
Q Consensus       226 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (401)
                      |++.......  ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......     .   .... ..
T Consensus       159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~-----~---~~~~-~~  227 (269)
T cd08528         159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS-----L---ATKI-VE  227 (269)
T ss_pred             cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH-----H---HHHH-hh
Confidence            9998655432  2334567889999999998889999999999999999999999986432211     1   1111 11


Q ss_pred             CccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          306 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       306 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                      ......       ........+.+++.+||+.||++||++.++..++.
T Consensus       228 ~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         228 AVYEPL-------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ccCCcC-------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            111110       01123457889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.4e-39  Score=304.47  Aligned_cols=266  Identities=19%  Similarity=0.214  Sum_probs=194.1

Q ss_pred             CCCeeeec--CcEEEEEEEE-CCCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecc
Q 015734           81 ESNIIGQG--GFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM  156 (401)
Q Consensus        81 ~~~~lG~G--~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  156 (401)
                      +.++||+|  +|++||++.. .+|..||+|++.... .......+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  7899999986 468999999987432 2334567788999999999999999999999999999999999


Q ss_pred             cCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCc
Q 015734          157 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT  236 (401)
Q Consensus       157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  236 (401)
                      ++++|.+++....  ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++.++++||+..........
T Consensus        82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            9999999986532  23588999999999999999999998   999999999999999999999999986543321111


Q ss_pred             c------eeccccCCccccccccccc--CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhc----
Q 015734          237 H------VTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR----  304 (401)
Q Consensus       237 ~------~~~~~~gt~~y~aPE~~~~--~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----  304 (401)
                      .      ......++..|+|||++.+  ..++.++|||||||++|||++|..||................+.....    
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence            0      1112245778999999876  458899999999999999999999997432211000000000000000    


Q ss_pred             -cCcc-----chhccC------------------cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          305 -EDRL-----NDIVDR------------------NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       305 -~~~~-----~~~~d~------------------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                       ...+     ....+.                  ............+.+++.+||+.||++|||+++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence             0000     000000                  0001122335678899999999999999999999764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.7e-39  Score=299.62  Aligned_cols=264  Identities=22%  Similarity=0.308  Sum_probs=203.7

Q ss_pred             CHHHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeee-
Q 015734           68 SCRELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT-  144 (401)
Q Consensus        68 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~-  144 (401)
                      .++.+..+.++|.+.+.||+|+||.||++... +++.+|+|.+...  ......+.+|+.+++.+ +|||++++++++. 
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI--HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc--cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            34555667889999999999999999999864 5789999987542  22345678899999998 6999999999874 


Q ss_pred             ----cCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcE
Q 015734          145 ----TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA  220 (401)
Q Consensus       145 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~  220 (401)
                          ..+..+++|||+++++|.+++.........+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence                34568999999999999998875443445688999999999999999999998   99999999999999999999


Q ss_pred             EEeecCCccccCCCCcceeccccCCccccccccccc-----CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhH
Q 015734          221 VLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL  295 (401)
Q Consensus       221 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~  295 (401)
                      +|+|||++........ ......|++.|+|||++..     ..++.++|||||||++|+|++|..||.......    ..
T Consensus       164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~----~~  238 (286)
T cd06638         164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR----AL  238 (286)
T ss_pred             EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH----HH
Confidence            9999999876543221 1223458899999999853     447889999999999999999999986432210    00


Q ss_pred             HHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 015734          296 LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML  352 (401)
Q Consensus       296 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  352 (401)
                          ... .........+      +.....++.+++.+||+.+|++|||+.++++++
T Consensus       239 ----~~~-~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         239 ----FKI-PRNPPPTLHQ------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             ----hhc-cccCCCcccC------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence                000 0000000001      112235688999999999999999999998764

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-39  Score=291.83  Aligned_cols=254  Identities=23%  Similarity=0.279  Sum_probs=204.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      .++|...+.||+|+||.||+|... ++..+++|.+..... .....+.+|+.+++.++|||++++++++...+..+++||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e   80 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME   80 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch-hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence            467889999999999999999964 578899999874322 356788999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+.+++|.+++...   ...++...+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          81 YCGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             CCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence            99999999988763   24588999999999999999999998   9999999999999999999999999998765432


Q ss_pred             CcceeccccCCcccccccccccC---CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTG---KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      .. ......++..|+|||.+.+.   .++.++|+||||+++|+|+||..||.........        .... ...    
T Consensus       155 ~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~--------~~~~-~~~----  220 (262)
T cd06613         155 IA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL--------FLIS-KSN----  220 (262)
T ss_pred             hh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--------HHHH-hcc----
Confidence            21 12234578899999998776   7889999999999999999999998753321110        0000 000    


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                      +.+.........+.++.+++.+||+.+|.+|||+++++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         221 FPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             CCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            001111123445677899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.7e-39  Score=292.75  Aligned_cols=253  Identities=22%  Similarity=0.299  Sum_probs=204.5

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeec--CCeeEEEE
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--SSERILVY  153 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  153 (401)
                      +|++.+.||.|+||.||++... ++..+++|.+... ......+.+..|+++++.++|||++++++++..  ....++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4778899999999999999854 6789999988642 344456678899999999999999999997754  34578999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH-----EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      ||+++++|.+++.........+++..++.++.|++.||.|||     +.   +++|+||+|+||++++++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999999875544567999999999999999999999     66   8999999999999999999999999998


Q ss_pred             cccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ......... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||......     ...+.+.    ..  
T Consensus       158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~----~~--  225 (265)
T cd08217         158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL-----QLASKIK----EG--  225 (265)
T ss_pred             ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH-----HHHHHHh----cC--
Confidence            866543321 22345889999999998888999999999999999999999999754321     1111111    11  


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                            .....+.....++.+++.+||+.+|.+||++.+|+++
T Consensus       226 ------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         226 ------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                  1112233445678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.2e-39  Score=293.05  Aligned_cols=249  Identities=29%  Similarity=0.412  Sum_probs=191.3

Q ss_pred             CeeeecCcEEEEEEEECC----CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeec-CCeeEEEEeccc
Q 015734           83 NIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSERILVYPFMQ  157 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~  157 (401)
                      +.||+|+||.||+|...+    +..+|+|.+...........+.+|+.+++.++|||++++++++.. .+..++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998532    357999988644344456788899999999999999999998754 456789999999


Q ss_pred             CCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcc
Q 015734          158 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH  237 (401)
Q Consensus       158 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  237 (401)
                      +++|.+++....   ...++.....++.|++.||+|||+.   +++|+||||+||++++++.+||+|||+++........
T Consensus        81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          81 HGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            999999987532   2367778889999999999999998   9999999999999999999999999998755332111


Q ss_pred             ---eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhC-CCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          238 ---VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG-QRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       238 ---~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                         ......++..|+|||.+.+..++.++||||||+++|||++| .+||......     ..   .........      
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-----~~---~~~~~~~~~------  220 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF-----DI---TVYLLQGRR------  220 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH-----HH---HHHHhcCCC------
Confidence               11223456789999999888899999999999999999995 4556532211     11   111111100      


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                         ...+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       221 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~  258 (262)
T cd05058         221 ---LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ  258 (262)
T ss_pred             ---CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence               01111224578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2e-39  Score=297.74  Aligned_cols=248  Identities=25%  Similarity=0.357  Sum_probs=200.8

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecc
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM  156 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  156 (401)
                      .|+..+.||+|+||.||+|.+. ++..||+|.+...........+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4556678999999999999864 578899998874444455678899999999999999999999999999999999999


Q ss_pred             cCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCc
Q 015734          157 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT  236 (401)
Q Consensus       157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  236 (401)
                      ++++|.+++..     ..+++..+..++.|++.|+.|||++   +++|+||+|+||++++++.++|+|||++........
T Consensus        85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            99999988753     3588999999999999999999998   999999999999999999999999999876543221


Q ss_pred             ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcC
Q 015734          237 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL  316 (401)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  316 (401)
                       ......++..|+|||.+.+..++.++|+||||+++|||++|..|+.......     ..   . .....        ..
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~~---~-~~~~~--------~~  218 (277)
T cd06642         157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-----VL---F-LIPKN--------SP  218 (277)
T ss_pred             -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-----HH---h-hhhcC--------CC
Confidence             1222457889999999998889999999999999999999999986332110     00   0 00000        01


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          317 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       317 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      +......+.++.+++.+||+.+|++||++.+++++
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            11223345678899999999999999999999885

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5.6e-39  Score=297.72  Aligned_cols=251  Identities=20%  Similarity=0.294  Sum_probs=202.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      ..+|+..+.||+|+||.||+|... ++..|++|.+..... .....+.+|+.+++.+.|+|++++++.+......++|||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e   97 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence            357888999999999999999954 688999998864332 345678899999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++++|.+++..     ..+++.....++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        98 ~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~  169 (296)
T cd06654          98 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (296)
T ss_pred             ccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence            9999999998864     2478899999999999999999999   9999999999999999999999999998754332


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccC
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR  314 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  314 (401)
                      .. ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||.......    ..   .. ..... ...    
T Consensus       170 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~----~~---~~-~~~~~-~~~----  235 (296)
T cd06654         170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----AL---YL-IATNG-TPE----  235 (296)
T ss_pred             cc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH----hH---HH-HhcCC-CCC----
Confidence            21 1223457889999999988889999999999999999999999997543211    00   00 00000 000    


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          315 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       315 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                       . ..+......+.+++.+||+.+|++||++.+++++
T Consensus       236 -~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         236 -L-QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             -C-CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence             0 1123344678899999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-39  Score=306.43  Aligned_cols=258  Identities=22%  Similarity=0.304  Sum_probs=194.7

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecC------
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------  146 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  146 (401)
                      ..++|...+.||+|+||+||+|.. .++..||+|++.... .......+.+|+.+++.++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            457899999999999999999996 467899999986432 223345677899999999999999999877543      


Q ss_pred             CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecC
Q 015734          147 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG  226 (401)
Q Consensus       147 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  226 (401)
                      ...+++++++ +++|...+..     ..+++..+..++.|++.||.|||++   +++||||||+||++++++.+||+|||
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence            3468899988 7788877653     3589999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhcc
Q 015734          227 LAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE  305 (401)
Q Consensus       227 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (401)
                      ++......    .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||........    +.. .......
T Consensus       164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~-~~~~~~~  234 (343)
T cd07878         164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ----LKR-IMEVVGT  234 (343)
T ss_pred             cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH----HHH-HHHHhCC
Confidence            99865432    223458999999999876 5689999999999999999999999975432111    000 0000000


Q ss_pred             -----------CccchhccCcCCCC--------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          306 -----------DRLNDIVDRNLNTY--------DSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       306 -----------~~~~~~~d~~~~~~--------~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                                 ....... ..++..        .......+.+++.+||+.||.+|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         235 PSPEVLKKISSEHARKYI-QSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             CCHHHHHhcchhhHHHHh-hccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                       0000000 000000        01122357799999999999999999999764

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.5e-39  Score=295.52  Aligned_cols=266  Identities=21%  Similarity=0.313  Sum_probs=201.0

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      ++|+..+.||+|+||.||+|..+ +++.||+|++.... .....+.+.+|+.+++.++|||++++++++...+..+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888999999999999999975 58899999886432 23344678899999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++++|...+..    ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            9999888776654    33589999999999999999999998   9999999999999999999999999999866443


Q ss_pred             CcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHH-------HhccC
Q 015734          235 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK-------LLRED  306 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~  306 (401)
                      .. ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||......+... ........       .....
T Consensus       154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07847         154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY-LIRKTLGDLIPRHQQIFSTN  231 (286)
T ss_pred             cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCChHHhhhcccc
Confidence            22 1223347889999999866 457899999999999999999999997544321110 00000000       00000


Q ss_pred             cc-chhccCcCC------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          307 RL-NDIVDRNLN------TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       307 ~~-~~~~d~~~~------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .. .....+...      ...+.....+.+++.+||+.+|++||++.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            00 000000000      0012235678899999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=6.5e-39  Score=293.46  Aligned_cols=253  Identities=24%  Similarity=0.341  Sum_probs=197.8

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeeecC------
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS------  146 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~------  146 (401)
                      +.+.|+..+.||+|+||.||+|... +++.||+|.+...  ......+..|+.++.++ +|||++++++++...      
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC--CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            5667888999999999999999964 5788999998642  23456788999999988 699999999998653      


Q ss_pred             CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecC
Q 015734          147 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG  226 (401)
Q Consensus       147 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  226 (401)
                      ...+++|||+.+++|.+++....  ...+++..+..++.|++.||+|||++   +++|+||||+||++++++.++|+|||
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg  156 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG  156 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence            35789999999999999988632  34588999999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCcceeccccCCcccccccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHH
Q 015734          227 LAKLVDAKLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK  301 (401)
Q Consensus       227 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~  301 (401)
                      ++........ ......|++.|+|||++.     ...++.++|||||||++|||++|..||........       .. .
T Consensus       157 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-------~~-~  227 (272)
T cd06637         157 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-------LF-L  227 (272)
T ss_pred             Cceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-------HH-H
Confidence            9876543222 223356889999999985     33578899999999999999999999864321110       00 0


Q ss_pred             HhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          302 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       302 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .. .......       .....+.++.+++.+||+.+|.+|||+.+++++
T Consensus       228 ~~-~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         228 IP-RNPAPRL-------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             Hh-cCCCCCC-------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            00 0000000       112234578899999999999999999999753

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=9.5e-39  Score=293.33  Aligned_cols=250  Identities=25%  Similarity=0.349  Sum_probs=204.7

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      ..|+..+.||+|+||.||+|.+. ++..||+|.+...........+.+|+.+++.++|||++++++++.+.+..++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45777888999999999999965 57899999887544445567889999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +++++|.+++..     .++++.....++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            999999998864     3478889999999999999999998   99999999999999999999999999987654332


Q ss_pred             cceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCc
Q 015734          236 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN  315 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  315 (401)
                      . ......++..|+|||.+.+..++.++|+||||+++|||+||..||.......     .   .. .....        .
T Consensus       156 ~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~---~~-~~~~~--------~  217 (277)
T cd06640         156 I-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-----V---LF-LIPKN--------N  217 (277)
T ss_pred             c-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-----H---hh-hhhcC--------C
Confidence            1 1223457889999999988889999999999999999999999986433211     0   00 00000        0


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 015734          316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML  352 (401)
Q Consensus       316 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  352 (401)
                      .+......+..+.+++..||+.+|++||++.+++++-
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06640         218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK  254 (277)
T ss_pred             CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence            1123345667889999999999999999999997763

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=5.2e-39  Score=291.44  Aligned_cols=251  Identities=20%  Similarity=0.320  Sum_probs=203.6

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      +|+..+.||+|+||.+|++... +++.|++|.+... ........+.+|+.+++.++|||++++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4788899999999999999954 6789999998632 2334556889999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +.+++|.+++....  ...+++.....++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            99999999887532  23578899999999999999999998   99999999999999999999999999987654332


Q ss_pred             cceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCc
Q 015734          236 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN  315 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  315 (401)
                      .. .....+++.|+|||.+.+..++.++|+||||+++++|++|..||......        +.+......         .
T Consensus       156 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--------~~~~~~~~~---------~  217 (256)
T cd08218         156 EL-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK--------NLVLKIIRG---------S  217 (256)
T ss_pred             hh-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH--------HHHHHHhcC---------C
Confidence            21 22345788999999998888999999999999999999999998743321        111111111         1


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       316 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ....+.....++.+++.+||+.+|.+||++.+++++
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         218 YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            111223345678899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.9e-39  Score=291.85  Aligned_cols=240  Identities=23%  Similarity=0.357  Sum_probs=187.3

Q ss_pred             CeeeecCcEEEEEEEECC-------------CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCee
Q 015734           83 NIIGQGGFGKVYKGVLSD-------------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  149 (401)
                      +.||+|+||.||+|...+             ...+++|.+... .......+.+|+.+++.++||||+++++++......
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS-HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh-hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            468999999999998432             225888887542 233455788899999999999999999999999999


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCc-------EEE
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE-------AVL  222 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~-------~kl  222 (401)
                      +++|||+++++|..++...   ...+++..+..++.|++.||+|||++   +++|+||||+|||++.++.       +++
T Consensus        80 ~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l  153 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL  153 (262)
T ss_pred             EEEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence            9999999999998887642   34589999999999999999999998   9999999999999987664       899


Q ss_pred             eecCCccccCCCCcceeccccCCcccccccccc-cCCCCcccchhHHHHHHHHHH-hCCCCCCCCcchhhhhhhHHHHHH
Q 015734          223 CDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS-TGKSSEKTDVFGYGITLLELV-TGQRAIDFSRLEEEEDVLLLDHIR  300 (401)
Q Consensus       223 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDi~slG~ll~ell-tg~~p~~~~~~~~~~~~~~~~~~~  300 (401)
                      +|||++......     ....++..|+|||.+. +..++.++|||||||++|||+ +|..|+......+.         .
T Consensus       154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---------~  219 (262)
T cd05077         154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK---------E  219 (262)
T ss_pred             CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH---------H
Confidence            999998654322     2234678899999886 466899999999999999997 58888764322110         0


Q ss_pred             HHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          301 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       301 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                      .... ...         ........++.+++.+||+.||.+||++.++++.++
T Consensus       220 ~~~~-~~~---------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         220 RFYE-GQC---------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             HHHh-cCc---------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            0000 000         001122356889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.9e-39  Score=310.14  Aligned_cols=261  Identities=22%  Similarity=0.261  Sum_probs=198.7

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC---CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      ...+|.+.+.||+|+||.||++...   .+..|++|.+...      ....+|+++++.++||||+++++++......++
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l  163 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM  163 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence            4557999999999999999999753   3578999987542      234689999999999999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      +||++. ++|.+++..    ...+++..+..++.|++.||.|||++   +++||||||+|||++.++.++|+|||++...
T Consensus       164 v~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        164 VMPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             EehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            999995 688887743    35689999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCc-ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccc-
Q 015734          232 DAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN-  309 (401)
Q Consensus       232 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  309 (401)
                      ..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+...... ....... 
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~l~~i~~~-~~~~~~~~  313 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-SSSQLRSIIRC-MQVHPLEF  313 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-cHHHHHHHHHH-hccCcccc
Confidence            43322 22234568999999999999999999999999999999999999996543321 11111111111 1000000 


Q ss_pred             -------------hh---ccCc--CCCC--CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          310 -------------DI---VDRN--LNTY--DSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       310 -------------~~---~d~~--~~~~--~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                                   ..   ..+.  .+..  ......++.+++.+||..||++|||+.+++.+
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                         00   0000  0000  01123567889999999999999999999775

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.8e-39  Score=294.62  Aligned_cols=264  Identities=25%  Similarity=0.361  Sum_probs=204.4

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-----CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeec--CCee
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--SSER  149 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  149 (401)
                      +.|...+.||+|+||.||++..+     ++..+|+|.+...........+.+|+++++.+.|||++++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45777899999999999999853     3678999998754333356789999999999999999999999877  5578


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      +++|||+++++|.+++....   ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence            99999999999999997632   3589999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCcce--eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhh------h-hhHHHHHH
Q 015734          230 LVDAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE------D-VLLLDHIR  300 (401)
Q Consensus       230 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~------~-~~~~~~~~  300 (401)
                      .........  .....++..|+|||.+.+..++.++||||||+++|||+||..|+.........      . ........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            665322211  11223456799999998888999999999999999999999998643221100      0 00001111


Q ss_pred             HHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          301 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       301 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                      .......         ...+...+.++.+++.+||+.+|.+|||+.++++.|+..
T Consensus       238 ~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         238 LLKEGER---------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHcCCc---------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1100000         011223346789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-38  Score=301.90  Aligned_cols=193  Identities=24%  Similarity=0.326  Sum_probs=164.6

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      ....+|.+.+.||+|+||.||+|... ++..||+|.....       ....|+.++++++||||+++++++...+..++|
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence            45568999999999999999999965 4678999975431       234689999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      +|++. ++|.+++..   ....+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++....
T Consensus       136 ~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        136 LPHYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             EEccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence            99995 588887764   235689999999999999999999999   99999999999999999999999999987533


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCC
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI  282 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~  282 (401)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       209 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        209 VAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            221  223345899999999999999999999999999999999966554

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.3e-38  Score=290.42  Aligned_cols=257  Identities=28%  Similarity=0.404  Sum_probs=206.2

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      ++|++.+.||.|+||+||+|... ++..+++|++...........+.+|++.++.++|+|++++++.+...+..++++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47889999999999999999954 57889999987544344678899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +++++|.+++..... ...+++.....++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            999999999976432 24588999999999999999999998   99999999999999999999999999987665432


Q ss_pred             cc---eeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          236 TH---VTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       236 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ..   ......++..|+|||.+... .++.++|+||||+++|+|++|..||.......    .    ........     
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----~----~~~~~~~~-----  223 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK----V----LMLTLQND-----  223 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh----h----HHHHhcCC-----
Confidence            22   22334578899999998776 78999999999999999999999997433211    1    11111110     


Q ss_pred             ccCcCCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          312 VDRNLNT--YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       312 ~d~~~~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                       .+....  .....+..+.+++..||+.||++||++.+++++
T Consensus       224 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         224 -PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             -CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence             001111  012445678899999999999999999999764

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4.6e-39  Score=316.51  Aligned_cols=267  Identities=19%  Similarity=0.246  Sum_probs=192.2

Q ss_pred             HHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccC------Ccccceeeee
Q 015734           71 ELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH------KNLLQLIGYC  143 (401)
Q Consensus        71 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~~~~~  143 (401)
                      ++....++|.+.+.||+|+||+||+|.+. ++..||||+++..  ......+..|+.++..+.|      ++++++++++
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV--PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc--hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            44556788999999999999999999964 5788999998642  2233455667777766654      4588888888


Q ss_pred             ecC-CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCceEEcCCC---
Q 015734          144 TTS-SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNF---  218 (401)
Q Consensus       144 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~---  218 (401)
                      ... ...++||+++ +++|.+++..    ...+++..+..++.|++.||.|||+ .   +|+||||||+|||++.++   
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~  272 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVV  272 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccc
Confidence            655 4678899988 7788888875    2458999999999999999999997 5   899999999999998765   


Q ss_pred             -------------cEEEeecCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCC
Q 015734          219 -------------EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS  285 (401)
Q Consensus       219 -------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~  285 (401)
                                   .+||+|||.+.....    ......||+.|+|||++.+..++.++|||||||++|||++|+.||+..
T Consensus       273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~  348 (467)
T PTZ00284        273 DPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH  348 (467)
T ss_pred             ccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                         499999998764322    223456899999999999999999999999999999999999999764


Q ss_pred             cchhhhhhhH-------HHHHH--------HHhcc-CccchhccCc-----CC--C-CCHHHHHHHHHHHHHcccCCCCC
Q 015734          286 RLEEEEDVLL-------LDHIR--------KLLRE-DRLNDIVDRN-----LN--T-YDSKEVETMVQVALLCTQSTPED  341 (401)
Q Consensus       286 ~~~~~~~~~~-------~~~~~--------~~~~~-~~~~~~~d~~-----~~--~-~~~~~~~~l~~l~~~cl~~~p~~  341 (401)
                      ...+......       ..+..        ..... ..+....++.     ..  . ........+.+|+..||+.||.+
T Consensus       349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~  428 (467)
T PTZ00284        349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK  428 (467)
T ss_pred             ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence            4321110000       00000        00000 0000000000     00  0 00011345779999999999999


Q ss_pred             CCCHHHHHHH
Q 015734          342 RPPMAQVVKM  351 (401)
Q Consensus       342 RPs~~~vl~~  351 (401)
                      |||++|++++
T Consensus       429 R~ta~e~L~H  438 (467)
T PTZ00284        429 RLNARQMTTH  438 (467)
T ss_pred             CCCHHHHhcC
Confidence            9999999764

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.2e-38  Score=291.19  Aligned_cols=256  Identities=21%  Similarity=0.303  Sum_probs=199.1

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      +..++++.....||+|+||.||+|.+. ++..|++|.+... .....+.+.+|+.+++.++|+||+++++++...+..++
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER-DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC-CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            345566666778999999999999954 5778999988643 23345688999999999999999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC-CCcEEEeecCCc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGL--DWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFGLA  228 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfgl~  228 (401)
                      ++||+++++|.+++....   ..+  +...+..++.|++.||+|||+.   +++|+||||+||+++. ++.++|+|||++
T Consensus        83 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~  156 (268)
T cd06624          83 FMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTS  156 (268)
T ss_pred             EEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence            999999999999987521   234  7888899999999999999998   9999999999999976 679999999998


Q ss_pred             cccCCCCcceeccccCCcccccccccccCC--CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED  306 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (401)
                      ........ ......+++.|+|||.+.+..  ++.++|+||||+++|+|++|..||.........   .  +....    
T Consensus       157 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~--~~~~~----  226 (268)
T cd06624         157 KRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---M--FKVGM----  226 (268)
T ss_pred             eecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---H--hhhhh----
Confidence            75533221 122235788999999986644  788999999999999999999998643211000   0  00000    


Q ss_pred             ccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       307 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                            ....+..+.....++.+++.+||+.+|.+|||+.+++++
T Consensus       227 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         227 ------FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             ------hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence                  000111223345678899999999999999999999764

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.2e-38  Score=293.34  Aligned_cols=252  Identities=25%  Similarity=0.319  Sum_probs=198.2

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecc
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM  156 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  156 (401)
                      .|++.+.||+|+||.||+|... ++..+++|.+... .......+.+|+++++.++|||++++++++...+..++|+||+
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC-CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            3567788999999999999975 4677888887532 3345677889999999999999999999999999999999999


Q ss_pred             cCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCc
Q 015734          157 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT  236 (401)
Q Consensus       157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  236 (401)
                      ++++|...+...   ..++++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        85 ~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  158 (282)
T cd06643          85 AGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ  158 (282)
T ss_pred             CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence            999998887642   34689999999999999999999998   999999999999999999999999999875433221


Q ss_pred             ceeccccCCcccccccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          237 HVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                       ......+++.|+|||++.     +..++.++|||||||++|+|++|..||.......    .    ......... ...
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~----~----~~~~~~~~~-~~~  228 (282)
T cd06643         159 -RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR----V----LLKIAKSEP-PTL  228 (282)
T ss_pred             -ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH----H----HHHHhhcCC-CCC
Confidence             223345889999999984     3457789999999999999999999986433211    1    111111000 000


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML  352 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  352 (401)
                            ..+...+.++.+++..||+.+|.+||++.+++++-
T Consensus       229 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         229 ------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             ------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence                  11222345788999999999999999999997653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.2e-38  Score=289.13  Aligned_cols=251  Identities=24%  Similarity=0.327  Sum_probs=195.1

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC----CcchHHHHHHHHHHHHhccCCcccceeeeeecC--Cee
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY----SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SER  149 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  149 (401)
                      .+|...+.||+|+||.||+|... ++..|++|.+....    .......+.+|+.+++.++||||+++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47889999999999999999964 58899999886321    123345788999999999999999999988653  567


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ++++||+++++|.+++..    ...+++.....++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence            899999999999999875    23478899999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCCc--ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          230 LVDAKLT--HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       230 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      .......  .......++..|+|||.+.+..++.++|+|||||++|||++|..||......        .......... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~--------~~~~~~~~~~-  225 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM--------AAIFKIATQP-  225 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH--------HHHHHHhcCC-
Confidence            5532211  1112345788999999998888999999999999999999999999743211        1111111000 


Q ss_pred             cchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       308 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                          ..+   ..+......+.+++ .||..+|++||++++++++
T Consensus       226 ----~~~---~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         226 ----TNP---QLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             ----CCC---CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence                011   12223344556666 6888999999999999763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.9e-39  Score=299.11  Aligned_cols=255  Identities=24%  Similarity=0.395  Sum_probs=200.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCC----EEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI  150 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  150 (401)
                      .++|...+.||+|+||.||+|.+. ++.    .+|+|.+...........+.+|+.+++.++|||++++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            456778899999999999999853 343    57889887544444456788999999999999999999998754 467


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      ++++|+++|+|.+++...   ...+++..+..++.|++.||.|||++   +++|+||||+||++++++.+||+|||+++.
T Consensus        85 ~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             eeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence            899999999999988752   33588999999999999999999998   999999999999999999999999999986


Q ss_pred             cCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          231 VDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       231 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ....... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.......     ..+..    .....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-----~~~~~----~~~~~  229 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-----IPDLL----EKGER  229 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHH----HCCCC
Confidence            5433221 1222335678999999988889999999999999999998 889986432211     11111    11110


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      .        ..+......+.+++..||..+|++||++.++++.|..
T Consensus       230 ~--------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~  267 (303)
T cd05110         230 L--------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR  267 (303)
T ss_pred             C--------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            0        0112234578899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.4e-39  Score=297.63  Aligned_cols=264  Identities=25%  Similarity=0.342  Sum_probs=204.4

Q ss_pred             cCHHHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeee
Q 015734           67 FSCRELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT  144 (401)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  144 (401)
                      +...++..+.++|.+.+.||+|+||.||++... +++.+|+|.+...  ......+.+|+.++.++ +|||++++++++.
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   89 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI--SDVDEEIEAEYNILQSLPNHPNVVKFYGMFY   89 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc--ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence            334455556889999999999999999999964 6889999988642  23346678899999988 7999999999886


Q ss_pred             cC-----CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCc
Q 015734          145 TS-----SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE  219 (401)
Q Consensus       145 ~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~  219 (401)
                      ..     +..++|+||+++++|.+++.........+++..++.++.|++.||.|||+.   +++|+||||+||++++++.
T Consensus        90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~  166 (291)
T cd06639          90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG  166 (291)
T ss_pred             eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence            54     357999999999999998875444455689999999999999999999998   9999999999999999999


Q ss_pred             EEEeecCCccccCCCCcceeccccCCcccccccccccCC-----CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhh
Q 015734          220 AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK-----SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL  294 (401)
Q Consensus       220 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~  294 (401)
                      ++|+|||++......... .....++..|+|||.+....     ++.++|||||||++|||++|+.||.......    .
T Consensus       167 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~----~  241 (291)
T cd06639         167 VKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK----T  241 (291)
T ss_pred             EEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH----H
Confidence            999999998765432221 12245788999999985433     6889999999999999999999986432211    0


Q ss_pred             HHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          295 LLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                          ....... ....+.      ........+.+++.+||+.+|++||++.+++++
T Consensus       242 ----~~~~~~~-~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         242 ----LFKIPRN-PPPTLL------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             ----HHHHhcC-CCCCCC------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                1111111 000110      122334578899999999999999999999764

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-39  Score=295.65  Aligned_cols=263  Identities=24%  Similarity=0.346  Sum_probs=197.6

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      ++|+..+.||+|++|.||+|..+ +++.||+|.+...........+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888999999999999999975 68899999987433333345677899999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +.+ +|.+++...   ...+++.....++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        85 ~~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          85 LDT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             CCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence            975 898888753   23588999999999999999999998   99999999999999999999999999987543222


Q ss_pred             cceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhcc---Cccchh
Q 015734          236 THVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE---DRLNDI  311 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  311 (401)
                      .. .....++..|+|||.+.+ ..++.++||||+|+++|+|++|..||..........    .........   ......
T Consensus       158 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~  232 (291)
T cd07844         158 KT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQL----HKIFRVLGTPTEETWPGV  232 (291)
T ss_pred             cc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH----HHHHHhcCCCChhhhhhh
Confidence            11 122346789999999865 457899999999999999999999997543211110    000000000   000000


Q ss_pred             ------c--------cCcCCCCCHHH--HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          312 ------V--------DRNLNTYDSKE--VETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       312 ------~--------d~~~~~~~~~~--~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                            .        ...+.......  ..++.+++.+||+.+|.+|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence                  0        00000000011  2567899999999999999999998753

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1e-38  Score=298.83  Aligned_cols=197  Identities=24%  Similarity=0.371  Sum_probs=159.3

Q ss_pred             CCeeeecCcEEEEEEEEC---CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeec--CCeeEEEEecc
Q 015734           82 SNIIGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--SSERILVYPFM  156 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~  156 (401)
                      ...||+|+||+||+|..+   ++..||+|.+...   .....+.+|+.+++.++|||++++++++..  ....++++||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT---GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCC---CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence            357999999999999964   3578999988642   223467889999999999999999998854  45678999998


Q ss_pred             cCCcHHHHhhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEE----cCCCcEEEeecCC
Q 015734          157 QNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGL  227 (401)
Q Consensus       157 ~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfgl  227 (401)
                      .+ +|.+.+....     .....+++..+..++.|++.||.|||+.   +++||||||+||++    +.++.+||+|||+
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            65 7776664321     1123588899999999999999999998   99999999999999    5678999999999


Q ss_pred             ccccCCCCcc--eeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCC
Q 015734          228 AKLVDAKLTH--VTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFS  285 (401)
Q Consensus       228 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~  285 (401)
                      ++........  ......+|+.|+|||.+.+. .++.++|||||||++|||+||..||...
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            9866543221  22334678999999998764 5799999999999999999999999743

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.5e-38  Score=291.77  Aligned_cols=254  Identities=25%  Similarity=0.335  Sum_probs=201.0

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      +.+.|++.+.||+|+||.||+|... ++..+++|.+... .......+.+|+.+++.++|||++++++.+...+..++||
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI   88 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence            3467899999999999999999965 4789999998642 3445677889999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++++|...+...   ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        89 e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          89 EFCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             ecCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            999999998877642   24589999999999999999999998   999999999999999999999999999875432


Q ss_pred             CCcceeccccCCcccccccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ... ......+++.|+|||++.     ...++.++|+|||||++|+|++|..||......        .......... .
T Consensus       163 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~-~  232 (292)
T cd06644         163 TLQ-RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSE-P  232 (292)
T ss_pred             ccc-ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--------HHHHHHhcCC-C
Confidence            211 122345788999999984     344688999999999999999999998643321        1111111110 0


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..     . ..+.....++.+++.+||+.+|++||++.+++++
T Consensus       233 ~~-----~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         233 PT-----L-SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             cc-----C-CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            00     0 1122344578899999999999999999999764

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.4e-38  Score=288.65  Aligned_cols=249  Identities=27%  Similarity=0.393  Sum_probs=201.4

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC----CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY----SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      +|+..+.||+|++|.||+|..+ ++..|++|.+....    .....+.+.+|+.+++.++|+|++++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4777899999999999999976 78999999886322    233557889999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      +||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~  153 (258)
T cd06632          81 LELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV  153 (258)
T ss_pred             EEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            9999999999998752    3588999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCCcceeccccCCcccccccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ...  ......++..|++||.+.... ++.++|+||||+++|+|++|..||......        ..........     
T Consensus       154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~--------~~~~~~~~~~-----  218 (258)
T cd06632         154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--------AAVFKIGRSK-----  218 (258)
T ss_pred             ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH--------HHHHHHHhcc-----
Confidence            332  223345788999999987766 899999999999999999999998643211        0111111100     


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                         .....+.....++.+++.+||+.+|.+||++.+++.+
T Consensus       219 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         219 ---ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             ---cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence               1111223345678889999999999999999999764

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.4e-38  Score=288.51  Aligned_cols=250  Identities=23%  Similarity=0.358  Sum_probs=202.1

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      +|+..+.||+|+||.||++... ++..+|+|.+... .+......+.+|+++++.++|||++++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5788899999999999999964 6889999998642 2444567889999999999999999999999989999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCC-CcEEEeecCCccccCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfgl~~~~~~~  234 (401)
                      +++++|.+++....  ...+++..+..++.+++.||.|||++   +++|+||+|+||+++++ +.++|+|||++......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            99999999997632  34588999999999999999999998   99999999999999855 46899999999866543


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccC
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR  314 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  314 (401)
                      ..  .....++..|+|||.+.+..++.++||||||+++|+|++|..||.......     .   ......         .
T Consensus       156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-----~---~~~~~~---------~  216 (256)
T cd08220         156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA-----L---VLKIMS---------G  216 (256)
T ss_pred             cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH-----H---HHHHHh---------c
Confidence            22  223457889999999998889999999999999999999999987543211     1   111111         0


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          315 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       315 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .....+.....++.+++.+||+.+|++|||+.+++++
T Consensus       217 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         217 TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            0111122345578899999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.1e-38  Score=293.69  Aligned_cols=255  Identities=21%  Similarity=0.325  Sum_probs=196.4

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHH-HHhccCCcccceeeeeecCCeeEEEEe
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHL-ISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      ++|++.+.||+|+||.||++..+ +|..||+|.+...........+..|+.. ++..+|||++++++++...+..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888999999999999999965 5899999998754333344455666665 566789999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |++ ++|.+++.........+++..+..++.|++.||+|||++.  +++|+||||+||+++.++.+||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            996 6888888765444567999999999999999999999853  7999999999999999999999999998765332


Q ss_pred             CcceeccccCCccccccccccc----CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccch
Q 015734          235 LTHVTTQIRGTMGHIAPEYLST----GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND  310 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      .  ......++..|+|||.+.+    ..++.++|+|||||++|+|++|..||.......       +....... ...  
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~-~~~--  225 (283)
T cd06617         158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-------QQLKQVVE-EPS--  225 (283)
T ss_pred             c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-------HHHHHHHh-cCC--
Confidence            1  1122457889999998864    446889999999999999999999986322110       00111110 000  


Q ss_pred             hccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       311 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                         +..  .....+.++.+++.+||+.+|.+||++++++++
T Consensus       226 ---~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         226 ---PQL--PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             ---CCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               011  011235678899999999999999999999763

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=7.7e-39  Score=295.06  Aligned_cols=262  Identities=23%  Similarity=0.274  Sum_probs=202.8

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      +|.+.+.||+|+||.||+|... +|..|++|++.... .......+.+|+.++++++|||++++++++...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788899999999999999964 68899999987433 234457899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      + +++|.+++....   ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            9 999999887532   5689999999999999999999998   99999999999999999999999999988665443


Q ss_pred             cceeccccCCcccccccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC--------
Q 015734          236 THVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED--------  306 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------  306 (401)
                      ........++..|+|||.+.+.. ++.++||||+|+++|+|++|.+||........    + ..........        
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~  228 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ----L-AIVFRTLGTPNEETWPGL  228 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH----H-HHHHHHcCCCChHHHhhc
Confidence            22233346889999999986544 68999999999999999999888764432111    1 1111110000        


Q ss_pred             ----ccchhccCc-----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          307 ----RLNDIVDRN-----LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       307 ----~~~~~~d~~-----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                          .......+.     +....+.....+.+++.+||+.+|.+||++++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                000000000     000112334788999999999999999999999765

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=306.37  Aligned_cols=241  Identities=24%  Similarity=0.274  Sum_probs=185.9

Q ss_pred             eeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhc---cCCcccceeeeeecCCeeEEEEecccC
Q 015734           85 IGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVA---IHKNLLQLIGYCTTSSERILVYPFMQN  158 (401)
Q Consensus        85 lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~  158 (401)
                      ||+|+||+||+|..+ ++..||+|++...  ........+..|..++...   .||||+++++.+...+..++||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999965 5899999998632  1222334455666776654   699999999999999999999999999


Q ss_pred             CcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcce
Q 015734          159 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV  238 (401)
Q Consensus       159 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  238 (401)
                      |+|..++..    ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.++|+|||++....... ..
T Consensus        81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~  152 (330)
T cd05586          81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT  152 (330)
T ss_pred             ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence            999988875    34589999999999999999999999   99999999999999999999999999987543221 12


Q ss_pred             eccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCC
Q 015734          239 TTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN  317 (401)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  317 (401)
                      .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.......        ....... ...      .++
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~--------~~~~i~~-~~~------~~~  217 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ--------MYRNIAF-GKV------RFP  217 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH--------HHHHHHc-CCC------CCC
Confidence            2345689999999998764 47999999999999999999999997543211        1111111 000      011


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 015734          318 TYDSKEVETMVQVALLCTQSTPEDRPP----MAQVVK  350 (401)
Q Consensus       318 ~~~~~~~~~l~~l~~~cl~~~p~~RPs----~~~vl~  350 (401)
                        ......++.+++.+||+.||.+||+    +.++++
T Consensus       218 --~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         218 --KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             --CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence              1122456778999999999999985    555544

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=9.7e-39  Score=289.43  Aligned_cols=247  Identities=27%  Similarity=0.397  Sum_probs=198.5

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecc
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM  156 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  156 (401)
                      ++|++.+.||+|+||.||++.. ++..||+|.+...   .....+.+|+.+++.++|||++++++++... ..+++|||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD---VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc---chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            5688899999999999999875 6788999988642   2346789999999999999999999988654 479999999


Q ss_pred             cCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCc
Q 015734          157 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT  236 (401)
Q Consensus       157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  236 (401)
                      .+++|.+++....  ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-  154 (254)
T cd05083          81 SKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-  154 (254)
T ss_pred             CCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence            9999999987632  34578999999999999999999998   99999999999999999999999999987543221 


Q ss_pred             ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCc
Q 015734          237 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN  315 (401)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  315 (401)
                         .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||.......     .....    ......      
T Consensus       155 ---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~----~~~~~~------  216 (254)
T cd05083         155 ---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-----VKECV----EKGYRM------  216 (254)
T ss_pred             ---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-----HHHHH----hCCCCC------
Confidence               11234568999999988889999999999999999998 999987543221     11111    111000      


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       316 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                        ......+..+.+++.+||+.+|++||+++++++.|+.
T Consensus       217 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         217 --EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             --CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence              0112334678899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.9e-39  Score=305.84  Aligned_cols=199  Identities=25%  Similarity=0.332  Sum_probs=174.3

Q ss_pred             CCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCcchHHHHHHHHHHHHhcc-C-----CcccceeeeeecCCeeE
Q 015734           78 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-H-----KNLLQLIGYCTTSSERI  150 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~~  150 (401)
                      +|.+.++||+|+||.|.+|.+ ++++.||||++++  ......+...|+.+|..++ |     -|+|++++++...++.|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN--~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN--KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeecc--ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            789999999999999999995 5699999999986  3445677788999999887 4     47999999999999999


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCC--CcEEEeecCCc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN--FEAVLCDFGLA  228 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~--~~~kl~Dfgl~  228 (401)
                      +|+|.+ .-+|.+++....  ..+++...++.|+.||+.||.+||..   +|||+||||+||||.+-  ..+||+|||.|
T Consensus       265 iVfELL-~~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  265 IVFELL-STNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             eeehhh-hhhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccc
Confidence            999999 559999999754  34599999999999999999999998   99999999999999643  37999999999


Q ss_pred             cccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcch
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLE  288 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~  288 (401)
                      +.......    ....+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+.+..
T Consensus       339 c~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~  394 (586)
T KOG0667|consen  339 CFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY  394 (586)
T ss_pred             cccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence            97655433    345688999999999999999999999999999999999989876543

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.6e-38  Score=294.85  Aligned_cols=251  Identities=19%  Similarity=0.275  Sum_probs=202.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      ..+|+..+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|+.+++.++|+|++++++++...+..++|||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            46789999999999999999996 468999999986432 2345678899999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++++|.+++..     ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        97 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          97 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             ccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            9999999998864     3478899999999999999999998   9999999999999999999999999998755433


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccC
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR  314 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  314 (401)
                      ... .....+++.|+|||.+.+..++.++|+|||||++|+|++|..||..........        .... ..      .
T Consensus       169 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~--------~~~~-~~------~  232 (297)
T cd06656         169 QSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--------LIAT-NG------T  232 (297)
T ss_pred             ccC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee--------eecc-CC------C
Confidence            221 223457889999999998889999999999999999999999996533211000        0000 00      0


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          315 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       315 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .....+......+.+++.+||+.+|++||++.+++++
T Consensus       233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0001122334567889999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.1e-39  Score=294.00  Aligned_cols=254  Identities=24%  Similarity=0.295  Sum_probs=198.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      .++|.+.+.||+|+||.||+|... ++..||+|.++... ......+.+|+.+++.++|||++++++.+...+..++++|
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e   86 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME   86 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence            457788889999999999999964 58899999886432 2344567889999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++++|.+++..    ...+++.....++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        87 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06645          87 FCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT  159 (267)
T ss_pred             ccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence            9999999998875    34589999999999999999999999   9999999999999999999999999998755432


Q ss_pred             CcceeccccCCcccccccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          235 LTHVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      .. ......|++.|+|||.+.   ...++.++|+|||||++|+|++|..||........    .    ........... 
T Consensus       160 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~----~----~~~~~~~~~~~-  229 (267)
T cd06645         160 IA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA----L----FLMTKSNFQPP-  229 (267)
T ss_pred             cc-ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh----H----HhhhccCCCCC-
Confidence            21 223346889999999874   45588999999999999999999999854322110    0    00000000000 


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                         ... .....+..+.+++.+||+.+|++||++++++++
T Consensus       230 ---~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         230 ---KLK-DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             ---ccc-ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence               000 011223467889999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.1e-38  Score=295.83  Aligned_cols=250  Identities=19%  Similarity=0.289  Sum_probs=202.0

Q ss_pred             cCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           77 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      .+|+..+.||.|++|.||+|.. .+++.|++|.+... .......+.+|+.+++.++|||++++++++...+..++|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ-KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc-cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            4688899999999999999985 46899999988643 233456788999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +++++|..++..     ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        98 ~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~  169 (296)
T cd06655          98 LAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ  169 (296)
T ss_pred             cCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence            999999998864     3488999999999999999999999   99999999999999999999999999987554332


Q ss_pred             cceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCc
Q 015734          236 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN  315 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  315 (401)
                      . ......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||.........        ..... .....     
T Consensus       170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~--------~~~~~-~~~~~-----  234 (296)
T cd06655         170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--------YLIAT-NGTPE-----  234 (296)
T ss_pred             c-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--------HHHHh-cCCcc-----
Confidence            2 122345788999999998888999999999999999999999999754331110        00000 00000     


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       316 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                       ...+......+.+++.+||..+|.+||++.+++.+
T Consensus       235 -~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         235 -LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             -cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence             01122334568889999999999999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.7e-39  Score=295.55  Aligned_cols=266  Identities=24%  Similarity=0.368  Sum_probs=200.3

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      ++|+..+.||+|+||.||+|..+ +++.||+|.+.... .....+.+.+|+++++.++|||++++++++...+..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999975 58899999886432 22345678899999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++++|..+...    ...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            9999888776653    23489999999999999999999998   9999999999999999999999999998765443


Q ss_pred             CcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHH-------HHhccC
Q 015734          235 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR-------KLLRED  306 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~  306 (401)
                      .. ......++..|+|||.+.+ ..++.++||||||+++|||++|.+||......+.. ........       ......
T Consensus       154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         154 GE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQL-YHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             cc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHH-HHHHHHhCCCchhhHHHhccc
Confidence            22 2223457889999999865 34788999999999999999999998754321110 00000000       000000


Q ss_pred             cc-chhccCcCC------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          307 RL-NDIVDRNLN------TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       307 ~~-~~~~d~~~~------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .. .....+...      ...+..+..+.+++.+||+.+|++||++.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            00 000000000      0112345678899999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=9.2e-39  Score=294.39  Aligned_cols=262  Identities=23%  Similarity=0.302  Sum_probs=196.3

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      +|...+.||+|+||.||+|... +|..|++|.+... ........+.+|+.++++++|||++++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4778899999999999999965 6889999998632 2233345678899999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +. ++|.+++...   ...+++..++.++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          81 CD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            97 4777776642   34589999999999999999999999   99999999999999999999999999987654332


Q ss_pred             cceeccccCCcccccccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCc------c
Q 015734          236 THVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR------L  308 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~  308 (401)
                      .. .....+++.|+|||.+.+.. ++.++|||||||++|+|+||..|+.........    ............      .
T Consensus       154 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07839         154 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ----LKRIFRLLGTPTEESWPGV  228 (284)
T ss_pred             CC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH----HHHHHHHhCCCChHHhHHh
Confidence            21 22335688999999987654 789999999999999999999886432211111    011111000000      0


Q ss_pred             chhccC----cCC------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          309 NDIVDR----NLN------TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       309 ~~~~d~----~~~------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ....+.    ...      ...+....++.+++.+||+.||.+|||+++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            000000    000      0112345678899999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.7e-38  Score=287.73  Aligned_cols=254  Identities=26%  Similarity=0.373  Sum_probs=201.9

Q ss_pred             CCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCC-----cchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           78 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS-----PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      +|+..+.||+|++|.||++.. .++..||+|.+.....     ......+.+|+++++.++|+|++++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            478889999999999999985 5688999998863221     1235678999999999999999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC-cEEEeecCCccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAKL  230 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfgl~~~  230 (401)
                      |+||+++++|.+++..    ..++++.....++.|++.||.|||++   +++|+||+|+||+++.++ .++|+|||.+..
T Consensus        81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~  153 (268)
T cd06630          81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR  153 (268)
T ss_pred             EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence            9999999999999875    24588999999999999999999999   999999999999998776 599999999876


Q ss_pred             cCCCCcc---eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          231 VDAKLTH---VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       231 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      .......   ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.........     .........  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~--  226 (268)
T cd06630         154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL-----ALIFKIASA--  226 (268)
T ss_pred             cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH-----HHHHHHhcc--
Confidence            6443211   122345788999999998888999999999999999999999998643321111     111110000  


Q ss_pred             cchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       308 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                            ......+.....++.+++.+||+.+|.+||++.+++++
T Consensus       227 ------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         227 ------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             ------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence                  00112234455688899999999999999999999753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.5e-38  Score=291.14  Aligned_cols=257  Identities=26%  Similarity=0.381  Sum_probs=198.6

Q ss_pred             CCCCCeeeecCcEEEEEEEEC----CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecCC------
Q 015734           79 FSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------  147 (401)
Q Consensus        79 ~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  147 (401)
                      |.+.++||+|+||.||+|...    ++..||+|.+... ......+.+.+|+++++.++|||++++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            566789999999999999853    3678999998743 23445677899999999999999999999886542      


Q ss_pred             eeEEEEecccCCcHHHHhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeec
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKP--GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF  225 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  225 (401)
                      ..+++++|+.+++|..++.....  ....+++.....++.|++.||+|||+.   +++|+||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            23688999999999888753221  123478889999999999999999998   9999999999999999999999999


Q ss_pred             CCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHh
Q 015734          226 GLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLL  303 (401)
Q Consensus       226 gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  303 (401)
                      |+++........ ......+++.|++||.+....++.++|||||||++|+|++ |..||......     .......   
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-----~~~~~~~---  229 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-----EIYNYLI---  229 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH-----HHHHHHH---
Confidence            998865432211 1222335678999999988889999999999999999999 88888643321     1111111   


Q ss_pred             ccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          304 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       304 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                      .....         ......+..+.+++.+||+.+|++|||+.++++.|++.
T Consensus       230 ~~~~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         230 KGNRL---------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             cCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11110         01123345789999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1e-38  Score=294.60  Aligned_cols=267  Identities=21%  Similarity=0.329  Sum_probs=202.8

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      ++|++.+.||+|+||.||+|..+ ++..|++|.+.... .......+.+|+++++.++|+|++++++++...+..++++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999975 57899999886432 33445788999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |++++.+......    ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          81 YVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            9998776655543    34488999999999999999999998   9999999999999999999999999998876554


Q ss_pred             CcceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHH-------HHHhc-c
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI-------RKLLR-E  305 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~-~  305 (401)
                      .........++..|+|||++.+. .++.++|+||||+++|+|++|..||......+.... .....       ..... .
T Consensus       154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07833         154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL-IQKCLGPLPPSHQELFSSN  232 (288)
T ss_pred             ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCCCHHHhhhcccC
Confidence            43233345578899999999888 789999999999999999999999975432211000 00000       00000 0


Q ss_pred             Cccc--hhccCcCC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          306 DRLN--DIVDRNLN-----TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       306 ~~~~--~~~d~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ....  ...+....     .++...+.++.+++.+||+.+|++||++++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            0000  00000000     0112236778999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.4e-38  Score=292.63  Aligned_cols=246  Identities=24%  Similarity=0.282  Sum_probs=201.2

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ++|++.+.||+|+||.||++... +++.+|+|.+....  .......+.+|++++++++||||+++++++...+..+++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888999999999999999965 58899999986422  2334567889999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++++|.+++...    ..++...+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            999999999998763    4588999999999999999999998   999999999999999999999999999886544


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      .    .....+++.|+|||.+.+...+.++||||||+++|+|++|..||.......     .   ..... ...      
T Consensus       154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~---~~~~~-~~~------  214 (290)
T cd05580         154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ-----I---YEKIL-EGK------  214 (290)
T ss_pred             C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-----H---HHHHh-cCC------
Confidence            3    233458899999999988888999999999999999999999997543210     1   11111 000      


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM  351 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  351 (401)
                         ...+......+.+++.+||+.+|.+||     ++++++++
T Consensus       215 ---~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         215 ---VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             ---ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence               011222345788999999999999999     67777553

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.3e-38  Score=287.50  Aligned_cols=238  Identities=26%  Similarity=0.382  Sum_probs=187.9

Q ss_pred             CeeeecCcEEEEEEEECCCC-----------EEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           83 NIIGQGGFGKVYKGVLSDNT-----------KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      +.||+|+||.||+|...+..           .+++|.+.....  ....+.+|+.+++.++|||++++++++.. ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR--DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh--hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence            46899999999999975433           477887654222  26788999999999999999999999988 77899


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC-------cEEEee
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-------EAVLCD  224 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-------~~kl~D  224 (401)
                      |+||+++++|.+++....   ..+++..+..++.|++.||+|||++   +++|+||||+||+++.++       .++|+|
T Consensus        78 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          78 VEEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             EEEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence            999999999999988632   2588999999999999999999998   999999999999999888       799999


Q ss_pred             cCCccccCCCCcceeccccCCcccccccccccC--CCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHH
Q 015734          225 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG--KSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRK  301 (401)
Q Consensus       225 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  301 (401)
                      ||++.....     .....++..|+|||++.+.  .++.++||||||+++|+|++ |..|+........        ...
T Consensus       152 fg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~--------~~~  218 (259)
T cd05037         152 PGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK--------ERF  218 (259)
T ss_pred             CCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH--------HHH
Confidence            999876543     1223467789999999776  78999999999999999999 5666654321110        000


Q ss_pred             HhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          302 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       302 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                      .....        ..+   ......+.+++.+||+.+|.+|||+.++++.|+
T Consensus       219 ~~~~~--------~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         219 YQDQH--------RLP---MPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HhcCC--------CCC---CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00000        000   011167889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.2e-38  Score=288.34  Aligned_cols=253  Identities=23%  Similarity=0.355  Sum_probs=207.4

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      ++|.+.+.||+|++|.||++... ++..|++|++...........+.+|+..+.+++|+|++++++++...+..++++||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36888899999999999999976 48999999987544335567899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      +++++|.+++...    ..++......++.|++.|+.|||+ .   +++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT  153 (264)
T ss_pred             cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence            9999999999763    568999999999999999999999 8   9999999999999999999999999998866443


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccC
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR  314 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  314 (401)
                      .... ....++..|+|||.+.+..++.++|+||||+++|+|+||..||......  .   ..+.......         .
T Consensus       154 ~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~---~~~~~~~~~~---------~  218 (264)
T cd06623         154 LDQC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--S---FFELMQAICD---------G  218 (264)
T ss_pred             CCcc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--C---HHHHHHHHhc---------C
Confidence            3221 2345788999999998888999999999999999999999999754320  1   1111111111         1


Q ss_pred             cCCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          315 NLNTYDSK-EVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       315 ~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ........ .+..+.+++..||+.+|++||++.+++++
T Consensus       219 ~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         219 PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            11112222 45688999999999999999999999774

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=293.17  Aligned_cols=254  Identities=28%  Similarity=0.368  Sum_probs=202.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      +.++|.+.+.||.|+||.||++... ++..+|+|.+... .......+..|++++++++|||++++++.+......++||
T Consensus         3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd06611           3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI   81 (280)
T ss_pred             chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence            3567889999999999999999964 5889999988642 3345567889999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++++|.+++...   ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          82 EFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence            999999999988753   34589999999999999999999999   999999999999999999999999999875433


Q ss_pred             CCcceeccccCCcccccccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ... ......+++.|+|||.+.     ...++.++|+||||+++|+|++|+.||.......        ......... .
T Consensus       156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~-~  225 (280)
T cd06611         156 TLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--------VLLKILKSE-P  225 (280)
T ss_pred             ccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--------HHHHHhcCC-C
Confidence            222 122345789999999874     3446789999999999999999999997532211        111111100 0


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                           +.+ ..+.....++.+++..||+.+|.+||++.+++++
T Consensus       226 -----~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         226 -----PTL-DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             -----CCc-CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                 000 1122334578889999999999999999999775

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.4e-39  Score=292.87  Aligned_cols=239  Identities=25%  Similarity=0.332  Sum_probs=185.3

Q ss_pred             eeeecCcEEEEEEEECC-------------------------CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccc
Q 015734           84 IIGQGGFGKVYKGVLSD-------------------------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ  138 (401)
Q Consensus        84 ~lG~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~  138 (401)
                      .||+|+||.||+|....                         ...|++|.+.... ......+.+|+.+++.++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence            58999999999997421                         1358888886422 233457888999999999999999


Q ss_pred             eeeeeecCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC
Q 015734          139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF  218 (401)
Q Consensus       139 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~  218 (401)
                      +++++...+..++||||+++++|..++...   ...+++..+..++.|++.||+|||++   +++||||||+||+++.++
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~  154 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG  154 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence            999999999999999999999999888652   34588999999999999999999998   999999999999997644


Q ss_pred             -------cEEEeecCCccccCCCCcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHH-hCCCCCCCCcchh
Q 015734          219 -------EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELV-TGQRAIDFSRLEE  289 (401)
Q Consensus       219 -------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~ell-tg~~p~~~~~~~~  289 (401)
                             .++++|||++......     ....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||.......
T Consensus       155 ~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         155 LAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             cccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence                   3799999987643221     12246788999998865 56899999999999999995 6888886543211


Q ss_pred             hhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          290 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                      .     ......   ..        ..   +.....++.+++.+||+.+|++|||+.++++.|.
T Consensus       230 ~-----~~~~~~---~~--------~~---~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 K-----ERFYEK---KH--------RL---PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             H-----HHHHHh---cc--------CC---CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            1     111110   00        01   1112246889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-39  Score=278.42  Aligned_cols=254  Identities=22%  Similarity=0.314  Sum_probs=204.3

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC----Ccc---hHHHHHHHHHHHHhc-cCCcccceeeeeec
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY----SPG---GEAAFQREVHLISVA-IHKNLLQLIGYCTT  145 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~---~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  145 (401)
                      ..++|...+.||.|..++|-++..+ +|..+|+|++....    ++.   -.+.-.+|+.+|+++ .||+|+++.+++..
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            4567888889999999999998854 68899999885322    111   234456789999987 59999999999999


Q ss_pred             CCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeec
Q 015734          146 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF  225 (401)
Q Consensus       146 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  225 (401)
                      +.-.++|+|.|+.|.|.++|..    .-.+++...++|+.|+..|++|||..   +|+||||||+|||++++.++||+||
T Consensus        95 ~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence            9999999999999999999986    34588999999999999999999999   9999999999999999999999999


Q ss_pred             CCccccCCCCcceeccccCCccccccccccc------CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHH
Q 015734          226 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLST------GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI  299 (401)
Q Consensus       226 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~  299 (401)
                      |.++.+...  ......+|||+|+|||.+..      ..|+...|+|+.|+++|.|+.|.+||-...      +.+   +
T Consensus       168 GFa~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk------Qml---M  236 (411)
T KOG0599|consen  168 GFACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK------QML---M  236 (411)
T ss_pred             ceeeccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH------HHH---H
Confidence            999977653  34566889999999999853      347889999999999999999999985211      111   1


Q ss_pred             HHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          300 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       300 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..+..++... +    ..+.+.+.+.+..+|+.+||+.||.+|.|++|.+.+
T Consensus       237 LR~ImeGkyq-F----~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  237 LRMIMEGKYQ-F----RSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             HHHHHhcccc-c----CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            1111122111 0    112356677789999999999999999999999664

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=291.51  Aligned_cols=256  Identities=28%  Similarity=0.369  Sum_probs=201.4

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeeecCC-----
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSS-----  147 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~-----  147 (401)
                      +.++|++.+.||+|++|.||+|..+ +++.+++|.+...  ......+.+|+.+++++ .|+|++++++++....     
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII--EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            4678999999999999999999975 5789999988642  23456789999999998 6999999999987644     


Q ss_pred             -eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecC
Q 015734          148 -ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG  226 (401)
Q Consensus       148 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  226 (401)
                       ..+++|||+++++|.+++.........+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence             47999999999999998876543345789999999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCcceeccccCCccccccccccc-----CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHH
Q 015734          227 LAKLVDAKLTHVTTQIRGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK  301 (401)
Q Consensus       227 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~  301 (401)
                      ++........ ......++..|+|||.+..     ..++.++||||||+++|+|++|..||.......    ..    ..
T Consensus       159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~----~~  229 (275)
T cd06608         159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR----AL----FK  229 (275)
T ss_pred             cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH----HH----HH
Confidence            9875543222 2233457889999998753     346789999999999999999999996432111    11    11


Q ss_pred             HhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          302 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       302 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .... ..     +.+ ........++.+++.+||+.||++|||+.+++++
T Consensus       230 ~~~~-~~-----~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         230 IPRN-PP-----PTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             hhcc-CC-----CCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            1110 00     001 1122345678899999999999999999999763

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.4e-38  Score=291.29  Aligned_cols=259  Identities=24%  Similarity=0.329  Sum_probs=201.1

Q ss_pred             CHHHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeeec
Q 015734           68 SCRELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT  145 (401)
Q Consensus        68 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  145 (401)
                      ++.++..+.+.|++.+.||+|+||.||+|... ++..+|+|.+..  .......+..|+.++.++ +|+|++++++++..
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~--~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV--TEDEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEec--ChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            44555567789999999999999999999964 578999998754  223446788899999888 69999999998853


Q ss_pred             ------CCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCc
Q 015734          146 ------SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE  219 (401)
Q Consensus       146 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~  219 (401)
                            .+..+++|||+.+++|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~  159 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE  159 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence                  456799999999999999887643  23578888999999999999999998   9999999999999999999


Q ss_pred             EEEeecCCccccCCCCcceeccccCCcccccccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhh
Q 015734          220 AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL  294 (401)
Q Consensus       220 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~  294 (401)
                      ++|+|||++........ ......|++.|+|||.+.     ...++.++|+|||||++|||++|..||.........   
T Consensus       160 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~---  235 (282)
T cd06636         160 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL---  235 (282)
T ss_pred             EEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh---
Confidence            99999999875532211 122345889999999875     345788999999999999999999999643221100   


Q ss_pred             HHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          295 LLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                           .......      ...  ......+.++.+++.+||+.||.+||++.++++
T Consensus       236 -----~~~~~~~------~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         236 -----FLIPRNP------PPK--LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             -----hhHhhCC------CCC--CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                 0000000      000  011234567899999999999999999999965

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=6e-38  Score=290.07  Aligned_cols=265  Identities=23%  Similarity=0.256  Sum_probs=196.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      .++|...+.||+|+||.||+|... ++..|++|.+...........+.+|+++++.++|+|++++.+++...+..++|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            467899999999999999999864 6889999998754444444567889999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+. +++..++...   ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          84 YMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             ccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            996 6776666542   23477888999999999999999998   9999999999999999999999999998754332


Q ss_pred             CcceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHH-----------H
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK-----------L  302 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~  302 (401)
                      ... .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||........   .+......           .
T Consensus       157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07870         157 SQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE---QLEKIWTVLGVPTEDTWPGV  232 (291)
T ss_pred             CCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH---HHHHHHHHcCCCChhhhhhh
Confidence            211 2233468899999998754 478899999999999999999999975432111   11110000           0


Q ss_pred             hcc-Cccchhcc----CcCCCCC--HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          303 LRE-DRLNDIVD----RNLNTYD--SKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       303 ~~~-~~~~~~~d----~~~~~~~--~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ... ........    .......  ......+.+++.+|++.||.+|||+++++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            000 00000000    0000000  0113567789999999999999999998653

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.9e-38  Score=292.26  Aligned_cols=263  Identities=24%  Similarity=0.323  Sum_probs=198.1

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      +|+..+.||.|++|.||+|... ++..||+|.+.... .......+.+|++++++++|||++++++++.+.+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999965 68899999886422 233446788999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +. ++|..++....  ...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            96 58888876532  34589999999999999999999998   99999999999999999999999999987554322


Q ss_pred             cceeccccCCcccccccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC--------
Q 015734          236 THVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED--------  306 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------  306 (401)
                      .. .....+++.|+|||.+.+.. ++.++||||||+++|+|+||+.||........    ........-...        
T Consensus       155 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07860         155 RT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ----LFRIFRTLGTPDEVVWPGVT  229 (284)
T ss_pred             cc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHHHhCCCChhhhhhhh
Confidence            21 22234678999999887654 68899999999999999999999975432111    111111000000        


Q ss_pred             -------ccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          307 -------RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       307 -------~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                             ..............+....++.+++.+||+.||.+|||+++++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence                   000000000000111233567889999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=309.49  Aligned_cols=253  Identities=26%  Similarity=0.362  Sum_probs=207.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC--CC--EEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSD--NT--KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~--~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      .+.....++||+|.||.|++|.++.  |.  .||||.++...-......|.+|+.+|.+++|||+++++|+..+ ....+
T Consensus       109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM  187 (1039)
T KOG0199|consen  109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM  187 (1039)
T ss_pred             HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence            3345556789999999999999753  43  5899999865444477899999999999999999999999887 67899


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      |+|+++.|+|.+.|++.  ....+.......++.|||.||.||.++   ++|||||..+|+|+-....|||+|||+.+.+
T Consensus       188 V~ELaplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaL  262 (1039)
T KOG0199|consen  188 VFELAPLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRAL  262 (1039)
T ss_pred             HhhhcccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceecc
Confidence            99999999999999982  345688899999999999999999999   9999999999999999999999999999977


Q ss_pred             CCCCcce--eccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          232 DAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       232 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      .......  .....-...|+|||.+....++.+||+|+|||++|||+| |..||.+....     .+   .... .    
T Consensus       263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~-----qI---L~~i-D----  329 (1039)
T KOG0199|consen  263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI-----QI---LKNI-D----  329 (1039)
T ss_pred             CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-----HH---HHhc-c----
Confidence            6554332  222334678999999999999999999999999999999 67888654321     11   1111 1    


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                          +.....-+..+++++++++..||+.+|.+|||+..+.+.
T Consensus       330 ----~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  330 ----AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             ----ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence                112223466778999999999999999999999999743

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5e-38  Score=286.12  Aligned_cols=252  Identities=25%  Similarity=0.370  Sum_probs=201.3

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCC-cchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      +|...+.||+|+||.||+|... ++..|++|.+..... ....+.+.+|+.+++.++|+||+++++.+...+..++++||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5788899999999999999964 688999999874322 24677899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +++++|.+++..    ...+++..+..++.+++.||.|||+.   +++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            999999998875    33478899999999999999999998   99999999999999999999999999988665433


Q ss_pred             ccee---ccccCCcccccccccccCC---CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccc
Q 015734          236 THVT---TQIRGTMGHIAPEYLSTGK---SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN  309 (401)
Q Consensus       236 ~~~~---~~~~gt~~y~aPE~~~~~~---~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ....   ....++..|+|||.+.+..   .+.++||||||+++|++++|..||.......    ..   .... ....  
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~----~~---~~~~-~~~~--  223 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF----QI---MFHV-GAGH--  223 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH----HH---HHHH-hcCC--
Confidence            2221   1345788999999998766   8899999999999999999999996432110    00   0000 0000  


Q ss_pred             hhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       310 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                         .+.++. .......+.+++.+||+.+|++||++.+++.
T Consensus       224 ---~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         224 ---KPPIPD-SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             ---CCCCCc-ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence               011111 1123556789999999999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4e-38  Score=288.29  Aligned_cols=255  Identities=23%  Similarity=0.350  Sum_probs=198.6

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCC---------cchHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS---------PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS  147 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  147 (401)
                      +|...+.||+|+||.||+|... ++..+|+|.+.....         ....+.+.+|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4777899999999999999854 688999998752111         112346788999999999999999999999999


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCC
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL  227 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl  227 (401)
                      ..++|+||+++++|.+++...    ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence            999999999999999998763    4588999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCcc-eeccccCCcccccccccccCC--CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhc
Q 015734          228 AKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR  304 (401)
Q Consensus       228 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (401)
                      +......... ......++..|+|||.+....  ++.++|+||||+++|++++|..||.......        .......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~  226 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA--------AMFKLGN  226 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH--------HHHHhhc
Confidence            8754432211 122345788999999987654  7899999999999999999999986332110        0111110


Q ss_pred             cCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          305 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       305 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .. ....++.   ......+..+.+++.+||+.+|.+||++++++++
T Consensus       227 ~~-~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         227 KR-SAPPIPP---DVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             cc-cCCcCCc---cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            10 0000111   1122345678899999999999999999999765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-38  Score=295.98  Aligned_cols=253  Identities=23%  Similarity=0.273  Sum_probs=201.1

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCc--chHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP--GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ++|...+.||+|++|+||+|... ++..||+|.+......  .....+..|+++++.++||||+++++.+......+++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888899999999999999965 4899999998743222  24567889999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+.+++|.+++....  ...+++.....++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            9999999999887532  34689999999999999999999998   999999999999999999999999999875432


Q ss_pred             CCcc----------------------------eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCC
Q 015734          234 KLTH----------------------------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS  285 (401)
Q Consensus       234 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~  285 (401)
                      ....                            ......||..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            2110                            111235788999999999888999999999999999999999999754


Q ss_pred             cchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 015734          286 RLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP----MAQVVK  350 (401)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs----~~~vl~  350 (401)
                      +....        ........ .      ... ........+.+++.+||+.+|++||+    +.+++.
T Consensus       236 ~~~~~--------~~~~~~~~-~------~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         236 NRDET--------FSNILKKE-V------TFP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             chHHH--------HHHHhcCC-c------cCC-CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            32110        11111100 0      000 11124568899999999999999999    666655

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-38  Score=289.72  Aligned_cols=249  Identities=24%  Similarity=0.387  Sum_probs=200.4

Q ss_pred             CCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCcchHHHHHHHHHHHHhcc---CCcccceeeeeecCCeeEEEE
Q 015734           78 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI---HKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~  153 (401)
                      .|+..+.||+|+||.||+|.. .++..|++|.+...........+.+|+.+++.+.   |||++++++++...+..+++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477788999999999999996 4689999999875444556677889999999886   999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++++|.+++..     ..+++.....++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            99999999988764     2588999999999999999999998   999999999999999999999999999886654


Q ss_pred             CCcceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      .... .....|+..|+|||.+.++ .++.++|+||||+++|+|++|..||.......        ... .....     .
T Consensus       154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--------~~~-~~~~~-----~  218 (277)
T cd06917         154 NSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR--------AMM-LIPKS-----K  218 (277)
T ss_pred             Cccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh--------hhh-ccccC-----C
Confidence            4322 2334588899999998654 46899999999999999999999997533211        000 00000     0


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .+.+.  ......++.+++.+||+.||++||++.+++++
T Consensus       219 ~~~~~--~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         219 PPRLE--DNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             CCCCC--cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            01111  11144678899999999999999999999763

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=8.3e-38  Score=285.12  Aligned_cols=251  Identities=22%  Similarity=0.298  Sum_probs=196.5

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC----CcchHHHHHHHHHHHHhccCCcccceeeeeecC--Cee
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY----SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SER  149 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  149 (401)
                      .+|.+.+.||+|+||.||+|... ++..|++|.+....    .......+.+|+.+++++.|||++++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57888999999999999999964 58899999875211    122346788899999999999999999988664  457


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ++++||+++++|.+++...    ..+++.....++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence            8999999999999988752    3478888999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCCc--ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          230 LVDAKLT--HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       230 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      .......  .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......       . ........ 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~-~~~~~~~~-  225 (265)
T cd06652         155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-------A-IFKIATQP-  225 (265)
T ss_pred             ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-------H-HHHHhcCC-
Confidence            5432111  11223457889999999988889999999999999999999999986432110       0 11111110 


Q ss_pred             cchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       308 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                             .....+......+.+++.+|+. +|.+||++++++++
T Consensus       226 -------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         226 -------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             -------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence                   1111234445677888889985 99999999999764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5e-38  Score=288.54  Aligned_cols=249  Identities=25%  Similarity=0.362  Sum_probs=201.6

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      +-|...+.||+|+||.||+|... ++..||+|.+...........+.+|+.+++.++|||++++++++...+..++||||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            34777889999999999999864 67899999876433344556788999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +++++|..++..     ..+++..+..++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          84 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence            999999988864     3588999999999999999999998   99999999999999999999999999987554322


Q ss_pred             cceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCc
Q 015734          236 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN  315 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  315 (401)
                      . ......++..|+|||.+.+...+.++|+|||||++|+|++|..||.......     .   .... ...        .
T Consensus       156 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~---~~~~-~~~--------~  217 (277)
T cd06641         156 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-----V---LFLI-PKN--------N  217 (277)
T ss_pred             h-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-----H---HHHH-hcC--------C
Confidence            1 1223457889999999988888999999999999999999999986432110     0   1111 000        0


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       316 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .+........++.+++.+||+.+|.+||++.+++++
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         218 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            111223345678899999999999999999999885

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.3e-38  Score=289.39  Aligned_cols=240  Identities=22%  Similarity=0.368  Sum_probs=187.4

Q ss_pred             CeeeecCcEEEEEEEECC--------CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           83 NIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      +.||+|+||.||+|..+.        ...+++|.+... .....+.+.+|+.+++.++|||++++++++......++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS-HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch-hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            468999999999998642        234788876532 22345678899999999999999999999999899999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCc--------EEEeecC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE--------AVLCDFG  226 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~--------~kl~Dfg  226 (401)
                      |+++|+|..++...   ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.        ++++|||
T Consensus        80 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          80 YVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             cCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence            99999999998753   23588999999999999999999998   9999999999999987765        6999999


Q ss_pred             CccccCCCCcceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCC-CCCCCCcchhhhhhhHHHHHHHHhc
Q 015734          227 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQ-RAIDFSRLEEEEDVLLLDHIRKLLR  304 (401)
Q Consensus       227 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~  304 (401)
                      ++......     ....+++.|+|||++.+. .++.++||||||+++|+|++|. .|+.......     ...    ...
T Consensus       154 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-----~~~----~~~  219 (258)
T cd05078         154 ISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-----KLQ----FYE  219 (258)
T ss_pred             cccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-----HHH----HHH
Confidence            98654321     223578899999999764 4799999999999999999995 5554322111     000    000


Q ss_pred             cCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          305 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       305 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                      ..          ...+.....++.+++.+||+.+|++|||++++++.|+
T Consensus       220 ~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         220 DR----------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             cc----------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00          0111223357889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.5e-38  Score=291.84  Aligned_cols=261  Identities=24%  Similarity=0.272  Sum_probs=199.2

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCC----cchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS----PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      +|...+.||+|+||.||+|... +++.|++|.+.....    ......+..|+++++.++|+|++++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4777889999999999999965 689999999974322    22345677899999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||+ +++|.+++....   ..+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            9999 899999887522   3689999999999999999999999   99999999999999999999999999998664


Q ss_pred             CCCcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC-----
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED-----  306 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  306 (401)
                      ..... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||......+...    . ........     
T Consensus       154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~----~-~~~~~~~~~~~~~  227 (298)
T cd07841         154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLG----K-IFEALGTPTEENW  227 (298)
T ss_pred             CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHH----H-HHHHcCCCchhhh
Confidence            43221 222346788999998854 457899999999999999999988876543221111    1 11000000     


Q ss_pred             ----ccchhcc------CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          307 ----RLNDIVD------RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       307 ----~~~~~~d------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                          .......      ............++.+++.+||+.+|++|||+++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence                0000000      00001112335678899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=287.66  Aligned_cols=267  Identities=25%  Similarity=0.334  Sum_probs=204.0

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHH--hccCCcccceeeeeecCC--
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS--VAIHKNLLQLIGYCTTSS--  147 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~~~~~~~~~~--  147 (401)
                      -+.......+.+.||+|.||.||+|.+ .|..||||++..    .+.+++.+|.++..  -++|+||+.+++.-..++  
T Consensus       206 QRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs  280 (513)
T KOG2052|consen  206 QRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGS  280 (513)
T ss_pred             HHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecc----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence            344566788899999999999999999 688999999854    34567788877776  469999999998775544  


Q ss_pred             --eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEEeCCCCCceEEcCCCcE
Q 015734          148 --ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-----QCNPKIIHRDLKAANILLDDNFEA  220 (401)
Q Consensus       148 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-----~~~~~i~H~dlkp~Nill~~~~~~  220 (401)
                        ++++|++|.+.|||.++|..     ..++.....+++..+|.||+|||.     +.+|.|.|||||+.|||++.|+.+
T Consensus       281 ~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C  355 (513)
T KOG2052|consen  281 WTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  355 (513)
T ss_pred             eEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence              57899999999999999986     358899999999999999999995     346889999999999999999999


Q ss_pred             EEeecCCccccCCCCcc---eeccccCCcccccccccccCC------CCcccchhHHHHHHHHHHhC----------CCC
Q 015734          221 VLCDFGLAKLVDAKLTH---VTTQIRGTMGHIAPEYLSTGK------SSEKTDVFGYGITLLELVTG----------QRA  281 (401)
Q Consensus       221 kl~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDi~slG~ll~elltg----------~~p  281 (401)
                      .|+|+|++-........   ..+..+||.+|||||++...-      .-..+||||||.++||+...          ..|
T Consensus       356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P  435 (513)
T KOG2052|consen  356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP  435 (513)
T ss_pred             EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence            99999999866554322   235567999999999985432      13468999999999999762          356


Q ss_pred             CCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          282 IDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      |....+.+.....    +++.+-..++.+.++.+  ....+....+.++|+.||..||..|-|+-.+-+.|..
T Consensus       436 yyd~Vp~DPs~ee----MrkVVCv~~~RP~ipnr--W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~  502 (513)
T KOG2052|consen  436 YYDVVPSDPSFEE----MRKVVCVQKLRPNIPNR--WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAK  502 (513)
T ss_pred             cccCCCCCCCHHH----HhcceeecccCCCCCcc--cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHH
Confidence            6543332222211    22222222222222211  1345678889999999999999999999888777654

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-39  Score=285.45  Aligned_cols=266  Identities=24%  Similarity=0.302  Sum_probs=217.8

Q ss_pred             HHHHHHHhcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeee
Q 015734           69 CRELQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY  142 (401)
Q Consensus        69 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~  142 (401)
                      ..++.+..++++...++.+|.||.||.|.+.      +.+.|.+|.++...++-+...+..|.-++..+.|||+..+.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            4567778888999999999999999999643      3456889999888888888999999999999999999999999


Q ss_pred             eecCC-eeEEEEecccCCcHHHHhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCC
Q 015734          143 CTTSS-ERILVYPFMQNLSVAYRLRDLKP----GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN  217 (401)
Q Consensus       143 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~  217 (401)
                      +.+.. ..+.+++++..|+|..+|...+.    ..+.++..+...++.|++.|++|||++   +++|.||..+|++||+.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence            87654 56888999999999999984332    234577778889999999999999999   99999999999999999


Q ss_pred             CcEEEeecCCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhH
Q 015734          218 FEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLL  295 (401)
Q Consensus       218 ~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~  295 (401)
                      .++||+|-.+++.+.....+ ...+...+..||+||.+....++.++|+||||+++|||+| |+.|+..-++.+.. .++
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~-~yl  511 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME-HYL  511 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH-HHH
Confidence            99999999999976554433 3344456779999999999999999999999999999999 88998755443211 111


Q ss_pred             HHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          296 LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       296 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      .       ...++.         .+-+++.+++.+|..||+..|++||+++|++..|.+
T Consensus       512 k-------dGyRla---------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  512 K-------DGYRLA---------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             h-------ccceec---------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence            1       111221         245567789999999999999999999999998853

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.8e-38  Score=286.64  Aligned_cols=251  Identities=22%  Similarity=0.341  Sum_probs=201.5

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      +|...+.||+|+||.||+|..+ ++..+|+|.+... ......+.+.+|+.+++.++|+|++++++.+...+..++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999965 5788999988632 2234556788999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC-cEEEeecCCccccCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAKLVDAK  234 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfgl~~~~~~~  234 (401)
                      +++++|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||||+||++++++ .++|+|||.+......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            99999999887532  23578999999999999999999998   999999999999999885 4699999998766443


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccC
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR  314 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  314 (401)
                      .. ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||......        +........         
T Consensus       156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~---------  217 (257)
T cd08225         156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH--------QLVLKICQG---------  217 (257)
T ss_pred             cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHhcc---------
Confidence            22 222345788999999998888999999999999999999999998643321        111111111         


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          315 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       315 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ......+....++.+++.+||+.+|++|||+.+++++
T Consensus       218 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         218 YFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             cCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            1111122334578899999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=7e-38  Score=288.05  Aligned_cols=262  Identities=21%  Similarity=0.244  Sum_probs=194.6

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCcccceeeeeecC--CeeEEEEe
Q 015734           79 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTS--SERILVYP  154 (401)
Q Consensus        79 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e  154 (401)
                      |.+.+.||+|+||.||+|... ++..||+|.++............+|+..+.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567788999999999999964 688999999875433333345567888888885 99999999999887  78999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+. +++.+.+...   ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++. +.+||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            997 5787777652   24689999999999999999999998   9999999999999999 99999999999865433


Q ss_pred             CcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhH-------HHHHHHHhccC
Q 015734          235 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL-------LDHIRKLLRED  306 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~  306 (401)
                      ...  ....++..|+|||.+.. ..++.++|||||||++|||++|..||...+..+......       ..+ .......
T Consensus       153 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  229 (282)
T cd07831         153 PPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV-LKKFRKS  229 (282)
T ss_pred             CCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH-HHhhccc
Confidence            221  22347889999997654 457889999999999999999999997644321100000       000 0000000


Q ss_pred             ccchhccC-----cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          307 RLNDIVDR-----NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       307 ~~~~~~d~-----~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .......+     .+.......+..+.+++.+||+.+|++||++++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            00000000     0001122346789999999999999999999999764

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.2e-38  Score=289.32  Aligned_cols=267  Identities=22%  Similarity=0.309  Sum_probs=201.2

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecc
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM  156 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  156 (401)
                      +|+..+.||.|++|.||+|..+ ++..||+|.+...........+.+|+.++++++|||++++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5788899999999999999975 588999999875444445567788999999999999999999999999999999999


Q ss_pred             cCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCc
Q 015734          157 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT  236 (401)
Q Consensus       157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  236 (401)
                      ++ +|.+++..... ...+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++........
T Consensus        81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            85 88887765332 34689999999999999999999998   999999999999999999999999999875543322


Q ss_pred             ceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHH--------HHHhccCc
Q 015734          237 HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI--------RKLLREDR  307 (401)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~  307 (401)
                      . .....++..|++||.+.+. .++.++|+||||+++|+|++|..||......+...... ...        ........
T Consensus       156 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         156 T-FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIF-RIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             c-cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH-HHhCCCChhhHHHHhcCch
Confidence            1 1223468899999988654 46889999999999999999999997654322111100 000        00000000


Q ss_pred             cch----hccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          308 LND----IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       308 ~~~----~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      +..    ..+.......+.....+.+++..||+.||.+||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            000    00000000112335678899999999999999999999753

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6e-38  Score=290.36  Aligned_cols=266  Identities=22%  Similarity=0.293  Sum_probs=198.5

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecC--CeeEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERILV  152 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  152 (401)
                      ++|...+.||+|+||.||+|..+ ++..+++|.++... .......+.+|+.++.+++|||++++++++...  +..+++
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            47888999999999999999975 57899999987432 223344677899999999999999999998777  789999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      +||+.+ +|.+.+....   ..+++.....++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        85 ~e~~~~-~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          85 MEYVEH-DLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             ehhcCc-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            999974 8888877532   3589999999999999999999998   99999999999999999999999999988665


Q ss_pred             CCCcceeccccCCcccccccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHH-------H----
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI-------R----  300 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~-------~----  300 (401)
                      ..... .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||............. ...       .    
T Consensus       158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  235 (293)
T cd07843         158 SPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIF-KLLGTPTEKIWPGFS  235 (293)
T ss_pred             CCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-HHhCCCchHHHHHhh
Confidence            43221 22234688999999987654 6899999999999999999999997544321111000 000       0    


Q ss_pred             HH--hccCccchhccCcCCC-CCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          301 KL--LREDRLNDIVDRNLNT-YDSK-EVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       301 ~~--~~~~~~~~~~d~~~~~-~~~~-~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..  .............+.. ++.. ....+.+++.+||+.+|++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            00  0000000000000111 1111 35668899999999999999999999764

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5.7e-38  Score=292.23  Aligned_cols=257  Identities=23%  Similarity=0.277  Sum_probs=200.6

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ++|...+.||+|+||.||++... +++.|++|.+....  .......+.+|+++++.++||||+++++.+...+..+++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888999999999999999965 47899999886432  1233467889999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++....
T Consensus        81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            99999999999875    24588999999999999999999998   999999999999999999999999999863211


Q ss_pred             CCc--------------ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHH
Q 015734          234 KLT--------------HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI  299 (401)
Q Consensus       234 ~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~  299 (401)
                      ...              .......++..|+|||.+.+..++.++|+||||+++|||++|..||.......     +   .
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-----~---~  225 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-----L---F  225 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----H---H
Confidence            100              01112346789999999988889999999999999999999999996433211     1   1


Q ss_pred             HHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          300 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       300 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                      ....... .   ..   +......+.++.+++.+||+.+|++||++.++.+.|+..
T Consensus       226 ~~~~~~~-~---~~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         226 GQVISDD-I---EW---PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             HHHHhcc-c---CC---CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence            1111000 0   00   001112345788999999999999999976666666543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-39  Score=303.88  Aligned_cols=253  Identities=25%  Similarity=0.345  Sum_probs=202.4

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECCCCEE-EEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      +.|.+...||.|+||.||++..++.... |.|.+ ...+....+.++-|+++|...+||+|+++++.+...+.++++.||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvI-etkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVI-ETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhh-cccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            4455667799999999999998764444 44544 445667788999999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      |.||-....+-.+   +.+++..++..++.|++.||.|||++   +|||||||..|||++-+|.++|+|||.+.... ..
T Consensus       111 C~GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t  183 (1187)
T KOG0579|consen  111 CGGGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-ST  183 (1187)
T ss_pred             cCCchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch-hH
Confidence            9999988887764   46799999999999999999999999   99999999999999999999999999975322 22


Q ss_pred             cceeccccCCcccccccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccch
Q 015734          236 THVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND  310 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ......+.|||.|||||+..     ..+|+.++||||||++|.||..+.+|...-.+        ...+.+.... .-+-
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp--------MRVllKiaKS-ePPT  254 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKS-EPPT  254 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch--------HHHHHHHhhc-CCCc
Confidence            23445678999999999874     46799999999999999999999998653221        1112221111 1111


Q ss_pred             hccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 015734          311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML  352 (401)
Q Consensus       311 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  352 (401)
                      ++      .++.-...+.+++..||.+||..||++.+++++-
T Consensus       255 Ll------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp  290 (1187)
T KOG0579|consen  255 LL------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP  290 (1187)
T ss_pred             cc------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence            11      2344456788999999999999999999998864

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=8e-38  Score=283.34  Aligned_cols=253  Identities=23%  Similarity=0.336  Sum_probs=207.3

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      +|...+.||.|+||.||++... ++..+++|.+.... .......+.+|+++++.++|||++++.+.+...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778899999999999999965 58899999987432 235567889999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +++++|.+++.........+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            999999999987543346799999999999999999999998   99999999999999999999999999988665443


Q ss_pred             cceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCc
Q 015734          236 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN  315 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  315 (401)
                       .......+++.|+|||...+..++.++|+||+|+++++|++|..||......        +........         .
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~---------~  219 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL--------ELALKILKG---------Q  219 (258)
T ss_pred             -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH--------HHHHHHhcC---------C
Confidence             2223346788999999998888999999999999999999999998754321        111111111         1


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       316 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ....+......+.+++.+||+.+|++|||+.+++++
T Consensus       220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            111222344678899999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.6e-38  Score=290.77  Aligned_cols=266  Identities=20%  Similarity=0.243  Sum_probs=196.8

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhcc-CCcccceeeeeecCCe-----
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSE-----  148 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~-----  148 (401)
                      ++|+..+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.+++.+. |||++++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999999965 68899999886432 2233467888999999995 6999999998876665     


Q ss_pred             eEEEEecccCCcHHHHhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC-CCcEEEeecC
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPG-EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFG  226 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfg  226 (401)
                      .+++|||+++ +|..++...... ...+++..++.++.|++.||.|||++   +++|+||+|+||+++. ++.++|+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999986 788887654322 35689999999999999999999998   9999999999999998 8999999999


Q ss_pred             CccccCCCCcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhcc
Q 015734          227 LAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE  305 (401)
Q Consensus       227 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (401)
                      ++......... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||........    +..........
T Consensus       157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~----~~~~~~~~~~~  231 (295)
T cd07837         157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ----LLHIFKLLGTP  231 (295)
T ss_pred             cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH----HHHHHHHhCCC
Confidence            98755332221 122346788999998865 4578999999999999999999999975432111    11111100000


Q ss_pred             C--ccchh------------ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          306 D--RLNDI------------VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       306 ~--~~~~~------------~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .  .....            .........+....++.+++..||+.||.+||++.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0  00000            0000000112245678899999999999999999999753

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-39  Score=304.30  Aligned_cols=244  Identities=23%  Similarity=0.372  Sum_probs=201.0

Q ss_pred             eeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCCcHH
Q 015734           84 IIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVA  162 (401)
Q Consensus        84 ~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  162 (401)
                      +||+|.||+||.|++. +...+|||.+.... ....+.+..|+.+-++++|.|||+++|.+.+++.+-+.||-.+||+|.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd-sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD-SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccccc-chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            7999999999999965 46678999987543 345678899999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEc-CCCcEEEeecCCccccCCCCccee
Q 015734          163 YRLRDLKPGEKGL--DWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVT  239 (401)
Q Consensus       163 ~~l~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~~  239 (401)
                      ..|+..-   +++  .+.++..+..||+.||.|||.+   .|+|||||-+|||++ -.|.+||+|||-++.+.. ....+
T Consensus       661 sLLrskW---GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~T  733 (1226)
T KOG4279|consen  661 SLLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCT  733 (1226)
T ss_pred             HHHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCccc
Confidence            9998632   344  7788899999999999999999   899999999999995 588999999999987643 34455


Q ss_pred             ccccCCcccccccccccCC--CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCC
Q 015734          240 TQIRGTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN  317 (401)
Q Consensus       240 ~~~~gt~~y~aPE~~~~~~--~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  317 (401)
                      ..+.||..|||||++..++  |+.++|||||||++.||.||++||-.....  ...        +++-+     +-..-+
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp--qAA--------MFkVG-----myKvHP  798 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP--QAA--------MFKVG-----MYKVHP  798 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh--hHh--------hhhhc-----ceecCC
Confidence            6677999999999997654  899999999999999999999999633221  100        11111     111123


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          318 TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       318 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                      ..+....++...++.+|+.++|.+||+++++++
T Consensus       799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            456777889999999999999999999999975

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.8e-38  Score=284.82  Aligned_cols=251  Identities=23%  Similarity=0.279  Sum_probs=206.8

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      +|++.+.||+|+||.||++... ++..+++|.+... ........+.+|+.+++.++|+|++++.+++......++++||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4778899999999999999854 6789999998642 2344566788999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +++++|.+++.........+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            999999999877544446689999999999999999999998   9999999999999999999999999999866544 


Q ss_pred             cceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCc
Q 015734          236 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN  315 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  315 (401)
                        ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+...     +..    ....        ..
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-----~~~----~~~~--------~~  217 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-----LRY----KVQR--------GK  217 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHH----HHhc--------CC
Confidence              2222457889999999988889999999999999999999999997543211     111    1111        11


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       316 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..........++.+++.+||+.+|++||++.+++++
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            122233556789999999999999999999999764

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-38  Score=288.30  Aligned_cols=262  Identities=24%  Similarity=0.331  Sum_probs=198.1

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecc
Q 015734           79 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM  156 (401)
Q Consensus        79 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  156 (401)
                      |+..+.||.|++|.||+|... +|..|++|++.... .......+.+|+++++.++|||++++++++.+.+..++++||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567889999999999999964 68999999986432 2334467889999999999999999999999999999999999


Q ss_pred             cCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCc
Q 015734          157 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT  236 (401)
Q Consensus       157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  236 (401)
                      + ++|.+++....  ...+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            5 68988887533  13589999999999999999999998   999999999999999999999999999875543322


Q ss_pred             ceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC---------
Q 015734          237 HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED---------  306 (401)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------  306 (401)
                      . .....+++.|+|||++.+. .++.++||||||+++|+|++|..||........    ............         
T Consensus       155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07835         155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ----LFRIFRTLGTPDEDVWPGVTS  229 (283)
T ss_pred             c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCChHHhhhhhh
Confidence            1 1223468899999988664 468899999999999999999999975433211    111111000000         


Q ss_pred             --c----cchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          307 --R----LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       307 --~----~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                        .    .............+.....+.+++.+||+.+|.+|||+++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence              0    00000001111122334678899999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.7e-38  Score=287.14  Aligned_cols=248  Identities=25%  Similarity=0.285  Sum_probs=202.0

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      +|.+.+.||+|+||.||+|..+ ++..||+|.+....  .......+.+|++++++++|||++++++.+...+..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788899999999999999975 58899999986422  22456789999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+.+++|.+++...    .+++...+..++.|++.||.|||++   +++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            99999999998762    4688999999999999999999998   9999999999999999999999999998765443


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccC
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR  314 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  314 (401)
                      .  ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......      ...+......         
T Consensus       154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~---------  216 (258)
T cd05578         154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI------RDQIRAKQET---------  216 (258)
T ss_pred             c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH------HHHHHHHhcc---------
Confidence            2  2233457889999999988889999999999999999999999998544311      1111111110         


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 015734          315 NLNTYDSKEVETMVQVALLCTQSTPEDRPPM--AQVV  349 (401)
Q Consensus       315 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~--~~vl  349 (401)
                      .....+...+..+.+++.+||+.||.+||++  ++++
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         217 ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            0011222334688899999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-38  Score=313.37  Aligned_cols=273  Identities=19%  Similarity=0.235  Sum_probs=190.4

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEECC--CCEEEEEE--------------ecc--cCCcchHHHHHHHHHHHHhccCC
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLSD--NTKVAVKR--------------LQD--YYSPGGEAAFQREVHLISVAIHK  134 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~--~~~vavK~--------------~~~--~~~~~~~~~~~~e~~~l~~l~h~  134 (401)
                      ....++|.+.+.||+|+||+||+|..+.  +...+.|.              +..  .........+.+|+.++++++||
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence            3456789999999999999999987532  22222221              100  01222445688999999999999


Q ss_pred             cccceeeeeecCCeeEEEEecccCCcHHHHhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceE
Q 015734          135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP-GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANIL  213 (401)
Q Consensus       135 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil  213 (401)
                      ||+++++++...+..+++++++. ++|..++..... ............++.|++.||.|||++   +++||||||+|||
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NIL  299 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIF  299 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence            99999999999999999999985 567666653211 122234566788999999999999998   9999999999999


Q ss_pred             EcCCCcEEEeecCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCC-CCCCcchhhhh
Q 015734          214 LDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRA-IDFSRLEEEED  292 (401)
Q Consensus       214 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p-~~~~~~~~~~~  292 (401)
                      ++.++.+||+|||++...............||+.|+|||++.+..++.++|||||||++|||++|..+ +......  ..
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~--~~  377 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK--PG  377 (501)
T ss_pred             ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC--HH
Confidence            99999999999999987654433334446789999999999999999999999999999999998754 4322111  11


Q ss_pred             hhHHHHHHHHh-ccCcc-------chhccC--------cCCCC--CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          293 VLLLDHIRKLL-REDRL-------NDIVDR--------NLNTY--DSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       293 ~~~~~~~~~~~-~~~~~-------~~~~d~--------~~~~~--~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..+...+.... ....+       .+.++.        .+...  ......++.+++.+||+.||.+|||+.|++++
T Consensus       378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            11111111100 00000       000000        00000  00112356778889999999999999999874

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=291.01  Aligned_cols=270  Identities=21%  Similarity=0.280  Sum_probs=198.0

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC---CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecC--CeeE
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS---DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERI  150 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  150 (401)
                      +|.+.+.||+|+||.||+|...   ++..||+|.+....  .......+.+|+.++..++|||++++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778889999999999999965   47899999987522  233446778899999999999999999999888  7899


Q ss_pred             EEEecccCCcHHHHhhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC----CCcEEEeec
Q 015734          151 LVYPFMQNLSVAYRLRDLKPG-EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD----NFEAVLCDF  225 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~----~~~~kl~Df  225 (401)
                      +||||+++ ++.+.+...... ...++...++.++.|++.||+|||+.   +++|+||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 666666543322 23689999999999999999999999   9999999999999999    999999999


Q ss_pred             CCccccCCCCc--ceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhh-----hhhHHH
Q 015734          226 GLAKLVDAKLT--HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE-----DVLLLD  297 (401)
Q Consensus       226 gl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~-----~~~~~~  297 (401)
                      |++........  .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||.........     ...+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99886544322  112334578899999988664 5789999999999999999999999754432200     000111


Q ss_pred             HHHHHhc-----------cCccchhccC-cCCCCC---------H--HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          298 HIRKLLR-----------EDRLNDIVDR-NLNTYD---------S--KEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       298 ~~~~~~~-----------~~~~~~~~d~-~~~~~~---------~--~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .+...-.           ........+. ......         .  ....++.+++.+||+.||++|||+.+++++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            1100000           0000000000 000011         0  233568899999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4.1e-38  Score=291.32  Aligned_cols=249  Identities=21%  Similarity=0.291  Sum_probs=198.0

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecc
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM  156 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  156 (401)
                      .|.....||+|+||.||++... ++..||+|.+... .....+.+.+|+..++.++|+|++++++.+...+..+++|||+
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc-hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            3444567999999999999864 5889999988642 2344567889999999999999999999999999999999999


Q ss_pred             cCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCc
Q 015734          157 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT  236 (401)
Q Consensus       157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  236 (401)
                      ++++|.+++..     ..+++.....++.|++.||.|||++   +++|+||||+||++++++.++|+|||++........
T Consensus       102 ~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~  173 (292)
T cd06658         102 EGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP  173 (292)
T ss_pred             CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence            99999988753     2478999999999999999999998   999999999999999999999999999875433222


Q ss_pred             ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcC
Q 015734          237 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL  316 (401)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  316 (401)
                       ......++..|+|||.+.+..++.++|+||||+++|||++|..||.......     ....+...         +....
T Consensus       174 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-----~~~~~~~~---------~~~~~  238 (292)
T cd06658         174 -KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-----AMRRIRDN---------LPPRV  238 (292)
T ss_pred             -cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhc---------CCCcc
Confidence             1223457899999999988889999999999999999999999987433211     11111110         01111


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          317 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       317 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      . ........+.+++..||+.||.+|||+++++++
T Consensus       239 ~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         239 K-DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             c-cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1 112234567889999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=8.1e-38  Score=288.72  Aligned_cols=258  Identities=23%  Similarity=0.359  Sum_probs=195.6

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCcccceeeeeecCCeeEEEEe
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      ++|...+.||+|+||.||++... ++..||+|.+...........+.+|+.++.++. |+||+++++++...+..+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            35556778999999999999964 588999999875433455677889999999986 9999999999999899999999


Q ss_pred             cccCCcHHHHhhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          155 FMQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       155 ~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      |+.. ++.++.... ......+++.....++.|++.||+|||+..  +++|+||||+||+++.++.++|+|||++.....
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            9864 554433221 112356899999999999999999999742  799999999999999999999999999875543


Q ss_pred             CCcceeccccCCcccccccccccC---CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccch
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTG---KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND  310 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ....  ....+++.|+|||.+.+.   .++.++|||||||++|+|++|+.||.....       ............ ...
T Consensus       161 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~-~~~  230 (288)
T cd06616         161 SIAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-------VFDQLTQVVKGD-PPI  230 (288)
T ss_pred             CCcc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-------HHHHHhhhcCCC-CCc
Confidence            2211  223478899999998766   689999999999999999999999864321       111111111100 000


Q ss_pred             hccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       311 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                       +..   ......+.++.+++.+||+.+|++|||+++++.+
T Consensus       231 -~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         231 -LSN---SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             -CCC---cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             000   1112345678999999999999999999999775

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=5.1e-38  Score=291.40  Aligned_cols=247  Identities=21%  Similarity=0.269  Sum_probs=197.0

Q ss_pred             CCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccC
Q 015734           80 SESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN  158 (401)
Q Consensus        80 ~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  158 (401)
                      .....||+|+||.||++... ++..||+|.+... .......+.+|+.++..++|||++++++++...+..++++||+++
T Consensus        24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR-KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEec-ccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            33457999999999999964 6889999998642 223456788999999999999999999999999999999999999


Q ss_pred             CcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcce
Q 015734          159 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV  238 (401)
Q Consensus       159 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  238 (401)
                      ++|..++..     ..+++..+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||++........ .
T Consensus       103 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~  173 (297)
T cd06659         103 GALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-K  173 (297)
T ss_pred             CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-c
Confidence            999887754     3478999999999999999999998   999999999999999999999999999875443222 1


Q ss_pred             eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCC
Q 015734          239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT  318 (401)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  318 (401)
                      .....++..|+|||++.+..++.++|||||||++|||++|..||.......     ......    ......      ..
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~~~~~----~~~~~~------~~  238 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-----AMKRLR----DSPPPK------LK  238 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHh----ccCCCC------cc
Confidence            223458899999999988889999999999999999999999987433211     011111    000000      00


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          319 YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       319 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ........+.+++.+||+.+|.+||++++++++
T Consensus       239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         239 NAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            112234568889999999999999999999884

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.7e-37  Score=285.79  Aligned_cols=249  Identities=28%  Similarity=0.356  Sum_probs=196.7

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      ...|...+.||+|+||+||+|... +++.||+|.+...  ........+.+|+++++.++|||++++.+++...+..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            456888899999999999999964 6889999988632  2233446788999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      +||+. |++.+.+...   ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++....
T Consensus        94 ~e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607          94 MEYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVS  166 (307)
T ss_pred             HHhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecC
Confidence            99997 5666666532   23589999999999999999999998   99999999999999999999999999987543


Q ss_pred             CCCcceeccccCCcccccccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN  309 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ..     ....+++.|+|||.+.   ...++.++||||||+++|||+||..||.......        ....... ... 
T Consensus       167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--------~~~~~~~-~~~-  231 (307)
T cd06607         167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQ-NDS-  231 (307)
T ss_pred             CC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--------HHHHHhc-CCC-
Confidence            22     2245788999999874   4568899999999999999999999986432211        0000000 000 


Q ss_pred             hhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 015734          310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML  352 (401)
Q Consensus       310 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  352 (401)
                          +..  ........+.+++.+||+.+|++||++.+++.+.
T Consensus       232 ----~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         232 ----PTL--SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             ----CCC--CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence                000  1223456789999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.4e-37  Score=279.09  Aligned_cols=250  Identities=28%  Similarity=0.382  Sum_probs=203.3

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecc
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM  156 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  156 (401)
                      +|...+.||+|++|.||++... ++..+++|++..... .....+.+|+.+++.++|+|++++++++...+..++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence            4777899999999999999975 688999999875333 45678999999999999999999999999999999999999


Q ss_pred             cCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCc
Q 015734          157 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT  236 (401)
Q Consensus       157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  236 (401)
                      ++++|.+++....   ..+++..+..++.|++.||.+||+.   +++|+||+|+||++++++.++|+|||.+........
T Consensus        80 ~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  153 (253)
T cd05122          80 SGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA  153 (253)
T ss_pred             CCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence            9999999887632   4689999999999999999999998   999999999999999999999999999876654332


Q ss_pred             ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcC
Q 015734          237 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL  316 (401)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  316 (401)
                        .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+....        ..... ........    
T Consensus       154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--------~~~~~-~~~~~~~~----  218 (253)
T cd05122         154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA--------LFKIA-TNGPPGLR----  218 (253)
T ss_pred             --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH--------HHHHH-hcCCCCcC----
Confidence              2344578899999999888899999999999999999999999875432110        00000 00001100    


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          317 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       317 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                        ........+.+++..||+.||++|||+.+++++
T Consensus       219 --~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         219 --NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             --cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              111124578899999999999999999999764

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-39  Score=281.16  Aligned_cols=245  Identities=22%  Similarity=0.273  Sum_probs=202.5

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCee
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  149 (401)
                      .+.-++|..+++||+|.||.|.+++-+ +++.||+|++++..  ..+....-..|-++|...+||.+..+...++..+.+
T Consensus       164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl  243 (516)
T KOG0690|consen  164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL  243 (516)
T ss_pred             eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence            345678899999999999999999955 68999999997532  334455667899999999999999999999999999


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      |+||||..||.|..+|..    ...+++...+.+...|+.||.|||++   +|+.||||.+|.++|.+|++||+|||+++
T Consensus       244 CFVMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCK  316 (516)
T KOG0690|consen  244 CFVMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCK  316 (516)
T ss_pred             EEEEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccch
Confidence            999999999999988886    55688899999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccc
Q 015734          230 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN  309 (401)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      .--.. ...+..++|||.|+|||++....|+.+.|+|.+||++|||++|+.||...+....-...+..       +-   
T Consensus       317 E~I~~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-------d~---  385 (516)
T KOG0690|consen  317 EEIKY-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-------DL---  385 (516)
T ss_pred             hcccc-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-------hc---
Confidence            43222 33456789999999999999999999999999999999999999999865442211111110       00   


Q ss_pred             hhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 015734          310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP  343 (401)
Q Consensus       310 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP  343 (401)
                              .++.....+...|+...|.+||.+|.
T Consensus       386 --------kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  386 --------KFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             --------cCCccCCHHHHHHHHHHhhcChHhhc
Confidence                    12333445667788889999999995

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=5e-38  Score=296.61  Aligned_cols=262  Identities=21%  Similarity=0.337  Sum_probs=196.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecC-----Cee
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-----SER  149 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  149 (401)
                      .++|.+.+.||+|+||.||+|... +|..||+|.+...........+.+|+.+++.++|||++++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999854 68999999986433344556788999999999999999999886544     357


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ++++||+.+ +|...+..     ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          84 YIVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             EEEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence            899999965 77666653     3589999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCCcc--eeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC
Q 015734          230 LVDAKLTH--VTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED  306 (401)
Q Consensus       230 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (401)
                      ........  ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.......     ............
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-----~~~~~~~~~~~~  229 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-----QLNLILGVLGTP  229 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHcCCC
Confidence            65432211  1123457899999998754 468999999999999999999999996543211     001111111000


Q ss_pred             c---cchhcc-------------CcCC--CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          307 R---LNDIVD-------------RNLN--TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       307 ~---~~~~~d-------------~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .   ...+.+             +...  ...+....++.+++.+||+.+|++|||+.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0   000000             0000  0012234678899999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.3e-37  Score=285.58  Aligned_cols=260  Identities=18%  Similarity=0.194  Sum_probs=183.3

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEECC----CCEEEEEEecccCCcch-H----------HHHHHHHHHHHhccCCcccc
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGG-E----------AAFQREVHLISVAIHKNLLQ  138 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~-~----------~~~~~e~~~l~~l~h~niv~  138 (401)
                      +..++|.+.++||+|+||+||+|...+    +..+++|.... ..... .          .....+...+..+.|+|+++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~-~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~   87 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENL-ENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK   87 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccc-cCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence            345689999999999999999999654    34566664321 11111 0          11122334455678999999


Q ss_pred             eeeeeecCC----eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEE
Q 015734          139 LIGYCTTSS----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL  214 (401)
Q Consensus       139 ~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill  214 (401)
                      +++.+....    ..+++++++.. ++.+.+...    ...++..+..++.|++.||+|||+.   +++||||||+|||+
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill  159 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMV  159 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehhcc-CHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            998765443    23566776643 555555432    2356788899999999999999998   99999999999999


Q ss_pred             cCCCcEEEeecCCccccCCCCcc------eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcch
Q 015734          215 DDNFEAVLCDFGLAKLVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLE  288 (401)
Q Consensus       215 ~~~~~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~  288 (401)
                      +.++.++|+|||+++........      ......||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus       160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~  239 (294)
T PHA02882        160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN  239 (294)
T ss_pred             cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence            99999999999999865332211      112245899999999999999999999999999999999999999765321


Q ss_pred             hh-hhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          289 EE-EDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       289 ~~-~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                      .. ......+....... .        ...  ....+..+.+++..|++.+|++||+++++.+.|+
T Consensus       240 ~~~~~~~~~~~~~~~~~-~--------~~~--~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        240 GNLIHAAKCDFIKRLHE-G--------KIK--IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             hHHHHHhHHHHHHHhhh-h--------hhc--cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            11 11111111111111 1        000  1122467889999999999999999999998763

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-37  Score=285.38  Aligned_cols=261  Identities=24%  Similarity=0.310  Sum_probs=198.7

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecC--CeeEEEEe
Q 015734           79 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERILVYP  154 (401)
Q Consensus        79 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  154 (401)
                      |.+.+.||+|++|.||+|... ++..+|+|.+.... .......+.+|+.+++.++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567789999999999999965 47899999997543 334456788999999999999999999999888  78999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++ +|..++...   ...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9975 888777642   24689999999999999999999998   9999999999999999999999999999866554


Q ss_pred             CcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhcc---Cccch
Q 015734          235 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE---DRLND  310 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  310 (401)
                      .........++..|+|||.+.+ ..++.++||||||+++|||+||..||........     ...+......   .....
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~  228 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ-----LEKIFELCGSPTDENWPG  228 (287)
T ss_pred             CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHHHhCCCchhhccc
Confidence            3222333456788999998765 4578999999999999999999999975442211     1111111000   00000


Q ss_pred             hcc--------------CcCCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          311 IVD--------------RNLNTYDSK-EVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       311 ~~d--------------~~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..+              ..+...... ++..+.+++.+||+.+|.+||++.++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            000              000000011 25678899999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.5e-37  Score=286.27  Aligned_cols=251  Identities=21%  Similarity=0.298  Sum_probs=201.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      .++|.+.+.||+|+||.||++... ++..|++|.+... .....+.+.+|+.+++.++|||++++++++...+..++|+|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e   96 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME   96 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc-cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence            468889999999999999999854 6789999988532 23345678899999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++++|.+++..     ..+++..+..++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||++......
T Consensus        97 ~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~  168 (293)
T cd06647          97 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (293)
T ss_pred             cCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence            9999999998874     2478889999999999999999999   9999999999999999999999999998755433


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccC
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR  314 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  314 (401)
                      ... .....+++.|+|||.+....++.++|+||||+++|++++|..||.........        ....... .     +
T Consensus       169 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~--------~~~~~~~-~-----~  233 (293)
T cd06647         169 QSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--------YLIATNG-T-----P  233 (293)
T ss_pred             ccc-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe--------eehhcCC-C-----C
Confidence            221 22345788999999998888999999999999999999999999754321100        0000000 0     0


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          315 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       315 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .. .........+.+++..||+.+|++||++.+++.+
T Consensus       234 ~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         234 EL-QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CC-CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00 1122334568889999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-40  Score=283.66  Aligned_cols=250  Identities=24%  Similarity=0.324  Sum_probs=208.7

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      .+-|.++++||+|+||.||++.++ +|+.+|||.+..   +...+++.+|+.++.+...|++|+++|.+-....+++|||
T Consensus        32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV---~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV---DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc---cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            344677889999999999999965 589999998864   3467889999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      ||..|++.+.++.   .++++++.++..++...++||.|||..   .-+|||||..|||++.+|.+||+|||.+..+.+.
T Consensus       109 YCGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT  182 (502)
T KOG0574|consen  109 YCGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT  182 (502)
T ss_pred             hcCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence            9999999999886   356899999999999999999999998   8999999999999999999999999999876554


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccC
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR  314 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  314 (401)
                      -.. ...+.|||-|||||++..-.|+.++||||||++..||..|++||..-.+-           +.      +..+...
T Consensus       183 MAK-RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM-----------RA------IFMIPT~  244 (502)
T KOG0574|consen  183 MAK-RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM-----------RA------IFMIPTK  244 (502)
T ss_pred             HHh-hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc-----------ce------eEeccCC
Confidence            333 34467999999999999999999999999999999999999999743220           00      0000000


Q ss_pred             cCCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 015734          315 NLNT--YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML  352 (401)
Q Consensus       315 ~~~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  352 (401)
                      .-++  -+..-+.++.+++++||-++|++|.|+-+++++-
T Consensus       245 PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~  284 (502)
T KOG0574|consen  245 PPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT  284 (502)
T ss_pred             CCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence            1111  1233456788999999999999999999998863

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-39  Score=301.68  Aligned_cols=245  Identities=27%  Similarity=0.349  Sum_probs=196.8

Q ss_pred             CCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           78 NFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      .|+.++.||.|+||.||-+++ .+...||||++.-.  .+...-..+.+|+..|+++.|||++.+.|++......++|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            466678899999999999995 46788999998621  122233578999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      ||- |+-.+.+.-.   .+++....+..|..+.+.||+|||+.   +.||||||..|||+++.|.|||+|||.+..... 
T Consensus       107 YCl-GSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-  178 (948)
T KOG0577|consen  107 YCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-  178 (948)
T ss_pred             HHh-ccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence            995 4777777653   45788999999999999999999999   999999999999999999999999999875543 


Q ss_pred             CcceeccccCCcccccccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          235 LTHVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                          ...++|||.|||||++.   .+.|+.++||||||++..||...++|+=..+.    ...+...+            
T Consensus       179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA----MSALYHIA------------  238 (948)
T KOG0577|consen  179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIA------------  238 (948)
T ss_pred             ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH----HHHHHHHH------------
Confidence                34578999999999974   57899999999999999999999988532211    01111111            


Q ss_pred             ccCcCCCC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          312 VDRNLNTY-DSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       312 ~d~~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                       ...-++. ...-+..+..++..||++-|.+|||..+++.+
T Consensus       239 -QNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  239 -QNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             -hcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence             1111121 23335668889999999999999999999875

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.5e-37  Score=285.17  Aligned_cols=253  Identities=23%  Similarity=0.333  Sum_probs=203.8

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ..+.|...+.||+|++|.||+|..+ ++..+++|.+.....  ....+.+|+++++.++|+|++++++.+...+..++++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            4567888889999999999999976 688999999864322  5677889999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++++|.+++....   ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence            9999999999998732   3689999999999999999999998   999999999999999999999999999865543


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      ... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||........        ..... .......  
T Consensus       169 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~--------~~~~~-~~~~~~~--  236 (286)
T cd06614         169 EKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA--------LFLIT-TKGIPPL--  236 (286)
T ss_pred             chh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH--------HHHHH-hcCCCCC--
Confidence            221 11223478899999999888899999999999999999999999874332110        01110 0000000  


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                          .........+.+++.+||+.+|.+||++.+++++
T Consensus       237 ----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         237 ----KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             ----cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                0112234678899999999999999999999763

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=312.61  Aligned_cols=265  Identities=26%  Similarity=0.373  Sum_probs=215.7

Q ss_pred             HHHHHhcCCCCCCeeeecCcEEEEEEEEC----C----CCEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCcccceee
Q 015734           71 ELQLATDNFSESNIIGQGGFGKVYKGVLS----D----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIG  141 (401)
Q Consensus        71 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~  141 (401)
                      .+++..++..+.+.||+|.||.|++|...    .    ...||||.+++.......+.+..|++++..+. |+|++.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            56667777778889999999999999842    1    35799999998777778899999999999885 999999999


Q ss_pred             eeecCCeeEEEEecccCCcHHHHhhhcC---CC--C-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC
Q 015734          142 YCTTSSERILVYPFMQNLSVAYRLRDLK---PG--E-------KGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKA  209 (401)
Q Consensus       142 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~--~-------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp  209 (401)
                      +|...+..++|+||+..|+|.++|+..+   .-  .       ..++......++.|||.||+||++.   +++||||..
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence            9999999999999999999999999765   10  0       2388999999999999999999999   899999999


Q ss_pred             CceEEcCCCcEEEeecCCccccCCCCcceecccc--CCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCc
Q 015734          210 ANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR--GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSR  286 (401)
Q Consensus       210 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~  286 (401)
                      +|||++++..+||+|||+++..............  -+..|||||.+....++.+|||||||++||||+| |..||....
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            9999999999999999999966554444323222  2457999999999999999999999999999999 778886522


Q ss_pred             chhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          287 LEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ..    ..+.++.+    .+.        ....+..+..++.++|+.||+.+|++||++.++++.|+.
T Consensus       527 ~~----~~l~~~l~----~G~--------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  527 PT----EELLEFLK----EGN--------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             cH----HHHHHHHh----cCC--------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence            11    11122222    111        111234446788999999999999999999999999987

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.3e-38  Score=290.21  Aligned_cols=254  Identities=24%  Similarity=0.317  Sum_probs=202.1

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEec-ccCCcchHHHHHHHHHHHHhcc-CCcccceeeeeecCCee
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSER  149 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~-~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~  149 (401)
                      +.+....|++.++||+||.+.||++...+.+.||+|++. ...+......|..|+.+|.+|. |.+|+.+++|...++.+
T Consensus       356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l  435 (677)
T KOG0596|consen  356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL  435 (677)
T ss_pred             EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence            345566799999999999999999998788888888776 4456667889999999999995 99999999999999999


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      |+||||- .-+|...|.....   .++...++.+..|++.++.++|.+   ||||.||||.|+|+-. |.+||+|||++.
T Consensus       436 YmvmE~G-d~DL~kiL~k~~~---~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~  507 (677)
T KOG0596|consen  436 YMVMECG-DIDLNKILKKKKS---IDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIAN  507 (677)
T ss_pred             EEEeecc-cccHHHHHHhccC---CCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhc
Confidence            9999987 4599999987432   233237889999999999999999   9999999999999865 589999999999


Q ss_pred             ccCCCCcce-eccccCCcccccccccccC-----------CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHH
Q 015734          230 LVDAKLTHV-TTQIRGTMGHIAPEYLSTG-----------KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD  297 (401)
Q Consensus       230 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~-----------~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~  297 (401)
                      ......... ....+||+.||+||.+...           +.+.+|||||||||||+|+.|+.||..-       .....
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-------~n~~a  580 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-------INQIA  580 (677)
T ss_pred             ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-------HHHHH
Confidence            776665443 3445799999999998432           2578899999999999999999999621       11111


Q ss_pred             HHHHHhccCccchhccCcC----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          298 HIRKLLREDRLNDIVDRNL----NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       298 ~~~~~~~~~~~~~~~d~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                               ++..+.++..    +..+.  ..++.+++..||+.||.+|||..+++++
T Consensus       581 ---------Kl~aI~~P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  581 ---------KLHAITDPNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             ---------HHHhhcCCCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence                     1222333322    11111  1238999999999999999999999875

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.5e-37  Score=287.35  Aligned_cols=266  Identities=24%  Similarity=0.285  Sum_probs=199.0

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCC----
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS----  147 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  147 (401)
                      ...++|++.+.||+|+||.||+|..+ ++..||+|.+.... .......+.+|+++++.++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999975 58899999986432 2334457788999999999999999999887654    


Q ss_pred             ------eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEE
Q 015734          148 ------ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV  221 (401)
Q Consensus       148 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~k  221 (401)
                            ..++++||+++ ++...+...   ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence                  78999999976 666666542   34589999999999999999999999   999999999999999999999


Q ss_pred             EeecCCccccCCCCcceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHH
Q 015734          222 LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR  300 (401)
Q Consensus       222 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~  300 (401)
                      |+|||++...............++..|+|||.+.+. .++.++|||||||++|+|++|+.||.......     ....+.
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~-----~~~~~~  231 (302)
T cd07864         157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA-----QLELIS  231 (302)
T ss_pred             eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHH
Confidence            999999986654332222223457789999988654 57899999999999999999999997543211     111111


Q ss_pred             HHhccC---ccchhc--------c------CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          301 KLLRED---RLNDIV--------D------RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       301 ~~~~~~---~~~~~~--------d------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ......   ....+.        +      ..........+..+.+++..||+.+|.+||++.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             HHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            111000   000000        0      00000111234678899999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.4e-37  Score=284.28  Aligned_cols=243  Identities=24%  Similarity=0.282  Sum_probs=187.0

Q ss_pred             eeeecCcEEEEEEEEC-CCCEEEEEEecccCCc--chHHHHHHHHHHHH---hccCCcccceeeeeecCCeeEEEEeccc
Q 015734           84 IIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP--GGEAAFQREVHLIS---VAIHKNLLQLIGYCTTSSERILVYPFMQ  157 (401)
Q Consensus        84 ~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~---~l~h~niv~~~~~~~~~~~~~lv~e~~~  157 (401)
                      .||+|+||.||++... +++.+|+|.+......  .....+.+|..++.   ..+|||++.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999964 5889999988643221  22233444444333   3479999999999999999999999999


Q ss_pred             CCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcc
Q 015734          158 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH  237 (401)
Q Consensus       158 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  237 (401)
                      +++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++.......  
T Consensus        81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--  151 (279)
T cd05633          81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (279)
T ss_pred             CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence            9999988875    34589999999999999999999998   99999999999999999999999999987554322  


Q ss_pred             eeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcC
Q 015734          238 VTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL  316 (401)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  316 (401)
                       .....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.........  .    .......      ...  
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~----~~~~~~~------~~~--  216 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--E----IDRMTLT------VNV--  216 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH--H----HHHHhhc------CCc--
Confidence             123458999999999864 55899999999999999999999999754321111  0    1110000      001  


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 015734          317 NTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM  351 (401)
Q Consensus       317 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  351 (401)
                       ..+...+.++.+++.+||+.||.+||     ++++++++
T Consensus       217 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         217 -ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             -CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence             12233456788999999999999999     59999776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=5.1e-37  Score=279.40  Aligned_cols=243  Identities=24%  Similarity=0.292  Sum_probs=196.1

Q ss_pred             eeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCCcH
Q 015734           85 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV  161 (401)
Q Consensus        85 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  161 (401)
                      ||.|++|.||++... ++..+++|.+....  .......+.+|+.+++.++|||++++++.+.+++..++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999975 48899999986432  234557899999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcceecc
Q 015734          162 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ  241 (401)
Q Consensus       162 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  241 (401)
                      .+++...    ..++...+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......  ....
T Consensus        81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~  151 (262)
T cd05572          81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT  151 (262)
T ss_pred             HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence            9999762    3488999999999999999999998   99999999999999999999999999998665432  2233


Q ss_pred             ccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCH
Q 015734          242 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS  321 (401)
Q Consensus       242 ~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  321 (401)
                      ..+++.|++||.+.+..++.++|+||||+++|+|++|..||.......      ..........        ......+.
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~--------~~~~~~~~  217 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP------MEIYNDILKG--------NGKLEFPN  217 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH------HHHHHHHhcc--------CCCCCCCc
Confidence            457889999999988889999999999999999999999997543210      1111111100        01111222


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 015734          322 KEVETMVQVALLCTQSTPEDRPP-----MAQVVK  350 (401)
Q Consensus       322 ~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~  350 (401)
                      ....++.+++.+||+.+|++||+     ++|+++
T Consensus       218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            23568899999999999999999     677755

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.8e-37  Score=288.13  Aligned_cols=264  Identities=25%  Similarity=0.298  Sum_probs=197.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecC--CeeE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERI  150 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  150 (401)
                      ..++|++.+.||+|+||.||+|..+ +|..||+|.+.... .......+.+|+.++++++|+|++++++++...  +..+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            3467999999999999999999964 58999999986322 222234567899999999999999999998655  4679


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      +||||+.+ +|.+++...   ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++..
T Consensus        85 lv~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~  157 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLART  157 (309)
T ss_pred             EEEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeee
Confidence            99999964 788877753   24689999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC--c
Q 015734          231 VDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED--R  307 (401)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~  307 (401)
                      ....... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+...     ....+.......  .
T Consensus       158 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-----~~~~~~~~~~~~~~~  231 (309)
T cd07845         158 YGLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-----QLDLIIQLLGTPNES  231 (309)
T ss_pred             cCCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHhcCCCChh
Confidence            6543221 222235778999999865 457899999999999999999999997543321     111111111000  0


Q ss_pred             c-c-----------hhccCcCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          308 L-N-----------DIVDRNLNT---YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       308 ~-~-----------~~~d~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      . .           .........   .......++.+++.+||+.||++|||+.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         232 IWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0 0           000000000   001135667889999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-39  Score=290.31  Aligned_cols=251  Identities=25%  Similarity=0.335  Sum_probs=201.7

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      ..+.|+.-++||+||||.||-++. .+|..||.|.+.+..  .........+|-.+|.+++.+.||.+-..+...+.+++
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            455677889999999999999984 468999999885321  22344567889999999999999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      |+..|.||+|..+|.+.  ++..+++..+..++.+|+.||.+||+.   +|++|||||+|||+|+.|+++|+|+|++..+
T Consensus       263 VLtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei  337 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEI  337 (591)
T ss_pred             EEEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEec
Confidence            99999999999998874  346799999999999999999999999   9999999999999999999999999999977


Q ss_pred             CCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ......  ...+||.+|||||++.+..|+...|+|||||++|||+.|+.||...-....     ...+......      
T Consensus       338 ~~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk-----~eEvdrr~~~------  404 (591)
T KOG0986|consen  338 PEGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK-----REEVDRRTLE------  404 (591)
T ss_pred             CCCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh-----HHHHHHHHhc------
Confidence            665433  334799999999999999999999999999999999999999973221100     0011111000      


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMA  346 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  346 (401)
                         .-..++...+++..++....|+.||++|....
T Consensus       405 ---~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  405 ---DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             ---chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence               00113445566777788889999999997543

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.7e-37  Score=290.88  Aligned_cols=265  Identities=20%  Similarity=0.289  Sum_probs=198.7

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecC------
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------  146 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  146 (401)
                      ..++|...+.||+|+||.||+|... +++.||+|.+... ........+.+|+.+++.++|||++++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999964 6899999998642 2334456778899999999999999999987543      


Q ss_pred             CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecC
Q 015734          147 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG  226 (401)
Q Consensus       147 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  226 (401)
                      ...++||||+. ++|.+.+..      .++...+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence            34699999996 477777653      278889999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhh----------HH
Q 015734          227 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL----------LL  296 (401)
Q Consensus       227 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~----------~~  296 (401)
                      ++........  .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+........          +.
T Consensus       164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         164 LARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             cceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            9986544322  22345788999999999999999999999999999999999999754321110000          00


Q ss_pred             HH----HHHHhccC------ccchhccCcCC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          297 DH----IRKLLRED------RLNDIVDRNLN-----TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       297 ~~----~~~~~~~~------~~~~~~d~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..    ........      .+.........     .........+.+++.+||+.||.+|||+.+++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00    00000000      00011111000     0112345678899999999999999999999764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.7e-37  Score=283.62  Aligned_cols=245  Identities=26%  Similarity=0.338  Sum_probs=192.0

Q ss_pred             eeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCCcH
Q 015734           85 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV  161 (401)
Q Consensus        85 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  161 (401)
                      ||+|+||+||++... +|+.||+|.+....  .......+..|+++++.++|||++++++.+...+..++|+||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999854 58899999886321  223345677899999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcceecc
Q 015734          162 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ  241 (401)
Q Consensus       162 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  241 (401)
                      .+++....  ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.......  ....
T Consensus        81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~  153 (277)
T cd05577          81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKG  153 (277)
T ss_pred             HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccc
Confidence            99987633  24689999999999999999999998   99999999999999999999999999987654321  1223


Q ss_pred             ccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCH
Q 015734          242 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS  321 (401)
Q Consensus       242 ~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  321 (401)
                      ..++..|+|||.+.+..++.++||||||+++|+|++|+.||.........     .........         .....+.
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~---------~~~~~~~  219 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK-----EELKRRTLE---------MAVEYPD  219 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH-----HHHHhcccc---------ccccCCc
Confidence            45788999999998888999999999999999999999999654321100     001100000         0001122


Q ss_pred             HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 015734          322 KEVETMVQVALLCTQSTPEDRP-----PMAQVVK  350 (401)
Q Consensus       322 ~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~  350 (401)
                      .....+.+++.+||+.+|.+||     ++.++++
T Consensus       220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             cCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            3356788999999999999999     5555643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.4e-36  Score=275.21  Aligned_cols=252  Identities=25%  Similarity=0.363  Sum_probs=204.9

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecC--CeeEEEE
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERILVY  153 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  153 (401)
                      +|...+.||+|++|.||+|... ++..|++|.+.... .....+.+.+|+..+++++|||++++++.+...  +..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4777899999999999999976 68899999986432 234567899999999999999999999999888  8899999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            999999999998863    2689999999999999999999998   999999999999999999999999999886655


Q ss_pred             CCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          234 KLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       234 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      .... ......++..|+|||.+.+...+.++||||||+++++|++|..||.....       ...........       
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~-------  219 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-------PMAALYKIGSS-------  219 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHHHhcccc-------
Confidence            4321 12334578899999999888899999999999999999999999975431       00111111100       


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                       ......+......+.+++.+|++.+|++||++.+++.+
T Consensus       220 -~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         220 -GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             -CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence             11111233335688999999999999999999999764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.9e-37  Score=283.14  Aligned_cols=249  Identities=20%  Similarity=0.272  Sum_probs=198.6

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecc
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM  156 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  156 (401)
                      .|...+.||+|++|.||++... ++..+++|.+... .....+.+.+|+.+++.++|||++++++++...+..++++||+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~   98 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL   98 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc-chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence            3455678999999999999964 6889999988532 2234566889999999999999999999999999999999999


Q ss_pred             cCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCc
Q 015734          157 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT  236 (401)
Q Consensus       157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  236 (401)
                      ++++|.+++..     ..+++..+..++.|++.||+|||++   +++|+||+|+||+++.++.++|+|||.+........
T Consensus        99 ~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~  170 (285)
T cd06648          99 EGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP  170 (285)
T ss_pred             CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence            99999998875     2478899999999999999999998   999999999999999999999999998875443222


Q ss_pred             ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcC
Q 015734          237 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL  316 (401)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  316 (401)
                       ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||......        ......... ..     +..
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--------~~~~~~~~~-~~-----~~~  235 (285)
T cd06648         171 -RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--------QAMKRIRDN-LP-----PKL  235 (285)
T ss_pred             -ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--------HHHHHHHhc-CC-----CCC
Confidence             122345889999999998888999999999999999999999998643321        111111111 00     000


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          317 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       317 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                       .........+.+++.+||+.+|++||++.+++++
T Consensus       236 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         236 -KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             -cccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence             0112234578999999999999999999999763

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.2e-37  Score=285.63  Aligned_cols=263  Identities=23%  Similarity=0.320  Sum_probs=195.9

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      ++|...+.||+|++|+||+|..+ +++.||+|.+.... .......+.+|++++++++|||++++++++...+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888999999999999999965 68899999886422 23345678899999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC-CCcEEEeecCCccccCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfgl~~~~~~  233 (401)
                      |++ ++|.+++....  ...+++..+..++.|++.||+|||++   +++|+||+|+||+++. ++.+||+|||++.....
T Consensus        82 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         82 YLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             ccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            996 57777775422  23467888889999999999999998   9999999999999985 56799999999975543


Q ss_pred             CCcceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC---cc-
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED---RL-  308 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~-  308 (401)
                      ... ......+++.|+|||.+.+. .++.++||||||+++|+|+||..||......+.    ...... .....   .+ 
T Consensus       156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~----~~~~~~-~~~~~~~~~~~  229 (294)
T PLN00009        156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE----LFKIFR-ILGTPNEETWP  229 (294)
T ss_pred             Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHH-HhCCCChhhcc
Confidence            221 11223468899999988664 578999999999999999999999975433211    111110 00000   00 


Q ss_pred             -----chh-------ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          309 -----NDI-------VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       309 -----~~~-------~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                           ...       .........+....++.+++.+||+.+|++||++.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        230 GVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             ccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 000       0000000112234568899999999999999999999763

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=277.47  Aligned_cols=251  Identities=22%  Similarity=0.283  Sum_probs=197.9

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc----CCcchHHHHHHHHHHHHhccCCcccceeeeeecC--Cee
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY----YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SER  149 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  149 (401)
                      .+|.+.+.||+|+||.||+|... ++..|++|.+...    ........+.+|++++++++|+|++++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            57889999999999999999964 5889999987522    1233456788999999999999999999988664  457


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ++++||+++++|.+++..    ...+++.....++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++
T Consensus        82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence            899999999999998875    23478899999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCCc--ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          230 LVDAKLT--HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       230 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      .......  .......++..|+|||.+.+..++.++|+|||||++|+|++|..||.......        .+....... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~-  225 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--------AIFKIATQP-  225 (264)
T ss_pred             ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--------HHHHHHcCC-
Confidence            5532111  11123457889999999988889999999999999999999999997432110        011111100 


Q ss_pred             cchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       308 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                             .....+......+.+++.+||+ +|..||++.+++.+
T Consensus       226 -------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         226 -------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             -------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence                   0111234455678899999999 57999999988764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.5e-37  Score=285.54  Aligned_cols=267  Identities=23%  Similarity=0.307  Sum_probs=194.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCC------
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------  147 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  147 (401)
                      .++|...+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.++++++|||++++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            457899999999999999999965 58899999886422 2233445678999999999999999999886654      


Q ss_pred             --eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeec
Q 015734          148 --ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF  225 (401)
Q Consensus       148 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  225 (401)
                        ..++||||+.+ +|.+.+...   ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence              34999999964 777776542   23589999999999999999999998   9999999999999999999999999


Q ss_pred             CCccccCCCCcc---eeccccCCcccccccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHH
Q 015734          226 GLAKLVDAKLTH---VTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK  301 (401)
Q Consensus       226 gl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~  301 (401)
                      |++.........   ......++..|+|||.+.+.. ++.++||||||+++|+|++|..||........  ......+..
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~--~~~~~~~~~  241 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ--LTLISQLCG  241 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhC
Confidence            999765433221   122345678899999886654 68899999999999999999999975432111  011111110


Q ss_pred             HhccCccch-----hccC-cCCC----------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          302 LLREDRLND-----IVDR-NLNT----------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       302 ~~~~~~~~~-----~~d~-~~~~----------~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .........     ..+. ..+.          ........+.+++.+||+.||.+|||+++++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            000000000     0000 0000          000112456789999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=7.5e-37  Score=282.60  Aligned_cols=253  Identities=22%  Similarity=0.282  Sum_probs=196.8

Q ss_pred             CCCCCCeeeecCcEEEEEEEE----CCCCEEEEEEecccC---CcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCee
Q 015734           78 NFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  149 (401)
                      +|++.+.||+|+||.||++..    .+|..||+|.+....   .....+.+.+|++++..+ +|+||+++++.+......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999985    368899999986421   123346788899999999 599999999999998999


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ++|+||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            999999999999999875    34588899999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCCcceeccccCCcccccccccccC--CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          230 LVDAKLTHVTTQIRGTMGHIAPEYLSTG--KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      ..............|+..|+|||.+...  .++.++||||||+++|+|++|..||........    ...........  
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~----~~~~~~~~~~~--  227 (290)
T cd05613         154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS----QAEISRRILKS--  227 (290)
T ss_pred             ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc----HHHHHHHhhcc--
Confidence            6544332223345588899999998653  467899999999999999999999874322111    11111111110  


Q ss_pred             cchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 015734          308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM  351 (401)
Q Consensus       308 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  351 (401)
                              ....+......+.+++.+||+.+|++||     ++.+++.+
T Consensus       228 --------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         228 --------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             --------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence                    0111223445778999999999999997     66666553

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4.3e-37  Score=290.35  Aligned_cols=268  Identities=21%  Similarity=0.329  Sum_probs=197.6

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhc-cCCcccceeeeeecC--Cee
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS--SER  149 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~  149 (401)
                      ..++|.+.+.||+|+||.||+|.+. ++..+|+|++... ........+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4567888999999999999999965 5789999988642 2233445677899999999 999999999988654  357


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ++||||+. ++|..++..    . .+++.....++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++.
T Consensus        85 ~lv~e~~~-~~L~~~~~~----~-~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA----N-ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             EEEecccc-cCHHHHHhc----C-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            99999997 588887764    1 578899999999999999999998   99999999999999999999999999988


Q ss_pred             ccCCCCc----ceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHH--------
Q 015734          230 LVDAKLT----HVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL--------  296 (401)
Q Consensus       230 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~--------  296 (401)
                      .......    .......+++.|+|||.+.+ ..++.++||||||+++|+|+||+.||..............        
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE  235 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            6543322    12233457889999998755 4578899999999999999999999975433211100000        


Q ss_pred             --HHHHHHhccCccchhccC---cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          297 --DHIRKLLREDRLNDIVDR---NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       297 --~~~~~~~~~~~~~~~~d~---~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                        ...........+......   ...........++.+++.+||+.+|.+|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence              000000000000000000   0001112245678899999999999999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.5e-37  Score=283.19  Aligned_cols=259  Identities=20%  Similarity=0.252  Sum_probs=202.2

Q ss_pred             CCCCCCeeeecCcEEEEEEEE----CCCCEEEEEEecccC---CcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCee
Q 015734           78 NFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  149 (401)
                      +|.+.+.||+|++|.||++..    .++..||+|.+....   .......+..|+.++.++ +|||++++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            467788999999999999884    256889999886321   122345688999999999 599999999999998999


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            999999999999988875    24588999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCCcceeccccCCcccccccccccCC--CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          230 LVDAKLTHVTTQIRGTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      ..............++..|+|||.+.+..  .+.++|+||||+++|+|++|..||........    ...........  
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----~~~~~~~~~~~--  227 (288)
T cd05583         154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS----QSEISRRILKS--  227 (288)
T ss_pred             ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch----HHHHHHHHHcc--
Confidence            65443332233345788999999987665  78899999999999999999999864321110    11111111110  


Q ss_pred             cchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCc
Q 015734          308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDL  357 (401)
Q Consensus       308 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  357 (401)
                              ....+......+.+++.+||+.+|++|||+.++.+.|+...+
T Consensus       228 --------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~  269 (288)
T cd05583         228 --------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF  269 (288)
T ss_pred             --------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccc
Confidence                    011122234567889999999999999999999888876544

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.9e-37  Score=291.18  Aligned_cols=263  Identities=21%  Similarity=0.320  Sum_probs=198.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeec----CCee
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTT----SSER  149 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~  149 (401)
                      .++|.+.+.||+|+||.||+|..+ ++..||+|++.... .......+.+|+.+++.++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            368999999999999999999964 68999999987432 23345677889999999999999999987753    3467


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ++|+||+. ++|.+++..    ...+++..+..++.|++.||.|||++   +++|+||||+||++++++.+||+|||++.
T Consensus        84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence            99999995 588887764    34589999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCCcc---eeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhc-
Q 015734          230 LVDAKLTH---VTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR-  304 (401)
Q Consensus       230 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-  304 (401)
                      ........   ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.....     ..+..... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~-----~~~~~~~g~  230 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL-----KLILSVLGS  230 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH-----HHHHHHhCC
Confidence            65432211   1223467889999999865 45899999999999999999999999754322110     00000000 


Q ss_pred             ----------cCccchhccC--cCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          305 ----------EDRLNDIVDR--NLNT-----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       305 ----------~~~~~~~~d~--~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                                ........+.  ....     .....+.++.+++.+||+.+|.+||++.+++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                      0000000000  0000     112345778999999999999999999999775

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-38  Score=268.25  Aligned_cols=252  Identities=22%  Similarity=0.332  Sum_probs=199.8

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCeeEEEEec
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      +...+..||.|..|.||++... +|...|||.+....+......+...++++..- +.|.||+.+|+|..+....+.||.
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            3445667999999999999965 58899999998776777778888888877655 489999999999999999999998


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      |. ..+..++...   ..++++..+-++...++.||.||-.++  +++|||+||+|||+|+.|++|+||||++..+.+..
T Consensus       173 Ms-~C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  173 MS-TCAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HH-HHHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence            84 3555555553   356899899999999999999999886  89999999999999999999999999998776543


Q ss_pred             cceeccccCCccccccccccc---CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          236 THVTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      .  .+...|-+.|||||.+..   .+|+.++||||||++++||.||..||.....+.    .....+.   ..  ....+
T Consensus       247 A--htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF----e~ltkvl---n~--ePP~L  315 (391)
T KOG0983|consen  247 A--HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF----EVLTKVL---NE--EPPLL  315 (391)
T ss_pred             c--cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH----HHHHHHH---hc--CCCCC
Confidence            3  344568899999999853   468999999999999999999999998643321    1111111   11  11122


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      +.     ....+..+.+++..||++|+.+||...+++++
T Consensus       316 ~~-----~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  316 PG-----HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             Cc-----ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            21     12256688999999999999999999999875

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=6e-37  Score=284.15  Aligned_cols=256  Identities=23%  Similarity=0.371  Sum_probs=196.2

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECC-CCEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCcccceeeeeecCCeeEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv  152 (401)
                      ..++|.+.+.||+|+||.||+|..++ +..||+|.+...........+..|+.++.... |||++++++++......+++
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            45678889999999999999999764 88999999975444445566777877666664 99999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||+. +++.+.+...   ...+++..+..++.|++.||+|||+..  +++|+||+|+||++++++.++|+|||++....
T Consensus        93 ~e~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          93 MELMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             eeccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            99985 4666665542   236899999999999999999999732  89999999999999999999999999987654


Q ss_pred             CCCcceeccccCCcccccccccccCC----CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGK----SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ....  .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||......       .+......... .
T Consensus       167 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~-~  236 (296)
T cd06618         167 DSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-------FEVLTKILQEE-P  236 (296)
T ss_pred             CCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-------HHHHHHHhcCC-C
Confidence            3222  12234778999999987554    788999999999999999999998642211       01111111111 0


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML  352 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  352 (401)
                      ..     .. .......++.+++.+||+.||.+||++.+++++.
T Consensus       237 ~~-----~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         237 PS-----LP-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             CC-----CC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            00     00 0112345788999999999999999999997753

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.2e-37  Score=280.44  Aligned_cols=252  Identities=20%  Similarity=0.320  Sum_probs=199.3

Q ss_pred             CCCCCCeeeecCcEEEEEEEECC-CCEEEEEEeccc----CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           78 NFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDY----YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      +|.+.+.||+|+||.||++.... +..+++|.++..    ........+..|+.+++.++|||++++++++.+....+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47888999999999999998643 455666665431    2233445677899999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      +||+++++|..++.........+++..+..++.|++.||.|||+.   +++|+||+|+||++++ +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999999876554456799999999999999999999998   9999999999999976 569999999987654


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      .... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......        .......         
T Consensus       157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--------~~~~~~~---------  218 (260)
T cd08222         157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL--------SVVLRIV---------  218 (260)
T ss_pred             CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHH---------
Confidence            3322 223345788999999998888899999999999999999999998643211        1111111         


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ....+..+.....++.+++.+||+.+|++||++.+++++
T Consensus       219 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         219 EGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             cCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            111112234556688899999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-37  Score=276.66  Aligned_cols=248  Identities=27%  Similarity=0.405  Sum_probs=202.2

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      +|.+.+.||+|++|.||++... ++..|++|.+.... .......+.+|++++.+++|||++++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999865 57899999987432 224567899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +++++|.+++...    ..+++..+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            9999999988763    4689999999999999999999998   99999999999999999999999999998665433


Q ss_pred             cceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCc
Q 015734          236 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN  315 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  315 (401)
                      .. .....++..|+|||...+..++.++|+||+|+++|+|++|..||.......    .    ...... .        .
T Consensus       154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~----~----~~~~~~-~--------~  215 (254)
T cd06627         154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA----A----LFRIVQ-D--------D  215 (254)
T ss_pred             cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH----H----HHHHhc-c--------C
Confidence            22 223457889999999988888999999999999999999999986432110    0    011100 0        1


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       316 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                      ....+......+.+++.+||+.+|++||++.+++.
T Consensus       216 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         216 HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            11122233467889999999999999999999975

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.1e-37  Score=292.45  Aligned_cols=266  Identities=21%  Similarity=0.322  Sum_probs=197.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecC-----Ce
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-----SE  148 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  148 (401)
                      .++|.+.+.||+|+||+||++... ++..||+|.+... ........+.+|+.+++.++|+|++++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457889999999999999999954 6899999998643 2333455678899999999999999999987644     34


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      .++++||+. ++|.+++..    ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence            799999996 688877764    34589999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHH-------
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR-------  300 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~-------  300 (401)
                      ....... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...+..... ........       
T Consensus       156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~  233 (337)
T cd07858         156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQL-KLITELLGSPSEEDL  233 (337)
T ss_pred             cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHH-HHHHHHhCCCChHHh
Confidence            8654432 12233457889999998765 46899999999999999999999999754321100 00000000       


Q ss_pred             HHhccCccchhc-------cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          301 KLLREDRLNDIV-------DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       301 ~~~~~~~~~~~~-------d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ............       +.......+..+.++.+++.+||+.+|++|||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            000000000000       000001112345678899999999999999999999876

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-37  Score=282.21  Aligned_cols=260  Identities=23%  Similarity=0.302  Sum_probs=200.8

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecc
Q 015734           79 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM  156 (401)
Q Consensus        79 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  156 (401)
                      |...+.||+|++|.||++... ++..+++|.+.... .+.....+.+|+.+++.++|+|++++++++...+..++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567788999999999999964 68899999986432 2244567889999999999999999999999999999999999


Q ss_pred             cCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCc
Q 015734          157 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT  236 (401)
Q Consensus       157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  236 (401)
                      ++ ++.+.+...   ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||.+....... 
T Consensus        81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-  152 (283)
T cd05118          81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-  152 (283)
T ss_pred             CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence            75 888777652   24689999999999999999999998   99999999999999999999999999987665543 


Q ss_pred             ceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhcc---Cccchh-
Q 015734          237 HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE---DRLNDI-  311 (401)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-  311 (401)
                      .......++..|+|||.+.+. .++.++|+||||+++|+|+||+.||......+....     .......   ...... 
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  227 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK-----IFRTLGTPDPEVWPKFT  227 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHHHcCCCchHhcccch
Confidence            122234577889999998776 689999999999999999999999975443211111     0000000   000000 


Q ss_pred             ----------cc---CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          312 ----------VD---RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       312 ----------~d---~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                                .+   .......+....++.+++.+||+.||.+||++.+++.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                      00   00001123456789999999999999999999999764

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.2e-36  Score=283.12  Aligned_cols=248  Identities=27%  Similarity=0.367  Sum_probs=195.7

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      .|...+.||+|+||.||++... ++..+|+|.+...  ........+.+|+++++.++|||++++++++...+..++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3677889999999999999964 6889999988632  223345678899999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+.+ ++.+.+...   ..++++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus       106 ~~~g-~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         106 YCLG-SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             CCCC-CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            9974 777666532   34589999999999999999999998   9999999999999999999999999998654321


Q ss_pred             CcceeccccCCcccccccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          235 LTHVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                           ....+++.|+|||.+.   ...++.++|||||||++|+|++|..||.......    ..    ........    
T Consensus       179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~----~~----~~~~~~~~----  241 (317)
T cd06635         179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----AL----YHIAQNES----  241 (317)
T ss_pred             -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH----HH----HHHHhccC----
Confidence                 2345788999999974   4568899999999999999999999986432110    01    11111000    


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                          ...........+.+++.+||+.+|.+||++.++++++-
T Consensus       242 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         242 ----PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             ----CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence                00112234456889999999999999999999998654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=8.7e-37  Score=285.39  Aligned_cols=260  Identities=24%  Similarity=0.276  Sum_probs=192.4

Q ss_pred             CCeeeecCcEEEEEEEECCCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCCc
Q 015734           82 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS  160 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  160 (401)
                      .+.+|.|+++.||++.. ++..||+|++... ........+.+|+++++.++|+||+++++++...+..+++|||+++++
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34445555555555544 6899999998743 345566789999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCc----
Q 015734          161 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT----  236 (401)
Q Consensus       161 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~----  236 (401)
                      |.+++....  ...+++.....++.|++.||.|||++   +++|+||||+||+++.++.++|+|||.+........    
T Consensus        86 l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          86 CEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             HHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            999988643  23588899999999999999999999   999999999999999999999999998875432211    


Q ss_pred             --ceeccccCCcccccccccccC--CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHH----hccCc-
Q 015734          237 --HVTTQIRGTMGHIAPEYLSTG--KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL----LREDR-  307 (401)
Q Consensus       237 --~~~~~~~gt~~y~aPE~~~~~--~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~-  307 (401)
                        .......++..|+|||.+...  .++.++|+|||||++|||++|..||........    ..+.....    ..... 
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~  236 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM----LLEKVRGTVPCLLDKSTY  236 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhccCccccccCch
Confidence              111223467789999998663  578999999999999999999999975432111    11111000    00000 


Q ss_pred             ------cch----hccCc-----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          308 ------LND----IVDRN-----LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       308 ------~~~----~~d~~-----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                            ...    ..++.     -.........++.+++..||+.||++|||+++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence                  000    00000     011223445678899999999999999999999764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=279.88  Aligned_cols=261  Identities=23%  Similarity=0.315  Sum_probs=195.2

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCC-cchHHHHHHHHHHHHhc---cCCcccceeeeeecCCe-----
Q 015734           79 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVA---IHKNLLQLIGYCTTSSE-----  148 (401)
Q Consensus        79 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~-----  148 (401)
                      |++.+.||+|+||.||+|..+ ++..||+|.+..... ......+.+|+.++.++   +|||++++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567789999999999999976 489999999974322 22344566787777655   59999999999987776     


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      .+++|||+.+ +|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eEEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence            8999999975 7888876532  23589999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ........  .....++..|+|||.+.+..++.++|+|||||++|+|++|.+||......+.    ..............
T Consensus       155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~  228 (287)
T cd07838         155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ----LDKIFDVIGLPSEE  228 (287)
T ss_pred             eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH----HHHHHHHcCCCChH
Confidence            76543321  1223468899999999988899999999999999999999999875433211    11111110000000


Q ss_pred             ---------chhccC----cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          309 ---------NDIVDR----NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       309 ---------~~~~d~----~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                               ......    ......+.....+.+++.+||+.||.+||++.+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence                     000000    0011122345677899999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.8e-37  Score=288.62  Aligned_cols=261  Identities=23%  Similarity=0.341  Sum_probs=201.1

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCC-cchHHHHHHHHHHHHhccCCcccceeeeeecCC-----eeE
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-----ERI  150 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  150 (401)
                      +|.+.+.||+|++|.||+|... ++..|++|.+..... ......+.+|+.+++.++||||+++.+++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5788899999999999999965 488999999875432 445578899999999999999999999987775     789


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      ++|+|+. ++|...+..    ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus        81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            9999997 478777764    33689999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCc--ceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhcc--
Q 015734          231 VDAKLT--HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE--  305 (401)
Q Consensus       231 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--  305 (401)
                      ......  .......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||......+..     ..+......  
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~-----~~i~~~~~~~~  227 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL-----NLIVEVLGTPS  227 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH-----HHHHHhcCCCC
Confidence            654431  112334578899999999887 7899999999999999999999999765432110     001110000  


Q ss_pred             ---------Cccchhcc-------CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          306 ---------DRLNDIVD-------RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       306 ---------~~~~~~~d-------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                               ........       .......+.....+.+++.+||+.+|.+||++.+++.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                     00000000       00000112245678899999999999999999999764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-37  Score=280.66  Aligned_cols=265  Identities=22%  Similarity=0.266  Sum_probs=197.7

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCcccceeeeeecCCeeEEEEecc
Q 015734           79 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPFM  156 (401)
Q Consensus        79 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  156 (401)
                      |.+.+.||+|++|+||+|... ++..|++|.+.............+|+..+.++. |||++++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567889999999999999975 578899999875443333445567899999999 999999999999999999999999


Q ss_pred             cCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCc
Q 015734          157 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT  236 (401)
Q Consensus       157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  236 (401)
                       +++|.+.+....  ...+++..+..++.|++.+|.|||++   +++|+||+|+||++++++.++|+|||++........
T Consensus        81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence             889988887632  24689999999999999999999998   999999999999999999999999999876543222


Q ss_pred             ceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhH--------HHHHHHHhccCc
Q 015734          237 HVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL--------LDHIRKLLREDR  307 (401)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~  307 (401)
                        .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......+......        ..+.........
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence              122457889999998754 457999999999999999999999997554322111000        000000000000


Q ss_pred             cchhccCc----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          308 LNDIVDRN----LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       308 ~~~~~d~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ........    +.........++.+++..||+.+|++|||++|++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            00000000    000111124678899999999999999999999764

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=5.3e-37  Score=281.76  Aligned_cols=250  Identities=24%  Similarity=0.331  Sum_probs=202.8

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhcc-CCcccceeeeeecCCeeEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv  152 (401)
                      ++|.+.+.||+|+||.||++... ++..|++|++...  ........+.+|..++.++. ||||+++++++...+..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888999999999999999965 6899999988642  22334567889999999998 99999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      ||++++++|.+++...    ..+++..+..++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          81 LEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            9999999999999863    3699999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCCc-------------------ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhh
Q 015734          233 AKLT-------------------HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV  293 (401)
Q Consensus       233 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~  293 (401)
                      ....                   .......++..|+|||.+....++.++|+||||++++++++|..||......     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----  228 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-----  228 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-----
Confidence            4322                   1223345788999999998888999999999999999999999999754311     


Q ss_pred             hHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCH----HHHHHH
Q 015734          294 LLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM----AQVVKM  351 (401)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~----~~vl~~  351 (401)
                      ..   ......          .....+......+.+++.+||+.+|++||++    .+++++
T Consensus       229 ~~---~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         229 LT---FQKILK----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             HH---HHHHHh----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            01   111110          0011122335678899999999999999999    777543

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-38  Score=312.78  Aligned_cols=262  Identities=22%  Similarity=0.272  Sum_probs=213.3

Q ss_pred             CHHHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeee
Q 015734           68 SCRELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCT  144 (401)
Q Consensus        68 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  144 (401)
                      ...+++...++|.++++||+|+||.|.+++.+ +++.||+|++.+..  ......-|..|-++|..-+.+.|+.++..|+
T Consensus        66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ  145 (1317)
T KOG0612|consen   66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ  145 (1317)
T ss_pred             HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence            34677888999999999999999999999975 58899999997521  2234567888999999999999999999999


Q ss_pred             cCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEee
Q 015734          145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD  224 (401)
Q Consensus       145 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D  224 (401)
                      +..++|+||||++||+|...|..+.    +++...++.++..|..||.-||+.   |+|||||||+|||+|.+|++||+|
T Consensus       146 D~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLAD  218 (1317)
T KOG0612|consen  146 DERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLAD  218 (1317)
T ss_pred             CccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeecc
Confidence            9999999999999999999998742    699999999999999999999999   999999999999999999999999


Q ss_pred             cCCccccCCCCcceeccccCCcccccccccc----c-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHH
Q 015734          225 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS----T-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI  299 (401)
Q Consensus       225 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~  299 (401)
                      ||.+-.+..+..-.....+|||.|.+||++.    + +.|+..+|+||+||++|||+.|.-||..++.        ...+
T Consensus       219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl--------veTY  290 (1317)
T KOG0612|consen  219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL--------VETY  290 (1317)
T ss_pred             chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH--------HHHH
Confidence            9999888777666667778999999999984    3 5689999999999999999999999985443        3333


Q ss_pred             HHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 015734          300 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP---MAQVVKM  351 (401)
Q Consensus       300 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~~vl~~  351 (401)
                      .++..-.....+.      .....+++..+||...+. +|+.|..   ++++-.+
T Consensus       291 ~KIm~hk~~l~FP------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  291 GKIMNHKESLSFP------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             HHHhchhhhcCCC------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence            3333221111111      113345666777776554 7777776   7777543

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-37  Score=282.62  Aligned_cols=251  Identities=22%  Similarity=0.280  Sum_probs=210.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      +..-|.+.+.||+|-|..|-++++ -+|..||||++.+. .+......+.+|++-|+.++|||||+++.+......+|+|
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi   95 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI   95 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence            345688899999999999999983 38999999999643 3444566889999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEE-cCCCcEEEeecCCcccc
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL-DDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill-~~~~~~kl~Dfgl~~~~  231 (401)
                      +|+-++|+|.+++...   +..+.+....+++.||+.|+.|+|.-   .++||||||+||.+ ..-|-+||+|||++..+
T Consensus        96 LELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             EEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccC
Confidence            9999999999999874   45689999999999999999999998   89999999999866 56788999999999765


Q ss_pred             CCCCcceeccccCCcccccccccccCCCC-cccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccch
Q 015734          232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSS-EKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND  310 (401)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ...  ......+|+..|-|||++.+..|+ ++.||||||||||.|.+|++||+.....+                 .+-.
T Consensus       170 ~PG--~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-----------------TLTm  230 (864)
T KOG4717|consen  170 QPG--KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-----------------TLTM  230 (864)
T ss_pred             CCc--chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-----------------hhhh
Confidence            443  234456899999999999999885 67899999999999999999998544321                 1222


Q ss_pred             hccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       311 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ++|.. .+.+.-...+..+||..||..||.+|.+.++++..
T Consensus       231 ImDCK-YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  231 IMDCK-YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             hhccc-ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            33332 23466677788899999999999999999999764

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.7e-36  Score=285.26  Aligned_cols=260  Identities=23%  Similarity=0.295  Sum_probs=192.0

Q ss_pred             Ceeeec--CcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccC
Q 015734           83 NIIGQG--GFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN  158 (401)
Q Consensus        83 ~~lG~G--~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  158 (401)
                      ..||.|  +||+||++.+. +++.||+|.+.... .....+.+.+|+.+++.++||||+++++++...+..++++||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  99999999964 68999999986432 334457888999999999999999999999999999999999999


Q ss_pred             CcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcce
Q 015734          159 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV  238 (401)
Q Consensus       159 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  238 (401)
                      +++.+++....  ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||+.+..........
T Consensus        84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            99999888643  23588999999999999999999998   99999999999999999999999998654322111110


Q ss_pred             ------eccccCCcccccccccccC--CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHH--------
Q 015734          239 ------TTQIRGTMGHIAPEYLSTG--KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL--------  302 (401)
Q Consensus       239 ------~~~~~gt~~y~aPE~~~~~--~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------  302 (401)
                            .....++..|+|||++.+.  .++.++|||||||++|+|++|..||........    ........        
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~  234 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM----LLQKLKGPPYSPLDIT  234 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH----HHHHhcCCCCCCcccc
Confidence                  0112245679999998764  478999999999999999999999975432110    00000000        


Q ss_pred             --------h----------------ccCccchhccCcCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          303 --------L----------------REDRLNDIVDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       303 --------~----------------~~~~~~~~~d~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                              .                .........+..+. .........+.+++.+||+.||++|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                    0                00000000001111 1123456788999999999999999999999764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.2e-36  Score=276.99  Aligned_cols=247  Identities=24%  Similarity=0.309  Sum_probs=196.1

Q ss_pred             eeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCCcH
Q 015734           85 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV  161 (401)
Q Consensus        85 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  161 (401)
                      ||+|+||.||++... ++..+++|.+....  .......+.+|++++.+++|||++++++.+...+..++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999976 48999999986422  124556788999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCc-----
Q 015734          162 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-----  236 (401)
Q Consensus       162 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~-----  236 (401)
                      .+++...    ..+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.++|+|||++........     
T Consensus        81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            9998763    2589999999999999999999998   999999999999999999999999999875433211     


Q ss_pred             --ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccC
Q 015734          237 --HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR  314 (401)
Q Consensus       237 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  314 (401)
                        .......++..|+|||.......+.++|+||||+++|+|++|..||.......        ....... ....     
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--------~~~~~~~-~~~~-----  219 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE--------IFQNILN-GKIE-----  219 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhc-CCcC-----
Confidence              12233457889999999988889999999999999999999999997543211        1111111 0000     


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          315 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       315 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                       .+. ....+..+.+++.+||+.+|.+|||+..+.+.|+.
T Consensus       220 -~~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         220 -WPE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             -CCc-cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence             000 01125678899999999999999999666666654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.3e-37  Score=288.58  Aligned_cols=261  Identities=23%  Similarity=0.348  Sum_probs=192.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCC------
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------  147 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  147 (401)
                      .++|...+.||+|+||.||+|... +|..||+|++.... .......+.+|+.+++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            468999999999999999999964 68999999986432 2334467889999999999999999999886543      


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCC
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL  227 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl  227 (401)
                      ..++++||+.. +|...+.      ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||+
T Consensus        94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            46899999864 6655432      2488999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHH-------H
Q 015734          228 AKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH-------I  299 (401)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~-------~  299 (401)
                      +......    .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||........... ....       .
T Consensus       164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~  238 (342)
T cd07879         164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ-ILKVTGVPGPEF  238 (342)
T ss_pred             CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhcCCCCHHH
Confidence            8754322    123356889999999866 4588999999999999999999999975432111000 0000       0


Q ss_pred             HHHhccCccchhcc-------CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          300 RKLLREDRLNDIVD-------RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       300 ~~~~~~~~~~~~~d-------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..............       .......+....++.+++.+||+.||.+||++++++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00000000000000       00000011234568899999999999999999999764

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.9e-36  Score=273.29  Aligned_cols=248  Identities=21%  Similarity=0.233  Sum_probs=190.2

Q ss_pred             HHHHHhcCCCCCCee--eecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHh-ccCCcccceeeeeecC
Q 015734           71 ELQLATDNFSESNII--GQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISV-AIHKNLLQLIGYCTTS  146 (401)
Q Consensus        71 ~~~~~~~~~~~~~~l--G~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~  146 (401)
                      +.....++|.+.+.+  |+|+||.||++..+ ++..+|+|.+......    .  .|...... .+|||++++++.+...
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~----~--~e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN----A--IEPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc----h--hhHHHHHHhhcCCCEEEEEEEEecC
Confidence            334445677777766  99999999999964 6788999987642111    1  12222222 2699999999999999


Q ss_pred             CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC-cEEEeec
Q 015734          147 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDF  225 (401)
Q Consensus       147 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Df  225 (401)
                      +..++||||+++++|.+++...    ..+++..+..++.|+++||.|||+.   +++|+||||+||+++.++ .++|+||
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~df  154 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDY  154 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecC
Confidence            9999999999999999998752    3689999999999999999999999   999999999999999998 9999999


Q ss_pred             CCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhcc
Q 015734          226 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE  305 (401)
Q Consensus       226 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (401)
                      |++.......     ...++..|+|||++.+..++.++||||||+++|+|++|..||........   ....+....  .
T Consensus       155 g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~--~  224 (267)
T PHA03390        155 GLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL---DLESLLKRQ--Q  224 (267)
T ss_pred             ccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh---hHHHHHHhh--c
Confidence            9987554321     23578899999999988899999999999999999999999974432211   111111111  0


Q ss_pred             CccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 015734          306 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-MAQVVK  350 (401)
Q Consensus       306 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~~vl~  350 (401)
                      .        . ..........+.+++.+||+.+|.+||+ ++++++
T Consensus       225 ~--------~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        225 K--------K-LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             c--------c-CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            0        0 0112234567889999999999999996 688864

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.2e-37  Score=311.87  Aligned_cols=254  Identities=26%  Similarity=0.334  Sum_probs=189.5

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeec--------
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--------  145 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  145 (401)
                      -..+|...+.||+||||.||+++.+ ||+.||||++.-..+......+.+|+..+++++|||||+++..+.+        
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            3456788899999999999999976 8999999999855566677889999999999999999998753210        


Q ss_pred             --------------------------------------------------------------------------------
Q 015734          146 --------------------------------------------------------------------------------  145 (401)
Q Consensus       146 --------------------------------------------------------------------------------  145 (401)
                                                                                                      
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------C--------CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 015734          146 -----------------------S--------SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL  194 (401)
Q Consensus       146 -----------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L  194 (401)
                                             .        .-+|+=||||+.-++.+.+++.....   .....++++++|+.||+|+
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHH
Confidence                                   0        01356688888877777776532211   4678899999999999999


Q ss_pred             HhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC------C-----------CCcceeccccCCcccccccccccC
Q 015734          195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD------A-----------KLTHVTTQIRGTMGHIAPEYLSTG  257 (401)
Q Consensus       195 H~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~------~-----------~~~~~~~~~~gt~~y~aPE~~~~~  257 (401)
                      |++   |+|||||||.|||+++++.|||+|||++....      .           ......+...||.-|+|||++.+.
T Consensus       714 H~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            999   99999999999999999999999999998621      0           001122445789999999999765


Q ss_pred             ---CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHc
Q 015734          258 ---KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLC  334 (401)
Q Consensus       258 ---~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~c  334 (401)
                         +|+.|+||||||++++||+.   ||+..    .+......    .++.+.++.-     ..+..+....=..++.++
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts----MERa~iL~----~LR~g~iP~~-----~~f~~~~~~~e~slI~~L  854 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTS----MERASILT----NLRKGSIPEP-----ADFFDPEHPEEASLIRWL  854 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCch----HHHHHHHH----hcccCCCCCC-----cccccccchHHHHHHHHH
Confidence               49999999999999999986   46532    11111111    1222222221     112333444556889999


Q ss_pred             ccCCCCCCCCHHHHHH
Q 015734          335 TQSTPEDRPPMAQVVK  350 (401)
Q Consensus       335 l~~~p~~RPs~~~vl~  350 (401)
                      ++.||.+||||.|++.
T Consensus       855 l~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  855 LSHDPSKRPTATELLN  870 (1351)
T ss_pred             hcCCCccCCCHHHHhh
Confidence            9999999999999965

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-36  Score=275.59  Aligned_cols=245  Identities=21%  Similarity=0.251  Sum_probs=188.4

Q ss_pred             CeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHH-HhccCCcccceeeeeecCCeeEEEEecccC
Q 015734           83 NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLI-SVAIHKNLLQLIGYCTTSSERILVYPFMQN  158 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  158 (401)
                      +.||+|+||.||+|... +++.||+|.+....  .......+..|..++ ...+|+|++++++++...+..++++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999964 58899999886421  111223344554443 455899999999999999999999999999


Q ss_pred             CcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcce
Q 015734          159 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV  238 (401)
Q Consensus       159 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  238 (401)
                      ++|.+++...    ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.....     
T Consensus        82 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----  149 (260)
T cd05611          82 GDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----  149 (260)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence            9999998752    3588999999999999999999998   999999999999999999999999999875432     


Q ss_pred             eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCC
Q 015734          239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT  318 (401)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  318 (401)
                      .....+++.|+|||.+.+..++.++||||||+++|+|++|..||.......     .   ..... .....  ...   .
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~---~~~~~-~~~~~--~~~---~  215 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-----V---FDNIL-SRRIN--WPE---E  215 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-----H---HHHHH-hcccC--CCC---c
Confidence            223457889999999988888999999999999999999999997543211     1   11110 00000  000   0


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          319 YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       319 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                      .....+.++.+++.+||+.+|++||++.++.+.|.
T Consensus       216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            11234567889999999999999998876655543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-37  Score=292.93  Aligned_cols=245  Identities=23%  Similarity=0.368  Sum_probs=194.5

Q ss_pred             CCCeeeecCcEEEEEEEEC-CCCEEEEEEec---ccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCe--eEEEEe
Q 015734           81 ESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQ---DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE--RILVYP  154 (401)
Q Consensus        81 ~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~---~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e  154 (401)
                      ...+||+|+|-+||+|.+. +|-.||=-.++   -..++...+.|..|+.+|+.|+||||++++.++.+...  ..+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            3567999999999999964 45555432222   23456667899999999999999999999998877665  789999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC-CCcEEEeecCCccccCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfgl~~~~~~  233 (401)
                      .+..|+|..++...+    .++...++.|++||++||.|||++ .|+|+|||||-+||||+. .|.|||+|+|+|.....
T Consensus       124 L~TSGtLr~Y~kk~~----~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  124 LFTSGTLREYRKKHR----RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             cccCCcHHHHHHHhc----cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            999999999998754    478889999999999999999997 678999999999999975 58999999999987765


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      ...   ..+.|||.|||||... ..|+...||||||+.++||.|+.-||.......    .....+-.......+..+-|
T Consensus       199 s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A----QIYKKV~SGiKP~sl~kV~d  270 (632)
T KOG0584|consen  199 SHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA----QIYKKVTSGIKPAALSKVKD  270 (632)
T ss_pred             ccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH----HHHHHHHcCCCHHHhhccCC
Confidence            432   2367999999999886 789999999999999999999999997543321    11122221111222222223


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                                 +++.++|..|+.. ..+|||+.|++.
T Consensus       271 -----------Pevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  271 -----------PEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             -----------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence                       3788999999999 999999999976

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3e-36  Score=276.87  Aligned_cols=243  Identities=24%  Similarity=0.298  Sum_probs=186.2

Q ss_pred             eeeecCcEEEEEEEEC-CCCEEEEEEecccCC--cchHHHHHHHH---HHHHhccCCcccceeeeeecCCeeEEEEeccc
Q 015734           84 IIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS--PGGEAAFQREV---HLISVAIHKNLLQLIGYCTTSSERILVYPFMQ  157 (401)
Q Consensus        84 ~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~---~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  157 (401)
                      +||+|+||.||++... +++.||+|.+.....  ......+..|.   ..++...|||++++++++...+..++|+||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999864 588999998864221  11122233443   34445679999999999999999999999999


Q ss_pred             CCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcc
Q 015734          158 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH  237 (401)
Q Consensus       158 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  237 (401)
                      +++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......  
T Consensus        81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--  151 (278)
T cd05606          81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (278)
T ss_pred             CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence            9999988864    34689999999999999999999998   99999999999999999999999999987553322  


Q ss_pred             eeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcC
Q 015734          238 VTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL  316 (401)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  316 (401)
                       .....|+..|+|||.+.++ .++.++||||+|+++|+|++|..||..........      .......      .... 
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~------~~~~~~~------~~~~-  217 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE------IDRMTLT------MAVE-  217 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH------HHHHhhc------cCCC-
Confidence             1234589999999998754 58999999999999999999999997542211110      0000000      0111 


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 015734          317 NTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM  351 (401)
Q Consensus       317 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  351 (401)
                        .+...+.++.+++.+|+..+|.+||     ++.+++++
T Consensus       218 --~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         218 --LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             --CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence              1222356788999999999999999     99999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.7e-36  Score=279.09  Aligned_cols=245  Identities=22%  Similarity=0.281  Sum_probs=195.0

Q ss_pred             CCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCCc
Q 015734           82 SNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS  160 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  160 (401)
                      ...||+|+||.||++..+ ++..||+|++... .......+.+|+.+++.++|+|++++++.+...+..+++|||+++++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  103 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence            357899999999999864 6889999987532 33455678999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcceec
Q 015734          161 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT  240 (401)
Q Consensus       161 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  240 (401)
                      |.+++..     ..+++.....++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++........ ...
T Consensus       104 L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~  174 (292)
T cd06657         104 LTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRK  174 (292)
T ss_pred             HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccc
Confidence            9887753     2478899999999999999999998   999999999999999999999999999875543221 123


Q ss_pred             cccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCC
Q 015734          241 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYD  320 (401)
Q Consensus       241 ~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  320 (401)
                      ...+++.|+|||.+.+..++.++|+||||+++|+|++|..||.......     ........         ...... ..
T Consensus       175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~-----~~~~~~~~---------~~~~~~-~~  239 (292)
T cd06657         175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-----AMKMIRDN---------LPPKLK-NL  239 (292)
T ss_pred             ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhh---------CCcccC-Cc
Confidence            3457889999999988888999999999999999999999987432211     11111110         001110 11


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          321 SKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       321 ~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ......+.+++.+||+.+|.+||++.+++++
T Consensus       240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             ccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            2234467888999999999999999999763

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.5e-37  Score=289.72  Aligned_cols=252  Identities=25%  Similarity=0.315  Sum_probs=208.8

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeE
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI  150 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  150 (401)
                      +.....|.+...||+|.|+.|.++.+ .++..||||.+.+.. .......+.+|+++|..++|||||+++.+......++
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly  131 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY  131 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence            34566799999999999999999995 469999999987543 3445567899999999999999999999999999999


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      +||||+.+|.+.+++...    ..+....+..++.|+.+|++|||++   .++|||||++||||+.+.++||+|||++..
T Consensus       132 lV~eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~  204 (596)
T KOG0586|consen  132 LVMEYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTF  204 (596)
T ss_pred             EEEEeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeecccccee
Confidence            999999999999999873    3455688899999999999999999   899999999999999999999999999987


Q ss_pred             cCCCCcceeccccCCcccccccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccc
Q 015734          231 VDAKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN  309 (401)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      +..  .......+|++.|.|||++.+..+ ++++|+||+|+++|.|+.|..||++....+.....+.       ...+  
T Consensus       205 ~~~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~-------gk~r--  273 (596)
T KOG0586|consen  205 FDY--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR-------GKYR--  273 (596)
T ss_pred             ecc--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee-------eeec--
Confidence            763  445667889999999999998886 6899999999999999999999997654332211110       0001  


Q ss_pred             hhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       310 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                               .+--...+..+++++++-.+|.+|++++++.+.
T Consensus       274 ---------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  274 ---------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             ---------ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence                     111222355678889999999999999999664

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.8e-36  Score=279.07  Aligned_cols=250  Identities=28%  Similarity=0.334  Sum_probs=195.6

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      +.|...+.||+|+||.||+|... ++..+++|.+...  ........+.+|+++++.++|+|++++.+++...+..++|+
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34666788999999999999965 5788999988632  23334567889999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+. +++.+.+...   ..++++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        95 e~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          95 EYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            9996 5777766542   34588999999999999999999998   999999999999999999999999999875533


Q ss_pred             CCcceeccccCCcccccccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccch
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND  310 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      .     ....+++.|+|||.+.   ...++.++|||||||++|+|++|..||.......    ....    ... .... 
T Consensus       168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~----~~~-~~~~-  232 (308)
T cd06634         168 A-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYH----IAQ-NESP-  232 (308)
T ss_pred             c-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH----HHHH----Hhh-cCCC-
Confidence            2     2235788999999974   3567889999999999999999999986432111    0000    000 0000 


Q ss_pred             hccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       311 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                          .  .........+.+++.+||+.+|++||++.+++++...
T Consensus       233 ----~--~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~  270 (308)
T cd06634         233 ----A--LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV  270 (308)
T ss_pred             ----C--cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence                0  0122345678899999999999999999999887543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.2e-36  Score=282.04  Aligned_cols=267  Identities=23%  Similarity=0.281  Sum_probs=193.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCC-cchHHHHHHHHHHHHhccCCcccceeeeeecCC------
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------  147 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  147 (401)
                      .++|.+.+.||+|+||.||+|..+ +++.+++|.+..... ......+.+|+++++.++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999965 588999998864322 223356778999999999999999998875443      


Q ss_pred             --eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeec
Q 015734          148 --ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF  225 (401)
Q Consensus       148 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  225 (401)
                        ..+++++|+.+ ++...+...   ...+++..+..++.|+++||+|||++   +++|+||||+||++++++.++|+||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence              35899999965 666666542   34689999999999999999999999   9999999999999999999999999


Q ss_pred             CCccccCCCCcc----------eeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhh
Q 015734          226 GLAKLVDAKLTH----------VTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL  294 (401)
Q Consensus       226 gl~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~  294 (401)
                      |++.........          ......+++.|+|||.+.+. .++.++|||||||++|||++|++||.......... .
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~-~  238 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH-L  238 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH-H
Confidence            998755432211          11223467889999987654 57899999999999999999999997543321111 0


Q ss_pred             HHHHHHHHhccCc------cchhc----cCcCCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          295 LLDHIRKLLREDR------LNDIV----DRNLNT----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       295 ~~~~~~~~~~~~~------~~~~~----d~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ...... ......      .....    ....+.    ........+.+++.+||+.+|.+|||+.+++.+
T Consensus       239 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         239 IFKLCG-TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHHhC-CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            000000 000000      00000    000000    011123568899999999999999999998753

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-36  Score=276.40  Aligned_cols=260  Identities=23%  Similarity=0.312  Sum_probs=199.2

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecc
Q 015734           79 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM  156 (401)
Q Consensus        79 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  156 (401)
                      |+..+.||+|++|.||+|... +++.+++|.+.... .......+..|+.+++.++|+|++++++++...+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            556788999999999999965 58999999987533 3344567889999999999999999999999999999999999


Q ss_pred             cCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCc
Q 015734          157 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT  236 (401)
Q Consensus       157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  236 (401)
                      . ++|.+++....   ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            7 58999888632   3589999999999999999999998   999999999999999999999999999886544322


Q ss_pred             ceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhc-----------
Q 015734          237 HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR-----------  304 (401)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------  304 (401)
                      . .....++..|+|||.+.+. .++.++|+||||+++|||++|..||.........     ..+.....           
T Consensus       154 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  227 (282)
T cd07829         154 T-YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQL-----FKIFQILGTPTEESWPGVT  227 (282)
T ss_pred             c-cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH-----HHHHHHhCCCcHHHHHhhc
Confidence            1 2223457789999998766 7899999999999999999999999754422110     00110000           


Q ss_pred             -----cCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          305 -----EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       305 -----~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                           ................+.....+.+++.+||+.+|++||++.+++.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         228 KLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             ccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence                 00000000000000111225678999999999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3e-36  Score=285.14  Aligned_cols=263  Identities=22%  Similarity=0.327  Sum_probs=195.6

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCC-----
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-----  147 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  147 (401)
                      ..++|...+.||+|+||.||++... ++..||+|++.... .......+.+|+.+++.++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            4678999999999999999999854 68999999986422 2334457889999999999999999999886554     


Q ss_pred             -eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecC
Q 015734          148 -ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG  226 (401)
Q Consensus       148 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  226 (401)
                       ..++|++|+ +++|..++..     ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence             358999998 7788877753     3588999999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHH------HHH
Q 015734          227 LAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL------DHI  299 (401)
Q Consensus       227 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~------~~~  299 (401)
                      ++......    .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||..............      ...
T Consensus       164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07880         164 LARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF  239 (343)
T ss_pred             cccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            98765432    122356889999999876 4588999999999999999999999975432111000000      000


Q ss_pred             HHHhccCccch-------hccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          300 RKLLREDRLND-------IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       300 ~~~~~~~~~~~-------~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                      ...........       .....+..........+.+++.+|++.||.+|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00000000000       0000000111223456889999999999999999999975

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.6e-36  Score=283.53  Aligned_cols=270  Identities=22%  Similarity=0.294  Sum_probs=198.6

Q ss_pred             CHHHHHHHhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeec
Q 015734           68 SCRELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTT  145 (401)
Q Consensus        68 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  145 (401)
                      ...++....++|.+.+.||+|+||.||+|.. .++..||+|++.... +......+.+|+.++.+++||||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            3456677889999999999999999999985 468899999986432 23335678889999999999999999998754


Q ss_pred             C------CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCc
Q 015734          146 S------SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE  219 (401)
Q Consensus       146 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~  219 (401)
                      .      ...+++++++ +++|.+.+..     ..+++..+..++.|++.||+|||+.   +++|+||||+||++++++.
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~  158 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE  158 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence            3      3357777776 7788877653     3488999999999999999999998   9999999999999999999


Q ss_pred             EEEeecCCccccCCCCcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHH
Q 015734          220 AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH  298 (401)
Q Consensus       220 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~  298 (401)
                      ++|+|||++......    .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.......... .....
T Consensus       159 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~  233 (345)
T cd07877         159 LKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK-LILRL  233 (345)
T ss_pred             EEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHH
Confidence            999999998754322    223457889999998866 467889999999999999999999996543211100 00000


Q ss_pred             -------HHHHhccCccchh---cc----CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          299 -------IRKLLREDRLNDI---VD----RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       299 -------~~~~~~~~~~~~~---~d----~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                             .............   ++    ............++.+++..|++.||.+||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                   0000000000000   00    00000001134568899999999999999999999765

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.1e-36  Score=284.31  Aligned_cols=263  Identities=22%  Similarity=0.256  Sum_probs=195.7

Q ss_pred             hcCCC-CCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcc-------------hHHHHHHHHHHHHhccCCccccee
Q 015734           76 TDNFS-ESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPG-------------GEAAFQREVHLISVAIHKNLLQLI  140 (401)
Q Consensus        76 ~~~~~-~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-------------~~~~~~~e~~~l~~l~h~niv~~~  140 (401)
                      .++|. +.+.||+|+||+||+|..+ +++.||+|.+.......             ....+.+|+++++.++|+|+++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            34565 3577999999999999965 68899999886432211             112577899999999999999999


Q ss_pred             eeeecCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcE
Q 015734          141 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA  220 (401)
Q Consensus       141 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~  220 (401)
                      +++...+..+++|||+. ++|.+++..    ...+++.....++.|++.||.|||+.   +++|+||+|+||+++.++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~  158 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGIC  158 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCE
Confidence            99999999999999996 588888764    34588999999999999999999998   99999999999999999999


Q ss_pred             EEeecCCccccCCCC-------------cceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCc
Q 015734          221 VLCDFGLAKLVDAKL-------------THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSR  286 (401)
Q Consensus       221 kl~Dfgl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~  286 (401)
                      +|+|||++.......             ........+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~  238 (335)
T PTZ00024        159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN  238 (335)
T ss_pred             EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999987654111             1111223467889999998764 46899999999999999999999997554


Q ss_pred             chhhhhhhHHHHHHHHhccCc---cchh------------ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          287 LEEEEDVLLLDHIRKLLREDR---LNDI------------VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~---~~~~------------~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..+.     ...+........   +...            ..............++.+++..||+.+|++||++++++.+
T Consensus       239 ~~~~-----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        239 EIDQ-----LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             HHHH-----HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            3211     111111111000   0000            0000001112234678899999999999999999999764

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=9.5e-36  Score=279.93  Aligned_cols=264  Identities=22%  Similarity=0.307  Sum_probs=197.6

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeec-CCee
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSER  149 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~  149 (401)
                      ...+++|+..+.||.|+||.||++... ++..||+|++... ........+..|+.++..++|||++++.+++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            346788999999999999999999955 6899999988642 233345678899999999999999999998865 4578


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ++++||+ +++|...+..     ..++......++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.
T Consensus        86 ~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          86 YFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             EEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence            8999998 5688877753     3478888899999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCCcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHH--------HHH
Q 015734          230 LVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD--------HIR  300 (401)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~--------~~~  300 (401)
                      .....    .....++..|+|||.+.+ ..++.++||||||+++|+|+||..||......... ....+        +..
T Consensus       157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~  231 (328)
T cd07856         157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQF-SIITDLLGTPPDDVIN  231 (328)
T ss_pred             ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHHH
Confidence            54322    122346789999998766 56899999999999999999999999754321100 00000        000


Q ss_pred             HHhccCccchhcc-CcC-CC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          301 KLLREDRLNDIVD-RNL-NT-----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       301 ~~~~~~~~~~~~d-~~~-~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ....... .++.. ... ..     ........+.+++.+||+.+|++||++.+++.+
T Consensus       232 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         232 TICSENT-LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hccchhh-HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000000 00000 000 00     011234678899999999999999999999765

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.1e-35  Score=275.90  Aligned_cols=245  Identities=28%  Similarity=0.378  Sum_probs=192.2

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           79 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        79 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      |...+.||+|+||+||+|... ++..|++|.+...  ........+.+|+++++.++|||++++++++.+.+..+++|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            666778999999999999964 6889999998632  2223446788999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +. +++.+.+...   ..++++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++.....  
T Consensus       103 ~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--  173 (313)
T cd06633         103 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--  173 (313)
T ss_pred             CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence            96 5777666542   34589999999999999999999998   999999999999999999999999999864322  


Q ss_pred             cceeccccCCcccccccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          236 THVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                         .....++..|+|||.+.   ...++.++||||||+++|+|++|..||.......        ......... ...  
T Consensus       174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~--------~~~~~~~~~-~~~--  239 (313)
T cd06633         174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQND-SPT--  239 (313)
T ss_pred             ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHHhcC-CCC--
Confidence               12345788999999984   4568889999999999999999999986432211        011111000 000  


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                         .  ........+.+++.+||+.+|.+||++.+++++
T Consensus       240 ---~--~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         240 ---L--QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ---C--CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               0  111223467889999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=6.2e-36  Score=281.87  Aligned_cols=265  Identities=20%  Similarity=0.293  Sum_probs=190.9

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-C--CCEEEEEEecccC-CcchHHHHHHHHHHHHhc-cCCcccceeeeeecC----Ce
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-D--NTKVAVKRLQDYY-SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS----SE  148 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~--~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~----~~  148 (401)
                      +|.+.+.||+|+||.||++... +  +..||+|.+.... .......+.+|+.++.++ .||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4777889999999999999964 3  6789999986432 223356788899999998 599999999875432    34


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      .+++++++. ++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            678888885 688888764    34589999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCcc---eeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhH-------HH
Q 015734          229 KLVDAKLTH---VTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL-------LD  297 (401)
Q Consensus       229 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~-------~~  297 (401)
                      .........   ......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.............       .+
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE  232 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            765432211   1223468899999998765 468999999999999999999999997543211000000       00


Q ss_pred             HHHHHhccCc------cchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          298 HIRKLLREDR------LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       298 ~~~~~~~~~~------~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                      ..........      ........+....+.....+.+++.+||+.||.+|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000000      0000000000011122457889999999999999999999854

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-37  Score=292.17  Aligned_cols=202  Identities=27%  Similarity=0.359  Sum_probs=177.0

Q ss_pred             CCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCC------eeEE
Q 015734           79 FSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------ERIL  151 (401)
Q Consensus        79 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~l  151 (401)
                      +...+.||+|+||.||+|++ .+|+.||||.++........+...+|++++++++|+|||++.+.-....      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            34567899999999999995 4799999999987777778899999999999999999999998765443      5689


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEc--CCC--cEEEeecCC
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD--DNF--EAVLCDFGL  227 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~--~~~--~~kl~Dfgl  227 (401)
                      +||||.+|||...|.+..+ ...+++.....++.+++.||.|||.+   +|+||||||.||++-  .+|  .-||+|||.
T Consensus        95 vmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            9999999999999998654 56699999999999999999999998   999999999999983  323  469999999


Q ss_pred             ccccCCCCcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCc
Q 015734          228 AKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSR  286 (401)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~  286 (401)
                      |+.+.++.  ....+.||..|++||.... ..|+...|.|||||++|++.||..||....
T Consensus       171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~  228 (732)
T KOG4250|consen  171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG  228 (732)
T ss_pred             cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence            99887654  5667889999999999985 778999999999999999999999996543

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-37  Score=276.17  Aligned_cols=247  Identities=24%  Similarity=0.324  Sum_probs=200.9

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhcc-CCcccceeeeeecCCe
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSE  148 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  148 (401)
                      .+...+|+.+.+||+|+||.|-++..+ +...+|||++++..  ..+..+--+.|-++|.... -|.++.++.+++.-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            455668999999999999999999865 46789999997532  3334444556777776654 5789999999999999


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      +++||||+.||+|..++++.-    .+.++.+..++..||-||-|||++   +|++||||.+||++|.+|++||+|||++
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~G----kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmc  497 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVG----KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC  497 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhc----ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccc
Confidence            999999999999999999753    477888999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      +.--- ....+..++|||.|+|||++...+|+.+.|+||||++||||+.|++||++.+..+     +.+           
T Consensus       498 KEni~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-----lF~-----------  560 (683)
T KOG0696|consen  498 KENIF-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-----LFQ-----------  560 (683)
T ss_pred             ccccc-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-----HHH-----------
Confidence            74322 1234566899999999999999999999999999999999999999999765432     111           


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM  345 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  345 (401)
                       .+++.++ .++...+.+...+....+.+.|.+|...
T Consensus       561 -aI~ehnv-syPKslSkEAv~ickg~ltK~P~kRLGc  595 (683)
T KOG0696|consen  561 -AIMEHNV-SYPKSLSKEAVAICKGLLTKHPGKRLGC  595 (683)
T ss_pred             -HHHHccC-cCcccccHHHHHHHHHHhhcCCccccCC
Confidence             1222222 2455666778888889999999999643

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=313.66  Aligned_cols=256  Identities=25%  Similarity=0.277  Sum_probs=205.3

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEE-ECCCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeE
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI  150 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  150 (401)
                      +..+-++.....||.|.||.||.|. ..+|...|+|.++-.. .........+|..++..++|||+|+++|+-......+
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence            3345567778899999999999999 4568889999876222 2344567889999999999999999999999999999


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      +.||||++|+|.+.+..    +.-.++.....+..|++.|++|||++   |||||||||.||+++.+|.+|++|||.+..
T Consensus      1311 IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred             HHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeE
Confidence            99999999999999886    33467777888999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcc---eeccccCCcccccccccccC---CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHH-Hh
Q 015734          231 VDAKLTH---VTTQIRGTMGHIAPEYLSTG---KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK-LL  303 (401)
Q Consensus       231 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~---~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~  303 (401)
                      +......   ......||+.|||||++.+.   ....+.|||||||++.||.||+.||...+..         |..- .+
T Consensus      1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---------~aIMy~V 1454 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---------WAIMYHV 1454 (1509)
T ss_pred             ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---------hHHHhHH
Confidence            6554322   23446799999999999754   3677899999999999999999999743321         1111 11


Q ss_pred             ccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 015734          304 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML  352 (401)
Q Consensus       304 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  352 (401)
                      ..+        ..++.+...+.+=.+++.+||..||..|-++.|++++=
T Consensus      1455 ~~g--------h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1455 AAG--------HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             hcc--------CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence            112        22334445666778899999999999999888886653

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.7e-36  Score=284.62  Aligned_cols=263  Identities=22%  Similarity=0.329  Sum_probs=196.6

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCe----
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE----  148 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----  148 (401)
                      ..++|...+.||+|++|.||+|... ++..||+|++.... +......+.+|+.+++.+.|||++++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4678999999999999999999975 57899999886422 23344667889999999999999999987765554    


Q ss_pred             --eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecC
Q 015734          149 --RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG  226 (401)
Q Consensus       149 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  226 (401)
                        .++|+||+ +++|.+++..     ..+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence              89999998 6688888764     3589999999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHH------
Q 015734          227 LAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI------  299 (401)
Q Consensus       227 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~------  299 (401)
                      ++......    .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......... ...+..      
T Consensus       164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~-~i~~~~~~~~~~  238 (343)
T cd07851         164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLK-RIMNLVGTPDEE  238 (343)
T ss_pred             cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHhcCCCCHH
Confidence            98765432    223357889999999865 367899999999999999999999997543211100 000000      


Q ss_pred             -HHHhccCccchhcc-------CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          300 -RKLLREDRLNDIVD-------RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       300 -~~~~~~~~~~~~~d-------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                       ............+.       ............++.+++.+||+.+|++|||+.+++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence             00000000000000       00000011235678899999999999999999999764

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=7.1e-36  Score=282.54  Aligned_cols=263  Identities=22%  Similarity=0.298  Sum_probs=191.7

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecC---------
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS---------  146 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---------  146 (401)
                      .+|...+.||.|+||.||+|... ++..||+|.+.... ....+.+.+|+++++.++|||++++++++...         
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC-CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            57889999999999999999964 58899999886432 34557788999999999999999998766543         


Q ss_pred             -----CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEc-CCCcE
Q 015734          147 -----SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFEA  220 (401)
Q Consensus       147 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~~  220 (401)
                           ...++++||+. ++|.+++..     ..+++..++.++.|++.||.|||+.   +++|+||||+||+++ +++.+
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence                 35789999997 588777753     3488999999999999999999998   999999999999997 55678


Q ss_pred             EEeecCCccccCCCCcce--eccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHH
Q 015734          221 VLCDFGLAKLVDAKLTHV--TTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD  297 (401)
Q Consensus       221 kl~Dfgl~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~  297 (401)
                      +|+|||++..........  .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||............+..
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            999999997654322111  122346889999998654 55788999999999999999999999754322111110000


Q ss_pred             H-------HHHHhccCccchhcc--CcCC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          298 H-------IRKLLREDRLNDIVD--RNLN-----TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       298 ~-------~~~~~~~~~~~~~~d--~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .       ......  .......  ....     ........++.+++.+||+.||.+|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         235 VPVVREEDRNELLN--VIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             cCCCChHHhhhhhh--hhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            0       000000  0000000  0000     0111234578899999999999999999999754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-35  Score=266.49  Aligned_cols=237  Identities=25%  Similarity=0.254  Sum_probs=192.1

Q ss_pred             eeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCCcH
Q 015734           85 IGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV  161 (401)
Q Consensus        85 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  161 (401)
                      ||+|+||.||++... ++..+++|.+....  .......+..|+++++.++|||++++++.+...+..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999965 58899999986432  223556889999999999999999999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcceecc
Q 015734          162 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ  241 (401)
Q Consensus       162 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  241 (401)
                      .+++...    ..+++.....++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus        81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~  152 (250)
T cd05123          81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT  152 (250)
T ss_pred             HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence            9998763    3589999999999999999999998   99999999999999999999999999987654432 12233


Q ss_pred             ccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCH
Q 015734          242 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS  321 (401)
Q Consensus       242 ~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  321 (401)
                      ..++..|+|||.+.+...+.++|+||||+++|++++|..||......     ..   ...... ..         ...+.
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-----~~---~~~~~~-~~---------~~~~~  214 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK-----EI---YEKILK-DP---------LRFPE  214 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-----HH---HHHHhc-CC---------CCCCC
Confidence            45788999999998888999999999999999999999999654321     11   111111 00         01122


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHH
Q 015734          322 KEVETMVQVALLCTQSTPEDRPPMAQ  347 (401)
Q Consensus       322 ~~~~~l~~l~~~cl~~~p~~RPs~~~  347 (401)
                      .....+.+++.+||..||++||++.+
T Consensus       215 ~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         215 FLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            22457889999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.2e-36  Score=261.82  Aligned_cols=272  Identities=22%  Similarity=0.322  Sum_probs=201.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC-----CCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeec-CCe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSD-----NTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSE  148 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~  148 (401)
                      ...|.....||+|.||.||+|.-++     ...+|+|+++.. ..........+|+.+++.++|||++.+..++.. ...
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            4568889999999999999996332     237899998742 233455788999999999999999999998877 667


Q ss_pred             eEEEEecccCCcHHHHhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCC----CcEEEe
Q 015734          149 RILVYPFMQNLSVAYRLRDLKP-GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN----FEAVLC  223 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~----~~~kl~  223 (401)
                      .++++||.+. +|...++..+. ....++....+.|+.||+.|+.|||++   -++||||||.|||+..+    |.|||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence            8999999976 78777764332 235789999999999999999999999   79999999999999877    999999


Q ss_pred             ecCCccccCCCCcce--eccccCCcccccccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhh-hhHHHHH
Q 015734          224 DFGLAKLVDAKLTHV--TTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEED-VLLLDHI  299 (401)
Q Consensus       224 Dfgl~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~-~~~~~~~  299 (401)
                      |||+++.+.+.....  ...++-|..|.|||.+.+.+ |+.+.|||+.|||+.||+|-.+.|.......... ..-.+.+
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            999999887765443  34456799999999998765 8999999999999999999998886544322111 1122222


Q ss_pred             HHHh---c---cCccchhc----------cCcCCCCCH-----------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          300 RKLL---R---EDRLNDIV----------DRNLNTYDS-----------KEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       300 ~~~~---~---~~~~~~~~----------d~~~~~~~~-----------~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .+.+   .   ++.+..+.          +-+...+.+           ......++|+..+|+.||-+|.|+++.+++
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            2211   1   11111110          000000000           011236788899999999999999999774

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=262.13  Aligned_cols=253  Identities=24%  Similarity=0.302  Sum_probs=199.1

Q ss_pred             HhcCCCCC-CeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHh-ccCCcccceeeeeecC----C
Q 015734           75 ATDNFSES-NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISV-AIHKNLLQLIGYCTTS----S  147 (401)
Q Consensus        75 ~~~~~~~~-~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~----~  147 (401)
                      .+++|++. ++||-|-.|.|-.+..+ +++.+|+|++.+.      ....+|+++--. -.|||||.+++++.+.    .
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk  132 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK  132 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence            46677653 68999999999999865 6899999998752      334677776443 4699999999987543    3


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEc---CCCcEEEee
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---DNFEAVLCD  224 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~---~~~~~kl~D  224 (401)
                      .+.+|||+++||.|...+++.  +...+++.++..|+.||+.|+.|||+.   +|.||||||+|+|.+   .|..+||+|
T Consensus       133 cLLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD  207 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD  207 (400)
T ss_pred             eeEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence            467899999999999999874  456799999999999999999999999   999999999999996   456799999


Q ss_pred             cCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhc
Q 015734          225 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR  304 (401)
Q Consensus       225 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (401)
                      ||+++.....  ......+-||.|.|||++...+|+...|+||+||++|-|++|.+||.....     ..+....+...+
T Consensus       208 fGFAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-----~aispgMk~rI~  280 (400)
T KOG0604|consen  208 FGFAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-----LAISPGMKRRIR  280 (400)
T ss_pred             cccccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-----ccCChhHHhHhh
Confidence            9999865432  223445679999999999999999999999999999999999999974322     111112222222


Q ss_pred             cCccchhccCcCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          305 EDRLNDIVDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       305 ~~~~~~~~d~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .+..      .++ ..++..++...++++.+|..+|.+|.|+.++..+
T Consensus       281 ~gqy------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  281 TGQY------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             ccCc------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            1111      111 2356778889999999999999999999999774

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=259.48  Aligned_cols=256  Identities=22%  Similarity=0.290  Sum_probs=197.0

Q ss_pred             CCeeeecCcEEEEEEE-ECCCCEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCcccceeeeeecCCeeEEEEecccCC
Q 015734           82 SNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPFMQNL  159 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g  159 (401)
                      .+.||+|+++.|-.+. ..+|..||||++.+. ....+....+|++++.+.+ |+||+.+++++.++..+|+|||-|.||
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG  161 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG  161 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence            3679999999999988 678999999998653 4456678899999998874 999999999999999999999999999


Q ss_pred             cHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC---cEEEeecCCccccCC--C
Q 015734          160 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF---EAVLCDFGLAKLVDA--K  234 (401)
Q Consensus       160 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl~Dfgl~~~~~~--~  234 (401)
                      +|..+++.    ...+++.++.++..+|+.||.|||.+   ||.||||||+|||.....   -+|||||.+..-...  +
T Consensus       162 plLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~  234 (463)
T KOG0607|consen  162 PLLSHIQK----RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND  234 (463)
T ss_pred             hHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence            99999987    44689999999999999999999999   999999999999997554   479999998763321  1


Q ss_pred             C----cceeccccCCcccccccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhh-------hhhHHHH
Q 015734          235 L----THVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE-------DVLLLDH  298 (401)
Q Consensus       235 ~----~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~-------~~~~~~~  298 (401)
                      .    .......+|+..|||||+..     ...|+.+.|.||||+++|-|++|.+||.+....+..       ...-...
T Consensus       235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L  314 (463)
T KOG0607|consen  235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL  314 (463)
T ss_pred             CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence            1    11223456888999999863     345899999999999999999999999754432221       1111111


Q ss_pred             HHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          299 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       299 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      +..+ .++ ..++.|.    .+...+.+..+++...+..++.+|.++.+++++
T Consensus       315 FesI-QEG-kYeFPdk----dWahIS~eakdlisnLlvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  315 FESI-QEG-KYEFPDK----DWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             HHHH-hcc-CCcCChh----hhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence            1111 111 1222221    133445566778888888999999999999873

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=6.7e-35  Score=297.02  Aligned_cols=146  Identities=27%  Similarity=0.351  Sum_probs=130.8

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ++|.+.+.||+|+||+||+|.+. +++.||+|++...  ........+..|+.++..++||||+++++++...+..++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999975 6889999998642  22334567889999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ||+.+++|..++...    ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999998752    3578899999999999999999998   99999999999999999999999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-37  Score=261.81  Aligned_cols=260  Identities=24%  Similarity=0.335  Sum_probs=199.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHH-hccCCcccceeeeeecCCeeEEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      .++.+.+..||.|+||+|++-.++ .|+..|||+++.........++..|.+... .-+.||||+++|.+-.++..++.|
T Consensus        63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM  142 (361)
T KOG1006|consen   63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM  142 (361)
T ss_pred             cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence            344455678999999999998865 689999999986666677788888988654 457899999999999999999999


Q ss_pred             ecccCCcHHHHhhh-cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          154 PFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       154 e~~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |+|+- |+..+... +.-....+++...-.|......||.||-...  .++|||+||+|||++..|.+||||||++..+.
T Consensus       143 ELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  143 ELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             HHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence            99954 55544331 1122456888888899999999999999875  79999999999999999999999999998665


Q ss_pred             CCCcceeccccCCccccccccccc--CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccch
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND  310 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ++...  +.-.|-..|||||.+..  ..|+.+||+||||++|+|+.||..||+..+.       ..+.+...+..+.  +
T Consensus       220 ~SiAk--T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-------vfeql~~Vv~gdp--p  288 (361)
T KOG1006|consen  220 DSIAK--TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-------VFEQLCQVVIGDP--P  288 (361)
T ss_pred             HHHHh--hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-------HHHHHHHHHcCCC--C
Confidence            54332  23357789999999853  3489999999999999999999999975443       2233333222211  1


Q ss_pred             hccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       311 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .+...  ...-.....+..++..|+.+|..+||...++.++
T Consensus       289 ~l~~~--~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  289 ILLFD--KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             eecCc--ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            11110  0112345678899999999999999999999764

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-35  Score=237.57  Aligned_cols=262  Identities=25%  Similarity=0.339  Sum_probs=197.9

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEec-ccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~-~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      +|...++||+|.||+||+++.. +++.||+|+++ +..++....+..+|+-+++.+.|.|||++++....+..+-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4566788999999999999954 57899999997 334455667889999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      |+. +|..+....   +..++....+.++.|+++||.|+|++   ++.|||+||.|.||+.||+.|++|||+++.++-..
T Consensus        83 cdq-dlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             hhH-HHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            964 777776653   45689999999999999999999999   99999999999999999999999999999776554


Q ss_pred             cceeccccCCcccccccccccCC-CCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHH--hccCccch-
Q 015734          236 THVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKL--LREDRLND-  310 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~-  310 (401)
                      .... ..+-|..|.+|.++.+.+ |+...|+||-||++.|+.. |++.|.+.+..+    ++...++..  ..++.+.. 
T Consensus       156 rcys-aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd----qlkrif~~lg~p~ed~wps~  230 (292)
T KOG0662|consen  156 RCYS-AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD----QLKRIFRLLGTPTEDQWPSM  230 (292)
T ss_pred             Eeee-ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH----HHHHHHHHhCCCccccCCcc
Confidence            3332 234689999999998766 7889999999999999988 556566554332    222222221  11222222 


Q ss_pred             --hccCcC-CCC-----CHHHHH----HHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          311 --IVDRNL-NTY-----DSKEVE----TMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       311 --~~d~~~-~~~-----~~~~~~----~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                        +.|... +.+     ..+..+    .=.+++...+.-+|.+|.+++..+++
T Consensus       231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence              112111 111     122222    22355556667799999999988664

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-36  Score=265.70  Aligned_cols=269  Identities=21%  Similarity=0.269  Sum_probs=207.3

Q ss_pred             HHHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccC--Cc----ccceee
Q 015734           69 CRELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH--KN----LLQLIG  141 (401)
Q Consensus        69 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~n----iv~~~~  141 (401)
                      +.......++|.+...+|+|.||.|-.+.+. .+..||+|+++..  ....+...-|++++.++.+  |+    ++.+.+
T Consensus        81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~  158 (415)
T KOG0671|consen   81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRD  158 (415)
T ss_pred             EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence            3334455889999999999999999999854 4789999998752  3456677889999998842  33    778888


Q ss_pred             eeecCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEc------
Q 015734          142 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD------  215 (401)
Q Consensus       142 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~------  215 (401)
                      ++.-.++.|+|+|.+ |.|+.++|...  +..+++...++.++.|++.+++|||+.   +++|.||||+|||+.      
T Consensus       159 wFdyrghiCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~  232 (415)
T KOG0671|consen  159 WFDYRGHICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFK  232 (415)
T ss_pred             hhhccCceEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEE
Confidence            999999999999998 77999999864  346789999999999999999999999   999999999999993      


Q ss_pred             --------------CCCcEEEeecCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCC
Q 015734          216 --------------DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRA  281 (401)
Q Consensus       216 --------------~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p  281 (401)
                                    .+..++++|||.+.......    ...+.|..|.|||++.+-.++..+||||+||||+|++||...
T Consensus       233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L  308 (415)
T KOG0671|consen  233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL  308 (415)
T ss_pred             EeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence                          24568999999998654432    445679999999999999999999999999999999999999


Q ss_pred             CCCCcchhhhhhhHHHHH--------------HHHhccCccc-----------hhccCcCC-----CCCHHHHHHHHHHH
Q 015734          282 IDFSRLEEEEDVLLLDHI--------------RKLLREDRLN-----------DIVDRNLN-----TYDSKEVETMVQVA  331 (401)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~-----------~~~d~~~~-----~~~~~~~~~l~~l~  331 (401)
                      |+..+..+.-  .+.+.+              .+.+..+.+.           ...++..+     .....+..++++|+
T Consensus       309 FqtHen~EHL--aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl  386 (415)
T KOG0671|consen  309 FQTHENLEHL--AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL  386 (415)
T ss_pred             cccCCcHHHH--HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence            9876533211  111111              1111111110           01111111     12345667899999


Q ss_pred             HHcccCCCCCCCCHHHHHHH
Q 015734          332 LLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       332 ~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..||..||.+|+|+.|.+++
T Consensus       387 ~~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  387 RRMLEFDPARRITLREALSH  406 (415)
T ss_pred             HHHHccCccccccHHHHhcC
Confidence            99999999999999999764

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.6e-34  Score=257.75  Aligned_cols=219  Identities=21%  Similarity=0.182  Sum_probs=174.6

Q ss_pred             cCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCCcHHHHhh
Q 015734           88 GGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLR  166 (401)
Q Consensus        88 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~  166 (401)
                      |.+|.||++.++ +++.||+|.+....      .+..|...+....|||++++++++...+..+++|||+++++|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            899999999964 68899999986421      23345555556679999999999999999999999999999999887


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcceeccccCCc
Q 015734          167 DLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM  246 (401)
Q Consensus       167 ~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~  246 (401)
                      ..    ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++++|||.+......    .....++.
T Consensus        78 ~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~  146 (237)
T cd05576          78 KF----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVEN  146 (237)
T ss_pred             Hh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCc
Confidence            52    3489999999999999999999998   9999999999999999999999999987654332    12234567


Q ss_pred             ccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHH
Q 015734          247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVET  326 (401)
Q Consensus       247 ~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  326 (401)
                      .|+|||.+.+..++.++|+||+|+++|||++|..|+.......              ..     ....   ..+......
T Consensus       147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--------------~~-----~~~~---~~~~~~~~~  204 (237)
T cd05576         147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI--------------NT-----HTTL---NIPEWVSEE  204 (237)
T ss_pred             cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--------------cc-----cccc---CCcccCCHH
Confidence            8999999988889999999999999999999998865321100              00     0000   012223457


Q ss_pred             HHHHHHHcccCCCCCCCCH
Q 015734          327 MVQVALLCTQSTPEDRPPM  345 (401)
Q Consensus       327 l~~l~~~cl~~~p~~RPs~  345 (401)
                      +.+++.+||+.||++||++
T Consensus       205 ~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         205 ARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHHHHccCCHHHhcCC
Confidence            8889999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=268.86  Aligned_cols=257  Identities=25%  Similarity=0.366  Sum_probs=196.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEec--ccCCc----chHHHHHHHHHHHHhccCCcccceeeeee-cCC
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQ--DYYSP----GGEAAFQREVHLISVAIHKNLLQLIGYCT-TSS  147 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~--~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~  147 (401)
                      .++|-.+.+||+|||+.||++.+ ..++.||+|+-.  +.+.+    .......+|.++-+.++||.||++++++. +.+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            44566778999999999999994 468899999764  22222    23356788999999999999999999986 455


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEc---CCCcEEEee
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---DNFEAVLCD  224 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~---~~~~~kl~D  224 (401)
                      .+|-|+|||+|.+|.-+|..    .+.+++.+++.|+.||+.||.||... +++|+|-||||.|||+-   ..|.+||+|
T Consensus       542 sFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             cceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence            78999999999999999986    45589999999999999999999986 56899999999999994   467899999


Q ss_pred             cCCccccCCCCcc------eeccccCCccccccccccc----CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhh
Q 015734          225 FGLAKLVDAKLTH------VTTQIRGTMGHIAPEYLST----GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL  294 (401)
Q Consensus       225 fgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~  294 (401)
                      ||+++.+......      .+....||..|++||.+.-    .+.+.+.||||.||++|+++.|+.||......    . 
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ----Q-  691 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ----Q-  691 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH----H-
Confidence            9999987654432      3455679999999998743    35788999999999999999999999854321    0 


Q ss_pred             HHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 015734          295 LLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV  349 (401)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl  349 (401)
                            .++....+.....-.++ .-+....+...+|++||++.-++|....++.
T Consensus       692 ------dILqeNTIlkAtEVqFP-~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  692 ------DILQENTILKATEVQFP-PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             ------HHHhhhchhcceeccCC-CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence                  11111111110000011 1123345677899999999999999877764

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=8.4e-34  Score=282.32  Aligned_cols=263  Identities=16%  Similarity=0.194  Sum_probs=169.8

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-C----CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeee------e
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-D----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY------C  143 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------~  143 (401)
                      ..++|.+.+.||+|+||.||+|.+. +    +..||+|++....   ..+....+  .+....+.++..+...      +
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~---~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG---AVEIWMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc---hhHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            5678999999999999999999964 4    6899999876421   11111111  1122222222222211      2


Q ss_pred             ecCCeeEEEEecccCCcHHHHhhhcCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 015734          144 TTSSERILVYPFMQNLSVAYRLRDLKPG----------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDL  207 (401)
Q Consensus       144 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl  207 (401)
                      ......++|+||+.+++|.+++......                ........+..++.|++.||+|||++   +|+||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL  281 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV  281 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence            4556789999999999999988742110                01112334567999999999999998   9999999


Q ss_pred             CCCceEEcC-CCcEEEeecCCccccCCCCcceeccccCCcccccccccccC----------------------CCCcccc
Q 015734          208 KAANILLDD-NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG----------------------KSSEKTD  264 (401)
Q Consensus       208 kp~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sD  264 (401)
                      ||+|||++. ++.+||+|||+++..............+++.|+|||.+...                      .++.++|
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            999999985 68999999999986544433344456789999999965322                      2345679


Q ss_pred             hhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHh-ccCccchhccCcCC-------CCCHHHHHHHHHHHHHccc
Q 015734          265 VFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL-REDRLNDIVDRNLN-------TYDSKEVETMVQVALLCTQ  336 (401)
Q Consensus       265 i~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~d~~~~-------~~~~~~~~~l~~l~~~cl~  336 (401)
                      ||||||++|||+++..|++....      .+...+...- ....+.....+...       ...........+|+.+||+
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~------~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLI------QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHH------HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence            99999999999997765432110      0000000000 00000000011000       0001112345589999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 015734          337 STPEDRPPMAQVVKM  351 (401)
Q Consensus       337 ~~p~~RPs~~~vl~~  351 (401)
                      .||.+|||+.+++++
T Consensus       436 ~dP~kR~ta~e~L~H  450 (566)
T PLN03225        436 FKGRQRISAKAALAH  450 (566)
T ss_pred             CCcccCCCHHHHhCC
Confidence            999999999999885

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-34  Score=279.20  Aligned_cols=258  Identities=26%  Similarity=0.357  Sum_probs=207.5

Q ss_pred             HHHHHhcCCCCCCeeeecCcEEEEEEE-ECCCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeee----
Q 015734           71 ELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT----  144 (401)
Q Consensus        71 ~~~~~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~----  144 (401)
                      .+...++-|.+.++||.|.+|.||+++ .++++..|+|++...  .+..+++..|.+++... .|||++.++|++.    
T Consensus        13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~--~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~   90 (953)
T KOG0587|consen   13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT--EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP   90 (953)
T ss_pred             hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC--ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence            334467788999999999999999999 457899999998653  33456777888988876 5999999999884    


Q ss_pred             -cCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEe
Q 015734          145 -TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLC  223 (401)
Q Consensus       145 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~  223 (401)
                       .+++++||||||.+||..+++....  +..+.|..+..|+..++.|+.+||.+   .++|||||-.|||++.++.|||+
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence             3468899999999999999999877  56799999999999999999999999   89999999999999999999999


Q ss_pred             ecCCccccCCCCcceeccccCCcccccccccccC-----CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHH
Q 015734          224 DFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-----KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH  298 (401)
Q Consensus       224 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~  298 (401)
                      |||++..+..... ......|||.|||||++...     .|+..+|+||||++..||--|.+|+...-+           
T Consensus       166 DFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-----------  233 (953)
T KOG0587|consen  166 DFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-----------  233 (953)
T ss_pred             eeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch-----------
Confidence            9999987755433 33446799999999999643     367789999999999999999999864322           


Q ss_pred             HHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          299 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       299 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ++.++.-.+-+   .+.+ ..+..-.+++.++|..||.+|-++||++.+++++
T Consensus       234 mraLF~IpRNP---PPkL-krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  234 MRALFLIPRNP---PPKL-KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             hhhhccCCCCC---Cccc-cchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence            11111111000   0011 1245567889999999999999999999999775

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-34  Score=272.33  Aligned_cols=240  Identities=21%  Similarity=0.256  Sum_probs=191.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCcchHHHHHHHHHHHHh-ccCCcccceeeeeecCCeeEEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISV-AIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ++.|.....+|.|+|+.|-.+.. .+++..++|++.+..     ....+|+.++.. -+|||++++.+.+.+..+.++||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            56788888899999999999985 468889999986531     122356655444 47999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEE-cCCCcEEEeecCCccccC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL-DDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill-~~~~~~kl~Dfgl~~~~~  232 (401)
                      |.+.++-+.+.+....     .....+..|+.+|+.|+.|||++   |++||||||+|||+ ++.++++|+|||.++...
T Consensus       396 e~l~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             hhccccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            9999998888777522     22267778999999999999998   99999999999999 699999999999998776


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ..    ....+-|..|.|||++....++.++||||||++||+|++|+.||......    .    .+...+..+      
T Consensus       468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~----ei~~~i~~~------  529 (612)
T KOG0603|consen  468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----I----EIHTRIQMP------  529 (612)
T ss_pred             hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----H----HHHHhhcCC------
Confidence            54    22334588999999999899999999999999999999999999754332    0    111111111      


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                           .+....+.+..+|+.+||+.||.+||+|.++..+
T Consensus       530 -----~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  530 -----KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             -----ccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence                 1223445677889999999999999999999553

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-36  Score=253.52  Aligned_cols=265  Identities=24%  Similarity=0.355  Sum_probs=196.6

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEec-ccCCcchHHHHHHHHHHHHhccCCcccceeeeeecC--------C
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--------S  147 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~-~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------~  147 (401)
                      .|....++|+|.||.||+|+.+ +|+.||+|++. +...+.......+|+++|..+.|+|++.++..|...        .
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            4556778999999999999954 57888988664 333445566778999999999999999999888432        2


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCC
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL  227 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl  227 (401)
                      .+++||.+|+. +|.-.|.+.   ...++..++.+++.++..||.|+|++   .|+|||+||.|+||+.+|.+||+|||+
T Consensus        98 t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence            47999999976 777777753   34589999999999999999999999   899999999999999999999999999


Q ss_pred             ccccCCCCc---ceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHh
Q 015734          228 AKLVDAKLT---HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL  303 (401)
Q Consensus       228 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  303 (401)
                      ++.+.....   ...++.+-|..|++||.+.+. .++++.|||+-||++.||.|+.+-++....  .....+........
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte--qqql~~Is~LcGs~  248 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE--QQQLHLISQLCGSI  248 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH--HHHHHHHHHHhccC
Confidence            986644322   123344568999999998765 589999999999999999999998876543  22222222222111


Q ss_pred             ccCccchhcc---------CcCCC----CCHHHH------HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          304 REDRLNDIVD---------RNLNT----YDSKEV------ETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       304 ~~~~~~~~~d---------~~~~~----~~~~~~------~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..+.++.+..         +.++.    ...+..      .+..+|+..++..||.+|+++++++.+
T Consensus       249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            1221111100         10111    011111      256788899999999999999999775

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-35  Score=269.69  Aligned_cols=246  Identities=22%  Similarity=0.255  Sum_probs=203.1

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEECCCC-EEEEEEecc--cCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeE
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVLSDNT-KVAVKRLQD--YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI  150 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~-~vavK~~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  150 (401)
                      +...++.....||-||||.|=++..+... .+|+|.+++  ....+..+....|-++|...+.|.||+++-.+.+....|
T Consensus       417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY  496 (732)
T KOG0614|consen  417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY  496 (732)
T ss_pred             cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence            34456667778999999999999975443 489998874  345667788899999999999999999999999999999


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      ++||-|-||.|...|++    .+.++..+.+.++..+..|++|||++   +|++|||||+|.+++.+|-+||.|||+++.
T Consensus       497 mLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKk  569 (732)
T KOG0614|consen  497 MLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKK  569 (732)
T ss_pred             hhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHH
Confidence            99999999999999997    44588889999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccch
Q 015734          231 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND  310 (401)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      .....  .+-.++|||.|.|||++.+..++.+.|.||||+++|||++|.+||+..++-.     ....+.+.+..-    
T Consensus       570 i~~g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk-----tYn~ILkGid~i----  638 (732)
T KOG0614|consen  570 IGSGR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK-----TYNLILKGIDKI----  638 (732)
T ss_pred             hccCC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH-----HHHHHHhhhhhh----
Confidence            76543  3455789999999999999999999999999999999999999998765421     112222211111    


Q ss_pred             hccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 015734          311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP  344 (401)
Q Consensus       311 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  344 (401)
                             .++........+++++.+..+|.+|..
T Consensus       639 -------~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  639 -------EFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             -------hcccccchhHHHHHHHHHhcCcHhhhc
Confidence                   123334456778888888999999975

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=238.76  Aligned_cols=215  Identities=21%  Similarity=0.324  Sum_probs=182.5

Q ss_pred             CHHHHHHHhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCcchHHHHHHHHHHHH-hccCCcccceeeeeec
Q 015734           68 SCRELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLLQLIGYCTT  145 (401)
Q Consensus        68 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~  145 (401)
                      ....+++..+.......||+|++|.|-+-++ .+|...|+|.+......+......+|+++.. ...+|.+|.++|....
T Consensus        37 ~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r  116 (282)
T KOG0984|consen   37 GDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR  116 (282)
T ss_pred             ecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence            3344666777777788999999999988884 5799999999987777777788889998765 4579999999999999


Q ss_pred             CCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeec
Q 015734          146 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF  225 (401)
Q Consensus       146 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  225 (401)
                      ....++.||.|+. ||..+.......+..+++..+-+|+..+..||.|||++.  .++|||+||+|||++.+|++|+|||
T Consensus       117 egdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDF  193 (282)
T KOG0984|consen  117 EGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDF  193 (282)
T ss_pred             cccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccc
Confidence            9999999999954 888888777667788999999999999999999999985  7999999999999999999999999


Q ss_pred             CCccccCCCCcceeccccCCccccccccccc----CCCCcccchhHHHHHHHHHHhCCCCCCCCcc
Q 015734          226 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLST----GKSSEKTDVFGYGITLLELVTGQRAIDFSRL  287 (401)
Q Consensus       226 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDi~slG~ll~elltg~~p~~~~~~  287 (401)
                      |++-.+.++.....  -.|-..|||||.+..    ..|+.+|||||||+++.||.+++.||+....
T Consensus       194 GIsG~L~dSiAkt~--daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  194 GISGYLVDSIAKTM--DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             ccceeehhhhHHHH--hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            99987765443322  236678999998853    3689999999999999999999999986543

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=267.37  Aligned_cols=246  Identities=22%  Similarity=0.316  Sum_probs=200.4

Q ss_pred             CCeeeecCcEEEEEEEE-CCCCEEEEEEecc-cCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCC
Q 015734           82 SNIIGQGGFGKVYKGVL-SDNTKVAVKRLQD-YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL  159 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  159 (401)
                      .++||+|.||+||-|.+ ++|+.||||++.+ ....+...++.+|+.+|.++.||.||.+.-.|...+..++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            57899999999999995 5799999999963 345667789999999999999999999999999999999999999664


Q ss_pred             cHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCC---CcEEEeecCCccccCCCCc
Q 015734          160 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN---FEAVLCDFGLAKLVDAKLT  236 (401)
Q Consensus       160 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~---~~~kl~Dfgl~~~~~~~~~  236 (401)
                      -|.-.|..   ....++......++.||+-||.|||-+   +|+|.||||+|||+...   ..+||||||.++..++.  
T Consensus       649 MLEMILSs---EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--  720 (888)
T KOG4236|consen  649 MLEMILSS---EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--  720 (888)
T ss_pred             HHHHHHHh---hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh--
Confidence            45444443   245688888899999999999999999   99999999999999643   46999999999988764  


Q ss_pred             ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcC
Q 015734          237 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL  316 (401)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  316 (401)
                      .....++|||.|+|||++..+.|...-|+||.|+++|--++|..||..+..       ..+.++.+       .++-+. 
T Consensus       721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-------IndQIQNA-------aFMyPp-  785 (888)
T KOG4236|consen  721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-------INDQIQNA-------AFMYPP-  785 (888)
T ss_pred             hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-------hhHHhhcc-------ccccCC-
Confidence            344567899999999999999999999999999999999999999974322       22222221       111111 


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          317 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       317 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                       ..+.+......++|...|+..-.+|.|.+.-+.+
T Consensus       786 -~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  786 -NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             -CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence             1245556678889999999999999998887664

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=3.3e-33  Score=250.28  Aligned_cols=239  Identities=26%  Similarity=0.307  Sum_probs=192.0

Q ss_pred             CcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCCcHHHHhhh
Q 015734           89 GFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD  167 (401)
Q Consensus        89 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  167 (401)
                      +||.||+|... ++..+++|++.........+.+.+|++.+++++|+|++++++++......++++||+.+++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999976 48999999987543333268899999999999999999999999999999999999999999998876


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcceeccccCCcc
Q 015734          168 LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG  247 (401)
Q Consensus       168 ~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~  247 (401)
                      ..    .+++.....++.+++.++.+||+.   +++|+||+|+||++++++.++|+|||.+.......  ......++..
T Consensus        81 ~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~  151 (244)
T smart00220       81 RG----RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE  151 (244)
T ss_pred             cc----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence            32    288999999999999999999998   99999999999999999999999999998665432  2233457889


Q ss_pred             cccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHH
Q 015734          248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETM  327 (401)
Q Consensus       248 y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l  327 (401)
                      |++||.+.+..++.++||||||+++++|++|..||......    ....+...    ......      .........++
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~----~~~~~~~~----~~~~~~------~~~~~~~~~~~  217 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL----LELFKKIG----KPKPPF------PPPEWKISPEA  217 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHh----ccCCCC------ccccccCCHHH
Confidence            99999998888999999999999999999999998652111    11111111    110000      00001144678


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHH
Q 015734          328 VQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       328 ~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                      .+++.+||..+|++||++.++++
T Consensus       218 ~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      218 KDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHccCCchhccCHHHHhh
Confidence            89999999999999999999976

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.6e-34  Score=266.90  Aligned_cols=207  Identities=22%  Similarity=0.263  Sum_probs=175.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEE-ECCCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      ..-|...+.||-|+||.|.+++ .++...||+|.+++.  ...........|-++|...+.+.||+++..|++.+.+|+|
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV  707 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV  707 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence            3446778899999999999998 556788999998742  1223455678899999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |+|++||++..+|...    .-+++..++.++..+..|+++.|..   |+|||||||+|||||.+|++||+||||+.-+.
T Consensus       708 MdYIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR  780 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  780 (1034)
T ss_pred             EeccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccce
Confidence            9999999999998863    4588889999999999999999999   99999999999999999999999999986331


Q ss_pred             ---CCCcc--------------------------------------eeccccCCcccccccccccCCCCcccchhHHHHH
Q 015734          233 ---AKLTH--------------------------------------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGIT  271 (401)
Q Consensus       233 ---~~~~~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~l  271 (401)
                         +....                                      .....+||+.|+|||++....++..+|+||.|||
T Consensus       781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi  860 (1034)
T KOG0608|consen  781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI  860 (1034)
T ss_pred             eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence               10000                                      0122458999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCcchh
Q 015734          272 LLELVTGQRAIDFSRLEE  289 (401)
Q Consensus       272 l~elltg~~p~~~~~~~~  289 (401)
                      ||||+.|+.||-...+.+
T Consensus       861 l~em~~g~~pf~~~tp~~  878 (1034)
T KOG0608|consen  861 LYEMLVGQPPFLADTPGE  878 (1034)
T ss_pred             HHHHhhCCCCccCCCCCc
Confidence            999999999997766543

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6e-33  Score=269.78  Aligned_cols=265  Identities=20%  Similarity=0.230  Sum_probs=180.6

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEE-----------------CCCCEEEEEEecccCCcchHH--------------HHH
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVL-----------------SDNTKVAVKRLQDYYSPGGEA--------------AFQ  122 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~  122 (401)
                      ...++|.+.++||+|+||+||+|..                 .+++.||||++..... ...+              ...
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~-~~~~~fl~e~~~~~~~~e~~~  220 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQ-GVRQDFLKTGTLAKGSAETGM  220 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccch-hhHHHHHhhhhhhhcccchhH
Confidence            3577999999999999999999963                 2356799999864221 1222              233


Q ss_pred             HHHHHHHhccCCcc-----cceeeeeec--------CCeeEEEEecccCCcHHHHhhhcCC-------------------
Q 015734          123 REVHLISVAIHKNL-----LQLIGYCTT--------SSERILVYPFMQNLSVAYRLRDLKP-------------------  170 (401)
Q Consensus       123 ~e~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~-------------------  170 (401)
                      .|+.++.+++|.++     ++++++|..        .+..++||||+.+++|.++++....                   
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            46667777766654     667777653        3467999999999999998874211                   


Q ss_pred             -CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcceeccccCCcccc
Q 015734          171 -GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI  249 (401)
Q Consensus       171 -~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~  249 (401)
                       ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++...............+|+.|+
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~  377 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS  377 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCccee
Confidence             012356788899999999999999998   9999999999999999999999999999755433222222223578999


Q ss_pred             cccccccCCC----------------------CcccchhHHHHHHHHHHhCCC-CCCCCcchhhhh----hhHHHHHHHH
Q 015734          250 APEYLSTGKS----------------------SEKTDVFGYGITLLELVTGQR-AIDFSRLEEEED----VLLLDHIRKL  302 (401)
Q Consensus       250 aPE~~~~~~~----------------------~~~sDi~slG~ll~elltg~~-p~~~~~~~~~~~----~~~~~~~~~~  302 (401)
                      |||.+.....                      ..+.||||+||++++|++|.. |+..........    ..+..|..  
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--  455 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--  455 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--
Confidence            9998754321                      134699999999999999875 664221110000    00111110  


Q ss_pred             hccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCC---CCCCCHHHHHHH
Q 015734          303 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTP---EDRPPMAQVVKM  351 (401)
Q Consensus       303 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p---~~RPs~~~vl~~  351 (401)
                      .....    .  ... ..........+++.++|..+|   .+|+|++|++++
T Consensus       456 ~~~~~----~--~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        456 YKGQK----Y--DFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             hcccC----C--Ccc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            00000    0  000 122234567888889998766   689999999764

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-34  Score=249.08  Aligned_cols=251  Identities=22%  Similarity=0.298  Sum_probs=199.7

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCe
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSE  148 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  148 (401)
                      .+...+|..+++||+|+|..|-.+.++ +.+.||+|++++.  ...+..+-.+.|-.+..+. +||.+|.+..+++..+.
T Consensus       246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr  325 (593)
T KOG0695|consen  246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR  325 (593)
T ss_pred             ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence            445677999999999999999999954 6789999998742  2334556677777777665 69999999999999999


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      +++|.||.+||+|.-+++.    ...+++..++.+...|+.||.|||++   ||++||||.+|||+|..|++||+|+|++
T Consensus       326 lffvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmc  398 (593)
T KOG0695|consen  326 LFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMC  398 (593)
T ss_pred             EEEEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchh
Confidence            9999999999999888876    34599999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcch---hhhhhhHHHHHHHHhcc
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLE---EEEDVLLLDHIRKLLRE  305 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~  305 (401)
                      +.--.+ ...+..++|||.|.|||.+.+..|....|+|+||++++||+.|+.||+.....   .....++.+.+..    
T Consensus       399 ke~l~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile----  473 (593)
T KOG0695|consen  399 KEGLGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE----  473 (593)
T ss_pred             hcCCCC-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh----
Confidence            854322 33456689999999999999999999999999999999999999999854322   2222333332221    


Q ss_pred             CccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 015734          306 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP  344 (401)
Q Consensus       306 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  344 (401)
                      .        .+. .+...+-....++..-|++||.+|..
T Consensus       474 k--------qir-iprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  474 K--------QIR-IPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             h--------ccc-ccceeehhhHHHHHHhhcCCcHHhcC
Confidence            1        110 12222334456777889999999853

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-33  Score=272.29  Aligned_cols=246  Identities=26%  Similarity=0.321  Sum_probs=185.4

Q ss_pred             CCCCCeeeecCcEE-EEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCeeEEEEecc
Q 015734           79 FSESNIIGQGGFGK-VYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFM  156 (401)
Q Consensus        79 ~~~~~~lG~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  156 (401)
                      |...+++|.|+.|+ ||+|.. +|+.||||++-.    .......+|+..|+.- .||||+++++.-.+....|+..|.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhh----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            44456789999876 799999 789999998853    3445678999999876 5999999988888888899999999


Q ss_pred             cCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC-----CCcEEEeecCCcccc
Q 015734          157 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-----NFEAVLCDFGLAKLV  231 (401)
Q Consensus       157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-----~~~~kl~Dfgl~~~~  231 (401)
                      . .+|.+++..-........-...+.++.|+++||++||+.   +|+||||||.||||+.     ..+++|+|||+++.+
T Consensus       586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            5 599998876211011111134567889999999999998   9999999999999975     357899999999977


Q ss_pred             CCCCcce--eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhC-CCCCCCCcchhhhhhhHHHHHHHHhcc-Cc
Q 015734          232 DAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG-QRAIDFSRLEEEEDVLLLDHIRKLLRE-DR  307 (401)
Q Consensus       232 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~  307 (401)
                      .......  .....||.+|+|||++.....+.+.||||+||++|+.++| .+||...-..  +        ...+.. ..
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~--------~NIl~~~~~  731 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--Q--------ANILTGNYT  731 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--h--------hhhhcCccc
Confidence            6554332  3456789999999999999889999999999999999996 8999732110  0        001110 00


Q ss_pred             cchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       308 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      +..+     .. ..++  +..+||.+|++.+|..||++.+|+.+
T Consensus       732 L~~L-----~~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  732 LVHL-----EP-LPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             eeee-----cc-CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            1100     00 1111  67789999999999999999999764

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-32  Score=247.06  Aligned_cols=265  Identities=23%  Similarity=0.320  Sum_probs=195.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCcchHHHHHHHHHHHHhcc-----CC---cccceeeeee--
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-----HK---NLLQLIGYCT--  144 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----h~---niv~~~~~~~--  144 (401)
                      ..+|.+.++||.|-|++||++.+ .+.+.||+|+.+.  .+...+..+.|+++|++++     |+   .||++++.|.  
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS--AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs  154 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS--AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS  154 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh--hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence            36788999999999999999995 4678999999874  3445677889999998874     33   4899999884  


Q ss_pred             --cCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC------
Q 015734          145 --TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD------  216 (401)
Q Consensus       145 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~------  216 (401)
                        ++.+.|||+|++ |-+|..++....  -+.++...++.|++||+.||.|||..|  +|||.||||+|||+..      
T Consensus       155 GpNG~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~  229 (590)
T KOG1290|consen  155 GPNGQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPA  229 (590)
T ss_pred             CCCCcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchh
Confidence              445789999999 778988888643  356899999999999999999999998  9999999999999930      


Q ss_pred             --------------------------------------------------------------------------------
Q 015734          217 --------------------------------------------------------------------------------  216 (401)
Q Consensus       217 --------------------------------------------------------------------------------  216 (401)
                                                                                                      
T Consensus       230 ~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~  309 (590)
T KOG1290|consen  230 KDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRI  309 (590)
T ss_pred             hhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCC
Confidence                                                                                            


Q ss_pred             ----------------------------C---------------------------------------------------
Q 015734          217 ----------------------------N---------------------------------------------------  217 (401)
Q Consensus       217 ----------------------------~---------------------------------------------------  217 (401)
                                                  +                                                   
T Consensus       310 n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~  389 (590)
T KOG1290|consen  310 NGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPEC  389 (590)
T ss_pred             CccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcc
Confidence                                        0                                                   


Q ss_pred             -CcEEEeecCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhh----hh
Q 015734          218 -FEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE----ED  292 (401)
Q Consensus       218 -~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~----~~  292 (401)
                       .++||+|||-++......    +.-..|..|+|||++.+..|+..+||||++|++|||.||...|+.......    +.
T Consensus       390 di~vKIaDlGNACW~~khF----T~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH  465 (590)
T KOG1290|consen  390 DIRVKIADLGNACWVHKHF----TEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH  465 (590)
T ss_pred             ceeEEEeeccchhhhhhhh----chhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence             014555555555443221    112357889999999999999999999999999999999988875432211    11


Q ss_pred             -hhHHHH---HH-HHhcc-CccchhccCc--------C------------CCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 015734          293 -VLLLDH---IR-KLLRE-DRLNDIVDRN--------L------------NTYDSKEVETMVQVALLCTQSTPEDRPPMA  346 (401)
Q Consensus       293 -~~~~~~---~~-~~~~~-~~~~~~~d~~--------~------------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  346 (401)
                       ....+.   +. .+... ..-.+++++.        +            ..++.+...++.+++.-||+.+|++||||.
T Consensus       466 iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~  545 (590)
T KOG1290|consen  466 IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAA  545 (590)
T ss_pred             HHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHH
Confidence             111111   11 11111 1112222221        1            124567788899999999999999999999


Q ss_pred             HHHHH
Q 015734          347 QVVKM  351 (401)
Q Consensus       347 ~vl~~  351 (401)
                      +.+++
T Consensus       546 ~cl~h  550 (590)
T KOG1290|consen  546 QCLKH  550 (590)
T ss_pred             HHhcC
Confidence            99875

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=7.6e-34  Score=243.02  Aligned_cols=259  Identities=23%  Similarity=0.323  Sum_probs=193.0

Q ss_pred             CCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCC-----eeEEEEe
Q 015734           82 SNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-----ERILVYP  154 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e  154 (401)
                      .+-||.|+||.||.+++. +|+.||.|++.+.. +-.....+.+|+++|..++|.|++..++..+-.+     +.|+++|
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            466999999999999864 68999999987533 2234567889999999999999999988765443     4567778


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      .+. .+|.+.+-.    .++++...++-++.||++||.|||+.   +|.||||||.|.|++.|...||||||+++....+
T Consensus       138 LmQ-SDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  138 LMQ-SDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHH-hhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence            774 366665554    46788899999999999999999999   9999999999999999999999999999977666


Q ss_pred             CcceeccccCCcccccccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhcc--------
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE--------  305 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------  305 (401)
                      ....++..+-|..|.|||.+.+.+ |+.+.||||.||++.||+..+-.|+..++-..-     +.+...+..        
T Consensus       210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL-----~lItdLLGTPs~EaMr~  284 (449)
T KOG0664|consen  210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQL-----QMIIDLLGTPSQEAMKY  284 (449)
T ss_pred             hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHH-----HHHHHHhCCCcHHHHHH
Confidence            555556666788999999998765 899999999999999999988888765442211     111111111        


Q ss_pred             ---CccchhccC--------cCCCCC--HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          306 ---DRLNDIVDR--------NLNTYD--SKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       306 ---~~~~~~~d~--------~~~~~~--~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                         +....++..        .+.+..  .....+...+...++..||++|.+-.+.+..+.
T Consensus       285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence               111111111        111111  123344566777899999999999888876543

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=4.6e-30  Score=224.44  Aligned_cols=212  Identities=33%  Similarity=0.487  Sum_probs=182.9

Q ss_pred             eeecCcEEEEEEEECC-CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCCcHHH
Q 015734           85 IGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAY  163 (401)
Q Consensus        85 lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  163 (401)
                      ||+|++|.||++...+ +..+++|++...........+.+|++.++.+.|++++++++++......++++|++.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999754 899999998753322245789999999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC-CCcEEEeecCCccccCCCCcceeccc
Q 015734          164 RLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFGLAKLVDAKLTHVTTQI  242 (401)
Q Consensus       164 ~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~  242 (401)
                      ++....   ..+++..+..++.+++.++.+||+.   +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~  153 (215)
T cd00180          81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI  153 (215)
T ss_pred             HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence            987632   3588999999999999999999999   9999999999999999 89999999999986644321 12234


Q ss_pred             cCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCH
Q 015734          243 RGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS  321 (401)
Q Consensus       243 ~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  321 (401)
                      .+...|++||.+... ..+.++|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            467899999999877 788999999999999999                                              


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 015734          322 KEVETMVQVALLCTQSTPEDRPPMAQVVKML  352 (401)
Q Consensus       322 ~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  352 (401)
                         ..+.+++..|++.+|++||++.++++.+
T Consensus       188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence               2577888999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=3.5e-31  Score=221.28  Aligned_cols=260  Identities=17%  Similarity=0.272  Sum_probs=193.4

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEE-ECCCCEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCcccceeeeeecCC--eeE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSS--ERI  150 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~~~  150 (401)
                      ..++|++.+++|+|-++.||.|. ..++.+++||++++    -....+.+|+++|..+. ||||+++++...+..  ...
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            45688999999999999999998 55788999999975    34567899999999997 999999999987654  468


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC-CCcEEEeecCCcc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFGLAK  229 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfgl~~  229 (401)
                      +++||.++.+.......       ++...++.++.+++.||.|+|++   ||+|||+||.|++||. ....+|+|+|++.
T Consensus       112 LiFE~v~n~Dfk~ly~t-------l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAE  181 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLYPT-------LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAE  181 (338)
T ss_pred             hHhhhhccccHHHHhhh-------hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHh
Confidence            99999998776555443       67788999999999999999999   9999999999999985 4568999999999


Q ss_pred             ccCCCCcceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhh---------hHHHHH
Q 015734          230 LVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV---------LLLDHI  299 (401)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~---------~~~~~~  299 (401)
                      ++.......  ..+.+..|..||.+..- .|+.+-|+|||||++..|+..+.||=.......+-+         .+...+
T Consensus       182 FYHp~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl  259 (338)
T KOG0668|consen  182 FYHPGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL  259 (338)
T ss_pred             hcCCCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence            887654432  23457788999998654 488999999999999999999999843222111110         111111


Q ss_pred             HHHh--ccCccchhccCcC--------CCCC-HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          300 RKLL--REDRLNDIVDRNL--------NTYD-SKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       300 ~~~~--~~~~~~~~~d~~~--------~~~~-~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                      .+..  -+.....+++...        +... .-...+..+++...|..|-.+|||++|...
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            1110  1111222222111        0000 112367788889999999999999999854

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-30  Score=226.12  Aligned_cols=263  Identities=22%  Similarity=0.270  Sum_probs=194.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecc-cCCcchHHHHHHHHHHHHhccCCcccceeeeeecCC------
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQD-YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------  147 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  147 (401)
                      ..+|..+..+|.|.- .|..+.+ -.+++||+|++.. .......+...+|..++..++|+|+++++.++.-..      
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            346777788899888 5665653 2588999998863 233334567789999999999999999999886443      


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCC
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL  227 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl  227 (401)
                      +.++|||+|. .+|...+..      .++-.++..|+.|++.|+.|||+.   +|+||||||+||++..++.+||.|||+
T Consensus        95 e~y~v~e~m~-~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~  164 (369)
T KOG0665|consen   95 EVYLVMELMD-ANLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGL  164 (369)
T ss_pred             hHHHHHHhhh-hHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchh
Confidence            5689999995 477777762      256678899999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcch--------------hhhhh
Q 015734          228 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLE--------------EEEDV  293 (401)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~--------------~~~~~  293 (401)
                      ++.-...  ...+....|..|.|||++.+..+.+.+||||+||++.||++|...|.+.+.-              +.-..
T Consensus       165 ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~  242 (369)
T KOG0665|consen  165 ARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK  242 (369)
T ss_pred             hcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence            9854433  3455667889999999999988999999999999999999999888643311              11111


Q ss_pred             hHHHHHHHHhccCc------cchhc-cCcCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          294 LLLDHIRKLLREDR------LNDIV-DRNLNT---YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       294 ~~~~~~~~~~~~~~------~~~~~-d~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .+...++..++...      ..+.+ |...+.   .+........+++.+||-.||++|.|+++++++
T Consensus       243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            22222332222110      11111 111111   122233456788889999999999999999876

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=7.4e-29  Score=219.77  Aligned_cols=200  Identities=30%  Similarity=0.402  Sum_probs=171.3

Q ss_pred             CCCCCeeeecCcEEEEEEEECC-CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEeccc
Q 015734           79 FSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQ  157 (401)
Q Consensus        79 ~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  157 (401)
                      |...+.||+|++|.||++...+ +..+++|.+...........+.+|++.+..++|+|++++++++......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5567889999999999999764 889999998753322256788999999999999999999999999899999999999


Q ss_pred             CCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcc
Q 015734          158 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH  237 (401)
Q Consensus       158 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  237 (401)
                      +++|.+++.....   .+++.....++.+++.++.+||+.   +++|+||+|.||+++.++.++|+|||.+.........
T Consensus        81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence            9999999886321   178899999999999999999998   9999999999999999999999999998876544311


Q ss_pred             eeccccCCccccccccc-ccCCCCcccchhHHHHHHHHHHhCCCCCCC
Q 015734          238 VTTQIRGTMGHIAPEYL-STGKSSEKTDVFGYGITLLELVTGQRAIDF  284 (401)
Q Consensus       238 ~~~~~~gt~~y~aPE~~-~~~~~~~~sDi~slG~ll~elltg~~p~~~  284 (401)
                      ......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            22334567889999998 666788899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=2.8e-30  Score=241.23  Aligned_cols=198  Identities=23%  Similarity=0.348  Sum_probs=166.7

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC-CCEEEEEEecccC-------CcchHHHHHHHHHHHHhcc---CCcccceeeeee
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYY-------SPGGEAAFQREVHLISVAI---HKNLLQLIGYCT  144 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~  144 (401)
                      ..+|+..+.+|+|+||.|++|.++. ...|+||.+.+..       .....-..-.|+.+|..++   |+||+++++++.
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            3458889999999999999999875 5678999875421       0111123456999999987   999999999999


Q ss_pred             cCCeeEEEEeccc-CCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEe
Q 015734          145 TSSERILVYPFMQ-NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLC  223 (401)
Q Consensus       145 ~~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~  223 (401)
                      +.+.+|++||... +.+|.+++..    .+.+++..+..|+.||+.|+++||++   +|+|||||-+||.++.+|-+||+
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEe
Confidence            9999999999764 5678888875    55699999999999999999999999   99999999999999999999999


Q ss_pred             ecCCccccCCCCcceeccccCCcccccccccccCCC-CcccchhHHHHHHHHHHhCCCCCC
Q 015734          224 DFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAID  283 (401)
Q Consensus       224 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi~slG~ll~elltg~~p~~  283 (401)
                      |||.+......   ....++||..|.|||++.+.+| +..-|||++|++||.++....||.
T Consensus       713 dfgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  713 DFGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99998755432   2345679999999999999887 566799999999999999888875

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=2.7e-30  Score=238.58  Aligned_cols=270  Identities=21%  Similarity=0.216  Sum_probs=203.0

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhcc------CCcccceeeeee
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI------HKNLLQLIGYCT  144 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~  144 (401)
                      .++...+|.+....|+|-|++|..|.+. .|+.||||++.+.  +--...=+.|+++|.+|+      --+.++++-.|.
T Consensus       427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN--E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~  504 (752)
T KOG0670|consen  427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN--EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK  504 (752)
T ss_pred             hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc--hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence            3456778888888999999999999964 4789999999863  333455578999999986      347899999999


Q ss_pred             cCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC-cEEEe
Q 015734          145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLC  223 (401)
Q Consensus       145 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~  223 (401)
                      ..+++|||+|-+ ..+|.+.|..+-. +-.+....+..++.|+..||..|-..   +++|.||||+|||++++. .+|||
T Consensus       505 hknHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLC  579 (752)
T KOG0670|consen  505 HKNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLC  579 (752)
T ss_pred             hcceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeec
Confidence            999999999988 6699999987643 44588889999999999999999998   999999999999998754 57999


Q ss_pred             ecCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhh-------hHH
Q 015734          224 DFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV-------LLL  296 (401)
Q Consensus       224 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~-------~~~  296 (401)
                      |||.+.......-   +...-+.-|.|||++.+.+|+...|+||.||.||||.||+-.|++.+.......       ...
T Consensus       580 DfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~  656 (752)
T KOG0670|consen  580 DFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN  656 (752)
T ss_pred             cCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence            9999987665432   222235579999999999999999999999999999999999987654322110       000


Q ss_pred             HHHHHHh-cc----Cccc------------------hhc------------cCcCCCCCHHHHHHHHHHHHHcccCCCCC
Q 015734          297 DHIRKLL-RE----DRLN------------------DIV------------DRNLNTYDSKEVETMVQVALLCTQSTPED  341 (401)
Q Consensus       297 ~~~~~~~-~~----~~~~------------------~~~------------d~~~~~~~~~~~~~l~~l~~~cl~~~p~~  341 (401)
                      ..+++.. .+    ..+.                  ..+            .+.++.........+.+|+..|+..||++
T Consensus       657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K  736 (752)
T KOG0670|consen  657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK  736 (752)
T ss_pred             HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence            1111100 00    0000                  000            01122223445677889999999999999


Q ss_pred             CCCHHHHHHH
Q 015734          342 RPPMAQVVKM  351 (401)
Q Consensus       342 RPs~~~vl~~  351 (401)
                      |.|..+.+.+
T Consensus       737 Rit~nqAL~H  746 (752)
T KOG0670|consen  737 RITVNQALKH  746 (752)
T ss_pred             cCCHHHHhcC
Confidence            9999988654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=2e-30  Score=245.85  Aligned_cols=255  Identities=24%  Similarity=0.272  Sum_probs=200.4

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      .+.++|.....+|+|.+|.||+++++ ++...|+|+++-. ..+...-...|+-+++..+||||+.+++.+.....+++.
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe-p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic   90 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE-PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC   90 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeecc-CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence            35678999999999999999999964 6889999998732 234566678899999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      ||||.+|+|.+..+-    ..++++.++....+...+||+|||++   +-+|||||-.||++++.|.+|++|||.+-.+.
T Consensus        91 MEycgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqit  163 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQIT  163 (829)
T ss_pred             EEecCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhh
Confidence            999999998776654    56799999999999999999999999   88999999999999999999999999987665


Q ss_pred             CCCcceeccccCCccccccccc---ccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYL---STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN  309 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ..... ...+.||+.|||||+.   ..+.|...+|||++|+...|+---.+|.-..-         ...+..+....   
T Consensus       164 ati~K-rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh---------pmr~l~LmTkS---  230 (829)
T KOG0576|consen  164 ATIAK-RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH---------PMRALFLMTKS---  230 (829)
T ss_pred             hhhhh-hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc---------hHHHHHHhhcc---
Confidence            54332 3456799999999986   35668999999999999999987776632110         01111111111   


Q ss_pred             hhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       310 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                       .+++.-..-...-.+.+.++++.|+.++|.+||+++.+++
T Consensus       231 -~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  231 -GFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             -CCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence             1111111111223456788999999999999999998876

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=217.03  Aligned_cols=248  Identities=22%  Similarity=0.326  Sum_probs=183.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeee-eecCCeeEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGY-CTTSSERILV  152 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~-~~~~~~~~lv  152 (401)
                      .+.|++.+.||+|.||.+-++.++ +++.+++|.+....  .....|.+|..---.| .|.||+.-++. ++..+.+.++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            467899999999999999999965 57889999887533  3467899998765555 48999887764 5666778899


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEc--CCCcEEEeecCCccc
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD--DNFEAVLCDFGLAKL  230 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~--~~~~~kl~Dfgl~~~  230 (401)
                      +||++.|+|.+-+..     ..+.+....+++.|+++|+.|+|++   +++|||||.+||||-  +..++||||||+++.
T Consensus       101 qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k  172 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRK  172 (378)
T ss_pred             eccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccc
Confidence            999999999887764     3477888999999999999999999   999999999999993  445899999999875


Q ss_pred             cCCCCcceeccccCCcccccccccccC-----CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhcc
Q 015734          231 VDAKLTHVTTQIRGTMGHIAPEYLSTG-----KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE  305 (401)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (401)
                      .+.....    ..-+..|.+||.....     ...+.+|+|.||+++|.++||+.||+.....+.......+|.....  
T Consensus       173 ~g~tV~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~--  246 (378)
T KOG1345|consen  173 VGTTVKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN--  246 (378)
T ss_pred             cCceehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC--
Confidence            5433222    2235578999976432     3578899999999999999999999865544444433333333221  


Q ss_pred             CccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 015734          306 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQ  347 (401)
Q Consensus       306 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~  347 (401)
                          ..+....+.    ..+.+.++.++-+..+|++|=-..+
T Consensus       247 ----~~~P~~F~~----fs~~a~r~Fkk~lt~~~~drcki~~  280 (378)
T KOG1345|consen  247 ----PALPKKFNP----FSEKALRLFKKSLTPRFKDRCKIWT  280 (378)
T ss_pred             ----ccCchhhcc----cCHHHHHHHHHhcCCcccccchhHH
Confidence                111112222    2345666777888999999943333

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=2.3e-28  Score=221.48  Aligned_cols=199  Identities=25%  Similarity=0.374  Sum_probs=165.5

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEEC----CCCEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCcccceeeeeecC
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTS  146 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~  146 (401)
                      +....+.|..+++||+|.|++||++.+.    .++.||+|.+.....   ...+.+|+++|..+. +.||+++.+++...
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---p~ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---PSRILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence            3445677899999999999999999843    467899999865333   356889999999885 89999999999999


Q ss_pred             CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC-CCcEEEeec
Q 015734          147 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDF  225 (401)
Q Consensus       147 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Df  225 (401)
                      +...+|+||++.-.-.+++..       ++...+..++..+..||+++|.+   ||+||||||+|+|.+. .+.-.|.||
T Consensus       108 d~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDF  177 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDF  177 (418)
T ss_pred             CeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEec
Confidence            999999999999888888876       67899999999999999999999   9999999999999974 566789999


Q ss_pred             CCccccCCCC-------------------------------------------cceeccccCCcccccccccccC-CCCc
Q 015734          226 GLAKLVDAKL-------------------------------------------THVTTQIRGTMGHIAPEYLSTG-KSSE  261 (401)
Q Consensus       226 gl~~~~~~~~-------------------------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~  261 (401)
                      |++.......                                           ........||++|.|||++... ..++
T Consensus       178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt  257 (418)
T KOG1167|consen  178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT  257 (418)
T ss_pred             hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence            9987221000                                           0011224589999999998654 4789


Q ss_pred             ccchhHHHHHHHHHHhCCCCCC
Q 015734          262 KTDVFGYGITLLELVTGQRAID  283 (401)
Q Consensus       262 ~sDi~slG~ll~elltg~~p~~  283 (401)
                      +.||||-|++++.++++..||-
T Consensus       258 aiDiws~GVI~Lslls~~~PFf  279 (418)
T KOG1167|consen  258 AIDIWSAGVILLSLLSRRYPFF  279 (418)
T ss_pred             ccceeeccceeehhhccccccc
Confidence            9999999999999999999984

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=1.6e-28  Score=256.10  Aligned_cols=196  Identities=13%  Similarity=0.104  Sum_probs=137.6

Q ss_pred             hccC-Ccccceeeee-------ecCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 015734          130 VAIH-KNLLQLIGYC-------TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK  201 (401)
Q Consensus       130 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~  201 (401)
                      .++| +||.++++++       ......+.++|++ +++|.++|...   ...+++..+..++.||+.||+|||++   +
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---g  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---G  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            3445 5777787776       2233567778887 66999999752   34589999999999999999999998   9


Q ss_pred             eEEeCCCCCceEEcCC-------------------CcEEEeecCCccccCCCCc---------------ceeccccCCcc
Q 015734          202 IIHRDLKAANILLDDN-------------------FEAVLCDFGLAKLVDAKLT---------------HVTTQIRGTMG  247 (401)
Q Consensus       202 i~H~dlkp~Nill~~~-------------------~~~kl~Dfgl~~~~~~~~~---------------~~~~~~~gt~~  247 (401)
                      |+||||||+|||++..                   +.+|++|||+++.......               .......||+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            9999999999999654                   4456666666543211000               00111347888


Q ss_pred             cccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHH
Q 015734          248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETM  327 (401)
Q Consensus       248 y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l  327 (401)
                      |+|||++.+..++.++|||||||++|||++|..|+....      ..........         +++.    ......+.
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~------~~~~~~~~~~---------~~~~----~~~~~~~~  241 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS------RTMSSLRHRV---------LPPQ----ILLNWPKE  241 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH------HHHHHHHHhh---------cChh----hhhcCHHH
Confidence            999999999999999999999999999999888764211      0011110000         0110    11122345


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHHH
Q 015734          328 VQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       328 ~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..++.+||+.+|.+||++.+++++
T Consensus       242 ~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        242 ASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHHHhCCCChhhCcChHHHhhc
Confidence            678889999999999999999864

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=3.9e-27  Score=201.23  Aligned_cols=166  Identities=21%  Similarity=0.194  Sum_probs=124.7

Q ss_pred             CcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcce
Q 015734          159 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV  238 (401)
Q Consensus       159 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  238 (401)
                      |+|.+++...   +.++++..++.++.|++.||.|||++   +      ||+||+++.++.+++  ||++.......   
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence            6888888752   34699999999999999999999998   5      999999999999999  99987654322   


Q ss_pred             eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCC
Q 015734          239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT  318 (401)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  318 (401)
                         ..||+.|+|||++.+..++.++|||||||++|||+||..||.......   ..+....... ...      ++....
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~---~~~~~~~~~~-~~~------~~~~~~  130 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS---AILEILLNGM-PAD------DPRDRS  130 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc---HHHHHHHHHh-ccC------Cccccc
Confidence               257899999999999999999999999999999999999986432211   1111111111 000      000001


Q ss_pred             CCHHHHH--HHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          319 YDSKEVE--TMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       319 ~~~~~~~--~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      .......  ++.+++..||+.+|.+||++.++++++..
T Consensus       131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            1122222  68999999999999999999999988753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.6e-27  Score=204.25  Aligned_cols=250  Identities=18%  Similarity=0.273  Sum_probs=190.7

Q ss_pred             CCCCCeeeecCcEEEEEEEECCCCEEEEEEec-ccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEeccc
Q 015734           79 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQ  157 (401)
Q Consensus        79 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~-~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  157 (401)
                      .....+|.+...|..|+|+++.+ .+++|++. ...+....+.|..|.-.|+.+.||||+++++.|....++.++..||+
T Consensus       192 lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp  270 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP  270 (448)
T ss_pred             hhhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence            34455788999999999999654 55567776 33455566789999999999999999999999999999999999999


Q ss_pred             CCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcc
Q 015734          158 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH  237 (401)
Q Consensus       158 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  237 (401)
                      .|+|...|+...  +-..+-.++.+++.++++|++|||+- .+-+.-.-|.+..|++|++.+++|+- +-.++...    
T Consensus       271 ~gslynvlhe~t--~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsfq----  342 (448)
T KOG0195|consen  271 FGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQ----  342 (448)
T ss_pred             chHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeeee----
Confidence            999999999743  34566778999999999999999996 33455667999999999999988752 11111110    


Q ss_pred             eeccccCCcccccccccccCCC---CcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccC
Q 015734          238 VTTQIRGTMGHIAPEYLSTGKS---SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR  314 (401)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~---~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  314 (401)
                       .....-.|.||+||.++..+.   -.++|+|||++++|||.|...||....+-+.....-.                ..
T Consensus       343 -e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial----------------eg  405 (448)
T KOG0195|consen  343 -EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL----------------EG  405 (448)
T ss_pred             -ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh----------------cc
Confidence             011123689999999987664   4578999999999999999999976544322211110                01


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          315 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       315 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      -....++..+..+.+++.-|++.||.+||.++.++-.|+.
T Consensus       406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilek  445 (448)
T KOG0195|consen  406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK  445 (448)
T ss_pred             ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence            1112456667789999999999999999999999988864

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=4.4e-25  Score=206.25  Aligned_cols=168  Identities=21%  Similarity=0.245  Sum_probs=130.6

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC--CCCEEEEEEecccC----CcchHHHHHHHHHHHHhccCCcccceeeeeecC
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLS--DNTKVAVKRLQDYY----SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS  146 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  146 (401)
                      ....++|...+.||+|+||+||+|.++  +++.||||++....    .......+.+|++++.+++|+|+++.+..   .
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence            445678999999999999999999864  47778999875321    22345679999999999999999863322   2


Q ss_pred             CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC-CCCceEEcCCCcEEEeec
Q 015734          147 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDL-KAANILLDDNFEAVLCDF  225 (401)
Q Consensus       147 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl-kp~Nill~~~~~~kl~Df  225 (401)
                      +..++||||++|++|.. ..   .    ..   ...++.++++||.|||++   +++|||| ||+|||++.++.+||+||
T Consensus        91 ~~~~LVmE~~~G~~L~~-~~---~----~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF  156 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHL-AR---P----HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF  156 (365)
T ss_pred             CCcEEEEEccCCCCHHH-hC---c----cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence            45799999999999862 11   1    11   146788999999999998   9999999 999999999999999999


Q ss_pred             CCccccCCCCcce-------eccccCCcccccccccccC
Q 015734          226 GLAKLVDAKLTHV-------TTQIRGTMGHIAPEYLSTG  257 (401)
Q Consensus       226 gl~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~  257 (401)
                      |+++.........       .....+++.|+|||.+...
T Consensus       157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9998765432111       1345678899999998643

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=5.9e-24  Score=198.92  Aligned_cols=257  Identities=19%  Similarity=0.243  Sum_probs=188.7

Q ss_pred             CCCCCCeeeecCcEEEEEEEECCC--CEEEEEEecccCCcchHHHHHHHHHHHHhccC----Ccccceeeee-ecCCeeE
Q 015734           78 NFSESNIIGQGGFGKVYKGVLSDN--TKVAVKRLQDYYSPGGEAAFQREVHLISVAIH----KNLLQLIGYC-TTSSERI  150 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~-~~~~~~~  150 (401)
                      +|.+.+.||+|+||.||++.....  ..+|+|........... .+..|..++..+..    +++..+++.. ......+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            799999999999999999997553  47888877643222222 67788888888763    5788888888 4666789


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCC-----CcEEEeec
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-----FEAVLCDF  225 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-----~~~kl~Df  225 (401)
                      +||+.+ |.+|.+......  .+.++..+...++.|++.+|.+||+.   |++||||||.|+.+...     ..+.|.||
T Consensus        98 iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             EEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            999988 889998776543  46799999999999999999999999   99999999999999765     46999999


Q ss_pred             CCcc--ccCCCCc-----c-e-eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHH
Q 015734          226 GLAK--LVDAKLT-----H-V-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL  296 (401)
Q Consensus       226 gl~~--~~~~~~~-----~-~-~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~  296 (401)
                      |+++  .+.....     . . .....||..|.++....+...+.+.|+||++.++.+++.|..||.........     
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~-----  246 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK-----  246 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH-----
Confidence            9998  3222211     0 1 23356999999999999999999999999999999999999999654332111     


Q ss_pred             HHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          297 DHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       297 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ..+...........     .....+.   ++.++...+-..+...+|....+...|..
T Consensus       247 ~~~~~~~~~~~~~~-----~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~  296 (322)
T KOG1164|consen  247 SKFEKDPRKLLTDR-----FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKD  296 (322)
T ss_pred             HHHHHHhhhhcccc-----ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHH
Confidence            11111111111000     1112223   34444444555889999999999887654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=2.4e-22  Score=187.73  Aligned_cols=262  Identities=26%  Similarity=0.337  Sum_probs=197.1

Q ss_pred             CCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcc--hHHHHHHHHHHHHhccCC-cccceeeeeecCCeeEEEEec
Q 015734           79 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHK-NLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        79 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~  155 (401)
                      |...+.||.|+||.||++...  ..+++|.+.......  ....+.+|..++..+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            567788999999999999976  789999987544433  477899999999999988 799999999777778999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC-cEEEeecCCccccCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAKLVDAK  234 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfgl~~~~~~~  234 (401)
                      +.++++...+...... ..++......++.|++.++.|+|+.   +++|||+||+||+++..+ .++++|||.+......
T Consensus        80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999999666642211 3588899999999999999999999   899999999999999988 7999999999855443


Q ss_pred             Ccc-----eeccccCCccccccccccc---CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC
Q 015734          235 LTH-----VTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED  306 (401)
Q Consensus       235 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (401)
                      ...     ......|+..|++||.+.+   ...+...|+||+|++++++++|..||...... .........+...... 
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~-  233 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-SATSQTLKIILELPTP-  233 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-ccHHHHHHHHHhcCCc-
Confidence            322     2355678999999999987   57889999999999999999999997654321 0001111111111100 


Q ss_pred             ccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       307 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .........   ........+.+++..|+..+|..|.+..+....
T Consensus       234 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 SLASPLSPS---NPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccccccCcc---ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            000000000   002223567788889999999999998877654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=2.1e-24  Score=214.60  Aligned_cols=254  Identities=19%  Similarity=0.201  Sum_probs=186.3

Q ss_pred             CCCCeeeecCcEEEEEEEEC-CCCEEEEEEec----ccCCcchH-HHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           80 SESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQ----DYYSPGGE-AAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        80 ~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~----~~~~~~~~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ...+++|.|++|.|+..... .....+.|...    ...++... ..+..|+.+-..+.|||++..+..+.+.....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            35778999999977777632 33333333322    21222222 22566777778899999988887777776666669


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      |||++ +|...+...    ..+....+..++.|++.|+.|+|+.   |+.|||+|++|++++.+|.+||+|||.+..+..
T Consensus       401 E~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             hcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence            99999 999888762    3478888999999999999999999   999999999999999999999999999886654


Q ss_pred             CCc---ceeccccCCcccccccccccCCCCc-ccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccc
Q 015734          234 KLT---HVTTQIRGTMGHIAPEYLSTGKSSE-KTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN  309 (401)
Q Consensus       234 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ...   ......+|+..|+|||++.+..|++ ..||||.|+++..|.+|+.||......+...       ..........
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-------~~~~~~~~~~  545 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-------KTNNYSDQRN  545 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-------hhhccccccc
Confidence            433   4556678999999999999999876 4699999999999999999998655433221       0000000000


Q ss_pred             hhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       310 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                      .  ...........+.+...++.++|+.+|.+|.|++++++
T Consensus       546 ~--~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  546 I--FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             c--ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            0  00001123445567778899999999999999999965

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=2.7e-22  Score=176.79  Aligned_cols=201  Identities=20%  Similarity=0.251  Sum_probs=170.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEE-ECCCCEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCcccceeeeeecCCeeEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv  152 (401)
                      ..-+|.++++||+|.||..+.|. +-++.+||||.-...   ....++..|.+..+.|. .++|..++.+..++-.-.+|
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk---S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV  102 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK---SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV  102 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEecccc---CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence            34579999999999999999999 458999999975421   22356778888887775 68999999888888888999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCC-----CcEEEeecCC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-----FEAVLCDFGL  227 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-----~~~kl~Dfgl  227 (401)
                      +|++ |.||.++..-   .+..++..+..-++.|++.-++++|++   .+|.|||||+|+||..-     ..+.++|||+
T Consensus       103 idLL-GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm  175 (449)
T KOG1165|consen  103 IDLL-GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM  175 (449)
T ss_pred             hhhh-CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccc
Confidence            9998 8899887764   356799999999999999999999999   89999999999999643     3589999999


Q ss_pred             ccccCCCCcc------eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCC
Q 015734          228 AKLVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS  285 (401)
Q Consensus       228 ~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~  285 (401)
                      ++.+.+....      ......||.+||+--...+...+.+-|+-|||-++.+.+-|..||++-
T Consensus       176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL  239 (449)
T KOG1165|consen  176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  239 (449)
T ss_pred             hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence            9987665433      234567999999999999999999999999999999999999999853

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.89  E-value=1.2e-23  Score=209.85  Aligned_cols=258  Identities=20%  Similarity=0.219  Sum_probs=187.3

Q ss_pred             CCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHH--HHhccCCcccceeeeeecCCeeEEEEec
Q 015734           78 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHL--ISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      ++...+.||++.|=.|.+|++++|. |+||++.+....-..+.|.+.++-  ....+|||.+++.-+.......|+|-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5777899999999999999987776 999998754444444555444433  4566899999998877777777888888


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc--CC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DA  233 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~--~~  233 (401)
                      ..+ +|.+.+..    .+-+...+.+.|+.|++.|+.-+|..   ||+|||||.+||||+.-.-+.|+||..-+..  ..
T Consensus       103 vkh-nLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  103 VKH-NLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             Hhh-hhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            855 88888775    44577888899999999999999999   9999999999999999999999999875522  11


Q ss_pred             CCcc----eeccccCCcccccccccccC----------C-CCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHH
Q 015734          234 KLTH----VTTQIRGTMGHIAPEYLSTG----------K-SSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLD  297 (401)
Q Consensus       234 ~~~~----~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~  297 (401)
                      +...    .......-.+|.|||.+...          . .+++.||||+||++.||++ |++||.....          
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL----------  244 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL----------  244 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH----------
Confidence            1111    11222234479999987531          1 5788999999999999988 7888863221          


Q ss_pred             HHHHHhc-cCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCchhhhh
Q 015734          298 HIRKLLR-EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWA  362 (401)
Q Consensus       298 ~~~~~~~-~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~~~  362 (401)
                       ....-. ......++. .+      +...+..++..|++.||++|.++++.++.-.+..+++-+-
T Consensus       245 -~aYr~~~~~~~e~~Le-~I------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~yFy  302 (1431)
T KOG1240|consen  245 -LAYRSGNADDPEQLLE-KI------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFPEYFY  302 (1431)
T ss_pred             -HhHhccCccCHHHHHH-hC------cCccHHHHHHHHHccCchhccCHHHHHHhhhccccHHHHH
Confidence             111000 000000110 00      0115778999999999999999999999998888876433

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=1.7e-22  Score=170.62  Aligned_cols=259  Identities=18%  Similarity=0.234  Sum_probs=193.7

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEE-ECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccC-CcccceeeeeecCCeeEE
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH-KNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~l  151 (401)
                      +...+|.+++.||+|+||.+|.|. ..+|..||||.-...   ....++.-|.++.+.++| ..|..+..+..+...-.+
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~---a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl   88 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK---AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL   88 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc---CCCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence            345689999999999999999999 567999999986532   234567788888888875 667778888888888899


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCC---CcEEEeecCCc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN---FEAVLCDFGLA  228 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~---~~~kl~Dfgl~  228 (401)
                      ||+.+ |.||.+...-.   +..++..+.+-++.|++.-++|+|.+   +++||||||+|.|..-+   ..+.++|||++
T Consensus        89 VMdLL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa  161 (341)
T KOG1163|consen   89 VMDLL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA  161 (341)
T ss_pred             eeecc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccch
Confidence            99998 88999887753   45688999999999999999999999   89999999999999643   45889999999


Q ss_pred             cccCCCCcc------eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHH
Q 015734          229 KLVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL  302 (401)
Q Consensus       229 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  302 (401)
                      +.+.+....      ......||.+|.+--...+...+.+.|+-|+|.++.+..-|..||++-.....     .+...+.
T Consensus       162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk-----~QKyEkI  236 (341)
T KOG1163|consen  162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK-----KQKYEKI  236 (341)
T ss_pred             hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH-----HHHHHHH
Confidence            876544322      23456799999998888888888999999999999999999999986443211     1112221


Q ss_pred             hccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 015734          303 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML  352 (401)
Q Consensus       303 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  352 (401)
                      .+.+ ..-    .+...+...+.++.-.+.-|-..--++-|...-+-+.+
T Consensus       237 ~EkK-~s~----~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF  281 (341)
T KOG1163|consen  237 SEKK-MST----PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLF  281 (341)
T ss_pred             HHhh-cCC----CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence            1111 100    01112233345666666677777777888776655543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=3.5e-22  Score=171.88  Aligned_cols=141  Identities=14%  Similarity=0.150  Sum_probs=108.0

Q ss_pred             CCeeeecCcEEEEEEEECCCCEEEEEEecccCCc-ch------------------------HHHHHHHHHHHHhccCCcc
Q 015734           82 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP-GG------------------------EAAFQREVHLISVAIHKNL  136 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~------------------------~~~~~~e~~~l~~l~h~ni  136 (401)
                      ...||+|+||.||+|...+|+.||+|+++..... ..                        ......|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999878999999999743211 11                        1122458999999988876


Q ss_pred             cceeeeeecCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEeCCCCCceEEc
Q 015734          137 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL-HEQCNPKIIHRDLKAANILLD  215 (401)
Q Consensus       137 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~dlkp~Nill~  215 (401)
                      .....+..  ...++||||++++++......    ..+++......++.|++.+|.++ |+.   +++||||||+||+++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence            44332222  233899999998776544322    24588899999999999999999 687   899999999999998


Q ss_pred             CCCcEEEeecCCccccC
Q 015734          216 DNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       216 ~~~~~kl~Dfgl~~~~~  232 (401)
                       ++.++|+|||++....
T Consensus       153 -~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 -DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             -CCcEEEEEccccccCC
Confidence             4789999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.87  E-value=2.8e-22  Score=174.55  Aligned_cols=175  Identities=12%  Similarity=0.081  Sum_probs=134.0

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcc--hHHH------HHHHHHHHHhccCCcccceeeeee
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAA------FQREVHLISVAIHKNLLQLIGYCT  144 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~------~~~e~~~l~~l~h~niv~~~~~~~  144 (401)
                      ....++|...++||.|+||.||+... ++..+|+|.+.+.....  ....      +.+|++.+.++.|+++..+..++.
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            45688999999999999999999665 67789999997543322  1122      678999999999999999988754


Q ss_pred             cC--------CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC
Q 015734          145 TS--------SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD  216 (401)
Q Consensus       145 ~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~  216 (401)
                      ..        +..+++|||++|.+|.+...        ++.    ....+++.++..+|+.   +++|+|++|+|++++.
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~  170 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK  170 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC
Confidence            32        35789999999999877632        222    2456899999999999   9999999999999999


Q ss_pred             CCcEEEeecCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh
Q 015734          217 NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT  277 (401)
Q Consensus       217 ~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt  277 (401)
                      ++ ++|+|||...........             ..++....+..++|+||||+++.....
T Consensus       171 ~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        171 NG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             CC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence            88 999999987644221111             012334456679999999998876543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=4.6e-21  Score=165.52  Aligned_cols=142  Identities=17%  Similarity=0.133  Sum_probs=110.6

Q ss_pred             CCeeeecCcEEEEEEEECCCCEEEEEEecccCCc-ch------------------------HHHHHHHHHHHHhccCCcc
Q 015734           82 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP-GG------------------------EAAFQREVHLISVAIHKNL  136 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~------------------------~~~~~~e~~~l~~l~h~ni  136 (401)
                      ...||+|+||.||+|...+|+.||||+++..... ..                        ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4679999999999999878999999998753211 00                        1234578899999999987


Q ss_pred             cceeeeeecCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCceEEc
Q 015734          137 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLD  215 (401)
Q Consensus       137 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~  215 (401)
                      .....+...  ..++||||++++++......    ...++......++.|++.++.++|+ .   +++|+||||+||+++
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence            554443332  34899999998855433221    2346778899999999999999999 7   999999999999999


Q ss_pred             CCCcEEEeecCCccccCC
Q 015734          216 DNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       216 ~~~~~kl~Dfgl~~~~~~  233 (401)
                       ++.++|+|||++.....
T Consensus       153 -~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 -DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             -CCCEEEEEcccceecCC
Confidence             88999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=2.4e-21  Score=173.77  Aligned_cols=233  Identities=22%  Similarity=0.253  Sum_probs=148.6

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccC-----------Ccccceeeeee
Q 015734           79 FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIH-----------KNLLQLIGYCT  144 (401)
Q Consensus        79 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h-----------~niv~~~~~~~  144 (401)
                      +...+.||.|+++.||.+++. +|+.+|+|+..-.  .+....+.+.+|.-....+.+           .-++++ +...
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~-d~~~   92 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL-DLLR   92 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S-EEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee-EEEE
Confidence            344678999999999999975 4899999988632  233355677777655544322           112222 2111


Q ss_pred             ---------cC---C-----eeEEEEecccCCcHHHHhhh---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 015734          145 ---------TS---S-----ERILVYPFMQNLSVAYRLRD---LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH  204 (401)
Q Consensus       145 ---------~~---~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H  204 (401)
                               ..   +     +.+++|+-+ .++|.+.+..   .......+....+..+..|+++.+++||+.   |++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence                     11   1     235677777 5577776543   222222344455567778999999999999   9999


Q ss_pred             eCCCCCceEEcCCCcEEEeecCCccccCCCCcceeccccCCccccccccccc--------CCCCcccchhHHHHHHHHHH
Q 015734          205 RDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST--------GKSSEKTDVFGYGITLLELV  276 (401)
Q Consensus       205 ~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDi~slG~ll~ell  276 (401)
                      +||+|+|++++.+|.++|+||+.....+.....    ...+..|.|||....        -.++.+.|.|+||+++|.|.
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            999999999999999999999887655443221    234578999997643        24688999999999999999


Q ss_pred             hCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 015734          277 TGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDR  342 (401)
Q Consensus       277 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~R  342 (401)
                      +|..||+..........                     .+.... +.++.+..|+..+|+.||.+|
T Consensus       245 C~~lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999986543221111                     122223 777889999999999999988

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.8e-22  Score=192.20  Aligned_cols=234  Identities=23%  Similarity=0.243  Sum_probs=182.2

Q ss_pred             eeeecCcEEEEEEE----ECCCCEEEEEEecccC-CcchHHHHHHHHHHHHhcc-CCcccceeeeeecCCeeEEEEeccc
Q 015734           84 IIGQGGFGKVYKGV----LSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPFMQ  157 (401)
Q Consensus        84 ~lG~G~~g~V~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  157 (401)
                      ++|+|.||.|+++.    .+.|..+|+|.+++.. ..........|..++...+ ||.++++...+......+++.++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            47999999999875    3357789999886422 1112225556777888776 9999999999999999999999999


Q ss_pred             CCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcc
Q 015734          158 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH  237 (401)
Q Consensus       158 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  237 (401)
                      +|.|...+..    ...+.......+...++.+++++|+.   +++|+|+|++||+++.+|++++.|||+++..-.....
T Consensus        81 gg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~  153 (612)
T KOG0603|consen   81 GGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA  153 (612)
T ss_pred             cchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence            9999887775    34567777888889999999999999   9999999999999999999999999999865443222


Q ss_pred             eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCC
Q 015734          238 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN  317 (401)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  317 (401)
                           +||..|||||++.  ....++|.||||++++||+||..||..            +....+...          -.
T Consensus       154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~----------~~  204 (612)
T KOG0603|consen  154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKA----------EL  204 (612)
T ss_pred             -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhh----------cc
Confidence                 7899999999998  678899999999999999999999974            111111110          11


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCH--HHHHHHhc
Q 015734          318 TYDSKEVETMVQVALLCTQSTPEDRPPM--AQVVKMLQ  353 (401)
Q Consensus       318 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~--~~vl~~L~  353 (401)
                      ..+........+++..++..+|.+|.-.  ..+.+..+
T Consensus       205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~  242 (612)
T KOG0603|consen  205 EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ  242 (612)
T ss_pred             CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence            2345556677778888889999999755  34444443

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.85  E-value=4.1e-21  Score=182.90  Aligned_cols=217  Identities=24%  Similarity=0.381  Sum_probs=161.2

Q ss_pred             HHhccCCcccceeeeeecCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 015734          128 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDL  207 (401)
Q Consensus       128 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl  207 (401)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+..   ....+++.....++++++.||.|||+.  +-..|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeee
Confidence            3567899999999999999999999999999999999986   345689999999999999999999987  13399999


Q ss_pred             CCCceEEcCCCcEEEeecCCccccCCCCc-ceeccccCCcccccccccccCC-------CCcccchhHHHHHHHHHHhCC
Q 015734          208 KAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGK-------SSEKTDVFGYGITLLELVTGQ  279 (401)
Q Consensus       208 kp~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDi~slG~ll~elltg~  279 (401)
                      ++.|+++|....+||+|||+......... .......-..-|.|||.+....       .+.+.||||||++++|+++..
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            99999999999999999999876643111 1111111244699999986531       467799999999999999999


Q ss_pred             CCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 015734          280 RAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED  356 (401)
Q Consensus       280 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  356 (401)
                      .||+......... .+...+..     .....+-+.+.... ....++..++..||..+|.+||+++++-..+....
T Consensus       156 ~~~~~~~~~~~~~-eii~~~~~-----~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  156 GPFDLRNLVEDPD-EIILRVKK-----GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             CccccccccCChH-HHHHHHHh-----cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence            9998654433321 11111222     01111111111111 33347889999999999999999999988776543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=1.6e-20  Score=160.14  Aligned_cols=185  Identities=16%  Similarity=0.088  Sum_probs=137.6

Q ss_pred             CCCCeeeecCcEEEEEEEECCCCEEEEEEecccCC---cchHHHHHHHHHHHHhcc-CCcccceeeeeecCCeeEEEEec
Q 015734           80 SESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS---PGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        80 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      .....|++|+||+||.+.. .+.+++.+.+.....   .-....+.+|+++|+++. |+++.+++++    +..+++|+|
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3467899999999997766 678888777753211   111225889999999996 5789888886    456999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC-CCCceEEcCCCcEEEeecCCccccCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDL-KAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl-kp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      +.|.+|...+..           ....++.|++.+|.++|++   |++|+|| ||+|||++.++.++|+|||++......
T Consensus        80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            999888643321           1134678999999999999   9999999 799999999999999999999865543


Q ss_pred             Ccc----e--------eccccCCcccccccccccC-CCC-cccchhHHHHHHHHHHhCCCCCC
Q 015734          235 LTH----V--------TTQIRGTMGHIAPEYLSTG-KSS-EKTDVFGYGITLLELVTGQRAID  283 (401)
Q Consensus       235 ~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~sDi~slG~ll~elltg~~p~~  283 (401)
                      ..-    .        ..-...++.|++|+...-. ..+ ...+.++.|+-+|.++|++.+.-
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            310    0        0112257778888754322 223 56799999999999999998764

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=4.2e-20  Score=166.70  Aligned_cols=197  Identities=22%  Similarity=0.267  Sum_probs=138.2

Q ss_pred             cCCcccceeeeeec---------------------------CCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHH
Q 015734          132 IHKNLLQLIGYCTT---------------------------SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVA  184 (401)
Q Consensus       132 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~  184 (401)
                      .|||||++.++|.+                           +..+|+||.-++. +|..++..     ...+.....-++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-----~~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-----RHRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----CCCchHHHHHHH
Confidence            59999999887643                           2245788877744 78888775     235666778889


Q ss_pred             HHHHHHHHHHHhcCCCCeEEeCCCCCceEE--cCCC--cEEEeecCCccccCC-----CCcceeccccCCcccccccccc
Q 015734          185 FGTAYGLEYLHEQCNPKIIHRDLKAANILL--DDNF--EAVLCDFGLAKLVDA-----KLTHVTTQIRGTMGHIAPEYLS  255 (401)
Q Consensus       185 ~~i~~~l~~LH~~~~~~i~H~dlkp~Nill--~~~~--~~kl~Dfgl~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~  255 (401)
                      .|++.|+.|||.+   ++.|||+|++|||+  |+|+  ...|+|||++-....     ...+..-...|...-||||+..
T Consensus       348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            9999999999999   99999999999999  3444  357899998753222     1111122234677899999875


Q ss_pred             cCC------CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHH
Q 015734          256 TGK------SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQ  329 (401)
Q Consensus       256 ~~~------~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~  329 (401)
                      ..+      ...++|.|+.|.+.||+++...||......      +.+. +. .+        ...++..+..++..+.+
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem------~L~~-r~-Yq--------e~qLPalp~~vpp~~rq  488 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM------LLDT-RT-YQ--------ESQLPALPSRVPPVARQ  488 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh------eech-hh-hh--------hhhCCCCcccCChHHHH
Confidence            432      246899999999999999999999742210      0000 00 11        12233344555667888


Q ss_pred             HHHHcccCCCCCCCCHHHHHHHhc
Q 015734          330 VALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       330 l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                      ++...|+.||++|++..-....|+
T Consensus       489 lV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  489 LVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHHhcCCccccCCccHHHhHHH
Confidence            999999999999999876665554

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=1.3e-20  Score=191.41  Aligned_cols=200  Identities=21%  Similarity=0.185  Sum_probs=159.0

Q ss_pred             HHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhcc---CCcccceeeeeecC
Q 015734           70 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI---HKNLLQLIGYCTTS  146 (401)
Q Consensus        70 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~  146 (401)
                      .+.++..+.|.+.+.||+|+||+||+|...+|+.||+|+-+....    -+|---.+++.+|.   -+-++.+.....-.
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~----WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~  766 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP----WEFYICLQVMERLKPQMLPSIMHISSAHVFQ  766 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc----eeeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence            345667788999999999999999999987899999998764211    11111122233333   34556666666777


Q ss_pred             CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEc-------CCCc
Q 015734          147 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-------DNFE  219 (401)
Q Consensus       147 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-------~~~~  219 (401)
                      +..++|++|.+.|+|.+.+.    ..+.+++.....++.|++.-+++||..   +|||+||||+|.+|.       ++..
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~  839 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKG  839 (974)
T ss_pred             CcceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccc
Confidence            88899999999999999888    366799999999999999999999999   999999999999994       3456


Q ss_pred             EEEeecCCccccCCC-CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCC
Q 015734          220 AVLCDFGLAKLVDAK-LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR  280 (401)
Q Consensus       220 ~kl~Dfgl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~  280 (401)
                      ++|+|||.+..+.-- ........++|-.+-.+|...+..++++.|.|+|+.+++-|+.|+.
T Consensus       840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            899999998744221 1234455678999999999999999999999999999999999874

>PRK10345 hypothetical protein; Provisional

Probab=99.80  E-value=1e-18  Score=151.82  Aligned_cols=137  Identities=19%  Similarity=0.243  Sum_probs=104.7

Q ss_pred             CCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhc-----cCCcccceeeeeecCC---e-e
Q 015734           79 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-----IHKNLLQLIGYCTTSS---E-R  149 (401)
Q Consensus        79 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~-~  149 (401)
                      ++..+.||+|+||.||.  +++....+||++.... ....+.+.+|+.+++.+     .||||+++++++.++.   . .
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            34567899999999995  4433334789886422 23457789999999999     5799999999998774   2 2


Q ss_pred             EEEEec--ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEEeCCCCCceEEcC----CCcEEE
Q 015734          150 ILVYPF--MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL-EYLHEQCNPKIIHRDLKAANILLDD----NFEAVL  222 (401)
Q Consensus       150 ~lv~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~i~H~dlkp~Nill~~----~~~~kl  222 (401)
                      .+|+||  +.+++|.+++.+.     .++..  ..++.+++.++ +|||++   +|+||||||+||+++.    ++.++|
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~L  150 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVV  150 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEE
Confidence            378999  5579999999752     24444  35577888777 999999   9999999999999974    347999


Q ss_pred             eecCCc
Q 015734          223 CDFGLA  228 (401)
Q Consensus       223 ~Dfgl~  228 (401)
                      +||+.+
T Consensus       151 iDg~G~  156 (210)
T PRK10345        151 CDNIGE  156 (210)
T ss_pred             EECCCC
Confidence            995443

>smart00090 RIO RIO-like kinase

Probab=99.79  E-value=1.4e-18  Score=154.65  Aligned_cols=143  Identities=15%  Similarity=0.112  Sum_probs=110.4

Q ss_pred             CCCCCCeeeecCcEEEEEEE--ECCCCEEEEEEecccCCcc-----------------------hHHHHHHHHHHHHhcc
Q 015734           78 NFSESNIIGQGGFGKVYKGV--LSDNTKVAVKRLQDYYSPG-----------------------GEAAFQREVHLISVAI  132 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~--~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~  132 (401)
                      .|.+.+.||+|+||.||+|.  ..+|+.||+|+++......                       ....+..|++.+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47889999999999999998  4579999999987432100                       1124568999999997


Q ss_pred             CCc--ccceeeeeecCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEEeCCCC
Q 015734          133 HKN--LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK-IIHRDLKA  209 (401)
Q Consensus       133 h~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-i~H~dlkp  209 (401)
                      +.+  +.+++++    ...++||||+++.+|......    ...........++.|++.++.+||+.   + ++|+||||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp  177 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE  177 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence            633  3344433    235899999999887654422    23355566788999999999999999   8 99999999


Q ss_pred             CceEEcCCCcEEEeecCCccccC
Q 015734          210 ANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       210 ~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      +||+++ ++.++|+|||.+....
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhccC
Confidence            999999 8899999999987443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=5.5e-18  Score=149.00  Aligned_cols=135  Identities=21%  Similarity=0.253  Sum_probs=113.0

Q ss_pred             CeeeecCcEEEEEEEECCCCEEEEEEecccCC-cc------hHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           83 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS-PG------GEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      +.||+|++|.||+|.. .|..+++|+...... ..      ....+.+|+.++..+.|+++.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5789999999999988 678899998653221 11      124577899999999999988777777777888999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      ++|++|.+.+...       .. ....++.+++.+|.++|+.   +++|+|++|.||+++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999888642       12 7888999999999999998   999999999999999 78899999998764

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.77  E-value=5.7e-18  Score=147.32  Aligned_cols=145  Identities=21%  Similarity=0.138  Sum_probs=111.2

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCc---------------------chHHHHHHHHHHHHh
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP---------------------GGEAAFQREVHLISV  130 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~e~~~l~~  130 (401)
                      +......|...+.||+|+||.||++..++|+.||||++......                     .....+..|...+..
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   89 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA   89 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence            33334448888999999999999999888999999987532100                     011236778888888


Q ss_pred             ccCCc--ccceeeeeecCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCC
Q 015734          131 AIHKN--LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLK  208 (401)
Q Consensus       131 l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk  208 (401)
                      +.|++  +.+.++    ....+++|||+++++|......          .....++.+++.++.++|+.   +++|+|||
T Consensus        90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~  152 (198)
T cd05144          90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLS  152 (198)
T ss_pred             HHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence            88874  444443    2445899999999988654321          23567888999999999998   99999999


Q ss_pred             CCceEEcCCCcEEEeecCCccccCC
Q 015734          209 AANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       209 p~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      |+||++++++.++|+|||++.....
T Consensus       153 p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         153 EFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             cccEEEcCCCcEEEEECCccccCCC
Confidence            9999999999999999999865443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.76  E-value=5.6e-19  Score=176.71  Aligned_cols=210  Identities=25%  Similarity=0.280  Sum_probs=145.6

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECC-CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ..++|...+.+..|++|.||.++++. .+.+|+|+=+..       .+.+.  ++.....|.+|                
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-------lilRn--ilt~a~npfvv----------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-------LILRN--ILTFAGNPFVV----------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcccccc-------hhhhc--cccccCCccee----------------
Confidence            45678999999999999999998764 567888432210       01111  22222333332                


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                           |+-...+..    .++++...        +.+++|||+.   +|+|||+||+|.+|+.-|++|++|||+++....
T Consensus       136 -----gDc~tllk~----~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLm  195 (1205)
T KOG0606|consen  136 -----GDCATLLKN----IGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM  195 (1205)
T ss_pred             -----chhhhhccc----CCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence                 333333332    23344332        7789999998   999999999999999999999999999875432


Q ss_pred             CCcc--------------eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHH
Q 015734          234 KLTH--------------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI  299 (401)
Q Consensus       234 ~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~  299 (401)
                      ....              ....++|||.|.|||++....|+...|+|++|+++||.+-|+.||.++.+++...+.+.+.+
T Consensus       196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i  275 (1205)
T KOG0606|consen  196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI  275 (1205)
T ss_pred             hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence            2111              12346799999999999999999999999999999999999999998776554443332222


Q ss_pred             HHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 015734          300 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP  344 (401)
Q Consensus       300 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  344 (401)
                      ...       +        .......+..+++.+.|+.+|..|--
T Consensus       276 ~wp-------E--------~dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  276 EWP-------E--------EDEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             ccc-------c--------cCcCCCHHHHHHHHHHHHhChHhhcc
Confidence            211       1        11222346778888999999999953

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.76  E-value=8.8e-18  Score=146.33  Aligned_cols=131  Identities=20%  Similarity=0.258  Sum_probs=106.7

Q ss_pred             eeeecCcEEEEEEEECCCCEEEEEEecccC-Ccc------hHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecc
Q 015734           84 IIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPG------GEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM  156 (401)
Q Consensus        84 ~lG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  156 (401)
                      .||+|+||.||+|.. ++..+++|...... ...      ....+.+|++++..+.|+++.....++...+..+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            479999999999996 67889999865321 111      1356778999999999988666555666667789999999


Q ss_pred             cCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          157 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      +|++|.+.+...    .   .    .++.+++.+|.+||+.   +++|+|++|.||+++ ++.+++.|||++..
T Consensus        80 ~g~~l~~~~~~~----~---~----~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEG----N---D----ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhc----H---H----HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999998877541    1   0    7889999999999999   999999999999999 88999999999864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=1.3e-17  Score=166.49  Aligned_cols=138  Identities=20%  Similarity=0.263  Sum_probs=111.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEec-ccCCc------chHHHHHHHHHHHHhccCCcccceeeeeecCCe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSP------GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE  148 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~-~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  148 (401)
                      ...|...+.||+|+||+||+|.+.+. .+++|+.. .....      ...+.+.+|++++..++|++++....++.....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            34456688999999999999987544 34444332 21111      123568899999999999999888878777778


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      .++||||+++++|.+++.            ....++.+++.+|.+||+.   +++||||||+||++ +++.++|+|||++
T Consensus       411 ~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla  474 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG  474 (535)
T ss_pred             CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence            899999999999988775            2467889999999999998   99999999999999 6779999999998


Q ss_pred             cc
Q 015734          229 KL  230 (401)
Q Consensus       229 ~~  230 (401)
                      +.
T Consensus       475 ~~  476 (535)
T PRK09605        475 KY  476 (535)
T ss_pred             cc
Confidence            74

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.75  E-value=3.8e-19  Score=166.57  Aligned_cols=123  Identities=27%  Similarity=0.359  Sum_probs=107.2

Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCC
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL  227 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl  227 (401)
                      .+++.|++|...+|.+||..... ....++.....++.|++.|+.|   +   +.+|+|+||.||+...+..+||+|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence            36789999999999999986443 3457888999999999999999   5   899999999999999999999999999


Q ss_pred             ccccCCCC-----cceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh
Q 015734          228 AKLVDAKL-----THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT  277 (401)
Q Consensus       228 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt  277 (401)
                      ........     ....+...||..||+||.+.+..|+.++||||||++++|++.
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            87655444     224455679999999999999999999999999999999998

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.68  E-value=4.1e-16  Score=134.37  Aligned_cols=138  Identities=22%  Similarity=0.247  Sum_probs=97.7

Q ss_pred             CCeeeecCcEEEEEEEECCCCEEEEEEecccCCc-chHHH----------------------HHHHHHHHHhccCCc--c
Q 015734           82 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP-GGEAA----------------------FQREVHLISVAIHKN--L  136 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~----------------------~~~e~~~l~~l~h~n--i  136 (401)
                      .+.||+|+||+||+|...+++.||||++...... .....                      ...|...+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999878999999988642211 11111                      134555555554432  3


Q ss_pred             cceeeeeecCCeeEEEEecccCCcHHH-HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCceEE
Q 015734          137 LQLIGYCTTSSERILVYPFMQNLSVAY-RLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILL  214 (401)
Q Consensus       137 v~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill  214 (401)
                      .+.++.    ...+++|||++++++.. .+....     .. .....++.+++.++.++|+ .   +++|+||||+||++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili  148 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV  148 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence            444332    24589999999865332 122111     11 5678899999999999999 7   99999999999999


Q ss_pred             cCCCcEEEeecCCccccCC
Q 015734          215 DDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       215 ~~~~~~kl~Dfgl~~~~~~  233 (401)
                      + ++.++|+|||.+.....
T Consensus       149 ~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         149 D-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             E-CCcEEEEECcccccccC
Confidence            9 88999999999875433

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=1.1e-15  Score=126.36  Aligned_cols=135  Identities=19%  Similarity=0.159  Sum_probs=112.6

Q ss_pred             CCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccC--CcccceeeeeecCCeeEEEEecccC
Q 015734           81 ESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH--KNLLQLIGYCTTSSERILVYPFMQN  158 (401)
Q Consensus        81 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~  158 (401)
                      +.+.||+|.++.||++...+ ..+++|.......   ...+.+|+..+..+.|  .++.+++++....+..++++||+.+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            35679999999999999844 7899998764322   5678899999999987  5889999888888889999999988


Q ss_pred             CcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          159 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       159 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      +.+...           +......++.+++.+++++|.....+++|+|++|+||++++++.+++.|||.+..
T Consensus        78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            765432           4566778889999999999986434799999999999999999999999998763

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.65  E-value=2.3e-15  Score=134.20  Aligned_cols=136  Identities=17%  Similarity=0.176  Sum_probs=104.8

Q ss_pred             CCeee-ecCcEEEEEEEECCCCEEEEEEeccc------------CCcchHHHHHHHHHHHHhccCCcc--cceeeeeecC
Q 015734           82 SNIIG-QGGFGKVYKGVLSDNTKVAVKRLQDY------------YSPGGEAAFQREVHLISVAIHKNL--LQLIGYCTTS  146 (401)
Q Consensus        82 ~~~lG-~G~~g~V~~~~~~~~~~vavK~~~~~------------~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~  146 (401)
                      ...|| .||.|+||.+.. .+..+++|.+...            .+......+.+|++++..+.|+++  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            45688 899999999987 4778999877421            011234567889999999998875  6666664433


Q ss_pred             Ce----eEEEEecccC-CcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEE
Q 015734          147 SE----RILVYPFMQN-LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV  221 (401)
Q Consensus       147 ~~----~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~k  221 (401)
                      ..    .++|+|++++ .+|.+++..     .+++..    .+.+++.++.+||+.   |++|+||||.|||++.++.++
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence            22    2599999997 688887754     234433    356899999999999   999999999999999999999


Q ss_pred             EeecCCccc
Q 015734          222 LCDFGLAKL  230 (401)
Q Consensus       222 l~Dfgl~~~  230 (401)
                      |+|||.+..
T Consensus       183 LIDfg~~~~  191 (239)
T PRK01723        183 LIDFDRGEL  191 (239)
T ss_pred             EEECCCccc
Confidence            999998864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.63  E-value=5.2e-17  Score=161.94  Aligned_cols=257  Identities=21%  Similarity=0.262  Sum_probs=190.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC--CCEEEEEEeccc-CCcchHHHHHHHHHHHHhcc-CCcccceeeeeecCCeeEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSD--NTKVAVKRLQDY-YSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l  151 (401)
                      ...|...+.||+|+|+.|-......  ...+|+|.+... .+.........|..+-..+. |+|++.+++.....+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            4567778889999999998887543  345666665432 23334455556777777776 9999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEEeCCCCCceEEcCCC-cEEEeecCCcc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH-EQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAK  229 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfgl~~  229 (401)
                      +.++..++++...+..  ......+......++.|+..++.|+| ..   ++.|+|+||+|.+++.++ ..+++|||++.
T Consensus        99 ~~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             ccCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence            9999999998877731  11224666778889999999999999 76   899999999999999999 99999999998


Q ss_pred             ccCC--CCcceeccccC-CcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhcc
Q 015734          230 LVDA--KLTHVTTQIRG-TMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE  305 (401)
Q Consensus       230 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (401)
                      .+..  .........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++..........   .|....   
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~---~~~~~~---  247 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS---SWKSNK---  247 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce---eecccc---
Confidence            7665  33334445567 9999999999885 457788999999999999999999986554321110   011000   


Q ss_pred             CccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          306 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       306 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                             +..-............++...++..+|..|.+.+++..
T Consensus       248 -------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  248 -------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             -------cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence                   00001122333445667777899999999999888743

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.56  E-value=9.6e-15  Score=129.37  Aligned_cols=205  Identities=20%  Similarity=0.280  Sum_probs=144.3

Q ss_pred             HHHHHhccCCcccceeeeeecCC-----eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 015734          125 VHLISVAIHKNLLQLIGYCTTSS-----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN  199 (401)
Q Consensus       125 ~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~  199 (401)
                      ++-+-++.|.||++++.|+.+..     ...++.||+..|++..+|+..+.....+......+|+.||..||.|||+ +.
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence            44556678999999999886543     4689999999999999999888877888888999999999999999999 57


Q ss_pred             CCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC----cceeccccCCcccccccccccCCCCcccchhHHHHHHHHH
Q 015734          200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL----THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLEL  275 (401)
Q Consensus       200 ~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~el  275 (401)
                      |.++|+++.-+.|++..+|-+|++--.-.. .....    ........+.++|.+||.=...+.+.++|||+||.-..+|
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence            899999999999999999988885322211 11110    0011122357899999987777788899999999999999


Q ss_pred             HhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          276 VTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       276 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .-|.--.............    .....  -.+..-++              ..++..|++..|..||+|.+++.+
T Consensus       276 ailEiq~tnseS~~~~ee~----ia~~i--~~len~lq--------------r~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEEN----IANVI--IGLENGLQ--------------RGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             HHheeccCCCcceeehhhh----hhhhe--eeccCccc--------------cCcCcccccCCCCCCcchhhhhcC
Confidence            8776432111110000000    00000  00011111              134557999999999999998765

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.52  E-value=1.3e-13  Score=133.51  Aligned_cols=143  Identities=22%  Similarity=0.238  Sum_probs=97.4

Q ss_pred             CCeeeecCcEEEEEEEECCCCEEEEEEecccCCcch---------------------------------------HHHHH
Q 015734           82 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGG---------------------------------------EAAFQ  122 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---------------------------------------~~~~~  122 (401)
                      .+.||+|++|.||+|++++|+.||||+.++......                                       .-.|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            467999999999999999999999999864321100                                       00133


Q ss_pred             HHHHHHHhcc----CCcccceeeee-ecCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 015734          123 REVHLISVAI----HKNLLQLIGYC-TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY-GLEYLHE  196 (401)
Q Consensus       123 ~e~~~l~~l~----h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~-~l~~LH~  196 (401)
                      +|...+.++.    |.+-+.+-..+ ...+..++||||++|++|.+.......   ..+   ...++..++. .+..+|.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~~---~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GLD---RKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CCC---HHHHHHHHHHHHHHHHHh
Confidence            4444444432    32222222222 224457999999999999887653111   122   3445555555 4678888


Q ss_pred             cCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          197 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       197 ~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      .   |++|+|++|.||+++.++.++++|||++.....
T Consensus       276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            7   999999999999999999999999999876543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.43  E-value=5e-12  Score=122.51  Aligned_cols=233  Identities=16%  Similarity=0.158  Sum_probs=151.9

Q ss_pred             ECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCCcHHHHhhhcCCCCCCCCH
Q 015734           98 LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW  177 (401)
Q Consensus        98 ~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~  177 (401)
                      ..++.+|.|........ .......+.++.|+.++||||++++......+..|+|+|-+.  -|...+..       +..
T Consensus        34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~  103 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGK  103 (690)
T ss_pred             eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHH
Confidence            34678888887764322 445667788899999999999999999999999999999875  45555654       234


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcceeccccCCcccccccccccC
Q 015734          178 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG  257 (401)
Q Consensus       178 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  257 (401)
                      .....-+.||+.||.|||+.+  +++|++|.-..|+++..|+.||++|.++........ .......--.|..|+.+...
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence            566677889999999999765  899999999999999999999999988764332221 01111112246666654333


Q ss_pred             CCCcccchhHHHHHHHHHHhCCCCCCCCcc-hhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHccc
Q 015734          258 KSSEKTDVFGYGITLLELVTGQRAIDFSRL-EEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQ  336 (401)
Q Consensus       258 ~~~~~sDi~slG~ll~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~  336 (401)
                      .  -..|.|.|||+++|++.|..+-..... .............+.....             ....+. .++++..|..
T Consensus       181 ~--~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ipk~~~~~~~k~~~~~-------------~~~r~n-~~~~~~~~~~  244 (690)
T KOG1243|consen  181 E--WSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIPKALIELYCKKLGAT-------------ELKRPN-KLRFILECRL  244 (690)
T ss_pred             c--cchhhhhHHHHHHHHhCcccCcchhhhccCccchhHHHHHHHHhccc-------------cccccc-hhhHHHHHHh
Confidence            2  346999999999999999322111100 0000001111111100000             000111 4566667777


Q ss_pred             CCCCCCCCHHHHHHHhccCCchh
Q 015734          337 STPEDRPPMAQVVKMLQGEDLAE  359 (401)
Q Consensus       337 ~~p~~RPs~~~vl~~L~~~~~~~  359 (401)
                      ..+--|=.+-+++..|++..+.+
T Consensus       245 ~~gff~n~fvd~~~fLeel~lks  267 (690)
T KOG1243|consen  245 LGGFFRNDFVDTLLFLEELRLKS  267 (690)
T ss_pred             ccccccchHHHHHHHHHhcccCc
Confidence            77777888888888887766643

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.40  E-value=4.5e-13  Score=131.36  Aligned_cols=148  Identities=20%  Similarity=0.187  Sum_probs=93.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC-CCEEEEEEecccCCc---------------------------------chHHHH
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSP---------------------------------GGEAAF  121 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---------------------------------~~~~~~  121 (401)
                      ...|+. +.||+|++|.||+|++++ |+.||||+.++...+                                 +..+.+
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345665 789999999999999877 999999999743210                                 011122


Q ss_pred             ------HHHHHHHHhcc----CCcccceeeeeec-CCeeEEEEecccCCcHHHHhhhcCCC--CCCCCHHHHHHHHHHHH
Q 015734          122 ------QREVHLISVAI----HKNLLQLIGYCTT-SSERILVYPFMQNLSVAYRLRDLKPG--EKGLDWPTRKRVAFGTA  188 (401)
Q Consensus       122 ------~~e~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~--~~~l~~~~~~~i~~~i~  188 (401)
                            .+|...+.++.    +.+.+.+-.++.+ .+..++||||++|+.+.+.-.-...+  ...+.......++.|+.
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif  277 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF  277 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence                  23333333332    3333333333332 45678999999999987642210111  01122233333344443


Q ss_pred             HHHHHHHhcCCCCeEEeCCCCCceEEcCCC----cEEEeecCCccccCCC
Q 015734          189 YGLEYLHEQCNPKIIHRDLKAANILLDDNF----EAVLCDFGLAKLVDAK  234 (401)
Q Consensus       189 ~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~Dfgl~~~~~~~  234 (401)
                             ..   |++|+|++|.||+++.++    .+++.|||+...++..
T Consensus       278 -------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        278 -------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             -------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence                   34   899999999999999988    9999999998876543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.38  E-value=2.7e-12  Score=108.57  Aligned_cols=130  Identities=20%  Similarity=0.145  Sum_probs=94.9

Q ss_pred             CCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccc-eeeeeecCCeeEEEEecccCCc
Q 015734           82 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ-LIGYCTTSSERILVYPFMQNLS  160 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~~~~gs  160 (401)
                      .+.|+.|.++.||++... +..|++|.......  ....+..|+..+..+.+.++++ ++.+.  ....++||||++|.+
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~   77 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE   77 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence            356789999999999874 77899998754321  2335678999998887666544 44433  234589999999987


Q ss_pred             HHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          161 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC--NPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       161 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      +...  .       .   ....++.+++.+|+.||+..  ...++|+|++|.||+++ ++.++++|||.+.
T Consensus        78 l~~~--~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          78 LLTE--D-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccc--c-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            6532  0       1   11345678999999999972  12369999999999999 6689999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.35  E-value=1.4e-12  Score=124.94  Aligned_cols=250  Identities=21%  Similarity=0.177  Sum_probs=175.5

Q ss_pred             hcCCCCCCeeee--cCcEEEEEEEE---CCCCEEEEEEecccCC-cchHHHHHHHHHHHHhc-cCCcccceeeeeecCCe
Q 015734           76 TDNFSESNIIGQ--GGFGKVYKGVL---SDNTKVAVKRLQDYYS-PGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSE  148 (401)
Q Consensus        76 ~~~~~~~~~lG~--G~~g~V~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  148 (401)
                      ...+...+.+|.  |.+|.+|.+..   .++..+|+|+-+...+ +.....=.+|+....++ .|+|.++....+...+.
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence            334566778999  99999999886   2577899987543222 22223334556555555 49999998888888888


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEEeCCCCCceEEcCC-CcEEEe
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLC  223 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~  223 (401)
                      .++-+|++. .+|..+.+..   ...++....+....+..+    |+.++|+.   +++|-|+||.||+...+ ...+++
T Consensus       193 lfiqtE~~~-~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~  265 (524)
T KOG0601|consen  193 LFIQTELCG-ESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLT  265 (524)
T ss_pred             ceeeecccc-chhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecC
Confidence            899999885 6777666643   233677778888888888    99999999   99999999999999999 899999


Q ss_pred             ecCCccccCCCCcce----eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHH
Q 015734          224 DFGLAKLVDAKLTHV----TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI  299 (401)
Q Consensus       224 Dfgl~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~  299 (401)
                      |||+........-..    .....|...|++||.. .+-++..+|+|++|.++.+-.++..+....-.        ..|.
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--------~~W~  336 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN--------SSWS  336 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC--------CCcc
Confidence            999988765543211    1223577789999977 45678899999999999999998876542200        0011


Q ss_pred             HHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          300 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       300 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                      .  .+...+..       .+...-..++...+..|++.+|-.|++++.+..
T Consensus       337 ~--~r~~~ip~-------e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  337 Q--LRQGYIPL-------EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             c--cccccCch-------hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            0  00000000       011222234555788899999999999888755

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.30  E-value=9.2e-11  Score=100.28  Aligned_cols=138  Identities=18%  Similarity=0.207  Sum_probs=98.1

Q ss_pred             CCeeeecCcEEEEEEEECC-------CCEEEEEEecccCC---------------------cchHHHHH----HHHHHHH
Q 015734           82 SNIIGQGGFGKVYKGVLSD-------NTKVAVKRLQDYYS---------------------PGGEAAFQ----REVHLIS  129 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~~-------~~~vavK~~~~~~~---------------------~~~~~~~~----~e~~~l~  129 (401)
                      ...||.|--+.||.|...+       +..+|||+.+....                     ......+.    +|++.|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3568999999999998543       47999998742110                     01122333    7999998


Q ss_pred             hccC--CcccceeeeeecCCeeEEEEecccCCcHH-HHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEe
Q 015734          130 VAIH--KNLLQLIGYCTTSSERILVYPFMQNLSVA-YRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL-HEQCNPKIIHR  205 (401)
Q Consensus       130 ~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~  205 (401)
                      ++..  -++..++++    ..-++||||+.+..+. ..+.+     ..++......+..+++.+|..| |..   +++|+
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG  149 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA  149 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence            8864  455566553    5568999999765432 12322     1244456677889999999998 777   99999


Q ss_pred             CCCCCceEEcCCCcEEEeecCCccccC
Q 015734          206 DLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       206 dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      ||++.||++++ +.+.|+|||.+-...
T Consensus       150 DLs~~NIL~~~-~~v~iIDF~qav~~~  175 (197)
T cd05146         150 DLSEYNMLWHD-GKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCCHHHEEEEC-CcEEEEECCCceeCC
Confidence            99999999974 679999999886543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.24  E-value=7.6e-12  Score=119.99  Aligned_cols=249  Identities=18%  Similarity=0.162  Sum_probs=171.5

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEE--CCCCEEEEEEecccCCcchH-HHHHHHHHHHHhc-cCCcccceeeeeecCCe
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVL--SDNTKVAVKRLQDYYSPGGE-AAFQREVHLISVA-IHKNLLQLIGYCTTSSE  148 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~-~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  148 (401)
                      .....+|..+..||.|.|+.|+....  .++..|++|.+.+....... ..-..|+-+...+ .|.+++.....+....+
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            34556788899999999999998874  35788999988754332222 2223455555544 48888887766666677


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCC-CcEEEeecCC
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGL  227 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfgl  227 (401)
                      .++=-|||+++++......    ...+.....+++..|++.++.++|+.   .++|+|+||+||++..+ +.-+++|||.
T Consensus       341 ~~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~  413 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGC  413 (524)
T ss_pred             ccCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccc
Confidence            7788899999988766632    23467778899999999999999998   99999999999999886 7789999999


Q ss_pred             ccccCCCCcceeccccCCcccc--cccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhcc
Q 015734          228 AKLVDAKLTHVTTQIRGTMGHI--APEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE  305 (401)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (401)
                      +..+.-.    ........++.  +|.......+..+.|++|||..+.+.++|...-.....          |       
T Consensus       414 ~t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----------~-------  472 (524)
T KOG0601|consen  414 WTRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----------S-------  472 (524)
T ss_pred             cccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCccccc----------c-------
Confidence            8642111    11112233444  45555566788999999999999999998753221100          0       


Q ss_pred             CccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          306 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       306 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                         ..+..... ...+.....+..+...+...++..||.+.++..+.+
T Consensus       473 ---~~i~~~~~-p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  473 ---LTIRSGDT-PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             ---eeeecccc-cCCCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence               00000101 111222255666677788999999999888765543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.24  E-value=1.4e-10  Score=102.52  Aligned_cols=142  Identities=18%  Similarity=0.204  Sum_probs=106.4

Q ss_pred             CeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccC--CcccceeeeeecCC---eeEEEEeccc
Q 015734           83 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH--KNLLQLIGYCTTSS---ERILVYPFMQ  157 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~---~~~lv~e~~~  157 (401)
                      +.|+.|..+.+|++...+|..+++|.............+..|+.++..+.+  .++.+++.+.....   ..+++|||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            568999999999999866689999987643322235678899999998876  44567777766543   5689999999


Q ss_pred             CCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 015734          158 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC---------------------------------------  198 (401)
Q Consensus       158 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------  198 (401)
                      |.++...+..     ..++......++.+++.+|..||+..                                       
T Consensus        84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9887654421     23566667777777777777777421                                       


Q ss_pred             --------------CCCeEEeCCCCCceEEcC--CCcEEEeecCCcc
Q 015734          199 --------------NPKIIHRDLKAANILLDD--NFEAVLCDFGLAK  229 (401)
Q Consensus       199 --------------~~~i~H~dlkp~Nill~~--~~~~kl~Dfgl~~  229 (401)
                                    ...++|+|+.|.||+++.  ++.+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                          235799999999999998  6678999999875

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.18  E-value=7.9e-12  Score=126.20  Aligned_cols=252  Identities=16%  Similarity=0.160  Sum_probs=167.8

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecc--cCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCee
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQD--YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  149 (401)
                      +...+.+.+.+-+-+|.++.++.+.- ..|...+.|....  .......+....+-.++-...+|-++.....+......
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            34566777777888999999987762 2343334443321  01111122233333333334456666555445566778


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      +++++|..+++|...|+...    +.+..-.+..+..+.+++++||+.   .+.|+|++|.|.++..+++.+++|||...
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~  952 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLS  952 (1205)
T ss_pred             chhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccc
Confidence            99999999999999888632    345455566677788999999997   68999999999999999999999998332


Q ss_pred             ccCCC---------------------C---------cceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCC
Q 015734          230 LVDAK---------------------L---------THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ  279 (401)
Q Consensus       230 ~~~~~---------------------~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~  279 (401)
                      .....                     .         ........+|+.|.+||...+......+|+|+.|+.++|.++|.
T Consensus       953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen  953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred             ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence            11100                     0         00122345899999999999999999999999999999999999


Q ss_pred             CCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 015734          280 RAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMA  346 (401)
Q Consensus       280 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  346 (401)
                      +||.......        .++.....       +...+..+.....+..+++...+..+|.+|-.+.
T Consensus      1033 pp~na~tpq~--------~f~ni~~~-------~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQ--------IFENILNR-------DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCcchhh--------hhhccccC-------CCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            9998654421        11111100       0111112333445667777788899999997766

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.15  E-value=1.2e-09  Score=90.48  Aligned_cols=131  Identities=21%  Similarity=0.293  Sum_probs=98.5

Q ss_pred             eeeecCcEEEEEEEECCCCEEEEEEec-ccCCcc------hHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecc
Q 015734           84 IIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPG------GEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM  156 (401)
Q Consensus        84 ~lG~G~~g~V~~~~~~~~~~vavK~~~-~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  156 (401)
                      .+++|+-+.+|.+.+. |.++++|.-. +.+.-.      ....-.+|..++.++.--.|.-..=+..+.+...++|||+
T Consensus         3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            5789999999999763 4456666432 222211      1235667899998887666655555677788889999999


Q ss_pred             cCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          157 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      +|..|.+.+...           ...++..+-.-+.-||..   +++|+||.++||++..+. +.++|||++..
T Consensus        82 ~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            998888888752           234556666777889999   999999999999998775 99999999863

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.15  E-value=3.4e-09  Score=97.84  Aligned_cols=264  Identities=16%  Similarity=0.136  Sum_probs=154.6

Q ss_pred             CCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHh-ccCCcccceeee------eecCCe-eEE
Q 015734           80 SESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISV-AIHKNLLQLIGY------CTTSSE-RIL  151 (401)
Q Consensus        80 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~------~~~~~~-~~l  151 (401)
                      ...+-||+|+-+.+|-.-.- +. .+.|+....... ...   +.+..|.. -.||-+..-+.+      .-+.+. ..+
T Consensus        14 ~~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa-~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPA-AQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             CCCccccCCccceeeecchh-hc-hhheeecCCCch-HHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            34677999999999954321 22 244666532211 111   22223332 345544331221      122222 567


Q ss_pred             EEecccCCc-HHHHhh--hcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          152 VYPFMQNLS-VAYRLR--DLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       152 v~e~~~~gs-L~~~l~--~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      +|+.+.+.. +..++.  ..+..-....|....+.++.++.+.+.||..   |.+-+|+.++|+|+++++.+.|.|-..-
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence            888877652 222221  1122235689999999999999999999999   9999999999999999999999985543


Q ss_pred             cccCCCCcceeccccCCcccccccccc-----cCCCCcccchhHHHHHHHHHHhC-CCCCCCCcchhh-hhhhHHHHHHH
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTG-QRAIDFSRLEEE-EDVLLLDHIRK  301 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDi~slG~ll~elltg-~~p~~~~~~~~~-~~~~~~~~~~~  301 (401)
                      ....+  .......+|.+.|++||.-.     +..-+..+|-|.||+++++++.| ++||.+...... ....-.+....
T Consensus       165 qi~~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         165 QINAN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             eeccC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            32211  22334456889999999754     34457789999999999999886 899975322111 10000000000


Q ss_pred             Hh--ccCccchhccCcCCCCCHHHHHHHHHHHHHcccCC--CCCCCCHHHHHHHhcc
Q 015734          302 LL--REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQST--PEDRPPMAQVVKMLQG  354 (401)
Q Consensus       302 ~~--~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~--p~~RPs~~~vl~~L~~  354 (401)
                      .+  ..+.-.....+.........+..+..+.-+|+...  +.-|||++-.+..|..
T Consensus       243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a  299 (637)
T COG4248         243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA  299 (637)
T ss_pred             eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence            00  00000111111111112233455666666787643  5689999999887754

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.15  E-value=3.2e-09  Score=100.31  Aligned_cols=219  Identities=16%  Similarity=0.136  Sum_probs=150.1

Q ss_pred             CcEEEEEEE-ECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeec----CCeeEEEEecccC-CcHH
Q 015734           89 GFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT----SSERILVYPFMQN-LSVA  162 (401)
Q Consensus        89 ~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-gsL~  162 (401)
                      .-.+.|++. ..||..|++|+++.... ........-+++++++.|.|+|++.+++..    ...+++||+|.++ ++|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~-~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRD-QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccc-cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            446789998 44899999999953221 112223456788999999999999998762    3467999999985 4666


Q ss_pred             HHhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          163 YRLRDLKP-----------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       163 ~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      +.-.....           .+...++..+|.++.|+..||.++|+.   |+..+-|.+.+|+++.+.+++|+..|+....
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence            54432211           234578899999999999999999999   9999999999999999999999998887655


Q ss_pred             CCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ..+..               |.+.   --.+-|.=.||.+++.|.||..--...+.   ......+              
T Consensus       444 ~~d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~---~~~s~~~--------------  488 (655)
T KOG3741|consen  444 QEDPT---------------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDS---TQSSHLT--------------  488 (655)
T ss_pred             cCCCC---------------cchh---HHhhhhHHHHHHHHHHHhhcccccccccc---hHHHHHH--------------
Confidence            44321               1111   12356899999999999999653211111   0000000              


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                            .....++.++.+++.-....++++ -+..+++.+..
T Consensus       489 ------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~  523 (655)
T KOG3741|consen  489 ------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIG  523 (655)
T ss_pred             ------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHH
Confidence                  012344455666666666667766 67777766544

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.14  E-value=1.6e-09  Score=89.39  Aligned_cols=143  Identities=20%  Similarity=0.209  Sum_probs=103.9

Q ss_pred             CCCeeeecCcEEEEEEEECCCCEEEEEEec-ccCC------cchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           81 ESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYS------PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        81 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~-~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ....+-+|+-+.|+++.+ .|+.+.||.-. +.+.      .-......+|.+++.++.--.|.-..-++.+...-.+.|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            467789999999999998 57777777442 2221      112345678999998877555544444666777778999


Q ss_pred             ecccC-CcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCc---EEEeecCCcc
Q 015734          154 PFMQN-LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE---AVLCDFGLAK  229 (401)
Q Consensus       154 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfgl~~  229 (401)
                      ||++| .++.+++.....  ..........++..+-..+.-||.+   +++|+||..+||++..++.   +.+.|||++.
T Consensus        90 E~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence            99987 467777765332  2222233367888899999999999   9999999999999965543   5899999986

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.03  E-value=1.1e-08  Score=92.50  Aligned_cols=141  Identities=13%  Similarity=0.042  Sum_probs=99.6

Q ss_pred             CeeeecCcEEEEEEEECCCCEEEEEEecccCCcc----------hHHHHHHHHHHHHhccCCc--ccceeeeeec-----
Q 015734           83 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG----------GEAAFQREVHLISVAIHKN--LLQLIGYCTT-----  145 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~-----  145 (401)
                      +.+-......|+++.. +|+.|.||.........          ....+.+|...+..+..-+  ....+++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4444444455667666 67789999764321110          1114778988888775333  3444555532     


Q ss_pred             CCeeEEEEecccCC-cHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC-------C
Q 015734          146 SSERILVYPFMQNL-SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-------N  217 (401)
Q Consensus       146 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-------~  217 (401)
                      ....++|+|++++. +|.+++....  ..+.+......++.+++..+.-||..   |++|+|++++|||++.       +
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~  181 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED  181 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence            23468999999886 7888876432  13345667789999999999999999   9999999999999975       5


Q ss_pred             CcEEEeecCCcc
Q 015734          218 FEAVLCDFGLAK  229 (401)
Q Consensus       218 ~~~kl~Dfgl~~  229 (401)
                      ..+.++||+.+.
T Consensus       182 ~~~~LIDl~r~~  193 (268)
T PRK15123        182 LKLSVIDLHRAQ  193 (268)
T ss_pred             ceEEEEECCccc
Confidence            689999999875

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.96  E-value=9.6e-09  Score=87.54  Aligned_cols=127  Identities=23%  Similarity=0.285  Sum_probs=81.7

Q ss_pred             EEEEEEECCCCEEEEEEecccCC-------------------------cchHHHHHHHHHHHHhccCC--cccceeeeee
Q 015734           92 KVYKGVLSDNTKVAVKRLQDYYS-------------------------PGGEAAFQREVHLISVAIHK--NLLQLIGYCT  144 (401)
Q Consensus        92 ~V~~~~~~~~~~vavK~~~~~~~-------------------------~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~  144 (401)
                      .||.|...+|..+|+|..+....                         ........+|.+.|.++..-  ++.+++++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            38999988899999998742110                         00124567899999998765  45555544  


Q ss_pred             cCCeeEEEEeccc--CCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEEeCCCCCceEEcCCCcEE
Q 015734          145 TSSERILVYPFMQ--NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY-LHEQCNPKIIHRDLKAANILLDDNFEAV  221 (401)
Q Consensus       145 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~i~H~dlkp~Nill~~~~~~k  221 (401)
                        +.-.+||||++  |..+.. +.+..     ++......++.+++..+.. +|..   |++|+||.+.||+++++ .+.
T Consensus        79 --~~~~ivME~I~~~G~~~~~-l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPR-LKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGC-HHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred             --eCCEEEEEecCCCccchhh-HHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence              24579999998  544433 43311     1123455667777775555 4677   99999999999999988 899


Q ss_pred             EeecCCccccC
Q 015734          222 LCDFGLAKLVD  232 (401)
Q Consensus       222 l~Dfgl~~~~~  232 (401)
                      ++|||.+....
T Consensus       147 iIDf~qav~~~  157 (188)
T PF01163_consen  147 IIDFGQAVDSS  157 (188)
T ss_dssp             E--GTTEEETT
T ss_pred             EEecCcceecC
Confidence            99999886443

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.89  E-value=2.1e-08  Score=88.10  Aligned_cols=135  Identities=20%  Similarity=0.185  Sum_probs=94.4

Q ss_pred             CCCCCeeeecCcEEEEEEEECCCCEEEEEEecccC---------------------CcchHHHHHHHHHHHHhccCC--c
Q 015734           79 FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY---------------------SPGGEAAFQREVHLISVAIHK--N  135 (401)
Q Consensus        79 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~---------------------~~~~~~~~~~e~~~l~~l~h~--n  135 (401)
                      ..++..||-|--+.||.|..++|.++|||.=+...                     -.-......+|.+.|.++.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            45678999999999999999999999999542110                     011244577899999888643  5


Q ss_pred             ccceeeeeecCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEc
Q 015734          136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD  215 (401)
Q Consensus       136 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~  215 (401)
                      +.+.+++    +.-.+|||+++|--|...-         ++......++..|+.-+.-+-..   |++|+|+++-||+++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~  236 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT  236 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence            5555543    4558999999885543211         11222333444444444444455   899999999999999


Q ss_pred             CCCcEEEeecCCcc
Q 015734          216 DNFEAVLCDFGLAK  229 (401)
Q Consensus       216 ~~~~~kl~Dfgl~~  229 (401)
                      +||.+.++||--+.
T Consensus       237 ~dg~~~vIDwPQ~v  250 (304)
T COG0478         237 EDGDIVVIDWPQAV  250 (304)
T ss_pred             cCCCEEEEeCcccc
Confidence            99999999997664

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.80  E-value=1e-09  Score=107.10  Aligned_cols=150  Identities=17%  Similarity=0.298  Sum_probs=102.8

Q ss_pred             HHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCccee--------ccccCCcccccccccccC
Q 015734          186 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT--------TQIRGTMGHIAPEYLSTG  257 (401)
Q Consensus       186 ~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~--------~~~~gt~~y~aPE~~~~~  257 (401)
                      +++.|+.|+|..  ++++|++|.|++|.++.++.+||+.|+.+...........        .-......|.|||++.+.
T Consensus       107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            455899999986  4899999999999999999999999998764433111100        011234579999999998


Q ss_pred             CCCcccchhHHHHHHHHHHhCCCC-CCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHccc
Q 015734          258 KSSEKTDVFGYGITLLELVTGQRA-IDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQ  336 (401)
Q Consensus       258 ~~~~~sDi~slG~ll~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~  336 (401)
                      -.+.++|+||+|+++|.+..|+.+ +.........     ...         ....+-....+....+.++.+=+.+++.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-----~~~---------~~~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-----SFS---------RNLLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchh-----hhh---------hcccccccccccccCcHHHHHHHHHHhc
Confidence            889999999999999999955544 4322111000     000         0011111222345556677788888999


Q ss_pred             CCCCCCCCHHHHHHH
Q 015734          337 STPEDRPPMAQVVKM  351 (401)
Q Consensus       337 ~~p~~RPs~~~vl~~  351 (401)
                      .++..||++..+...
T Consensus       251 ~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLSI  265 (700)
T ss_pred             CCcccCcchhhhhcc
Confidence            999999988887553

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.70  E-value=2e-07  Score=81.42  Aligned_cols=106  Identities=20%  Similarity=0.222  Sum_probs=82.6

Q ss_pred             HHHHHHHHHHHHhccC--CcccceeeeeecCC----eeEEEEecccCC-cHHHHhhhcCCCCCCCCHHHHHHHHHHHHHH
Q 015734          118 EAAFQREVHLISVAIH--KNLLQLIGYCTTSS----ERILVYPFMQNL-SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG  190 (401)
Q Consensus       118 ~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~  190 (401)
                      .....+|...+..+..  -.+.+.+++.....    ..++|+|++++. +|.+++.....    .+......++.+++..
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~  130 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARL  130 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHH
Confidence            4467788887777653  33556666655432    347999999874 78888876322    5566778999999999


Q ss_pred             HHHHHhcCCCCeEEeCCCCCceEEcCCC---cEEEeecCCccc
Q 015734          191 LEYLHEQCNPKIIHRDLKAANILLDDNF---EAVLCDFGLAKL  230 (401)
Q Consensus       191 l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl~Dfgl~~~  230 (401)
                      ++-||..   |++|+|+++.|||++.+.   .+.++||+-++.
T Consensus       131 i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  131 IAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999999   999999999999999887   899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.68  E-value=7.2e-07  Score=76.63  Aligned_cols=139  Identities=18%  Similarity=0.133  Sum_probs=101.4

Q ss_pred             eeecCcEEEEEEEECCCCEEEEEEecccC--C---cchHHHHHHHHHHHHhccCC--cccceeeeeecCC----eeEEEE
Q 015734           85 IGQGGFGKVYKGVLSDNTKVAVKRLQDYY--S---PGGEAAFQREVHLISVAIHK--NLLQLIGYCTTSS----ERILVY  153 (401)
Q Consensus        85 lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~---~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~----~~~lv~  153 (401)
                      -|.||-+.|+.... +|..+-+|+-.+..  +   +-....|.+|...+..+..-  ++.+.........    .-.+|+
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            36789999998777 45578888764211  1   44567899999999888632  2444442222211    347889


Q ss_pred             ecccC-CcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCc--EEEeecCCcc
Q 015734          154 PFMQN-LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE--AVLCDFGLAK  229 (401)
Q Consensus       154 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~--~kl~Dfgl~~  229 (401)
                      |-+.+ -+|.+++.+..  -.+.+......++.+++..++-||+.   |+.|+|+.+.||+++.++.  ++++||.-++
T Consensus       105 e~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        105 EDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            97754 57888876522  22456777889999999999999999   9999999999999986667  9999998765

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.59  E-value=2.8e-07  Score=90.25  Aligned_cols=143  Identities=19%  Similarity=0.220  Sum_probs=89.4

Q ss_pred             CeeeecCcEEEEEEEECCCCEEEEEEecccCCcch-----------------------------H----H------HHHH
Q 015734           83 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGG-----------------------------E----A------AFQR  123 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-----------------------------~----~------~~~~  123 (401)
                      +-|+.++-|.||+|++++|+.||||+.++...+..                             .    +      .+.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            67899999999999999999999998864322110                             0    1      1223


Q ss_pred             HHHHHHhcc-----CCcccceeeeee-cCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 015734          124 EVHLISVAI-----HKNLLQLIGYCT-TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ  197 (401)
Q Consensus       124 e~~~l~~l~-----h~niv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~  197 (401)
                      |..-+.++.     .+++ .+=.++. -.+...++|||++|-.+.+...-..   ..++...+.....++.-  ..+-..
T Consensus       211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~ia~~~~~~f~--~q~~~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKELAELLVRAFL--RQLLRD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHHHHHHHHHHHH--HHHHhc
Confidence            333333332     2222 2222332 3466799999999988877643211   22343333322222221  112223


Q ss_pred             CCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       198 ~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                         |++|.|..|.||+++.+|++.+.|||+.......
T Consensus       285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             ---CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence               8999999999999999999999999998766543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.52  E-value=2.5e-06  Score=75.47  Aligned_cols=138  Identities=14%  Similarity=0.178  Sum_probs=84.9

Q ss_pred             CeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCc--ccceeeeeecCCeeEEEEecccCCc
Q 015734           83 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN--LLQLIGYCTTSSERILVYPFMQNLS  160 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gs  160 (401)
                      ..||+|..+.||+.   .+..+++|......   ......+|.++++.+..-+  +.+.++++...+...++|++++|.+
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            56899999999984   24567788765422   3345688999998886433  4667777777777889999998863


Q ss_pred             -HH--------------HH-------hhhcCCCCCCCCHHHHH-HHHHH----------HHH-HHHHHHhc-CCCCeEEe
Q 015734          161 -VA--------------YR-------LRDLKPGEKGLDWPTRK-RVAFG----------TAY-GLEYLHEQ-CNPKIIHR  205 (401)
Q Consensus       161 -L~--------------~~-------l~~~~~~~~~l~~~~~~-~i~~~----------i~~-~l~~LH~~-~~~~i~H~  205 (401)
                       +.              ..       ++......  .+..... .+..+          +.. ...+|.+. ..+.++|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~--~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg  158 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDT--STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG  158 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCC--CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence             11              11       12111111  1111111 11000          001 12222211 13467999


Q ss_pred             CCCCCceEEcCCCcEEEeecCCcc
Q 015734          206 DLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       206 dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      |+.|.||++++++ +.++||+.+.
T Consensus       159 D~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       159 DFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCCCcEEEcCCC-cEEEechhcC
Confidence            9999999999988 9999998765

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.45  E-value=6e-06  Score=72.13  Aligned_cols=156  Identities=21%  Similarity=0.196  Sum_probs=101.0

Q ss_pred             ccccCHHHHHHHhcCCCCCCee---eecCcEEEEEEEECCCCEEEEEEecccCCcc------------------h-----
Q 015734           64 LRRFSCRELQLATDNFSESNII---GQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG------------------G-----  117 (401)
Q Consensus        64 ~~~~~~~~~~~~~~~~~~~~~l---G~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------------------~-----  117 (401)
                      +...+...+....++..+....   ++|--+.||+|...++..+|+|+.+...+.-                  .     
T Consensus        32 ~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv  111 (268)
T COG1718          32 FDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV  111 (268)
T ss_pred             hhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence            4455566666666666665554   5677788999998889999999986422110                  0     


Q ss_pred             HHHHHHHHHHHHhcc--CCcccceeeeeecCCeeEEEEecccCC-cHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 015734          118 EAAFQREVHLISVAI--HKNLLQLIGYCTTSSERILVYPFMQNL-SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL  194 (401)
Q Consensus       118 ~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L  194 (401)
                      ..-..+|+.-|.++.  +-.+.+.+++    .+..+||||+... .-.-.|.+     -++.......+..++++.+.-|
T Consensus       112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l  182 (268)
T COG1718         112 FAWARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRL  182 (268)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHH
Confidence            011334566555553  2233333332    2347999999643 22222332     2233335777788888888888


Q ss_pred             HhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       195 H~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      -...  +++|+||+.-|||+. ++.+.++|||-+...
T Consensus       183 ~~~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         183 YKEA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             HHhc--CcccccchhhheEEE-CCeEEEEECcccccc
Confidence            7732  899999999999999 789999999987644

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.38  E-value=7.7e-06  Score=70.65  Aligned_cols=139  Identities=14%  Similarity=0.127  Sum_probs=90.3

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHH---------HHHHHHHHhcc---CCccccee
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAF---------QREVHLISVAI---HKNLLQLI  140 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~---------~~e~~~l~~l~---h~niv~~~  140 (401)
                      .+...+|...+++-......|.+-.. +|..+++|..++... ...+.|         .+.+..+.++.   --....++
T Consensus        27 ~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~-r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y  104 (229)
T PF06176_consen   27 KILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENR-RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY  104 (229)
T ss_pred             HHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhh-hHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence            44677888888888888888887777 678999998764221 111111         22233233332   22233322


Q ss_pred             eee-----ecCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEc
Q 015734          141 GYC-----TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD  215 (401)
Q Consensus       141 ~~~-----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~  215 (401)
                      ...     .-....+++|||++|..|.+...        ++.    .+...+.+++.-||+.   |+.|+|..|.|++++
T Consensus       105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~  169 (229)
T PF06176_consen  105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVS  169 (229)
T ss_pred             eeeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEE
Confidence            222     22234568999999987655432        222    2445677789999999   999999999999999


Q ss_pred             CCCcEEEeecCCcc
Q 015734          216 DNFEAVLCDFGLAK  229 (401)
Q Consensus       216 ~~~~~kl~Dfgl~~  229 (401)
                      +++ +++.||+..+
T Consensus       170 ~~~-i~iID~~~k~  182 (229)
T PF06176_consen  170 NNG-IRIIDTQGKR  182 (229)
T ss_pred             CCc-EEEEECcccc
Confidence            665 9999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.32  E-value=9e-06  Score=72.16  Aligned_cols=144  Identities=17%  Similarity=0.180  Sum_probs=83.8

Q ss_pred             CCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCC--cccceeeeeec---CCeeEEEEecc
Q 015734           82 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK--NLLQLIGYCTT---SSERILVYPFM  156 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~---~~~~~lv~e~~  156 (401)
                      ++.|+.|..+.||++...+ ..+++|.....   .....+..|..++..+...  .+.+++.++..   ....+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            3568999999999999866 69999986542   3566788888888877533  34566654422   23468999999


Q ss_pred             cCCcHHH----------------Hh---hhcCCCCCCCCHHHHH------H---H------------HHHHHH-HHHHHH
Q 015734          157 QNLSVAY----------------RL---RDLKPGEKGLDWPTRK------R---V------------AFGTAY-GLEYLH  195 (401)
Q Consensus       157 ~~gsL~~----------------~l---~~~~~~~~~l~~~~~~------~---i------------~~~i~~-~l~~LH  195 (401)
                      ++..+..                .+   +.......+.......      .   .            ...+.. .+..++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            9887766                11   1211111111111100      0   0            011222 233333


Q ss_pred             hc----CCCCeEEeCCCCCceEEc-CCCcEEEeecCCcc
Q 015734          196 EQ----CNPKIIHRDLKAANILLD-DNFEAVLCDFGLAK  229 (401)
Q Consensus       196 ~~----~~~~i~H~dlkp~Nill~-~~~~~kl~Dfgl~~  229 (401)
                      +.    ....++|+|+.|.||+++ +++.+.|.||+.+.
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            21    234799999999999999 66667899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PLN02876 acyl-CoA dehydrogenase

Probab=98.21  E-value=2.4e-05  Score=82.48  Aligned_cols=79  Identities=10%  Similarity=0.209  Sum_probs=57.5

Q ss_pred             CCeeeecCcEEEEEEEECCC---CEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCcc--cceeeeeecC---CeeEEE
Q 015734           82 SNIIGQGGFGKVYKGVLSDN---TKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNL--LQLIGYCTTS---SERILV  152 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv  152 (401)
                      .+.++.|.++.+|+....++   ..+++|+............+.+|+++++.+. |.++  .+++.+|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            56788999999999886554   4677777643222233457889999999885 6654  7788887664   457899


Q ss_pred             EecccCCc
Q 015734          153 YPFMQNLS  160 (401)
Q Consensus       153 ~e~~~~gs  160 (401)
                      |||++|..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99998764

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.20  E-value=6.2e-05  Score=64.77  Aligned_cols=131  Identities=23%  Similarity=0.317  Sum_probs=91.4

Q ss_pred             CCCCeeeecCcEEEEEEEECCCCEEEEEEecccC---------------CcchHHHHHHHHHHHHhcc------CCcccc
Q 015734           80 SESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY---------------SPGGEAAFQREVHLISVAI------HKNLLQ  138 (401)
Q Consensus        80 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~e~~~l~~l~------h~niv~  138 (401)
                      +....||+|+.-.||  .++++....||+.....               ......+..+|+.-...+.      +.+|.+
T Consensus         4 ~~~~~i~~G~~R~cy--~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    4 SESDLIAQGGERDCY--QHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCCcccccCCCceEE--ECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            345679999999999  66677778889886533               1123466677776655555      788999


Q ss_pred             eeeeeecCCeeEEEEecccCC------cHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCce
Q 015734          139 LIGYCTTSSERILVYPFMQNL------SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI  212 (401)
Q Consensus       139 ~~~~~~~~~~~~lv~e~~~~g------sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Ni  212 (401)
                      ++|+..++-...+|+|.+.+.      +|.+++.+     ..++. .....   +-.-..+|-+.   .|+.+|++|.||
T Consensus        82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~~~---L~~f~~~l~~~---~Iv~~dl~~~NI  149 (199)
T PF10707_consen   82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELRQA---LDEFKRYLLDH---HIVIRDLNPHNI  149 (199)
T ss_pred             EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHHHH---HHHHHHHHHHc---CCeecCCCcccE
Confidence            999999999999999987542      46666643     23444 33333   33445566666   799999999999


Q ss_pred             EEcCCC----cEEEee
Q 015734          213 LLDDNF----EAVLCD  224 (401)
Q Consensus       213 ll~~~~----~~kl~D  224 (401)
                      ++..+.    .+.|+|
T Consensus       150 v~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  150 VVQRRDSGEFRLVLID  165 (199)
T ss_pred             EEEecCCCceEEEEEe
Confidence            995332    466666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.17  E-value=1.5e-05  Score=78.05  Aligned_cols=145  Identities=19%  Similarity=0.187  Sum_probs=88.1

Q ss_pred             CCeeeecCcEEEEEEEECCCCEEEEEEecccCCcch------------------------------HH------HHHHHH
Q 015734           82 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGG------------------------------EA------AFQREV  125 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~------------------------------~~------~~~~e~  125 (401)
                      .+-||..+.|.||+|+.++|+.||||+-++......                              .+      .|.+|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            467899999999999999999999998764322110                              00      122333


Q ss_pred             HHH----HhccCCcc---cceeeeee-cCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 015734          126 HLI----SVAIHKNL---LQLIGYCT-TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ  197 (401)
Q Consensus       126 ~~l----~~l~h~ni---v~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~  197 (401)
                      +-.    ..+.|-+.   |.+=.++. -.....++|||++|..+.+.-.- .  ...++...+..-+.+..     ++..
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i-~--~~gi~~~~i~~~l~~~~-----~~qI  317 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI-D--KRGISPHDILNKLVEAY-----LEQI  317 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH-H--HcCCCHHHHHHHHHHHH-----HHHH
Confidence            222    22334441   11112222 23467999999999877665321 1  12244443333333322     2222


Q ss_pred             CCCCeEEeCCCCCceEEc----CCCcEEEeecCCccccCCC
Q 015734          198 CNPKIIHRDLKAANILLD----DNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       198 ~~~~i~H~dlkp~Nill~----~~~~~kl~Dfgl~~~~~~~  234 (401)
                      ...|++|.|-.|.||+++    .++.+.+-|||+.......
T Consensus       318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            222899999999999998    4778999999998765443

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.17  E-value=3.6e-05  Score=69.09  Aligned_cols=140  Identities=16%  Similarity=0.116  Sum_probs=82.7

Q ss_pred             eeecCc-EEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCcccceeeeeecCCeeEEEEecccCCcHH
Q 015734           85 IGQGGF-GKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPFMQNLSVA  162 (401)
Q Consensus        85 lG~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  162 (401)
                      |-.|.. ..||+.... +..+.+|+.....    ...+.+|++++..+. +-.+.+++++....+..++||++++|.++.
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            334444 788988764 4778888765421    335677888887774 334556777776666778999999987765


Q ss_pred             HHh-------------------hhcCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHHh----c
Q 015734          163 YRL-------------------RDLKPGEKGLDWP--TRKRVAF--------------------GTAYGLEYLHE----Q  197 (401)
Q Consensus       163 ~~l-------------------~~~~~~~~~l~~~--~~~~i~~--------------------~i~~~l~~LH~----~  197 (401)
                      ...                   +.......++...  .......                    .+...+..|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            331                   1111101111100  0000000                    01111222211    1


Q ss_pred             CCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       198 ~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ..+.++|+|+.|.||+++++..+.|+||+.+.
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            23469999999999999998778899998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.16  E-value=0.00012  Score=62.66  Aligned_cols=102  Identities=20%  Similarity=0.189  Sum_probs=81.0

Q ss_pred             HHHHHHHHhccC-CcccceeeeeecCCeeEEEEecccCCcHHHH---hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 015734          122 QREVHLISVAIH-KNLLQLIGYCTTSSERILVYPFMQNLSVAYR---LRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ  197 (401)
Q Consensus       122 ~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~---l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~  197 (401)
                      ..|.-++..+++ +++.+++|+|-    ..++.|+...+++...   +..+    ...+|..+.+|+.+++..+.+|++.
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~----~~~~w~~R~~iA~~lL~~l~~l~~~   78 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQF----LQSPWEQRAKIALQLLELLEELDHG   78 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccc----cccCHHHHHHHHHHHHHHHHHHhcC
Confidence            357888888876 68999999983    4778899987655321   1111    2368999999999999999999986


Q ss_pred             CCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       198 ~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      ....+.-.|++++|+-+++++++|++|.......
T Consensus        79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   79 PLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             CCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            5446888999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.11  E-value=6.8e-07  Score=86.98  Aligned_cols=184  Identities=16%  Similarity=0.119  Sum_probs=129.9

Q ss_pred             CCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCc-ccceeeeeecCCeeEEEEecccCC
Q 015734           81 ESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN-LLQLIGYCTTSSERILVYPFMQNL  159 (401)
Q Consensus        81 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~g  159 (401)
                      ..+.+++|+++.++|.+-...+....+.+..      .....-++++|.+++||| .+..++-++.+....+.++++.++
T Consensus       246 ~fh~fvK~altknpKkRptaeklL~h~fvs~------~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~  319 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ------TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG  319 (829)
T ss_pred             HHHHHHHHHhcCCCccCCChhhheeceeecc------chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence            3456789999999988743333333444322      144566889999999999 666666666677778899999876


Q ss_pred             -cHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcce
Q 015734          160 -SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV  238 (401)
Q Consensus       160 -sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  238 (401)
                       +.......   ..-.+.......+.+.-+++++++|+.   .-+|+|    ||+..+ +..+.+||+....+....  .
T Consensus       320 rs~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~  386 (829)
T KOG0576|consen  320 RSSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--K  386 (829)
T ss_pred             ccccccCCh---hhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--c
Confidence             22111110   111233344455666677899999987   458888    777766 578999999987665543  3


Q ss_pred             eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCC
Q 015734          239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID  283 (401)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~  283 (401)
                      .....+|+.|+|||+...+.+....|.|++|.-..++--|.+|-.
T Consensus       387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            344568999999999999999999999999987777877777754

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.06  E-value=3.9e-05  Score=63.53  Aligned_cols=128  Identities=16%  Similarity=0.201  Sum_probs=87.0

Q ss_pred             CCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCC
Q 015734           80 SESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNL  159 (401)
Q Consensus        80 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  159 (401)
                      ...+.|++|.+|.||+|.+ .|..+|+|+-+.   +.....+..|.++|..+.-.++.+=+-.+   +.-.+.|||++|.
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~---ds~r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRR---DSPRRNLEKEAKILEILAGEGVTPEVYFY---GEDFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeec-cCceEEEEEecC---CcchhhHHHHHHHHHHhhhcCCCceEEEe---chhhhhhhhhcCc
Confidence            3456799999999999998 566899997653   44567899999999988877765533222   2223459999988


Q ss_pred             cHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCC--CceEEcCCCcEEEeecCCcc
Q 015734          160 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKA--ANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       160 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp--~Nill~~~~~~kl~Dfgl~~  229 (401)
                      .|.+.-..       .+..    -...++..-.-|...   ||-|+.|.-  .||++.+ +.+.|+||..++
T Consensus        98 ~L~~~~~~-------~~rk----~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~-~~~~iIDFd~At  154 (201)
T COG2112          98 PLGKLEIG-------GDRK----HLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVND-RDVYIIDFDSAT  154 (201)
T ss_pred             chhhhhhc-------ccHH----HHHHHHHHHHHHHHh---ccchhhhcCCceeEEecC-CcEEEEEccchh
Confidence            87654432       1112    223344544445555   888888864  4555554 489999999876

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.86  E-value=0.00019  Score=64.00  Aligned_cols=72  Identities=11%  Similarity=0.194  Sum_probs=43.6

Q ss_pred             CeeeecCcE-EEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCC---cccceeeeeecCC---eeEEEEec
Q 015734           83 NIIGQGGFG-KVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK---NLLQLIGYCTTSS---ERILVYPF  155 (401)
Q Consensus        83 ~~lG~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~---~~~lv~e~  155 (401)
                      +.++.|+.. .||+.    +..+++|....   ......+.+|.+.+..+...   .+.++++.....+   ..+++|++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~---~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA---AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc---cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            456766666 58875    23567776443   12345788999998877532   2344444433322   34789999


Q ss_pred             ccCCcH
Q 015734          156 MQNLSV  161 (401)
Q Consensus       156 ~~~gsL  161 (401)
                      ++|.++
T Consensus        76 i~G~~l   81 (235)
T cd05155          76 LEGETA   81 (235)
T ss_pred             ecCCCC
Confidence            988665

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=97.86  E-value=0.00044  Score=63.93  Aligned_cols=78  Identities=14%  Similarity=0.171  Sum_probs=56.2

Q ss_pred             CCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccC---CcccceeeeeecC---CeeEEEE
Q 015734           80 SESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH---KNLLQLIGYCTTS---SERILVY  153 (401)
Q Consensus        80 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~---~~~~lv~  153 (401)
                      ...+.||.|..+.||.....++ .+++|..+. .  .....+..|...++.+..   -.+.+++++|...   +..++||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~-~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQG-NPMPLMARS-F--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             heeeecCCccceeEEEEEcCCC-CEEEEEecc-c--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            3456799999999998876555 466676432 1  123578899999988753   3678888877543   5689999


Q ss_pred             ecccCCcH
Q 015734          154 PFMQNLSV  161 (401)
Q Consensus       154 e~~~~gsL  161 (401)
                      |++++.++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.80  E-value=0.00012  Score=76.43  Aligned_cols=198  Identities=18%  Similarity=0.189  Sum_probs=134.5

Q ss_pred             HHHHHHHHHHHhccCCcccceeeeeecCCee----EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 015734          119 AAFQREVHLISVAIHKNLLQLIGYCTTSSER----ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL  194 (401)
Q Consensus       119 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L  194 (401)
                      ....-|...+.+..|+|++.++.|..+.-..    .+..+++...++...+..    -..++..+.+.+..+...|++++
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHH
Confidence            3444566777888999999999887554322    234567777777777775    34588899999999999999999


Q ss_pred             HhcCCCCeEEeCCCCC---ceEEcCCCcEEEe--ecCCccccCCCCcceeccccCCcccccccccccCCCC--cccchhH
Q 015734          195 HEQCNPKIIHRDLKAA---NILLDDNFEAVLC--DFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS--EKTDVFG  267 (401)
Q Consensus       195 H~~~~~~i~H~dlkp~---Nill~~~~~~kl~--Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~sDi~s  267 (401)
                      |+.   ...|.-+..+   +--.+..+.+.++  ||+.+............  .-+..+.+||........  ...|+|+
T Consensus       303 h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~--~~~~~~~~~e~~~~~~~~~~r~~dL~~  377 (1351)
T KOG1035|consen  303 HSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSD--LLAEIRNADEDLKENTAKKSRLTDLWC  377 (1351)
T ss_pred             HHh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhh--cCccccccccccccccchhhhhhHHHH
Confidence            998   5666555555   4445566677777  89888766554333222  234567788877665544  3479999


Q ss_pred             HHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 015734          268 YGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQ  347 (401)
Q Consensus       268 lG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~  347 (401)
                      +|.+...+..|..+-.....                    ...+++..    ..   ..+.+....|+..++++|+++.+
T Consensus       378 lgll~~~~~~~~~i~~~~~~--------------------~~~~l~~~----~~---~~~~d~~~~~~~~~~~~Rl~~~~  430 (1351)
T KOG1035|consen  378 LGLLLLQLSQGEDISEKSAV--------------------PVSLLDVL----ST---SELLDALPKCLDEDSEERLSALE  430 (1351)
T ss_pred             HHHHHhhhhhcCcccccccc--------------------hhhhhccc----cc---hhhhhhhhhhcchhhhhccchhh
Confidence            99999999988765321110                    00111110    00   14556677899999999999999


Q ss_pred             HHHHh
Q 015734          348 VVKML  352 (401)
Q Consensus       348 vl~~L  352 (401)
                      ++.+.
T Consensus       431 ll~~~  435 (1351)
T KOG1035|consen  431 LLTHP  435 (1351)
T ss_pred             hhhch
Confidence            97754

>PRK05231 homoserine kinase; Provisional

Probab=97.75  E-value=0.0011  Score=62.12  Aligned_cols=157  Identities=15%  Similarity=0.121  Sum_probs=81.5

Q ss_pred             CHHHHHHHhcCCCC-----CCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCc--cccee
Q 015734           68 SCRELQLATDNFSE-----SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN--LLQLI  140 (401)
Q Consensus        68 ~~~~~~~~~~~~~~-----~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~  140 (401)
                      +..++......|.+     .+.++.|....+|+....+| .+++|+.. ...   ......|..++..+...+  +.+.+
T Consensus         8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~~~---~~~l~~~~~~l~~L~~~glpvP~~i   82 (319)
T PRK05231          8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE-RLT---AEDLPFFLGLMQHLAARGVPVPAPV   82 (319)
T ss_pred             CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec-cCC---hHHhHHHHHHHHHHHHCCCCCCcce
Confidence            33444443345544     34566777789999887555 68888765 222   233334555554443212  33333


Q ss_pred             ee------eecCCeeEEEEecccCCcHH-----------HHh---hhcCCC-------CCCCCH-HHHHH----------
Q 015734          141 GY------CTTSSERILVYPFMQNLSVA-----------YRL---RDLKPG-------EKGLDW-PTRKR----------  182 (401)
Q Consensus       141 ~~------~~~~~~~~lv~e~~~~gsL~-----------~~l---~~~~~~-------~~~l~~-~~~~~----------  182 (401)
                      ..      ....+..+++++|++|..+.           ..+   +.....       ...+.| .....          
T Consensus        83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (319)
T PRK05231         83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ  162 (319)
T ss_pred             eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence            21      12245568999999886421           111   111100       001111 11110          


Q ss_pred             --HHHH-HHHHHHHHHhc----CCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          183 --VAFG-TAYGLEYLHEQ----CNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       183 --i~~~-i~~~l~~LH~~----~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                        .+.+ +...+..+.+.    ...+++|+|+.|.||+++++...-|.||+.+.
T Consensus       163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence              1111 11122333211    23489999999999999977656899999875

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.67  E-value=0.0013  Score=58.54  Aligned_cols=73  Identities=16%  Similarity=0.151  Sum_probs=46.6

Q ss_pred             CeeeecCcEEEEEEEECC--CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCccc-ceeeeeecCCeeEEEEecccCC
Q 015734           83 NIIGQGGFGKVYKGVLSD--NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL-QLIGYCTTSSERILVYPFMQNL  159 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~g  159 (401)
                      +.|..|-...+|+....+  +..|++|+......  ......+|+.++..+...+++ ++++.+.    ..++|||++|.
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~--~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~   77 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE--LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR   77 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc--ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence            457778889999998654  67889997653211  112334688888877544443 3433322    24799999886


Q ss_pred             cH
Q 015734          160 SV  161 (401)
Q Consensus       160 sL  161 (401)
                      ++
T Consensus        78 ~l   79 (235)
T cd05157          78 TL   79 (235)
T ss_pred             cC
Confidence            64

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.64  E-value=0.00079  Score=57.63  Aligned_cols=126  Identities=24%  Similarity=0.322  Sum_probs=87.1

Q ss_pred             cCCCCCCeeeecCc-EEEEEEEECCCCEEEEEEecc--c---------CCc---------chHHHHHHHHHHHHhcc---
Q 015734           77 DNFSESNIIGQGGF-GKVYKGVLSDNTKVAVKRLQD--Y---------YSP---------GGEAAFQREVHLISVAI---  132 (401)
Q Consensus        77 ~~~~~~~~lG~G~~-g~V~~~~~~~~~~vavK~~~~--~---------~~~---------~~~~~~~~e~~~l~~l~---  132 (401)
                      .+++..+.||.|.- |.||++.. +|..+|+|.+..  .         ...         ...+.|..|-+...+++   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            78889999999999 99999998 678999999421  0         000         12235777887777664   


Q ss_pred             CCcc--cceeeeeecC------------------CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 015734          133 HKNL--LQLIGYCTTS------------------SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE  192 (401)
Q Consensus       133 h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~  192 (401)
                      +.++  ++.+||..-.                  ....+|.||.+...             .+....    +.++.+-|.
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~~----~~~~~~dl~  178 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIRD----IPQMLRDLK  178 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchhH----HHHHHHHHH
Confidence            4556  8888876221                  11346666665432             122222    345667788


Q ss_pred             HHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       193 ~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      .+|..   ||+-+|+++.|..     .-+|+|||.+
T Consensus       179 ~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            89998   9999999999985     3589999864

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.56  E-value=0.0045  Score=57.57  Aligned_cols=156  Identities=17%  Similarity=0.159  Sum_probs=85.3

Q ss_pred             HHHHHHhcCCCC-----CCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCc--ccceeee
Q 015734           70 RELQLATDNFSE-----SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN--LLQLIGY  142 (401)
Q Consensus        70 ~~~~~~~~~~~~-----~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~  142 (401)
                      +++...-+.|.+     .+.++.|....+|+....++ .+++|+.....+   ......|.+++..+....  +.+++..
T Consensus        10 ~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~---~~~i~~e~~~l~~L~~~g~pvp~~i~t   85 (307)
T TIGR00938        10 EEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK---AEELPFFLALTTHLAARGLPVPKPVKS   85 (307)
T ss_pred             HHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCCC---HHHHHHHHHHHHHHHHCCCCCCccccC
Confidence            444444444543     34567777789998876444 677887654222   234455666666654222  3444332


Q ss_pred             e------ecCCeeEEEEecccCCcHH-----------HH---hhhcCCC---C-C----CCCHHHHH------------H
Q 015734          143 C------TTSSERILVYPFMQNLSVA-----------YR---LRDLKPG---E-K----GLDWPTRK------------R  182 (401)
Q Consensus       143 ~------~~~~~~~lv~e~~~~gsL~-----------~~---l~~~~~~---~-~----~l~~~~~~------------~  182 (401)
                      .      ...+..+++++|++|..+.           ..   ++....+   . .    .-.|....            .
T Consensus        86 ~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~  165 (307)
T TIGR00938        86 RDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAH  165 (307)
T ss_pred             CCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHH
Confidence            1      2234568999999885421           11   1111110   0 0    01111100            0


Q ss_pred             HHHHHHHHHHHHHh----cCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          183 VAFGTAYGLEYLHE----QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       183 i~~~i~~~l~~LH~----~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ....+...++++..    ....+++|+|+.+.||++++++...|.||+.+.
T Consensus       166 ~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       166 MGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            01123334555542    223589999999999999998877899999864

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.56  E-value=0.0015  Score=58.94  Aligned_cols=138  Identities=12%  Similarity=0.038  Sum_probs=77.5

Q ss_pred             eeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCccc-ceeeeeecCCeeEEEEecccCCcHHH
Q 015734           85 IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL-QLIGYCTTSSERILVYPFMQNLSVAY  163 (401)
Q Consensus        85 lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gsL~~  163 (401)
                      +..|-.+.+|+... ++..+++|........ ......+|..+++.+....++ ++++.+.    ..+|++|++|..+..
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKA-LGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCccccc-ccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            45677889998874 5678888875432111 112356788888887644443 3333322    368999999865431


Q ss_pred             --------------H---hhhcCCCCCCCCHHH-HHHHHHHH---------HHHHHHHHhc-----CCCCeEEeCCCCCc
Q 015734          164 --------------R---LRDLKPGEKGLDWPT-RKRVAFGT---------AYGLEYLHEQ-----CNPKIIHRDLKAAN  211 (401)
Q Consensus       164 --------------~---l~~~~~~~~~l~~~~-~~~i~~~i---------~~~l~~LH~~-----~~~~i~H~dlkp~N  211 (401)
                                    .   ++.......+++... ...+..++         ...+..+-..     ....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence                          1   222221122222221 11111111         1112222111     12358999999999


Q ss_pred             eEEcCCCcEEEeecCCcc
Q 015734          212 ILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       212 ill~~~~~~kl~Dfgl~~  229 (401)
                      |++++++ +.+.||..+.
T Consensus       158 il~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             EEEeCCC-CEEEeccccC
Confidence            9999877 7899998775

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.50  E-value=0.0042  Score=57.38  Aligned_cols=143  Identities=16%  Similarity=0.132  Sum_probs=83.0

Q ss_pred             CCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCc--ccceeee------eecCCeeEEEE
Q 015734           82 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN--LLQLIGY------CTTSSERILVY  153 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~  153 (401)
                      .+.+..|....+|+.... +..+++|+...    .....+..|+.++..+.+.+  +.+++..      ....+..+.++
T Consensus        19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeC-CCcEEEEEcCC----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            445677877899998764 45788887654    22345667777777775332  4444332      12234567899


Q ss_pred             ecccCCcHHH--------------HhhhcCCC-C------CCCCHHHHH----------HHHHHHHHHHHHHHh----cC
Q 015734          154 PFMQNLSVAY--------------RLRDLKPG-E------KGLDWPTRK----------RVAFGTAYGLEYLHE----QC  198 (401)
Q Consensus       154 e~~~~gsL~~--------------~l~~~~~~-~------~~l~~~~~~----------~i~~~i~~~l~~LH~----~~  198 (401)
                      ++++|..+..              .++..... .      ....|....          .....+..++.++.+    ..
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9998865421              11111100 0      111221111          011122334444443    12


Q ss_pred             CCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       199 ~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ..+++|+|+.|.||++++++.+.|.||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            3479999999999999998777899998765

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.44  E-value=0.0057  Score=58.53  Aligned_cols=76  Identities=17%  Similarity=0.219  Sum_probs=52.8

Q ss_pred             CCeeeecCcEEEEEEEECCC-CEEEEEEecccC-----C-cchHHHHHHHHHHHHhcc---CCcccceeeeeecCCeeEE
Q 015734           82 SNIIGQGGFGKVYKGVLSDN-TKVAVKRLQDYY-----S-PGGEAAFQREVHLISVAI---HKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~~~-~~vavK~~~~~~-----~-~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~l  151 (401)
                      .+.||.|.++.||++...+| +.++||.-.+..     + +...+.+..|.+.|..+.   -.++.+++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            35689999999999998776 489999754211     1 224566777888887653   2346666655  3455789


Q ss_pred             EEecccCC
Q 015734          152 VYPFMQNL  159 (401)
Q Consensus       152 v~e~~~~g  159 (401)
                      |||++++.
T Consensus       109 VME~L~~~  116 (401)
T PRK09550        109 VMEDLSDH  116 (401)
T ss_pred             EEecCCCc
Confidence            99999864

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.34  E-value=0.0024  Score=59.25  Aligned_cols=141  Identities=25%  Similarity=0.234  Sum_probs=80.8

Q ss_pred             CeeeecCcEEEEEEEECC-------CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCccc-ceeeeeecCCeeEEEEe
Q 015734           83 NIIGQGGFGKVYKGVLSD-------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL-QLIGYCTTSSERILVYP  154 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e  154 (401)
                      +.+..|-...+|+....+       +..+++|+.....  .......+|.+++..+...++. ++++++.    ...|++
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e   77 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV--ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEE   77 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC--cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhh
Confidence            345667778999988654       5789999865422  2234556788888777543333 4444443    235889


Q ss_pred             cccCCcHHHH-----------------hhhcCCCC-----CCCC--HHHHHH--------------------------HH
Q 015734          155 FMQNLSVAYR-----------------LRDLKPGE-----KGLD--WPTRKR--------------------------VA  184 (401)
Q Consensus       155 ~~~~gsL~~~-----------------l~~~~~~~-----~~l~--~~~~~~--------------------------i~  184 (401)
                      |++|..+...                 ++......     ...+  +.....                          +.
T Consensus        78 ~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (302)
T cd05156          78 FIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFL  157 (302)
T ss_pred             eeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHH
Confidence            9887654321                 12111110     0011  111111                          11


Q ss_pred             HHHHHHHHHHHh------cCCCCeEEeCCCCCceEEcCC----CcEEEeecCCcc
Q 015734          185 FGTAYGLEYLHE------QCNPKIIHRDLKAANILLDDN----FEAVLCDFGLAK  229 (401)
Q Consensus       185 ~~i~~~l~~LH~------~~~~~i~H~dlkp~Nill~~~----~~~kl~Dfgl~~  229 (401)
                      ..+...+..+-.      .....++|+|+.+.||+++++    +.+.++||..+.
T Consensus       158 ~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         158 EDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            122223334432      134579999999999999985    889999998874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.28  E-value=5.8e-05  Score=80.61  Aligned_cols=164  Identities=11%  Similarity=-0.021  Sum_probs=118.3

Q ss_pred             HHHHHHHHHHHHhccCCcccceeeeee--cCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 015734          118 EAAFQREVHLISVAIHKNLLQLIGYCT--TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH  195 (401)
Q Consensus       118 ~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH  195 (401)
                      .+....|.+.++...|+++.....-..  ...+.+.+++++.+|.+...+.......+++..........+......-+|
T Consensus      1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred             HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence            344555666667778988766543322  233557889999999999988765444444444444444444455566655


Q ss_pred             hcC--CCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHH
Q 015734          196 EQC--NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLL  273 (401)
Q Consensus       196 ~~~--~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~  273 (401)
                      +..  +.-.+|+++|+-|.+|..+-+++++++|+.+..+.. ....+...+++-|+.|+..+.-.++.++|+|..|+.+|
T Consensus      1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred             hcccCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence            542  234789999999999999999999999999843332 22334456788899999998888999999999999999


Q ss_pred             HHHhCCCCC
Q 015734          274 ELVTGQRAI  282 (401)
Q Consensus       274 elltg~~p~  282 (401)
                      +..-|..+|
T Consensus      1432 ~rs~~n~~f 1440 (2724)
T KOG1826|consen 1432 LRSDGNAYF 1440 (2724)
T ss_pred             HHhcccHHH
Confidence            999888776

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.13  E-value=0.0083  Score=55.41  Aligned_cols=147  Identities=17%  Similarity=0.208  Sum_probs=81.1

Q ss_pred             CeeeecCcEEEEEEEECCCCEEEEEEecc-cCCcchHHHHHHHHHHHHhccC--CcccceeeeeecCC--eeEEEEeccc
Q 015734           83 NIIGQGGFGKVYKGVLSDNTKVAVKRLQD-YYSPGGEAAFQREVHLISVAIH--KNLLQLIGYCTTSS--ERILVYPFMQ  157 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~e~~~  157 (401)
                      +.+..|....+|.... ++++++++ ... ...........+|+.+++.+.-  .-+...++.|.+..  ..+.||+|++
T Consensus        31 ~~~~~G~sn~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve  108 (321)
T COG3173          31 EEISGGWSNDTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE  108 (321)
T ss_pred             eeccCCcccceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence            3343344444555544 37788887 331 2233345566778888877642  23445566776665  6689999998


Q ss_pred             CCcHHH------------------Hhhhc---CCCC-------------CCCCHHHHHHHH--------HHHHHHHHHHH
Q 015734          158 NLSVAY------------------RLRDL---KPGE-------------KGLDWPTRKRVA--------FGTAYGLEYLH  195 (401)
Q Consensus       158 ~gsL~~------------------~l~~~---~~~~-------------~~l~~~~~~~i~--------~~i~~~l~~LH  195 (401)
                      |..+..                  .|...   ....             +...|....+.+        -....-..+|+
T Consensus       109 Ge~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~  188 (321)
T COG3173         109 GEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE  188 (321)
T ss_pred             ceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence            843221                  11111   0000             000011111000        01122234444


Q ss_pred             hcC-----CCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          196 EQC-----NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       196 ~~~-----~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      .+.     .+.++|+|+.+.|++++.++.+=+.||+++..-
T Consensus       189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            332     356999999999999999988999999998643

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.08  E-value=0.00095  Score=60.79  Aligned_cols=135  Identities=18%  Similarity=0.119  Sum_probs=89.3

Q ss_pred             CCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccc---------------------CCcchHHHHHHHHHHHHhcc-CCc
Q 015734           78 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY---------------------YSPGGEAAFQREVHLISVAI-HKN  135 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~---------------------~~~~~~~~~~~e~~~l~~l~-h~n  135 (401)
                      -++.++.||-|--+-+|.+.+.+|++.++|.-+-.                     +---..-...+|+..|+.+. |-.
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            46778999999999999999989999998843100                     00011234566777777664 322


Q ss_pred             -ccceeeeeecCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEE
Q 015734          136 -LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL  214 (401)
Q Consensus       136 -iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill  214 (401)
                       +.+.+    +.+.-++|||++.+..|...-+       ..+.+++.   ..+..-+.-|..+   |+||+|..-=||++
T Consensus       173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~-------v~d~~~ly---~~lm~~Iv~la~~---GlIHgDFNEFNimv  235 (465)
T KOG2268|consen  173 PVPKPI----DHNRHCVVMELVDGYPLRQVRH-------VEDPPTLY---DDLMGLIVRLANH---GLIHGDFNEFNIMV  235 (465)
T ss_pred             CCCCcc----cccceeeHHHhhcccceeeeee-------cCChHHHH---HHHHHHHHHHHHc---CceecccchheeEE
Confidence             33333    3345588999998876543221       12223332   2333334455566   99999999999999


Q ss_pred             cCCCcEEEeecCCcc
Q 015734          215 DDNFEAVLCDFGLAK  229 (401)
Q Consensus       215 ~~~~~~kl~Dfgl~~  229 (401)
                      ++++.++++||--..
T Consensus       236 ~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  236 KDDDKIVVIDFPQMV  250 (465)
T ss_pred             ecCCCEEEeechHhh
Confidence            999999999997644

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.03  E-value=0.0062  Score=55.76  Aligned_cols=74  Identities=15%  Similarity=0.236  Sum_probs=47.8

Q ss_pred             CCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhcc---CCcccceeeeeecCCeeEEEEeccc
Q 015734           81 ESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI---HKNLLQLIGYCTTSSERILVYPFMQ  157 (401)
Q Consensus        81 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~  157 (401)
                      ..+.++.|....+|+.. .+++.+.+|.-..    .....|..|..-|+.+.   --.+.+++++....+..++++||++
T Consensus        21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSE----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeEecCCCChhheEEEE-CCCccEEEEecCh----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            34567889999999877 5788899997652    23456888888888773   3457788888877777899999998


Q ss_pred             CC
Q 015734          158 NL  159 (401)
Q Consensus       158 ~g  159 (401)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            76

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.93  E-value=0.015  Score=54.06  Aligned_cols=141  Identities=18%  Similarity=0.227  Sum_probs=93.0

Q ss_pred             CCCeeeecCcEEEEEEEECCCCEEEEEEeccc--------------------CCcch-----HHHHHHHHHHHHhccCCc
Q 015734           81 ESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY--------------------YSPGG-----EAAFQREVHLISVAIHKN  135 (401)
Q Consensus        81 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~--------------------~~~~~-----~~~~~~e~~~l~~l~h~n  135 (401)
                      +...|..|--+.||.+...+|..+|||+.+..                    +....     ..-..+|++-|.++....
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            34567889999999999889999999987531                    00111     112345666666665433


Q ss_pred             ccceeeeeecCCeeEEEEecccCCc-HHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEE
Q 015734          136 LLQLIGYCTTSSERILVYPFMQNLS-VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL  214 (401)
Q Consensus       136 iv~~~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill  214 (401)
                      |...--...  ..-.|||+|+..-. -.-.|.+     -.++...+..+-.+++.-|.-|...|  ++||.||.--|+|+
T Consensus       228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd-----~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly  298 (520)
T KOG2270|consen  228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKLKD-----ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY  298 (520)
T ss_pred             CCCCCceee--ecceEeeeeccCCCCcCccccc-----ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence            221110000  12378999995321 1122322     34667778888889999999998887  89999999999999


Q ss_pred             cCCCcEEEeecCCcccc
Q 015734          215 DDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       215 ~~~~~~kl~Dfgl~~~~  231 (401)
                      -+ |.+.++|.+-+...
T Consensus       299 hd-G~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  299 HD-GKLYIIDVSQSVEH  314 (520)
T ss_pred             EC-CEEEEEEccccccC
Confidence            65 57999998876543

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.84  E-value=0.019  Score=52.43  Aligned_cols=30  Identities=33%  Similarity=0.548  Sum_probs=25.2

Q ss_pred             CCeEEeCCCCCceEEcCCCc-EEEeecCCcc
Q 015734          200 PKIIHRDLKAANILLDDNFE-AVLCDFGLAK  229 (401)
Q Consensus       200 ~~i~H~dlkp~Nill~~~~~-~kl~Dfgl~~  229 (401)
                      +.++|+|+.|.||++++++. .-|.||+.+.
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~  215 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAK  215 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence            45899999999999997555 4699999875

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.57  E-value=0.066  Score=49.73  Aligned_cols=29  Identities=34%  Similarity=0.464  Sum_probs=25.2

Q ss_pred             CCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          200 PKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       200 ~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      .+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47999999999999988 578999998654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02236 choline kinase

Probab=96.39  E-value=0.06  Score=50.90  Aligned_cols=140  Identities=16%  Similarity=0.156  Sum_probs=78.3

Q ss_pred             eeeecCcEEEEEEEECC-----CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCccc-ceeeeeecCCeeEEEEeccc
Q 015734           84 IIGQGGFGKVYKGVLSD-----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL-QLIGYCTTSSERILVYPFMQ  157 (401)
Q Consensus        84 ~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~  157 (401)
                      .|-.|-...+|++...+     +..|++|+..... . ..-.-.+|..++..+..-++. ++++.+..+    .|.+|++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-E-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-C-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            44457788899987532     3678888775432 2 222236788888877655544 444544322    5788887


Q ss_pred             CCcHHHH-----------------hhhcCCCC-C-CCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 015734          158 NLSVAYR-----------------LRDLKPGE-K-GLDWPTRKRVAFGT-----------------AYGLEYL----HE-  196 (401)
Q Consensus       158 ~gsL~~~-----------------l~~~~~~~-~-~l~~~~~~~i~~~i-----------------~~~l~~L----H~-  196 (401)
                      +.++...                 ++...... . ...+..+..+..++                 ...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            7664311                 12211111 1 12233333332211                 1112222    21 


Q ss_pred             cCCCCeEEeCCCCCceEEcC-CCcEEEeecCCcc
Q 015734          197 QCNPKIIHRDLKAANILLDD-NFEAVLCDFGLAK  229 (401)
Q Consensus       197 ~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfgl~~  229 (401)
                      .....++|+|+++.||++++ ++.+.++||..+.
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            11236899999999999986 4689999998765

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.37  E-value=0.024  Score=49.07  Aligned_cols=152  Identities=14%  Similarity=0.110  Sum_probs=88.3

Q ss_pred             cCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCCcHHHHhhh
Q 015734           88 GGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD  167 (401)
Q Consensus        88 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  167 (401)
                      |+.++.-.+..+- .+..+|+++...-.-...-|..+.++++++.  .|+++..-  +.-...++.|.|-...       
T Consensus        73 ~gNsTl~~~kt~i-G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-------  140 (308)
T PF07387_consen   73 NGNSTLLIGKTKI-GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-------  140 (308)
T ss_pred             CCceEEEEecccc-chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-------
Confidence            3444444444322 3456666654322223456778888888764  45666521  3335568888885321       


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcceeccccCCcc
Q 015734          168 LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG  247 (401)
Q Consensus       168 ~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~  247 (401)
                               ....-.|..+ +.+|.-.|+. ..+.+|+|-.|+||+-|..|.+||.|-+.--  .           .+.-
T Consensus       141 ---------i~~~N~i~ag-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~-----------~~V~  196 (308)
T PF07387_consen  141 ---------INFSNFITAG-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--E-----------NQVN  196 (308)
T ss_pred             ---------cchhHHHHHh-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhh--h-----------heee
Confidence                     1111222222 3567788865 3489999999999999999999999976532  0           1112


Q ss_pred             cccccccccCCCCcccchhHHHHHHHHHHhC
Q 015734          248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTG  278 (401)
Q Consensus       248 y~aPE~~~~~~~~~~sDi~slG~ll~elltg  278 (401)
                      |.--   .....+.++.+-+|=.-++++...
T Consensus       197 ~vN~---~Y~~lT~~aE~~~fv~s~l~~v~~  224 (308)
T PF07387_consen  197 MVNI---EYESLTQEAEVKVFVKSCLKLVEK  224 (308)
T ss_pred             EEee---eccccChHHHHHHHHHHHHHHHHH
Confidence            2221   133446677777766666666553

The function of this family is unknown.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.36  E-value=0.069  Score=50.23  Aligned_cols=74  Identities=15%  Similarity=0.122  Sum_probs=46.9

Q ss_pred             eeeecCcEEEEEEEECCC-CEEEEEEeccc------CCcchHHHHHHHHHHHHhcc--CCcccceeeeeecCCeeEEEEe
Q 015734           84 IIGQGGFGKVYKGVLSDN-TKVAVKRLQDY------YSPGGEAAFQREVHLISVAI--HKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        84 ~lG~G~~g~V~~~~~~~~-~~vavK~~~~~------~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      .+|.|....||++..++| +.|+||.-.+.      .-+-..+...-|...|....  -|..++-+ ++.+.....++||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~v-y~~D~e~~~~vME   80 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRI-FHFDTEMAVTVME   80 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeE-EEEccccceehHh
Confidence            479999999999997654 58999965421      11334455566777776543  35444433 2334455578999


Q ss_pred             cccC
Q 015734          155 FMQN  158 (401)
Q Consensus       155 ~~~~  158 (401)
                      +++.
T Consensus        81 dL~~   84 (370)
T TIGR01767        81 DLSH   84 (370)
T ss_pred             hCcc
Confidence            8865

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.27  E-value=0.059  Score=50.11  Aligned_cols=30  Identities=20%  Similarity=0.368  Sum_probs=27.3

Q ss_pred             CCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          200 PKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       200 ~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      .+++|+|+.++|++++.++.+.++||..+.
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            479999999999999999999999998775

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.23  E-value=0.27  Score=45.95  Aligned_cols=141  Identities=18%  Similarity=0.214  Sum_probs=80.1

Q ss_pred             eeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccC---Ccccc---eeee--eecC--CeeEEEE
Q 015734           84 IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH---KNLLQ---LIGY--CTTS--SERILVY  153 (401)
Q Consensus        84 ~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~---~~~~--~~~~--~~~~lv~  153 (401)
                      .|.+ .-..+|+....+|+. ++|+....   ....++..|...+..+.-   +=.++   .-|-  ..-.  ....-++
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~---~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf  107 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG---WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF  107 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC---CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence            3444 567789888866666 88877653   234556666666665532   22222   1111  1112  2567889


Q ss_pred             ecccCCcHHH---------------Hhh----hcC----CCCCCCCHHH----H---------HHHHHHHHHHHHHHHhc
Q 015734          154 PFMQNLSVAY---------------RLR----DLK----PGEKGLDWPT----R---------KRVAFGTAYGLEYLHEQ  197 (401)
Q Consensus       154 e~~~~gsL~~---------------~l~----~~~----~~~~~l~~~~----~---------~~i~~~i~~~l~~LH~~  197 (401)
                      +|++|..+..               .|+    ++.    .......|..    .         .....++...+..+.+.
T Consensus       108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~  187 (331)
T COG2334         108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR  187 (331)
T ss_pred             EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence            9999877662               011    111    0011223321    0         11233444455555543


Q ss_pred             C----CCC---eEEeCCCCCceEEcCCCc-EEEeecCCcc
Q 015734          198 C----NPK---IIHRDLKAANILLDDNFE-AVLCDFGLAK  229 (401)
Q Consensus       198 ~----~~~---i~H~dlkp~Nill~~~~~-~kl~Dfgl~~  229 (401)
                      .    ...   +||+|+.|.||+++.+.. +.+.||+-+.
T Consensus       188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            2    223   899999999999999885 8899999875

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.21  E-value=0.15  Score=48.81  Aligned_cols=74  Identities=12%  Similarity=0.147  Sum_probs=48.9

Q ss_pred             CCeeeecCcEEEEEEEECCCCEEEEEEecccC---Cc---chHHHHHHHHHHHHhcc---CCcccceeeeeecCCeeEEE
Q 015734           82 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY---SP---GGEAAFQREVHLISVAI---HKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~---~~---~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv  152 (401)
                      .+.||.|....||+.... +..++||.-....   +.   .....-..|...|..+.   -.++.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            457899999999998874 5578899765211   11   13334445566665543   246777887776  445788


Q ss_pred             EecccC
Q 015734          153 YPFMQN  158 (401)
Q Consensus       153 ~e~~~~  158 (401)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.01  E-value=0.43  Score=44.73  Aligned_cols=72  Identities=14%  Similarity=0.095  Sum_probs=43.6

Q ss_pred             ecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCc--cccee---e--eeecCCeeEEEEecccCC
Q 015734           87 QGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN--LLQLI---G--YCTTSSERILVYPFMQNL  159 (401)
Q Consensus        87 ~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~---~--~~~~~~~~~lv~e~~~~g  159 (401)
                      .+.-..||+....++..+++|..+...  .....+..|.+.+..+....  ++...   |  ....++..+.++++++|.
T Consensus        35 ~s~eN~vy~v~~~~~~~~vlKv~r~~~--~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~  112 (325)
T PRK11768         35 NSYENRVYQFGDEDGRRVVAKFYRPER--WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGR  112 (325)
T ss_pred             ccccceEEEEecCCCCEEEEEEcCccc--CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCC
Confidence            455678999988778889999875322  23456667777776553211  22211   1  112234567789998875


Q ss_pred             c
Q 015734          160 S  160 (401)
Q Consensus       160 s  160 (401)
                      .
T Consensus       113 ~  113 (325)
T PRK11768        113 A  113 (325)
T ss_pred             C
Confidence            4

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.97  E-value=0.074  Score=49.98  Aligned_cols=141  Identities=15%  Similarity=0.162  Sum_probs=77.1

Q ss_pred             CeeeecCcEEEEEEEECC----CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCccc-ceeeeeecCCeeEEEEeccc
Q 015734           83 NIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL-QLIGYCTTSSERILVYPFMQ  157 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~  157 (401)
                      +.|..|-...+|+....+    +..|++|+......  ..-.-.+|..+++.+..-++. ++++++.  +.  +|.+|++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~IdR~~E~~il~~l~~~gl~P~~l~~~~--~G--~i~~fi~   93 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--YVIDRERELQAIKYLSAAGFGAKLLGVFG--NG--MIQSFIN   93 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--eEechHHHHHHHHHHHhcCCCCceeEEeC--Cc--Eeehhhc
Confidence            345557778889887543    23788887754221  222335788888877655553 4455542  22  4888887


Q ss_pred             CCcHHH--------------H---hhhcCCC-CC-CCCHHHHHHHHHHH----------------------HHHHHH---
Q 015734          158 NLSVAY--------------R---LRDLKPG-EK-GLDWPTRKRVAFGT----------------------AYGLEY---  193 (401)
Q Consensus       158 ~gsL~~--------------~---l~~~~~~-~~-~l~~~~~~~i~~~i----------------------~~~l~~---  193 (401)
                      +.++..              .   ++..... .. +-.+..+..+..++                      ..-+..   
T Consensus        94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~  173 (330)
T PLN02421         94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE  173 (330)
T ss_pred             CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence            665421              1   1221111 11 11233333222221                      111111   


Q ss_pred             -HHhc-CCCCeEEeCCCCCceEEcC-CCcEEEeecCCcc
Q 015734          194 -LHEQ-CNPKIIHRDLKAANILLDD-NFEAVLCDFGLAK  229 (401)
Q Consensus       194 -LH~~-~~~~i~H~dlkp~Nill~~-~~~~kl~Dfgl~~  229 (401)
                       +.+. ...-++|.|+.+.||++++ ++.++++||..+.
T Consensus       174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence             1111 1124799999999999974 5789999998874

>PRK06148 hypothetical protein; Provisional

Probab=95.94  E-value=0.15  Score=55.29  Aligned_cols=153  Identities=16%  Similarity=0.199  Sum_probs=80.9

Q ss_pred             HHHhcCCCCC---CeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhcc-------CCcccceee-
Q 015734           73 QLATDNFSES---NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-------HKNLLQLIG-  141 (401)
Q Consensus        73 ~~~~~~~~~~---~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-------h~niv~~~~-  141 (401)
                      ++....|.+.   +.|+ |..-.+|+....+|..+++|+.+....   ......|...+..+.       -|.+++-.+ 
T Consensus        18 ~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~---~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G   93 (1013)
T PRK06148         18 ALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSEP---RVESDFQTAALDHLAAVAPDLPVPRLIPSLSG   93 (1013)
T ss_pred             HHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCccc---hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCC
Confidence            3444555542   3454 456888998877788999999875332   223334444554332       223332211 


Q ss_pred             ----eeec-CC--eeEEEEecccCCcHHHH---------------------hhhcCC--CCCCCCHHH------------
Q 015734          142 ----YCTT-SS--ERILVYPFMQNLSVAYR---------------------LRDLKP--GEKGLDWPT------------  179 (401)
Q Consensus       142 ----~~~~-~~--~~~lv~e~~~~gsL~~~---------------------l~~~~~--~~~~l~~~~------------  179 (401)
                          .... .+  ..+-+++|++|..+.+.                     +.++..  ....+.|..            
T Consensus        94 ~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~  173 (1013)
T PRK06148         94 ASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHF  173 (1013)
T ss_pred             CeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhh
Confidence                1111 22  35678999998766431                     111111  011122221            


Q ss_pred             -----HHHHHHHHHHHHHH----HHhcCCCCeEEeCCCCCceEEcCCC--cEE-EeecCCcc
Q 015734          180 -----RKRVAFGTAYGLEY----LHEQCNPKIIHRDLKAANILLDDNF--EAV-LCDFGLAK  229 (401)
Q Consensus       180 -----~~~i~~~i~~~l~~----LH~~~~~~i~H~dlkp~Nill~~~~--~~k-l~Dfgl~~  229 (401)
                           .+.++.++.....-    .-.....++||+|+.+.||+++.++  ++. |.|||.+.
T Consensus       174 i~d~~~r~~l~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        174 IDDPEDRALVERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence                 12222233222221    1112234799999999999999875  555 99999875

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.73  E-value=0.12  Score=45.15  Aligned_cols=75  Identities=12%  Similarity=0.135  Sum_probs=52.5

Q ss_pred             CeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccC---CcccceeeeeecCCeeEEEEecccCC
Q 015734           83 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH---KNLLQLIGYCTTSSERILVYPFMQNL  159 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~~~~~lv~e~~~~g  159 (401)
                      +.+.-|.--..|...+ +..++.+|.=.    ......|..|+.-|..+.-   -++.+++.+....+..++|++|++-+
T Consensus        22 ~~v~gG~inea~~v~d-g~~~~FvK~n~----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~   96 (286)
T COG3001          22 EEVSGGDINEAWRLRD-GTDPFFVKCNQ----REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG   96 (286)
T ss_pred             cccCCccccceeEeec-CCcceEEEecc----hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence            3455555566665554 56788888532    2345678888877766643   55788888888899999999999976


Q ss_pred             cHH
Q 015734          160 SVA  162 (401)
Q Consensus       160 sL~  162 (401)
                      .+.
T Consensus        97 ~~d   99 (286)
T COG3001          97 PLD   99 (286)
T ss_pred             CCC
Confidence            543

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.67  E-value=0.053  Score=47.32  Aligned_cols=29  Identities=38%  Similarity=0.532  Sum_probs=21.0

Q ss_pred             CeEEeCCCCCceEE-cCCCcEEEeecCCcc
Q 015734          201 KIIHRDLKAANILL-DDNFEAVLCDFGLAK  229 (401)
Q Consensus       201 ~i~H~dlkp~Nill-~~~~~~kl~Dfgl~~  229 (401)
                      .++|.|+.|.||++ +.++.++++||..+.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            58899999999999 889999999998875

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK12396 5-methylribose kinase; Reviewed

Probab=94.89  E-value=0.22  Score=47.50  Aligned_cols=76  Identities=18%  Similarity=0.179  Sum_probs=48.9

Q ss_pred             CCeeeecCcEEEEEEEECC-CCEEEEEEecccC-----CcchHHHHHHHHHHHHhcc--CCcccceeeeeecCCeeEEEE
Q 015734           82 SNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYY-----SPGGEAAFQREVHLISVAI--HKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~  153 (401)
                      .+.||.|.-..||++...+ ++.|+||.-.+..     -+-..+...-|.+.|+...  -|..++-+ ++.+.....+||
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~v-y~~D~e~~~~vM  112 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKV-YLFDSVMNCCVM  112 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeE-EEECcHHhhHHH
Confidence            4578999999999999743 5679999653211     1334566677777777653  35444433 233445557888


Q ss_pred             ecccC
Q 015734          154 PFMQN  158 (401)
Q Consensus       154 e~~~~  158 (401)
                      |+++.
T Consensus       113 EdL~~  117 (409)
T PRK12396        113 EDLSD  117 (409)
T ss_pred             HhCcc
Confidence            88854

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=94.61  E-value=0.17  Score=45.47  Aligned_cols=77  Identities=14%  Similarity=0.029  Sum_probs=50.9

Q ss_pred             CeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEeccc-CCcH
Q 015734           83 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQ-NLSV  161 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~gsL  161 (401)
                      ..+..|..+.|+.+...+|.+.++|+..+....  ..+ ......|+..+-...|++++.-  .....+++|.+. +.+|
T Consensus         8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~--~~E-~~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~~L   82 (253)
T PF04655_consen    8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEA--EHE-ARGEAALRWWNGRGAVRLLAAD--PERGALLLERLDPGRSL   82 (253)
T ss_pred             CCCCCCcceEEEEEEcCCCCeEEEEecCCcccc--hhh-hhHHhHhheeCCCCceeeeccc--cccchhhhhhccCCCch
Confidence            445678999999999889999999987642211  111 1122557777778888988754  334567788884 4455


Q ss_pred             HHH
Q 015734          162 AYR  164 (401)
Q Consensus       162 ~~~  164 (401)
                      .+.
T Consensus        83 ~~~   85 (253)
T PF04655_consen   83 ASL   85 (253)
T ss_pred             hhc
Confidence            443

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.54  E-value=0.21  Score=46.75  Aligned_cols=84  Identities=18%  Similarity=0.229  Sum_probs=60.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcceeccccCCccccccccc
Q 015734          175 LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL  254 (401)
Q Consensus       175 l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~  254 (401)
                      ..+.+...|+.+.+.-++-+..+.  ..-|||+.-.||||+ +|++-|+||-+++.-... .....     ...--|-.+
T Consensus       318 ~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl~~~q-~~isy-----~rldhp~lF  388 (488)
T COG5072         318 DRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRLSYSQ-GIISY-----NRLDHPDLF  388 (488)
T ss_pred             ccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeecccCC-ceeec-----cccCchhhh
Confidence            567889999999999898888876  789999999999999 999999999999843221 11111     122234445


Q ss_pred             ccCCCCcccchhHH
Q 015734          255 STGKSSEKTDVFGY  268 (401)
Q Consensus       255 ~~~~~~~~sDi~sl  268 (401)
                      .| .-+.+-|||-+
T Consensus       389 ~G-~dd~QFeIYrl  401 (488)
T COG5072         389 NG-VDDYQFEIYRL  401 (488)
T ss_pred             cC-ccceeeeHHHH
Confidence            43 33667777764

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=94.50  E-value=0.1  Score=50.81  Aligned_cols=49  Identities=16%  Similarity=0.245  Sum_probs=37.5

Q ss_pred             HHHHHHHHHHHHhccCCcccceeeeeecCC-eeEEEEecccCCcHHHHhhh
Q 015734          118 EAAFQREVHLISVAIHKNLLQLIGYCTTSS-ERILVYPFMQNLSVAYRLRD  167 (401)
Q Consensus       118 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~  167 (401)
                      ..++.-...+++.+.|+|+...+++..... ...+|+|++ +.||.+.+..
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~   75 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT   75 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence            345666788889999999999998876554 356788888 6688887765

>PF02439 Adeno_E3_CR2: Adenovirus E3 region protein CR2; InterPro: IPR003470 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host []

Probab=94.37  E-value=0.029  Score=33.32  Aligned_cols=23  Identities=26%  Similarity=0.537  Sum_probs=11.0

Q ss_pred             HHHHHHHHHHHHHHHHHHHHhhh
Q 015734           20 SCGAFVLLSLGALFACRYQKLRK   42 (401)
Q Consensus        20 ~~~~~~~~~~~~~~~~~~~~~~~   42 (401)
                      ++|+++++...+++.|+|||.++
T Consensus        13 ~vg~~iiii~~~~YaCcykk~~~   35 (38)
T PF02439_consen   13 VVGMAIIIICMFYYACCYKKHRR   35 (38)
T ss_pred             HHHHHHHHHHHHHHHHHHccccc
Confidence            33444443334444566666553

This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D adenovirus) 49 kDa protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	401
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-108
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-105
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-42
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-42
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		8e-42
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-40
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-40
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-38
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-22
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-20
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-20
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-20
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-20
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		8e-20
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		8e-20
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		8e-20
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		8e-20
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		8e-20
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		9e-20
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		9e-20
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-19
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-19
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-19
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-19
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-19
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		7e-19
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		8e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-18
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-18
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-18
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-18
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-18
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-18
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-18
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-18
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-18
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-18
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-18
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-18
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-18
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-18
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		6e-18
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-18
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-18
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-18
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		9e-18
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		9e-18
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-17
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-17
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-17
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-17
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-17
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-17
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-17
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-17
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		9e-17
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-16
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		8e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-15
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-15
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-15
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-15
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-15
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-15
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-15
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-15
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-15
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-15
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-15
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-15
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-15
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-15
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-15
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-15
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-15
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-15
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-15
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-15
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-15
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-15
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-15
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-14
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-14
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-14
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-14
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-14
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-14
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-14
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-14
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		7e-14
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-14
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		7e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		7e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		7e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-14
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		8e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		8e-14
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		8e-14
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		9e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-13
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-13
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-13
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		7e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		8e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		8e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		8e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		8e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		9e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		9e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		9e-13
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		9e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		9e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		9e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-12
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-12
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-12
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-12
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		5e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		6e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-12
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		6e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		6e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		6e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		6e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		7e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		7e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		7e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		7e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		7e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		8e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		8e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		8e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		8e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		9e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		9e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		9e-12
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		9e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-11
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-11
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-11
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-11
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-11
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-11
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		5e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		5e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		5e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		7e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-11
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		8e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		8e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		8e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		8e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		8e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		8e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		8e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		9e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		9e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		9e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		9e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		9e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		9e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		9e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-10
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-10
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-10
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-10
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-10
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-10
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-10
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-10
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-10
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-10
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-10
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-10
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		6e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-10
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		6e-10
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		7e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		8e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		8e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		8e-10
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		8e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		9e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		9e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		9e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		9e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-09
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-09
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-09
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-09
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-09
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-09
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-09
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-09
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-09
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-09
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-09
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-09
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-09
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-09
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-09
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-09
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-09
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-09
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-09
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		6e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-09
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		8e-09
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-09
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		8e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		9e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-08
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-08
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-08
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-08
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-08
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-08
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-08
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-08
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-08
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		5e-08
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		6e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		6e-08
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		6e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		6e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		6e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		6e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		6e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		6e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		6e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-08
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		7e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		7e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		7e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		8e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		8e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		8e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-08
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		8e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		8e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		9e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		9e-08
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		9e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		9e-08
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		9e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		9e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		9e-08
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		9e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-07
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-07
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-07
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-07
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-07
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-07
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-07
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-07
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-07
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-07
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		5e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		6e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		6e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-07
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		7e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		7e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		7e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		7e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		7e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		7e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		8e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		8e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		8e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		8e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		8e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		8e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		8e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		8e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		9e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		9e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-06
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-06
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-06
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-06
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-06
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		5e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-06
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		6e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		7e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		7e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		7e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		8e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		8e-06
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		9e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		9e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-05
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-05
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-05
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-05
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-05
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-05
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-05
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-05
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-05
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-05
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-05
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-05
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-05
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-05
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-05
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-05
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-05
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-05
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-05
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-05
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-05
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-05
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-05
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-05
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-05
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-05
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-05
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-05
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-05
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-05
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-05
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-05
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		6e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		6e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-05
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		7e-05
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		7e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		7e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		7e-05
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		8e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-04
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-04
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-04
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-04
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-04
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-04
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-04
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-04
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-04
3soa_A	444	Full-Length Human Camkii Length = 444		5e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		6e-04
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-04
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		7e-04
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		8e-04
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		8e-04
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  388 bits (997), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 188/316 (59%), Positives = 239/316 (75%), Gaps = 1/316 (0%)
Query: 41  RKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSD 100
           RK   D FFDV  E+D +V L QL+RFS RELQ+A+DNFS  NI+G+GGFGKVYKG L+D
Sbjct: 2   RKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD 61
Query: 101 NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS 160
            T VAVKRL++    GGE  FQ EV +IS+A+H+NLL+L G+C T +ER+LVYP+M N S
Sbjct: 62  GTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 121
Query: 161 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA 220
           VA  LR+    +  LDWP R+R+A G+A GL YLH+ C+PKIIHRD+KAANILLD+ FEA
Sbjct: 122 VASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 181
Query: 221 VLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 280
           V+ DFGLAKL+D K  HV   +RGT+GHIAPEYLSTGKSSEKTDVFGYG+ LLEL+TGQR
Sbjct: 182 VVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 241
Query: 281 AIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLN-TYDSKEVETMVQVALLCTQSTP 339
           A D +R            ++ LL+E +L  +VD +L   Y  +EVE ++QVALLCTQS+P
Sbjct: 242 AFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSP 301
Query: 340 EDRPPMAQVVKMLQGE 355
            +RP M++VV+ML+G+
Sbjct: 302 MERPKMSEVVRMLEGD 317

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  379 bits (974), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 182/309 (58%), Positives = 234/309 (75%), Gaps = 1/309 (0%)
Query: 48  FFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVK 107
           FFDV  E+D +V L QL+RFS RELQ+A+DNF   NI+G+GGFGKVYKG L+D   VAVK
Sbjct: 1   FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVK 60
Query: 108 RLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD 167
           RL++  + GGE  FQ EV +IS+A+H+NLL+L G+C T +ER+LVYP+M N SVA  LR+
Sbjct: 61  RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 168 LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 227
               +  LDWP R+R+A G+A GL YLH+ C+PKIIHRD+KAANILLD+ FEAV+ DFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 228 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRX 287
           AKL+D K  HV   +RG +GHIAPEYLSTGKSSEKTDVFGYG+ LLEL+TGQRA D +R 
Sbjct: 181 AKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 288 XXXXXXXXXXHIRKLLREDRLNDIVDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMA 346
                      ++ LL+E +L  +VD +L   Y  +EVE ++QVALLCTQS+P +RP M+
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300
Query: 347 QVVKMLQGE 355
           +VV+ML+G+
Sbjct: 301 EVVRMLEGD 309

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 111/306 (36%), Positives = 170/306 (55%), Gaps = 19/306 (6%)
Query: 58  KVSLTQLRRFSCRELQLATDNFSE------SNIIGQGGFGKVYKGVLSDNTKVAVKRLQ- 110
           +VS T+   FS  EL+  T+NF E       N +G+GGFG VYKG + +NT VAVK+L  
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 111 --DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL 168
             D  +   +  F +E+ +++   H+NL++L+G+ +   +  LVY +M N S+  RL  L
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 169 KPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 228
             G   L W  R ++A G A G+ +LHE  +   IHRD+K+ANILLD+ F A + DFGLA
Sbjct: 125 D-GTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLA 180
Query: 229 KLVDA-KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRX 287
           +  +    T + ++I GT  ++APE L  G+ + K+D++ +G+ LLE++TG  A+D  R 
Sbjct: 181 RASEKFAQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239
Query: 288 XXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQ 347
                            E  + D +D+ +N  DS  VE M  VA  C       RP + +
Sbjct: 240 PQLLLDIKE---EIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKK 296
Query: 348 VVKMLQ 353
           V ++LQ
Sbjct: 297 VQQLLQ 302

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 111/306 (36%), Positives = 169/306 (55%), Gaps = 19/306 (6%)
Query: 58  KVSLTQLRRFSCRELQLATDNFSE------SNIIGQGGFGKVYKGVLSDNTKVAVKRLQ- 110
           +VS T+   FS  EL+  T+NF E       N +G+GGFG VYKG + +NT VAVK+L  
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 111 --DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL 168
             D  +   +  F +E+ +++   H+NL++L+G+ +   +  LVY +M N S+  RL  L
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 169 KPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 228
             G   L W  R ++A G A G+ +LHE  +   IHRD+K+ANILLD+ F A + DFGLA
Sbjct: 125 D-GTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLA 180
Query: 229 KLVDA-KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRX 287
           +  +    T +  +I GT  ++APE L  G+ + K+D++ +G+ LLE++TG  A+D  R 
Sbjct: 181 RASEKFAQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239
Query: 288 XXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQ 347
                            E  + D +D+ +N  DS  VE M  VA  C       RP + +
Sbjct: 240 PQLLLDIKE---EIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKK 296
Query: 348 VVKMLQ 353
           V ++LQ
Sbjct: 297 VQQLLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  167 bits (424), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 111/305 (36%), Positives = 167/305 (54%), Gaps = 19/305 (6%)
Query: 59  VSLTQLRRFSCRELQLATDNFSE------SNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-- 110
           VS T+   FS  EL+  T+NF E       N +G+GGFG VYKG + +NT VAVK+L   
Sbjct: 1   VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAM 59
Query: 111 -DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK 169
            D  +   +  F +E+ +++   H+NL++L+G+ +   +  LVY +M N S+  RL  L 
Sbjct: 60  VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD 119
Query: 170 PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 229
            G   L W  R ++A G A G+ +LHE  +   IHRD+K+ANILLD+ F A + DFGLA+
Sbjct: 120 -GTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR 175
Query: 230 LVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXX 288
             +     V   +I GT  ++APE L  G+ + K+D++ +G+ LLE++TG  A+D  R  
Sbjct: 176 ASEKFAQXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREP 234
Query: 289 XXXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQV 348
                           E  + D +D+ +N  DS  VE M  VA  C       RP + +V
Sbjct: 235 QLLLDIKE---EIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKV 291
Query: 349 VKMLQ 353
            ++LQ
Sbjct: 292 QQLLQ 296

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 104/293 (35%), Positives = 150/293 (51%), Gaps = 14/293 (4%)
Query: 66  RFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREV 125
           R    +L+ AT+NF    +IG G FGKVYKGVL D  KVA+KR     S G E       
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 126 HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF 185
            L S   H +L+ LIG+C   +E IL+Y +M+N ++   L         + W  R  +  
Sbjct: 88  TL-SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 186 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL-VDAKLTHVTTQIRG 244
           G A GL YLH +    IIHRD+K+ NILLD+NF   + DFG++K   +   TH+   ++G
Sbjct: 147 GAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKG 203
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS---RXXXXXXXXXXXHIRK 301
           T+G+I PEY   G+ +EK+DV+ +G+ L E++  + AI  S               H   
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH--- 260
Query: 302 LLREDRLNDIVDRNL-NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                +L  IVD NL +    + +      A+ C   + EDRP M  V+  L+
Sbjct: 261 --NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 104/293 (35%), Positives = 150/293 (51%), Gaps = 14/293 (4%)
Query: 66  RFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREV 125
           R    +L+ AT+NF    +IG G FGKVYKGVL D  KVA+KR     S G E       
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 126 HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF 185
            L S   H +L+ LIG+C   +E IL+Y +M+N ++   L         + W  R  +  
Sbjct: 88  TL-SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 186 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL-VDAKLTHVTTQIRG 244
           G A GL YLH +    IIHRD+K+ NILLD+NF   + DFG++K   +   TH+   ++G
Sbjct: 147 GAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKG 203
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS---RXXXXXXXXXXXHIRK 301
           T+G+I PEY   G+ +EK+DV+ +G+ L E++  + AI  S               H   
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH--- 260
Query: 302 LLREDRLNDIVDRNL-NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                +L  IVD NL +    + +      A+ C   + EDRP M  V+  L+
Sbjct: 261 --NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 107/302 (35%), Positives = 160/302 (52%), Gaps = 19/302 (6%)
Query: 62  TQLRRFSCRELQLATDNFSE------SNIIGQGGFGKVYKGVLSDNTKVAVKRLQ---DY 112
           T+   FS  EL+  T+NF E       N  G+GGFG VYKG + +NT VAVK+L    D 
Sbjct: 1   TRFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDI 59
Query: 113 YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGE 172
            +   +  F +E+ + +   H+NL++L+G+ +   +  LVY +  N S+  RL  L  G 
Sbjct: 60  TTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLD-GT 118
Query: 173 KGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 232
             L W  R ++A G A G+ +LHE  +   IHRD+K+ANILLD+ F A + DFGLA+  +
Sbjct: 119 PPLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE 175
Query: 233 AKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXX 291
                V  ++I GT  + APE L  G+ + K+D++ +G+ LLE++TG  A+D  R     
Sbjct: 176 KFAQXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 234
Query: 292 XXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 351
                        E  + D +D+  N  DS  VE    VA  C       RP + +V ++
Sbjct: 235 LDIKE---EIEDEEKTIEDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQL 291
Query: 352 LQ 353
           LQ
Sbjct: 292 LQ 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/199 (35%), Positives = 106/199 (53%), Gaps = 7/199 (3%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           IG G FG V++      + VAVK L  QD+++      F REV ++    H N++  +G 
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 202
            T      +V  ++   S+ YRL       + LD   R  +A+  A G+ YLH + NP I
Sbjct: 103 VTQPPNLSIVTEYLSRGSL-YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPI 160
Query: 203 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 262
           +HRDLK+ N+L+D  +   +CDFGL++L  A     +    GT   +APE L    S+EK
Sbjct: 161 VHRDLKSPNLLVDKKYTVKVCDFGLSRL-KASXFLXSKXAAGTPEWMAPEVLRDEPSNEK 219
Query: 263 TDVFGYGITLLELVTGQRA 281
           +DV+ +G+ L EL T Q+ 
Sbjct: 220 SDVYSFGVILWELATLQQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 69/199 (34%), Positives = 106/199 (53%), Gaps = 7/199 (3%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           IG G FG V++      + VAVK L  QD+++      F REV ++    H N++  +G 
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNE-FLREVAIMKRLRHPNIVLFMGA 102
Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 202
            T      +V  ++   S+ YRL       + LD   R  +A+  A G+ YLH + NP I
Sbjct: 103 VTQPPNLSIVTEYLSRGSL-YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPI 160
Query: 203 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 262
           +HR+LK+ N+L+D  +   +CDFGL++L  A     +    GT   +APE L    S+EK
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMAPEVLRDEPSNEK 219
Query: 263 TDVFGYGITLLELVTGQRA 281
           +DV+ +G+ L EL T Q+ 
Sbjct: 220 SDVYSFGVILWELATLQQP 238

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 123/263 (46%), Gaps = 32/263 (12%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G FG+V+ G  + +TKVAVK L Q   SP    AF  E +L+    H+ L++L  Y 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRL--YA 75
Query: 144 TTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--RVAFGTAYGLEYLHEQCNP 200
             + E I ++  +M+N S    L D      G+     K   +A   A G+ ++ E+   
Sbjct: 76  VVTQEPIYIITEYMENGS----LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 128
Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 260
             IHRDL+AANIL+ D     + DFGLA+L++          +  +   APE ++ G  +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 261 EKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYD 320
            K+DV+ +GI L E+VT  R I +                +++R D              
Sbjct: 189 IKSDVWSFGILLTEIVTHGR-IPYPGMTNPEVIQNLERGYRMVRPDNCP----------- 236
Query: 321 SKEVETMVQVALLCTQSTPEDRP 343
               E + Q+  LC +  PEDRP
Sbjct: 237 ----EELYQLMRLCWKERPEDRP 255

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 123/263 (46%), Gaps = 32/263 (12%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G FG+V+ G  + +TKVAVK L Q   SP    AF  E +L+    H+ L++L  Y 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRL--YA 76
Query: 144 TTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--RVAFGTAYGLEYLHEQCNP 200
             + E I ++  +M+N S    L D      G+     K   +A   A G+ ++ E+   
Sbjct: 77  VVTQEPIYIITEYMENGS----LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 129
Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 260
             IHRDL+AANIL+ D     + DFGLA+L++          +  +   APE ++ G  +
Sbjct: 130 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 189
Query: 261 EKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYD 320
            K+DV+ +GI L E+VT  R I +                +++R D              
Sbjct: 190 IKSDVWSFGILLTEIVTHGR-IPYPGMTNPEVIQNLERGYRMVRPDNCP----------- 237
Query: 321 SKEVETMVQVALLCTQSTPEDRP 343
               E + Q+  LC +  PEDRP
Sbjct: 238 ----EELYQLMRLCWKERPEDRP 256

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 123/263 (46%), Gaps = 32/263 (12%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G FG+V+ G  + +TKVAVK L Q   SP    AF  E +L+    H+ L++L  Y 
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRL--YA 84
Query: 144 TTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--RVAFGTAYGLEYLHEQCNP 200
             + E I ++  +M+N S    L D      G+     K   +A   A G+ ++ E+   
Sbjct: 85  VVTQEPIYIITEYMENGS----LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 137
Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 260
             IHRDL+AANIL+ D     + DFGLA+L++          +  +   APE ++ G  +
Sbjct: 138 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 197
Query: 261 EKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYD 320
            K+DV+ +GI L E+VT  R I +                +++R D              
Sbjct: 198 IKSDVWSFGILLTEIVTHGR-IPYPGMTNPEVIQNLERGYRMVRPDNCP----------- 245
Query: 321 SKEVETMVQVALLCTQSTPEDRP 343
               E + Q+  LC +  PEDRP
Sbjct: 246 ----EELYQLMRLCWKERPEDRP 264

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 123/263 (46%), Gaps = 32/263 (12%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G FG+V+ G  + +TKVAVK L Q   SP    AF  E +L+    H+ L++L  Y 
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRL--YA 77
Query: 144 TTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--RVAFGTAYGLEYLHEQCNP 200
             + E I ++  +M+N S    L D      G+     K   +A   A G+ ++ E+   
Sbjct: 78  VVTQEPIYIITEYMENGS----LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 130
Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 260
             IHRDL+AANIL+ D     + DFGLA+L++          +  +   APE ++ G  +
Sbjct: 131 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 190
Query: 261 EKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYD 320
            K+DV+ +GI L E+VT  R I +                +++R D              
Sbjct: 191 IKSDVWSFGILLTEIVTHGR-IPYPGMTNPEVIQNLERGYRMVRPDNCP----------- 238
Query: 321 SKEVETMVQVALLCTQSTPEDRP 343
               E + Q+  LC +  PEDRP
Sbjct: 239 ----EELYQLMRLCWKERPEDRP 257

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 123/263 (46%), Gaps = 32/263 (12%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G FG+V+ G  + +TKVAVK L Q   SP    AF  E +L+    H+ L++L  Y 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRL--YA 75
Query: 144 TTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--RVAFGTAYGLEYLHEQCNP 200
             + E I ++  +M+N S    L D      G+     K   +A   A G+ ++ E+   
Sbjct: 76  VVTQEPIYIITEYMENGS----LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 128
Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 260
             IHRDL+AANIL+ D     + DFGLA+L++          +  +   APE ++ G  +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 261 EKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYD 320
            K+DV+ +GI L E+VT  R I +                +++R D              
Sbjct: 189 IKSDVWSFGILLTEIVTHGR-IPYPGMTNPEVIQNLERGYRMVRPDNCP----------- 236
Query: 321 SKEVETMVQVALLCTQSTPEDRP 343
               E + Q+  LC +  PEDRP
Sbjct: 237 ----EELYQLMRLCWKERPEDRP 255

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 123/263 (46%), Gaps = 32/263 (12%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G FG+V+ G  + +TKVAVK L Q   SP    AF  E +L+    H+ L++L  Y 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRL--YA 81
Query: 144 TTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--RVAFGTAYGLEYLHEQCNP 200
             + E I ++  +M+N S    L D      G+     K   +A   A G+ ++ E+   
Sbjct: 82  VVTQEPIYIITEYMENGS----LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 134
Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 260
             IHRDL+AANIL+ D     + DFGLA+L++          +  +   APE ++ G  +
Sbjct: 135 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 194
Query: 261 EKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYD 320
            K+DV+ +GI L E+VT  R I +                +++R D              
Sbjct: 195 IKSDVWSFGILLTEIVTHGR-IPYPGMTNPEVIQNLERGYRMVRPDNCP----------- 242
Query: 321 SKEVETMVQVALLCTQSTPEDRP 343
               E + Q+  LC +  PEDRP
Sbjct: 243 ----EELYQLMRLCWKERPEDRP 261

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 123/263 (46%), Gaps = 32/263 (12%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G FG+V+ G  + +TKVAVK L Q   SP    AF  E +L+    H+ L++L  Y 
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRL--YA 83
Query: 144 TTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--RVAFGTAYGLEYLHEQCNP 200
             + E I ++  +M+N S    L D      G+     K   +A   A G+ ++ E+   
Sbjct: 84  VVTQEPIYIITEYMENGS----LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 136
Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 260
             IHRDL+AANIL+ D     + DFGLA+L++          +  +   APE ++ G  +
Sbjct: 137 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 196
Query: 261 EKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYD 320
            K+DV+ +GI L E+VT  R I +                +++R D              
Sbjct: 197 IKSDVWSFGILLTEIVTHGR-IPYPGMTNPEVIQNLERGYRMVRPDNCP----------- 244
Query: 321 SKEVETMVQVALLCTQSTPEDRP 343
               E + Q+  LC +  PEDRP
Sbjct: 245 ----EELYQLMRLCWKERPEDRP 263

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 123/263 (46%), Gaps = 32/263 (12%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G FG+V+ G  + +TKVAVK L Q   SP    AF  E +L+    H+ L++L  Y 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRL--YA 75
Query: 144 TTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--RVAFGTAYGLEYLHEQCNP 200
             + E I ++  +M+N S    L D      G+     K   +A   A G+ ++ E+   
Sbjct: 76  VVTQEPIYIITEYMENGS----LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 128
Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 260
             IHRDL+AANIL+ D     + DFGLA+L++          +  +   APE ++ G  +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 261 EKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYD 320
            K+DV+ +GI L E+VT  R I +                +++R D              
Sbjct: 189 IKSDVWSFGILLTEIVTHGR-IPYPGMTNPEVIQNLERGYRMVRPDNCP----------- 236
Query: 321 SKEVETMVQVALLCTQSTPEDRP 343
               E + Q+  LC +  PEDRP
Sbjct: 237 ----EELYQLMRLCWKERPEDRP 255

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 123/263 (46%), Gaps = 32/263 (12%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G FG+V+ G  + +TKVAVK L Q   SP    AF  E +L+    H+ L++L  Y 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRL--YA 70
Query: 144 TTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--RVAFGTAYGLEYLHEQCNP 200
             + E I ++  +M+N S    L D      G+     K   +A   A G+ ++ E+   
Sbjct: 71  VVTQEPIYIITEYMENGS----LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 123
Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 260
             IHRDL+AANIL+ D     + DFGLA+L++          +  +   APE ++ G  +
Sbjct: 124 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 183
Query: 261 EKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYD 320
            K+DV+ +GI L E+VT  R I +                +++R D              
Sbjct: 184 IKSDVWSFGILLTEIVTHGR-IPYPGMTNPEVIQNLERGYRMVRPDNCP----------- 231
Query: 321 SKEVETMVQVALLCTQSTPEDRP 343
               E + Q+  LC +  PEDRP
Sbjct: 232 ----EELYQLMRLCWKERPEDRP 250

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 123/263 (46%), Gaps = 32/263 (12%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G FG+V+ G  + +TKVAVK L Q   SP    AF  E +L+    H+ L++L  Y 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRL--YA 81
Query: 144 TTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--RVAFGTAYGLEYLHEQCNP 200
             + E I ++  +M+N S    L D      G+     K   +A   A G+ ++ E+   
Sbjct: 82  VVTQEPIYIITEYMENGS----LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 134
Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 260
             IHRDL+AANIL+ D     + DFGLA+L++          +  +   APE ++ G  +
Sbjct: 135 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 194
Query: 261 EKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYD 320
            K+DV+ +GI L E+VT  R I +                +++R D              
Sbjct: 195 IKSDVWSFGILLTEIVTHGR-IPYPGMTNPEVIQNLERGYRMVRPDNCP----------- 242
Query: 321 SKEVETMVQVALLCTQSTPEDRP 343
               E + Q+  LC +  PEDRP
Sbjct: 243 ----EELYQLMRLCWKERPEDRP 261

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 123/263 (46%), Gaps = 32/263 (12%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G FG+V+ G  + +TKVAVK L Q   SP    AF  E +L+    H+ L++L  Y 
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRL--YA 80
Query: 144 TTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--RVAFGTAYGLEYLHEQCNP 200
             + E I ++  +M+N S    L D      G+     K   +A   A G+ ++ E+   
Sbjct: 81  VVTQEPIYIITEYMENGS----LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 133
Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 260
             IHRDL+AANIL+ D     + DFGLA+L++          +  +   APE ++ G  +
Sbjct: 134 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 193
Query: 261 EKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYD 320
            K+DV+ +GI L E+VT  R I +                +++R D              
Sbjct: 194 IKSDVWSFGILLTEIVTHGR-IPYPGMTNPEVIQNLERGYRMVRPDNCP----------- 241
Query: 321 SKEVETMVQVALLCTQSTPEDRP 343
               E + Q+  LC +  PEDRP
Sbjct: 242 ----EELYQLMRLCWKERPEDRP 260

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 123/263 (46%), Gaps = 32/263 (12%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G FG+V+ G  + +TKVAVK L Q   SP    AF  E +L+    H+ L++L  Y 
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRL--YA 85
Query: 144 TTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--RVAFGTAYGLEYLHEQCNP 200
             + E I ++  +M+N S    L D      G+     K   +A   A G+ ++ E+   
Sbjct: 86  VVTQEPIYIITEYMENGS----LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 138
Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 260
             IHRDL+AANIL+ D     + DFGLA+L++          +  +   APE ++ G  +
Sbjct: 139 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 198
Query: 261 EKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYD 320
            K+DV+ +GI L E+VT  R I +                +++R D              
Sbjct: 199 IKSDVWSFGILLTEIVTHGR-IPYPGMTNPEVIQNLERGYRMVRPDNCP----------- 246
Query: 321 SKEVETMVQVALLCTQSTPEDRP 343
               E + Q+  LC +  PEDRP
Sbjct: 247 ----EELYQLMRLCWKERPEDRP 265

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 131/293 (44%), Gaps = 38/293 (12%)
Query: 74  LATDNFSESNIIGQGGFGKVYKG-VLSDNTKVAVKRLQDYYSPGGEA------AFQREVH 126
           LA +       IG+GGFG V+KG ++ D + VA+K L    S G          FQREV 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 127 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           ++S   H N+++L G         +V  F+    + +RL D       + W  + R+   
Sbjct: 76  IMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLD 130
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANIL---LDDNFE--AVLCDFGLAKLVDAKLTHVTTQ 241
            A G+EY+  Q NP I+HRDL++ NI    LD+N    A + DFGL++    +  H  + 
Sbjct: 131 IALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSG 185
Query: 242 IRGTMGHIAPEYLSTGKSS--EKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHI 299
           + G    +APE +   + S  EK D + + + L  ++TG+   D                
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-------EYSYGKIKF 238
Query: 300 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
             ++RE+ L   +  +           +  V  LC    P+ RP  + +VK L
Sbjct: 239 INMIREEGLRPTIPEDCPP-------RLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 123/263 (46%), Gaps = 32/263 (12%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G FG+V+ G  + +TKVAVK L Q   SP    AF  E +L+    H+ L++L  Y 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRL--YA 71
Query: 144 TTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--RVAFGTAYGLEYLHEQCNP 200
             + E I ++  +M+N S    L D      G+     K   +A   A G+ ++ E+   
Sbjct: 72  VVTQEPIYIITEYMENGS----LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 124
Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 260
             IHR+L+AANIL+ D     + DFGLA+L++          +  +   APE ++ G  +
Sbjct: 125 NYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 184
Query: 261 EKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYD 320
            K+DV+ +GI L E+VT  R I +                +++R D              
Sbjct: 185 IKSDVWSFGILLTEIVTHGR-IPYPGMTNPEVIQNLERGYRMVRPDNCP----------- 232
Query: 321 SKEVETMVQVALLCTQSTPEDRP 343
               E + Q+  LC +  PEDRP
Sbjct: 233 ----EELYQLMRLCWKERPEDRP 251

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 130/293 (44%), Gaps = 38/293 (12%)
Query: 74  LATDNFSESNIIGQGGFGKVYKG-VLSDNTKVAVKRLQDYYSPGGEA------AFQREVH 126
           LA +       IG+GGFG V+KG ++ D + VA+K L    S G          FQREV 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 127 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           ++S   H N+++L G         +V  F+    + +RL D       + W  + R+   
Sbjct: 76  IMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLD 130
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANIL---LDDNFE--AVLCDFGLAKLVDAKLTHVTTQ 241
            A G+EY+  Q NP I+HRDL++ NI    LD+N    A + DFG ++    +  H  + 
Sbjct: 131 IALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ----QSVHSVSG 185
Query: 242 IRGTMGHIAPEYLSTGKSS--EKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHI 299
           + G    +APE +   + S  EK D + + + L  ++TG+   D                
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-------EYSYGKIKF 238
Query: 300 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
             ++RE+ L   +  +           +  V  LC    P+ RP  + +VK L
Sbjct: 239 INMIREEGLRPTIPEDCPP-------RLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 131/295 (44%), Gaps = 42/295 (14%)
Query: 74  LATDNFSESNIIGQGGFGKVYKG-VLSDNTKVAVKRLQDYYSPGGEA------AFQREVH 126
           LA +       IG+GGFG V+KG ++ D + VA+K L    S G          FQREV 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 127 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           ++S   H N+++L G         +V  F+    + +RL D       + W  + R+   
Sbjct: 76  IMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLD 130
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANIL---LDDNFEAVLCDFGLAKLVDAKLT----HVT 239
            A G+EY+  Q NP I+HRDL++ NI    LD+N  A +C    AK+ D  L+    H  
Sbjct: 131 IALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDEN--APVC----AKVADFSLSQQSVHSV 183
Query: 240 TQIRGTMGHIAPEYLSTGKSS--EKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXX 297
           + + G    +APE +   + S  EK D + + + L  ++TG+   D              
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-------EYSYGKI 236
Query: 298 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
               ++RE+ L   +  +           +  V  LC    P+ RP  + +VK L
Sbjct: 237 KFINMIREEGLRPTIPEDCPP-------RLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 117/233 (50%), Gaps = 16/233 (6%)
Query: 53  GEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-D 111
           G +D     T  RR S  + ++     +    IG G FG VYKG    +  VAVK L   
Sbjct: 12  GSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVT 69
Query: 112 YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG 171
             +P    AF+ EV ++    H N+L  +GY +T  +  +V  + +  S+ + L  +   
Sbjct: 70  APTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHII--- 125
Query: 172 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 231
           E   +      +A  TA G++YLH +    IIHRDLK+ NI L ++    + DFGLA  V
Sbjct: 126 ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLAT-V 181
Query: 232 DAKL--THVTTQIRGTMGHIAPEYL---STGKSSEKTDVFGYGITLLELVTGQ 279
            ++   +H   Q+ G++  +APE +        S ++DV+ +GI L EL+TGQ
Sbjct: 182 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 122/263 (46%), Gaps = 32/263 (12%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G  G+V+ G  + +TKVAVK L Q   SP    AF  E +L+    H+ L++L  Y 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRL--YA 75
Query: 144 TTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--RVAFGTAYGLEYLHEQCNP 200
             + E I ++  +M+N S    L D      G+     K   +A   A G+ ++ E+   
Sbjct: 76  VVTQEPIYIITEYMENGS----LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 128
Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 260
             IHRDL+AANIL+ D     + DFGLA+L++          +  +   APE ++ G  +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 261 EKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYD 320
            K+DV+ +GI L E+VT  R I +                +++R D              
Sbjct: 189 IKSDVWSFGILLTEIVTHGR-IPYPGMTNPEVIQNLERGYRMVRPDNCP----------- 236
Query: 321 SKEVETMVQVALLCTQSTPEDRP 343
               E + Q+  LC +  PEDRP
Sbjct: 237 ----EELYQLMRLCWKERPEDRP 255

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 113/221 (51%), Gaps = 16/221 (7%)
Query: 65  RRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQR 123
           RR S  + ++     +    IG G FG VYKG    +  VAVK L     +P    AF+ 
Sbjct: 23  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKN 80
Query: 124 EVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 183
           EV ++    H N+L  +GY +T  +  +V  + +  S+ + L  +   E   +      +
Sbjct: 81  EVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDI 136
Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL--THVTTQ 241
           A  TA G++YLH +    IIHRDLK+ NI L ++    + DFGLA  V ++   +H   Q
Sbjct: 137 ARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQ 192
Query: 242 IRGTMGHIAPEYL---STGKSSEKTDVFGYGITLLELVTGQ 279
           + G++  +APE +        S ++DV+ +GI L EL+TGQ
Sbjct: 193 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/200 (35%), Positives = 104/200 (52%), Gaps = 16/200 (8%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 142
           +G G FG+V+ G  + NTKVA+K L+    PG     +F  E  ++    H  L+QL  Y
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLK----PGTMSPESFLEEAQIMKKLKHDKLVQL--Y 70
Query: 143 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGE-KGLDWPTRKRVAFGTAYGLEYLHEQCNP 200
              S E I +V  +M   S+   L  LK GE + L  P    +A   A G+ Y+ E+ N 
Sbjct: 71  AVVSEEPIYIVTEYMNKGSL---LDFLKDGEGRALKLPNLVDMAAQVAAGMAYI-ERMN- 125
Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 260
             IHRDL++ANIL+ +     + DFGLA+L++          +  +   APE    G+ +
Sbjct: 126 -YIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFT 184
Query: 261 EKTDVFGYGITLLELVTGQR 280
            K+DV+ +GI L ELVT  R
Sbjct: 185 IKSDVWSFGILLTELVTKGR 204

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/201 (35%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 142
           +GQG FG+V+ G  +  T+VA+K L+    PG     AF +E  ++    H+ L+QL  Y
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLK----PGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 69
Query: 143 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKG--LDWPTRKRVAFGTAYGLEYLHEQCN 199
              S E I +V  +M   S    L D   GE G  L  P    +A   A G+ Y+ E+ N
Sbjct: 70  AVVSEEPIXIVTEYMSKGS----LLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-ERMN 124
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 259
              +HRDL+AANIL+ +N    + DFGLA+L++          +  +   APE    G+ 
Sbjct: 125 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRF 182
Query: 260 SEKTDVFGYGITLLELVTGQR 280
           + K+DV+ +GI L EL T  R
Sbjct: 183 TIKSDVWSFGILLTELTTKGR 203

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/229 (32%), Positives = 113/229 (49%), Gaps = 18/229 (7%)
Query: 57  CKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG 116
           C  S  Q +  +    ++  ++      +GQG FG+V+ G  +  T+VA+K L+    PG
Sbjct: 164 CPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK----PG 219
Query: 117 --GEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEK 173
                AF +E  ++    H+ L+QL  Y   S E I +V  +M   S    L D   GE 
Sbjct: 220 TMSPEAFLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVTEYMSKGS----LLDFLKGET 273
Query: 174 G--LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 231
           G  L  P    +A   A G+ Y+ E+ N   +HRDL+AANIL+ +N    + DFGLA+L+
Sbjct: 274 GKYLRLPQLVDMAAQIASGMAYV-ERMN--YVHRDLRAANILVGENLVCKVADFGLARLI 330
Query: 232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 280
           +          +  +   APE    G+ + K+DV+ +GI L EL T  R
Sbjct: 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 105/200 (52%), Gaps = 16/200 (8%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 142
           +GQG FG+V+ G  +  T+VA+K L+    PG     AF +E  ++    H+ L+QL  Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK----PGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 79
Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKG--LDWPTRKRVAFGTAYGLEYLHEQCNP 200
              S E I  Y  M+ +S    L  LK GE G  L  P    +A   A G+ Y+ E+ N 
Sbjct: 80  AVVSEEPI--YIVMEYMSKGCLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYV-ERMN- 134
Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 260
             +HRDL+AANIL+ +N    + DFGLA+L++          +  +   APE    G+ +
Sbjct: 135 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 261 EKTDVFGYGITLLELVTGQR 280
            K+DV+ +GI L EL T  R
Sbjct: 194 IKSDVWSFGILLTELTTKGR 213

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/229 (32%), Positives = 113/229 (49%), Gaps = 18/229 (7%)
Query: 57  CKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG 116
           C  S  Q +  +    ++  ++      +GQG FG+V+ G  +  T+VA+K L+    PG
Sbjct: 164 CPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK----PG 219
Query: 117 --GEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEK 173
                AF +E  ++    H+ L+QL  Y   S E I +V  +M   S    L D   GE 
Sbjct: 220 TMSPEAFLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVTEYMSKGS----LLDFLKGET 273
Query: 174 G--LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 231
           G  L  P    +A   A G+ Y+ E+ N   +HRDL+AANIL+ +N    + DFGLA+L+
Sbjct: 274 GKYLRLPQLVDMAAQIASGMAYV-ERMN--YVHRDLRAANILVGENLVCKVADFGLARLI 330
Query: 232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 280
           +          +  +   APE    G+ + K+DV+ +GI L EL T  R
Sbjct: 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/201 (35%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 142
           +GQG FG+V+ G  +  T+VA+K L+    PG     AF +E  ++    H+ L+QL  Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK----PGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 79
Query: 143 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKG--LDWPTRKRVAFGTAYGLEYLHEQCN 199
              S E I +V  +M   S    L D   GE G  L  P    +A   A G+ Y+ E+ N
Sbjct: 80  AVVSEEPIYIVIEYMSKGS----LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMN 134
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 259
              +HRDL+AANIL+ +N    + DFGLA+L++          +  +   APE    G+ 
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRF 192
Query: 260 SEKTDVFGYGITLLELVTGQR 280
           + K+DV+ +GI L EL T  R
Sbjct: 193 TIKSDVWSFGILLTELTTKGR 213

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/232 (31%), Positives = 115/232 (49%), Gaps = 14/232 (6%)
Query: 53  GEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-D 111
           G +D     T  RR S  + ++     +    IG G FG VYKG    +  VAVK L   
Sbjct: 12  GSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVT 69
Query: 112 YYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG 171
             +P    AF+ EV ++    H N+L  +GY +T  +  +V  + +  S+ + L  +   
Sbjct: 70  APTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHII--- 125
Query: 172 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KL 230
           E   +      +A  TA G++YLH +    IIHRDLK+ NI L ++    + DFGLA + 
Sbjct: 126 ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEK 182
Query: 231 VDAKLTHVTTQIRGTMGHIAPEYL---STGKSSEKTDVFGYGITLLELVTGQ 279
                +H   Q+ G++  +APE +        S ++DV+ +GI L EL+TGQ
Sbjct: 183 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/229 (32%), Positives = 113/229 (49%), Gaps = 18/229 (7%)
Query: 57  CKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG 116
           C  S  Q +  +    ++  ++      +GQG FG+V+ G  +  T+VA+K L+    PG
Sbjct: 164 CPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK----PG 219
Query: 117 --GEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEK 173
                AF +E  ++    H+ L+QL  Y   S E I +V  +M   S    L D   GE 
Sbjct: 220 TMSPEAFLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVGEYMSKGS----LLDFLKGET 273
Query: 174 G--LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 231
           G  L  P    +A   A G+ Y+ E+ N   +HRDL+AANIL+ +N    + DFGLA+L+
Sbjct: 274 GKYLRLPQLVDMAAQIASGMAYV-ERMN--YVHRDLRAANILVGENLVCKVADFGLARLI 330
Query: 232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 280
           +          +  +   APE    G+ + K+DV+ +GI L EL T  R
Sbjct: 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/229 (32%), Positives = 113/229 (49%), Gaps = 18/229 (7%)
Query: 57  CKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG 116
           C  S  Q +  +    ++  ++      +GQG FG+V+ G  +  T+VA+K L+    PG
Sbjct: 247 CPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK----PG 302
Query: 117 --GEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEK 173
                AF +E  ++    H+ L+QL  Y   S E I +V  +M   S    L D   GE 
Sbjct: 303 TMSPEAFLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVTEYMSKGS----LLDFLKGET 356
Query: 174 G--LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 231
           G  L  P    +A   A G+ Y+ E+ N   +HRDL+AANIL+ +N    + DFGLA+L+
Sbjct: 357 GKYLRLPQLVDMAAQIASGMAYV-ERMN--YVHRDLRAANILVGENLVCKVADFGLARLI 413
Query: 232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 280
           +          +  +   APE    G+ + K+DV+ +GI L EL T  R
Sbjct: 414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 462

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 125/274 (45%), Gaps = 36/274 (13%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           IG G FG V+ G   +  KVA+K +++      E  F  E  ++    H  L+QL G C 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRKRVAFGTAYGLEYLHEQCNPKII 203
             +   LV+ FM++  ++  LR     ++GL    T   +      G+ YL E C   +I
Sbjct: 71  EQAPICLVFEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 123
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N L+ +N    + DFG+ + V       +T  +  +   +PE  S  + S K+
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 264 DVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNT----Y 319
           DV+ +G+ + E+        FS               K+  E+R N  V  +++T    Y
Sbjct: 184 DVWSFGVLMWEV--------FSEG-------------KIPYENRSNSEVVEDISTGFRLY 222
Query: 320 DSKEVETMV-QVALLCTQSTPEDRPPMAQVVKML 352
             +   T V Q+   C +  PEDRP  +++++ L
Sbjct: 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/201 (35%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 142
           +GQG FG+V+ G  +  T+VA+K L+    PG     AF +E  ++    H+ L+QL  Y
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLK----PGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 70
Query: 143 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKG--LDWPTRKRVAFGTAYGLEYLHEQCN 199
              S E I +V  +M   S    L D   GE G  L  P    +A   A G+ Y+ E+ N
Sbjct: 71  AVVSEEPIYIVTEYMSKGS----LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMN 125
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 259
              +HRDL+AANIL+ +N    + DFGLA+L++          +  +   APE    G+ 
Sbjct: 126 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 183
Query: 260 SEKTDVFGYGITLLELVTGQR 280
           + K+DV+ +GI L EL T  R
Sbjct: 184 TIKSDVWSFGILLTELTTKGR 204

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 125/274 (45%), Gaps = 36/274 (13%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           IG G FG V+ G   +  KVA+K +++      E  F  E  ++    H  L+QL G C 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRKRVAFGTAYGLEYLHEQCNPKII 203
             +   LV+ FM++  ++  LR     ++GL    T   +      G+ YL E C   +I
Sbjct: 73  EQAPICLVFEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 125
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N L+ +N    + DFG+ + V       +T  +  +   +PE  S  + S K+
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 264 DVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNT----Y 319
           DV+ +G+ + E+        FS               K+  E+R N  V  +++T    Y
Sbjct: 186 DVWSFGVLMWEV--------FSEG-------------KIPYENRSNSEVVEDISTGFRLY 224
Query: 320 DSKEVETMV-QVALLCTQSTPEDRPPMAQVVKML 352
             +   T V Q+   C +  PEDRP  +++++ L
Sbjct: 225 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/201 (35%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 142
           +GQG FG+V+ G  +  T+VA+K L+    PG     AF +E  ++    H+ L+QL  Y
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLK----PGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 68
Query: 143 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKG--LDWPTRKRVAFGTAYGLEYLHEQCN 199
              S E I +V  +M   S    L D   GE G  L  P    +A   A G+ Y+ E+ N
Sbjct: 69  AVVSEEPIYIVTEYMSKGS----LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMN 123
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 259
              +HRDL+AANIL+ +N    + DFGLA+L++          +  +   APE    G+ 
Sbjct: 124 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 181
Query: 260 SEKTDVFGYGITLLELVTGQR 280
           + K+DV+ +GI L EL T  R
Sbjct: 182 TIKSDVWSFGILLTELTTKGR 202

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/201 (35%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 142
           +GQG FG+V+ G  +  T+VA+K L+    PG     AF +E  ++    H+ L+QL  Y
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLK----PGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 72
Query: 143 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKG--LDWPTRKRVAFGTAYGLEYLHEQCN 199
              S E I +V  +M   S    L D   GE G  L  P    +A   A G+ Y+ E+ N
Sbjct: 73  AVVSEEPIYIVTEYMSKGS----LLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-ERMN 127
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 259
              +HRDL+AANIL+ +N    + DFGLA+L++          +  +   APE    G+ 
Sbjct: 128 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 185
Query: 260 SEKTDVFGYGITLLELVTGQR 280
           + K+DV+ +GI L EL T  R
Sbjct: 186 TIKSDVWSFGILLTELTTKGR 206

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/201 (35%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 142
           +GQG FG+V+ G  +  T+VA+K L+    PG     AF +E  ++    H+ L+QL  Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK----PGTMSPEAFLQEAQVMKKIRHEKLVQL--Y 79
Query: 143 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKG--LDWPTRKRVAFGTAYGLEYLHEQCN 199
              S E I +V  +M   S    L D   GE G  L  P    +A   A G+ Y+ E+ N
Sbjct: 80  AVVSEEPIYIVTEYMSKGS----LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMN 134
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 259
              +HRDL+AANIL+ +N    + DFGLA+L++          +  +   APE    G+ 
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 192
Query: 260 SEKTDVFGYGITLLELVTGQR 280
           + K+DV+ +GI L EL T  R
Sbjct: 193 TIKSDVWSFGILLTELTTKGR 213

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/201 (35%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 142
           +GQG FG+V+ G  +  T+VA+K L+    PG     AF +E  ++    H+ L+QL  Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK----PGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 79
Query: 143 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKG--LDWPTRKRVAFGTAYGLEYLHEQCN 199
              S E I +V  +M   S    L D   GE G  L  P    +A   A G+ Y+ E+ N
Sbjct: 80  AVVSEEPIYIVIEYMSKGS----LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMN 134
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 259
              +HRDL+AANIL+ +N    + DFGLA+L++          +  +   APE    G+ 
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 192
Query: 260 SEKTDVFGYGITLLELVTGQR 280
           + K+DV+ +GI L EL T  R
Sbjct: 193 TIKSDVWSFGILLTELTTKGR 213

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 125/274 (45%), Gaps = 36/274 (13%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           IG G FG V+ G   +  KVA+K +++      E  F  E  ++    H  L+QL G C 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRKRVAFGTAYGLEYLHEQCNPKII 203
             +   LV+ FM++  ++  LR     ++GL    T   +      G+ YL E C   +I
Sbjct: 76  EQAPICLVFEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 128
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N L+ +N    + DFG+ + V       +T  +  +   +PE  S  + S K+
Sbjct: 129 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 188
Query: 264 DVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNT----Y 319
           DV+ +G+ + E+        FS               K+  E+R N  V  +++T    Y
Sbjct: 189 DVWSFGVLMWEV--------FSEG-------------KIPYENRSNSEVVEDISTGFRLY 227
Query: 320 DSKEVETMV-QVALLCTQSTPEDRPPMAQVVKML 352
             +   T V Q+   C +  PEDRP  +++++ L
Sbjct: 228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQL 261

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 111/220 (50%), Gaps = 14/220 (6%)
Query: 65  RRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQR 123
           RR S  + ++     +    IG G FG VYKG    +  VAVK L     +P    AF+ 
Sbjct: 16  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKN 73
Query: 124 EVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 183
           EV ++    H N+L  +GY +T  +  +V  + +  S+ + L  +   E   +      +
Sbjct: 74  EVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDI 129
Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQI 242
           A  TA G++YLH +    IIHRDLK+ NI L ++    + DFGLA +      +H   Q+
Sbjct: 130 ARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQL 186
Query: 243 RGTMGHIAPEYL---STGKSSEKTDVFGYGITLLELVTGQ 279
            G++  +APE +        S ++DV+ +GI L EL+TGQ
Sbjct: 187 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 112/211 (53%), Gaps = 18/211 (8%)
Query: 80  SESNIIGQGGFGKVYKGVLSDNT-----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 134
           +   +IG G FG+VYKG+L  ++      VA+K L+  Y+      F  E  ++    H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--GTAYGLE 192
           N+++L G  +     +++  +M+N ++   LR     EK  ++   + V    G A G++
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLR-----EKDGEFSVLQLVGMLRGIAAGMK 161
Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIA 250
           YL    N   +HRDL A NIL++ N    + DFGL++++  D + T+ T+  +  +   A
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 218
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVT-GQR 280
           PE +S  K +  +DV+ +GI + E++T G+R
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGER 249

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/201 (35%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 142
           +GQG FG+V+ G  +  T+VA+K L+    PG     AF +E  ++    H+ L+QL  Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK----PGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 79
Query: 143 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKG--LDWPTRKRVAFGTAYGLEYLHEQCN 199
              S E I +V  +M   S    L D   GE G  L  P    +A   A G+ Y+ E+ N
Sbjct: 80  AVVSEEPIYIVTEYMSKGS----LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMN 134
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 259
              +HRDL+AANIL+ +N    + DFGLA+L++          +  +   APE    G+ 
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 192
Query: 260 SEKTDVFGYGITLLELVTGQR 280
           + K+DV+ +GI L EL T  R
Sbjct: 193 TIKSDVWSFGILLTELTTKGR 213

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 125/274 (45%), Gaps = 36/274 (13%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           IG G FG V+ G   +  KVA+K +++      E  F  E  ++    H  L+QL G C 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKE--GSMSEDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRKRVAFGTAYGLEYLHEQCNPKII 203
             +   LV+ FM++  ++  LR     ++GL    T   +      G+ YL E C   +I
Sbjct: 93  EQAPICLVFEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 145
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N L+ +N    + DFG+ + V       +T  +  +   +PE  S  + S K+
Sbjct: 146 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 205
Query: 264 DVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNT----Y 319
           DV+ +G+ + E+        FS               K+  E+R N  V  +++T    Y
Sbjct: 206 DVWSFGVLMWEV--------FSEG-------------KIPYENRSNSEVVEDISTGFRLY 244
Query: 320 DSKEVETMV-QVALLCTQSTPEDRPPMAQVVKML 352
             +   T V Q+   C +  PEDRP  +++++ L
Sbjct: 245 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 278

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/201 (35%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 142
           +GQG FG+V+ G  +  T+VA+K L+    PG     AF +E  ++    H+ L+QL  Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK----PGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 79
Query: 143 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKG--LDWPTRKRVAFGTAYGLEYLHEQCN 199
              S E I +V  +M   S    L D   GE G  L  P    +A   A G+ Y+ E+ N
Sbjct: 80  AVVSEEPIYIVCEYMSKGS----LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMN 134
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 259
              +HRDL+AANIL+ +N    + DFGLA+L++          +  +   APE    G+ 
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 192
Query: 260 SEKTDVFGYGITLLELVTGQR 280
           + K+DV+ +GI L EL T  R
Sbjct: 193 TIKSDVWSFGILLTELTTKGR 213

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/201 (34%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 142
           +GQG FG+V+ G  +  T+VA+K L+    PG     AF +E  ++    H+ L+QL  Y
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK----PGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 76
Query: 143 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKG--LDWPTRKRVAFGTAYGLEYLHEQCN 199
              S E I +V  +M   S    L D   GE G  L  P    ++   A G+ Y+ E+ N
Sbjct: 77  AVVSEEPIYIVTEYMNKGS----LLDFLKGETGKYLRLPQLVDMSAQIASGMAYV-ERMN 131
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 259
              +HRDL+AANIL+ +N    + DFGLA+L++          +  +   APE    G+ 
Sbjct: 132 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRF 189
Query: 260 SEKTDVFGYGITLLELVTGQR 280
           + K+DV+ +GI L EL T  R
Sbjct: 190 TIKSDVWSFGILLTELTTKGR 210

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 112/220 (50%), Gaps = 16/220 (7%)
Query: 66  RFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQRE 124
           R S  + ++     +    IG G FG VYKG    +  VAVK L     +P    AF+ E
Sbjct: 1   RDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNE 58
Query: 125 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVA 184
           V ++    H N+L  +GY +T  +  +V  + +  S+ + L      E   +      +A
Sbjct: 59  VGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIA 114
Query: 185 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL--THVTTQI 242
             TA G++YLH +    IIHRDLK+ NI L ++    + DFGLA  V ++   +H   Q+
Sbjct: 115 RQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLAT-VKSRWSGSHQFEQL 170
Query: 243 RGTMGHIAPEYLSTGKS---SEKTDVFGYGITLLELVTGQ 279
            G++  +APE +    S   S ++DV+ +GI L EL+TGQ
Sbjct: 171 SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/201 (34%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 142
           +GQG FG+V+ G  +  T+VA+K L+    PG     AF +E  ++    H+ L+QL  Y
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK----PGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 76
Query: 143 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKG--LDWPTRKRVAFGTAYGLEYLHEQCN 199
              S E I +V  +M   S    L D   GE G  L  P    ++   A G+ Y+ E+ N
Sbjct: 77  AVVSEEPIYIVTEYMNKGS----LLDFLKGETGKYLRLPQLVDMSAQIASGMAYV-ERMN 131
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 259
              +HRDL+AANIL+ +N    + DFGLA+L++          +  +   APE    G+ 
Sbjct: 132 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 189
Query: 260 SEKTDVFGYGITLLELVTGQR 280
           + K+DV+ +GI L EL T  R
Sbjct: 190 TIKSDVWSFGILLTELTTKGR 210

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 107/201 (53%), Gaps = 16/201 (7%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           IG G FG VYKG    +  VAVK L     +P    AF+ EV ++    H N+L  +GY 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           +T+ +  +V  + +  S+ + L  +   E   +      +A  TA G++YLH +    II
Sbjct: 73  STAPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---II 126
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKL--THVTTQIRGTMGHIAPEYL---STGK 258
           HRDLK+ NI L ++    + DFGLA  V ++   +H   Q+ G++  +APE +       
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 259 SSEKTDVFGYGITLLELVTGQ 279
            S ++DV+ +GI L EL+TGQ
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQ 206

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 73/229 (31%), Positives = 113/229 (49%), Gaps = 18/229 (7%)
Query: 57  CKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG 116
           C  S  Q +  +    ++  ++      +GQG FG+V+ G  +  T+VA+K L+    PG
Sbjct: 165 CPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK----PG 220
Query: 117 GEA--AFQREVHLISVAIHKNLLQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEK 173
             +  AF +E  ++    H+ L+QL  Y   S E I +V  +M   S    L D   GE 
Sbjct: 221 NMSPEAFLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVTEYMSKGS----LLDFLKGEM 274
Query: 174 G--LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 231
           G  L  P    +A   A G+ Y+ E+ N   +HRDL+AANIL+ +N    + DFGL +L+
Sbjct: 275 GKYLRLPQLVDMAAQIASGMAYV-ERMN--YVHRDLRAANILVGENLVCKVADFGLGRLI 331
Query: 232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 280
           +          +  +   APE    G+ + K+DV+ +GI L EL T  R
Sbjct: 332 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 380

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/201 (35%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 142
           +GQG FG+V+ G  +  T+VA+K L+    PG     AF +E  ++    H+ L+QL  Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK----PGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 79
Query: 143 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKG--LDWPTRKRVAFGTAYGLEYLHEQCN 199
              S E I +V  +M   S    L D   GE G  L  P    +A   A G+ Y+ E+ N
Sbjct: 80  AVVSEEPIYIVTEYMSKGS----LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMN 134
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 259
              +HRDL AANIL+ +N    + DFGLA+L++          +  +   APE    G+ 
Sbjct: 135 --YVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 192
Query: 260 SEKTDVFGYGITLLELVTGQR 280
           + K+DV+ +GI L EL T  R
Sbjct: 193 TIKSDVWSFGILLTELTTKGR 213

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 16/201 (7%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           IG G FG VYKG    +  VAVK L     +P    AF+ EV ++    H N+L  +GY 
Sbjct: 18  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 74
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           +T  +  +V  + +  S+ + L  +   E   +      +A  TA G++YLH +    II
Sbjct: 75  STKPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---II 128
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKL--THVTTQIRGTMGHIAPEYL---STGK 258
           HRDLK+ NI L ++    + DFGLA  V ++   +H   Q+ G++  +APE +       
Sbjct: 129 HRDLKSNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 187
Query: 259 SSEKTDVFGYGITLLELVTGQ 279
            S ++DV+ +GI L EL+TGQ
Sbjct: 188 YSFQSDVYAFGIVLYELMTGQ 208

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 16/201 (7%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           IG G FG VYKG    +  VAVK L     +P    AF+ EV ++    H N+L  +GY 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           +T  +  +V  + +  S+ + L  +   E   +      +A  TA G++YLH +    II
Sbjct: 73  STKPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---II 126
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKL--THVTTQIRGTMGHIAPEYL---STGK 258
           HRDLK+ NI L ++    + DFGLA  V ++   +H   Q+ G++  +APE +       
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 259 SSEKTDVFGYGITLLELVTGQ 279
            S ++DV+ +GI L EL+TGQ
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQ 206

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           IG G FG VYKG    +  VAVK L     +P    AF+ EV ++    H N+L  +GY 
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 88
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           +T+ +  +V  + +  S+ + L      E   +      +A  TA G++YLH +    II
Sbjct: 89  STAPQLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHAKS---II 142
Query: 204 HRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS--- 259
           HRDLK+ NI L ++    + DFGLA +      +H   Q+ G++  +APE +    S   
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 260 SEKTDVFGYGITLLELVTGQ 279
           S ++DV+ +GI L EL+TGQ
Sbjct: 203 SFQSDVYAFGIVLYELMTGQ 222

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 16/201 (7%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           IG G FG VYKG    +  VAVK L     +P    AF+ EV ++    H N+L  +GY 
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 77
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           +T  +  +V  + +  S+ + L  +   E   +      +A  TA G++YLH +    II
Sbjct: 78  STKPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---II 131
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKL--THVTTQIRGTMGHIAPEYL---STGK 258
           HRDLK+ NI L ++    + DFGLA  V ++   +H   Q+ G++  +APE +       
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 259 SSEKTDVFGYGITLLELVTGQ 279
            S ++DV+ +GI L EL+TGQ
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQ 211

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 16/201 (7%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           IG G FG VYKG    +  VAVK L     +P    AF+ EV ++    H N+L  +GY 
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 77
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           +T  +  +V  + +  S+ + L  +   E   +      +A  TA G++YLH +    II
Sbjct: 78  STKPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---II 131
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKL--THVTTQIRGTMGHIAPEYL---STGK 258
           HRDLK+ NI L ++    + DFGLA  V ++   +H   Q+ G++  +APE +       
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 259 SSEKTDVFGYGITLLELVTGQ 279
            S ++DV+ +GI L EL+TGQ
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQ 211

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 14/219 (6%)
Query: 66  RFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQRE 124
           R S  + ++     +    IG G FG VYKG    +  VAVK L     +P    AF+ E
Sbjct: 13  RDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNE 70
Query: 125 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVA 184
           V ++    H N+L  +GY +T  +  +V  + +  S+ + L      E   +      +A
Sbjct: 71  VGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIA 126
Query: 185 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIR 243
             TA G++YLH +    IIHRDLK+ NI L ++    + DFGLA +      +H   Q+ 
Sbjct: 127 RQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS 183
Query: 244 GTMGHIAPEYLSTGKS---SEKTDVFGYGITLLELVTGQ 279
           G++  +APE +    S   S ++DV+ +GI L EL+TGQ
Sbjct: 184 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/200 (35%), Positives = 104/200 (52%), Gaps = 16/200 (8%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG--GEAAFQREVHLISVAIHKNLLQLIGY 142
           +GQG FG+V+ G  +  T+VA+K L+    PG     AF +E  ++    H+ L+QL  Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK----PGTMSPEAFLQEAQVMKKLRHEKLVQL--Y 79
Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKG--LDWPTRKRVAFGTAYGLEYLHEQCNP 200
              S E I  Y   + +S    L  LK GE G  L  P    +A   A G+ Y+ E+ N 
Sbjct: 80  AVVSEEPI--YIVTEYMSKGCLLDFLK-GEMGKYLRLPQLVDMAAQIASGMAYV-ERMN- 134
Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 260
             +HRDL+AANIL+ +N    + DFGLA+L++          +  +   APE    G+ +
Sbjct: 135 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 261 EKTDVFGYGITLLELVTGQR 280
            K+DV+ +GI L EL T  R
Sbjct: 194 IKSDVWSFGILLTELTTKGR 213

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 124/274 (45%), Gaps = 36/274 (13%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           IG G FG V+ G   +  KVA+K +++      E  F  E  ++    H  L+QL G C 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRKRVAFGTAYGLEYLHEQCNPKII 203
             +   LV  FM++  ++  LR     ++GL    T   +      G+ YL E C   +I
Sbjct: 74  EQAPICLVTEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 126
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N L+ +N    + DFG+ + V       +T  +  +   +PE  S  + S K+
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 264 DVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNT----Y 319
           DV+ +G+ + E+        FS               K+  E+R N  V  +++T    Y
Sbjct: 187 DVWSFGVLMWEV--------FSEG-------------KIPYENRSNSEVVEDISTGFRLY 225
Query: 320 DSKEVETMV-QVALLCTQSTPEDRPPMAQVVKML 352
             +   T V Q+   C +  PEDRP  +++++ L
Sbjct: 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQL 259

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 130/283 (45%), Gaps = 38/283 (13%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIH 133
           +F+E  +IG+G FG VY G L DN       AVK L      G  + F  E  ++    H
Sbjct: 25  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 82
Query: 134 KNLLQLIGYCTTS-SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR-VAFG--TAY 189
            N+L L+G C  S    ++V P+M++  +   +R+          PT K  + FG   A 
Sbjct: 83  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAK 136
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKL--THVTTQIRGTM 246
           G++YL  +   K +HRDL A N +LD+ F   + DFGLA+ + D +    H  T  +  +
Sbjct: 137 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 193
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLRED 306
             +A E L T K + K+DV+ +G+ L EL+T + A  +               R+LL+ +
Sbjct: 194 KWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 252
Query: 307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 349
              D                + +V L C     E RP  +++V
Sbjct: 253 YCPD---------------PLYEVMLKCWHPKAEMRPSFSELV 280

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 130/283 (45%), Gaps = 38/283 (13%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIH 133
           +F+E  +IG+G FG VY G L DN       AVK L      G  + F  E  ++    H
Sbjct: 32  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 134 KNLLQLIGYCTTS-SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR-VAFG--TAY 189
            N+L L+G C  S    ++V P+M++  +   +R+          PT K  + FG   A 
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAK 143
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKL--THVTTQIRGTM 246
           G++YL  +   K +HRDL A N +LD+ F   + DFGLA+ + D +    H  T  +  +
Sbjct: 144 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 200
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLRED 306
             +A E L T K + K+DV+ +G+ L EL+T + A  +               R+LL+ +
Sbjct: 201 KWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 259
Query: 307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 349
              D                + +V L C     E RP  +++V
Sbjct: 260 YCPD---------------PLYEVMLKCWHPKAEMRPSFSELV 287

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 130/283 (45%), Gaps = 38/283 (13%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIH 133
           +F+E  +IG+G FG VY G L DN       AVK L      G  + F  E  ++    H
Sbjct: 30  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 134 KNLLQLIGYCTTS-SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR-VAFG--TAY 189
            N+L L+G C  S    ++V P+M++  +   +R+          PT K  + FG   A 
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAK 141
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKL--THVTTQIRGTM 246
           G++YL  +   K +HRDL A N +LD+ F   + DFGLA+ + D +    H  T  +  +
Sbjct: 142 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 198
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLRED 306
             +A E L T K + K+DV+ +G+ L EL+T + A  +               R+LL+ +
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 257
Query: 307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 349
              D                + +V L C     E RP  +++V
Sbjct: 258 YCPD---------------PLYEVMLKCWHPKAEMRPSFSELV 285

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 130/283 (45%), Gaps = 38/283 (13%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIH 133
           +F+E  +IG+G FG VY G L DN       AVK L      G  + F  E  ++    H
Sbjct: 51  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 108
Query: 134 KNLLQLIGYCTTS-SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR-VAFG--TAY 189
            N+L L+G C  S    ++V P+M++  +   +R+          PT K  + FG   A 
Sbjct: 109 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAK 162
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKL--THVTTQIRGTM 246
           G++YL  +   K +HRDL A N +LD+ F   + DFGLA+ + D +    H  T  +  +
Sbjct: 163 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 219
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLRED 306
             +A E L T K + K+DV+ +G+ L EL+T + A  +               R+LL+ +
Sbjct: 220 KWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 278
Query: 307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 349
              D                + +V L C     E RP  +++V
Sbjct: 279 YCPD---------------PLYEVMLKCWHPKAEMRPSFSELV 306

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 130/283 (45%), Gaps = 38/283 (13%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIH 133
           +F+E  +IG+G FG VY G L DN       AVK L      G  + F  E  ++    H
Sbjct: 32  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 134 KNLLQLIGYCTTS-SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR-VAFG--TAY 189
            N+L L+G C  S    ++V P+M++  +   +R+          PT K  + FG   A 
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAK 143
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKL--THVTTQIRGTM 246
           G++YL  +   K +HRDL A N +LD+ F   + DFGLA+ + D +    H  T  +  +
Sbjct: 144 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPV 200
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLRED 306
             +A E L T K + K+DV+ +G+ L EL+T + A  +               R+LL+ +
Sbjct: 201 KWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 259
Query: 307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 349
              D                + +V L C     E RP  +++V
Sbjct: 260 YCPD---------------PLYEVMLKCWHPKAEMRPSFSELV 287

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 130/283 (45%), Gaps = 38/283 (13%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIH 133
           +F+E  +IG+G FG VY G L DN       AVK L      G  + F  E  ++    H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 134 KNLLQLIGYCTTS-SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR-VAFG--TAY 189
            N+L L+G C  S    ++V P+M++  +   +R+          PT K  + FG   A 
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAK 144
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKL--THVTTQIRGTM 246
           G++YL  +   K +HRDL A N +LD+ F   + DFGLA+ + D +    H  T  +  +
Sbjct: 145 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 201
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLRED 306
             +A E L T K + K+DV+ +G+ L EL+T + A  +               R+LL+ +
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 260
Query: 307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 349
              D                + +V L C     E RP  +++V
Sbjct: 261 YCPD---------------PLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 130/283 (45%), Gaps = 38/283 (13%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIH 133
           +F+E  +IG+G FG VY G L DN       AVK L      G  + F  E  ++    H
Sbjct: 31  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 134 KNLLQLIGYCTTS-SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR-VAFG--TAY 189
            N+L L+G C  S    ++V P+M++  +   +R+          PT K  + FG   A 
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAK 142
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKL--THVTTQIRGTM 246
           G++YL  +   K +HRDL A N +LD+ F   + DFGLA+ + D +    H  T  +  +
Sbjct: 143 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 199
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLRED 306
             +A E L T K + K+DV+ +G+ L EL+T + A  +               R+LL+ +
Sbjct: 200 KWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 258
Query: 307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 349
              D                + +V L C     E RP  +++V
Sbjct: 259 YCPD---------------PLYEVMLKCWHPKAEMRPSFSELV 286

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 104/200 (52%), Gaps = 14/200 (7%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           IG G FG VYKG    +  VAVK L     +P    AF+ EV ++    H N+L  +GY 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           +T  +  +V  + +  S+ + L  +   E   +      +A  TA G++YLH +    II
Sbjct: 73  STKPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---II 126
Query: 204 HRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYL---STGKS 259
           HRDLK+ NI L ++    + DFGLA +      +H   Q+ G++  +APE +        
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 260 SEKTDVFGYGITLLELVTGQ 279
           S ++DV+ +GI L EL+TGQ
Sbjct: 187 SFQSDVYAFGIVLYELMTGQ 206

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 130/283 (45%), Gaps = 38/283 (13%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIH 133
           +F+E  +IG+G FG VY G L DN       AVK L      G  + F  E  ++    H
Sbjct: 52  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 109
Query: 134 KNLLQLIGYCTTS-SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR-VAFG--TAY 189
            N+L L+G C  S    ++V P+M++  +   +R+          PT K  + FG   A 
Sbjct: 110 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAK 163
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKL--THVTTQIRGTM 246
           G++YL  +   K +HRDL A N +LD+ F   + DFGLA+ + D +    H  T  +  +
Sbjct: 164 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 220
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLRED 306
             +A E L T K + K+DV+ +G+ L EL+T + A  +               R+LL+ +
Sbjct: 221 KWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 279
Query: 307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 349
              D                + +V L C     E RP  +++V
Sbjct: 280 YCPD---------------PLYEVMLKCWHPKAEMRPSFSELV 307

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 131/283 (46%), Gaps = 38/283 (13%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIH 133
           +F+E  +IG+G FG VY G L DN       AVK L      G  + F  E  ++    H
Sbjct: 34  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 91
Query: 134 KNLLQLIGYCTTS-SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR-VAFG--TAY 189
            N+L L+G C  S    ++V P+M++  +   +R+          PT K  + FG   A 
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAK 145
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKL--THVTTQIRGTM 246
           G+++L  +   K +HRDL A N +LD+ F   + DFGLA+ ++D +    H  T  +  +
Sbjct: 146 GMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPV 202
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLRED 306
             +A E L T K + K+DV+ +G+ L EL+T + A  +               R+LL+ +
Sbjct: 203 KWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 261
Query: 307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 349
              D                + +V L C     E RP  +++V
Sbjct: 262 YCPD---------------PLYEVMLKCWHPKAEMRPSFSELV 289

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 130/283 (45%), Gaps = 38/283 (13%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIH 133
           +F+E  +IG+G FG VY G L DN       AVK L      G  + F  E  ++    H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 134 KNLLQLIGYCTTS-SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR-VAFG--TAY 189
            N+L L+G C  S    ++V P+M++  +   +R+          PT K  + FG   A 
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAK 144
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKL--THVTTQIRGTM 246
           G++YL  +   K +HRDL A N +LD+ F   + DFGLA+ + D +    H  T  +  +
Sbjct: 145 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 201
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLRED 306
             +A E L T K + K+DV+ +G+ L EL+T + A  +               R+LL+ +
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 260
Query: 307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 349
              D                + +V L C     E RP  +++V
Sbjct: 261 YCPD---------------PLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 130/283 (45%), Gaps = 38/283 (13%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIH 133
           +F+E  +IG+G FG VY G L DN       AVK L      G  + F  E  ++    H
Sbjct: 28  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 134 KNLLQLIGYCTTS-SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR-VAFG--TAY 189
            N+L L+G C  S    ++V P+M++  +   +R+          PT K  + FG   A 
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAK 139
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKL--THVTTQIRGTM 246
           G++YL  +   K +HRDL A N +LD+ F   + DFGLA+ + D +    H  T  +  +
Sbjct: 140 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLRED 306
             +A E L T K + K+DV+ +G+ L EL+T + A  +               R+LL+ +
Sbjct: 197 KWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 255
Query: 307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 349
              D                + +V L C     E RP  +++V
Sbjct: 256 YCPD---------------PLYEVMLKCWHPKAEMRPSFSELV 283

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 101/192 (52%), Gaps = 8/192 (4%)
Query: 85  IGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           IG+G FG+V+ G L +DNT VAVK  ++   P  +A F +E  ++    H N+++LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           T   ++  +Y  M+ +     L  L+     L   T  ++    A G+EYL  +C    I
Sbjct: 182 T---QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CI 235
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT-MGHIAPEYLSTGKSSEK 262
           HRDL A N L+ +     + DFG+++     +   +  +R   +   APE L+ G+ S +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 263 TDVFGYGITLLE 274
           +DV+ +GI L E
Sbjct: 296 SDVWSFGILLWE 307

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 124/274 (45%), Gaps = 36/274 (13%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           IG G FG V+ G   +  KVA+K +++      E  F  E  ++    H  L+QL G C 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRKRVAFGTAYGLEYLHEQCNPKII 203
             +   LV+ FM++  ++  LR     ++GL    T   +      G+ YL E     +I
Sbjct: 73  EQAPICLVFEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEA---SVI 125
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N L+ +N    + DFG+ + V       +T  +  +   +PE  S  + S K+
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 264 DVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNT----Y 319
           DV+ +G+ + E+        FS               K+  E+R N  V  +++T    Y
Sbjct: 186 DVWSFGVLMWEV--------FSEG-------------KIPYENRSNSEVVEDISTGFRLY 224
Query: 320 DSKEVETMV-QVALLCTQSTPEDRPPMAQVVKML 352
             +   T V Q+   C +  PEDRP  +++++ L
Sbjct: 225 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 130/283 (45%), Gaps = 38/283 (13%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIH 133
           +F+E  +IG+G FG VY G L DN       AVK L      G  + F  E  ++    H
Sbjct: 31  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 134 KNLLQLIGYCTTS-SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR-VAFG--TAY 189
            N+L L+G C  S    ++V P+M++  +   +R+          PT K  + FG   A 
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAK 142
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKL--THVTTQIRGTM 246
           G+++L  +   K +HRDL A N +LD+ F   + DFGLA+ + D +    H  T  +  +
Sbjct: 143 GMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 199
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLRED 306
             +A E L T K + K+DV+ +G+ L EL+T + A  +               R+LL+ +
Sbjct: 200 KWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 258
Query: 307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 349
              D                + +V L C     E RP  +++V
Sbjct: 259 YCPD---------------PLYEVMLKCWHPKAEMRPSFSELV 286

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 101/192 (52%), Gaps = 8/192 (4%)
Query: 85  IGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           IG+G FG+V+ G L +DNT VAVK  ++   P  +A F +E  ++    H N+++LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           T   ++  +Y  M+ +     L  L+     L   T  ++    A G+EYL  +C    I
Sbjct: 182 T---QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CI 235
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT-MGHIAPEYLSTGKSSEK 262
           HRDL A N L+ +     + DFG+++     +   +  +R   +   APE L+ G+ S +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 263 TDVFGYGITLLE 274
           +DV+ +GI L E
Sbjct: 296 SDVWSFGILLWE 307

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 130/283 (45%), Gaps = 38/283 (13%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIH 133
           +F+E  +IG+G FG VY G L DN       AVK L      G  + F  E  ++    H
Sbjct: 92  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 149
Query: 134 KNLLQLIGYCTTS-SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR-VAFG--TAY 189
            N+L L+G C  S    ++V P+M++  +   +R+          PT K  + FG   A 
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAK 203
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKL--THVTTQIRGTM 246
           G+++L  +   K +HRDL A N +LD+ F   + DFGLA+ + D +    H  T  +  +
Sbjct: 204 GMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 260
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLRED 306
             +A E L T K + K+DV+ +G+ L EL+T + A  +               R+LL+ +
Sbjct: 261 KWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 319
Query: 307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 349
              D                + +V L C     E RP  +++V
Sbjct: 320 YCPD---------------PLYEVMLKCWHPKAEMRPSFSELV 347

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 130/283 (45%), Gaps = 38/283 (13%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIH 133
           +F+E  +IG+G FG VY G L DN       AVK L      G  + F  E  ++    H
Sbjct: 38  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 95
Query: 134 KNLLQLIGYCTTS-SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR-VAFG--TAY 189
            N+L L+G C  S    ++V P+M++  +   +R+          PT K  + FG   A 
Sbjct: 96  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAK 149
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKL--THVTTQIRGTM 246
           G+++L  +   K +HRDL A N +LD+ F   + DFGLA+ + D +    H  T  +  +
Sbjct: 150 GMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 206
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLRED 306
             +A E L T K + K+DV+ +G+ L EL+T + A  +               R+LL+ +
Sbjct: 207 KWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 265
Query: 307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 349
              D                + +V L C     E RP  +++V
Sbjct: 266 YCPD---------------PLYEVMLKCWHPKAEMRPSFSELV 293

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 130/283 (45%), Gaps = 38/283 (13%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIH 133
           +F+E  +IG+G FG VY G L DN       AVK L      G  + F  E  ++    H
Sbjct: 34  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 91
Query: 134 KNLLQLIGYCTTS-SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR-VAFG--TAY 189
            N+L L+G C  S    ++V P+M++  +   +R+          PT K  + FG   A 
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAK 145
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKL--THVTTQIRGTM 246
           G+++L  +   K +HRDL A N +LD+ F   + DFGLA+ + D +    H  T  +  +
Sbjct: 146 GMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 202
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLRED 306
             +A E L T K + K+DV+ +G+ L EL+T + A  +               R+LL+ +
Sbjct: 203 KWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 261
Query: 307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 349
              D                + +V L C     E RP  +++V
Sbjct: 262 YCPD---------------PLYEVMLKCWHPKAEMRPSFSELV 289

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 130/283 (45%), Gaps = 38/283 (13%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIH 133
           +F+E  +IG+G FG VY G L DN       AVK L      G  + F  E  ++    H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 134 KNLLQLIGYCTTS-SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR-VAFG--TAY 189
            N+L L+G C  S    ++V P+M++  +   +R+          PT K  + FG   A 
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAK 144
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKL--THVTTQIRGTM 246
           G+++L  +   K +HRDL A N +LD+ F   + DFGLA+ + D +    H  T  +  +
Sbjct: 145 GMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 201
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLRED 306
             +A E L T K + K+DV+ +G+ L EL+T + A  +               R+LL+ +
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 260
Query: 307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 349
              D                + +V L C     E RP  +++V
Sbjct: 261 YCPD---------------PLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 130/283 (45%), Gaps = 38/283 (13%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIH 133
           +F+E  +IG+G FG VY G L DN       AVK L      G  + F  E  ++    H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 134 KNLLQLIGYCTTS-SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR-VAFG--TAY 189
            N+L L+G C  S    ++V P+M++  +   +R+          PT K  + FG   A 
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAK 144
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKL--THVTTQIRGTM 246
           G+++L  +   K +HRDL A N +LD+ F   + DFGLA+ + D +    H  T  +  +
Sbjct: 145 GMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 201
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLRED 306
             +A E L T K + K+DV+ +G+ L EL+T + A  +               R+LL+ +
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQGRRLLQPE 260
Query: 307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 349
              D                + +V L C     E RP  +++V
Sbjct: 261 YCPD---------------PLYEVMLKCWHPKAEMRPSFSELV 288

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 127/264 (48%), Gaps = 34/264 (12%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA--AFQREVHLISVAIHKNLLQLIGY 142
           +G G FG+V+    + +TKVAVK ++    PG  +  AF  E +++    H  L++L  +
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMK----PGSMSVEAFLAEANVMKTLQHDKLVKL--H 76
Query: 143 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--AYGLEYLHEQCN 199
              + E I ++  FM   S    L D    ++G   P  K + F    A G+ ++ EQ N
Sbjct: 77  AVVTKEPIYIITEFMAKGS----LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI-EQRN 131
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 259
              IHRDL+AANIL+  +    + DFGLA++++          +  +   APE ++ G  
Sbjct: 132 --YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 189
Query: 260 SEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTY 319
           + K+DV+ +GI L+E+VT  R I +              IR L R  R+     R  N  
Sbjct: 190 TIKSDVWSFGILLMEIVTYGR-IPYPGMSNPEV------IRALERGYRM----PRPENC- 237
Query: 320 DSKEVETMVQVALLCTQSTPEDRP 343
                E +  + + C ++ PE+RP
Sbjct: 238 ----PEELYNIMMRCWKNRPEERP 257

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 130/273 (47%), Gaps = 34/273 (12%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA--AFQREVHLISVAIHKNLLQLIGY 142
           +G G FG+V+    + +TKVAVK ++    PG  +  AF  E +++    H  L++L  +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMK----PGSMSVEAFLAEANVMKTLQHDKLVKL--H 249
Query: 143 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--AYGLEYLHEQCN 199
              + E I ++  FM   S    L D    ++G   P  K + F    A G+ ++ EQ N
Sbjct: 250 AVVTKEPIYIITEFMAKGS----LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI-EQRN 304
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 259
              IHRDL+AANIL+  +    + DFGLA++++          +  +   APE ++ G  
Sbjct: 305 --YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 362
Query: 260 SEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTY 319
           + K+DV+ +GI L+E+VT  R I +              IR L R  R+     R  N  
Sbjct: 363 TIKSDVWSFGILLMEIVTYGR-IPYPGMSNPEV------IRALERGYRM----PRPENC- 410
Query: 320 DSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
                E +  + + C ++ PE+RP    +  +L
Sbjct: 411 ----PEELYNIMMRCWKNRPEERPTFEYIQSVL 439

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 107/219 (48%), Gaps = 33/219 (15%)
Query: 84  IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAA-----FQREVHLISVAIHKNLLQ 138
           IIG GGFGKVY+     + +VAVK  +  + P  + +      ++E  L ++  H N++ 
Sbjct: 14  IIGIGGFGKVYRAFWIGD-EVAVKAAR--HDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLK-PGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
           L G C       LV  F +   +   L   + P +  ++W      A   A G+ YLH++
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------AVQIARGMNYLHDE 124
Query: 198 CNPKIIHRDLKAANILLDDNFEA--------VLCDFGLAKLVDAKLTHVTTQIR--GTMG 247
               IIHRDLK++NIL+    E          + DFGL     A+  H TT++   G   
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL-----AREWHRTTKMSAAGAYA 179
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ---RAID 283
            +APE +     S+ +DV+ YG+ L EL+TG+   R ID
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 101/195 (51%), Gaps = 11/195 (5%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA--AFQREVHLISVAIHKNLLQLIGY 142
           +G G FG+V+ G  +++TKVAVK L+    PG  +  AF  E +L+    H  L++L   
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLK----PGTMSVQAFLEEANLMKTLQHDKLVRLYAV 76
Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 202
            T      ++  +M   S+   L+  + G+  L  P     +   A G+ Y+  +     
Sbjct: 77  VTREEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERK---NY 131
Query: 203 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 262
           IHRDL+AAN+L+ ++    + DFGLA++++          +  +   APE ++ G  + K
Sbjct: 132 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK 191
Query: 263 TDVFGYGITLLELVT 277
           +DV+ +GI L E+VT
Sbjct: 192 SDVWSFGILLYEIVT 206

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 129/282 (45%), Gaps = 36/282 (12%)
Query: 82  SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
           S  IG G FG VYKG    +  V + ++ D  +P    AF+ EV ++    H N+L  +G
Sbjct: 41  STRIGSGSFGTVYKGKWHGDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMG 99
Query: 142 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 201
           Y T  +  I+     Q    +   + L   E          +A  TA G++YLH +    
Sbjct: 100 YMTKDNLAIVT----QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---N 152
Query: 202 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL--THVTTQIRGTMGHIAPEYL---ST 256
           IIHRD+K+ NI L +     + DFGLA  V ++   +    Q  G++  +APE +     
Sbjct: 153 IIHRDMKSNNIFLHEGLTVKIGDFGLAT-VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDN 211
Query: 257 GKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNL 316
              S ++DV+ YGI L EL+TG+  + +S            HI      D++  +V R  
Sbjct: 212 NPFSFQSDVYSYGIVLYELMTGE--LPYS------------HINN---RDQIIFMVGRGY 254
Query: 317 NTYDSKEV-----ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
            + D  ++     + M ++   C +   E+RP   Q++  ++
Sbjct: 255 ASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIE 296

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 101/195 (51%), Gaps = 11/195 (5%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA--AFQREVHLISVAIHKNLLQLIGY 142
           +G G FG+V+ G  +++TKVAVK L+    PG  +  AF  E +L+    H  L++L   
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLK----PGTMSVQAFLEEANLMKTLQHDKLVRLYAV 75
Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 202
            T      ++  FM   S+   L+  + G+  L  P     +   A G+ Y+  +     
Sbjct: 76  VTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERK---NY 130
Query: 203 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 262
           IHRDL+AAN+L+ ++    + DFGLA++++          +  +   APE ++ G  + K
Sbjct: 131 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK 190
Query: 263 TDVFGYGITLLELVT 277
           ++V+ +GI L E+VT
Sbjct: 191 SNVWSFGILLYEIVT 205

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 123/269 (45%), Gaps = 32/269 (11%)
Query: 85  IGQGGFGKVYKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G +G+VY+GV    +  VAVK L++      E  F +E  ++    H NL+QL+G C
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 83
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           T      ++  FM   ++   LR+    E  ++      +A   +  +EYL ++     I
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N L+ +N    + DFGL++L+           +  +   APE L+  K S K+
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 264 DVFGYGITLLELVT----GQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTY 319
           DV+ +G+ L E+ T        ID S+            + +LL +D     ++R     
Sbjct: 199 DVWAFGVLLWEIATYGMSPYPGIDLSQ------------VYELLEKDYR---MERPEGC- 242
Query: 320 DSKEVETMVQVALLCTQSTPEDRPPMAQV 348
                E + ++   C Q  P DRP  A++
Sbjct: 243 ----PEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 123/269 (45%), Gaps = 32/269 (11%)
Query: 85  IGQGGFGKVYKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G +G+VY+GV    +  VAVK L++      E  F +E  ++    H NL+QL+G C
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 79
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           T      ++  FM   ++   LR+    E  ++      +A   +  +EYL ++     I
Sbjct: 80  TREPPFYIIIEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK---NFI 134
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N L+ +N    + DFGL++L+           +  +   APE L+  K S K+
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 194
Query: 264 DVFGYGITLLELVT----GQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTY 319
           DV+ +G+ L E+ T        ID S+            + +LL +D     ++R     
Sbjct: 195 DVWAFGVLLWEIATYGMSPYPGIDLSQ------------VYELLEKDYR---MERPEGC- 238
Query: 320 DSKEVETMVQVALLCTQSTPEDRPPMAQV 348
                E + ++   C Q  P DRP  A++
Sbjct: 239 ----PEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 131/273 (47%), Gaps = 44/273 (16%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA--AFQREVHLISVAIHKNLLQLIGY 142
           +G G FG+V+    + +TKVAVK ++    PG  +  AF  E +++    H  L++L  +
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMK----PGSMSVEAFLAEANVMKTLQHDKLVKL--H 243
Query: 143 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--AYGLEYLHEQCN 199
              + E I ++  FM   S    L D    ++G   P  K + F    A G+ ++ EQ N
Sbjct: 244 AVVTKEPIYIITEFMAKGS----LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI-EQRN 298
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 259
              IHRDL+AANIL+  +    + DFGLA+ V AK       I+ T    APE ++ G  
Sbjct: 299 --YIHRDLRAANILVSASLVCKIADFGLAR-VGAKFP-----IKWT----APEAINFGSF 346
Query: 260 SEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTY 319
           + K+DV+ +GI L+E+VT  R I +              IR L R  R+     R  N  
Sbjct: 347 TIKSDVWSFGILLMEIVTYGR-IPYPGMSNPEV------IRALERGYRM----PRPENC- 394
Query: 320 DSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
                E +  + + C ++ PE+RP    +  +L
Sbjct: 395 ----PEELYNIMMRCWKNRPEERPTFEYIQSVL 423

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 123/269 (45%), Gaps = 32/269 (11%)
Query: 85  IGQGGFGKVYKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G +G+VY+GV    +  VAVK L++      E  F +E  ++    H NL+QL+G C
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 79
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           T      ++  FM   ++   LR+    E  ++      +A   +  +EYL ++     I
Sbjct: 80  TREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK---NFI 134
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N L+ +N    + DFGL++L+           +  +   APE L+  K S K+
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKS 194
Query: 264 DVFGYGITLLELVT----GQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTY 319
           DV+ +G+ L E+ T        ID S+            + +LL +D     ++R     
Sbjct: 195 DVWAFGVLLWEIATYGMSPYPGIDLSQ------------VYELLEKDYR---MERPEGC- 238
Query: 320 DSKEVETMVQVALLCTQSTPEDRPPMAQV 348
                E + ++   C Q  P DRP  A++
Sbjct: 239 ----PEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 123/269 (45%), Gaps = 32/269 (11%)
Query: 85  IGQGGFGKVYKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G +G+VY+GV    +  VAVK L++      E  F +E  ++    H NL+QL+G C
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 80
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           T      ++  FM   ++   LR+    E  ++      +A   +  +EYL ++     I
Sbjct: 81  TREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK---NFI 135
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N L+ +N    + DFGL++L+           +  +   APE L+  K S K+
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 264 DVFGYGITLLELVT----GQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTY 319
           DV+ +G+ L E+ T        ID S+            + +LL +D     ++R     
Sbjct: 196 DVWAFGVLLWEIATYGMSPYPGIDLSQ------------VYELLEKDYR---MERPEGC- 239
Query: 320 DSKEVETMVQVALLCTQSTPEDRPPMAQV 348
                E + ++   C Q  P DRP  A++
Sbjct: 240 ----PEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 130/289 (44%), Gaps = 34/289 (11%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLI 128
           +L   N S   ++G G FG+V  G L   +K    VA+K L+  Y+      F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 129 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--G 186
               H N+++L G  T S   ++V  +M+N S+   LR     +    +   + V    G
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-----KHDAQFTVIQLVGMLRG 155
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRG 244
            A G++YL +      +HRDL A NIL++ N    + DFGLA+++  D +  + T   + 
Sbjct: 156 IASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKI 212
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRXXXXXXXXXXXHIRKLL 303
            +   +PE ++  K +  +DV+ YGI L E+++ G+R                  I+ + 
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--------YWEMSNQDVIKAVD 264
Query: 304 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
              RL   +D     Y         Q+ L C Q    +RP   Q+V +L
Sbjct: 265 EGYRLPPPMDCPAALY---------QLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 123/269 (45%), Gaps = 32/269 (11%)
Query: 85  IGQGGFGKVYKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G +G+VY+GV    +  VAVK L++      E  F +E  ++    H NL+QL+G C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 78
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           T      ++  FM   ++   LR+    E  ++      +A   +  +EYL ++     I
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N L+ +N    + DFGL++L+           +  +   APE L+  K S K+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 264 DVFGYGITLLELVT----GQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTY 319
           DV+ +G+ L E+ T        ID S+            + +LL +D     ++R     
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPGIDLSQ------------VYELLEKDYR---MERPEGC- 237
Query: 320 DSKEVETMVQVALLCTQSTPEDRPPMAQV 348
                E + ++   C Q  P DRP  A++
Sbjct: 238 ----PEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 123/269 (45%), Gaps = 32/269 (11%)
Query: 85  IGQGGFGKVYKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G +G+VY+GV    +  VAVK L++      E  F +E  ++    H NL+QL+G C
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 82
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           T      ++  FM   ++   LR+    E  ++      +A   +  +EYL ++     I
Sbjct: 83  TREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK---NFI 137
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N L+ +N    + DFGL++L+           +  +   APE L+  K S K+
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 197
Query: 264 DVFGYGITLLELVT----GQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTY 319
           DV+ +G+ L E+ T        ID S+            + +LL +D     ++R     
Sbjct: 198 DVWAFGVLLWEIATYGMSPYPGIDLSQ------------VYELLEKDYR---MERPEGC- 241
Query: 320 DSKEVETMVQVALLCTQSTPEDRPPMAQV 348
                E + ++   C Q  P DRP  A++
Sbjct: 242 ----PEKVYELMRACWQWNPSDRPSFAEI 266

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 123/269 (45%), Gaps = 32/269 (11%)
Query: 85  IGQGGFGKVYKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G +G+VY+GV    +  VAVK L++      E  F +E  ++    H NL+QL+G C
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 83
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           T      ++  FM   ++   LR+    E  ++      +A   +  +EYL ++     I
Sbjct: 84  TREPPFYIIIEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N L+ +N    + DFGL++L+           +  +   APE L+  K S K+
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 264 DVFGYGITLLELVT----GQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTY 319
           DV+ +G+ L E+ T        ID S+            + +LL +D     ++R     
Sbjct: 199 DVWAFGVLLWEIATYGMSPYPGIDLSQ------------VYELLEKDYR---MERPEGC- 242
Query: 320 DSKEVETMVQVALLCTQSTPEDRPPMAQV 348
                E + ++   C Q  P DRP  A++
Sbjct: 243 ----PEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 123/269 (45%), Gaps = 32/269 (11%)
Query: 85  IGQGGFGKVYKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G +G+VY+GV    +  VAVK L++      E  F +E  ++    H NL+QL+G C
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 83
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           T      ++  FM   ++   LR+    E  ++      +A   +  +EYL ++     I
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N L+ +N    + DFGL++L+           +  +   APE L+  K S K+
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 264 DVFGYGITLLELVT----GQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTY 319
           DV+ +G+ L E+ T        ID S+            + +LL +D     ++R     
Sbjct: 199 DVWAFGVLLWEIATYGMSPYPGIDLSQ------------VYELLEKDYR---MERPEGC- 242
Query: 320 DSKEVETMVQVALLCTQSTPEDRPPMAQV 348
                E + ++   C Q  P DRP  A++
Sbjct: 243 ----PEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 123/269 (45%), Gaps = 32/269 (11%)
Query: 85  IGQGGFGKVYKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G +G+VY+GV    +  VAVK L++      E  F +E  ++    H NL+QL+G C
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 91
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           T      ++  FM   ++   LR+    E  ++      +A   +  +EYL ++     I
Sbjct: 92  TREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK---NFI 146
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N L+ +N    + DFGL++L+           +  +   APE L+  K S K+
Sbjct: 147 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 206
Query: 264 DVFGYGITLLELVT----GQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTY 319
           DV+ +G+ L E+ T        ID S+            + +LL +D     ++R     
Sbjct: 207 DVWAFGVLLWEIATYGMSPYPGIDLSQ------------VYELLEKDYR---MERPEGC- 250
Query: 320 DSKEVETMVQVALLCTQSTPEDRPPMAQV 348
                E + ++   C Q  P DRP  A++
Sbjct: 251 ----PEKVYELMRACWQWNPSDRPSFAEI 275

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 124/296 (41%), Gaps = 46/296 (15%)
Query: 85  IGQGGFGKVYK----GVLSDN--TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           IG+G FG+V++    G+L     T VAVK L++  S   +A FQRE  L++   + N+++
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 139 LIGYCTTSSERILVYPFM--------------------QNLSVAYRLRDLKPGEKGLDWP 178
           L+G C       L++ +M                     +  ++ R R   PG   L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 179 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTH 237
            +  +A   A G+ YL E+   K +HRDL   N L+ +N    + DFGL++ +  A    
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 238 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXX 297
                   +  + PE +   + + ++DV+ YG+ L E+ +      +             
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG------------ 279
Query: 298 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
               +  E+ +  + D N+          +  +  LC    P DRP    + ++LQ
Sbjct: 280 ----MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 331

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 123/269 (45%), Gaps = 32/269 (11%)
Query: 85  IGQGGFGKVYKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G +G+VY+GV    +  VAVK L++      E  F +E  ++    H NL+QL+G C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 78
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           T      ++  FM   ++   LR+    E  ++      +A   +  +EYL ++     I
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N L+ +N    + DFGL++L+           +  +   APE L+  K S K+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 264 DVFGYGITLLELVT----GQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTY 319
           DV+ +G+ L E+ T        ID S+            + +LL +D     ++R     
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPGIDLSQ------------VYELLEKDYR---MERPEGC- 237
Query: 320 DSKEVETMVQVALLCTQSTPEDRPPMAQV 348
                E + ++   C Q  P DRP  A++
Sbjct: 238 ----PEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 123/269 (45%), Gaps = 32/269 (11%)
Query: 85  IGQGGFGKVYKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G +G+VY+GV    +  VAVK L++      E  F +E  ++    H NL+QL+G C
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 80
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           T      ++  FM   ++   LR+    E  ++      +A   +  +EYL ++     I
Sbjct: 81  TREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK---NFI 135
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N L+ +N    + DFGL++L+           +  +   APE L+  K S K+
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 264 DVFGYGITLLELVT----GQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTY 319
           DV+ +G+ L E+ T        ID S+            + +LL +D     ++R     
Sbjct: 196 DVWAFGVLLWEIATYGMSPYPGIDLSQ------------VYELLEKDYR---MERPEGC- 239
Query: 320 DSKEVETMVQVALLCTQSTPEDRPPMAQV 348
                E + ++   C Q  P DRP  A++
Sbjct: 240 ----PEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 123/269 (45%), Gaps = 32/269 (11%)
Query: 85  IGQGGFGKVYKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G +G+VY+GV    +  VAVK L++      E  F +E  ++    H NL+QL+G C
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 80
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           T      ++  FM   ++   LR+    E  ++      +A   +  +EYL ++     I
Sbjct: 81  TREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK---NFI 135
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N L+ +N    + DFGL++L+           +  +   APE L+  K S K+
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 264 DVFGYGITLLELVT----GQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTY 319
           DV+ +G+ L E+ T        ID S+            + +LL +D     ++R     
Sbjct: 196 DVWAFGVLLWEIATYGMSPYPGIDLSQ------------VYELLEKDYR---MERPEGC- 239
Query: 320 DSKEVETMVQVALLCTQSTPEDRPPMAQV 348
                E + ++   C Q  P DRP  A++
Sbjct: 240 ----PEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 123/269 (45%), Gaps = 32/269 (11%)
Query: 85  IGQGGFGKVYKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G +G+VY+GV    +  VAVK L++      E  F +E  ++    H NL+QL+G C
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 83
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           T      ++  FM   ++   LR+    E  ++      +A   +  +EYL ++     I
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N L+ +N    + DFGL++L+           +  +   APE L+  K S K+
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 264 DVFGYGITLLELVT----GQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTY 319
           DV+ +G+ L E+ T        ID S+            + +LL +D     ++R     
Sbjct: 199 DVWAFGVLLWEIATYGMSPYPGIDLSQ------------VYELLEKDYR---MERPEGC- 242
Query: 320 DSKEVETMVQVALLCTQSTPEDRPPMAQV 348
                E + ++   C Q  P DRP  A++
Sbjct: 243 ----PEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/269 (27%), Positives = 122/269 (45%), Gaps = 32/269 (11%)
Query: 85  IGQGGFGKVYKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G FG+VY+GV    +  VAVK L++      E  F +E  ++    H NL+QL+G C
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 76
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           T      ++  FM   ++   LR+    E  +       +A   +  +EYL ++     I
Sbjct: 77  TREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEKK---NFI 131
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N L+ +N    + DFGL++L+           +  +   APE L+  K S K+
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 264 DVFGYGITLLELVT----GQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTY 319
           DV+ +G+ L E+ T        ID S+            + +LL +D     ++R     
Sbjct: 192 DVWAFGVLLWEIATYGMSPYPGIDPSQ------------VYELLEKDYR---MERPEGC- 235
Query: 320 DSKEVETMVQVALLCTQSTPEDRPPMAQV 348
                E + ++   C Q  P DRP  A++
Sbjct: 236 ----PEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 32/269 (11%)
Query: 85  IGQGGFGKVYKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G +G+VY+GV    +  VAVK L++      E  F +E  ++    H NL+QL+G C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 78
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           T      ++  FM   ++   LR+    E  +       +A   +  +EYL ++     I
Sbjct: 79  TREPPFYIIIEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N L+ +N    + DFGL++L+           +  +   APE L+  K S K+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 264 DVFGYGITLLELVT----GQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTY 319
           DV+ +G+ L E+ T        ID S+            + +LL +D     ++R     
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPGIDLSQ------------VYELLEKDYR---MERPEGC- 237
Query: 320 DSKEVETMVQVALLCTQSTPEDRPPMAQV 348
                E + ++   C Q  P DRP  A++
Sbjct: 238 ----PEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 130/289 (44%), Gaps = 34/289 (11%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLI 128
           +L   N S   ++G G FG+V  G L   +K    VA+K L+  Y+      F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 129 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--G 186
               H N+++L G  T S   ++V  +M+N S+   LR     +    +   + V    G
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-----KHDAQFTVIQLVGMLRG 155
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRG 244
            A G++YL +      +HRDL A NIL++ N    + DFGL++++  D +  + T   + 
Sbjct: 156 IASGMKYLSDM---GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRXXXXXXXXXXXHIRKLL 303
            +   +PE ++  K +  +DV+ YGI L E+++ G+R                  I+ + 
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--------YWEMSNQDVIKAVD 264
Query: 304 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
              RL   +D     Y         Q+ L C Q    +RP   Q+V +L
Sbjct: 265 EGYRLPPPMDCPAALY---------QLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 119/275 (43%), Gaps = 37/275 (13%)
Query: 84  IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           ++G+G FG V K        VA+K+++   S     AF  E+  +S   H N+++L G C
Sbjct: 16  VVGRGAFGVVCKAKWRAK-DVAIKQIE---SESERKAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKP-----GEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
                  LV  + +  S+   L   +P         + W          + G+ YLH   
Sbjct: 72  LNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQ 123
Query: 199 NPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 257
              +IHRDLK  N+LL      + +CDFG A  +    TH+T   +G+   +APE     
Sbjct: 124 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNN-KGSAAWMAPEVFEGS 179
Query: 258 KSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLN 317
             SEK DVF +GI L E++T ++  D               I   +       ++ +NL 
Sbjct: 180 NYSEKCDVFSWGIILWEVITRRKPFD-------EIGGPAFRIMWAVHNGTRPPLI-KNL- 230
Query: 318 TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
               K +E+++     C    P  RP M ++VK++
Sbjct: 231 ---PKPIESLMT---RCWSKDPSQRPSMEEIVKIM 259

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 130/289 (44%), Gaps = 34/289 (11%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLI 128
           +L   N S   ++G G FG+V  G L   +K    VA+K L+  Y+      F  E  ++
Sbjct: 29  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 88
Query: 129 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--G 186
               H N+++L G  T S   ++V  +M+N S+   LR     +    +   + V    G
Sbjct: 89  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-----KHDAQFTVIQLVGMLRG 143
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRG 244
            A G++YL +      +HRDL A NIL++ N    + DFGL++++  D +  + T   + 
Sbjct: 144 IASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 200
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRXXXXXXXXXXXHIRKLL 303
            +   +PE ++  K +  +DV+ YGI L E+++ G+R                  I+ + 
Sbjct: 201 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--------YWEMSNQDVIKAVD 252
Query: 304 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
              RL   +D     Y         Q+ L C Q    +RP   Q+V +L
Sbjct: 253 EGYRLPPPMDCPAALY---------QLMLDCWQKDRNNRPKFEQIVSIL 292

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 32/269 (11%)
Query: 85  IGQGGFGKVYKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G +G+VY+GV    +  VAVK L++      E  F +E  ++    H NL+QL+G C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 78
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           T      ++  FM   ++   LR+    E  +       +A   +  +EYL ++     I
Sbjct: 79  TREPPFYIIIEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N L+ +N    + DFGL++L+           +  +   APE L+  K S K+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 264 DVFGYGITLLELVT----GQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTY 319
           DV+ +G+ L E+ T        ID S+            + +LL +D     ++R     
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPGIDLSQ------------VYELLEKDYR---MERPEGC- 237
Query: 320 DSKEVETMVQVALLCTQSTPEDRPPMAQV 348
                E + ++   C Q  P DRP  A++
Sbjct: 238 ----PEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 119/275 (43%), Gaps = 37/275 (13%)
Query: 84  IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           ++G+G FG V K        VA+K+++   S     AF  E+  +S   H N+++L G C
Sbjct: 15  VVGRGAFGVVCKAKWRAK-DVAIKQIE---SESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKP-----GEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
                  LV  + +  S+   L   +P         + W          + G+ YLH   
Sbjct: 71  LNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQ 122
Query: 199 NPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 257
              +IHRDLK  N+LL      + +CDFG A  +    TH+T   +G+   +APE     
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNN-KGSAAWMAPEVFEGS 178
Query: 258 KSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLN 317
             SEK DVF +GI L E++T ++  D               I   +       ++ +NL 
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFD-------EIGGPAFRIMWAVHNGTRPPLI-KNL- 229
Query: 318 TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
               K +E+++     C    P  RP M ++VK++
Sbjct: 230 ---PKPIESLMT---RCWSKDPSQRPSMEEIVKIM 258

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 32/269 (11%)
Query: 85  IGQGGFGKVYKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G +G+VY+GV    +  VAVK L++      E  F +E  ++    H NL+QL+G C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 78
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           T      ++  FM   ++   LR+    E  +       +A   +  +EYL ++     I
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N L+ +N    + DFGL++L+           +  +   APE L+  K S K+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 264 DVFGYGITLLELVT----GQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTY 319
           DV+ +G+ L E+ T        ID S+            + +LL +D     ++R     
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPGIDLSQ------------VYELLEKDYR---MERPEGC- 237
Query: 320 DSKEVETMVQVALLCTQSTPEDRPPMAQV 348
                E + ++   C Q  P DRP  A++
Sbjct: 238 ----PEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 32/269 (11%)
Query: 85  IGQGGFGKVYKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G +G+VY+GV    +  VAVK L++      E  F +E  ++    H NL+QL+G C
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 78
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           T      ++  FM   ++   LR+    E  +       +A   +  +EYL ++     I
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N L+ +N    + DFGL++L+           +  +   APE L+  K S K+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 264 DVFGYGITLLELVT----GQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTY 319
           DV+ +G+ L E+ T        ID S+            + +LL +D     ++R     
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPGIDLSQ------------VYELLEKDYR---MERPEGC- 237
Query: 320 DSKEVETMVQVALLCTQSTPEDRPPMAQV 348
                E + ++   C Q  P DRP  A++
Sbjct: 238 ----PEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 32/269 (11%)
Query: 85  IGQGGFGKVYKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G +G+VY+GV    +  VAVK L++      E  F +E  ++    H NL+QL+G C
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 83
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           T      ++  FM   ++   LR+    E  +       +A   +  +EYL ++     I
Sbjct: 84  TREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N L+ +N    + DFGL++L+           +  +   APE L+  K S K+
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 264 DVFGYGITLLELVT----GQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTY 319
           DV+ +G+ L E+ T        ID S+            + +LL +D     ++R     
Sbjct: 199 DVWAFGVLLWEIATYGMSPYPGIDLSQ------------VYELLEKDYR---MERPEGC- 242
Query: 320 DSKEVETMVQVALLCTQSTPEDRPPMAQV 348
                E + ++   C Q  P DRP  A++
Sbjct: 243 ----PEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 130/289 (44%), Gaps = 34/289 (11%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLI 128
           +L   N S   ++G G FG+V  G L   +K    VA+K L+  Y+      F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 129 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--G 186
               H N+++L G  T S   ++V  +M+N S+   LR     +    +   + V    G
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-----KHDAQFTVIQLVGMLRG 155
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRG 244
            A G++YL +      +HRDL A NIL++ N    + DFGL++++  D +  + T   + 
Sbjct: 156 IASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRXXXXXXXXXXXHIRKLL 303
            +   +PE ++  K +  +DV+ YGI L E+++ G+R                  I+ + 
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--------YWEMSNQDVIKAVD 264
Query: 304 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
              RL   +D     Y         Q+ L C Q    +RP   Q+V +L
Sbjct: 265 EGYRLPPPMDCPAALY---------QLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 130/289 (44%), Gaps = 34/289 (11%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLI 128
           +L   N S   ++G G FG+V  G L   +K    VA+K L+  Y+      F  E  ++
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 129 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--G 186
               H N+++L G  T S   ++V  +M+N S+   LR     +    +   + V    G
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-----KHDAQFTVIQLVGMLRG 126
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRG 244
            A G++YL +      +HRDL A NIL++ N    + DFGL++++  D +  + T   + 
Sbjct: 127 IASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 183
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRXXXXXXXXXXXHIRKLL 303
            +   +PE ++  K +  +DV+ YGI L E+++ G+R                  I+ + 
Sbjct: 184 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--------YWEMSNQDVIKAVD 235
Query: 304 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
              RL   +D     Y         Q+ L C Q    +RP   Q+V +L
Sbjct: 236 EGYRLPPPMDCPAALY---------QLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 130/289 (44%), Gaps = 34/289 (11%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLI 128
           +L   N S   ++G G FG+V  G L   +K    VA+K L+  Y+      F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 129 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--G 186
               H N+++L G  T S   ++V  +M+N S+   LR     +    +   + V    G
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-----KHDAQFTVIQLVGMLRG 155
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRG 244
            A G++YL +      +HRDL A NIL++ N    + DFGL++++  D +  + T   + 
Sbjct: 156 IASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRXXXXXXXXXXXHIRKLL 303
            +   +PE ++  K +  +DV+ YGI L E+++ G+R                  I+ + 
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--------YWEMSNQDVIKAVD 264
Query: 304 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
              RL   +D     Y         Q+ L C Q    +RP   Q+V +L
Sbjct: 265 EGYRLPPPMDCPAALY---------QLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 130/289 (44%), Gaps = 34/289 (11%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLI 128
           +L   N S   ++G G FG+V  G L   +K    VA+K L+  Y+      F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 129 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--G 186
               H N+++L G  T S   ++V  +M+N S+   LR     +    +   + V    G
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-----KHDAQFTVIQLVGMLRG 155
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRG 244
            A G++YL +      +HRDL A NIL++ N    + DFGL++++  D +  + T   + 
Sbjct: 156 IASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRXXXXXXXXXXXHIRKLL 303
            +   +PE ++  K +  +DV+ YGI L E+++ G+R                  I+ + 
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--------YWEMSNQDVIKAVD 264
Query: 304 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
              RL   +D     Y         Q+ L C Q    +RP   Q+V +L
Sbjct: 265 EGYRLPPPMDCPAALY---------QLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 130/289 (44%), Gaps = 34/289 (11%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLI 128
           +L   N S   ++G G FG+V  G L   +K    VA+K L+  Y+      F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 129 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--G 186
               H N+++L G  T S   ++V  +M+N S+   LR     +    +   + V    G
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-----KHDAQFTVIQLVGMLRG 155
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRG 244
            A G++YL +      +HRDL A NIL++ N    + DFGL++++  D +  + T   + 
Sbjct: 156 IASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRXXXXXXXXXXXHIRKLL 303
            +   +PE ++  K +  +DV+ YGI L E+++ G+R                  I+ + 
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--------YWEMSNQDVIKAVD 264
Query: 304 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
              RL   +D     Y         Q+ L C Q    +RP   Q+V +L
Sbjct: 265 EGYRLPPPMDCPAALY---------QLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 130/289 (44%), Gaps = 34/289 (11%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLI 128
           +L   N S   ++G G FG+V  G L   +K    VA+K L+  Y+      F  E  ++
Sbjct: 39  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 98
Query: 129 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--G 186
               H N+++L G  T S   ++V  +M+N S+   LR     +    +   + V    G
Sbjct: 99  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-----KHDAQFTVIQLVGMLRG 153
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRG 244
            A G++YL +      +HRDL A NIL++ N    + DFGL++++  D +  + T   + 
Sbjct: 154 IASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 210
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRXXXXXXXXXXXHIRKLL 303
            +   +PE ++  K +  +DV+ YGI L E+++ G+R                  I+ + 
Sbjct: 211 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--------YWEMSNQDVIKAVD 262
Query: 304 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
              RL   +D     Y         Q+ L C Q    +RP   Q+V +L
Sbjct: 263 EGYRLPPPMDCPAALY---------QLMLDCWQKDRNNRPKFEQIVSIL 302

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 121/269 (44%), Gaps = 32/269 (11%)
Query: 85  IGQGGFGKVYKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G +G+VY+GV    +  VAVK L++      E  F +E  ++    H NL+QL+G C
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 76
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           T      ++  FM   ++   LR+    E          +A   +  +EYL ++     I
Sbjct: 77  TREPPFYIIIEFMTYGNLLDYLRECNRQEVSA--VVLLYMATQISSAMEYLEKK---NFI 131
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N L+ +N    + DFGL++L+           +  +   APE L+  K S K+
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 264 DVFGYGITLLELVT----GQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTY 319
           DV+ +G+ L E+ T        ID S+            + +LL +D     ++R     
Sbjct: 192 DVWAFGVLLWEIATYGMSPYPGIDPSQ------------VYELLEKDYR---MERPEGC- 235
Query: 320 DSKEVETMVQVALLCTQSTPEDRPPMAQV 348
                E + ++   C Q  P DRP  A++
Sbjct: 236 ----PEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 129/289 (44%), Gaps = 34/289 (11%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLI 128
           +L   N S   ++G G FG+V  G L   +K    VA+K L+  Y+      F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 129 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--G 186
               H N+++L G  T S   ++V  +M+N S+   LR     +    +   + V    G
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-----KHDAQFTVIQLVGMLRG 155
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRG 244
            A G++YL +      +HRDL A NIL++ N    + DFGL +++  D +  + T   + 
Sbjct: 156 IASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRXXXXXXXXXXXHIRKLL 303
            +   +PE ++  K +  +DV+ YGI L E+++ G+R                  I+ + 
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--------YWEMSNQDVIKAVD 264
Query: 304 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
              RL   +D     Y         Q+ L C Q    +RP   Q+V +L
Sbjct: 265 EGYRLPPPMDCPAALY---------QLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 32/269 (11%)
Query: 85  IGQGGFGKVYKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G +G+VY+GV    +  VAVK L++      E  F +E  ++    H NL+QL+G C
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 76
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           T      ++  FM   ++   LR+    E  +       +A   +  +EYL ++     I
Sbjct: 77  TREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEKK---NFI 131
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N L+ +N    + DFGL++L+           +  +   APE L+  K S K+
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 264 DVFGYGITLLELVT----GQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTY 319
           DV+ +G+ L E+ T        ID S+            + +LL +D     ++R     
Sbjct: 192 DVWAFGVLLWEIATYGMSPYPGIDPSQ------------VYELLEKDYR---MERPEGC- 235
Query: 320 DSKEVETMVQVALLCTQSTPEDRPPMAQV 348
                E + ++   C Q  P DRP  A++
Sbjct: 236 ----PEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 114/224 (50%), Gaps = 15/224 (6%)
Query: 60  SLTQLRRFSCRELQLATDN-FSESNIIGQGGFGKVYKGVLSDNTK--VAVKRLQDYYSPG 116
           S+  LR F+ +  ++  +  F++ + IG+G FG+VYKG+  ++TK  VA+K +    +  
Sbjct: 1   SMAHLRGFANQHSRVDPEELFTKLDRIGKGSFGEVYKGI-DNHTKEVVAIKIIDLEEAED 59
Query: 117 GEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLD 176
                Q+E+ ++S      + +  G    S++  ++   M+ L     L  LKPG   L+
Sbjct: 60  EIEDIQQEITVLSQCDSPYITRYFGSYLKSTKLWII---MEYLGGGSALDLLKPGP--LE 114
Query: 177 WPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKL 235
                 +      GL+YLH +   + IHRD+KAAN+LL +  +  L DFG+A +L D ++
Sbjct: 115 ETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 171
Query: 236 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
                   GT   +APE +       K D++  GIT +EL  G+
Sbjct: 172 KR--NXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE 213

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 129/289 (44%), Gaps = 34/289 (11%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLI 128
           +L   N S   ++G G FG+V  G L   +K    VA+K L+  Y+      F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 129 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--G 186
               H N+++L G  T S   ++V   M+N S+   LR     +    +   + V    G
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR-----KHDAQFTVIQLVGMLRG 155
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRG 244
            A G++YL +      +HRDL A NIL++ N    + DFGL++++  D +  + T   + 
Sbjct: 156 IASGMKYLSDM---GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRXXXXXXXXXXXHIRKLL 303
            +   +PE ++  K +  +DV+ YGI L E+++ G+R                  I+ + 
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--------YWEMSNQDVIKAVD 264
Query: 304 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
              RL   +D     Y         Q+ L C Q    +RP   Q+V +L
Sbjct: 265 EGYRLPPPMDCPAALY---------QLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 129/289 (44%), Gaps = 34/289 (11%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLI 128
           +L   N S   ++G G FG+V  G L   +K    VA+K L+  Y+      F  E  ++
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 129 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--G 186
               H N+++L G  T S   ++V   M+N S+   LR     +    +   + V    G
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR-----KHDAQFTVIQLVGMLRG 126
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRG 244
            A G++YL +      +HRDL A NIL++ N    + DFGL++++  D +  + T   + 
Sbjct: 127 IASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 183
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRXXXXXXXXXXXHIRKLL 303
            +   +PE ++  K +  +DV+ YGI L E+++ G+R                  I+ + 
Sbjct: 184 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--------YWEMSNQDVIKAVD 235
Query: 304 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
              RL   +D     Y         Q+ L C Q    +RP   Q+V +L
Sbjct: 236 EGYRLPPPMDCPAALY---------QLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 125/274 (45%), Gaps = 32/274 (11%)
Query: 85  IGQGGFGKVYKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G +G+VY+GV    +  VAVK L++      E  F +E  ++    H NL+QL+G C
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 324
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           T      ++  FM   ++   LR+    E  ++      +A   +  +EYL ++     I
Sbjct: 325 TREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK---NFI 379
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HR+L A N L+ +N    + DFGL++L+           +  +   APE L+  K S K+
Sbjct: 380 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 439
Query: 264 DVFGYGITLLELVT----GQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTY 319
           DV+ +G+ L E+ T        ID S+            + +LL +D     ++R     
Sbjct: 440 DVWAFGVLLWEIATYGMSPYPGIDLSQ------------VYELLEKDYR---MERPEGC- 483
Query: 320 DSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                E + ++   C Q  P DRP  A++ +  +
Sbjct: 484 ----PEKVYELMRACWQWNPSDRPSFAEIHQAFE 513

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 129/289 (44%), Gaps = 34/289 (11%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLI 128
           +L   N S   ++G G FG+V  G L   +K    VA+K L+  Y+      F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 129 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--G 186
               H N+++L G  T S   ++V   M+N S+   LR     +    +   + V    G
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR-----KHDAQFTVIQLVGMLRG 155
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRG 244
            A G++YL +      +HRDL A NIL++ N    + DFGL++++  D +  + T   + 
Sbjct: 156 IASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRXXXXXXXXXXXHIRKLL 303
            +   +PE ++  K +  +DV+ YGI L E+++ G+R                  I+ + 
Sbjct: 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--------YWEMSNQDVIKAVD 264
Query: 304 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
              RL   +D     Y         Q+ L C Q    +RP   Q+V +L
Sbjct: 265 EGYRLPPPMDCPAALY---------QLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 110/219 (50%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++G G FG VYKG+ + +  KV    A+K L++  SP        E +++
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 129 SVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ +++  + PF   L      +D    +  L+W         
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNW------CVQ 125
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFGLAKL+ A+      +  +  
Sbjct: 126 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 115/256 (44%), Gaps = 33/256 (12%)
Query: 51  VAGEDDCKVSLTQLRRFSCR-ELQLATDNFSESNIIGQGGFGKVYKGVLSDNTK------ 103
           V G  D +      R +    + +   +N     ++G G FGKV        +K      
Sbjct: 18  VTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQ 77
Query: 104 VAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLLQLIGYCTTSSERILVYPF--MQNLS 160
           VAVK L++        A   E+ +++ +  H+N++ L+G CT S    L++ +    +L 
Sbjct: 78  VAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLL 137
Query: 161 VAYRLRDLKPGEKGLDWPTRKRV-----------------AFGTAYGLEYLH-EQCNPKI 202
              R +  K  E  +++  +KR+                 A+  A G+E+L  + C    
Sbjct: 138 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC---- 193
Query: 203 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QIRGTMGHIAPEYLSTGKSSE 261
           +HRDL A N+L+       +CDFGLA+ + +   +V     R  +  +APE L  G  + 
Sbjct: 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI 253
Query: 262 KTDVFGYGITLLELVT 277
           K+DV+ YGI L E+ +
Sbjct: 254 KSDVWSYGILLWEIFS 269

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 110/219 (50%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++G G FG VYKG+ + +  KV    A+K L++  SP        E +++
Sbjct: 13  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 72
Query: 129 SVAIHKNLLQLIGYCTTSSERILV--YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ ++++   PF   L      +D    +  L+W         
Sbjct: 73  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNW------CVQ 126
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFGLAKL+ A+      +  +  
Sbjct: 127 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 183
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 110/219 (50%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++G G FG VYKG+ + +  KV    A+K L++  SP        E +++
Sbjct: 22  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 81
Query: 129 SVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ +++  + PF   L      +D    +  L+W         
Sbjct: 82  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 135
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFGLAKL+ A+      +  +  
Sbjct: 136 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 192
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 193 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 125/279 (44%), Gaps = 36/279 (12%)
Query: 84  IIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +IG G FG+V  G L    K    VA+K L+  Y+      F  E  ++    H N++ L
Sbjct: 36  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 95
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--GTAYGLEYLHEQ 197
            G  T     +++  +M+N S+   LR     +    +   + V    G   G++YL + 
Sbjct: 96  EGVVTKCKPVMIITEYMENGSLDAFLR-----KNDGRFTVIQLVGMLRGIGSGMKYLSDM 150
Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLS 255
                +HRDL A NIL++ N    + DFG+++++  D +  + T   +  +   APE ++
Sbjct: 151 ---SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 207
Query: 256 TGKSSEKTDVFGYGITLLELVT-GQRAI-DFSRXXXXXXXXXXXHIRKLLREDRLNDIVD 313
             K +  +DV+ YGI + E+++ G+R   D S             I+ +    RL   +D
Sbjct: 208 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---------IKAIEEGYRLPPPMD 258
Query: 314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
             +  +         Q+ L C Q    DRP   Q+V ML
Sbjct: 259 CPIALH---------QLMLDCWQKERSDRPKFGQIVNML 288

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 124/274 (45%), Gaps = 32/274 (11%)
Query: 85  IGQGGFGKVYKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G G +G+VY+GV    +  VAVK L++      E  F +E  ++    H NL+QL+G C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 285
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           T      ++  FM   ++   LR+    E  +       +A   +  +EYL ++     I
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEKK---NFI 340
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HR+L A N L+ +N    + DFGL++L+           +  +   APE L+  K S K+
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 264 DVFGYGITLLELVT----GQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTY 319
           DV+ +G+ L E+ T        ID S+            + +LL +D     ++R     
Sbjct: 401 DVWAFGVLLWEIATYGMSPYPGIDLSQ------------VYELLEKDYR---MERPEGC- 444
Query: 320 DSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                E + ++   C Q  P DRP  A++ +  +
Sbjct: 445 ----PEKVYELMRACWQWNPSDRPSFAEIHQAFE 474

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 110/219 (50%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++G G FG VYKG+ + +  KV    A+K L++  SP        E +++
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 129 SVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ +++  + PF   L      +D    +  L+W         
Sbjct: 66  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 119
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFGLAKL+ A+      +  +  
Sbjct: 120 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 125/279 (44%), Gaps = 36/279 (12%)
Query: 84  IIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +IG G FG+V  G L    K    VA+K L+  Y+      F  E  ++    H N++ L
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 80
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--GTAYGLEYLHEQ 197
            G  T     +++  +M+N S+   LR     +    +   + V    G   G++YL + 
Sbjct: 81  EGVVTKCKPVMIITEYMENGSLDAFLR-----KNDGRFTVIQLVGMLRGIGSGMKYLSDM 135
Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLS 255
                +HRDL A NIL++ N    + DFG+++++  D +  + T   +  +   APE ++
Sbjct: 136 ---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 192
Query: 256 TGKSSEKTDVFGYGITLLELVT-GQRAI-DFSRXXXXXXXXXXXHIRKLLREDRLNDIVD 313
             K +  +DV+ YGI + E+++ G+R   D S             I+ +    RL   +D
Sbjct: 193 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---------IKAIEEGYRLPPPMD 243
Query: 314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
             +  +         Q+ L C Q    DRP   Q+V ML
Sbjct: 244 CPIALH---------QLMLDCWQKERSDRPKFGQIVNML 273

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 110/219 (50%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++G G FG VYKG+ + +  KV    A+K L++  SP        E +++
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 129 SVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ +++  + PF   L      +D    +  L+W         
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 125
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFGLAKL+ A+      +  +  
Sbjct: 126 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 110/219 (50%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++G G FG VYKG+ + +  KV    A+K L++  SP        E +++
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 129 SVAIHKNLLQLIGYCTTSSERILV--YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ ++++   PF   L      +D    +  L+W         
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 125
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFGLAKL+ A+      +  +  
Sbjct: 126 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 110/219 (50%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++G G FG VYKG+ + +  KV    A+K L++  SP        E +++
Sbjct: 13  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 72
Query: 129 SVAIHKNLLQLIGYCTTSSERILV--YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ ++++   PF   L      +D    +  L+W         
Sbjct: 73  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 126
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFGLAKL+ A+      +  +  
Sbjct: 127 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 183
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 184 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 110/219 (50%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++G G FG VYKG+ + +  KV    A+K L++  SP        E +++
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 129 SVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ +++  + PF   L      +D    +  L+W         
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 125
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFGLAKL+ A+      +  +  
Sbjct: 126 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 110/219 (50%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++G G FG VYKG+ + +  KV    A+K L++  SP        E +++
Sbjct: 9   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 68
Query: 129 SVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ +++  + PF   L      +D    +  L+W         
Sbjct: 69  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 122
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFGLAKL+ A+      +  +  
Sbjct: 123 IAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 179
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 180 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 110/219 (50%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++G G FG VYKG+ + +  KV    A+K L++  SP        E +++
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 129 SVAIHKNLLQLIGYCTTSSERILV--YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ ++++   PF   L      +D    +  L+W         
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 127
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFGLAKL+ A+      +  +  
Sbjct: 128 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 184
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 110/219 (50%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++G G FG VYKG+ + +  KV    A+K L++  SP        E +++
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 129 SVAIHKNLLQLIGYCTTSSERILV--YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ ++++   PF   L      +D    +  L+W         
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 128
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFGLAKL+ A+      +  +  
Sbjct: 129 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 110/219 (50%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++G G FG VYKG+ + +  KV    A+K L++  SP        E +++
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 129 SVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ +++  + PF   L      +D    +  L+W         
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 128
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFGLAKL+ A+      +  +  
Sbjct: 129 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 110/219 (50%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++G G FG VYKG+ + +  KV    A+K L++  SP        E +++
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 129 SVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ +++  + PF   L      +D    +  L+W         
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 128
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFGLAKL+ A+      +  +  
Sbjct: 129 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 125/279 (44%), Gaps = 36/279 (12%)
Query: 84  IIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +IG G FG+V  G L    K    VA+K L+  Y+      F  E  ++    H N++ L
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 74
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--GTAYGLEYLHEQ 197
            G  T     +++  +M+N S+   LR     +    +   + V    G   G++YL + 
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDAFLR-----KNDGRFTVIQLVGMLRGIGSGMKYLSDM 129
Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLS 255
                +HRDL A NIL++ N    + DFG+++++  D +  + T   +  +   APE ++
Sbjct: 130 ---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 186
Query: 256 TGKSSEKTDVFGYGITLLELVT-GQRAI-DFSRXXXXXXXXXXXHIRKLLREDRLNDIVD 313
             K +  +DV+ YGI + E+++ G+R   D S             I+ +    RL   +D
Sbjct: 187 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---------IKAIEEGYRLPPPMD 237
Query: 314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
             +  +         Q+ L C Q    DRP   Q+V ML
Sbjct: 238 CPIALH---------QLMLDCWQKERSDRPKFGQIVNML 267

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 110/219 (50%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++G G FG VYKG+ + +  KV    A+K L++  SP        E +++
Sbjct: 16  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 75
Query: 129 SVAIHKNLLQLIGYCTTSSERILV--YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ ++++   PF   L      +D    +  L+W         
Sbjct: 76  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 129
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFGLAKL+ A+      +  +  
Sbjct: 130 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 186
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 110/219 (50%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++G G FG VYKG+ + +  KV    A+K L++  SP        E +++
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 129 SVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ +++  + PF   L      +D    +  L+W         
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 128
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFGLAKL+ A+      +  +  
Sbjct: 129 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 186 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 110/219 (50%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++G G FG VYKG+ + +  KV    A+K L++  SP        E +++
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 129 SVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ +++  + PF   L      +D    +  L+W         
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 127
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFGLAKL+ A+      +  +  
Sbjct: 128 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 184
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 110/219 (50%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++G G FG VYKG+ + +  KV    A+K L++  SP        E +++
Sbjct: 18  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 77
Query: 129 SVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ +++  + PF   L      +D    +  L+W         
Sbjct: 78  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 131
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFGLAKL+ A+      +  +  
Sbjct: 132 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 188
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 189 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 227

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 110/219 (50%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++G G FG VYKG+ + +  KV    A+K L++  SP        E +++
Sbjct: 19  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 129 SVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ +++  + PF   L      +D    +  L+W         
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 132
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFGLAKL+ A+      +  +  
Sbjct: 133 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 7/208 (3%)
Query: 75  ATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH 133
           ++  F +   +G G +  VYKG+  +    VA+K ++     G  +   RE+ L+    H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 134 KNLLQLIGYCTTSSERILVYPFMQN-LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 192
           +N+++L     T ++  LV+ FM N L      R +    +GL+    K   +    GL 
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 252
           + HE    KI+HRDLK  N+L++   +  L DFGLA+     +   ++++  T+ + AP+
Sbjct: 123 FCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPD 178
Query: 253 YLSTGKS-SEKTDVFGYGITLLELVTGQ 279
            L   ++ S   D++  G  L E++TG+
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 110/219 (50%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++G G FG VYKG+ + +  KV    A+K L++  SP        E +++
Sbjct: 37  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 96
Query: 129 SVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ +++  + PF   L      +D    +  L+W         
Sbjct: 97  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 150
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFGLAKL+ A+      +  +  
Sbjct: 151 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 207
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 208 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 102/207 (49%), Gaps = 24/207 (11%)
Query: 84  IIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +IG+G FG VY G   D  +     A+K L          AF RE  L+    H N+L L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 140 IGYCTTSS--ERILVYPFMQNLSVAYRLRDLK--PGEKGLDWPTRKRVAFG--TAYGLEY 193
           IG          +L+ P+M +  +   +R  +  P  K L       ++FG   A G+EY
Sbjct: 88  IGIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTVKDL-------ISFGLQVARGMEY 139
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHVTT--QIRGTMGHIA 250
           L EQ   K +HRDL A N +LD++F   + DFGLA+ ++D +   V      R  +   A
Sbjct: 140 LAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA 196
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVT 277
            E L T + + K+DV+ +G+ L EL+T
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 84  IIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           ++G G FG VYKG+      +    VA+K L +   P     F  E  +++   H +L++
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 139 LIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 196
           L+G C + + +++  + P    L   +  +D    +  L+W          A G+ YL E
Sbjct: 82  LLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE 135
Query: 197 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGTMGHIAPEYLS 255
           +   +++HRDL A N+L+       + DFGLA+L++           +  +  +A E + 
Sbjct: 136 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 192
Query: 256 TGKSSEKTDVFGYGITLLELVT 277
             K + ++DV+ YG+T+ EL+T
Sbjct: 193 YRKFTHQSDVWSYGVTIWELMT 214

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 21/209 (10%)
Query: 84  IIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +IG G FG+V +G L    K    VA+K L+  Y+      F  E  ++    H N+++L
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--GTAYGLEYLHEQ 197
            G  T S   +++  FM+N ++   LR L  G+    +   + V    G A G+ YL E 
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLR-LNDGQ----FTVIQLVGMLRGIASGMRYLAEM 137
Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI-----APE 252
                +HRDL A NIL++ N    + DFGL++ ++   +   T+     G I     APE
Sbjct: 138 ---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSD-PTETSSLGGKIPIRWTAPE 193
Query: 253 YLSTGKSSEKTDVFGYGITLLELVT-GQR 280
            ++  K +  +D + YGI + E+++ G+R
Sbjct: 194 AIAFRKFTSASDAWSYGIVMWEVMSFGER 222

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 12/203 (5%)
Query: 79  FSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
           F++   IG+G FG+V+KG+ +   KV A+K +    +       Q+E+ ++S      + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
           +  G     ++  ++   M+ L     L  L+PG   LD      +      GL+YLH +
Sbjct: 89  KYYGSYLKDTKLWII---MEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSE 143
Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYLST 256
              K IHRD+KAAN+LL ++ E  L DFG+A +L D ++   T    GT   +APE +  
Sbjct: 144 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 198
Query: 257 GKSSEKTDVFGYGITLLELVTGQ 279
                K D++  GIT +EL  G+
Sbjct: 199 SAYDSKADIWSLGITAIELARGE 221

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 12/203 (5%)
Query: 79  FSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
           F++   IG+G FG+V+KG+ +   KV A+K +    +       Q+E+ ++S      + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
           +  G     ++  ++   M+ L     L  L+PG   LD      +      GL+YLH +
Sbjct: 69  KYYGSYLKDTKLWII---MEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSE 123
Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYLST 256
              K IHRD+KAAN+LL ++ E  L DFG+A +L D ++   T    GT   +APE +  
Sbjct: 124 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 178
Query: 257 GKSSEKTDVFGYGITLLELVTGQ 279
                K D++  GIT +EL  G+
Sbjct: 179 SAYDSKADIWSLGITAIELARGE 201

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 99/203 (48%), Gaps = 17/203 (8%)
Query: 83  NIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
            ++G G FG VYKG+      +    VA+K L +   P     F  E  +++   H +L+
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 138 QLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
           +L+G C + + +++  + P    L   +  +D    +  L+W          A G+ YL 
Sbjct: 104 RLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 157
Query: 196 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGTMGHIAPEYL 254
           E+   +++HRDL A N+L+       + DFGLA+L++           +  +  +A E +
Sbjct: 158 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 214
Query: 255 STGKSSEKTDVFGYGITLLELVT 277
              K + ++DV+ YG+T+ EL+T
Sbjct: 215 HYRKFTHQSDVWSYGVTIWELMT 237

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 84  IIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +IG G FG+V +G L    K    VA+K L+  Y+      F  E  ++    H N+++L
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--GTAYGLEYLHEQ 197
            G  T S   +++  FM+N ++   LR L  G+    +   + V    G A G+ YL E 
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFLR-LNDGQ----FTVIQLVGMLRGIASGMRYLAEM 135
Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH--VTTQIRGTMG--HIAPEY 253
                +HRDL A NIL++ N    + DFGL++ ++   +    T+ + G +     APE 
Sbjct: 136 ---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEA 192
Query: 254 LSTGKSSEKTDVFGYGITLLELVT-GQR 280
           ++  K +  +D + YGI + E+++ G+R
Sbjct: 193 IAFRKFTSASDAWSYGIVMWEVMSFGER 220

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 84  IIGQGGFGKVYKGVL--SDNT--KVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           I+G+G FG V +G L   D T  KVAVK ++ D  S      F  E   +    H N+++
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 139 LIGYCTTSSER-----ILVYPFMQ--NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL 191
           L+G C   S +     +++ PFM+  +L        L+ G K +   T  +     A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 192 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI-RGTMGHIA 250
           EYL    N   +HRDL A N +L D+    + DFGL+K + +   +   +I +  +  IA
Sbjct: 161 EYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVT 277
            E L+    + K+DV+ +G+T+ E+ T
Sbjct: 218 IESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 19/209 (9%)
Query: 84  IIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +IG G FG+V  G L    K    VA+K L+  Y+      F  E  ++    H N++ L
Sbjct: 40  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 99
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--GTAYGLEYLHEQ 197
            G  T S+  +++  FM+N S+   LR     +    +   + V    G A G++YL + 
Sbjct: 100 EGVVTKSTPVMIITEFMENGSLDSFLR-----QNDGQFTVIQLVGMLRGIAAGMKYLADM 154
Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMG--HIAPEY 253
                +HRDL A NIL++ N    + DFGL++ +  D      T+ + G +     APE 
Sbjct: 155 ---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 211
Query: 254 LSTGKSSEKTDVFGYGITLLELVT-GQRA 281
           +   K +  +DV+ YGI + E+++ G+R 
Sbjct: 212 IQYRKFTSASDVWSYGIVMWEVMSYGERP 240

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 12/203 (5%)
Query: 79  FSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
           F++   IG+G FG+V+KG+ +   KV A+K +    +       Q+E+ ++S      + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
           +  G     ++  ++   M+ L     L  L+PG   LD      +      GL+YLH +
Sbjct: 84  KYYGSYLKDTKLWII---MEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSE 138
Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYLST 256
              K IHRD+KAAN+LL ++ E  L DFG+A +L D ++        GT   +APE +  
Sbjct: 139 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NXFVGTPFWMAPEVIKQ 193
Query: 257 GKSSEKTDVFGYGITLLELVTGQ 279
                K D++  GIT +EL  G+
Sbjct: 194 SAYDSKADIWSLGITAIELARGE 216

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++G G FG VYKG+ + +  KV    A+  L++  SP        E +++
Sbjct: 46  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVM 105
Query: 129 SVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ +++  + PF   L      +D    +  L+W         
Sbjct: 106 ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 159
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFGLAKL+ A+      +  +  
Sbjct: 160 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 216
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 217 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 255

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 12/203 (5%)
Query: 79  FSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
           F++   IG+G FG+V+KG+ +   KV A+K +    +       Q+E+ ++S      + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
           +  G     ++  ++   M+ L     L  L+PG   LD      +      GL+YLH +
Sbjct: 69  KYYGSYLKDTKLWII---MEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSE 123
Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYLST 256
              K IHRD+KAAN+LL ++ E  L DFG+A +L D ++        GT   +APE +  
Sbjct: 124 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NXFVGTPFWMAPEVIKQ 178
Query: 257 GKSSEKTDVFGYGITLLELVTGQ 279
                K D++  GIT +EL  G+
Sbjct: 179 SAYDSKADIWSLGITAIELARGE 201

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 103/229 (44%), Gaps = 16/229 (6%)
Query: 60  SLTQLRRFSCRELQ---LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG 116
           SL  LR    + L+   +  D F +  ++G+GGFG+V+   +    K+   +  +     
Sbjct: 165 SLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK 224
Query: 117 GEAAFQREV--HLISVAIHKNLLQLIGYC-TTSSERILVYPFMQNLSVAYRLRDLKPGEK 173
               +Q  +    I   +H   +  + Y   T ++  LV   M    + Y + ++     
Sbjct: 225 KRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP 284
Query: 174 GLDWPTRKRVAFGTAY---GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 230
           G   P   R  F TA    GLE+LH++    II+RDLK  N+LLDD+    + D GLA  
Sbjct: 285 GFQEP---RAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVE 338
Query: 231 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           + A  T  T    GT G +APE L   +     D F  G+TL E++  +
Sbjct: 339 LKAGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 103/229 (44%), Gaps = 16/229 (6%)
Query: 60  SLTQLRRFSCRELQ---LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG 116
           SL  LR    + L+   +  D F +  ++G+GGFG+V+   +    K+   +  +     
Sbjct: 165 SLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK 224
Query: 117 GEAAFQREV--HLISVAIHKNLLQLIGYC-TTSSERILVYPFMQNLSVAYRLRDLKPGEK 173
               +Q  +    I   +H   +  + Y   T ++  LV   M    + Y + ++     
Sbjct: 225 KRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP 284
Query: 174 GLDWPTRKRVAFGTAY---GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 230
           G   P   R  F TA    GLE+LH++    II+RDLK  N+LLDD+    + D GLA  
Sbjct: 285 GFQEP---RAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVE 338
Query: 231 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           + A  T  T    GT G +APE L   +     D F  G+TL E++  +
Sbjct: 339 LKAGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++G G FG VYKG+ + +  KV    A+K L++  SP        E +++
Sbjct: 16  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 75
Query: 129 SVAIHKNLLQLIGYCTTSSERILV--YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ ++++   PF   L      +D    +  L+W         
Sbjct: 76  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 129
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFG AKL+ A+      +  +  
Sbjct: 130 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 186
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 187 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++G G FG VYKG+ + +  KV    A+K L++  SP        E +++
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 129 SVAIHKNLLQLIGYCTTSSERILV--YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ ++++   PF   L      +D    +  L+W         
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 127
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFG AKL+ A+      +  +  
Sbjct: 128 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++G G FG VYKG+ + +  KV    A+K L++  SP        E +++
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 129 SVAIHKNLLQLIGYCTTSSERILV--YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ ++++   PF   L      +D    +  L+W         
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 127
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFG AKL+ A+      +  +  
Sbjct: 128 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 103/229 (44%), Gaps = 16/229 (6%)
Query: 60  SLTQLRRFSCRELQ---LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPG 116
           SL  LR    + L+   +  D F +  ++G+GGFG+V+   +    K+   +  +     
Sbjct: 165 SLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK 224
Query: 117 GEAAFQREV--HLISVAIHKNLLQLIGYC-TTSSERILVYPFMQNLSVAYRLRDLKPGEK 173
               +Q  +    I   +H   +  + Y   T ++  LV   M    + Y + ++     
Sbjct: 225 KRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP 284
Query: 174 GLDWPTRKRVAFGTAY---GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 230
           G   P   R  F TA    GLE+LH++    II+RDLK  N+LLDD+    + D GLA  
Sbjct: 285 GFQEP---RAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVE 338
Query: 231 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           + A  T  T    GT G +APE L   +     D F  G+TL E++  +
Sbjct: 339 LKAGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++G G FG VYKG+ + +  KV    A+K L++  SP        E +++
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 129 SVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ +++  + PF   L      +D    +  L+W         
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 125
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFG AKL+ A+      +  +  
Sbjct: 126 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 182
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++  G FG VYKG+ + +  KV    A+K L++  SP        E +++
Sbjct: 12  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 129 SVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ +++  + PF   L      +D    +  L+W         
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 125
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFGLAKL+ A+      +  +  
Sbjct: 126 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++  G FG VYKG+ + +  KV    A+K L++  SP        E +++
Sbjct: 19  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 129 SVAIHKNLLQLIGYCTTSSERILV--YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ ++++   PF   L      +D    +  L+W         
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 132
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFGLAKL+ A+      +  +  
Sbjct: 133 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 122/240 (50%), Gaps = 38/240 (15%)
Query: 54  EDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDY 112
           E DC+  L         E     D   +  ++G+G +G VY G  LS+  ++A+K +   
Sbjct: 7   EGDCESDLL--------EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI--- 55
Query: 113 YSPGGEAAFQREVHLISVAIHKNLLQ--LIGYCTTSSERILVYPFMQNL---SVAYRLRD 167
             P  ++ + + +H   +A+HK+L    ++ Y  + SE   +  FM+ +   S++  LR 
Sbjct: 56  --PERDSRYSQPLHE-EIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRS 112
Query: 168 ----LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL- 222
               LK  E+ + + T++ +      GL+YLH+    +I+HRD+K  N+L+ + +  VL 
Sbjct: 113 KWGPLKDNEQTIGFYTKQILE-----GLKYLHDN---QIVHRDIKGDNVLI-NTYSGVLK 163
Query: 223 -CDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS--SEKTDVFGYGITLLELVTGQ 279
             DFG +K + A +   T    GT+ ++APE +  G     +  D++  G T++E+ TG+
Sbjct: 164 ISDFGTSKRL-AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++G G FG VYKG+ + +  KV    A+K L++  SP        E +++
Sbjct: 19  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 129 SVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ +++  + PF   L      +D    +  L+W         
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 132
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFG AKL+ A+      +  +  
Sbjct: 133 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 189
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++  G FG VYKG+ + +  KV    A+K L++  SP        E +++
Sbjct: 19  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 129 SVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ +++  + PF   L      +D    +  L+W         
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 132
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFGLAKL+ A+      +  +  
Sbjct: 133 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 109/219 (49%), Gaps = 18/219 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGV-LSDNTKV----AVKRLQDYYSPGGEAAFQREVHLI 128
           L    F +  ++G G FG VYKG+ + +  KV    A+K L++  SP        E +++
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 129 SVAIHKNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +   + ++ +L+G C TS+ +++  + PF   L      +D    +  L+W         
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 127
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGT 245
            A G+ YL ++   +++HRDL A N+L+       + DFG AKL+ A+      +  +  
Sbjct: 128 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID 283
           +  +A E +     + ++DV+ YG+T+ EL+T G +  D
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 13/212 (6%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREV--HLISVA 131
           +  D F +  ++G+GGFG+V+   +    K+   +  +         +Q  +    I   
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 132 IHKNLLQLIGYC-TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY- 189
           +H   +  + Y   T ++  LV   M    + Y + ++     G   P   R  F TA  
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP---RAIFYTAQI 298
Query: 190 --GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 247
             GLE+LH++    II+RDLK  N+LLDD+    + D GLA  + A  T  T    GT G
Sbjct: 299 VSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPG 354
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
            +APE L   +     D F  G+TL E++  +
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 123/278 (44%), Gaps = 34/278 (12%)
Query: 84  IIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +IG G FG+V  G L    K    VA+K L+  Y+      F  E  ++    H N++ L
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--GTAYGLEYLHEQ 197
            G  T S   ++V  +M+N S+   L+     +    +   + V    G + G++YL + 
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFLK-----KNDGQFTVIQLVGMLRGISAGMKYLSDM 143
Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLS 255
                +HRDL A NIL++ N    + DFGL++++  D +  + T   +  +   APE ++
Sbjct: 144 ---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 200
Query: 256 TGKSSEKTDVFGYGITLLELVT-GQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDR 314
             K +  +DV+ YGI + E+V+ G+R                  I+ +    RL   +D 
Sbjct: 201 FRKFTSASDVWSYGIVMWEVVSYGERP--------YWEMTNQDVIKAVEEGYRLPSPMDC 252
Query: 315 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
               Y         Q+ L C Q     RP   ++V ML
Sbjct: 253 PAALY---------QLMLDCWQKERNSRPKFDEIVNML 281

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 25/227 (11%)
Query: 73  QLATDNFSESNIIGQGGFGKVYK----GVLSDNTK----VAVKRLQDYYSPGGEAAFQRE 124
           +   D  +    +G+G FG+V      G+  D  K    VAVK L+D  +    +    E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 125 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG------------ 171
           + ++  +  HKN++ L+G CT      ++  +    ++   LR  +P             
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVP 150
Query: 172 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 231
           E+ + +       +  A G+EYL  Q   K IHRDL A N+L+ +N    + DFGLA+ +
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 232 -DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
            +      TT  R  +  +APE L     + ++DV+ +G+ + E+ T
Sbjct: 208 NNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 25/227 (11%)
Query: 73  QLATDNFSESNIIGQGGFGKVYK----GVLSDNTK----VAVKRLQDYYSPGGEAAFQRE 124
           +   D  +    +G+G FG+V      G+  D  K    VAVK L+D  +    +    E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 125 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG------------ 171
           + ++  +  HKN++ L+G CT      ++  +    ++   LR  +P             
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 172 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 231
           E+ + +       +  A G+EYL  Q   K IHRDL A N+L+ +N    + DFGLA+ +
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 232 -DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
            +      TT  R  +  +APE L     + ++DV+ +G+ + E+ T
Sbjct: 208 NNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 122/277 (44%), Gaps = 32/277 (11%)
Query: 84  IIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +IG G FG+V  G L      +  VA+K L+  Y+      F  E  ++    H N++ L
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
            G  T     ++V  FM+N ++   LR        +      R   G A G+ YL +   
Sbjct: 110 EGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLR---GIAAGMRYLADM-- 164
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLSTG 257
              +HRDL A NIL++ N    + DFGL++++  D +  + TT  +  +   APE +   
Sbjct: 165 -GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYR 223
Query: 258 KSSEKTDVFGYGITLLELVT-GQRAI-DFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRN 315
           K +  +DV+ YGI + E+++ G+R   D S             I+ +    RL   +D  
Sbjct: 224 KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---------IKAIEEGYRLPAPMDCP 274
Query: 316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
              +         Q+ L C Q    +RP   Q+V +L
Sbjct: 275 AGLH---------QLMLDCWQKERAERPKFEQIVGIL 302

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 85  IGQGGFGKVYKGVLSDNT----KVAVKRLQDYYSPGGEAA-----FQREVHLISVAIHKN 135
           +G GG   VY   L+++T    KVA+K +   + P  E       F+REVH  S   H+N
Sbjct: 19  LGGGGMSTVY---LAEDTILNIKVAIKAI---FIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
           ++ +I          LV  +++  +++  +    P    L   T          G+++ H
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP----LSVDTAINFTNQILDGIKHAH 128
Query: 196 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAPEYL 254
           +    +I+HRD+K  NIL+D N    + DFG+AK L +  LT  T  + GT+ + +PE  
Sbjct: 129 DM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQA 184
Query: 255 STGKSSEKTDVFGYGITLLELVTGQ 279
               + E TD++  GI L E++ G+
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 84  IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           ++G+G FG+  K    +  +V V +    +    +  F +EV ++    H N+L+ IG  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG--TAYGLEYLHEQCNPK 201
                   +  +++  ++   ++ +        +P  +RV+F    A G+ YLH      
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSMDS-----QYPWSQRVSFAKDIASGMAYLHSM---N 128
Query: 202 IIHRDLKAANILLDDNFEAVLCDFGLAKL-VDAKLTHVTTQ------------IRGTMGH 248
           IIHRDL + N L+ +N   V+ DFGLA+L VD K      +            + G    
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELV 276
           +APE ++     EK DVF +GI L E++
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 117/223 (52%), Gaps = 30/223 (13%)
Query: 71  ELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS 129
           E     D   +  ++G+G +G VY G  LS+  ++A+K +     P  ++ + + +H   
Sbjct: 2   EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI-----PERDSRYSQPLHE-E 55
Query: 130 VAIHKNLLQ--LIGYCTTSSERILVYPFMQNL---SVAYRLRD----LKPGEKGLDWPTR 180
           +A+HK+L    ++ Y  + SE   +  FM+ +   S++  LR     LK  E+ + + T+
Sbjct: 56  IALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK 115
Query: 181 KRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL--CDFGLAKLVDAKLTHV 238
           + +      GL+YLH+    +I+HRD+K  N+L+ + +  VL   DFG +K + A +   
Sbjct: 116 QILE-----GLKYLHDN---QIVHRDIKGDNVLI-NTYSGVLKISDFGTSKRL-AGINPC 165
Query: 239 TTQIRGTMGHIAPEYLSTGKS--SEKTDVFGYGITLLELVTGQ 279
           T    GT+ ++APE +  G     +  D++  G T++E+ TG+
Sbjct: 166 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 131/302 (43%), Gaps = 41/302 (13%)
Query: 73  QLATDNFSESNIIGQGGFGKVYK----GVLSDNTK----VAVKRLQDYYSPGGEAAFQRE 124
           +   D  +    +G+G FG+V      G+  D  K    VAVK L+D  +    +    E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 125 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG------------ 171
           + ++  +  HKN++ L+G CT      ++  +    ++   LR  +P             
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 172 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 231
           E+ + +       +  A G+EYL  Q   K IHRDL A N+L+ +N    + DFGLA+ +
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 232 -DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXX 290
            +      TT  R  +  +APE L     + ++DV+ +G+ + E+        F+     
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI--------FTLGGSP 259
Query: 291 XXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
                   + KLL+E      +D+  N   + E+  M++    C  + P  RP   Q+V+
Sbjct: 260 YPGIPVEELFKLLKEGHR---MDKPANC--TNELYMMMRD---CWHAVPSQRPTFKQLVE 311
Query: 351 ML 352
            L
Sbjct: 312 DL 313

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 131/302 (43%), Gaps = 41/302 (13%)
Query: 73  QLATDNFSESNIIGQGGFGKVYK----GVLSDNTK----VAVKRLQDYYSPGGEAAFQRE 124
           +   D  +    +G+G FG+V      G+  D  K    VAVK L+D  +    +    E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 125 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG------------ 171
           + ++  +  HKN++ L+G CT      ++  +    ++   LR  +P             
Sbjct: 91  MEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 172 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 231
           E+ + +       +  A G+EYL  Q   K IHRDL A N+L+ +N    + DFGLA+ +
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 232 -DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXX 290
            +      TT  R  +  +APE L     + ++DV+ +G+ + E+        F+     
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI--------FTLGGSP 259
Query: 291 XXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
                   + KLL+E      +D+  N   + E+  M++    C  + P  RP   Q+V+
Sbjct: 260 YPGIPVEELFKLLKEGHR---MDKPANC--TNELYMMMRD---CWHAVPSQRPTFKQLVE 311
Query: 351 ML 352
            L
Sbjct: 312 DL 313

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 131/302 (43%), Gaps = 41/302 (13%)
Query: 73  QLATDNFSESNIIGQGGFGKVYK----GVLSDNTK----VAVKRLQDYYSPGGEAAFQRE 124
           +   D  +    +G+G FG+V      G+  D  K    VAVK L+D  +    +    E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 125 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG------------ 171
           + ++  +  HKN++ L+G CT      ++  +    ++   LR  +P             
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 172 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 231
           E+ + +       +  A G+EYL  Q   K IHRDL A N+L+ +N    + DFGLA+ +
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLARDI 207
Query: 232 -DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXX 290
            +      TT  R  +  +APE L     + ++DV+ +G+ + E+        F+     
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI--------FTLGGSP 259
Query: 291 XXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
                   + KLL+E      +D+  N   + E+  M++    C  + P  RP   Q+V+
Sbjct: 260 YPGIPVEELFKLLKEGHR---MDKPANC--TNELYMMMRD---CWHAVPSQRPTFKQLVE 311
Query: 351 ML 352
            L
Sbjct: 312 DL 313

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 131/302 (43%), Gaps = 41/302 (13%)
Query: 73  QLATDNFSESNIIGQGGFGKVYK----GVLSDNTK----VAVKRLQDYYSPGGEAAFQRE 124
           +   D  +    +G+G FG+V      G+  D  K    VAVK L+D  +    +    E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 125 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG------------ 171
           + ++  +  HKN++ L+G CT      ++  +    ++   LR  +P             
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 172 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 231
           E+ + +       +  A G+EYL  Q   K IHRDL A N+L+ +N    + DFGLA+ +
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 232 -DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXX 290
            +      TT  R  +  +APE L     + ++DV+ +G+ + E+        F+     
Sbjct: 208 NNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI--------FTLGGSP 259
Query: 291 XXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
                   + KLL+E      +D+  N   + E+  M++    C  + P  RP   Q+V+
Sbjct: 260 YPGIPVEELFKLLKEGHR---MDKPANC--TNELYMMMRD---CWHAVPSQRPTFKQLVE 311
Query: 351 ML 352
            L
Sbjct: 312 DL 313

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 131/302 (43%), Gaps = 41/302 (13%)
Query: 73  QLATDNFSESNIIGQGGFGKVYK----GVLSDNTK----VAVKRLQDYYSPGGEAAFQRE 124
           +   D  +    +G+G FG+V      G+  D  K    VAVK L+D  +    +    E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSE 90
Query: 125 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG------------ 171
           + ++  +  HKN++ L+G CT      ++  +    ++   LR  +P             
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 172 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 231
           E+ + +       +  A G+EYL  Q   K IHRDL A N+L+ +N    + DFGLA+ +
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 232 -DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXX 290
            +      TT  R  +  +APE L     + ++DV+ +G+ + E+        F+     
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI--------FTLGGSP 259
Query: 291 XXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
                   + KLL+E      +D+  N   + E+  M++    C  + P  RP   Q+V+
Sbjct: 260 YPGIPVEELFKLLKEGHR---MDKPANC--TNELYMMMRD---CWHAVPSQRPTFKQLVE 311
Query: 351 ML 352
            L
Sbjct: 312 DL 313

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 131/302 (43%), Gaps = 41/302 (13%)
Query: 73  QLATDNFSESNIIGQGGFGKVYK----GVLSDNTK----VAVKRLQDYYSPGGEAAFQRE 124
           +   D  +    +G+G FG+V      G+  D  K    VAVK L+D  +    +    E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 125 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG------------ 171
           + ++  +  HKN++ L+G CT      ++  +    ++   LR  +P             
Sbjct: 91  MEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 172 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 231
           E+ + +       +  A G+EYL  Q   K IHRDL A N+L+ +N    + DFGLA+ +
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 232 -DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXX 290
            +      TT  R  +  +APE L     + ++DV+ +G+ + E+        F+     
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI--------FTLGGSP 259
Query: 291 XXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
                   + KLL+E      +D+  N   + E+  M++    C  + P  RP   Q+V+
Sbjct: 260 YPGIPVEELFKLLKEGHR---MDKPANC--TNELYMMMRD---CWHAVPSQRPTFKQLVE 311
Query: 351 ML 352
            L
Sbjct: 312 DL 313

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 84  IIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +IG G FG+V  G L    K    VA+K L+  Y+      F  E  ++    H N++ L
Sbjct: 14  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 73
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--GTAYGLEYLHEQ 197
            G  T S+  +++  FM+N S+   LR     +    +   + V    G A G++YL + 
Sbjct: 74  EGVVTKSTPVMIITEFMENGSLDSFLR-----QNDGQFTVIQLVGMLRGIAAGMKYLADM 128
Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMG--HIAPEY 253
                +HR L A NIL++ N    + DFGL++ +  D      T+ + G +     APE 
Sbjct: 129 ---NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 185
Query: 254 LSTGKSSEKTDVFGYGITLLELVT-GQR 280
           +   K +  +DV+ YGI + E+++ G+R
Sbjct: 186 IQYRKFTSASDVWSYGIVMWEVMSYGER 213

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 131/302 (43%), Gaps = 41/302 (13%)
Query: 73  QLATDNFSESNIIGQGGFGKVYK----GVLSDNTK----VAVKRLQDYYSPGGEAAFQRE 124
           +   D  +    +G+G FG+V      G+  D  K    VAVK L+D  +    +    E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 125 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG------------ 171
           + ++  +  HKN++ L+G CT      ++  +    ++   LR  +P             
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 172 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 231
           E+ + +       +  A G+EYL  Q   K IHRDL A N+L+ +N    + DFGLA+ +
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 232 -DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXX 290
            +      TT  R  +  +APE L     + ++DV+ +G+ + E+        F+     
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI--------FTLGGSP 259
Query: 291 XXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
                   + KLL+E      +D+  N   + E+  M++    C  + P  RP   Q+V+
Sbjct: 260 YPGIPVEELFKLLKEGHR---MDKPANC--TNELYMMMRD---CWHAVPSQRPTFKQLVE 311
Query: 351 ML 352
            L
Sbjct: 312 DL 313

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 131/302 (43%), Gaps = 41/302 (13%)
Query: 73  QLATDNFSESNIIGQGGFGKVYK----GVLSDNTK----VAVKRLQDYYSPGGEAAFQRE 124
           +   D  +    +G+G FG+V      G+  D  K    VAVK L+D  +    +    E
Sbjct: 23  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 82
Query: 125 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG------------ 171
           + ++  +  HKN++ L+G CT      ++  +    ++   LR  +P             
Sbjct: 83  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 142
Query: 172 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 231
           E+ + +       +  A G+EYL  Q   K IHRDL A N+L+ +N    + DFGLA+ +
Sbjct: 143 EEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI 199
Query: 232 -DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXX 290
            +      TT  R  +  +APE L     + ++DV+ +G+ + E+        F+     
Sbjct: 200 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI--------FTLGGSP 251
Query: 291 XXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
                   + KLL+E      +D+  N   + E+  M++    C  + P  RP   Q+V+
Sbjct: 252 YPGIPVEELFKLLKEGHR---MDKPANC--TNELYMMMRD---CWHAVPSQRPTFKQLVE 303
Query: 351 ML 352
            L
Sbjct: 304 DL 305

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 131/302 (43%), Gaps = 41/302 (13%)
Query: 73  QLATDNFSESNIIGQGGFGKVYK----GVLSDNTK----VAVKRLQDYYSPGGEAAFQRE 124
           +   D  +    +G+G FG+V      G+  D  K    VAVK L+D  +    +    E
Sbjct: 20  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 79
Query: 125 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG------------ 171
           + ++  +  HKN++ L+G CT      ++  +    ++   LR  +P             
Sbjct: 80  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 139
Query: 172 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 231
           E+ + +       +  A G+EYL  Q   K IHRDL A N+L+ +N    + DFGLA+ +
Sbjct: 140 EEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI 196
Query: 232 -DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXX 290
            +      TT  R  +  +APE L     + ++DV+ +G+ + E+        F+     
Sbjct: 197 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI--------FTLGGSP 248
Query: 291 XXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
                   + KLL+E      +D+  N   + E+  M++    C  + P  RP   Q+V+
Sbjct: 249 YPGIPVEELFKLLKEGHR---MDKPANC--TNELYMMMRD---CWHAVPSQRPTFKQLVE 300
Query: 351 ML 352
            L
Sbjct: 301 DL 302

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 83  NIIGQGGFGKVYKGVL---SDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
            ++G G FG VYKG+     +N K  VA+K L++  SP        E ++++      + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 138 QLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
           +L+G C TS+ +++  + P+   L      R     +  L+W          A G+ YL 
Sbjct: 83  RLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNW------CMQIAKGMSYLE 136
Query: 196 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGTMGHIAPEYL 254
           +    +++HRDL A N+L+       + DFGLA+L+D   T       +  +  +A E +
Sbjct: 137 DV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 193
Query: 255 STGKSSEKTDVFGYGITLLELVT 277
              + + ++DV+ YG+T+ EL+T
Sbjct: 194 LRRRFTHQSDVWSYGVTVWELMT 216

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 25/227 (11%)
Query: 73  QLATDNFSESNIIGQGGFGKVYK----GVLSDNTK----VAVKRLQDYYSPGGEAAFQRE 124
           +   D  +    +G+G FG+V      G+  D  K    VAVK L+D  +    +    E
Sbjct: 77  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136
Query: 125 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG------------ 171
           + ++  +  HKN++ L+G CT      ++  +    ++   LR  +P             
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196
Query: 172 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 231
           E+ + +       +  A G+EYL  Q   K IHRDL A N+L+ +N    + DFGLA+ +
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI 253
Query: 232 -DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
            +      TT  R  +  +APE L     + ++DV+ +G+ + E+ T
Sbjct: 254 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 131/302 (43%), Gaps = 41/302 (13%)
Query: 73  QLATDNFSESNIIGQGGFGKVYK----GVLSDNTK----VAVKRLQDYYSPGGEAAFQRE 124
           +   D  +    +G+G FG+V      G+  D  K    VAVK L+D  +    +    E
Sbjct: 18  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 77
Query: 125 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG------------ 171
           + ++  +  HKN++ L+G CT      ++  +    ++   LR  +P             
Sbjct: 78  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 137
Query: 172 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 231
           E+ + +       +  A G+EYL  Q   K IHRDL A N+L+ +N    + DFGLA+ +
Sbjct: 138 EEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLARDI 194
Query: 232 -DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXX 290
            +      TT  R  +  +APE L     + ++DV+ +G+ + E+        F+     
Sbjct: 195 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI--------FTLGGSP 246
Query: 291 XXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
                   + KLL+E      +D+  N   + E+  M++    C  + P  RP   Q+V+
Sbjct: 247 YPGIPVEELFKLLKEGHR---MDKPANC--TNELYMMMRD---CWHAVPSQRPTFKQLVE 298
Query: 351 ML 352
            L
Sbjct: 299 DL 300

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 83  NIIGQGGFGKVYKG-VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
            I  +G FG V+K  +++D   V +  LQD  S   E    RE+       H+NLLQ I 
Sbjct: 21  EIKARGRFGCVWKAQLMNDFVAVKIFPLQDKQSWQSE----REIFSTPGMKHENLLQFIA 76
Query: 142 YCTTSS----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
                S    E  L+  F    S+   L+        + W     VA   + GL YLHE 
Sbjct: 77  AEKRGSNLEVELWLITAFHDKGSLTDYLKG-----NIITWNELCHVAETMSRGLSYLHED 131
Query: 198 C--------NPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGH 248
                     P I HRD K+ N+LL  +  AVL DFGLA +    K    T    GT  +
Sbjct: 132 VPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRY 191
Query: 249 IAPEYLSTGKSSE-----KTDVFGYGITLLELVTGQRAID 283
           +APE L    + +     + D++  G+ L ELV+  +A D
Sbjct: 192 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 8/211 (3%)
Query: 68  SCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVH 126
           S  + ++   + +  + +G G +G+VY GV    +  VAVK L++      E  F +E  
Sbjct: 23  SMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAA 80
Query: 127 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           ++    H NL+QL+G CT      +V  +M   ++   LR+    E  +       +A  
Sbjct: 81  VMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREE--VTAVVLLYMATQ 138
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
            +  +EYL ++     IHRDL A N L+ +N    + DFGL++L+           +  +
Sbjct: 139 ISSAMEYLEKK---NFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPI 195
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
              APE L+    S K+DV+ +G+ L E+ T
Sbjct: 196 KWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 111/272 (40%), Gaps = 30/272 (11%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           +G G FG V  G       VAVK +++      E  F +E   +    H  L++  G C 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKE--GSMSEDEFFQEAQTMMKLSHPKLVKFYGVC- 72
Query: 145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 204
             S+   +Y   + +S    L  L+   KGL+      + +    G+ +L      + IH
Sbjct: 73  --SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 205 RDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 262
           RDL A N L+D +    + DFG+ + V  D  ++ V T+    +   APE     K S K
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF--PVKWSAPEVFHYFKYSSK 185
Query: 263 TDVFGYGITLLELVT-GQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYDS 321
           +DV+ +GI + E+ + G+   D              H  +L R    +D           
Sbjct: 186 SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH--RLYRPHLASD----------- 232
Query: 322 KEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
               T+ Q+   C    PE RP   Q++  ++
Sbjct: 233 ----TIYQIMYSCWHELPEKRPTFQQLLSSIE 260

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/304 (22%), Positives = 127/304 (41%), Gaps = 40/304 (13%)
Query: 67  FSCRELQLATDNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAA 120
           F   E +++ +  +    +GQG FG VY+G   D       T+VAVK + +  S      
Sbjct: 4   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 63
Query: 121 FQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDW 177
           F  E  ++      ++++L+G  +     ++V   M +  +   LR L+P      G   
Sbjct: 64  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 123
Query: 178 PTRK---RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 234
           PT +   ++A   A G+ YL+ +   K +HRDL A N ++  +F   + DFG+ +     
Sbjct: 124 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----D 176
Query: 235 LTHVTTQIRGTMG-----HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXX 289
           +       +G  G      +APE L  G  +  +D++ +G+ L E+ +            
Sbjct: 177 IXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------------ 224
Query: 290 XXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 349
                     + L  E  L  ++D           E +  +  +C Q  P+ RP   ++V
Sbjct: 225 ----LAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 280
Query: 350 KMLQ 353
            +L+
Sbjct: 281 NLLK 284

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 85  IGQGGFGKVYK---GVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +G+G FG V       L DNT   VAVK+LQ + +      F+RE+ ++    H N+++ 
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
            G C ++  R L    M+ L     LRD L+  ++ +D     +       G+EYL  + 
Sbjct: 76  KGVCYSAGRRNLKL-IMEYLPYG-SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK- 132
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLST 256
             + IHRDL   NIL+++     + DFGL K++  D +   V       +   APE L+ 
Sbjct: 133 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 190
Query: 257 GKSSEKTDVFGYGITLLELVT 277
            K S  +DV+ +G+ L EL T
Sbjct: 191 SKFSVASDVWSFGVVLYELFT 211

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 124/278 (44%), Gaps = 19/278 (6%)
Query: 85  IGQGGFGKVY---KGVLSDNT--KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +G+G FGKV        +D T   VAVK L++   P   + +QRE+ ++    H+++++ 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
            G C    E+  V   M+ + +   LRD  P    +        A     G+ YLH Q  
Sbjct: 77  KGCCEDQGEKS-VQLVMEYVPLG-SLRDYLP-RHCVGLAQLLLFAQQICEGMAYLHAQ-- 131
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG--TMGHIAPEYLSTG 257
              IHR L A N+LLD++    + DFGLAK V     +   +  G   +   APE L   
Sbjct: 132 -HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEC 190
Query: 258 KSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRN-- 315
           K    +DV+ +G+TL EL+T     D ++           H +  +   RL ++++R   
Sbjct: 191 KFYYASDVWSFGVTLYELLT---YCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGER 247
Query: 316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
           L   D    E +  +   C ++    RP    +V +LQ
Sbjct: 248 LPRPDRCPCE-IYHLMKNCWETEASFRPTFQNLVPILQ 284

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 69/304 (22%), Positives = 127/304 (41%), Gaps = 40/304 (13%)
Query: 67  FSCRELQLATDNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAA 120
           F   E +++ +  +    +GQG FG VY+G   D       T+VAVK + +  S      
Sbjct: 7   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 121 FQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDW 177
           F  E  ++      ++++L+G  +     ++V   M +  +   LR L+P      G   
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 178 PTRK---RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 234
           PT +   ++A   A G+ YL+ +   K +HRDL A N ++  +F   + DFG+ +     
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----D 179
Query: 235 LTHVTTQIRGTMG-----HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXX 289
           +       +G  G      +APE L  G  +  +D++ +G+ L E+ +            
Sbjct: 180 IXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------------ 227
Query: 290 XXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 349
                     + L  E  L  ++D           E +  +  +C Q  P+ RP   ++V
Sbjct: 228 ----LAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 283
Query: 350 KMLQ 353
            +L+
Sbjct: 284 NLLK 287

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 85  IGQGGFGKVYK---GVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +G+G FG V       L DNT   VAVK+LQ + +      F+RE+ ++    H N+++ 
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
            G C ++  R L    M+ L     LRD L+  ++ +D     +       G+EYL  + 
Sbjct: 83  KGVCYSAGRRNLKL-IMEYLPYG-SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK- 139
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLST 256
             + IHRDL   NIL+++     + DFGL K++  D +   V       +   APE L+ 
Sbjct: 140 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 197
Query: 257 GKSSEKTDVFGYGITLLELVT 277
            K S  +DV+ +G+ L EL T
Sbjct: 198 SKFSVASDVWSFGVVLYELFT 218

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 85  IGQGGFGKVYK---GVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +G+G FG V       L DNT   VAVK+LQ + +      F+RE+ ++    H N+++ 
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
            G C ++  R L    M+ L     LRD L+  ++ +D     +       G+EYL  + 
Sbjct: 81  KGVCYSAGRRNLKL-IMEYLPYG-SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK- 137
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLST 256
             + IHRDL   NIL+++     + DFGL K++  D +   V       +   APE L+ 
Sbjct: 138 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 195
Query: 257 GKSSEKTDVFGYGITLLELVT 277
            K S  +DV+ +G+ L EL T
Sbjct: 196 SKFSVASDVWSFGVVLYELFT 216

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 124/278 (44%), Gaps = 19/278 (6%)
Query: 85  IGQGGFGKVY---KGVLSDNT--KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +G+G FGKV        +D T   VAVK L++   P   + +QRE+ ++    H+++++ 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
            G C    E+  V   M+ + +   LRD  P    +        A     G+ YLH Q  
Sbjct: 76  KGCCEDQGEKS-VQLVMEYVPLG-SLRDYLP-RHCVGLAQLLLFAQQICEGMAYLHAQ-- 130
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG--TMGHIAPEYLSTG 257
              IHR L A N+LLD++    + DFGLAK V     +   +  G   +   APE L   
Sbjct: 131 -HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEC 189
Query: 258 KSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRN-- 315
           K    +DV+ +G+TL EL+T     D ++           H +  +   RL ++++R   
Sbjct: 190 KFYYASDVWSFGVTLYELLT---YCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGER 246
Query: 316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
           L   D    E +  +   C ++    RP    +V +LQ
Sbjct: 247 LPRPDRCPCE-IYHLMKNCWETEASFRPTFQNLVPILQ 283

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 85  IGQGGFGKVYK---GVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +G+G FG V       L DNT   VAVK+LQ + +      F+RE+ ++    H N+++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
            G C ++  R L    M+ L     LRD L+  ++ +D     +       G+EYL  + 
Sbjct: 80  KGVCYSAGRRNLKL-IMEYLPYG-SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK- 136
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLST 256
             + IHRDL   NIL+++     + DFGL K++  D +   V       +   APE L+ 
Sbjct: 137 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 257 GKSSEKTDVFGYGITLLELVT 277
            K S  +DV+ +G+ L EL T
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 85  IGQGGFGKVYK---GVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +G+G FG V       L DNT   VAVK+LQ + +      F+RE+ ++    H N+++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
            G C ++  R L    M+ L     LRD L+  ++ +D     +       G+EYL  + 
Sbjct: 77  KGVCYSAGRRNLKL-IMEYLPYG-SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK- 133
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLST 256
             + IHRDL   NIL+++     + DFGL K++  D +   V       +   APE L+ 
Sbjct: 134 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 257 GKSSEKTDVFGYGITLLELVT 277
            K S  +DV+ +G+ L EL T
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 85  IGQGGFGKVYK---GVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +G+G FG V       L DNT   VAVK+LQ + +      F+RE+ ++    H N+++ 
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
            G C ++  R L    M+ L     LRD L+  ++ +D     +       G+EYL  + 
Sbjct: 82  KGVCYSAGRRNLKL-IMEYLPYG-SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK- 138
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLST 256
             + IHRDL   NIL+++     + DFGL K++  D +   V       +   APE L+ 
Sbjct: 139 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 196
Query: 257 GKSSEKTDVFGYGITLLELVT 277
            K S  +DV+ +G+ L EL T
Sbjct: 197 SKFSVASDVWSFGVVLYELFT 217

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 85  IGQGGFGKVYK---GVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +G+G FG V       L DNT   VAVK+LQ + +      F+RE+ ++    H N+++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
            G C ++  R L    M+ L     LRD L+  ++ +D     +       G+EYL  + 
Sbjct: 77  KGVCYSAGRRNLKL-IMEYLPYG-SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK- 133
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLST 256
             + IHRDL   NIL+++     + DFGL K++  D +   V       +   APE L+ 
Sbjct: 134 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191
Query: 257 GKSSEKTDVFGYGITLLELVT 277
            K S  +DV+ +G+ L EL T
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 85  IGQGGFGKVYK---GVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +G+G FG V       L DNT   VAVK+LQ + +      F+RE+ ++    H N+++ 
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
            G C ++  R L    M+ L     LRD L+  ++ +D     +       G+EYL  + 
Sbjct: 108 KGVCYSAGRRNLKL-IMEYLPYG-SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK- 164
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLST 256
             + IHRDL   NIL+++     + DFGL K++  D +   V       +   APE L+ 
Sbjct: 165 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 222
Query: 257 GKSSEKTDVFGYGITLLELVT 277
            K S  +DV+ +G+ L EL T
Sbjct: 223 SKFSVASDVWSFGVVLYELFT 243

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/302 (22%), Positives = 131/302 (43%), Gaps = 40/302 (13%)
Query: 71  ELQLATDNFSESNIIGQGGFGKVY----KGVLSDN--TKVAVKRLQDYYSPGGEAAFQRE 124
           E ++A +  + S  +GQG FG VY    KGV+ D   T+VA+K + +  S      F  E
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 63
Query: 125 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG---LDWPTRK 181
             ++      ++++L+G  +     +++   M    +   LR L+P  +    L  P+  
Sbjct: 64  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 123
Query: 182 RV---AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 238
           ++   A   A G+ YL+     K +HRDL A N ++ ++F   + DFG+ +     +   
Sbjct: 124 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXET 176
Query: 239 TTQIRGTMG-----HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXX 293
               +G  G      ++PE L  G  +  +DV+ +G+ L E+ T                
Sbjct: 177 DXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------- 220
Query: 294 XXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                 + L  E  L  +++  L        + ++++  +C Q  P+ RP   +++  ++
Sbjct: 221 LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIK 280
Query: 354 GE 355
            E
Sbjct: 281 EE 282

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 85  IGQGGFGKVYK---GVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +G+G FG V       L DNT   VAVK+LQ + +      F+RE+ ++    H N+++ 
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
            G C ++  R L    M+ L     LRD L+  ++ +D     +       G+EYL  + 
Sbjct: 84  KGVCYSAGRRNLKL-IMEYLPYG-SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK- 140
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLST 256
             + IHRDL   NIL+++     + DFGL K++  D +   V       +   APE L+ 
Sbjct: 141 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 198
Query: 257 GKSSEKTDVFGYGITLLELVT 277
            K S  +DV+ +G+ L EL T
Sbjct: 199 SKFSVASDVWSFGVVLYELFT 219

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 85  IGQGGFGKVYK---GVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +G+G FG V       L DNT   VAVK+LQ + +      F+RE+ ++    H N+++ 
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 74
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
            G C ++  R L    M+ L     LRD L+  ++ +D     +       G+EYL  + 
Sbjct: 75  KGVCYSAGRRNLKL-IMEYLPYG-SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK- 131
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLST 256
             + IHRDL   NIL+++     + DFGL K++  D +   V       +   APE L+ 
Sbjct: 132 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 189
Query: 257 GKSSEKTDVFGYGITLLELVT 277
            K S  +DV+ +G+ L EL T
Sbjct: 190 SKFSVASDVWSFGVVLYELFT 210

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 85  IGQGGFGKVYK---GVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +G+G FG V       L DNT   VAVK+LQ + +      F+RE+ ++    H N+++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
            G C ++  R L    M+ L     LRD L+  ++ +D     +       G+EYL  + 
Sbjct: 77  KGVCYSAGRRNLKL-IMEYLPYG-SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK- 133
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLST 256
             + IHRDL   NIL+++     + DFGL K++  D +   V       +   APE L+ 
Sbjct: 134 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 257 GKSSEKTDVFGYGITLLELVT 277
            K S  +DV+ +G+ L EL T
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G+G +G VYK   S    VA+KR++ D    G  +   RE+ L+    H N++ LI   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKP----GEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
            +     LV+ FM+        +DLK      + GL     K   +    G+ + H+   
Sbjct: 89  HSERCLTLVFEFME--------KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH-- 138
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-STGK 258
            +I+HRDLK  N+L++ +    L DFGLA+     +   T ++  T+ + AP+ L  + K
Sbjct: 139 -RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKK 196
Query: 259 SSEKTDVFGYGITLLELVTGQ 279
            S   D++  G    E++TG+
Sbjct: 197 YSTSVDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G+G +G VYK   S    VA+KR++ D    G  +   RE+ L+    H N++ LI   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKP----GEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
            +     LV+ FM+        +DLK      + GL     K   +    G+ + H+   
Sbjct: 89  HSERCLTLVFEFME--------KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH-- 138
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-STGK 258
            +I+HRDLK  N+L++ +    L DFGLA+     +   T ++  T+ + AP+ L  + K
Sbjct: 139 -RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKK 196
Query: 259 SSEKTDVFGYGITLLELVTGQ 279
            S   D++  G    E++TG+
Sbjct: 197 YSTSVDIWSIGCIFAEMITGK 217

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 85  IGQGGFGKVYK---GVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +G+G FG V       L DNT   VAVK+LQ + +      F+RE+ ++    H N+++ 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
            G C ++  R L    M+ L     LRD L+  ++ +D     +       G+EYL  + 
Sbjct: 95  KGVCYSAGRRNLKL-IMEYLPYG-SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK- 151
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLST 256
             + IHRDL   NIL+++     + DFGL K++  D +   V       +   APE L+ 
Sbjct: 152 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 257 GKSSEKTDVFGYGITLLELVT 277
            K S  +DV+ +G+ L EL T
Sbjct: 210 SKFSVASDVWSFGVVLYELFT 230

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/302 (22%), Positives = 130/302 (43%), Gaps = 40/302 (13%)
Query: 71  ELQLATDNFSESNIIGQGGFGKVY----KGVLSDN--TKVAVKRLQDYYSPGGEAAFQRE 124
           E ++A +  + S  +GQG FG VY    KGV+ D   T+VA+K + +  S      F  E
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 125 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG---LDWPTRK 181
             ++      ++++L+G  +     +++   M    +   LR L+P  +    L  P+  
Sbjct: 73  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 132
Query: 182 RV---AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 238
           ++   A   A G+ YL+     K +HRDL A N ++ ++F   + DFG+ +     +   
Sbjct: 133 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXET 185
Query: 239 TTQIRGTMG-----HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXX 293
               +G  G      ++PE L  G  +  +DV+ +G+ L E+ T                
Sbjct: 186 DXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------- 229
Query: 294 XXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                 + L  E  L  +++  L        + + ++  +C Q  P+ RP   +++  ++
Sbjct: 230 LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 289
Query: 354 GE 355
            E
Sbjct: 290 EE 291

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 85  IGQGGFGKVYK---GVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +G+G FG V       L DNT   VAVK+LQ + +      F+RE+ ++    H N+++ 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
            G C ++  R L    M+ L     LRD L+  ++ +D     +       G+EYL  + 
Sbjct: 95  KGVCYSAGRRNLKL-IMEYLPYG-SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK- 151
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLST 256
             + IHRDL   NIL+++     + DFGL K++  D +   V       +   APE L+ 
Sbjct: 152 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 257 GKSSEKTDVFGYGITLLELVT 277
            K S  +DV+ +G+ L EL T
Sbjct: 210 SKFSVASDVWSFGVVLYELFT 230

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 85  IGQGGFGKVYK---GVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +G+G FG V       L DNT   VAVK+LQ + +      F+RE+ ++    H N+++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
            G C ++  R L    M+ L     LRD L+   + +D     +       G+EYL  + 
Sbjct: 80  KGVCYSAGRRNLKL-IMEYLPYG-SLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTK- 136
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLST 256
             + IHRDL   NIL+++     + DFGL K++  D +   V       +   APE L+ 
Sbjct: 137 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 257 GKSSEKTDVFGYGITLLELVT 277
            K S  +DV+ +G+ L EL T
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/311 (24%), Positives = 133/311 (42%), Gaps = 48/311 (15%)
Query: 71  ELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQRE 124
           + +    N      +G+G FGKV K         +  T VAVK L++  SP        E
Sbjct: 17  KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSE 76
Query: 125 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD---LKPG---------E 172
            +++    H ++++L G C+     +L+  + +  S+   LR+   + PG          
Sbjct: 77  FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 173 KGLDWPTRKRVAFG--------TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 224
             LD P  + +  G         + G++YL E    K++HRDL A NIL+ +  +  + D
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISD 193
Query: 225 FGLAKLVDAKLTHVT-TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAI 282
           FGL++ V  + ++V  +Q R  +  +A E L     + ++DV+ +G+ L E+VT G    
Sbjct: 194 FGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 283 DFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDR 342
                          H  ++ R D  +               E M ++ L C +  P+ R
Sbjct: 254 PGIPPERLFNLLKTGH--RMERPDNCS---------------EEMYRLMLQCWKQEPDKR 296
Query: 343 PPMAQVVKMLQ 353
           P  A + K L+
Sbjct: 297 PVFADISKDLE 307

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 85  IGQGGFGKVYK---GVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +G+G FG V       L DNT   VAVK+LQ + +      F+RE+ ++    H N+++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
            G C ++  R L    M+ L        L+  ++ +D     +       G+EYL  +  
Sbjct: 80  KGVCYSAGRRNLKL-IMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTK-- 136
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLSTG 257
            + IHRDL   NIL+++     + DFGL K++  D +   V       +   APE L+  
Sbjct: 137 -RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 258 KSSEKTDVFGYGITLLELVT 277
           K S  +DV+ +G+ L EL T
Sbjct: 196 KFSVASDVWSFGVVLYELFT 215

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/286 (23%), Positives = 119/286 (41%), Gaps = 40/286 (13%)
Query: 85  IGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +GQG FG VY+G   D       T+VAVK + +  S      F  E  ++      ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRK---RVAFGTAYGLE 192
           L+G  +     ++V   M +  +   LR L+P      G   PT +   ++A   A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG----- 247
           YL+ +   K +HRDL A N ++  +F   + DFG+ +     +       +G  G     
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPVR 197
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDR 307
            +APE L  G  +  +D++ +G+ L E+ +                      + L  E  
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS----------------LAEQPYQGLSNEQV 241
Query: 308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
           L  ++D           E +  +  +C Q  P  RP   ++V +L+
Sbjct: 242 LKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 11/208 (5%)
Query: 75  ATDNFSESNIIGQGGFGKVYKGVLSDNTK-VAVKR-LQDYYSPGGEAAFQREVHLISVAI 132
           + + +    ++G+G +G V K    D  + VA+K+ L+       +    RE+ L+    
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 133 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 192
           H+NL+ L+  C       LV+ F+ +      L DL+    GLD+   ++  F    G+ 
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTI----LDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 252
           + H      IIHRD+K  NIL+  +    LCDFG A+ + A    V      T  + APE
Sbjct: 139 FCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-GEVYDDEVATRWYRAPE 194
Query: 253 YL-STGKSSEKTDVFGYGITLLELVTGQ 279
            L    K  +  DV+  G  + E+  G+
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/304 (22%), Positives = 127/304 (41%), Gaps = 40/304 (13%)
Query: 67  FSCRELQLATDNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAA 120
           F   E +++ +  +    +GQG FG VY+G   D       T+VAVK + +  S      
Sbjct: 7   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 121 FQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDW 177
           F  E  ++      ++++L+G  +     ++V   M +  +   LR L+P      G   
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 178 PTRK---RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 234
           PT +   ++A   A G+ YL+ +   K +HRDL A N ++  +F   + DFG+ +     
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----D 179
Query: 235 LTHVTTQIRGTMG-----HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXX 289
           +       +G  G      +APE L  G  +  +D++ +G+ L E+ +            
Sbjct: 180 IYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------------ 227
Query: 290 XXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 349
                     + L  E  L  ++D           E +  +  +C Q  P+ RP   ++V
Sbjct: 228 ----LAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 283
Query: 350 KMLQ 353
            +L+
Sbjct: 284 NLLK 287

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 77  DNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 133
           +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+    H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFGTA 188
            N+++L+    T ++  LV+ F+         +DLK         G+  P  K   F   
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 248
            GL + H     +++HRDLK  N+L++      L DFGLA+     +   T ++  T+ +
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWY 169
Query: 249 IAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
            APE L   K  S   D++  G    E+VT +RA+
Sbjct: 170 RAPEILLGXKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 128/305 (41%), Gaps = 37/305 (12%)
Query: 67  FSCRELQLATDNFSESNIIGQGGFGKVYK----GVLSDNTK--VAVKRLQDYYSPGGEAA 120
           +   + +   D       +G+G FG+V +    G+    T   VAVK L++  +     A
Sbjct: 19  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 78
Query: 121 FQREVH-LISVAIHKNLLQLIGYCTTSSERILV---YPFMQNLSVAYRLR-----DLKPG 171
              E+  LI +  H N++ L+G CT     ++V   +    NLS   R +       KP 
Sbjct: 79  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPE 138
Query: 172 EKGLDWPTRKRV---AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 228
           +   D+ T + +   +F  A G+E+L  +   K IHRDL A NILL +     +CDFGLA
Sbjct: 139 DLYKDFLTLEHLIXYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLA 195
Query: 229 KLVDAKLTHVTT-QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRX 287
           + +      V     R  +  +APE +     + ++DV+ +G+ L E+ +          
Sbjct: 196 RDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGAS 249
Query: 288 XXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQ 347
                       R+L    R+          Y + E   M Q  L C    P  RP  ++
Sbjct: 250 PYPGVKIDEEFCRRLKEGTRM------RAPDYTTPE---MYQTMLDCWHGEPSQRPTFSE 300
Query: 348 VVKML 352
           +V+ L
Sbjct: 301 LVEHL 305

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 77  DNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 133
           +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+    H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFGTA 188
            N+++L+    T ++  LV+ F+         +DLK         G+  P  K   F   
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 248
            GL + H     +++HRDLK  N+L++      L DFGLA+     +   T ++  T+ +
Sbjct: 114 QGLSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWY 169
Query: 249 IAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
            APE L   K  S   D++  G    E+VT +RA+
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 85  IGQGGFGKV---YKGVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL-- 137
           +G+G FG V       L DNT   VAVK+LQ +  P  +  FQRE+ ++  A+H + +  
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILK-ALHSDFIVK 72
Query: 138 -QLIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
            + + Y     E  LV  ++ +      LRD L+     LD       +     G+EYL 
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGC----LRDFLQRHRARLDASRLLLYSSQICKGMEYLG 128
Query: 196 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL--VDAKLTHVTTQIRGTMGHIAPEY 253
            +   + +HRDL A NIL++      + DFGLAKL  +D     V    +  +   APE 
Sbjct: 129 SR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPES 185
Query: 254 LSTGKSSEKTDVFGYGITLLELVT 277
           LS    S ++DV+ +G+ L EL T
Sbjct: 186 LSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 23/217 (10%)
Query: 75  ATDNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVA 131
           + +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+   
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 132 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFG 186
            H N+++L+    T ++  LV+ F+         +DLK         G+  P  K   F 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
              GL + H     +++HRDLK  N+L++      L DFGLA+     +   T ++  T+
Sbjct: 113 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TL 168
Query: 247 GHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
            + APE L   K  S   D++  G    E+VT +RA+
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 77  DNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 133
           +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+    H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFGTA 188
            N+++L+    T ++  LV+ F+         +DLK         G+  P  K   F   
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 248
            GL + H     +++HRDLK  N+L++      L DFGLA+     +   T ++  T+ +
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWY 169
Query: 249 IAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
            APE L   K  S   D++  G    E+VT +RA+
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 77  DNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 133
           +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+    H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFGTA 188
            N+++L+    T ++  LV+ F+         +DLK         G+  P  K   F   
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 248
            GL + H     +++HRDLK  N+L++      L DFGLA+     +   T ++  T+ +
Sbjct: 113 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWY 168
Query: 249 IAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
            APE L   K  S   D++  G    E+VT +RA+
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/306 (22%), Positives = 131/306 (42%), Gaps = 40/306 (13%)
Query: 67  FSCRELQLATDNFSESNIIGQGGFGKVY----KGVLSDN--TKVAVKRLQDYYSPGGEAA 120
           F   E ++A +  + S  +GQG FG VY    KGV+ D   T+VA+K + +  S      
Sbjct: 6   FVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 65
Query: 121 FQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG---LDW 177
           F  E  ++      ++++L+G  +     +++   M    +   LR L+P  +    L  
Sbjct: 66  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 125
Query: 178 PTRKRV---AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 234
           P+  ++   A   A G+ YL+     K +HRDL A N ++ ++F   + DFG+ +     
Sbjct: 126 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----D 178
Query: 235 LTHVTTQIRGTMG-----HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXX 289
           +       +G  G      ++PE L  G  +  +DV+ +G+ L E+ T            
Sbjct: 179 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------------ 226
Query: 290 XXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 349
                     + L  E  L  +++  L        + + ++  +C Q  P+ RP   +++
Sbjct: 227 ----LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 282
Query: 350 KMLQGE 355
             ++ E
Sbjct: 283 SSIKEE 288

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/302 (22%), Positives = 129/302 (42%), Gaps = 40/302 (13%)
Query: 71  ELQLATDNFSESNIIGQGGFGKVY----KGVLSDN--TKVAVKRLQDYYSPGGEAAFQRE 124
           E ++A +  + S  +GQG FG VY    KGV+ D   T+VA+K + +  S      F  E
Sbjct: 9   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 68
Query: 125 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG---LDWPTRK 181
             ++      ++++L+G  +     +++   M    +   LR L+P       L  P+  
Sbjct: 69  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 128
Query: 182 RV---AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 238
           ++   A   A G+ YL+     K +HRDL A N ++ ++F   + DFG+ +     +   
Sbjct: 129 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYET 181
Query: 239 TTQIRGTMG-----HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXX 293
               +G  G      ++PE L  G  +  +DV+ +G+ L E+ T                
Sbjct: 182 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------- 225
Query: 294 XXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                 + L  E  L  +++  L        + + ++  +C Q  P+ RP   +++  ++
Sbjct: 226 LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 285
Query: 354 GE 355
            E
Sbjct: 286 EE 287

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 13/211 (6%)
Query: 79  FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGE--AAFQREVHLISVAIHKNL 136
           +     +G+GGF K Y+    D  +V   ++     P        Q+E     +AIHK+L
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKV----VPKSMLLKPHQKEKMSTEIAIHKSL 99
Query: 137 --LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
               ++G+     +   VY  ++ +     L +L    K +  P  +     T  G++YL
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLE-ICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 254
           H   N ++IHRDLK  N+ L+D+ +  + DFGLA  ++       T + GT  +IAPE L
Sbjct: 159 H---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-LCGTPNYIAPEVL 214
Query: 255 STGKSSEKTDVFGYGITLLELVTGQRAIDFS 285
                S + D++  G  L  L+ G+   + S
Sbjct: 215 CKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 77  DNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 133
           +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+    H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFGTA 188
            N+++L+    T ++  LV+ F+         +DLK         G+  P  K   F   
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 248
            GL + H     +++HRDLK  N+L++      L DFGLA+     +   T ++  T+ +
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWY 169
Query: 249 IAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
            APE L   K  S   D++  G    E+VT +RA+
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/304 (22%), Positives = 127/304 (41%), Gaps = 40/304 (13%)
Query: 67  FSCRELQLATDNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAA 120
           F   E +++ +  +    +GQG FG VY+G   D       T+VAVK + +  S      
Sbjct: 7   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 121 FQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDW 177
           F  E  ++      ++++L+G  +     ++V   M +  +   LR L+P      G   
Sbjct: 67  FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 178 PTRK---RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 234
           PT +   ++A   A G+ YL+ +   K +HRDL A N ++  +F   + DFG+ +     
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----D 179
Query: 235 LTHVTTQIRGTMG-----HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXX 289
           +       +G  G      +APE L  G  +  +D++ +G+ L E+ +            
Sbjct: 180 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------------ 227
Query: 290 XXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 349
                     + L  E  L  ++D           E +  +  +C Q  P+ RP   ++V
Sbjct: 228 ----LAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 283
Query: 350 KMLQ 353
            +L+
Sbjct: 284 NLLK 287

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 77  DNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 133
           +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+    H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFGTA 188
            N+++L+    T ++  LV+ F+         +DLK         G+  P  K   F   
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 248
            GL + H     +++HRDLK  N+L++      L DFGLA+     +   T ++  T+ +
Sbjct: 121 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWY 176
Query: 249 IAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
            APE L   K  S   D++  G    E+VT +RA+
Sbjct: 177 RAPEILLGXKYYSTAVDIWSLGCIFAEMVT-RRAL 210

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 77  DNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 133
           +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+    H
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFGTA 188
            N+++L+    T ++  LV+ F+         +DLK         G+  P  K   F   
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 117
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 248
            GL + H     +++HRDLK  N+L++      L DFGLA+     +   T ++  T+ +
Sbjct: 118 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWY 173
Query: 249 IAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
            APE L   K  S   D++  G    E+VT +RA+
Sbjct: 174 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 207

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 77  DNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 133
           +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+    H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFGTA 188
            N+++L+    T ++  LV+ F+         +DLK         G+  P  K   F   
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 248
            GL + H     +++HRDLK  N+L++      L DFGLA+     +   T ++  T+ +
Sbjct: 113 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWY 168
Query: 249 IAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
            APE L   K  S   D++  G    E+VT +RA+
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 77  DNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 133
           +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+    H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFGTA 188
            N+++L+    T ++  LV+ F+         +DLK         G+  P  K   F   
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 248
            GL + H     +++HRDLK  N+L++      L DFGLA+     +   T ++  T+ +
Sbjct: 121 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWY 176
Query: 249 IAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
            APE L   K  S   D++  G    E+VT +RA+
Sbjct: 177 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 210

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/311 (24%), Positives = 132/311 (42%), Gaps = 48/311 (15%)
Query: 71  ELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQRE 124
           + +    N      +G+G FGKV K         +  T VAVK L++  SP        E
Sbjct: 17  KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSE 76
Query: 125 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD---LKPG---------E 172
            +++    H ++++L G C+     +L+  + +  S+   LR+   + PG          
Sbjct: 77  FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 173 KGLDWPTRKRVAFG--------TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 224
             LD P  + +  G         + G++YL E    K++HRDL A NIL+ +  +  + D
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISD 193
Query: 225 FGLAKLVDAKLTHVT-TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAI 282
           FGL++ V  + + V  +Q R  +  +A E L     + ++DV+ +G+ L E+VT G    
Sbjct: 194 FGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 283 DFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDR 342
                          H  ++ R D  +               E M ++ L C +  P+ R
Sbjct: 254 PGIPPERLFNLLKTGH--RMERPDNCS---------------EEMYRLMLQCWKQEPDKR 296
Query: 343 PPMAQVVKMLQ 353
           P  A + K L+
Sbjct: 297 PVFADISKDLE 307

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 11/152 (7%)
Query: 127 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           ++S+  H  ++++ G    + +  ++  +++   +   LR      +    P  K  A  
Sbjct: 59  MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAE 114
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
               LEYLH +    II+RDLK  NILLD N    + DFG AK V      VT  + GT 
Sbjct: 115 VCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYXLCGTP 167
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
            +IAPE +ST   ++  D + +GI + E++ G
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/302 (22%), Positives = 130/302 (43%), Gaps = 40/302 (13%)
Query: 71  ELQLATDNFSESNIIGQGGFGKVY----KGVLSDN--TKVAVKRLQDYYSPGGEAAFQRE 124
           E ++A +  + S  +GQG FG VY    KGV+ D   T+VA+K + +  S      F  E
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 125 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG---LDWPTRK 181
             ++      ++++L+G  +     +++   M    +   LR L+P  +    L  P+  
Sbjct: 73  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 132
Query: 182 RV---AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 238
           ++   A   A G+ YL+     K +HRDL A N ++ ++F   + DFG+ +     +   
Sbjct: 133 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYET 185
Query: 239 TTQIRGTMG-----HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXX 293
               +G  G      ++PE L  G  +  +DV+ +G+ L E+ T                
Sbjct: 186 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------- 229
Query: 294 XXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                 + L  E  L  +++  L        + + ++  +C Q  P+ RP   +++  ++
Sbjct: 230 LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 289
Query: 354 GE 355
            E
Sbjct: 290 EE 291

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 85  IGQGGFGKVY----KGVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G+G FGKV+      +L +  K  VAVK L++  S      FQRE  L+++  H+++++
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVR 84
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLR-------------DLKPGEKGLDWPTRKRVAF 185
             G CT     ++V+ +M++  +   LR             D+ PG  GL       VA 
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG--QLLAVAS 142
Query: 186 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHVTTQIRG 244
             A G+ YL        +HRDL   N L+       + DFG+++ +       V  +   
Sbjct: 143 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 199
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
            +  + PE +   K + ++DV+ +G+ L E+ T
Sbjct: 200 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/286 (23%), Positives = 120/286 (41%), Gaps = 40/286 (13%)
Query: 85  IGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +GQG FG VY+G   D       T+VAVK + +  S      F  E  ++      ++++
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRK---RVAFGTAYGLE 192
           L+G  +     ++V   M +  +   LR L+P      G   PT +   ++A   A G+ 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG----- 247
           YL+ +   K +HRDL A N ++  +F   + DFG+ +     +       +G  G     
Sbjct: 144 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 196
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDR 307
            +APE L  G  +  +D++ +G+ L E+ +                      + L  E  
Sbjct: 197 WMAPESLKDGVFTTSSDMWSFGVVLWEITS----------------LAEQPYQGLSNEQV 240
Query: 308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
           L  ++D           E +  +  +C Q  P+ RP   ++V +L+
Sbjct: 241 LKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 13/211 (6%)
Query: 79  FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGE--AAFQREVHLISVAIHKNL 136
           +     +G+GGF K Y+    D  +V   ++     P        Q+E     +AIHK+L
Sbjct: 28  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKV----VPKSMLLKPHQKEKMSTEIAIHKSL 83
Query: 137 --LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
               ++G+     +   VY  ++ +     L +L    K +  P  +     T  G++YL
Sbjct: 84  DNPHVVGFHGFFEDDDFVYVVLE-ICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 142
Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 254
           H   N ++IHRDLK  N+ L+D+ +  + DFGLA  ++         + GT  +IAPE L
Sbjct: 143 H---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD-GERKKDLCGTPNYIAPEVL 198
Query: 255 STGKSSEKTDVFGYGITLLELVTGQRAIDFS 285
                S + D++  G  L  L+ G+   + S
Sbjct: 199 CKKGHSFEVDIWSLGCILYTLLVGKPPFETS 229

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/302 (22%), Positives = 130/302 (43%), Gaps = 40/302 (13%)
Query: 71  ELQLATDNFSESNIIGQGGFGKVY----KGVLSDN--TKVAVKRLQDYYSPGGEAAFQRE 124
           E ++A +  + S  +GQG FG VY    KGV+ D   T+VA+K + +  S      F  E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 125 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG---LDWPTRK 181
             ++      ++++L+G  +     +++   M    +   LR L+P  +    L  P+  
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 125
Query: 182 RV---AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 238
           ++   A   A G+ YL+     K +HRDL A N ++ ++F   + DFG+ +     +   
Sbjct: 126 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYET 178
Query: 239 TTQIRGTMG-----HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXX 293
               +G  G      ++PE L  G  +  +DV+ +G+ L E+ T                
Sbjct: 179 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------- 222
Query: 294 XXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                 + L  E  L  +++  L        + + ++  +C Q  P+ RP   +++  ++
Sbjct: 223 LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 282
Query: 354 GE 355
            E
Sbjct: 283 EE 284

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 85  IGQGGFGKVY----KGVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G+G FGKV+      +L +  K  VAVK L++  S      FQRE  L+++  H+++++
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVR 78
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLR-------------DLKPGEKGLDWPTRKRVAF 185
             G CT     ++V+ +M++  +   LR             D+ PG  GL       VA 
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG--QLLAVAS 136
Query: 186 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHVTTQIRG 244
             A G+ YL        +HRDL   N L+       + DFG+++ +       V  +   
Sbjct: 137 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
            +  + PE +   K + ++DV+ +G+ L E+ T
Sbjct: 194 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/302 (22%), Positives = 130/302 (43%), Gaps = 40/302 (13%)
Query: 71  ELQLATDNFSESNIIGQGGFGKVY----KGVLSDN--TKVAVKRLQDYYSPGGEAAFQRE 124
           E ++A +  + S  +GQG FG VY    KGV+ D   T+VA+K + +  S      F  E
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 125 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG---LDWPTRK 181
             ++      ++++L+G  +     +++   M    +   LR L+P  +    L  P+  
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 131
Query: 182 RV---AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 238
           ++   A   A G+ YL+     K +HRDL A N ++ ++F   + DFG+ +     +   
Sbjct: 132 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYET 184
Query: 239 TTQIRGTMG-----HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXX 293
               +G  G      ++PE L  G  +  +DV+ +G+ L E+ T                
Sbjct: 185 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------- 228
Query: 294 XXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                 + L  E  L  +++  L        + + ++  +C Q  P+ RP   +++  ++
Sbjct: 229 LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 288
Query: 354 GE 355
            E
Sbjct: 289 EE 290

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/302 (22%), Positives = 129/302 (42%), Gaps = 40/302 (13%)
Query: 71  ELQLATDNFSESNIIGQGGFGKVY----KGVLSDN--TKVAVKRLQDYYSPGGEAAFQRE 124
           E ++A +  + S  +GQG FG VY    KGV+ D   T+VA+K + +  S      F  E
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 125 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG---LDWPTRK 181
             ++      ++++L+G  +     +++   M    +   LR L+P       L  P+  
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138
Query: 182 RV---AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 238
           ++   A   A G+ YL+     K +HRDL A N ++ ++F   + DFG+ +     +   
Sbjct: 139 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYET 191
Query: 239 TTQIRGTMG-----HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXX 293
               +G  G      ++PE L  G  +  +DV+ +G+ L E+ T                
Sbjct: 192 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------- 235
Query: 294 XXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                 + L  E  L  +++  L        + + ++  +C Q  P+ RP   +++  ++
Sbjct: 236 LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295
Query: 354 GE 355
            E
Sbjct: 296 EE 297

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/302 (22%), Positives = 130/302 (43%), Gaps = 40/302 (13%)
Query: 71  ELQLATDNFSESNIIGQGGFGKVY----KGVLSDN--TKVAVKRLQDYYSPGGEAAFQRE 124
           E ++A +  + S  +GQG FG VY    KGV+ D   T+VA+K + +  S      F  E
Sbjct: 41  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 100
Query: 125 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG---LDWPTRK 181
             ++      ++++L+G  +     +++   M    +   LR L+P  +    L  P+  
Sbjct: 101 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 160
Query: 182 RV---AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 238
           ++   A   A G+ YL+     K +HRDL A N ++ ++F   + DFG+ +     +   
Sbjct: 161 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYET 213
Query: 239 TTQIRGTMG-----HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXX 293
               +G  G      ++PE L  G  +  +DV+ +G+ L E+ T                
Sbjct: 214 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------- 257
Query: 294 XXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                 + L  E  L  +++  L        + + ++  +C Q  P+ RP   +++  ++
Sbjct: 258 LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 317
Query: 354 GE 355
            E
Sbjct: 318 EE 319

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/302 (22%), Positives = 130/302 (43%), Gaps = 40/302 (13%)
Query: 71  ELQLATDNFSESNIIGQGGFGKVY----KGVLSDN--TKVAVKRLQDYYSPGGEAAFQRE 124
           E ++A +  + S  +GQG FG VY    KGV+ D   T+VA+K + +  S      F  E
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 125 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG---LDWPTRK 181
             ++      ++++L+G  +     +++   M    +   LR L+P  +    L  P+  
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 131
Query: 182 RV---AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 238
           ++   A   A G+ YL+     K +HRDL A N ++ ++F   + DFG+ +     +   
Sbjct: 132 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYET 184
Query: 239 TTQIRGTMG-----HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXX 293
               +G  G      ++PE L  G  +  +DV+ +G+ L E+ T                
Sbjct: 185 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------- 228
Query: 294 XXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                 + L  E  L  +++  L        + + ++  +C Q  P+ RP   +++  ++
Sbjct: 229 LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 288
Query: 354 GE 355
            E
Sbjct: 289 EE 290

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 16/205 (7%)
Query: 79  FSESNIIGQGGFGKVYKGVLSDNTK---VAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           F++   IG+G FG+V+KG+  DN     VA+K +    +       Q+E+ ++S      
Sbjct: 25  FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSY 82
Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
           + +  G     S+  ++   M+ L     L  L+ G    D      +      GL+YLH
Sbjct: 83  VTKYYGSYLKGSKLWII---MEYLGGGSALDLLRAGP--FDEFQIATMLKEILKGLDYLH 137
Query: 196 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYL 254
            +   K IHRD+KAAN+LL +  +  L DFG+A +L D ++   T    GT   +APE +
Sbjct: 138 SE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 192
Query: 255 STGKSSEKTDVFGYGITLLELVTGQ 279
                  K D++  GIT +EL  G+
Sbjct: 193 QQSAYDSKADIWSLGITAIELAKGE 217

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 17/214 (7%)
Query: 75  ATDNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVA 131
           + +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+   
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 132 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGE--KGLDWPTRKRVAFGTAY 189
            H N+++L+    T ++  LV+ F+        L+D        G+  P  K   F    
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKDFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL + H     +++HRDLK  N+L++      L DFGLA+     +     ++  T+ + 
Sbjct: 115 GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 170
Query: 250 APEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
           APE L   K  S   D++  G    E+VT +RA+
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 85  IGQGGFGKVYK---GVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +G+G FG V       L DNT   VAVK+LQ + +      F+RE+ ++    H N+++ 
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
            G C ++  R L    M+ L     LRD L+  ++ +D     +       G+EYL  + 
Sbjct: 78  KGVCYSAGRRNLKL-IMEYLPYG-SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK- 134
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLST 256
             + IHR+L   NIL+++     + DFGL K++  D +   V       +   APE L+ 
Sbjct: 135 --RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 192
Query: 257 GKSSEKTDVFGYGITLLELVT 277
            K S  +DV+ +G+ L EL T
Sbjct: 193 SKFSVASDVWSFGVVLYELFT 213

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 13/211 (6%)
Query: 79  FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGE--AAFQREVHLISVAIHKNL 136
           +     +G+GGF K Y+    D  +V   ++     P        Q+E     +AIHK+L
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKV----VPKSMLLKPHQKEKMSTEIAIHKSL 99
Query: 137 --LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
               ++G+     +   VY  ++ +     L +L    K +  P  +     T  G++YL
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLE-ICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 254
           H   N ++IHRDLK  N+ L+D+ +  + DFGLA  ++         + GT  +IAPE L
Sbjct: 159 H---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD-GERKKDLCGTPNYIAPEVL 214
Query: 255 STGKSSEKTDVFGYGITLLELVTGQRAIDFS 285
                S + D++  G  L  L+ G+   + S
Sbjct: 215 CKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/302 (22%), Positives = 130/302 (43%), Gaps = 40/302 (13%)
Query: 71  ELQLATDNFSESNIIGQGGFGKVY----KGVLSDN--TKVAVKRLQDYYSPGGEAAFQRE 124
           E ++A +  + S  +GQG FG VY    KGV+ D   T+VA+K + +  S      F  E
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 125 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG---LDWPTRK 181
             ++      ++++L+G  +     +++   M    +   LR L+P  +    L  P+  
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 138
Query: 182 RV---AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 238
           ++   A   A G+ YL+     K +HRDL A N ++ ++F   + DFG+ +     +   
Sbjct: 139 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYET 191
Query: 239 TTQIRGTMG-----HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXX 293
               +G  G      ++PE L  G  +  +DV+ +G+ L E+ T                
Sbjct: 192 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------- 235
Query: 294 XXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                 + L  E  L  +++  L        + + ++  +C Q  P+ RP   +++  ++
Sbjct: 236 LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295
Query: 354 GE 355
            E
Sbjct: 296 EE 297

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 27/218 (12%)
Query: 84  IIGQGGFGKVYKG-VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           +  +G FG V+K  +L++   V +  +QD  S   E     EV+ +    H+N+LQ IG 
Sbjct: 31  VKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNE----YEVYSLPGMKHENILQFIGA 86
Query: 143 ----CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
                +   +  L+  F +  S++  L+        + W     +A   A GL YLHE  
Sbjct: 87  EKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCHIAETMARGLAYLHEDI 141
Query: 199 -------NPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIA 250
                   P I HRD+K+ N+LL +N  A + DFGLA K    K    T    GT  ++A
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMA 201
Query: 251 PEYLSTGKSSE-----KTDVFGYGITLLELVTGQRAID 283
           PE L    + +     + D++  G+ L EL +   A D
Sbjct: 202 PEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 129/307 (42%), Gaps = 39/307 (12%)
Query: 67  FSCRELQLATDNFSESNIIGQGGFGKVYK----GVLSDNT--KVAVKRLQDYYSPGGEAA 120
           +   + +   D       +G+G FG+V +    G+    T   VAVK L++  +     A
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 121 FQREVH-LISVAIHKNLLQLIGYCTTSSERILV---YPFMQNLSVAYRLR-------DLK 169
              E+  LI +  H N++ L+G CT     ++V   +    NLS   R +        + 
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 170 PGEKGLDWPTRKRV---AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 226
           P +   D+ T + +   +F  A G+E+L  +   K IHRDL A NILL +     +CDFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFG 193
Query: 227 LAKLVDAKLTHVTT-QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 285
           LA+ +     +V     R  +  +APE +     + ++DV+ +G+ L E+ +        
Sbjct: 194 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LG 247
Query: 286 RXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 345
                         R+L    R+          Y + E   M Q  L C    P  RP  
Sbjct: 248 ASPYPGVKIDEEFCRRLKEGTRM------RAPDYTTPE---MYQTMLDCWHGEPSQRPTF 298
Query: 346 AQVVKML 352
           +++V+ L
Sbjct: 299 SELVEHL 305

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 13/211 (6%)
Query: 79  FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGE--AAFQREVHLISVAIHKNL 136
           +     +G+GGF K Y+    D  +V   ++     P        Q+E     +AIHK+L
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKV----VPKSMLLKPHQKEKMSTEIAIHKSL 99
Query: 137 --LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
               ++G+     +   VY  ++ +     L +L    K +  P  +     T  G++YL
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLE-ICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 254
           H   N ++IHRDLK  N+ L+D+ +  + DFGLA  ++         + GT  +IAPE L
Sbjct: 159 H---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD-GERKKXLCGTPNYIAPEVL 214
Query: 255 STGKSSEKTDVFGYGITLLELVTGQRAIDFS 285
                S + D++  G  L  L+ G+   + S
Sbjct: 215 CKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 77  DNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 134
           +NF +   IG+G +G VYK    L+       K   D  + G  +   RE+ L+    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFGTAY 189
           N+++L+    T ++  LV+ F+         +DLK         G+  P  K   F    
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL + H     +++HRDLK  N+L++      L DFGLA+     +   T ++  T+ + 
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYR 170
Query: 250 APEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
           APE L   K  S   D++  G    E+VT +RA+
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 77  DNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 134
           +NF +   IG+G +G VYK    L+       K   D  + G  +   RE+ L+    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFGTAY 189
           N+++L+    T ++  LV+ F+         +DLK         G+  P  K   F    
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL + H     +++HRDLK  N+L++      L DFGLA+     +   T ++  T+ + 
Sbjct: 114 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYR 169
Query: 250 APEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
           APE L   K  S   D++  G    E+VT +RA+
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 129/307 (42%), Gaps = 39/307 (12%)
Query: 67  FSCRELQLATDNFSESNIIGQGGFGKVYK----GVLSDNT--KVAVKRLQDYYSPGGEAA 120
           +   + +   D       +G+G FG+V +    G+    T   VAVK L++  +     A
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 121 FQREVH-LISVAIHKNLLQLIGYCTTSSERILV---YPFMQNLSVAYRLR-------DLK 169
              E+  LI +  H N++ L+G CT     ++V   +    NLS   R +        + 
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 170 PGEKGLDWPTRKRV---AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 226
           P +   D+ T + +   +F  A G+E+L  +   K IHRDL A NILL +     +CDFG
Sbjct: 128 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFG 184
Query: 227 LAKLVDAKLTHVTT-QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 285
           LA+ +     +V     R  +  +APE +     + ++DV+ +G+ L E+ +        
Sbjct: 185 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LG 238
Query: 286 RXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 345
                         R+L    R+          Y + E   M Q  L C    P  RP  
Sbjct: 239 ASPYPGVKIDEEFCRRLKEGTRM------RAPDYTTPE---MYQTMLDCWHGEPSQRPTF 289
Query: 346 AQVVKML 352
           +++V+ L
Sbjct: 290 SELVEHL 296

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           +G G FGKVYK    + + +A  ++ D  S      +  E+ +++   H N+++L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 204
             +   ++  F    +V   + +L   E+ L     + V   T   L YLH+    KIIH
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 205 RDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR----GTMGHIAPEYLSTGKSS 260
           RDLKA NIL   + +  L DFG    V AK T  T Q R    GT   +APE +    S 
Sbjct: 159 RDLKAGNILFTLDGDIKLADFG----VSAKNTR-TIQRRDSFIGTPYWMAPEVVMCETSK 213
Query: 261 E-----KTDVFGYGITLLEL 275
           +     K DV+  GITL+E+
Sbjct: 214 DRPYDYKADVWSLGITLIEM 233

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 17/214 (7%)
Query: 75  ATDNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVA 131
           + +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+   
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 132 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGE--KGLDWPTRKRVAFGTAY 189
            H N+++L+    T ++  LV+ F+     +  L+D        G+  P  K   F    
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-----SMDLKDFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL + H     +++HRDLK  N+L++      L DFGLA+     +     ++  T+ + 
Sbjct: 118 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 173
Query: 250 APEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
           APE L   K  S   D++  G    E+VT +RA+
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 15/213 (7%)
Query: 75  ATDNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVA 131
           + +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+   
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 132 IHKNLLQLIGYCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG 190
            H N+++L+    T ++  LV+ F+ Q+L        L     G+  P  K   F    G
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALT----GIPLPLIKSYLFQLLQG 118
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
           L + H     +++HRDLK  N+L++      L DFGLA+     +     ++  T+ + A
Sbjct: 119 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 174
Query: 251 PEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
           PE L   K  S   D++  G    E+VT +RA+
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/302 (22%), Positives = 130/302 (43%), Gaps = 40/302 (13%)
Query: 71  ELQLATDNFSESNIIGQGGFGKVY----KGVLSD--NTKVAVKRLQDYYSPGGEAAFQRE 124
           E ++A +  + S  +GQG FG VY    KGV+ D   T+VA+K + +  S      F  E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 125 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG---LDWPTRK 181
             ++      ++++L+G  +     +++   M    +   LR L+P  +    L  P+  
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 125
Query: 182 R---VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 238
           +   +A   A G+ YL+     K +HRDL A N  + ++F   + DFG+ +     +   
Sbjct: 126 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR----DIYET 178
Query: 239 TTQIRGTMG-----HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXX 293
               +G  G      ++PE L  G  +  +DV+ +G+ L E+ T                
Sbjct: 179 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------- 222
Query: 294 XXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                 + L  E  L  +++  L        + ++++  +C Q  P+ RP   +++  ++
Sbjct: 223 LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIK 282
Query: 354 GE 355
            E
Sbjct: 283 EE 284

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 129/307 (42%), Gaps = 39/307 (12%)
Query: 67  FSCRELQLATDNFSESNIIGQGGFGKVYK----GVLSDNT--KVAVKRLQDYYSPGGEAA 120
           +   + +   D       +G+G FG+V +    G+    T   VAVK L++  +     A
Sbjct: 54  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 113
Query: 121 FQREVH-LISVAIHKNLLQLIGYCTTSSERILV---YPFMQNLSVAYRLR-------DLK 169
              E+  LI +  H N++ L+G CT     ++V   +    NLS   R +        + 
Sbjct: 114 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 173
Query: 170 PGEKGLDWPTRKRV---AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 226
           P +   D+ T + +   +F  A G+E+L  +   K IHRDL A NILL +     +CDFG
Sbjct: 174 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFG 230
Query: 227 LAKLVDAKLTHVTT-QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 285
           LA+ +     +V     R  +  +APE +     + ++DV+ +G+ L E+ +        
Sbjct: 231 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LG 284
Query: 286 RXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 345
                         R+L    R+          Y + E   M Q  L C    P  RP  
Sbjct: 285 ASPYPGVKIDEEFCRRLKEGTRM------RAPDYTTPE---MYQTMLDCWHGEPSQRPTF 335
Query: 346 AQVVKML 352
           +++V+ L
Sbjct: 336 SELVEHL 342

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 17/214 (7%)
Query: 75  ATDNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVA 131
           + +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+   
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 132 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGE--KGLDWPTRKRVAFGTAY 189
            H N+++L+    T ++  LV+ F+     +  L+D        G+  P  K   F    
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-----SMDLKDFMDASALTGIPLPLIKSYLFQLLQ 116
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL + H     +++HRDLK  N+L++      L DFGLA+     +     ++  T+ + 
Sbjct: 117 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 172
Query: 250 APEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
           APE L   K  S   D++  G    E+VT +RA+
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 85  IGQGGFGKVY----KGVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G+G FGKV+      +L +  K  VAVK L++  S      FQRE  L+++  H+++++
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVR 107
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLR-------------DLKPGEKGLDWPTRKRVAF 185
             G CT     ++V+ +M++  +   LR             D+ PG  GL       VA 
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG--QLLAVAS 165
Query: 186 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHVTTQIRG 244
             A G+ YL        +HRDL   N L+       + DFG+++ +       V  +   
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
            +  + PE +   K + ++DV+ +G+ L E+ T
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 118/291 (40%), Gaps = 35/291 (12%)
Query: 77  DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           D++    +IG G    V     +    KVA+KR+             +E+  +S   H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL-KPGEKG---LDWPTRKRVAFGTAYGL 191
           ++          E  LV   +   SV   ++ +   GE     LD  T   +      GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 192 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV----DAKLTHVTTQIRGTMG 247
           EYLH+      IHRD+KA NILL ++    + DFG++  +    D     V     GT  
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 248 HIAPEYLSTGKSSE-KTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLRED 306
            +APE +   +  + K D++ +GIT +EL TG  A  + +              K+L   
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATG--AAPYHKYPPM----------KVLMLT 239
Query: 307 RLND-------IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
             ND       + D+ +     K    M+    LC Q  PE RP  A++++
Sbjct: 240 LQNDPPSLETGVQDKEMLKKYGKSFRKMIS---LCLQKDPEKRPTAAELLR 287

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 128/307 (41%), Gaps = 39/307 (12%)
Query: 67  FSCRELQLATDNFSESNIIGQGGFGKVYK----GVLSDNT--KVAVKRLQDYYSPGGEAA 120
           +   + +   D       +G+G FG+V +    G+    T   VAVK L++  +     A
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 121 FQREVH-LISVAIHKNLLQLIGYCTTSSERILV---YPFMQNLSVAYRLR-------DLK 169
              E+  LI +  H N++ L+G CT     ++V   +    NLS   R +        + 
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 170 PGEKGLDWPTRKRV---AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 226
           P +   D+ T + +   +F  A G+E+L  +   K IHRDL A NILL +     +CDFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFG 193
Query: 227 LAKLVDAKLTHVTT-QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 285
           LA+ +      V     R  +  +APE +     + ++DV+ +G+ L E+ +        
Sbjct: 194 LARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LG 247
Query: 286 RXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 345
                         R+L    R+          Y + E   M Q  L C    P  RP  
Sbjct: 248 ASPYPGVKIDEEFCRRLKEGTRM------RAPDYTTPE---MYQTMLDCWHGEPSQRPTF 298
Query: 346 AQVVKML 352
           +++V+ L
Sbjct: 299 SELVEHL 305

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 105/208 (50%), Gaps = 27/208 (12%)
Query: 83  NIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREV-HLISVAI--HK 134
            ++G G FG V+KGV      S    V +K ++D     G  +FQ    H++++    H 
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK---SGRQSFQAVTDHMLAIGSLDHA 75
Query: 135 NLLQLIGYCTTSSERILV--YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 192
           ++++L+G C  SS +++    P    L    + R     +  L+W  +       A G+ 
Sbjct: 76  HIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMY 129
Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTHVTTQIRGTMGHI 249
           YL E     ++HR+L A N+LL    +  + DFG+A L+   D +L +  ++ +  +  +
Sbjct: 130 YLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWM 184
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVT 277
           A E +  GK + ++DV+ YG+T+ EL+T
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 108/233 (46%), Gaps = 37/233 (15%)
Query: 73  QLATDNFSESNIIGQGGFGKVYK----GVLSDN----TKVAVKRLQDYYSPGGEAAFQRE 124
           +L  D       +G+G FG+V      G+  D     TKVAVK L+   +    +    E
Sbjct: 9   ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68
Query: 125 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW---PTR 180
           + ++  +  HKN++ L+G CT      ++  +    ++   L+  +P   GL++   P+ 
Sbjct: 69  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP--PGLEYCYNPSH 126
Query: 181 K-----------RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 229
                         A+  A G+EYL  +   K IHRDL A N+L+ ++    + DFGLA+
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 183
Query: 230 LVDAKLTHV-----TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
                + H+     TT  R  +  +APE L     + ++DV+ +G+ L E+ T
Sbjct: 184 ----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 84  IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGE--AAFQREVHLISVAIHKNLLQ--L 139
            +G+GGF K ++   +D  +V   ++     P        QRE   + ++IH++L    +
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKI----VPKSLLLKPHQREKMSMEISIHRSLAHQHV 79
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
           +G+     +   V+  ++ L     L +L    K L  P  +        G +YLH    
Sbjct: 80  VGFHGFFEDNDFVFVVLE-LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN-- 136
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 259
            ++IHRDLK  N+ L+++ E  + DFGLA  V+       T + GT  +IAPE LS    
Sbjct: 137 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGH 194
Query: 260 SEKTDVFGYGITLLELVTGQRAIDFS 285
           S + DV+  G  +  L+ G+   + S
Sbjct: 195 SFEVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 27/208 (12%)
Query: 83  NIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREV-HLISVAI--HK 134
            ++G G FG V+KGV      S    V +K ++D     G  +FQ    H++++    H 
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK---SGRQSFQAVTDHMLAIGSLDHA 93
Query: 135 NLLQLIGYCTTSSERILV--YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 192
           ++++L+G C  SS +++    P    L    + R     +  L+W          A G+ 
Sbjct: 94  HIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMY 147
Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTHVTTQIRGTMGHI 249
           YL E     ++HR+L A N+LL    +  + DFG+A L+   D +L +  ++ +  +  +
Sbjct: 148 YLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWM 202
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVT 277
           A E +  GK + ++DV+ YG+T+ EL+T
Sbjct: 203 ALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 129/307 (42%), Gaps = 39/307 (12%)
Query: 67  FSCRELQLATDNFSESNIIGQGGFGKVYK----GVLSDNT--KVAVKRLQDYYSPGGEAA 120
           +   + +   D       +G+G FG+V +    G+    T   VAVK L++  +     A
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 121 FQREVH-LISVAIHKNLLQLIGYCTTSSERILV---YPFMQNLSVAYRLR-------DLK 169
              E+  LI +  H N++ L+G CT     ++V   +    NLS   R +        + 
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 170 PGEKGLDWPTRKRV---AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 226
           P +   D+ T + +   +F  A G+E+L  +   K IHRDL A NILL +     +CDFG
Sbjct: 128 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFG 184
Query: 227 LAKLVDAKLTHVTT-QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 285
           LA+ +     +V     R  +  +APE +     + ++DV+ +G+ L E+ +        
Sbjct: 185 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LG 238
Query: 286 RXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 345
                         R+L    R+          Y + E   M Q  L C    P  RP  
Sbjct: 239 ASPYPGVKIDEEFCRRLKEGTRM------RAPDYTTPE---MYQTMLDCWHGEPSQRPTF 289
Query: 346 AQVVKML 352
           +++V+ L
Sbjct: 290 SELVEHL 296

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 135/308 (43%), Gaps = 53/308 (17%)
Query: 73  QLATDNFSESNIIGQGGFGKVYK----GVLSDN----TKVAVKRLQDYYSPGGEAAFQRE 124
           +L  D       +G+G FG+V      G+  D     TKVAVK L+   +    +    E
Sbjct: 24  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 83
Query: 125 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW---PTR 180
           + ++  +  HKN++ L+G CT      ++  +    ++   L+  +P   GL++   P+ 
Sbjct: 84  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP--PGLEYCYNPSH 141
Query: 181 K-----------RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 229
                         A+  A G+EYL  +   K IHRDL A N+L+ ++    + DFGLA+
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 198
Query: 230 LVDAKLTHV-----TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 284
                + H+     TT  R  +  +APE L     + ++DV+ +G+ L E+        F
Sbjct: 199 ----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI--------F 246
Query: 285 SRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP 344
           +             + KLL+E      +D+  N   + E+  M++    C  + P  RP 
Sbjct: 247 TLGGSPYPGVPVEELFKLLKEGHR---MDKPSNC--TNELYMMMRD---CWHAVPSQRPT 298
Query: 345 MAQVVKML 352
             Q+V+ L
Sbjct: 299 FKQLVEDL 306

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 118/291 (40%), Gaps = 35/291 (12%)
Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           D++    +IG G    V     +    KVA+KR+             +E+  +S   H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL-KPGEKG---LDWPTRKRVAFGTAYGL 191
           ++          E  LV   +   SV   ++ +   GE     LD  T   +      GL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 192 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV----DAKLTHVTTQIRGTMG 247
           EYLH+      IHRD+KA NILL ++    + DFG++  +    D     V     GT  
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 248 HIAPEYLSTGKSSE-KTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLRED 306
            +APE +   +  + K D++ +GIT +EL TG  A  + +              K+L   
Sbjct: 187 WMAPEVMEQVRGYDFKADIWSFGITAIELATG--AAPYHKYPPM----------KVLMLT 234
Query: 307 RLND-------IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
             ND       + D+ +     K    M+    LC Q  PE RP  A++++
Sbjct: 235 LQNDPPSLETGVQDKEMLKKYGKSFRKMIS---LCLQKDPEKRPTAAELLR 282

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 14/218 (6%)
Query: 70  RELQLATDNFSESNI-IGQGGFGKVYKGVLSDNTK---VAVKRLQDYYSPGGEAAFQREV 125
           ++L L  DN   ++I +G G FG V +GV     K   VA+K L+            RE 
Sbjct: 2   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 61
Query: 126 HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF 185
            ++    +  +++LIG C   +E +++   M      ++    K  E  +       +  
Sbjct: 62  QIMHQLDNPYIVRLIGVC--QAEALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLH 117
Query: 186 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG- 244
             + G++YL E+     +HRDL A N+LL +   A + DFGL+K + A  ++ T +  G 
Sbjct: 118 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174
Query: 245 -TMGHIAPEYLSTGKSSEKTDVFGYGITLLE-LVTGQR 280
             +   APE ++  K S ++DV+ YG+T+ E L  GQ+
Sbjct: 175 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 84  IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGE--AAFQREVHLISVAIHKNLLQ--L 139
            +G+GGF K ++   +D  +V   ++     P        QRE   + ++IH++L    +
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKI----VPKSLLLKPHQREKMSMEISIHRSLAHQHV 83
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
           +G+     +   V+  ++ L     L +L    K L  P  +        G +YLH    
Sbjct: 84  VGFHGFFEDNDFVFVVLE-LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN-- 140
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 259
            ++IHRDLK  N+ L+++ E  + DFGLA  V+       T + GT  +IAPE LS    
Sbjct: 141 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGH 198
Query: 260 SEKTDVFGYGITLLELVTGQRAIDFS 285
           S + DV+  G  +  L+ G+   + S
Sbjct: 199 SFEVDVWSIGCIMYTLLVGKPPFETS 224

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 84  IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGE--AAFQREVHLISVAIHKNLLQ--L 139
            +G+GGF K ++   +D  +V   ++     P        QRE   + ++IH++L    +
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKI----VPKSLLLKPHQREKMSMEISIHRSLAHQHV 79
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
           +G+     +   V+  ++ L     L +L    K L  P  +        G +YLH    
Sbjct: 80  VGFHGFFEDNDFVFVVLE-LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN-- 136
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 259
            ++IHRDLK  N+ L+++ E  + DFGLA  V+       T + GT  +IAPE LS    
Sbjct: 137 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGH 194
Query: 260 SEKTDVFGYGITLLELVTGQRAIDFS 285
           S + DV+  G  +  L+ G+   + S
Sbjct: 195 SFEVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 135/308 (43%), Gaps = 53/308 (17%)
Query: 73  QLATDNFSESNIIGQGGFGKVYK----GVLSDN----TKVAVKRLQDYYSPGGEAAFQRE 124
           +L  D       +G+G FG+V      G+  D     TKVAVK L+   +    +    E
Sbjct: 16  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 75
Query: 125 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW---PTR 180
           + ++  +  HKN++ L+G CT      ++  +    ++   L+  +P   GL++   P+ 
Sbjct: 76  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP--PGLEYSYNPSH 133
Query: 181 K-----------RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 229
                         A+  A G+EYL  +   K IHRDL A N+L+ ++    + DFGLA+
Sbjct: 134 NPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 190
Query: 230 LVDAKLTHV-----TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 284
                + H+     TT  R  +  +APE L     + ++DV+ +G+ L E+        F
Sbjct: 191 ----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI--------F 238
Query: 285 SRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP 344
           +             + KLL+E      +D+  N   + E+  M++    C  + P  RP 
Sbjct: 239 TLGGSPYPGVPVEELFKLLKEGHR---MDKPSNC--TNELYMMMRD---CWHAVPSQRPT 290
Query: 345 MAQVVKML 352
             Q+V+ L
Sbjct: 291 FKQLVEDL 298

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 128/307 (41%), Gaps = 39/307 (12%)
Query: 67  FSCRELQLATDNFSESNIIGQGGFGKVYK----GVLSDNT--KVAVKRLQDYYSPGGEAA 120
           +   + +   D       +G+G FG+V +    G+    T   VAVK L++  +     A
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 121 FQREVH-LISVAIHKNLLQLIGYCTTSSERILV---YPFMQNLSVAYRLR-------DLK 169
              E+  LI +  H N++ L+G CT     ++V   +    NLS   R +        + 
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 170 PGEKGLDWPTRKRV---AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 226
           P +   D+ T + +   +F  A G+E+L  +   K IHRDL A NILL +     +CDFG
Sbjct: 128 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFG 184
Query: 227 LAKLVDAKLTHVTT-QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 285
           LA+ +      V     R  +  +APE +     + ++DV+ +G+ L E+ +        
Sbjct: 185 LARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LG 238
Query: 286 RXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 345
                         R+L    R+          Y + E   M Q  L C    P  RP  
Sbjct: 239 ASPYPGVKIDEEFCRRLKEGTRM------RAPDYTTPE---MYQTMLDCWHGEPSQRPTF 289
Query: 346 AQVVKML 352
           +++V+ L
Sbjct: 290 SELVEHL 296

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 75  ATDNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVA 131
           + +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+   
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 132 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFG 186
            H N+++L+    T ++  LV+ F+         +DLK         G+  P  K   F 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
              GL + H     +++HRDLK  N+L++      L DFGLA+     +     ++  T+
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 167
Query: 247 GHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
            + APE L   K  S   D++  G    E+VT +RA+
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 108/233 (46%), Gaps = 37/233 (15%)
Query: 73  QLATDNFSESNIIGQGGFGKVYK----GVLSDN----TKVAVKRLQDYYSPGGEAAFQRE 124
           +L  D       +G+G FG+V      G+  D     TKVAVK L+   +    +    E
Sbjct: 24  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 83
Query: 125 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW---PTR 180
           + ++  +  HKN++ L+G CT      ++  +    ++   L+  +P   GL++   P+ 
Sbjct: 84  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP--PGLEFSFNPSH 141
Query: 181 K-----------RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 229
                         A+  A G+EYL  +   K IHRDL A N+L+ ++    + DFGLA+
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 198
Query: 230 LVDAKLTHV-----TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
                + H+     TT  R  +  +APE L     + ++DV+ +G+ L E+ T
Sbjct: 199 ----DIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 128/307 (41%), Gaps = 39/307 (12%)
Query: 67  FSCRELQLATDNFSESNIIGQGGFGKVYK----GVLSDNT--KVAVKRLQDYYSPGGEAA 120
           +   + +   D       +G+G FG+V +    G+    T   VAVK L++  +     A
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 121 FQREVH-LISVAIHKNLLQLIGYCTTSSERILV---YPFMQNLSVAYRLR-------DLK 169
              E+  LI +  H N++ L+G CT     ++V   +    NLS   R +        + 
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 170 PGEKGLDWPTRKRV---AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 226
           P +   D+ T + +   +F  A G+E+L  +   K IHRDL A NILL +     +CDFG
Sbjct: 128 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFG 184
Query: 227 LAKLVDAKLTHVTT-QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 285
           LA+ +      V     R  +  +APE +     + ++DV+ +G+ L E+ +        
Sbjct: 185 LARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LG 238
Query: 286 RXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 345
                         R+L    R+          Y + E   M Q  L C    P  RP  
Sbjct: 239 ASPYPGVKIDEEFCRRLKEGTRM------RAPDYTTPE---MYQTMLDCWHGEPSQRPTF 289
Query: 346 AQVVKML 352
           +++V+ L
Sbjct: 290 SELVEHL 296

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 135/308 (43%), Gaps = 53/308 (17%)
Query: 73  QLATDNFSESNIIGQGGFGKVY----KGVLSDN----TKVAVKRLQDYYSPGGEAAFQRE 124
           +L  D       +G+G FG+V      G+  D     TKVAVK L+   +    +    E
Sbjct: 24  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 83
Query: 125 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW---PTR 180
           + ++  +  HKN++ L+G CT      ++  +    ++   L+  +P   GL++   P+ 
Sbjct: 84  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP--PGLEYSYNPSH 141
Query: 181 K-----------RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 229
                         A+  A G+EYL  +   K IHRDL A N+L+ ++    + DFGLA+
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 198
Query: 230 LVDAKLTHV-----TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 284
                + H+     TT  R  +  +APE L     + ++DV+ +G+ L E+        F
Sbjct: 199 ----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI--------F 246
Query: 285 SRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP 344
           +             + KLL+E      +D+  N   + E+  M++    C  + P  RP 
Sbjct: 247 TLGGSPYPGVPVEELFKLLKEGHR---MDKPSNC--TNELYMMMRD---CWHAVPSQRPT 298
Query: 345 MAQVVKML 352
             Q+V+ L
Sbjct: 299 FKQLVEDL 306

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 108/233 (46%), Gaps = 37/233 (15%)
Query: 73  QLATDNFSESNIIGQGGFGKVYK----GVLSDN----TKVAVKRLQDYYSPGGEAAFQRE 124
           +L  D       +G+G FG+V      G+  D     TKVAVK L+   +    +    E
Sbjct: 17  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 76
Query: 125 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW---PTR 180
           + ++  +  HKN++ L+G CT      ++  +    ++   L+  +P   GL++   P+ 
Sbjct: 77  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP--PGLEYSYNPSH 134
Query: 181 K-----------RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 229
                         A+  A G+EYL  +   K IHRDL A N+L+ ++    + DFGLA+
Sbjct: 135 NPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 191
Query: 230 LVDAKLTHV-----TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
                + H+     TT  R  +  +APE L     + ++DV+ +G+ L E+ T
Sbjct: 192 ----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 75  ATDNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVA 131
           + +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+   
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 132 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFG 186
            H N+++L+    T ++  LV+ F+         +DLK         G+  P  K   F 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
              GL + H     +++HRDLK  N+L++      L DFGLA+     +     ++  T+
Sbjct: 113 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 168
Query: 247 GHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
            + APE L   K  S   D++  G    E+VT +RA+
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 75  ATDNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVA 131
           + +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+   
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 132 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFG 186
            H N+++L+    T ++  LV+ F+         +DLK         G+  P  K   F 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
              GL + H     +++HRDLK  N+L++      L DFGLA+     +     ++  T+
Sbjct: 115 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 170
Query: 247 GHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
            + APE L   K  S   D++  G    E+VT +RA+
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 75  ATDNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVA 131
           + +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+   
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 132 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFG 186
            H N+++L+    T ++  LV+ F+         +DLK         G+  P  K   F 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
              GL + H     +++HRDLK  N+L++      L DFGLA+     +     ++  T+
Sbjct: 114 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 169
Query: 247 GHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
            + APE L   K  S   D++  G    E+VT +RA+
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 75  ATDNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVA 131
           + +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+   
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 132 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFG 186
            H N+++L+    T ++  LV+ F+         +DLK         G+  P  K   F 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
              GL + H     +++HRDLK  N+L++      L DFGLA+     +     ++  T+
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 167
Query: 247 GHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
            + APE L   K  S   D++  G    E+VT +RA+
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 75/311 (24%), Positives = 131/311 (42%), Gaps = 48/311 (15%)
Query: 71  ELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQRE 124
           + +    N      +G+G FGKV K         +  T VAVK L++  SP        E
Sbjct: 17  KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSE 76
Query: 125 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD---LKPG---------E 172
            +++    H ++++L G C+     +L+  + +  S+   LR+   + PG          
Sbjct: 77  FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 173 KGLDWPTRKRVAFG--------TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 224
             LD P  + +  G         + G++YL E     ++HRDL A NIL+ +  +  + D
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISD 193
Query: 225 FGLAKLVDAKLTHVT-TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAI 282
           FGL++ V  + + V  +Q R  +  +A E L     + ++DV+ +G+ L E+VT G    
Sbjct: 194 FGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 283 DFSRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDR 342
                          H  ++ R D  +               E M ++ L C +  P+ R
Sbjct: 254 PGIPPERLFNLLKTGH--RMERPDNCS---------------EEMYRLMLQCWKQEPDKR 296
Query: 343 PPMAQVVKMLQ 353
           P  A + K L+
Sbjct: 297 PVFADISKDLE 307

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 75  ATDNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVA 131
           + +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+   
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 132 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFG 186
            H N+++L+    T ++  LV+ F+         +DLK         G+  P  K   F 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
              GL + H     +++HRDLK  N+L++      L DFGLA+     +     ++  T+
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 167
Query: 247 GHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
            + APE L   K  S   D++  G    E+VT +RA+
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 108/233 (46%), Gaps = 37/233 (15%)
Query: 73  QLATDNFSESNIIGQGGFGKVYK----GVLSDN----TKVAVKRLQDYYSPGGEAAFQRE 124
           +L  D       +G+G FG+V      G+  D     TKVAVK L+   +    +    E
Sbjct: 13  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 72
Query: 125 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW---PTR 180
           + ++  +  HKN++ L+G CT      ++  +    ++   L+  +P   GL++   P+ 
Sbjct: 73  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP--PGLEYSYNPSH 130
Query: 181 K-----------RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 229
                         A+  A G+EYL  +   K IHRDL A N+L+ ++    + DFGLA+
Sbjct: 131 NPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 187
Query: 230 LVDAKLTHV-----TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
                + H+     TT  R  +  +APE L     + ++DV+ +G+ L E+ T
Sbjct: 188 ----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 75  ATDNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVA 131
           + +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+   
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 132 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFG 186
            H N+++L+    T ++  LV+ F+         +DLK         G+  P  K   F 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
              GL + H     +++HRDLK  N+L++      L DFGLA+     +     ++  T+
Sbjct: 115 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 170
Query: 247 GHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
            + APE L   K  S   D++  G    E+VT +RA+
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 57/229 (24%)
Query: 83  NIIGQGGFGKVYKGVLSDN---TKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQ 138
           ++IG+G FG+V K  +  +      A+KR+++Y S      F  E+  L  +  H N++ 
Sbjct: 21  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 80
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV--------------- 183
           L+G C     R  +Y     L++ Y      P    LD+  + RV               
Sbjct: 81  LLGAC---EHRGYLY-----LAIEY-----APHGNLLDFLRKSRVLETDPAFAIANSTAS 127
Query: 184 ----------AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 233
                     A   A G++YL ++   + IHRDL A NIL+ +N+ A + DFGL++  + 
Sbjct: 128 TLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE- 183
Query: 234 KLTHVTTQIRGTMGHI-----APEYLSTGKSSEKTDVFGYGITLLELVT 277
                   ++ TMG +     A E L+    +  +DV+ YG+ L E+V+
Sbjct: 184 ------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 57/229 (24%)
Query: 83  NIIGQGGFGKVYKGVLSDN---TKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQ 138
           ++IG+G FG+V K  +  +      A+KR+++Y S      F  E+  L  +  H N++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV--------------- 183
           L+G C     R  +Y     L++ Y      P    LD+  + RV               
Sbjct: 91  LLGAC---EHRGYLY-----LAIEY-----APHGNLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 184 ----------AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 233
                     A   A G++YL ++   + IHRDL A NIL+ +N+ A + DFGL++  + 
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE- 193
Query: 234 KLTHVTTQIRGTMGHI-----APEYLSTGKSSEKTDVFGYGITLLELVT 277
                   ++ TMG +     A E L+    +  +DV+ YG+ L E+V+
Sbjct: 194 ------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 75  ATDNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVA 131
           + +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+   
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 132 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFG 186
            H N+++L+    T ++  LV+ F+         +DLK         G+  P  K   F 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
              GL + H     +++HRDLK  N+L++      L DFGLA+     +     ++  T+
Sbjct: 112 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 167
Query: 247 GHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
            + APE L   K  S   D++  G    E+VT +RA+
Sbjct: 168 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 75  ATDNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVA 131
           + +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+   
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 132 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFG 186
            H N+++L+    T ++  LV+ F+         +DLK         G+  P  K   F 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
              GL + H     +++HRDLK  N+L++      L DFGLA+     +     ++  T+
Sbjct: 113 LLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 168
Query: 247 GHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
            + APE L   K  S   D++  G    E+VT +RA+
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 75  ATDNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVA 131
           + +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+   
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 132 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFG 186
            H N+++L+    T ++  LV+ F+         +DLK         G+  P  K   F 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
              GL + H     +++HRDLK  N+L++      L DFGLA+     +     ++  T+
Sbjct: 114 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 169
Query: 247 GHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
            + APE L   K  S   D++  G    E+VT +RA+
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 75  ATDNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVA 131
           + +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+   
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 132 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFG 186
            H N+++L+    T ++  LV+ F+         +DLK         G+  P  K   F 
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQ 115
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
              GL + H     +++HRDLK  N+L++      L DFGLA+     +     ++  T+
Sbjct: 116 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 171
Query: 247 GHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
            + APE L   K  S   D++  G    E+VT +RA+
Sbjct: 172 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 207

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 77  DNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 133
           +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+    H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFGTA 188
            N+++L+    T ++  LV+ F+         +DLK         G+  P  K   F   
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 248
            GL + H     +++HRDLK  N+L++      L DFGLA+     +     ++  T+ +
Sbjct: 113 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWY 168
Query: 249 IAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
            APE L   K  S   D++  G    E+VT +RA+
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 75  ATDNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVA 131
           + +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+   
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 132 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFG 186
            H N+++L+    T ++  LV+ F+         +DLK         G+  P  K   F 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQ 113
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
              GL + H     +++HRDLK  N+L++      L DFGLA+     +     ++  T+
Sbjct: 114 LLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 169
Query: 247 GHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
            + APE L   K  S   D++  G    E+VT +RA+
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 85  IGQGGFGKVY---KGVLSDNT--KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +G+G FGKV        +D T   VAVK L+    P   + +++E+ ++    H+++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
            G C    E+ L    M+ + +   LRD  P    +        A     G+ YLH Q  
Sbjct: 82  KGCCEDQGEKSLQL-VMEYVPLG-SLRDYLP-RHSIGLAQLLLFAQQICEGMAYLHSQ-- 136
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG--TMGHIAPEYLSTG 257
              IHR+L A N+LLD++    + DFGLAK V     +   +  G   +   APE L   
Sbjct: 137 -HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 195
Query: 258 KSSEKTDVFGYGITLLELVT 277
           K    +DV+ +G+TL EL+T
Sbjct: 196 KFYYASDVWSFGVTLYELLT 215

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 85  IGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G G FG+VY+G +S         +VAVK L + YS   E  F  E  +IS   H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKRVAFGTAYGLEYLH 195
            IG    S  R ++   M    +   LR+ +P       L       VA   A G +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 196 EQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAP 251
           E      IHRD+ A N LL        A + DFG+A+ +  A            +  + P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 252 EYLSTGKSSEKTDVFGYGITLLELVT 277
           E    G  + KTD + +G+ L E+ +
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 77  DNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 133
           +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+    H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFGTA 188
            N+++L+    T ++  LV+ F+         +DLK         G+  P  K   F   
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 248
            GL + H     +++HRDLK  N+L++      L DFGLA+     +     ++  T+ +
Sbjct: 113 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWY 168
Query: 249 IAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
            APE L   K  S   D++  G    E+VT +RA+
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTK--VAVKRL--QDYYSPGGEAAFQREVHLI 128
           Q A ++F     +G+G FG VY      N+K  +A+K L        G E   +REV + 
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAR-EKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 129 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 188
           S   H N+L+L GY   S+    VY  ++   +    R+L+   K  +  T   +    A
Sbjct: 63  SHLRHPNILRLYGYFHDSTR---VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELA 118
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR----G 244
             L Y H +   K+IHRD+K  N+LL    E  + DFG +        H  +  R    G
Sbjct: 119 NALSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRAALCG 168
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
           T+ ++ PE +      EK D++  G+   E + G+   +
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 135/308 (43%), Gaps = 53/308 (17%)
Query: 73  QLATDNFSESNIIGQGGFGKVYK----GVLSDN----TKVAVKRLQDYYSPGGEAAFQRE 124
           +L  D       +G+G FG+V      G+  D     TKVAVK L+   +    +    E
Sbjct: 24  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 83
Query: 125 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW---PTR 180
           + ++  +  HKN++ L+G CT      ++  +    ++   L+  +P   GL++   P+ 
Sbjct: 84  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREP--PGLEYSYNPSH 141
Query: 181 K-----------RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 229
                         A+  A G+EYL  +   K IHRDL A N+L+ ++    + DFGLA+
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 198
Query: 230 LVDAKLTHV-----TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 284
                + H+     TT  R  +  +APE L     + ++DV+ +G+ L E+        F
Sbjct: 199 ----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI--------F 246
Query: 285 SRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP 344
           +             + KLL+E      +D+  N   + E+  M++    C  + P  RP 
Sbjct: 247 TLGGSPYPGVPVEELFKLLKEGHR---MDKPSNC--TNELYMMMRD---CWHAVPSQRPT 298
Query: 345 MAQVVKML 352
             Q+V+ L
Sbjct: 299 FKQLVEDL 306

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 77/306 (25%), Positives = 129/306 (42%), Gaps = 38/306 (12%)
Query: 67  FSCRELQLATDNFSESNIIGQGGFGKVYK----GVLSDNT--KVAVKRLQDYYSPGGEAA 120
           +   + +   D  +    +G+G FG+V +    G+    T   VAVK L++  +     A
Sbjct: 18  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 77
Query: 121 FQREVH-LISVAIHKNLLQLIGYCTTSSERILV---YPFMQNLSVAYRLRDLK------P 170
              E+  LI +  H N++ L+G CT     ++V   +    NLS   R +  +      P
Sbjct: 78  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTP 137
Query: 171 GEKGLDWPTRKRV---AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 227
            +   D+ T + +   +F  A G+E+L  +   K IHRDL A NILL +     +CDFGL
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGL 194
Query: 228 AKLVDAKLTHVTT-QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR 286
           A+ +      V     R  +  +APE +     + ++DV+ +G+ L E+ +         
Sbjct: 195 ARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGA 248
Query: 287 XXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMA 346
                        R+L    R+          Y + E   M Q  L C    P  RP  +
Sbjct: 249 SPYPGVKIDEEFCRRLKEGTRM------RAPDYTTPE---MYQTMLDCWHGEPSQRPTFS 299
Query: 347 QVVKML 352
           ++V+ L
Sbjct: 300 ELVEHL 305

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 77  DNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 133
           +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+    H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFGTA 188
            N+++L+    T ++  LV+ F+         +DLK         G+  P  K   F   
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 248
            GL + H     +++HRDLK  N+L++      L DFGLA+     +     ++  T+ +
Sbjct: 115 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWY 170
Query: 249 IAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
            APE L   K  S   D++  G    E+VT +RA+
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 79  FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           F    ++G G +G+VYKG      ++A  ++ D      E   Q    L   + H+N+  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 139 LIGYCTTSS------ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF---GTAY 189
             G     +      +  LV  F    SV   +++ K      +W     +A+       
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYICREILR 140
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL +LH+    K+IHRD+K  N+LL +N E  L DFG++  +D  +    T I GT   +
Sbjct: 141 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWM 196
Query: 250 APEYLSTGKSSE-----KTDVFGYGITLLELVTG 278
           APE ++  ++ +     K+D++  GIT +E+  G
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 128/307 (41%), Gaps = 39/307 (12%)
Query: 67  FSCRELQLATDNFSESNIIGQGGFGKVYK----GVLSDNT--KVAVKRLQDYYSPGGEAA 120
           +   + +   D       +G+G FG+V +    G+    T   VAVK L++  +     A
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 121 FQREVH-LISVAIHKNLLQLIGYCTTSSERILV---YPFMQNLSVAYRLR-------DLK 169
              E+  LI +  H N++ L+G CT     ++V   +    NLS   R +        + 
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 170 PGEKGLDWPTRKRV---AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 226
           P +   D+ T + +   +F  A G+E+L  +   K IHRDL A NILL +     +CDFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFG 193
Query: 227 LAKLVDAKLTHVTT-QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 285
           LA+ +      V     R  +  +APE +     + ++DV+ +G+ L E+ +        
Sbjct: 194 LARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LG 247
Query: 286 RXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 345
                         R+L    R+          Y + E   M Q  L C    P  RP  
Sbjct: 248 ASPYPGVKIDEEFCRRLKEGTRM------RAPDYTTPE---MYQTMLDCWHGEPSQRPTF 298
Query: 346 AQVVKML 352
           +++V+ L
Sbjct: 299 SELVEHL 305

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 85  IGQGGFGKVY---KGVLSDNT--KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +G+G FGKV        +D T   VAVK L+    P   + +++E+ ++    H+++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
            G C    E+ L    M+ + +   LRD  P    +        A     G+ YLH Q  
Sbjct: 82  KGCCEDQGEKSLQL-VMEYVPLG-SLRDYLP-RHSIGLAQLLLFAQQICEGMAYLHAQ-- 136
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG--TMGHIAPEYLSTG 257
              IHR+L A N+LLD++    + DFGLAK V     +   +  G   +   APE L   
Sbjct: 137 -HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 195
Query: 258 KSSEKTDVFGYGITLLELVT 277
           K    +DV+ +G+TL EL+T
Sbjct: 196 KFYYASDVWSFGVTLYELLT 215

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 119/286 (41%), Gaps = 40/286 (13%)
Query: 85  IGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +GQG FG VY+G   D       T+VAVK + +  S      F  E  ++      ++++
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRK---RVAFGTAYGLE 192
           L+G  +     ++V   M +  +   LR L+P      G   PT +   ++A   A G+ 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG----- 247
           YL+ +   K +HR+L A N ++  +F   + DFG+ +     +       +G  G     
Sbjct: 146 YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 198
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDR 307
            +APE L  G  +  +D++ +G+ L E+ +                      + L  E  
Sbjct: 199 WMAPESLKDGVFTTSSDMWSFGVVLWEITS----------------LAEQPYQGLSNEQV 242
Query: 308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
           L  ++D           E +  +  +C Q  P  RP   ++V +L+
Sbjct: 243 LKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 288

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 129/307 (42%), Gaps = 39/307 (12%)
Query: 67  FSCRELQLATDNFSESNIIGQGGFGKVYK----GVLSDNT--KVAVKRLQDYYSPGGEAA 120
           +   + +   D       +G+G FG+V +    G+    T   VAVK L++  +     A
Sbjct: 19  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 78
Query: 121 FQREVH-LISVAIHKNLLQLIGYCTTSSERILV---YPFMQNLSVAYRLRDLK------- 169
              E+  LI +  H N++ L+G CT     ++V   +    NLS   R +  +       
Sbjct: 79  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEA 138
Query: 170 PGEKGLDWPTRKRV---AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 226
           P +   D+ T + +   +F  A G+E+L  +   K IHRDL A NILL +     +CDFG
Sbjct: 139 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFG 195
Query: 227 LAKLVDAKLTHVTT-QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 285
           LA+ +     +V     R  +  +APE +     + ++DV+ +G+ L E+ +        
Sbjct: 196 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LG 249
Query: 286 RXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 345
                         R+L    R+          Y + E   M Q  L C    P  RP  
Sbjct: 250 ASPYPGVKIDEEFCRRLKEGTRM------RAPDYTTPE---MYQTMLDCWHGEPSQRPTF 300
Query: 346 AQVVKML 352
           +++V+ L
Sbjct: 301 SELVEHL 307

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 96/201 (47%), Gaps = 14/201 (6%)
Query: 85  IGQGGFGKV---YKGVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +G+G FG V       L DNT   VAVK+LQ +  P  +  FQRE+ ++  A+H + +  
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILK-ALHSDFIVK 75
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
               +    R  +   M+ L     LRD L+     LD       +     G+EYL  + 
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGC-LRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR- 133
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKL--VDAKLTHVTTQIRGTMGHIAPEYLST 256
             + +HRDL A NIL++      + DFGLAKL  +D     V    +  +   APE LS 
Sbjct: 134 --RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 191
Query: 257 GKSSEKTDVFGYGITLLELVT 277
              S ++DV+ +G+ L EL T
Sbjct: 192 NIFSRQSDVWSFGVVLYELFT 212

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 135/308 (43%), Gaps = 53/308 (17%)
Query: 73  QLATDNFSESNIIGQGGFGKVYK----GVLSDN----TKVAVKRLQDYYSPGGEAAFQRE 124
           +L  D       +G+G FG+V      G+  D     TKVAVK L+   +    +    E
Sbjct: 65  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 124
Query: 125 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDW---PTR 180
           + ++  +  HKN++ L+G CT      ++  +    ++   L+  +P   GL++   P+ 
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP--PGLEYSYNPSH 182
Query: 181 K-----------RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 229
                         A+  A G+EYL  +   K IHRDL A N+L+ ++    + DFGLA+
Sbjct: 183 NPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 239
Query: 230 LVDAKLTHV-----TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDF 284
                + H+     TT  R  +  +APE L     + ++DV+ +G+ L E+        F
Sbjct: 240 ----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI--------F 287
Query: 285 SRXXXXXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP 344
           +             + KLL+E      +D+  N   + E+  M++    C  + P  RP 
Sbjct: 288 TLGGSPYPGVPVEELFKLLKEGHR---MDKPSNC--TNELYMMMRD---CWHAVPSQRPT 339
Query: 345 MAQVVKML 352
             Q+V+ L
Sbjct: 340 FKQLVEDL 347

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 17/218 (7%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGVLSDN----TKVAVKRLQ-DYYSPGGEAAFQREVHLI 128
           +    F+   ++G+G FG V +  L        KVAVK L+ D  +      F RE   +
Sbjct: 20  IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACM 79
Query: 129 SVAIHKNLLQLIGYCTTSSER------ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR 182
               H ++ +L+G    S  +      +++ PFM++  +   L   + GE   + P +  
Sbjct: 80  KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139
Query: 183 VAF--GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVT 239
           V F    A G+EYL  +     IHRDL A N +L ++    + DFGL+ K+         
Sbjct: 140 VRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQG 196
Query: 240 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
              +  +  +A E L+    +  +DV+ +G+T+ E++T
Sbjct: 197 CASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 119/286 (41%), Gaps = 40/286 (13%)
Query: 85  IGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +GQG FG VY+G   D       T+VAVK + +  S      F  E  ++      ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRK---RVAFGTAYGLE 192
           L+G  +     ++V   M +  +   LR L+P      G   PT +   ++A   A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG----- 247
           YL+ +   K +HR+L A N ++  +F   + DFG+ +     +       +G  G     
Sbjct: 145 YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 197
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLREDR 307
            +APE L  G  +  +D++ +G+ L E+ +                      + L  E  
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS----------------LAEQPYQGLSNEQV 241
Query: 308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
           L  ++D           E +  +  +C Q  P  RP   ++V +L+
Sbjct: 242 LKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 17/208 (8%)
Query: 84  IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGE--AAFQREVHLISVAIHKNLLQ--L 139
            +G+GGF K ++   +D  +V   ++     P        QRE   + ++IH++L    +
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKI----VPKSLLLKPHQREKMSMEISIHRSLAHQHV 77
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
           +G+     +   V+  ++ L     L +L    K L  P  +        G +YLH    
Sbjct: 78  VGFHGFFEDNDFVFVVLE-LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN-- 134
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLSTG 257
            ++IHRDLK  N+ L+++ E  + DFGLA  V  D +   V     GT  +IAPE LS  
Sbjct: 135 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKK 190
Query: 258 KSSEKTDVFGYGITLLELVTGQRAIDFS 285
             S + DV+  G  +  L+ G+   + S
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPPFETS 218

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 96/201 (47%), Gaps = 14/201 (6%)
Query: 85  IGQGGFGKV---YKGVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +G+G FG V       L DNT   VAVK+LQ +  P  +  FQRE+ ++  A+H + +  
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILK-ALHSDFIVK 76
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
               +    R  +   M+ L     LRD L+     LD       +     G+EYL  + 
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGC-LRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR- 134
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKL--VDAKLTHVTTQIRGTMGHIAPEYLST 256
             + +HRDL A NIL++      + DFGLAKL  +D     V    +  +   APE LS 
Sbjct: 135 --RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 192
Query: 257 GKSSEKTDVFGYGITLLELVT 277
              S ++DV+ +G+ L EL T
Sbjct: 193 NIFSRQSDVWSFGVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 96/201 (47%), Gaps = 14/201 (6%)
Query: 85  IGQGGFGKV---YKGVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +G+G FG V       L DNT   VAVK+LQ +  P  +  FQRE+ ++  A+H + +  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILK-ALHSDFIVK 88
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
               +    R  +   M+ L     LRD L+     LD       +     G+EYL  + 
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGC-LRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR- 146
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKL--VDAKLTHVTTQIRGTMGHIAPEYLST 256
             + +HRDL A NIL++      + DFGLAKL  +D     V    +  +   APE LS 
Sbjct: 147 --RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 204
Query: 257 GKSSEKTDVFGYGITLLELVT 277
              S ++DV+ +G+ L EL T
Sbjct: 205 NIFSRQSDVWSFGVVLYELFT 225

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 17/208 (8%)
Query: 84  IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGE--AAFQREVHLISVAIHKNLLQ--L 139
            +G+GGF K ++   +D  +V   ++     P        QRE   + ++IH++L    +
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKI----VPKSLLLKPHQREKMSMEISIHRSLAHQHV 103
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
           +G+     +   V+  ++ L     L +L    K L  P  +        G +YLH    
Sbjct: 104 VGFHGFFEDNDFVFVVLE-LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN-- 160
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLSTG 257
            ++IHRDLK  N+ L+++ E  + DFGLA  V  D +   V     GT  +IAPE LS  
Sbjct: 161 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKK 216
Query: 258 KSSEKTDVFGYGITLLELVTGQRAIDFS 285
             S + DV+  G  +  L+ G+   + S
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPPFETS 244

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 75  ATDNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVA 131
           + +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+   
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 132 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFG 186
            H N+++L+    T ++  LV+ F+          DLK         G+  P  K   F 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLS--------MDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
              GL + H     +++HRDLK  N+L++      L DFGLA+     +     ++  T+
Sbjct: 113 LLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 168
Query: 247 GHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
            + APE L   K  S   D++  G    E+VT +RA+
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 17/208 (8%)
Query: 84  IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGE--AAFQREVHLISVAIHKNLLQ--L 139
            +G+GGF K ++   +D  +V   ++     P        QRE   + ++IH++L    +
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKI----VPKSLLLKPHQREKMSMEISIHRSLAHQHV 101
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
           +G+     +   V+  ++ L     L +L    K L  P  +        G +YLH    
Sbjct: 102 VGFHGFFEDNDFVFVVLE-LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN-- 158
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLSTG 257
            ++IHRDLK  N+ L+++ E  + DFGLA  V  D +   V     GT  +IAPE LS  
Sbjct: 159 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKK 214
Query: 258 KSSEKTDVFGYGITLLELVTGQRAIDFS 285
             S + DV+  G  +  L+ G+   + S
Sbjct: 215 GHSFEVDVWSIGCIMYTLLVGKPPFETS 242

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 17/216 (7%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY      +  + A+K L        G E   +REV + S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT-- 187
              H N+L+L GY   ++   L+  +     V   L+ L   ++      ++   + T  
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDE------QRTATYITEL 122
Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 247
           A  L Y H +   ++IHRD+K  N+LL    E  + DFG +  V A  +  TT + GT+ 
Sbjct: 123 ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLD 176
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
           ++ PE +      EK D++  G+   E + G+   +
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 75  ATDNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVA 131
           + +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+   
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 132 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFG 186
            H N+++L+    T ++  LV+ F+          DLK         G+  P  K   F 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLS--------MDLKKFMDASALTGIPLPLIKSYLFQ 114
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
              GL + H     +++HRDLK  N+L++      L DFGLA+     +     ++  T+
Sbjct: 115 LLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TL 170
Query: 247 GHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
            + APE L   K  S   D++  G    E+VT +RA+
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 19/216 (8%)
Query: 72  LQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY----YSPGGEAAFQREVHL 127
           + L  ++FS   IIG+GGFG+VY    +D  K+   +  D        G   A    + L
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 128 ISVAIHK-NLLQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV-A 184
             V+      +  + Y   + +++  +   M    + Y L      + G+      R  A
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVFSEADMRFYA 298
Query: 185 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG 244
                GLE++H   N  +++RDLK ANILLD++    + D GLA     K  H +    G
Sbjct: 299 AEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---G 352
Query: 245 TMGHIAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
           T G++APE L  G + + + D F  G  L +L+ G 
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 19/216 (8%)
Query: 72  LQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY----YSPGGEAAFQREVHL 127
           + L  ++FS   IIG+GGFG+VY    +D  K+   +  D        G   A    + L
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 128 ISVAIHK-NLLQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV-A 184
             V+      +  + Y   + +++  +   M    + Y L      + G+      R  A
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVFSEADMRFYA 298
Query: 185 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG 244
                GLE++H   N  +++RDLK ANILLD++    + D GLA     K  H +    G
Sbjct: 299 AEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---G 352
Query: 245 TMGHIAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
           T G++APE L  G + + + D F  G  L +L+ G 
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 93/199 (46%), Gaps = 18/199 (9%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           +G G FGKVYK    + + +A  ++ D  S      +  E+ +++   H N+++L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 204
             +   ++  F    +V   + +L   E+ L     + V   T   L YLH+    KIIH
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 205 RDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ---IRGTMGHIAPEYLSTGKSSE 261
           RDLKA NIL   + +  L DFG    V AK T    +     GT   +APE +    S +
Sbjct: 159 RDLKAGNILFTLDGDIKLADFG----VSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 262 -----KTDVFGYGITLLEL 275
                K DV+  GITL+E+
Sbjct: 215 RPYDYKADVWSLGITLIEM 233

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 93/199 (46%), Gaps = 18/199 (9%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           +G G FGKVYK    + + +A  ++ D  S      +  E+ +++   H N+++L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 204
             +   ++  F    +V   + +L   E+ L     + V   T   L YLH+    KIIH
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 205 RDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ---IRGTMGHIAPEYLSTGKSSE 261
           RDLKA NIL   + +  L DFG    V AK T    +     GT   +APE +    S +
Sbjct: 159 RDLKAGNILFTLDGDIKLADFG----VSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 262 -----KTDVFGYGITLLEL 275
                K DV+  GITL+E+
Sbjct: 215 RPYDYKADVWSLGITLIEM 233

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 19/216 (8%)
Query: 72  LQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY----YSPGGEAAFQREVHL 127
           + L  ++FS   IIG+GGFG+VY    +D  K+   +  D        G   A    + L
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 128 ISVAIHK-NLLQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV-A 184
             V+      +  + Y   + +++  +   M    + Y L      + G+      R  A
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVFSEADMRFYA 298
Query: 185 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG 244
                GLE++H   N  +++RDLK ANILLD++    + D GLA     K  H +    G
Sbjct: 299 AEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---G 352
Query: 245 TMGHIAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
           T G++APE L  G + + + D F  G  L +L+ G 
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 19/216 (8%)
Query: 72  LQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY----YSPGGEAAFQREVHL 127
           + L  ++FS   IIG+GGFG+VY    +D  K+   +  D        G   A    + L
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 242
Query: 128 ISVAIHK-NLLQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV-A 184
             V+      +  + Y   + +++  +   M    + Y L      + G+      R  A
Sbjct: 243 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVFSEADMRFYA 297
Query: 185 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG 244
                GLE++H   N  +++RDLK ANILLD++    + D GLA     K  H +    G
Sbjct: 298 AEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---G 351
Query: 245 TMGHIAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
           T G++APE L  G + + + D F  G  L +L+ G 
Sbjct: 352 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 387

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 103/204 (50%), Gaps = 23/204 (11%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           +G G +G V   +      KVA+K+L + + S        RE+ L+    H+N++ L+  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 143 CTTSS------ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 196
            T +S      +  LV PFMQ  +   ++  LK  E+ + +     + +    GL+Y+H 
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQ--TDLQKIMGLKFSEEKIQY-----LVYQMLKGLKYIH- 143
Query: 197 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY-LS 255
             +  ++HRDLK  N+ ++++ E  + DFGLA+  DA++T        T  + APE  LS
Sbjct: 144 --SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYRAPEVILS 197
Query: 256 TGKSSEKTDVFGYGITLLELVTGQ 279
               ++  D++  G  + E++TG+
Sbjct: 198 WMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 73  QLATDNFSESNIIGQGGFGKVY-------KGVLSDNTKVAVKRLQDYYSPGGEAAFQREV 125
           Q A ++F     +G+G FG VY       K +L+   KV  K   +    G E   +REV
Sbjct: 1   QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILA--LKVLFKAQLE--KAGVEHQLRREV 56
Query: 126 HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF 185
            + S   H N+L+L GY   ++    VY  ++   +    R+L+   K  +  T   +  
Sbjct: 57  EIQSHLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 112
Query: 186 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 245
             A  L Y H +   ++IHRD+K  N+LL    E  + DFG +  V A  +  TT + GT
Sbjct: 113 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGT 166
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
           + ++ PE +      EK D++  G+   E + G+   +
Sbjct: 167 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 204

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 13/214 (6%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY      +  + A+K L        G E   +REV + S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
              H N+L+L GY   ++    VY  ++   +    R+L+   K  +  T   +    A 
Sbjct: 67  HLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 122
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L Y H +   ++IHRD+K  N+LL    E  + DFG +  V A  +  TT + GT+ ++
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYL 176
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
            PE +      EK D++  G+   E + G+   +
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 13/214 (6%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY      +  + A+K L        G E   +REV + S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
              H N+L+L GY   ++    VY  ++   +    R+L+   K  +  T   +    A 
Sbjct: 64  HLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 119
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L Y H +   ++IHRD+K  N+LL    E  + DFG +  V A  +  TT + GT+ ++
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYL 173
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
            PE +      EK D++  G+   E + G+   +
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 85  IGQGGFGKVYKG------VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G+G FGKV+           D   VAVK L+D  +      FQRE  L++   H+++++
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVK 81
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP--------------GEKGLDWPTRKRVA 184
             G C      I+V+ +M++  +   LR   P              GE GL       +A
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS--QMLHIA 139
Query: 185 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIR 243
              A G+ YL  Q     +HRDL   N L+  N    + DFG+++ V       V     
Sbjct: 140 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 244 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
             +  + PE +   K + ++DV+ +G+ L E+ T
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 131/304 (43%), Gaps = 37/304 (12%)
Query: 67  FSCRELQLATDNFSESNIIGQGGFGKVYK----GVLSDNTK--VAVKRLQDYYSPGGEAA 120
           +   + +   D  +    +G+G FG+V +    G+    T   VAVK L++  +     A
Sbjct: 17  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 76
Query: 121 FQREVH-LISVAIHKNLLQLIGYCTTSSERILV---YPFMQNLSVAYRLR--DLKPGEKG 174
              E+  LI +  H N++ L+G CT     ++V   +    NLS   R +  +  P  K 
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP-YKD 135
Query: 175 L--DWPTRKRV---AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 229
           L  D+ T + +   +F  A G+E+L  +   K IHRDL A NILL +     +CDFGLA+
Sbjct: 136 LYKDFLTLEHLICYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLAR 192
Query: 230 LVDAKLTHVTT-QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXX 288
            +     +V     R  +  +APE +     + ++DV+ +G+ L E+ +           
Sbjct: 193 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASP 246
Query: 289 XXXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQV 348
                      R+L    R+          Y + E   M Q  L C    P  RP  +++
Sbjct: 247 YPGVKIDEEFCRRLKEGTRM------RAPDYTTPE---MYQTMLDCWHGEPSQRPTFSEL 297
Query: 349 VKML 352
           V+ L
Sbjct: 298 VEHL 301

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 15/211 (7%)
Query: 77  DNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 133
           +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+    H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 134 KNLLQLIGYCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 192
            N+++L+    T ++  LV+  + Q+L        L     G+  P  K   F    GL 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALT----GIPLPLIKSYLFQLLQGLA 116
Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 252
           + H     +++HRDLK  N+L++      L DFGLA+     +   T ++  T+ + APE
Sbjct: 117 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 172
Query: 253 YLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
            L   K  S   D++  G    E+VT +RA+
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 13/214 (6%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY      +  + A+K L        G E   +REV + S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
              H N+L+L GY   ++    VY  ++   +    R+L+   K  +  T   +    A 
Sbjct: 69  HLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 124
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L Y H +   ++IHRD+K  N+LL    E  + DFG +  V A  +  TT + GT+ ++
Sbjct: 125 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYL 178
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
            PE +      EK D++  G+   E + G+   +
Sbjct: 179 PPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 28/203 (13%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           +G G FG V  G       VA+K +++      E  F  E  ++    H+ L+QL G CT
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC------ 198
                 ++  +M N  +   LR++             R  F T   LE   + C      
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREM-------------RHRFQTQQLLEMCKDVCEAMEYL 121
Query: 199 -NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---APEYL 254
            + + +HRDL A N L++D     + DFGL++ V   L    T  RG+   +    PE L
Sbjct: 122 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSRGSKFPVRWSPPEVL 178
Query: 255 STGKSSEKTDVFGYGITLLELVT 277
              K S K+D++ +G+ + E+ +
Sbjct: 179 MYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 13/214 (6%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY      +  + A+K L        G E   +REV + S
Sbjct: 3   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 62
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
              H N+L+L GY   ++    VY  ++   +    R+L+   K  +  T   +    A 
Sbjct: 63  HLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 118
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L Y H +   ++IHRD+K  N+LL    E  + DFG +  V A  +  TT + GT+ ++
Sbjct: 119 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYL 172
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
            PE +      EK D++  G+   E + G+   +
Sbjct: 173 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 206

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 136/304 (44%), Gaps = 62/304 (20%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
           +F E  +IG GGFG+V+K     + K  V R   Y +   E    REV  ++   H N++
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE----REVKALAKLDHVNIV 68
Query: 138 QLIGYC--------TTSSERILVYPF-MQNLSVAYRLR------DLKPGEKGL--DWPTR 180
              G C         TS + +    +  +N   + R +       ++  +KG    W  +
Sbjct: 69  HYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 127
Query: 181 KR-----------VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 229
           +R           +      G++Y+H +   K+IHRDLK +NI L D  +  + DFGL  
Sbjct: 128 RRGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGL-- 182
Query: 230 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELV-TGQRAIDFSRXX 288
           +   K     T+ +GT+ +++PE +S+    ++ D++  G+ L EL+     A + S+  
Sbjct: 183 VTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFF 242
Query: 289 XXXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQV 348
                         LR+  ++DI D        K+ +T++Q  L      PEDRP  +++
Sbjct: 243 TD------------LRDGIISDIFD--------KKEKTLLQKLL---SKKPEDRPNTSEI 279
Query: 349 VKML 352
           ++ L
Sbjct: 280 LRTL 283

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 13/214 (6%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY      +  + A+K L        G E   +REV + S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
              H N+L+L GY   ++    VY  ++   +    R+L+   K  +  T   +    A 
Sbjct: 67  HLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 122
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L Y H +   ++IHRD+K  N+LL    E  + DFG +  V A  +  TT + GT+ ++
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYL 176
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
            PE +      EK D++  G+   E + G+   +
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 13/214 (6%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY      +  + A+K L        G E   +REV + S
Sbjct: 21  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 80
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
              H N+L+L GY   ++    VY  ++   +    R+L+   K  +  T   +    A 
Sbjct: 81  HLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 136
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L Y H +   ++IHRD+K  N+LL    E  + DFG +  V A  +  TT + GT+ ++
Sbjct: 137 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYL 190
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
            PE +      EK D++  G+   E + G+   +
Sbjct: 191 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 224

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 13/205 (6%)
Query: 83  NIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
            IIG G  G+V  G L      +  VA+K L+  Y+      F  E  ++    H N+++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
           L G  T     ++V  +M+N S+   LR        +      R   G   G+ YL +  
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR---GVGAGMRYLSDL- 170
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLST 256
               +HRDL A N+L+D N    + DFGL++++  D    + TT  +  +   APE ++ 
Sbjct: 171 --GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 257 GKSSEKTDVFGYGITLLE-LVTGQR 280
              S  +DV+ +G+ + E L  G+R
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGER 253

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 13/214 (6%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY      +  + A+K L        G E   +REV + S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
              H N+L+L GY   ++    VY  ++   +    R+L+   K  +  T   +    A 
Sbjct: 69  HLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 124
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L Y H +   ++IHRD+K  N+LL    E  + DFG +  V A  +  TT + GT+ ++
Sbjct: 125 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYL 178
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
            PE +      EK D++  G+   E + G+   +
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 13/214 (6%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY      +  + A+K L        G E   +REV + S
Sbjct: 8   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 67
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
              H N+L+L GY   ++    VY  ++   +    R+L+   K  +  T   +    A 
Sbjct: 68  HLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 123
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L Y H +   ++IHRD+K  N+LL    E  + DFG +  V A  +  TT + GT+ ++
Sbjct: 124 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYL 177
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
            PE +      EK D++  G+   E + G+   +
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 211

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 98/197 (49%), Gaps = 12/197 (6%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           IG+G +G VYK   +     A+K+++ +    G  +   RE+ ++    H N+++L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 144 TTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 202
            T    +LV+  + Q+L    +L D+  G  GL+  T K        G+ Y H++   ++
Sbjct: 70  HTKKRLVLVFEHLDQDLK---KLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDR---RV 121
Query: 203 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-STGKSSE 261
           +HRDLK  N+L++   E  + DFGLA+     +   T +I  T+ + AP+ L  + K S 
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYST 180
Query: 262 KTDVFGYGITLLELVTG 278
             D++  G    E+V G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 17/216 (7%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY      +  + A+K L        G E   +REV + S
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT-- 187
              H N+L+L GY   ++   L+  +    +V   L+ L        +  ++   + T  
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS------KFDEQRTATYITEL 143
Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 247
           A  L Y H +   ++IHRD+K  N+LL    E  + DFG +  V A  +  TT + GT+ 
Sbjct: 144 ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLD 197
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
           ++ PE +      EK D++  G+   E + G+   +
Sbjct: 198 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 104/229 (45%), Gaps = 57/229 (24%)
Query: 83  NIIGQGGFGKVYKGVLSDN---TKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQ 138
           ++IG+G FG+V K  +  +      A+KR+++Y S      F  E+  L  +  H N++ 
Sbjct: 28  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 87
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV--------------- 183
           L+G C     R  +Y     L++ Y      P    LD+  + RV               
Sbjct: 88  LLGAC---EHRGYLY-----LAIEY-----APHGNLLDFLRKSRVLETDPAFAIANSTAS 134
Query: 184 ----------AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 233
                     A   A G++YL ++   + IHR+L A NIL+ +N+ A + DFGL++  + 
Sbjct: 135 TLSSQQLLHFAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSRGQE- 190
Query: 234 KLTHVTTQIRGTMGHI-----APEYLSTGKSSEKTDVFGYGITLLELVT 277
                   ++ TMG +     A E L+    +  +DV+ YG+ L E+V+
Sbjct: 191 ------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 73  QLATDNFSESNIIGQGGFGKVY-------KGVLSDNTKVAVKRLQDYYSPGGEAAFQREV 125
           Q   ++F     +G+G FG VY       K +L+   KV  K   +    G E   +REV
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILA--LKVLFKTQLE--KAGVEHQLRREV 63
Query: 126 HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF 185
            + S   H N+L+L GY   ++   L+  +    +V   L+ L   ++      ++   +
Sbjct: 64  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE------QRTATY 117
Query: 186 GT--AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 243
            T  A  L Y H +   ++IHRD+K  N+LL  N E  + DFG +  V A  +  TT + 
Sbjct: 118 ITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRTT-LC 171
Query: 244 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           GT+ ++ PE +      EK D++  G+   E + G
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 88/211 (41%), Gaps = 16/211 (7%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQ----REVHLI- 128
           +AT  +     IG G +G VYK    D        L+    P GE        REV L+ 
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGEEGLPISTVREVALLR 58
Query: 129 --SVAIHKNLLQLIGYCTTS--SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVA 184
                 H N+++L+  C TS     I V    +++    R    K    GL   T K + 
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 185 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG 244
                GL++LH  C   I+HRDLK  NIL+       L DFGLA++   ++      +  
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV-- 173
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLEL 275
           T+ + APE L     +   D++  G    E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 88/211 (41%), Gaps = 16/211 (7%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQ----REVHLI- 128
           +AT  +     IG G +G VYK    D        L+    P GE        REV L+ 
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGEEGLPISTVREVALLR 58
Query: 129 --SVAIHKNLLQLIGYCTTS--SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVA 184
                 H N+++L+  C TS     I V    +++    R    K    GL   T K + 
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 185 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG 244
                GL++LH  C   I+HRDLK  NIL+       L DFGLA++   ++      +  
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV-- 173
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLEL 275
           T+ + APE L     +   D++  G    E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 13/214 (6%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY      +  + A+K L        G E   +REV + S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
              H N+L+L GY   ++    VY  ++   +    R+L+   K  +  T   +    A 
Sbjct: 64  HLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 119
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L Y H +   ++IHRD+K  N+LL    E  + DFG +  V A  +   T++ GT+ ++
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RTELCGTLDYL 173
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
            PE +      EK D++  G+   E + G+   +
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 91/198 (45%), Gaps = 12/198 (6%)
Query: 85  IGQGGFGKVYKGV--LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           +G+G +  VYKG   L+DN  VA+K ++  +  G      REV L+    H N++ L   
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 202
             T     LV+ ++      Y    L      ++    K   F    GL Y H Q   K+
Sbjct: 69  IHTEKSLTLVFEYLDKDLKQY----LDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KV 121
Query: 203 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE-YLSTGKSSE 261
           +HRDLK  N+L+++  E  L DFGLA+           ++  T+ +  P+  L +   S 
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTDYST 180
Query: 262 KTDVFGYGITLLELVTGQ 279
           + D++G G    E+ TG+
Sbjct: 181 QIDMWGVGCIFYEMATGR 198

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 106/218 (48%), Gaps = 14/218 (6%)
Query: 70  RELQLATDNFSESNI-IGQGGFGKVYKGVLSDNTK---VAVKRLQDYYSPGGEAAFQREV 125
           ++L L  DN   ++I +G G FG V +GV     K   VA+K L+            RE 
Sbjct: 328 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 387
Query: 126 HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF 185
            ++    +  +++LIG C   +E +++   M      ++    K  E  +       +  
Sbjct: 388 QIMHQLDNPYIVRLIGVC--QAEALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLH 443
Query: 186 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG- 244
             + G++YL E+     +HR+L A N+LL +   A + DFGL+K + A  ++ T +  G 
Sbjct: 444 QVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 500
Query: 245 -TMGHIAPEYLSTGKSSEKTDVFGYGITLLE-LVTGQR 280
             +   APE ++  K S ++DV+ YG+T+ E L  GQ+
Sbjct: 501 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 12/211 (5%)
Query: 77  DNFSESNIIGQGGFGKVYKG-VLSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIH 133
           ++F   N++G+G F  VY+   +    +VA+K +  +  Y  G     Q EV +     H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
            ++L+L  Y   S+   LV     N  +    R LK   K       +        G+ Y
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMN---RYLKNRVKPFSENEARHFMHQIITGMLY 127
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QIRGTMGHIAPE 252
           LH      I+HRDL  +N+LL  N    + DFGLA     K+ H     + GT  +I+PE
Sbjct: 128 LHSH---GILHRDLTLSNLLLTRNMNIKIADFGLA--TQLKMPHEKHYTLCGTPNYISPE 182
Query: 253 YLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
             +      ++DV+  G     L+ G+   D
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 98/197 (49%), Gaps = 12/197 (6%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           IG+G +G VYK   +     A+K+++ +    G  +   RE+ ++    H N+++L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 144 TTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 202
            T    +LV+  + Q+L    +L D+  G  GL+  T K        G+ Y H++   ++
Sbjct: 70  HTKKRLVLVFEHLDQDLK---KLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDR---RV 121
Query: 203 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-STGKSSE 261
           +HRDLK  N+L++   E  + DFGLA+     +   T ++  T+ + AP+ L  + K S 
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKYST 180
Query: 262 KTDVFGYGITLLELVTG 278
             D++  G    E+V G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 85  IGQGGFGKV---YKGVLSDNT--KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +G+G FGKV         DNT  +VAVK L+        A  ++E+ ++    H+N+++ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 140 IGYCTTSSER--ILVYPFMQNLSVAYRLRDLKPGEKG-LDWPTRKRVAFGTAYGLEYLHE 196
            G CT        L+  F+ + S    L++  P  K  ++   + + A     G++YL  
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGS----LKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS 132
Query: 197 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYL 254
           +   + +HRDL A N+L++   +  + DFGL K +  D +   V       +   APE L
Sbjct: 133 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 189
Query: 255 STGKSSEKTDVFGYGITLLELVT 277
              K    +DV+ +G+TL EL+T
Sbjct: 190 MQSKFYIASDVWSFGVTLHELLT 212

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 16/215 (7%)
Query: 71  ELQLATDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQD--YYSPGGEAAFQREVHL 127
           +++L  ++F    ++G+G FGKV+       N   A+K L+               E  +
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 128 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 187
           +S+A     L  + +CT  ++  L +  M+ L+    +  ++   K  D       A   
Sbjct: 72  LSLAWEHPFLTHM-FCTFQTKENLFF-VMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEI 128
Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK---LVDAKLTHVTTQIRG 244
             GL++LH +    I++RDLK  NILLD +    + DFG+ K   L DAK    T +  G
Sbjct: 129 ILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK----TNEFCG 181
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           T  +IAPE L   K +   D + +G+ L E++ GQ
Sbjct: 182 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 85  IGQGGFGKV---YKGVLSDNT--KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +G+G FGKV         DNT  +VAVK L+        A  ++E+ ++    H+N+++ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 140 IGYCTTSSER--ILVYPFMQNLSVAYRLRDLKPGEKG-LDWPTRKRVAFGTAYGLEYLHE 196
            G CT        L+  F+ + S    L++  P  K  ++   + + A     G++YL  
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGS----LKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 197 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYL 254
           +   + +HRDL A N+L++   +  + DFGL K +  D +   V       +   APE L
Sbjct: 145 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 201
Query: 255 STGKSSEKTDVFGYGITLLELVT 277
              K    +DV+ +G+TL EL+T
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLT 224

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 98/197 (49%), Gaps = 12/197 (6%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           IG+G +G VYK   +     A+K+++ +    G  +   RE+ ++    H N+++L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 144 TTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 202
            T    +LV+  + Q+L    +L D+  G  GL+  T K        G+ Y H++   ++
Sbjct: 70  HTKKRLVLVFEHLDQDLK---KLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDR---RV 121
Query: 203 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL-STGKSSE 261
           +HRDLK  N+L++   E  + DFGLA+     +   T ++  T+ + AP+ L  + K S 
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKYST 180
Query: 262 KTDVFGYGITLLELVTG 278
             D++  G    E+V G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 113/251 (45%), Gaps = 18/251 (7%)
Query: 37  YQKLRKLKHDVFFDVAGEDDC--KVSLTQLRRFSCRELQLATDN-FSESNIIGQGGFGKV 93
           +Q+L +L H+ +  VA   D    +   +  ++   E Q  T N F +  ++G+GGFG+V
Sbjct: 142 FQELTRLTHE-YLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEV 200
Query: 94  YKGVLSDNTKV---AVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 150
               +    K+        +      GEA    E  ++     + ++ L     T     
Sbjct: 201 CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260
Query: 151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--AYGLEYLHEQCNPKIIHRDLK 208
           LV   M    + + +  +  G+ G   P  + V +      GLE LH +   +I++RDLK
Sbjct: 261 LVLTLMNGGDLKFHIYHM--GQAGF--PEARAVFYAAEICCGLEDLHRE---RIVYRDLK 313
Query: 209 AANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGY 268
             NILLDD+    + D GLA  V    T +  ++ GT+G++APE +   + +   D +  
Sbjct: 314 PENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERYTFSPDWWAL 371
Query: 269 GITLLELVTGQ 279
           G  L E++ GQ
Sbjct: 372 GCLLYEMIAGQ 382

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 113/251 (45%), Gaps = 18/251 (7%)
Query: 37  YQKLRKLKHDVFFDVAGEDDC--KVSLTQLRRFSCRELQLATDN-FSESNIIGQGGFGKV 93
           +Q+L +L H+ +  VA   D    +   +  ++   E Q  T N F +  ++G+GGFG+V
Sbjct: 142 FQELTRLTHE-YLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEV 200
Query: 94  YKGVLSDNTKV---AVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI 150
               +    K+        +      GEA    E  ++     + ++ L     T     
Sbjct: 201 CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260
Query: 151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--AYGLEYLHEQCNPKIIHRDLK 208
           LV   M    + + +  +  G+ G   P  + V +      GLE LH +   +I++RDLK
Sbjct: 261 LVLTLMNGGDLKFHIYHM--GQAGF--PEARAVFYAAEICCGLEDLHRE---RIVYRDLK 313
Query: 209 AANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGY 268
             NILLDD+    + D GLA  V    T +  ++ GT+G++APE +   + +   D +  
Sbjct: 314 PENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERYTFSPDWWAL 371
Query: 269 GITLLELVTGQ 279
           G  L E++ GQ
Sbjct: 372 GCLLYEMIAGQ 382

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 85  IGQGGFGKVY---KGVLSDNTK--VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           +G+G FGKV        +D T   VAVK L+    P   + +++E+ ++    H+++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
            G C  +    L    M+ + +   LRD  P    +        A     G+ YLH Q  
Sbjct: 99  KGCCEDAGAASLQL-VMEYVPLG-SLRDYLP-RHSIGLAQLLLFAQQICEGMAYLHAQ-- 153
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR----GTMGHIAPEYLS 255
              IHRDL A N+LLD++    + DFGLAK V     H   ++R      +   APE L 
Sbjct: 154 -HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE--GHEXYRVREDGDSPVFWYAPECLK 210
Query: 256 TGKSSEKTDVFGYGITLLELVT 277
             K    +DV+ +G+TL EL+T
Sbjct: 211 EYKFYYASDVWSFGVTLYELLT 232

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 13/214 (6%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY      +  + A+K L        G E   +REV + S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
              H N+L+L GY   ++    VY  ++   +    R+L+   K  +  T   +    A 
Sbjct: 65  HLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 120
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L Y H +   ++IHRD+K  N+LL    E  + DFG +    A  +  TT + GT+ ++
Sbjct: 121 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--CHAPSSRRTT-LSGTLDYL 174
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
            PE +      EK D++  G+   E + G+   +
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 13/205 (6%)
Query: 83  NIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
            IIG G  G+V  G L      +  VA+K L+  Y+      F  E  ++    H N+++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
           L G  T     ++V  +M+N S+   LR        +      R   G   G+ YL +  
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR---GVGAGMRYLSDL- 170
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLST 256
               +HRDL A N+L+D N    + DFGL++++  D      TT  +  +   APE ++ 
Sbjct: 171 --GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAF 228
Query: 257 GKSSEKTDVFGYGITLLE-LVTGQR 280
              S  +DV+ +G+ + E L  G+R
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGER 253

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 105/226 (46%), Gaps = 38/226 (16%)
Query: 72  LQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHL-ISV 130
           ++L  D+F + + +G G  G V+K                 + P G    ++ +HL I  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK---------------VSHKPSGLVMARKLIHLEIKP 45
Query: 131 AIHKNL---LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------ 181
           AI   +   LQ++  C +         F  +  ++  +  +  G   LD   +K      
Sbjct: 46  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPE 103
Query: 182 ----RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLT 236
               +V+     GL YL E+   KI+HRD+K +NIL++   E  LCDFG++ +L+D+   
Sbjct: 104 QILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 158
Query: 237 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 282
            +     GT  +++PE L     S ++D++  G++L+E+  G+  I
Sbjct: 159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 41/103 (39%), Positives = 60/103 (58%), Gaps = 10/103 (9%)
Query: 182 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTT 240
           ++   T   L +L E  N KIIHRD+K +NILLD +    LCDFG++ +LVD   +   T
Sbjct: 129 KITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD---SIAKT 183
Query: 241 QIRGTMGHIAPEYLSTGKSSE----KTDVFGYGITLLELVTGQ 279
           +  G   ++APE +    S +    ++DV+  GITL EL TG+
Sbjct: 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 105/226 (46%), Gaps = 38/226 (16%)
Query: 72  LQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHL-ISV 130
           ++L  D+F + + +G G  G V+K                 + P G    ++ +HL I  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK---------------VSHKPSGLVMARKLIHLEIKP 45
Query: 131 AIHKNL---LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------ 181
           AI   +   LQ++  C +         F  +  ++  +  +  G   LD   +K      
Sbjct: 46  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPE 103
Query: 182 ----RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLT 236
               +V+     GL YL E+   KI+HRD+K +NIL++   E  LCDFG++ +L+D+   
Sbjct: 104 QILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 158
Query: 237 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 282
            +     GT  +++PE L     S ++D++  G++L+E+  G+  I
Sbjct: 159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 102/240 (42%), Gaps = 32/240 (13%)
Query: 61  LTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYS 114
           + Q ++   +E+ L+   F E   +G+  FGKVYKG L           VA+K L+D   
Sbjct: 12  INQHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE 69
Query: 115 PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG--- 171
                 F+ E  L +   H N++ L+G  T      +++ +  +  +   L    P    
Sbjct: 70  GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDV 129
Query: 172 ---------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL 222
                    +  L+ P    +    A G+EYL       ++H+DL   N+L+ D     +
Sbjct: 130 GSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKI 186
Query: 223 CDFGLAKLVDAK-----LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
            D GL + V A      L +    IR     +APE +  GK S  +D++ YG+ L E+ +
Sbjct: 187 SDLGLFREVYAADYYKLLGNSLLPIRW----MAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 105/226 (46%), Gaps = 38/226 (16%)
Query: 72  LQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHL-ISV 130
           ++L  D+F + + +G G  G V+K                 + P G    ++ +HL I  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK---------------VSHKPSGLVMARKLIHLEIKP 45
Query: 131 AIHKNL---LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------ 181
           AI   +   LQ++  C +         F  +  ++  +  +  G   LD   +K      
Sbjct: 46  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPE 103
Query: 182 ----RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLT 236
               +V+     GL YL E+   KI+HRD+K +NIL++   E  LCDFG++ +L+D+   
Sbjct: 104 QILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 158
Query: 237 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 282
            +     GT  +++PE L     S ++D++  G++L+E+  G+  I
Sbjct: 159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 105/226 (46%), Gaps = 38/226 (16%)
Query: 72  LQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHL-ISV 130
           ++L  D+F + + +G G  G V+K                 + P G    ++ +HL I  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK---------------VSHKPSGLVMARKLIHLEIKP 45
Query: 131 AIHKNL---LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------ 181
           AI   +   LQ++  C +         F  +  ++  +  +  G   LD   +K      
Sbjct: 46  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPE 103
Query: 182 ----RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLT 236
               +V+     GL YL E+   KI+HRD+K +NIL++   E  LCDFG++ +L+D+   
Sbjct: 104 QILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 158
Query: 237 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 282
            +     GT  +++PE L     S ++D++  G++L+E+  G+  I
Sbjct: 159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 13/214 (6%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY      +  + A+K L        G E   +REV + S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
              H N+L+L GY   ++    VY  ++   +    R+L+   K  +  T   +    A 
Sbjct: 65  HLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 120
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L Y H +   ++IHRD+K  N+LL    E  + DFG +  V A  +   T + GT+ ++
Sbjct: 121 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RTDLCGTLDYL 174
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
            PE +      EK D++  G+   E + G+   +
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 26/202 (12%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           +G G FG V  G       VA+K +++      E  F  E  ++    H+ L+QL G CT
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC------ 198
                 ++  +M N  +   LR++             R  F T   LE   + C      
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREM-------------RHRFQTQQLLEMCKDVCEAMEYL 136
Query: 199 -NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLS 255
            + + +HRDL A N L++D     + DFGL++ V  D + + V ++    +    PE L 
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKF--PVRWSPPEVLM 194
Query: 256 TGKSSEKTDVFGYGITLLELVT 277
             K S K+D++ +G+ + E+ +
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 13/214 (6%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY      +  + A+K L        G E   +REV + S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
              H N+L+L GY   ++    VY  ++   +    R+L+   K  +  T   +    A 
Sbjct: 64  HLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 119
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L Y H +   ++IHRD+K  N+LL    E  + DFG +  V A  +   T + GT+ ++
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RTDLCGTLDYL 173
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
            PE +      EK D++  G+   E + G+   +
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 105/226 (46%), Gaps = 38/226 (16%)
Query: 72  LQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHL-ISV 130
           ++L  D+F + + +G G  G V+K                 + P G    ++ +HL I  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK---------------VSHKPSGLVMARKLIHLEIKP 45
Query: 131 AIHKNL---LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------ 181
           AI   +   LQ++  C +         F  +  ++  +  +  G   LD   +K      
Sbjct: 46  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPE 103
Query: 182 ----RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLT 236
               +V+     GL YL E+   KI+HRD+K +NIL++   E  LCDFG++ +L+D+   
Sbjct: 104 QILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 158
Query: 237 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 282
            +     GT  +++PE L     S ++D++  G++L+E+  G+  I
Sbjct: 159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 13/214 (6%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY      +  + A+K L        G E   +REV + S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
              H N+L+L GY   ++    VY  ++   +    R+L+   K  +  T   +    A 
Sbjct: 64  HLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 119
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L Y H +   ++IHRD+K  N+LL    E  + DFG +  V A  +   T + GT+ ++
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RTDLCGTLDYL 173
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
            PE +      EK D++  G+   E + G+   +
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 85  IGQGGFGKVYKGVLSDNTK--VAVKRLQ-DYYSPGGEAAFQREV----HLISVAIHKNLL 137
           IG+G +GKV+K     N    VA+KR++      G   +  REV    HL +   H N++
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE-HPNVV 77
Query: 138 QLIGYCTTS-----SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 192
           +L   CT S     ++  LV+  +      Y   D  P E G+   T K + F    GL+
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVP-EPGVPTETIKDMMFQLLRGLD 134
Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 252
           +LH     +++HRDLK  NIL+  + +  L DFGLA++   ++    T +  T+ + APE
Sbjct: 135 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAPE 189
Query: 253 YLSTGKSSEKTDVFGYGITLLEL 275
            L     +   D++  G    E+
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEM 212

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 85  IGQGGFGKVYKGVLSDNTK--VAVKRLQ-DYYSPGGEAAFQREV----HLISVAIHKNLL 137
           IG+G +GKV+K     N    VA+KR++      G   +  REV    HL +   H N++
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE-HPNVV 77
Query: 138 QLIGYCTTS-----SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 192
           +L   CT S     ++  LV+  +      Y   D  P E G+   T K + F    GL+
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVP-EPGVPTETIKDMMFQLLRGLD 134
Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 252
           +LH     +++HRDLK  NIL+  + +  L DFGLA++   ++    T +  T+ + APE
Sbjct: 135 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAPE 189
Query: 253 YLSTGKSSEKTDVFGYGITLLEL 275
            L     +   D++  G    E+
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEM 212

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 13/214 (6%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY      +  + A+K L        G E   +REV + S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
              H N+L+L GY   ++    VY  ++   +    R+L+   K  +  T   +    A 
Sbjct: 69  HLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 124
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L Y H +   ++IHRD+K  N+LL    E  + DFG +  V A  +   T + GT+ ++
Sbjct: 125 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RTDLCGTLDYL 178
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
            PE +      EK D++  G+   E + G+   +
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 13/214 (6%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY      +  + A+K L        G E   +REV + S
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
              H N+L+L GY   ++    VY  ++   +    R+L+   K  +  T   +    A 
Sbjct: 66  HLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 121
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L Y H +   ++IHRD+K  N+LL    E  + +FG +  V A  +  TT + GT+ ++
Sbjct: 122 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTT-LCGTLDYL 175
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
            PE +      EK D++  G+   E + G+   +
Sbjct: 176 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 85  IGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREV----HLISVAIHKNLL 137
           IG+G +GKV+K   + +    VA+KR++      G   +  REV    HL +   H N++
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE-HPNVV 77
Query: 138 QLIGYCTTS-----SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 192
           +L   CT S     ++  LV+  +      Y   D  P E G+   T K + F    GL+
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVP-EPGVPTETIKDMMFQLLRGLD 134
Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 252
           +LH     +++HRDLK  NIL+  + +  L DFGLA++   ++    T +  T+ + APE
Sbjct: 135 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAPE 189
Query: 253 YLSTGKSSEKTDVFGYGITLLEL 275
            L     +   D++  G    E+
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEM 212

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 13/214 (6%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY      +  + A+K L        G E   +REV + S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
              H N+L+L GY   ++    VY  ++   +    R+L+   K  +  T   +    A 
Sbjct: 67  HLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 122
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L Y H +   ++IHRD+K  N+LL    E  + +FG +  V A  +  TT + GT+ ++
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTT-LCGTLDYL 176
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
            PE +      EK D++  G+   E + G+   +
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 88/211 (41%), Gaps = 16/211 (7%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQ----REVHLI- 128
           +AT  +     IG G +G VYK    D        L+    P GE        REV L+ 
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGEEGLPISTVREVALLR 58
Query: 129 --SVAIHKNLLQLIGYCTTS--SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVA 184
                 H N+++L+  C TS     I V    +++    R    K    GL   T K + 
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 185 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG 244
                GL++LH  C   I+HRDLK  NIL+       L DFGLA++   ++      +  
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LDPVVV 173
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLEL 275
           T+ + APE L     +   D++  G    E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 30/204 (14%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           +G G FG V  G       VA+K +++      E  F  E  ++    H+ L+QL G CT
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC------ 198
                 ++  +M N  +   LR++             R  F T   LE   + C      
Sbjct: 74  KQRPIFIITEYMANGCLLNYLREM-------------RHRFQTQQLLEMCKDVCEAMEYL 120
Query: 199 -NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQ--IRGTMGHIAPEY 253
            + + +HRDL A N L++D     + DFGL++ V  D   + V ++  +R +     PE 
Sbjct: 121 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEV 176
Query: 254 LSTGKSSEKTDVFGYGITLLELVT 277
           L   K S K+D++ +G+ + E+ +
Sbjct: 177 LMYSKFSSKSDIWAFGVLMWEIYS 200

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 93/197 (47%), Gaps = 14/197 (7%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           IG+G FG V  G    N KVAVK +++        AF  E  +++   H NL+QL+G   
Sbjct: 14  IGKGEFGDVMLGDYRGN-KVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 145 TSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
                + +V  +M   S+   LR    G   L      + +      +EYL        +
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFV 124
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N+L+ ++  A + DFGL K  +A  T  T ++   +   APE L   K S K+
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREKKFSTKS 180
Query: 264 DVFGYGITLLELVTGQR 280
           DV+ +GI L E+ +  R
Sbjct: 181 DVWSFGILLWEIYSFGR 197

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 93/197 (47%), Gaps = 14/197 (7%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           IG+G FG V  G    N KVAVK +++        AF  E  +++   H NL+QL+G   
Sbjct: 29  IGKGEFGDVMLGDYRGN-KVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 145 TSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
                + +V  +M   S+   LR    G   L      + +      +EYL        +
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFV 139
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N+L+ ++  A + DFGL K  +A  T  T ++   +   APE L   K S K+
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREKKFSTKS 195
Query: 264 DVFGYGITLLELVTGQR 280
           DV+ +GI L E+ +  R
Sbjct: 196 DVWSFGILLWEIYSFGR 212

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 85  IGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G G FG+VY+G +S         +VAVK L +  S   E  F  E  +IS   H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKRVAFGTAYGLEYLH 195
            IG    S  R ++   M    +   LR+ +P       L       VA   A G +YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 196 EQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAP 251
           E      IHRD+ A N LL        A + DFG+A+ +  A            +  + P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 252 EYLSTGKSSEKTDVFGYGITLLELVT 277
           E    G  + KTD + +G+ L E+ +
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 13/214 (6%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY      +  + A+K L        G E   +REV + S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
              H N+L+L GY   ++    VY  ++   +    R+L+   K  +  T   +    A 
Sbjct: 64  HLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 119
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L Y H +   ++IHRD+K  N+LL    E  + DFG +  V A  +   T + GT+ ++
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RTXLCGTLDYL 173
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
            PE +      EK D++  G+   E + G+   +
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 103/213 (48%), Gaps = 11/213 (5%)
Query: 68  SCRELQLATDNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQR 123
           S R+ ++  +       IG+G FG V++G+     +    VA+K  ++  S      F +
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 124 EVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 183
           E   +    H ++++LIG  T +     V+  M+  ++      L+  +  LD  +    
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILY 116
Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 243
           A+  +  L YL  +   + +HRD+ A N+L+  N    L DFGL++ ++    +  ++ +
Sbjct: 117 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 173
Query: 244 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELV 276
             +  +APE ++  + +  +DV+ +G+ + E++
Sbjct: 174 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 85  IGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G G FG+VY+G +S         +VAVK L +  S   E  F  E  +IS   H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKRVAFGTAYGLEYLH 195
            IG    S  R ++   M    +   LR+ +P       L       VA   A G +YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 196 EQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAP 251
           E      IHRD+ A N LL        A + DFG+A+ +  A            +  + P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 252 EYLSTGKSSEKTDVFGYGITLLELVT 277
           E    G  + KTD + +G+ L E+ +
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 38/225 (16%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHL-ISVA 131
           +L  D+F + + +G G  G V+K                 + P G    ++ +HL I  A
Sbjct: 29  ELKDDDFEKISELGAGNGGVVFK---------------VSHKPSGLVMARKLIHLEIKPA 73
Query: 132 IHKNL---LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------- 181
           I   +   LQ++  C +         F  +  ++  +  +  G   LD   +K       
Sbjct: 74  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPEQ 131
Query: 182 ---RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTH 237
              +V+     GL YL E+   KI+HRD+K +NIL++   E  LCDFG++ +L+D+    
Sbjct: 132 ILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 185
Query: 238 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 282
           +     GT  +++PE L     S ++D++  G++L+E+  G+  I
Sbjct: 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 129/293 (44%), Gaps = 53/293 (18%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
           +F E  +IG GGFG+V+K     + K  V +   Y +   E    REV  ++   H N++
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE----REVKALAKLDHVNIV 67
Query: 138 QLIG------YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR--------- 182
              G      Y   +S +       + L +     D    E+   W  ++R         
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQ---WIEKRRGEKLDKVLA 124
Query: 183 --VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT 240
             +      G++Y+H +   K+I+RDLK +NI L D  +  + DFGL  +   K      
Sbjct: 125 LELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGL--VTSLKNDGKRX 179
Query: 241 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELV-TGQRAIDFSRXXXXXXXXXXXHI 299
           + +GT+ +++PE +S+    ++ D++  G+ L EL+     A + S+             
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD--------- 230
Query: 300 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
              LR+  ++DI D        K+ +T++Q  L      PEDRP  +++++ L
Sbjct: 231 ---LRDGIISDIFD--------KKEKTLLQKLL---SKKPEDRPNTSEILRTL 269

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 28/207 (13%)
Query: 85  IGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQ----REVHLISVAIHKNLLQL 139
           +G G +G V   V      KVA+K+L   Y P     F     RE+ L+    H+N++ L
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKL---YRPFQSELFAKRAYRELRLLKHMRHENVIGL 89
Query: 140 IGYCTTS------SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
           +   T        ++  LV PFM    +   ++  K GE  + +     + +    GL Y
Sbjct: 90  LDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQF-----LVYQMLKGLRY 143
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           +H      IIHRDLK  N+ ++++ E  + DFGLA+  D+++         T  + APE 
Sbjct: 144 IHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVV----TRWYRAPEV 196
Query: 254 -LSTGKSSEKTDVFGYGITLLELVTGQ 279
            L+  + ++  D++  G  + E++TG+
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 30/204 (14%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           +G G FG V  G       VA+K +++      E  F  E  ++    H+ L+QL G CT
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC------ 198
                 ++  +M N  +   LR++             R  F T   LE   + C      
Sbjct: 70  KQRPIFIITEYMANGCLLNYLREM-------------RHRFQTQQLLEMCKDVCEAMEYL 116
Query: 199 -NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQ--IRGTMGHIAPEY 253
            + + +HRDL A N L++D     + DFGL++ V  D   + V ++  +R +     PE 
Sbjct: 117 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEV 172
Query: 254 LSTGKSSEKTDVFGYGITLLELVT 277
           L   K S K+D++ +G+ + E+ +
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYS 196

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 30/204 (14%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           +G G FG V  G       VA+K +++      E  F  E  ++    H+ L+QL G CT
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC------ 198
                 ++  +M N  +   LR++             R  F T   LE   + C      
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREM-------------RHRFQTQQLLEMCKDVCEAMEYL 121
Query: 199 -NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQ--IRGTMGHIAPEY 253
            + + +HRDL A N L++D     + DFGL++ V  D   + V ++  +R +     PE 
Sbjct: 122 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEV 177
Query: 254 LSTGKSSEKTDVFGYGITLLELVT 277
           L   K S K+D++ +G+ + E+ +
Sbjct: 178 LMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 13/214 (6%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY      +  + A+K L        G E   +REV + S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
              H N+L+L GY   ++    VY  ++   +    R+L+   K  +  T   +    A 
Sbjct: 65  HLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 120
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L Y H +   ++IHRD+K  N+LL    E  + DFG +  V A  +   T + GT+ ++
Sbjct: 121 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDT-LCGTLDYL 174
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
            PE +      EK D++  G+   E + G+   +
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 85  IGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G+G FGKV+           D   VAVK L+D  S      F RE  L++   H+++++
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVK 79
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL---DWPTR------KRVAFGTAY 189
             G C      I+V+ +M++  +   LR   P    +   + PT         +A   A 
Sbjct: 80  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAA 139
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGH 248
           G+ YL  Q     +HRDL   N L+ +N    + DFG+++ V       V       +  
Sbjct: 140 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 196
Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVT 277
           + PE +   K + ++DV+  G+ L E+ T
Sbjct: 197 MPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 38/225 (16%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHL-ISVA 131
           +L  D+F + + +G G  G V+K                 + P G    ++ +HL I  A
Sbjct: 21  ELKDDDFEKISELGAGNGGVVFK---------------VSHKPSGLVMARKLIHLEIKPA 65
Query: 132 IHKNL---LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------- 181
           I   +   LQ++  C +         F  +  ++  +  +  G   LD   +K       
Sbjct: 66  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPEQ 123
Query: 182 ---RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTH 237
              +V+     GL YL E+   KI+HRD+K +NIL++   E  LCDFG++ +L+D+    
Sbjct: 124 ILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 177
Query: 238 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 282
           +     GT  +++PE L     S ++D++  G++L+E+  G+  I
Sbjct: 178 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 85  IGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G G FG+VY+G +S         +VAVK L +  S   E  F  E  +IS   H+N+++
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKRVAFGTAYGLEYLH 195
            IG    S  R ++   M    +   LR+ +P       L       VA   A G +YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 196 EQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAP 251
           E      IHRD+ A N LL        A + DFG+A+ +  A            +  + P
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 252 EYLSTGKSSEKTDVFGYGITLLELVT 277
           E    G  + KTD + +G+ L E+ +
Sbjct: 207 EAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 28/210 (13%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI--HKNLLQLIGY 142
           +G+G +G+V++G       VAVK     +S   E ++ RE  L +  +  H+N+L  I  
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVK----IFSSRDEKSWFRETELYNTVMLRHENILGFIAS 99
Query: 143 CTTS---SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH---- 195
             TS   S ++ +      +   Y    L      LD  +  R+    A GL +LH    
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEIF 155
Query: 196 -EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH--VTTQIR-GTMGHIAP 251
             Q  P I HRDLK+ NIL+  N +  + D GLA +         V    R GT  ++AP
Sbjct: 156 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 215
Query: 252 EYLSTG------KSSEKTDVFGYGITLLEL 275
           E L          S ++ D++ +G+ L E+
Sbjct: 216 EVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 85  IGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G G FG+VY+G +S         +VAVK L +  S   E  F  E  +IS   H+N+++
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKRVAFGTAYGLEYLH 195
            IG    S  R ++   M    +   LR+ +P       L       VA   A G +YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 196 EQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAP 251
           E      IHRD+ A N LL        A + DFG+A+ +  A            +  + P
Sbjct: 175 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 231
Query: 252 EYLSTGKSSEKTDVFGYGITLLELVT 277
           E    G  + KTD + +G+ L E+ +
Sbjct: 232 EAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 28/210 (13%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI--HKNLLQLIGY 142
           +G+G +G+V++G       VAVK     +S   E ++ RE  L +  +  H+N+L  I  
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVK----IFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 143 CTTS---SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH---- 195
             TS   S ++ +      +   Y    L      LD  +  R+    A GL +LH    
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 196 -EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH--VTTQIR-GTMGHIAP 251
             Q  P I HRDLK+ NIL+  N +  + D GLA +         V    R GT  ++AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 252 EYLSTG------KSSEKTDVFGYGITLLEL 275
           E L          S ++ D++ +G+ L E+
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 85  IGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G G FG+VY+G +S         +VAVK L +  S   E  F  E  +IS   H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKRVAFGTAYGLEYLH 195
            IG    S  R ++   M    +   LR+ +P       L       VA   A G +YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 196 EQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAP 251
           E      IHRD+ A N LL        A + DFG+A+ +  A            +  + P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 252 EYLSTGKSSEKTDVFGYGITLLELVT 277
           E    G  + KTD + +G+ L E+ +
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 85  IGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G G FG+VY+G +S         +VAVK L +  S   E  F  E  +IS   H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKRVAFGTAYGLEYLH 195
            IG    S  R ++   M    +   LR+ +P       L       VA   A G +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 196 EQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAP 251
           E      IHRD+ A N LL        A + DFG+A+ +  A            +  + P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 252 EYLSTGKSSEKTDVFGYGITLLELVT 277
           E    G  + KTD + +G+ L E+ +
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 85  IGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G G FG+VY+G +S         +VAVK L +  S   E  F  E  +IS   H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKRVAFGTAYGLEYLH 195
            IG    S  R ++   M    +   LR+ +P       L       VA   A G +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 196 EQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAP 251
           E      IHRD+ A N LL        A + DFG+A+ +  A            +  + P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 252 EYLSTGKSSEKTDVFGYGITLLELVT 277
           E    G  + KTD + +G+ L E+ +
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 103/213 (48%), Gaps = 11/213 (5%)
Query: 68  SCRELQLATDNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQR 123
           S R+ ++  +       IG+G FG V++G+     +    VA+K  ++  S      F +
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 60
Query: 124 EVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 183
           E   +    H ++++LIG  T +     V+  M+  ++      L+  +  LD  +    
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILY 116
Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 243
           A+  +  L YL  +   + +HRD+ A N+L+  N    L DFGL++ ++    +  ++ +
Sbjct: 117 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 173
Query: 244 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELV 276
             +  +APE ++  + +  +DV+ +G+ + E++
Sbjct: 174 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 85  IGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G G FG+VY+G +S         +VAVK L +  S   E  F  E  +IS   H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKRVAFGTAYGLEYLH 195
            IG    S  R ++   M    +   LR+ +P       L       VA   A G +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 196 EQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAP 251
           E      IHRD+ A N LL        A + DFG+A+ +  A            +  + P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 252 EYLSTGKSSEKTDVFGYGITLLELVT 277
           E    G  + KTD + +G+ L E+ +
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 85  IGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G G FG+VY+G +S         +VAVK L +  S   E  F  E  +IS   H+N+++
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKRVAFGTAYGLEYLH 195
            IG    S  R ++   M    +   LR+ +P       L       VA   A G +YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 196 EQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAP 251
           E      IHRD+ A N LL        A + DFG+A+ +  A            +  + P
Sbjct: 185 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 252 EYLSTGKSSEKTDVFGYGITLLELVT 277
           E    G  + KTD + +G+ L E+ +
Sbjct: 242 EAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 30/204 (14%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           +G G FG V  G       VA+K +++      E  F  E  ++    H+ L+QL G CT
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC------ 198
                 ++  +M N  +   LR++             R  F T   LE   + C      
Sbjct: 81  KQRPIFIITEYMANGCLLNYLREM-------------RHRFQTQQLLEMCKDVCEAMEYL 127
Query: 199 -NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQ--IRGTMGHIAPEY 253
            + + +HRDL A N L++D     + DFGL++ V  D   + V ++  +R +     PE 
Sbjct: 128 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEV 183
Query: 254 LSTGKSSEKTDVFGYGITLLELVT 277
           L   K S K+D++ +G+ + E+ +
Sbjct: 184 LMYSKFSSKSDIWAFGVLMWEIYS 207

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 17/216 (7%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY      +  + A+K L        G E   +REV + S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT-- 187
              H N+L+L GY   ++   L+  +     V   L+ L        +  ++   + T  
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLS------KFDEQRTATYITEL 122
Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 247
           A  L Y H +   ++IHRD+K  N+LL    E  + DFG +  V A  +     + GT+ 
Sbjct: 123 ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSR-RXXLXGTLD 176
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
           ++ PE +      EK D++  G+   E + G+   +
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 103/204 (50%), Gaps = 23/204 (11%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           +G G +G V   +      KVA+K+L + + S        RE+ L+    H+N++ L+  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 143 CTTSS------ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 196
            T +S      +  LV PFMQ  +   ++  ++  E+ + +     + +    GL+Y+H 
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQ--TDLQKIMGMEFSEEKIQY-----LVYQMLKGLKYIH- 161
Query: 197 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY-LS 255
             +  ++HRDLK  N+ ++++ E  + DFGLA+  DA++T        T  + APE  LS
Sbjct: 162 --SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYRAPEVILS 215
Query: 256 TGKSSEKTDVFGYGITLLELVTGQ 279
               ++  D++  G  + E++TG+
Sbjct: 216 WMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 85  IGQGGFGKV--YKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           +G+GGF  V   +G L D    A+KR+  +     E A QRE  +  +  H N+L+L+ Y
Sbjct: 37  LGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEA-QREADMHRLFNHPNILRLVAY 94
Query: 143 CT----TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF---GTAYGLEYLH 195
           C        E  L+ PF +  ++   +  LK  +KG ++ T  ++ +   G   GLE +H
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLK--DKG-NFLTEDQILWLLLGICRGLEAIH 151
Query: 196 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL----VDAKLTHVTTQ----IRGTMG 247
            +      HRDLK  NILL D  + VL D G        V+     +T Q     R T+ 
Sbjct: 152 AK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 248 HIAPEYLSTGKS---SEKTDVFGYGITLLELVTGQRAIDF 284
           + APE  S        E+TDV+  G  L  ++ G+   D 
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 85  IGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G G FG+VY+G +S         +VAVK L +  S   E  F  E  +IS   H+N+++
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKRVAFGTAYGLEYLH 195
            IG    S  R ++   M    +   LR+ +P       L       VA   A G +YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 196 EQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAP 251
           E      IHRD+ A N LL        A + DFG+A+ +  A            +  + P
Sbjct: 165 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 252 EYLSTGKSSEKTDVFGYGITLLELVT 277
           E    G  + KTD + +G+ L E+ +
Sbjct: 222 EAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 103/213 (48%), Gaps = 11/213 (5%)
Query: 68  SCRELQLATDNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQR 123
           S R+ ++  +       IG+G FG V++G+     +    VA+K  ++  S      F +
Sbjct: 3   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 62
Query: 124 EVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 183
           E   +    H ++++LIG  T +     V+  M+  ++      L+  +  LD  +    
Sbjct: 63  EALTMRQFDHPHIVKLIGVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILY 118
Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 243
           A+  +  L YL  +   + +HRD+ A N+L+  N    L DFGL++ ++    +  ++ +
Sbjct: 119 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 175
Query: 244 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELV 276
             +  +APE ++  + +  +DV+ +G+ + E++
Sbjct: 176 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 28/210 (13%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI--HKNLLQLIGY 142
           +G+G +G+V++G       VAVK     +S   E ++ RE  L +  +  H+N+L  I  
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVK----IFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 143 CTTS---SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH---- 195
             TS   S ++ +      +   Y    L      LD  +  R+    A GL +LH    
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 196 -EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH--VTTQIR-GTMGHIAP 251
             Q  P I HRDLK+ NIL+  N +  + D GLA +         V    R GT  ++AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 252 EYLSTG------KSSEKTDVFGYGITLLEL 275
           E L          S ++ D++ +G+ L E+
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY      +  + A+K L        G E   +REV + S
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
              H N+L+L GY   ++    VY  ++   +    R+L+   K  +  T   +    A 
Sbjct: 66  HLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 121
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR----GT 245
            L Y H +   ++IHRD+K  N+LL    E  + DFG +        H  +  R    GT
Sbjct: 122 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGT 171
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
           + ++ PE +      EK D++  G+   E + G+   +
Sbjct: 172 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 93/197 (47%), Gaps = 14/197 (7%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           IG+G FG V  G    N KVAVK +++        AF  E  +++   H NL+QL+G   
Sbjct: 201 IGKGEFGDVMLGDYRGN-KVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 145 TSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
                + +V  +M   S+   LR    G   L      + +      +EYL        +
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFV 311
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N+L+ ++  A + DFGL K  +A  T  T ++   +   APE L   K S K+
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREKKFSTKS 367
Query: 264 DVFGYGITLLELVTGQR 280
           DV+ +GI L E+ +  R
Sbjct: 368 DVWSFGILLWEIYSFGR 384

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 38/225 (16%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHL-ISVA 131
           +L  D+F + + +G G  G V+K                 + P G    ++ +HL I  A
Sbjct: 64  ELKDDDFEKISELGAGNGGVVFK---------------VSHKPSGLVMARKLIHLEIKPA 108
Query: 132 IHKNL---LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------- 181
           I   +   LQ++  C +         F  +  ++  +  +  G   LD   +K       
Sbjct: 109 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPEQ 166
Query: 182 ---RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTH 237
              +V+     GL YL E+   KI+HRD+K +NIL++   E  LCDFG++ +L+D+    
Sbjct: 167 ILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 220
Query: 238 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 282
           +     GT  +++PE L     S ++D++  G++L+E+  G+  I
Sbjct: 221 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 26/202 (12%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           +G G FG V  G       VA+K +++      E  F  E  ++    H+ L+QL G CT
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC------ 198
                 ++  +M N  +   LR++             R  F T   LE   + C      
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREM-------------RHRFQTQQLLEMCKDVCEAMEYL 136
Query: 199 -NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGTMGHIAPEYLS 255
            + + +HRDL A N L++D     + DFGL++ V  D   + V ++    +    PE L 
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLM 194
Query: 256 TGKSSEKTDVFGYGITLLELVT 277
             K S K+D++ +G+ + E+ +
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYS 216

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 61/102 (59%), Gaps = 7/102 (6%)
Query: 182 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTT 240
           +V+     GL YL E+   +I+HRD+K +NIL++   E  LCDFG++ +L+D+    +  
Sbjct: 118 KVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 171
Query: 241 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 282
              GT  ++APE L     S ++D++  G++L+EL  G+  I
Sbjct: 172 SFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 16/215 (7%)
Query: 71  ELQLATDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQD--YYSPGGEAAFQREVHL 127
           +++L  ++F    ++G+G FGKV+       N   A+K L+               E  +
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 128 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 187
           +S+A     L  + +CT  ++  L +  M+ L+    +  ++   K  D       A   
Sbjct: 71  LSLAWEHPFLTHM-FCTFQTKENLFF-VMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEI 127
Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK---LVDAKLTHVTTQIRG 244
             GL++LH +    I++RDLK  NILLD +    + DFG+ K   L DAK    T    G
Sbjct: 128 ILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK----TNXFCG 180
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           T  +IAPE L   K +   D + +G+ L E++ GQ
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 103/213 (48%), Gaps = 11/213 (5%)
Query: 68  SCRELQLATDNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQR 123
           S R+ ++  +       IG+G FG V++G+     +    VA+K  ++  S      F +
Sbjct: 6   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 65
Query: 124 EVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 183
           E   +    H ++++LIG  T +     V+  M+  ++      L+  +  LD  +    
Sbjct: 66  EALTMRQFDHPHIVKLIGVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILY 121
Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 243
           A+  +  L YL  +   + +HRD+ A N+L+  N    L DFGL++ ++    +  ++ +
Sbjct: 122 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 178
Query: 244 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELV 276
             +  +APE ++  + +  +DV+ +G+ + E++
Sbjct: 179 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 85  IGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G G FG+VY+G +S         +VAVK L +  S   E  F  E  +IS   H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKRVAFGTAYGLEYLH 195
            IG    S  R ++   M    +   LR+ +P       L       VA   A G +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 196 EQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAP 251
           E      IHRD+ A N LL        A + DFG+A+ +  A            +  + P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 252 EYLSTGKSSEKTDVFGYGITLLELVT 277
           E    G  + KTD + +G+ L E+ +
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY      +  + A+K L        G E   +REV + S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
              H N+L+L GY   ++    VY  ++   +    R+L+   K  +  T   +    A 
Sbjct: 67  HLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 122
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR----GT 245
            L Y H +   ++IHRD+K  N+LL    E  + DFG +        H  +  R    GT
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGT 172
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
           + ++ PE +      EK D++  G+   E + G+   +
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY      +  + A+K L        G E   +REV + S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
              H N+L+L GY   ++    VY  ++   +    R+L+   K  +  T   +    A 
Sbjct: 64  HLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 119
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR----GT 245
            L Y H +   ++IHRD+K  N+LL    E  + DFG +        H  +  R    GT
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRAALCGT 169
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
           + ++ PE +      EK D++  G+   E + G+   +
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 103/213 (48%), Gaps = 11/213 (5%)
Query: 68  SCRELQLATDNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQR 123
           S R+ ++  +       IG+G FG V++G+     +    VA+K  ++  S      F +
Sbjct: 4   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 63
Query: 124 EVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 183
           E   +    H ++++LIG  T +     V+  M+  ++      L+  +  LD  +    
Sbjct: 64  EALTMRQFDHPHIVKLIGVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILY 119
Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 243
           A+  +  L YL  +   + +HRD+ A N+L+  N    L DFGL++ ++    +  ++ +
Sbjct: 120 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 176
Query: 244 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELV 276
             +  +APE ++  + +  +DV+ +G+ + E++
Sbjct: 177 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 80/173 (46%), Gaps = 25/173 (14%)
Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QI 242
           +F  A G+E+L  +   K IHRDL A NILL +N    +CDFGLA+ +     +V     
Sbjct: 205 SFQVARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDT 261
Query: 243 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKL 302
           R  +  +APE +     S K+DV+ YG+ L E+ +                    +    
Sbjct: 262 RLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS---------------LGGSPYPGVQ 306
Query: 303 LRED---RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
           + ED   RL + +      Y + E+    Q+ L C    P++RP  A++V+ L
Sbjct: 307 MDEDFCSRLREGMRMRAPEYSTPEI---YQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 103/213 (48%), Gaps = 11/213 (5%)
Query: 68  SCRELQLATDNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQR 123
           S R+ ++  +       IG+G FG V++G+     +    VA+K  ++  S      F +
Sbjct: 29  STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 88
Query: 124 EVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 183
           E   +    H ++++LIG  T +     V+  M+  ++      L+  +  LD  +    
Sbjct: 89  EALTMRQFDHPHIVKLIGVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILY 144
Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 243
           A+  +  L YL  +   + +HRD+ A N+L+  N    L DFGL++ ++    +  ++ +
Sbjct: 145 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 201
Query: 244 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELV 276
             +  +APE ++  + +  +DV+ +G+ + E++
Sbjct: 202 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY      +  + A+K L        G E   +REV + S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
              H N+L+L GY   ++    VY  ++   +    R+L+   K  +  T   +    A 
Sbjct: 67  HLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 122
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR----GT 245
            L Y H +   ++IHRD+K  N+LL    E  + DFG +        H  +  R    GT
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRAALCGT 172
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
           + ++ PE +      EK D++  G+   E + G+   +
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY      +  + A+K L        G E   +REV + S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
              H N+L+L GY   ++    VY  ++   +    R+L+   K  +  T   +    A 
Sbjct: 67  HLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 122
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR----GT 245
            L Y H +   ++IHRD+K  N+LL    E  + DFG +        H  +  R    GT
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCGT 172
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
           + ++ PE +      EK D++  G+   E + G+   +
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY      +  + A+K L        G E   +REV + S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
              H N+L+L GY   ++    VY  ++   +    R+L+   K  +  T   +    A 
Sbjct: 64  HLRHPNILRLYGYFHDATR---VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 119
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR----GT 245
            L Y H +   ++IHRD+K  N+LL    E  + DFG +        H  +  R    GT
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGT 169
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
           + ++ PE +      EK D++  G+   E + G+   +
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 25/215 (11%)
Query: 73  QLATDNFSESNIIGQGGFGKVY-------KGVLSDNTKVAVKRLQDYYSPGGEAAFQREV 125
           Q   ++F     +G+G FG VY       K +L+   KV  K   +    G E   +REV
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILA--LKVLFKTQLE--KAGVEHQLRREV 63
Query: 126 HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF 185
            + S   H N+L+L GY   ++   L+  +    +V   L+ L   ++      ++   +
Sbjct: 64  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE------QRTATY 117
Query: 186 GT--AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 243
            T  A  L Y H +   ++IHRD+K  N+LL  N E  + DFG +  V A  +   T + 
Sbjct: 118 ITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDT-LC 171
Query: 244 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           GT+ ++ PE +      EK D++  G+   E + G
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 25/220 (11%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY      +  + A+K L        G E   +REV + S
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT-- 187
              H N+L+L GY   ++   L+  +    +V   L+ L        +  ++   + T  
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS------KFDEQRTATYITEL 143
Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR---- 243
           A  L Y H +   ++IHRD+K  N+LL    E  + DFG +        H  +  R    
Sbjct: 144 ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLC 193
Query: 244 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
           GT+ ++ PE +      EK D++  G+   E + G+   +
Sbjct: 194 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 15/213 (7%)
Query: 75  ATDNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVA 131
           + +NF +   IG+G +G VYK    L+    VA+K+++ D  + G  +   RE+ L+   
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 132 IHKNLLQLIGYCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG 190
            H N+++L+    T ++  LV+  + Q+L        L     G+  P  K   F    G
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALT----GIPLPLIKSYLFQLLQG 118
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
           L + H     +++HRDLK  N+L++      L DFGLA+     +     ++  T+ + A
Sbjct: 119 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 174
Query: 251 PEYLSTGK-SSEKTDVFGYGITLLELVTGQRAI 282
           PE L   K  S   D++  G    E+VT +RA+
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 85  IGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G G FG+VY+G +S         +VAVK L +  S   E  F  E  +IS   H+N+++
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKRVAFGTAYGLEYLH 195
            IG    S  R ++   M    +   LR+ +P       L       VA   A G +YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 196 EQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAP 251
           E      IHRD+ A N LL        A + DFG+A+ +  A            +  + P
Sbjct: 176 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 252 EYLSTGKSSEKTDVFGYGITLLELVT 277
           E    G  + KTD + +G+ L E+ +
Sbjct: 233 EAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 85  IGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G G FG+VY+G +S         +VAVK L +  S   E  F  E  +IS   H+N+++
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKRVAFGTAYGLEYLH 195
            IG    S  R ++   M    +   LR+ +P       L       VA   A G +YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 196 EQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAP 251
           E      IHRD+ A N LL        A + DFG+A+ +  A            +  + P
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 252 EYLSTGKSSEKTDVFGYGITLLELVT 277
           E    G  + KTD + +G+ L E+ +
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 103/222 (46%), Gaps = 38/222 (17%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHL-ISVA 131
           +L  D+F + + +G G  G V+K                 + P G    ++ +HL I  A
Sbjct: 5   ELKDDDFEKISELGAGNGGVVFK---------------VSHKPSGLVMARKLIHLEIKPA 49
Query: 132 IHKNL---LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------- 181
           I   +   LQ++  C +         F  +  ++  +  +  G   LD   +K       
Sbjct: 50  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS--LDQVLKKAGRIPEQ 107
Query: 182 ---RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTH 237
              +V+     GL YL E+   KI+HRD+K +NIL++   E  LCDFG++ +L+D     
Sbjct: 108 ILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----E 161
Query: 238 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           +  +  GT  +++PE L     S ++D++  G++L+E+  G+
Sbjct: 162 MANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 98/231 (42%), Gaps = 32/231 (13%)
Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQR 123
           +E+ L+   F E   +G+  FGKVYKG L           VA+K L+D         F+ 
Sbjct: 4   KEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH 61
Query: 124 EVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG------------ 171
           E  L +   H N++ L+G  T      +++ +  +  +   L    P             
Sbjct: 62  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 172 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 231
           +  L+ P    +    A G+EYL       ++H+DL   N+L+ D     + D GL + V
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREV 178
Query: 232 DAK-----LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
            A      L +    IR     +APE +  GK S  +D++ YG+ L E+ +
Sbjct: 179 YAADYYKLLGNSLLPIRW----MAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 102/213 (47%), Gaps = 11/213 (5%)
Query: 68  SCRELQLATDNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQR 123
           S R+ ++  +       IG+G FG V++G+     +    VA+K  ++  S      F +
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 124 EVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 183
           E   +    H ++++LIG  T +     V+  M+  ++      L+  +  LD  +    
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILY 116
Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 243
           A+  +  L YL  +   + +HRD+ A N+L+  N    L DFGL++ ++       ++ +
Sbjct: 117 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGK 173
Query: 244 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELV 276
             +  +APE ++  + +  +DV+ +G+ + E++
Sbjct: 174 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 103/213 (48%), Gaps = 11/213 (5%)
Query: 68  SCRELQLATDNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQR 123
           S R+ ++  +       IG+G FG V++G+     +    VA+K  ++  S      F +
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 440
Query: 124 EVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 183
           E   +    H ++++LIG  T +     V+  M+  ++      L+  +  LD  +    
Sbjct: 441 EALTMRQFDHPHIVKLIGVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILY 496
Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 243
           A+  +  L YL  +   + +HRD+ A N+L+  N    L DFGL++ ++    +  ++ +
Sbjct: 497 AYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 553
Query: 244 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELV 276
             +  +APE ++  + +  +DV+ +G+ + E++
Sbjct: 554 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 104/235 (44%), Gaps = 37/235 (15%)
Query: 68  SCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAF--QREV 125
           +  E  L  DN     +IG+G +G VYKG L D   VAVK     +S      F  ++ +
Sbjct: 4   AASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVK----VFSFANRQNFINEKNI 58
Query: 126 HLISVAIHKNLLQLI-GYCTTSS----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR 180
           + + +  H N+ + I G    ++    E +LV  +  N S+   L          DW + 
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSS 113
Query: 181 KRVAFGTAYGLEYLH------EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDA 233
            R+A     GL YLH      +   P I HRDL + N+L+ ++   V+ DFGL+ +L   
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 234 KLTHVTTQIR------GTMGHIAPEYLSTG-------KSSEKTDVFGYGITLLEL 275
           +L     +        GT+ ++APE L           + ++ D++  G+   E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 93/197 (47%), Gaps = 14/197 (7%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           IG+G FG V  G    N KVAVK +++  +     AF  E  +++   H NL+QL+G   
Sbjct: 20  IGKGEFGDVMLGDYRGN-KVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGVIV 75
Query: 145 TSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
                + +V  +M   S+   LR    G   L      + +      +EYL        +
Sbjct: 76  EEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFV 130
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRDL A N+L+ ++  A + DFGL K  +A  T  T ++   +   APE L     S K+
Sbjct: 131 HRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREAAFSTKS 186
Query: 264 DVFGYGITLLELVTGQR 280
           DV+ +GI L E+ +  R
Sbjct: 187 DVWSFGILLWEIYSFGR 203

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 111/269 (41%), Gaps = 34/269 (12%)
Query: 85  IGQGGFGKVYKGVL----SDNTKVAVKRLQ-DYYS-PGGEAAFQREVHLISVAIHKNLLQ 138
           +G G FG V +G           VAVK L+ D  S P     F REV+ +    H+NL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
           L G   T   +++     +   +   L  L+  +      T  R A   A G+ YL  + 
Sbjct: 76  LYGVVLTPPMKMVT----ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK- 130
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--IRGTMGHIAPEYLST 256
             + IHRDL A N+LL       + DFGL + +     H   Q   +      APE L T
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 257 GKSSEKTDVFGYGITLLELVT-GQRAIDFSRXXXXXXXXXXXHIRKLLRE-DRLNDIVDR 314
              S  +D + +G+TL E+ T GQ                   + K+ +E +RL    D 
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEP--------WIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 315 NLNTYDSKEVETMVQVALLCTQSTPEDRP 343
             + Y+      MVQ    C    PEDRP
Sbjct: 241 PQDIYN-----VMVQ----CWAHKPEDRP 260

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 18/205 (8%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
           +G+G FGKV          KVA+K +  Q           +RE+  + +  H ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 142 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 201
             TT ++ ++V  +         L D    +K +     +R        +EY H     K
Sbjct: 77  VITTPTDIVMVIEY-----AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---K 128
Query: 202 IIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHIAPEYLSTGK-- 258
           I+HRDLK  N+LLDDN    + DFGL+ ++ D      +    G+  + APE ++ GK  
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEVIN-GKLY 184
Query: 259 SSEKTDVFGYGITLLELVTGQRAID 283
           +  + DV+  GI L  ++ G+   D
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 111/269 (41%), Gaps = 34/269 (12%)
Query: 85  IGQGGFGKVYKGVL----SDNTKVAVKRLQ-DYYS-PGGEAAFQREVHLISVAIHKNLLQ 138
           +G G FG V +G           VAVK L+ D  S P     F REV+ +    H+NL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
           L G   T   +++     +   +   L  L+  +      T  R A   A G+ YL  + 
Sbjct: 76  LYGVVLTPPMKMVT----ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK- 130
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--IRGTMGHIAPEYLST 256
             + IHRDL A N+LL       + DFGL + +     H   Q   +      APE L T
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 188
Query: 257 GKSSEKTDVFGYGITLLELVT-GQRAIDFSRXXXXXXXXXXXHIRKLLRE-DRLNDIVDR 314
              S  +D + +G+TL E+ T GQ                   + K+ +E +RL    D 
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEP--------WIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 315 NLNTYDSKEVETMVQVALLCTQSTPEDRP 343
             + Y+      MVQ    C    PEDRP
Sbjct: 241 PQDIYN-----VMVQ----CWAHKPEDRP 260

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 111/269 (41%), Gaps = 34/269 (12%)
Query: 85  IGQGGFGKVYKGVL----SDNTKVAVKRLQ-DYYS-PGGEAAFQREVHLISVAIHKNLLQ 138
           +G G FG V +G           VAVK L+ D  S P     F REV+ +    H+NL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
           L G   T   +++     +   +   L  L+  +      T  R A   A G+ YL  + 
Sbjct: 76  LYGVVLTPPMKMVT----ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK- 130
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--IRGTMGHIAPEYLST 256
             + IHRDL A N+LL       + DFGL + +     H   Q   +      APE L T
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 257 GKSSEKTDVFGYGITLLELVT-GQRAIDFSRXXXXXXXXXXXHIRKLLRE-DRLNDIVDR 314
              S  +D + +G+TL E+ T GQ                   + K+ +E +RL    D 
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEP--------WIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 315 NLNTYDSKEVETMVQVALLCTQSTPEDRP 343
             + Y+      MVQ    C    PEDRP
Sbjct: 241 PQDIYN-----VMVQ----CWAHKPEDRP 260

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 111/269 (41%), Gaps = 34/269 (12%)
Query: 85  IGQGGFGKVYKGVL----SDNTKVAVKRLQ-DYYS-PGGEAAFQREVHLISVAIHKNLLQ 138
           +G G FG V +G           VAVK L+ D  S P     F REV+ +    H+NL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
           L G   T   +++     +   +   L  L+  +      T  R A   A G+ YL  + 
Sbjct: 86  LYGVVLTPPMKMVT----ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK- 140
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--IRGTMGHIAPEYLST 256
             + IHRDL A N+LL       + DFGL + +     H   Q   +      APE L T
Sbjct: 141 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 198
Query: 257 GKSSEKTDVFGYGITLLELVT-GQRAIDFSRXXXXXXXXXXXHIRKLLRE-DRLNDIVDR 314
              S  +D + +G+TL E+ T GQ                   + K+ +E +RL    D 
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEPW--------IGLNGSQILHKIDKEGERLPRPEDC 250
Query: 315 NLNTYDSKEVETMVQVALLCTQSTPEDRP 343
             + Y+      MVQ    C    PEDRP
Sbjct: 251 PQDIYN-----VMVQ----CWAHKPEDRP 270

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 111/269 (41%), Gaps = 34/269 (12%)
Query: 85  IGQGGFGKVYKGVL----SDNTKVAVKRLQ-DYYS-PGGEAAFQREVHLISVAIHKNLLQ 138
           +G G FG V +G           VAVK L+ D  S P     F REV+ +    H+NL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
           L G   T   +++     +   +   L  L+  +      T  R A   A G+ YL  + 
Sbjct: 80  LYGVVLTPPMKMVT----ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK- 134
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--IRGTMGHIAPEYLST 256
             + IHRDL A N+LL       + DFGL + +     H   Q   +      APE L T
Sbjct: 135 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 257 GKSSEKTDVFGYGITLLELVT-GQRAIDFSRXXXXXXXXXXXHIRKLLRE-DRLNDIVDR 314
              S  +D + +G+TL E+ T GQ                   + K+ +E +RL    D 
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQEP--------WIGLNGSQILHKIDKEGERLPRPEDC 244
Query: 315 NLNTYDSKEVETMVQVALLCTQSTPEDRP 343
             + Y+      MVQ    C    PEDRP
Sbjct: 245 PQDIYN-----VMVQ----CWAHKPEDRP 264

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 90/201 (44%), Gaps = 15/201 (7%)
Query: 85  IGQGGFGKVYKGVL----SDNTKVAVKRLQ-DYYS-PGGEAAFQREVHLISVAIHKNLLQ 138
           +G G FG V +G           VAVK L+ D  S P     F REV+ +    H+NL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
           L G   T   + +V       S+  RLR  + G   L   T  R A   A G+ YL  + 
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQ-GHFLLG--TLSRYAVQVAEGMGYLESK- 134
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--IRGTMGHIAPEYLST 256
             + IHRDL A N+LL       + DFGL + +     H   Q   +      APE L T
Sbjct: 135 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 257 GKSSEKTDVFGYGITLLELVT 277
              S  +D + +G+TL E+ T
Sbjct: 193 RTFSHASDTWMFGVTLWEMFT 213

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 93/205 (45%), Gaps = 7/205 (3%)
Query: 78  NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ--DYYSPGGEAAFQREVHLISVAIHK 134
           NF     IG+G F +VY+   L D   VA+K++Q  D       A   +E+ L+    H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           N+++        +E  +V        ++  ++  K  ++ +   T  +        LE++
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 254
           H +   +++HRD+K AN+ +       L D GL +   +K T   + + GT  +++PE +
Sbjct: 153 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 208
Query: 255 STGKSSEKTDVFGYGITLLELVTGQ 279
                + K+D++  G  L E+   Q
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQ 233

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 79  FSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQR----EVHLISVAIH 133
           + + + +G+G F  VYK    + N  VA+K+++  +    +    R    E+ L+    H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 134 KNLLQLIGYCTTSSERILVYPFMQ-NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 192
            N++ L+      S   LV+ FM+ +L V  +   L      +     K     T  GLE
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHI-----KAYMLMTLQGLE 126
Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 252
           YLH+     I+HRDLK  N+LLD+N    L DFGLAK   +       Q+  T  + APE
Sbjct: 127 YLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV-TRWYRAPE 182
Query: 253 YLSTGKS-SEKTDVFGYGITLLELV 276
            L   +      D++  G  L EL+
Sbjct: 183 LLFGARMYGVGVDMWAVGCILAELL 207

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 111/269 (41%), Gaps = 34/269 (12%)
Query: 85  IGQGGFGKVYKGVL----SDNTKVAVKRLQ-DYYS-PGGEAAFQREVHLISVAIHKNLLQ 138
           +G G FG V +G           VAVK L+ D  S P     F REV+ +    H+NL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
           L G   T   +++     +   +   L  L+  +      T  R A   A G+ YL  + 
Sbjct: 86  LYGVVLTPPMKMVT----ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK- 140
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--IRGTMGHIAPEYLST 256
             + IHRDL A N+LL       + DFGL + +     H   Q   +      APE L T
Sbjct: 141 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 257 GKSSEKTDVFGYGITLLELVT-GQRAIDFSRXXXXXXXXXXXHIRKLLRE-DRLNDIVDR 314
              S  +D + +G+TL E+ T GQ                   + K+ +E +RL    D 
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEP--------WIGLNGSQILHKIDKEGERLPRPEDC 250
Query: 315 NLNTYDSKEVETMVQVALLCTQSTPEDRP 343
             + Y+      MVQ    C    PEDRP
Sbjct: 251 PQDIYN-----VMVQ----CWAHKPEDRP 270

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 93/221 (42%), Gaps = 42/221 (19%)
Query: 85  IGQGGFGKVYKGVLSDN-TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL------- 136
           +G GGFG V + +  D   +VA+K+ +   SP     +  E+ ++    H N+       
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 137 ------------LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVA 184
                       L  + YC     R  +  F +N         LK G      P R  ++
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF-ENCC------GLKEG------PIRTLLS 128
Query: 185 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL---CDFGLAKLVDAKLTHVTTQ 241
              +  L YLHE    +IIHRDLK  NI+L    + ++    D G AK +D     + T+
Sbjct: 129 -DISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTE 182
Query: 242 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 282
             GT+ ++APE L   K +   D + +G    E +TG R  
Sbjct: 183 FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 85/203 (41%), Gaps = 18/203 (8%)
Query: 79  FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQ---REVHLISVAIHKN 135
           FS+   IG G FG VY      N++V   +   Y        +Q   +EV  +    H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
            +Q  G         LV  +   L  A  L  L+  +K L       V  G   GL YLH
Sbjct: 77  TIQYRGCYLREHTAWLVMEYC--LGSASDL--LEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 196 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY-- 253
                 +IHRD+KA NILL +     L DFG A ++      V     GT   +APE   
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVIL 184
Query: 254 -LSTGKSSEKTDVFGYGITLLEL 275
            +  G+   K DV+  GIT +EL
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 93/221 (42%), Gaps = 42/221 (19%)
Query: 85  IGQGGFGKVYKGVLSDN-TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL------- 136
           +G GGFG V + +  D   +VA+K+ +   SP     +  E+ ++    H N+       
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 137 ------------LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVA 184
                       L  + YC     R  +  F +N         LK G      P R  ++
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF-ENCC------GLKEG------PIRTLLS 129
Query: 185 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL---CDFGLAKLVDAKLTHVTTQ 241
              +  L YLHE    +IIHRDLK  NI+L    + ++    D G AK +D     + T+
Sbjct: 130 -DISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTE 183
Query: 242 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI 282
             GT+ ++APE L   K +   D + +G    E +TG R  
Sbjct: 184 FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 85/203 (41%), Gaps = 18/203 (8%)
Query: 79  FSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQ---REVHLISVAIHKN 135
           FS+   IG G FG VY      N++V   +   Y        +Q   +EV  +    H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
            +Q  G         LV  +   L  A  L  L+  +K L       V  G   GL YLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYC--LGSASDL--LEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 196 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY-- 253
                 +IHRD+KA NILL +     L DFG A ++      V     GT   +APE   
Sbjct: 172 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVIL 223
Query: 254 -LSTGKSSEKTDVFGYGITLLEL 275
            +  G+   K DV+  GIT +EL
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIEL 246

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 130/304 (42%), Gaps = 37/304 (12%)
Query: 67  FSCRELQLATDNFSESNIIGQGGFGKVYK----GVLSDNTK--VAVKRLQDYYSPGGEAA 120
           +   + +   D  +    +G+G FG+V +    G+    T   VAVK L++  +     A
Sbjct: 17  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 76
Query: 121 FQREVH-LISVAIHKNLLQLIGYCTTSSERILV---YPFMQNLSVAYRLR--DLKPGEKG 174
              E+  LI +  H N++ L+G CT     ++V   +    NLS   R +  +  P  K 
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP-YKD 135
Query: 175 L--DWPTRKRV---AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 229
           L  D+ T + +   +F  A G+E+L  +   K IHRDL A NILL +     + DFGLA+
Sbjct: 136 LYKDFLTLEHLIXYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLAR 192
Query: 230 LVDAKLTHVTT-QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXX 288
            +     +V     R  +  +APE +     + ++DV+ +G+ L E+ +           
Sbjct: 193 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASP 246
Query: 289 XXXXXXXXXHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQV 348
                      R+L    R+          Y + E   M Q  L C    P  RP  +++
Sbjct: 247 YPGVKIDEEFXRRLKEGTRM------RAPDYTTPE---MYQTMLDCWHGEPSQRPTFSEL 297
Query: 349 VKML 352
           V+ L
Sbjct: 298 VEHL 301

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 97/196 (49%), Gaps = 11/196 (5%)
Query: 85  IGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLI 140
           IG+G FG V++G+     +    VA+K  ++  S      F +E   +    H ++++LI
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 141 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 200
           G  T +     V+  M+  ++      L+  +  LD  +    A+  +  L YL  +   
Sbjct: 75  GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--- 127
Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 260
           + +HRD+ A N+L+  N    L DFGL++ ++    +  ++ +  +  +APE ++  + +
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 261 EKTDVFGYGITLLELV 276
             +DV+ +G+ + E++
Sbjct: 188 SASDVWMFGVCMWEIL 203

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           +G G FGKVYK    +   +A  ++ +  S      +  E+ +++   H  +++L+G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 204
              +  ++  F    +V   + +L   ++GL  P  + V       L +LH +   +IIH
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIH 140
Query: 205 RDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL--STGKSSE- 261
           RDLKA N+L+    +  L DFG++   + K         GT   +APE +   T K +  
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPY 199
Query: 262 --KTDVFGYGITLLEL 275
             K D++  GITL+E+
Sbjct: 200 DYKADIWSLGITLIEM 215

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 110/235 (46%), Gaps = 30/235 (12%)
Query: 70  RELQLATDNFSESNIIGQGGFGKVYK----GVLSDNT--KVAVKRLQDYYSPGGEAAFQR 123
            + +   +N      +G G FGKV +    G+  ++   KVAVK L+       + A   
Sbjct: 24  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 83
Query: 124 EVHLIS-VAIHKNLLQLIGYCTTSSERILVYP---------FMQNLSVAYRLRDLKPGE- 172
           E+ ++S +  H+N++ L+G CT     +++           F++  + A     L PG+ 
Sbjct: 84  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQD 143
Query: 173 -KGLD------WPTRKRVAFGT--AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLC 223
            +GLD         R  + F +  A G+ +L  +     IHRD+ A N+LL +   A + 
Sbjct: 144 PEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIG 200
Query: 224 DFGLAK-LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
           DFGLA+ +++     V    R  +  +APE +     + ++DV+ YGI L E+ +
Sbjct: 201 DFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           +G G FGKVYK    +   +A  ++ +  S      +  E+ +++   H  +++L+G   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH 204
              +  ++  F    +V   + +L   ++GL  P  + V       L +LH +   +IIH
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIH 132
Query: 205 RDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL--STGKSSE- 261
           RDLKA N+L+    +  L DFG++   + K         GT   +APE +   T K +  
Sbjct: 133 RDLKAGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPY 191
Query: 262 --KTDVFGYGITLLEL 275
             K D++  GITL+E+
Sbjct: 192 DYKADIWSLGITLIEM 207

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 104/221 (47%), Gaps = 25/221 (11%)
Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGE--AAFQREVHL 127
           +E  +  +      +IG+G FG+VY G    + +VA+ RL D      +   AF+REV  
Sbjct: 26  QEWDIPFEQLEIGELIGKGRFGQVYHGRW--HGEVAI-RLIDIERDNEDQLKAFKREVMA 82
Query: 128 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 187
                H+N++  +G C +     ++    +  ++   +RD K     LD    +++A   
Sbjct: 83  YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEI 139
Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL---AKLVDAKLTHVTTQIR- 243
             G+ YLH +    I+H+DLK+ N+   DN + V+ DFGL   + ++ A       +I+ 
Sbjct: 140 VKGMGYLHAKG---ILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQN 195
Query: 244 GTMGHIAPEY---LSTGKSSEK------TDVFGYGITLLEL 275
           G + H+APE    LS     +K      +DVF  G    EL
Sbjct: 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 23/211 (10%)
Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAI 132
           D +   +++G G F +V   +L+++ +    VA+K +      G E + + E+ ++    
Sbjct: 18  DIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIK 74
Query: 133 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR--KRVAFGTAYG 190
           H N++ L     +     L+   +    +  R+      EKG  +  R   R+ F     
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-----EKGF-YTERDASRLIFQVLDA 128
Query: 191 LEYLHEQCNPKIIHRDLKAANIL---LDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 247
           ++YLH+     I+HRDLK  N+L   LD++ + ++ DFGL+K+ D     V +   GT G
Sbjct: 129 VKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPG 183
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           ++APE L+    S+  D +  G+    L+ G
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 23/211 (10%)
Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAI 132
           D +   +++G G F +V   +L+++ +    VA+K +      G E + + E+ ++    
Sbjct: 18  DIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIK 74
Query: 133 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR--KRVAFGTAYG 190
           H N++ L     +     L+   +    +  R+      EKG  +  R   R+ F     
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-----EKGF-YTERDASRLIFQVLDA 128
Query: 191 LEYLHEQCNPKIIHRDLKAANIL---LDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 247
           ++YLH+     I+HRDLK  N+L   LD++ + ++ DFGL+K+ D     V +   GT G
Sbjct: 129 VKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPG 183
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           ++APE L+    S+  D +  G+    L+ G
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 28/210 (13%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI--HKNLLQLIGY 142
           +G+G +G+V++G L     VAVK     +S   E ++ RE  + +  +  H N+L  I  
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVK----IFSSRDEQSWFRETEIYNTVLLRHDNILGFIAS 70
Query: 143 CTTS---SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH---- 195
             TS   S ++ +          Y     +  E  L      R+A   A GL +LH    
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHL----ALRLAVSAACGLAHLHVEIF 126
Query: 196 -EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD--AKLTHVTTQIR-GTMGHIAP 251
             Q  P I HRD K+ N+L+  N +  + D GLA +    +    +    R GT  ++AP
Sbjct: 127 GTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAP 186
Query: 252 EYLSTG------KSSEKTDVFGYGITLLEL 275
           E L         +S + TD++ +G+ L E+
Sbjct: 187 EVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 23/211 (10%)
Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAI 132
           D +   +++G G F +V   +L+++ +    VA+K +      G E + + E+ ++    
Sbjct: 18  DIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIK 74
Query: 133 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR--KRVAFGTAYG 190
           H N++ L     +     L+   +    +  R+      EKG  +  R   R+ F     
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-----EKGF-YTERDASRLIFQVLDA 128
Query: 191 LEYLHEQCNPKIIHRDLKAANIL---LDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 247
           ++YLH+     I+HRDLK  N+L   LD++ + ++ DFGL+K+ D     V +   GT G
Sbjct: 129 VKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPG 183
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           ++APE L+    S+  D +  G+    L+ G
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 37/215 (17%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKR-LQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           IGQG FG+V+K        KVA+K+ L +    G      RE+ ++ +  H+N++ LI  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 143 CTTSSERI--------LVYPF--------MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           C T +           LV+ F        + N+ V + L ++K            RV   
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIK------------RVMQM 133
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG-- 244
              GL Y+H     KI+HRD+KAAN+L+  +    L DFGLA+           +     
Sbjct: 134 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 245 -TMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVT 277
            T+ +  PE L   +      D++G G  + E+ T
Sbjct: 191 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI--HKNLLQLIGY 142
           IG+G FG+V++G      +VAVK     +S   E ++ RE  +    +  H+N+L  I  
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVK----IFSSREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 143 CT----TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH--- 195
                 T ++  LV  + ++ S+   L       +G+      ++A  TA GL +LH   
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEI 120
Query: 196 --EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR---GTMGHIA 250
              Q  P I HRDLK+ NIL+  N    + D GLA   D+    +        GT  ++A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 251 PEYLSTG------KSSEKTDVFGYGITLLEL 275
           PE L         +S ++ D++  G+   E+
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 37/215 (17%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKR-LQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           IGQG FG+V+K        KVA+K+ L +    G      RE+ ++ +  H+N++ LI  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 143 CTTSSERI--------LVYPF--------MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           C T +           LV+ F        + N+ V + L ++K            RV   
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK------------RVMQM 133
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG-- 244
              GL Y+H     KI+HRD+KAAN+L+  +    L DFGLA+           +     
Sbjct: 134 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 245 -TMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVT 277
            T+ +  PE L   +      D++G G  + E+ T
Sbjct: 191 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 37/215 (17%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKR-LQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           IGQG FG+V+K        KVA+K+ L +    G      RE+ ++ +  H+N++ LI  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 143 CTTSSERI--------LVYPF--------MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           C T +           LV+ F        + N+ V + L ++K            RV   
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK------------RVMQM 132
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG-- 244
              GL Y+H     KI+HRD+KAAN+L+  +    L DFGLA+           +     
Sbjct: 133 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 189
Query: 245 -TMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVT 277
            T+ +  PE L   +      D++G G  + E+ T
Sbjct: 190 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 37/215 (17%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKR-LQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           IGQG FG+V+K        KVA+K+ L +    G      RE+ ++ +  H+N++ LI  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 143 CTTSSERI--------LVYPF--------MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           C T +           LV+ F        + N+ V + L ++K            RV   
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK------------RVMQM 133
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG-- 244
              GL Y+H     KI+HRD+KAAN+L+  +    L DFGLA+           +     
Sbjct: 134 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 245 -TMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVT 277
            T+ +  PE L   +      D++G G  + E+ T
Sbjct: 191 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI--HKNLLQLIGY 142
           IG+G FG+V++G      +VAVK     +S   E ++ RE  +    +  H+N+L  I  
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVK----IFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 143 CT----TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH--- 195
                 T ++  LV  + ++ S+   L       +G+      ++A  TA GL +LH   
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEI 159
Query: 196 --EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR---GTMGHIA 250
              Q  P I HRDLK+ NIL+  N    + D GLA   D+    +        GT  ++A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 251 PEYLSTG------KSSEKTDVFGYGITLLEL 275
           PE L         +S ++ D++  G+   E+
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 23/211 (10%)
Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAI 132
           D +   +++G G F +V   +L+++ +    VA+K +      G E + + E+ ++    
Sbjct: 18  DIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 74
Query: 133 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR--KRVAFGTAYG 190
           H N++ L     +     L+   +    +  R+      EKG  +  R   R+ F     
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-----EKGF-YTERDASRLIFQVLDA 128
Query: 191 LEYLHEQCNPKIIHRDLKAANIL---LDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 247
           ++YLH+     I+HRDLK  N+L   LD++ + ++ DFGL+K+ D     V +   GT G
Sbjct: 129 VKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPG 183
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           ++APE L+    S+  D +  G+    L+ G
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI--HKNLLQLIGY 142
           IG+G FG+V++G      +VAVK     +S   E ++ RE  +    +  H+N+L  I  
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVK----IFSSREERSWFREAEIYQTVMLRHENILGFIAA 66
Query: 143 CT----TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH--- 195
                 T ++  LV  + ++ S+   L       +G+      ++A  TA GL +LH   
Sbjct: 67  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEI 121
Query: 196 --EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR---GTMGHIA 250
              Q  P I HRDLK+ NIL+  N    + D GLA   D+    +        GT  ++A
Sbjct: 122 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 181
Query: 251 PEYLSTG------KSSEKTDVFGYGITLLEL 275
           PE L         +S ++ D++  G+   E+
Sbjct: 182 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 113/259 (43%), Gaps = 11/259 (4%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQLIGY 142
           IG G +G+  K     + K+ V +  DY S     +     EV+L+    H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 143 CT--TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN- 199
               T++   +V  + +   +A  +       + LD     RV       L+  H + + 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 200 -PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 258
              ++HRDLK AN+ LD      L DFGLA++++   +   T + GT  +++PE ++   
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRMS 192
Query: 259 SSEKTDVFGYGITLLELVTGQRAID-FSRXXXXXXXXXXXHIRKLLR-EDRLNDIVDR-- 314
            +EK+D++  G  L EL         FS+             R   R  D LN+I+ R  
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRML 252
Query: 315 NLNTYDSKEVETMVQVALL 333
           NL  Y    VE +++  L+
Sbjct: 253 NLKDYHRPSVEEILENPLI 271

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 91/220 (41%), Gaps = 25/220 (11%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           +   D+F     +G+G FG VY      N  + A+K L        G E   +RE+ + S
Sbjct: 11  KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 70
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT-- 187
              H N+L++  Y        L+      L  A R    K  +K   +  ++   F    
Sbjct: 71  HLRHPNILRMYNYFHDRKRIYLM------LEFAPRGELYKELQKHGRFDEQRSATFMEEL 124
Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR---- 243
           A  L Y HE+   K+IHRD+K  N+L+    E  + DFG +        H  +  R    
Sbjct: 125 ADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMC 174
Query: 244 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
           GT+ ++ PE +      EK D++  G+   E + G    D
Sbjct: 175 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 102/213 (47%), Gaps = 11/213 (5%)
Query: 68  SCRELQLATDNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQR 123
           S R+ ++  +       IG+G FG V++G+     +    VA+K  ++  S      F +
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 124 EVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 183
           E   +    H ++++LIG  T +     V+  M+  ++      L+  +  LD  +    
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILY 116
Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 243
           A+  +  L YL  +   + +HRD+ A N+L+       L DFGL++ ++    +  ++ +
Sbjct: 117 AYQLSTALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGK 173
Query: 244 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELV 276
             +  +APE ++  + +  +DV+ +G+ + E++
Sbjct: 174 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI--HKNLLQLIGY 142
           IG+G FG+V++G      +VAVK     +S   E ++ RE  +    +  H+N+L  I  
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVK----IFSSREERSWFREAEIYQTVMLRHENILGFIAA 71
Query: 143 CT----TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH--- 195
                 T ++  LV  + ++ S+   L       +G+      ++A  TA GL +LH   
Sbjct: 72  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEI 126
Query: 196 --EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR---GTMGHIA 250
              Q  P I HRDLK+ NIL+  N    + D GLA   D+    +        GT  ++A
Sbjct: 127 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 186
Query: 251 PEYLSTG------KSSEKTDVFGYGITLLEL 275
           PE L         +S ++ D++  G+   E+
Sbjct: 187 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 108/229 (47%), Gaps = 27/229 (11%)
Query: 71  ELQLATDNFSESNIIGQGGFGKVYK----GVLSDNT--KVAVKRLQDYYSPGGEAAFQRE 124
           + +   +N      +G G FGKV +    G+  ++   KVAVK L+       + A   E
Sbjct: 40  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 125 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWP----- 178
           + ++S +  H+N++ L+G CT     +++  +     +   LR  +P   GL++      
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRP--PGLEYSYNPSH 157
Query: 179 -------TRKRVAFGT--AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK 229
                  +R  + F +  A G+ +L  +     IHRD+ A N+LL +   A + DFGLA+
Sbjct: 158 NPEEQLSSRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLAR 214
Query: 230 -LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
            +++     V    R  +  +APE +     + ++DV+ YGI L E+ +
Sbjct: 215 DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI--HKNLLQLIGY 142
           IG+G FG+V++G      +VAVK     +S   E ++ RE  +    +  H+N+L  I  
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVK----IFSSREERSWFREAEIYQTVMLRHENILGFIAA 91
Query: 143 CT----TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH--- 195
                 T ++  LV  + ++ S+   L       +G+      ++A  TA GL +LH   
Sbjct: 92  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEI 146
Query: 196 --EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR---GTMGHIA 250
              Q  P I HRDLK+ NIL+  N    + D GLA   D+    +        GT  ++A
Sbjct: 147 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 206
Query: 251 PEYLSTG------KSSEKTDVFGYGITLLEL 275
           PE L         +S ++ D++  G+   E+
Sbjct: 207 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI--HKNLLQLIGY 142
           IG+G FG+V++G      +VAVK     +S   E ++ RE  +    +  H+N+L  I  
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVK----IFSSREERSWFREAEIYQTVMLRHENILGFIAA 68
Query: 143 CT----TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH--- 195
                 T ++  LV  + ++ S+   L       +G+      ++A  TA GL +LH   
Sbjct: 69  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEI 123
Query: 196 --EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR---GTMGHIA 250
              Q  P I HRDLK+ NIL+  N    + D GLA   D+    +        GT  ++A
Sbjct: 124 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 183
Query: 251 PEYLSTG------KSSEKTDVFGYGITLLEL 275
           PE L         +S ++ D++  G+   E+
Sbjct: 184 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 105/223 (47%), Gaps = 19/223 (8%)
Query: 70  RELQLATDNFSESNIIGQGGFGKVYK----GVLSDNT--KVAVKRLQDYYSPGGEAAFQR 123
            + +   +N      +G G FGKV +    G+  ++   KVAVK L+       + A   
Sbjct: 31  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 90
Query: 124 EVHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLR-----DLKPGEKGLDW 177
           E+ ++S +  H+N++ L+G CT     +++  +     +   LR     DL   E G   
Sbjct: 91  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDK-EDGRPL 149
Query: 178 PTRKRVAFGT--AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAK 234
             R  + F +  A G+ +L  +     IHRD+ A N+LL +   A + DFGLA+ +++  
Sbjct: 150 ELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 206
Query: 235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
              V    R  +  +APE +     + ++DV+ YGI L E+ +
Sbjct: 207 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 91/220 (41%), Gaps = 25/220 (11%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
           +   D+F     +G+G FG VY      N  + A+K L        G E   +RE+ + S
Sbjct: 10  KFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--GT 187
              H N+L++  Y        L+      L  A R    K  +K   +  ++   F    
Sbjct: 70  HLRHPNILRMYNYFHDRKRIYLM------LEFAPRGELYKELQKHGRFDEQRSATFMEEL 123
Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR---- 243
           A  L Y HE+   K+IHRD+K  N+L+    E  + DFG +        H  +  R    
Sbjct: 124 ADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMC 173
Query: 244 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
           GT+ ++ PE +      EK D++  G+   E + G    D
Sbjct: 174 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 85  IGQGGFGKVYKGVLSDNTK-VAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           IG+G +G V+K    +  + VA+KR++ D    G  ++  RE+ L+    HKN+++L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 143 CTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 201
             +  +  LV+ F  Q+L   +   D   G+  LD    K   F    GL + H +    
Sbjct: 70  LHSDKKLTLVFEFCDQDLKKYF---DSCNGD--LDPEIVKSFLFQLLKGLGFCHSR---N 121
Query: 202 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK-SS 260
           ++HRDLK  N+L++ N E  L DFGLA+     +   + ++  T+ +  P+ L   K  S
Sbjct: 122 VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYS 180
Query: 261 EKTDVFGYGITLLELVTGQRAI 282
              D++  G    EL    R +
Sbjct: 181 TSIDMWSAGCIFAELANAARPL 202

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 79  FSESNIIGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           ++  + IG+G +G V   Y  V  +  +VA+K++  +          RE+ ++    H+N
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHEN 84
Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY------ 189
           ++ +          I+  P ++ +   Y ++DL   +      T+        Y      
Sbjct: 85  IIGI--------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 136
Query: 190 -GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTM 246
            GL+Y+H      ++HRDLK +N+LL+   +  +CDFGLA++ D    H    T+   T 
Sbjct: 137 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 247 GHIAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
            + APE +   K   K+ D++  G  L E+++ +
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 105/222 (47%), Gaps = 19/222 (8%)
Query: 71  ELQLATDNFSESNIIGQGGFGKVYK----GVLSDNT--KVAVKRLQDYYSPGGEAAFQRE 124
           + +   +N      +G G FGKV +    G+  ++   KVAVK L+       + A   E
Sbjct: 40  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 125 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLR-----DLKPGEKGLDWP 178
           + ++S +  H+N++ L+G CT     +++  +     +   LR     DL   E G    
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDK-EDGRPLE 158
Query: 179 TRKRVAFGT--AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKL 235
            R  + F +  A G+ +L  +     IHRD+ A N+LL +   A + DFGLA+ +++   
Sbjct: 159 LRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 215
Query: 236 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
             V    R  +  +APE +     + ++DV+ YGI L E+ +
Sbjct: 216 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 102/213 (47%), Gaps = 11/213 (5%)
Query: 68  SCRELQLATDNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQR 123
           S R+ ++  +       IG+G FG V++G+     +    VA+K  ++  S      F +
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 440
Query: 124 EVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 183
           E   +    H ++++LIG  T +     V+  M+  ++      L+  +  LD  +    
Sbjct: 441 EALTMRQFDHPHIVKLIGVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILY 496
Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 243
           A+  +  L YL  +   + +HRD+ A N+L+       L DFGL++ ++    +  ++ +
Sbjct: 497 AYQLSTALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGK 553
Query: 244 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELV 276
             +  +APE ++  + +  +DV+ +G+ + E++
Sbjct: 554 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G+G +G+V   V       VAVK +    +       ++E+ +  +  H+N+++  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH- 73
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  + Y F++  S       ++P + G+  P  +R       G+ YLH      I 
Sbjct: 74  --RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVD-AKLTHVTTQIRGTMGHIAPEYLSTGK-SSE 261
           HRD+K  N+LLD+     + DFGLA +        +  ++ GT+ ++APE L   +  +E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 187
Query: 262 KTDVFGYGITLLELVTGQRAID 283
             DV+  GI L  ++ G+   D
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWD 209

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 114/262 (43%), Gaps = 27/262 (10%)
Query: 38  QKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKV---- 93
           + + +++  V  ++ G +   +  TQL      + +   +  S    +G G FGKV    
Sbjct: 2   KPMYEVQWKVVEEINGNNXVXIDPTQLPY--DHKWEFPRNRLSFGKTLGAGAFGKVVEAT 59
Query: 94  -YKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLLQLIGYCTTSSERI 150
            Y  + SD    VAVK L+         A   E+ ++S +  H N++ L+G CT     +
Sbjct: 60  AYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 119
Query: 151 LVYPFM---QNLSVAYRLRD-----------LKPGEKGLDWPTRKRVAFGTAYGLEYLHE 196
           ++  +      L+   R RD           ++  E  LD       ++  A G+ +L  
Sbjct: 120 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS 179
Query: 197 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QIRGTMGHIAPEYLS 255
           +     IHRDL A NILL       +CDFGLA+ +     +V     R  +  +APE + 
Sbjct: 180 K---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF 236
Query: 256 TGKSSEKTDVFGYGITLLELVT 277
               + ++DV+ YGI L EL +
Sbjct: 237 NCVYTFESDVWSYGIFLWELFS 258

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G+G +G+V   V       VAVK +    +       ++E+ +  +  H+N+++  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH- 72
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  + Y F++  S       ++P + G+  P  +R       G+ YLH      I 
Sbjct: 73  --RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVD-AKLTHVTTQIRGTMGHIAPEYLSTGK-SSE 261
           HRD+K  N+LLD+     + DFGLA +        +  ++ GT+ ++APE L   +  +E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 262 KTDVFGYGITLLELVTGQRAID 283
             DV+  GI L  ++ G+   D
Sbjct: 187 PVDVWSCGIVLTAMLAGELPWD 208

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 20/223 (8%)
Query: 68  SCRELQLATDNFSESNIIGQGGFGKVY--KGVLSDNTKVAVKRL-QDYYSPGGEAAFQRE 124
           SC + Q    N+     IG+G F KV   + +L+   +VA+K + +   +P       RE
Sbjct: 6   SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFRE 64
Query: 125 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV-AYRLRDLKPGEKGLDWPTRKRV 183
           V ++ +  H N+++L     T     L+  +     V  Y +   +  EK      R+ V
Sbjct: 65  VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV 124
Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQ 241
           +      ++Y H++   +I+HRDLKA N+LLD +    + DFG +    V  KL      
Sbjct: 125 S-----AVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC-- 174
Query: 242 IRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAID 283
             G   + APE     K    + DV+  G+ L  LV+G    D
Sbjct: 175 --GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 79  FSESNIIGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           ++  + IG+G +G V   Y  V  +  +VA+K++  +          RE+ ++    H+N
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHEN 84
Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY------ 189
           ++ +          I+  P ++ +   Y ++DL   +      T+        Y      
Sbjct: 85  IIGI--------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 136
Query: 190 -GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTM 246
            GL+Y+H      ++HRDLK +N+LL+   +  +CDFGLA++ D    H    T+   T 
Sbjct: 137 RGLKYIHSA---NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 247 GHIAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
            + APE +   K   K+ D++  G  L E+++ +
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 17/207 (8%)
Query: 83  NIIGQGGFGKVYKGVLS-DNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           + +G G FGKV  G       KVAVK L  Q   S       +RE+  + +  H ++++L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
               +T S+  +V  ++        L D       LD    +R+      G++Y H    
Sbjct: 82  YQVISTPSDIFMVMEYVS----GGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM- 136
Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHIAPEYLSTGK 258
             ++HRDLK  N+LLD +  A + DFGL+ ++ D +    +    G+  + APE +S G+
Sbjct: 137 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC---GSPNYAAPEVIS-GR 190
Query: 259 --SSEKTDVFGYGITLLELVTGQRAID 283
             +  + D++  G+ L  L+ G    D
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 116/267 (43%), Gaps = 31/267 (11%)
Query: 37  YQKLRKLKHDVFFDVA----GEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGK 92
           Y+ L+K  ++V + V     G +   +  TQL      + +   +  S    +G G FGK
Sbjct: 4   YKYLQKPMYEVQWKVVEEINGNNYVYIDPTQLPY--DHKWEFPRNRLSFGKTLGAGAFGK 61
Query: 93  V-----YKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLLQLIGYCTT 145
           V     Y  + SD    VAVK L+         A   E+ ++S +  H N++ L+G CT 
Sbjct: 62  VVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 121
Query: 146 SSERILVYPFM---QNLSVAYRLRD-----------LKPGEKGLDWPTRKRVAFGTAYGL 191
               +++  +      L+   R RD           ++  E  LD       ++  A G+
Sbjct: 122 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM 181
Query: 192 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QIRGTMGHIA 250
            +L  +     IHRDL A NILL       +CDFGLA+ +     +V     R  +  +A
Sbjct: 182 AFLASK---NCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMA 238
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVT 277
           PE +     + ++DV+ YGI L EL +
Sbjct: 239 PESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G+G +G+V   V       VAVK +    +       ++E+ +  +  H+N+++  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 72
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  + Y F++  S       ++P + G+  P  +R       G+ YLH      I 
Sbjct: 73  --RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVD-AKLTHVTTQIRGTMGHIAPEYLSTGK-SSE 261
           HRD+K  N+LLD+     + DFGLA +        +  ++ GT+ ++APE L   +  +E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 262 KTDVFGYGITLLELVTGQRAID 283
             DV+  GI L  ++ G+   D
Sbjct: 187 PVDVWSCGIVLTAMLAGELPWD 208

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 98/212 (46%), Gaps = 22/212 (10%)
Query: 79  FSESNIIGQGGFGKVYKGVLSDN-TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
           ++  + IG+G +G V     + N  +VA+K++  +          RE+ ++    H+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY-------G 190
            +          I+  P ++ +   Y ++DL   +      T+        Y       G
Sbjct: 89  GI--------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 140
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMGH 248
           L+Y+H      ++HRDLK +N+LL+   +  +CDFGLA++ D    H    T+   T  +
Sbjct: 141 LKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 249 IAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
            APE +   K   K+ D++  G  L E+++ +
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 100/218 (45%), Gaps = 29/218 (13%)
Query: 76  TDNFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHK 134
           + +F   +++G+G +G V         + VA+K+++ +  P       RE+ ++    H+
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR-------KRVAFGT 187
           N++ +       S         +N +  Y +++L   +      T+       +   + T
Sbjct: 70  NIITIFNIQRPDS--------FENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT 121
Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD---AKLTHVTTQIRG 244
              ++ LH      +IHRDLK +N+L++ N +  +CDFGLA+++D   A  +  T Q  G
Sbjct: 122 LRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 245 TMGHI------APE-YLSTGKSSEKTDVFGYGITLLEL 275
              ++      APE  L++ K S   DV+  G  L EL
Sbjct: 179 MTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 85  IGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAIHKN----LLQL 139
           +G G  G+V+K        V AVK+++     G +   +R +  + V +  +    ++Q 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMR---RSGNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR--KRVAFGTAYGLEYLHEQ 197
            G   T+++  +    M   +   + R   P       P R   ++       L YL E+
Sbjct: 90  FGTFITNTDVFIAMELMGTCAEKLKKRMQGP------IPERILGKMTVAIVKALYYLKEK 143
Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYLST 256
               +IHRD+K +NILLD+  +  LCDFG++ +LVD K    +    G   ++APE +  
Sbjct: 144 HG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA---GCAAYMAPERIDP 198
Query: 257 GKSSE-----KTDVFGYGITLLELVTGQ 279
              ++     + DV+  GI+L+EL TGQ
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G+G +G+V   V       VAVK +    +       ++E+ +  +  H+N+++  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 72
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  + Y F++  S       ++P + G+  P  +R       G+ YLH      I 
Sbjct: 73  --RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVD-AKLTHVTTQIRGTMGHIAPEYLSTGK-SSE 261
           HRD+K  N+LLD+     + DFGLA +        +  ++ GT+ ++APE L   +  +E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 262 KTDVFGYGITLLELVTGQRAID 283
             DV+  GI L  ++ G+   D
Sbjct: 187 PVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 79  FSESNIIGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           ++  + IG+G +G V   Y  V  +  +VA+K++  +          RE+ ++    H+N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY------ 189
           ++ +          I+  P ++ +   Y ++DL   +      T+        Y      
Sbjct: 83  IIGI--------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 134
Query: 190 -GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTM 246
            GL+Y+H      ++HRDLK +N+LL+   +  +CDFGLA++ D    H    T+   T 
Sbjct: 135 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 247 GHIAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
            + APE +   K   K+ D++  G  L E+++ +
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 79  FSESNIIGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           ++  + IG+G +G V   Y  V  +  +VA+K++  +          RE+ ++    H+N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY------ 189
           ++ +          I+  P ++ +   Y ++DL   +      T+        Y      
Sbjct: 83  IIGI--------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 134
Query: 190 -GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTM 246
            GL+Y+H      ++HRDLK +N+LL+   +  +CDFGLA++ D    H    T+   T 
Sbjct: 135 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 247 GHIAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
            + APE +   K   K+ D++  G  L E+++ +
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 10/202 (4%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G+G +G+V   V       VAVK +    +       ++E+ + ++  H+N+++  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGH- 73
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  + Y F++  S       ++P + G+  P  +R       G+ YLH      I 
Sbjct: 74  --RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVD-AKLTHVTTQIRGTMGHIAPEYLSTGK-SSE 261
           HRD+K  N+LLD+     + DFGLA +        +  ++ GT+ ++APE L   +  +E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 262 KTDVFGYGITLLELVTGQRAID 283
             DV+  GI L  ++ G+   D
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWD 209

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 100/218 (45%), Gaps = 29/218 (13%)
Query: 76  TDNFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHK 134
           + +F   +++G+G +G V         + VA+K+++ +  P       RE+ ++    H+
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR-------KRVAFGT 187
           N++ +       S         +N +  Y +++L   +      T+       +   + T
Sbjct: 70  NIITIFNIQRPDS--------FENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT 121
Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD---AKLTHVTTQIRG 244
              ++ LH      +IHRDLK +N+L++ N +  +CDFGLA+++D   A  +  T Q  G
Sbjct: 122 LRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 245 ------TMGHIAPE-YLSTGKSSEKTDVFGYGITLLEL 275
                 T  + APE  L++ K S   DV+  G  L EL
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 116/267 (43%), Gaps = 31/267 (11%)
Query: 37  YQKLRKLKHDVFFDVA----GEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGK 92
           Y+ L+K  ++V + V     G +   +  TQL      + +   +  S    +G G FGK
Sbjct: 4   YKYLQKPMYEVQWKVVEEINGNNYVYIDPTQLPY--DHKWEFPRNRLSFGKTLGAGAFGK 61
Query: 93  V-----YKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLLQLIGYCTT 145
           V     Y  + SD    VAVK L+         A   E+ ++S +  H N++ L+G CT 
Sbjct: 62  VVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 121
Query: 146 SSERILVYPFM---QNLSVAYRLRD-----------LKPGEKGLDWPTRKRVAFGTAYGL 191
               +++  +      L+   R RD           ++  E  LD       ++  A G+
Sbjct: 122 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM 181
Query: 192 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QIRGTMGHIA 250
            +L  +     IHRDL A NILL       +CDFGLA+ +     +V     R  +  +A
Sbjct: 182 AFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMA 238
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVT 277
           PE +     + ++DV+ YGI L EL +
Sbjct: 239 PESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 79  FSESNIIGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           ++  + IG+G +G V   Y  V  +  +VA+K++  +          RE+ ++    H+N
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 84
Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY------ 189
           ++ +          I+  P ++ +   Y ++DL   +      T+        Y      
Sbjct: 85  IIGI--------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 136
Query: 190 -GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTM 246
            GL+Y+H      ++HRDLK +N+LL+   +  +CDFGLA++ D    H    T+   T 
Sbjct: 137 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 247 GHIAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
            + APE +   K   K+ D++  G  L E+++ +
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 111/259 (42%), Gaps = 11/259 (4%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQLIGY 142
           IG G +G+  K     + K+ V +  DY S     +     EV+L+    H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 143 CT--TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN- 199
               T++   +V  + +   +A  +       + LD     RV       L+  H + + 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 200 -PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 258
              ++HRDLK AN+ LD      L DFGLA++++   T       GT  +++PE ++   
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMSPEQMNRMS 192
Query: 259 SSEKTDVFGYGITLLELVTGQRAID-FSRXXXXXXXXXXXHIRKLLR-EDRLNDIVDR-- 314
            +EK+D++  G  L EL         FS+             R   R  D LN+I+ R  
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRML 252
Query: 315 NLNTYDSKEVETMVQVALL 333
           NL  Y    VE +++  L+
Sbjct: 253 NLKDYHRPSVEEILENPLI 271

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 88/214 (41%), Gaps = 19/214 (8%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQ-------REVH 126
           +AT  +     IG G +G VYK    D        L+    P G            REV 
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVA 63
Query: 127 LI---SVAIHKNLLQLIGYCTTS--SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK 181
           L+       H N+++L+  C TS     I V    +++    R    K    GL   T K
Sbjct: 64  LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK 123
Query: 182 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 241
            +      GL++LH  C   I+HRDLK  NIL+       L DFGLA++   ++    T 
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTP 178
Query: 242 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLEL 275
           +  T+ + APE L     +   D++  G    E+
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 79  FSESNIIGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           ++  + IG+G +G V   Y  V  +  +VA+K++  +          RE+ ++    H+N
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 90
Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY------ 189
           ++ +          I+  P ++ +   Y ++DL   +      T+        Y      
Sbjct: 91  IIGI--------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 142
Query: 190 -GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTM 246
            GL+Y+H      ++HRDLK +N+LL+   +  +CDFGLA++ D    H    T+   T 
Sbjct: 143 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 199
Query: 247 GHIAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
            + APE +   K   K+ D++  G  L E+++ +
Sbjct: 200 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 79  FSESNIIGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           ++  + IG+G +G V   Y  V  +  +VA+K++  +          RE+ ++    H+N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY------ 189
           ++ +          I+  P ++ +   Y ++DL   +      T+        Y      
Sbjct: 83  IIGI--------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 134
Query: 190 -GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTM 246
            GL+Y+H      ++HRDLK +N+LL+   +  +CDFGLA++ D    H    T+   T 
Sbjct: 135 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 247 GHIAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
            + APE +   K   K+ D++  G  L E+++ +
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 100/218 (45%), Gaps = 29/218 (13%)
Query: 76  TDNFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHK 134
           + +F   +++G+G +G V         + VA+K+++ +  P       RE+ ++    H+
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR-------KRVAFGT 187
           N++ +       S         +N +  Y +++L   +      T+       +   + T
Sbjct: 70  NIITIFNIQRPDS--------FENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT 121
Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD---AKLTHVTTQIRG 244
              ++ LH      +IHRDLK +N+L++ N +  +CDFGLA+++D   A  +  T Q  G
Sbjct: 122 LRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 245 ------TMGHIAPE-YLSTGKSSEKTDVFGYGITLLEL 275
                 T  + APE  L++ K S   DV+  G  L EL
Sbjct: 179 MTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 108/237 (45%), Gaps = 45/237 (18%)
Query: 72  LQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISV 130
           L+ A+D F E  ++GQG FG+V K   + D+   A+K+++  ++    +    EV L++ 
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKLSTILSEVMLLAS 58
Query: 131 AIHKNLLQLIGYCTTSSERILVYP----------FMQNLSVAYR-LRDLKPGEKGLDWPT 179
             H+ +++   Y      R  V P          F+Q      R L DL   E       
Sbjct: 59  LNHQYVVRY--YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSEN----LN 112
Query: 180 RKRVAFGTAY-----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 234
           ++R  +   +      L Y+H Q    IIHRDLK  NI +D++    + DFGLAK V   
Sbjct: 113 QQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 235 L--------------THVTTQIRGTMGHIAPEYLS-TGKSSEKTDVFGYGITLLELV 276
           L               ++T+ I GT  ++A E L  TG  +EK D++  GI   E++
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 21/201 (10%)
Query: 85  IGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G+G +G VYK +  +  + VA+K++        E+  Q  +  IS+    +   ++ Y 
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVP------VESDLQEIIKEISIMQQCDSPHVVKYY 90
Query: 144 TTSSERILVYPFMQ-----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
            +  +   ++  M+     ++S   RLR+     K L       +   T  GLEYLH   
Sbjct: 91  GSYFKNTDLWIVMEYCGAGSVSDIIRLRN-----KTLTEDEIATILQSTLKGLEYLHFM- 144
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 258
             + IHRD+KA NILL+    A L DFG+A  +   +      I GT   +APE +    
Sbjct: 145 --RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVI-GTPFWMAPEVIQEIG 201
Query: 259 SSEKTDVFGYGITLLELVTGQ 279
            +   D++  GIT +E+  G+
Sbjct: 202 YNCVADIWSLGITAIEMAEGK 222

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G+G +G+V   V       VAVK +    +       ++E+ +  +  H+N+++  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH- 72
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  + Y F++  S       ++P + G+  P  +R       G+ YLH      I 
Sbjct: 73  --RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVD-AKLTHVTTQIRGTMGHIAPEYLSTGK-SSE 261
           HRD+K  N+LLD+     + DFGLA +        +  ++ GT+ ++APE L   +  +E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 262 KTDVFGYGITLLELVTGQRAID 283
             DV+  GI L  ++ G+   D
Sbjct: 187 PVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 72/156 (46%), Gaps = 23/156 (14%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L+YL  Q   +IIHRD+K  NILLD++    + DF +A ++  + T +TT + GT  ++
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITT-MAGTKPYM 181
Query: 250 APEYLSTGKS---SEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKLLRED 306
           APE  S+ K    S   D +  G+T  EL+ G+R                 HIR      
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY---------------HIRSSTSSK 226
Query: 307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDR 342
            +    +  + TY S   + MV +     +  P+ R
Sbjct: 227 EIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQR 262

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 79  FSESNIIGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           ++  + IG+G +G V   Y  V  +  +VA+K++  +          RE+ ++    H+N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY------ 189
           ++ +          I+  P ++ +   Y ++DL   +      T+        Y      
Sbjct: 83  IIGI--------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 134
Query: 190 -GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTM 246
            GL+Y+H      ++HRDLK +N+LL+   +  +CDFGLA++ D    H    T+   T 
Sbjct: 135 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 247 GHIAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
            + APE +   K   K+ D++  G  L E+++ +
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G+G +G+V   V       VAVK +    +       ++E+ +  +  H+N+++  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  + Y F++  S       ++P + G+  P  +R       G+ YLH      I 
Sbjct: 74  --RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVD-AKLTHVTTQIRGTMGHIAPEYLSTGK-SSE 261
           HRD+K  N+LLD+     + DFGLA +        +  ++ GT+ ++APE L   +  +E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 262 KTDVFGYGITLLELVTGQRAID 283
             DV+  GI L  ++ G+   D
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWD 209

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 79  FSESNIIGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           ++  + IG+G +G V   Y  V  +  +VA+K++  +          RE+ ++    H+N
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 102
Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY------ 189
           ++ +          I+  P ++ +   Y ++DL   +      T+        Y      
Sbjct: 103 IIGI--------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 154
Query: 190 -GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTM 246
            GL+Y+H      ++HRDLK +N+LL+   +  +CDFGLA++ D    H    T+   T 
Sbjct: 155 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 247 GHIAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
            + APE +   K   K+ D++  G  L E+++ +
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G+G +G+V   V       VAVK +    +       ++E+ +  +  H+N+++  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 72
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  + Y F++  S       ++P + G+  P  +R       G+ YLH      I 
Sbjct: 73  --RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVD-AKLTHVTTQIRGTMGHIAPEYLSTGK-SSE 261
           HRD+K  N+LLD+     + DFGLA +        +  ++ GT+ ++APE L   +  +E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 262 KTDVFGYGITLLELVTGQRAID 283
             DV+  GI L  ++ G+   D
Sbjct: 187 PVDVWSCGIVLTAMLAGELPWD 208

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G+G +G+V   V       VAVK +    +       ++E+ +  +  H+N+++  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 72
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  + Y F++  S       ++P + G+  P  +R       G+ YLH      I 
Sbjct: 73  --RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVD-AKLTHVTTQIRGTMGHIAPEYLSTGK-SSE 261
           HRD+K  N+LLD+     + DFGLA +        +  ++ GT+ ++APE L   +  +E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 262 KTDVFGYGITLLELVTGQRAID 283
             DV+  GI L  ++ G+   D
Sbjct: 187 PVDVWSCGIVLTAMLAGELPWD 208

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G+G +G+V   V       VAVK +    +       ++E+ +  +  H+N+++  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 72
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  + Y F++  S       ++P + G+  P  +R       G+ YLH      I 
Sbjct: 73  --RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVD-AKLTHVTTQIRGTMGHIAPEYLSTGK-SSE 261
           HRD+K  N+LLD+     + DFGLA +        +  ++ GT+ ++APE L   +  +E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 262 KTDVFGYGITLLELVTGQRAID 283
             DV+  GI L  ++ G+   D
Sbjct: 187 PVDVWSCGIVLTAMLAGELPWD 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G+G +G+V   V       VAVK +    +       ++E+ +  +  H+N+++  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 72
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  + Y F++  S       ++P + G+  P  +R       G+ YLH      I 
Sbjct: 73  --RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVD-AKLTHVTTQIRGTMGHIAPEYLSTGK-SSE 261
           HRD+K  N+LLD+     + DFGLA +        +  ++ GT+ ++APE L   +  +E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 262 KTDVFGYGITLLELVTGQRAID 283
             DV+  GI L  ++ G+   D
Sbjct: 187 PVDVWSCGIVLTAMLAGELPWD 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G+G +G+V   V       VAVK +    +       ++E+ +  +  H+N+++  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  + Y F++  S       ++P + G+  P  +R       G+ YLH      I 
Sbjct: 74  --RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVD-AKLTHVTTQIRGTMGHIAPEYLSTGK-SSE 261
           HRD+K  N+LLD+     + DFGLA +        +  ++ GT+ ++APE L   +  +E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 262 KTDVFGYGITLLELVTGQRAID 283
             DV+  GI L  ++ G+   D
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWD 209

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 106/225 (47%), Gaps = 21/225 (9%)
Query: 71  ELQLATDNFSESNIIGQGGFGKVYK----GVLSDNT--KVAVKRLQDYYSPGGEAAFQRE 124
           + +   +N      +G G FGKV +    G+  ++   KVAVK L+       + A   E
Sbjct: 40  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 125 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPF------MQNLSVAYRLRDLKPGEKGLD- 176
           + ++S +  H+N++ L+G CT     +++  +      +  L    R+ +  P     + 
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 177 -WPTRKRVAFGT--AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVD 232
              TR  + F +  A G+ +L  +     IHRD+ A N+LL +   A + DFGLA+ +++
Sbjct: 160 TLSTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
                V    R  +  +APE +     + ++DV+ YGI L E+ +
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G+G +G+V   V       VAVK +    +       ++E+ +  +  H+N+++  G+ 
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 71
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  + Y F++  S       ++P + G+  P  +R       G+ YLH      I 
Sbjct: 72  --RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 125
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVD-AKLTHVTTQIRGTMGHIAPEYLSTGK-SSE 261
           HRD+K  N+LLD+     + DFGLA +        +  ++ GT+ ++APE L   +  +E
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185
Query: 262 KTDVFGYGITLLELVTGQRAID 283
             DV+  GI L  ++ G+   D
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWD 207

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G+G +G+V   V       VAVK +    +       ++E+ +  +  H+N+++  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 72
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  + Y F++  S       ++P + G+  P  +R       G+ YLH      I 
Sbjct: 73  --RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVD-AKLTHVTTQIRGTMGHIAPEYLSTGK-SSE 261
           HRD+K  N+LLD+     + DFGLA +        +  ++ GT+ ++APE L   +  +E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 262 KTDVFGYGITLLELVTGQRAID 283
             DV+  GI L  ++ G+   D
Sbjct: 187 PVDVWSCGIVLTAMLAGELPWD 208

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 37/233 (15%)
Query: 72  LQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISV 130
           L+ A+D F E  ++GQG FG+V K   + D+   A+K+++  ++    +    EV L++ 
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKLSTILSEVMLLAS 58
Query: 131 AIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWP-------TRKRV 183
             H+ +++   Y      R  V P       +     ++  E G  +         ++R 
Sbjct: 59  LNHQYVVRY--YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116
Query: 184 AFGTAY-----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL--- 235
            +   +      L Y+H Q    IIHRDLK  NI +D++    + DFGLAK V   L   
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 236 -----------THVTTQIRGTMGHIAPEYL-STGKSSEKTDVFGYGITLLELV 276
                       ++T+ I GT  ++A E L  TG  +EK D++  GI   E++
Sbjct: 174 KLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 114/262 (43%), Gaps = 27/262 (10%)
Query: 38  QKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKV---- 93
           + + +++  V  ++ G +   +  TQL      + +   +  S    +G G FGKV    
Sbjct: 4   KPMYEVQWKVVEEINGNNYVYIDPTQLPY--DHKWEFPRNRLSFGKTLGAGAFGKVVEAT 61
Query: 94  -YKGVLSDNT-KVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLLQLIGYCTTSSERI 150
            Y  + SD    VAVK L+         A   E+ ++S +  H N++ L+G CT     +
Sbjct: 62  AYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 121
Query: 151 LVYPFM---QNLSVAYRLRD-----------LKPGEKGLDWPTRKRVAFGTAYGLEYLHE 196
           ++  +      L+   R RD           ++  E  LD       ++  A G+ +L  
Sbjct: 122 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS 181
Query: 197 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QIRGTMGHIAPEYLS 255
           +     IHRDL A NILL       +CDFGLA+ +     +V     R  +  +APE + 
Sbjct: 182 K---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF 238
Query: 256 TGKSSEKTDVFGYGITLLELVT 277
               + ++DV+ YGI L EL +
Sbjct: 239 NCVYTFESDVWSYGIFLWELFS 260

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 98/212 (46%), Gaps = 22/212 (10%)
Query: 79  FSESNIIGQGGFGKVYKGVLSDN-TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
           ++  + IG+G +G V     + N  +VA+K++  +          RE+ ++    H+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY-------G 190
            +          I+  P ++ +   Y ++DL   +      T+        Y       G
Sbjct: 89  GI--------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 140
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMGH 248
           L+Y+H      ++HRDLK +N+LL+   +  +CDFGLA++ D    H    T+   T  +
Sbjct: 141 LKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 249 IAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
            APE +   K   K+ D++  G  L E+++ +
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G+G +G+V   V       VAVK +    +       ++E+ +  +  H+N+++  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 72
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  + Y F++  S       ++P + G+  P  +R       G+ YLH      I 
Sbjct: 73  --RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVD-AKLTHVTTQIRGTMGHIAPEYLSTGK-SSE 261
           HRD+K  N+LLD+     + DFGLA +        +  ++ GT+ ++APE L   +  +E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 262 KTDVFGYGITLLELVTGQRAID 283
             DV+  GI L  ++ G+   D
Sbjct: 187 PVDVWSCGIVLTAMLAGELPWD 208

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 77/166 (46%), Gaps = 16/166 (9%)
Query: 120 AFQREVHLI-SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWP 178
           A +RE H++  VA H +++ LI    +SS   LV+  M+       L D    +  L   
Sbjct: 145 ATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRK----GELFDYLTEKVALSEK 200
Query: 179 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 238
             + +       + +LH      I+HRDLK  NILLDDN +  L DFG +  ++      
Sbjct: 201 ETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP--GEK 255
Query: 239 TTQIRGTMGHIAPEYLSTGKSS------EKTDVFGYGITLLELVTG 278
             ++ GT G++APE L            ++ D++  G+ L  L+ G
Sbjct: 256 LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 98/212 (46%), Gaps = 22/212 (10%)
Query: 79  FSESNIIGQGGFGKVYKGVLSDN-TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
           ++  + IG+G +G V     + N  +VA+K++  +          RE+ ++    H+N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY-------G 190
            +          I+  P ++ +   Y ++DL   +      T+        Y       G
Sbjct: 83  GI--------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 134
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMGH 248
           L+Y+H      ++HRDLK +N+LL+   +  +CDFGLA++ D    H    T+   T  +
Sbjct: 135 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 191
Query: 249 IAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
            APE +   K   K+ D++  G  L E+++ +
Sbjct: 192 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 98/212 (46%), Gaps = 22/212 (10%)
Query: 79  FSESNIIGQGGFGKVYKGVLSDN-TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
           ++  + IG+G +G V     + N  +VA+K++  +          RE+ ++    H+N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY-------G 190
            +          I+  P ++ +   Y ++DL   +      T+        Y       G
Sbjct: 90  GI--------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 141
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMGH 248
           L+Y+H      ++HRDLK +N+LL+   +  +CDFGLA++ D    H    T+   T  +
Sbjct: 142 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 198
Query: 249 IAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
            APE +   K   K+ D++  G  L E+++ +
Sbjct: 199 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 98/212 (46%), Gaps = 22/212 (10%)
Query: 79  FSESNIIGQGGFGKVYKGVLSDN-TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
           ++  + IG+G +G V     + N  +VA+K++  +          RE+ ++    H+N++
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 90
Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY-------G 190
            +          I+  P ++ +   Y ++DL   +      T+        Y       G
Sbjct: 91  GI--------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 142
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMGH 248
           L+Y+H      ++HRDLK +N+LL+   +  +CDFGLA++ D    H    T+   T  +
Sbjct: 143 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 199
Query: 249 IAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
            APE +   K   K+ D++  G  L E+++ +
Sbjct: 200 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 98/212 (46%), Gaps = 22/212 (10%)
Query: 79  FSESNIIGQGGFGKVYKGVLSDN-TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
           ++  + IG+G +G V     + N  +VA+K++  +          RE+ ++    H+N++
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 81
Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY-------G 190
            +          I+  P ++ +   Y ++DL   +      T+        Y       G
Sbjct: 82  GI--------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 133
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMGH 248
           L+Y+H      ++HRDLK +N+LL+   +  +CDFGLA++ D    H    T+   T  +
Sbjct: 134 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 190
Query: 249 IAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
            APE +   K   K+ D++  G  L E+++ +
Sbjct: 191 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 98/212 (46%), Gaps = 22/212 (10%)
Query: 79  FSESNIIGQGGFGKVYKGVLSDN-TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
           ++  + IG+G +G V     + N  +VA+K++  +          RE+ ++    H+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY-------G 190
            +          I+  P ++ +   Y ++DL   +      T+        Y       G
Sbjct: 89  GI--------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 140
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMGH 248
           L+Y+H      ++HRDLK +N+LL+   +  +CDFGLA++ D    H    T+   T  +
Sbjct: 141 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 249 IAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
            APE +   K   K+ D++  G  L E+++ +
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 98/212 (46%), Gaps = 22/212 (10%)
Query: 79  FSESNIIGQGGFGKVYKGVLSDN-TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
           ++  + IG+G +G V     + N  +VA+K++  +          RE+ ++    H+N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY-------G 190
            +          I+  P ++ +   Y ++DL   +      T+        Y       G
Sbjct: 83  GI--------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 134
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMGH 248
           L+Y+H      ++HRDLK +N+LL+   +  +CDFGLA++ D    H    T+   T  +
Sbjct: 135 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 191
Query: 249 IAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
            APE +   K   K+ D++  G  L E+++ +
Sbjct: 192 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 4/90 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGH 248
            LEYLH +    IIHRDLK  NILL+++    + DFG AK++  +          GT  +
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 200
Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           ++PE L+   +S+ +D++  G  + +LV G
Sbjct: 201 VSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 106/225 (47%), Gaps = 21/225 (9%)
Query: 71  ELQLATDNFSESNIIGQGGFGKVYK----GVLSDNT--KVAVKRLQDYYSPGGEAAFQRE 124
           + +   +N      +G G FGKV +    G+  ++   KVAVK L+       + A   E
Sbjct: 40  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 125 VHLIS-VAIHKNLLQLIGYCTTSSERILVYPF------MQNLSVAYRLRDLKPGEKGLD- 176
           + ++S +  H+N++ L+G CT     +++  +      +  L    R+ +  P     + 
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 177 -WPTRKRVAFGT--AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVD 232
              TR  + F +  A G+ +L  +     IHRD+ A N+LL +   A + DFGLA+ +++
Sbjct: 160 TASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
                V    R  +  +APE +     + ++DV+ YGI L E+ +
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G+G +G+V   V       VAVK +    +       ++E+ +  +  H+N+++  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  + Y F++  S       ++P + G+  P  +R       G+ YLH      I 
Sbjct: 74  --RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVD-AKLTHVTTQIRGTMGHIAPEYLSTGK-SSE 261
           HRD+K  N+LLD+     + DFGLA +        +  ++ GT+ ++APE L   +  +E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 262 KTDVFGYGITLLELVTGQRAID 283
             DV+  GI L  ++ G+   D
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G+G +G+V   V       VAVK +    +       ++E+ +  +  H+N+++  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  + Y F++  S       ++P + G+  P  +R       G+ YLH      I 
Sbjct: 74  --RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVD-AKLTHVTTQIRGTMGHIAPEYLSTGK-SSE 261
           HRD+K  N+LLD+     + DFGLA +        +  ++ GT+ ++APE L   +  +E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 262 KTDVFGYGITLLELVTGQRAID 283
             DV+  GI L  ++ G+   D
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G+G +G+V   V       VAVK +    +       ++E+ +  +  H+N+++  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  + Y F++  S       ++P + G+  P  +R       G+ YLH      I 
Sbjct: 74  --RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVD-AKLTHVTTQIRGTMGHIAPEYLSTGK-SSE 261
           HRD+K  N+LLD+     + DFGLA +        +  ++ GT+ ++APE L   +  +E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 262 KTDVFGYGITLLELVTGQRAID 283
             DV+  GI L  ++ G+   D
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWD 209

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 11/205 (5%)
Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTK-VAVKR-LQDYYSPGGEAAFQREVHLISVAIHK 134
           + + +   IG+G +G V+K    D  + VA+K+ L+    P  +    RE+ ++    H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           NL+ L+          LV+ +  +      L +L   ++G+     K + + T   + + 
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTV----LHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 254
           H+      IHRD+K  NIL+  +    LCDFG A+L+     +   ++  T  + +PE L
Sbjct: 119 HKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV-ATRWYRSPELL 174
Query: 255 -STGKSSEKTDVFGYGITLLELVTG 278
               +     DV+  G    EL++G
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 98/212 (46%), Gaps = 22/212 (10%)
Query: 79  FSESNIIGQGGFGKVYKGVLSDN-TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
           ++  + IG+G +G V     + N  +VA+K++  +          RE+ ++    H+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFGTAYG 190
            +          I+  P ++ +   Y ++DL   +       + L         +    G
Sbjct: 89  GI--------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRG 140
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMGH 248
           L+Y+H      ++HRDLK +N+LL+   +  +CDFGLA++ D    H    T+   T  +
Sbjct: 141 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 249 IAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
            APE +   K   K+ D++  G  L E+++ +
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI--HKNLLQLIGY 142
           IG+G +G+V+ G      KVAVK     +    EA++ RE  +    +  H+N+L  I  
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVK----VFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 143 ----CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-- 196
                 + ++  L+  + +N S+   L+        LD  +  ++A+ +  GL +LH   
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 197 ---QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIR-GTMGHIA 250
              Q  P I HRDLK+ NIL+  N    + D GLA   + D     +    R GT  ++ 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 251 PEYLSTG------KSSEKTDVFGYGITLLEL 275
           PE L         +S    D++ +G+ L E+
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G+G +G+V   V       VAVK +    +       ++E+ +  +  H+N+++  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 72
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  + Y F++  S       ++P + G+  P  +R       G+ YLH      I 
Sbjct: 73  --RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVD-AKLTHVTTQIRGTMGHIAPEYLSTGK-SSE 261
           HRD+K  N+LLD+     + DFGLA +        +  ++ GT+ ++APE L   +  +E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 262 KTDVFGYGITLLELVTGQRAID 283
             DV+  GI L  ++ G+   D
Sbjct: 187 PVDVWSCGIVLTAMLAGELPWD 208

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G+G +G+V   V       VAVK +    +       ++E+ +  +  H+N+++  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  + Y F++  S       ++P + G+  P  +R       G+ YLH      I 
Sbjct: 74  --RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVD-AKLTHVTTQIRGTMGHIAPEYLSTGK-SSE 261
           HRD+K  N+LLD+     + DFGLA +        +  ++ GT+ ++APE L   +  +E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 262 KTDVFGYGITLLELVTGQRAID 283
             DV+  GI L  ++ G+   D
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWD 209

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 85  IGQGGFGKVYKGVLSDNTK-VAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           IG+G +G V+K    +  + VA+KR++ D    G  ++  RE+ L+    HKN+++L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 143 CTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 201
             +  +  LV+ F  Q+L   +   D   G+  LD    K   F    GL + H +    
Sbjct: 70  LHSDKKLTLVFEFCDQDLKKYF---DSCNGD--LDPEIVKSFLFQLLKGLGFCHSR---N 121
Query: 202 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK-SS 260
           ++HRDLK  N+L++ N E  L +FGLA+     +   + ++  T+ +  P+ L   K  S
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYS 180
Query: 261 EKTDVFGYGITLLELVTGQRAI 282
              D++  G    EL    R +
Sbjct: 181 TSIDMWSAGCIFAELANAGRPL 202

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 111/259 (42%), Gaps = 11/259 (4%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQLIGY 142
           IG G +G+  K     + K+ V +  DY S     +     EV+L+    H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 143 CT--TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN- 199
               T++   +V  + +   +A  +       + LD     RV       L+  H + + 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 200 -PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 258
              ++HRDLK AN+ LD      L DFGLA++++        +  GT  +++PE ++   
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-EDFAKEFVGTPYYMSPEQMNRMS 192
Query: 259 SSEKTDVFGYGITLLELVTGQRAID-FSRXXXXXXXXXXXHIRKLLR-EDRLNDIVDR-- 314
            +EK+D++  G  L EL         FS+             R   R  D LN+I+ R  
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRML 252
Query: 315 NLNTYDSKEVETMVQVALL 333
           NL  Y    VE +++  L+
Sbjct: 253 NLKDYHRPSVEEILENPLI 271

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 100/230 (43%), Gaps = 25/230 (10%)
Query: 70  RELQLATDNFSESNIIGQGGFGKV-----YKGVLSDNT-KVAVKRLQDYYSPGGEAAFQR 123
            + +   +  S    +G G FGKV     Y  + SD    VAVK L+         A   
Sbjct: 16  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75
Query: 124 EVHLIS-VAIHKNLLQLIGYCTTSSERILVYPFM---QNLSVAYRLRD-----------L 168
           E+ ++S +  H N++ L+G CT     +++  +      L+   R RD           +
Sbjct: 76  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 169 KPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 228
           +  E  LD       ++  A G+ +L  +     IHRDL A NILL       +CDFGLA
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLA 192
Query: 229 KLVDAKLTHVTT-QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
           + +     +V     R  +  +APE +     + ++DV+ YGI L EL +
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 98/212 (46%), Gaps = 22/212 (10%)
Query: 79  FSESNIIGQGGFGKVYKGVLSDN-TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
           ++  + IG+G +G V     + N  +VA++++  +          RE+ ++    H+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY-------G 190
            +          I+  P ++ +   Y ++DL   +      T+        Y       G
Sbjct: 89  GI--------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 140
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMGH 248
           L+Y+H      ++HRDLK +N+LL+   +  +CDFGLA++ D    H    T+   T  +
Sbjct: 141 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 249 IAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
            APE +   K   K+ D++  G  L E+++ +
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 29/223 (13%)
Query: 71  ELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAF--------- 121
           EL      ++    I  G +G V  GV S+   VA+KR+ +  S G              
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 122 -QREVHLISVAIHKNLLQL----IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLD 176
             RE+ L++   H N+L L    + +   +  ++ +   +    +A  + D    ++ + 
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD----QRIVI 131
Query: 177 WPTR-KRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDA 233
            P   +   +    GL  LHE     ++HRDL   NILL DN +  +CDF LA+    DA
Sbjct: 132 SPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEK-TDVFGYGITLLEL 275
             TH  T       + APE +   K   K  D++  G  + E+
Sbjct: 189 NKTHYVTH----RWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 29/223 (13%)
Query: 71  ELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAF--------- 121
           EL      ++    I  G +G V  GV S+   VA+KR+ +  S G              
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 122 -QREVHLISVAIHKNLLQL----IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLD 176
             RE+ L++   H N+L L    + +   +  ++ +   +    +A  + D    ++ + 
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD----QRIVI 131
Query: 177 WPTR-KRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDA 233
            P   +   +    GL  LHE     ++HRDL   NILL DN +  +CDF LA+    DA
Sbjct: 132 SPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEK-TDVFGYGITLLEL 275
             TH  T       + APE +   K   K  D++  G  + E+
Sbjct: 189 NKTHYVTH----RWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 14/212 (6%)
Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAI 132
           +D +    I+G GG  +V+    L D+  VAVK L+   +  P     F+RE    +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 133 HKNLLQLIGYCTTSSERI---LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
           H  ++ +  Y T  +E     L Y  M+ +     LRD+   E  +       V      
Sbjct: 71  HPAIVAV--YDTGEAETPAGPLPYIVMEYVD-GVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMG 247
            L + H+     IIHRD+K ANIL+       + DFG+A+ +      V  T  + GT  
Sbjct: 128 ALNFSHQN---GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQ 184
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           +++PE         ++DV+  G  L E++TG+
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 20/223 (8%)
Query: 68  SCRELQLATDNFSESNIIGQGGFGKVY--KGVLSDNTKVAVKRL-QDYYSPGGEAAFQRE 124
           S  + Q    N+     IG+G F KV   + VL+   +VAVK + +   +P       RE
Sbjct: 6   SATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLT-GREVAVKIIDKTQLNPTSLQKLFRE 64
Query: 125 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV-AYRLRDLKPGEKGLDWPTRKRV 183
           V ++ +  H N+++L     T     LV  +     V  Y +   +  EK      R+ V
Sbjct: 65  VRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV 124
Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQ 241
           +      ++Y H++    I+HRDLKA N+LLD +    + DFG +    V  KL      
Sbjct: 125 S-----AVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC-- 174
Query: 242 IRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAID 283
             G+  + APE     K    + DV+  G+ L  LV+G    D
Sbjct: 175 --GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 78  NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQD--YYSPGGEAAFQREVHLISVAIHK 134
           N+     +G+G FGKV      +   KVA+K +          +   +RE+  + +  H 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           ++++L     +  E I+V  +  N    Y ++  K  E+       +R        +EY 
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ-----EARRFFQQIISAVEYC 119
Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHIAPEY 253
           H     KI+HRDLK  N+LLD++    + DFGL+ ++ D      +    G+  + APE 
Sbjct: 120 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEV 173
Query: 254 LSTGK--SSEKTDVFGYGITLLELVTGQRAID 283
           +S GK  +  + DV+  G+ L  ++  +   D
Sbjct: 174 IS-GKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 78  NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQD--YYSPGGEAAFQREVHLISVAIHK 134
           N+     +G+G FGKV      +   KVA+K +          +   +RE+  + +  H 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           ++++L     +  E I+V  +  N    Y ++  K  E+       +R        +EY 
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ-----EARRFFQQIISAVEYC 123
Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHIAPEY 253
           H     KI+HRDLK  N+LLD++    + DFGL+ ++ D      +    G+  + APE 
Sbjct: 124 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEV 177
Query: 254 LSTGK--SSEKTDVFGYGITLLELVTGQRAID 283
           +S GK  +  + DV+  G+ L  ++  +   D
Sbjct: 178 IS-GKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 34/218 (15%)
Query: 76  TDNFSESNIIGQGGFGKVY---KGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI 132
           +D +    ++G+G FG+V      +      V V   +       + +  REV L+    
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 133 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLD-WPTRKRVAFGTA--- 188
           H N+++L             Y F ++    Y + ++  G +  D   +RKR +   A   
Sbjct: 85  HPNIMKL-------------YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI 131
Query: 189 -----YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV---LCDFGLAKLVDAKLTHVTT 240
                 G+ Y+H+    KI+HRDLK  N+LL+   +     + DFGL+   +A    +  
Sbjct: 132 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKD 187
Query: 241 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           +I GT  +IAPE L  G   EK DV+  G+ L  L++G
Sbjct: 188 KI-GTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 78  NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQD--YYSPGGEAAFQREVHLISVAIHK 134
           N+     +G+G FGKV      +   KVA+K +          +   +RE+  + +  H 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           ++++L     +  E I+V  +  N    Y ++  K  E+       +R        +EY 
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ-----EARRFFQQIISAVEYC 128
Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHIAPEY 253
           H     KI+HRDLK  N+LLD++    + DFGL+ ++ D      +    G+  + APE 
Sbjct: 129 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEV 182
Query: 254 LSTGK--SSEKTDVFGYGITLLELVTGQRAID 283
           +S GK  +  + DV+  G+ L  ++  +   D
Sbjct: 183 IS-GKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 104/223 (46%), Gaps = 47/223 (21%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
            F    ++GQG FGKV+           VK++      G +A   R+++ + V + K  L
Sbjct: 25  QFELLKVLGQGSFGKVF----------LVKKIS-----GSDA---RQLYAMKV-LKKATL 65
Query: 138 QLIGYCTTSSER-ILV---YPFMQNLSVAY----RLRDLKPGEKGLDWPTR--KRVAFGT 187
           ++     T  ER ILV   +PF+  L  A+    +L  +    +G D  TR  K V F  
Sbjct: 66  KVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE 125
Query: 188 ----------AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 237
                     A  L++LH      II+RDLK  NILLD+     L DFGL+K     + H
Sbjct: 126 EDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDH 179
Query: 238 VTTQIR--GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
                   GT+ ++APE ++    ++  D + +G+ + E++TG
Sbjct: 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 16/209 (7%)
Query: 79  FSESNIIGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           +++   IG+G +G V   Y  V    T+VA+K++  +          RE+ ++    H+N
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHV--RKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHEN 102
Query: 136 LLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
           ++ +      S+   +  VY  +Q+L      + LK  +   D        +    GL+Y
Sbjct: 103 VIGIRDILRASTLEAMRDVY-IVQDLMETDLYKLLKSQQLSNDHICY--FLYQILRGLKY 159
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMGHIAP 251
           +H   +  ++HRDLK +N+L++   +  +CDFGLA++ D +  H    T+   T  + AP
Sbjct: 160 IH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAP 216
Query: 252 EYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
           E +   K   K+ D++  G  L E+++ +
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 104/223 (46%), Gaps = 47/223 (21%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
            F    ++GQG FGKV+           VK++      G +A   R+++ + V + K  L
Sbjct: 25  QFELLKVLGQGSFGKVF----------LVKKIS-----GSDA---RQLYAMKV-LKKATL 65
Query: 138 QLIGYCTTSSER-ILV---YPFMQNLSVAY----RLRDLKPGEKGLDWPTR--KRVAFGT 187
           ++     T  ER ILV   +PF+  L  A+    +L  +    +G D  TR  K V F  
Sbjct: 66  KVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE 125
Query: 188 ----------AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 237
                     A  L++LH      II+RDLK  NILLD+     L DFGL+K     + H
Sbjct: 126 EDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDH 179
Query: 238 VTTQIR--GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
                   GT+ ++APE ++    ++  D + +G+ + E++TG
Sbjct: 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 104/223 (46%), Gaps = 47/223 (21%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
            F    ++GQG FGKV+           VK++      G +A   R+++ + V + K  L
Sbjct: 26  QFELLKVLGQGSFGKVF----------LVKKIS-----GSDA---RQLYAMKV-LKKATL 66
Query: 138 QLIGYCTTSSER-ILV---YPFMQNLSVAY----RLRDLKPGEKGLDWPTR--KRVAFGT 187
           ++     T  ER ILV   +PF+  L  A+    +L  +    +G D  TR  K V F  
Sbjct: 67  KVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE 126
Query: 188 ----------AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 237
                     A  L++LH      II+RDLK  NILLD+     L DFGL+K     + H
Sbjct: 127 EDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDH 180
Query: 238 VTTQIR--GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
                   GT+ ++APE ++    ++  D + +G+ + E++TG
Sbjct: 181 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 78  NFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQD--YYSPGGEAAFQREVHLISVAIHK 134
           N+     +G+G FGKV      +   KVA+K +          +   +RE+  + +  H 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           ++++L     +  E I+V  +  N    Y ++  K  E+       +R        +EY 
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ-----EARRFFQQIISAVEYC 129
Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHIAPEY 253
           H     KI+HRDLK  N+LLD++    + DFGL+ ++ D      +    G+  + APE 
Sbjct: 130 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEV 183
Query: 254 LSTGK--SSEKTDVFGYGITLLELVTGQRAID 283
           +S GK  +  + DV+  G+ L  ++  +   D
Sbjct: 184 IS-GKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 28/215 (13%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 136
           +++++ +IG G FG VY+  L D+ + VA+K++       G+A   RE+ ++    H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----GKAFKNRELQIMRKLDHCNI 75
Query: 137 LQLIGYCTTSSERI------LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRKRVAFGTAY 189
           ++L  +  +S E+       LV  ++      YR+ R     ++ L     K   +    
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLV---DAKLTHVTTQIRGT 245
            L Y+H      I HRD+K  N+LLD +   + LCDFG AK +   +  ++++ ++    
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 187
Query: 246 MGHIAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 279
             + APE +      +   DV+  G  L EL+ GQ
Sbjct: 188 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QIRGTMGH 248
           GL +LH++    II+RDLK  N++LD      + DFG+ K  +  +  VTT +  GT  +
Sbjct: 132 GLFFLHKR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTREFCGTPDY 186
Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
           IAPE ++     +  D + YG+ L E++ GQ   D
Sbjct: 187 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 28/215 (13%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 136
           +++++ +IG G FG VY+  L D+ + VA+K++       G+A   RE+ ++    H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----GKAFKNRELQIMRKLDHCNI 75
Query: 137 LQLIGYCTTSSERI------LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRKRVAFGTAY 189
           ++L  +  +S E+       LV  ++      YR+ R     ++ L     K   +    
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLV---DAKLTHVTTQIRGT 245
            L Y+H      I HRD+K  N+LLD +   + LCDFG AK +   +  ++++ ++    
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 187
Query: 246 MGHIAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 279
             + APE +      +   DV+  G  L EL+ GQ
Sbjct: 188 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 94/202 (46%), Gaps = 10/202 (4%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G+G  G+V   V       VAVK +    +       ++E+ +  +  H+N+++  G+ 
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 72
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  + Y F++  S       ++P + G+  P  +R       G+ YLH      I 
Sbjct: 73  --RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVD-AKLTHVTTQIRGTMGHIAPEYLSTGK-SSE 261
           HRD+K  N+LLD+     + DFGLA +        +  ++ GT+ ++APE L   +  +E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 262 KTDVFGYGITLLELVTGQRAID 283
             DV+  GI L  ++ G+   D
Sbjct: 187 PVDVWSCGIVLTAMLAGELPWD 208

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 11/196 (5%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           IGQG  G VY  + ++   +VA++++     P  E     E+ ++    + N++  +   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 86
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  +V  ++   S    L D+   E  +D      V       LE+LH     ++I
Sbjct: 87  LVGDELWVVMEYLAGGS----LTDVV-TETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRD+K+ NILL  +    L DFG    +  + +  +T + GT   +APE ++      K 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 264 DVFGYGITLLELVTGQ 279
           D++  GI  +E++ G+
Sbjct: 198 DIWSLGIMAIEMIEGE 213

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGH 248
            LEYLH +    IIHRDLK  NILL+++    + DFG AK++  +          GT  +
Sbjct: 121 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 177
Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           ++PE L+   + + +D++  G  + +LV G
Sbjct: 178 VSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGH 248
            LEYLH +    IIHRDLK  NILL+++    + DFG AK++  +          GT  +
Sbjct: 122 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 178
Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           ++PE L+   + + +D++  G  + +LV G
Sbjct: 179 VSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 79  FSESNIIGQGGFGKVYKGVLSDN-TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
           ++  + IG+G +G V     + N  +VA+K++  +          RE+ ++    H+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY-------G 190
            +          I+  P ++ +   Y ++DL   +      T+        Y       G
Sbjct: 89  GI--------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 140
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMGH 248
           L+Y+H      ++HRDLK +N+LL+   +  +CDFGLA++ D    H     +   T  +
Sbjct: 141 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWY 197
Query: 249 IAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
            APE +   K   K+ D++  G  L E+++ +
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 79  FSESNIIGQGGFGKVYKGVLSDN-TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
           ++  + IG+G +G V     + N  +VA+K++  +          RE+ ++    H+N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY-------G 190
            +          I+  P ++ +   Y ++DL   +      T+        Y       G
Sbjct: 90  GI--------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG 141
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMGH 248
           L+Y+H      ++HRDLK +N+LL+   +  +CDFGLA++ D    H     +   T  +
Sbjct: 142 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWY 198
Query: 249 IAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
            APE +   K   K+ D++  G  L E+++ +
Sbjct: 199 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGH 248
            LEYLH +    IIHRDLK  NILL+++    + DFG AK++  +          GT  +
Sbjct: 120 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 176
Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           ++PE L+   + + +D++  G  + +LV G
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 14/212 (6%)
Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAI 132
           +D +    I+G GG  +V+    L D+  VAVK L+   +  P     F+RE    +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 133 HKNLLQLIGYCTTSSERI---LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
           H  ++ +  Y T  +E     L Y  M+ +     LRD+   E  +       V      
Sbjct: 71  HPAIVAV--YDTGEAETPAGPLPYIVMEYVD-GVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMG 247
            L + H+     IIHRD+K ANI++       + DFG+A+ +      V  T  + GT  
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           +++PE         ++DV+  G  L E++TG+
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 14/212 (6%)
Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAI 132
           +D +    I+G GG  +V+    L D+  VAVK L+   +  P     F+RE    +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 133 HKNLLQLIGYCTTSSERI---LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
           H  ++ +  Y T  +E     L Y  M+ +     LRD+   E  +       V      
Sbjct: 71  HPAIVAV--YDTGEAETPAGPLPYIVMEYVD-GVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMG 247
            L + H+     IIHRD+K ANI++       + DFG+A+ +      V  T  + GT  
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           +++PE         ++DV+  G  L E++TG+
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGH 248
            LEYLH +    IIHRDLK  NILL+++    + DFG AK++  +          GT  +
Sbjct: 119 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 175
Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           ++PE L+   + + +D++  G  + +LV G
Sbjct: 176 VSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 34/220 (15%)
Query: 74  LATDNFSESNIIGQGGFGKVY---KGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISV 130
           + +D +    ++G+G FG+V      +      V V   +       + +  REV L+  
Sbjct: 29  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 88
Query: 131 AIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLD-WPTRKRVAFGTA- 188
             H N+++L             Y F ++    Y + ++  G +  D   +RKR +   A 
Sbjct: 89  LDHPNIMKL-------------YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA 135
Query: 189 -------YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV---LCDFGLAKLVDAKLTHV 238
                   G+ Y+H+    KI+HRDLK  N+LL+   +     + DFGL+   +A    +
Sbjct: 136 RIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKM 191
Query: 239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
             +I GT  +IAPE L  G   EK DV+  G+ L  L++G
Sbjct: 192 KDKI-GTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 229

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGH 248
            LEYLH +    IIHRDLK  NILL+++    + DFG AK++  +          GT  +
Sbjct: 145 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 201
Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           ++PE L+   + + +D++  G  + +LV G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 34/218 (15%)
Query: 76  TDNFSESNIIGQGGFGKVY---KGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI 132
           +D +    ++G+G FG+V      +      V V   +       + +  REV L+    
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 133 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLD-WPTRKRVAFGTA--- 188
           H N+++L             Y F ++    Y + ++  G +  D   +RKR +   A   
Sbjct: 108 HPNIMKL-------------YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI 154
Query: 189 -----YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV---LCDFGLAKLVDAKLTHVTT 240
                 G+ Y+H+    KI+HRDLK  N+LL+   +     + DFGL+   +A    +  
Sbjct: 155 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKD 210
Query: 241 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           +I GT  +IAPE L  G   EK DV+  G+ L  L++G
Sbjct: 211 KI-GTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 246

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGH 248
            LEYLH +    IIHRDLK  NILL+++    + DFG AK++  +          GT  +
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           ++PE L+   + + +D++  G  + +LV G
Sbjct: 201 VSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 136
           +++++ +IG G FG VY+  L D+ + VA+K++       G+A   RE+ ++    H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----GKAFKNRELQIMRKLDHCNI 75
Query: 137 LQLIGYCTTSSERI------LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRKRVAFGTAY 189
           ++L  +  +S E+       LV  ++   +  YR+ R     ++ L     K   +    
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVP--ATVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMGH 248
            L Y+H      I HRD+K  N+LLD +   + LCDFG AK +     +V+     +  +
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYY 188
Query: 249 IAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 279
            APE +      +   DV+  G  L EL+ GQ
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 23/221 (10%)
Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHL 127
           +E +     +    ++G GGFG VY G+ +SDN  VA+K ++ D  S  GE      V +
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
Query: 128 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------ 181
             V     LL+ +    +   R+L + F +  S    L  ++P +   D+ T +      
Sbjct: 61  EVV-----LLKKVSSGFSGVIRLLDW-FERPDSFVLILERMEPVQDLFDFITERGALQEE 114
Query: 182 --RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKLVDAKLTHV 238
             R  F     LE +    N  ++HRD+K  NIL+D N  E  L DFG   L+      V
Sbjct: 115 LARSFFWQV--LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---V 169
Query: 239 TTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELVTG 278
            T   GT  +  PE++   +   ++  V+  GI L ++V G
Sbjct: 170 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 97/205 (47%), Gaps = 16/205 (7%)
Query: 85  IGQGGFGK-VYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           IG+G FGK +      D  +  +K +     S       +REV +++   H N++Q    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
              +    +V  + +   +  R+   K      ++ LDW  +  +A      L+++H++ 
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA------LKHVHDR- 144
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 258
             KI+HRD+K+ NI L  +    L DFG+A+++++ +      I GT  +++PE      
Sbjct: 145 --KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKP 201
Query: 259 SSEKTDVFGYGITLLELVTGQRAID 283
            + K+D++  G  L EL T + A +
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFE 226

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 14/216 (6%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQD--YYSPGGEAAFQREVHLIS 129
           +L  DNF    ++G+G FGKV    + +   + AVK L+               E  ++S
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 130 VAIHKNLLQLIGYCTTSSERIL-VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 188
           +A +   L  +  C  + +R+  V  F+    + + ++      +  D    +  A    
Sbjct: 79  LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEII 134
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QIRGTMG 247
             L +LH++    II+RDLK  N+LLD      L DFG+ K  +     VTT    GT  
Sbjct: 135 SALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPD 189
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
           +IAPE L         D +  G+ L E++ G    +
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 51/90 (56%), Gaps = 5/90 (5%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
           LE+LH+     II+RD+K  NILLD N   VL DFGL+K   A  T       GT+ ++A
Sbjct: 172 LEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 228
Query: 251 PEYLSTGKSS--EKTDVFGYGITLLELVTG 278
           P+ +  G S   +  D +  G+ + EL+TG
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 34/218 (15%)
Query: 76  TDNFSESNIIGQGGFGKVY---KGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI 132
           +D +    ++G+G FG+V      +      V V   +       + +  REV L+    
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 133 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLD-WPTRKRVAFGTA--- 188
           H N+++L             Y F ++    Y + ++  G +  D   +RKR +   A   
Sbjct: 109 HPNIMKL-------------YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI 155
Query: 189 -----YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV---LCDFGLAKLVDAKLTHVTT 240
                 G+ Y+H+    KI+HRDLK  N+LL+   +     + DFGL+   +A    +  
Sbjct: 156 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKD 211
Query: 241 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           +I GT  +IAPE L  G   EK DV+  G+ L  L++G
Sbjct: 212 KI-GTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 247

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGH 248
            LEYLH +    IIHRDLK  NILL+++    + DFG AK++  +          GT  +
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           ++PE L+   + + +D++  G  + +LV G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGH 248
            LEYLH +    IIHRDLK  NILL+++    + DFG AK++  +          GT  +
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           ++PE L+   + + +D++  G  + +LV G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGH 248
            LEYLH +    IIHRDLK  NILL+++    + DFG AK++  +          GT  +
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           ++PE L+   + + +D++  G  + +LV G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGH 248
            LEYLH +    IIHRDLK  NILL+++    + DFG AK++  +          GT  +
Sbjct: 145 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 201
Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           ++PE L+   + + +D++  G  + +LV G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGH 248
            LEYLH +    IIHRDLK  NILL+++    + DFG AK++  +          GT  +
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           ++PE L+   + + +D++  G  + +LV G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGH 248
            LEYLH +    IIHRDLK  NILL+++    + DFG AK++  +          GT  +
Sbjct: 147 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 203
Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           ++PE L+   + + +D++  G  + +LV G
Sbjct: 204 VSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGH 248
            LEYLH +    IIHRDLK  NILL+++    + DFG AK++  +          GT  +
Sbjct: 141 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 197
Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           ++PE L+   + + +D++  G  + +LV G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGH 248
            LEYLH +    IIHRDLK  NILL+++    + DFG AK++  +          GT  +
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           ++PE L+   + + +D++  G  + +LV G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGH 248
            LEYLH +    IIHRDLK  NILL+++    + DFG AK++  +          GT  +
Sbjct: 149 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 205
Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           ++PE L+   + + +D++  G  + +LV G
Sbjct: 206 VSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGH 248
            LEYLH +    IIHRDLK  NILL+++    + DFG AK++  +          GT  +
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQY 198
Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           ++PE L+   + + +D++  G  + +LV G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 106/237 (44%), Gaps = 45/237 (18%)
Query: 72  LQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISV 130
           L+ A+D F E  ++GQG FG+V K   + D+   A+K+++  ++    +    EV L++ 
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKLSTILSEVXLLAS 58
Query: 131 AIHKNLLQLIGYCTTSSERILVYP----------FMQNLSVAYR-LRDLKPGEKGLDWPT 179
             H+ +++   Y      R  V P          F+Q      R L DL   E       
Sbjct: 59  LNHQYVVRY--YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSEN----LN 112
Query: 180 RKRVAFGTAY-----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 234
           ++R  +   +      L Y+H Q    IIHR+LK  NI +D++    + DFGLAK V   
Sbjct: 113 QQRDEYWRLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 235 L--------------THVTTQIRGTMGHIAPEYLS-TGKSSEKTDVFGYGITLLELV 276
           L               ++T+ I GT  ++A E L  TG  +EK D +  GI   E +
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAI-GTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 106/242 (43%), Gaps = 34/242 (14%)
Query: 60  SLTQLRRFSCREL---QLATDNFSES--------NIIGQGGFGKVYKGV-LSDNTKVAVK 107
           SL  LR   C +L   +LA     E          ++G GGFG VY G+ +SDN  VA+K
Sbjct: 23  SLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK 82
Query: 108 RLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLR 166
            ++ D  S  GE      V +  V     LL+ +    +   R+L + F +  S    L 
Sbjct: 83  HVEKDRISDWGELPNGTRVPMEVV-----LLKKVSSGFSGVIRLLDW-FERPDSFVLILE 136
Query: 167 DLKPGEKGLDWPTRK--------RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN- 217
             +P +   D+ T +        R  F     LE +    N  ++HRD+K  NIL+D N 
Sbjct: 137 RPEPVQDLFDFITERGALQEELARSFFWQV--LEAVRHCHNCGVLHRDIKDENILIDLNR 194
Query: 218 FEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELV 276
            E  L DFG   L+      V T   GT  +  PE++   +   ++  V+  GI L ++V
Sbjct: 195 GELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251
Query: 277 TG 278
            G
Sbjct: 252 CG 253

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGH 248
            LEYLH +    IIHRDLK  NILL+++    + DFG AK++  +          GT  +
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           ++PE L+   + + +D++  G  + +LV G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 28/223 (12%)
Query: 78  NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 136
           +F     +G+GGFG V++     D+   A+KR++            REV  ++   H  +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 137 LQLIG---------YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK---RVA 184
           ++                SS ++ +Y  MQ L     L+D   G   ++   R     + 
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQ-LCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 185 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK------LTHV 238
              A  +E+LH +    ++HRDLK +NI    +    + DFGL   +D        LT +
Sbjct: 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 239 TTQIR-----GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELV 276
               R     GT  +++PE +     S K D+F  G+ L EL+
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGH 248
            LEYLH +    IIHRDLK  NILL+++    + DFG AK++  +          GT  +
Sbjct: 126 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 182
Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           ++PE L+   + + +D++  G  + +LV G
Sbjct: 183 VSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGH 248
            LEYLH +    IIHRDLK  NILL+++    + DFG AK++  +          GT  +
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           ++PE L+   + + +D++  G  + +LV G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV-TTQIRGTMGH 248
            LEYLH +    IIHRDLK  NILL+++    + DFG AK++  +          GT  +
Sbjct: 141 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 197
Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           ++PE L+   + + +D++  G  + +LV G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 81/165 (49%), Gaps = 20/165 (12%)
Query: 123 REVHLISVAIHKNLLQLIGYCTTSSERILVYPF-MQNLSVAYRLRDLKPGEKGLDWPTRK 181
           +E+ ++    H N+++L+      +E  L   F + N      +  LKP  +      + 
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSE-----DQA 139
Query: 182 RVAF-GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA---KLVDAKLTH 237
           R  F     G+EYLH Q   KIIHRD+K +N+L+ ++    + DFG++   K  DA L++
Sbjct: 140 RFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN 196
Query: 238 VTTQIRGTMGHIAPEYLSTGK---SSEKTDVFGYGITLLELVTGQ 279
                 GT   +APE LS  +   S +  DV+  G+TL   V GQ
Sbjct: 197 TV----GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 106/242 (43%), Gaps = 34/242 (14%)
Query: 60  SLTQLRRFSCREL---QLATDNFSES--------NIIGQGGFGKVYKGV-LSDNTKVAVK 107
           SL  LR   C +L   +LA     E          ++G GGFG VY G+ +SDN  VA+K
Sbjct: 8   SLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK 67
Query: 108 RLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLR 166
            ++ D  S  GE      V +  V     LL+ +    +   R+L + F +  S    L 
Sbjct: 68  HVEKDRISDWGELPNGTRVPMEVV-----LLKKVSSGFSGVIRLLDW-FERPDSFVLILE 121
Query: 167 DLKPGEKGLDWPTRK--------RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN- 217
             +P +   D+ T +        R  F     LE +    N  ++HRD+K  NIL+D N 
Sbjct: 122 RPEPVQDLFDFITERGALQEELARSFFWQV--LEAVRHCHNCGVLHRDIKDENILIDLNR 179
Query: 218 FEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELV 276
            E  L DFG   L+      V T   GT  +  PE++   +   ++  V+  GI L ++V
Sbjct: 180 GELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236
Query: 277 TG 278
            G
Sbjct: 237 CG 238

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 106/242 (43%), Gaps = 34/242 (14%)
Query: 60  SLTQLRRFSCREL---QLATDNFSES--------NIIGQGGFGKVYKGV-LSDNTKVAVK 107
           SL  LR   C +L   +LA     E          ++G GGFG VY G+ +SDN  VA+K
Sbjct: 8   SLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK 67
Query: 108 RLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLR 166
            ++ D  S  GE      V +  V     LL+ +    +   R+L + F +  S    L 
Sbjct: 68  HVEKDRISDWGELPNGTRVPMEVV-----LLKKVSSGFSGVIRLLDW-FERPDSFVLILE 121
Query: 167 DLKPGEKGLDWPTRK--------RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN- 217
             +P +   D+ T +        R  F     LE +    N  ++HRD+K  NIL+D N 
Sbjct: 122 RPEPVQDLFDFITERGALQEELARSFFWQV--LEAVRHCHNCGVLHRDIKDENILIDLNR 179
Query: 218 FEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELV 276
            E  L DFG   L+      V T   GT  +  PE++   +   ++  V+  GI L ++V
Sbjct: 180 GELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236
Query: 277 TG 278
            G
Sbjct: 237 CG 238

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 20/213 (9%)
Query: 78  NFSESNIIGQGGFGKVY--KGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHK 134
           N+     IG+G F KV   + +L+   +VA+K + +   +P       REV ++ +  H 
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 71
Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSV-AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
           N+++L     T     L+  +     V  Y +   +  EK      R+ V+      ++Y
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS-----AVQY 126
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGTMGHIAP 251
            H++   +I+HRDLKA N+LLD +    + DFG +    V  KL        G+  + AP
Sbjct: 127 CHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFC----GSPPYAAP 179
Query: 252 EYLSTGK-SSEKTDVFGYGITLLELVTGQRAID 283
           E     K    + DV+  G+ L  LV+G    D
Sbjct: 180 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 106/242 (43%), Gaps = 34/242 (14%)
Query: 60  SLTQLRRFSCREL---QLATDNFSES--------NIIGQGGFGKVYKGV-LSDNTKVAVK 107
           SL  LR   C +L   +LA     E          ++G GGFG VY G+ +SDN  VA+K
Sbjct: 9   SLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK 68
Query: 108 RLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLR 166
            ++ D  S  GE      V +  V     LL+ +    +   R+L + F +  S    L 
Sbjct: 69  HVEKDRISDWGELPNGTRVPMEVV-----LLKKVSSGFSGVIRLLDW-FERPDSFVLILE 122
Query: 167 DLKPGEKGLDWPTRK--------RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN- 217
             +P +   D+ T +        R  F     LE +    N  ++HRD+K  NIL+D N 
Sbjct: 123 RPEPVQDLFDFITERGALQEELARSFFWQV--LEAVRHCHNCGVLHRDIKDENILIDLNR 180
Query: 218 FEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELV 276
            E  L DFG   L+      V T   GT  +  PE++   +   ++  V+  GI L ++V
Sbjct: 181 GELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237
Query: 277 TG 278
            G
Sbjct: 238 CG 239

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 106/242 (43%), Gaps = 34/242 (14%)
Query: 60  SLTQLRRFSCREL---QLATDNFSES--------NIIGQGGFGKVYKGV-LSDNTKVAVK 107
           SL  LR   C +L   +LA     E          ++G GGFG VY G+ +SDN  VA+K
Sbjct: 9   SLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK 68
Query: 108 RLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLR 166
            ++ D  S  GE      V +  V     LL+ +    +   R+L + F +  S    L 
Sbjct: 69  HVEKDRISDWGELPNGTRVPMEVV-----LLKKVSSGFSGVIRLLDW-FERPDSFVLILE 122
Query: 167 DLKPGEKGLDWPTRK--------RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN- 217
             +P +   D+ T +        R  F     LE +    N  ++HRD+K  NIL+D N 
Sbjct: 123 RPEPVQDLFDFITERGALQEELARSFFWQV--LEAVRHCHNCGVLHRDIKDENILIDLNR 180
Query: 218 FEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELV 276
            E  L DFG   L+      V T   GT  +  PE++   +   ++  V+  GI L ++V
Sbjct: 181 GELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237
Query: 277 TG 278
            G
Sbjct: 238 CG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 106/242 (43%), Gaps = 34/242 (14%)
Query: 60  SLTQLRRFSCREL---QLATDNFSES--------NIIGQGGFGKVYKGV-LSDNTKVAVK 107
           SL  LR   C +L   +LA     E          ++G GGFG VY G+ +SDN  VA+K
Sbjct: 8   SLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK 67
Query: 108 RLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLR 166
            ++ D  S  GE      V +  V     LL+ +    +   R+L + F +  S    L 
Sbjct: 68  HVEKDRISDWGELPNGTRVPMEVV-----LLKKVSSGFSGVIRLLDW-FERPDSFVLILE 121
Query: 167 DLKPGEKGLDWPTRK--------RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN- 217
             +P +   D+ T +        R  F     LE +    N  ++HRD+K  NIL+D N 
Sbjct: 122 RPEPVQDLFDFITERGALQEELARSFFWQV--LEAVRHCHNCGVLHRDIKDENILIDLNR 179
Query: 218 FEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELV 276
            E  L DFG   L+      V T   GT  +  PE++   +   ++  V+  GI L ++V
Sbjct: 180 GELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236
Query: 277 TG 278
            G
Sbjct: 237 CG 238

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 81/181 (44%), Gaps = 21/181 (11%)
Query: 99  SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN 158
           S+N K+++K   D         F+ E+ +I+   ++  L   G  T   E  ++Y +M+N
Sbjct: 76  SNNDKISIKSKYD--------DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMEN 127
Query: 159 LSV----AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL 214
            S+     Y     K     +     K +         Y+H + N  I HRD+K +NIL+
Sbjct: 128 DSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILM 185
Query: 215 DDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSE--KTDVFGYGIT 271
           D N    L DFG ++ +VD K+       RGT   + PE+ S   S    K D++  GI 
Sbjct: 186 DKNGRVKLSDFGESEYMVDKKIKGS----RGTYEFMPPEFFSNESSYNGAKVDIWSLGIC 241
Query: 272 L 272
           L
Sbjct: 242 L 242

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 97/214 (45%), Gaps = 26/214 (12%)
Query: 79  FSESNIIGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           ++  + IG+G +G V   Y  V  +  +VA+K++  +          RE+ ++    H+N
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 102
Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY------ 189
           ++ +          I+  P ++ +   Y +  L   +      T+        Y      
Sbjct: 103 IIGI--------NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQIL 154
Query: 190 -GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTM 246
            GL+Y+H      ++HRDLK +N+LL+   +  +CDFGLA++ D    H    T+   T 
Sbjct: 155 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 247 GHIAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
            + APE +   K   K+ D++  G  L E+++ +
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 106/242 (43%), Gaps = 34/242 (14%)
Query: 60  SLTQLRRFSCREL---QLATDNFSES--------NIIGQGGFGKVYKGV-LSDNTKVAVK 107
           SL  LR   C +L   +LA     E          ++G GGFG VY G+ +SDN  VA+K
Sbjct: 8   SLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK 67
Query: 108 RLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLR 166
            ++ D  S  GE      V +  V     LL+ +    +   R+L + F +  S    L 
Sbjct: 68  HVEKDRISDWGELPNGTRVPMEVV-----LLKKVSSGFSGVIRLLDW-FERPDSFVLILE 121
Query: 167 DLKPGEKGLDWPTRK--------RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN- 217
             +P +   D+ T +        R  F     LE +    N  ++HRD+K  NIL+D N 
Sbjct: 122 RPEPVQDLFDFITERGALQEELARSFFWQV--LEAVRHCHNCGVLHRDIKDENILIDLNR 179
Query: 218 FEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELV 276
            E  L DFG   L+      V T   GT  +  PE++   +   ++  V+  GI L ++V
Sbjct: 180 GELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236
Query: 277 TG 278
            G
Sbjct: 237 CG 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 106/242 (43%), Gaps = 34/242 (14%)
Query: 60  SLTQLRRFSCREL---QLATDNFSES--------NIIGQGGFGKVYKGV-LSDNTKVAVK 107
           SL  LR   C +L   +LA     E          ++G GGFG VY G+ +SDN  VA+K
Sbjct: 9   SLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK 68
Query: 108 RLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLR 166
            ++ D  S  GE      V +  V     LL+ +    +   R+L + F +  S    L 
Sbjct: 69  HVEKDRISDWGELPNGTRVPMEVV-----LLKKVSSGFSGVIRLLDW-FERPDSFVLILE 122
Query: 167 DLKPGEKGLDWPTRK--------RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN- 217
             +P +   D+ T +        R  F     LE +    N  ++HRD+K  NIL+D N 
Sbjct: 123 RPEPVQDLFDFITERGALQEELARSFFWQV--LEAVRHCHNCGVLHRDIKDENILIDLNR 180
Query: 218 FEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELV 276
            E  L DFG   L+      V T   GT  +  PE++   +   ++  V+  GI L ++V
Sbjct: 181 GELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237
Query: 277 TG 278
            G
Sbjct: 238 CG 239

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 106/242 (43%), Gaps = 34/242 (14%)
Query: 60  SLTQLRRFSCREL---QLATDNFSES--------NIIGQGGFGKVYKGV-LSDNTKVAVK 107
           SL  LR   C +L   +LA     E          ++G GGFG VY G+ +SDN  VA+K
Sbjct: 9   SLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK 68
Query: 108 RLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLR 166
            ++ D  S  GE      V +  V     LL+ +    +   R+L + F +  S    L 
Sbjct: 69  HVEKDRISDWGELPNGTRVPMEVV-----LLKKVSSGFSGVIRLLDW-FERPDSFVLILE 122
Query: 167 DLKPGEKGLDWPTRK--------RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN- 217
             +P +   D+ T +        R  F     LE +    N  ++HRD+K  NIL+D N 
Sbjct: 123 RPEPVQDLFDFITERGALQEELARSFFWQV--LEAVRHCHNCGVLHRDIKDENILIDLNR 180
Query: 218 FEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELV 276
            E  L DFG   L+      V T   GT  +  PE++   +   ++  V+  GI L ++V
Sbjct: 181 GELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237
Query: 277 TG 278
            G
Sbjct: 238 CG 239

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR--GT 245
           A GL++LH      II+RDLK  NILLD+     L DFGL+K     + H        GT
Sbjct: 140 ALGLDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK---EAIDHEKKAYSFCGT 193
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           + ++APE ++    S   D + YG+ + E++TG
Sbjct: 194 VEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 17/217 (7%)
Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS---PGGEAAFQREVH 126
           R LQ+  +++    +IG+G FG+V       + KV   +L   +        A F  E  
Sbjct: 68  RGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERD 127
Query: 127 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +++ A    ++QL  +C    ++ L Y  M+ +       DL       D P  K   F 
Sbjct: 128 IMAFANSPWVVQL--FCAFQDDKYL-YMVMEYMPGG----DLVNLMSNYDVP-EKWAKFY 179
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGT 245
           TA  +  L    +  +IHRD+K  N+LLD +    L DFG   K+ +  + H  T + GT
Sbjct: 180 TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GT 238
Query: 246 MGHIAPEYLST----GKSSEKTDVFGYGITLLELVTG 278
             +I+PE L +    G    + D +  G+ L E++ G
Sbjct: 239 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 106/242 (43%), Gaps = 34/242 (14%)
Query: 60  SLTQLRRFSCREL---QLATDNFSES--------NIIGQGGFGKVYKGV-LSDNTKVAVK 107
           SL  LR   C +L   +LA     E          ++G GGFG VY G+ +SDN  VA+K
Sbjct: 28  SLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK 87
Query: 108 RLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLR 166
            ++ D  S  GE      V +  V     LL+ +    +   R+L + F +  S    L 
Sbjct: 88  HVEKDRISDWGELPNGTRVPMEVV-----LLKKVSSGFSGVIRLLDW-FERPDSFVLILE 141
Query: 167 DLKPGEKGLDWPTRK--------RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN- 217
             +P +   D+ T +        R  F     LE +    N  ++HRD+K  NIL+D N 
Sbjct: 142 RPEPVQDLFDFITERGALQEELARSFFWQV--LEAVRHCHNCGVLHRDIKDENILIDLNR 199
Query: 218 FEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELV 276
            E  L DFG   L+      V T   GT  +  PE++   +   ++  V+  GI L ++V
Sbjct: 200 GELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 256
Query: 277 TG 278
            G
Sbjct: 257 CG 258

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 26/205 (12%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  +L  N  VA+K+L   +     A    RE+ L+ V  HKN++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 141 GYCTTS---SERILVYPFMQ----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
              T      E   VY  M+    NLS   ++         LD      + +    G+++
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVIQME--------LDHERMSYLLYQMLVGIKH 141
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH      IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 196
Query: 254 LSTGKSSEKTDVFGYGITLLELVTG 278
           +      E  D++  G+ + E++ G
Sbjct: 197 ILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 106/242 (43%), Gaps = 34/242 (14%)
Query: 60  SLTQLRRFSCREL---QLATDNFSES--------NIIGQGGFGKVYKGV-LSDNTKVAVK 107
           SL  LR   C +L   +LA     E          ++G GGFG VY G+ +SDN  VA+K
Sbjct: 23  SLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK 82
Query: 108 RLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLR 166
            ++ D  S  GE      V +  V     LL+ +    +   R+L + F +  S    L 
Sbjct: 83  HVEKDRISDWGELPNGTRVPMEVV-----LLKKVSSGFSGVIRLLDW-FERPDSFVLILE 136
Query: 167 DLKPGEKGLDWPTRK--------RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN- 217
             +P +   D+ T +        R  F     LE +    N  ++HRD+K  NIL+D N 
Sbjct: 137 RPEPVQDLFDFITERGALQEELARSFFWQV--LEAVRHCHNCGVLHRDIKDENILIDLNR 194
Query: 218 FEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELV 276
            E  L DFG   L+      V T   GT  +  PE++   +   ++  V+  GI L ++V
Sbjct: 195 GELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251
Query: 277 TG 278
            G
Sbjct: 252 CG 253

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 26/205 (12%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  +L  N  VA+K+L   +     A    RE+ L+ V  HKN++ L+
Sbjct: 32  IGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 141 GYCTTS---SERILVYPFMQ----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
              T      E   VY  M+    NLS   ++         LD      + +    G+++
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVIQME--------LDHERMSYLLYQMLVGIKH 141
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH      IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 196
Query: 254 LSTGKSSEKTDVFGYGITLLELVTG 278
           +      E  D++  G+ + E++ G
Sbjct: 197 ILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 29/213 (13%)
Query: 82  SNIIGQGGFGKVYKGVLSDNT--KVAVKRLQDYYS---PGGEAAFQREVHLISVAIHKNL 136
            +++G+G +GKV K VL   T  + AVK L+       P GEA  ++E+ L+    HKN+
Sbjct: 10  GDLLGEGSYGKV-KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 137 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY------- 189
           +QL+     + E+  +Y  M+              ++ LD    KR     A+       
Sbjct: 69  IQLVD-VLYNEEKQKMYMVMEYCVCGM--------QEMLDSVPEKRFPVCQAHGYFCQLI 119
Query: 190 -GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 248
            GLEYLH Q    I+H+D+K  N+LL       +   G+A+ +       T +       
Sbjct: 120 DGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 249 IAPEYLSTGK---SSEKTDVFGYGITLLELVTG 278
             P  ++ G    S  K D++  G+TL  + TG
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 23/207 (11%)
Query: 84  IIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
           ++G GGFG VY G+ +SDN  VA+K ++ D  S  GE      V +  V     LL+ + 
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV-----LLKKVS 65
Query: 142 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--------RVAFGTAYGLEY 193
              +   R+L + F +  S    L   +P +   D+ T +        R  F     LE 
Sbjct: 66  SGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV--LEA 122
Query: 194 LHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 252
           +    N  ++HRD+K  NIL+D N  E  L DFG   L+      V T   GT  +  PE
Sbjct: 123 VRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPE 179
Query: 253 YLSTGKSSEKT-DVFGYGITLLELVTG 278
           ++   +   ++  V+  GI L ++V G
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLIS 129
           +A ++   + I+G+G FG+VY+GV +++      VAVK  +   +   +  F  E  ++ 
Sbjct: 5   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 64
Query: 130 VAIHKNLLQLIGYCTTSSERILV--YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 187
              H ++++LIG        I++  YP+ +   + + L   K   K L   T    +   
Sbjct: 65  NLDHPHIVKLIGIIEEEPTWIIMELYPYGE---LGHYLERNKNSLKVL---TLVLYSLQI 118
Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 247
              + YL E  N   +HRD+   NIL+       L DFGL++ ++ +  +  +  R  + 
Sbjct: 119 CKAMAYL-ESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK 175
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
            ++PE ++  + +  +DV+ + + + E+++
Sbjct: 176 WMSPESINFRRFTTASDVWMFAVCMWEILS 205

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 90/196 (45%), Gaps = 11/196 (5%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           IGQG  G VY  + ++   +VA++++     P  E     E+ ++    + N++  +   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 86
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  +V  ++   S    L D+   E  +D      V       LE+LH     ++I
Sbjct: 87  LVGDELWVVMEYLAGGS----LTDVV-TETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRD+K+ NILL  +    L DFG    +  + +   +++ GT   +APE ++      K 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSEMVGTPYWMAPEVVTRKAYGPKV 197
Query: 264 DVFGYGITLLELVTGQ 279
           D++  GI  +E++ G+
Sbjct: 198 DIWSLGIMAIEMIEGE 213

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 90/196 (45%), Gaps = 11/196 (5%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           IGQG  G VY  + ++   +VA++++     P  E     E+ ++    + N++  +   
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 87
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  +V  ++   S    L D+   E  +D      V       LE+LH     ++I
Sbjct: 88  LVGDELWVVMEYLAGGS----LTDVV-TETCMDEGQIAAVCRECLQALEFLHSN---QVI 139
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HR++K+ NILL  +    L DFG    +  + +  +T + GT   +APE ++      K 
Sbjct: 140 HRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 198
Query: 264 DVFGYGITLLELVTGQ 279
           D++  GI  +E++ G+
Sbjct: 199 DIWSLGIMAIEMIEGE 214

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 23/221 (10%)
Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHL 127
           +E +     +    ++G GGFG VY G+ +SDN  VA+K ++ D  S  GE      V +
Sbjct: 16  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 75
Query: 128 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------ 181
             V     LL+ +    +   R+L + F +  S    L   +P +   D+ T +      
Sbjct: 76  EVV-----LLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEE 129
Query: 182 --RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKLVDAKLTHV 238
             R  F     LE +    N  ++HRD+K  NIL+D N  E  L DFG   L+      V
Sbjct: 130 LARSFFWQV--LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---V 184
Query: 239 TTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELVTG 278
            T   GT  +  PE++   +   ++  V+  GI L ++V G
Sbjct: 185 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLIS 129
           +A ++   + I+G+G FG+VY+GV +++      VAVK  +   +   +  F  E  ++ 
Sbjct: 21  IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 80
Query: 130 VAIHKNLLQLIGYCTTSSERILV--YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 187
              H ++++LIG        I++  YP+ +   + + L   K   K L   T    +   
Sbjct: 81  NLDHPHIVKLIGIIEEEPTWIIMELYPYGE---LGHYLERNKNSLKVL---TLVLYSLQI 134
Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 247
              + YL E  N   +HRD+   NIL+       L DFGL++ ++ +  +  +  R  + 
Sbjct: 135 CKAMAYL-ESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK 191
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
            ++PE ++  + +  +DV+ + + + E+++
Sbjct: 192 WMSPESINFRRFTTASDVWMFAVCMWEILS 221

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 84  IIGQGGFGKVYK-GVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLIG 141
           ++G+G FG+V K        + AVK +    +   + +   REV L+    H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 142 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 201
               SS   +V      L     L D     K        R+      G+ Y+H+     
Sbjct: 89  ILEDSSSFYIV----GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---N 141
Query: 202 IIHRDLKAANILLDD---NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 258
           I+HRDLK  NILL+    + +  + DFGL+       T +  +I GT  +IAPE L  G 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPEVLR-GT 198
Query: 259 SSEKTDVFGYGITLLELVTG 278
             EK DV+  G+ L  L++G
Sbjct: 199 YDEKCDVWSAGVILYILLSG 218

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 23/221 (10%)
Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHL 127
           +E +     +    ++G GGFG VY G+ +SDN  VA+K ++ D  S  GE      V +
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 61
Query: 128 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------ 181
             V     LL+ +    +   R+L + F +  S    L   +P +   D+ T +      
Sbjct: 62  EVV-----LLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEE 115
Query: 182 --RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKLVDAKLTHV 238
             R  F     LE +    N  ++HRD+K  NIL+D N  E  L DFG   L+      V
Sbjct: 116 LARSFFWQV--LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---V 170
Query: 239 TTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELVTG 278
            T   GT  +  PE++   +   ++  V+  GI L ++V G
Sbjct: 171 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 23/207 (11%)
Query: 84  IIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
           ++G GGFG VY G+ +SDN  VA+K ++ D  S  GE      V +  V     LL+ + 
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV-----LLKKVS 65
Query: 142 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--------RVAFGTAYGLEY 193
              +   R+L + F +  S    L   +P +   D+ T +        R  F     LE 
Sbjct: 66  SGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV--LEA 122
Query: 194 LHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 252
           +    N  ++HRD+K  NIL+D N  E  L DFG   L+      V T   GT  +  PE
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPE 179
Query: 253 YLSTGKSSEKT-DVFGYGITLLELVTG 278
           ++   +   ++  V+  GI L ++V G
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 89/196 (45%), Gaps = 11/196 (5%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           IGQG  G VY  + ++   +VA++++     P  E     E+ ++    + N++  +   
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 87
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  +V  ++   S    L D+   E  +D      V       LE+LH     ++I
Sbjct: 88  LVGDELWVVMEYLAGGS----LTDVV-TETCMDEGQIAAVCRECLQALEFLHSN---QVI 139
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRD+K+ NILL  +    L DFG    +  + +  +  + GT   +APE ++      K 
Sbjct: 140 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPKV 198
Query: 264 DVFGYGITLLELVTGQ 279
           D++  GI  +E++ G+
Sbjct: 199 DIWSLGIMAIEMIEGE 214

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 23/221 (10%)
Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHL 127
           +E +     +    ++G GGFG VY G+ +SDN  VA+K ++ D  S  GE      V +
Sbjct: 16  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 75
Query: 128 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------ 181
             V     LL+ +    +   R+L + F +  S    L   +P +   D+ T +      
Sbjct: 76  EVV-----LLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEE 129
Query: 182 --RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKLVDAKLTHV 238
             R  F     LE +    N  ++HRD+K  NIL+D N  E  L DFG   L+      V
Sbjct: 130 LARSFFWQV--LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---V 184
Query: 239 TTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELVTG 278
            T   GT  +  PE++   +   ++  V+  GI L ++V G
Sbjct: 185 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 23/221 (10%)
Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHL 127
           +E +     +    ++G GGFG VY G+ +SDN  VA+K ++ D  S  GE      V +
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
Query: 128 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------ 181
             V     LL+ +    +   R+L + F +  S    L   +P +   D+ T +      
Sbjct: 77  EVV-----LLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEE 130
Query: 182 --RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKLVDAKLTHV 238
             R  F     LE +    N  ++HRD+K  NIL+D N  E  L DFG   L+      V
Sbjct: 131 LARSFFWQV--LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---V 185
Query: 239 TTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELVTG 278
            T   GT  +  PE++   +   ++  V+  GI L ++V G
Sbjct: 186 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 23/207 (11%)
Query: 84  IIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
           ++G GGFG VY G+ +SDN  VA+K ++ D  S  GE      V +  V     LL+ + 
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV-----LLKKVS 65
Query: 142 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--------RVAFGTAYGLEY 193
              +   R+L + F +  S    L   +P +   D+ T +        R  F     LE 
Sbjct: 66  SGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV--LEA 122
Query: 194 LHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 252
           +    N  ++HRD+K  NIL+D N  E  L DFG   L+      V T   GT  +  PE
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPE 179
Query: 253 YLSTGKSSEKT-DVFGYGITLLELVTG 278
           ++   +   ++  V+  GI L ++V G
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 23/221 (10%)
Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHL 127
           +E +     +    ++G GGFG VY G+ +SDN  VA+K ++ D  S  GE      V +
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
Query: 128 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------ 181
             V     LL+ +    +   R+L + F +  S    L   +P +   D+ T +      
Sbjct: 77  EVV-----LLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEE 130
Query: 182 --RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKLVDAKLTHV 238
             R  F     LE +    N  ++HRD+K  NIL+D N  E  L DFG   L+      V
Sbjct: 131 LARSFFWQV--LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---V 185
Query: 239 TTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELVTG 278
            T   GT  +  PE++   +   ++  V+  GI L ++V G
Sbjct: 186 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 23/221 (10%)
Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHL 127
           +E +     +    ++G GGFG VY G+ +SDN  VA+K ++ D  S  GE      V +
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 61
Query: 128 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------ 181
             V     LL+ +    +   R+L + F +  S    L   +P +   D+ T +      
Sbjct: 62  EVV-----LLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEE 115
Query: 182 --RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKLVDAKLTHV 238
             R  F     LE +    N  ++HRD+K  NIL+D N  E  L DFG   L+      V
Sbjct: 116 LARSFFWQV--LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---V 170
Query: 239 TTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELVTG 278
            T   GT  +  PE++   +   ++  V+  GI L ++V G
Sbjct: 171 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLIS 129
           +A ++   + I+G+G FG+VY+GV +++      VAVK  +   +   +  F  E  ++ 
Sbjct: 9   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 68
Query: 130 VAIHKNLLQLIGYCTTSSERILV--YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 187
              H ++++LIG        I++  YP+ +   + + L   K   K L   T    +   
Sbjct: 69  NLDHPHIVKLIGIIEEEPTWIIMELYPYGE---LGHYLERNKNSLKVL---TLVLYSLQI 122
Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMG 247
              + YL E  N   +HRD+   NIL+       L DFGL++ ++ +  +  +  R  + 
Sbjct: 123 CKAMAYL-ESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK 179
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
            ++PE ++  + +  +DV+ + + + E+++
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILS 209

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 23/221 (10%)
Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHL 127
           +E +     +    ++G GGFG VY G+ +SDN  VA+K ++ D  S  GE      V +
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
Query: 128 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------ 181
             V     LL+ +    +   R+L + F +  S    L   +P +   D+ T +      
Sbjct: 61  EVV-----LLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEE 114
Query: 182 --RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKLVDAKLTHV 238
             R  F     LE +    N  ++HRD+K  NIL+D N  E  L DFG   L+      V
Sbjct: 115 LARSFFWQV--LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---V 169
Query: 239 TTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELVTG 278
            T   GT  +  PE++   +   ++  V+  GI L ++V G
Sbjct: 170 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 23/207 (11%)
Query: 84  IIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
           ++G GGFG VY G+ +SDN  VA+K ++ D  S  GE      V +  V     LL+ + 
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV-----LLKKVS 68
Query: 142 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--------RVAFGTAYGLEY 193
              +   R+L + F +  S    L   +P +   D+ T +        R  F     LE 
Sbjct: 69  SGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV--LEA 125
Query: 194 LHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 252
           +    N  ++HRD+K  NIL+D N  E  L DFG   L+      V T   GT  +  PE
Sbjct: 126 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPE 182
Query: 253 YLSTGKSSEKT-DVFGYGITLLELVTG 278
           ++   +   ++  V+  GI L ++V G
Sbjct: 183 WIRYHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 23/221 (10%)
Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHL 127
           +E +     +    ++G GGFG VY G+ +SDN  VA+K ++ D  S  GE      V +
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
Query: 128 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------ 181
             V     LL+ +    +   R+L + F +  S    L   +P +   D+ T +      
Sbjct: 77  EVV-----LLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEE 130
Query: 182 --RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKLVDAKLTHV 238
             R  F     LE +    N  ++HRD+K  NIL+D N  E  L DFG   L+      V
Sbjct: 131 LARSFFWQV--LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---V 185
Query: 239 TTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELVTG 278
            T   GT  +  PE++   +   ++  V+  GI L ++V G
Sbjct: 186 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 98/214 (45%), Gaps = 26/214 (12%)
Query: 79  FSESNIIGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           ++  + IG+G +G V   Y  V  +  +VA+K++  +          RE+ ++    H+N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY------ 189
           ++ +          I+  P ++ +   Y ++DL   +      T+        Y      
Sbjct: 83  IIGI--------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 134
Query: 190 -GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTM 246
            GL+Y+H      ++HRDLK +N+LL+   +  + DFGLA++ D    H    T+   T 
Sbjct: 135 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATR 191
Query: 247 GHIAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
            + APE +   K   K+ D++  G  L E+++ +
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 89/196 (45%), Gaps = 11/196 (5%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           IGQG  G VY  + ++   +VA++++     P  E     E+ ++    + N++  +   
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 86
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  +V  ++   S    L D+   E  +D      V       LE+LH     ++I
Sbjct: 87  LVGDELWVVMEYLAGGS----LTDVV-TETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRD+K+ NILL  +    L DFG    +  + +  +  + GT   +APE ++      K 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 264 DVFGYGITLLELVTGQ 279
           D++  GI  +E++ G+
Sbjct: 198 DIWSLGIMAIEMIEGE 213

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 23/221 (10%)
Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHL 127
           +E +     +    ++G GGFG VY G+ +SDN  VA+K ++ D  S  GE      V +
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 61
Query: 128 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------ 181
             V     LL+ +    +   R+L + F +  S    L   +P +   D+ T +      
Sbjct: 62  EVV-----LLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEE 115
Query: 182 --RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKLVDAKLTHV 238
             R  F     LE +    N  ++HRD+K  NIL+D N  E  L DFG   L+      V
Sbjct: 116 LARSFFWQV--LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---V 170
Query: 239 TTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELVTG 278
            T   GT  +  PE++   +   ++  V+  GI L ++V G
Sbjct: 171 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 23/221 (10%)
Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHL 127
           +E +     +    ++G GGFG VY G+ +SDN  VA+K ++ D  S  GE      V +
Sbjct: 36  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 95
Query: 128 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------ 181
             V     LL+ +    +   R+L + F +  S    L   +P +   D+ T +      
Sbjct: 96  EVV-----LLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEE 149
Query: 182 --RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKLVDAKLTHV 238
             R  F     LE +    N  ++HRD+K  NIL+D N  E  L DFG   L+      V
Sbjct: 150 LARSFFWQV--LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---V 204
Query: 239 TTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELVTG 278
            T   GT  +  PE++   +   ++  V+  GI L ++V G
Sbjct: 205 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG--TMG 247
           G++YL E      +HRDL A N+LL     A + DFGL+K + A   +   Q  G   + 
Sbjct: 139 GMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 195
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQR 280
             APE ++  K S K+DV+ +G+ + E  + GQ+
Sbjct: 196 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 229

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG--TMG 247
           G++YL E      +HRDL A N+LL     A + DFGL+K + A   +   Q  G   + 
Sbjct: 139 GMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 195
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQR 280
             APE ++  K S K+DV+ +G+ + E  + GQ+
Sbjct: 196 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 229

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 23/221 (10%)
Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHL 127
           +E +     +    ++G GGFG VY G+ +SDN  VA+K ++ D  S  GE      V +
Sbjct: 24  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 83
Query: 128 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------ 181
             V     LL+ +    +   R+L + F +  S    L   +P +   D+ T +      
Sbjct: 84  EVV-----LLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEE 137
Query: 182 --RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLAKLVDAKLTHV 238
             R  F     LE +    N  ++HRD+K  NIL+D N  E  L DFG   L+      V
Sbjct: 138 LARSFFWQV--LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---V 192
Query: 239 TTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELVTG 278
            T   GT  +  PE++   +   ++  V+  GI L ++V G
Sbjct: 193 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG--TMG 247
           G++YL E      +HRDL A N+LL     A + DFGL+K + A   +   Q  G   + 
Sbjct: 119 GMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQR 280
             APE ++  K S K+DV+ +G+ + E  + GQ+
Sbjct: 176 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 209

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 14/212 (6%)
Query: 76  TDNFSESNIIGQGGFGKVYKGV---LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI 132
           +D +    I+G GG  +V+      L  +  V V R      P     F+RE    +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 133 HKNLLQLIGYCTTSSERI---LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
           H  ++ +  Y T  +E     L Y  M+ +     LRD+   E  +       V      
Sbjct: 71  HPAIVAV--YATGEAETPAGPLPYIVMEYVD-GVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMG 247
            L + H+     IIHRD+K ANI++       + DFG+A+ +      V  T  + GT  
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           +++PE         ++DV+  G  L E++TG+
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG--TMG 247
           G++YL E      +HRDL A N+LL     A + DFGL+K + A   +   Q  G   + 
Sbjct: 137 GMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 193
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQR 280
             APE ++  K S K+DV+ +G+ + E  + GQ+
Sbjct: 194 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 227

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG--TMG 247
           G++YL E      +HRDL A N+LL     A + DFGL+K + A   +   Q  G   + 
Sbjct: 123 GMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 179
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQR 280
             APE ++  K S K+DV+ +G+ + E  + GQ+
Sbjct: 180 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 213

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           DNF +   IG+G  G V    +  + K VAVK++        E  F  EV ++    H+N
Sbjct: 32  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHEN 87
Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
           ++++        E  +V  F++  ++   +   +  E+ +       V       L  LH
Sbjct: 88  VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLH 142
Query: 196 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 255
            Q    +IHRD+K+ +ILL  +    L DFG    V  ++      + GT   +APE +S
Sbjct: 143 AQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELIS 198
Query: 256 TGKSSEKTDVFGYGITLLELVTGQ 279
                 + D++  GI ++E+V G+
Sbjct: 199 RLPYGPEVDIWSLGIMVIEMVDGE 222

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKR-LQDYYSPGGEAAFQREVHLISVAIHKN 135
           +++++ +IG G FG VY+  L D+ + VA+K+ LQD      +    RE+ ++    H N
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCN 87
Query: 136 LLQLIGYCTTSSERI------LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRKRVAFGTA 188
           +++L  +  +S E+       LV  ++      YR+ R     ++ L     K   +   
Sbjct: 88  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 145
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLV---DAKLTHVTTQIRG 244
             L Y+H      I HRD+K  N+LLD +   + LCDFG AK +   +  ++++ ++   
Sbjct: 146 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 200
Query: 245 TMGHIAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 279
              + APE +      +   DV+  G  L EL+ GQ
Sbjct: 201 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG--TMG 247
           G++YL E      +HRDL A N+LL     A + DFGL+K + A   +   Q  G   + 
Sbjct: 129 GMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 185
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQR 280
             APE ++  K S K+DV+ +G+ + E  + GQ+
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKR-LQDYYSPGGEAAFQREVHLISVAIHKN 135
           +++++ +IG G FG VY+  L D+ + VA+K+ LQD      +    RE+ ++    H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCN 74
Query: 136 LLQLIGYCTTSSERI------LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRKRVAFGTA 188
           +++L  +  +S E+       LV  ++      YR+ R     ++ L     K   +   
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLV---DAKLTHVTTQIRG 244
             L Y+H      I HRD+K  N+LLD +   + LCDFG AK +   +  ++++ ++   
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 187
Query: 245 TMGHIAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 279
              + APE +      +   DV+  G  L EL+ GQ
Sbjct: 188 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           DNF +   IG+G  G V    +  + K VAVK++        E  F  EV ++    H+N
Sbjct: 34  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHEN 89
Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
           ++++        E  +V  F++  ++   +   +  E+ +       V       L  LH
Sbjct: 90  VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLH 144
Query: 196 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 255
            Q    +IHRD+K+ +ILL  +    L DFG    V  ++      + GT   +APE +S
Sbjct: 145 AQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELIS 200
Query: 256 TGKSSEKTDVFGYGITLLELVTGQ 279
                 + D++  GI ++E+V G+
Sbjct: 201 RLPYGPEVDIWSLGIMVIEMVDGE 224

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKR-LQDYYSPGGEAAFQREVHLISVAIHKN 135
           +++++ +IG G FG VY+  L D+ + VA+K+ LQD      +    RE+ ++    H N
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCN 108
Query: 136 LLQLIGYCTTSSERI------LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRKRVAFGTA 188
           +++L  +  +S E+       LV  ++      YR+ R     ++ L     K   +   
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLV---DAKLTHVTTQIRG 244
             L Y+H      I HRD+K  N+LLD +   + LCDFG AK +   +  ++++ ++   
Sbjct: 167 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 221
Query: 245 TMGHIAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 279
              + APE +      +   DV+  G  L EL+ GQ
Sbjct: 222 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 84  IIGQGGFGKVYKGVLSD---NTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQL 139
           ++G+G FG+V K    D     + AVK +    +   + +   REV L+    H N+++L
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
                 SS   +V      L     L D     K        R+      G+ Y+H+   
Sbjct: 87  FEILEDSSSFYIV----GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH-- 140
Query: 200 PKIIHRDLKAANILLDD---NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST 256
             I+HRDLK  NILL+    + +  + DFGL+       T +  +I GT  +IAPE L  
Sbjct: 141 -NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPEVLR- 196
Query: 257 GKSSEKTDVFGYGITLLELVTG 278
           G   EK DV+  G+ L  L++G
Sbjct: 197 GTYDEKCDVWSAGVILYILLSG 218

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG--TMG 247
           G++YL E      +HRDL A N+LL     A + DFGL+K + A   +   Q  G   + 
Sbjct: 117 GMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 173
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQR 280
             APE ++  K S K+DV+ +G+ + E  + GQ+
Sbjct: 174 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 207

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 83/198 (41%), Gaps = 8/198 (4%)
Query: 85  IGQGGFGKVYKGVLSDNT-KVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLIGY 142
           IG+G F  VYKG+ ++ T +VA   LQD      E   F+ E   +    H N+++    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 202
             ++ +       +  L  +  L+      K       +        GL++LH +  P I
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTR-TPPI 152
Query: 203 IHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSE 261
           IHRDLK  NI +     +V + D GLA L  A        + GT    APE     K  E
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFXAPEXYEE-KYDE 208
Query: 262 KTDVFGYGITLLELVTGQ 279
             DV+ +G   LE  T +
Sbjct: 209 SVDVYAFGXCXLEXATSE 226

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           DNF +   IG+G  G V    +  + K VAVK++        E  F  EV ++    H+N
Sbjct: 23  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHEN 78
Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
           ++++        E  +V  F++  ++   +   +  E+ +       V       L  LH
Sbjct: 79  VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLH 133
Query: 196 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 255
            Q    +IHRD+K+ +ILL  +    L DFG    V  ++      + GT   +APE +S
Sbjct: 134 AQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELIS 189
Query: 256 TGKSSEKTDVFGYGITLLELVTGQ 279
                 + D++  GI ++E+V G+
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGE 213

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKR-LQDYYSPGGEAAFQREVHLISVAIHKN 135
           +++++ +IG G FG VY+  L D+ + VA+K+ LQD      +    RE+ ++    H N
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCN 79
Query: 136 LLQLIGYCTTSSERI------LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRKRVAFGTA 188
           +++L  +  +S E+       LV  ++      YR+ R     ++ L     K   +   
Sbjct: 80  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 137
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLV---DAKLTHVTTQIRG 244
             L Y+H      I HRD+K  N+LLD +   + LCDFG AK +   +  ++++ ++   
Sbjct: 138 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 192
Query: 245 TMGHIAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 279
              + APE +      +   DV+  G  L EL+ GQ
Sbjct: 193 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 26/205 (12%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  +L  N  VA+K+L   +     A    RE+ L+ V  HKN++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 141 GYCTTS---SERILVYPFMQ----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
              T      E   VY  M+    NLS   ++         LD      + +    G+++
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVIQME--------LDHERMSYLLYQMLVGIKH 141
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH      IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 196
Query: 254 LSTGKSSEKTDVFGYGITLLELVTG 278
           +      E  D++  G  + E++ G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKR-LQDYYSPGGEAAFQREVHLISVAIHKN 135
           +++++ +IG G FG VY+  L D+ + VA+K+ LQD      +    RE+ ++    H N
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCN 110
Query: 136 LLQLIGYCTTSSERI------LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRKRVAFGTA 188
           +++L  +  +S E+       LV  ++      YR+ R     ++ L     K   +   
Sbjct: 111 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 168
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLV---DAKLTHVTTQIRG 244
             L Y+H      I HRD+K  N+LLD +   + LCDFG AK +   +  ++++ ++   
Sbjct: 169 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 223
Query: 245 TMGHIAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 279
              + APE +      +   DV+  G  L EL+ GQ
Sbjct: 224 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKR-LQDYYSPGGEAAFQREVHLISVAIHKN 135
           +++++ +IG G FG VY+  L D+ + VA+K+ LQD      +    RE+ ++    H N
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCN 102
Query: 136 LLQLIGYCTTSSERI------LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRKRVAFGTA 188
           +++L  +  +S E+       LV  ++      YR+ R     ++ L     K   +   
Sbjct: 103 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 160
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLV---DAKLTHVTTQIRG 244
             L Y+H      I HRD+K  N+LLD +   + LCDFG AK +   +  ++++ ++   
Sbjct: 161 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 215
Query: 245 TMGHIAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 279
              + APE +      +   DV+  G  L EL+ GQ
Sbjct: 216 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 102/223 (45%), Gaps = 39/223 (17%)
Query: 85  IGQGGFGKVYKGVLSDNTKV-AVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIG 141
           +G+G +G V+K +     +V AVK++ D +  S   +  F+  + L  ++ H+N++ L+ 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 142 YCTTSSER--ILVYPFMQ-NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
                ++R   LV+ +M+ +L    R   L+P  K       + V +     ++YLH   
Sbjct: 77  VLRADNDRDVYLVFDYMETDLHAVIRANILEPVHK-------QYVVYQLIKVIKYLHSGG 129
Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR--------------- 243
              ++HRD+K +NILL+      + DFGL++     +  VT  I                
Sbjct: 130 ---LLHRDMKPSNILLNAECHVKVADFGLSRSF-VNIRRVTNNIPLSINENTENFDDDQP 185
Query: 244 ------GTMGHIAPEY-LSTGKSSEKTDVFGYGITLLELVTGQ 279
                  T  + APE  L + K ++  D++  G  L E++ G+
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 93/219 (42%), Gaps = 32/219 (14%)
Query: 78  NFSESNIIGQGGFGKVY--KGVLS---------DNTKVAVKRLQDYYSPGGEAAFQREVH 126
           N+     IG+G F KV   + +L+         D T++    LQ  +         REV 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLF---------REVR 65
Query: 127 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV-AYRLRDLKPGEKGLDWPTRKRVAF 185
           ++ V  H N+++L     T     LV  +     V  Y +   +  EK      R+ V+ 
Sbjct: 66  IMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS- 124
Query: 186 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 245
                ++Y H++    I+HRDLKA N+LLD +    + DFG +   +    +   +  G+
Sbjct: 125 ----AVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDEFCGS 175
Query: 246 MGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAID 283
             + APE     K    + DV+  G+ L  LV+G    D
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 84  IIGQGGFGKVYKGVLSD---NTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQL 139
           ++G+G FG+V K    D     + AVK +    +   + +   REV L+    H N+++L
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
                 SS   +V      L     L D     K        R+      G+ Y+H+   
Sbjct: 87  FEILEDSSSFYIV----GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH-- 140
Query: 200 PKIIHRDLKAANILLDD---NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST 256
             I+HRDLK  NILL+    + +  + DFGL+       T +  +I GT  +IAPE L  
Sbjct: 141 -NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPEVLR- 196
Query: 257 GKSSEKTDVFGYGITLLELVTG 278
           G   EK DV+  G+ L  L++G
Sbjct: 197 GTYDEKCDVWSAGVILYILLSG 218

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKR-LQDYYSPGGEAAFQREVHLISVAIHKN 135
           +++++ +IG G FG VY+  L D+ + VA+K+ LQD      +    RE+ ++    H N
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCN 112
Query: 136 LLQLIGYCTTSSERI------LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRKRVAFGTA 188
           +++L  +  +S E+       LV  ++      YR+ R     ++ L     K   +   
Sbjct: 113 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 170
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLV---DAKLTHVTTQIRG 244
             L Y+H      I HRD+K  N+LLD +   + LCDFG AK +   +  ++++ ++   
Sbjct: 171 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 225
Query: 245 TMGHIAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 279
              + APE +      +   DV+  G  L EL+ GQ
Sbjct: 226 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 34/218 (15%)
Query: 76  TDNFSESNIIGQGGFGKVY---KGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI 132
           +D +    ++G+G FG+V      +      V V   +       + +  REV L+    
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 133 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLD-WPTRKRVAFGTA--- 188
           H N+ +L             Y F ++    Y + ++  G +  D   +RKR +   A   
Sbjct: 85  HPNIXKL-------------YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI 131
Query: 189 -----YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV---LCDFGLAKLVDAKLTHVTT 240
                 G+ Y H+    KI+HRDLK  N+LL+   +     + DFGL+   +A  +    
Sbjct: 132 IRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKXK 186
Query: 241 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
              GT  +IAPE L  G   EK DV+  G+ L  L++G
Sbjct: 187 DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG--TMG 247
           G++YL E      +HRDL A N+LL     A + DFGL+K + A   +   Q  G   + 
Sbjct: 481 GMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 537
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQR 280
             APE ++  K S K+DV+ +G+ + E  + GQ+
Sbjct: 538 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 571

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG--TMG 247
           G++YL E      +HRDL A N+LL     A + DFGL+K + A   +   Q  G   + 
Sbjct: 482 GMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 538
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQR 280
             APE ++  K S K+DV+ +G+ + E  + GQ+
Sbjct: 539 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 572

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           DNF +   IG+G  G V    +  + K VAVK++        E  F  EV ++    H+N
Sbjct: 27  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHEN 82
Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
           ++++        E  +V  F++  ++   +   +  E+ +       V       L  LH
Sbjct: 83  VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLH 137
Query: 196 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 255
            Q    +IHRD+K+ +ILL  +    L DFG    V  ++      + GT   +APE +S
Sbjct: 138 AQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELIS 193
Query: 256 TGKSSEKTDVFGYGITLLELVTGQ 279
                 + D++  GI ++E+V G+
Sbjct: 194 RLPYGPEVDIWSLGIMVIEMVDGE 217

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKR-LQDYYSPGGEAAFQREVHLISVAIHKN 135
           +++++ +IG G FG VY+  L D+ + VA+K+ LQD      +    RE+ ++    H N
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCN 153
Query: 136 LLQLIGYCTTSSERI------LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRKRVAFGTA 188
           +++L  +  +S E+       LV  ++      YR+ R     ++ L     K   +   
Sbjct: 154 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 211
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLV---DAKLTHVTTQIRG 244
             L Y+H      I HRD+K  N+LLD +   + LCDFG AK +   +  ++++ ++   
Sbjct: 212 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 266
Query: 245 TMGHIAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 279
              + APE +      +   DV+  G  L EL+ GQ
Sbjct: 267 ---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 55/97 (56%), Gaps = 6/97 (6%)
Query: 182 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHVTT 240
           ++A      LE+LH + +  +IHRD+K +N+L++   +  +CDFG++  LVD+    +  
Sbjct: 157 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDA 214
Query: 241 QIRGTMG--HIAPEYLSTGKSSEKTDVFGYGITLLEL 275
             +  M    I PE    G S  K+D++  GIT++EL
Sbjct: 215 GCKPYMAPERINPELNQKGYSV-KSDIWSLGITMIEL 250

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 28/207 (13%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLI 140
           +G G +G V   Y   L    KVAVK+L + + S        RE+ L+    H+N++ L+
Sbjct: 28  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 141 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFGTAYGLEY 193
              T ++        +++ S  Y +  L   +       + L     + + +    GL+Y
Sbjct: 86  DVFTPATS-------IEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKY 138
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE- 252
           +H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + APE 
Sbjct: 139 IH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYV----ATRWYRAPEI 191
Query: 253 YLSTGKSSEKTDVFGYGITLLELVTGQ 279
            L+    ++  D++  G  + EL+ G+
Sbjct: 192 MLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           DNF +   IG+G  G V    +  + K VAVK++        E  F  EV ++    H+N
Sbjct: 154 DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHEN 209
Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
           ++++        E  +V  F++  ++   +   +  E+ +       V       L  LH
Sbjct: 210 VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLH 264
Query: 196 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 255
            Q    +IHRD+K+ +ILL  +    L DFG    V  ++      + GT   +APE +S
Sbjct: 265 AQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELIS 320
Query: 256 TGKSSEKTDVFGYGITLLELVTGQ 279
                 + D++  GI ++E+V G+
Sbjct: 321 RLPYGPEVDIWSLGIMVIEMVDGE 344

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 88/205 (42%), Gaps = 24/205 (11%)
Query: 84  IIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQR--EVHLISV-------AIH 133
           +IG+G FGKV      ++    AVK LQ       +A  ++  E H++S          H
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQK------KAILKKKEEKHIMSERNVLLKNVKH 98
Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
             L+ L     T+ +   V  ++    + Y L+     E+    P  +  A   A  L Y
Sbjct: 99  PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGY 154
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH      I++RDLK  NILLD     VL DFGL K  + +    T+   GT  ++APE 
Sbjct: 155 LHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYLAPEV 210
Query: 254 LSTGKSSEKTDVFGYGITLLELVTG 278
           L         D +  G  L E++ G
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 26/205 (12%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  +L  N  VA+K+L   +     A    RE+ L+ V  HKN++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 141 GYCTTS---SERILVYPFMQ----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
              T      E   VY  M+    NLS   ++         LD      + +    G+++
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVIQME--------LDHERMSYLLYQMLCGIKH 141
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH      IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 196
Query: 254 LSTGKSSEKTDVFGYGITLLELVTG 278
           +      E  D++  G  + E++ G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKR-LQDYYSPGGEAAFQREVHLISVAIHKN 135
           +++++ +IG G FG VY+  L D+ + VA+K+ LQD      +    RE+ ++    H N
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCN 82
Query: 136 LLQLIGYCTTSSERI------LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRKRVAFGTA 188
           +++L  +  +S E+       LV  ++      YR+ R     ++ L     K   +   
Sbjct: 83  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 140
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMG 247
             L Y+H      I HRD+K  N+LLD +   + LCDFG AK +     +V+     +  
Sbjct: 141 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRY 195
Query: 248 HIAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 279
           + APE +      +   DV+  G  L EL+ GQ
Sbjct: 196 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 28/207 (13%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLI 140
           +G G +G V   Y   L    KVAVK+L + + S        RE+ L+    H+N++ L+
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 141 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFGTAYGLEY 193
              T ++        +++ S  Y +  L   +       + L     + + +    GL+Y
Sbjct: 94  DVFTPATS-------IEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKY 146
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE- 252
           +H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + APE 
Sbjct: 147 IH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYV----ATRWYRAPEI 199
Query: 253 YLSTGKSSEKTDVFGYGITLLELVTGQ 279
            L+    ++  D++  G  + EL+ G+
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 73/170 (42%), Gaps = 19/170 (11%)
Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QI 242
           +F  A G+E+L  +   K IHRDL A NILL +     +CDFGLA+ +     +V     
Sbjct: 206 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 262
Query: 243 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKL 302
           R  +  +APE +     + ++DV+ +G+ L E+ +                      R+L
Sbjct: 263 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYPGVKIDEEFCRRL 316
Query: 303 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
               R+          Y + E   M Q  L C    P  RP  +++V+ L
Sbjct: 317 KEGTRM------RAPDYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           DNF +   IG+G  G V    +  + K VAVK++        E  F  EV ++    H+N
Sbjct: 77  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHEN 132
Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
           ++++        E  +V  F++  ++   +   +  E+ +       V       L  LH
Sbjct: 133 VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLH 187
Query: 196 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 255
            Q    +IHRD+K+ +ILL  +    L DFG    V  ++      + GT   +APE +S
Sbjct: 188 AQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELIS 243
Query: 256 TGKSSEKTDVFGYGITLLELVTGQ 279
                 + D++  GI ++E+V G+
Sbjct: 244 RLPYGPEVDIWSLGIMVIEMVDGE 267

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKR-LQDYYSPGGEAAFQREVHLISVAIHKN 135
           +++++ +IG G FG VY+  L D+ + VA+K+ LQD      +    RE+ ++    H N
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCN 75
Query: 136 LLQLIGYCTTSSERI------LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRKRVAFGTA 188
           +++L  +  +S E+       LV  ++      YR+ R     ++ L     K   +   
Sbjct: 76  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 133
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMG 247
             L Y+H      I HRD+K  N+LLD +   + LCDFG AK +     +V+     +  
Sbjct: 134 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRY 188
Query: 248 HIAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 279
           + APE +      +   DV+  G  L EL+ GQ
Sbjct: 189 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 14/212 (6%)
Query: 76  TDNFSESNIIGQGGFGKVYKGV---LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI 132
           +D +    I+G GG  +V+      L  +  V V R      P     F+RE    +   
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 133 HKNLLQLIGYCTTSSERI---LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
           H  ++ +  Y T  +E     L Y  M+ +     LRD+   E  +       V      
Sbjct: 88  HPAIVAV--YDTGEAETPAGPLPYIVMEYVD-GVTLRDIVHTEGPMTPKRAIEVIADACQ 144
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMG 247
            L + H+     IIHRD+K ANI++       + DFG+A+ +      V  T  + GT  
Sbjct: 145 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 201
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           +++PE         ++DV+  G  L E++TG+
Sbjct: 202 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKR-LQDYYSPGGEAAFQREVHLISVAIHKN 135
           +++++ +IG G FG VY+  L D+ + VA+K+ LQD      +    RE+ ++    H N
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCN 86
Query: 136 LLQLIGYCTTSSERI------LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRKRVAFGTA 188
           +++L  +  +S E+       LV  ++      YR+ R     ++ L     K   +   
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMG 247
             L Y+H      I HRD+K  N+LLD +   + LCDFG AK +     +V+     +  
Sbjct: 145 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRY 199
Query: 248 HIAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 279
           + APE +      +   DV+  G  L EL+ GQ
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKR-LQDYYSPGGEAAFQREVHLISVAIHKN 135
           +++++ +IG G FG VY+  L D+ + VA+K+ LQD      +    RE+ ++    H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCN 74
Query: 136 LLQLIGYCTTSSERI------LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRKRVAFGTA 188
           +++L  +  +S E+       LV  ++      YR+ R     ++ L     K   +   
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMG 247
             L Y+H      I HRD+K  N+LLD +   + LCDFG AK +     +V+     +  
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRY 187
Query: 248 HIAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 279
           + APE +      +   DV+  G  L EL+ GQ
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 73/170 (42%), Gaps = 19/170 (11%)
Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QI 242
           +F  A G+E+L  +   K IHRDL A NILL +     +CDFGLA+ +     +V     
Sbjct: 199 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 243 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKL 302
           R  +  +APE +     + ++DV+ +G+ L E+ +                      R+L
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYPGVKIDEEFCRRL 309
Query: 303 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
               R+          Y + E   M Q  L C    P  RP  +++V+ L
Sbjct: 310 KEGTRM------RAPDYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKR-LQDYYSPGGEAAFQREVHLISVAIHKN 135
           +++++ +IG G FG VY+  L D+ + VA+K+ LQD      +    RE+ ++    H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCN 74
Query: 136 LLQLIGYCTTSSERI-LVYPFMQNL------SVAYRL-RDLKPGEKGLDWPTRKRVAFGT 187
           +++L  +  +S E+  +VY    NL         YR+ R     ++ L     K   +  
Sbjct: 75  IVRLRYFFYSSGEKKDVVY---LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTM 246
              L Y+H      I HRD+K  N+LLD +   + LCDFG AK +     +V+     + 
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SR 186
Query: 247 GHIAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 279
            + APE +      +   DV+  G  L EL+ GQ
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKR-LQDYYSPGGEAAFQREVHLISVAIHKN 135
           +++++ +IG G FG VY+  L D+ + VA+K+ LQD      +    RE+ ++    H N
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCN 86
Query: 136 LLQLIGYCTTSSERI------LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRKRVAFGTA 188
           +++L  +  +S E+       LV  ++      YR+ R     ++ L     K   +   
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMG 247
             L Y+H      I HRD+K  N+LLD +   + LCDFG AK +     +V+     +  
Sbjct: 145 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRY 199
Query: 248 HIAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 279
           + APE +      +   DV+  G  L EL+ GQ
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKR-LQDYYSPGGEAAFQREVHLISVAIHKN 135
           +++++ +IG G FG VY+  L D+ + VA+K+ LQD      +    RE+ ++    H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCN 74
Query: 136 LLQLIGYCTTSSERI------LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRKRVAFGTA 188
           +++L  +  +S E+       LV  ++      YR+ R     ++ L     K   +   
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMG 247
             L Y+H      I HRD+K  N+LLD +   + LCDFG AK +     +V+     +  
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRY 187
Query: 248 HIAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 279
           + APE +      +   DV+  G  L EL+ GQ
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 73/170 (42%), Gaps = 19/170 (11%)
Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QI 242
           +F  A G+E+L  +   K IHRDL A NILL +     +CDFGLA+ +     +V     
Sbjct: 197 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 253
Query: 243 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKL 302
           R  +  +APE +     + ++DV+ +G+ L E+ +                      R+L
Sbjct: 254 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYPGVKIDEEFCRRL 307
Query: 303 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
               R+          Y + E   M Q  L C    P  RP  +++V+ L
Sbjct: 308 KEGTRM------RAPDYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 73/170 (42%), Gaps = 19/170 (11%)
Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT-QI 242
           +F  A G+E+L  +   K IHRDL A NILL +     +CDFGLA+ +     +V     
Sbjct: 204 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 260
Query: 243 RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRXXXXXXXXXXXHIRKL 302
           R  +  +APE +     + ++DV+ +G+ L E+ +                      R+L
Sbjct: 261 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------LGASPYPGVKIDEEFCRRL 314
Query: 303 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
               R+          Y + E   M Q  L C    P  RP  +++V+ L
Sbjct: 315 KEGTRM------RAPDYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKR-LQDYYSPGGEAAFQREVHLISVAIHKN 135
           +++++ +IG G FG VY+  L D+ + VA+K+ LQD      +    RE+ ++    H N
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCN 93
Query: 136 LLQLIGYCTTSSERI------LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRKRVAFGTA 188
           +++L  +  +S E+       LV  ++      YR+ R     ++ L     K   +   
Sbjct: 94  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 151
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMG 247
             L Y+H      I HRD+K  N+LLD +   + LCDFG AK +     +V+     +  
Sbjct: 152 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRY 206
Query: 248 HIAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 279
           + APE +      +   DV+  G  L EL+ GQ
Sbjct: 207 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKR-LQDYYSPGGEAAFQREVHLISVAIHKN 135
           +++++ +IG G FG VY+  L D+ + VA+K+ LQD      +    RE+ ++    H N
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCN 108
Query: 136 LLQLIGYCTTSSERI------LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRKRVAFGTA 188
           +++L  +  +S E+       LV  ++      YR+ R     ++ L     K   +   
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMG 247
             L Y+H      I HRD+K  N+LLD +   + LCDFG AK +     +V+     +  
Sbjct: 167 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRY 221
Query: 248 HIAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 279
           + APE +      +   DV+  G  L EL+ GQ
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 16/211 (7%)
Query: 78  NFSESNIIGQGGFGKVY--KGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHK 134
           N+     IG+G F KV   + +L+   +VAVK + +   +        REV ++ V  H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSV-AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
           N+++L     T     LV  +     V  Y +   +  EK      R+ V+      ++Y
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-----AVQY 128
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
            H++    I+HRDLKA N+LLD +    + DFG +   +    +      G+  + APE 
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDTFCGSPPYAAPEL 183
Query: 254 LSTGK-SSEKTDVFGYGITLLELVTGQRAID 283
               K    + DV+  G+ L  LV+G    D
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 28/207 (13%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           +G G +G V   Y   L    KVAVK+L   +     A    RE+ L+    H+N++ L+
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 141 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFGTAYGLEY 193
              T ++        +++ S  Y +  L   +       + L     + + +    GL+Y
Sbjct: 94  DVFTPATS-------IEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKY 146
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE- 252
           +H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + APE 
Sbjct: 147 IH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYV----ATRWYRAPEI 199
Query: 253 YLSTGKSSEKTDVFGYGITLLELVTGQ 279
            L+    ++  D++  G  + EL+ G+
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 95/231 (41%), Gaps = 42/231 (18%)
Query: 84  IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           ++ +GGF  VY+   +    + A+KRL         A  Q    +  ++ H N++Q   +
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ---F 91
Query: 143 CTTSS-----------ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL 191
           C+ +S           E +L+    +   V +  +    G    D  T  ++ + T   +
Sbjct: 92  CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCD--TVLKIFYQTCRAV 149
Query: 192 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA----------------KLVDAKL 235
           +++H Q  P IIHRDLK  N+LL +     LCDFG A                 LV+ ++
Sbjct: 150 QHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 236 THVTTQIRGTMGHIAPEYL---STGKSSEKTDVFGYGITLLELVTGQRAID 283
           T  TT +  T     PE +   S     EK D++  G  L  L   Q   +
Sbjct: 209 TRNTTPMYRT-----PEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG--TMG 247
           G++YL E      +HRDL A N+LL     A + DFGL+K + A       Q  G   + 
Sbjct: 123 GMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVK 179
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQR 280
             APE ++  K S K+DV+ +G+ + E  + GQ+
Sbjct: 180 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 213

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 16/211 (7%)
Query: 78  NFSESNIIGQGGFGKVY--KGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHK 134
           N+     IG+G F KV   + +L+   +VAVK + +   +        REV ++ V  H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSV-AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
           N+++L     T     LV  +     V  Y +   +  EK      R+ V+      ++Y
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-----AVQY 128
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
            H++    I+HRDLKA N+LLD +    + DFG +   +    +      G+  + APE 
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDTFCGSPPYAAPEL 183
Query: 254 LSTGK-SSEKTDVFGYGITLLELVTGQRAID 283
               K    + DV+  G+ L  LV+G    D
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 14/212 (6%)
Query: 76  TDNFSESNIIGQGGFGKVYKGV---LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI 132
           +D +    I+G GG  +V+      L  +  V V R      P     F+RE    +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 133 HKNLLQLIGYCTTSSERI---LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
           H  ++ +  Y T  +E     L Y  M+ +     LRD+   E  +       V      
Sbjct: 71  HPAIVAV--YDTGEAETPAGPLPYIVMEYVD-GVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMG 247
            L + H+     IIHRD+K ANI++       + DFG+A+ +      V  T  + GT  
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           +++PE         ++DV+  G  L E++TG+
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTK-VAVKR-LQDYYSPGGEAAFQREVHLISVAIHKN 135
           +++++ +IG G FG VY+  L D+ + VA+K+ LQD      +    RE+ ++    H N
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCN 78
Query: 136 LLQLIGYCTTSSERI------LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRKRVAFGTA 188
           +++L  +  +S E+       LV  ++      YR+ R     ++ L     K   +   
Sbjct: 79  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE--TVYRVARHYSRAKQTLPVIYVKLYMYQLF 136
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMG 247
             L Y+H      I HRD+K  N+LLD +   + LCDFG AK +     +V+     +  
Sbjct: 137 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRY 191
Query: 248 HIAPEYL-STGKSSEKTDVFGYGITLLELVTGQ 279
           + APE +      +   DV+  G  L EL+ GQ
Sbjct: 192 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 32/219 (14%)
Query: 78  NFSESNIIGQGGFGKVY--KGVLS---------DNTKVAVKRLQDYYSPGGEAAFQREVH 126
           N+     IG+G F KV   + +L+         D T++    LQ  +         REV 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLF---------REVR 65
Query: 127 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSV-AYRLRDLKPGEKGLDWPTRKRVAF 185
           ++ V  H N+++L     T     LV  +     V  Y +   +  EK      R+ V+ 
Sbjct: 66  IMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS- 124
Query: 186 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 245
                ++Y H++    I+HRDLKA N+LLD +    + DFG +   +    +      G+
Sbjct: 125 ----AVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDTFCGS 175
Query: 246 MGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAID 283
             + APE     K    + DV+  G+ L  LV+G    D
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 14/200 (7%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           +G G +G V     +    K+AVK+L + + S        RE+ L+    H+N++ L+  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 143 CT--TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 200
            T  TS E       + +L  A  L ++   +K  D    + + +    GL+Y+H   + 
Sbjct: 119 FTPATSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTD-DHVQFLIYQILRGLKYIH---SA 173
Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSS 260
            IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + APE +      
Sbjct: 174 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNWMHY 229
Query: 261 EKT-DVFGYGITLLELVTGQ 279
             T D++  G  + EL+TG+
Sbjct: 230 NMTVDIWSVGCIMAELLTGR 249

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 16/211 (7%)
Query: 78  NFSESNIIGQGGFGKVY--KGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHK 134
           N+     IG+G F KV   + +L+   +VAVK + +   +        REV ++ V  H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSV-AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
           N+++L     T     LV  +     V  Y +   +  EK      R+ V+      ++Y
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS-----AVQY 128
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
            H++    I+HRDLKA N+LLD +    + DFG +   +    +      G   + APE 
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDAFCGAPPYAAPEL 183
Query: 254 LSTGK-SSEKTDVFGYGITLLELVTGQRAID 283
               K    + DV+  G+ L  LV+G    D
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 32/216 (14%)
Query: 78  NFSESNIIGQGGFGK-VYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKN 135
           +F   +++G G  G  VY+G+  DN  VAVKR+     P   +   REV L+  +  H N
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRIL----PECFSFADREVQLLRESDEHPN 79
Query: 136 LLQLIGYCTTSSERILVYPFMQ----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL 191
           +++   Y  T  +R   Y  ++     L      +D      GL+  T   +   T  GL
Sbjct: 80  VIR---YFCTEKDRQFQYIAIELCAATLQEYVEQKDF--AHLGLEPIT---LLQQTTSGL 131
Query: 192 EYLHEQCNPKIIHRDLKAANILLD-----DNFEAVLCDFGLAKLVDAKLTHVTTQ--IRG 244
            +LH   +  I+HRDLK  NIL+         +A++ DFGL K +       + +  + G
Sbjct: 132 AHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPG 188
Query: 245 TMGHIAPEYLSTGKSSEKT---DVFGYGITLLELVT 277
           T G IAPE LS       T   D+F  G     +++
Sbjct: 189 TEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILL-DDNFEAVLCDFGLAKLVD----AKLTHVTTQIRG 244
           GLEYLH +   +I+H D+KA N+LL  D   A LCDFG A  +      K       I G
Sbjct: 197 GLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPG 253
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           T  H+APE +       K DV+     +L ++ G
Sbjct: 254 TETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 79  FSESNIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLISV 130
           F+ES  +GQG F K++KGV  +         T+V +K L   +    E+ F+    ++S 
Sbjct: 12  FNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE-AASMMSK 68
Query: 131 AIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG 190
             HK+L+   G C    E ILV  F++  S+      LK  +  ++   +  VA   A+ 
Sbjct: 69  LSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTY---LKKNKNCINILWKLEVAKQLAWA 125
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ---IRGTMG 247
           + +L E     +IH ++ A NILL    +    +    KL D  ++        ++  + 
Sbjct: 126 MHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP 182
Query: 248 HIAPEYLSTGKS-SEKTDVFGYGITLLELVTG 278
            + PE +   K+ +  TD + +G TL E+ +G
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 30/208 (14%)
Query: 85  IGQGGFGKVYKGVLSDN-TKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           IG G +G V     +    +VAVK+L + + S        RE+ L+    H+N++ L+  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 143 CTTS------SERILVYPFM----QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 192
            T +      ++  LV   M     N+    +L D             + + +    GL+
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD----------DHVQFLIYQILRGLK 144
Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 252
           Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + APE
Sbjct: 145 YIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV----ATRWYRAPE 197
Query: 253 -YLSTGKSSEKTDVFGYGITLLELVTGQ 279
             L+    ++  D++  G  + EL+TG+
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 75  ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAI 132
           + D +     +G+G +G+VYK + +  N  VA+KR++ ++   G      REV L+    
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ 91
Query: 133 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP-GEKGLDWPTR--KRVAFGTAY 189
           H+N+++L      +    L++ + +N        DLK   +K  D   R  K   +    
Sbjct: 92  HRNIIELKSVIHHNHRLHLIFEYAEN--------DLKKYMDKNPDVSMRVIKSFLYQLIN 143
Query: 190 GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVL--CDFGLAKLVDAKLTHVTTQIRG 244
           G+ + H +   + +HRDLK  N+LL   D +   VL   DFGLA+     +   T +I  
Sbjct: 144 GVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII- 199
Query: 245 TMGHIAPEYLSTGKS-SEKTDVFGYGITLLELV 276
           T+ +  PE L   +  S   D++       E++
Sbjct: 200 TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 6/97 (6%)
Query: 182 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHVTT 240
           ++A      LE+LH + +  +IHRD+K +N+L++   +  +CDFG++  LVD     +  
Sbjct: 113 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA 170
Query: 241 QIRGTMG--HIAPEYLSTGKSSEKTDVFGYGITLLEL 275
             +  M    I PE    G S  K+D++  GIT++EL
Sbjct: 171 GCKPYMAPERINPELNQKGYSV-KSDIWSLGITMIEL 206

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 52/100 (52%), Gaps = 8/100 (8%)
Query: 183 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAV-LCDFGLAKLVDAKLTHV 238
           V F     +EYLH Q    ++HRDLK +NIL  D   N E++ +CDFG AK + A+   +
Sbjct: 121 VLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
            T    T   +APE L         D++  G+ L  ++TG
Sbjct: 178 MTPCY-TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY----SPG-GEAAFQREVHLI 128
           L  D +    +IG+G F  V + +  +  +    ++ D      SPG      +RE  + 
Sbjct: 21  LFEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80
Query: 129 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 188
            +  H ++++L+   ++     +V+ FM    + + +  +K  + G  +      A  + 
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEI--VKRADAGFVYSE----AVASH 134
Query: 189 Y------GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLA-KLVDAKLTHV 238
           Y       L Y H+     IIHRD+K  N+LL   +++    L DFG+A +L ++ L  V
Sbjct: 135 YMRQILEALRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGL--V 189
Query: 239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
                GT   +APE +      +  DV+G G+ L  L++G
Sbjct: 190 AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILL-DDNFEAVLCDFGLAKLVD----AKLTHVTTQIRG 244
           GLEYLH +   +I+H D+KA N+LL  D   A LCDFG A  +      K       I G
Sbjct: 162 GLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           T  H+APE +       K D++     +L ++ G
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 16/215 (7%)
Query: 74  LATDNFSESNIIGQGGFGKVY--KGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISV 130
           L   N+     IG+G F KV   + +L+   +VAVK + +   +        REV ++ V
Sbjct: 4   LHIGNYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKV 62
Query: 131 AIHKNLLQLIGYCTTSSERILVYPFMQNLSVA-YRLRDLKPGEKGLDWPTRKRVAFGTAY 189
             H N+++L     T     LV  +     V  Y +      EK      R+ V+     
Sbjct: 63  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVS----- 117
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            ++Y H++    I+HRDLKA N+LLD +    + DFG +   +    +      G+  + 
Sbjct: 118 AVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDTFCGSPPYA 172
Query: 250 APEYLSTGK-SSEKTDVFGYGITLLELVTGQRAID 283
           APE     K    + DV+  G+ L  LV+G    D
Sbjct: 173 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 142 GLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV----ATRWYR 194
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILL-DDNFEAVLCDFGLAKLVD----AKLTHVTTQIRG 244
           GLEYLH +   +I+H D+KA N+LL  D   A LCDFG A  +      K       I G
Sbjct: 176 GLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 232
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           T  H+APE +       K D++     +L ++ G
Sbjct: 233 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 189
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 190 APEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV----ATRWYR 189
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 148 GLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV----ATRWYR 200
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 46/94 (48%), Gaps = 4/94 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L YLHE+    II+RDLK  N+LLD      L D+G+ K    +    T+   GT  +I
Sbjct: 133 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYI 188
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
           APE L         D +  G+ + E++ G+   D
Sbjct: 189 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 30/212 (14%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH 133
           L T  FSE  +  +   GK++          AVK +      G E++ + E+ ++    H
Sbjct: 30  LGTGAFSEVVLAEEKATGKLF----------AVKCIPKKALKGKESSIENEIAVLRKIKH 79
Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL----DWPTRKRVAFGTAY 189
           +N++ L     + +   LV   +    +  R+      EKG     D  T  R      Y
Sbjct: 80  ENIVALEDIYESPNHLYLVMQLVSGGELFDRIV-----EKGFYTEKDASTLIRQVLDAVY 134
Query: 190 GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
              YLH      I+HRDLK  N+L    D+  + ++ DFGL+K+ + K   ++T   GT 
Sbjct: 135 ---YLHRMG---IVHRDLKPENLLYYSQDEESKIMISDFGLSKM-EGKGDVMSTAC-GTP 186
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           G++APE L+    S+  D +  G+    L+ G
Sbjct: 187 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 46/94 (48%), Gaps = 4/94 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L YLHE+    II+RDLK  N+LLD      L D+G+ K    +    T+   GT  +I
Sbjct: 122 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYI 177
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
           APE L         D +  G+ + E++ G+   D
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILL-DDNFEAVLCDFGLAKLVD----AKLTHVTTQIRG 244
           GLEYLH +   +I+H D+KA N+LL  D   A LCDFG A  +      K       I G
Sbjct: 178 GLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 234
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           T  H+APE +       K D++     +L ++ G
Sbjct: 235 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/256 (22%), Positives = 106/256 (41%), Gaps = 29/256 (11%)
Query: 35  CRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVY 94
           C +  LR+ K+     VA   +     TQL     +E+QL  ++F    +IG+G FG+V 
Sbjct: 41  CSHSALRRDKY-----VAEFLEWAKPFTQL----VKEMQLHREDFEIIKVIGRGAFGEVA 91
Query: 95  KGVLSDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 152
              + +  ++   ++ + +      E A  RE   + V      +  + Y       + +
Sbjct: 92  VVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYL 151
Query: 153 ----YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLK 208
               Y     L++  +  D  P +    +     +A  + + L Y         +HRD+K
Sbjct: 152 VMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY---------VHRDIK 202
Query: 209 AANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-----GKSSEKT 263
             N+LLD N    L DFG    ++   T  ++   GT  +I+PE L       GK   + 
Sbjct: 203 PDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPEC 262
Query: 264 DVFGYGITLLELVTGQ 279
           D +  G+ + E++ G+
Sbjct: 263 DWWSLGVCMYEMLYGE 278

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 26/205 (12%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  +L  N  VA+K+L   +     A    RE+ L+    HKN++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 141 GYCTTS---SERILVYPFMQ----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
              T      E   VY  M+    NLS   ++         LD      + +    G+++
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVIQME--------LDHERMSYLLYQMLCGIKH 141
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH   +  IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE 
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 196
Query: 254 LSTGKSSEKTDVFGYGITLLELVTG 278
           +      E  D++  G  + E++ G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 26/205 (12%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  +L  N  VA+K+L   +     A    RE+ L+    HKN++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 141 GYCTTS---SERILVYPFMQ----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
              T      E   VY  M+    NLS   ++         LD      + +    G+++
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVIQME--------LDHERMSYLLYQMLCGIKH 141
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH   +  IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE 
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 196
Query: 254 LSTGKSSEKTDVFGYGITLLELVTG 278
           +      E  D++  G  + E++ G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 46/94 (48%), Gaps = 4/94 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L YLHE+    II+RDLK  N+LLD      L D+G+ K    +    T+   GT  +I
Sbjct: 118 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYI 173
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
           APE L         D +  G+ + E++ G+   D
Sbjct: 174 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILL-DDNFEAVLCDFGLAKLVD----AKLTHVTTQIRG 244
           GLEYLH +   +I+H D+KA N+LL  D   A LCDFG A  +      K       I G
Sbjct: 178 GLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPG 234
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           T  H+APE +       K DV+     +L ++ G
Sbjct: 235 TETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 46/94 (48%), Gaps = 4/94 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L YLHE+    II+RDLK  N+LLD      L D+G+ K    +    T+   GT  +I
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYI 220
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
           APE L         D +  G+ + E++ G+   D
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 17/212 (8%)
Query: 78  NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIHK 134
           ++   + +G G FGKV  G       KVAVK L  Q   S       +RE+  + +  H 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           ++++L    +T ++  +V  ++        L D       ++    +R+       ++Y 
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVS----GGELFDYICKHGRVEEMEARRLFQQILSAVDYC 127
Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHIAPEY 253
           H      ++HRDLK  N+LLD +  A + DFGL+ ++ D +    +    G+  + APE 
Sbjct: 128 HRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEV 181
Query: 254 LSTGK--SSEKTDVFGYGITLLELVTGQRAID 283
           +S G+  +  + D++  G+ L  L+ G    D
Sbjct: 182 IS-GRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 189
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 189
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/256 (22%), Positives = 106/256 (41%), Gaps = 29/256 (11%)
Query: 35  CRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVY 94
           C +  LR+ K+     VA   +     TQL     +E+QL  ++F    +IG+G FG+V 
Sbjct: 57  CSHSALRRDKY-----VAEFLEWAKPFTQL----VKEMQLHREDFEIIKVIGRGAFGEVA 107
Query: 95  KGVLSDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV 152
              + +  ++   ++ + +      E A  RE   + V      +  + Y       + +
Sbjct: 108 VVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYL 167
Query: 153 ----YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLK 208
               Y     L++  +  D  P +    +     +A  + + L Y         +HRD+K
Sbjct: 168 VMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY---------VHRDIK 218
Query: 209 AANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-----GKSSEKT 263
             N+LLD N    L DFG    ++   T  ++   GT  +I+PE L       GK   + 
Sbjct: 219 PDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPEC 278
Query: 264 DVFGYGITLLELVTGQ 279
           D +  G+ + E++ G+
Sbjct: 279 DWWSLGVCMYEMLYGE 294

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 196
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 142 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 194
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 136 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 188
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 189 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 189
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 149 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 201
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 189
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 149 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 201
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 143 GLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYV----ATRWYR 195
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 189
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 139 GLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYV----ATRWYR 191
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 189
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 189
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXV----ATRWYR 189
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 189
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 143 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 195
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 147 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 199
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 200 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 139 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 191
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 139 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 191
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 189
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 149 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 201
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 94/222 (42%), Gaps = 22/222 (9%)
Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS--PGGEAAFQREVHL 127
           ++++L  ++F    +IG+G FG+V    L +  KV   ++ + +      E A  RE   
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERD 126
Query: 128 ISVAIHKNLLQLIGYCTTSSERILV----YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 183
           + V      +  + Y       + +    Y     L++  +  D  P E    +     +
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI 186
Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG-LAKLVDAKLTHVTTQI 242
           A  + + L Y         +HRD+K  NIL+D N    L DFG   KL++      +  +
Sbjct: 187 AIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV 237
Query: 243 RGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQ 279
            GT  +I+PE L       G+   + D +  G+ + E++ G+
Sbjct: 238 -GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 134 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 186
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 26/214 (12%)
Query: 82  SNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLI 140
           S ++G+G + KV   V L +  + AVK ++          F+    L     +KN+L+LI
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 141 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 200
            +    +   LV+  +Q  S+   ++     +K  +     RV    A  L++LH +   
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQK----QKHFNEREASRVVRDVAAALDFLHTK--- 130
Query: 201 KIIHRDLKAANILLDDNFEAV---LCDFGLAKLVDAKLTHVTTQIR--------GTMGHI 249
            I HRDLK  NIL +   +     +CDF L   +  KL +  T I         G+  ++
Sbjct: 131 GIAHRDLKPENILCESPEKVSPVKICDFDLGSGM--KLNNSCTPITTPELTTPCGSAEYM 188
Query: 250 APEYLS--TGKSS---EKTDVFGYGITLLELVTG 278
           APE +   T +++   ++ D++  G+ L  +++G
Sbjct: 189 APEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 148 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 200
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 156 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 208
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 135 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 187
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 188 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 185
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 139 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 191
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 157 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 209
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 134 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 186
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 142 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 194
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 157 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 209
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 185
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 160 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 212
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 156 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 208
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 143 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 195
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 185
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++T        T  + 
Sbjct: 143 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYR 195
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 26/203 (12%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  VL  N  VA+K+L   +     A    RE+ L+    HKN++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 141 GYCT---TSSERILVYPFMQ----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
              T   T  E   VY  M+    NL    ++         LD      + +    G+++
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQME--------LDHERMSYLLYQMLXGIKH 141
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH      IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 196
Query: 254 LSTGKSSEKTDVFGYGITLLELV 276
           +      E  D++  G  + E+V
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 26/203 (12%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  VL  N  VA+K+L   +     A    RE+ L+    HKN++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 141 GYCT---TSSERILVYPFMQ----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
              T   T  E   VY  M+    NL    ++         LD      + +    G+++
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQME--------LDHERMSYLLYQMLXGIKH 141
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH      IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 196
Query: 254 LSTGKSSEKTDVFGYGITLLELV 276
           +      E  D++  G  + E+V
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 16/211 (7%)
Query: 78  NFSESNIIGQGGFGKVY--KGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHK 134
           N+     IG+G F KV   + +L+   +VAVK + +   +        REV +  V  H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHP 73
Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSV-AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
           N+++L     T     LV  +     V  Y +   +  EK      R+ V+      ++Y
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVS-----AVQY 128
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
            H++    I+HRDLKA N+LLD +    + DFG +   +    +      G   + APE 
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADXNIKIADFGFSN--EFTFGNKLDAFCGAPPYAAPEL 183
Query: 254 LSTGK-SSEKTDVFGYGITLLELVTGQRAID 283
               K    + DV+  G+ L  LV+G    D
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 26/203 (12%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  VL  N  VA+K+L   +     A    RE+ L+    HKN++ L+
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 141 GYCT---TSSERILVYPFMQ----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
              T   T  E   VY  M+    NL    ++         LD      + +    G+++
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQME--------LDHERMSYLLYQMLXGIKH 134
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH      IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE 
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 189
Query: 254 LSTGKSSEKTDVFGYGITLLELV 276
           +      E  D++  G  + E+V
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMV 212

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 85/196 (43%), Gaps = 11/196 (5%)
Query: 85  IGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           IG+G  G V         K VAVK++        E  F  EV ++    H N++ +    
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN-EVVIMRDYHHDNVVDMYSSY 111
Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
               E  +V  F++  ++   +   +  E+ +       V       L YLH Q    +I
Sbjct: 112 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLHNQ---GVI 163
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT 263
           HRD+K+ +ILL  +    L DFG    V  ++      + GT   +APE +S      + 
Sbjct: 164 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLV-GTPYWMAPEVISRLPYGTEV 222
Query: 264 DVFGYGITLLELVTGQ 279
           D++  GI ++E++ G+
Sbjct: 223 DIWSLGIMVIEMIDGE 238

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 51/100 (51%), Gaps = 8/100 (8%)
Query: 183 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAV-LCDFGLAKLVDAKLTHV 238
           V F     +EYLH Q    ++HRDLK +NIL  D   N E++ +CDFG AK + A+   +
Sbjct: 121 VLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
            T    T   +APE L         D++  G+ L   +TG
Sbjct: 178 XTPCY-TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 89/205 (43%), Gaps = 26/205 (12%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   +  VL  N  VAVK+L   +     A    RE+ L+    HKN++ L+
Sbjct: 30  IGSGAQGIVCAAFDTVLGIN--VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 87
Query: 141 GYCT---TSSERILVYPFMQ----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
              T   T  E   VY  M+    NL     +         LD      + +    G+++
Sbjct: 88  NVFTPQKTLEEFQDVYLVMELMDANLCQVIHME--------LDHERMSYLLYQMLCGIKH 139
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH   +  IIHRDLK +NI++  +    + DFGLA+   A    + T    T  + APE 
Sbjct: 140 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TASTNFMMTPYVVTRYYRAPEV 194
Query: 254 LSTGKSSEKTDVFGYGITLLELVTG 278
           +      E  D++  G  + ELV G
Sbjct: 195 ILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 49/92 (53%), Gaps = 8/92 (8%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDD---NFEAV-LCDFGLAKLVDAKLTHVTTQIRGTM 246
           +EYLH Q    ++HRDLK +NIL  D   N E + +CDFG AK + A+   + T    T 
Sbjct: 134 VEYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TA 189
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
             +APE L      E  D++  GI L  ++ G
Sbjct: 190 NFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 92/219 (42%), Gaps = 23/219 (10%)
Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTK----VAVKRL--QDYYSPGGEAAFQREVH 126
               D+F     +G+G FG VY   L+   K    VA+K L        G E   +RE+ 
Sbjct: 19  HFTIDDFEIGRPLGKGKFGNVY---LAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIE 75
Query: 127 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF- 185
           + +   H N+L+L  Y        L+      L  A R    K  +K   +  ++     
Sbjct: 76  IQAHLHHPNILRLYNYFYDRRRIYLI------LEYAPRGELYKELQKSCTFDEQRTATIM 129
Query: 186 -GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG 244
              A  L Y H +   K+IHRD+K  N+LL    E  + DFG +  V A      T   G
Sbjct: 130 EELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWS--VHAPSLRRKTMC-G 183
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
           T+ ++ PE +     +EK D++  G+   EL+ G    +
Sbjct: 184 TLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFE 222

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  +L  N  VA+K+L   +     A    RE+ L+    HKN++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 141 GYCTTSSERILVYPFMQNLSVAYRLRD---LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
              T            Q++ +   L D    +  +  LD      + +    G+++LH  
Sbjct: 90  NVFTPQKS----LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH-- 143
Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 257
            +  IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE +   
Sbjct: 144 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 258 KSSEKTDVFGYGITLLELVTG 278
              E  D++  G  + E++ G
Sbjct: 201 GYKENVDIWSVGCIMGEMIKG 221

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 21/212 (9%)
Query: 79  FSESNIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLISV 130
           F+ES  +GQG F K++KGV  +         T+V +K L   +    E+ F+    ++S 
Sbjct: 12  FNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE-AASMMSK 68
Query: 131 AIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG 190
             HK+L+   G C    E ILV  F++  S+      LK  +  ++   +  VA   A  
Sbjct: 69  LSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTY---LKKNKNCINILWKLEVAKQLAAA 125
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ---IRGTMG 247
           + +L E     +IH ++ A NILL    +    +    KL D  ++        ++  + 
Sbjct: 126 MHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP 182
Query: 248 HIAPEYLSTGKS-SEKTDVFGYGITLLELVTG 278
            + PE +   K+ +  TD + +G TL E+ +G
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  VL  N  VA+K+L   +     A    RE+ L+    HKN++ L+
Sbjct: 70  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 141 GYCT---TSSERILVYPFMQ----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
              T   T  E   VY  M+    NL    ++         LD      + +    G+++
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--------LDHERMSYLLYQMLCGIKH 179
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH   +  IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE 
Sbjct: 180 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEV 234
Query: 254 LSTGKSSEKTDVFGYGITLLELV 276
           +      E  D++  G  + E+V
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMV 257

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 49/92 (53%), Gaps = 8/92 (8%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDD---NFEAV-LCDFGLAKLVDAKLTHVTTQIRGTM 246
           +EYLH Q    ++HRDLK +NIL  D   N E + +CDFG AK + A+   + T    T 
Sbjct: 134 VEYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TA 189
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
             +APE L      E  D++  GI L  ++ G
Sbjct: 190 NFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  VL  N  VA+K+L   +     A    RE+ L+    HKN++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 141 GYCT---TSSERILVYPFMQ----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
              T   T  E   VY  M+    NL    ++         LD      + +    G+++
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--------LDHERMSYLLYQMLCGIKH 141
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH   +  IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE 
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 196
Query: 254 LSTGKSSEKTDVFGYGITLLELV 276
           +      E  D++  G  + E+V
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  VL  N  VA+K+L   +     A    RE+ L+    HKN++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 141 GYCT---TSSERILVYPFMQ----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
              T   T  E   VY  M+    NL    ++         LD      + +    G+++
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQME--------LDHERMSYLLYQMLCGIKH 141
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH   +  IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE 
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 196
Query: 254 LSTGKSSEKTDVFGYGITLLELV 276
           +      E  D++  G  + E+V
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  VL  N  VA+K+L   +     A    RE+ L+    HKN++ L+
Sbjct: 33  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 141 GYCT---TSSERILVYPFMQ----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
              T   T  E   VY  M+    NL    ++         LD      + +    G+++
Sbjct: 91  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--------LDHERMSYLLYQMLCGIKH 142
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH   +  IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE 
Sbjct: 143 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 197
Query: 254 LSTGKSSEKTDVFGYGITLLELV 276
           +      E  D++  G  + E+V
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  VL  N  VA+K+L   +     A    RE+ L+    HKN++ L+
Sbjct: 31  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 88
Query: 141 GYCT---TSSERILVYPFMQ----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
              T   T  E   VY  M+    NL    ++         LD      + +    G+++
Sbjct: 89  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--------LDHERMSYLLYQMLCGIKH 140
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH   +  IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE 
Sbjct: 141 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 195
Query: 254 LSTGKSSEKTDVFGYGITLLELV 276
           +      E  D++  G  + E+V
Sbjct: 196 ILGMGYKENVDIWSVGCIMGEMV 218

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  +L  N  VA+K+L   +     A    RE+ L+    HKN++ L+
Sbjct: 33  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 141 GYCTTSSERILVYPFMQNLSVAYRLRD---LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
              T            Q++ +   L D    +  +  LD      + +    G+++LH  
Sbjct: 91  NVFTPQKS----LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH-- 144
Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 257
            +  IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE +   
Sbjct: 145 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 201
Query: 258 KSSEKTDVFGYGITLLELVTG 278
              E  D++  G  + E++ G
Sbjct: 202 GYKENVDIWSVGCIMGEMIKG 222

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  VL  N  VA+K+L   +     A    RE+ L+    HKN++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 141 GYCT---TSSERILVYPFMQ----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
              T   T  E   VY  M+    NL    ++         LD      + +    G+++
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--------LDHERMSYLLYQMLCGIKH 141
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH   +  IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE 
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 196
Query: 254 LSTGKSSEKTDVFGYGITLLELV 276
           +      E  D++  G  + E+V
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  VL  N  VA+K+L   +     A    RE+ L+    HKN++ L+
Sbjct: 33  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 141 GYCT---TSSERILVYPFMQ----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
              T   T  E   VY  M+    NL    ++         LD      + +    G+++
Sbjct: 91  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--------LDHERMSYLLYQMLCGIKH 142
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH   +  IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE 
Sbjct: 143 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 197
Query: 254 LSTGKSSEKTDVFGYGITLLELV 276
           +      E  D++  G  + E+V
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMV 220

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  VL  N  VA+K+L   +     A    RE+ L+    HKN++ L+
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 141 GYCT---TSSERILVYPFMQ----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
              T   T  E   VY  M+    NL    ++         LD      + +    G+++
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--------LDHERMSYLLYQMLCGIKH 134
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH   +  IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE 
Sbjct: 135 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 189
Query: 254 LSTGKSSEKTDVFGYGITLLELV 276
           +      E  D++  G  + E+V
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMV 212

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  VL  N  VA+K+L   +     A    RE+ L+    HKN++ L+
Sbjct: 26  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 141 GYCT---TSSERILVYPFMQ----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
              T   T  E   VY  M+    NL    ++         LD      + +    G+++
Sbjct: 84  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--------LDHERMSYLLYQMLCGIKH 135
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH   +  IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE 
Sbjct: 136 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 190
Query: 254 LSTGKSSEKTDVFGYGITLLELV 276
           +      E  D++  G  + E+V
Sbjct: 191 ILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  VL  N  VA+K+L   +     A    RE+ L+    HKN++ L+
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 141 GYCT---TSSERILVYPFMQ----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
              T   T  E   VY  M+    NL    ++         LD      + +    G+++
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--------LDHERMSYLLYQMLCGIKH 141
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH   +  IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE 
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 196
Query: 254 LSTGKSSEKTDVFGYGITLLELV 276
           +      E  D++  G  + E+V
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 87/201 (43%), Gaps = 18/201 (8%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  +L  N  VA+K+L   +     A    RE+ L+    HKN++ L+
Sbjct: 34  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 91
Query: 141 GYCTTSSERILVYPFMQNLSVAYRLRD---LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
              T            Q++ +   L D    +  +  LD      + +    G+++LH  
Sbjct: 92  NVFTPQKS----LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH-- 145
Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 257
            +  IIHRDLK +NI++  +    + DFGLA+        V   +  T  + APE +   
Sbjct: 146 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVV--TRYYRAPEVILGM 202
Query: 258 KSSEKTDVFGYGITLLELVTG 278
              E  D++  G  + E++ G
Sbjct: 203 GYKENVDIWSVGCIMGEMIKG 223

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 9/92 (9%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
            ++YLHE     I+HRDLK  N+L    ++N + ++ DFGL+K+   +   + +   GT 
Sbjct: 118 AVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTACGTP 171
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           G++APE L+    S+  D +  G+    L+ G
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  VL  N  VA+K+L   +     A    RE+ L+    HKN++ L+
Sbjct: 26  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 141 GYCT---TSSERILVYPFMQ----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
              T   T  E   VY  M+    NL    ++         LD      + +    G+++
Sbjct: 84  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--------LDHERMSYLLYQMLCGIKH 135
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH   +  IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE 
Sbjct: 136 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 190
Query: 254 LSTGKSSEKTDVFGYGITLLELV 276
           +      E  D++  G  + E+V
Sbjct: 191 ILGMGYKENVDIWSVGCIMGEMV 213

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  +L  N  VA+K+L   +     A    RE+ L+    HKN++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 141 GYCTTSSERILVYPFMQNLSVAYRLRD---LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
              T            Q++ +   L D    +  +  LD      + +    G+++LH  
Sbjct: 90  NVFTPQKS----LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH-- 143
Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 257
            +  IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE +   
Sbjct: 144 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 258 KSSEKTDVFGYGITLLELVTG 278
              E  D++  G  + E++ G
Sbjct: 201 GYKENVDIWSVGCIMGEMIKG 221

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 17/212 (8%)
Query: 78  NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIHK 134
           ++   + +G G FGKV  G       KVAVK L  Q   S       +RE+  + +  H 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           ++++L    +T ++  +V  ++        L D       ++    +R+       ++Y 
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVS----GGELFDYICKHGRVEEMEARRLFQQILSAVDYC 127
Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHIAPEY 253
           H      ++HRDLK  N+LLD +  A + DFGL+ ++ D +    +    G+  + APE 
Sbjct: 128 HRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC---GSPNYAAPEV 181
Query: 254 LSTGK--SSEKTDVFGYGITLLELVTGQRAID 283
           +S G+  +  + D++  G+ L  L+ G    D
Sbjct: 182 IS-GRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 19/201 (9%)
Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGY 142
           +G+G F    K V    N   AVK +    S   EA  Q+E+  + +   H N+++L   
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKII----SKRMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLKP-GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 201
                   LV   +    +  R++  K   E    +  RK V+      + ++H+     
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS-----AVSHMHDV---G 126
Query: 202 IIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 258
           ++HRDLK  N+L    +DN E  + DFG A+L       + T    T+ + APE L+   
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF-TLHYAAPELLNQNG 185
Query: 259 SSEKTDVFGYGITLLELVTGQ 279
             E  D++  G+ L  +++GQ
Sbjct: 186 YDESCDLWSLGVILYTMLSGQ 206

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + D+GLA+  D ++T        T  + 
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYV----ATRWYR 189
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 3/90 (3%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L+YLH + N  +++RDLK  N++LD +    + DFGL K    K         GT  ++
Sbjct: 260 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYL 316
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE L         D +G G+ + E++ G+
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 3/90 (3%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L+YLH + N  +++RDLK  N++LD +    + DFGL K    K         GT  ++
Sbjct: 263 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYL 319
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE L         D +G G+ + E++ G+
Sbjct: 320 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 3/90 (3%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L+YLH + N  +++RDLK  N++LD +    + DFGL K    K         GT  ++
Sbjct: 121 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYL 177
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE L         D +G G+ + E++ G+
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  VL  N  VA+K+L   +     A    RE+ L+    HKN++ L+
Sbjct: 70  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 141 GYCT---TSSERILVYPFMQ----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
              T   T  E   VY  M+    NL    ++         LD      + +    G+++
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--------LDHERMSYLLYQMLCGIKH 179
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH   +  IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE 
Sbjct: 180 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 234
Query: 254 LSTGKSSEKTDVFGYGITLLELV 276
           +      E  D++  G  + E+V
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 6/97 (6%)
Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGTM 246
           A GL +L  +    II+RDLK  N++LD      + DFG+ K  +     VTT+   GT 
Sbjct: 452 AIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTP 506
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
            +IAPE ++     +  D + +G+ L E++ GQ   +
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 3/90 (3%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L+YLH + N  +++RDLK  N++LD +    + DFGL K    K         GT  ++
Sbjct: 122 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYL 178
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE L         D +G G+ + E++ G+
Sbjct: 179 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 3/90 (3%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L+YLH + N  +++RDLK  N++LD +    + DFGL K    K         GT  ++
Sbjct: 120 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPEYL 176
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE L         D +G G+ + E++ G+
Sbjct: 177 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  +L  N  VA+K+L   +     A    RE+ L+    HKN++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 141 GYCTTSSERILVYPFMQNLSVAYRLRD---LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
              T            Q++ +   L D    +  +  LD      + +    G+++LH  
Sbjct: 90  NVFTPQKS----LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH-- 143
Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 257
            +  IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE +   
Sbjct: 144 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPEVVTRYYRAPEVILGM 200
Query: 258 KSSEKTDVFGYGITLLELVTG 278
              E  D++  G  + E++ G
Sbjct: 201 GYKENVDIWSVGCIMGEMIKG 221

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 85  IGQGGFGKVYKGVLSDN-TKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           +G G +G V     +    +VAVK+L + + S        RE+ L+    H+N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 143 CTTS------SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 196
            T +      ++  LV   M        L ++   +K  D    + + +    GL+Y+H 
Sbjct: 90  FTPARSLEEFNDVYLVTHLM-----GADLNNIVKSQKLTD-DHVQFLIYQILRGLKYIH- 142
Query: 197 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE-YLS 255
             +  IIHRDLK +N+ ++++ E  + DFGL +  D ++T        T  + APE  L+
Sbjct: 143 --SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYV----ATRWYRAPEIMLN 196
Query: 256 TGKSSEKTDVFGYGITLLELVTGQ 279
               ++  D++  G  + EL+TG+
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 6/97 (6%)
Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGTM 246
           A GL +L  +    II+RDLK  N++LD      + DFG+ K  +     VTT+   GT 
Sbjct: 131 AIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTP 185
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
            +IAPE ++     +  D + +G+ L E++ GQ   +
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 52/91 (57%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++         T  + 
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV----ATRWYR 189
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 52/91 (57%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++         T  + 
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV----ATRWYR 189
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 35/223 (15%)
Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQ----REVHLISVAI 132
           +N+    I+G+G    V + +     K    ++ D    G  +A +    RE  L  V I
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 133 ------HKNLLQLIGYCTTSSERILVYPFMQNLSV-AYRLRDLKPGEKGLDWPTRK--RV 183
                 H N++QL     T++   LV+  M+   +  Y    +   EK     TRK  R 
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEK----ETRKIMRA 119
Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA--KLTHVTTQ 241
                  L  L+      I+HRDLK  NILLDD+    L DFG +  +D   KL  V   
Sbjct: 120 LLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC-- 171
Query: 242 IRGTMGHIAPEYLSTGKS------SEKTDVFGYGITLLELVTG 278
             GT  ++APE +    +       ++ D++  G+ +  L+ G
Sbjct: 172 --GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 52/91 (57%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++         T  + 
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV----ATRWYR 185
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 35/223 (15%)
Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQ----REVHLISVAI 132
           +N+    I+G+G    V + +     K    ++ D    G  +A +    RE  L  V I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 133 ------HKNLLQLIGYCTTSSERILVYPFMQNLSV-AYRLRDLKPGEKGLDWPTRK--RV 183
                 H N++QL     T++   LV+  M+   +  Y    +   EK     TRK  R 
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEK----ETRKIMRA 132
Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA--KLTHVTTQ 241
                  L  L+      I+HRDLK  NILLDD+    L DFG +  +D   KL  V   
Sbjct: 133 LLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC-- 184
Query: 242 IRGTMGHIAPEYLSTGKS------SEKTDVFGYGITLLELVTG 278
             GT  ++APE +    +       ++ D++  G+ +  L+ G
Sbjct: 185 --GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 79  FSESNIIGQGGFGKVYKGVLSDNTKVAVKR-LQDYYSPGGEAAFQREVHLISVAIHKNLL 137
           ++   +IG G FG V++  L ++ +VA+K+ LQD      +    RE+ ++ +  H N++
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD------KRFKNRELQIMRIVKHPNVV 95
Query: 138 QLIGYCTTSSERI------LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRKRVAFGTAYG 190
            L  +  ++ ++       LV  ++      YR  R     ++ +     K   +     
Sbjct: 96  DLKAFFYSNGDKKDEVFLNLVLEYVP--ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           L Y+H      I HRD+K  N+LLD     + L DFG AK++ A   +V+     +  + 
Sbjct: 154 LAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXIC--SRYYR 208
Query: 250 APEYL-STGKSSEKTDVFGYGITLLELVTGQ 279
           APE +      +   D++  G  + EL+ GQ
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 52/91 (57%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++         T  + 
Sbjct: 160 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYV----ATRWYR 212
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 52/91 (57%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+  D ++         T  + 
Sbjct: 157 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXV----ATRWYR 209
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 35/223 (15%)
Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQ----REVHLISVAI 132
           +N+    I+G+G    V + +     K    ++ D    G  +A +    RE  L  V I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 133 ------HKNLLQLIGYCTTSSERILVYPFMQNLSV-AYRLRDLKPGEKGLDWPTRK--RV 183
                 H N++QL     T++   LV+  M+   +  Y    +   EK     TRK  R 
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEK----ETRKIMRA 132
Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA--KLTHVTTQ 241
                  L  L+      I+HRDLK  NILLDD+    L DFG +  +D   KL  V   
Sbjct: 133 LLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVC-- 184
Query: 242 IRGTMGHIAPEYLSTGKS------SEKTDVFGYGITLLELVTG 278
             GT  ++APE +    +       ++ D++  G+ +  L+ G
Sbjct: 185 --GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 84  IIGQGGFGKVY--KGVLSDNTK--VAVKRLQDYY---SPGGEAAFQREVHLISVAIHKNL 136
           ++G+GG+GKV+  + V   NT    A+K L+      +    A  + E +++    H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 137 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 196
           + LI    T  +  L+  ++    +  +L   + G    D           A G  +LH+
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLE--REGIFMEDTACFYLAEISMALG--HLHQ 139
Query: 197 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGTMGHIAPEYL 254
           +    II+RDLK  NI+L+      L DFGL K  + D  +TH      GT+ ++APE L
Sbjct: 140 KG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC---GTIEYMAPEIL 193
Query: 255 STGKSSEKTDVFGYGITLLELVTG 278
                +   D +  G  + +++TG
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L YLH Q    +IHRD+K+ +ILL  +    L DFG    + +K       + GT   +
Sbjct: 153 ALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI-SKDVPKRKXLVGTPYWM 208
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE +S    + + D++  GI ++E+V G+
Sbjct: 209 APEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/76 (36%), Positives = 42/76 (55%), Gaps = 2/76 (2%)
Query: 204 HRDLKAANILLDDNFEAVLCDFGLAK-LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 262
           HRD+K  NIL+  +  A L DFG+A    D KLT +   + GT+ + APE  S   ++ +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYXAPERFSESHATYR 215
Query: 263 TDVFGYGITLLELVTG 278
            D++     L E +TG
Sbjct: 216 ADIYALTCVLYECLTG 231

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 53/94 (56%), Gaps = 14/94 (14%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG---TM 246
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+       H   ++ G   T 
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVATR 193
Query: 247 GHIAPE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
            + APE  L+    ++  D++  G  + EL+TG+
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 53/94 (56%), Gaps = 14/94 (14%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG---TM 246
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+       H   ++ G   T 
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVATR 193
Query: 247 GHIAPE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
            + APE  L+    ++  D++  G  + EL+TG+
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLXGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 53/94 (56%), Gaps = 14/94 (14%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG---TM 246
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+       H   ++ G   T 
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVATR 193
Query: 247 GHIAPE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
            + APE  L+    ++  D++  G  + EL+TG+
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 84  IIGQGGFGKVY--KGVLSDNTK--VAVKRLQDYY---SPGGEAAFQREVHLISVAIHKNL 136
           ++G+GG+GKV+  + V   NT    A+K L+      +    A  + E +++    H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 137 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 196
           + LI    T  +  L+  ++    +  +L   + G    D           A G  +LH+
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLE--REGIFMEDTACFYLAEISMALG--HLHQ 139
Query: 197 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGTMGHIAPEYL 254
           +    II+RDLK  NI+L+      L DFGL K  + D  +TH      GT+ ++APE L
Sbjct: 140 KG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFC---GTIEYMAPEIL 193
Query: 255 STGKSSEKTDVFGYGITLLELVTG 278
                +   D +  G  + +++TG
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 52/91 (57%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  +  FGLA+  D ++T        T  + 
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYV----ATRWYR 189
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 26/205 (12%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   +  VL  N  VAVK+L   +     A    RE+ L+    HKN++ L+
Sbjct: 32  IGSGAQGIVCAAFDTVLGIN--VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 89
Query: 141 GYCT---TSSERILVYPFMQ----NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
              T   T  E   VY  M+    NL     +         LD      + +    G+++
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIHME--------LDHERMSYLLYQMLCGIKH 141
Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH   +  IIHRDLK +NI++  +    + DFGLA+   A    + T    T  + APE 
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEV 196
Query: 254 LSTGKSSEKTDVFGYGITLLELVTG 278
           +     +   D++  G  + ELV G
Sbjct: 197 ILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 17/218 (7%)
Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS---PGGEAAFQREVH 126
           R+L++  +++    +IG+G FG+V         KV   +L   +        A F  E  
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 126
Query: 127 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +++ A    ++QL           +V  +M    +   + +    EK   + T + V   
Sbjct: 127 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVL-- 184
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGT 245
               L+ +H       IHRD+K  N+LLD +    L DFG   K+    +    T + GT
Sbjct: 185 ---ALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GT 237
Query: 246 MGHIAPEYLST----GKSSEKTDVFGYGITLLELVTGQ 279
             +I+PE L +    G    + D +  G+ L E++ G 
Sbjct: 238 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 275

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 49/97 (50%), Gaps = 12/97 (12%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDN--FEAVLCDFGLA----KLVDAKLTHVTTQIR 243
            L YLH Q    I HRD+K  N L   N  FE  L DFGL+    KL + +   +TT+  
Sbjct: 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA- 235
Query: 244 GTMGHIAPEYLSTGKSS--EKTDVFGYGITLLELVTG 278
           GT   +APE L+T   S   K D +  G+ L  L+ G
Sbjct: 236 GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMG 272

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 17/218 (7%)
Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS---PGGEAAFQREVH 126
           R+L++  +++    +IG+G FG+V         KV   +L   +        A F  E  
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121
Query: 127 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +++ A    ++QL           +V  +M    +   + +    EK   + T + V   
Sbjct: 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVL-- 179
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGT 245
               L+ +H       IHRD+K  N+LLD +    L DFG   K+    +    T + GT
Sbjct: 180 ---ALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GT 232
Query: 246 MGHIAPEYLST----GKSSEKTDVFGYGITLLELVTGQ 279
             +I+PE L +    G    + D +  G+ L E++ G 
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 17/218 (7%)
Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS---PGGEAAFQREVH 126
           R+L++  +++    +IG+G FG+V         KV   +L   +        A F  E  
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 126
Query: 127 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +++ A    ++QL           +V  +M    +   + +    EK   + T + V   
Sbjct: 127 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVL-- 184
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVDAKLTHVTTQIRGT 245
               L+ +H       IHRD+K  N+LLD +    L DFG   K+    +    T + GT
Sbjct: 185 ---ALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GT 237
Query: 246 MGHIAPEYLST----GKSSEKTDVFGYGITLLELVTGQ 279
             +I+PE L +    G    + D +  G+ L E++ G 
Sbjct: 238 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 275

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLAGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 53/92 (57%), Gaps = 7/92 (7%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTHVTTQIRGTM 246
           GL+Y+H     ++IHRDLK +N+L+++N E  + DFG+A+ +    A+  +  T+   T 
Sbjct: 171 GLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 227
Query: 247 GHIAPE-YLSTGKSSEKTDVFGYGITLLELVT 277
            + APE  LS  + ++  D++  G    E++ 
Sbjct: 228 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 259

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 18/199 (9%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  +L  N  VA+K+L   +     A    RE+ L+    HKN++ L+
Sbjct: 26  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 83
Query: 141 GYCTTSSERILVYPFMQNLSVAYRLRD---LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
              T            Q++ +   L D    +  +  LD      + +    G+++LH  
Sbjct: 84  NVFTPQKS----LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH-- 137
Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 257
            +  IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE +   
Sbjct: 138 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 194
Query: 258 KSSEKTDVFGYGITLLELV 276
              E  D++  G  + E+V
Sbjct: 195 GYKENVDLWSVGCIMGEMV 213

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 18/199 (9%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  +L  N  VA+K+L   +     A    RE+ L+    HKN++ L+
Sbjct: 37  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 94
Query: 141 GYCTTSSERILVYPFMQNLSVAYRLRD---LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
              T            Q++ +   L D    +  +  LD      + +    G+++LH  
Sbjct: 95  NVFTPQKS----LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH-- 148
Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 257
            +  IIHRDLK +NI++  +    + DFGLA+   A  + + T    T  + APE +   
Sbjct: 149 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 205
Query: 258 KSSEKTDVFGYGITLLELV 276
              E  D++  G  + E+V
Sbjct: 206 GYKENVDLWSVGCIMGEMV 224

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 52/91 (57%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + DF LA+  D ++T        T  + 
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYV----ATRWYR 189
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 47/88 (53%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D+     + DFG AK V  +    T  + GT  ++A
Sbjct: 141 FEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 193
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 194 PEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 52/91 (57%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + D GLA+  D ++T        T  + 
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYV----ATRWYR 189
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 52/97 (53%), Gaps = 6/97 (6%)
Query: 182 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK-LVD--AKLTHV 238
           ++A      LE+LH + +  +IHRD+K +N+L++   +   CDFG++  LVD  AK    
Sbjct: 140 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA 197
Query: 239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLEL 275
             +       I PE    G S  K+D++  GIT +EL
Sbjct: 198 GCKPYXAPERINPELNQKGYSV-KSDIWSLGITXIEL 233

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 54/92 (58%), Gaps = 7/92 (7%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTHVTTQIRGTM 246
           GL+Y+H   + ++IHRDLK +N+L+++N E  + DFG+A+ +    A+  +  T+   T 
Sbjct: 170 GLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 226
Query: 247 GHIAPE-YLSTGKSSEKTDVFGYGITLLELVT 277
            + APE  LS  + ++  D++  G    E++ 
Sbjct: 227 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 258

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 9/92 (9%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL---CDFGLAKLVDAKLTHVTTQIRGTM 246
           G+ YLH+     I+HRDLK  N+LL+   +  L    DFGL+ + + +      +  GT 
Sbjct: 148 GVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--KKMKERLGTA 202
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
            +IAPE L   K  EK DV+  G+ L  L+ G
Sbjct: 203 YYIAPEVLRK-KYDEKCDVWSIGVILFILLAG 233

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 52/91 (57%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + D GLA+  D ++T        T  + 
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYV----ATRWYR 189
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            LEYLH +    +++RD+K  N++LD +    + DFGL K   +    + T   GT  ++
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYL 172
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE L         D +G G+ + E++ G+
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 47/88 (53%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+++D      + DFGLAK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 47/88 (53%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+++D      + DFGLAK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            LEYLH +    +++RD+K  N++LD +    + DFGL K   +    + T   GT  ++
Sbjct: 120 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYL 175
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE L         D +G G+ + E++ G+
Sbjct: 176 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            LEYLH +    +++RD+K  N++LD +    + DFGL K   +    + T   GT  ++
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYL 172
Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE L         D +G G+ + E++ G+
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 155 FEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 86/183 (46%), Gaps = 16/183 (8%)
Query: 77  DNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHK 134
           DN+   ++IG+G +G VY     + N  VA+K++   +    +     RE+ +++     
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRL--RDLKPGEKGLDWPTR---KRVAFGTAY 189
            +++L  +     E +L +     L +   +   DLK   K   + T    K + +    
Sbjct: 88  YIIRL--HDLIIPEDLLKF---DELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLL 142
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA-KLTHVTTQIRGTMGH 248
           G +++HE     IIHRDLK AN LL+ +    +CDFGLA+ +++ K  H+   +     +
Sbjct: 143 GEKFIHES---GIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEEN 199
Query: 249 IAP 251
             P
Sbjct: 200 EEP 202

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 52/91 (57%), Gaps = 8/91 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL+Y+H   +  IIHRDLK +N+ ++++ E  + D GLA+  D ++T        T  + 
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYV----ATRWYR 189
Query: 250 APE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE  L+    ++  D++  G  + EL+TG+
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 149 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 201
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 202 PEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 155 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 155 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 155 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 147 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 199
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 155 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 147 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 199
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 155 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 155 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 175 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 227
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 46/92 (50%), Gaps = 8/92 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGTMG 247
            LEYLH +    +++RD+K  N++LD +    + DFGL K  + D           GT  
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKXFCGTPE 170
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           ++APE L         D +G G+ + E++ G+
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 46/92 (50%), Gaps = 8/92 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGTMG 247
            LEYLH +    +++RD+K  N++LD +    + DFGL K  + D           GT  
Sbjct: 122 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKXFCGTPE 175
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           ++APE L         D +G G+ + E++ G+
Sbjct: 176 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 46/92 (50%), Gaps = 8/92 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGTMG 247
            LEYLH +    +++RD+K  N++LD +    + DFGL K  + D           GT  
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKXFCGTPE 170
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           ++APE L         D +G G+ + E++ G+
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 46/92 (50%), Gaps = 8/92 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK--LVDAKLTHVTTQIRGTMG 247
            LEYLH +    +++RD+K  N++LD +    + DFGL K  + D           GT  
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKXFCGTPE 170
Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           ++APE L         D +G G+ + E++ G+
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 175 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 227
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 140 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEYLA 192
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 193 PEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 100/215 (46%), Gaps = 31/215 (14%)
Query: 85  IGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL---- 139
           +G GG G V+  V +D + +VA+K++     P       RE+ +I    H N++++    
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIV-LTDPQSVKHALREIKIIRRLDHDNIVKVFEIL 77
Query: 140 ----------IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV-AFGTA 188
                     +G  T  +   +V  +M+   +A  L      E+G       R+  +   
Sbjct: 78  GPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL------EQGPLLEEHARLFMYQLL 130
Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQIRG--T 245
            GL+Y+H   +  ++HRDLK AN+ ++ ++    + DFGLA+++D   +H      G  T
Sbjct: 131 RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 246 MGHIAPE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
             + +P   LS    ++  D++  G    E++TG+
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 155 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEYLA 207
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 85/199 (42%), Gaps = 18/199 (9%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  +L  N  VA+K+L   +     A    RE+ L+    HKN++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 141 GYCTTSSERILVYPFMQNLSVAYRLRD---LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
              T            Q++ +   L D    +  +  LD      + +    G+++LH  
Sbjct: 90  NVFTPQKS----LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH-- 143
Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 257
            +  IIHRDLK +NI++  +    + DFGLA+            +  T  + APE +   
Sbjct: 144 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV--TRYYRAPEVILGM 200
Query: 258 KSSEKTDVFGYGITLLELV 276
              E  D++  G  + E+V
Sbjct: 201 GYKENVDIWSVGCIMGEMV 219

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 84  IIGQGGFGKVYKG-VLSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLI----SVAIH 133
           ++G+GGFG V+ G  L+D  +VA+K     R+  +           EV L+    +   H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG-TAYGLE 192
             +++L+ +  T    +LV   ++    A  L D    EKG       R  FG     ++
Sbjct: 98  PGVIRLLDWFETQEGFMLV---LERPLPAQDLFDYI-TEKGPLGEGPSRCFFGQVVAAIQ 153
Query: 193 YLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAP 251
           + H +    ++HRD+K  NIL+D     A L DFG   L+  +     T   GT  +  P
Sbjct: 154 HCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE---PYTDFDGTRVYSPP 207
Query: 252 EYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSR 286
           E++S  +  +    V+  GI L ++V G   I F R
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGD--IPFER 241

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+++D      + DFG AK V  +    T  + GT  ++A
Sbjct: 155 FEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+++D      + DFG AK V  +    T  + GT  ++A
Sbjct: 155 FEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+++D      + DFG AK V  +    T  + GT  ++A
Sbjct: 155 FEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+++D      + DFG AK V  +    T  + GT  ++A
Sbjct: 155 FEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 207
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+++D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+++D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+++D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+++D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V       T  + GT  ++A
Sbjct: 175 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----ATWTLCGTPEYLA 227
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 16/199 (8%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           +G G FG V++ V     +V V +  +   P  +   + E+ +++   H  L+ L     
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 145 TSSERILVYPFMQNLSVAYRL--RDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 202
              E +L+  F+    +  R+   D K  E  +    R+        GL+++HE     I
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ-----ACEGLKHMHEHS---I 170
Query: 203 IHRDLKAANILLDDNFEAV--LCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 259
           +H D+K  NI+ +    +   + DFGLA KL   ++  VTT    T    APE +     
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPV 227
Query: 260 SEKTDVFGYGITLLELVTG 278
              TD++  G+    L++G
Sbjct: 228 GFYTDMWAIGVLGYVLLSG 246

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 16/208 (7%)
Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           +G+G +G VYK    D        L+     G   +  RE+ L+    H N++ L     
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 145 TSSER--ILVYPFMQN--LSVAYRLRDLKPGEKGLDWP--TRKRVAFGTAYGLEYLHEQC 198
           + ++R   L++ + ++    +    R  K  +K +  P    K + +    G+ YLH   
Sbjct: 89  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 148
Query: 199 NPKIIHRDLKAANILL----DDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTMGHIAPE 252
              ++HRDLK ANIL+     +     + D G A+L ++ L  +     +  T  + APE
Sbjct: 149 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 205
Query: 253 YLSTGKSSEKT-DVFGYGITLLELVTGQ 279
            L   +   K  D++  G    EL+T +
Sbjct: 206 LLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 85/199 (42%), Gaps = 18/199 (9%)
Query: 85  IGQGGFGKV---YKGVLSDNTKVAVKRLQDYYSPGGEAA-FQREVHLISVAIHKNLLQLI 140
           IG G  G V   Y  +L  N  VA+K+L   +     A    RE+ L+    HKN++ L+
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 141 GYCTTSSERILVYPFMQNLSVAYRLRD---LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
              T            Q++ +   L D    +  +  LD      + +    G+++LH  
Sbjct: 90  NVFTPQKS----LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH-- 143
Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 257
            +  IIHRDLK +NI++  +    + DFGLA+            +  T  + APE +   
Sbjct: 144 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV--TRYYRAPEVILGM 200
Query: 258 KSSEKTDVFGYGITLLELV 276
              E  D++  G  + E+V
Sbjct: 201 GYKENVDLWSVGCIMGEMV 219

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + ++  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 88/217 (40%), Gaps = 26/217 (11%)
Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNT--KVAVKRLQDYYSPGGEA-------AFQREVHL 127
           D +  S  +G G  G+V K      T  KVA+K +       G A         + E+ +
Sbjct: 10  DEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 128 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 187
           +    H  ++++  +          Y  +  L     L D   G K L   T K   +  
Sbjct: 69  LKKLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL---CDFGLAKLVDAKLTHVTTQIRG 244
              ++YLHE     IIHRDLK  N+LL    E  L    DFG +K++    T +   + G
Sbjct: 124 LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCG 178
Query: 245 TMGHIAPEYL---STGKSSEKTDVFGYGITLLELVTG 278
           T  ++APE L    T   +   D +  G+ L   ++G
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 88/217 (40%), Gaps = 26/217 (11%)
Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNT--KVAVKRLQDYYSPGGEA-------AFQREVHL 127
           D +  S  +G G  G+V K      T  KVA+K +       G A         + E+ +
Sbjct: 10  DEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 128 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 187
           +    H  ++++  +          Y  +  L     L D   G K L   T K   +  
Sbjct: 69  LKKLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL---CDFGLAKLVDAKLTHVTTQIRG 244
              ++YLHE     IIHRDLK  N+LL    E  L    DFG +K++    T +   + G
Sbjct: 124 LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCG 178
Query: 245 TMGHIAPEYL---STGKSSEKTDVFGYGITLLELVTG 278
           T  ++APE L    T   +   D +  G+ L   ++G
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 99/247 (40%), Gaps = 38/247 (15%)
Query: 47  VFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNT--KV 104
           VFFD+   DD  V    LR           D +  S  +G G  G+V K      T  KV
Sbjct: 117 VFFDLTV-DDQSVYPKALR-----------DEYIMSKTLGSGACGEV-KLAFERKTCKKV 163
Query: 105 AVKRLQDYYSPGGEA-------AFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQ 157
           A++ +       G A         + E+ ++    H  ++++  +       I++     
Sbjct: 164 AIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVL----- 218
Query: 158 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN 217
            L     L D   G K L   T K   +     ++YLHE     IIHRDLK  N+LL   
Sbjct: 219 ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQ 275
Query: 218 FEAVL---CDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL---STGKSSEKTDVFGYGIT 271
            E  L    DFG +K++    T +   + GT  ++APE L    T   +   D +  G+ 
Sbjct: 276 EEDCLIKITDFGHSKILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333
Query: 272 LLELVTG 278
           L   ++G
Sbjct: 334 LFICLSG 340

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 99/247 (40%), Gaps = 38/247 (15%)
Query: 47  VFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNT--KV 104
           VFFD+   DD  V    LR           D +  S  +G G  G+V K      T  KV
Sbjct: 131 VFFDLTV-DDQSVYPKALR-----------DEYIMSKTLGSGACGEV-KLAFERKTCKKV 177
Query: 105 AVKRLQDYYSPGGEA-------AFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQ 157
           A++ +       G A         + E+ ++    H  ++++  +       I++     
Sbjct: 178 AIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVL----- 232
Query: 158 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN 217
            L     L D   G K L   T K   +     ++YLHE     IIHRDLK  N+LL   
Sbjct: 233 ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQ 289
Query: 218 FEAVL---CDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL---STGKSSEKTDVFGYGIT 271
            E  L    DFG +K++    T +   + GT  ++APE L    T   +   D +  G+ 
Sbjct: 290 EEDCLIKITDFGHSKILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 347
Query: 272 LLELVTG 278
           L   ++G
Sbjct: 348 LFICLSG 354

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 88/217 (40%), Gaps = 26/217 (11%)
Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNT--KVAVKRLQDYYSPGGEA-------AFQREVHL 127
           D +  S  +G G  G+V K      T  KVA+K +       G A         + E+ +
Sbjct: 9   DEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 67
Query: 128 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 187
           +    H  ++++  +          Y  +  L     L D   G K L   T K   +  
Sbjct: 68  LKKLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 122
Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL---CDFGLAKLVDAKLTHVTTQIRG 244
              ++YLHE     IIHRDLK  N+LL    E  L    DFG +K++    T +   + G
Sbjct: 123 LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCG 177
Query: 245 TMGHIAPEYL---STGKSSEKTDVFGYGITLLELVTG 278
           T  ++APE L    T   +   D +  G+ L   ++G
Sbjct: 178 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT   +A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEALA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           PE + +   ++  D +  G+ + E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 88/217 (40%), Gaps = 26/217 (11%)
Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNT--KVAVKRLQDYYSPGGEA-------AFQREVHL 127
           D +  S  +G G  G+V K      T  KVA+K +       G A         + E+ +
Sbjct: 10  DEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 128 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 187
           +    H  ++++  +          Y  +  L     L D   G K L   T K   +  
Sbjct: 69  LKKLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL---CDFGLAKLVDAKLTHVTTQIRG 244
              ++YLHE     IIHRDLK  N+LL    E  L    DFG +K++    T +   + G
Sbjct: 124 LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCG 178
Query: 245 TMGHIAPEYL---STGKSSEKTDVFGYGITLLELVTG 278
           T  ++APE L    T   +   D +  G+ L   ++G
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 88/217 (40%), Gaps = 26/217 (11%)
Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNT--KVAVKRLQDYYSPGGEA-------AFQREVHL 127
           D +  S  +G G  G+V K      T  KVA+K +       G A         + E+ +
Sbjct: 16  DEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 74
Query: 128 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 187
           +    H  ++++  +          Y  +  L     L D   G K L   T K   +  
Sbjct: 75  LKKLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 129
Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL---CDFGLAKLVDAKLTHVTTQIRG 244
              ++YLHE     IIHRDLK  N+LL    E  L    DFG +K++    T +   + G
Sbjct: 130 LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCG 184
Query: 245 TMGHIAPEYL---STGKSSEKTDVFGYGITLLELVTG 278
           T  ++APE L    T   +   D +  G+ L   ++G
Sbjct: 185 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 49/94 (52%), Gaps = 13/94 (13%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDN---FEAVLCDFGLAKLV--DAKLTHVTTQIRG 244
           G+ YLH+     I+HRD+K  NILL++        + DFGL+     D KL        G
Sbjct: 158 GICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL----G 210
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           T  +IAPE L   K +EK DV+  G+ +  L+ G
Sbjct: 211 TAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCG 243

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 8/92 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
            + YLHE     I+HRDLK  N+L      +    + DFGL+K+V+ ++   T  + GT 
Sbjct: 160 AVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT--VCGTP 214
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           G+ APE L       + D++  GI    L+ G
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 68/162 (41%), Gaps = 40/162 (24%)
Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------------RVAFGT 187
           +G    SS ++ +Y  MQ      R  +LK      DW  R+             +    
Sbjct: 124 VGQLQPSSPKVYLYIQMQ----LCRKENLK------DWMNRRCSLEDREHGVCLHIFIQI 173
Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD-------------AK 234
           A  +E+LH +    ++HRDLK +NI    +    + DFGL   +D             A 
Sbjct: 174 AEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 230
Query: 235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELV 276
            TH   Q+ GT  +++PE +     S K D+F  G+ L EL+
Sbjct: 231 ATH-XGQV-GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 44/81 (54%), Gaps = 7/81 (8%)
Query: 202 IIHRDLKAANILLDDNFEAV---LCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYLSTG 257
           I+HR+LK  N+LL    +     L DFGLA ++ D++  H      GT G+++PE L   
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSPEVLKKD 182
Query: 258 KSSEKTDVFGYGITLLELVTG 278
             S+  D++  G+ L  L+ G
Sbjct: 183 PYSKPVDIWACGVILYILLVG 203

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 80/167 (47%), Gaps = 15/167 (8%)
Query: 75  ATDNFSESNIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAA-FQREVHLISVAI 132
             DN+   ++IG+G +G VY     +  K VA+K++   +    +     RE+ +++   
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK 83
Query: 133 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRL--RDLKPGEKGLDWPTR---KRVAFGT 187
              +++L  Y     + +L +     L +   +   DLK   K   + T    K + +  
Sbjct: 84  SDYIIRL--YDLIIPDDLLKF---DELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNL 138
Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 234
             G  ++HE     IIHRDLK AN LL+ +    +CDFGLA+ ++++
Sbjct: 139 LLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 53/124 (42%), Gaps = 30/124 (24%)
Query: 181 KRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD-------- 232
           K + +    G++Y+H   +  I+HRDLK AN L++ +    +CDFGLA+ VD        
Sbjct: 159 KTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215
Query: 233 ------------AKLTHVTTQIRGTMGHI------APEYLSTGKS-SEKTDVFGYGITLL 273
                           H     R   GH+      APE +   ++ +E  DV+  G    
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA 275
Query: 274 ELVT 277
           EL+ 
Sbjct: 276 ELLN 279

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 45/88 (51%), Gaps = 7/88 (7%)
Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
            EYLH   +  +I+RDLK  N+L+D      + DFG AK V  +    T  + GT  ++A
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLA 206
Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTG 278
           P  + +   ++  D +  G+ + E+  G
Sbjct: 207 PAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 44/81 (54%), Gaps = 7/81 (8%)
Query: 202 IIHRDLKAANILLDDNFEAV---LCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYLSTG 257
           I+HR+LK  N+LL    +     L DFGLA ++ D++  H      GT G+++PE L   
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSPEVLKKD 205
Query: 258 KSSEKTDVFGYGITLLELVTG 278
             S+  D++  G+ L  L+ G
Sbjct: 206 PYSKPVDIWACGVILYILLVG 226

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 44/81 (54%), Gaps = 7/81 (8%)
Query: 202 IIHRDLKAANILLDDNFEAV---LCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYLSTG 257
           I+HR+LK  N+LL    +     L DFGLA ++ D++  H      GT G+++PE L   
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSPEVLKKD 182
Query: 258 KSSEKTDVFGYGITLLELVTG 278
             S+  D++  G+ L  L+ G
Sbjct: 183 PYSKPVDIWACGVILYILLVG 203

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 97/220 (44%), Gaps = 26/220 (11%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY----SPG-GEAAFQREVHLI 128
           L  D +    +IG+G F  V + +  +  +    ++ D      SPG      +RE  + 
Sbjct: 21  LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80
Query: 129 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 188
            +  H ++++L+   ++     +V+ FM    + + +  +K  + G  +      A  + 
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEI--VKRADAGFVYSE----AVASH 134
Query: 189 Y------GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLA-KLVDAKLTHV 238
           Y       L Y H+     IIHRD+K   +LL   +++    L  FG+A +L ++ L  V
Sbjct: 135 YMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--V 189
Query: 239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
                GT   +APE +      +  DV+G G+ L  L++G
Sbjct: 190 AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/81 (34%), Positives = 44/81 (54%), Gaps = 7/81 (8%)
Query: 202 IIHRDLKAANILLDDNFEAV---LCDFGLA-KLVDAKLTHVTTQIRGTMGHIAPEYLSTG 257
           I+HR+LK  N+LL    +     L DFGLA ++ D++  H      GT G+++PE L   
Sbjct: 125 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSPEVLKKD 181
Query: 258 KSSEKTDVFGYGITLLELVTG 278
             S+  D++  G+ L  L+ G
Sbjct: 182 PYSKPVDIWACGVILYILLVG 202

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 97/220 (44%), Gaps = 26/220 (11%)
Query: 74  LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY----SPG-GEAAFQREVHLI 128
           L  D +    +IG+G F  V + +  +  +    ++ D      SPG      +RE  + 
Sbjct: 23  LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 82
Query: 129 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 188
            +  H ++++L+   ++     +V+ FM    + + +  +K  + G  +      A  + 
Sbjct: 83  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEI--VKRADAGFVYSE----AVASH 136
Query: 189 Y------GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLA-KLVDAKLTHV 238
           Y       L Y H+     IIHRD+K   +LL   +++    L  FG+A +L ++ L  V
Sbjct: 137 YMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--V 191
Query: 239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
                GT   +APE +      +  DV+G G+ L  L++G
Sbjct: 192 AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 12/93 (12%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNF---EAVLCDFGLAKLVDAKLTHVTT--QIRG 244
           G+ YLH+     I+H DLK  NILL   +   +  + DFG+++    K+ H     +I G
Sbjct: 143 GVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR----KIGHACELREIMG 195
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
           T  ++APE L+    +  TD++  GI    L+T
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 45/92 (48%), Gaps = 8/92 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL--CDFGLAKLVDAKLTHVTTQIRGTMG 247
           G+ Y H     +I HRDLK  N LLD +    L  CDFG +K   + L        GT  
Sbjct: 128 GVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPA 182
Query: 248 HIAPEYLSTGKSSEK-TDVFGYGITLLELVTG 278
           +IAPE L   +   K  DV+  G+TL  ++ G
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 42/90 (46%), Gaps = 6/90 (6%)
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
           T   L +LH Q    ++H D+K ANI L       L DFGL  LV+           G  
Sbjct: 166 TLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEVQEGDP 220
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELV 276
            ++APE L  G      DVF  G+T+LE+ 
Sbjct: 221 RYMAPELLQ-GSYGTAADVFSLGLTILEVA 249

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 46/92 (50%), Gaps = 9/92 (9%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
            L Y H Q    ++H+DLK  NIL  D   +    + DFGLA+L   K    +T   GT 
Sbjct: 136 ALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF--KSDEHSTNAAGTA 190
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
            ++APE      +  K D++  G+ +  L+TG
Sbjct: 191 LYMAPEVFKRDVTF-KCDIWSAGVVMYFLLTG 221

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 40/80 (50%), Gaps = 4/80 (5%)
Query: 202 IIHRDLKAANILLDDNFEAV---LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 258
           ++HRDLK  N+LL    +     L DFGLA  V+ +         GT G+++PE L    
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFAGTPGYLSPEVLRKDP 200
Query: 259 SSEKTDVFGYGITLLELVTG 278
             +  D++  G+ L  L+ G
Sbjct: 201 YGKPVDLWACGVILYILLVG 220

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 46/92 (50%), Gaps = 9/92 (9%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL---CDFGLAKLVDAKLTHVTTQIRGTM 246
           G  YLH+     I+HRDLK  N+LL+      L    DFGL+     ++     +  GT 
Sbjct: 133 GTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLS--AHFEVGGKMKERLGTA 187
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
            +IAPE L   K  EK DV+  G+ L  L+ G
Sbjct: 188 YYIAPEVLRK-KYDEKCDVWSCGVILYILLCG 218

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 73  QLATDNF---SESNIIGQGGFGKVYK-GVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLI 128
           Q A ++F   S++ I+G G FG+V+K    +   K+A K ++       E   + E+ ++
Sbjct: 82  QGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEV-KNEISVM 140
Query: 129 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF--G 186
           +   H NL+QL     + ++ +LV  ++    +  R+ D       LD      + F   
Sbjct: 141 NQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD-----TILFMKQ 195
Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILL--DDNFEAVLCDFGLAKLVDAKLTHVTTQIRG 244
              G+ ++H+     I+H DLK  NIL    D  +  + DFGLA+    +         G
Sbjct: 196 ICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN--FG 250
Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           T   +APE ++    S  TD++  G+    L++G
Sbjct: 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 45/92 (48%), Gaps = 8/92 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL--CDFGLAKLVDAKLTHVTTQIRGTMG 247
           G+ Y H     ++ HRDLK  N LLD +    L  CDFG +K   + L        GT  
Sbjct: 126 GVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPA 180
Query: 248 HIAPEYLSTGKSSEKT-DVFGYGITLLELVTG 278
           +IAPE L   +   K  DV+  G+TL  ++ G
Sbjct: 181 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 45/92 (48%), Gaps = 8/92 (8%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL--CDFGLAKLVDAKLTHVTTQIRGTMG 247
           G+ Y H     ++ HRDLK  N LLD +    L  CDFG +K   + L        GT  
Sbjct: 127 GVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPA 181
Query: 248 HIAPEYLSTGKSSEKT-DVFGYGITLLELVTG 278
           +IAPE L   +   K  DV+  G+TL  ++ G
Sbjct: 182 YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 92/219 (42%), Gaps = 47/219 (21%)
Query: 84  IIGQGGFGKV-YKGVLSDNTKVAVKR-LQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
           I+G G  G V ++G       VAVKR L D+     + A      L     H N+++   
Sbjct: 22  ILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRY-- 74
Query: 142 YCTTSSERILVYPF-MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT-------AYGLEY 193
           YC+ +++R L     + NL+    L+DL   +   D   + +  +         A G+ +
Sbjct: 75  YCSETTDRFLYIALELCNLN----LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 194 LHEQCNPKIIHRDLKAANILLD-------------DNFEAVLCDFGLAKLVDAKLTHVTT 240
           LH     KIIHRDLK  NIL+              +N   ++ DFGL K +D+  +   T
Sbjct: 131 LHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 241 QIR---GTMGHIAPEYLSTGKS-------SEKTDVFGYG 269
            +    GT G  APE L    +       +   D+F  G
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG 226

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 39/80 (48%), Gaps = 4/80 (5%)
Query: 202 IIHRDLKAANILLDDNFEAV---LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 258
           I+HRDLK  N+LL    +     L DFGLA  V  +         GT G+++PE L    
Sbjct: 151 IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGE-QQAWFGFAGTPGYLSPEVLRKDP 209
Query: 259 SSEKTDVFGYGITLLELVTG 278
             +  D++  G+ L  L+ G
Sbjct: 210 YGKPVDIWACGVILYILLVG 229

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 46/92 (50%), Gaps = 9/92 (9%)
Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL---CDFGLAKLVDAKLTHVTTQIRGTM 246
           G  YLH+     I+HRDLK  N+LL+      L    DFGL+     ++     +  GT 
Sbjct: 116 GTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLS--AHFEVGGKMKERLGTA 170
Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
            +IAPE L   K  EK DV+  G+ L  L+ G
Sbjct: 171 YYIAPEVLRK-KYDEKCDVWSCGVILYILLCG 201

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 84/213 (39%), Gaps = 28/213 (13%)
Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           D++     +G G FG V++    +     A K +   +    E   ++E+  +SV  H  
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV-RKEIQTMSVLRHPT 109
Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
           L+ L       +E +++Y FM    +  ++ D             +         +EY+ 
Sbjct: 110 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD-------------EHNKMSEDEAVEYMR 156
Query: 196 EQC-------NPKIIHRDLKAANILLDD--NFEAVLCDFGLAKLVDAKLT-HVTTQIRGT 245
           + C           +H DLK  NI+     + E  L DFGL   +D K +  VTT   GT
Sbjct: 157 QVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GT 213
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
               APE          TD++  G+    L++G
Sbjct: 214 AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 84/213 (39%), Gaps = 28/213 (13%)
Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           D++     +G G FG V++    +     A K +   +    E   ++E+  +SV  H  
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV-RKEIQTMSVLRHPT 215
Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
           L+ L       +E +++Y FM    +  ++ D             +         +EY+ 
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD-------------EHNKMSEDEAVEYMR 262
Query: 196 EQC-------NPKIIHRDLKAANILLDD--NFEAVLCDFGLAKLVDAKLT-HVTTQIRGT 245
           + C           +H DLK  NI+     + E  L DFGL   +D K +  VTT   GT
Sbjct: 263 QVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GT 319
Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
               APE          TD++  G+    L++G
Sbjct: 320 AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 38/80 (47%), Gaps = 4/80 (5%)
Query: 202 IIHRDLKAANILLDDNFEAV---LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 258
           I+HRDLK  N+LL    +     L DFGLA  V            GT G+++PE L    
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGD-QQAWFGFAGTPGYLSPEVLRKDP 182
Query: 259 SSEKTDVFGYGITLLELVTG 278
             +  D++  G+ L  L+ G
Sbjct: 183 YGKPVDMWACGVILYILLVG 202

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 38/80 (47%), Gaps = 4/80 (5%)
Query: 202 IIHRDLKAANILLDDNFEAV---LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 258
           I+HRDLK  N+LL    +     L DFGLA  V            GT G+++PE L    
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGD-QQAWFGFAGTPGYLSPEVLRKDP 182
Query: 259 SSEKTDVFGYGITLLELVTG 278
             +  D++  G+ L  L+ G
Sbjct: 183 YGKPVDMWACGVILYILLVG 202

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/80 (31%), Positives = 40/80 (50%), Gaps = 4/80 (5%)
Query: 202 IIHRDLKAANILLDDNFEAV---LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 258
           ++HR+LK  N+LL    +     L DFGLA  V+ +         GT G+++PE L    
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFAGTPGYLSPEVLRKDP 189
Query: 259 SSEKTDVFGYGITLLELVTG 278
             +  D++  G+ L  L+ G
Sbjct: 190 YGKPVDLWACGVILYILLVG 209

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 19/211 (9%)
Query: 76  TDNFSESNIIGQGGFGKVYKGVLSDNTKVAV-------KRLQDYYSPGGE-AAFQREVHL 127
           +  +S  + +G G FG V+  V  +  K  V       K L+D +    +      E+ +
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 128 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 187
           +S   H N+++++          LV   M+       L         LD P    +    
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLV---MEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD-AKLTHVTTQIRGTM 246
              + YL  +    IIHRD+K  NI++ ++F   L DFG A  ++  KL +      GT+
Sbjct: 140 VSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTI 193
Query: 247 GHIAPEYL-STGKSSEKTDVFGYGITLLELV 276
            + APE L        + +++  G+TL  LV
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 38/80 (47%), Gaps = 4/80 (5%)
Query: 202 IIHRDLKAANILLDDNFEAV---LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 258
           ++HRDLK  N+LL    +     L DFGLA  V            GT G+++PE L    
Sbjct: 124 VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGD-QQAWFGFAGTPGYLSPEVLRKEA 182
Query: 259 SSEKTDVFGYGITLLELVTG 278
             +  D++  G+ L  L+ G
Sbjct: 183 YGKPVDIWACGVILYILLVG 202

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 81/197 (41%), Gaps = 38/197 (19%)
Query: 22  GAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSE 81
           G + L+ +G LF  RY  +RKL    F  V    D      Q ++F   ++  + ++++E
Sbjct: 8   GGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWD-----IQGKKFVAMKVVKSAEHYTE 62
Query: 82  SNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLI 140
           + +        V     +D N ++ V+ L D+   G        + ++   +  +LL+ I
Sbjct: 63  TALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGT---HICMVFEVLGHHLLKWI 119
Query: 141 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 200
                                      +K   +GL  P  K++      GL+YLH +C  
Sbjct: 120 ---------------------------IKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC-- 150
Query: 201 KIIHRDLKAANILLDDN 217
           +IIH D+K  NILL  N
Sbjct: 151 RIIHTDIKPENILLSVN 167

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 80/196 (40%), Gaps = 18/196 (9%)
Query: 87  QGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS 146
           Q G GK Y         +  +RL            +REV+++    H N++ L       
Sbjct: 33  QKGTGKEYAAKF-----IKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK 87
Query: 147 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRD 206
           ++ +L+      L     L D    ++ L      +       G+ YLH +   +I H D
Sbjct: 88  TDVVLIL----ELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFD 140
Query: 207 LKAANILLDD----NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 262
           LK  NI+L D    N    L DFG+A  ++A   +    I GT   +APE ++      +
Sbjct: 141 LKPENIMLLDKNVPNPRIKLIDFGIAHKIEA--GNEFKNIFGTPEFVAPEIVNYEPLGLE 198
Query: 263 TDVFGYGITLLELVTG 278
            D++  G+    L++G
Sbjct: 199 ADMWSIGVITYILLSG 214

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 81/197 (41%), Gaps = 38/197 (19%)
Query: 22  GAFVLLSLGALFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSE 81
           G + L+ +G LF  RY  +RKL    F  V    D      Q ++F   ++  + ++++E
Sbjct: 24  GGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWD-----IQGKKFVAMKVVKSAEHYTE 78
Query: 82  SNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLI 140
           + +        V     +D N ++ V+ L D+   G        + ++   +  +LL+ I
Sbjct: 79  TALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGT---HICMVFEVLGHHLLKWI 135
Query: 141 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 200
                                      +K   +GL  P  K++      GL+YLH +C  
Sbjct: 136 ---------------------------IKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC-- 166
Query: 201 KIIHRDLKAANILLDDN 217
           +IIH D+K  NILL  N
Sbjct: 167 RIIHTDIKPENILLSVN 183

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 80/196 (40%), Gaps = 18/196 (9%)
Query: 87  QGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS 146
           Q G GK Y         +  +RL            +REV+++    H N++ L       
Sbjct: 26  QKGTGKEYAAKF-----IKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK 80
Query: 147 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRD 206
           ++ +L+      L     L D    ++ L      +       G+ YLH +   +I H D
Sbjct: 81  TDVVLIL----ELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFD 133
Query: 207 LKAANILLDD----NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 262
           LK  NI+L D    N    L DFG+A  ++A   +    I GT   +APE ++      +
Sbjct: 134 LKPENIMLLDKNVPNPRIKLIDFGIAHKIEA--GNEFKNIFGTPEFVAPEIVNYEPLGLE 191
Query: 263 TDVFGYGITLLELVTG 278
            D++  G+    L++G
Sbjct: 192 ADMWSIGVITYILLSG 207

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	401
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	0.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-140
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-127
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-76
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-64
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-58
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-56
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-55
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-54
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-54
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-53
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-52
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-51
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-51
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-51
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-51
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-50
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-48
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-37
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-37
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-37
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-36
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-36
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-35
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-35
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-35
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-35
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-35
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-35
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-34
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-34
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-34
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-34
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-34
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-34
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-34
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-34
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-34
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-34
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	8e-34
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-33
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-33
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-33
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-33
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-33
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-33
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-33
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-33
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	9e-33
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-33
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-32
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-32
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-32
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-32
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-32
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-32
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-32
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-32
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-32
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	6e-32
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-31
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-31
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-31
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-31
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-31
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	9e-31
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-30
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-30
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-30
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-30
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-30
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-29
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-29
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-29
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-29
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-29
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-29
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	9e-29
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-28
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-28
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	8e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-27
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-27
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-26
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-26
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-25
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-25
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-25
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-25
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-25
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-25
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-25
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-25
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-25
3fme_A	290	Dual specificity mitogen-activated protein kinase;	9e-25
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-24
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-24
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-24
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	9e-24
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-23
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-23
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-23
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-23
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-23
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-23
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-23
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-22
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-22
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-22
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-22
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-22
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-22
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	8e-22
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-22
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-21
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-21
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-20
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-20
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-20
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-20
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-20
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	8e-20
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-19
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-19
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-19
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	8e-19
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	9e-19
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-18
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-18
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-18
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-18
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-18
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-18
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-18
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	8e-18
3o0g_A	292	Cell division protein kinase 5; kinase activator c	9e-18
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-17
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-17
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-17
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-17
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-17
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-16
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-16
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-16
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-16
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-16
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-16
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-15
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-15
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-15
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-15
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-15
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-15
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-15
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-08
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-15
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-15
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-15
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-15
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	8e-15
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	8e-15
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-15
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-14
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-14
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-14
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-14
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-14
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-14
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-14
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-14
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	7e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-14
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	9e-14
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	9e-14
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-13
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-13
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-13
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-13
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-13
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-13
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-13
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-13
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-13
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-13
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-13
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-13
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-13
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-13
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-13
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-13
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-12
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-12
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-12
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-12
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-12
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-12
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-12
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-12
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-12
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-12
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	8e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	9e-12
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-11
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	8e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	7e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	9e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	9e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-06
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-06
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	7e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	8e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  526 bits (1357), Expect = 0.0
 Identities = 204/326 (62%), Positives = 261/326 (80%), Gaps = 1/326 (0%)

Query: 48  FFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVK 107
           FFDV  E+D +V L QL+RFS RELQ+A+DNFS  NI+G+GGFGKVYKG L+D T VAVK
Sbjct: 1   FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60

Query: 108 RLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD 167
           RL++  + GGE  FQ EV +IS+A+H+NLL+L G+C T +ER+LVYP+M N SVA  LR+
Sbjct: 61  RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120

Query: 168 LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 227
               +  LDWP R+R+A G+A GL YLH+ C+PKIIHRD+KAANILLD+ FEAV+ DFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180

Query: 228 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL 287
           AKL+D K THVTT +RGT+GHIAPEYLSTGKSSEKTDVFGYG+ LLEL+TGQRA D +RL
Sbjct: 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240

Query: 288 EEEEDVLLLDHIRKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMA 346
             ++DV+LLD ++ LL+E +L  +VD +L   Y  +EVE ++QVALLCTQS+P +RP M+
Sbjct: 241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300

Query: 347 QVVKMLQGEDLAERWAEWEELEEVRQ 372
           +VV+ML+G+ LAERW EW++ E  RQ
Sbjct: 301 EVVRMLEGDGLAERWEEWQKEEMFRQ 326

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  401 bits (1033), Expect = e-140
 Identities = 116/312 (37%), Positives = 178/312 (57%), Gaps = 21/312 (6%)

Query: 54  EDDCKVSLTQLRRFSCRELQLATDNFSE------SNIIGQGGFGKVYKGVLSDNTKVAVK 107
               +VS T+   FS  EL+  T+NF E       N +G+GGFG VYKG + +NT VAVK
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60

Query: 108 RL---QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYR 164
           +L    D  +   +  F +E+ +++   H+NL++L+G+ +   +  LVY +M N S+  R
Sbjct: 61  KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120

Query: 165 LRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 224
           L     G   L W  R ++A G A G+ +LHE      IHRD+K+ANILLD+ F A + D
Sbjct: 121 LSC-LDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176

Query: 225 FGLAKLVDA-KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
           FGLA+  +    T +T++I GT  ++APE L  G+ + K+D++ +G+ LLE++TG  A+D
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235

Query: 284 FSRLEEEEDVLLLDHIRKLLREDR-LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDR 342
             R    E  LLLD   ++  E++ + D +D+ +N  DS  VE M  VA  C       R
Sbjct: 236 EHR----EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKR 291

Query: 343 PPMAQVVKMLQG 354
           P + +V ++LQ 
Sbjct: 292 PDIKKVQQLLQE 303

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  368 bits (947), Expect = e-127
 Identities = 106/295 (35%), Positives = 160/295 (54%), Gaps = 8/295 (2%)

Query: 62  TQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAF 121
            +  R    +L+ AT+NF    +IG G FGKVYKGVL D  KVA+KR     S  G   F
Sbjct: 24  FESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEF 82

Query: 122 QREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK 181
           + E+  +S   H +L+ LIG+C   +E IL+Y +M+N ++   L         + W  R 
Sbjct: 83  ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142

Query: 182 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTT 240
            +  G A GL YLH +    IIHRD+K+ NILLD+NF   + DFG++K   +   TH++T
Sbjct: 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST 199

Query: 241 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 300
            ++GT+G+I PEY   G+ +EK+DV+ +G+ L E++  + AI  S   E  +  L +   
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN--LAEWAV 257

Query: 301 KLLREDRLNDIVDRNL-NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 354
           +     +L  IVD NL +    + +      A+ C   + EDRP M  V+  L+ 
Sbjct: 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  237 bits (607), Expect = 6e-76
 Identities = 72/313 (23%), Positives = 121/313 (38%), Gaps = 38/313 (12%)

Query: 67  FSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQRE-- 124
                L   +       +  +G FG V+K  L  N  VAVK          + ++Q E  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIF----PIQDKQSWQNEYE 68

Query: 125 VHLISVAIHKNLLQLIGYCTTSS----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR 180
           V+ +    H+N+LQ IG     +    +  L+  F +  S++  L+        + W   
Sbjct: 69  VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNEL 123

Query: 181 KRVAFGTAYGLEYLHE-------QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 233
             +A   A GL YLHE          P I HRD+K+ N+LL +N  A + DFGLA   +A
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183

Query: 234 KLTHV-TTQIRGTMGHIAPEYLSTG-----KSSEKTDVFGYGITLLELVTGQRAIDFSRL 287
             +   T    GT  ++APE L         +  + D++  G+ L EL +   A D    
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV- 242

Query: 288 EEEEDVLLLDHIRKLLREDRLNDIVDRNL------NTYDSKEV-ETMVQVALLCTQSTPE 340
            +E  +   + I +    + + ++V          + +        + +    C     E
Sbjct: 243 -DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301

Query: 341 DRPPMAQVVKMLQ 353
            R     V + + 
Sbjct: 302 ARLSAGCVGERIT 314

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  206 bits (527), Expect = 6e-64
 Identities = 69/322 (21%), Positives = 117/322 (36%), Gaps = 45/322 (13%)

Query: 67  FSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQRE-- 124
            +  E  L  DN     +IG+G +G VYKG L D   VAVK      S      F  E  
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF----SFANRQNFINEKN 57

Query: 125 VHLISVAIHKNLLQLIGYCTTSS-----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPT 179
           ++ + +  H N+ + I      +     E +LV  +  N S+   L          DW +
Sbjct: 58  IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVS 112

Query: 180 RKRVAFGTAYGLEYLHE------QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD- 232
             R+A     GL YLH          P I HRDL + N+L+ ++   V+ DFGL+  +  
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172

Query: 233 ------AKLTHVTTQIRGTMGHIAPEYL-------STGKSSEKTDVFGYGITLLELVTGQ 279
                  +  +      GT+ ++APE L           + ++ D++  G+   E+    
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232

Query: 280 RAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR--------NLNTYDSKEVETMVQVA 331
             +       E  +     +      + +  +V R             +S  V ++ +  
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292

Query: 332 LLCTQSTPEDRPPMAQVVKMLQ 353
             C     E R       + + 
Sbjct: 293 EDCWDQDAEARLTAQXAEERMA 314

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  191 bits (487), Expect = 4e-58
 Identities = 76/272 (27%), Positives = 124/272 (45%), Gaps = 21/272 (7%)

Query: 83  NIIGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
             IG G FG V++      + VAVK L +  +       F REV ++    H N++  +G
Sbjct: 43  EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 142 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 201
             T      +V  ++   S+   L      E+ LD   R  +A+  A G+ YLH   NP 
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLH-NRNPP 159

Query: 202 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSE 261
           I+HR+LK+ N+L+D  +   +CDFGL++L  A     +    GT   +APE L    S+E
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLK-ASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218

Query: 262 KTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS 321
           K+DV+ +G+ L EL T Q    +  L   + V  +    K  R +   ++        + 
Sbjct: 219 KSDVYSFGVILWELATLQ--QPWGNLNPAQVVAAV--GFKCKRLEIPRNL--------NP 266

Query: 322 KEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
           +    +      C  + P  RP  A ++ +L+
Sbjct: 267 QVAAIIEG----CWTNEPWKRPSFATIMDLLR 294

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  186 bits (474), Expect = 2e-56
 Identities = 68/283 (24%), Positives = 109/283 (38%), Gaps = 37/283 (13%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 136
                  ++G+G FG V K        VA+K+++   S     AF  E+  +S   H N+
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE---SESERKAFIVELRQLSRVNHPNI 63

Query: 137 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 196
           ++L G C   +   LV  + +  S+   L   +P                 + G+ YLH 
Sbjct: 64  VKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLHS 120

Query: 197 QCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 255
                +IHRDLK  N+LL      + +CDFG A  +   +T+      G+   +APE   
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK----GSAAWMAPEVFE 176

Query: 256 TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 315
               SEK DVF +GI L E++T ++   F  +      ++                V   
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKP--FDEIGGPAFRIM--------------WAVHNG 220

Query: 316 L-----NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                           M +    C    P  RP M ++VK++ 
Sbjct: 221 TRPPLIKNLPKPIESLMTR----CWSKDPSQRPSMEEIVKIMT 259

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  180 bits (459), Expect = 3e-54
 Identities = 78/275 (28%), Positives = 129/275 (46%), Gaps = 28/275 (10%)

Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           IG G FG VYKG    +  VAVK L     +P    AF+ EV ++    H N+L  +GY 
Sbjct: 32  IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 144 TTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 202
           T  + ++ +V  + +  S+ Y    L   E   +      +A  TA G++YLH +    I
Sbjct: 90  T--APQLAIVTQWCEGSSL-YHH--LHASETKFEMKKLIDIARQTARGMDYLHAK---SI 141

Query: 203 IHRDLKAANILLDDNFEAVLCDFGLAKL-VDAKLTHVTTQIRGTMGHIAPE---YLSTGK 258
           IHRDLK+ NI L ++    + DFGLA        +H   Q+ G++  +APE      +  
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201

Query: 259 SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT 318
            S ++DV+ +GI L EL+TGQ  + +S +   + +     I  + R     D+     N 
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQI-----IEMVGRGSLSPDLSKVRSNC 254

Query: 319 YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                   M ++   C +   ++RP   +++  ++
Sbjct: 255 PKR-----MKRLMAECLKKKRDERPSFPRILAEIE 284

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  180 bits (459), Expect = 4e-54
 Identities = 62/285 (21%), Positives = 109/285 (38%), Gaps = 36/285 (12%)

Query: 83  NIIGQGGFGKVYKGVLSDNTK-VAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
            ++G+G FG+  K    +  + + +K L   +    +  F +EV ++    H N+L+ IG
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIR-FDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 142 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 201
                     +  +++  ++   ++     +    W  R   A   A G+ YLH      
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---N 128

Query: 202 IIHRDLKAANILLDDNFEAVLCDFGLAKLVD-------------AKLTHVTTQIRGTMGH 248
           IIHRDL + N L+ +N   V+ DFGLA+L+                       + G    
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188

Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 308
           +APE ++     EK DVF +GI L E++    A              L+ +R  L     
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA--DPDYLPRTMDFGLN-VRGFLDRYCP 245

Query: 309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
            +               +   + + C    PE RP   ++   L+
Sbjct: 246 PNC------------PPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  176 bits (449), Expect = 8e-53
 Identities = 74/291 (25%), Positives = 119/291 (40%), Gaps = 38/291 (13%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL------QDYYSPGGEAAFQREVHLIS 129
           +       IG+GGFG V+KG  + D + VA+K L       +         FQREV ++S
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
              H N+++L G         +V  F+    + +RL D       + W  + R+    A 
Sbjct: 79  NLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIAL 133

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-----LCDFGLAKLVDAKLTHVTTQIRG 244
           G+EY+    NP I+HRDL++ NI L    E       + DFGL++       H  + + G
Sbjct: 134 GIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS----VHSVSGLLG 188

Query: 245 TMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL 302
               +APE +       +EK D + + + L  ++TG+    F      +   +     + 
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP--FDEYSYGKIKFINMIREEG 246

Query: 303 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
           LR     D                +  V  LC    P+ RP  + +VK L 
Sbjct: 247 LRPTIPEDC------------PPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  174 bits (443), Expect = 3e-52
 Identities = 73/287 (25%), Positives = 109/287 (37%), Gaps = 46/287 (16%)

Query: 83  NIIGQGGFGKVYKGVLSDNTKVAVKRL---QDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
            IIG GGFGKVY+       +VAVK      D          ++E  L ++  H N++ L
Sbjct: 13  EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
            G C       LV  F +   +   L       K +        A   A G+ YLH++  
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 200 PKIIHRDLKAANILLDDNFEAV--------LCDFGLAKLVDAKLTHVTTQIRGTMGHIAP 251
             IIHRDLK++NIL+    E          + DFGLA+      T   +   G    +AP
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR--TTKMSAA-GAYAWMAP 183

Query: 252 EYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 311
           E +     S+ +DV+ YG+ L EL+TG+  + F  ++                      +
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE--VPFRGIDGLAVAY---------------GV 226

Query: 312 VDRNL-----NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
               L     +T      + M      C    P  RP    ++  L 
Sbjct: 227 AMNKLALPIPSTCPEPFAKLMED----CWNPDPHSRPSFTNILDQLT 269

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  174 bits (444), Expect = 1e-51
 Identities = 63/285 (22%), Positives = 116/285 (40%), Gaps = 39/285 (13%)

Query: 83  NIIGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
            +IG+G FG+VY G    + +VA++ +  +  +     AF+REV       H+N++  +G
Sbjct: 39  ELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 142 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 201
            C +     ++    +  ++   +RD K     LD    +++A     G+ YLH      
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLH---AKG 150

Query: 202 IIHRDLKAANILLDDNFEAVLCDFGLAKLVD----AKLTHVTTQIRGTMGHIAPEYLSTG 257
           I+H+DLK+ N+  D+  + V+ DFGL  +       +         G + H+APE +   
Sbjct: 151 ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 258 KS---------SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 308
                      S+ +DVF  G    EL   +    F     E        I   +     
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHARE--WPFKTQPAEA-------IIWQMGTGMK 260

Query: 309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
            ++    +        + +  + L C     E+RP   +++ ML+
Sbjct: 261 PNLSQIGMG-------KEISDILLFCWAFEQEERPTFTKLMDMLE 298

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  171 bits (436), Expect = 4e-51
 Identities = 54/306 (17%), Positives = 104/306 (33%), Gaps = 65/306 (21%)

Query: 78  NFSE---SNIIGQGGFGKVYKGVLSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIH 133
           +F +      + +   G+++KG       + VK L    +S      F  E   + +  H
Sbjct: 8   DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66

Query: 134 KNLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDL--KPGEKGLDWPTRKRVAFGTAY 189
            N+L ++G C +        +  +M   S    L ++  +     +D     + A   A 
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWMPYGS----LYNVLHEGTNFVVDQSQAVKFALDMAR 122

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           G+ +LH    P I    L + ++++D++  A +    +        +  +         +
Sbjct: 123 GMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVK------FSFQSPGRMYAPAWV 175

Query: 250 APEYLSTGKS---SEKTDVFGYGITLLELVTGQRA-IDFSRLEEEEDVLLLD-------- 297
           APE L            D++ + + L ELVT +    D S +E    V L          
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPG 235

Query: 298 ---HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 354
              H+ KL++                             C    P  RP    +V +L  
Sbjct: 236 ISPHVSKLMKI----------------------------CMNEDPAKRPKFDMIVPIL-- 265

Query: 355 EDLAER 360
           E + ++
Sbjct: 266 EKMQDK 271

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  172 bits (438), Expect = 5e-51
 Identities = 72/323 (22%), Positives = 121/323 (37%), Gaps = 63/323 (19%)

Query: 66  RFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREV 125
           R   R++ L          +G+G +G+V++G       VAVK      S   E ++ RE 
Sbjct: 4   RTVARDITL-------LECVGKGRYGEVWRGSW-QGENVAVKIF----SSRDEKSWFRET 51

Query: 126 HLISVAI--HKNLLQLIGYCTTSSERI----LVYPFMQNLSVAYRLRDLKPGEKGLDWPT 179
            L +  +  H+N+L  I    TS        L+  + +  S+   L+        LD  +
Sbjct: 52  ELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVS 106

Query: 180 RKRVAFGTAYGLEYLHE-----QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 234
             R+    A GL +LH      Q  P I HRDLK+ NIL+  N +  + D GLA +    
Sbjct: 107 CLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS 166

Query: 235 LTHV---TTQIRGTMGHIAPE------YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFS 285
              +        GT  ++APE       +    S ++ D++ +G+ L E+     +    
Sbjct: 167 TNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226

Query: 286 R---------------LEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQV 330
                            E+   V+ +D  R  +     +D    +L        + M + 
Sbjct: 227 EDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSL-------AKLMKE- 278

Query: 331 ALLCTQSTPEDRPPMAQVVKMLQ 353
              C    P  R    ++ K L 
Sbjct: 279 ---CWYQNPSARLTALRIKKTLT 298

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  172 bits (438), Expect = 1e-50
 Identities = 68/319 (21%), Positives = 119/319 (37%), Gaps = 63/319 (19%)

Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS 129
           +++Q+          IG+G +G+V+ G      KVAVK          EA++ RE  +  
Sbjct: 37  KQIQM-------VKQIGKGRYGEVWMGKW-RGEKVAVKVF----FTTEEASWFRETEIYQ 84

Query: 130 VAI--HKNLLQLIGYCTTSSERI----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 183
             +  H+N+L  I      +       L+  + +N S+   L+        LD  +  ++
Sbjct: 85  TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLKL 139

Query: 184 AFGTAYGLEYLHE-----QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 238
           A+ +  GL +LH      Q  P I HRDLK+ NIL+  N    + D GLA    +    V
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199

Query: 239 ---TTQIRGTMGHIAPE------YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR--- 286
                   GT  ++ PE        +  +S    D++ +G+ L E+     +        
Sbjct: 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259

Query: 287 ------------LEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLC 334
                        E+  +++ +  +R        +D   R +        + M +    C
Sbjct: 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQM-------GKLMTE----C 308

Query: 335 TQSTPEDRPPMAQVVKMLQ 353
               P  R    +V K L 
Sbjct: 309 WAHNPASRLTALRVKKTLA 327

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  166 bits (421), Expect = 4e-48
 Identities = 69/319 (21%), Positives = 116/319 (36%), Gaps = 63/319 (19%)

Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQRE--VHL 127
           R + L          IG+G FG+V++G      +VAVK      S   E ++ RE  ++ 
Sbjct: 42  RTIVL-------QESIGKGRFGEVWRGKW-RGEEVAVKIF----SSREERSWFREAEIYQ 89

Query: 128 ISVAIHKNLLQLIGYCTTSSERI----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 183
             +  H+N+L  I      +       LV  + ++ S+   L         +      ++
Sbjct: 90  TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKL 144

Query: 184 AFGTAYGLEYLHE-----QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 238
           A  TA GL +LH      Q  P I HRDLK+ NIL+  N    + D GLA   D+    +
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 204

Query: 239 T---TQIRGTMGHIAPEYL------STGKSSEKTDVFGYGITLLELVTGQRAIDFSR--- 286
                   GT  ++APE L         +S ++ D++  G+   E+              
Sbjct: 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264

Query: 287 ------------LEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLC 334
                       +EE   V+    +R  +     +    R +        + M +    C
Sbjct: 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVM-------AKIMRE----C 313

Query: 335 TQSTPEDRPPMAQVVKMLQ 353
             +    R    ++ K L 
Sbjct: 314 WYANGAARLTALRIKKTLS 332

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  138 bits (351), Expect = 1e-37
 Identities = 72/283 (25%), Positives = 122/283 (43%), Gaps = 36/283 (12%)

Query: 85  IGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           IG+G FG+V+ G L +DNT VAVK  ++   P  +A F +E  ++    H N+++LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
           T      +V   +Q       LR        L   T  ++    A G+EYL  +     I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLESK---CCI 235

Query: 204 HRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQ---IRGTMGHIAPEYLSTGK 258
           HRDL A N L+ +     + DFG+++             +   ++ T    APE L+ G+
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEALNYGR 291

Query: 259 SSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN 317
            S ++DV+ +GI L E  + G     +  L  ++          + +  RL         
Sbjct: 292 YSSESDVWSFGILLWETFSLGASP--YPNLSNQQ-T-----REFVEKGGRL----PCPEL 339

Query: 318 TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAER 360
             D+     + ++   C    P  RP  + + + L  + + +R
Sbjct: 340 CPDA-----VFRLMEQCWAYEPGQRPSFSTIYQEL--QSIRKR 375

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  135 bits (342), Expect = 5e-37
 Identities = 64/293 (21%), Positives = 120/293 (40%), Gaps = 43/293 (14%)

Query: 83  NIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
             +G+G FGKV          +   +VAVK L+        A  ++E+ ++    H+N++
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 138 QLIGYCTTSSER--ILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           +  G CT        L+  F+ + S    L++ L   +  ++   + + A     G++YL
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGS----LKEYLPKNKNKINLKQQLKYAVQICKGMDYL 142

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGH 248
             +   + +HRDL A N+L++   +  + DFGL K ++    + T +      +      
Sbjct: 143 GSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY--- 196

Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEE------DVLLLDHIRK 301
            APE L   K    +DV+ +G+TL EL+T          L  +        + +   +  
Sbjct: 197 -APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255

Query: 302 LLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
           L    RL        N     EV + M +    C +  P +R     +++  +
Sbjct: 256 LKEGKRL----PCPPNC--PDEVYQLMRK----CWEFQPSNRTSFQNLIEGFE 298

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  135 bits (343), Expect = 6e-37
 Identities = 59/240 (24%), Positives = 107/240 (44%), Gaps = 34/240 (14%)

Query: 53  GEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVL-----SDNTKVAVK 107
           GE   +  L  L+     E +          ++G G FG VYKG+           VA+K
Sbjct: 1   GEAPNQALLRILKE---TEFKK-------IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK 50

Query: 108 RLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD 167
            L++  SP        E ++++   + ++ +L+G C TS+ ++ +   M        L D
Sbjct: 51  ELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGC----LLD 105

Query: 168 -LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 226
            ++  +  +            A G+ YL ++   +++HRDL A N+L+       + DFG
Sbjct: 106 YVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFG 162

Query: 227 LAKLVDAKLTHVTTQ-----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQR 280
           LAKL+ A+      +     I+      A E +     + ++DV+ YG+T+ EL+T G +
Sbjct: 163 LAKLLGAEEKEYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  133 bits (337), Expect = 2e-36
 Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 16/206 (7%)

Query: 81  ESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 136
              +IG+G FG VY G   D      + A+K L          AF RE  L+    H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 137 LQLIGYCTTSSERIL-VYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           L LIG           + P+M +      L   ++  ++              A G+EYL
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGD----LLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---AP 251
            EQ   K +HRDL A N +LD++F   + DFGLA+ +  +  +   Q R     +   A 
Sbjct: 141 AEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197

Query: 252 EYLSTGKSSEKTDVFGYGITLLELVT 277
           E L T + + K+DV+ +G+ L EL+T
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  132 bits (334), Expect = 6e-36
 Identities = 77/284 (27%), Positives = 119/284 (41%), Gaps = 40/284 (14%)

Query: 83  NIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
            +IG+G FG VY G L DN       AVK L      G  + F  E  ++    H N+L 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 139 LIGYCTTSSERIL-VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
           L+G C  S    L V P+M++  +   +R+                    A G++YL  +
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKYLASK 147

Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---APEYL 254
              K +HRDL A N +LD+ F   + DFGLA+ +  K  +      G    +   A E L
Sbjct: 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204

Query: 255 STGKSSEKTDVFGYGITLLELVT-GQR---AIDFSRLEEEEDVLLLDHIRKLLREDRLND 310
            T K + K+DV+ +G+ L EL+T G      ++        D+        LL+  RL  
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN------TFDI-----TVYLLQGRRL-- 251

Query: 311 IVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
              +         + E M++    C     E RP  +++V  + 
Sbjct: 252 --LQPEYC--PDPLYEVMLK----CWHPKAEMRPSFSELVSRIS 287

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  130 bits (329), Expect = 2e-35
 Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 16/203 (7%)

Query: 84  IIGQGGFGKVYKGV-LSDNTKVAVKRLQD-YYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
            IG+G F  VYKG+      +VA   LQD   +      F+ E  ++    H N+++   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 142 YCTTSSER----ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
              ++ +     +LV   M + ++   L+  K     +     +        GL++LH  
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHT- 147

Query: 198 CNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST 256
             P IIHRDLK  NI +     +V + D GLA L  A        + GT   +APE    
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEE 204

Query: 257 GKSSEKTDVFGYGITLLELVTGQ 279
               E  DV+ +G+ +LE+ T +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  130 bits (330), Expect = 4e-35
 Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 24/210 (11%)

Query: 83  NIIGQGGFGKVYKGVLSD-----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
            ++G G FG V+KGV           V +K ++D        A    +  I    H +++
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHE 196
           +L+G C  SS ++ V  ++   S    L D ++     L            A G+ YL E
Sbjct: 79  RLLGLCPGSSLQL-VTQYLPLGS----LLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE 133

Query: 197 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-----IRGTMGHIAP 251
                ++HR+L A N+LL    +  + DFG+A L+      +        I+      A 
Sbjct: 134 H---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM----AL 186

Query: 252 EYLSTGKSSEKTDVFGYGITLLELVT-GQR 280
           E +  GK + ++DV+ YG+T+ EL+T G  
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  129 bits (326), Expect = 4e-35
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 18/200 (9%)

Query: 83  NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
             IG G FG V+ G   +  KVA+K +++      E  F  E  ++    H  L+QL G 
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 143 CTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 201
           C   +   LV  FM++      L D L+         T   +      G+ YL E     
Sbjct: 72  CLEQAPICLVTEFMEHGC----LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---C 124

Query: 202 IIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQ--IRGTMGHIAPEYLSTG 257
           +IHRDL A N L+ +N    + DFG+ + V  D   +   T+  ++      +PE  S  
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA----SPEVFSFS 180

Query: 258 KSSEKTDVFGYGITLLELVT 277
           + S K+DV+ +G+ + E+ +
Sbjct: 181 RYSSKSDVWSFGVLMWEVFS 200

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  131 bits (332), Expect = 5e-35
 Identities = 63/203 (31%), Positives = 93/203 (45%), Gaps = 14/203 (6%)

Query: 83  NIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
            +IG+G FG VY G L DN       AVK L      G  + F  E  ++    H N+L 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 139 LIGYCTTSSERIL-VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
           L+G C  S    L V P+M++  +   +R+                    A G+++L  +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK 211

Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---APEYL 254
              K +HRDL A N +LD+ F   + DFGLA+ +  K         G    +   A E L
Sbjct: 212 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268

Query: 255 STGKSSEKTDVFGYGITLLELVT 277
            T K + K+DV+ +G+ L EL+T
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMT 291

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  130 bits (329), Expect = 5e-35
 Identities = 78/292 (26%), Positives = 119/292 (40%), Gaps = 42/292 (14%)

Query: 83  NIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
           + +G+G FG V          +    VAVK+LQ    P  +  FQRE+ ++       ++
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIV 87

Query: 138 QLIGYCTTSSER--ILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           +  G       +   LV  ++ +      LRD L+     LD       +     G+EYL
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGC----LRDFLQRHRARLDASRLLLYSSQICKGMEYL 143

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI----- 249
             +   + +HRDL A NIL++      + DFGLAKL+     +   +     G       
Sbjct: 144 GSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR---EPGQSPIFWY 197

Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVT-GQR-----AIDFSRLEEEEDVLLLDHIRKLL 303
           APE LS    S ++DV+ +G+ L EL T   +     A     +  E DV  L  + +LL
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257

Query: 304 RED-RLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
            E  RL              EV E M      C   +P+DRP  + +   L 
Sbjct: 258 EEGQRL----PAPPAC--PAEVHELMKL----CWAPSPQDRPSFSALGPQLD 299

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  130 bits (329), Expect = 7e-35
 Identities = 59/240 (24%), Positives = 107/240 (44%), Gaps = 34/240 (14%)

Query: 53  GEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSD-----NTKVAVK 107
           GE   +  L  L+     E +          ++G G FG VYKG+           VA+K
Sbjct: 1   GEAPNQALLRILKE---TEFKK-------IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK 50

Query: 108 RLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD 167
            L++  SP        E ++++   + ++ +L+G C TS+ ++ +   M        L D
Sbjct: 51  ELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGC----LLD 105

Query: 168 -LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG 226
            ++  +  +            A G+ YL ++   +++HRDL A N+L+       + DFG
Sbjct: 106 YVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFG 162

Query: 227 LAKLVDAKLTHVTTQ-----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQR 280
           LAKL+ A+      +     I+      A E +     + ++DV+ YG+T+ EL+T G +
Sbjct: 163 LAKLLGAEEKEYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  133 bits (336), Expect = 1e-34
 Identities = 73/272 (26%), Positives = 121/272 (44%), Gaps = 26/272 (9%)

Query: 83  NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
             +GQG FG+V+ G  +  T+VA+K L+         AF +E  ++    H+ L+QL   
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 202
            +     I V  +M   S+   L+      K L  P    +A   A G+ Y+        
Sbjct: 331 VSEEPIYI-VTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM---NY 384

Query: 203 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 262
           +HRDL+AANIL+ +N    + DFGLA+L++          +  +   APE    G+ + K
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444

Query: 263 TDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSK 322
           +DV+ +GI L EL T  R + +  +   E   +LD + +  R     +           +
Sbjct: 445 SDVWSFGILLTELTTKGR-VPYPGMVNRE---VLDQVERGYRMPCPPEC---------PE 491

Query: 323 EV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
            + + M Q    C +  PE+RP    +   L+
Sbjct: 492 SLHDLMCQ----CWRKEPEERPTFEYLQAFLE 519

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  129 bits (326), Expect = 1e-34
 Identities = 76/312 (24%), Positives = 121/312 (38%), Gaps = 48/312 (15%)

Query: 69  CRELQLATDN--FSESNI-----IGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPG 116
               Q   D   F +  +     +G+G FGKV               VAVK L+    P 
Sbjct: 16  EVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQ 75

Query: 117 GEAAFQREVHLISVAIHKNLLQLIGYCTTSSER--ILVYPFMQNLSVAYRLRDLKPGEKG 174
             + +++E+ ++    H+++++  G C  +      LV  ++   S    LRD  P    
Sbjct: 76  HRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGS----LRDYLPRHS- 130

Query: 175 LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 234
           +        A     G+ YLH Q     IHRDL A N+LLD++    + DFGLAK V   
Sbjct: 131 IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187

Query: 235 LTHVTTQIRGT-----MGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLE 288
             +   +  G          APE L   K    +DV+ +G+TL EL+T    +       
Sbjct: 188 HEYYRVREDGDSPVFWY---APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF 244

Query: 289 EEEDV-----LLLDHIRKLLRE-DRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPED 341
            E        + +  + +LL   +RL     R        EV   M      C ++    
Sbjct: 245 LELIGIAQGQMTVLRLTELLERGERL----PRPDKC--PAEVYHLMKN----CWETEASF 294

Query: 342 RPPMAQVVKMLQ 353
           RP    ++ +L+
Sbjct: 295 RPTFENLIPILK 306

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  131 bits (332), Expect = 2e-34
 Identities = 71/271 (26%), Positives = 119/271 (43%), Gaps = 24/271 (8%)

Query: 83  NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
             +GQG FG+V+ G  +  T+VA+K L+         AF +E  ++    H+ L+QL   
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 202
            +     I V  +M   S+   L+      K L  P    +A   A G+ Y+        
Sbjct: 248 VSEEPIYI-VTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM---NY 301

Query: 203 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK 262
           +HRDL+AANIL+ +N    + DFGLA+L++          +  +   APE    G+ + K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361

Query: 263 TDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSK 322
           +DV+ +GI L EL T  R + +  +   E   +LD + +  R     +  +         
Sbjct: 362 SDVWSFGILLTELTTKGR-VPYPGMVNRE---VLDQVERGYRMPCPPECPES-------- 409

Query: 323 EVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
               +  +   C +  PE+RP    +   L+
Sbjct: 410 ----LHDLMCQCWRKEPEERPTFEYLQAFLE 436

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  128 bits (325), Expect = 2e-34
 Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 24/212 (11%)

Query: 83  NIIGQGGFGKVYKGVLSD----NTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLL 137
            I+G+G FG V +G L      + KVAVK +  D  S      F  E   +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 138 QLIGYCT-----TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--AYG 190
           +L+G C         + +++ PFM+   +   L   +        P +  + F    A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI- 249
           +EYL  +     +HRDL A N +L D+    + DFGL+K + +   +     +G +  + 
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR----QGRIAKMP 212

Query: 250 ----APEYLSTGKSSEKTDVFGYGITLLELVT 277
               A E L+    + K+DV+ +G+T+ E+ T
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  129 bits (326), Expect = 2e-34
 Identities = 73/322 (22%), Positives = 131/322 (40%), Gaps = 53/322 (16%)

Query: 83  NIIGQGGFGKVYKGVLSDN----TKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLL 137
            ++G+G FG V +  L        KVAVK L  D  +      F RE   +    H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 138 QLIGYCTTSSERI------LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--AY 189
           +L+G    S  +       ++ PFM++  +   L   + GE   + P +  V F    A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           G+EYL  +     IHRDL A N +L ++    + DFGL++ + +   +     +G    +
Sbjct: 149 GMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR----QGCASKL 201

Query: 250 -----APEYLSTGKSSEKTDVFGYGITLLELVT-GQR---AIDFSRLEEEEDVLLLDHIR 300
                A E L+    +  +DV+ +G+T+ E++T GQ     I+        ++       
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE------NAEI-----YN 250

Query: 301 KLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAE 359
            L+  +RL     +       +EV + M Q    C  + P+ RP    +   L  E++  
Sbjct: 251 YLIGGNRL----KQPPEC--MEEVYDLMYQ----CWSADPKQRPSFTCLRMEL--ENILG 298

Query: 360 RWAEWEELEEVRQQEVSLLPHQ 381
             +     ++     +    H 
Sbjct: 299 HLSVLSTSQDPLYINIERAHHH 320

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  127 bits (322), Expect = 2e-34
 Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 18/200 (9%)

Query: 83  NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
             +G G FG V  G       VA+K +++      E  F  E  ++    H+ L+QL G 
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 143 CTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 201
           CT      ++  +M N      L + L+             +       +EYL  +   +
Sbjct: 88  CTKQRPIFIITEYMANGC----LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---Q 140

Query: 202 IIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQ--IRGTMGHIAPEYLSTG 257
            +HRDL A N L++D     + DFGL++ V  D   + V ++  +R +     PE L   
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLMYS 196

Query: 258 KSSEKTDVFGYGITLLELVT 277
           K S K+D++ +G+ + E+ +
Sbjct: 197 KFSSKSDIWAFGVLMWEIYS 216

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  126 bits (320), Expect = 3e-34
 Identities = 52/198 (26%), Positives = 84/198 (42%), Gaps = 16/198 (8%)

Query: 84  IIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
            +G G FG V  G       VAVK +++      E  F +E   +    H  L++  G C
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 144 TTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 202
           +      +V  ++ N      L + L+   KGL+      + +    G+ +L      + 
Sbjct: 73  SKEYPIYIVTEYISNGC----LLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QF 125

Query: 203 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---APEYLSTGKS 259
           IHRDL A N L+D +    + DFG+ + V            GT   +   APE     K 
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVL---DDQYVSSVGTKFPVKWSAPEVFHYFKY 182

Query: 260 SEKTDVFGYGITLLELVT 277
           S K+DV+ +GI + E+ +
Sbjct: 183 SSKSDVWAFGILMWEVFS 200

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  127 bits (320), Expect = 7e-34
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 26/209 (12%)

Query: 83  NIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
             +G+G FG V          +    VAVK+LQ   +      F+RE+ ++    H N++
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIV 74

Query: 138 QLIGYCTTSSER--ILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           +  G C ++  R   L+  ++   S    LRD L+  ++ +D     +       G+EYL
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGS----LRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGH 248
             +   + IHRDL   NIL+++     + DFGL K++         +      I      
Sbjct: 131 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY--- 184

Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVT 277
            APE L+  K S  +DV+ +G+ L EL T
Sbjct: 185 -APESLTESKFSVASDVWSFGVVLYELFT 212

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  126 bits (319), Expect = 7e-34
 Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 23/207 (11%)

Query: 85  IGQGGFGKVYKGVL---SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
           +G G FG V +GV         VA+K L+            RE  ++    +  +++LIG
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 142 YCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 200
            C   +  + V            L   L    + +       +    + G++YL E+   
Sbjct: 78  VCQAEALML-VMEMAGGGP----LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--- 129

Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG------TMGHIAPEYL 254
             +HRDL A N+LL +   A + DFGL+K + A  ++ T +  G           APE +
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECI 185

Query: 255 STGKSSEKTDVFGYGITLLELVT-GQR 280
           +  K S ++DV+ YG+T+ E ++ GQ+
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQK 212

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  127 bits (321), Expect = 7e-34
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 23/210 (10%)

Query: 83  NIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
            IIG G  G+V  G L      +  VA+K L+  Y+      F  E  ++    H N+++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
           L G  T     ++V  +M+N S    L   L+  +          +  G   G+ YL + 
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGS----LDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL 170

Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGHIAP 251
                +HRDL A N+L+D N    + DFGL+++++       T       IR T    AP
Sbjct: 171 ---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----AP 223

Query: 252 EYLSTGKSSEKTDVFGYGITLLELVT-GQR 280
           E ++    S  +DV+ +G+ + E++  G+R
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGER 253

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  130 bits (329), Expect = 8e-34
 Identities = 69/288 (23%), Positives = 131/288 (45%), Gaps = 26/288 (9%)

Query: 83  NIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
           + +G G +G+VY+GV    +  VAVK L++         F +E  ++    H NL+QL+G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 142 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 201
            CT      ++  FM   ++   LR  +   + +       +A   +  +EYL ++    
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKK---N 338

Query: 202 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSE 261
            IHR+L A N L+ +N    + DFGL++L+           +  +   APE L+  K S 
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398

Query: 262 KTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDS 321
           K+DV+ +G+ L E+ T      +  ++  +   + + + K  R +R     ++       
Sbjct: 399 KSDVWAFGVLLWEIATYGM-SPYPGIDLSQ---VYELLEKDYRMERPEGCPEK------- 447

Query: 322 KEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEE 369
                + ++   C Q  P DRP  A++ +    E + +  +  +E+E+
Sbjct: 448 -----VYELMRACWQWNPSDRPSFAEIHQAF--ETMFQESSISDEVEK 488

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  127 bits (320), Expect = 1e-33
 Identities = 69/294 (23%), Positives = 120/294 (40%), Gaps = 45/294 (15%)

Query: 83  NIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
             +G+G FG V          +    VAVK+LQ   +      F+RE+ ++    H N++
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIV 105

Query: 138 QLIGYCTTSSER--ILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           +  G C ++  R   L+  ++   S    LRD L+  ++ +D     +       G+EYL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGS----LRDYLQKHKERIDHIKLLQYTSQICKGMEYL 161

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGH 248
             +   + IHRDL   NIL+++     + DFGL K++     +   +      I      
Sbjct: 162 GTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY--- 215

Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV-------LLLDHIRK 301
            APE L+  K S  +DV+ +G+ L EL T          E    +       +++ H+ +
Sbjct: 216 -APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274

Query: 302 LLRED-RLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
           LL+ + RL     R        E+   M +    C  +    RP    +   + 
Sbjct: 275 LLKNNGRL----PRPDGC--PDEIYMIMTE----CWNNNVNQRPSFRDLALRVD 318

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  127 bits (320), Expect = 1e-33
 Identities = 74/295 (25%), Positives = 131/295 (44%), Gaps = 53/295 (17%)

Query: 83  NIIGQGGFGKVYKGVLSDN---TKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLLQ 138
           ++IG+G FG+V K  +  +      A+KR+++Y S      F  E+ ++  +  H N++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------------RVAFG 186
           L+G C       L   +  + ++   LR  +  E    +                  A  
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
            A G++YL ++   + IHRDL A NIL+ +N+ A + DFGL++  +         ++ TM
Sbjct: 151 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTM 200

Query: 247 GHI-----APEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIR 300
           G +     A E L+    +  +DV+ YG+ L E+V+ G     +  +   E       + 
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCAE-------LY 251

Query: 301 KLLRED-RLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
           + L +  RL    ++ LN     EV + M Q    C +  P +RP  AQ++  L 
Sbjct: 252 EKLPQGYRL----EKPLNC--DDEVYDLMRQ----CWREKPYERPSFAQILVSLN 296

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  125 bits (317), Expect = 1e-33
 Identities = 43/203 (21%), Positives = 86/203 (42%), Gaps = 21/203 (10%)

Query: 84  IIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
           I+G+G FG+VY+GV      +   VAVK  +   +   +  F  E  ++    H ++++L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
           IG        I +            L   L+  +  L   T    +      + YL    
Sbjct: 79  IGIIEEEPTWI-IMELYPYGE----LGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI- 132

Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ----IRGTMGHIAPEYL 254
               +HRD+   NIL+       L DFGL++ ++ +  +  +     I+      +PE +
Sbjct: 133 --NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----SPESI 186

Query: 255 STGKSSEKTDVFGYGITLLELVT 277
           +  + +  +DV+ + + + E+++
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILS 209

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  124 bits (314), Expect = 4e-33
 Identities = 74/293 (25%), Positives = 133/293 (45%), Gaps = 36/293 (12%)

Query: 83  NIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
           + +G G +G+VY+GV    +  VAVK L++         F +E  ++    H NL+QL+G
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLG 76

Query: 142 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 201
            CT      ++  FM   ++   LR+    E  +       +A   +  +EYL ++    
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYLEKK---N 131

Query: 202 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ----IRGTMGHIAPEYLSTG 257
            IHRDL A N L+ +N    + DFGL++L+              I+ T    APE L+  
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 187

Query: 258 KSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 316
           K S K+DV+ +G+ L E+ T G     +  ++  +   + + + K  R +R     ++  
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSP--YPGIDLSQ---VYELLEKDYRMERPEGCPEK-- 240

Query: 317 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEE 369
                     + ++   C Q  P DRP  A++ +    E + +  +  +E+E+
Sbjct: 241 ----------VYELMRACWQWNPSDRPSFAEIHQAF--ETMFQESSISDEVEK 281

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  125 bits (316), Expect = 5e-33
 Identities = 75/290 (25%), Positives = 117/290 (40%), Gaps = 44/290 (15%)

Query: 83  NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 136
             +G G FG+VY+G +S         +VAVK L +  S   E  F  E  +IS   H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 137 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR---VAFGTAYGLEY 193
           ++ IG    S  R ++   M    +   LR+ +P               VA   A G +Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLC---DFGLAKLVDAKLTHVTTQIR-GTMGHI 249
           L E      IHRD+ A N LL       +    DFG+A+ +     +  +  R G    +
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-----YRASYYRKGGCAML 207

Query: 250 -----APEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLL 303
                 PE    G  + KTD + +G+ L E+ + G     +     +E   +L+ +    
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQE---VLEFVTSGG 262

Query: 304 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
           R D   +        Y       M Q    C Q  PEDRP  A +++ ++
Sbjct: 263 RMDPPKNCPGP---VY-----RIMTQ----CWQHQPEDRPNFAIILERIE 300

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  125 bits (315), Expect = 5e-33
 Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 24/212 (11%)

Query: 83  NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 136
             +GQG FG VY+GV          T+VA+K + +  S      F  E  ++      ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 137 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKR---VAFGTAYG 190
           ++L+G  +     +++   M    +   LR L+P       L  P+  +   +A   A G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI- 249
           + YL+     K +HRDL A N ++ ++F   + DFG+ + +     +     +G  G + 
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR----KGGKGLLP 203

Query: 250 ----APEYLSTGKSSEKTDVFGYGITLLELVT 277
               +PE L  G  +  +DV+ +G+ L E+ T
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  125 bits (315), Expect = 6e-33
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 24/210 (11%)

Query: 84  IIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +IG G FG+VYKG+L          VA+K L+  Y+      F  E  ++    H N+++
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
           L G  +     +++  +M+N +    L   L+  +          +  G A G++YL   
Sbjct: 111 LEGVISKYKPMMIITEYMENGA----LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 166

Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQ-----IRGTMGHIAP 251
                +HRDL A NIL++ N    + DFGL++++ D      TT      IR T    AP
Sbjct: 167 ---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----AP 219

Query: 252 EYLSTGKSSEKTDVFGYGITLLELVT-GQR 280
           E +S  K +  +DV+ +GI + E++T G+R
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGER 249

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  127 bits (321), Expect = 7e-33
 Identities = 61/198 (30%), Positives = 93/198 (46%), Gaps = 18/198 (9%)

Query: 83  NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
             IG+G FG V  G      KVAVK +++  +     AF  E  +++   H NL+QL+G 
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGV 254

Query: 143 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 201
                  + +V  +M   S+   LR    G   L      + +      +EYL       
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 309

Query: 202 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--IRGTMGHIAPEYLSTGKS 259
            +HRDL A N+L+ ++  A + DFGL K  +A  T  T +  ++ T    APE L   K 
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVKWT----APEALREKKF 363

Query: 260 SEKTDVFGYGITLLELVT 277
           S K+DV+ +GI L E+ +
Sbjct: 364 STKSDVWSFGILLWEIYS 381

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  123 bits (311), Expect = 9e-33
 Identities = 49/207 (23%), Positives = 95/207 (45%), Gaps = 22/207 (10%)

Query: 84  IIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
            IG+G FG V++G+          VA+K  ++  S      F +E   +    H ++++L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
           IG  T +   I +            LR  L+  +  LD  +    A+  +  L YL  + 
Sbjct: 82  IGVITENPVWI-IMELCTLGE----LRSFLQVRKYSLDLASLILYAYQLSTALAYLESK- 135

Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ----IRGTMGHIAPEYL 254
             + +HRD+ A N+L+  N    L DFGL++ ++    +  ++    I+      APE +
Sbjct: 136 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESI 189

Query: 255 STGKSSEKTDVFGYGITLLELVT-GQR 280
           +  + +  +DV+ +G+ + E++  G +
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILMHGVK 216

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  123 bits (312), Expect = 9e-33
 Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 25/209 (11%)

Query: 84  IIGQGGFGKVYKGVL---SDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
            +G G FG V KG          VAVK L  +   P  +     E +++    +  ++++
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
           IG C   S  + V    +       L   L+     +       +    + G++YL E  
Sbjct: 84  IGICEAESWML-VMEMAELGP----LNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEES- 136

Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGHIAPE 252
               +HRDL A N+LL     A + DFGL+K + A   +   Q      ++      APE
Sbjct: 137 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----APE 190

Query: 253 YLSTGKSSEKTDVFGYGITLLELVT-GQR 280
            ++  K S K+DV+ +G+ + E  + GQ+
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  125 bits (316), Expect = 1e-32
 Identities = 72/290 (24%), Positives = 116/290 (40%), Gaps = 44/290 (15%)

Query: 83  NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 136
             +G G FG+VY+G +S         +VAVK L +  S   E  F  E  +IS   H+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 137 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR---VAFGTAYGLEY 193
           ++ IG    S  R ++   M    +   LR+ +P               VA   A G +Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLC---DFGLAKLVDAKLTHVTTQIR-GTMGHI 249
           L E      IHRD+ A N LL       +    DFG+A+ +     +     R G    +
Sbjct: 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-----YRAGYYRKGGCAML 248

Query: 250 -----APEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLL 303
                 PE    G  + KTD + +G+ L E+ + G     +     +E   +L+ +    
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQE---VLEFVTSGG 303

Query: 304 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
           R D   +                + ++   C Q  PEDRP  A +++ ++
Sbjct: 304 RMDPPKNCPGP------------VYRIMTQCWQHQPEDRPNFAIILERIE 341

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  123 bits (310), Expect = 1e-32
 Identities = 61/198 (30%), Positives = 93/198 (46%), Gaps = 18/198 (9%)

Query: 83  NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
             IG+G FG V  G      KVAVK +++  +     AF  E  +++   H NL+QL+G 
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA---QAFLAEASVMTQLRHSNLVQLLGV 82

Query: 143 CTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK 201
                  + +V  +M   S+   LR    G   L      + +      +EYL       
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 137

Query: 202 IIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--IRGTMGHIAPEYLSTGKS 259
            +HRDL A N+L+ ++  A + DFGL K  +A  T  T +  ++ T    APE L   K 
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVKWT----APEALREKKF 191

Query: 260 SEKTDVFGYGITLLELVT 277
           S K+DV+ +GI L E+ +
Sbjct: 192 STKSDVWSFGILLWEIYS 209

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  122 bits (309), Expect = 2e-32
 Identities = 63/211 (29%), Positives = 87/211 (41%), Gaps = 26/211 (12%)

Query: 84  IIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLL 137
            +G G FG V +G           VAVK L+      P     F REV+ +    H+NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHE 196
           +L G   T   ++ V       S    L D L+  +      T  R A   A G+ YL  
Sbjct: 85  RLYGVVLTPPMKM-VTELAPLGS----LLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139

Query: 197 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGHIA 250
           +   + IHRDL A N+LL       + DFGL + +     H   Q              A
Sbjct: 140 K---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC----A 192

Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVT-GQR 280
           PE L T   S  +D + +G+TL E+ T GQ 
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  123 bits (312), Expect = 2e-32
 Identities = 67/299 (22%), Positives = 120/299 (40%), Gaps = 53/299 (17%)

Query: 83  NIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIH 133
             +G+G FG+V                  VAVK L+D  +    +    E+ ++  +  H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 134 KNLLQLIGYCTTSSERILVYPFMQN------------LSVAYRLRDLKPGEKGLDWPTRK 181
           KN++ L+G CT      ++  +                 + Y     +  E+ + +    
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 182 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 241
              +  A G+EYL  Q   K IHRDL A N+L+ +N    + DFGLA+ ++    +  T 
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217

Query: 242 -----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLL 295
                ++      APE L     + ++DV+ +G+ + E+ T G     +  +  EE   L
Sbjct: 218 NGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGG--SPYPGIPVEE---L 268

Query: 296 LDHIRKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
              +++  R D+  +          + E+   M      C  + P  RP   Q+V+ L 
Sbjct: 269 FKLLKEGHRMDKPANC---------TNELYMMMRD----CWHAVPSQRPTFKQLVEDLD 314

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  124 bits (314), Expect = 2e-32
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 23/210 (10%)

Query: 83  NIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
            ++G G FG+V  G L         VA+K L+  Y+      F  E  ++    H N+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
           L G  T S   ++V  +M+N S    L   L+  +          +  G A G++YL + 
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGS----LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166

Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGHIAP 251
                +HRDL A NIL++ N    + DFGL ++++       T       IR T    +P
Sbjct: 167 ---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT----SP 219

Query: 252 EYLSTGKSSEKTDVFGYGITLLELVT-GQR 280
           E ++  K +  +DV+ YGI L E+++ G+R
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  121 bits (307), Expect = 3e-32
 Identities = 66/204 (32%), Positives = 101/204 (49%), Gaps = 26/204 (12%)

Query: 83  NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
             +G G FG+V+ G  + +TKVAVK L+         AF  E +L+    H+ L++L   
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 202
            T     I +  +M+N S+   L+   P    L       +A   A G+ ++ E+     
Sbjct: 77  VTQEPIYI-ITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 130

Query: 203 IHRDLKAANILLDDNFEAVLCDFGLAKLVD---------AKLTHVTTQIRGTMGHIAPEY 253
           IHRDL+AANIL+ D     + DFGLA+L++         AK       I+ T    APE 
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-----IKWT----APEA 181

Query: 254 LSTGKSSEKTDVFGYGITLLELVT 277
           ++ G  + K+DV+ +GI L E+VT
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVT 205

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  127 bits (320), Expect = 3e-32
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 23/207 (11%)

Query: 85  IGQGGFGKVYKGVL---SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
           +G G FG V +GV         VA+K L+            RE  ++    +  +++LIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 142 YCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNP 200
            C   +  + V            L   L    + +       +    + G++YL E+   
Sbjct: 404 VCQAEALML-VMEMAGGGP----LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--- 455

Query: 201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ------IRGTMGHIAPEYL 254
             +HR+L A N+LL +   A + DFGL+K + A  ++ T +      ++      APE +
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECI 511

Query: 255 STGKSSEKTDVFGYGITLLELVT-GQR 280
           +  K S ++DV+ YG+T+ E ++ GQ+
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQK 538

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  124 bits (312), Expect = 4e-32
 Identities = 67/299 (22%), Positives = 120/299 (40%), Gaps = 53/299 (17%)

Query: 83  NIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIH 133
             +G+G FG+V                  VAVK L+D  +    +    E+ ++  +  H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 134 KNLLQLIGYCTTSSERILVYPFMQN------------LSVAYRLRDLKPGEKGLDWPTRK 181
           KN++ L+G CT      ++  +                 + Y     +  E+ + +    
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 182 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 241
              +  A G+EYL  Q   K IHRDL A N+L+ +N    + DFGLA+ ++    +  T 
Sbjct: 207 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263

Query: 242 -----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLL 295
                ++      APE L     + ++DV+ +G+ + E+ T G     +  +  EE   L
Sbjct: 264 NGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGG--SPYPGIPVEE---L 314

Query: 296 LDHIRKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
              +++  R D+  +          + E+   M      C  + P  RP   Q+V+ L 
Sbjct: 315 FKLLKEGHRMDKPANC---------TNELYMMMRD----CWHAVPSQRPTFKQLVEDLD 360

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  125 bits (315), Expect = 4e-32
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 14/198 (7%)

Query: 83  NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
             +G G FG+V+    + +TKVAVK ++         AF  E +++    H  L++L   
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS--VEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 202
            T     I +  FM   S+   L+           P     +   A G+ ++ ++     
Sbjct: 252 VTKEPIYI-ITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NY 305

Query: 203 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---APEYLSTGKS 259
           IHRDL+AANIL+  +    + DFGLA++++    +  T   G    I   APE ++ G  
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGSF 362

Query: 260 SEKTDVFGYGITLLELVT 277
           + K+DV+ +GI L+E+VT
Sbjct: 363 TIKSDVWSFGILLMEIVT 380

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  121 bits (307), Expect = 6e-32
 Identities = 69/298 (23%), Positives = 125/298 (41%), Gaps = 51/298 (17%)

Query: 83  NIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKN 135
             +G+G FG+V +         +    VAVK L++  +     A   E+ ++  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 136 LLQLIGYCTTSSERILV-YPFMQN------------LSVAYRLRDLKPGEKGLDWPTRKR 182
           ++ L+G CT     ++V   F +               V Y++      +  L       
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 183 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ- 241
            +F  A G+E+L  +   K IHRDL A NILL +     +CDFGLA+ +     +V    
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209

Query: 242 ----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLL 296
               ++      APE +     + ++DV+ +G+ L E+ + G     +  ++ +E+    
Sbjct: 210 ARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLGA--SPYPGVKIDEEFC-- 261

Query: 297 DHIRKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
              R+L    R+         T  + E+ +TM+     C    P  RP  +++V+ L 
Sbjct: 262 ---RRLKEGTRM----RAPDYT--TPEMYQTMLD----CWHGEPSQRPTFSELVEHLG 306

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  120 bits (304), Expect = 1e-31
 Identities = 64/296 (21%), Positives = 109/296 (36%), Gaps = 50/296 (16%)

Query: 83  NIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 136
             +G+  FGKVYKG L           VA+K L+D         F+ E  L +   H N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 137 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK------------RVA 184
           + L+G  T      +++ +  +  +   L    P          +             + 
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 185 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--- 241
              A G+EYL       ++H+DL   N+L+ D     + D GL + V A   +       
Sbjct: 135 AQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191

Query: 242 --IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDH 298
             IR      APE +  GK S  +D++ YG+ L E+ + G +   +     ++   +++ 
Sbjct: 192 LPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--YCGYSNQD---VVEM 242

Query: 299 IRKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
           IR        +D             V   M++    C    P  RP    +   L+
Sbjct: 243 IRNRQVLPCPDDC---------PAWVYALMIE----CWNEFPSRRPRFKDIHSRLR 285

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  121 bits (306), Expect = 3e-31
 Identities = 73/337 (21%), Positives = 128/337 (37%), Gaps = 64/337 (18%)

Query: 85  IGQGGFGKVYKGVL--------SDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKN 135
           +G+G FG+V             +  TKVAVK L+   +    +    E+ ++  +  HKN
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 136 LLQLIGYCTTSSERILVYPFMQN------------LSVAYRLRDLKPGEKGLDWPTRKRV 183
           ++ L+G CT      ++  +                 + Y        E+ L        
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-- 241
           A+  A G+EYL  +   K IHRDL A N+L+ ++    + DFGLA+ +     +  T   
Sbjct: 197 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253

Query: 242 ---IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLD 297
              ++      APE L     + ++DV+ +G+ L E+ T G     +  +  EE   L  
Sbjct: 254 RLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFTLGG--SPYPGVPVEE---LFK 304

Query: 298 HIRKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQGED 356
            +++  R D+ ++          + E+   M      C  + P  RP   Q+V+ L    
Sbjct: 305 LLKEGHRMDKPSNC---------TNELYMMMRD----CWHAVPSQRPTFKQLVEDLD--- 348

Query: 357 LAERWAEWEELEEVRQQEVSLLPHQFAWGEDSSIDQE 393
                     +     QE+    H      D    + 
Sbjct: 349 --------RIVALTSNQEMGYYHHHHHHDYDIPTTEN 377

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  119 bits (301), Expect = 5e-31
 Identities = 69/309 (22%), Positives = 114/309 (36%), Gaps = 47/309 (15%)

Query: 67  FSCRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREV 125
           F    + +   ++     +G+GGF  V     L D    A+KR+   +        QRE 
Sbjct: 19  FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI-LCHEQQDREEAQREA 77

Query: 126 HLISVAIHKNLLQLIGYCTTSSER----ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK 181
            +  +  H N+L+L+ YC           L+ PF +  ++   +  LK     L      
Sbjct: 78  DMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL 137

Query: 182 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--------DA 233
            +  G   GLE +H        HRDLK  NILL D  + VL D G              A
Sbjct: 138 WLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194

Query: 234 KLTHVTTQIRGTMGHIAPEYLSTGKS----SEKTDVFGYGITLLELVTGQRAIDFSRLEE 289
                    R T+ + APE L + +S     E+TDV+  G  L  ++ G+    +  + +
Sbjct: 195 LTLQDWAAQRCTISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP--YDMVFQ 251

Query: 290 EEDVLLLDHIRKLLREDRLNDIVDRNL-----NTYDSKEVETMVQVALLCTQSTPEDRPP 344
           + D + L               V   L       + S  +  ++   +      P  RP 
Sbjct: 252 KGDSVAL--------------AVQNQLSIPQSPRH-SSALWQLLNSMM---TVDPHQRPH 293

Query: 345 MAQVVKMLQ 353
           +  ++  L+
Sbjct: 294 IPLLLSQLE 302

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  119 bits (301), Expect = 6e-31
 Identities = 62/300 (20%), Positives = 110/300 (36%), Gaps = 58/300 (19%)

Query: 83  NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKN 135
             +G G FGKV +             KVAVK L+       + A   E+ ++S +  H+N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK----------RVAF 185
           ++ L+G CT     +++  +     +   LR      +                    + 
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 186 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV----------DAKL 235
             A G+ +L  +     IHRD+ A N+LL +   A + DFGLA+ +          +A+L
Sbjct: 172 QVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228

Query: 236 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVL 294
                 ++      APE +     + ++DV+ YGI L E+ + G     +  +       
Sbjct: 229 P-----VKWM----APESIFDCVYTVQSDVWSYGILLWEIFSLG--LNPYPGILVNSKFY 277

Query: 295 LLDHIRKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                + +    ++     +       K +   M      C    P  RP   Q+   LQ
Sbjct: 278 -----KLVKDGYQM----AQPAFA--PKNIYSIMQA----CWALEPTHRPTFQQICSFLQ 322

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  119 bits (300), Expect = 6e-31
 Identities = 73/304 (24%), Positives = 131/304 (43%), Gaps = 58/304 (19%)

Query: 83  NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 136
             +G+G FGKV K            T VAVK L++  SP        E +++    H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 137 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT--------- 187
           ++L G C+     +L+  + +  S+   LR+ +    G       R +            
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 188 -----------AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 236
                      + G++YL E    K++HRDL A NIL+ +  +  + DFGL++ V  + +
Sbjct: 149 MGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205

Query: 237 HVTTQIRGTMGHI-----APEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEE 290
           +V    + + G I     A E L     + ++DV+ +G+ L E+VT G     +  +  E
Sbjct: 206 YV----KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG--NPYPGIPPE 259

Query: 291 EDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVV 349
               L + ++   R +R ++          S+E+   M+Q    C +  P+ RP  A + 
Sbjct: 260 R---LFNLLKTGHRMERPDNC---------SEEMYRLMLQ----CWKQEPDKRPVFADIS 303

Query: 350 KMLQ 353
           K L+
Sbjct: 304 KDLE 307

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  123 bits (310), Expect = 9e-31
 Identities = 49/217 (22%), Positives = 99/217 (45%), Gaps = 21/217 (9%)

Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYYSPGGEAAFQREV 125
           R+ ++  +       IG+G FG V++G+     +    VA+K  ++  S      F +E 
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442

Query: 126 HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVA 184
             +    H ++++LIG  T +   I +            LR  L+  +  LD  +    A
Sbjct: 443 LTMRQFDHPHIVKLIGVITENPVWI-IMELCTLGE----LRSFLQVRKFSLDLASLILYA 497

Query: 185 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--- 241
           +  +  L YL  +   + +HRD+ A N+L+  N    L DFGL++ ++    +  ++   
Sbjct: 498 YQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 554

Query: 242 -IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT 277
            I+      APE ++  + +  +DV+ +G+ + E++ 
Sbjct: 555 PIKWM----APESINFRRFTSASDVWMFGVCMWEILM 587

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  117 bits (296), Expect = 2e-30
 Identities = 64/299 (21%), Positives = 113/299 (37%), Gaps = 52/299 (17%)

Query: 83  NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKN 135
             +G G FGKV +              VAVK L+         A   E+ ++S +  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 136 LLQLIGYCTTSSERILVYPFMQN--------------LSVAYRLRDLKPGEKGLDWPTRK 181
           ++ L+G CT     +++  +                 +        ++  E  LD     
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 182 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 241
             ++  A G+ +L  +     IHRDL A NILL       +CDFGLA+ +     +V   
Sbjct: 149 SFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 242 -----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLL 295
                ++      APE +     + ++DV+ YGI L EL + G     +  +  +     
Sbjct: 206 NARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFSLGS--SPYPGMPVDSKFY- 258

Query: 296 LDHIRKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
               + +    R+        +     E+ + M      C  + P  RP   Q+V++++
Sbjct: 259 ----KMIKEGFRM----LSPEHA--PAEMYDIMKT----CWDADPLKRPTFKQIVQLIE 303

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  118 bits (297), Expect = 3e-30
 Identities = 65/304 (21%), Positives = 120/304 (39%), Gaps = 57/304 (18%)

Query: 83  NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKN 135
            ++G G FGKV             + +VAVK L++        A   E+ +++ +  H+N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 136 LLQLIGYCTTSSERILVYPFMQN----------------LSVAYRLRDLKPGEKGLDWPT 179
           ++ L+G CT S    L++ +                     + Y  +     E+ L+  T
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 180 RKR---VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 236
            +     A+  A G+E+L  +     +HRDL A N+L+       +CDFGLA+ + +   
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227

Query: 237 HVTTQ-----IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEE 290
           +V        ++      APE L  G  + K+DV+ YGI L E+ + G     +  +  +
Sbjct: 228 YVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFSLG--VNPYPGIPVD 281

Query: 291 EDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVV 349
            +       + +    ++    D+      ++E+   M      C       RP    + 
Sbjct: 282 ANFY-----KLIQNGFKM----DQPFYA--TEEIYIIMQS----CWAFDSRKRPSFPNLT 326

Query: 350 KMLQ 353
             L 
Sbjct: 327 SFLG 330

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  116 bits (293), Expect = 5e-30
 Identities = 72/294 (24%), Positives = 124/294 (42%), Gaps = 51/294 (17%)

Query: 85  IGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G+G FGKV+           D   VAVK L+D  +      FQRE  L++   H+++++
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVK 81

Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR------------VAFG 186
             G C      I+V+ +M++  +   LR   P    L     ++            +A  
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141

Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQ---- 241
            A G+ YL  Q     +HRDL   N L+  N    + DFG+++ V       V       
Sbjct: 142 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198

Query: 242 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIR 300
           IR       PE +   K + ++DV+ +G+ L E+ T G++   + +L   E   +++ I 
Sbjct: 199 IRWM----PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--WFQLSNTE---VIECIT 249

Query: 301 KLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
           +    +R              KEV + M+     C Q  P+ R  + ++ K+L 
Sbjct: 250 QGRVLERPRVC---------PKEVYDVMLG----CWQREPQQRLNIKEIYKILH 290

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  117 bits (294), Expect = 5e-30
 Identities = 72/295 (24%), Positives = 118/295 (40%), Gaps = 50/295 (16%)

Query: 83  NIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 136
             +G+G FGKV+           D   VAVK L++  S      FQRE  L+++  H+++
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHI 105

Query: 137 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR-----------VAF 185
           ++  G CT     ++V+ +M++  +   LR   P  K L                  VA 
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 186 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQ--- 241
             A G+ YL        +HRDL   N L+       + DFG+++ +       V  +   
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222

Query: 242 -IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHI 299
            IR       PE +   K + ++DV+ +G+ L E+ T G++   + +L   E    +D I
Sbjct: 223 PIRWM----PPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--WYQLSNTE---AIDCI 273

Query: 300 RKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
            +    +R               EV   M      C Q  P+ R  +  V   LQ
Sbjct: 274 TQGRELERPRAC---------PPEVYAIMRG----CWQREPQQRHSIKDVHARLQ 315

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  117 bits (295), Expect = 6e-30
 Identities = 70/304 (23%), Positives = 123/304 (40%), Gaps = 58/304 (19%)

Query: 83  NIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 136
             IG+G FG+V++            T VAVK L++  S   +A FQRE  L++   + N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 137 LQLIGYCTTSSERILVYPFMQN--------------------LSVAYRLRDLKPGEKGLD 176
           ++L+G C       L++ +M                        ++ R R   PG   L 
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 177 WPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 236
              +  +A   A G+ YL E+   K +HRDL   N L+ +N    + DFGL++ + +   
Sbjct: 173 CAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229

Query: 237 HVTTQIRGTMGHI-----APEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEE 290
           +           I      PE +   + + ++DV+ YG+ L E+ + G +   +  +  E
Sbjct: 230 YK----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP--YYGMAHE 283

Query: 291 EDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEV-ETMVQVALLCTQSTPEDRPPMAQVV 349
           E   ++ ++R         +            E+   M      C    P DRP    + 
Sbjct: 284 E---VIYYVRDGNILACPENC---------PLELYNLMRL----CWSKLPADRPSFCSIH 327

Query: 350 KMLQ 353
           ++LQ
Sbjct: 328 RILQ 331

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  114 bits (288), Expect = 2e-29
 Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 31/212 (14%)

Query: 84  IIGQGGFGKVYKGVL--------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
            +GQG F K++KGV            T+V +K L          +F     ++S   HK+
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKH 73

Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRD-LKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           L+   G C    E ILV  F++  S    L   LK  +  ++   +  VA   A  + +L
Sbjct: 74  LVLNYGVCVCGDENILVQEFVKFGS----LDTYLKKNKNCINILWKLEVAKQLAAAMHFL 129

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAV--------LCDFGLAKLVDAKLTHVTTQIRGTM 246
            E     +IH ++ A NILL    +          L D G++  V  K   +  +I    
Sbjct: 130 EEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-DILQERIPWV- 184

Query: 247 GHIAPEYLSTGKS-SEKTDVFGYGITLLELVT 277
               PE +   K+ +  TD + +G TL E+ +
Sbjct: 185 ---PPECIENPKNLNLATDKWSFGTTLWEICS 213

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  114 bits (287), Expect = 4e-29
 Identities = 59/278 (21%), Positives = 114/278 (41%), Gaps = 21/278 (7%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQREVHLISVAIH 133
            NF     IG+G F +VY+   L D   VA+K  ++ D       A   +E+ L+    H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
            N+++        +E  +V        ++  ++  K  ++ +   T  +        LE+
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           +H +   +++HRD+K AN+ +       L D GL +   +K T   + + GT  +++PE 
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207

Query: 254 LSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 313
           +     + K+D++  G  L E+   Q      ++       L   I +         +  
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS---LCKKIEQ----CDYPPLPS 260

Query: 314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 351
            +     S+E+  +V    +C    PE RP +  V  +
Sbjct: 261 DHY----SEELRQLVN---MCINPDPEKRPDVTYVYDV 291

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  113 bits (285), Expect = 5e-29
 Identities = 61/298 (20%), Positives = 109/298 (36%), Gaps = 47/298 (15%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
            +F     +G+GGFG V++     D+   A+KR++            REV  ++   H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 136 LLQLIGY---------CTTSSERILVYPFMQ---NLSVAYRLRDLKPGEKGLDWPTRKRV 183
           +++                SS ++ +Y  MQ     ++   +      E+  +      +
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE-RERSVCLHI 123

Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 243
               A  +E+LH +    ++HRDLK +NI    +    + DFGL   +D      T    
Sbjct: 124 FLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180

Query: 244 -----------GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEED 292
                      GT  +++PE +     S K D+F  G+ L EL+       FS   E   
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP-----FSTQMERVR 235

Query: 293 VLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
            L        +R  +   +  +            MVQ        +P +RP    +++
Sbjct: 236 TL------TDVRNLKFPPLFTQK-----YPCEYVMVQ---DMLSPSPMERPEAINIIE 279

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  114 bits (287), Expect = 5e-29
 Identities = 50/235 (21%), Positives = 89/235 (37%), Gaps = 23/235 (9%)

Query: 54  EDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK--RLQ 110
           ED+  V LT+  +    E +      +    +G+G FG+V++        + AVK  RL+
Sbjct: 35  EDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE 94

Query: 111 DYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP 170
                        E+   +      ++ L G         +    ++  S+   ++ +  
Sbjct: 95  V--------FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC 146

Query: 171 GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAK 229
               L              GLEYLH +   +I+H D+KA N+LL  +     LCDFG A 
Sbjct: 147 ----LPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHAL 199

Query: 230 LVDAKLTHVTTQIRGTM-G---HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 280
            +       +      + G   H+APE +       K D++     +L ++ G  
Sbjct: 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  113 bits (286), Expect = 6e-29
 Identities = 51/215 (23%), Positives = 89/215 (41%), Gaps = 30/215 (13%)

Query: 83  NIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNL--LQL 139
             IG GG  KV++ +       A+K +  +        +++ E+  ++     +   ++L
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 140 IGYCTTSSERILVYPFM--QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
             Y  T      +Y  M   N+ +   L+     +K +D   RK         +  +H+ 
Sbjct: 94  YDYEITDQY---IYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH 146

Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMGHIAPEYL- 254
               I+H DLK AN L+ D     L DFG+A  +    T V   +Q+ GT+ ++ PE + 
Sbjct: 147 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIK 201

Query: 255 ----------STGKSSEKTDVFGYGITLLELVTGQ 279
                     S  K S K+DV+  G  L  +  G+
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  114 bits (287), Expect = 7e-29
 Identities = 54/279 (19%), Positives = 96/279 (34%), Gaps = 40/279 (14%)

Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGVLSDNT------KVAVK-----RLQDYYSPGGE 118
            E QL +      +++G+G F +VY+    D        K  +K        ++Y     
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFY----- 112

Query: 119 AAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK-PGEKGLDW 177
               + +  +  ++    ++        +  +LV       ++   +   K   EK +  
Sbjct: 113 -IGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQ 171

Query: 178 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA-----------VLCDFG 226
                 A    Y +E +H+    +IIH D+K  N +L + F              L D G
Sbjct: 172 GLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG 228

Query: 227 LAKLVDAKL---THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
            +  +D KL     + T    T G    E LS    + + D FG   T+  ++ G   + 
Sbjct: 229 QS--IDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG-TYMK 285

Query: 284 FSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSK 322
                E  +       R+L   D  N+     LN  D  
Sbjct: 286 VK--NEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCH 322

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  114 bits (286), Expect = 9e-29
 Identities = 51/215 (23%), Positives = 90/215 (41%), Gaps = 30/215 (13%)

Query: 83  NIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNL--LQL 139
             IG GG  KV++ +       A+K +  +        +++ E+  ++     +   ++L
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 140 IGYCTTSSERILVYPFMQ--NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
             Y  T      +Y  M+  N+ +   L+     +K +D   RK         +  +H+ 
Sbjct: 75  YDYEITDQY---IYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH 127

Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMGHIAPEYL- 254
               I+H DLK AN L+ D     L DFG+A  +    T V   +Q+ GT+ ++ PE + 
Sbjct: 128 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIK 182

Query: 255 ----------STGKSSEKTDVFGYGITLLELVTGQ 279
                     S  K S K+DV+  G  L  +  G+
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  113 bits (285), Expect = 3e-28
 Identities = 49/215 (22%), Positives = 88/215 (40%), Gaps = 30/215 (13%)

Query: 83  NIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNL--LQL 139
             IG GG  KV++ +       A+K +  +        +++ E+  ++     +   ++L
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 140 IGYCTTSSERILVYPFMQ--NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
             Y  T      +Y  M+  N+ +   L+     +K +D   RK         +  +H+ 
Sbjct: 122 YDYEITDQY---IYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH 174

Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTMGHIAPEYLS 255
               I+H DLK AN L+ D     L DFG+A  +    T V   +Q+ G + ++ PE + 
Sbjct: 175 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GAVNYMPPEAIK 229

Query: 256 -----------TGKSSEKTDVFGYGITLLELVTGQ 279
                        K S K+DV+  G  L  +  G+
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  110 bits (278), Expect = 4e-28
 Identities = 65/292 (22%), Positives = 117/292 (40%), Gaps = 49/292 (16%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
            +F E  +IG GGFG+V+K     D     +KR+            +REV  ++   H N
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-----KYNNEKAEREVKALAKLDHVN 65

Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRL---------RDL-----KPGEKGLDWPTRK 181
           ++   G                + S    L           L     K   + LD     
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125

Query: 182 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 241
            +      G++Y+H +   K+I+RDLK +NI L D  +  + DFGL   +        + 
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS- 181

Query: 242 IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR-AIDFSRLEEEEDVLLLDHIR 300
            +GT+ +++PE +S+    ++ D++  G+ L EL+     A + S+              
Sbjct: 182 -KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF------------- 227

Query: 301 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML 352
                    D+ D  ++    K+ +T++Q         PEDRP  +++++ L
Sbjct: 228 -------FTDLRDGIISDIFDKKEKTLLQ---KLLSKKPEDRPNTSEILRTL 269

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  111 bits (280), Expect = 8e-28
 Identities = 63/313 (20%), Positives = 128/313 (40%), Gaps = 36/313 (11%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 134
           + +     IG+G FGK        D  +  +K +     S       +REV +++   H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG----EKGLDWPTRKRVAFGTAYG 190
           N++Q       +    +V  + +   +  R+   K      ++ LDW             
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------FVQICLA 137

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
           L+++H++   KI+HRD+K+ NI L  +    L DFG+A+++++ +      I GT  +++
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLS 193

Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 310
           PE       + K+D++  G  L EL T + A +   ++      L+  I           
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-----LVLKIIS--------G 240

Query: 311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEEV 370
                   Y S ++ ++V       +  P DRP +  +   L+   +A+R  ++   + +
Sbjct: 241 SFPPVSLHY-SYDLRSLVS---QLFKRNPRDRPSVNSI---LEKGFIAKRIEKFLSPQLI 293

Query: 371 RQQEVSLLPHQFA 383
            ++       +F 
Sbjct: 294 AEEFCLKTFSKFG 306

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  111 bits (278), Expect = 1e-27
 Identities = 25/300 (8%), Positives = 71/300 (23%), Gaps = 49/300 (16%)

Query: 84  IIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQREVHLISVAIHKNLLQLI 140
            +  G    V+    +      A+K   +    S              +  + ++  +  
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 141 GYC--------------------------TTSSERILVYPFMQ--NLSVAYRLRDLKPGE 172
                                           +  +L+ P        +   L  +    
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 173 KGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 232
                     +          L  +    ++H      N+ +  +   +L D      V 
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245

Query: 233 AKLTHVTTQIRGTMGHIAPEYLSTGKS--SEKTDVFGYGITLLELVTGQRAIDFSRLEEE 290
            +    +      + +   E+L+   +  +   + +  G+++  +        F  +   
Sbjct: 246 TRGPASS----VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP--FGLVTPG 299

Query: 291 EDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
                     ++   D L       L       V+T++    L        R    + ++
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPL----PDFVKTLIG-RFLNFD--RRRRLLPLEAME 352

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  110 bits (276), Expect = 1e-27
 Identities = 55/222 (24%), Positives = 78/222 (35%), Gaps = 45/222 (20%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVH-LISVAIH 133
            +F   + +G G +G+V+K     D    AVKR    +  P   A    EV     V  H
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 134 KNLLQLIG-------------YCTTSSERILVYPFMQNLS---VAYRLRDLKPGEKGLDW 177
              ++L                C  S ++     +  +L    V   LRD          
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCGPSLQQHC-EAWGASLPEAQVWGYLRDT--------- 166

Query: 178 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 237
                        L +LH Q    ++H D+K ANI L       L DFGL   +      
Sbjct: 167 ----------LLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGA 212

Query: 238 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
              Q  G   ++APE L  G      DVF  G+T+LE+    
Sbjct: 213 GEVQE-GDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNM 252

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  108 bits (272), Expect = 4e-27
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 20/210 (9%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 134
            + F++   IG+G FG+V+KG+       VA+K +    +       Q+E+ ++S     
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTAYGLEY 193
            + +  G     ++  ++  ++   S      DL +PG   LD      +      GL+Y
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPG--PLDETQIATILREILKGLDY 134

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM-GH---I 249
           LH +   K IHRD+KAAN+LL ++ E  L DFG    V  +LT  T   R T  G    +
Sbjct: 135 LHSE---KKIHRDIKAANVLLSEHGEVKLADFG----VAGQLTD-TQIKRNTFVGTPFWM 186

Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE +       K D++  GIT +EL  G+
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARGE 216

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  107 bits (269), Expect = 1e-26
 Identities = 60/220 (27%), Positives = 86/220 (39%), Gaps = 27/220 (12%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           D++    +IG G    V          KVA+KR+             +E+  +S   H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVA----YRLRDLKPGEKGLDWPTRKRVAFGTAYGL 191
           ++          E  LV   +   SV     + +   +     LD  T   +      GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 192 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR-------- 243
           EYLH+      IHRD+KA NILL ++    + DFG    V A L       R        
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG----VSAFLATGGDITRNKVRKTFV 187

Query: 244 GT---MGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 279
           GT   M   APE +   +    K D++ +GIT +EL TG 
Sbjct: 188 GTPCWM---APEVMEQVRGYDFKADIWSFGITAIELATGA 224

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  108 bits (271), Expect = 1e-26
 Identities = 67/280 (23%), Positives = 115/280 (41%), Gaps = 20/280 (7%)

Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLI 128
           +  +L  D+F + + +G G  G V+K         +A K +     P       RE+ ++
Sbjct: 26  KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 85

Query: 129 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP-GEKGLDWPTRKRVAFGT 187
                  ++   G   +  E  +    M   S+   L+      E+ L      +V+   
Sbjct: 86  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL-----GKVSIAV 140

Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA-KLVD--AKLTHVTTQIRG 244
             GL YL E+   KI+HRD+K +NIL++   E  LCDFG++ +L+D  A  + V     G
Sbjct: 141 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFV-----G 192

Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 304
           T  +++PE L     S ++D++  G++L+E+  G+  I     +E E +           
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252

Query: 305 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP 344
                    R LN +       M    LL       + PP
Sbjct: 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELL--DYIVNEPPP 290

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  105 bits (265), Expect = 3e-26
 Identities = 60/281 (21%), Positives = 110/281 (39%), Gaps = 24/281 (8%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 134
           +++     IG G +G+  K    SD   +  K L     +   +     EV+L+    H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 135 NLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 192
           N+++        +   L  V  + +   +A  +       + LD     RV       L+
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 193 YLHEQCNP--KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
             H + +    ++HRDLK AN+ LD      L DFGLA++++   +   T + GT  +++
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184

Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 310
           PE ++    +EK+D++  G  L EL            +E     L   IR+         
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-----LAGKIRE--------G 231

Query: 311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 351
              R    Y S E+  ++             RP + ++++ 
Sbjct: 232 KFRRIPYRY-SDELNEIIT---RMLNLKDYHRPSVEEILEN 268

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  104 bits (261), Expect = 1e-25
 Identities = 64/252 (25%), Positives = 103/252 (40%), Gaps = 39/252 (15%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 134
             +F E  ++GQG FG+V K     D+   A+K+++  ++    +    EV L++   H+
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR--HTEEKLSTILSEVMLLASLNHQ 62

Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAY---------RLRDL-KPGEKGLDWPTRKRVA 184
            +++           +     ++  S  +          L DL              R+ 
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122

Query: 185 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV------ 238
                 L Y+H Q    IIHRDLK  NI +D++    + DFGLAK V   L  +      
Sbjct: 123 RQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 239 --------TTQIRGTMGHIAPEYLS-TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE 289
                   T+ I GT  ++A E L  TG  +EK D++  GI   E++       FS    
Sbjct: 180 LPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-----FS--TG 231

Query: 290 EEDVLLLDHIRK 301
            E V +L  +R 
Sbjct: 232 MERVNILKKLRS 243

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  103 bits (260), Expect = 2e-25
 Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 16/204 (7%)

Query: 84  IIGQGGFGKVYKGVLSDN-TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           ++G+G +G VY G    N  ++A+K + +  S   +     E+ L     HKN++Q +G 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP-LHEEIALHKHLKHKNIVQYLGS 87

Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI 202
            + +    +    +   S++  LR  K G    +  T          GL+YLH+    +I
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRS-KWGPLKDNEQTIGFYTKQILEGLKYLHDN---QI 143

Query: 203 IHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGT---MGHIAPEYLSTGK 258
           +HRD+K  N+L++     + + DFG +K +        T   GT   M   APE +  G 
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYM---APEIIDKGP 199

Query: 259 S--SEKTDVFGYGITLLELVTGQR 280
               +  D++  G T++E+ TG+ 
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKP 223

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  105 bits (264), Expect = 2e-25
 Identities = 40/313 (12%), Positives = 74/313 (23%), Gaps = 62/313 (19%)

Query: 84  IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAA------------FQREVHLISV 130
           ++GQ       +           V        P   A              +   +    
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 131 AIHKNLLQLIGYCTTSS-----------------ERILVYPFMQ--NLSVAYRLRDLKPG 171
            +H   +                            R  +YP MQ    +    L      
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 172 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 231
            K L    R ++       L  LH      ++H  L+  +I+LD      L  F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 232 DAKLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSR 286
            A       +        A   L          +   D +  G+ +  +         + 
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--NTD 319

Query: 287 LEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMA 346
                          + R  +  +I          + V  +++  L   +   EDR    
Sbjct: 320 DAALGG------SEWIFRSCK--NI---------PQPVRALLEGFL---RYPKEDRLLPL 359

Query: 347 QVVKMLQGEDLAE 359
           Q ++  + E L  
Sbjct: 360 QAMETPEYEQLRT 372

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  106 bits (265), Expect = 2e-25
 Identities = 64/259 (24%), Positives = 104/259 (40%), Gaps = 42/259 (16%)

Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNL 136
           +F   +++G G  G +    + DN  VAVKR+     P   +   REV  L     H N+
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI----LPECFSFADREVQLLRESDEHPNV 80

Query: 137 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTAYGLEYLH 195
           ++   +CT    +   Y  ++    A  L++  +  +          +   T  GL +LH
Sbjct: 81  IRY--FCTEKDRQ-FQYIAIEL--CAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH 135

Query: 196 EQCNPKIIHRDLKAANILLDDNFE-----AVLCDFGLAKLVDA--KLTHVTTQIRGTMGH 248
                 I+HRDLK  NIL+          A++ DFGL K +          + + GT G 
Sbjct: 136 SL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192

Query: 249 IAPEYLS---TGKSSEKTDVFGYGITLLELVT------------------GQRAIDFSRL 287
           IAPE LS       +   D+F  G     +++                  G  ++D    
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHP 252

Query: 288 EEEEDVLLLDHIRKLLRED 306
           E+ EDV+  + I K++  D
Sbjct: 253 EKHEDVIARELIEKMIAMD 271

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  104 bits (260), Expect = 3e-25
 Identities = 50/238 (21%), Positives = 90/238 (37%), Gaps = 36/238 (15%)

Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-L 127
           + ++L         ++ +GGF  VY+   +    + A+KRL          A  +EV  +
Sbjct: 21  QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL-LSNEEEKNRAIIQEVCFM 79

Query: 128 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKR----- 182
             ++ H N++Q     +   E           +    L +L  G+  +++  +       
Sbjct: 80  KKLSGHPNIVQFCSAASIGKEES-----DTGQAEFLLLTELCKGQ-LVEFLKKMESRGPL 133

Query: 183 -------VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 235
                  + + T   ++++H Q  P IIHRDLK  N+LL +     LCDFG A  +    
Sbjct: 134 SCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYP 192

Query: 236 THVTT-----------QIRGTMGHIAPEYLSTGKS---SEKTDVFGYGITLLELVTGQ 279
            +  +               T  +  PE +    +    EK D++  G  L  L   Q
Sbjct: 193 DYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  104 bits (260), Expect = 4e-25
 Identities = 49/218 (22%), Positives = 80/218 (36%), Gaps = 32/218 (14%)

Query: 85  IGQGGFGKVYKGVLSDNTKVAVK----------------RLQDYYSPGGEAAFQREVHLI 128
           + QG F K+      DN   A+K                             F+ E+ +I
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 129 SVAIHKNLLQLIGYCTTSSERILVYPFMQN------LSVAYRLRDLKPGEKGLDWPTRKR 182
           +   ++  L   G  T   E  ++Y +M+N          + L         +     K 
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF--IPIQVIKC 155

Query: 183 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 242
           +         Y+H + N  I HRD+K +NIL+D N    L DFG ++ +  K     +  
Sbjct: 156 IIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK-GS-- 210

Query: 243 RGTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTG 278
           RGT   + PE+ S     +  K D++  GI L  +   
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  102 bits (256), Expect = 6e-25
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 28/217 (12%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 134
            + +     +G G FGKVYK          A K + +  S      +  E+ +++   H 
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI-ETKSEEELEDYIVEIEILATCDHP 76

Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTAYGLEY 193
            +++L+G      +  ++  F    +V      +    ++GL  P  + V       L +
Sbjct: 77  YIVKLLGAYYHDGKLWIMIEFCPGGAVD----AIMLELDRGLTEPQIQVVCRQMLEALNF 132

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI---- 249
           LH +   +IIHRDLKA N+L+    +  L DFG    V AK    T Q R +   I    
Sbjct: 133 LHSK---RIIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLK-TLQKRDSF--IGTPY 182

Query: 250 --APEYLSTGKSSE-----KTDVFGYGITLLELVTGQ 279
             APE +      +     K D++  GITL+E+   +
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  103 bits (259), Expect = 7e-25
 Identities = 42/221 (19%), Positives = 76/221 (34%), Gaps = 27/221 (12%)

Query: 76  TDNFSESNIIGQG--GFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVA 131
              +    +IG+G      V           V V+R+  +  S       Q E+H+  + 
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 132 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL 191
            H N++         +E  +V  FM   S    +        G++      +  G    L
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD--GMNELAIAYILQGVLKAL 141

Query: 192 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI-- 249
           +Y+H       +HR +KA++IL+  + +  L         +  +     Q +  +     
Sbjct: 142 DYIHHM---GYVHRSVKASHILISVDGKVYLSGLR----SNLSMIS-HGQRQRVVHDFPK 193

Query: 250 ---------APEYLSTGKS--SEKTDVFGYGITLLELVTGQ 279
                    +PE L         K+D++  GIT  EL  G 
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  102 bits (255), Expect = 7e-25
 Identities = 45/230 (19%), Positives = 78/230 (33%), Gaps = 37/230 (16%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAI- 132
           T  F E   IG G FG V+K V   D    A+KR +        E    REV+  +V   
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 133 HKNLLQLIGYCTTSSERILVYPFM---QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
           H ++   + Y +  +E   +          S+A  + +             K +      
Sbjct: 70  HSHV---VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-------------------LCDFGLAKL 230
           GL Y+H      ++H D+K +NI +                          + D G    
Sbjct: 127 GLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT- 182

Query: 231 VDAKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 279
              +++    +  G    +A E L    +   K D+F   +T++     +
Sbjct: 183 ---RISSPQVEE-GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  102 bits (257), Expect = 9e-25
 Identities = 60/213 (28%), Positives = 85/213 (39%), Gaps = 24/213 (11%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGE--AAFQREVHLISVAI 132
              FS+   IG G FG VY    + ++  VA+K++        E      +EV  +    
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 133 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 192
           H N +Q  G         LV  +    S       L+  +K L       V  G   GL 
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLG-SA---SDLLEVHKKPLQEVEIAAVTHGALQGLA 168

Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT---MGHI 249
           YLH      +IHRD+KA NILL +     L DFG      + +    + + GT   M   
Sbjct: 169 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANSFV-GTPYWM--- 217

Query: 250 APEYLSTGKSSE---KTDVFGYGITLLELVTGQ 279
           APE +      +   K DV+  GIT +EL   +
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERK 250

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  101 bits (255), Expect = 9e-25
 Identities = 46/217 (21%), Positives = 94/217 (43%), Gaps = 17/217 (7%)

Query: 72  LQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-LIS 129
           +++  D+      +G+G +G V K   +     +AVKR++   +   +     ++   + 
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61

Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
                  +   G      +  +    M + S+    + +    + +      ++A     
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL-AKLVD--AKLTHVTTQIRGTM 246
            LE+LH      +IHRD+K +N+L++   +  +CDFG+   LVD  AK         G  
Sbjct: 121 ALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA-----GCK 173

Query: 247 GHIAPEYLSTGKS----SEKTDVFGYGITLLELVTGQ 279
            ++APE ++   +    S K+D++  GIT++EL   +
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  101 bits (253), Expect = 2e-24
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 42/232 (18%)

Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-L 127
           +      ++  +   IG+G +G V K V       +AVKR++       +     ++  +
Sbjct: 15  QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74

Query: 128 ISVAIHKNLLQLIG-------------YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG 174
           +  +    ++Q  G               +TS ++             Y + D    E+ 
Sbjct: 75  MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFY--------KYVYSVLDDVIPEEI 126

Query: 175 LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL-AKLVD- 232
           L      ++   T   L +L E  N KIIHRD+K +NILLD +    LCDFG+  +LVD 
Sbjct: 127 L-----GKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179

Query: 233 -AKLTHVTTQIRGTMGHIAPEYLSTGKS----SEKTDVFGYGITLLELVTGQ 279
            AK         G   ++APE +    S      ++DV+  GITL EL TG+
Sbjct: 180 IAKTRDA-----GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  100 bits (251), Expect = 5e-24
 Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 33/223 (14%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIH 133
              F    ++G G +G+VYKG  +      A+K +    +   E   ++E++++   + H
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEIKQEINMLKKYSHH 80

Query: 134 KNLLQLIG-YCTTSSERI-----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF-- 185
           +N+    G +   +   +     LV  F    SV   +++ K      +W     +A+  
Sbjct: 81  RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYIC 135

Query: 186 -GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRG 244
                GL +LH+    K+IHRD+K  N+LL +N E  L DFG++  +D  +    T I G
Sbjct: 136 REILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-G 191

Query: 245 T---MGHIAPEYLSTGKSSE-----KTDVFGYGITLLELVTGQ 279
           T   M   APE ++  ++ +     K+D++  GIT +E+  G 
Sbjct: 192 TPYWM---APEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  100 bits (251), Expect = 5e-24
 Identities = 52/220 (23%), Positives = 96/220 (43%), Gaps = 21/220 (9%)

Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-L 127
           +  Q   ++      +G G  G+V+K         +AVK+++   +         ++  +
Sbjct: 18  QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77

Query: 128 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 187
           +       ++Q  G   T+++  +    M   +     +  K  +  +      ++    
Sbjct: 78  LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCA----EKLKKRMQGPIPERILGKMTVAI 133

Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL-AKLVD--AKLTHVTTQIRG 244
              L YL E+    +IHRD+K +NILLD+  +  LCDFG+  +LVD  AK         G
Sbjct: 134 VKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA-----G 186

Query: 245 TMGHIAPEYLSTGKSSE-----KTDVFGYGITLLELVTGQ 279
              ++APE +     ++     + DV+  GI+L+EL TGQ
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 99.4 bits (248), Expect = 9e-24
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 29/214 (13%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKR--LQDYYSPGGEAAFQREVHLISVAI 132
            + F     +G+G +G VYK +       VA+K+  ++            +E+ ++    
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCD 82

Query: 133 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL-KPGEKGLDWPTRKRVAFGTAYGL 191
             ++++  G    +++  +V  +    SV+    D+ +   K L       +   T  GL
Sbjct: 83  SPHVVKYYGSYFKNTDLWIVMEYCGAGSVS----DIIRLRNKTLTEDEIATILQSTLKGL 138

Query: 192 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI-- 249
           EYLH     + IHRD+KA NILL+    A L DFG+A     +LT  T   R T+  I  
Sbjct: 139 EYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA----GQLTD-TMAKRNTV--IGT 188

Query: 250 ----APEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
               APE +     +   D++  GIT +E+  G+
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 98.5 bits (246), Expect = 1e-23
 Identities = 49/209 (23%), Positives = 91/209 (43%), Gaps = 19/209 (9%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 134
              ++    IGQG  G VY  + ++   +VA++++ +      +     E+ ++    + 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNP 77

Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           N++  +       E  +V  ++   S+   +      E  +D      V       LE+L
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFL 132

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM-GH---IA 250
           H     ++IHRD+K+ NILL  +    L DFG      A++T      R TM G    +A
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC----AQITP-EQSKRSTMVGTPYWMA 184

Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           PE ++      K D++  GI  +E++ G+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 98.0 bits (245), Expect = 2e-23
 Identities = 50/200 (25%), Positives = 82/200 (41%), Gaps = 17/200 (8%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G+GGF K ++          A K      L     P        E+ +     H++++ 
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLL---KPHQREKMSMEISIHRSLAHQHVVG 79

Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
             G+   +    +V    +  S+    +  K     L  P  +        G +YLH   
Sbjct: 80  FHGFFEDNDFVFVVLELCRRRSLLELHKRRKA----LTEPEARYYLRQIVLGCQYLHRN- 134

Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 258
             ++IHRDLK  N+ L+++ E  + DFGLA  V+         + GT  +IAPE LS   
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKG 191

Query: 259 SSEKTDVFGYGITLLELVTG 278
            S + DV+  G  +  L+ G
Sbjct: 192 HSFEVDVWSIGCIMYTLLVG 211

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 99.3 bits (247), Expect = 3e-23
 Identities = 41/310 (13%), Positives = 79/310 (25%), Gaps = 73/310 (23%)

Query: 84  IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAA---------------------- 120
           ++GQ       +           V        P   A                       
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 121 -----FQREVHLISVAIHKNLLQLIGYCTTSS--ERILVYPFMQ--NLSVAYRLRDLKPG 171
                F     L+     K ++++           R  +YP MQ    +    L      
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 172 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV 231
            K L    R ++       L  LH      ++H  L+  +I+LD      L  F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 232 DAKLTHVTTQIRGTMGHIAPEYLST-----------GKSSEKTDVFGYGITLLELVTGQR 280
            A++         + G   PE  +               +   D +  G+ +  +     
Sbjct: 257 GARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311

Query: 281 AIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPE 340
               ++               + R  +  +I          + V  +++   L  +   E
Sbjct: 312 P--ITKDAALGG------SEWIFRSCK--NI---------PQPVRALLE-GFL--RYPKE 349

Query: 341 DRPPMAQVVK 350
           DR    Q ++
Sbjct: 350 DRLLPLQAME 359

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 97.8 bits (244), Expect = 3e-23
 Identities = 49/209 (23%), Positives = 88/209 (42%), Gaps = 19/209 (9%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 134
                    IG+G  G V          +VAVK + D            EV ++    H 
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM-DLRKQQRRELLFNEVVIMRDYQHF 102

Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           N++++        E  ++  F+Q  ++   +  ++  E+ +       V       L YL
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQI-----ATVCEAVLQALAYL 157

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM-GH---IA 250
           H Q    +IHRD+K+ +ILL  +    L DFG      A+++      R ++ G    +A
Sbjct: 158 HAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFC----AQISK-DVPKRKSLVGTPYWMA 209

Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           PE +S    + + D++  GI ++E+V G+
Sbjct: 210 PEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 98.1 bits (245), Expect = 4e-23
 Identities = 50/200 (25%), Positives = 82/200 (41%), Gaps = 17/200 (8%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G+GGF K ++          A K      L     P        E+ +     H++++ 
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLL---KPHQREKMSMEISIHRSLAHQHVVG 105

Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
             G+   +    +V    +  S+    +      K L  P  +        G +YLH   
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN- 160

Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 258
             ++IHRDLK  N+ L+++ E  + DFGLA  V+         + GT  +IAPE LS   
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKG 217

Query: 259 SSEKTDVFGYGITLLELVTG 278
            S + DV+  G  +  L+ G
Sbjct: 218 HSFEVDVWSIGCIMYTLLVG 237

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 96.9 bits (242), Expect = 5e-23
 Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 13/209 (6%)

Query: 73  QLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLIS 129
           Q A ++F     +G+G FG VY          +A+K L        G E   +REV + S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64

Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
              H N+L+L GY   ++   L+  +    +V   L+ L       D           A 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 120

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L Y H +   ++IHRD+K  N+LL    E  + DFG +    +          GT+ ++
Sbjct: 121 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---GTLDYL 174

Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTG 278
            PE +      EK D++  G+   E + G
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 95.7 bits (239), Expect = 1e-22
 Identities = 51/209 (24%), Positives = 83/209 (39%), Gaps = 13/209 (6%)

Query: 73  QLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLIS 129
           +   D+F     +G+G FG VY      +   +A+K L        G E   +RE+ + S
Sbjct: 10  KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69

Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
              H N+L++  Y        L+  F     +   L+         D           A 
Sbjct: 70  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR----FDEQRSATFMEELAD 125

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L Y HE+   K+IHRD+K  N+L+    E  + DFG +    +          GT+ ++
Sbjct: 126 ALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYL 179

Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTG 278
            PE +      EK D++  G+   E + G
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 97.5 bits (243), Expect = 2e-22
 Identities = 65/304 (21%), Positives = 108/304 (35%), Gaps = 57/304 (18%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVH-LISVAIHK 134
           +      I+G G  G V          VAVKR+  D+           E+  L     H 
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD-----IALMEIKLLTESDDHP 69

Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDL-------KPGEKGLDWPTRKRVAFGT 187
           N+++     TT     +    ++       L+DL           K         +    
Sbjct: 70  NVIRYYCSETTDRFLYIA---LEL--CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124

Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLD-------------DNFEAVLCDFGLAKLVDAK 234
           A G+ +LH     KIIHRDLK  NIL+              +N   ++ DFGL K +D+ 
Sbjct: 125 ASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181

Query: 235 LTHVTTQIR---GTMGHIAPEYLS-------TGKSSEKTDVFGYGITLLELVTGQRAIDF 284
            +   T +    GT G  APE L          + +   D+F  G     +++  +    
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241

Query: 285 SRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP 344
            +   E +++     R +   D +  + DR+L      E   ++   ++     P  RP 
Sbjct: 242 DKYSRESNII-----RGIFSLDEMKCLHDRSL----IAEATDLIS-QMIDHD--PLKRPT 289

Query: 345 MAQV 348
             +V
Sbjct: 290 AMKV 293

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 98.4 bits (245), Expect = 2e-22
 Identities = 42/205 (20%), Positives = 74/205 (36%), Gaps = 27/205 (13%)

Query: 85  IGQGGFGKVYKG---VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
           I  GG G +Y      ++    V +K L        +A    E   ++  +H +++Q+  
Sbjct: 88  IAHGGLGWIYLALDRNVNGRP-VVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 142 YCTTSSERILVYPF--MQNLSVAY----RLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
           +   +        +  M+     Y     L+  K  +  L               L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVME-----YVGGQSLKRSKGQK--LPVAEAIAYLLEILPALSYLH 199

Query: 196 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 255
                 +++ DLK  NI+L +  +  L D G    +++        + GT G  APE + 
Sbjct: 200 SI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPGFQAPE-IV 249

Query: 256 TGKSSEKTDVFGYGITLLELVTGQR 280
               +  TD++  G TL  L     
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDLP 274

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 95.6 bits (238), Expect = 2e-22
 Identities = 47/218 (21%), Positives = 81/218 (37%), Gaps = 21/218 (9%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
             +  S+I+GQG    V++G         A+K   +           RE  ++    HKN
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 136 LLQLIGY--CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
           +++L      TT+  ++L+  F    S+   L +      GL       V      G+ +
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNH 127

Query: 194 LHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           L E     I+HR++K  NI+     D      L DFG A+ ++         + GT  ++
Sbjct: 128 LREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED--DEQFVSLYGTEEYL 182

Query: 250 APEYLSTGKS--------SEKTDVFGYGITLLELVTGQ 279
            P+                   D++  G+T     TG 
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 95.0 bits (237), Expect = 3e-22
 Identities = 59/284 (20%), Positives = 104/284 (36%), Gaps = 59/284 (20%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQLIG 141
           +G GG   VY       N KVA+K +             F+REVH  S   H+N++    
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS--- 75

Query: 142 YCTTSSERILVYPFMQNLSVAY---------RLRDLKPGEKGLDWPTRKRVAFGTAYGLE 192
                     +    +     Y          L +       L   T          G++
Sbjct: 76  ----------MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125

Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHIAP 251
           + H+    +I+HRD+K  NIL+D N    + DFG+AK + +  LT  T  + GT+ + +P
Sbjct: 126 HAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSP 181

Query: 252 EYLSTGKSSEKTDVFGYGITLLELVTGQR--------AIDFSRLEEEEDVLLLDHIRKLL 303
           E      + E TD++  GI L E++ G+         +I    +++    +         
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVT-------- 233

Query: 304 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQ 347
                      ++     + +  ++   L  T+    +R    Q
Sbjct: 234 ----------TDVRKDIPQSLSNVI---LRATEKDKANRYKTIQ 264

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 94.1 bits (235), Expect = 4e-22
 Identities = 53/200 (26%), Positives = 81/200 (40%), Gaps = 16/200 (8%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G+G F  VY+   +    +VA+K      +      G     Q EV +     H ++L+
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY---KAGMVQRVQNEVKIHCQLKHPSILE 75

Query: 139 LIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC 198
           L  Y   S+   LV     N  +    R LK   K       +        G+ YLH   
Sbjct: 76  LYNYFEDSNYVYLVLEMCHNGEM---NRYLKNRVKPFSENEARHFMHQIITGMLYLHSH- 131

Query: 199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK 258
              I+HRDL  +N+LL  N    + DFGLA  +        T + GT  +I+PE  +   
Sbjct: 132 --GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSA 188

Query: 259 SSEKTDVFGYGITLLELVTG 278
              ++DV+  G     L+ G
Sbjct: 189 HGLESDVWSLGCMFYTLLIG 208

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 96.7 bits (240), Expect = 8e-22
 Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 16/215 (7%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 134
              +     +G GGFG V + +      +VA+K+ +   SP     +  E+ ++    H 
Sbjct: 13  CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72

Query: 135 NLLQLI------GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 188
           N++              +   +L   + +   +   L        GL     + +    +
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLSDIS 131

Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV---LCDFGLAKLVDAKLTHVTTQIRGT 245
             L YLHE    +IIHRDLK  NI+L    + +   + D G AK +D     + T+  GT
Sbjct: 132 SALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTEFVGT 186

Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR 280
           + ++APE L   K +   D + +G    E +TG R
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 93.8 bits (234), Expect = 9e-22
 Identities = 63/235 (26%), Positives = 89/235 (37%), Gaps = 43/235 (18%)

Query: 67  FSCRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ--- 122
                   AT  +     IG G +G VYK         VA+K ++     GG        
Sbjct: 3   LGSM----ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPIST 58

Query: 123 -REVHL---ISVAIHKNLLQLIGYCTTSSERI-----LVYPFMQNLSVAYRLRDLK---- 169
            REV L   +    H N+++L+  C TS         LV+  +         +DL+    
Sbjct: 59  VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD--------QDLRTYLD 110

Query: 170 -PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 228
                GL   T K +      GL++LH      I+HRDLK  NIL+       L DFGLA
Sbjct: 111 KAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLA 167

Query: 229 KL--VDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           ++      LT   VT   R      APE L     +   D++  G    E+   +
Sbjct: 168 RIYSYQMALTPVVVTLWYR------APEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 50/211 (23%), Positives = 80/211 (37%), Gaps = 34/211 (16%)

Query: 85  IGQGGFGKVYKGVLSDNTK---VAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQL 139
           +G+GG G VY+    D  +   VA+K + +  S  P      QRE          +++  
Sbjct: 42  VGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP- 98

Query: 140 IGYCTTSSERILVYPFMQNLSVAY---------RLRDLKPGEKGLDWPTRKRVAFGTAYG 190
                       ++ F +     Y          L  +   +  L  P    +       
Sbjct: 99  ------------IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSA 146

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHI 249
           L+  H        HRD+K  NIL+  +  A L DFG+A    D KLT       GT+ ++
Sbjct: 147 LDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYM 202

Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQR 280
           APE  S   ++ + D++     L E +TG  
Sbjct: 203 APERFSESHATYRADIYALTCVLYECLTGSP 233

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 93.0 bits (231), Expect = 4e-21
 Identities = 47/218 (21%), Positives = 81/218 (37%), Gaps = 21/218 (9%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
             +  S+I+GQG    V++G         A+K   +           RE  ++    HKN
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 136 LLQLIGY--CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
           +++L      TT+  ++L+  F    S+   L +      GL       V      G+ +
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNH 127

Query: 194 LHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           L E     I+HR++K  NI+     D      L DFG A+ ++       +   GT  ++
Sbjct: 128 LREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYL 182

Query: 250 APEYLSTGKS--------SEKTDVFGYGITLLELVTGQ 279
            P+                   D++  G+T     TG 
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 92.2 bits (229), Expect = 2e-20
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 18/214 (8%)

Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQ--DYYSPGGEAAFQREVHLIS 129
            +  + F +  ++G+GGFG+V    +    K+ A K+L+        GEA    E  ++ 
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE 239

Query: 130 VAIHKNLLQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 188
               + ++ L  Y   + + + LV   M    + + +     G+ G       R  F  A
Sbjct: 240 KVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFP---EARAVFYAA 293

Query: 189 ---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 245
               GLE LH +   +I++RDLK  NILLDD+    + D GLA  V    T       GT
Sbjct: 294 EICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGT 348

Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           +G++APE +   + +   D +  G  L E++ GQ
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 89.6 bits (223), Expect = 3e-20
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 24/209 (11%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAI--HKNLLQL 139
           +G GG  +V+    L D+  VAVK L+   +  P     F+RE    + A   H  ++ +
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQ--NAAALNHPAIVAV 77

Query: 140 --IGYCTTSSERILVYPFMQNLSVAY----RLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
              G    +    L Y  M+     Y     LRD+   E  +       V       L +
Sbjct: 78  YDTG-EAETPAGPLPYIVME-----YVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT--QIRGTMGHIAP 251
            H+     IIHRD+K ANI++       + DFG+A+ +      VT    + GT  +++P
Sbjct: 132 SHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

Query: 252 EYLSTGKSSEKTDVFGYGITLLELVTGQR 280
           E         ++DV+  G  L E++TG+ 
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 91.4 bits (227), Expect = 4e-20
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 17/215 (7%)

Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVHLIS 129
            +  D F +  ++G+GGFG+V+   +    K+ A K+L  +      G      E  +++
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240

Query: 130 VAIHKNLLQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 188
               + ++ L  Y   +   + LV   M    + Y + ++     G   P   R  F TA
Sbjct: 241 KVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP---RAIFYTA 296

Query: 189 ---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR-G 244
               GLE+LH++    II+RDLK  N+LLDD+    + D GLA   + K     T+   G
Sbjct: 297 QIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAG 351

Query: 245 TMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           T G +APE L   +     D F  G+TL E++  +
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 91.5 bits (226), Expect = 5e-20
 Identities = 58/403 (14%), Positives = 125/403 (31%), Gaps = 133/403 (33%)

Query: 32  LFACRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNII--GQGG 89
               R Q   KL+               +L +LR                 N++  G  G
Sbjct: 129 YNVSRLQPYLKLRQ--------------ALLELR--------------PAKNVLIDGVLG 160

Query: 90  FGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER 149
            GK         T VA+     Y     +     ++  +++            C +    
Sbjct: 161 SGK---------TWVALDVCLSY---KVQCKMDFKIFWLNL----------KNCNSPETV 198

Query: 150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKA 209
           + +   +Q L     L  + P     +W +R   +      +  +  +    +  +  + 
Sbjct: 199 LEM---LQKL-----LYQIDP-----NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN 245

Query: 210 ANILLDDNFEAVLCDFGLAKLVDA-----KLTHVTTQIRG--------TMGHIAPEYLST 256
             ++L +     + +   AK  +A     K   +TT+ +         T  HI+ ++ S 
Sbjct: 246 CLLVLLN-----VQN---AKAWNAFNLSCK-ILLTTRFKQVTDFLSAATTTHISLDHHSM 296

Query: 257 GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE----------- 305
             + ++        +LL      R  D  R     +   L  I + +R+           
Sbjct: 297 TLTPDEVK------SLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHV 350

Query: 306 --DRLNDIVDRNLNTYDSKEVETM-VQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWA 362
             D+L  I++ +LN  +  E   M  ++++      P        ++ ++          
Sbjct: 351 NCDKLTTIIESSLNVLEPAEYRKMFDRLSVF-----PPSAHIPTILLSLI---------- 395

Query: 363 EWEELEEVRQQEV-------SLLPHQFAWGEDSSIDQEAIQLS 398
            W ++ +     V       SL+       ++S+I   +I L 
Sbjct: 396 -WFDVIKSDVMVVVNKLHKYSLV---EKQPKESTISIPSIYLE 434

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 88.4 bits (220), Expect = 7e-20
 Identities = 64/232 (27%), Positives = 97/232 (41%), Gaps = 41/232 (17%)

Query: 68  SCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTK--VAVKRLQ-DYYSPGGEAAFQRE 124
            CR    A   +     IG+G +GKV+K     N    VA+KR++      G   +  RE
Sbjct: 6   LCR----ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE 61

Query: 125 VHL---ISVAIHKNLLQLIGYCTTSSERI-----LVYPFMQNLSVAYRLRDLK-----PG 171
           V +   +    H N+++L   CT S         LV+  +         +DL        
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD--------QDLTTYLDKVP 113

Query: 172 EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL- 230
           E G+   T K + F    GL++LH     +++HRDLK  NIL+  + +  L DFGLA++ 
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 170

Query: 231 -VDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
                LT   VT   R      APE L     +   D++  G    E+   +
Sbjct: 171 SFQMALTSVVVTLWYR------APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 90.7 bits (225), Expect = 8e-20
 Identities = 70/272 (25%), Positives = 110/272 (40%), Gaps = 59/272 (21%)

Query: 35  CRYQKLRKLKHDVFFDVAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVY 94
              +  + L+ DVF      D          +     + L  ++FS   IIG+GGFG+VY
Sbjct: 149 YIEEICQNLRGDVFQKFIESDKFTRFCQW--KNVELNIHLTMNDFSVHRIIGRGGFGEVY 206

Query: 95  KGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER-ILV 152
               +D  K+ A+K L                        K +    G     +ER +L 
Sbjct: 207 GCRKADTGKMYAMKCLDK----------------------KRIKMKQGETLALNERIMLS 244

Query: 153 ------YPFMQNLSVAYRLRD--------LKPGEKGLDWPTRK-------RVAFGTA--- 188
                  PF+  +S A+   D        +  G+  L +   +        + F  A   
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGD--LHYHLSQHGVFSEADMRFYAAEII 302

Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 248
            GLE++H +    +++RDLK ANILLD++    + D GLA     K  H    + GT G+
Sbjct: 303 LGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGY 356

Query: 249 IAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
           +APE L  G + + + D F  G  L +L+ G 
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 53/213 (24%), Positives = 82/213 (38%), Gaps = 40/213 (18%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK--------RLQDYYSPGGEAAFQREVH 126
            +N+    I+G+G    V + +      + AVK                    A  +EV 
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 127 -LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK---- 181
            L  V+ H N++QL     T++   LV+  M+             GE   D+ T K    
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKK------------GEL-FDYLTEKVTLS 122

Query: 182 -RVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 236
            +            +  LH+     I+HRDLK  NILLDD+    L DFG +  +D    
Sbjct: 123 EKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--G 177

Query: 237 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYG 269
               ++ GT  ++APE +    +       GYG
Sbjct: 178 EKLREVCGTPSYLAPEIIECSMNDNHP---GYG 207

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 85.7 bits (213), Expect = 5e-19
 Identities = 49/217 (22%), Positives = 88/217 (40%), Gaps = 33/217 (15%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHK 134
           + + +   IG+G +G V+K         VA+K+  +    P  +    RE+ ++    H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 135 NLLQLIGYCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
           NL+ L+          LV+ +    +     L +L   ++G+     K + + T   + +
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTV-----LHELDRYQRGVPEHLVKSITWQTLQAVNF 117

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI-----RGTMGH 248
            H+      IHRD+K  NIL+  +    LCDFG A+L+     +   ++     R     
Sbjct: 118 CHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR----- 169

Query: 249 IAPEYL------STGKSSEKTDVFGYGITLLELVTGQ 279
            +PE L               DV+  G    EL++G 
Sbjct: 170 -SPELLVGDTQYGPP-----VDVWAIGCVFAELLSGV 200

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 86.1 bits (214), Expect = 5e-19
 Identities = 54/224 (24%), Positives = 92/224 (41%), Gaps = 27/224 (12%)

Query: 65  RRFSCRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQ 122
                + +    + +    ++G+G +G V K         VA+K+  +       +    
Sbjct: 17  ENLYFQSM----EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM 72

Query: 123 REVHLISVAIHKNLLQLIGYCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRK 181
           RE+ L+    H+NL+ L+  C       LV+ F+   +     L DL+    GLD+   +
Sbjct: 73  REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTI-----LDDLELFPNGLDYQVVQ 127

Query: 182 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ 241
           +  F    G+ + H      IIHRD+K  NIL+  +    LCDFG A+ + A       +
Sbjct: 128 KYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE 184

Query: 242 I-----RGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 279
           +     R      APE L       +  DV+  G  + E+  G+
Sbjct: 185 VATRWYR------APELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 86.6 bits (215), Expect = 6e-19
 Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 35/220 (15%)

Query: 76  TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKR-LQDYYSPGGEAAFQ-REVHLISVAIH 133
              ++   +IG G FG V++  L ++ +VA+K+ LQD         F+ RE+ ++ +  H
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-------KRFKNRELQIMRIVKH 91

Query: 134 KNLLQLIGYCTTSSERI------LVYPFM-QNLSVAYR-LRDLKPGEKGLDWPTRKRVAF 185
            N++ L  +  ++ ++       LV  ++ + +   YR  R     ++ +     K   +
Sbjct: 92  PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETV---YRASRHYAKLKQTMPMLLIKLYMY 148

Query: 186 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDA--KLTH--VTT 240
                L Y+H      I HRD+K  N+LLD     + L DFG AK++ A         + 
Sbjct: 149 QLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR 205

Query: 241 QIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 279
             R      APE +    + +   D++  G  + EL+ GQ
Sbjct: 206 YYR------APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 86.0 bits (213), Expect = 8e-19
 Identities = 51/251 (20%), Positives = 77/251 (30%), Gaps = 51/251 (20%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK----RLQDYYSPGGEAAFQREVHLISV 130
              +     IGQG +G V   +        A+K          +P      + EV L+  
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 131 AIHKNLLQLIGYCTTSS---------------ERILVYPFMQNLSVAYRLRDLKPGEKGL 175
             H N+ +L                       +++ V+        A  +   +      
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 176 DWPTRKRVAFGTAY---------------------GLEYLHEQCNPKIIHRDLKAANILL 214
                   +                           L YLH Q    I HRD+K  N L 
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLF 201

Query: 215 --DDNFEAVLCDFGLAKLVDAKLT---HVTTQIRGTMGHIAPEYLSTG--KSSEKTDVFG 267
             + +FE  L DFGL+K          +  T   GT   +APE L+T       K D + 
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 268 YGITLLELVTG 278
            G+ L  L+ G
Sbjct: 262 AGVLLHLLLMG 272

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 85.9 bits (213), Expect = 9e-19
 Identities = 62/212 (29%), Positives = 89/212 (41%), Gaps = 39/212 (18%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-------RLQDYYSPGGEAAFQREVH- 126
              +   ++IG+G    V + V  +   + AVK       RL          A +RE H 
Sbjct: 93  YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152

Query: 127 LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK----- 181
           L  VA H +++ LI    +SS   LV+  M+             GE   D+ T K     
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRK------------GEL-FDYLTEKVALSE 199

Query: 182 ---RVAFGT-AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 237
              R    +    + +LH      I+HRDLK  NILLDDN +  L DFG +  ++     
Sbjct: 200 KETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP--GE 254

Query: 238 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYG 269
              ++ GT G++APE L   K S      GYG
Sbjct: 255 KLRELCGTPGYLAPEIL---KCSMDETHPGYG 283

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 52/215 (24%), Positives = 88/215 (40%), Gaps = 39/215 (18%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVH----LISVAIHK 134
           +G+GGFG V+ G  L+D  +VA+K     R+  +           EV     + +   H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--------RVAFG 186
            +++L+ +  T    +LV                 P +   D+ T K        R  FG
Sbjct: 99  GVIRLLDWFETQEGFMLVLERP------------LPAQDLFDYITEKGPLGEGPSRCFFG 146

Query: 187 -TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRG 244
                +++ H +    ++HRD+K  NIL+D       L DFG   L+  +         G
Sbjct: 147 QVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---G 200

Query: 245 TMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTG 278
           T  +  PE++S  +  +    V+  GI L ++V G
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 63/235 (26%), Positives = 96/235 (40%), Gaps = 45/235 (19%)

Query: 69  CRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVH 126
           C E+      + +   IGQG FG+V+K        KVA+K++  +    G      RE+ 
Sbjct: 13  CDEV----SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK 68

Query: 127 LISVAIHKNLLQLIGYCTTSSERI--------LVYPFMQNLSVAYRLRDLK----PGEKG 174
           ++ +  H+N++ LI  C T +           LV+ F ++        DL          
Sbjct: 69  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH--------DLAGLLSNVLVK 120

Query: 175 LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA------ 228
                 KRV      GL Y+H     KI+HRD+KAAN+L+  +    L DFGLA      
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLA 177

Query: 229 -KLVDAKLTH--VTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 279
                 + T+  VT   R       PE L   +      D++G G  + E+ T  
Sbjct: 178 KNSQPNRYTNRVVTLWYR------PPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 52/213 (24%), Positives = 86/213 (40%), Gaps = 37/213 (17%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLISVAIHK--NL 136
           +G GGFG VY G+ +SDN  VA+K     R+ D+           EV L+         +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 137 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--------RVAFG-T 187
           ++L+ +       +L+            ++DL       D+ T +        R  F   
Sbjct: 111 IRLLDWFERPDSFVLILER------PEPVQDL------FDFITERGALQEELARSFFWQV 158

Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDAKLTHVTTQIRGTM 246
              + + H      ++HRD+K  NIL+D N   + L DFG   L+   +        GT 
Sbjct: 159 LEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTR 212

Query: 247 GHIAPEYLSTGK-SSEKTDVFGYGITLLELVTG 278
            +  PE++   +       V+  GI L ++V G
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 84.2 bits (208), Expect = 3e-18
 Identities = 38/173 (21%), Positives = 66/173 (38%), Gaps = 33/173 (19%)

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR------ 243
            +E+LH +    ++HRDLK +NI    +    + DFGL   +D      T          
Sbjct: 176 AVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232

Query: 244 -----GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH 298
                GT  +++PE +     S K D+F  G+ L EL+       FS   E   ++    
Sbjct: 233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS-----FSTQMERVRII---- 283

Query: 299 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 351
               +R  +   +  +        +   MVQ        +P +RP    +++ 
Sbjct: 284 --TDVRNLKFPLLFTQ-----KYPQEHMMVQ---DMLSPSPTERPEATDIIEN 326

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 83.8 bits (208), Expect = 3e-18
 Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 28/214 (13%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKN 135
           + + +   +G+G +G VYK   S    VA+KR++ D    G  +   RE+ L+    H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80

Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYGL 191
           ++ LI    +     LV+ FM+         DLK      + GL     K   +    G+
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEK--------DLKKVLDENKTGLQDSQIKIYLYQLLRGV 132

Query: 192 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTH--VTTQIRGTM 246
            + H+    +I+HRDLK  N+L++ +    L DFGLA+         TH  VT   R   
Sbjct: 133 AHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR--- 186

Query: 247 GHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 279
              AP+ L   K  S   D++  G    E++TG+
Sbjct: 187 ---APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 84.4 bits (209), Expect = 4e-18
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 36/221 (16%)

Query: 76  TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKR-LQDYYSPGGEAAFQ-REVHLISVAI 132
             +++++ +IG G FG VY+  L D    VA+K+ LQD         F+ RE+ ++    
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLD 105

Query: 133 HKNLLQLIGYCTTSSERI------LVYPFM-QNLSVAYR-LRDLKPGEKGLDWPTRKRVA 184
           H N+++L  +  +S E+       LV  ++ + +   YR  R     ++ L     K   
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRAKQTLPVIYVKLYM 162

Query: 185 FGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-LCDFGLAKLVDA--KLTH--VT 239
           +     L Y+H      I HRD+K  N+LLD +   + LCDFG AK +           +
Sbjct: 163 YQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 219

Query: 240 TQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 279
              R      APE +      +   DV+  G  L EL+ GQ
Sbjct: 220 RYYR------APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 82.3 bits (204), Expect = 8e-18
 Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 43/217 (19%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLISVAIHKNLLQ 138
           +G+G +GKV + +      + AVK     +L+    P GEA  ++E+ L+    HKN++Q
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR--IPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 139 L--IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRKRVAFGTA------- 188
           L  + Y     +  +V  +               G + + D    KR     A       
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVC------------GMQEMLDSVPEKRFPVCQAHGYFCQL 118

Query: 189 -YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK----LTHVTTQIR 243
             GLEYLH Q    I+H+D+K  N+LL       +   G+A+ +           T+Q  
Sbjct: 119 IDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR-TSQ-- 172

Query: 244 GTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTG 278
           G+     PE  +     S  K D++  G+TL  + TG
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 81.8 bits (203), Expect = 9e-18
 Identities = 58/218 (26%), Positives = 91/218 (41%), Gaps = 29/218 (13%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 134
             + +   IG+G +G V+K      +  VA+KR++ D    G  ++  RE+ L+    HK
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYG 190
           N+++L     +  +  LV+ F           DLK         LD    K   F    G
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQ--------DLKKYFDSCNGDLDPEIVKSFLFQLLKG 113

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTH--VTTQIRGT 245
           L + H +    ++HRDLK  N+L++ N E  L +FGLA+         +   VT   R  
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR-- 168

Query: 246 MGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAI 282
                P+ L   K  S   D++  G    EL    R +
Sbjct: 169 ----PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 28/214 (13%)

Query: 77  DNFSESNIIGQGGFGKVYKG-VLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           + + + + +G+G +  VYKG     +  VA+K ++  +  G      REV L+    H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYGL 191
           ++ L     T     LV+ ++         +DLK         ++    K   F    GL
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLD--------KDLKQYLDDCGNIINMHNVKLFLFQLLRGL 113

Query: 192 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTH--VTTQIRGTM 246
            Y H Q   K++HRDLK  N+L+++  E  L DFGLA+          +  VT   R   
Sbjct: 114 AYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR--- 167

Query: 247 GHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 279
               P+ L      S + D++G G    E+ TG+
Sbjct: 168 ---PPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 81.0 bits (201), Expect = 2e-17
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 28/214 (13%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKN 135
           + +     IG+G +G VYK   +     A+K+++ +    G  +   RE+ ++    H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGTAYGL 191
           +++L     T    +LV+  +          DLK      E GL+  T K        G+
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQ--------DLKKLLDVCEGGLESVTAKSFLLQLLNGI 113

Query: 192 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA---KLTH--VTTQIRGTM 246
            Y H++   +++HRDLK  N+L++   E  + DFGLA+       K TH  VT   R   
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR--- 167

Query: 247 GHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 279
              AP+ L   K  S   D++  G    E+V G 
Sbjct: 168 ---APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 29/219 (13%)

Query: 75  ATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQ----REVHL 127
           ++  F +   +G G +  VYKG+  +    VA+K  +L        E        RE+ L
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS------EEGTPSTAIREISL 56

Query: 128 ISVAIHKNLLQLIGYCTTSSERILVYPFM-QNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +    H+N+++L     T ++  LV+ FM  +L      R +    +GL+    K   + 
Sbjct: 57  MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116

Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA---KLTH--VTTQ 241
              GL + HE    KI+HRDLK  N+L++   +  L DFGLA+         +   VT  
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLW 173

Query: 242 IRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 279
            R      AP+ L   ++ S   D++  G  L E++TG+
Sbjct: 174 YR------APDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 55/177 (31%), Positives = 78/177 (44%), Gaps = 25/177 (14%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL----QDYYSPGGEAAFQREVHLISVA 131
             + + + +G+G F  VYK    + N  VA+K++    +     G      RE+ L+   
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 132 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK----PGEKGLDWPTRKRVAFGT 187
            H N++ L+      S   LV+ FM+         DL+         L     K     T
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFME--------TDLEVIIKDNSLVLTPSHIKAYMLMT 121

Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTH--VT 239
             GLEYLH+     I+HRDLK  N+LLD+N    L DFGLAK     +   TH  VT
Sbjct: 122 LQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVT 175

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 80.8 bits (200), Expect = 4e-17
 Identities = 53/225 (23%), Positives = 87/225 (38%), Gaps = 38/225 (16%)

Query: 76  TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKR-LQDYYSPGGEAAFQ----REVHLIS 129
            D F    + GQG FG V  G        VA+K+ +QD         F+    + +  ++
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-------PRFRNRELQIMQDLA 74

Query: 130 VAIHKNLLQLIGYCTTSSER-------ILVYPFM-QNLSVAYR-LRDLKPGEKGLDWPTR 180
           V  H N++QL  Y  T  ER        +V  ++   L   +R  R+    +        
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTL---HRCCRNYYRRQVAPPPILI 131

Query: 181 KRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLV--DAKLTH 237
           K   F     +  LH      + HRD+K  N+L++  +    LCDFG AK +        
Sbjct: 132 KVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190

Query: 238 --VTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 279
              +   R      APE +   +  +   D++  G    E++ G+
Sbjct: 191 YICSRYYR------APELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 73/330 (22%), Positives = 124/330 (37%), Gaps = 54/330 (16%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRL-------QDYYSPGGEAAFQREVHLISVAIHKNL 136
           +G G FG V+  V    N +V VK +         +           E+ ++S   H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 137 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 196
           ++++          LV   M+       L         LD P    +       + YL  
Sbjct: 92  IKVLDIFENQGFFQLV---MEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL 148

Query: 197 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTHVTTQIRGTMGHIAPEYLS 255
           +    IIHRD+K  NI++ ++F   L DFG A  +   KL +      GT+ + APE L 
Sbjct: 149 K---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEYCAPEVLM 202

Query: 256 TGKSSE--KTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 313
            G      + +++  G+TL  LV  +                   + +          V+
Sbjct: 203 -GNPYRGPELEMWSLGVTLYTLVFEE--------------NPFCELEE---------TVE 238

Query: 314 RNLN--TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK---MLQGEDLAERWAEWEELE 368
             ++     SKE+ ++V   L   Q  PE R  + ++V    + Q  +LA+    WEE+ 
Sbjct: 239 AAIHPPYLVSKELMSLVSGLL---QPVPERRTTLEKLVTDPWVTQPVNLADY--TWEEVF 293

Query: 369 EVRQQEVSLLPHQFAWGEDSSIDQEAIQLS 398
            V + E  +L        + S+   A    
Sbjct: 294 RVNKPESGVLSAASLEMGNRSLSDVAQAQE 323

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 51/228 (22%), Positives = 91/228 (39%), Gaps = 37/228 (16%)

Query: 68  SCRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREV 125
           S   +    D +     +G+G +G+VYK +    N  VA+KR+  ++   G      REV
Sbjct: 29  SATSI----DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREV 84

Query: 126 HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKR 182
            L+    H+N+++L      +    L++ + +         DLK        +     K 
Sbjct: 85  SLLKELQHRNIIELKSVIHHNHRLHLIFEYAE--------NDLKKYMDKNPDVSMRVIKS 136

Query: 183 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-----LCDFGLAKLV---DAK 234
             +    G+ + H +   + +HRDLK  N+LL  +  +      + DFGLA+       +
Sbjct: 137 FLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ 193

Query: 235 LTH--VTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ 279
            TH  +T   R       PE L   +  S   D++       E++   
Sbjct: 194 FTHEIITLWYR------PPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 46/226 (20%), Positives = 85/226 (37%), Gaps = 42/226 (18%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-------RLQDYYSPGGEAAFQREVHL 127
            D +  S  +G G  G+V          KVA++        +            + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 128 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG--------EKG-LDWP 178
           +    H  ++++  +          Y  +          +L  G            L   
Sbjct: 194 LKKLNHPCIIKIKNFFDAED----YYIVL----------ELMEGGELFDKVVGNKRLKEA 239

Query: 179 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKL 235
           T K   +     ++YLHE     IIHRDLK  N+LL   +++    + DFG +K++    
Sbjct: 240 TCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-- 294

Query: 236 THVTTQIRGTMGHIAPEYLSTGKS---SEKTDVFGYGITLLELVTG 278
           T +   + GT  ++APE L +  +   +   D +  G+ L   ++G
Sbjct: 295 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 8/94 (8%)

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L+YL  Q   +IIHRD+K  NILLD++    + DF +A ++  +    T  + GT  ++
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYM 181

Query: 250 APEYLSTGKSSEKT---DVFGYGITLLELVTGQR 280
           APE  S+ K +  +   D +  G+T  EL+ G+R
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 48/211 (22%), Positives = 86/211 (40%), Gaps = 17/211 (8%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 133
           ++ +     +G G +G+V        + + A+K ++    S    +    EV ++ +  H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP-GEKGLDWPTRKRVAFGTAYGLE 192
            N+++L  +        LV    +   +   +       E          +      G+ 
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDA-----AVIIKQVLSGVT 150

Query: 193 YLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           YLH+     I+HRDLK  N+LL   + +    + DFGL+ + +        +  GT  +I
Sbjct: 151 YLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN--QKKMKERLGTAYYI 205

Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQR 280
           APE L   K  EK DV+  G+ L  L+ G  
Sbjct: 206 APEVLR-KKYDEKCDVWSIGVILFILLAGYP 235

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 44/191 (23%), Positives = 78/191 (40%), Gaps = 33/191 (17%)

Query: 85  IGQGGFGKVYKGVLSDNT---KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
           +G+G +G VYK    D       A+K+++     G   +  RE+ L+    H N++ L  
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVISLQK 85

Query: 142 YCTTSSERI--LVYPFMQN----LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
              + ++R   L++ + ++    +   +R          L     K + +    G+ YLH
Sbjct: 86  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 196 EQCNPKIIHRDLKAANILLDDNFEAV----LCDFGLAKLVDA---KLTHVTTQI-----R 243
                 ++HRDLK ANIL+           + D G A+L ++    L  +   +     R
Sbjct: 146 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 202

Query: 244 GTMGHIAPEYL 254
                 APE L
Sbjct: 203 ------APELL 207

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 57/229 (24%), Positives = 93/229 (40%), Gaps = 43/229 (18%)

Query: 76  TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEA-AFQ---------REV 125
              ++    I  G +G V  GV S+   VA+KR+ +  S G                RE+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 126 HLISVAIHKNLLQLIGYCTTSSERI-----LVYPFMQ-NLSVAYRLRDLKPGEKGLDWPT 179
            L++   H N+L L        E       LV   M+ +L+     + +      +   +
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLA-----QVIHDQRIVI---S 132

Query: 180 RKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DA 233
            + + +   Y    GL  LH      ++HRDL   NILL DN +  +CDF LA+    DA
Sbjct: 133 PQHIQY-FMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188

Query: 234 KLT-HVTTQ-IRGTMGHIAPEY-LSTGKSSEKTDVFGYGITLLELVTGQ 279
             T +VT +  R      APE  +     ++  D++  G  + E+   +
Sbjct: 189 NKTHYVTHRWYR------APELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 78.6 bits (194), Expect = 4e-16
 Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 22/218 (10%)

Query: 72  LQLATDNFSE----SNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ--DYYSPGGEAAFQRE 124
           +Q +T  FS+      ++G+G FG+V          + AVK +          + +  RE
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 125 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP-GEKGLDWPTRKRV 183
           V L+    H N+++L  +        LV        +   +   K   E         R+
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA-----ARI 131

Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTT 240
                 G+ Y+H+    KI+HRDLK  N+LL     +    + DFGL+   +A  +    
Sbjct: 132 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMK 186

Query: 241 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
              GT  +IAPE L  G   EK DV+  G+ L  L++G
Sbjct: 187 DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 42/218 (19%), Positives = 75/218 (34%), Gaps = 44/218 (20%)

Query: 70  RELQLATDNFSE-----SNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQR 123
           +  +      ++       ++G G  GKV +        K A+K L D          ++
Sbjct: 17  QGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD------SPKARQ 70

Query: 124 EV-HLISVAIHKNLLQLIG-YCTTSSERILVYPFMQNLSVAYRLRDLKPG--------EK 173
           EV H    +   +++ ++  Y      +  +   M          +   G        E+
Sbjct: 71  EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM----------ECMEGGELFSRIQER 120

Query: 174 GLDWPTRKRVAFGT---AYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGL 227
           G    T +  A         +++LH      I HRD+K  N+L    + +    L DFG 
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177

Query: 228 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 265
           AK       +       T  ++APE L   K  +  D+
Sbjct: 178 AKETT---QNALQTPCYTPYYVAPEVLGPEKYDKSCDM 212

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 75.7 bits (187), Expect = 1e-15
 Identities = 46/203 (22%), Positives = 85/203 (41%), Gaps = 33/203 (16%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 134
              F    ++G G F +V+           A+K +        +++ + E+ ++    H+
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCI-KKSPAFRDSSLENEIAVLKKIKHE 66

Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-----RVAFGTAY 189
           N++ L     +++   LV   MQ          L  G +  D    +     + A     
Sbjct: 67  NIVTLEDIYESTTHYYLV---MQ----------LVSGGELFDRILERGVYTEKDASLVIQ 113

Query: 190 ----GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQI 242
                ++YLHE     I+HRDLK  N+L    ++N + ++ DFGL+K+       + +  
Sbjct: 114 QVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---NGIMSTA 167

Query: 243 RGTMGHIAPEYLSTGKSSEKTDV 265
            GT G++APE L+    S+  D 
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVDC 190

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 53/228 (23%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 125
              +     +G G +G V   +      KVA+K+L           FQ         RE+
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--------PFQSEIFAKRAYREL 74

Query: 126 HLISVAIHKNLLQLIGYCTTSSERI------LVYPFMQ-NLSVAYRLRDLKPGEKGLDWP 178
            L+    H+N++ L+   T +S         LV PFMQ +L     L+            
Sbjct: 75  LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK-----------F 123

Query: 179 TRKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 234
           + +++ +   Y    GL+Y+H   +  ++HRDLK  N+ ++++ E  + DFGLA+  DA+
Sbjct: 124 SEEKIQY-LVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179

Query: 235 LTH-VTTQ-IRGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           +T  V T+  R      APE  LS    ++  D++  G  + E++TG+
Sbjct: 180 MTGYVVTRWYR------APEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 76.8 bits (189), Expect = 2e-15
 Identities = 48/231 (20%), Positives = 84/231 (36%), Gaps = 36/231 (15%)

Query: 65  RRFSCRELQLATDNFSE----SNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEA 119
           +++  + +++  D+  +       +G G FG V++    +     A K +        + 
Sbjct: 141 KQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV-MTPHESDKE 199

Query: 120 AFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPT 179
             ++E+  +SV  H  L+ L       +E +++Y FM              GE   +   
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG------------GEL-FEKVA 246

Query: 180 RKRVAF----GTAY------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL--CDFGL 227
            +           Y      GL ++HE      +H DLK  NI+        L   DFGL
Sbjct: 247 DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGL 303

Query: 228 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
              +D K         GT    APE          TD++  G+    L++G
Sbjct: 304 TAHLDPK--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 76.3 bits (188), Expect = 3e-15
 Identities = 46/234 (19%), Positives = 84/234 (35%), Gaps = 56/234 (23%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL------------QDYYSPGGEAAFQ 122
            +++ +   +G G +G+V      + +++ A+K +             +           
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 123 REVHLISVAIHKNLLQLIGYCTTSS---------------ERILVYPFMQNLSVAYRLRD 167
            E+ L+    H N+++L                       E+I+          A  ++ 
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154

Query: 168 LKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCD 224
           +                     G+ YLH+     I+HRD+K  NILL   +      + D
Sbjct: 155 I-------------------LSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVD 192

Query: 225 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           FGL+        +      GT  +IAPE L   K +EK DV+  G+ +  L+ G
Sbjct: 193 FGLSSFFSK--DYKLRDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCG 243

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 74.6 bits (184), Expect = 3e-15
 Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 52/232 (22%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVK-------------------------RLQDYYSPGGE 118
           IG+G +G V      +DNT  A+K                                 G  
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 119 AAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWP 178
               +E+ ++    H N+++L+      +E  L Y   +          +  G   ++ P
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFE-----L----VNQGPV-MEVP 129

Query: 179 TRKRVAFGTA--------YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 230
           T K ++   A         G+EYLH Q   KIIHRD+K +N+L+ ++    + DFG++  
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186

Query: 231 VDAKLTHVTTQIRGTMGHIAPEYLSTGK---SSEKTDVFGYGITLLELVTGQ 279
                  ++  + GT   +APE LS  +   S +  DV+  G+TL   V GQ
Sbjct: 187 FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 75.6 bits (186), Expect = 4e-15
 Identities = 53/236 (22%), Positives = 91/236 (38%), Gaps = 50/236 (21%)

Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLI 128
           ++++L  ++F    +IG+G FG+V    L +  KV A+K L  +     E   + E    
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW-----EMLKRAETA-- 119

Query: 129 SVAIHKNLLQLIGYCTTSSERILVY---PFMQNLSVA-------YRLRDLKPG------- 171
                         C      +LV     ++  L  A       Y + D   G       
Sbjct: 120 --------------CFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL 165

Query: 172 EKGLDWPTRKRVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA 228
            K  D    +   F  A     ++ +H+      +HRD+K  NIL+D N    L DFG  
Sbjct: 166 SKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSC 222

Query: 229 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKT-----DVFGYGITLLELVTGQ 279
             +    T  ++   GT  +I+PE L   +  +       D +  G+ + E++ G+
Sbjct: 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 75.1 bits (185), Expect = 5e-15
 Identities = 40/218 (18%), Positives = 80/218 (36%), Gaps = 36/218 (16%)

Query: 65  RRFSCRELQLATDNFSE----SNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEA 119
           +++  + +++   +  +       +G G FG V++ V  +       K + +   P  + 
Sbjct: 35  KKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFI-NTPYPLDKY 93

Query: 120 AFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPT 179
             + E+ +++   H  L+ L        E +L+  F+              GE   D   
Sbjct: 94  TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG------------GEL-FDRIA 140

Query: 180 RKRVAFGTAY----------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL--CDFGL 227
            +      A           GL+++HE     I+H D+K  NI+ +    + +   DFGL
Sbjct: 141 AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGL 197

Query: 228 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 265
           A  ++     +      T    APE +        TD+
Sbjct: 198 ATKLNP--DEIVKVTTATAEFAAPEIVDREPVGFYTDM 233

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 74.6 bits (184), Expect = 5e-15
 Identities = 44/197 (22%), Positives = 74/197 (37%), Gaps = 33/197 (16%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVH-LISVAIHKNLLQLIG 141
           +G+G F  V + +  S   + A K L+         A    E+  L        ++ L  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 142 YCTTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFGT---AYGL 191
               +SE IL+  +               GE       +  +  +   V         G+
Sbjct: 97  VYENTSEIILILEYAAG------------GEIFSLCLPELAEMVSENDVIRLIKQILEGV 144

Query: 192 EYLHEQCNPKIIHRDLKAANILLDDNFEAV---LCDFGLAKLVDAKLTHVTTQIRGTMGH 248
            YLH+     I+H DLK  NILL   +      + DFG+++ +         +I GT  +
Sbjct: 145 YYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA--CELREIMGTPEY 199

Query: 249 IAPEYLSTGKSSEKTDV 265
           +APE L+    +  TD+
Sbjct: 200 LAPEILNYDPITTATDM 216

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 74.6 bits (183), Expect = 6e-15
 Identities = 32/99 (32%), Positives = 51/99 (51%), Gaps = 12/99 (12%)

Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 243
           +F  A G+E+L  +   K IHRDL A NILL +     +CDFGLA+ +     +V    R
Sbjct: 199 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV----R 251

Query: 244 GTMGHI-----APEYLSTGKSSEKTDVFGYGITLLELVT 277
                +     APE +     + ++DV+ +G+ L E+ +
Sbjct: 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 54.9 bits (132), Expect = 1e-08
 Identities = 23/90 (25%), Positives = 39/90 (43%), Gaps = 8/90 (8%)

Query: 77  DNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREV-HLIS 129
           D       +G+G FG+V +         +    VAVK L++  +     A   E+  LI 
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 130 VAIHKNLLQLIGYCTTSSERILV-YPFMQN 158
           +  H N++ L+G CT     ++V   F + 
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKF 111

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 75.3 bits (185), Expect = 6e-15
 Identities = 52/221 (23%), Positives = 84/221 (38%), Gaps = 38/221 (17%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 125
              +     IG G  G V        +  VA+K+L           FQ         RE+
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR--------PFQNQTHAKRAYREL 112

Query: 126 HLISVAIHKNLLQLI------GYCTTSSERILVYPFMQ-NLSVAYRLRDLKPGEKGLDWP 178
            L+    HKN++ L+             +  LV   M  NL    +          LD  
Sbjct: 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--------MELDHE 164

Query: 179 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 238
               + +    G+++LH   +  IIHRDLK +NI++  +    + DFGLA+      + +
Sbjct: 165 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFM 219

Query: 239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
            T    T  + APE +      E  D++  G  + E+V  +
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 74.3 bits (183), Expect = 7e-15
 Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 52/228 (22%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 125
              + +   +G G +G V   V      KVA+K+L           FQ         RE+
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--------PFQSELFAKRAYREL 75

Query: 126 HLISVAIHKNLLQLI------GYCTTSSERILVYPFMQ-NLSVAYRLRDLKPGEKGLDWP 178
            L+    H+N++ L+            ++  LV PFM  +L    +   L          
Sbjct: 76  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKL---------- 125

Query: 179 TRKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 234
              R+ F   Y    GL Y+H      IIHRDLK  N+ ++++ E  + DFGLA+  D++
Sbjct: 126 GEDRIQF-LVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181

Query: 235 LT-HVTTQ-IRGTMGHIAPEY-LSTGKSSEKTDVFGYGITLLELVTGQ 279
           +T +V T+  R      APE  L+  + ++  D++  G  + E++TG+
Sbjct: 182 MTGYVVTRWYR------APEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 73.4 bits (181), Expect = 7e-15
 Identities = 47/215 (21%), Positives = 79/215 (36%), Gaps = 49/215 (22%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLIS 129
            D++     +G G F  V K        + A K     RL            +REV+++ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQ------------NLS---VAYRLRDLKPGEKG 174
              H N++ L       ++ +L+   +             +L+       L+ +      
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI------ 117

Query: 175 LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLAKL 230
           LD             G+ YLH +   +I H DLK  NI+L      N    L DFG+A  
Sbjct: 118 LD-------------GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161

Query: 231 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 265
           ++A   +    I GT   +APE ++      + D+
Sbjct: 162 IEAG--NEFKNIFGTPEFVAPEIVNYEPLGLEADM 194

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 73.4 bits (181), Expect = 7e-15
 Identities = 43/202 (21%), Positives = 76/202 (37%), Gaps = 26/202 (12%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 134
            D F     +G G FG V+     S   +  +K +    S       + E+ ++    H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 135 NLLQLIGYCTTSSERILVYPFMQNLS--------VAYRLRDLKPGEKGLDWPTRKRVAFG 186
           N++++           +V   M+           V+ + R     E  +    ++ +   
Sbjct: 81  NIIKIFEVFEDYHNMYIV---METCEGGELLERIVSAQARGKALSEGYVAELMKQMMN-- 135

Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQIR 243
               L Y H Q    ++H+DLK  NIL      +    + DFGLA+L  +     +T   
Sbjct: 136 ---ALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS--DEHSTNAA 187

Query: 244 GTMGHIAPEYLSTGKSSEKTDV 265
           GT  ++APE       + K D+
Sbjct: 188 GTALYMAPEVFK-RDVTFKCDI 208

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 74.4 bits (183), Expect = 8e-15
 Identities = 44/199 (22%), Positives = 73/199 (36%), Gaps = 38/199 (19%)

Query: 84  IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQLIG 141
           ++G G  GKV +        K A+K LQD          +REV      +   ++++++ 
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVD 122

Query: 142 -YCTTSSERILVYPFMQNLSVAYRLRDLKPG--------EKGLDWPTRKRVAFGT---AY 189
            Y    + R  +   M          +   G        ++G    T +  +        
Sbjct: 123 VYENLYAGRKCLLIVM----------ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAV---LCDFGLAKLVDAKLTHVTTQIRGTM 246
            ++YLH      I HRD+K  N+L           L DFG AK   +   +  T    T 
Sbjct: 173 AIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPCYTP 227

Query: 247 GHIAPEYLSTGKSSEKTDV 265
            ++APE L   K  +  D+
Sbjct: 228 YYVAPEVLGPEKYDKSCDM 246

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 74.7 bits (184), Expect = 8e-15
 Identities = 54/226 (23%), Positives = 88/226 (38%), Gaps = 51/226 (22%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 133
            + ++   ++G+G FG+V K        + AVK +          +   REV L+    H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 134 KNLLQLIGYCTTSS---------------ERILVYPFMQNLS---VAYRLRDLKPGEKGL 175
            N+++L      SS               + I+     +  S    A  ++ +       
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQV------- 130

Query: 176 DWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVD 232
                         G+ Y+H+     I+HRDLK  NILL   + + +  + DFGL+    
Sbjct: 131 ------------FSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175

Query: 233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
                      GT  +IAPE L  G   EK DV+  G+ L  L++G
Sbjct: 176 Q--NTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 73.8 bits (182), Expect = 8e-15
 Identities = 34/93 (36%), Positives = 50/93 (53%), Gaps = 10/93 (10%)

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGTMGHI 249
           LEYLH +    IIHRDLK  NILL+++    + DFG AK++  +          GT  ++
Sbjct: 143 LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199

Query: 250 APEYLST---GKSSEKTDVFGYGITLLELVTGQ 279
           +PE L+     KSS   D++  G  + +LV G 
Sbjct: 200 SPELLTEKSACKSS---DLWALGCIIYQLVAGL 229

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 74.3 bits (183), Expect = 8e-15
 Identities = 51/221 (23%), Positives = 84/221 (38%), Gaps = 38/221 (17%)

Query: 76  TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQ---------REV 125
              +     IG G  G V     +     VA+K+L           FQ         RE+
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR--------PFQNQTHAKRAYREL 75

Query: 126 HLISVAIHKNLLQLI------GYCTTSSERILVYPFMQ-NLSVAYRLRDLKPGEKGLDWP 178
            L+    HKN++ L+             +  +V   M  NL    +          LD  
Sbjct: 76  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--------MELDHE 127

Query: 179 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 238
               + +    G+++LH   +  IIHRDLK +NI++  +    + DFGLA+      + +
Sbjct: 128 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFM 182

Query: 239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
            T    T  + APE +      E  D++  G  + E++ G 
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 73.0 bits (180), Expect = 1e-14
 Identities = 52/204 (25%), Positives = 81/204 (39%), Gaps = 33/204 (16%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 133
            + ++   ++G+G FG+V K        + AVK +          +   REV L+    H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-----RVAFGTA 188
            N+++L      SS   +V              +L  G +  D   ++       A    
Sbjct: 81  PNIMKLFEILEDSSSFYIV---G----------ELYTGGELFDEIIKRKRFSEHDAARII 127

Query: 189 Y----GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQ 241
                G+ Y+H+     I+HRDLK  NILL   + + +  + DFGL+             
Sbjct: 128 KQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKD 182

Query: 242 IRGTMGHIAPEYLSTGKSSEKTDV 265
             GT  +IAPE L  G   EK DV
Sbjct: 183 RIGTAYYIAPEVLR-GTYDEKCDV 205

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 48/224 (21%), Positives = 85/224 (37%), Gaps = 50/224 (22%)

Query: 67  FSCRELQLATDNFSE------SNIIGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYS 114
           F  R +       +       + I+G G FG+V+K    +   K+A K      ++D   
Sbjct: 73  FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD--- 129

Query: 115 PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG 174
              +   + E+ +++   H NL+QL     + ++ +LV  ++              GE  
Sbjct: 130 ---KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG------------GE-- 172

Query: 175 L-DWPTRKRVAFGTAY----------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL- 222
           L D    +                  G+ ++H+     I+H DLK  NIL  +     + 
Sbjct: 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIK 229

Query: 223 -CDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 265
             DFGLA+    +         GT   +APE ++    S  TD+
Sbjct: 230 IIDFGLARRYKPR--EKLKVNFGTPEFLAPEVVNYDFVSFPTDM 271

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 47/215 (21%), Positives = 75/215 (34%), Gaps = 49/215 (22%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLIS 129
            D +     +G G F  V K    S   + A K     + +           +REV ++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRKRVAFGTA 188
             +H N++ L       ++ +L+   +              GE  L D      +A   +
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSG------------GE--LFD-----FLAQKES 111

Query: 189 Y--------------GLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLAKL 230
                          G+ YLH +   KI H DLK  NI+L           L DFGLA  
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168

Query: 231 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 265
           ++         I GT   +APE ++      + D+
Sbjct: 169 IEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADM 201

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 47/215 (21%), Positives = 75/215 (34%), Gaps = 49/215 (22%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLIS 129
            D +     +G G F  V K    S   + A K     + +           +REV ++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRKRVAFGTA 188
             +H N++ L       ++ +L+   +              GE  L D      +A   +
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSG------------GE--LFD-----FLAQKES 111

Query: 189 Y--------------GLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLAKL 230
                          G+ YLH +   KI H DLK  NI+L           L DFGLA  
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168

Query: 231 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 265
           ++         I GT   +APE ++      + D+
Sbjct: 169 IED--GVEFKNIFGTPEFVAPEIVNYEPLGLEADM 201

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 53/224 (23%), Positives = 89/224 (39%), Gaps = 24/224 (10%)

Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRL--QDYYSPGGEAAFQREVH 126
           +E++L  D+F    +IG+G F +V    +    +V A+K +   D    G  + F+ E  
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERD 113

Query: 127 LISVAIHKNLLQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF 185
           ++     + + QL  +       + LV  +     +   L   K GE+       +   F
Sbjct: 114 VLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS--KFGERI----PAEMARF 166

Query: 186 GTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI 242
             A     ++ +H       +HRD+K  NILLD      L DFG    + A  T  +   
Sbjct: 167 YLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA 223

Query: 243 RGTMGHIAPEYLSTGKSSEKTDVFG-------YGITLLELVTGQ 279
            GT  +++PE L        T  +G        G+   E+  GQ
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 71.9 bits (177), Expect = 3e-14
 Identities = 34/203 (16%), Positives = 75/203 (36%), Gaps = 33/203 (16%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 134
            + +  +  +G+G FG V++ V  S       K ++       +   ++E+ ++++A H+
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHR 61

Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG----TAY- 189
           N+L L     +  E ++++ F+               +   +               +Y 
Sbjct: 62  NILHLHESFESMEELVMIFEFISG------------LDI-FERINTSAFELNEREIVSYV 108

Query: 190 -----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL--CDFGLAKLVDAKLTHVTTQI 242
                 L++LH      I H D++  NI+      + +   +FG A+ +          +
Sbjct: 109 HQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLL 163

Query: 243 RGTMGHIAPEYLSTGKSSEKTDV 265
                + APE       S  TD+
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDM 186

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 71.9 bits (177), Expect = 4e-14
 Identities = 45/214 (21%), Positives = 79/214 (36%), Gaps = 45/214 (21%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-------RLQDYYSPGGEAAFQREVHL 127
            D +  S  +G G  G+V          KVA+K        +            + E+ +
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 128 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG--------EKG-LDWP 178
           +    H  ++++  +          Y  +          +L  G            L   
Sbjct: 69  LKKLNHPCIIKIKNFFDAED----YYIVL----------ELMEGGELFDKVVGNKRLKEA 114

Query: 179 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKL 235
           T K   +     ++YLHE     IIHRDLK  N+LL   +++    + DFG +K++    
Sbjct: 115 TCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-- 169

Query: 236 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYG 269
           T +   + GT  ++APE L +  ++      GY 
Sbjct: 170 TSLMRTLCGTPTYLAPEVLVSVGTA------GYN 197

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 72.3 bits (178), Expect = 5e-14
 Identities = 40/204 (19%), Positives = 73/204 (35%), Gaps = 31/204 (15%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 133
           T+ +     +G+G F  V + V +    + A   +     S       +RE  +  +  H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-----RVAFGTA 188
            N+++L    +      L+              DL  G +  +    +       A    
Sbjct: 70  PNIVRLHDSISEEGHHYLI---F----------DLVTGGELFEDIVAREYYSEADASHCI 116

Query: 189 Y----GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQ 241
                 + + H+     ++HR+LK  N+LL          L DFGLA  V+ +       
Sbjct: 117 QQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFG 172

Query: 242 IRGTMGHIAPEYLSTGKSSEKTDV 265
             GT G+++PE L      +  D+
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDL 196

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 71.7 bits (176), Expect = 6e-14
 Identities = 43/249 (17%), Positives = 83/249 (33%), Gaps = 60/249 (24%)

Query: 76  TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAF-QREVHLISVAIH 133
           +  +S    +G G FG V +    +   + A+K++        +  +  RE+ ++ V  H
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDH 59

Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR------------- 180
            N+++L+ Y  T+ +     P   +       ++                          
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 181 -----KRVAFGTA---------------Y----GLEYLHEQCNPKIIHRDLKAANILLD- 215
                 +V                    Y     + ++H      I HRD+K  N+L++ 
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNS 176

Query: 216 DNFEAVLCDFGLAKLV--DAKLTH--VTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGI 270
            +    LCDFG AK +           +   R      APE +      +   D++  G 
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR------APELMLGATEYTPSIDLWSIGC 230

Query: 271 TLLELVTGQ 279
              EL+ G+
Sbjct: 231 VFGELILGK 239

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 71.5 bits (176), Expect = 7e-14
 Identities = 48/227 (21%), Positives = 99/227 (43%), Gaps = 46/227 (20%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 125
              ++  + IG+G +G V       +  +VA+K++           F+         RE+
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS---------PFEHQTYCQRTLREI 76

Query: 126 HLISVAIHKNLLQLIGYCTTSSERI-----LVYPFMQ-NLSVAYRLRDLKPGEKGLDWPT 179
            ++    H+N++ +       +        +V   M+ +L    + + L          +
Sbjct: 77  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHL----------S 126

Query: 180 RKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 235
              + +   Y    GL+Y+H   +  ++HRDLK +N+LL+   +  +CDFGLA++ D   
Sbjct: 127 NDHICYFL-YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182

Query: 236 THVT--TQIRGTMGHIAPEY-LSTGKSSEKTDVFGYGITLLELVTGQ 279
            H    T+   T  + APE  L++   ++  D++  G  L E+++ +
Sbjct: 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 71.2 bits (175), Expect = 7e-14
 Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 52/228 (22%)

Query: 76  TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQ---------REV 125
            + +   + +G G +G V     +    +VAVK+L           FQ         RE+
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--------PFQSIIHAKRTYREL 79

Query: 126 HLISVAIHKNLLQLI------GYCTTSSERILVYPFMQ-NLSVAYRLRDLKPGEKGLDWP 178
            L+    H+N++ L+            ++  LV   M  +L+   + + L          
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL---------- 129

Query: 179 TRKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 234
           T   V F   Y    GL+Y+H   +  IIHRDLK +N+ ++++ E  + DFGLA+    +
Sbjct: 130 TDDHVQF-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185

Query: 235 LT-HVTTQ-IRGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELVTGQ 279
           +T +V T+  R      APE  L+    ++  D++  G  + EL+TG+
Sbjct: 186 MTGYVATRWYR------APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 71.2 bits (175), Expect = 7e-14
 Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 37/223 (16%)

Query: 77  DNFSESNIIGQGGFGKVY---KGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAI 132
           +NF    ++G G +GKV+   K    D  K+ A+K L+           Q+         
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK------ATIVQKAKTTEHTRT 107

Query: 133 HKNLLQLIG---------YCTTSSERI-LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRK 181
            + +L+ I          Y   +  ++ L+  ++    +   L +  +  E         
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH-------- 159

Query: 182 RVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 238
            V          LE+LH+     II+RD+K  NILLD N   VL DFGL+K   A  T  
Sbjct: 160 EVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER 216

Query: 239 TTQIRGTMGHIAPEYLSTGKSSEKTDV--FGYGITLLELVTGQ 279
                GT+ ++AP+ +  G S     V  +  G+ + EL+TG 
Sbjct: 217 AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 70.7 bits (174), Expect = 9e-14
 Identities = 46/215 (21%), Positives = 75/215 (34%), Gaps = 49/215 (22%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLIS 129
            D +     +G G F  V K    S   + A K     R +           +REV ++ 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQ------------NLS---VAYRLRDLKPGEKG 174
              H N++ L       ++ IL+   +             +L+       L+ +      
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI------ 123

Query: 175 LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLAKL 230
           L+             G+ YLH     +I H DLK  NI+L           + DFGLA  
Sbjct: 124 LN-------------GVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167

Query: 231 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 265
           +D    +    I GT   +APE ++      + D+
Sbjct: 168 IDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADM 200

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 70.8 bits (174), Expect = 9e-14
 Identities = 54/210 (25%), Positives = 84/210 (40%), Gaps = 38/210 (18%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNLLQLIGY 142
           IG+G F KV     +    +VA+K +     +P       REV ++ +  H N+++L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 143 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK--------RVAFG-TAYGLEY 193
             T     L+  +               GE   D+            R  F      ++Y
Sbjct: 83  IETEKTLYLIMEYASG------------GE-VFDYLVAHGRMKEKEARSKFRQIVSAVQY 129

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKL-THVTTQIRGTMGHIA 250
            H++    I+HRDLKA N+LLD +    + DFG +       KL         G   + A
Sbjct: 130 CHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC-----GAPPYAA 181

Query: 251 PEYLSTGKSSE--KTDVFGYGITLLELVTG 278
           PE    GK  +  + DV+  G+ L  LV+G
Sbjct: 182 PELFQ-GKKYDGPEVDVWSLGVILYTLVSG 210

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 69.9 bits (172), Expect = 1e-13
 Identities = 47/204 (23%), Positives = 75/204 (36%), Gaps = 32/204 (15%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 133
           +DN+     +G+G F  V + V  +   + A K +     S       +RE  +     H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-----RVAFGTA 188
            N+++L       S   LV              DL  G +  +    +       A    
Sbjct: 65  PNIVRLHDSIQEESFHYLV---F----------DLVTGGELFEDIVAREFYSEADASHCI 111

Query: 189 Y----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAV---LCDFGLAKLVDAKLTHVTTQ 241
                 + Y H      I+HR+LK  N+LL    +     L DFGLA  V+   +     
Sbjct: 112 QQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHG 166

Query: 242 IRGTMGHIAPEYLSTGKSSEKTDV 265
             GT G+++PE L     S+  D+
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDI 190

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 69.5 bits (171), Expect = 1e-13
 Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 48/216 (22%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G+G +G+V   V       VAVK +    +       ++E+ +  +  H+N+++  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFGTA-------- 188
              + + L   +               GE                 +    A        
Sbjct: 75  REGNIQYLFLEYCSG------------GELFDRIEPDI-------GMPEPDAQRFFHQLM 115

Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD----AKLTHVTTQIRG 244
            G+ YLH      I HRD+K  N+LLD+     + DFGLA +       +L +      G
Sbjct: 116 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---G 169

Query: 245 TMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTG 278
           T+ ++APE L   +   +E  DV+  GI L  ++ G
Sbjct: 170 TLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAG 204

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 50/215 (23%), Positives = 81/215 (37%), Gaps = 41/215 (19%)

Query: 70  RELQLATDNFSE----SNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQRE 124
           ++L   +  F++       IG G +    + +  + N + AVK +              E
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP-----TEE 65

Query: 125 VH-LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-- 181
           +  L+    H N++ L           +V              +L  G + LD   R+  
Sbjct: 66  IEILLRYGQHPNIITLKDVYDDGKYVYVV---T----------ELMKGGELLDKILRQKF 112

Query: 182 -------RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAV-LCDFGLAKL 230
                   V F     +EYLH Q    ++HRDLK +NIL      N E++ +CDFG AK 
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169

Query: 231 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDV 265
           + A+   +      T   +APE L         D+
Sbjct: 170 LRAE-NGLLMTPCYTANFVAPEVLERQGYDAACDI 203

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 70.3 bits (173), Expect = 1e-13
 Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 39/221 (17%)

Query: 77  DNFSESNIIGQGGFGKVY---KGVLSDNTKV-AVKRLQDYYSPGGEAAFQR-EVHLISVA 131
             F    ++GQG FGKV+   K   SD  ++ A+K L+            R  V      
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK------ATLKVRDRVRTKM-- 75

Query: 132 IHKNLLQLIG--------YCTTSSERI-LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRK 181
             +++L  +         Y   +  ++ L+  F++   +  RL +++   E+        
Sbjct: 76  -ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-------- 126

Query: 182 RVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 238
            V F  A     L++LH      II+RDLK  NILLD+     L DFGL+K         
Sbjct: 127 DVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKK 182

Query: 239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
                GT+ ++APE ++    ++  D + +G+ + E++TG 
Sbjct: 183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 47/202 (23%), Positives = 72/202 (35%), Gaps = 47/202 (23%)

Query: 84  IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQLIG 141
            +G+G F    K V    N   AVK +        EA  Q+E+  L     H N+++L  
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKLHE 73

Query: 142 YCTTSS---------------ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
                                ERI           +Y +R L                  
Sbjct: 74  VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL------------------ 115

Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQIR 243
               + ++H+     ++HRDLK  N+L    +DN E  + DFG A+L       + T   
Sbjct: 116 -VSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC- 170

Query: 244 GTMGHIAPEYLSTGKSSEKTDV 265
            T+ + APE L+     E  D+
Sbjct: 171 FTLHYAAPELLNQNGYDESCDL 192

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 50/221 (22%), Positives = 87/221 (39%), Gaps = 32/221 (14%)

Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVA 131
           ++  + F    ++G+G FGKV         +  A+K L+       +     +  +    
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILK-------KEVIVAKDEVAHTL 196

Query: 132 IHKNLLQLIG--------YCTTSSERI-LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRK 181
               +LQ           Y   + +R+  V  +     + + L R+    E         
Sbjct: 197 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-------- 248

Query: 182 RVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 238
           R  F  A     L+YLH + N  +++RDLK  N++LD +    + DFGL K    K    
Sbjct: 249 RARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGAT 305

Query: 239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
                GT  ++APE L         D +G G+ + E++ G+
Sbjct: 306 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 47/204 (23%), Positives = 74/204 (36%), Gaps = 32/204 (15%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIH 133
           +DN+     +G+G F  V + V  +   + A K +     S       +RE  +     H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-----RVAFGTA 188
            N+++L       S   LV              DL  G +  +    +       A    
Sbjct: 88  PNIVRLHDSIQEESFHYLV---F----------DLVTGGELFEDIVAREFYSEADASHCI 134

Query: 189 Y----GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQ 241
                 + Y H      I+HR+LK  N+LL          L DFGLA  V+   +     
Sbjct: 135 QQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHG 189

Query: 242 IRGTMGHIAPEYLSTGKSSEKTDV 265
             GT G+++PE L     S+  D+
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDI 213

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 69.0 bits (169), Expect = 2e-13
 Identities = 28/281 (9%), Positives = 73/281 (25%), Gaps = 55/281 (19%)

Query: 85  IGQGGFGKVYKGVLSDNT---KVAVK--RLQDYYSPGGEAAFQREVHLISVAIHKNLLQL 139
            G     + ++ +  D     +VA+     Q                 +S      + ++
Sbjct: 39  HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 140 IGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCN 199
           +    T +  ++V    +       L+++   +         R     A   +  H    
Sbjct: 97  LDVVHTRAGGLVV---AE-WIRGGSLQEV--ADTSPSPVGAIRAMQSLAAAADAAHRA-- 148

Query: 200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS 259
             +       + + +  + + VL         + +                         
Sbjct: 149 -GVALSIDHPSRVRVSIDGDVVLAYPATMPDANPQ------------------------- 182

Query: 260 SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTY 319
               D+ G G +L  L+  +  +  + +         D   + +    ++  +   ++  
Sbjct: 183 ---DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA- 238

Query: 320 DSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAER 360
                     VA    Q     R     +  M Q   +A+R
Sbjct: 239 ----------VAARSVQGDGGIRSASTLLNLMQQATAVADR 269

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 69.5 bits (171), Expect = 2e-13
 Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 35/220 (15%)

Query: 77  DNFSESNIIGQGGFGKVY---KGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAI 132
           + F    ++G+GG+GKV+   K   ++  K+ A+K L+           +          
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKK------AMIVRNAKDTAHTKA 70

Query: 133 HKNLLQLIG--------YCTTSSERI-LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRKR 182
            +N+L+ +         Y   +  ++ L+  ++    +  +L R+    E          
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED--------T 122

Query: 183 VAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 239
             F  A     L +LH++    II+RDLK  NI+L+      L DFGL K        VT
Sbjct: 123 ACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVT 178

Query: 240 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
               GT+ ++APE L     +   D +  G  + +++TG 
Sbjct: 179 HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 52/228 (22%), Positives = 84/228 (36%), Gaps = 58/228 (25%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           D F     +G G FG+V      ++    A+K L                      +   
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-----------------KQKVVKLK 83

Query: 136 LLQLIGYCTTSSERILV---YPFMQNLSVA-------YRLRDLKPGEKG-LDWPTRKRVA 184
            ++     T + +RIL    +PF+  L  +       Y + +   G  G +    R+   
Sbjct: 84  QIE----HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG--GEMFSHLRRIGR 137

Query: 185 FGTA----Y------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK 234
           F       Y        EYLH      +I+RDLK  N+L+D      + DFG AK V  +
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194

Query: 235 LTHVTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQ 279
               T  + GT   +APE + +    K+    D +  G+ + E+  G 
Sbjct: 195 ----TWTLCGTPEALAPEIILSKGYNKA---VDWWALGVLIYEMAAGY 235

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 69.7 bits (171), Expect = 3e-13
 Identities = 51/236 (21%), Positives = 85/236 (36%), Gaps = 53/236 (22%)

Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLI 128
           R+L++  +++    +IG+G FG+V         KV A+K L                   
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS-----------------K 104

Query: 129 SVAIHKNLLQLIGYCTTSSERILVY---PFMQNLSVA-------YRLRDLKPG------- 171
              I ++              I+ +   P++  L  A       Y + +  PG       
Sbjct: 105 FEMIKRSDSA----FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM 160

Query: 172 -EKGLDWPTRKRVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL 227
               +     K   F TA     L+ +H       IHRD+K  N+LLD +    L DFG 
Sbjct: 161 SNYDVP---EKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 214

Query: 228 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK----TDVFGYGITLLELVTGQ 279
              ++ +         GT  +I+PE L +           D +  G+ L E++ G 
Sbjct: 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 68.4 bits (168), Expect = 3e-13
 Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 33/208 (15%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
           +G G FGKV  G       KVAVK L  Q   S       +RE+  + +  H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 142 YCTTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFG-TAYGLEY 193
             +T ++  +V  ++              GE        G       R  F      ++Y
Sbjct: 79  VISTPTDFFMVMEYVSG------------GELFDYICKHGRVEEMEARRLFQQILSAVDY 126

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL-VDAKLTHVTTQIRGTMGHIAPE 252
            H      ++HRDLK  N+LLD +  A + DFGL+ +  D +    +    G+  + APE
Sbjct: 127 CHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE 180

Query: 253 YLSTGK--SSEKTDVFGYGITLLELVTG 278
            +S G+  +  + D++  G+ L  L+ G
Sbjct: 181 VIS-GRLYAGPEVDIWSCGVILYALLCG 207

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 68.4 bits (168), Expect = 4e-13
 Identities = 42/200 (21%), Positives = 72/200 (36%), Gaps = 43/200 (21%)

Query: 84  IIGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLISVAIHKNLL 137
            IG+G +G+V   V      + A K      ++D         F++E+ ++    H N++
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED------VDRFKQEIEIMKSLDHPNII 69

Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-----RVAFGTAY--- 189
           +L      +++  LV   M          +L  G +  +    K       A        
Sbjct: 70  RLYETFEDNTDIYLV---M----------ELCTGGELFERVVHKRVFRESDAARIMKDVL 116

Query: 190 -GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 245
             + Y H+     + HRDLK  N L      +    L DFGLA         +     GT
Sbjct: 117 SAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMMRTKVGT 171

Query: 246 MGHIAPEYLSTGKSSEKTDV 265
             +++P+ L  G    + D 
Sbjct: 172 PYYVSPQVLE-GLYGPECDE 190

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 68.9 bits (169), Expect = 4e-13
 Identities = 50/206 (24%), Positives = 81/206 (39%), Gaps = 40/206 (19%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL---QDYYSPGGEAAFQREVHLISVA 131
           +D F   + +G+G    VY+          A+K L    D      +   + E+ ++   
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD------KKIVRTEIGVLLRL 105

Query: 132 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-----RVAFG 186
            H N+++L     T +E  LV   +          +L  G +  D    K     R A  
Sbjct: 106 SHPNIIKLKEIFETPTEISLV---L----------ELVTGGELFDRIVEKGYYSERDAAD 152

Query: 187 TAY----GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVT 239
                   + YLHE     I+HRDLK  N+L      +    + DFGL+K+V+     + 
Sbjct: 153 AVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QVLM 207

Query: 240 TQIRGTMGHIAPEYLSTGKSSEKTDV 265
             + GT G+ APE L       + D+
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEVDM 233

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 68.5 bits (168), Expect = 4e-13
 Identities = 50/225 (22%), Positives = 80/225 (35%), Gaps = 52/225 (23%)

Query: 75  ATDNFSES---------NIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQRE 124
           +TD+FS           +++G+G   +V   + L  + + AVK ++          F RE
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF-RE 60

Query: 125 VH-LISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 183
           V  L     H+N+L+LI +        LV+  M+  S+   +               KR 
Sbjct: 61  VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH--------------KRR 106

Query: 184 AFG----------TAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKL 230
            F            A  L++LH +    I HRDLK  NIL    +      +CDF L   
Sbjct: 107 HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163

Query: 231 VDAKLTHVTTQIR------GTMGHIAPEYLSTGKSSEKTDVFGYG 269
           +                  G+  ++APE +             Y 
Sbjct: 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEAS----IYD 204

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 68.5 bits (168), Expect = 5e-13
 Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 48/216 (22%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           +G+G +G+V   V       VAVK +    +       ++E+ +  +  H+N+++  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFGTA-------- 188
              + + L   +               GE                 +    A        
Sbjct: 75  REGNIQYLFLEYCSG------------GELFDRIEPDI-------GMPEPDAQRFFHQLM 115

Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD----AKLTHVTTQIRG 244
            G+ YLH      I HRD+K  N+LLD+     + DFGLA +       +L +      G
Sbjct: 116 AGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---G 169

Query: 245 TMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTG 278
           T+ ++APE L   +   +E  DV+  GI L  ++ G
Sbjct: 170 TLPYVAPELLK-RREFHAEPVDVWSCGIVLTAMLAG 204

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 67.9 bits (167), Expect = 6e-13
 Identities = 39/93 (41%), Positives = 50/93 (53%), Gaps = 13/93 (13%)

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            LEYLH +    II+RDLK  NILLD N    + DFG AK V       T  + GT  +I
Sbjct: 118 ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYI 170

Query: 250 APEYLST---GKSSEKTDVFGYGITLLELVTGQ 279
           APE +ST    KS    D + +GI + E++ G 
Sbjct: 171 APEVVSTKPYNKS---IDWWSFGILIYEMLAGY 200

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 68.4 bits (166), Expect = 6e-13
 Identities = 39/211 (18%), Positives = 59/211 (27%), Gaps = 44/211 (20%)

Query: 74  LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVK--RLQDYYSPGGEAAFQREVHLISVA 131
           L T+       IG+G FG+V++ +  D+T VA+K   ++      G      E  L  + 
Sbjct: 17  LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 132 IHKNLLQLIGYCTTSSERILVY--------PFMQNLSVAYRLRDLKPG------------ 171
           I K L  L G     +E  +           +   L  A+   +   G            
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 172 -------------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI 212
                               K     T K +       L         +  HRDL   N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNV 193

Query: 213 LLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 243
           LL       L      K        +   I 
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 54/210 (25%), Positives = 78/210 (37%), Gaps = 39/210 (18%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           IG G FG             VAVK ++       +   QRE+       H N+++     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85

Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRK-RVAFGTA--------YGLEY 193
            T +   ++  +               GE  L +      R +   A         G+ Y
Sbjct: 86  LTPTHLAIIMEYASG------------GE--LYERICNAGRFSEDEARFFFQQLLSGVSY 131

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVL--CDFGLAKL-VDAKLTHVTTQIRGTMGHIA 250
            H     +I HRDLK  N LLD +    L  CDFG +K  V       T    GT  +IA
Sbjct: 132 CHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYIA 185

Query: 251 PEYLSTGK--SSEKTDVFGYGITLLELVTG 278
           PE L   +    +  DV+  G+TL  ++ G
Sbjct: 186 PEVLL-RQEYDGKIADVWSCGVTLYVMLVG 214

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 46/221 (20%), Positives = 79/221 (35%), Gaps = 44/221 (19%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK----RLQDYYSPGGEAAFQREVHLISV 130
            D +    +IG+G F  V + +      + AVK                  +RE  +  +
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 131 AIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR--KRVAFGTA 188
             H ++++L+   ++     +V+ FM               +          KR   G  
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDG------------ADL-CF---EIVKRADAGFV 126

Query: 189 Y--------------GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLV 231
           Y               L Y H+     IIHRD+K   +LL   +++    L  FG+A  +
Sbjct: 127 YSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183

Query: 232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITL 272
             +   V     GT   +APE +      +  DV+G G+ L
Sbjct: 184 G-ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 57/224 (25%), Positives = 85/224 (37%), Gaps = 46/224 (20%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           DNF    ++G+G FGKV    + +   + AVK L+       +   Q +  +      K 
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKK------DVILQDD-DVECTMTEKR 75

Query: 136 LLQLIG---------YCTTSSERI-LVYPF------MQNLSVAYRLRDLKPGEKGLDWPT 179
           +L L            C  + +R+  V  F      M ++  + R               
Sbjct: 76  ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF-------------D 122

Query: 180 RKRVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 236
             R  F  A     L +LH++    II+RDLK  N+LLD      L DFG+ K       
Sbjct: 123 EARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GICNG 178

Query: 237 HVTTQIRGTMGHIAPEYLSTGKSSEKT-DVFGYGITLLELVTGQ 279
             T    GT  +IAPE L          D +  G+ L E++ G 
Sbjct: 179 VTTATFCGTPDYIAPEIL-QEMLYGPAVDWWAMGVLLYEMLCGH 221

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 4/90 (4%)

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL++LH +    I++RDLK  NILLD +    + DFG+ K  +      T    GT  +I
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGDAKTNTFCGTPDYI 185

Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE L   K +   D + +G+ L E++ GQ
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 53/227 (23%), Positives = 88/227 (38%), Gaps = 44/227 (19%)

Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVA 131
           ++   +F+   ++G+G FGKV         ++ AVK L+       +   Q +  +    
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKK------DVVIQDD-DVECTM 389

Query: 132 IHKNLLQLIGYCTTSSERILVYPFMQNLSVA-------YRLRDLKPG---------EKGL 175
           + K +L L G            PF+  L          Y + +   G             
Sbjct: 390 VEKRVLALPGKP----------PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRF 439

Query: 176 DWPTRKRVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 232
             P      F  A    GL +L  +    II+RDLK  N++LD      + DFG+ K  +
Sbjct: 440 KEP---HAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-N 492

Query: 233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
                 T    GT  +IAPE ++     +  D + +G+ L E++ GQ
Sbjct: 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 66.5 bits (163), Expect = 3e-12
 Identities = 49/221 (22%), Positives = 88/221 (39%), Gaps = 33/221 (14%)

Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVA 131
           ++  ++F    ++G+G FGKV         +  A+K L+       E    ++  +    
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK------EVIIAKD-EVAHTV 53

Query: 132 IHKNLLQLIG--------YCTTSSERI-LVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRK 181
               +LQ           Y   + +R+  V  +     + + L R+    E+        
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-------- 105

Query: 182 RVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV 238
           R  F  A     LEYLH +    +++RD+K  N++LD +    + DFGL K         
Sbjct: 106 RARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGAT 161

Query: 239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
                GT  ++APE L         D +G G+ + E++ G+
Sbjct: 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 33/208 (15%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
           +G G FGKV  G       KVAVK L  Q   S       +RE+  + +  H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 142 YCTTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFG-TAYGLEY 193
             +T S+  +V  ++              GE        G       R  F     G++Y
Sbjct: 84  VISTPSDIFMVMEYVSG------------GELFDYICKNGRLDEKESRRLFQQILSGVDY 131

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL-VDAKLTHVTTQIRGTMGHIAPE 252
            H      ++HRDLK  N+LLD +  A + DFGL+ +  D +    +    G+  + APE
Sbjct: 132 CHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE 185

Query: 253 YLSTGKSSE--KTDVFGYGITLLELVTG 278
            +S G+     + D++  G+ L  L+ G
Sbjct: 186 VIS-GRLYAGPEVDIWSSGVILYALLCG 212

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 66.5 bits (163), Expect = 3e-12
 Identities = 33/90 (36%), Positives = 43/90 (47%), Gaps = 4/90 (4%)

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
            L YLH      I++RDLK  NILLD     VL DFGL K  + +    T+   GT  ++
Sbjct: 151 ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFCGTPEYL 206

Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE L         D +  G  L E++ G 
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 39/205 (19%), Positives = 73/205 (35%), Gaps = 37/205 (18%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 125
            D +   ++IG G +G V +     +   VA+K++           F+         RE+
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR--------VFEDLIDCKRILREI 103

Query: 126 HLISVAIHKNLLQLIGYCTTSSERI-----LVYPFMQNLSVAYRLRDLK---PGEKGLDW 177
            +++   H ++++++               +V              D K        L  
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD--------SDFKKLFRTPVYLTE 155

Query: 178 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 237
              K + +    G++Y+H      I+HRDLK AN L++ +    +CDFGLA+ VD     
Sbjct: 156 LHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212

Query: 238 VTTQIRGTMGHIAPEYLSTGKSSEK 262
            +                    + K
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLK 237

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 65.7 bits (161), Expect = 4e-12
 Identities = 52/227 (22%), Positives = 87/227 (38%), Gaps = 44/227 (19%)

Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVA 131
            L   +F    +IG+G + KV    L    ++ A+K ++       E     E  +  V 
Sbjct: 5   PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKK------ELVNDDE-DIDWVQ 57

Query: 132 IHKNLLQLIG---------YCTTSSERI-LVYPF------MQNLSVAYRLRDLKPGEKGL 175
             K++ +             C  +  R+  V  +      M ++    +L          
Sbjct: 58  TEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKL---------- 107

Query: 176 DWPTRKRVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 232
                +   F +A     L YLHE+    II+RDLK  N+LLD      L D+G+ K   
Sbjct: 108 ---PEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-G 160

Query: 233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
            +    T+   GT  +IAPE L         D +  G+ + E++ G+
Sbjct: 161 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 65.0 bits (159), Expect = 5e-12
 Identities = 37/168 (22%), Positives = 61/168 (36%), Gaps = 36/168 (21%)

Query: 84  IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQLIG 141
           ++G G  GKV +        K A+K LQD          +REV      +   ++++++ 
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVD 78

Query: 142 -YCTTSSERILVYPFMQNLSVAYRLRDLKPG--------EKGLDWPTRKRVAFGT---AY 189
            Y    + R  +   M          +   G        ++G    T +  +        
Sbjct: 79  VYENLYAGRKCLLIVM----------ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128

Query: 190 GLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAK 234
            ++YLH      I HRD+K  N+L      N    L DFG AK    +
Sbjct: 129 AIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 65.9 bits (161), Expect = 5e-12
 Identities = 43/196 (21%), Positives = 74/196 (37%), Gaps = 39/196 (19%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 125
            DN+   ++IG+G +G VY     +    VA+K++           F+         RE+
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR--------MFEDLIDCKRILREI 76

Query: 126 HLISVAIHKNLLQLIGYCTTSSERI-----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTR 180
            +++      +++L                +V              DLK   K   + T 
Sbjct: 77  TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD--------SDLKKLFKTPIFLTE 128

Query: 181 KRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 236
           + +     Y    G  ++HE     IIHRDLK AN LL+ +    +CDFGLA+ ++++  
Sbjct: 129 EHIKT-ILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184

Query: 237 HVTTQIRGTMGHIAPE 252
                         P 
Sbjct: 185 TNIVNDLEENEEPGPH 200

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 65.4 bits (160), Expect = 6e-12
 Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 34/208 (16%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIHKNLLQLIG 141
           +G+G FGKV          KVA+K +  Q           +RE+  + +  H ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 142 YCTTSSERILVYPFMQNLSVAYRLRDLKPGE-------KGLDWPTRKRVAFG-TAYGLEY 193
             TT ++ ++V  +               GE       K        R  F      +EY
Sbjct: 77  VITTPTDIVMVIEYAG-------------GELFDYIVEKKRMTEDEGRRFFQQIICAIEY 123

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL-VDAKLTHVTTQIRGTMGHIAPE 252
            H     KI+HRDLK  N+LLDDN    + DFGL+ +  D      +    G+  + APE
Sbjct: 124 CHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE 177

Query: 253 YLSTGKSSE--KTDVFGYGITLLELVTG 278
            ++ GK     + DV+  GI L  ++ G
Sbjct: 178 VIN-GKLYAGPEVDVWSCGIVLYVMLVG 204

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 65.3 bits (160), Expect = 6e-12
 Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 4/90 (4%)

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHI 249
           GL +L  +    II+RDLK  N++LD      + DFG+ K  +      T    GT  +I
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPDYI 188

Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
           APE ++     +  D + +G+ L E++ GQ
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 65.4 bits (160), Expect = 8e-12
 Identities = 51/227 (22%), Positives = 87/227 (38%), Gaps = 44/227 (19%)

Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNTKV-AVKRLQDYYSPGGEAAFQREVHLISVA 131
            L   +F    +IG+G + KV    L    ++ A++ ++       E     E  +  V 
Sbjct: 48  SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKK------ELVNDDE-DIDWVQ 100

Query: 132 IHKNLLQLIG---------YCTTSSERI-LVYPF------MQNLSVAYRLRDLKPGEKGL 175
             K++ +             C  +  R+  V  +      M ++    +L          
Sbjct: 101 TEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKL---------- 150

Query: 176 DWPTRKRVAFGTA---YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 232
                +   F +A     L YLHE+    II+RDLK  N+LLD      L D+G+ K   
Sbjct: 151 ---PEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-G 203

Query: 233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
            +    T+   GT  +IAPE L         D +  G+ + E++ G+
Sbjct: 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 64.6 bits (158), Expect = 9e-12
 Identities = 50/243 (20%), Positives = 98/243 (40%), Gaps = 69/243 (28%)

Query: 76  TDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQ---------REV 125
              + +   +G GG G V+  V +D + +VA+K++                      RE+
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI----------VLTDPQSVKHALREI 59

Query: 126 HLISVAIHKNLLQLI--------------GYCTTSSERILVYPFMQ-NLSVAYRLRDLKP 170
            +I    H N++++               G  T  +   +V  +M+ +L+       L  
Sbjct: 60  KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL-- 117

Query: 171 GEKGLDWPTRKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDF 225
                     +       Y    GL+Y+H   +  ++HRDLK AN+ ++ ++    + DF
Sbjct: 118 --------LEEHARL-FMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDF 165

Query: 226 GLAKLVDAKLTH-------VTTQ-IRGTMGHIAPE-YLSTGKSSEKTDVFGYGITLLELV 276
           GLA+++D   +H       + T+  R      +P   LS    ++  D++  G    E++
Sbjct: 166 GLARIMDPHYSHKGHLSEGLVTKWYR------SPRLLLSPNNYTKAIDMWAAGCIFAEML 219

Query: 277 TGQ 279
           TG+
Sbjct: 220 TGK 222

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 50/235 (21%), Positives = 94/235 (40%), Gaps = 55/235 (23%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 125
           + +F   +++G+G +G V           VA+K+++          F          RE+
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---------PFDKPLFALRTLREI 60

Query: 126 HLISVAIHKNLLQLIGYCTTSSERI-----LVYPFMQ-NLSVAYRLRDLKPGEKGLDWPT 179
            ++    H+N++ +       S        ++   MQ +L      + L          +
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQML----------S 110

Query: 180 RKRVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 235
              + +   Y     ++ LH      +IHRDLK +N+L++ N +  +CDFGLA+++D   
Sbjct: 111 DDHIQY-FIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES- 165

Query: 236 THVTTQIRGTMGHI----------APEY-LSTGKSSEKTDVFGYGITLLELVTGQ 279
               ++  G    +          APE  L++ K S   DV+  G  L EL   +
Sbjct: 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 41/200 (20%), Positives = 77/200 (38%), Gaps = 40/200 (20%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQ---------REV 125
              +     +G+G +G V+K +       VAVK++ D        AFQ         RE+
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD--------AFQNSTDAQRTFREI 59

Query: 126 HLIS-VAIHKNLLQLIGYCTTSSER--ILVYPFMQ-NLSVAYRLRDLKPGEKGLDWPTRK 181
            +++ ++ H+N++ L+      ++R   LV+ +M+ +L    R   L             
Sbjct: 60  MILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANIL----------EPV 109

Query: 182 RVAFGTAY----GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH 237
              +   Y     ++YLH      ++HRD+K +NILL+      + DFGL++        
Sbjct: 110 HKQY-VVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165

Query: 238 VTTQIRGTMGHIAPEYLSTG 257
                     +         
Sbjct: 166 TNNIPLSINENTENFDDDQP 185

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 61.9 bits (151), Expect = 8e-11
 Identities = 36/156 (23%), Positives = 70/156 (44%), Gaps = 15/156 (9%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVH-LISVAIH 133
            D++     +G+G + +V++ + +++N KV VK L+    P  +   +RE+  L ++   
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK----PVKKKKIKREIKILENLRGG 90

Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
            N++ L         R     F    +      D K   + L     +   +     L+Y
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNT-----DFKQLYQTLTDYDIRFYMYEILKALDY 145

Query: 194 LHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLA 228
            H      I+HRD+K  N+++D ++ +  L D+GLA
Sbjct: 146 CHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 57/247 (23%), Positives = 98/247 (39%), Gaps = 49/247 (19%)

Query: 84  IIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQREVHLI-----------S 129
            +G G F  V+    + +NT VA+K  R    Y    EAA + E+ L+            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY---TEAA-EDEIKLLQRVNDADNTKED 81

Query: 130 VAIHKNLLQLIG---YCTTSSERI-LVYPFM-QNLSVAYRLRDL--KPGEKGLDWPTRKR 182
                ++L+L+    +   +   + +V+  + +NL        L  K   +G+     K+
Sbjct: 82  SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENL------LALIKKYEHRGIPLIYVKQ 135

Query: 183 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD------NFEAVLCDFGLAKLVDAKLT 236
           ++     GL+Y+H +C   IIH D+K  N+L++         +  + D G A   D   T
Sbjct: 136 ISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193

Query: 237 H--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 294
           +   T + R      +PE L         D++     + EL+TG     F   E      
Sbjct: 194 NSIQTREYR------SPEVLLGAPWGCGADIWSTACLIFELITGDFL--FEPDEGHSYTK 245

Query: 295 LLDHIRK 301
             DHI +
Sbjct: 246 DDDHIAQ 252

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 33/174 (18%), Positives = 57/174 (32%), Gaps = 43/174 (24%)

Query: 85  IGQGGFGKVYKGV---------LSDNTKVAVKRLQDYYSPGGEAAF-QREVHLISVAIHK 134
             +   G +Y+                K ++K          E  F QR    + V   K
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 135 NLL--------QLIGYCTTSSE-RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF 185
            L           +G+     + R LV   + +L      R L   +  LD   +  ++ 
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLV---LPSLG-----RSL---QSALDVSPKHVLSE 158

Query: 186 GTAY--------GLEYLHEQCNPKIIHRDLKAANILLDDNFEAV--LCDFGLAK 229
            +           LE+LHE      +H ++ A NI +D   ++   L  +G A 
Sbjct: 159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 42/170 (24%), Positives = 67/170 (39%), Gaps = 35/170 (20%)

Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRL----QDYYSPGG---EAAFQREV---HLISVAIHK 134
           IGQGGFG +Y   ++ +  V          +    G    E  F +       I   I  
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 135 NLLQLIG-----YCTTSSERILVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRK------- 181
             L+ +G           +    Y FM    +  R   DL   +K  +   ++       
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFM----IMDRFGSDL---QKIYEANAKRFSRKTVL 155

Query: 182 RVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFEAV-LCDFGLAK 229
           +++      LEY+HE      +H D+KA+N+LL+  N + V L D+GLA 
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 53.2 bits (128), Expect = 6e-08
 Identities = 53/221 (23%), Positives = 86/221 (38%), Gaps = 53/221 (23%)

Query: 84  IIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQREVHLISV------AIHK 134
           +IG+G FG+V K      +  VA+K  R +  +      A   E+ ++            
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH---RQA-AEEIRILEHLRKQDKDNTM 159

Query: 135 NLLQLIGY-------CTTSSERILVYPFM-QNLSVAYRLRDLKPGE-KGLDWPTRKRVAF 185
           N++ ++         C       + +  +  NL   Y L  +K  + +G   P  ++ A 
Sbjct: 160 NVIHMLENFTFRNHIC-------MTFELLSMNL---YEL--IKKNKFQGFSLPLVRKFAH 207

Query: 186 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV--LCDFGLAKLVDAKLTHVTTQI- 242
                L+ LH+    +IIH DLK  NILL     +   + DFG +         V T I 
Sbjct: 208 SILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH---QRVYTYIQ 261

Query: 243 ----RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
               R      APE +   +     D++  G  L EL+TG 
Sbjct: 262 SRFYR------APEVILGARYGMPIDMWSLGCILAELLTGY 296

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 52.8 bits (127), Expect = 7e-08
 Identities = 44/168 (26%), Positives = 62/168 (36%), Gaps = 34/168 (20%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGG----EAAFQREV---HLISVAIHKNL 136
           IG GGFG +Y     +   K A   ++  Y   G    E  F + V     I   I +  
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 137 LQLIG-----YCTTSSERILVYPFMQNLSVAYRL-RDLKPGEKGLDWPTRK-------RV 183
           L  +G         +  +   Y FM    V  RL  DL   +K               ++
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFM----VMERLGIDL---QKISGQ-NGTFKKSTVLQL 156

Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV--LCDFGLAK 229
                  LEY+HE      +H D+KAAN+LL         L D+GL+ 
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 49.3 bits (118), Expect = 9e-07
 Identities = 37/158 (23%), Positives = 59/158 (37%), Gaps = 31/158 (19%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLL----- 137
           IG G FG +Y G  ++   +VA+K          E    +   L     I+K +      
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKL---------ECVKTKHPQLHIESKIYKMMQGGVGI 67

Query: 138 -QLIGYCTTSSERILVYPFMQNL--SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
             +          ++V   M+ L  S+   L +     +     T   +A      +EY+
Sbjct: 68  PTIRWCGAEGDYNVMV---MELLGPSLED-LFNFCS--RKFSLKTVLLLADQMISRIEYI 121

Query: 195 HEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAK 229
           H +     IHRD+K  N L+          + DFGLAK
Sbjct: 122 HSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 49.5 bits (118), Expect = 9e-07
 Identities = 42/201 (20%), Positives = 60/201 (29%), Gaps = 66/201 (32%)

Query: 151 LVYPFMQ-NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKA 209
           +V+  +  +L    +        +GL  P  K++      GL+YLH +C   IIH D+K 
Sbjct: 122 MVFEVLGHHL---LKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKP 175

Query: 210 ANILL-------------------------------------------------DDNFEA 220
            NILL                                                  +  + 
Sbjct: 176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKV 235

Query: 221 VLCDFGLAKLVDAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
            + D G A  V    T    T Q R      + E L     +   D++       EL TG
Sbjct: 236 KIADLGNACWVHKHFTEDIQTRQYR------SLEVLIGSGYNTPADIWSTACMAFELATG 289

Query: 279 QRAIDFSRLEEEEDVLLLDHI 299
                F     EE     DHI
Sbjct: 290 DYL--FEPHSGEEYTRDEDHI 308

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 47.7 bits (114), Expect = 2e-06
 Identities = 38/165 (23%), Positives = 62/165 (37%), Gaps = 43/165 (26%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLL----- 137
           IG+G FG +++G  L +N +VA+K          E        L      +K L      
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKF---------EPRRSDAPQLRDEYRTYKLLAGCTGI 68

Query: 138 -QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-------RVAFGTAY 189
             +  +       +LV   +  L     L DL      LD   RK         A     
Sbjct: 69  PNVYYFGQEGLHNVLV---IDLLG--PSLEDL------LDLCGRKFSVKTVAMAAKQMLA 117

Query: 190 GLEYLHEQCNPKIIHRDLKAANILL----DDNFEAV-LCDFGLAK 229
            ++ +HE+    +++RD+K  N L+      N   + + DFG+ K
Sbjct: 118 RVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 49/213 (23%), Positives = 86/213 (40%), Gaps = 33/213 (15%)

Query: 83  NIIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQREVHLISV------AIH 133
           ++IG+G FG+V K     +   VA+K  + +  +      A Q EV L+ +       + 
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL---NQA-QIEVRLLELMNKHDTEMK 115

Query: 134 KNLLQLIGYCTTSSERILVYPFM-QNLSVAYRLRDL--KPGEKGLDWPTRKRVAFGTAYG 190
             ++ L  +    +   LV+  +  NL       DL      +G+     ++ A      
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNL------YDLLRNTNFRGVSLNLTRKFAQQMCTA 169

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAV--LCDFGLAKLVDAKLTH--VTTQIRGTM 246
           L +L       IIH DLK  NILL +   +   + DFG +  +  ++     +   R   
Sbjct: 170 LLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--- 225

Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ 279
              +PE L         D++  G  L+E+ TG+
Sbjct: 226 ---SPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 40/163 (24%), Positives = 64/163 (39%), Gaps = 41/163 (25%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLL----- 137
           IG G FG++Y G  +  N +VA+K          E    +   L+    I++ L      
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKL---------ENVKTKHPQLLYESKIYRILQGGTGI 65

Query: 138 -QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-------RVAFGTAY 189
             +  +       +LV   M  L     L DL       ++ +RK        +A     
Sbjct: 66  PNVRWFGVEGDYNVLV---MDLLG--PSLEDL------FNFCSRKLSLKTVLMLADQMIN 114

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEA---VLCDFGLAK 229
            +E++H +     +HRD+K  N L+     A    + DFGLAK
Sbjct: 115 RVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 46.6 bits (111), Expect = 7e-06
 Identities = 36/161 (22%), Positives = 57/161 (35%), Gaps = 35/161 (21%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVK---RLQDYYSPGGEAAFQREVHLISVAIHKNLLQLI 140
           IG G FG++  G  L  N  VA+K             E  F +++          + Q+ 
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSG-----DGIPQVY 71

Query: 141 GYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRK-------RVAFGTAYGLEY 193
            +        +V   ++ L     L DL       D   R         +A      +EY
Sbjct: 72  YFGPCGKYNAMV---LELLG--PSLEDL------FDLCDRTFSLKTVLMIAIQLISRMEY 120

Query: 194 LHEQCNPKIIHRDLKAANILL-----DDNFEAVLCDFGLAK 229
           +H +    +I+RD+K  N L+            + DF LAK
Sbjct: 121 VHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 45/241 (18%), Positives = 83/241 (34%), Gaps = 75/241 (31%)

Query: 84  IIGQGGFGKVYKGV--LSDNTKVAVK---RLQDYYSPGGEAAFQREVHLISV------AI 132
            +G+G FGKV + +      ++VA+K    +  Y     EAA + E++++          
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYR----EAA-RLEINVLKKIKEKDKEN 80

Query: 133 HKNLLQLIGY-------CTTSSERILVYPFM-QNLSVAYRLRDL--KPGEKGLDWPTRKR 182
               + +  +       C       + +  + +N        +   +   +    P  + 
Sbjct: 81  KFLCVLMSDWFNFHGHMC-------IAFELLGKNT------FEFLKENNFQPYPLPHVRH 127

Query: 183 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-------------------LC 223
           +A+   + L +LHE    ++ H DLK  NIL  ++                       + 
Sbjct: 128 MAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184

Query: 224 DFGLAKLVDAKLTHVTTQI-----RGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG 278
           DFG A        H TT +     R       PE +     ++  DV+  G  L E   G
Sbjct: 185 DFGSATFDH---EHHTTIVATRHYR------PPEVILELGWAQPCDVWSIGCILFEYYRG 235

Query: 279 Q 279
            
Sbjct: 236 F 236

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 50/247 (20%), Positives = 79/247 (31%), Gaps = 83/247 (33%)

Query: 84  IIGQGGFGKVYKGV-LSDNTKVAVK--RLQDYYSPGGEAAFQREVHLISV-----AIHKN 135
            +G G FG+V     + +    AVK  R    Y+    +A + E  ++         + N
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT---RSA-KIEADILKKIQNDDINNNN 97

Query: 136 LLQLIGY-------CTTSSERILVYPFM-QNLSVAYRLRDL--KPGEKGLDWPTRKRVAF 185
           +++  G        C       L++  +  +L       ++  +    G      K    
Sbjct: 98  IVKYHGKFMYYDHMC-------LIFEPLGPSL------YEIITRNNYNGFHIEDIKLYCI 144

Query: 186 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV------------------------ 221
                L YL +     + H DLK  NILLDD +                           
Sbjct: 145 EILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201

Query: 222 -LCDFGLAKLVDAKLTHV--TTQIRGTMGHIAPE------YLSTGKSSEKTDVFGYGITL 272
            L DFG A         +  T Q R      APE      +         +D++ +G  L
Sbjct: 202 KLIDFGCATFKSDYHGSIINTRQYR------APEVILNLGW------DVSSDMWSFGCVL 249

Query: 273 LELVTGQ 279
            EL TG 
Sbjct: 250 AELYTGS 256

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 40.0 bits (94), Expect = 8e-04
 Identities = 49/247 (19%), Positives = 83/247 (33%), Gaps = 87/247 (35%)

Query: 84  IIGQGGFGKVYKGV--LSDNTKVAVK---RLQDYYSPGGEAAFQREVHLISV------AI 132
            +G+G FGKV + +   +    VAVK    +  Y     EAA + E+ ++          
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC----EAA-RSEIQVLEHLNTTDPNS 75

Query: 133 HKNLLQLIGY-------CTTSSERILVYPFM-QNLSVAYRLRDL--KPGEKGLDWPTRKR 182
               +Q++ +       C       +V+  +  +        D   + G         ++
Sbjct: 76  TFRCVQMLEWFEHHGHIC-------IVFELLGLST------YDFIKENGFLPFRLDHIRK 122

Query: 183 VAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV-------------------LC 223
           +A+     + +LH     K+ H DLK  NIL   +                       + 
Sbjct: 123 MAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179

Query: 224 DFGLAKLVDAKLTHVTTQI-----RGTMGHIAPE------YLSTGKSSEKTDVFGYGITL 272
           DFG A   D    H +T +     R      APE      +      S+  DV+  G  L
Sbjct: 180 DFGSATYDD---EHHSTLVSTRHYR------APEVILALGW------SQPCDVWSIGCIL 224

Query: 273 LELVTGQ 279
           +E   G 
Sbjct: 225 IEYYLGF 231

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	401
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.83
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.74
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.35
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.24
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.17
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.06
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.75
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.57
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.55
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.49
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.35
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.23
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.11
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.04
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.93
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.82
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.66
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.5
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.47
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.47
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.35
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.34
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.12
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.07
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.86
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.77
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.62
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.92
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.18
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	92.87
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.16
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	91.95
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	91.88
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	91.16
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	90.34
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	86.62

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.7e-58  Score=426.61  Aligned_cols=258  Identities=24%  Similarity=0.342  Sum_probs=213.3

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI  150 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  150 (401)
                      +++.+.+.||+|+||+||+|.+.      +++.||||+++........+.|.+|+.++++++|||||+++|+|.+.+..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            34566789999999999999863      467899999986656666789999999999999999999999999999999


Q ss_pred             EEEecccCCcHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC
Q 015734          151 LVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF  218 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~  218 (401)
                      +|||||++|+|.++|.....            ....+++..+..|+.|||.||+|||++   +++||||||+|||+++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence            99999999999999975321            124689999999999999999999999   999999999999999999


Q ss_pred             cEEEeecCCccccCCCC-cceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHH
Q 015734          219 EAVLCDFGLAKLVDAKL-THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLL  296 (401)
Q Consensus       219 ~~kl~Dfgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~  296 (401)
                      ++||+|||+++...... ........||+.|||||++.+..++.++|||||||++|||+| |..||......     .+.
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~-----~~~  257 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-----DVV  257 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH-----HHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH-----HHH
Confidence            99999999998664432 223445679999999999999999999999999999999999 89999764321     111


Q ss_pred             HHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          297 DHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       297 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ..+.    .+.        ....+..++.++.+++.+||+.||.+||||.+|++.|+.
T Consensus       258 ~~i~----~~~--------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          258 EMIR----NRQ--------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             HHHH----TTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHHH----cCC--------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            2111    111        112234456688999999999999999999999999975

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.3e-58  Score=424.07  Aligned_cols=262  Identities=28%  Similarity=0.427  Sum_probs=207.5

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeE
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI  150 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  150 (401)
                      +++..+++.+.+.||+|+||+||+|.+++  .||||+++.. .+....+.|.+|+.++++++|||||++++++.+ +..+
T Consensus        31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~  107 (307)
T 3omv_A           31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA  107 (307)
T ss_dssp             CBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred             cEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence            34556788899999999999999998743  6999998733 345566889999999999999999999999865 5689


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      +|||||++|+|.++|...   ...+++..+..|+.|++.||+|||++   +|+||||||+|||+++++++||+|||+|+.
T Consensus       108 iVmEy~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  181 (307)
T 3omv_A          108 IVTQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATV  181 (307)
T ss_dssp             EEEECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred             EEEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCcee
Confidence            999999999999999753   34699999999999999999999998   999999999999999999999999999986


Q ss_pred             cCCCC-cceeccccCCccccccccccc---CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC
Q 015734          231 VDAKL-THVTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED  306 (401)
Q Consensus       231 ~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (401)
                      ..... ........||+.|||||++.+   ..++.++|||||||++|||+||+.||.......    .+    .......
T Consensus       182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~----~~----~~~~~~~  253 (307)
T 3omv_A          182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD----QI----IFMVGRG  253 (307)
T ss_dssp             ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HH----HHHHHTT
T ss_pred             cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH----HH----HHHHhcC
Confidence            64432 223455679999999999864   458999999999999999999999997543211    11    1111111


Q ss_pred             ccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       307 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                          ...+.....+..++.++.+++.+||+.||++||||.+|++.|+.
T Consensus       254 ----~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~  297 (307)
T 3omv_A          254 ----YASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL  297 (307)
T ss_dssp             ----CCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred             ----CCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                11122223344556788999999999999999999999998864

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.9e-58  Score=423.20  Aligned_cols=258  Identities=25%  Similarity=0.375  Sum_probs=212.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCee
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  149 (401)
                      .++|.+.+.||+|+||+||+|.+.      ++..||||+++. .+....+.|.+|++++++++|||||+++++|.+.+..
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~   90 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   90 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC-CChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            457888899999999999999863      467899999975 3455677899999999999999999999999999999


Q ss_pred             EEEEecccCCcHHHHhhhcC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcE
Q 015734          150 ILVYPFMQNLSVAYRLRDLK---------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA  220 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~  220 (401)
                      ++|||||++|+|.++|+...         .....+++..+..++.|++.||+|||++   +|+||||||+|||+++++.+
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~  167 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV  167 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcE
Confidence            99999999999999997632         1235699999999999999999999998   99999999999999999999


Q ss_pred             EEeecCCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHH
Q 015734          221 VLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDH  298 (401)
Q Consensus       221 kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~  298 (401)
                      ||+|||+++........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||......     .+...
T Consensus       168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~-----~~~~~  242 (299)
T 4asz_A          168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-----EVIEC  242 (299)
T ss_dssp             EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHHH
T ss_pred             EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHH
Confidence            99999999866544332 2334568999999999999999999999999999999999 89999764321     11111


Q ss_pred             HHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          299 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       299 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      +..    +.        ....+..++.++.+|+.+||+.||++|||+++|++.|+.
T Consensus       243 i~~----~~--------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~  286 (299)
T 4asz_A          243 ITQ----GR--------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN  286 (299)
T ss_dssp             HHH----TC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHc----CC--------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            111    11        112233445688999999999999999999999998865

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.8e-57  Score=422.28  Aligned_cols=258  Identities=25%  Similarity=0.374  Sum_probs=206.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCee
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  149 (401)
                      .++|.+.++||+|+||+||+|.+.      ++..||||+++. .+....+.|.+|++++++++|||||+++++|.+.+..
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~  118 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL  118 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC-CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            356777889999999999999864      477899999975 3455678899999999999999999999999999999


Q ss_pred             EEEEecccCCcHHHHhhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC
Q 015734          150 ILVYPFMQNLSVAYRLRDLKP-----------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF  218 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~  218 (401)
                      ++|||||++|+|.++++....           ...+++|..+..|+.|++.||+|||++   +|+||||||+|||+++++
T Consensus       119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~  195 (329)
T 4aoj_A          119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGL  195 (329)
T ss_dssp             EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCC
Confidence            999999999999999986432           124699999999999999999999998   999999999999999999


Q ss_pred             cEEEeecCCccccCCCCc-ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHH
Q 015734          219 EAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLL  296 (401)
Q Consensus       219 ~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~  296 (401)
                      .+||+|||+++....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||......+     ..
T Consensus       196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~-----~~  270 (329)
T 4aoj_A          196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-----AI  270 (329)
T ss_dssp             EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH-----HH
T ss_pred             cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH-----HH
Confidence            999999999986644322 23345679999999999999999999999999999999999 899997543211     11


Q ss_pred             HHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          297 DHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       297 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ..+..   ..+         ...+..++.++.+|+.+||+.||++||||++|++.|+.
T Consensus       271 ~~i~~---g~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~  316 (329)
T 4aoj_A          271 DCITQ---GRE---------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA  316 (329)
T ss_dssp             HHHHH---TCC---------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHH
T ss_pred             HHHHc---CCC---------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence            21211   111         11223345678999999999999999999999999875

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2e-57  Score=423.68  Aligned_cols=252  Identities=20%  Similarity=0.312  Sum_probs=205.6

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      ++|.+.+.||+|+||+||+|.++ +|+.||||++... .+....+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            68999999999999999999964 6899999999743 344566789999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      ||+||+|.+++....  ...+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       104 y~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             CCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             CCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            999999999997632  34578999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccC
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR  314 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  314 (401)
                      . ......+||+.|||||++.+..|+.++|||||||++|||+||+.||...+..+        .+......         
T Consensus       179 ~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--------~~~~i~~~---------  240 (350)
T 4b9d_A          179 V-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN--------LVLKIISG---------  240 (350)
T ss_dssp             H-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHT---------
T ss_pred             c-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--------HHHHHHcC---------
Confidence            2 22344679999999999999999999999999999999999999998654321        11111111         


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          315 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       315 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..+..+...+.++.+|+.+||+.||.+|||++|++++
T Consensus       241 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          241 SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1112223345678899999999999999999999864

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.8e-56  Score=417.93  Aligned_cols=269  Identities=25%  Similarity=0.380  Sum_probs=220.6

Q ss_pred             cCHHHHHHHhcCCCCCCeeeecCcEEEEEEEECC------CCEEEEEEecccCCcchHHHHHHHHHHHHhccC-Ccccce
Q 015734           67 FSCRELQLATDNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH-KNLLQL  139 (401)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~  139 (401)
                      +...++++..++|.+.+.||+|+||+||+|.+..      ++.||||++.........+.|.+|++++.++.| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            4456788889999999999999999999998542      357999999876666667889999999999976 899999


Q ss_pred             eeeeecC-CeeEEEEecccCCcHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeC
Q 015734          140 IGYCTTS-SERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRD  206 (401)
Q Consensus       140 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~d  206 (401)
                      +++|.+. +..++|||||++|+|.++|+....            ....+++..+..++.|||.||+|||++   +++|||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence            9999765 568999999999999999976321            134589999999999999999999999   999999


Q ss_pred             CCCCceEEcCCCcEEEeecCCccccCCCCc-ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCC
Q 015734          207 LKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDF  284 (401)
Q Consensus       207 lkp~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~  284 (401)
                      |||+|||+++++.+||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+| |..||..
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999987654433 33455678999999999999999999999999999999998 8999975


Q ss_pred             CcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          285 SRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      .....    .+...+.    .+.        ....+...+.++.+++.+||+.||.+|||+.+++++|+.
T Consensus       291 ~~~~~----~~~~~i~----~g~--------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~  344 (353)
T 4ase_A          291 VKIDE----EFCRRLK----EGT--------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  344 (353)
T ss_dssp             CCCSH----HHHHHHH----HTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCHHH----HHHHHHH----cCC--------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence            43221    1111111    111        011223345678899999999999999999999999864

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.6e-56  Score=407.33  Aligned_cols=249  Identities=20%  Similarity=0.289  Sum_probs=209.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      .++|.+.+.||+|+||+||+|..+ +|+.||+|++...  ......+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            367999999999999999999964 6899999999632  1234567899999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||++||+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+.
T Consensus       111 mEy~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~  183 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLS  183 (311)
T ss_dssp             ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence            9999999999999863    4599999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCC-cceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          233 AKL-THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       233 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ... .......+||+.|||||++.+..++.++||||+||++|||+||..||...+...     +...+.   ...     
T Consensus       184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-----~~~~i~---~~~-----  250 (311)
T 4aw0_A          184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-----IFAKII---KLE-----  250 (311)
T ss_dssp             TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHH---HTC-----
T ss_pred             CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHH---cCC-----
Confidence            432 234456789999999999999999999999999999999999999997644321     111111   111     


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV  349 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl  349 (401)
                        .   .++...+.++.+|+.+||+.||.+|||++|++
T Consensus       251 --~---~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          251 --Y---DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             --C---CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             --C---CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence              0   11223345788999999999999999999864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.3e-55  Score=409.16  Aligned_cols=250  Identities=22%  Similarity=0.279  Sum_probs=208.3

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      +.|+..+.||+|+||+||+|.++ +|+.||||++... .....+.+.+|+++|+.++|||||++++++.+.+..++||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGG-GCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecC-chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            56999999999999999999975 6899999999643 223446688999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      |++|+|.+++..     ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++++||+|||+++......
T Consensus       153 ~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  224 (346)
T 4fih_A          153 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  224 (346)
T ss_dssp             CTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             CCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence            999999998875     3489999999999999999999999   99999999999999999999999999998765443


Q ss_pred             cceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCc
Q 015734          236 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN  315 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  315 (401)
                      . .....+||+.|||||++.+..|+.++|||||||++|||++|..||......+     ....+..    ..     .+.
T Consensus       225 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-----~~~~i~~----~~-----~~~  289 (346)
T 4fih_A          225 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-----AMKMIRD----NL-----PPR  289 (346)
T ss_dssp             C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHH----SS-----CCC
T ss_pred             C-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-----HHHHHHc----CC-----CCC
Confidence            2 3345689999999999999999999999999999999999999997543211     1111111    10     001


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       316 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      . ......+.++.+|+.+||+.||++|||++|++++
T Consensus       290 ~-~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          290 L-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             C-SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             C-CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1 1123345678899999999999999999999653

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.2e-55  Score=406.98  Aligned_cols=249  Identities=20%  Similarity=0.218  Sum_probs=202.8

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      +.|...++||+|+||+||+|.++ +|+.||||+++....      ..+|+.+++.++|||||++++++.+.+..++||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            45777889999999999999975 689999999974221      24799999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC-cEEEeecCCccccCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAKLVDAK  234 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfgl~~~~~~~  234 (401)
                      |+||+|.+++...    ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++ ++||+|||+++.....
T Consensus       132 ~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          132 LEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD  204 (336)
T ss_dssp             CTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred             cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence            9999999999863    4599999999999999999999999   999999999999999987 6999999999876543


Q ss_pred             Ccc----eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccch
Q 015734          235 LTH----VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND  310 (401)
Q Consensus       235 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ...    .....+||+.|||||++.+..++.++|||||||++|||+||+.||........    . ..+.   ....   
T Consensus       205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----~-~~i~---~~~~---  273 (336)
T 4g3f_A          205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL----C-LKIA---SEPP---  273 (336)
T ss_dssp             ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC----H-HHHH---HSCC---
T ss_pred             CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH----H-HHHH---cCCC---
Confidence            221    22345799999999999999999999999999999999999999975443221    1 1111   1110   


Q ss_pred             hccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       311 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                          .....++..+.++.+++.+||+.||.+|||+.|++++|.
T Consensus       274 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~  312 (336)
T 4g3f_A          274 ----PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG  312 (336)
T ss_dssp             ----GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ----CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence                011123344567889999999999999999999998874

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=9.5e-55  Score=397.15  Aligned_cols=248  Identities=24%  Similarity=0.366  Sum_probs=197.6

Q ss_pred             CCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeec----CCeeEEEE
Q 015734           80 SESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT----SSERILVY  153 (401)
Q Consensus        80 ~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~  153 (401)
                      .+.+.||+|+||+||+|.+. ++..||+|++... .+....+.|.+|++++++++|||||++++++.+    .+..++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            45678999999999999975 5889999999743 344556789999999999999999999998864    34579999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEc-CCCcEEEeecCCccccC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfgl~~~~~  232 (401)
                      |||++|+|.+++...    ..+++..+..++.||+.||+|||++ +++|+||||||+|||++ .++.+||+|||+|+...
T Consensus       109 Ey~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            999999999999863    4689999999999999999999998 11399999999999998 48999999999998543


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ..   .....+||+.|||||++.+ +++.++|||||||++|||+||+.||.......    .+   .. ...........
T Consensus       184 ~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~----~~---~~-~i~~~~~~~~~  251 (290)
T 3fpq_A          184 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA----QI---YR-RVTSGVKPASF  251 (290)
T ss_dssp             TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH----HH---HH-HHTTTCCCGGG
T ss_pred             CC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH----HH---HH-HHHcCCCCCCC
Confidence            32   2345679999999998864 69999999999999999999999996433211    11   11 11111111111


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      +       ...++++.+|+.+||+.||++|||++|++++
T Consensus       252 ~-------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          252 D-------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             G-------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             C-------ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1       1123468899999999999999999999763

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=6.7e-55  Score=394.80  Aligned_cols=247  Identities=21%  Similarity=0.327  Sum_probs=192.4

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ++|++.+.||+|+||+||+|..+ +|+.||+|++....  .......+.+|+++++.++||||+++++++.+.+..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            58999999999999999999964 68999999996432  2344678999999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+ +|+|.+++..    ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++++||+|||+|+....
T Consensus        93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            999 6899999876    34699999999999999999999999   999999999999999999999999999986544


Q ss_pred             CCcceeccccCCcccccccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ..  .....+||+.|+|||++.+..+ +.++||||+||++|+|+||+.||...+..     .+...+..   . .     
T Consensus       165 ~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~-----~~~~~i~~---~-~-----  228 (275)
T 3hyh_A          165 GN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP-----VLFKNISN---G-V-----  228 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHH---T-C-----
T ss_pred             CC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHc---C-C-----
Confidence            32  2344679999999999988876 57999999999999999999999754321     11111111   1 0     


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                          ...+...+.++.+++.+||+.||++|||++|++++
T Consensus       229 ----~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          229 ----YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                01122334578899999999999999999999763

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.3e-54  Score=401.13  Aligned_cols=266  Identities=23%  Similarity=0.306  Sum_probs=200.4

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCC----eeEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS----ERILV  152 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv  152 (401)
                      .+|.+.+.||+|+||+||+|.+ +|+.||||++...  ......+..|+..+.+++||||++++++|.+.+    ..++|
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~--~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc--chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            3567788999999999999998 6899999998642  122223345666667899999999999997654    57999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEeCCCCCceEEcCCCcEEEeecCC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ-----CNPKIIHRDLKAANILLDDNFEAVLCDFGL  227 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl  227 (401)
                      |||+++|+|.++++.     .++++..+.+++.|++.||+|||++     ..++|+||||||+|||++.++++||+|||+
T Consensus        80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl  154 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence            999999999999986     3489999999999999999999975     245899999999999999999999999999


Q ss_pred             ccccCCCCcc---eeccccCCcccccccccccC------CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhh-----
Q 015734          228 AKLVDAKLTH---VTTQIRGTMGHIAPEYLSTG------KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV-----  293 (401)
Q Consensus       228 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~-----  293 (401)
                      ++........   ......||+.|||||++.+.      .++.++|||||||++|||+||.+|+...........     
T Consensus       155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~  234 (303)
T 3hmm_A          155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence            9876544322   22345799999999998754      367899999999999999999888754322111000     


Q ss_pred             -hHHHHHHHHhccCccchhccCcCCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          294 -LLLDHIRKLLREDRLNDIVDRNLNT--YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       294 -~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                       ..............    +++.++.  ...+.+..+.+++.+||+.||++||||.+|++.|+.
T Consensus       235 ~~~~~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  294 (303)
T 3hmm_A          235 DPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             SCCHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             cchHHHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence             00111222221111    1222221  234567789999999999999999999999999865

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.2e-54  Score=403.94  Aligned_cols=321  Identities=62%  Similarity=1.038  Sum_probs=261.9

Q ss_pred             ccCCCccccccccccccCHHHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHh
Q 015734           51 VAGEDDCKVSLTQLRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISV  130 (401)
Q Consensus        51 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~  130 (401)
                      .+.++.......+.+.++..++....++|...+.||+|+||.||+|..++++.||+|++...........+.+|+++++.
T Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~   83 (326)
T 3uim_A            4 VPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISM   83 (326)
T ss_dssp             -----------CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGT
T ss_pred             CCcccCcccccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHh
Confidence            34444444556677889999999999999999999999999999999888999999999754433344478999999999


Q ss_pred             ccCCcccceeeeeecCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 015734          131 AIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAA  210 (401)
Q Consensus       131 l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~  210 (401)
                      ++||||+++++++...+..++||||+++++|.+++.........+++..+..++.|++.||+|||+++.++++|+||||+
T Consensus        84 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~  163 (326)
T 3uim_A           84 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAA  163 (326)
T ss_dssp             CCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGG
T ss_pred             ccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchh
Confidence            99999999999999999999999999999999999886655667999999999999999999999986678999999999


Q ss_pred             ceEEcCCCcEEEeecCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhh
Q 015734          211 NILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE  290 (401)
Q Consensus       211 Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~  290 (401)
                      ||+++.++.+||+|||++...............||+.|+|||.+.+..++.++||||||+++|+|++|..||+.......
T Consensus       164 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  243 (326)
T 3uim_A          164 NILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND  243 (326)
T ss_dssp             GEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTT
T ss_pred             hEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccc
Confidence            99999999999999999987765555555666799999999999988999999999999999999999999975444444


Q ss_pred             hhhhHHHHHHHHhccCccchhccCcCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCchhhhhhHHHHHH
Q 015734          291 EDVLLLDHIRKLLREDRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEE  369 (401)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~~~~~~~~~~  369 (401)
                      ......++..............+..... .....+..+.+++.+||+.||.+|||+.+++++|++....+.+.+|...+-
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~  323 (326)
T 3uim_A          244 DDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEEM  323 (326)
T ss_dssp             SCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC-------
T ss_pred             cchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhhhhhHHHh
Confidence            4455666666666666666666665543 678889999999999999999999999999999999999998888776654


Q ss_pred             HH
Q 015734          370 VR  371 (401)
Q Consensus       370 ~~  371 (401)
                      .+
T Consensus       324 ~~  325 (326)
T 3uim_A          324 FR  325 (326)
T ss_dssp             --
T ss_pred             hc
Confidence            43

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.1e-54  Score=410.33  Aligned_cols=251  Identities=22%  Similarity=0.277  Sum_probs=208.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      .+.|...+.||+|+||.||+|.++ +|+.||||++... .....+.+.+|+.+|+.++|||||++++++.+.+..++|||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE  228 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  228 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEST-TCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEecc-chhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence            356999999999999999999975 6899999999643 23345678999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      ||+||+|.+++..     ..+++..+..++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+++.....
T Consensus       229 y~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~  300 (423)
T 4fie_A          229 FLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  300 (423)
T ss_dssp             CCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred             CCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence            9999999999875     2489999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccC
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR  314 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  314 (401)
                      .. .....+||+.|||||++.+..|+.++|||||||++|||++|..||.......     ....+..    ..     .+
T Consensus       301 ~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-----~~~~i~~----~~-----~~  365 (423)
T 4fie_A          301 VP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-----AMKMIRD----NL-----PP  365 (423)
T ss_dssp             CC-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHH----SC-----CC
T ss_pred             Cc-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-----HHHHHHc----CC-----CC
Confidence            32 3345679999999999999999999999999999999999999997543211     1111111    10     00


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          315 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       315 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .+ ......+.++.+|+.+||+.||.+|||+.|++++
T Consensus       366 ~~-~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          366 RL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             CC-SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CC-cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            11 1122344678899999999999999999999663

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.2e-55  Score=401.46  Aligned_cols=243  Identities=23%  Similarity=0.269  Sum_probs=194.7

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC----CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      ++|++.+.||+|+||+||+|+..    +++.||+|++.... .......+.+|++++++++|||||++++++.+.+..++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999852    46899999986422 22334468899999999999999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      ||||++||+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++++||+|||+|+..
T Consensus       104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            9999999999999986    34699999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      .... ......+||+.|||||++.+..++.++|||||||++|||+||+.||...+..+     +.   .......     
T Consensus       177 ~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-----~~---~~i~~~~-----  242 (304)
T 3ubd_A          177 IDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-----TM---TMILKAK-----  242 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HH---HHHHHCC-----
T ss_pred             cCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-----HH---HHHHcCC-----
Confidence            4332 22344679999999999999999999999999999999999999998654321     11   1111111     


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM  345 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  345 (401)
                           ...+...+.++.+|+.+||+.||++|||+
T Consensus       243 -----~~~p~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          243 -----LGMPQFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             -----CCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence                 01122345678899999999999999985

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.3e-53  Score=392.94  Aligned_cols=252  Identities=20%  Similarity=0.297  Sum_probs=191.4

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCC--------
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS--------  147 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--------  147 (401)
                      ++|++.+.||+|+||+||+|.++ +|+.||||++.....+...+.+.+|++++++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            35888999999999999999965 689999999975545556678999999999999999999999986544        


Q ss_pred             ----eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEe
Q 015734          148 ----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLC  223 (401)
Q Consensus       148 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~  223 (401)
                          ..++|||||++|+|.+++..... ....++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence                36899999999999999986322 23356777899999999999999999   99999999999999999999999


Q ss_pred             ecCCccccCCCCcc-----------eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhh
Q 015734          224 DFGLAKLVDAKLTH-----------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEED  292 (401)
Q Consensus       224 Dfgl~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~  292 (401)
                      |||+++........           .....+||+.|||||++.+..++.++|||||||++|||++   ||....    ..
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----~~  233 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----ER  233 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----HH
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----HH
Confidence            99999876543221           1234579999999999999999999999999999999996   665311    10


Q ss_pred             hhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          293 VLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .   ..... ......        +...........+++.+||+.||.+|||+.|++++
T Consensus       234 ~---~~~~~-~~~~~~--------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          234 V---RTLTD-VRNLKF--------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             H---HHHHH-HHTTCC--------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             H---HHHHH-HhcCCC--------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            0   11111 111111        11123334567789999999999999999999773

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-50  Score=383.39  Aligned_cols=262  Identities=18%  Similarity=0.262  Sum_probs=202.3

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeec------CCe
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTT------SSE  148 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  148 (401)
                      ++|.+.+.||+|+||+||+|.++ +|+.||||++.... .......+.+|+++|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999964 68999999997433 33445678899999999999999999998754      357


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      .++|||||+ |+|.+++..    ...+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       134 ~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence            899999995 689888875    45699999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCC---cceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhc
Q 015734          229 KLVDAKL---THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR  304 (401)
Q Consensus       229 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (401)
                      +.+....   .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||...+..+.     ...+.....
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~-----l~~I~~~~g  280 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ-----LQLIMMVLG  280 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-----HHHHHHHHC
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH-----HHHHHHhcC
Confidence            8664332   2233456899999999998775 469999999999999999999999986543221     111111111


Q ss_pred             cCccc-----------hh---ccCcCCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          305 EDRLN-----------DI---VDRNLNT----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       305 ~~~~~-----------~~---~d~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .....           ..   +.+..+.    ..+....++.+|+.+||+.||.+|||+.|++++
T Consensus       281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            10000           00   0000000    011224578899999999999999999999764

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.3e-49  Score=375.72  Aligned_cols=198  Identities=23%  Similarity=0.369  Sum_probs=170.0

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC----CCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCee
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  149 (401)
                      ..++|.+.+.||+|+||+||+|+.+    +++.||+|++...   .....+.+|++++..+ +||||+++++++.+.+..
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~---~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT---SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT---SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc---cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            4578999999999999999999853    4678999998653   2345688999999988 699999999999999999


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCC-CcEEEeecCCc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLA  228 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfgl~  228 (401)
                      ++||||+++|+|.+++..       +++..++.++.|++.||+|||++   +|+||||||+|||++.+ +.+||+|||+|
T Consensus        96 ~lvmE~~~g~~L~~~~~~-------l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla  165 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILNS-------LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLA  165 (361)
T ss_dssp             EEEEECCCCCCHHHHHTT-------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEeCCCcccHHHHHcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence            999999999999998853       88999999999999999999999   99999999999999876 79999999999


Q ss_pred             cccCCCCc---------------------------ceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCC
Q 015734          229 KLVDAKLT---------------------------HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQR  280 (401)
Q Consensus       229 ~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~  280 (401)
                      +.......                           ......+||+.|+|||++.+. .++.++||||+||++|||+||+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~  245 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY  245 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence            86543211                           112335799999999999775 48999999999999999999999


Q ss_pred             CCCCC
Q 015734          281 AIDFS  285 (401)
Q Consensus       281 p~~~~  285 (401)
                      ||...
T Consensus       246 Pf~~~  250 (361)
T 4f9c_A          246 PFYKA  250 (361)
T ss_dssp             SSSCC
T ss_pred             CCCCC
Confidence            99543

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.8e-48  Score=364.11  Aligned_cols=281  Identities=37%  Similarity=0.614  Sum_probs=233.7

Q ss_pred             CHHHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 015734           68 SCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS  147 (401)
Q Consensus        68 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  147 (401)
                      ...++....++|...+.||+|+||+||+|.+++++.||+|++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus        30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC-CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            333445567899999999999999999999888999999988653 3455778999999999999999999999999999


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCC
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL  227 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl  227 (401)
                      ..++||||+++++|.+++.........+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence            99999999999999999876544445699999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCc-ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC
Q 015734          228 AKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED  306 (401)
Q Consensus       228 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (401)
                      +........ .......||+.|+|||++.+..++.++||||||+++|||+||+.||......+  ......+........
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~  263 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE--MVNLAEWAVESHNNG  263 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS--CCCHHHHTHHHHTTT
T ss_pred             ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHH--HHHHHHHhhhccccc
Confidence            986543222 22333458999999999998999999999999999999999999997544322  222334444444445


Q ss_pred             ccchhccCcCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          307 RLNDIVDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       307 ~~~~~~d~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      .+...+++... ......+..+.+++.+||+.||++|||+.++++.|+.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  312 (321)
T 2qkw_B          264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY  312 (321)
T ss_dssp             CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            55555665544 3567889999999999999999999999999999874

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=7.3e-49  Score=390.59  Aligned_cols=250  Identities=24%  Similarity=0.274  Sum_probs=200.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHH---HHHHHHhccCCcccceeeeeecCCee
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQR---EVHLISVAIHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~---e~~~l~~l~h~niv~~~~~~~~~~~~  149 (401)
                      -++|.+.++||+|+||.||+|..+ +|+.||||++....  .......+.+   ++.+++.++|||||++++++.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            467999999999999999999965 68999999996321  1122233333   45666778999999999999999999


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ++||||++||+|..+|..    ...+++..++.++.||+.||+|||++   +|+||||||+|||++.+|++||+|||+|+
T Consensus       268 ylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~  340 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC  340 (689)
T ss_dssp             EEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence            999999999999999986    34599999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          230 LVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ......   ....+||+.|||||++.+ ..|+.++|||||||++|||++|..||......+.     ...........  
T Consensus       341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-----~~i~~~i~~~~--  410 (689)
T 3v5w_A          341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTLTMA--  410 (689)
T ss_dssp             ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-----HHHHHHHHHCC--
T ss_pred             ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHhhcCCC--
Confidence            765432   344689999999999965 5799999999999999999999999975433211     11111111110  


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVK  350 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~  350 (401)
                              ..++...+.++.+|+..||+.||.+|++     ++++.+
T Consensus       411 --------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          411 --------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             --------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                    0122334567889999999999999998     677744

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.2e-48  Score=386.63  Aligned_cols=252  Identities=22%  Similarity=0.281  Sum_probs=208.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      .++|.+.+.||+|+||.||+|..+ +|+.||+|++... .....+.+.+|+++|+.++||||+++++++.+.+..++|||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E  234 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  234 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc-chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            468999999999999999999975 6899999998643 33456788999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCC--CcEEEeecCCccccC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN--FEAVLCDFGLAKLVD  232 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~--~~~kl~Dfgl~~~~~  232 (401)
                      ||+||+|.+++...   ...+++..+..++.||+.||.|||++   +|+||||||+|||++.+  +.+||+|||+++...
T Consensus       235 ~~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~  308 (573)
T 3uto_A          235 FMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  308 (573)
T ss_dssp             CCCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred             ecCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence            99999999988642   34689999999999999999999999   99999999999999854  899999999998775


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC-ccchh
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED-RLNDI  311 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  311 (401)
                      ...  .....+||+.|+|||++.+..++.++|||||||++|||++|..||......+     .   ........ .... 
T Consensus       309 ~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~-----~---~~~i~~~~~~~~~-  377 (573)
T 3uto_A          309 PKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-----T---LRNVKSCDWNMDD-  377 (573)
T ss_dssp             TTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----H---HHHHHTTCCCCCS-
T ss_pred             CCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-----H---HHHHHhCCCCCCc-
Confidence            432  2344579999999999999999999999999999999999999997644321     1   11111111 1110 


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                        .    .....+.++.+|+.+||+.||.+|||+.|++++
T Consensus       378 --~----~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          378 --S----AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             --G----GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --c----cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              0    112234577899999999999999999999985

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.6e-45  Score=341.87  Aligned_cols=283  Identities=38%  Similarity=0.637  Sum_probs=234.2

Q ss_pred             cccccCHHHHHHHhcCCCCC------CeeeecCcEEEEEEEECCCCEEEEEEecccC---CcchHHHHHHHHHHHHhccC
Q 015734           63 QLRRFSCRELQLATDNFSES------NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVAIH  133 (401)
Q Consensus        63 ~~~~~~~~~~~~~~~~~~~~------~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h  133 (401)
                      ....+++.++...+++|...      +.||+|+||.||+|.. +++.||+|++....   .....+.+.+|+.+++.++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            45688999999999999887      8999999999999987 68899999986432   33456789999999999999


Q ss_pred             CcccceeeeeecCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceE
Q 015734          134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANIL  213 (401)
Q Consensus       134 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil  213 (401)
                      |||+++++++...+..+++|||+++++|.+++..... ..++++..+..++.|++.||.|||++   +++|+||||+||+
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil  165 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL  165 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence            9999999999999999999999999999999975432 45699999999999999999999999   9999999999999


Q ss_pred             EcCCCcEEEeecCCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhh
Q 015734          214 LDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEED  292 (401)
Q Consensus       214 l~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~  292 (401)
                      ++.++.+||+|||++......... ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||........  
T Consensus       166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--  242 (307)
T 2nru_A          166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--  242 (307)
T ss_dssp             ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--
T ss_pred             EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--
Confidence            999999999999999866543222 2334568999999998865 588999999999999999999999975443211  


Q ss_pred             hhHHHHHHHH-hccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          293 VLLLDHIRKL-LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       293 ~~~~~~~~~~-~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                        ........ .....+...+++.+.......+..+.+++.+||+.||.+|||+.++++.|+..
T Consensus       243 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          243 --LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             --TTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             --HHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence              11111111 12233455566666667788889999999999999999999999999999753

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=6.5e-47  Score=344.37  Aligned_cols=258  Identities=24%  Similarity=0.369  Sum_probs=214.4

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      ..++|.+.+.||+|+||.||+|..+++..||+|++...  ....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG--SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE   83 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT--TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC--CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence            45788999999999999999999988889999999753  2345778999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++++|.+++...   ...+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++......
T Consensus        84 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           84 YISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             CCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             ccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            99999999999763   23589999999999999999999999   9999999999999999999999999999876555


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      .........+|+.|+|||.+.+..++.++||||||+++|+|+| |..||.......        ..........      
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~------  223 (268)
T 3sxs_A          158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE--------VVLKVSQGHR------  223 (268)
T ss_dssp             CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH--------HHHHHHTTCC------
T ss_pred             hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH--------HHHHHHcCCC------
Confidence            4444444556788999999998899999999999999999999 999997544321        1111111110      


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCc
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDL  357 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  357 (401)
                         ...+...+..+.+++..||+.||.+|||+.++++.|+....
T Consensus       224 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          224 ---LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             ---CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             ---CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence               01112234578899999999999999999999999987543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.6e-46  Score=357.57  Aligned_cols=260  Identities=27%  Similarity=0.411  Sum_probs=213.3

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC--------CCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeeec
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS--------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT  145 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  145 (401)
                      ..++|.+.+.||+|+||.||+|.+.        ++..||+|++...........+.+|+.+++.+ +||||+++++++..
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            4567889999999999999999852        34579999998655555677899999999999 89999999999999


Q ss_pred             CCeeEEEEecccCCcHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceE
Q 015734          146 SSERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANIL  213 (401)
Q Consensus       146 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil  213 (401)
                      .+..++||||+++|+|.+++.....            ....+++..+..++.|++.||+|||++   +++||||||+|||
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIl  235 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL  235 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEE
Confidence            9999999999999999999986432            124589999999999999999999999   9999999999999


Q ss_pred             EcCCCcEEEeecCCccccCCCCc-ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhh
Q 015734          214 LDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEE  291 (401)
Q Consensus       214 l~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~  291 (401)
                      ++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||+| |..||.......  
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--  313 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--  313 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence            99999999999999986654322 12233457889999999999999999999999999999999 999997543321  


Q ss_pred             hhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          292 DVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                         +...+.    ...        ....+...+.++.+++..||+.||.+|||+.++++.|+.
T Consensus       314 ---~~~~~~----~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~  361 (370)
T 2psq_A          314 ---LFKLLK----EGH--------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  361 (370)
T ss_dssp             ---HHHHHH----TTC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---HHHHHh----cCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence               111111    110        111223345678899999999999999999999999875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.5e-46  Score=350.29  Aligned_cols=250  Identities=24%  Similarity=0.313  Sum_probs=208.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      ..++|.+.+.||+|+||.||+|.+ .+|+.||+|++... .+......+.+|+++++.++||||+++++++...+..++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            356899999999999999999997 57899999999643 3445567889999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||+++++|.+++...    ..+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++....
T Consensus        93 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             ECCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred             EECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence            9999999999999763    4589999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCcceeccccCCcccccccccccCCCC-cccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSS-EKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ...  ......||+.|+|||++.+..++ .++|||||||++|+|++|..||.......     +.   .......     
T Consensus       166 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~---~~i~~~~-----  230 (328)
T 3fe3_A          166 VGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE-----LR---ERVLRGK-----  230 (328)
T ss_dssp             SSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HH---HHHHHCC-----
T ss_pred             CCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH-----HH---HHHHhCC-----
Confidence            432  23445799999999999888764 79999999999999999999998654321     11   1111110     


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                           ...+...+.++.+++.+||+.||.+|||+++++++
T Consensus       231 -----~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          231 -----YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             -----CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                 01122234568899999999999999999999764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7.1e-46  Score=344.85  Aligned_cols=258  Identities=23%  Similarity=0.391  Sum_probs=210.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      .++|.+.+.||+|+||+||+|.+. ++..||+|++.. .+....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   87 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR-FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE   87 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence            467888999999999999999975 589999998854 345567889999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++++|.+++...   ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++......
T Consensus        88 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           88 YIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             CCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred             ecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence            99999999999863   34589999999999999999999999   9999999999999999999999999999866443


Q ss_pred             Ccce-------------eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhh-hHHHHHH
Q 015734          235 LTHV-------------TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV-LLLDHIR  300 (401)
Q Consensus       235 ~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~-~~~~~~~  300 (401)
                      ....             .....||+.|+|||++.+..++.++||||||+++|||++|..|+........... .......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD  241 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence            2211             1145689999999999999999999999999999999999999875333211111 1111111


Q ss_pred             HHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 015734          301 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED  356 (401)
Q Consensus       301 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  356 (401)
                      .             .   .+...+..+.+++.+||+.||++|||+.++++.|+...
T Consensus       242 ~-------------~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          242 R-------------Y---CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             H-------------T---CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             c-------------c---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            0             0   01222346889999999999999999999999987643

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.6e-46  Score=348.97  Aligned_cols=265  Identities=26%  Similarity=0.407  Sum_probs=205.5

Q ss_pred             HHHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 015734           69 CRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS  147 (401)
Q Consensus        69 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  147 (401)
                      ..++.+..++|.+.+.||+|+||+||+|.. +++.||+|++.... .......+.+|++++++++||||+++++++...+
T Consensus        29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 3p86_A           29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP  107 (309)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             cccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            344555678899999999999999999987 68899999987432 3445578999999999999999999999999999


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEeCCCCCceEEcCCCcEEEeec
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK--IIHRDLKAANILLDDNFEAVLCDF  225 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlkp~Nill~~~~~~kl~Df  225 (401)
                      ..++||||+++++|.+++..... ...+++..+..++.|++.||+|||++   +  ++||||||+||+++.++.+||+||
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Df  183 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDF  183 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred             ceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCC
Confidence            99999999999999999985221 12388999999999999999999998   7  999999999999999999999999


Q ss_pred             CCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhcc
Q 015734          226 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE  305 (401)
Q Consensus       226 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (401)
                      |+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......     ....+..  ..
T Consensus       184 g~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-----~~~~~~~--~~  255 (309)
T 3p86_A          184 GLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ-----VVAAVGF--KC  255 (309)
T ss_dssp             C------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH-----HHHHHHH--SC
T ss_pred             CCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHh--cC
Confidence            9997544332 12334568999999999999999999999999999999999999997543321     1111110  00


Q ss_pred             CccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          306 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       306 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                               .....+...+.++.+++.+||+.||.+|||+.++++.|+..
T Consensus       256 ---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~  296 (309)
T 3p86_A          256 ---------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL  296 (309)
T ss_dssp             ---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                     00112233445788999999999999999999999998753

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.1e-46  Score=350.72  Aligned_cols=257  Identities=25%  Similarity=0.367  Sum_probs=210.0

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC----CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI  150 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  150 (401)
                      ..++|.+.+.||+|+||.||+|.+.    .+..||||++...........+.+|+.+++.++||||+++++++.+.+..+
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  126 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM  126 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence            4567888999999999999999974    345699999986666667788999999999999999999999999999999


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      +||||+++++|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus       127 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          127 IVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             EEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            999999999999999752   34689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcc--eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          231 VDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       231 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      .......  ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......     .   ........ 
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----~---~~~~~~~~-  271 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-----V---ISSVEEGY-  271 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-----H---HHHHHTTC-
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-----H---HHHHHcCC-
Confidence            6543222  2223346778999999998899999999999999999999 999997543321     1   11111110 


Q ss_pred             cchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       308 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                              ....+...+..+.+++..||+.||.+|||+.++++.|+.
T Consensus       272 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~  310 (325)
T 3kul_A          272 --------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA  310 (325)
T ss_dssp             --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                    011223345678899999999999999999999999975

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.5e-46  Score=342.26  Aligned_cols=255  Identities=25%  Similarity=0.377  Sum_probs=212.3

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      ..++|.+.+.||+|+||.||+|.+.++..||+|++...  ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   85 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT--SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             ChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccc--ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence            45678889999999999999999988899999999753  2345779999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++++|.+++...   ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++......
T Consensus        86 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           86 FMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  159 (269)
T ss_dssp             CCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             eCCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc
Confidence            99999999999752   34689999999999999999999999   9999999999999999999999999999866544


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      .........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.......     .   ........       
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~-----~---~~~~~~~~-------  224 (269)
T 4hcu_A          160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-----V---VEDISTGF-------  224 (269)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----H---HHHHHTTC-------
T ss_pred             ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH-----H---HHHHhcCc-------
Confidence            3333444557788999999998999999999999999999999 999997543321     1   11111110       


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                        ....+...+..+.+++..||+.||.+|||+.+++++|+.
T Consensus       225 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~  263 (269)
T 4hcu_A          225 --RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE  263 (269)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence              001122234578899999999999999999999999875

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.7e-45  Score=338.94  Aligned_cols=251  Identities=20%  Similarity=0.288  Sum_probs=207.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      .++|...+.||+|+||+||+|.+ .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            46899999999999999999995 468999999986432 2346778999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++++|.+++...     .+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++......
T Consensus        98 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A           98 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             CCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             CCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            99999999999762     489999999999999999999999   9999999999999999999999999999866543


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccC
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR  314 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  314 (401)
                      .. ......||+.|+|||++.+..++.++|||||||++|+|++|..||........    .    ........ ..    
T Consensus       170 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~----~~~~~~~~-~~----  235 (297)
T 3fxz_A          170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA----L----YLIATNGT-PE----  235 (297)
T ss_dssp             TC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----H----HHHHHHCS-CC----
T ss_pred             cc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----H----HHHHhCCC-CC----
Confidence            32 23345689999999999999999999999999999999999999975432111    1    11110000 00    


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          315 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       315 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                        ...+...+..+.+++.+||+.||.+|||+.+++++
T Consensus       236 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          236 --LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             --CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence              01123345678899999999999999999999774

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=6.3e-47  Score=361.48  Aligned_cols=261  Identities=26%  Similarity=0.386  Sum_probs=213.0

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeE
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI  150 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  150 (401)
                      +.+..++|.+.+.||+|+||.||+|.+. +++.||+|.++..........+.+|++++++++||||+++++++...+..+
T Consensus       109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  188 (377)
T 3cbl_A          109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY  188 (377)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence            4455678889999999999999999976 689999999876545555667899999999999999999999999999999


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      +||||+++|+|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++.
T Consensus       189 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~  262 (377)
T 3cbl_A          189 IVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSRE  262 (377)
T ss_dssp             EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence            999999999999999853   23589999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCccee-ccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          231 VDAKLTHVT-TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       231 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ......... ....+++.|+|||.+.+..++.++|||||||++|||+| |..||.......     ....+.   .... 
T Consensus       263 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-----~~~~~~---~~~~-  333 (377)
T 3cbl_A          263 EADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-----TREFVE---KGGR-  333 (377)
T ss_dssp             CTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-----HHHHHH---TTCC-
T ss_pred             cCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHH---cCCC-
Confidence            543322111 11235678999999998899999999999999999998 999997543211     111111   1111 


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                              ...+...+.++.+++.+||+.||++|||+.++++.|+..
T Consensus       334 --------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          334 --------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence                    111223345788999999999999999999999999753

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.7e-45  Score=339.84  Aligned_cols=261  Identities=23%  Similarity=0.316  Sum_probs=207.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      .++|.+.+.||+|+||.||+|.+. ++..||+|.+....  .......+.+|+.++.+++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            467999999999999999999964 68899999986322  334457889999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||+++++|.+++...    .++++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++....
T Consensus        90 ~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            9999999999999863    3589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ...........||+.|+|||.+.+..++.++||||||+++|+|+||..||........        ........ .....
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--------~~~~~~~~-~~~~~  233 (294)
T 4eqm_A          163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--------AIKHIQDS-VPNVT  233 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH--------HHHHHSSC-CCCHH
T ss_pred             cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--------HHHHhhcc-CCCcc
Confidence            5444444456789999999999999999999999999999999999999976443211        11111111 11100


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhccCC
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRP-PMAQVVKMLQGED  356 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~~vl~~L~~~~  356 (401)
                      .    ......+..+.+++.+||+.||.+|| +++++.+.|+...
T Consensus       234 ~----~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          234 T----DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             H----HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             h----hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence            0    01223345788999999999999998 8999999887644

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2e-46  Score=353.35  Aligned_cols=267  Identities=26%  Similarity=0.411  Sum_probs=217.4

Q ss_pred             HHHHHHhcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeee
Q 015734           70 RELQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC  143 (401)
Q Consensus        70 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~  143 (401)
                      ..+....++|.+.+.||+|+||.||+|...      ++..||+|.+...........+.+|+.+++.++||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            344556789999999999999999999974      34789999998655556677899999999999999999999999


Q ss_pred             ecCCeeEEEEecccCCcHHHHhhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 015734          144 TTSSERILVYPFMQNLSVAYRLRDLKPG--------------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII  203 (401)
Q Consensus       144 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~  203 (401)
                      ...+..++||||+++++|.+++......                    ...+++..++.++.|++.||.|||++   +++
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv  196 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV  196 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence            9999999999999999999999874321                    25689999999999999999999999   999


Q ss_pred             EeCCCCCceEEcCCCcEEEeecCCccccCCCCc-ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCC
Q 015734          204 HRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRA  281 (401)
Q Consensus       204 H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p  281 (401)
                      |+||||+||+++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|+| |..|
T Consensus       197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence            999999999999999999999999986543322 22334457899999999998899999999999999999999 9999


Q ss_pred             CCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 015734          282 IDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED  356 (401)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  356 (401)
                      |.......     .   .. ......        ....+...+.++.+++..||+.||.+|||+.++++.|+...
T Consensus       277 ~~~~~~~~-----~---~~-~~~~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~  334 (343)
T 1luf_A          277 YYGMAHEE-----V---IY-YVRDGN--------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  334 (343)
T ss_dssp             TTTSCHHH-----H---HH-HHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCChHH-----H---HH-HHhCCC--------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence            97543211     1   11 111111        11122334467889999999999999999999999998754

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.9e-46  Score=344.06  Aligned_cols=258  Identities=21%  Similarity=0.335  Sum_probs=210.6

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      +.+..++|.+.+.||+|+||.||++.+.++..||+|++...  ....+.+.+|++++..++||||+++++++.+.+..++
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   96 (283)
T 3gen_A           19 WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI   96 (283)
T ss_dssp             TBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT--SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             ccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC--CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence            34456789999999999999999999988889999999753  2345779999999999999999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      ||||+++++|.+++...   ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++...
T Consensus        97 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  170 (283)
T 3gen_A           97 ITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV  170 (283)
T ss_dssp             EECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred             EEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccc
Confidence            99999999999999763   23589999999999999999999999   9999999999999999999999999999866


Q ss_pred             CCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccch
Q 015734          232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND  310 (401)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ............+|+.|+|||.+.+..++.++||||||+++|+|+| |..||.......     .   .........   
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~-----~---~~~~~~~~~---  239 (283)
T 3gen_A          171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-----T---AEHIAQGLR---  239 (283)
T ss_dssp             CCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----H---HHHHHTTCC---
T ss_pred             cccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH-----H---HHHHhcccC---
Confidence            5443333344456788999999998899999999999999999998 999997544321     1   111111100   


Q ss_pred             hccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       311 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                            ...+......+.+++.+||+.||.+|||+.+++++|+.
T Consensus       240 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  277 (283)
T 3gen_A          240 ------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  277 (283)
T ss_dssp             ------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence                  01112224578899999999999999999999999875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.2e-46  Score=349.81  Aligned_cols=267  Identities=24%  Similarity=0.375  Sum_probs=212.2

Q ss_pred             HHHHHhcCCCCCCeeeecCcEEEEEEEE------CCCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeee
Q 015734           71 ELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYC  143 (401)
Q Consensus        71 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  143 (401)
                      ++++..++|.+.+.||+|+||.||+|.+      .++..||+|.+...........+.+|+.++.++ +||||+++++++
T Consensus        39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            3456778999999999999999999996      235689999997554455567899999999999 899999999999


Q ss_pred             ecCCeeEEEEecccCCcHHHHhhhcCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 015734          144 TTSSERILVYPFMQNLSVAYRLRDLKPG-------------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIH  204 (401)
Q Consensus       144 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H  204 (401)
                      ...+..++||||+++|+|.+++......                   ...+++..++.++.|++.||+|||++   +++|
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH  195 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH  195 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence            9999999999999999999999864321                   13489999999999999999999999   9999


Q ss_pred             eCCCCCceEEcCCCcEEEeecCCccccCCCCc-ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCC
Q 015734          205 RDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAI  282 (401)
Q Consensus       205 ~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~  282 (401)
                      +||||+||+++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|+| |..||
T Consensus       196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            99999999999999999999999986644332 22334557889999999999999999999999999999998 99999


Q ss_pred             CCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 015734          283 DFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED  356 (401)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  356 (401)
                      .......    .......    ...     .   ...+...+.++.+++.+||+.||.+|||+.+++++|+...
T Consensus       276 ~~~~~~~----~~~~~~~----~~~-----~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~  333 (344)
T 1rjb_A          276 PGIPVDA----NFYKLIQ----NGF-----K---MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL  333 (344)
T ss_dssp             TTCCCSH----HHHHHHH----TTC-----C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             ccCCcHH----HHHHHHh----cCC-----C---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            7543321    1111111    110     0   0112233467889999999999999999999999997643

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.9e-46  Score=354.02  Aligned_cols=258  Identities=27%  Similarity=0.403  Sum_probs=200.9

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC----CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI  150 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  150 (401)
                      ..++|.+.+.||+|+||.||+|..+    ++..||||.+.........+.+.+|+.++++++||||+++++++...+..+
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  122 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM  122 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence            4568999999999999999999864    467899999976556666788999999999999999999999999999999


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      +||||+++++|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++.
T Consensus       123 lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          123 IVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             EEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            999999999999999752   34689999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCcce--eccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          231 VDAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       231 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      ........  .....+|+.|+|||++.+..++.++||||||+++|||++ |..||.......     ....+.    ...
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-----~~~~i~----~~~  267 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-----VIKAVD----EGY  267 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-----HHHHHH----TTE
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHH----cCC
Confidence            65432221  122235778999999999999999999999999999998 999997543211     111111    110


Q ss_pred             cchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       308 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                              ....+...+..+.+++.+||+.||.+||++.++++.|+..
T Consensus       268 --------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          268 --------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             --------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence                    0011223456788999999999999999999999998753

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.3e-46  Score=362.71  Aligned_cols=265  Identities=21%  Similarity=0.261  Sum_probs=212.3

Q ss_pred             CHHHHHHHhcCCCCCCeeeecCcEEEEEEEECC-CCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeee
Q 015734           68 SCRELQLATDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCT  144 (401)
Q Consensus        68 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  144 (401)
                      .+.++++..++|.+.++||+|+||+||+|..+. ++.||+|++....  .......+.+|..++..++||||+++++++.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            345566778899999999999999999999764 7889999986411  1122334889999999999999999999999


Q ss_pred             cCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEee
Q 015734          145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD  224 (401)
Q Consensus       145 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D  224 (401)
                      +.+..++||||+++|+|.+++...   ...+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+||+|
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D  218 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD  218 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence            999999999999999999999863   34699999999999999999999999   999999999999999999999999


Q ss_pred             cCCccccCCCCcceeccccCCcccccccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHH
Q 015734          225 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI  299 (401)
Q Consensus       225 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~  299 (401)
                      ||+++.............+||+.|+|||++.     ...++.++|||||||++|||++|+.||...+..+.        .
T Consensus       219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~--------~  290 (437)
T 4aw2_A          219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET--------Y  290 (437)
T ss_dssp             CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--------H
T ss_pred             hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH--------H
Confidence            9999876555444445567999999999987     45689999999999999999999999986543211        1


Q ss_pred             HHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 015734          300 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPED--RPPMAQVVKM  351 (401)
Q Consensus       300 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~vl~~  351 (401)
                      ........     ....+......+.++.+++.+||+.+|++  ||++++++++
T Consensus       291 ~~i~~~~~-----~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          291 GKIMNHKE-----RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HHHHTHHH-----HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             Hhhhhccc-----cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            11111000     00111111223457888999999888888  9999999764

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.6e-46  Score=341.92  Aligned_cols=258  Identities=20%  Similarity=0.322  Sum_probs=199.6

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEECC----CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCee
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  149 (401)
                      +..++|.+.+.||+|+||.||+|.+..    +..||+|.+.........+.+.+|+.++++++||||+++++++. .+..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   90 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   90 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence            345688999999999999999999643    45799999876555566778999999999999999999999984 4668


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ++||||+++++|.+++...   ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++.
T Consensus        91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             EEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccc
Confidence            9999999999999999863   34589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          230 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ..............+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+     ....+.   ...  
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-----~~~~i~---~~~--  234 (281)
T 1mp8_A          165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VIGRIE---NGE--  234 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HHHHHH---TTC--
T ss_pred             ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-----HHHHHH---cCC--
Confidence            765443333334456789999999998899999999999999999997 999997544321     111111   111  


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                             ....+...+..+.+++.+||+.||.+|||+.++++.|+..
T Consensus       235 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          235 -------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                   1112233456788999999999999999999999998753

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.7e-45  Score=338.59  Aligned_cols=276  Identities=18%  Similarity=0.202  Sum_probs=217.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCC--eeEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS--ERILV  152 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv  152 (401)
                      .++|.+.+.||+|+||+||+|... +++.||+|++.........+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            457889999999999999999975 489999999975444455778899999999999999999999987665  67999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEE----cCCCcEEEeecCCc
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLA  228 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfgl~  228 (401)
                      |||+++++|.+++..... ...+++..++.++.|++.||+|||++   +++|+||||+||++    +.++.+||+|||++
T Consensus        88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            999999999999986432 23489999999999999999999999   99999999999999    88888999999999


Q ss_pred             cccCCCCcceeccccCCcccccccccc--------cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHH
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLS--------TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR  300 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~  300 (401)
                      +.......  .....||+.|+|||++.        +..++.++|||||||++|||+||..||..................
T Consensus       164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             EECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             eecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            87654332  23356899999999986        467899999999999999999999999754332222222222221


Q ss_pred             HHhccCccchhc---------cCcC---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCch
Q 015734          301 KLLREDRLNDIV---------DRNL---NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLA  358 (401)
Q Consensus       301 ~~~~~~~~~~~~---------d~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  358 (401)
                       ...........         ...+   ..........+.+++..||+.||++|||++|++++..+....
T Consensus       242 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~  310 (319)
T 4euu_A          242 -GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (319)
T ss_dssp             -HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred             -CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence             11111111000         0111   124567788899999999999999999999999998765443

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.4e-45  Score=341.52  Aligned_cols=264  Identities=23%  Similarity=0.310  Sum_probs=204.4

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ..++|.+.+.||+|+||+||+|.+.+++.||+|++.... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            346799999999999999999999889999999997432 3344578899999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++ +|.+.+...   ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++.....
T Consensus        99 e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           99 EFMEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             ECCSE-EHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             cCCCC-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            99975 788777652   34589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCc---cc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR---LN  309 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~  309 (401)
                      .... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+.    + ..+........   ..
T Consensus       172 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~-~~i~~~~~~~~~~~~~  245 (311)
T 3niz_A          172 PVRS-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ----L-PKIFSILGTPNPREWP  245 (311)
T ss_dssp             CCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH----H-HHHHHHHCCCCTTTSG
T ss_pred             Cccc-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH----H-HHHHHHHCCCChHHhh
Confidence            3222 233468999999999876 5689999999999999999999999976543221    1 11111111110   00


Q ss_pred             h------hccCcCC---C-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          310 D------IVDRNLN---T-----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       310 ~------~~d~~~~---~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .      ..+....   .     ..+....++.+++.+||+.||.+|||+.+++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            0      0000000   0     112234578899999999999999999999764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.9e-46  Score=352.96  Aligned_cols=270  Identities=25%  Similarity=0.396  Sum_probs=217.0

Q ss_pred             ccCHHHHHHHhcCCCCCCeeeecCcEEEEEEEE------CCCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccc
Q 015734           66 RFSCRELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQ  138 (401)
Q Consensus        66 ~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~  138 (401)
                      .+...++++..++|.+.+.||+|+||.||+|.+      .+++.||||++.........+.+.+|++++.++ +||||++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            345566777889999999999999999999983      235789999998655555667899999999999 7899999


Q ss_pred             eeeeeecCCe-eEEEEecccCCcHHHHhhhcCCC----------------------------------------------
Q 015734          139 LIGYCTTSSE-RILVYPFMQNLSVAYRLRDLKPG----------------------------------------------  171 (401)
Q Consensus       139 ~~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------  171 (401)
                      +++++...+. .++||||+++|+|.+++......                                              
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            9999887654 89999999999999999864321                                              


Q ss_pred             ----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          172 ----------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       172 ----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                                      ...+++..++.++.|++.||+|||++   +++||||||+|||++.++.+||+|||++.......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                            12288999999999999999999999   99999999999999999999999999998654332


Q ss_pred             c-ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          236 T-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       236 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      . .......||+.|+|||++.+..++.++|||||||++|||+| |..||........    ......    ...      
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~----~~~~~~----~~~------  313 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----FCRRLK----EGT------  313 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH----HHHHHH----HTC------
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH----HHHHHH----cCC------
Confidence            2 23344567899999999999999999999999999999998 9999976443211    111111    110      


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                        ....+...+.++.+++..||+.||.+|||+.+++++|+.
T Consensus       314 --~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  352 (359)
T 3vhe_A          314 --RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  352 (359)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence              011122234578899999999999999999999999975

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.6e-45  Score=344.43  Aligned_cols=250  Identities=21%  Similarity=0.257  Sum_probs=206.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      .++|.+.+.||+|+||.||+|..+ +|+.||+|++....  .......+.+|+.+++.++||||+++++++...+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            467889999999999999999975 68999999996421  233467788999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||+++|+|..++...    ..+++..++.++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++...
T Consensus        84 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           84 MEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            9999999999998763    4589999999999999999999999   99999999999999999999999999998543


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ... .......||+.|+|||++.+..++.++|||||||++|||++|..||.......     +   ........      
T Consensus       157 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~---~~~i~~~~------  221 (337)
T 1o6l_A          157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----L---FELILMEE------  221 (337)
T ss_dssp             CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----H---HHHHHHCC------
T ss_pred             cCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH-----H---HHHHHcCC------
Confidence            322 22344578999999999999999999999999999999999999997543211     1   11111110      


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM  351 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  351 (401)
                          ...+...+.++.+++.+||+.||.+||     ++++++++
T Consensus       222 ----~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          222 ----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ----CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence                011223345788999999999999999     89999764

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.8e-45  Score=339.08  Aligned_cols=259  Identities=25%  Similarity=0.373  Sum_probs=202.2

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHh--ccCCcccceeeeeec----CCe
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISV--AIHKNLLQLIGYCTT----SSE  148 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~----~~~  148 (401)
                      ..++|.+.+.||+|+||+||+|.. +++.||||++..    .....+..|.+++..  ++||||+++++++..    ...
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~   80 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ   80 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc----ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence            356899999999999999999998 689999999864    244566677777766  799999999998654    345


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEEeCCCCCceEEcCCCcE
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH--------EQCNPKIIHRDLKAANILLDDNFEA  220 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~i~H~dlkp~Nill~~~~~~  220 (401)
                      .++||||+++|+|.+++..     ..+++..+..++.|++.||+|||        +.   +++||||||+|||++.++.+
T Consensus        81 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~  152 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQC  152 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCE
T ss_pred             eEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCE
Confidence            7899999999999999964     35899999999999999999999        76   99999999999999999999


Q ss_pred             EEeecCCccccCCCCcce---eccccCCcccccccccccC------CCCcccchhHHHHHHHHHHhC----------CCC
Q 015734          221 VLCDFGLAKLVDAKLTHV---TTQIRGTMGHIAPEYLSTG------KSSEKTDVFGYGITLLELVTG----------QRA  281 (401)
Q Consensus       221 kl~Dfgl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDi~slG~ll~elltg----------~~p  281 (401)
                      ||+|||++..........   .....||+.|+|||++.+.      .++.++|||||||++|||+||          ..|
T Consensus       153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p  232 (301)
T 3q4u_A          153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP  232 (301)
T ss_dssp             EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence            999999997655443322   2334689999999999876      455799999999999999999          777


Q ss_pred             CCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          282 IDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT--YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      |...........    ...........    .+..+.  .....+.++.+++..||+.||.+|||+.++++.|+.
T Consensus       233 f~~~~~~~~~~~----~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          233 FYDVVPNDPSFE----DMRKVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             TTTTSCSSCCHH----HHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             ccccCCCCcchh----hhhHHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            754322211111    11111111110    011111  234567889999999999999999999999999875

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.2e-46  Score=366.31  Aligned_cols=264  Identities=24%  Similarity=0.376  Sum_probs=216.1

Q ss_pred             HHHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCe
Q 015734           69 CRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE  148 (401)
Q Consensus        69 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  148 (401)
                      ..++++..++|.+.+.||+|+||.||+|.++++..||||+++..  ....+.|.+|+.+++.++||||+++++++. .+.
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~  256 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEP  256 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT--SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC--CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence            34456677889999999999999999999988899999999753  345788999999999999999999999986 567


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      .++||||+++|+|.+++....  ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++
T Consensus       257 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a  331 (454)
T 1qcf_A          257 IYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLA  331 (454)
T ss_dssp             CEEEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred             cEEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence            899999999999999997532  23478899999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      +..............+|+.|+|||++....++.++|||||||++|||+| |..||......+     ....+..   ...
T Consensus       332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~-----~~~~i~~---~~~  403 (454)
T 1qcf_A          332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALER---GYR  403 (454)
T ss_dssp             GGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----HHHHHHH---TCC
T ss_pred             eEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHc---CCC
Confidence            8765432222233446789999999998999999999999999999999 999997543211     1111111   111


Q ss_pred             cchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCc
Q 015734          308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDL  357 (401)
Q Consensus       308 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  357 (401)
                               ...+...+.++.+++.+||+.||++|||+.++++.|+....
T Consensus       404 ---------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          404 ---------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             ---------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence                     01123345678899999999999999999999999987543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=5e-46  Score=346.19  Aligned_cols=263  Identities=27%  Similarity=0.402  Sum_probs=215.0

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEE------CCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeec
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT  145 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  145 (401)
                      ++...++|.+.+.||+|+||.||+|..      .++..||+|++.........+.+.+|+++++.++||||+++++++..
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   97 (314)
T 2ivs_A           18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ   97 (314)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence            344567899999999999999999985      23578999999865566667889999999999999999999999999


Q ss_pred             CCeeEEEEecccCCcHHHHhhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 015734          146 SSERILVYPFMQNLSVAYRLRDLKP--------------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHR  205 (401)
Q Consensus       146 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~  205 (401)
                      .+..++||||+++++|.+++.....                    ....+++..+..++.|++.||+|||++   +++|+
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~  174 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHR  174 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECC
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccc
Confidence            9999999999999999999986432                    123488999999999999999999999   99999


Q ss_pred             CCCCCceEEcCCCcEEEeecCCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCC
Q 015734          206 DLKAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID  283 (401)
Q Consensus       206 dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~  283 (401)
                      ||||+||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus       175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  254 (314)
T 2ivs_A          175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  254 (314)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999999866443322 2233456889999999998889999999999999999999 999997


Q ss_pred             CCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          284 FSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ......     ....+.    ...        ....+...+.++.+++.+||+.||.+|||+.++++.|+.
T Consensus       255 ~~~~~~-----~~~~~~----~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~  308 (314)
T 2ivs_A          255 GIPPER-----LFNLLK----TGH--------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK  308 (314)
T ss_dssp             TCCGGG-----HHHHHH----TTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCHHH-----HHHHhh----cCC--------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            544321     111111    110        011223345678899999999999999999999999875

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-45  Score=351.41  Aligned_cols=264  Identities=27%  Similarity=0.390  Sum_probs=216.1

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEEC--------CCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeee
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVLS--------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGY  142 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~  142 (401)
                      +++..++|.+.+.||+|+||+||+|.+.        ++..||+|++...........+.+|+++++.+ +||||++++++
T Consensus        64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  143 (382)
T 3tt0_A           64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA  143 (382)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence            3456678999999999999999999852        23579999998766666678899999999999 89999999999


Q ss_pred             eecCCeeEEEEecccCCcHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 015734          143 CTTSSERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAA  210 (401)
Q Consensus       143 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~  210 (401)
                      +...+..++||||+++|+|.+++.....            ....+++..++.++.|++.||+|||++   +++||||||+
T Consensus       144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~  220 (382)
T 3tt0_A          144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR  220 (382)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred             eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcc
Confidence            9999999999999999999999987432            124599999999999999999999999   9999999999


Q ss_pred             ceEEcCCCcEEEeecCCccccCCCCc-ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcch
Q 015734          211 NILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLE  288 (401)
Q Consensus       211 Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~  288 (401)
                      |||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus       221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~  300 (382)
T 3tt0_A          221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  300 (382)
T ss_dssp             GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999986644322 22334457889999999999999999999999999999999 99999754321


Q ss_pred             hhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          289 EEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                      .     ....+.    ...        ....+...+.++.+++.+||+.||.+|||+.++++.|+..
T Consensus       301 ~-----~~~~~~----~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  350 (382)
T 3tt0_A          301 E-----LFKLLK----EGH--------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  350 (382)
T ss_dssp             H-----HHHHHH----TTC--------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H-----HHHHHH----cCC--------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1     111111    111        0111223345788999999999999999999999998753

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.3e-45  Score=345.04  Aligned_cols=254  Identities=22%  Similarity=0.313  Sum_probs=203.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      .++|.+.+.||+|+||+||+|... +++.||+|++.........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            367899999999999999999975 6899999998754444445678999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++++|.+++..    ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        86 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            9999999988864    34589999999999999999999999   9999999999999999999999999999865432


Q ss_pred             C-cceeccccCCcccccccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          235 L-THVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       235 ~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      . ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.........   ...    ........   
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~~----~~~~~~~~---  228 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---YSD----WKEKKTYL---  228 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH---HHH----HHTTCTTS---
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH---HHH----HhcccccC---
Confidence            2 222334578999999999987775 78899999999999999999999754432111   111    11110000   


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                           .........+.+++.+||+.||.+|||+.|++++
T Consensus       229 -----~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          229 -----NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             -----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -----CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                 0112334577899999999999999999999765

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-46  Score=354.00  Aligned_cols=260  Identities=28%  Similarity=0.373  Sum_probs=211.5

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCe
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE  148 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  148 (401)
                      ..++|.+.+.||+|+||+||+|...      ++..||||++...........+.+|+.++++++||||+++++++...+.
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  148 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  148 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            4567889999999999999999943      3568999999766566667789999999999999999999999999999


Q ss_pred             eEEEEecccCCcHHHHhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC---cEEE
Q 015734          149 RILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF---EAVL  222 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl  222 (401)
                      .++||||+++|+|.+++.....   ....+++..++.++.|++.||+|||++   +++||||||+|||++.++   .+||
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEE
Confidence            9999999999999999987542   224589999999999999999999999   999999999999999555   5999


Q ss_pred             eecCCccccCCCC-cceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHH
Q 015734          223 CDFGLAKLVDAKL-THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIR  300 (401)
Q Consensus       223 ~Dfgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~  300 (401)
                      +|||+++...... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||.......     ....+ 
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-----~~~~i-  299 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-----VLEFV-  299 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----HHHHH-
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHH-
Confidence            9999997543221 222334557899999999999999999999999999999998 999997543211     11111 


Q ss_pred             HHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          301 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       301 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                        .....         ...+...+..+.+++..||+.||.+|||+.++++.|+.
T Consensus       300 --~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~  342 (367)
T 3l9p_A          300 --TSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  342 (367)
T ss_dssp             --HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --HcCCC---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence              11110         11122334578899999999999999999999999864

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.4e-45  Score=344.66  Aligned_cols=269  Identities=26%  Similarity=0.300  Sum_probs=206.9

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCC----eeE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS----ERI  150 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~  150 (401)
                      ..++|.+.+.||+|+||+||+|... ++.||||++..  .......+..|+.++++++||||+++++++....    ..+
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   98 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPI--QDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW   98 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECG--GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC-CCEEEEEEeec--CchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence            4568899999999999999999984 88999999864  2334456677899999999999999999998754    369


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------CCCCeEEeCCCCCceEEcCCCcEEEe
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ-------CNPKIIHRDLKAANILLDDNFEAVLC  223 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------~~~~i~H~dlkp~Nill~~~~~~kl~  223 (401)
                      +||||+++|+|.+++..     ..+++..+..++.|++.||+|||+.       +.++++||||||+|||++.++.+||+
T Consensus        99 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence            99999999999999976     2489999999999999999999985       12379999999999999999999999


Q ss_pred             ecCCccccCCCCcc-eeccccCCccccccccccc-----CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhh-----
Q 015734          224 DFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEED-----  292 (401)
Q Consensus       224 Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~-----  292 (401)
                      |||+++........ ......||+.|+|||++.+     ..++.++|||||||++|||+||+.||..........     
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            99999866543322 2334568999999999976     346678999999999999999999997543211100     


Q ss_pred             ---hhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          293 ---VLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       293 ---~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                         ....+..... ........+....  .....+.++.+++.+||+.||.+|||+.++++.|+.
T Consensus       254 ~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  315 (322)
T 3soc_A          254 GQHPSLEDMQEVV-VHKKKRPVLRDYW--QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ  315 (322)
T ss_dssp             CSSCCHHHHHHHH-TTSCCCCCCCGGG--GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ccCCchhhhhhhh-hcccCCCCccccc--cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence               0111111111 1111111111000  123456779999999999999999999999999875

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.8e-45  Score=350.63  Aligned_cols=255  Identities=23%  Similarity=0.289  Sum_probs=200.9

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCee
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  149 (401)
                      +..++|.+.++||+|+||.||+|..+ +++.||+|+++...  .......+..|..++.++ +||||+++++++.+.+..
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~  128 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL  128 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence            34568999999999999999999975 57889999997432  223345678899999877 899999999999999999


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ++||||+++|+|..++...    ..+++..++.++.|++.||+|||++   +++||||||+|||++.++++||+|||+++
T Consensus       129 ~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~  201 (396)
T 4dc2_A          129 FFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK  201 (396)
T ss_dssp             EEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceee
Confidence            9999999999999999863    4589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccc
Q 015734          230 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN  309 (401)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ..... .......+||+.|+|||++.+..++.++|||||||++|||++|..||......+.......+..........  
T Consensus       202 ~~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--  278 (396)
T 4dc2_A          202 EGLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--  278 (396)
T ss_dssp             CCCCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--
T ss_pred             ecccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--
Confidence            53322 223445679999999999999999999999999999999999999997543221111111111111111110  


Q ss_pred             hhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 015734          310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM  345 (401)
Q Consensus       310 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  345 (401)
                             ...+...+.++.+++.+||+.||.+||++
T Consensus       279 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          279 -------IRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             -------cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                   11223344578899999999999999996

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.9e-44  Score=341.54  Aligned_cols=253  Identities=21%  Similarity=0.268  Sum_probs=207.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCc-----chHHHHHHHHHHHHhccCCcccceeeeeecCCe
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP-----GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE  148 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  148 (401)
                      ..+.|.+.+.||+|+||.||+|..+ +|..||+|.+......     ...+.+.+|+.++..++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            3567999999999999999999975 5899999999743221     245789999999999999999999999999999


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC----cEEEee
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF----EAVLCD  224 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~D  224 (401)
                      .++||||+++|+|.+++..    ...+++..+..++.|++.||.|||++   +++||||||+||+++.++    .+||+|
T Consensus        90 ~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~D  162 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID  162 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence            9999999999999999975    34699999999999999999999999   999999999999998877    799999


Q ss_pred             cCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhc
Q 015734          225 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR  304 (401)
Q Consensus       225 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (401)
                      ||++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+     .   ......
T Consensus       163 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-----~---~~~i~~  232 (361)
T 2yab_A          163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----T---LANITA  232 (361)
T ss_dssp             CSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----H---HHHHHT
T ss_pred             cCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-----H---HHHHHh
Confidence            99998765432  2334569999999999999899999999999999999999999997543211     1   111111


Q ss_pred             cC-ccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          305 ED-RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       305 ~~-~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .. .....       .....+..+.+++..||+.||.+|||+.+++++
T Consensus       233 ~~~~~~~~-------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          233 VSYDFDEE-------FFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             TCCCCCHH-------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cCCCCCch-------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            10 00000       011224568899999999999999999999874

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.3e-44  Score=336.37  Aligned_cols=262  Identities=20%  Similarity=0.260  Sum_probs=212.7

Q ss_pred             cccCHHHHHHHhcC----------CCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccC
Q 015734           65 RRFSCRELQLATDN----------FSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH  133 (401)
Q Consensus        65 ~~~~~~~~~~~~~~----------~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h  133 (401)
                      ..++.+++..+.+.          |...+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.+++.++|
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR-KQQRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT-TCCSHHHHHHHHHHHTTCCC
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEecc-chhHHHHHHHHHHHHHhCCC
Confidence            45677777766654          566779999999999999976 6999999998743 33456788999999999999


Q ss_pred             CcccceeeeeecCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceE
Q 015734          134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANIL  213 (401)
Q Consensus       134 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil  213 (401)
                      |||+++++++...+..++||||+++++|.+++..     ..+++..+..++.|++.||.|||+.   +++||||||+||+
T Consensus       102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl  173 (321)
T 2c30_A          102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL  173 (321)
T ss_dssp             TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred             CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence            9999999999999999999999999999998864     3589999999999999999999998   9999999999999


Q ss_pred             EcCCCcEEEeecCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhh
Q 015734          214 LDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV  293 (401)
Q Consensus       214 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~  293 (401)
                      ++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......    
T Consensus       174 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~----  248 (321)
T 2c30_A          174 LTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ----  248 (321)
T ss_dssp             ECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----
T ss_pred             ECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----
Confidence            99999999999999986654322 2334568999999999999999999999999999999999999997543211    


Q ss_pred             hHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          294 LLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                       ....+..    ...     +.. ......+..+.+++.+||+.||.+|||+.+++++
T Consensus       249 -~~~~~~~----~~~-----~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          249 -AMKRLRD----SPP-----PKL-KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             -HHHHHHH----SSC-----CCC-TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -HHHHHhc----CCC-----CCc-CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             1111111    100     000 0112334578899999999999999999999874

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.1e-45  Score=362.80  Aligned_cols=265  Identities=26%  Similarity=0.395  Sum_probs=218.4

Q ss_pred             HHHHHhcCCCCCCeeeecCcEEEEEEEECC-CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCee
Q 015734           71 ELQLATDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        71 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  149 (401)
                      .+++..++|.+.+.||+|+||.||+|.++. +..||||.+...  ....+.|.+|+.++++++||||+++++++...+..
T Consensus       214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  291 (495)
T 1opk_A          214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF  291 (495)
T ss_dssp             CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc--ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence            344566778889999999999999999764 789999998753  33467899999999999999999999999999999


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ++||||+++|+|.+++....  ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~  366 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSR  366 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred             EEEEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccce
Confidence            99999999999999998632  34589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          230 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ..............+++.|+|||++.+..++.++|||||||++|||+| |..||.......     ....+..   ... 
T Consensus       367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-----~~~~~~~---~~~-  437 (495)
T 1opk_A          367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYELLEK---DYR-  437 (495)
T ss_dssp             CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----HHHHHHT---TCC-
T ss_pred             eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHc---CCC-
Confidence            765443333344456789999999998899999999999999999999 999997644321     1111111   100 


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCchh
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAE  359 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~  359 (401)
                              ...+...+.++.+++.+||+.||.+|||+.++++.|+......
T Consensus       438 --------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~  480 (495)
T 1opk_A          438 --------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  480 (495)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred             --------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence                    0122334567889999999999999999999999998765443

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=6e-46  Score=362.90  Aligned_cols=263  Identities=27%  Similarity=0.389  Sum_probs=209.3

Q ss_pred             HHHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCe
Q 015734           69 CRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE  148 (401)
Q Consensus        69 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  148 (401)
                      ...+++..++|.+.+.||+|+||.||+|.++++..||||+++...  ...+.|.+|+.++++++||||+++++++.+ +.
T Consensus       176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~  252 (452)
T 1fmk_A          176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP  252 (452)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence            344556778899999999999999999999888889999987532  345789999999999999999999999876 67


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      .++||||+++|+|.+++....  ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++
T Consensus       253 ~~iv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a  327 (452)
T 1fmk_A          253 IYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA  327 (452)
T ss_dssp             CEEEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             eEEEehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccc
Confidence            899999999999999997522  24589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      +..............+|+.|+|||.+.+..++.++||||||+++|||+| |..||......+     ...   .......
T Consensus       328 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-----~~~---~i~~~~~  399 (452)
T 1fmk_A          328 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLD---QVERGYR  399 (452)
T ss_dssp             C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHH---HHHTTCC
T ss_pred             eecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-----HHH---HHHcCCC
Confidence            8765433333333456789999999999999999999999999999999 999997543211     111   1111111


Q ss_pred             cchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 015734          308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED  356 (401)
Q Consensus       308 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  356 (401)
                               ...+...+..+.+++.+||+.||++|||++++++.|+...
T Consensus       400 ---------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          400 ---------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             ---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                     1122344567889999999999999999999999998754

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.3e-45  Score=343.02  Aligned_cols=255  Identities=23%  Similarity=0.379  Sum_probs=201.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCC----EEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI  150 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  150 (401)
                      .++|...+.||+|+||+||+|.+. ++.    +||+|.+...........+.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            457888999999999999999964 344    468888865555566788999999999999999999999998754 78


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      ++++|+.+|+|.+++...   ...+++..++.++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++.
T Consensus        93 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence            999999999999999863   34689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          231 VDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       231 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ....... ......+|+.|+|||.+.+..++.++|||||||++|||+| |..||.......     ....+.    ... 
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~~~~~~----~~~-  236 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISSILE----KGE-  236 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HHHHHH----TTC-
T ss_pred             ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-----HHHHHH----cCC-
Confidence            6543322 2233456889999999999999999999999999999999 999997644321     111111    110 


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                             ....+.....++.+++.+||+.||.+|||+.++++.|+.
T Consensus       237 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~  275 (327)
T 3poz_A          237 -------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK  275 (327)
T ss_dssp             -------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHH
T ss_pred             -------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence                   011223345578899999999999999999999999875

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.2e-45  Score=343.55  Aligned_cols=248  Identities=21%  Similarity=0.311  Sum_probs=203.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      .++|.+.+.||+|+||.||+|.+ .+++.||+|++....  .......+.+|+.+++.++||||+++++++...+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            35789999999999999999996 568999999986321  122345788999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||+ +|+|.+++...    ..+++..++.++.|++.||.|||++   +++||||||+||++++++.+||+|||++....
T Consensus        88 ~E~~-~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             ECCC-CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             EECC-CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            9999 78998888763    4589999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCcceeccccCCcccccccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ...  ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||+.......                  ...
T Consensus       160 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~------------------~~~  219 (336)
T 3h4j_B          160 DGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL------------------FKK  219 (336)
T ss_dssp             TSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC------------------BCC
T ss_pred             CCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH------------------HHH
Confidence            432  2234569999999999988776 7899999999999999999999975432110                  001


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      +.......+...+.++.+++.+||+.||.+|||+++++++
T Consensus       220 i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          220 VNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             CCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             HHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            1111112233345678899999999999999999999663

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.5e-45  Score=332.52  Aligned_cols=255  Identities=25%  Similarity=0.373  Sum_probs=210.9

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      ..++|.+.+.||+|+||.||+|...++..||+|++....  ...+.+.+|+++++.++||||+++++++...+..+++||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE   83 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred             chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence            346788899999999999999999888899999997532  345789999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++++|.+++...   ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++......
T Consensus        84 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  157 (267)
T 3t9t_A           84 FMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  157 (267)
T ss_dssp             CCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             CCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc
Confidence            99999999999863   34589999999999999999999999   9999999999999999999999999999866443


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      .........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.......     .   .........      
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~---~~~i~~~~~------  223 (267)
T 3t9t_A          158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-----V---VEDISTGFR------  223 (267)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----H---HHHHHTTCC------
T ss_pred             cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH-----H---HHHHhcCCc------
Confidence            3233334457789999999998899999999999999999999 899997543211     1   111111100      


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                         ...+...+..+.+++.+||+.||.+|||+.++++.|+.
T Consensus       224 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  261 (267)
T 3t9t_A          224 ---LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE  261 (267)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence               01122234578899999999999999999999999875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.2e-45  Score=346.73  Aligned_cols=266  Identities=23%  Similarity=0.346  Sum_probs=214.4

Q ss_pred             HHHHHhcCCCCCCeeeecCcEEEEEEEECC-C-----CEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeee
Q 015734           71 ELQLATDNFSESNIIGQGGFGKVYKGVLSD-N-----TKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYC  143 (401)
Q Consensus        71 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  143 (401)
                      ++++..++|.+.+.||+|+||.||+|.... +     ..||+|.+...........+.+|+.++..+ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            355667889999999999999999999643 2     479999998655556678899999999999 899999999999


Q ss_pred             ecCCeeEEEEecccCCcHHHHhhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceE
Q 015734          144 TTSSERILVYPFMQNLSVAYRLRDLKP----------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANIL  213 (401)
Q Consensus       144 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil  213 (401)
                      ...+..++||||+++|+|.+++.....          ....+++..+..++.|++.||+|||++   +++|+||||+||+
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence            999999999999999999999875321          134589999999999999999999999   9999999999999


Q ss_pred             EcCCCcEEEeecCCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhh
Q 015734          214 LDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEE  291 (401)
Q Consensus       214 l~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~  291 (401)
                      ++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|+| |..||........ 
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-  275 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-  275 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-
Confidence            999999999999999865443222 2333456889999999999899999999999999999999 8999975433211 


Q ss_pred             hhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          292 DVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                         .........         ..   ..+...+..+.+++..||+.||.+|||+.++++.|+..
T Consensus       276 ---~~~~~~~~~---------~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          276 ---FYKLVKDGY---------QM---AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             ---HHHHHHHTC---------CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHHHhcCC---------CC---CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence               111111110         00   11122345788999999999999999999999998753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.2e-45  Score=347.10  Aligned_cols=252  Identities=25%  Similarity=0.339  Sum_probs=201.3

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCe
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSE  148 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  148 (401)
                      .+..++|.+.+.||+|+||+||+|..+ +++.||+|++...  ........+.+|..++..+ +||||+++++++.+.+.
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~   98 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR   98 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence            345678999999999999999999975 5899999999742  1233456788999999987 69999999999999999


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      .++||||+++|+|..++...    ..+++..++.++.|++.||+|||++   +++||||||+|||++.++++||+|||++
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a  171 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMC  171 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccce
Confidence            99999999999999999863    4589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      +..... .......+||+.|+|||++.+..++.++|||||||++|||++|..||......+     .   ........  
T Consensus       172 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-----~---~~~i~~~~--  240 (353)
T 3txo_A          172 KEGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-----L---FEAILNDE--  240 (353)
T ss_dssp             BCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----H---HHHHHHCC--
T ss_pred             eecccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-----H---HHHHHcCC--
Confidence            854322 223344679999999999998899999999999999999999999997654321     1   11111111  


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM------AQVVK  350 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~------~~vl~  350 (401)
                              ..++.....++.+++.+||+.||.+||++      .++++
T Consensus       241 --------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          241 --------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             --------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                    01122234578899999999999999998      66655

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.4e-45  Score=343.03  Aligned_cols=253  Identities=20%  Similarity=0.283  Sum_probs=201.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCC-------
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-------  147 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------  147 (401)
                      .++|.+.+.||+|+||.||+|.++ +++.||||++.........+.+.+|++++++++||||+++++++.+.+       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            357888999999999999999976 789999999975555567788999999999999999999999885543       


Q ss_pred             --------------------------------------------------eeEEEEecccCCcHHHHhhhcCCCCCCCCH
Q 015734          148 --------------------------------------------------ERILVYPFMQNLSVAYRLRDLKPGEKGLDW  177 (401)
Q Consensus       148 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~  177 (401)
                                                                        ..++||||+++++|.+++..... ....++
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~  163 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH  163 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence                                                              27899999999999999986432 234577


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCc-----------ceeccccCCc
Q 015734          178 PTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-----------HVTTQIRGTM  246 (401)
Q Consensus       178 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~-----------~~~~~~~gt~  246 (401)
                      ..++.++.|++.||+|||++   +++||||||+||+++.++.+||+|||++........           .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            78899999999999999999   999999999999999999999999999987654421           1223356899


Q ss_pred             ccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHH
Q 015734          247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVET  326 (401)
Q Consensus       247 ~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  326 (401)
                      .|+|||.+.+..++.++|||||||++|||++|..|+..       ....   ... ....        ..+........+
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-------~~~~---~~~-~~~~--------~~~~~~~~~~~~  301 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-------RVRI---ITD-VRNL--------KFPLLFTQKYPQ  301 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-------HHHH---HHH-HHTT--------CCCHHHHHHCHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-------HHHH---HHH-hhcc--------CCCcccccCChh
Confidence            99999999999999999999999999999998766421       0001   111 1111        111112344567


Q ss_pred             HHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          327 MVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       327 l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      +.+++.+||+.||.+|||+.+++++
T Consensus       302 ~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          302 EHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHccCCCCcCCCHHHHhhc
Confidence            7899999999999999999999874

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.7e-45  Score=338.76  Aligned_cols=252  Identities=16%  Similarity=0.237  Sum_probs=206.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      .++|.+.+.||+|+||+||+|... ++..||+|.+..  .......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV--KGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC--CTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEec--CcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            467899999999999999999975 578999999864  23455678999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC--CCcEEEeecCCccccC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD--NFEAVLCDFGLAKLVD  232 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~--~~~~kl~Dfgl~~~~~  232 (401)
                      |+++++|.+++...   ...+++..+..++.|++.||.|||++   +++||||||+||+++.  ++.+||+|||++....
T Consensus        82 ~~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           82 FISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             CCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             eCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence            99999999998752   34689999999999999999999999   9999999999999987  7899999999998765


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ...  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......     ....+...  ....... 
T Consensus       156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i~~~--~~~~~~~-  225 (321)
T 1tki_A          156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-----IIENIMNA--EYTFDEE-  225 (321)
T ss_dssp             TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHHHT--CCCCCHH-
T ss_pred             CCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-----HHHHHHcC--CCCCChh-
Confidence            432  2334568999999999998889999999999999999999999997543211     11111110  0000000 


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                            .....+.++.+++.+||+.||.+|||+.+++++
T Consensus       226 ------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          226 ------AFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             ------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                  001234578899999999999999999999884

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=351.48  Aligned_cols=255  Identities=18%  Similarity=0.233  Sum_probs=206.7

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      ..++|.+.+.||+|+||+||+|... +|+.||+|++.... +......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            4567999999999999999999964 68899999987432 334556789999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEc---CCCcEEEeecCCcc
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---DNFEAVLCDFGLAK  229 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfgl~~  229 (401)
                      |||+++|+|.+.+..    ...+++..+..++.|++.||.|||++   +++||||||+|||++   +++.+||+|||++.
T Consensus        89 ~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           89 FDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             ECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            999999999999886    34589999999999999999999999   999999999999998   56889999999998


Q ss_pred             ccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccc
Q 015734          230 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN  309 (401)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......     ....+..    ... 
T Consensus       162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-----~~~~i~~----~~~-  230 (444)
T 3soa_A          162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-----LYQQIKA----GAY-  230 (444)
T ss_dssp             CCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHH----TCC-
T ss_pred             EecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-----HHHHHHh----CCC-
Confidence            6654322 2234579999999999999899999999999999999999999997543211     1111111    110 


Q ss_pred             hhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       310 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ....+    .....+.++.+++..||+.||.+|||+.+++++
T Consensus       231 ~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          231 DFPSP----EWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             CCCTT----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCcc----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            00001    112334578899999999999999999999875

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=9.4e-45  Score=343.12  Aligned_cols=258  Identities=20%  Similarity=0.256  Sum_probs=206.9

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc----CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCee
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY----YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  149 (401)
                      ..++|.+.+.||+|+||+||+|..+ +++.||+|++...    ......+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            3467999999999999999999965 6899999998531    1223467899999999999999999999999999999


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCc---EEEeecC
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE---AVLCDFG  226 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfg  226 (401)
                      ++||||+++++|.+.+.........+++..+..++.|++.||+|||++   +++||||||+|||++.++.   +||+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence            999999999999988875443445689999999999999999999999   9999999999999986655   9999999


Q ss_pred             CccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC
Q 015734          227 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED  306 (401)
Q Consensus       227 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (401)
                      ++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....      .....+...  ..
T Consensus       179 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~i~~~--~~  249 (351)
T 3c0i_A          179 VAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE------RLFEGIIKG--KY  249 (351)
T ss_dssp             TCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH------HHHHHHHHT--CC
T ss_pred             ceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH------HHHHHHHcC--CC
Confidence            9987654322 23345699999999999999999999999999999999999999975321      111111110  00


Q ss_pred             ccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       307 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .....       .....+.++.+++.+||+.||.+|||+.+++++
T Consensus       250 ~~~~~-------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          250 KMNPR-------QWSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             CCCHH-------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCcc-------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            00000       001224578899999999999999999999874

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.8e-45  Score=336.41  Aligned_cols=262  Identities=23%  Similarity=0.334  Sum_probs=201.7

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      ++|.+.+.||+|+||+||+|...+++.||+|++.... .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            4788899999999999999999889999999986432 223346788999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +++ +|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.......
T Consensus        82 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             CSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             cCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence            975 888888753   34589999999999999999999999   99999999999999999999999999998654332


Q ss_pred             cceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC---ccch-
Q 015734          236 THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED---RLND-  310 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-  310 (401)
                      . ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||......+    .+.... ......   .... 
T Consensus       155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~~~-~~~~~~~~~~~~~~  228 (288)
T 1ob3_A          155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD----QLMRIF-RILGTPNSKNWPNV  228 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHH-HHHCCCCTTTSTTG
T ss_pred             c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHH-HHHCCCChhhchhh
Confidence            2 22334689999999998764 58999999999999999999999997643221    111111 111110   0000 


Q ss_pred             ----hccCcCC--------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          311 ----IVDRNLN--------TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       311 ----~~d~~~~--------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                          ..++...        ........++.+++.+||+.||.+|||+.+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                0111110        0112345678899999999999999999999764

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.7e-45  Score=340.13  Aligned_cols=264  Identities=26%  Similarity=0.401  Sum_probs=215.0

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEE------CCCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeee
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT  144 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  144 (401)
                      +++..++|.+.+.||+|+||.||+|..      .++..||+|++.........+.+.+|+.++.++ +||||+++++++.
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            345567899999999999999999985      246789999998655555668899999999999 8999999999999


Q ss_pred             cCCeeEEEEecccCCcHHHHhhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 015734          145 TSSERILVYPFMQNLSVAYRLRDLKPG--------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAA  210 (401)
Q Consensus       145 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~  210 (401)
                      ..+..++||||+++|+|.+++......              ...+++..++.++.|++.||+|||++   +++|+||||+
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~  174 (313)
T 1t46_A           98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR  174 (313)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccc
Confidence            999999999999999999999864321              23589999999999999999999999   9999999999


Q ss_pred             ceEEcCCCcEEEeecCCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcch
Q 015734          211 NILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLE  288 (401)
Q Consensus       211 Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~  288 (401)
                      ||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|+| |..||......
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  254 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence            999999999999999999866544332 2333456889999999999999999999999999999999 99999754332


Q ss_pred             hhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          289 EEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ..    ..........            ...+...+.++.+++.+||+.||.+|||+.++++.|+.
T Consensus       255 ~~----~~~~~~~~~~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  304 (313)
T 1t46_A          255 SK----FYKMIKEGFR------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (313)
T ss_dssp             HH----HHHHHHHTCC------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hH----HHHHhccCCC------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence            11    1111111100            01122334678899999999999999999999999875

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.8e-45  Score=338.24  Aligned_cols=261  Identities=26%  Similarity=0.399  Sum_probs=217.4

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEECC-CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeE
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI  150 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  150 (401)
                      +++..++|.+.+.||+|+||+||+|.+.. +..||+|.+..  .....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   85 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS--CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence            34466789999999999999999999764 78899999875  3345678999999999999999999999999999999


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      +||||+++++|.+++....  ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||++..
T Consensus        86 ~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  160 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL  160 (288)
T ss_dssp             EEEECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred             EEEEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCcccee
Confidence            9999999999999998632  35689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccc
Q 015734          231 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN  309 (401)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      .............+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.......     .......   ..   
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-----~~~~~~~---~~---  229 (288)
T 3kfa_A          161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYELLEK---DY---  229 (288)
T ss_dssp             SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----HHHHHHT---TC---
T ss_pred             ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHhc---cC---
Confidence            76555444555567889999999999999999999999999999999 999997544321     1111111   00   


Q ss_pred             hhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 015734          310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED  356 (401)
Q Consensus       310 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  356 (401)
                            ....+...+.++.+++..||+.||.+|||+.++++.|+...
T Consensus       230 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~  270 (288)
T 3kfa_A          230 ------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  270 (288)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence                  01112333467889999999999999999999999997643

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.3e-45  Score=343.38  Aligned_cols=262  Identities=25%  Similarity=0.385  Sum_probs=196.4

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEECC-C---CEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLSD-N---TKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS  147 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  147 (401)
                      .+..++|.+.+.||+|+||.||+|.+.. +   ..||+|++.... .....+.+.+|+.++++++||||+++++++....
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            4456789999999999999999999654 3   279999987432 4455688999999999999999999999998776


Q ss_pred             ee------EEEEecccCCcHHHHhhhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCc
Q 015734          148 ER------ILVYPFMQNLSVAYRLRDLKPG--EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE  219 (401)
Q Consensus       148 ~~------~lv~e~~~~gsL~~~l~~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~  219 (401)
                      ..      +++|||+++++|.+++......  ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCC
Confidence            55      8999999999999998754322  23589999999999999999999999   9999999999999999999


Q ss_pred             EEEeecCCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHH
Q 015734          220 AVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLD  297 (401)
Q Consensus       220 ~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~  297 (401)
                      +||+|||++......... ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.......     ...
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----~~~  250 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-----IYN  250 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HHH
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-----HHH
Confidence            999999999865443221 2223446789999999999999999999999999999999 899997544321     111


Q ss_pred             HHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          298 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       298 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      .   ....         .....+...+.++.+++.+||+.||.+|||+.++++.|+.
T Consensus       251 ~---~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~  295 (323)
T 3qup_A          251 Y---LIGG---------NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELEN  295 (323)
T ss_dssp             H---HHTT---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             H---HhcC---------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            1   1111         1111233345678999999999999999999999999875

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.6e-45  Score=335.85  Aligned_cols=265  Identities=23%  Similarity=0.336  Sum_probs=204.7

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEE-----CCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecC--C
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--S  147 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~  147 (401)
                      ..++|++.+.||+|+||+||+|.+     .+++.||+|++... .....+.+.+|++++++++||||+++++++...  .
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   86 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   86 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            456788999999999999999984     25789999998742 344567899999999999999999999998654  4


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCC
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL  227 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl  227 (401)
                      ..++||||+++++|.+++...   ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~  160 (295)
T 3ugc_A           87 NLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL  160 (295)
T ss_dssp             SCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred             ceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence            589999999999999999863   23589999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCcc--eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhh-------hhhhHHHH
Q 015734          228 AKLVDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE-------EDVLLLDH  298 (401)
Q Consensus       228 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~-------~~~~~~~~  298 (401)
                      +.........  ......++..|+|||.+.+..++.++||||||+++|+|+||..|+........       ........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence            9866443221  22334467789999999999999999999999999999999999864321100       00000001


Q ss_pred             HHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          299 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       299 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      .......        ......+...+.++.+++..||+.||.+|||+.++++.|+.
T Consensus       241 ~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~  288 (295)
T 3ugc_A          241 LIELLKN--------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ  288 (295)
T ss_dssp             HHHHHHT--------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHhc--------cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence            1111111        11112233445688999999999999999999999999875

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.4e-44  Score=340.86  Aligned_cols=253  Identities=23%  Similarity=0.282  Sum_probs=201.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCeeEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  151 (401)
                      .++|.+.+.||+|+||.||+|..+ +++.||+|++....  .......+.+|..++.++ +||||+++++++.+.+..++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            357888999999999999999975 58899999997432  333456788999999887 89999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      ||||+++|+|..++...    ..+++..++.++.|++.||.|||++   +++||||||+|||++.++++||+|||+++..
T Consensus        88 v~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             EECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            99999999999999863    3589999999999999999999999   9999999999999999999999999999854


Q ss_pred             CCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++|..||.........................    
T Consensus       161 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~----  235 (345)
T 3a8x_A          161 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----  235 (345)
T ss_dssp             CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC----
T ss_pred             cCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC----
Confidence            3222 22344679999999999999999999999999999999999999997532211111000111111111111    


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM  345 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  345 (401)
                           ...+...+.++.+++.+||+.||.+||++
T Consensus       236 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          236 -----IRIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             -----CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence                 01222344578899999999999999996

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.8e-45  Score=352.44  Aligned_cols=260  Identities=19%  Similarity=0.258  Sum_probs=209.6

Q ss_pred             HHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecC
Q 015734           70 RELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS  146 (401)
Q Consensus        70 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  146 (401)
                      .+++...++|.+.++||+|+||+||+|..+ +++.||+|++....  .......+.+|..++..++||||+++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            455567789999999999999999999975 58899999986311  112234578999999999999999999999999


Q ss_pred             CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecC
Q 015734          147 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG  226 (401)
Q Consensus       147 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  226 (401)
                      +..++||||+++|+|.+++..     ..+++..++.++.|++.||+|||++   +++||||||+|||++.++++||+|||
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG  213 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG  213 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccc
Confidence            999999999999999999875     2489999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCcceeccccCCcccccccccccCC----CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHH
Q 015734          227 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK----SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL  302 (401)
Q Consensus       227 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  302 (401)
                      +++..............||+.|+|||++.+..    ++.++|||||||++|||++|..||...+....        ....
T Consensus       214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--------~~~i  285 (410)
T 3v8s_A          214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT--------YSKI  285 (410)
T ss_dssp             TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--------HHHH
T ss_pred             eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH--------HHHH
Confidence            99876554444445667999999999997655    78999999999999999999999986543211        1111


Q ss_pred             hccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 015734          303 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPED--RPPMAQVVKM  351 (401)
Q Consensus       303 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~~vl~~  351 (401)
                      .....  .+   ..+ .....+.++.+++.+||+.+|.+  ||++++++++
T Consensus       286 ~~~~~--~~---~~p-~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          286 MNHKN--SL---TFP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HTHHH--HC---CCC-TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             Hhccc--cc---cCC-CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            11000  00   000 01123457889999999999988  9999999875

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.7e-44  Score=332.70  Aligned_cols=263  Identities=23%  Similarity=0.297  Sum_probs=202.5

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      ++|.+.+.||+|+||+||+|... +++.||+|++.... .......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            47888999999999999999975 58899999997433 34455788999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++ ++.+.+...   ...+++..++.++.|++.||+|||++   +++||||||+||+++.++.+||+|||++......
T Consensus        82 ~~~~-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             cCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            9976 555555542   34699999999999999999999999   9999999999999999999999999999866433


Q ss_pred             CcceeccccCCcccccccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC---ccch
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED---RLND  310 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  310 (401)
                      .. ......||+.|+|||++.+.. ++.++|||||||++|+|++|..|+-......   ..+ ..+.......   ....
T Consensus       155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~---~~~-~~i~~~~~~~~~~~~~~  229 (292)
T 3o0g_A          155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD---DQL-KRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH---HHH-HHHHHHHCCCCTTTCTT
T ss_pred             cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH---HHH-HHHHHHhCCCChhhhhh
Confidence            22 233456899999999997766 7999999999999999999888853222111   111 1111111110   0000


Q ss_pred             hc-------------cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          311 IV-------------DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       311 ~~-------------d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..             ........+....++.+++.+||+.||.+|||++|++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            00             000111223445678899999999999999999999764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.9e-44  Score=342.28  Aligned_cols=254  Identities=21%  Similarity=0.243  Sum_probs=207.2

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      ..++|.+.+.||+|+||.||+|..+ ++..||+|++... ......+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4568999999999999999999975 5899999999743 3444567889999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCC---CcEEEeecCCcc
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN---FEAVLCDFGLAK  229 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~---~~~kl~Dfgl~~  229 (401)
                      |||+++++|.+++..    ...+++..+..++.|++.||.|||++   +++||||||+|||++.+   +.+||+|||++.
T Consensus       107 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          107 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             ECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            999999999998875    34589999999999999999999999   99999999999999865   459999999998


Q ss_pred             ccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccc
Q 015734          230 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN  309 (401)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||......     .+...+...  .....
T Consensus       180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-----~~~~~i~~~--~~~~~  250 (362)
T 2bdw_A          180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-----RLYAQIKAG--AYDYP  250 (362)
T ss_dssp             CCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHT--CCCCC
T ss_pred             EecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHhC--CCCCC
Confidence            665432  223456999999999999989999999999999999999999999754321     111111111  00000


Q ss_pred             hhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       310 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .       ......+.++.+++.+||+.||.+|||+.+++++
T Consensus       251 ~-------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          251 S-------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             T-------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             c-------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0       0112334678899999999999999999999875

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.8e-45  Score=335.51  Aligned_cols=258  Identities=29%  Similarity=0.429  Sum_probs=210.9

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      +++..++|.+.+.||+|+||.||+|...++..||+|.+...  ....+.+.+|+++++.++||||+++++++.. +..++
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   84 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG--SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC--cccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence            44556789999999999999999999888889999998753  2346789999999999999999999999864 56899


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      ||||+++++|.+++....  ...+++..+..++.|++.||+|||++   +++|+||||+||++++++.+||+|||++...
T Consensus        85 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (279)
T ss_dssp             EEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence            999999999999987521  12589999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccch
Q 015734          232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND  310 (401)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ............+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......     .   .........   
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----~---~~~~~~~~~---  228 (279)
T 1qpc_A          160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-----V---IQNLERGYR---  228 (279)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----H---HHHHHTTCC---
T ss_pred             cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH-----H---HHHHhcccC---
Confidence            5544333344457889999999988889999999999999999999 899987543211     1   111111100   


Q ss_pred             hccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       311 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                            ...+...+.++.+++..||+.||++|||+.++++.|+.
T Consensus       229 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  266 (279)
T 1qpc_A          229 ------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (279)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence                  01122334678899999999999999999999999875

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3e-44  Score=344.50  Aligned_cols=271  Identities=20%  Similarity=0.218  Sum_probs=205.5

Q ss_pred             hcCCCCCCeeeec--CcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           76 TDNFSESNIIGQG--GFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        76 ~~~~~~~~~lG~G--~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      .++|.+.+.||+|  +||+||+|..+ +++.||+|++... ........+.+|+.+++.++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4578999999999  99999999976 6899999999743 334456788899999999999999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      ||||+++++|.+++....  ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||.+...
T Consensus       104 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            999999999999998642  24589999999999999999999999   9999999999999999999999999998644


Q ss_pred             CCCCc------ceeccccCCccccccccccc--CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHh
Q 015734          232 DAKLT------HVTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL  303 (401)
Q Consensus       232 ~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  303 (401)
                      .....      .......||+.|+|||++.+  ..++.++|||||||++|||++|..||.....................
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  258 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence            22211      11223468899999999987  57899999999999999999999999754432211111110000000


Q ss_pred             ccC------------------ccchh----------ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          304 RED------------------RLNDI----------VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       304 ~~~------------------~~~~~----------~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ...                  .....          .+............++.+|+.+||+.||.+|||+.+++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            000                  00000          0000001223345678999999999999999999999765

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-44  Score=336.37  Aligned_cols=247  Identities=25%  Similarity=0.311  Sum_probs=205.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      .++|.+.+.||+|+||.||+|..+ +|+.||+|++....  .....+.+.+|..+++.++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            457888999999999999999975 68999999996421  223456788999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||+++|+|.+++..    ...+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++...
T Consensus        85 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           85 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             EeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            999999999999986    34589999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ..    .....||+.|+|||++.+..++.++|||||||++|||++|..||.......        .........      
T Consensus       158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~------  219 (318)
T 1fot_A          158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--------TYEKILNAE------  219 (318)
T ss_dssp             SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHCC------
T ss_pred             Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCC------
Confidence            32    234579999999999999999999999999999999999999997543211        111111111      


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM  351 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  351 (401)
                          ...+.....++.+++.+||+.||.+||     ++++++++
T Consensus       220 ----~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          220 ----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ----CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence                011223345788999999999999999     88888754

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.2e-44  Score=334.11  Aligned_cols=253  Identities=21%  Similarity=0.264  Sum_probs=206.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCC-----cchHHHHHHHHHHHHhccCCcccceeeeeecCCee
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-----PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  149 (401)
                      .++|.+.+.||+|+||.||+|... ++..||+|.+.....     ....+.+.+|+.+++.++||||+++++++...+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            456889999999999999999975 589999999874322     12467899999999999999999999999999999


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC----cEEEeec
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF----EAVLCDF  225 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~Df  225 (401)
                      ++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++    .+||+||
T Consensus        90 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            999999999999999875    34689999999999999999999999   999999999999999887    8999999


Q ss_pred             CCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhcc
Q 015734          226 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE  305 (401)
Q Consensus       226 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (401)
                      |++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......     ....+...  .
T Consensus       163 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~~~~~--~  233 (326)
T 2y0a_A          163 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----TLANVSAV--N  233 (326)
T ss_dssp             TTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----HHHHHHHT--C
T ss_pred             CCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-----HHHHHHhc--C
Confidence            9998664332  2234568999999999998999999999999999999999999997543211     11111110  0


Q ss_pred             CccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          306 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       306 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ......       .....+..+.+++.+||+.||.+|||+.+++++
T Consensus       234 ~~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          234 YEFEDE-------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             CCCCHH-------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CCcCcc-------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            000000       011223568899999999999999999999885

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.9e-45  Score=341.55  Aligned_cols=270  Identities=23%  Similarity=0.379  Sum_probs=218.6

Q ss_pred             cCHHHHHHHhcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCccccee
Q 015734           67 FSCRELQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLI  140 (401)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~  140 (401)
                      +..+++++..++|.+.+.||+|+||.||+|.+.      ++..||+|.+...........+.+|+.+++.++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            444556677889999999999999999999854      36789999997655555667899999999999999999999


Q ss_pred             eeeecCCeeEEEEecccCCcHHHHhhhcCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEE
Q 015734          141 GYCTTSSERILVYPFMQNLSVAYRLRDLKP------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL  214 (401)
Q Consensus       141 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill  214 (401)
                      +++.+.+..++||||+++++|.+++.....      ....+++..+..++.|++.||.|||++   +++||||||+||++
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence            999999999999999999999999875321      124578999999999999999999999   99999999999999


Q ss_pred             cCCCcEEEeecCCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhh
Q 015734          215 DDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEED  292 (401)
Q Consensus       215 ~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~  292 (401)
                      +.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.......   
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---  248 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---  248 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH---
Confidence            99999999999999865443222 2233346889999999999899999999999999999999 889987543211   


Q ss_pred             hhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 015734          293 VLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED  356 (401)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  356 (401)
                        .   ..... ..        .....+...+..+.+++..||+.||.+|||+.++++.|+...
T Consensus       249 --~---~~~~~-~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          249 --V---LRFVM-EG--------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             --H---HHHHH-TT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             --H---HHHHH-cC--------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence              1   11111 11        111122334567889999999999999999999999998754

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.9e-44  Score=328.57  Aligned_cols=254  Identities=28%  Similarity=0.377  Sum_probs=196.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCC---cchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS---PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      .++|...+.||+|+||.||+|.+ .+..||+|++.....   ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            46788899999999999999998 488999999864322   23457889999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC--------CCcEEEee
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD--------NFEAVLCD  224 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~--------~~~~kl~D  224 (401)
                      |||+++++|.+++..     ..+++..+..++.|++.||+|||++...+++|+||||+||+++.        ++.+||+|
T Consensus        85 ~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           85 MEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            999999999988853     35899999999999999999999982112999999999999986        77899999


Q ss_pred             cCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhc
Q 015734          225 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR  304 (401)
Q Consensus       225 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (401)
                      ||++........   ....||+.|+|||.+.+..++.++||||||+++|+|++|..||........        ......
T Consensus       160 fg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--------~~~~~~  228 (271)
T 3dtc_A          160 FGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV--------AYGVAM  228 (271)
T ss_dssp             CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH--------HHHHHT
T ss_pred             CCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--------HHhhhc
Confidence            999986543322   234689999999999999999999999999999999999999975432110        111111


Q ss_pred             cCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          305 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       305 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      .. .       ....+...+..+.+++.+||+.||.+|||+.+++++|+.
T Consensus       229 ~~-~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          229 NK-L-------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             SC-C-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             CC-C-------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            11 0       011223345678899999999999999999999999975

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=6.9e-45  Score=346.75  Aligned_cols=251  Identities=24%  Similarity=0.343  Sum_probs=204.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      .++|.+.+.||+|+||.||+|... +++.||+|++...  ........+.+|+.++..++||||+++++++.+.+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            467889999999999999999965 5889999998632  1233457889999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||+.+|+|..++..    ...+++..++.++.|++.||.|||++   +++||||||+|||++.++.+||+|||++....
T Consensus        94 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             ECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence            999999999999985    34599999999999999999999999   99999999999999999999999999998664


Q ss_pred             CCCcceeccccCCccccccccccc---CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN  309 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ..  .......||+.|+|||++.+   ..++.++|||||||++|||++|..||.........     ........     
T Consensus       167 ~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~-----~~~~~~~~-----  234 (384)
T 4fr4_A          167 RE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK-----EIVHTFET-----  234 (384)
T ss_dssp             TT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH-----HHHHHHHH-----
T ss_pred             CC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH-----HHHHHHhh-----
Confidence            33  22344679999999999864   45899999999999999999999999754332111     11111110     


Q ss_pred             hhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 015734          310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-MAQVVK  350 (401)
Q Consensus       310 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~~vl~  350 (401)
                           .....+...+.++.+++..||+.||.+||+ ++++.+
T Consensus       235 -----~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          235 -----TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -----CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -----cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                 111123334567889999999999999998 777654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3e-45  Score=352.47  Aligned_cols=265  Identities=21%  Similarity=0.231  Sum_probs=210.7

Q ss_pred             cCHHHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeee
Q 015734           67 FSCRELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYC  143 (401)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~  143 (401)
                      +.+.+..+..++|.+.++||+|+||.||+|..+ +++.||+|++....  .......+.+|..++..++||||+++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            345566677889999999999999999999975 68999999996421  122334578899999999999999999999


Q ss_pred             ecCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEe
Q 015734          144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLC  223 (401)
Q Consensus       144 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~  223 (401)
                      .+.+..++||||+++|+|.+++...   ...+++..++.++.|++.||+|||++   +++||||||+|||++.++++||+
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~  204 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLA  204 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEe
Confidence            9999999999999999999999863   23589999999999999999999999   99999999999999999999999


Q ss_pred             ecCCccccCCCCcceeccccCCcccccccccc-------cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHH
Q 015734          224 DFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS-------TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL  296 (401)
Q Consensus       224 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~  296 (401)
                      |||+++.............+||+.|+|||++.       ...++.++|||||||++|||++|+.||......+.      
T Consensus       205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------  278 (412)
T 2vd5_A          205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET------  278 (412)
T ss_dssp             CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------
T ss_pred             echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH------
Confidence            99999876554443444567999999999987       35689999999999999999999999976443211      


Q ss_pred             HHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCC---CCHHHHHHH
Q 015734          297 DHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDR---PPMAQVVKM  351 (401)
Q Consensus       297 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~R---Ps~~~vl~~  351 (401)
                        .........  .   ...+......+.++.+++.+||+ +|.+|   |++++++++
T Consensus       279 --~~~i~~~~~--~---~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          279 --YGKIVHYKE--H---LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             --HHHHHTHHH--H---CCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             --HHHHHhccc--C---cCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence              111111000  0   00111112234578899999999 99998   589998764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.8e-44  Score=334.29  Aligned_cols=266  Identities=24%  Similarity=0.338  Sum_probs=193.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      .++|.+.+.||+|+||.||+|..+ +++.||+|++...........+.+|+.+++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            468999999999999999999964 6899999999754444455788899999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          155 FMQNLSVAYRLRDLKP--GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |++ ++|.+++.....  ....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 599988875322  234589999999999999999999999   99999999999999999999999999998664


Q ss_pred             CCCcceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC---cc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED---RL  308 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~  308 (401)
                      .... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||......+.     ...+.......   ..
T Consensus       160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-----~~~i~~~~~~~~~~~~  233 (317)
T 2pmi_A          160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ-----LKLIFDIMGTPNESLW  233 (317)
T ss_dssp             SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----HHHHHHHHCSCCTTTC
T ss_pred             CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHHHhCCCChhHh
Confidence            3322 22334689999999998764 589999999999999999999999986543211     11111111100   00


Q ss_pred             chh-----ccCcCCC-------------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          309 NDI-----VDRNLNT-------------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       309 ~~~-----~d~~~~~-------------~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ...     ..+....             .......++.+++.+||+.||.+|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            000     0000000             011234578899999999999999999999653

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1e-44  Score=340.57  Aligned_cols=263  Identities=26%  Similarity=0.404  Sum_probs=213.5

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC--------CCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeee
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLS--------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYC  143 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  143 (401)
                      .+..++|.+.+.||+|+||.||+|.+.        ++..||+|++...........+.+|+.+++.+ +||||+++++++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            345678999999999999999999863        46789999998655556677899999999999 899999999999


Q ss_pred             ecCCeeEEEEecccCCcHHHHhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCc
Q 015734          144 TTSSERILVYPFMQNLSVAYRLRDLKPG------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN  211 (401)
Q Consensus       144 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N  211 (401)
                      ...+..++||||+++++|.+++......            ...+++..+..++.|++.||.|||+.   +++|+||||+|
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N  187 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN  187 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccce
Confidence            9999999999999999999999864321            23489999999999999999999999   99999999999


Q ss_pred             eEEcCCCcEEEeecCCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchh
Q 015734          212 ILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEE  289 (401)
Q Consensus       212 ill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~  289 (401)
                      |+++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  267 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  267 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence            99999999999999999866543322 2233456889999999988889999999999999999999 999997543211


Q ss_pred             hhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          290 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                           ....+..    ..        ....+...+.++.+++..||+.||.+|||+.++++.|+..
T Consensus       268 -----~~~~~~~----~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l  316 (334)
T 2pvf_A          268 -----LFKLLKE----GH--------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  316 (334)
T ss_dssp             -----HHHHHHH----TC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----HHHHHhc----CC--------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                 1111111    10        0111223445788999999999999999999999999764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=7.6e-45  Score=334.52  Aligned_cols=263  Identities=29%  Similarity=0.458  Sum_probs=199.2

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      ++..++|.+.+.||+|+||+||+|...  ..||+|++.... .....+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l   96 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI   96 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence            445678999999999999999999864  359999997433 445567899999999999999999999965 4556899


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      ||||+++++|.+++...   ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++...
T Consensus        97 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  170 (289)
T 3og7_A           97 VTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK  170 (289)
T ss_dssp             EEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             EEEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccc
Confidence            99999999999988652   35689999999999999999999999   9999999999999999999999999999755


Q ss_pred             CCCC-cceeccccCCcccccccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          232 DAKL-THVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       232 ~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      .... ........||+.|+|||.+.   +..++.++||||||+++|+|++|..||.......    .....+.    ...
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~----~~~  242 (289)
T 3og7_A          171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD----QIIEMVG----RGS  242 (289)
T ss_dssp             -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH----HHHHHHH----HTS
T ss_pred             ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH----HHHHHhc----ccc
Confidence            4321 22233456899999999986   5668889999999999999999999997543321    1111111    111


Q ss_pred             cchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 015734          308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED  356 (401)
Q Consensus       308 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  356 (401)
                      .    .+.........+.++.+++.+||+.||.+|||+.++++.|+...
T Consensus       243 ~----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          243 L----SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             C----CCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             c----CcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            1    11111223344568899999999999999999999999997643

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.4e-44  Score=351.29  Aligned_cols=253  Identities=26%  Similarity=0.352  Sum_probs=207.1

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCC-eeEE
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS-ERIL  151 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~l  151 (401)
                      .+..++|.+.+.||+|+||.||+|.++ ++.||||+++...   ..+.|.+|+.++++++||||+++++++.... ..++
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i  264 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI  264 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred             ccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence            345678888999999999999999984 7899999997532   4578999999999999999999999987665 7899


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      ||||+++|+|.+++....  ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++..
T Consensus       265 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  339 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  339 (450)
T ss_dssp             EEECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence            999999999999998642  33478999999999999999999999   9999999999999999999999999999854


Q ss_pred             CCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccch
Q 015734          232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND  310 (401)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ...    .....+++.|+|||.+.+..++.++|||||||++|||+| |..||......+     ....+.   ....   
T Consensus       340 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-----~~~~i~---~~~~---  404 (450)
T 1k9a_A          340 SST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPRVE---KGYK---  404 (450)
T ss_dssp             C----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-----HHHHHH---TTCC---
T ss_pred             ccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHH---cCCC---
Confidence            322    122346889999999999999999999999999999998 999997544321     111111   1110   


Q ss_pred             hccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       311 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                            ...+..++.++.+++..||+.||.+|||+.++++.|+..
T Consensus       405 ------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i  443 (450)
T 1k9a_A          405 ------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI  443 (450)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                  112234456888999999999999999999999998753

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.5e-44  Score=336.46  Aligned_cols=258  Identities=17%  Similarity=0.167  Sum_probs=206.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCeeEEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|.+.....   ...+.+|+.+++.+ +||||+++++++...+..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            46789999999999999999996 4688999999874322   23578999999999 9999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCc-----EEEeecCCc
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE-----AVLCDFGLA  228 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~-----~kl~Dfgl~  228 (401)
                      ||+ +++|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.     +||+|||++
T Consensus        85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a  157 (330)
T 2izr_A           85 ELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA  157 (330)
T ss_dssp             ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred             EeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence            999 99999999863   34699999999999999999999999   9999999999999999887     999999999


Q ss_pred             cccCCCCcc------eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHH
Q 015734          229 KLVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL  302 (401)
Q Consensus       229 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  302 (401)
                      +........      ......||+.|+|||++.+..++.++|||||||++|||++|..||.........  .....+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~--~~~~~i~~~  235 (330)
T 2izr_A          158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK--ERYQKIGDT  235 (330)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH--HHHHHHHHH
T ss_pred             eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHH--HHHHHHHhh
Confidence            865443221      123467999999999999999999999999999999999999999864322111  111111111


Q ss_pred             hccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          303 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       303 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ........ .       ....+ ++.+++..||+.||.+||+++++.+.|+.
T Consensus       236 ~~~~~~~~-~-------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~  278 (330)
T 2izr_A          236 KRATPIEV-L-------CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD  278 (330)
T ss_dssp             HHHSCHHH-H-------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             hccCCHHH-H-------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence            00000000 0       01112 78899999999999999999999998864

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.2e-44  Score=331.74  Aligned_cols=257  Identities=21%  Similarity=0.333  Sum_probs=205.9

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECC----CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI  150 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  150 (401)
                      ..++|.+.+.||+|+||+||+|.+.+    +..||+|.+.........+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            45688899999999999999998543    236999998765555667889999999999999999999999865 4568


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      +||||+++++|.+++...   ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++..
T Consensus        89 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             EEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             EEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            999999999999999763   34589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccc
Q 015734          231 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN  309 (401)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      .............+|+.|+|||.+.+..++.++||||||+++|+|+| |+.||.......     ....+...   ..  
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-----~~~~~~~~---~~--  232 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-----VIGVLEKG---DR--  232 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-----HHHHHHHT---CC--
T ss_pred             cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-----HHHHHhcC---CC--
Confidence            65543333344557889999999998899999999999999999998 999997543321     11111111   00  


Q ss_pred             hhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       310 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                             ...+...+..+.+++.+||+.||.+|||+.++++.|+..
T Consensus       233 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          233 -------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence                   011222345788999999999999999999999999763

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.9e-45  Score=338.34  Aligned_cols=265  Identities=22%  Similarity=0.328  Sum_probs=206.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-----CCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecC--Ce
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SE  148 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~  148 (401)
                      ...|.+.+.||+|+||.||+|.+     .+++.||+|++...........+.+|+.+++.++||||+++++++...  +.
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            34588899999999999999983     357899999998655556678899999999999999999999999876  56


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      .++||||+++++|.+++...   ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             EEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence            89999999999999999653   34589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcc--eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchh------hhhhhHHHHHH
Q 015734          229 KLVDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE------EEDVLLLDHIR  300 (401)
Q Consensus       229 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~------~~~~~~~~~~~  300 (401)
                      .........  ......+|..|+|||.+.+..++.++||||||+++|+|+||..|+.......      ...........
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV  253 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence            876554322  2334557888999999999999999999999999999999999864321100      00000001111


Q ss_pred             HHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          301 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       301 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      .....        ......+...+.++.+++.+||+.||.+|||+.++++.|+.
T Consensus       254 ~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          254 NTLKE--------GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             HHHHT--------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHhc--------cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            11111        11111233445688999999999999999999999999864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.5e-45  Score=343.83  Aligned_cols=253  Identities=25%  Similarity=0.356  Sum_probs=204.6

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhc-cCCcccceeeeeecCC
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSS  147 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  147 (401)
                      .....++|.+.+.||+|+||.||+|..+ +++.||+|++....  .......+..|..++..+ +||||+++++++.+.+
T Consensus        12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence            3456788999999999999999999975 58899999997421  123456788899999876 8999999999999999


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCC
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL  227 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl  227 (401)
                      ..++||||+++|+|.+++...    ..+++..+..++.|++.||.|||++   +++||||||+|||++.++++||+|||+
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~  164 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGM  164 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChh
Confidence            999999999999999999863    3589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          228 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      ++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||...+...     +...+.   ... 
T Consensus       165 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~~~i~---~~~-  234 (345)
T 1xjd_A          165 CKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-----LFHSIR---MDN-  234 (345)
T ss_dssp             CBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHH---HCC-
T ss_pred             hhhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHH---hCC-
Confidence            97543222 22345679999999999999999999999999999999999999997543321     111111   110 


Q ss_pred             cchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 015734          308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMA-QVVK  350 (401)
Q Consensus       308 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-~vl~  350 (401)
                            .   ..+...+.++.+++.+||+.||.+||++. ++++
T Consensus       235 ------~---~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          235 ------P---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             ------C---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ------C---CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence                  0   11222345788999999999999999997 6543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-44  Score=331.78  Aligned_cols=255  Identities=23%  Similarity=0.277  Sum_probs=202.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      .++|.+.+.||+|+||+||++... ++..+|+|++.........+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            467899999999999999999964 5889999999865555567889999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEE---cCCCcEEEeecCCcccc
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfgl~~~~  231 (401)
                      |+++++|.+.+.........+++..+..++.|++.||+|||+.   +++|+||||+||++   +.++.+||+|||++...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            9999999999876433346799999999999999999999999   99999999999999   55688999999999765


Q ss_pred             CCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ....  ......||+.|+|||.+. ..++.++||||||+++|+|++|..||........     .   ........    
T Consensus       178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~-----~---~~~~~~~~----  242 (285)
T 3is5_A          178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV-----Q---QKATYKEP----  242 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----H---HHHHHCCC----
T ss_pred             CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH-----H---hhhccCCc----
Confidence            4432  223456899999999885 5689999999999999999999999976443211     1   11100000    


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                         ...........++.+++.+||+.||.+|||+.+++++
T Consensus       243 ---~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          243 ---NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             ---CCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             ---ccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               0000011123578899999999999999999999763

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-44  Score=331.23  Aligned_cols=257  Identities=24%  Similarity=0.360  Sum_probs=209.1

Q ss_pred             hcCCCCCC-eeeecCcEEEEEEEEC---CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           76 TDNFSESN-IIGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        76 ~~~~~~~~-~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      .++|.+.+ .||+|+||.||+|.+.   ++..||+|++.........+.+.+|+++++.++||||+++++++ ..+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            34566666 8999999999999853   57789999998655556678899999999999999999999999 4566899


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      ||||+++++|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++...
T Consensus        87 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence            9999999999999874   234689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcce--eccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          232 DAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       232 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      .......  .....+|+.|+|||.+.+..++.++||||||+++|+|+| |..||.......     ....+.    ... 
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~~~~i~----~~~-  230 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----VMAFIE----QGK-  230 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-----HHHHHH----TTC-
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-----HHHHHh----cCC-
Confidence            5433222  223346889999999988889999999999999999999 999997543321     111111    110 


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED  356 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  356 (401)
                             ....+...+.++.+++..||+.||.+||++.++++.|+...
T Consensus       231 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  271 (287)
T 1u59_A          231 -------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  271 (287)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                   11123344568889999999999999999999999987643

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.4e-44  Score=339.73  Aligned_cols=247  Identities=21%  Similarity=0.253  Sum_probs=205.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      .++|.+.+.||+|+||.||+|..+ +|+.||+|++....  .......+.+|++++..++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            357888999999999999999975 68999999986321  223457788999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||+++|+|.+++...    ..+++..++.++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++...
T Consensus       120 ~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~  192 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             EECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceecc
Confidence            9999999999999863    3589999999999999999999999   99999999999999999999999999998664


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ..    .....||+.|+|||++.+..++.++|||||||++|||++|..||.......        ......... .    
T Consensus       193 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--------~~~~i~~~~-~----  255 (350)
T 1rdq_E          193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--------IYEKIVSGK-V----  255 (350)
T ss_dssp             SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCC-C----
T ss_pred             CC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH--------HHHHHHcCC-C----
Confidence            43    234568999999999999999999999999999999999999997543211        111111111 0    


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVKM  351 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~~  351 (401)
                           ..+...+.++.+++.+||+.||.+||+     +++++++
T Consensus       256 -----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             -----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -----CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence                 112233457889999999999999998     7888654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.8e-44  Score=335.73  Aligned_cols=251  Identities=22%  Similarity=0.253  Sum_probs=196.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEE----CCCCEEEEEEecccC---CcchHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS  147 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  147 (401)
                      ..++|.+.+.||+|+||.||++..    .+++.||+|++....   .......+.+|+.+++.++||||+++++++...+
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG   94 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence            456899999999999999999996    468999999997532   2234566789999999999999999999999999


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCC
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL  227 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl  227 (401)
                      ..++||||+++++|.+++...    ..+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~  167 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGL  167 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred             EEEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCc
Confidence            999999999999999999863    3588999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          228 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      ++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......     .   ........ 
T Consensus       168 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~---~~~i~~~~-  237 (327)
T 3a62_A          168 CKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-----T---IDKILKCK-  237 (327)
T ss_dssp             C-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----H---HHHHHHTC-
T ss_pred             ccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-----H---HHHHHhCC-
Confidence            87543322 22334568999999999999899999999999999999999999997543321     1   11111110 


Q ss_pred             cchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 015734          308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM  351 (401)
Q Consensus       308 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  351 (401)
                               ...+.....++.+++.+||+.||.+||     ++.+++++
T Consensus       238 ---------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          238 ---------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             ---------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence                     011223345788999999999999999     77788664

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6.5e-44  Score=329.42  Aligned_cols=260  Identities=15%  Similarity=0.197  Sum_probs=208.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCeeEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  152 (401)
                      ..++|.+.+.||+|+||.||+|.. .+++.||+|++....   ....+.+|+..+..+ +|+|++++++++......++|
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   84 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   84 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence            456799999999999999999996 568999999986432   234578899999998 799999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCc-----EEEeecCC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE-----AVLCDFGL  227 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~-----~kl~Dfgl  227 (401)
                      |||+ +++|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.     +||+|||+
T Consensus        85 ~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~  157 (298)
T 1csn_A           85 IDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  157 (298)
T ss_dssp             EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             EEec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence            9999 99999999863   34589999999999999999999998   9999999999999987776     99999999


Q ss_pred             ccccCCCCcc------eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHH
Q 015734          228 AKLVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK  301 (401)
Q Consensus       228 ~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~  301 (401)
                      +.........      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........  .....+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~  235 (298)
T 1csn_A          158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK--QKYERIGE  235 (298)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH--HHHHHHHH
T ss_pred             ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH--HHHHHHHh
Confidence            9876543321      234456899999999999999999999999999999999999999864322111  11111111


Q ss_pred             HhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          302 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       302 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ..........        ....+.++.+++..||+.||.+|||++++++.|+.
T Consensus       236 ~~~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~  280 (298)
T 1csn_A          236 KKQSTPLREL--------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK  280 (298)
T ss_dssp             HHHHSCHHHH--------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             hccCccHHHH--------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHH
Confidence            1111111111        11234578899999999999999999999999875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.6e-44  Score=336.42  Aligned_cols=270  Identities=24%  Similarity=0.383  Sum_probs=216.8

Q ss_pred             cCHHHHHHHhcCCCCCCeeeecCcEEEEEEEE------CCCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccce
Q 015734           67 FSCRELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQL  139 (401)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~  139 (401)
                      +...++....++|.+.+.||+|+||+||+|.+      .+++.||+|++...........+.+|+.++..+ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            44556667788999999999999999999984      246789999998655555667899999999999 69999999


Q ss_pred             eeeeecCC-eeEEEEecccCCcHHHHhhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeC
Q 015734          140 IGYCTTSS-ERILVYPFMQNLSVAYRLRDLKPG------------EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRD  206 (401)
Q Consensus       140 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~d  206 (401)
                      ++++...+ ..++||||+++++|.+++......            ...+++..+..++.|++.||.|||++   +++|+|
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence            99987765 489999999999999999864321            12388999999999999999999999   999999


Q ss_pred             CCCCceEEcCCCcEEEeecCCccccCCCCc-ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCC
Q 015734          207 LKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDF  284 (401)
Q Consensus       207 lkp~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~  284 (401)
                      |||+||+++.++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|+| |..||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999986644322 23344557889999999999999999999999999999998 9999975


Q ss_pred             CcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          285 SRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                      .....    ........    ...        ...+.....++.+++.+||+.||.+|||+.+++++|+..
T Consensus       254 ~~~~~----~~~~~~~~----~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          254 VKIDE----EFCRRLKE----GTR--------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             CCCSH----HHHHHHHH----TCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhH----HHHHHhcc----Ccc--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            43321    11111111    100        011222345788999999999999999999999999754

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.7e-44  Score=326.32  Aligned_cols=252  Identities=19%  Similarity=0.264  Sum_probs=205.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecC--CeeEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERIL  151 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  151 (401)
                      ..++|.+.+.||+|+||.||+|.+ +++.||+|++.... +....+.+.+|+.++++++||||+++++++.+.  +..++
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            346788999999999999999998 48899999997432 444567899999999999999999999999887  77899


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK--IIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ||||+++++|.+++....  ...+++..+..++.|++.||+|||+.   +  ++|+||||+||+++.++.++|+|||++.
T Consensus        87 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             EEECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             eecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEecccee
Confidence            999999999999998632  33689999999999999999999998   7  9999999999999999999999999876


Q ss_pred             ccCCCCcceeccccCCcccccccccccCCCCc---ccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC
Q 015734          230 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSE---KTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED  306 (401)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (401)
                      ....      ....||+.|+|||.+.+..++.   ++||||||+++|||++|..||........        ........
T Consensus       162 ~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--------~~~~~~~~  227 (271)
T 3kmu_A          162 SFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI--------GMKVALEG  227 (271)
T ss_dssp             TTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH--------HHHHHHSC
T ss_pred             eecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH--------HHHHHhcC
Confidence            4322      2345799999999998765544   79999999999999999999975432211        11111111


Q ss_pred             ccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       307 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      .        ....+...+.++.+++..||+.||.+|||+.++++.|+.
T Consensus       228 ~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~  267 (271)
T 3kmu_A          228 L--------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEK  267 (271)
T ss_dssp             C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             C--------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            0        011223345678899999999999999999999999875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.4e-45  Score=364.56  Aligned_cols=263  Identities=27%  Similarity=0.390  Sum_probs=214.5

Q ss_pred             HHHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCe
Q 015734           69 CRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE  148 (401)
Q Consensus        69 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  148 (401)
                      ...+++..++|.+.+.||+|+||.||+|.++++..||||+++...  ...+.|.+|++++++++||||+++++++.+ +.
T Consensus       259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~  335 (535)
T 2h8h_A          259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP  335 (535)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence            344556778899999999999999999999888889999997532  345789999999999999999999999876 67


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      .++||||+.+|+|.+++....  ...+++..+..++.|++.||+|||++   +++||||||+|||+++++.+||+|||++
T Consensus       336 ~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a  410 (535)
T 2h8h_A          336 IYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA  410 (535)
T ss_dssp             CEEEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred             ceEeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccc
Confidence            899999999999999997532  23588999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      +..............++..|+|||++.+..++.++|||||||++|||+| |..||......+     ....+   .....
T Consensus       411 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-----~~~~i---~~~~~  482 (535)
T 2h8h_A          411 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQV---ERGYR  482 (535)
T ss_dssp             TTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-----HHHHH---HTTCC
T ss_pred             eecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHH---HcCCC
Confidence            8665432222233446789999999999999999999999999999999 999997543211     11111   11111


Q ss_pred             cchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 015734          308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED  356 (401)
Q Consensus       308 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  356 (401)
                               ...+..++..+.+++.+||+.||++|||+.++++.|+...
T Consensus       483 ---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          483 ---------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                     0112334567889999999999999999999999998754

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.5e-44  Score=337.18  Aligned_cols=260  Identities=25%  Similarity=0.332  Sum_probs=207.0

Q ss_pred             CCCCCeeeecCcEEEEEEEEC-----CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecC--CeeEE
Q 015734           79 FSESNIIGQGGFGKVYKGVLS-----DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS--SERIL  151 (401)
Q Consensus        79 ~~~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  151 (401)
                      |.+.+.||+|+||+||++.++     +++.||+|++...........+.+|+++++.++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            388899999999999998743     57889999998665556678899999999999999999999999874  56799


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      ||||+++++|.+++...     .+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++...
T Consensus       113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence            99999999999999752     389999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcc--eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhh------hhhHHHHHHHHh
Q 015734          232 DAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE------DVLLLDHIRKLL  303 (401)
Q Consensus       232 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~------~~~~~~~~~~~~  303 (401)
                      ......  ......+|+.|+|||.+.+..++.++||||||+++|+|+||..||.........      ............
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence            544322  223345788899999999989999999999999999999999998643221000      000000011111


Q ss_pred             ccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          304 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       304 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ..        ......+...+.++.+++.+||+.||.+|||+.++++.|+.
T Consensus       265 ~~--------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  307 (318)
T 3lxp_A          265 ER--------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT  307 (318)
T ss_dssp             HT--------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hc--------ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            11        11112233445689999999999999999999999999865

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=6.3e-44  Score=327.89  Aligned_cols=254  Identities=31%  Similarity=0.489  Sum_probs=203.0

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcch------HHHHHHHHHHHHhccCCcccceeeeeecCC
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGG------EAAFQREVHLISVAIHKNLLQLIGYCTTSS  147 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  147 (401)
                      ..++|.+.+.||+|+||+||+|.+. +++.||+|++........      .+.+.+|+.++++++||||+++++++.+..
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP   96 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence            3468889999999999999999974 689999999864332221      167899999999999999999999987655


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEeCCCCCceEEcCCCc-----E
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK--IIHRDLKAANILLDDNFE-----A  220 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlkp~Nill~~~~~-----~  220 (401)
                        ++||||+++++|.+.+...   ...+++..+..++.|++.||+|||++   +  ++|+||||+||+++.++.     +
T Consensus        97 --~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~  168 (287)
T 4f0f_A           97 --RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCA  168 (287)
T ss_dssp             --EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred             --eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeE
Confidence              7999999999998888752   34699999999999999999999998   7  999999999999988776     9


Q ss_pred             EEeecCCccccCCCCcceeccccCCcccccccccc--cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHH
Q 015734          221 VLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS--TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH  298 (401)
Q Consensus       221 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~  298 (401)
                      ||+|||++.....    ......||+.|+|||++.  ...++.++|||||||++|+|++|..||.........   ....
T Consensus       169 kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~  241 (287)
T 4f0f_A          169 KVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK---FINM  241 (287)
T ss_dssp             EECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH---HHHH
T ss_pred             EeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH---HHHH
Confidence            9999999974433    233456899999999984  455789999999999999999999999754432111   1111


Q ss_pred             HHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          299 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       299 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ..   . ....       ...+...+.++.+++..||+.||.+|||+.++++.|+.
T Consensus       242 ~~---~-~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          242 IR---E-EGLR-------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HH---H-SCCC-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             Hh---c-cCCC-------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            11   1 1111       11223345678899999999999999999999999875

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.3e-44  Score=340.52  Aligned_cols=254  Identities=21%  Similarity=0.258  Sum_probs=195.0

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ..++|.+.+.||+|+||+||++... +++.||+|++....  .....+.+|+.+++.++||||+++++++...+..++||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   95 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA--AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM   95 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST--TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc--cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence            3568999999999999999999975 68999999997532  23366889999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCc--EEEeecCCcccc
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE--AVLCDFGLAKLV  231 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~--~kl~Dfgl~~~~  231 (401)
                      ||+++|+|.+++...    ..+++..++.++.|++.||+|||++   +++||||||+||+++.++.  +||+|||+++..
T Consensus        96 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           96 EYASGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             EeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            999999999998763    3589999999999999999999999   9999999999999987765  999999998743


Q ss_pred             CCCCcceeccccCCcccccccccccCCCCcc-cchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccch
Q 015734          232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEK-TDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND  310 (401)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ...  .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........    .............   
T Consensus       169 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~~~~~~~~~~~---  239 (361)
T 3uc3_A          169 VLH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD----YRKTIQRILSVKY---  239 (361)
T ss_dssp             --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC----HHHHHHHHHTTCC---
T ss_pred             ccc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH----HHHHHHHHhcCCC---
Confidence            322  12233468999999999988887655 8999999999999999999975432211    1111222111110   


Q ss_pred             hccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       311 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                          ..+ .....+.++.+++.+||+.||.+|||+.+++++
T Consensus       240 ----~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          240 ----SIP-DDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             ----CCC-TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ----CCC-CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence                000 011224578899999999999999999999875

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.4e-44  Score=335.28  Aligned_cols=256  Identities=23%  Similarity=0.369  Sum_probs=202.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCC----EEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI  150 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  150 (401)
                      .++|.+.+.||+|+||+||+|.+. ++.    +|++|.+...........+.+|+.+++.++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            467899999999999999999964 344    468888776556667889999999999999999999999998755 78


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      ++++++.+|+|.+++...   ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++..
T Consensus        93 ~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred             EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence            999999999999999863   34589999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          231 VDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       231 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ....... ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||.......     ....+.    ... 
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----~~~~~~----~~~-  236 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISSILE----KGE-  236 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HHHHHH----TTC-
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----HHHHHH----cCC-
Confidence            6443222 2233446789999999999999999999999999999999 999997644322     111111    110 


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                             ....+...+.++.+++..||+.||.+|||+.++++.|+..
T Consensus       237 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  276 (327)
T 3lzb_A          237 -------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             -------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                   1112233455788999999999999999999999998753

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.8e-44  Score=338.52  Aligned_cols=253  Identities=22%  Similarity=0.295  Sum_probs=204.7

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEECC-CCEEEEEEecccC--CcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCe
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYY--SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSE  148 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  148 (401)
                      ....++|.+.+.||+|+||.||+|..+. ++.||+|++....  .......+..|..++..+ +||||+++++++.+.+.
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            3456789999999999999999999764 7889999997421  233456788999999887 79999999999999999


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      .++||||+++|+|.+++...    ..+++..++.++.|++.||.|||++   +++||||||+|||++.++++||+|||++
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a  168 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC  168 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence            99999999999999999863    3589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      +...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.......     +   ........  
T Consensus       169 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-----~---~~~i~~~~--  237 (353)
T 2i0e_A          169 KENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-----L---FQSIMEHN--  237 (353)
T ss_dssp             BCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----H---HHHHHHCC--
T ss_pred             cccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH-----H---HHHHHhCC--
Confidence            8543221 22344679999999999999999999999999999999999999997543211     1   11111111  


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVKM  351 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~~  351 (401)
                              ..++...+.++.+++.+||+.||.+||+     +++++++
T Consensus       238 --------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          238 --------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             --------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                    0112234467889999999999999995     4666543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-43  Score=328.72  Aligned_cols=248  Identities=22%  Similarity=0.227  Sum_probs=195.3

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCeeEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  151 (401)
                      ..++|+..+.||+|+||+||+|.+. +++.||||++.... .......+..|+..+..+ .||||+++++++.+.+..++
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            4467999999999999999999976 68999999986432 333444556666666555 89999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      ||||+ +++|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++...
T Consensus       135 v~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~  207 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL  207 (311)
T ss_dssp             EEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred             EEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence            99999 67998888764   34699999999999999999999999   9999999999999999999999999998866


Q ss_pred             CCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ....  ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.....           .. ..........
T Consensus       208 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-----------~~-~~~~~~~~~~  272 (311)
T 3p1a_A          208 GTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-----------WQ-QLRQGYLPPE  272 (311)
T ss_dssp             C--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----------HH-HHTTTCCCHH
T ss_pred             ccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------HH-HHhccCCCcc
Confidence            4432  2333468999999999875 789999999999999999999776643211           01 1111111111


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .       ....+.++.+++.+||+.||++|||+.+++++
T Consensus       273 ~-------~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          273 F-------TAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             H-------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             c-------ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence            1       11234578899999999999999999999764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.8e-44  Score=329.18  Aligned_cols=250  Identities=25%  Similarity=0.329  Sum_probs=195.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCC-------------------------cchHHHHHHHHHHHH
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-------------------------PGGEAAFQREVHLIS  129 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------------------------~~~~~~~~~e~~~l~  129 (401)
                      .++|.+.+.||+|+||.||+|... +++.||+|++.....                         ....+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            468999999999999999999964 588999999864321                         112356889999999


Q ss_pred             hccCCcccceeeeeec--CCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 015734          130 VAIHKNLLQLIGYCTT--SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDL  207 (401)
Q Consensus       130 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl  207 (401)
                      .++||||+++++++..  .+..++||||+++++|.+++.     ...+++..+..++.|++.||+|||++   +++|+||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl  163 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI  163 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence            9999999999999986  567899999999999876543     34699999999999999999999999   9999999


Q ss_pred             CCCceEEcCCCcEEEeecCCccccCCCCcceeccccCCcccccccccccCC---CCcccchhHHHHHHHHHHhCCCCCCC
Q 015734          208 KAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK---SSEKTDVFGYGITLLELVTGQRAIDF  284 (401)
Q Consensus       208 kp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDi~slG~ll~elltg~~p~~~  284 (401)
                      ||+||+++.++.+||+|||++........ ......||+.|+|||.+.+..   ++.++|||||||++|+|++|..||..
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            99999999999999999999987654322 233456899999999997665   37889999999999999999999975


Q ss_pred             CcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          285 SRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                      .....     ....+.    ..... .  +    .....+.++.+++.+||+.||.+|||+.++++
T Consensus       243 ~~~~~-----~~~~~~----~~~~~-~--~----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          243 ERIMC-----LHSKIK----SQALE-F--P----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SSHHH-----HHHHHH----HCCCC-C--C----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccHHH-----HHHHHh----cccCC-C--C----CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            43211     111111    11000 0  0    01223457889999999999999999999965

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-44  Score=335.87  Aligned_cols=257  Identities=26%  Similarity=0.418  Sum_probs=203.2

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECC-----CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCee
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLSD-----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  149 (401)
                      ..++|...+.||+|+||.||+|....     +..||+|.+...........+.+|+.+++.++||||+++++++...+..
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  121 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM  121 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence            34567778999999999999998643     2369999998655556667899999999999999999999999999999


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ++||||+++++|.+++...   ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++.
T Consensus       122 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          122 MIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcch
Confidence            9999999999999999762   34689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcc--eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccC
Q 015734          230 LVDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLRED  306 (401)
Q Consensus       230 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (401)
                      ........  ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+     ..   .......
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-----~~---~~~~~~~  267 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-----VM---KAINDGF  267 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HH---HHHHTTC
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-----HH---HHHHCCC
Confidence            66543221  1222345788999999998899999999999999999999 999996543211     11   1111111


Q ss_pred             ccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       307 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      .         ...+...+..+.+++.+||+.||.+||++.++++.|+.
T Consensus       268 ~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  306 (333)
T 1mqb_A          268 R---------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK  306 (333)
T ss_dssp             C---------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             c---------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            1         11122345678899999999999999999999999865

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.2e-44  Score=331.38  Aligned_cols=259  Identities=21%  Similarity=0.283  Sum_probs=208.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeee--cCCeeEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCT--TSSERIL  151 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~l  151 (401)
                      .++|.+.+.||+|+||.||++... +++.||+|.+... .+....+.+.+|+.++++++||||+++++++.  ..+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            467889999999999999999975 6899999999743 34455678999999999999999999999874  4567899


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEEeCCCCCceEEcCCCcEEEeecC
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK-----IIHRDLKAANILLDDNFEAVLCDFG  226 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----i~H~dlkp~Nill~~~~~~kl~Dfg  226 (401)
                      ||||+++++|.+++.........+++..++.++.|++.||+|||+.   +     ++|+||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            9999999999999986544455699999999999999999999998   7     9999999999999999999999999


Q ss_pred             CccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC
Q 015734          227 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED  306 (401)
Q Consensus       227 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (401)
                      ++........ ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.......     ....+.    ..
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~i~----~~  231 (279)
T 2w5a_A          162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-----LAGKIR----EG  231 (279)
T ss_dssp             HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHH----HT
T ss_pred             hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH-----HHHHHh----hc
Confidence            9976544322 2233468999999999998899999999999999999999999997543211     111111    11


Q ss_pred             ccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       307 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                      ..        ...+...+.++.+++.+||+.||.+|||+.++++++...
T Consensus       232 ~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~  272 (279)
T 2w5a_A          232 KF--------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL  272 (279)
T ss_dssp             CC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred             cc--------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence            11        112223446788999999999999999999999887643

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.2e-44  Score=337.72  Aligned_cols=253  Identities=21%  Similarity=0.291  Sum_probs=198.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccC--CcccceeeeeecCCeeEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIH--KNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~l  151 (401)
                      ..++|.+.+.||+|+||.||++...+++.||+|++... ......+.+.+|+.++..++|  |||+++++++...+..++
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            34678899999999999999999888999999998743 334455788999999999987  999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      ||| +.+++|.+++..    ...+++..+..++.|++.||+|||++   +++||||||+|||++ ++.+||+|||++...
T Consensus        87 v~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM  157 (343)
T ss_dssp             EEC-CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred             EEe-CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence            999 568899999986    34689999999999999999999999   999999999999997 578999999999866


Q ss_pred             CCCCcc-eeccccCCccccccccccc-----------CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHH
Q 015734          232 DAKLTH-VTTQIRGTMGHIAPEYLST-----------GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI  299 (401)
Q Consensus       232 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~  299 (401)
                      ...... ......||+.|+|||++.+           ..++.++|||||||++|+|++|..||.......       ...
T Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~  230 (343)
T 3dbq_A          158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-------SKL  230 (343)
T ss_dssp             ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-------HHH
T ss_pred             CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-------HHH
Confidence            543322 2334569999999999865           678899999999999999999999997432210       111


Q ss_pred             HHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          300 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       300 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .........        ...+.....++.+++..||+.||.+|||+.+++++
T Consensus       231 ~~~~~~~~~--------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          231 HAIIDPNHE--------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HHHHCTTSC--------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHhcCCcc--------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            111111100        01122223568899999999999999999999875

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.5e-44  Score=338.91  Aligned_cols=252  Identities=21%  Similarity=0.296  Sum_probs=191.4

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ..++|.+.+.||+|+||.||+|... +++.||+|++....   ..+.+.+|+.++.+++||||+++++++...+..++||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            4567999999999999999999976 57899999997532   3456889999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC---CCcEEEeecCCccc
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCDFGLAKL  230 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfgl~~~  230 (401)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+||+++.   ++.+||+|||++..
T Consensus       128 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~  200 (349)
T 2w4o_A          128 ELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI  200 (349)
T ss_dssp             CCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred             EeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence            99999999998875    34589999999999999999999999   9999999999999975   88999999999986


Q ss_pred             cCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccch
Q 015734          231 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND  310 (401)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|..||.......    ..   .........  .
T Consensus       201 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~---~~~i~~~~~--~  269 (349)
T 2w4o_A          201 VEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ----FM---FRRILNCEY--Y  269 (349)
T ss_dssp             --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH----HH---HHHHHTTCC--C
T ss_pred             cCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH----HH---HHHHHhCCC--c
Confidence            54322  2234568999999999999899999999999999999999999996543211    11   111111110  0


Q ss_pred             hccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       311 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .    ........+.++.+++.+||+.||++|||+.+++++
T Consensus       270 ~----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          270 F----ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             C----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             c----CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0    011123345678899999999999999999999885

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.8e-43  Score=324.21  Aligned_cols=253  Identities=21%  Similarity=0.260  Sum_probs=206.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      .++|.+.+.||+|+||.||+|..+ ++..||+|++... .+......+.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            468999999999999999999965 5889999999743 34445678899999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCc---EEEeecCCccc
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE---AVLCDFGLAKL  230 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfgl~~~  230 (401)
                      ||+++++|.+.+...    ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.   +||+|||++..
T Consensus        85 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           85 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            999999999888763    4589999999999999999999999   9999999999999986655   99999999976


Q ss_pred             cCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccch
Q 015734          231 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND  310 (401)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ......  .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.......     ....+..    .... 
T Consensus       158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~~~----~~~~-  225 (284)
T 3kk8_A          158 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-----LYAQIKA----GAYD-  225 (284)
T ss_dssp             CCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH----TCCC-
T ss_pred             cccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-----HHHHHHh----cccc-
Confidence            654322  233568999999999999999999999999999999999999997543211     1111111    1000 


Q ss_pred             hccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       311 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ...    ......+.++.+++.+||+.||.+|||+.+++++
T Consensus       226 ~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          226 YPS----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             CCT----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CCc----hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            000    0112334578899999999999999999999663

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.7e-44  Score=340.86  Aligned_cols=266  Identities=17%  Similarity=0.203  Sum_probs=201.2

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECC------CCEEEEEEecccCCcc----------hHHHHHHHHHHHHhccCCcccc
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLSD------NTKVAVKRLQDYYSPG----------GEAAFQREVHLISVAIHKNLLQ  138 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~  138 (401)
                      ..++|.+.+.||+|+||.||+|.+.+      +..||+|++.......          ....+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            45589999999999999999999754      4789999986432110          0112334555667778999999


Q ss_pred             eeeeeecC----CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEE
Q 015734          139 LIGYCTTS----SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL  214 (401)
Q Consensus       139 ~~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill  214 (401)
                      +++++...    ...++||||+ +++|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+|||+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill  185 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL  185 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence            99998765    4479999999 99999999862   35699999999999999999999999   99999999999999


Q ss_pred             c--CCCcEEEeecCCccccCCCCcce------eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCc
Q 015734          215 D--DNFEAVLCDFGLAKLVDAKLTHV------TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSR  286 (401)
Q Consensus       215 ~--~~~~~kl~Dfgl~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~  286 (401)
                      +  .++.+||+|||+++.........      .....||+.|+|||++.+..++.++|||||||++|||+||..||....
T Consensus       186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            9  89999999999998664432211      133458999999999999999999999999999999999999997432


Q ss_pred             chhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          287 LEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ....    ......... ...+..++++.+.  ....+.++.+++..||+.+|.+||++.++++.|+.
T Consensus       266 ~~~~----~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~  326 (364)
T 3op5_A          266 KDPK----YVRDSKIRY-RENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ  326 (364)
T ss_dssp             TCHH----HHHHHHHHH-HHCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             cCHH----HHHHHHHHh-hhhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence            2111    111111111 1122233332221  11224578899999999999999999999998875

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.2e-44  Score=351.44  Aligned_cols=251  Identities=20%  Similarity=0.248  Sum_probs=196.9

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      ..++|.+.+.||+|+||.||+|... +++.||+|++...  ........+.+|+.+++.++||||+++++++...+..++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            4567999999999999999999964 6899999999742  233445678899999999999999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      ||||+++++|..++...    ..+++..+..++.|++.||+|||+ .   +++||||||+|||++.++.+||+|||+++.
T Consensus       226 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~  298 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKE  298 (446)
T ss_dssp             EECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred             EEeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence            99999999999998763    458999999999999999999998 7   899999999999999999999999999975


Q ss_pred             cCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccch
Q 015734          231 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND  310 (401)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ..... .......||+.|+|||++.+..++.++|||||||++|||++|..||.......     +...+.   ...    
T Consensus       299 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~~~i~---~~~----  365 (446)
T 4ejn_A          299 GIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----LFELIL---MEE----  365 (446)
T ss_dssp             TCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHH---HCC----
T ss_pred             ccCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-----HHHHHH---hCC----
Confidence            43322 22344679999999999999999999999999999999999999997543321     111111   110    


Q ss_pred             hccCcCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 015734          311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM  351 (401)
Q Consensus       311 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  351 (401)
                            ...+.....++.+++..||+.||.+||     ++++++++
T Consensus       366 ------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          366 ------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence                  011223345788999999999999999     99999764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=7.1e-44  Score=329.35  Aligned_cols=256  Identities=27%  Similarity=0.389  Sum_probs=202.7

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC----CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeee-cCCeeE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT-TSSERI  150 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~  150 (401)
                      ..+|.+.+.||+|+||+||+|.+.+    ...+|+|.+.........+.+.+|+.++++++||||+++++++. ..+..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3467888999999999999998643    23589999886556666788999999999999999999999864 456789


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      +||||+++++|.+++..   ....+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++..
T Consensus       104 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD  177 (298)
T ss_dssp             EEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred             EEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccc
Confidence            99999999999999975   234588999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCcc---eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccC
Q 015734          231 VDAKLTH---VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLRED  306 (401)
Q Consensus       231 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (401)
                      .......   ......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||.......     ......   ...
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-----~~~~~~---~~~  249 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----ITVYLL---QGR  249 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-----HHHHHH---TTC
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-----HHHHHh---cCC
Confidence            6443221   2233457889999999999999999999999999999999 555665433211     111111   110


Q ss_pred             ccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       307 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                               ....+...+..+.+++.+||+.||.+|||+.++++.|+.
T Consensus       250 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~  288 (298)
T 3f66_A          250 ---------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA  288 (298)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                     001122234578899999999999999999999999875

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-43  Score=338.81  Aligned_cols=253  Identities=20%  Similarity=0.242  Sum_probs=206.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      .++|.+.+.||+|+||.||+|..+ +++.||+|.+... .......+.+|+.+++.++||||+++++++.+....++|||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc-chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            468999999999999999999975 6889999998643 23345678999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC--CCcEEEeecCCccccC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD--NFEAVLCDFGLAKLVD  232 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~--~~~~kl~Dfgl~~~~~  232 (401)
                      |+++++|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+|||++.  ++.+||+|||++....
T Consensus       129 ~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          129 FLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  202 (387)
T ss_dssp             CCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             cCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecC
Confidence            99999999988752   34689999999999999999999999   9999999999999974  5789999999998765


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ....  .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......     ....+.   ... ..  .
T Consensus       203 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-----~~~~i~---~~~-~~--~  269 (387)
T 1kob_A          203 PDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-----TLQNVK---RCD-WE--F  269 (387)
T ss_dssp             TTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----HHHHHH---HCC-CC--C
T ss_pred             CCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH-----HHHHHH---hCC-CC--C
Confidence            4322  233468999999999999999999999999999999999999997543211     111111   110 00  0


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      +.   ......+.++.+++.+||+.||.+|||+.+++++
T Consensus       270 ~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          270 DE---DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             CS---STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             Cc---cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            11   1122334578899999999999999999999885

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=9.6e-44  Score=337.42  Aligned_cols=211  Identities=23%  Similarity=0.275  Sum_probs=183.2

Q ss_pred             ccccCHHHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhcc-----CCccc
Q 015734           64 LRRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-----HKNLL  137 (401)
Q Consensus        64 ~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv  137 (401)
                      ...+++.+.....++|.+.+.||+|+||+||+|... +++.||+|++..  .......+..|+.++..+.     ||||+
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~h~~iv   99 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN--IKKYTRSAKIEADILKKIQNDDINNNNIV   99 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CHHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc--chhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence            344555666667889999999999999999999974 688999999864  3345567788999999886     99999


Q ss_pred             ceeeeeecCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC-
Q 015734          138 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-  216 (401)
Q Consensus       138 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-  216 (401)
                      ++++++...+..++||||+ +++|.+++....  ...+++..+..++.|++.||+|||++   +++||||||+|||++. 
T Consensus       100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~  173 (360)
T 3llt_A          100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDP  173 (360)
T ss_dssp             CEEEEEEETTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCT
T ss_pred             cccceeeECCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccc
Confidence            9999999999999999999 999999998633  24589999999999999999999999   9999999999999975 


Q ss_pred             ------------------------CCcEEEeecCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHH
Q 015734          217 ------------------------NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITL  272 (401)
Q Consensus       217 ------------------------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll  272 (401)
                                              ++.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  249 (360)
T 3llt_A          174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL  249 (360)
T ss_dssp             TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred             cccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence                                    889999999999865432    2345689999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCc
Q 015734          273 LELVTGQRAIDFSR  286 (401)
Q Consensus       273 ~elltg~~p~~~~~  286 (401)
                      |+|++|..||....
T Consensus       250 ~ell~g~~pf~~~~  263 (360)
T 3llt_A          250 AELYTGSLLFRTHE  263 (360)
T ss_dssp             HHHHHSSCSCCCSS
T ss_pred             HHHHHCCCCCCCCc
Confidence            99999999997644

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=9.5e-45  Score=339.57  Aligned_cols=257  Identities=24%  Similarity=0.351  Sum_probs=203.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCC----EEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI  150 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  150 (401)
                      .++|.+.+.||+|+||+||+|.+. ++.    +||+|.+...........+.+|+.+++.++||||+++++++. .+..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            457888999999999999999964 344    388888765444444566788999999999999999999986 46689


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      +|+||+.+|+|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++.
T Consensus        91 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             EEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             EEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence            999999999999998753   24588899999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          231 VDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       231 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ....... ......+|+.|+|||.+.+..++.++|||||||++|+|+| |..||.......     ....+.    ....
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~----~~~~  235 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-----VPDLLE----KGER  235 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH-----HHHHHH----TTCB
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH-----HHHHHH----cCCC
Confidence            6544322 2334557889999999999999999999999999999999 999997644321     111111    1100


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED  356 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  356 (401)
                              ...+...+.++.+++.+||+.||.+|||+.++++.|+...
T Consensus       236 --------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          236 --------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             --------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             --------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                    0111122336778999999999999999999999997643

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-43  Score=329.82  Aligned_cols=269  Identities=24%  Similarity=0.342  Sum_probs=203.1

Q ss_pred             CHHHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHh--ccCCcccceeeeeec
Q 015734           68 SCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISV--AIHKNLLQLIGYCTT  145 (401)
Q Consensus        68 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~  145 (401)
                      .....+...++|.+.+.||+|+||.||+|... ++.||+|++...    ....+..|.+++..  ++||||+++++++..
T Consensus        28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~  102 (337)
T 3mdy_A           28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIK  102 (337)
T ss_dssp             CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence            33444556789999999999999999999984 899999998642    23445556665554  489999999999887


Q ss_pred             C----CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEEeCCCCCceEEcC
Q 015734          146 S----SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC-----NPKIIHRDLKAANILLDD  216 (401)
Q Consensus       146 ~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~dlkp~Nill~~  216 (401)
                      .    ...++||||+++|+|.+++..     ..+++..+..++.|++.||+|||++.     .++++||||||+||+++.
T Consensus       103 ~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~  177 (337)
T 3mdy_A          103 GTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK  177 (337)
T ss_dssp             SCGGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred             CCCCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECC
Confidence            7    678999999999999999975     24899999999999999999999751     337999999999999999


Q ss_pred             CCcEEEeecCCccccCCCCcce---eccccCCcccccccccccCCCCcc------cchhHHHHHHHHHHhC---------
Q 015734          217 NFEAVLCDFGLAKLVDAKLTHV---TTQIRGTMGHIAPEYLSTGKSSEK------TDVFGYGITLLELVTG---------  278 (401)
Q Consensus       217 ~~~~kl~Dfgl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------sDi~slG~ll~elltg---------  278 (401)
                      ++.+||+|||++..........   .....||+.|+|||++.+...+..      +|||||||++|||+||         
T Consensus       178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~  257 (337)
T 3mdy_A          178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE  257 (337)
T ss_dssp             TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence            9999999999997654433221   124568999999999987766655      9999999999999999         


Q ss_pred             -CCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          279 -QRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT--YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       279 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                       ..||..........    .............    +..+.  .....+.++.+++.+||+.||.+|||+.+++++|+.
T Consensus       258 ~~~p~~~~~~~~~~~----~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  328 (337)
T 3mdy_A          258 YQLPYHDLVPSDPSY----EDMREIVCIKKLR----PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK  328 (337)
T ss_dssp             CCCTTTTTSCSSCCH----HHHHHHHTTSCCC----CCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             ccccHhhhcCCCCch----hhhHHHHhhhccC----ccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence             55554322211111    1111111111111    11111  123677889999999999999999999999999975

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-44  Score=340.67  Aligned_cols=258  Identities=22%  Similarity=0.278  Sum_probs=206.2

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEE----CCCCEEEEEEecccC---CcchHHHHHHHHHHHHhc-cCCcccceeeeeecC
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRLQDYY---SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTS  146 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  146 (401)
                      ..++|.+.+.||+|+||.||+|..    .+++.||||++....   .......+.+|+.++..+ +||||+++++++...
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  131 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  131 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence            346899999999999999999997    368999999986421   122345677899999999 699999999999999


Q ss_pred             CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecC
Q 015734          147 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG  226 (401)
Q Consensus       147 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  226 (401)
                      +..++||||+++++|.+++...    ..+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||
T Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG  204 (355)
T 1vzo_A          132 TKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG  204 (355)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             ceEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCC
Confidence            9999999999999999999863    3589999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCcceeccccCCcccccccccccC--CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhc
Q 015734          227 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG--KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR  304 (401)
Q Consensus       227 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (401)
                      +++..............||+.|+|||++.+.  .++.++|||||||++|||++|..||.........    .........
T Consensus       205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~----~~~~~~~~~  280 (355)
T 1vzo_A          205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ----AEISRRILK  280 (355)
T ss_dssp             EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH----HHHHHHHHH
T ss_pred             CCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH----HHHHHHHhc
Confidence            9986654444444456799999999999753  4789999999999999999999999754322111    111111111


Q ss_pred             cCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHhc
Q 015734          305 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKMLQ  353 (401)
Q Consensus       305 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~L~  353 (401)
                      .          ....+......+.+++.+||+.||.+||     ++++++++.-
T Consensus       281 ~----------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~  324 (355)
T 1vzo_A          281 S----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF  324 (355)
T ss_dssp             C----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred             c----------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence            1          0112233445788999999999999999     9999987653

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.7e-43  Score=326.52  Aligned_cols=266  Identities=20%  Similarity=0.294  Sum_probs=200.6

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCC-cchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      ++|.+.+.||+|+||+||+|.+. +++.||+|++..... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57889999999999999999975 589999999864332 3345678899999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++++|..++..    ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++......
T Consensus        83 ~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           83 YCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             CCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             eCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            9999999888765    34589999999999999999999999   9999999999999999999999999999866533


Q ss_pred             CcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHH-------HHHhccC
Q 015734          235 LTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI-------RKLLRED  306 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~  306 (401)
                      .. ......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||......+..... ....       .......
T Consensus       156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLI-RKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHHHCSCCHHHHHHHHTC
T ss_pred             cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HHHhcccccccccccccc
Confidence            22 2234468999999999876 56899999999999999999999999765432211100 0000       0000000


Q ss_pred             ccc-h--hccCcC-CC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          307 RLN-D--IVDRNL-NT---YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       307 ~~~-~--~~d~~~-~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ... .  ..++.. ..   ..+..+.++.+++.+||+.||.+|||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            000 0  000000 00   012344568899999999999999999999875

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=8.6e-44  Score=348.07  Aligned_cols=249  Identities=23%  Similarity=0.335  Sum_probs=205.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      .++|.+.+.||+|+||.||+|.+. +|+.||+|++....  .......+.+|+.+++.++||||+++++++...+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            457889999999999999999975 68999999996421  223456789999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||+++++|.+++..    ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++....
T Consensus        95 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~  167 (476)
T 2y94_A           95 MEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  167 (476)
T ss_dssp             EECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence            999999999999875    34689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcceeccccCCcccccccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ...  ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......     +   ...... ..    
T Consensus       168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-----~---~~~i~~-~~----  232 (476)
T 2y94_A          168 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-----L---FKKICD-GI----  232 (476)
T ss_dssp             TTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH-----H---HHHHHT-TC----
T ss_pred             ccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH-----H---HHHHhc-CC----
Confidence            432  2334569999999999988765 789999999999999999999997543321     1   111111 10    


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                           ...+.....++.+++.+||+.||.+|||+.+++++
T Consensus       233 -----~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          233 -----FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             -----cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence                 01112234578899999999999999999999873

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=6.6e-44  Score=332.48  Aligned_cols=265  Identities=24%  Similarity=0.308  Sum_probs=207.8

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeee----cCCee
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT----TSSER  149 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~  149 (401)
                      ..++|.+.+.||+|+||.||++.. .+++.||+|++.. ......+.+.+|+.+++.++||||+++++++.    .....
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC-HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE-SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec-CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            457899999999999999999996 5789999998864 23455678999999999999999999999986    34477


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ++||||+++++|.+++.........+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++.
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            899999999999999987655567799999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCCcc--------eeccccCCcccccccccccCC---CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHH
Q 015734          230 LVDAKLTH--------VTTQIRGTMGHIAPEYLSTGK---SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH  298 (401)
Q Consensus       230 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~  298 (401)
                      ........        ......||+.|+|||.+.+..   ++.++||||||+++|+|++|..||.......   ......
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~  259 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG---DSVALA  259 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT---SCHHHH
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc---chhhHH
Confidence            54322111        012234799999999987554   6889999999999999999999985321110   001111


Q ss_pred             HHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCch
Q 015734          299 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLA  358 (401)
Q Consensus       299 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  358 (401)
                      ..    .. .       ........+.++.+++.+||+.||.+|||+.++++.|+.....
T Consensus       260 ~~----~~-~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          260 VQ----NQ-L-------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             HH----CC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             hh----cc-C-------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence            11    00 0       0011223345788999999999999999999999999875543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5.5e-44  Score=332.30  Aligned_cols=254  Identities=22%  Similarity=0.307  Sum_probs=196.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCee---
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER---  149 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~---  149 (401)
                      .++|.+.+.||+|+||.||+|.+ .+++.||+|++....  .......+.+|+.++.+++||||+++++++......   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46899999999999999999996 468899999997532  233456789999999999999999999998765543   


Q ss_pred             -EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          150 -ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       150 -~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                       ++||||+++++|.+++...    ..+++..++.++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             cEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence             9999999999999999863    3589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcc--eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC
Q 015734          229 KLVDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED  306 (401)
Q Consensus       229 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (401)
                      .........  ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......        .........
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~--------~~~~~~~~~  235 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--------VAYQHVRED  235 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHCC
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHhcCC
Confidence            865443222  2233568999999999999999999999999999999999999997644321        111111111


Q ss_pred             ccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       307 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                      ......      .....+.++.+++.+||+.||.+||++.+++.
T Consensus       236 ~~~~~~------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          236 PIPPSA------RHEGLSADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             CCCHHH------HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             CCCccc------ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence            111000      01123457889999999999999998777654

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.8e-44  Score=331.02  Aligned_cols=258  Identities=24%  Similarity=0.336  Sum_probs=205.7

Q ss_pred             HHHhcCCCCCC-eeeecCcEEEEEEEE---CCCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 015734           73 QLATDNFSESN-IIGQGGFGKVYKGVL---SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS  147 (401)
Q Consensus        73 ~~~~~~~~~~~-~lG~G~~g~V~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  147 (401)
                      .+..++|.+.+ .||+|+||+||+|.+   .++..||+|++.... .....+.+.+|+.+++.++||||+++++++ ..+
T Consensus        12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~   90 (291)
T 1xbb_A           12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE   90 (291)
T ss_dssp             BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred             eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence            33456777777 999999999999964   246789999997533 334467899999999999999999999999 566


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCC
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL  227 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl  227 (401)
                      ..++||||+++++|.+++..    ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+
T Consensus        91 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~  163 (291)
T 1xbb_A           91 SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGL  163 (291)
T ss_dssp             SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             CcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCc
Confidence            78999999999999999986    34589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcce--eccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhc
Q 015734          228 AKLVDAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLR  304 (401)
Q Consensus       228 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (401)
                      +..........  .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.......     ....+.    
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~~----  234 (291)
T 1xbb_A          164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----VTAMLE----  234 (291)
T ss_dssp             CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHHH----
T ss_pred             ceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHH----
Confidence            98765443322  222346788999999988889999999999999999999 999997543211     111111    


Q ss_pred             cCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          305 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       305 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                      ...        ....+...+..+.+++..||+.||.+|||+.++++.|+..
T Consensus       235 ~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          235 KGE--------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             TTC--------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             cCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111        1112233456788999999999999999999999999753

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-44  Score=341.83  Aligned_cols=254  Identities=27%  Similarity=0.399  Sum_probs=194.5

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC--CC--CEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeec-CCeeEEE
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS--DN--TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSERILV  152 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv  152 (401)
                      .|.+.+.||+|+||+||+|...  ++  ..||+|.+.........+.+.+|+.++++++||||+++++++.. .+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            3566789999999999999853  22  36899998765556677889999999999999999999998754 4578999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||+++++|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++...
T Consensus       170 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence            9999999999999752   34588999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCcc---eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          233 AKLTH---VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       233 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      .....   ......+|+.|+|||.+.+..++.++|||||||++|||+| |.+||......+     ......   .... 
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-----~~~~~~---~~~~-  314 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----ITVYLL---QGRR-  314 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-----HHHHHH---TTCC-
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-----HHHHHH---cCCC-
Confidence            33211   1223456789999999999999999999999999999999 677776543221     111111   1110 


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                              ...+...+..+.+++.+||+.||.+|||+.++++.|+.
T Consensus       315 --------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~  352 (373)
T 3c1x_A          315 --------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA  352 (373)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                    01122334578899999999999999999999999875

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.1e-43  Score=351.22  Aligned_cols=252  Identities=26%  Similarity=0.360  Sum_probs=205.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      .++|...++||+|+||.||+|..+ +|+.||+|++....  .......+.+|..++..++||||+++++++...+..++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            467888899999999999999975 68999999996421  223456788999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||+++|+|.+++.........+++..+..++.||+.||.|||++   +++||||||+|||++.++++||+|||+++...
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            999999999999987554456799999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      .... ......||+.|+|||++.+..++.++|||||||++|||++|..||.........    ...........      
T Consensus       341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~----~~~~~~i~~~~------  409 (543)
T 3c4z_A          341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN----KELKQRVLEQA------  409 (543)
T ss_dssp             TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH----HHHHHHHHHCC------
T ss_pred             CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH----HHHHHHHhhcc------
Confidence            4322 233457999999999999999999999999999999999999999764321111    11111111110      


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM  345 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  345 (401)
                          ..++...+..+.+++..||+.||.+||++
T Consensus       410 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          410 ----VTYPDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             ----cCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence                11223345678899999999999999975

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.9e-43  Score=326.31  Aligned_cols=261  Identities=20%  Similarity=0.250  Sum_probs=200.4

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      ..++|.+.+.||+|+||.||+|... +++.||+|++....  .....+.+.+|+.++..++||||+++++++...+..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            4578999999999999999999975 68899999987432  22335788999999999999999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      ++||+++++|.+++...    ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++...
T Consensus       112 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT  184 (309)
T ss_dssp             EEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred             EEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence            99999999999999863    3589999999999999999999999   9999999999999999999999999999866


Q ss_pred             CCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ............||+.|+|||.+.+..++.++||||||+++|+|++|..||......     ......   ........ 
T Consensus       185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~---~~~~~~~~-  255 (309)
T 2h34_A          185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-----VMGAHI---NQAIPRPS-  255 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-----HHHHHH---HSCCCCGG-
T ss_pred             cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-----HHHHHh---ccCCCCcc-
Confidence            544333344556899999999999999999999999999999999999999754321     111111   11110000 


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhccCCc
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-PMAQVVKMLQGEDL  357 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~~vl~~L~~~~~  357 (401)
                            ......+.++.+++.+||+.||++|| +++++++.|+....
T Consensus       256 ------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          256 ------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             ------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             ------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence                  11223344788999999999999999 99999999986443

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=6.4e-44  Score=327.50  Aligned_cols=248  Identities=21%  Similarity=0.277  Sum_probs=201.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCeeEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  152 (401)
                      .++|.+.+.||+|+||+||+|... +++.||+|++... ........+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            467899999999999999999975 6899999999743 3344567888999999998 899999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC----------------
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD----------------  216 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~----------------  216 (401)
                      |||+++++|.+++.........+++..++.++.|++.||+|||++   +++|+||||+||+++.                
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            999999999999986433335689999999999999999999999   9999999999999984                


Q ss_pred             ---CCcEEEeecCCccccCCCCcceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhh
Q 015734          217 ---NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEED  292 (401)
Q Consensus       217 ---~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~  292 (401)
                         ...+||+|||++.......     ...||+.|+|||.+.+. .++.++|||||||++|+|++|.+|+.....     
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----  236 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ-----  236 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-----
T ss_pred             cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-----
Confidence               4479999999998665432     23489999999999766 567899999999999999999887643211     


Q ss_pred             hhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          293 VLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                            .... ...        ..+..+...+.++.+++.+||+.||.+|||+.+++++
T Consensus       237 ------~~~~-~~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          237 ------WHEI-RQG--------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             ------HHHH-HTT--------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             ------HHHH-HcC--------CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence                  0011 111        1111222334578899999999999999999999764

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.2e-44  Score=338.63  Aligned_cols=263  Identities=21%  Similarity=0.210  Sum_probs=202.9

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc----CCcchHHHHHHHHHHHHhccCCcccceeeeeecC
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY----YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS  146 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  146 (401)
                      +....++|.+.+.||+|+||.||+|... ++..||+|++...    ......+.+.+|+++++.++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            3456778999999999999999999964 6789999998632    2345678899999999999999999999999999


Q ss_pred             CeeEEEEecccCCcHHHHhhhcCCC------------------------------------CCCCCHHHHHHHHHHHHHH
Q 015734          147 SERILVYPFMQNLSVAYRLRDLKPG------------------------------------EKGLDWPTRKRVAFGTAYG  190 (401)
Q Consensus       147 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~i~~~  190 (401)
                      +..++||||+++|+|.+++......                                    ...+++..++.++.|++.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            9999999999999999988632111                                    1123567788899999999


Q ss_pred             HHHHHhcCCCCeEEeCCCCCceEEcCCC--cEEEeecCCccccCCCCc---ceeccccCCccccccccccc--CCCCccc
Q 015734          191 LEYLHEQCNPKIIHRDLKAANILLDDNF--EAVLCDFGLAKLVDAKLT---HVTTQIRGTMGHIAPEYLST--GKSSEKT  263 (401)
Q Consensus       191 l~~LH~~~~~~i~H~dlkp~Nill~~~~--~~kl~Dfgl~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~s  263 (401)
                      |+|||++   +++|+||||+||+++.++  .+||+|||++........   .......||+.|+|||.+.+  ..++.++
T Consensus       181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            9999999   999999999999998776  899999999986543221   12344568999999999865  6789999


Q ss_pred             chhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 015734          264 DVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP  343 (401)
Q Consensus       264 Di~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP  343 (401)
                      |||||||++|+|++|..||......+        .............  .+    .....+..+.+++..||+.||.+||
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~--------~~~~~~~~~~~~~--~~----~~~~~~~~~~~li~~~l~~~p~~Rp  323 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDAD--------TISQVLNKKLCFE--NP----NYNVLSPLARDLLSNLLNRNVDERF  323 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCTT--SG----GGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHH--------HHHHHHhcccccC--Cc----ccccCCHHHHHHHHHHcCCChhHCC
Confidence            99999999999999999997544321        1111111110000  00    1112345788999999999999999


Q ss_pred             CHHHHHHH
Q 015734          344 PMAQVVKM  351 (401)
Q Consensus       344 s~~~vl~~  351 (401)
                      |+.+++++
T Consensus       324 s~~~~l~h  331 (345)
T 3hko_A          324 DAMRALQH  331 (345)
T ss_dssp             CHHHHHHS
T ss_pred             CHHHHhcC
Confidence            99999774

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.1e-43  Score=340.39  Aligned_cols=252  Identities=20%  Similarity=0.286  Sum_probs=198.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccc-CCcchHHHHHHHHHHHHhcc--CCcccceeeeeecCCeeEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAI--HKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv  152 (401)
                      ..+|.+.+.||+|+||.||+|...+++.||||++... ........+.+|+.++..+.  ||||+++++++...+..++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            4569999999999999999999888999999998643 34445678999999999997  59999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      || +.+++|.+++...    ..+++..+..++.|++.||.|||++   +++||||||+|||++ ++.+||+|||++....
T Consensus       135 ~E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~  205 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  205 (390)
T ss_dssp             EE-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred             Ee-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence            99 5688999999863    3588999999999999999999999   999999999999996 5789999999998664


Q ss_pred             CCCcc-eeccccCCccccccccccc-----------CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHH
Q 015734          233 AKLTH-VTTQIRGTMGHIAPEYLST-----------GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR  300 (401)
Q Consensus       233 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~  300 (401)
                      ..... ......||+.|+|||++.+           ..++.++|||||||++|||++|..||.......       ....
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-------~~~~  278 (390)
T 2zmd_A          206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-------SKLH  278 (390)
T ss_dssp             --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-------HHHH
T ss_pred             CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-------HHHH
Confidence            43222 2344579999999999865           368899999999999999999999997432210       1111


Q ss_pred             HHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          301 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       301 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ........     ..   .+.....++.+++.+||+.||.+|||+.+++++
T Consensus       279 ~~~~~~~~-----~~---~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          279 AIIDPNHE-----IE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHHCTTSC-----CC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHhCcccc-----CC---CCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            11111100     01   111124578899999999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.1e-44  Score=360.53  Aligned_cols=247  Identities=24%  Similarity=0.370  Sum_probs=199.9

Q ss_pred             eeeecCcEEEEEEEEC---CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCCc
Q 015734           84 IIGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS  160 (401)
Q Consensus        84 ~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  160 (401)
                      .||+|+||.||+|.+.   ++..||||+++........+.+.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999864   4567999999865555677899999999999999999999999976 56899999999999


Q ss_pred             HHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcce--
Q 015734          161 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--  238 (401)
Q Consensus       161 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~--  238 (401)
                      |.+++...   ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++.........  
T Consensus       422 L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  495 (613)
T 2ozo_A          422 LHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA  495 (613)
T ss_dssp             HHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred             HHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence            99999752   34689999999999999999999999   99999999999999999999999999998764432221  


Q ss_pred             eccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCC
Q 015734          239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN  317 (401)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  317 (401)
                      .....+|+.|+|||++.+..++.++|||||||++|||+| |..||......+     ....+.   ....         .
T Consensus       496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-----~~~~i~---~~~~---------~  558 (613)
T 2ozo_A          496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----VMAFIE---QGKR---------M  558 (613)
T ss_dssp             ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-----HHHHHH---TTCC---------C
T ss_pred             ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----HHHHHH---cCCC---------C
Confidence            122335689999999999999999999999999999998 999997644321     111111   1110         1


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          318 TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       318 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ..+..++.++.+++..||+.||++||++.++++.|+.
T Consensus       559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  595 (613)
T 2ozo_A          559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  595 (613)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            1233445688999999999999999999999999875

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-43  Score=326.07  Aligned_cols=254  Identities=27%  Similarity=0.366  Sum_probs=202.6

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CC---CEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCee-EEE
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DN---TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER-ILV  152 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~lv  152 (401)
                      .|...+.||+|+||+||+|.+. ++   ..||+|.+.........+.+.+|+.+++.++||||+++++++...+.. +++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            3555689999999999999853 22   379999998655556678899999999999999999999999877665 999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      +||+.+++|.+++..   ....+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++....
T Consensus       102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            999999999999976   235689999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCc---ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCC-CCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          233 AKLT---HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRA-IDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       233 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ....   .......+|+.|+|||.+.+..++.++||||||+++|+|++|..| |.......     .......    .. 
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-----~~~~~~~----~~-  245 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-----LTHFLAQ----GR-  245 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-----HHHHHHT----TC-
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-----HHHHhhc----CC-
Confidence            3321   122334578899999999999999999999999999999996555 44322211     1111111    10 


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                             ....+...+..+.+++.+||+.||.+|||+.++++.|+.
T Consensus       246 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~  284 (298)
T 3pls_A          246 -------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ  284 (298)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                   011122334578899999999999999999999999865

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=8.9e-44  Score=335.75  Aligned_cols=268  Identities=18%  Similarity=0.198  Sum_probs=200.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC----CCCEEEEEEecccCCcc----------hHHHHHHHHHHHHhccCCccccee
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYYSPG----------GEAAFQREVHLISVAIHKNLLQLI  140 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~~~  140 (401)
                      ..++|.+.+.||+|+||.||+|...    ++..+|+|+........          ....+.+|+..+..++||||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~  114 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY  114 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence            3467999999999999999999975    56789999987532211          112466788889999999999999


Q ss_pred             eeeec----CCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC
Q 015734          141 GYCTT----SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD  216 (401)
Q Consensus       141 ~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~  216 (401)
                      +++..    ....++||||+ +++|.+++...    ..+++..++.++.|++.||+|||++   +++||||||+|||++.
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~  186 (345)
T 2v62_A          115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGY  186 (345)
T ss_dssp             EEEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEES
T ss_pred             cccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEcc
Confidence            99887    67889999999 99999998763    2689999999999999999999999   9999999999999998


Q ss_pred             CC--cEEEeecCCccccCCCCcc------eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcch
Q 015734          217 NF--EAVLCDFGLAKLVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLE  288 (401)
Q Consensus       217 ~~--~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~  288 (401)
                      ++  .+||+|||+++........      ......||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus       187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~  266 (345)
T 2v62_A          187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD  266 (345)
T ss_dssp             SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred             CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence            87  9999999999866433211      113456899999999999989999999999999999999999999642221


Q ss_pred             hhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCc
Q 015734          289 EEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDL  357 (401)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  357 (401)
                      .....    ......... ....+.....  ....+.++.+++..||+.||.+|||+.++++.|+....
T Consensus       267 ~~~~~----~~~~~~~~~-~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          267 PVAVQ----TAKTNLLDE-LPQSVLKWAP--SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHH----HHHHHHHHT-TTHHHHHHSC--TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             cHHHH----HHHHhhccc-ccHHHHhhcc--ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            11111    111111100 1111100000  01234578899999999999999999999999987654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.5e-44  Score=333.78  Aligned_cols=263  Identities=25%  Similarity=0.386  Sum_probs=200.2

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEEC----CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecC
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS  146 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  146 (401)
                      +.+..++|.+.+.||+|+||.||+|...    ++..||+|.+... ......+.+.+|+.++++++||||+++++++...
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            3446678899999999999999999853    2458999998743 2344567899999999999999999999998776


Q ss_pred             Ce-----eEEEEecccCCcHHHHhhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCc
Q 015734          147 SE-----RILVYPFMQNLSVAYRLRDLK--PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE  219 (401)
Q Consensus       147 ~~-----~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~  219 (401)
                      +.     .++||||+++++|.+++....  .....+++..++.++.|++.||.|||++   +++|+||||+||+++.++.
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSC
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCc
Confidence            53     499999999999999985432  2346699999999999999999999999   9999999999999999999


Q ss_pred             EEEeecCCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHH
Q 015734          220 AVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLD  297 (401)
Q Consensus       220 ~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~  297 (401)
                      +||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......     ...
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----~~~  260 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-----MYD  260 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----HHH
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH-----HHH
Confidence            999999999865443221 2233456889999999999999999999999999999999 888987544321     111


Q ss_pred             HHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          298 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       298 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ...   ...         ....+...+.++.+++.+||+.||.+|||+.++++.|+.
T Consensus       261 ~~~---~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  305 (313)
T 3brb_A          261 YLL---HGH---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK  305 (313)
T ss_dssp             HHH---TTC---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHH---cCC---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            111   110         111223344678899999999999999999999999875

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.8e-43  Score=329.51  Aligned_cols=250  Identities=20%  Similarity=0.262  Sum_probs=181.0

Q ss_pred             CCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCcccceeeeeecCCeeEEEEecccCC
Q 015734           82 SNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPFMQNL  159 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g  159 (401)
                      .+.||+|+||+||+|.++ +++.||+|++..    .....+.+|+.++..+. ||||+++++++.+....++||||++++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~   91 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG   91 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEG----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEECh----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence            478999999999999975 589999999864    34567889999999997 999999999999999999999999999


Q ss_pred             cHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC---cEEEeecCCccccCCCCc
Q 015734          160 SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF---EAVLCDFGLAKLVDAKLT  236 (401)
Q Consensus       160 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---~~kl~Dfgl~~~~~~~~~  236 (401)
                      +|.+++..    ...+++..+..++.|++.||+|||++   +++||||||+||+++.++   .+||+|||++........
T Consensus        92 ~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~  164 (325)
T 3kn6_A           92 ELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ  164 (325)
T ss_dssp             BHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred             cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence            99999986    34699999999999999999999999   999999999999997765   899999999986544322


Q ss_pred             ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcC
Q 015734          237 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL  316 (401)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  316 (401)
                       ......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ....+...... .....      .
T Consensus       165 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~i~-~~~~~------~  235 (325)
T 3kn6_A          165 -PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC-TSAVEIMKKIK-KGDFS------F  235 (325)
T ss_dssp             --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C-CCHHHHHHHHT-TTCCC------C
T ss_pred             -cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc-ccHHHHHHHHH-cCCCC------C
Confidence             233456899999999999999999999999999999999999999754321110 01111111111 11100      0


Q ss_pred             CC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          317 NT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       317 ~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .. .....+.++.+++..||+.||.+|||+.+++++
T Consensus       236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            00 012235678899999999999999999999754

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.2e-43  Score=323.96  Aligned_cols=254  Identities=22%  Similarity=0.313  Sum_probs=206.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      .++|.+.+.||+|+||.||+|... +++.||+|++.........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467889999999999999999975 6899999999754445567889999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++++|.+++..    ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++......
T Consensus        86 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             ecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            9999999988864    34589999999999999999999999   9999999999999999999999999999765432


Q ss_pred             Cc-ceeccccCCcccccccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          235 LT-HVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       235 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      .. .......||+.|+|||.+.+..+ +.++||||||+++|+|++|..||.........   ...    ........   
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~----~~~~~~~~---  228 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---YSD----WKEKKTYL---  228 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH---HHH----HHTTCTTS---
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH---HHH----hhhccccc---
Confidence            21 22334568999999999987765 78999999999999999999999754332111   111    11110000   


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                           .........+.+++.+||+.||.+|||+.+++++
T Consensus       229 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          229 -----NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             -----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -----CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence                 0112334578899999999999999999999764

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.5e-43  Score=330.28  Aligned_cols=268  Identities=24%  Similarity=0.327  Sum_probs=210.8

Q ss_pred             cCHHHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHh--ccCCcccceeeeee
Q 015734           67 FSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISV--AIHKNLLQLIGYCT  144 (401)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~  144 (401)
                      ..........++|.+.+.||+|+||.||+|.. +++.||+|++..    .....+.+|.+++..  ++||||+++++++.
T Consensus        32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~  106 (342)
T 1b6c_B           32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIAADN  106 (342)
T ss_dssp             SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred             CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence            34444566778999999999999999999998 589999999864    345677889988887  78999999999998


Q ss_pred             cCC----eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEEeCCCCCce
Q 015734          145 TSS----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH--------EQCNPKIIHRDLKAANI  212 (401)
Q Consensus       145 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~i~H~dlkp~Ni  212 (401)
                      ...    ..++||||+++++|.+++..     ..+++..++.++.|++.||+|||        +.   +++|+||||+||
T Consensus       107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NI  178 (342)
T 1b6c_B          107 KDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNI  178 (342)
T ss_dssp             CCCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGE
T ss_pred             ccCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHE
Confidence            776    78999999999999999975     24899999999999999999999        66   999999999999


Q ss_pred             EEcCCCcEEEeecCCccccCCCCcc---eeccccCCcccccccccccC------CCCcccchhHHHHHHHHHHhC-----
Q 015734          213 LLDDNFEAVLCDFGLAKLVDAKLTH---VTTQIRGTMGHIAPEYLSTG------KSSEKTDVFGYGITLLELVTG-----  278 (401)
Q Consensus       213 ll~~~~~~kl~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDi~slG~ll~elltg-----  278 (401)
                      +++.++.+||+|||++.........   ......||+.|+|||.+.+.      .++.++||||||+++|||+||     
T Consensus       179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~  258 (342)
T 1b6c_B          179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  258 (342)
T ss_dssp             EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred             EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence            9999999999999999866544322   22345689999999998765      234789999999999999999     


Q ss_pred             -----CCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          279 -----QRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT--YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       279 -----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                           ..||...........   . ..........    .+.++.  ........+.+++.+||+.||.+|||+.+++++
T Consensus       259 ~~~~~~~p~~~~~~~~~~~~---~-~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          259 IHEDYQLPYYDLVPSDPSVE---E-MRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             BCCCCCCTTTTTSCSSCCHH---H-HHHHHTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cccccccCccccCcCcccHH---H-HHHHHHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence                 667754332211111   1 1111111111    111111  134667889999999999999999999999999


Q ss_pred             hccC
Q 015734          352 LQGE  355 (401)
Q Consensus       352 L~~~  355 (401)
                      |+..
T Consensus       331 L~~i  334 (342)
T 1b6c_B          331 LSQL  334 (342)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9763

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6.7e-44  Score=326.46  Aligned_cols=249  Identities=25%  Similarity=0.392  Sum_probs=201.9

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      ..++|.+.+.||+|+||+||+|... ++..||+|++....  .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3467889999999999999999965 57799999986321  12235678899999999999999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      ||||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++...
T Consensus        87 v~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~  159 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA  159 (279)
T ss_dssp             EECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred             EEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence            99999999999999864    3489999999999999999999998   9999999999999999999999999998644


Q ss_pred             CCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ...   ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.......     ....+..   .      
T Consensus       160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~---~------  222 (279)
T 3fdn_A          160 PSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-----TYKRISR---V------  222 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHHH---T------
T ss_pred             Ccc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-----HHHHHHh---C------
Confidence            332   2234568999999999999999999999999999999999999997544321     1111111   0      


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                       ..   ..+......+.+++..||+.||.+|||+.+++++
T Consensus       223 -~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          223 -EF---TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             -CC---CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             -CC---CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence             00   1122234578899999999999999999999875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.3e-44  Score=334.74  Aligned_cols=257  Identities=26%  Similarity=0.402  Sum_probs=204.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCE--EEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCeeEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTK--VAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  151 (401)
                      .++|.+.+.||+|+||.||+|... ++..  +|+|.+.........+.+.+|+.++.++ +||||+++++++...+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            367889999999999999999964 4554  4999987655555667899999999999 89999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCc
Q 015734          152 VYPFMQNLSVAYRLRDLK------------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE  219 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~  219 (401)
                      ||||+++++|.+++....            .....+++..++.++.|++.||.|||++   +++|+||||+||+++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence            999999999999998643            2234689999999999999999999999   9999999999999999999


Q ss_pred             EEEeecCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHH
Q 015734          220 AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDH  298 (401)
Q Consensus       220 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~  298 (401)
                      +||+|||++.......  ......+++.|+|||.+.+..++.++||||||+++|+|+| |..||.......        .
T Consensus       181 ~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--------~  250 (327)
T 1fvr_A          181 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------L  250 (327)
T ss_dssp             EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------H
T ss_pred             EEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--------H
Confidence            9999999987433221  1222346889999999988889999999999999999998 999997543211        1


Q ss_pred             HHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          299 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       299 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      .... ....        ....+...+.++.+++.+||+.||.+|||+.++++.|+.
T Consensus       251 ~~~~-~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  297 (327)
T 1fvr_A          251 YEKL-PQGY--------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  297 (327)
T ss_dssp             HHHG-GGTC--------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHh-hcCC--------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            1111 1110        011122334678899999999999999999999998864

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=340.20  Aligned_cols=272  Identities=18%  Similarity=0.214  Sum_probs=212.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCC--eeEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS--ERILV  152 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv  152 (401)
                      .++|.+.+.||+|+||+||+|.+. +++.||+|++.........+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            457889999999999999999975 489999999975444455678889999999999999999999987665  67999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEE----cCCCcEEEeecCCc
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL----DDNFEAVLCDFGLA  228 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill----~~~~~~kl~Dfgl~  228 (401)
                      |||+++++|.+++..... ...+++..++.++.|++.||+|||++   +++||||||+||++    +.++.+||+|||++
T Consensus        88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            999999999999986432 23489999999999999999999999   99999999999999    78888999999999


Q ss_pred             cccCCCCcceeccccCCccccccccccc--------CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHH
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLST--------GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR  300 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~  300 (401)
                      +......  ......||+.|+|||++.+        ..++.++|||||||++|||++|..||..................
T Consensus       164 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          164 RELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             EECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             eEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            8665432  2233568999999999865        56788999999999999999999999753332222111111111


Q ss_pred             HHhccCccchhc---------cCcC---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          301 KLLREDRLNDIV---------DRNL---NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       301 ~~~~~~~~~~~~---------d~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                       ...........         ....   ..........+.+++..||+.||++||+++++++.++.
T Consensus       242 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~  306 (396)
T 4eut_A          242 -GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (396)
T ss_dssp             -SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             -CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence             11111110000         0011   12456778889999999999999999999999888765

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.2e-43  Score=326.37  Aligned_cols=255  Identities=23%  Similarity=0.342  Sum_probs=202.5

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECC-C-------CEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecC
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLSD-N-------TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS  146 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  146 (401)
                      ..++|.+.+.||+|+||+||+|.... +       ..||+|.+... .....+.+.+|+.+++.++||||+++++++...
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG   84 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence            34678889999999999999998643 3       47999998643 334567899999999999999999999999999


Q ss_pred             CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCc-------
Q 015734          147 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE-------  219 (401)
Q Consensus       147 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~-------  219 (401)
                      +..++||||+++++|.+++...   ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.       
T Consensus        85 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~  158 (289)
T 4fvq_A           85 DENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP  158 (289)
T ss_dssp             TCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred             CCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence            9999999999999999999863   23489999999999999999999999   9999999999999998887       


Q ss_pred             -EEEeecCCccccCCCCcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCC-CCCCcchhhhhhhHH
Q 015734          220 -AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRA-IDFSRLEEEEDVLLL  296 (401)
Q Consensus       220 -~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p-~~~~~~~~~~~~~~~  296 (401)
                       +||+|||++......     ....+|+.|+|||.+.+ ..++.++||||||+++|+|++|..| +.......     . 
T Consensus       159 ~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-----~-  227 (289)
T 4fvq_A          159 FIKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-----K-  227 (289)
T ss_dssp             EEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----H-
T ss_pred             eeeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-----H-
Confidence             999999998754332     22347889999999987 6789999999999999999996544 43322110     0 


Q ss_pred             HHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCchhh
Q 015734          297 DHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAER  360 (401)
Q Consensus       297 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~~~  360 (401)
                        ..........           +...+.++.+++..||+.||.+|||+.++++.|+....+..
T Consensus       228 --~~~~~~~~~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~  278 (289)
T 4fvq_A          228 --LQFYEDRHQL-----------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL  278 (289)
T ss_dssp             --HHHHHTTCCC-----------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred             --HHHhhccCCC-----------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence              1111111111           11113367899999999999999999999999998766543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=323.60  Aligned_cols=251  Identities=24%  Similarity=0.369  Sum_probs=184.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|.+....  .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            35788899999999999999996 478999999986321  123357789999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||+++++|.+++...   ...+++..++.++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++....
T Consensus        90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             EECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            9999999999998852   35689999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      .... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||........        .....    ..   
T Consensus       164 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------~~~~~----~~---  227 (278)
T 3cok_A          164 MPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--------LNKVV----LA---  227 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CC----SS---
T ss_pred             CCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--------HHHHh----hc---
Confidence            3322 22235689999999999988899999999999999999999999975432210        00000    00   


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      +.   ..+...+.++.+++.+||+.||.+|||+.+++++
T Consensus       228 ~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          228 DY---EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             CC---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cc---CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence            00   1122334578899999999999999999999763

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.7e-43  Score=327.43  Aligned_cols=263  Identities=22%  Similarity=0.339  Sum_probs=201.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      .++|.+.+.||+|+||.||+|.. .++..||+|++...  ........+.+|+.+++.++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            45789999999999999999996 46899999999742  2344567889999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||+++++|.+++.........+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999986554456789999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      .... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||......      ........ ........ 
T Consensus       188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~~~~~-  258 (310)
T 2wqm_A          188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKI-EQCDYPPL-  258 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC------HHHHHHHH-HTTCSCCC-
T ss_pred             CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh------HHHHHHHh-hcccCCCC-
Confidence            4322 223346899999999999999999999999999999999999999743321      11111111 11111110 


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED  356 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  356 (401)
                            .....+.++.+++.+||+.||.+|||+.++++.|+...
T Consensus       259 ------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~  296 (310)
T 2wqm_A          259 ------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH  296 (310)
T ss_dssp             ------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence                  11223457889999999999999999999999987643

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=8.3e-43  Score=325.79  Aligned_cols=253  Identities=21%  Similarity=0.264  Sum_probs=206.8

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCc-----chHHHHHHHHHHHHhccCCcccceeeeeecCCe
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP-----GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE  148 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  148 (401)
                      ..++|.+.+.||+|+||.||+|..+ ++..||+|.+......     ...+.+.+|+.++..++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            3467899999999999999999975 5899999999743221     246789999999999999999999999999999


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC----cEEEee
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF----EAVLCD  224 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~D  224 (401)
                      .++||||+++++|.+++..    ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++    .+||+|
T Consensus        90 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~D  162 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID  162 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEcc
Confidence            9999999999999999975    34589999999999999999999999   999999999999999888    799999


Q ss_pred             cCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhc
Q 015734          225 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR  304 (401)
Q Consensus       225 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (401)
                      ||++.......  ......||+.|+|||.+.+..++.++||||||+++|+|++|..||......+     .   ......
T Consensus       163 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~---~~~i~~  232 (321)
T 2a2a_A          163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----T---LANITS  232 (321)
T ss_dssp             CTTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----H---HHHHHT
T ss_pred             CccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-----H---HHHHHh
Confidence            99998665432  2234568999999999999999999999999999999999999997543211     1   111111


Q ss_pred             cC-ccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          305 ED-RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       305 ~~-~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .. ......       ....+..+.+++.+||+.||.+|||+.+++++
T Consensus       233 ~~~~~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          233 VSYDFDEEF-------FSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             TCCCCCHHH-------HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             cccccChhh-------hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00 000000       01223568899999999999999999999885

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=8e-44  Score=338.00  Aligned_cols=268  Identities=22%  Similarity=0.291  Sum_probs=207.4

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ..++|.+.+.||+|+||+||+|.+. ++..||+|++...........+.+|+.+++.++||||+++++++...+..++||
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  110 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM  110 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence            3567899999999999999999975 689999999986555666788999999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++++|.+++...    ..+++..+..++.|++.||+|||+..  +++|+||||+||+++.++.+||+|||++.....
T Consensus       111 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          111 EHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             CCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             ECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            999999999999863    35899999999999999999999842  799999999999999999999999999875432


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHH-----------
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL-----------  302 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------  302 (401)
                      .   ......||+.|+|||++.+..++.++|||||||++|+|++|..||....................           
T Consensus       185 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          185 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             H---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             c---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence            2   22335689999999999999999999999999999999999999976443221100000000000           


Q ss_pred             ----------hccCccch----hccCcCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          303 ----------LREDRLND----IVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       303 ----------~~~~~~~~----~~d~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                                .......+    ........ .....+.++.+++.+||+.||.+|||+.+++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                      00000000    00011111 112235578899999999999999999999764

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-43  Score=329.00  Aligned_cols=254  Identities=26%  Similarity=0.383  Sum_probs=197.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      .++|.+.+.||+|+||+||+|.. .++.||+|.+..   ....+.+.+|++++++++||||+++++++.+  ..++||||
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~   80 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES---ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY   80 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSS---TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred             HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecC---hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence            35788889999999999999998 478899999863   3456789999999999999999999998874  47999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCc-EEEeecCCccccCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE-AVLCDFGLAKLVDAK  234 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~-~kl~Dfgl~~~~~~~  234 (401)
                      +++++|.+++..... ...+++..+..++.|++.||+|||+....+++|+||||+||+++.++. +||+|||++......
T Consensus        81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~  159 (307)
T 2eva_A           81 AEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH  159 (307)
T ss_dssp             CTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred             CCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence            999999999986321 234788999999999999999999932228999999999999998886 799999999755332


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccC
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR  314 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  314 (401)
                          .....||+.|+|||++.+..++.++||||||+++|||++|+.||........      ........ ..       
T Consensus       160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~-~~-------  221 (307)
T 2eva_A          160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF------RIMWAVHN-GT-------  221 (307)
T ss_dssp             ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH------HHHHHHHT-TC-------
T ss_pred             ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH------HHHHHHhc-CC-------
Confidence                2234589999999999999999999999999999999999999975332110      11111111 10       


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          315 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       315 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                       ........+..+.+++.+||+.||.+|||+.++++.|+..
T Consensus       222 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  261 (307)
T 2eva_A          222 -RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL  261 (307)
T ss_dssp             -CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence             0111223345788999999999999999999999998753

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.1e-43  Score=338.52  Aligned_cols=264  Identities=22%  Similarity=0.309  Sum_probs=193.8

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhcc-CCcccceeeeeecCC--e
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSS--E  148 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~  148 (401)
                      ...++|.+.+.||+|+||.||+|.+. +++.||+|++... ........+.+|+.++..+. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            35678999999999999999999964 6899999998643 23445667889999999997 999999999987544  6


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      .++||||++ ++|...+..     ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a  156 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS  156 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence            899999997 589888875     3588999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCC--------------------cceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcc
Q 015734          229 KLVDAKL--------------------THVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRL  287 (401)
Q Consensus       229 ~~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~  287 (401)
                      +......                    ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  236 (388)
T 3oz6_A          157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST  236 (388)
T ss_dssp             EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            8653211                    112234579999999999876 6789999999999999999999999986543


Q ss_pred             hhhhhhhHHHHHHHHhccCccchh-----------c----------cCcCCCC-------------CHHHHHHHHHHHHH
Q 015734          288 EEEEDVLLLDHIRKLLREDRLNDI-----------V----------DRNLNTY-------------DSKEVETMVQVALL  333 (401)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~-----------~----------d~~~~~~-------------~~~~~~~l~~l~~~  333 (401)
                      .....     .+...........+           +          .......             ......++.+|+.+
T Consensus       237 ~~~~~-----~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~  311 (388)
T 3oz6_A          237 MNQLE-----RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDK  311 (388)
T ss_dssp             HHHHH-----HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHH
T ss_pred             HHHHH-----HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHH
Confidence            22111     11111100000000           0          0000000             01224578899999


Q ss_pred             cccCCCCCCCCHHHHHHH
Q 015734          334 CTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       334 cl~~~p~~RPs~~~vl~~  351 (401)
                      ||+.||.+|||+.+++++
T Consensus       312 ~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          312 LLQFNPNKRISANDALKH  329 (388)
T ss_dssp             HCCSSGGGSCCHHHHTTS
T ss_pred             hhccCcccCCCHHHHhCC
Confidence            999999999999999876

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=337.61  Aligned_cols=262  Identities=25%  Similarity=0.332  Sum_probs=196.2

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      ++|.+.+.||+|+||+||+|... +++.||+|++...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57888999999999999999975 68999999986433322223456799999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      ++ ++|.+++...   ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        82 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           82 LD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  154 (324)
T ss_dssp             CS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred             cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence            97 5888888763   34689999999999999999999999   99999999999999999999999999997554332


Q ss_pred             cceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC---ccchh
Q 015734          236 THVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED---RLNDI  311 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  311 (401)
                      . ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+     ....+.......   .+...
T Consensus       155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~~i~~~~~~~~~~~~~~~  228 (324)
T 3mtl_A          155 K-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-----QLHFIFRILGTPTEETWPGI  228 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCCCCTTTSTTG
T ss_pred             c-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHhCCCChHhchhh
Confidence            2 2233468999999999876 568999999999999999999999998654322     111122211111   11111


Q ss_pred             ccC------cCC--------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          312 VDR------NLN--------TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       312 ~d~------~~~--------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ...      ...        ........++.+++.+||+.||.+|||+.|++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            000      000        0112234578899999999999999999999663

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.8e-43  Score=333.73  Aligned_cols=248  Identities=28%  Similarity=0.351  Sum_probs=200.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      .+.|...+.||+|+||+||+|.. .+++.||+|++....  .....+.+.+|++++++++||||+++++++...+..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            34588899999999999999996 468899999986432  233446789999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||+. |+|.+.+...   ...+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++....
T Consensus       133 ~e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  205 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  205 (348)
T ss_dssp             EECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             EecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence            99997 6888777642   34689999999999999999999999   99999999999999999999999999997654


Q ss_pred             CCCcceeccccCCcccccccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN  309 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ..     ....||+.|+|||++.   ...++.++|||||||++|||++|..||.......        ......... ..
T Consensus       206 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--------~~~~~~~~~-~~  271 (348)
T 1u5q_A          206 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNE-SP  271 (348)
T ss_dssp             SB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSC-CC
T ss_pred             CC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHHhcC-CC
Confidence            32     2346899999999984   5678999999999999999999999997543211        111111111 00


Q ss_pred             hhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       310 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .     .  .....+..+.+++.+||+.||.+|||+.+++++
T Consensus       272 ~-----~--~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          272 A-----L--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             C-----C--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             C-----C--CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0     0  112234568899999999999999999999875

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.2e-44  Score=335.44  Aligned_cols=267  Identities=25%  Similarity=0.306  Sum_probs=209.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-----CCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeee--cCCe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT--TSSE  148 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~  148 (401)
                      .++|.+.+.||+|+||.||+|.+     .++..||+|++... .....+.+.+|++++++++||||+++++++.  ..+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence            46788899999999999999984     35789999998753 3445677999999999999999999999886  4456


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      .++||||+++++|.+++....   ..+++..++.++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  174 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA  174 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred             EEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccc
Confidence            889999999999999998632   3589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcc--eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhh------hHHHHHH
Q 015734          229 KLVDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV------LLLDHIR  300 (401)
Q Consensus       229 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~------~~~~~~~  300 (401)
                      .........  ......+|+.|+|||.+.+..++.++||||||+++|+|++|..||...........      .......
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL  254 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred             eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence            876543322  22334578889999999998899999999999999999999999864322110000      0000011


Q ss_pred             HHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCc
Q 015734          301 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDL  357 (401)
Q Consensus       301 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  357 (401)
                      .....        ......+...+..+.+++..||+.||.+|||+.+++++|+....
T Consensus       255 ~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          255 ELLEE--------GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             HHHHT--------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             HHhhc--------ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            11110        11112234455678999999999999999999999999986543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.4e-43  Score=326.68  Aligned_cols=251  Identities=25%  Similarity=0.356  Sum_probs=208.6

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ..+.|...+.||+|+||.||+|... +++.||+|++.........+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   99 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   99 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            3456888999999999999999964 688999999976555566788999999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++++|.+++..     ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.....
T Consensus       100 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A          100 EYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             ECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             EeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCc
Confidence            99999999998864     3589999999999999999999999   999999999999999999999999999986644


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      ... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.......     ....+.    ...      
T Consensus       172 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~----~~~------  235 (303)
T 3a7i_A          172 TQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-----VLFLIP----KNN------  235 (303)
T ss_dssp             TBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHH----HSC------
T ss_pred             ccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH-----HHHHhh----cCC------
Confidence            322 2234568999999999999999999999999999999999999997543211     111111    110      


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                        ........+..+.+++..||+.||.+|||+.+++++
T Consensus       236 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          236 --PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             --CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             --CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence              011122334578899999999999999999999775

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.9e-43  Score=349.27  Aligned_cols=256  Identities=23%  Similarity=0.318  Sum_probs=208.0

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      ..++|...++||+|+||.||+|..+ +|+.||+|++...  ........+.+|++++..++||||+++++++.+.+..++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            4567888999999999999999975 6899999999632  122345678899999999999999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      ||||+++|+|.+++....  ...+++..++.++.||+.||.|||++   +++||||||+|||++.++++||+|||++...
T Consensus       262 VmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             EECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceec
Confidence            999999999999987632  34589999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|..||......... ..+...+..   ..     
T Consensus       337 ~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~-~~i~~~i~~---~~-----  405 (576)
T 2acx_A          337 PEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERLVKE---VP-----  405 (576)
T ss_dssp             CTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH-HHHHHHHHH---CC-----
T ss_pred             ccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH-HHHHHHhhc---cc-----
Confidence            5432  223457999999999999989999999999999999999999999764321111 111111111   00     


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM  351 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  351 (401)
                           ..++...+.++.+++.+||+.||.+||     ++++++++
T Consensus       406 -----~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          406 -----EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             -----ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence                 011223346788999999999999999     77888664

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=8.6e-44  Score=338.43  Aligned_cols=252  Identities=25%  Similarity=0.272  Sum_probs=195.5

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHH-HHhccCCcccceeeeeecCCeeE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHL-ISVAIHKNLLQLIGYCTTSSERI  150 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~  150 (401)
                      ..++|.+.+.||+|+||.||+|..+ ++..||+|++....  .......+..|..+ ++.++||||+++++++.+.+..+
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~  115 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY  115 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence            4568999999999999999999975 57899999997432  23344566677776 56789999999999999999999


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      +||||+++|+|.+++...    ..+++..++.++.|++.||+|||++   +++||||||+|||++.++++||+|||+++.
T Consensus       116 lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~  188 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE  188 (373)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred             EEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccc
Confidence            999999999999999863    3588999999999999999999999   999999999999999999999999999985


Q ss_pred             cCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccch
Q 015734          231 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND  310 (401)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ..... ......+||+.|+|||++.+..++.++|||||||++|||++|..||......+     .   ........    
T Consensus       189 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-----~---~~~i~~~~----  255 (373)
T 2r5t_A          189 NIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-----M---YDNILNKP----  255 (373)
T ss_dssp             GBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-----H---HHHHHHSC----
T ss_pred             cccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-----H---HHHHHhcc----
Confidence            43222 23345679999999999999999999999999999999999999997543321     1   11111110    


Q ss_pred             hccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 015734          311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML  352 (401)
Q Consensus       311 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  352 (401)
                           . ..+.....++.+++.+||+.||.+||++.+.++.+
T Consensus       256 -----~-~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i  291 (373)
T 2r5t_A          256 -----L-QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI  291 (373)
T ss_dssp             -----C-CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred             -----c-CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence                 0 11222345788999999999999999986544443

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.7e-43  Score=326.21  Aligned_cols=265  Identities=25%  Similarity=0.296  Sum_probs=200.1

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccC----CcchHHHHHHHHHHHHhcc---CCcccceeeeeec
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY----SPGGEAAFQREVHLISVAI---HKNLLQLIGYCTT  145 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~  145 (401)
                      ...++|.+.+.||+|+||+||+|.+ .+++.||+|++....    .......+.+|+.+++.+.   ||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            4567999999999999999999996 468999999986322    1222346677777777664   9999999999876


Q ss_pred             CC-----eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcE
Q 015734          146 SS-----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA  220 (401)
Q Consensus       146 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~  220 (401)
                      ..     ..+++|||+. ++|.+++....  ...+++..++.++.|++.||+|||++   +++||||||+||+++.++.+
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~  159 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV  159 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence            55     4789999997 59999988632  23489999999999999999999999   99999999999999999999


Q ss_pred             EEeecCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHH
Q 015734          221 VLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR  300 (401)
Q Consensus       221 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~  300 (401)
                      ||+|||++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||........    + ..+.
T Consensus       160 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~-~~i~  232 (308)
T 3g33_A          160 KLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ----L-GKIF  232 (308)
T ss_dssp             EECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH----H-HHHH
T ss_pred             EEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH----H-HHHH
Confidence            999999998654332  23445689999999999999999999999999999999999999976543221    1 1111


Q ss_pred             HHhccC---ccchh-------ccCcCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          301 KLLRED---RLNDI-------VDRNLN----TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       301 ~~~~~~---~~~~~-------~d~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ......   .+...       +.+...    ...+.....+.+++.+||+.||.+|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            111110   00000       000000    0112334678899999999999999999999764

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.9e-43  Score=343.18  Aligned_cols=268  Identities=21%  Similarity=0.279  Sum_probs=187.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecC-----Ce
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-----SE  148 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  148 (401)
                      .++|.+.+.||+|+||+||+|.+. +++.||||++.... .......+.+|+.+++.++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            468999999999999999999965 68999999986432 334557889999999999999999999998433     56


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      .++||||+ +++|..++..    ...+++..++.++.||+.||+|||+.   +++||||||+|||++.++.+||+|||++
T Consensus       132 ~~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence            89999998 5789888875    34699999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCc--------------------------ceeccccCCccccccccc-ccCCCCcccchhHHHHHHHHHHh----
Q 015734          229 KLVDAKLT--------------------------HVTTQIRGTMGHIAPEYL-STGKSSEKTDVFGYGITLLELVT----  277 (401)
Q Consensus       229 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDi~slG~ll~ellt----  277 (401)
                      +.......                          .......||+.|+|||++ .+..++.++|||||||++|||++    
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~  283 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE  283 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence            86643211                          122345689999999986 56679999999999999999999    


Q ss_pred             -------CCCCCCCCcchhh---------------hhhhHHHHHHHHhccCccch--------------hc----cCcCC
Q 015734          278 -------GQRAIDFSRLEEE---------------EDVLLLDHIRKLLREDRLND--------------IV----DRNLN  317 (401)
Q Consensus       278 -------g~~p~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~--------------~~----d~~~~  317 (401)
                             |+++|.+......               ........+...........              .+    ...+.
T Consensus       284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (458)
T 3rp9_A          284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA  363 (458)
T ss_dssp             TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred             cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence                   5666654321000               00000111111111000000              00    00000


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          318 TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       318 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ...+....++.+|+.+||+.||.+|||++|++++
T Consensus       364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            1122335678899999999999999999999885

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.1e-43  Score=332.50  Aligned_cols=261  Identities=27%  Similarity=0.371  Sum_probs=207.3

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEE------CCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCC
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS  147 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  147 (401)
                      +..++|.+.+.||+|+||.||+|.+      .++..||+|.+...........+.+|+.+++.++||||+++++++...+
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            3567899999999999999999983      2467899999976556666778999999999999999999999999999


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC---CCcEE
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPG---EKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAV  221 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~k  221 (401)
                      ..++||||+++++|.+++......   ...+++..++.++.|++.||.|||++   +++|+||||+||+++.   +..+|
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEE
Confidence            999999999999999999875321   24589999999999999999999999   9999999999999984   45699


Q ss_pred             EeecCCccccCCCCc-ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHH
Q 015734          222 LCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHI  299 (401)
Q Consensus       222 l~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~  299 (401)
                      |+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|+| |..||.......     ....+
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~~~~~  258 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-----VLEFV  258 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----HHHHH
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH-----HHHHH
Confidence            999999875433221 22233457899999999998899999999999999999998 999987543211     11111


Q ss_pred             HHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          300 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       300 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      .   ...         ....+...+..+.+++..||+.||.+|||+.++++.|+.
T Consensus       259 ~---~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  301 (327)
T 2yfx_A          259 T---SGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  301 (327)
T ss_dssp             H---TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             h---cCC---------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            1   111         011122334578899999999999999999999998864

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.2e-42  Score=318.81  Aligned_cols=261  Identities=18%  Similarity=0.225  Sum_probs=201.0

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeee-ecCCeeEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC-TTSSERILV  152 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv  152 (401)
                      ..++|.+.+.||+|+||.||+|.. .+++.||+|++.....   ...+.+|+.++..++|++++..+..+ ...+..++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            457899999999999999999996 5688999998754222   23578899999999998877777665 566678999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEE---cCCCcEEEeecCCcc
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAK  229 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfgl~~  229 (401)
                      |||+ +++|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||++   +.++.+||+|||++.
T Consensus        84 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEcc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence            9999 99999998853   34589999999999999999999999   99999999999999   789999999999998


Q ss_pred             ccCCCCcc------eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHh
Q 015734          230 LVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL  303 (401)
Q Consensus       230 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  303 (401)
                      ........      ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.......... ..........
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~  235 (296)
T 4hgt_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-KYERISEKKM  235 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS-HHHHHHHHHH
T ss_pred             eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh-hhhhhhcccc
Confidence            66543321      2234568999999999999999999999999999999999999997643321111 1111111111


Q ss_pred             ccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          304 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       304 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                      . .....        .....+.++.+++..||+.||.+|||+.++++.|+..
T Consensus       236 ~-~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          236 S-TPIEV--------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             H-SCHHH--------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             c-chhhh--------hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence            0 00000        0111235788999999999999999999999998753

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=6.7e-44  Score=335.07  Aligned_cols=245  Identities=22%  Similarity=0.268  Sum_probs=202.9

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCC-------cchHHHHHHHHHHHHhccCCcccceeeeeecC
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-------PGGEAAFQREVHLISVAIHKNLLQLIGYCTTS  146 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  146 (401)
                      ..++|.+.+.||+|+||+||+|... ++..||+|++.....       ......+.+|+.+++.++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            4568999999999999999999964 688999999974321       11334677899999999999999999999999


Q ss_pred             CeeEEEEecccCC-cHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeec
Q 015734          147 SERILVYPFMQNL-SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF  225 (401)
Q Consensus       147 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  225 (401)
                      +..++||||+.+| +|..++..    ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred             CEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence            9999999999776 99998875    34599999999999999999999999   9999999999999999999999999


Q ss_pred             CCccccCCCCcceeccccCCcccccccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhc
Q 015734          226 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR  304 (401)
Q Consensus       226 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (401)
                      |++........  .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||......                
T Consensus       175 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------  236 (335)
T 3dls_A          175 GSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------  236 (335)
T ss_dssp             TTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred             ccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence            99987654322  233568999999999988876 88999999999999999999999642110                


Q ss_pred             cCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 015734          305 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML  352 (401)
Q Consensus       305 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  352 (401)
                             ..... ..+...+.++.+++..||+.||.+|||+.+++++-
T Consensus       237 -------~~~~~-~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp  276 (335)
T 3dls_A          237 -------VEAAI-HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP  276 (335)
T ss_dssp             -------TTTCC-CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred             -------Hhhcc-CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence                   00000 01112345788999999999999999999998863

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.6e-43  Score=320.47  Aligned_cols=250  Identities=19%  Similarity=0.263  Sum_probs=203.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ..++|.+.+.||+|+||.||+|... ++..||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence            3567899999999999999999975 467899999875332 34678999999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEE---cCCCcEEEeecCCccc
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKL  230 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfgl~~~  230 (401)
                      ||+++++|.+++...    ..+++..+..++.|++.||.|||++   +++|+||||+||++   +.++.++|+|||++..
T Consensus        86 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~  158 (277)
T 3f3z_A           86 ELCTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR  158 (277)
T ss_dssp             ECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             eccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence            999999999988763    4589999999999999999999999   99999999999999   8889999999999986


Q ss_pred             cCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC-ccc
Q 015734          231 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED-RLN  309 (401)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  309 (401)
                      .....  ......||+.|+|||.+.+. ++.++||||||+++|+|++|..||.......     .   ........ ...
T Consensus       159 ~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~---~~~~~~~~~~~~  227 (277)
T 3f3z_A          159 FKPGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-----V---MLKIREGTFTFP  227 (277)
T ss_dssp             CCTTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----H---HHHHHHCCCCCC
T ss_pred             ccCcc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-----H---HHHHHhCCCCCC
Confidence            65432  22345689999999998654 8999999999999999999999997543221     1   11111110 000


Q ss_pred             hhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       310 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                      ...       ....+..+.+++.+||+.||.+|||+.++++
T Consensus       228 ~~~-------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          228 EKD-------WLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HHH-------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             chh-------hhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000       0123457889999999999999999999965

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.7e-43  Score=328.87  Aligned_cols=268  Identities=23%  Similarity=0.360  Sum_probs=200.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCC-cchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      .++|.+.+.||+|+||.||+|... +++.||+|++..... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            357888999999999999999975 489999999864332 334567889999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++++|..++..    ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.....
T Consensus       104 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          104 EFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             ECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            99999988887654    34589999999999999999999999   999999999999999999999999999976544


Q ss_pred             CCcceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHH------HHHHHHhc-c
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL------DHIRKLLR-E  305 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~------~~~~~~~~-~  305 (401)
                      ... ......||+.|+|||.+.+. .++.++|||||||++|+|++|..||......+.......      ........ .
T Consensus       177 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          177 PGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             Ccc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            322 22335689999999999775 689999999999999999999999986543221111000      00000000 0


Q ss_pred             CccchhccCcCCC------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          306 DRLNDIVDRNLNT------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       306 ~~~~~~~d~~~~~------~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ........+....      ..+..+..+.+++.+||+.||.+|||+.+++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0000000111110      112335678999999999999999999999663

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.4e-42  Score=318.61  Aligned_cols=259  Identities=18%  Similarity=0.232  Sum_probs=203.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeee-ecCCeeEEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC-TTSSERILVY  153 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~  153 (401)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|++.....   ...+.+|+.++..+.|++++..+.++ ...+..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            46899999999999999999996 5789999999864322   24688999999999998877766665 5566779999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEE---cCCCcEEEeecCCccc
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKL  230 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfgl~~~  230 (401)
                      ||+ +++|.+++...   ...+++..+..++.|++.||+|||++   +++|+||||+||++   +.++.+||+|||++..
T Consensus        85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             Eec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            999 99999999753   34699999999999999999999999   99999999999999   4889999999999986


Q ss_pred             cCCCCcc------eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhc
Q 015734          231 VDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR  304 (401)
Q Consensus       231 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (401)
                      .......      ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.......... ...........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~  236 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-KYERISEKKMS  236 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS-HHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhh-hhhhhcccccC
Confidence            6544321      1234568999999999999999999999999999999999999997643221111 11111111110


Q ss_pred             cCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          305 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       305 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                       ..... .       ....+.++.+++..||+.||.+|||+.++++.|+.
T Consensus       237 -~~~~~-~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~  277 (296)
T 3uzp_A          237 -TPIEV-L-------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  277 (296)
T ss_dssp             -SCHHH-H-------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred             -CchHH-H-------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence             00000 0       11223578899999999999999999999999865

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=5.2e-43  Score=336.66  Aligned_cols=253  Identities=21%  Similarity=0.268  Sum_probs=191.8

Q ss_pred             hcCCCCC-CeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHH-hccCCcccceeeeeec----CCe
Q 015734           76 TDNFSES-NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHKNLLQLIGYCTT----SSE  148 (401)
Q Consensus        76 ~~~~~~~-~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~----~~~  148 (401)
                      .++|.+. ++||+|+||+||+|.++ +++.||||++..      ...+.+|+.++. ..+||||+++++++..    ...
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence            3456655 68999999999999975 588999999863      235678888774 4589999999998865    566


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC---CCcEEEeec
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCDF  225 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Df  225 (401)
                      .++||||+++|+|.+++...  ....+++..+..++.|++.||.|||+.   +++||||||+|||++.   ++.+||+||
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEec
Confidence            89999999999999999863  234689999999999999999999998   9999999999999997   789999999


Q ss_pred             CCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhcc
Q 015734          226 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE  305 (401)
Q Consensus       226 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (401)
                      |+++......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||........... ....+..    
T Consensus       209 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~i~~----  281 (400)
T 1nxk_A          209 GFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-MKTRIRM----  281 (400)
T ss_dssp             TTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS-HHHHHHH----
T ss_pred             ccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH-HHHHHHc----
Confidence            9998654322  22345689999999999999999999999999999999999999975432211110 1111111    


Q ss_pred             CccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          306 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       306 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ... ....    ......+.++.+++..||+.||.+|||+.+++++
T Consensus       282 ~~~-~~~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          282 GQY-EFPN----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             TCC-CCCT----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             Ccc-cCCC----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            100 0000    0112344678899999999999999999999985

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.5e-43  Score=333.76  Aligned_cols=271  Identities=23%  Similarity=0.280  Sum_probs=202.1

Q ss_pred             cCHHHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCc----------chHHHHHHHHHHHHhccCCcc
Q 015734           67 FSCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP----------GGEAAFQREVHLISVAIHKNL  136 (401)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~e~~~l~~l~h~ni  136 (401)
                      ....++....++|.+.+.||+|+||.||+|...++..||+|++......          ...+.+.+|++++++++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            3456778889999999999999999999999888999999998643221          123789999999999999999


Q ss_pred             cceeeeeec-----CCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCc
Q 015734          137 LQLIGYCTT-----SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN  211 (401)
Q Consensus       137 v~~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N  211 (401)
                      +++++++..     ....++||||+. |+|.+.+..   ....+++..+..++.|++.||.|||++   +++|+||||+|
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N  164 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGN  164 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGG
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHH
Confidence            999999843     346799999997 688888774   234689999999999999999999999   99999999999


Q ss_pred             eEEcCCCcEEEeecCCccccCCCCcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhh
Q 015734          212 ILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE  290 (401)
Q Consensus       212 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~  290 (401)
                      |+++.++.+||+|||++.......  ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||........
T Consensus       165 Il~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~  242 (362)
T 3pg1_A          165 ILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ  242 (362)
T ss_dssp             EEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             EEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999999999999999997543322  2233468999999999876 6789999999999999999999999986543211


Q ss_pred             hhhhHHHHHHHHhccCccc-----------hhccCcC---C-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          291 EDVLLLDHIRKLLREDRLN-----------DIVDRNL---N-----TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~-----------~~~d~~~---~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .     ..+..........           .......   .     ...+.....+.+++.+||+.||.+|||+.+++++
T Consensus       243 ~-----~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          243 L-----NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             H-----HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             H-----HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            1     1111111111000           0000000   0     0112234568899999999999999999999774

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.8e-43  Score=321.61  Aligned_cols=248  Identities=24%  Similarity=0.345  Sum_probs=204.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      .++|.+.+.||+|+||.||+|... ++..||+|++....  .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            467889999999999999999975 57789999986321  123356789999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||+++++|.+++...    ..+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++....
T Consensus        93 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A           93 LEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP  165 (284)
T ss_dssp             ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred             EEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence            9999999999999863    3589999999999999999999998   99999999999999999999999999987554


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ...   .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.......        .........      
T Consensus       166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~------  228 (284)
T 2vgo_A          166 SLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE--------THRRIVNVD------  228 (284)
T ss_dssp             SSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTTC------
T ss_pred             ccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH--------HHHHHhccc------
Confidence            322   233568999999999999899999999999999999999999997543221        111111100      


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                       .   ..+...+.++.+++.+||+.||.+|||+.+++++
T Consensus       229 -~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          229 -L---KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             -C---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             -c---CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence             0   1122334578899999999999999999999653

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.8e-43  Score=331.47  Aligned_cols=258  Identities=23%  Similarity=0.333  Sum_probs=197.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCC------
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------  147 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  147 (401)
                      .++|...+.||+|+||.||+|.+. +|+.||+|++.... +......+.+|+++++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467899999999999999999974 68999999986432 3344577899999999999999999999987653      


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCC
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL  227 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl  227 (401)
                      ..++||||+ +++|.+++..     ..+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence            459999999 8899998875     3489999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC
Q 015734          228 AKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED  306 (401)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (401)
                      ++.....    .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.....    . .+.......
T Consensus       175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l----~-~i~~~~g~~  245 (367)
T 1cm8_A          175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL----K-EIMKVTGTP  245 (367)
T ss_dssp             CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----H-HHHHHHCCC
T ss_pred             ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----H-HHHHhcCCC
Confidence            9865432    234568999999999877 67999999999999999999999999865432111    1 111100000


Q ss_pred             ------------------ccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          307 ------------------RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       307 ------------------~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                                        .+..................+.+++.+||+.||.+|||+.+++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          246 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence                              000000111111223345678899999999999999999999885

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=7.4e-43  Score=341.57  Aligned_cols=264  Identities=20%  Similarity=0.263  Sum_probs=196.7

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecC------C
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------S  147 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  147 (401)
                      .++|.+.+.||+|+||+||+|.+. +++.||||++... ........+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            468999999999999999999965 5889999999743 2344567888999999999999999999998654      3


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCC
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL  227 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl  227 (401)
                      ..++||||+++ +|...+..      .+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~  210 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  210 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred             eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence            56999999976 45555542      388999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHH-----------
Q 015734          228 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL-----------  296 (401)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~-----------  296 (401)
                      ++.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.......           
T Consensus       211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          211 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             C-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             eeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            9866442  223445789999999999999999999999999999999999999986543211110000           


Q ss_pred             ---HHHHHHhccC------ccchhccCcCCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          297 ---DHIRKLLRED------RLNDIVDRNLNT----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       297 ---~~~~~~~~~~------~~~~~~d~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                         ..........      .+...+...+..    .......++.+|+.+||+.||.+|||++|++++
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               0000010000      000011110000    011225678999999999999999999999885

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=8.2e-43  Score=321.66  Aligned_cols=250  Identities=22%  Similarity=0.355  Sum_probs=206.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      .++|.+.+.||+|+||.||++... +++.||+|++....  .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            457888999999999999999975 57899999986432  334567889999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||+++++|.+++...    ..+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++....
T Consensus        94 ~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           94 LELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            9999999999988762    4589999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      .... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||......+        .........      
T Consensus       167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~------  231 (294)
T 2rku_A          167 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--------TYLRIKKNE------  231 (294)
T ss_dssp             STTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTTC------
T ss_pred             cCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhhcc------
Confidence            3322 2233568999999999998889999999999999999999999997544321        111111110      


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                          ...+......+.+++.+||+.||.+|||+.+++++
T Consensus       232 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          232 ----YSIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                01122234578889999999999999999999663

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.3e-42  Score=316.76  Aligned_cols=252  Identities=21%  Similarity=0.283  Sum_probs=202.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCC-----cchHHHHHHHHHHHHhccCCcccceeeeeecCCee
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS-----PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  149 (401)
                      .++|.+.+.||+|+||.||+|... +++.||+|.+.....     ....+.+.+|+.+++.++||||+++++++...+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            457889999999999999999976 689999999874321     22467899999999999999999999999999999


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC----cEEEeec
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF----EAVLCDF  225 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~Df  225 (401)
                      ++||||+++++|.+++..    ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++    .+||+||
T Consensus        84 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence            999999999999999976    24589999999999999999999999   999999999999998877    8999999


Q ss_pred             CCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhcc
Q 015734          226 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE  305 (401)
Q Consensus       226 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (401)
                      |++.......  ......+|+.|+|||.+.+..++.++||||||+++|+|++|..||.......     .   .......
T Consensus       157 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~---~~~~~~~  226 (283)
T 3bhy_A          157 GIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-----T---LTNISAV  226 (283)
T ss_dssp             TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----H---HHHHHTT
T ss_pred             ccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-----H---HHHhHhc
Confidence            9998664432  2233468999999999998899999999999999999999999997543211     1   1111100


Q ss_pred             C-ccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          306 D-RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       306 ~-~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      . .....       .....+..+.+++.+||+.||.+|||+.+++++
T Consensus       227 ~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          227 NYDFDEE-------YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             CCCCCHH-------HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             ccCCcch-------hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence            0 00000       001223568899999999999999999999763

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=331.45  Aligned_cols=247  Identities=22%  Similarity=0.240  Sum_probs=195.6

Q ss_pred             CCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccCCc
Q 015734           82 SNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLS  160 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  160 (401)
                      .+.||+|+||.||+|... +|..||+|++... .....+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTR-GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccc-ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            567999999999999964 6899999998753 23456789999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEE--cCCCcEEEeecCCccccCCCCcce
Q 015734          161 VAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL--DDNFEAVLCDFGLAKLVDAKLTHV  238 (401)
Q Consensus       161 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill--~~~~~~kl~Dfgl~~~~~~~~~~~  238 (401)
                      |.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+|||+  +.++.+||+|||++........  
T Consensus       173 L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--  244 (373)
T 2x4f_A          173 LFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--  244 (373)
T ss_dssp             EHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred             HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence            99988752   24589999999999999999999999   99999999999999  6778999999999987654322  


Q ss_pred             eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCC
Q 015734          239 TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNT  318 (401)
Q Consensus       239 ~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  318 (401)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..||......+     .   .........  .....    
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-----~---~~~i~~~~~--~~~~~----  310 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-----T---LNNILACRW--DLEDE----  310 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----H---HHHHHHTCC--CSCSG----
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-----H---HHHHHhccC--CCChh----
Confidence            233468999999999998899999999999999999999999997543221     1   111111100  00000    


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          319 YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       319 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .......++.+++.+||+.||.+|||+.+++++
T Consensus       311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          311 EFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            011234578899999999999999999999874

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.6e-43  Score=325.15  Aligned_cols=263  Identities=20%  Similarity=0.256  Sum_probs=197.6

Q ss_pred             hcCCCCC-CeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCeeEEE
Q 015734           76 TDNFSES-NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        76 ~~~~~~~-~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  152 (401)
                      .+.|.+. +.||+|+||+||+|... +++.||+|++... .......+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   89 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ-PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV   89 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC-SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC-cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            3567774 78999999999999954 6899999999753 334567889999999884 799999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCc---EEEeecCCcc
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE---AVLCDFGLAK  229 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl~Dfgl~~  229 (401)
                      |||+++++|.+++...    ..+++..+..++.|++.||+|||++   +++||||||+||+++.++.   +||+|||++.
T Consensus        90 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~  162 (316)
T 2ac3_A           90 FEKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGS  162 (316)
T ss_dssp             EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred             EEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence            9999999999999863    3589999999999999999999999   9999999999999998776   9999999987


Q ss_pred             ccCCCCc------ceeccccCCccccccccccc-----CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhh-----
Q 015734          230 LVDAKLT------HVTTQIRGTMGHIAPEYLST-----GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV-----  293 (401)
Q Consensus       230 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~-----  293 (401)
                      .......      .......||+.|+|||++.+     ..++.++|||||||++|+|++|..||......+....     
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  242 (316)
T 2ac3_A          163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC  242 (316)
T ss_dssp             -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred             ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence            5532211      11223458999999999875     5578999999999999999999999976432210000     


Q ss_pred             -hHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          294 -LLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       294 -~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                       ................ .....    ....+.++.+++.+||+.||.+|||+.+++++
T Consensus       243 ~~~~~~~~~~i~~~~~~-~~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          243 PACQNMLFESIQEGKYE-FPDKD----WAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHHHHHHCCCC-CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhHHHHHHHHHhccCcc-cCchh----cccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence             0000011111111100 00000    01124578899999999999999999999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.6e-43  Score=355.81  Aligned_cols=247  Identities=25%  Similarity=0.358  Sum_probs=198.2

Q ss_pred             CeeeecCcEEEEEEEEC---CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccC
Q 015734           83 NIIGQGGFGKVYKGVLS---DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN  158 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  158 (401)
                      +.||+|+||.||+|.+.   ++..||||+++.. ......+.+.+|++++.+++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999653   4678999999743 234456889999999999999999999999964 458899999999


Q ss_pred             CcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCc--
Q 015734          159 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT--  236 (401)
Q Consensus       159 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~--  236 (401)
                      |+|.+++..    ...+++..+..++.||+.||+|||++   +++||||||+|||++.++.+||+|||+++.......  
T Consensus       454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            999999976    34589999999999999999999999   999999999999999999999999999986654322  


Q ss_pred             ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCc
Q 015734          237 HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN  315 (401)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  315 (401)
                      .......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+     ....+.    ...        
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-----~~~~i~----~~~--------  589 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----VTAMLE----KGE--------  589 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHHH----TTC--------
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHH----cCC--------
Confidence            12233346789999999999999999999999999999998 999997644321     111111    111        


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       316 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ....+...+.++.+++..||+.||++||++.++++.|+.
T Consensus       590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            111233445688999999999999999999999999874

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4e-43  Score=330.50  Aligned_cols=253  Identities=23%  Similarity=0.305  Sum_probs=200.3

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCeeEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  152 (401)
                      ..++|.+.+.||+|+||.||+|..+ +++.||+|++.....     ...+|++++.++ +||||+++++++.+.+..++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   94 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV   94 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence            4567999999999999999999975 588999999975322     234688888877 799999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCC----CcEEEeecCCc
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN----FEAVLCDFGLA  228 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~----~~~kl~Dfgl~  228 (401)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||++   +++||||||+|||+.++    +.+||+|||++
T Consensus        95 ~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a  167 (342)
T 2qr7_A           95 TELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFA  167 (342)
T ss_dssp             ECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred             EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence            999999999999875    34589999999999999999999999   99999999999998543    35999999999


Q ss_pred             cccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||......  ....+...+.    ....
T Consensus       168 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~i~----~~~~  240 (342)
T 2qr7_A          168 KQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEILARIG----SGKF  240 (342)
T ss_dssp             EECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHHHHHHH----HCCC
T ss_pred             ccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHHHHHHc----cCCc
Confidence            86644322 233456899999999998888999999999999999999999999753211  1111111111    1111


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      . . .   ...+...+.++.+++.+||+.||.+|||+.+++++
T Consensus       241 ~-~-~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          241 S-L-S---GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             C-C-C---STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             c-c-C---ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0 0 0   01223345678899999999999999999999764

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-43  Score=333.11  Aligned_cols=260  Identities=18%  Similarity=0.218  Sum_probs=202.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC---------CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccc--------
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSD---------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQ--------  138 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~--------  138 (401)
                      .++|.+.+.||+|+||.||+|....         ++.||+|.+...      ..+.+|++++++++|||+++        
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST  114 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence            4688999999999999999999763         789999998642      35789999999999999988        


Q ss_pred             -------eeeeeec-CCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 015734          139 -------LIGYCTT-SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAA  210 (401)
Q Consensus       139 -------~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~  210 (401)
                             +++++.. .+..++||||+ +++|.+++....  ...+++..+..++.|++.||.|||++   +++||||||+
T Consensus       115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~  188 (352)
T 2jii_A          115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAE  188 (352)
T ss_dssp             TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGG
T ss_pred             CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHH
Confidence                   5666665 67789999999 999999998632  24699999999999999999999999   9999999999


Q ss_pred             ceEEcCCC--cEEEeecCCccccCCCCcc------eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCC
Q 015734          211 NILLDDNF--EAVLCDFGLAKLVDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI  282 (401)
Q Consensus       211 Nill~~~~--~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~  282 (401)
                      ||+++.++  .+||+|||+++........      ......||+.|+|||.+.+..++.++|||||||++|||++|..||
T Consensus       189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99999998  9999999999866543221      113346899999999999989999999999999999999999999


Q ss_pred             CCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          283 DFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ........   ............  ...+.+...  .....+.++.+++..||+.||.+|||+.++++.|+.
T Consensus       269 ~~~~~~~~---~~~~~~~~~~~~--~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  333 (352)
T 2jii_A          269 TNCLPNTE---DIMKQKQKFVDK--PGPFVGPCG--HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA  333 (352)
T ss_dssp             GGGTTCHH---HHHHHHHHHHHS--CCCEECTTS--CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             ccCCcCHH---HHHHHHHhccCC--hhhhhhhcc--ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence            75432111   111111111111  111111100  011224578899999999999999999999999865

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7.6e-43  Score=337.66  Aligned_cols=256  Identities=21%  Similarity=0.314  Sum_probs=192.7

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-------CcchHHHHHHHHHHHHhccCCcccceeeeee
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-------SPGGEAAFQREVHLISVAIHKNLLQLIGYCT  144 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  144 (401)
                      ....++|.+.+.||+|+||+||+|... +++.||+|++....       .......+.+|+.++++++||||+++++++.
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            345789999999999999999999965 57899999986421       1112235789999999999999999999975


Q ss_pred             cCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCC---CcEE
Q 015734          145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN---FEAV  221 (401)
Q Consensus       145 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~---~~~k  221 (401)
                       .+..++||||+++++|.+++..    ...+++..+..++.|++.||+|||++   +++||||||+|||++.+   +.+|
T Consensus       211 -~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k  282 (419)
T 3i6u_A          211 -AEDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIK  282 (419)
T ss_dssp             -SSEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEE
T ss_pred             -cCceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEE
Confidence             4557999999999999888764    35699999999999999999999999   99999999999999754   4599


Q ss_pred             EeecCCccccCCCCcceeccccCCccccccccccc---CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHH
Q 015734          222 LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH  298 (401)
Q Consensus       222 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~  298 (401)
                      |+|||+++.....  .......||+.|+|||++.+   ..++.++|||||||++|+|++|..||.......    .+...
T Consensus       283 l~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~----~~~~~  356 (419)
T 3i6u_A          283 ITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV----SLKDQ  356 (419)
T ss_dssp             ECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC----CHHHH
T ss_pred             EeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH----HHHHH
Confidence            9999999876542  22344568999999999853   567889999999999999999999997533211    11111


Q ss_pred             HHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          299 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       299 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      +.    ...... ..    ......+..+.+++.+||+.||.+|||+.+++++
T Consensus       357 i~----~~~~~~-~~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          357 IT----SGKYNF-IP----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             HH----TTCCCC-CH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             Hh----cCCCCC-Cc----hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            11    110000 00    0011234578899999999999999999999775

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5.2e-43  Score=329.09  Aligned_cols=269  Identities=24%  Similarity=0.358  Sum_probs=196.6

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHH--HHhccCCcccceeeeee-----cCC
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHL--ISVAIHKNLLQLIGYCT-----TSS  147 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~-----~~~  147 (401)
                      ..++|.+.+.||+|+||.||+|.. +++.||+|++...    ....+..|.++  +..++||||+++++.+.     ...
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   85 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM   85 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence            456889999999999999999987 6899999998642    23444445444  45689999999997543     233


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEEeCCCCCceEEcCCCcEE
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC------NPKIIHRDLKAANILLDDNFEAV  221 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~i~H~dlkp~Nill~~~~~~k  221 (401)
                      ..++||||+++|+|.+++...     ..++..+..++.|++.||+|||+..      .++++||||||+|||++.++.+|
T Consensus        86 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           86 EYLLVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             eEEEEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence            568999999999999999752     3588999999999999999999862      23799999999999999999999


Q ss_pred             EeecCCccccCCCCc-------ceeccccCCccccccccccc-------CCCCcccchhHHHHHHHHHHhCCCCCCCCcc
Q 015734          222 LCDFGLAKLVDAKLT-------HVTTQIRGTMGHIAPEYLST-------GKSSEKTDVFGYGITLLELVTGQRAIDFSRL  287 (401)
Q Consensus       222 l~Dfgl~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDi~slG~ll~elltg~~p~~~~~~  287 (401)
                      |+|||++........       .......||+.|+|||++.+       ..++.++|||||||++|||++|..|+.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            999999986643221       12233468999999999976       4567889999999999999999776532221


Q ss_pred             hhhhhhhH---------HHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          288 EEEEDVLL---------LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       288 ~~~~~~~~---------~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ........         ................+... .......+.++.+++.+||+.||++|||+.++++.|+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~  315 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA-WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE  315 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT-CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc-cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence            11100000         01111111111111111111 11234577789999999999999999999999999875

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=7.9e-43  Score=344.14  Aligned_cols=253  Identities=23%  Similarity=0.286  Sum_probs=204.0

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      ..++|.+.+.||+|+||+||+|... +++.||+|++... ........+.+|++++++++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            4567999999999999999999975 6899999998632 2234567899999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEc---CCCcEEEeecCCcc
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---DNFEAVLCDFGLAK  229 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfgl~~  229 (401)
                      |||+.+++|.+.+...    ..+++..+..++.|++.||.|||++   +++||||||+|||++   .++.+||+|||++.
T Consensus       100 ~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A          100 GELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            9999999999988763    3589999999999999999999999   999999999999995   56679999999998


Q ss_pred             ccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccc
Q 015734          230 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN  309 (401)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ......  ......||+.|+|||++.+ .++.++|||||||++|+|++|..||......+     ....+..    ....
T Consensus       173 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i~~----~~~~  240 (486)
T 3mwu_A          173 CFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-----ILKRVET----GKYA  240 (486)
T ss_dssp             TBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH----TCCC
T ss_pred             ECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHh----CCCC
Confidence            654432  2334569999999999865 58999999999999999999999997543311     1111111    1100


Q ss_pred             hhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       310 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..    . ......+.++.+++.+||+.||.+|||+.+++++
T Consensus       241 ~~----~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          241 FD----L-PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             SC----S-GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             CC----C-cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00    0 0112334578899999999999999999999885

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.5e-42  Score=319.26  Aligned_cols=248  Identities=23%  Similarity=0.360  Sum_probs=198.2

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeec----CCeeEE
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT----SSERIL  151 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~l  151 (401)
                      .|.+.+.||+|+||+||+|.+. ++..||+|.+... .+....+.+.+|+.+++.++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            4677789999999999999964 5789999998743 345566789999999999999999999998765    345799


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEeCCCCCceEEc-CCCcEEEeecCCc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK--IIHRDLKAANILLD-DNFEAVLCDFGLA  228 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlkp~Nill~-~~~~~kl~Dfgl~  228 (401)
                      ||||+++++|.+++...    ..+++..++.++.|++.||.|||+.   +  ++|+||||+||+++ .++.+||+|||++
T Consensus       107 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            99999999999999863    4589999999999999999999998   7  99999999999997 8899999999999


Q ss_pred             cccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      .......   .....||+.|+|||.+. ..++.++||||||+++|+|++|..||.......       ...... .....
T Consensus       180 ~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------~~~~~~-~~~~~  247 (290)
T 1t4h_A          180 TLKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------QIYRRV-TSGVK  247 (290)
T ss_dssp             GGCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------HHHHHH-TTTCC
T ss_pred             ccccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH-------HHHHHH-hccCC
Confidence            7544332   23346899999999886 458999999999999999999999997533211       111111 11111


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ....       +...+.++.+++..||+.||.+|||+.+++++
T Consensus       248 ~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          248 PASF-------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             CGGG-------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccc-------CCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            1111       11123468899999999999999999999764

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-42  Score=327.20  Aligned_cols=267  Identities=27%  Similarity=0.309  Sum_probs=199.1

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCc----chHHHHHHHHHHHHhccCCcccceeeeeecCCe
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP----GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE  148 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  148 (401)
                      ...++|.+.+.||+|+||.||+|.+. +|+.||+|++......    .....+.+|+.+++.++||||+++++++...+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34678999999999999999999965 5899999998642221    123468899999999999999999999999999


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      .++||||+++ +|..++..   ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++
T Consensus        87 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             eEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccc
Confidence            9999999986 88887765   234688899999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhc--c
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR--E  305 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~  305 (401)
                      ........ ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||......+    .+.........  .
T Consensus       160 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~----~~~~i~~~~~~~~~  234 (346)
T 1ua2_A          160 KSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD----QLTRIFETLGTPTE  234 (346)
T ss_dssp             STTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCCCCT
T ss_pred             eeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHHHcCCCCh
Confidence            86644322 23345689999999998764 48999999999999999999999997654321    11111111100  0


Q ss_pred             Cccchhc---c----CcCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 015734          306 DRLNDIV---D----RNLNTYD-----SKEVETMVQVALLCTQSTPEDRPPMAQVVKML  352 (401)
Q Consensus       306 ~~~~~~~---d----~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  352 (401)
                      ..+....   +    ...+..+     .....++.+++.+||+.||.+|||+.|++++-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~  293 (346)
T 1ua2_A          235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK  293 (346)
T ss_dssp             TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence            0011000   0    0001111     23346789999999999999999999998753

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.7e-43  Score=329.31  Aligned_cols=266  Identities=19%  Similarity=0.278  Sum_probs=194.6

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeE
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI  150 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  150 (401)
                      ....++|.+.+.||+|+||+||+|... +++.||+|++.... .......+.+|+.++++++||||+++++++...+..+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            345678999999999999999999964 68899999997432 2334567789999999999999999999999999999


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEE-----cCCCcEEEeec
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL-----DDNFEAVLCDF  225 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill-----~~~~~~kl~Df  225 (401)
                      +||||+++ +|.+++..    ...+++..++.++.|++.||+|||++   +++||||||+|||+     +.++.+||+||
T Consensus       110 lv~e~~~~-~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df  181 (329)
T 3gbz_A          110 LIFEYAEN-DLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDF  181 (329)
T ss_dssp             EEEECCSE-EHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred             EEEecCCC-CHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcC
Confidence            99999974 99999886    34589999999999999999999999   99999999999999     45556999999


Q ss_pred             CCccccCCCCcceeccccCCcccccccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHh-
Q 015734          226 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL-  303 (401)
Q Consensus       226 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-  303 (401)
                      |++........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||......+    .+........ 
T Consensus       182 g~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~~~~~~~~  256 (329)
T 3gbz_A          182 GLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID----QLFKIFEVLGL  256 (329)
T ss_dssp             THHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCC
T ss_pred             CCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH----HHHHHHHHhCC
Confidence            99986643322 223345799999999997754 8999999999999999999999997644321    1111111110 


Q ss_pred             c-cCccchhc-----cCcC---CCC------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          304 R-EDRLNDIV-----DRNL---NTY------DSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       304 ~-~~~~~~~~-----d~~~---~~~------~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      . ........     ....   ...      ......++.+++.+||+.||.+|||+.+++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            0 00000000     0000   000      01134678899999999999999999999763

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5.7e-43  Score=319.59  Aligned_cols=250  Identities=22%  Similarity=0.320  Sum_probs=197.7

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      ..++|.+.+.||+|+||.||+|... +++.||+|.+....  .......+.+|+.+++.++||||+++++++...+..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            4468899999999999999999976 68999999986321  22345688999999999999999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      ||||+++++|.+++...    ..+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++...
T Consensus        89 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  161 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM  161 (276)
T ss_dssp             EEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred             EEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccccc
Confidence            99999999999999763    3589999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCcceeccccCCcccccccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccch
Q 015734          232 DAKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND  310 (401)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ....  ......+|+.|+|||.+.+..+ +.++||||||+++|+|++|..||.......     ....+..    ..   
T Consensus       162 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~----~~---  227 (276)
T 2h6d_A          162 SDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-----LFKKIRG----GV---  227 (276)
T ss_dssp             CC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH----CC---
T ss_pred             CCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-----HHHHhhc----Cc---
Confidence            4432  2233468999999999987765 689999999999999999999997543211     1111111    10   


Q ss_pred             hccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       311 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                            ...+......+.+++.+||+.||.+|||+.+++++
T Consensus       228 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          228 ------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                  01122234578899999999999999999999874

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.3e-43  Score=326.17  Aligned_cols=265  Identities=22%  Similarity=0.331  Sum_probs=207.6

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEE-----CCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCC--
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVL-----SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS--  147 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--  147 (401)
                      ..++|.+.+.||+|+||.||+|.+     .+++.||+|++... .....+.+.+|+++++.++||||+++++++...+  
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  117 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR  117 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence            356788899999999999999984     35889999998753 4455678999999999999999999999987654  


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCC
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL  227 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl  227 (401)
                      ..++||||+++++|.+++...   ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~  191 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL  191 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             ceEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence            679999999999999999863   24589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcce--eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhh-------hhhhHHHH
Q 015734          228 AKLVDAKLTHV--TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE-------EDVLLLDH  298 (401)
Q Consensus       228 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~-------~~~~~~~~  298 (401)
                      +..........  .....++..|+|||.+.+..++.++||||||+++|+|+||..|+........       ........
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (326)
T 2w1i_A          192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  271 (326)
T ss_dssp             CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence            98765443221  2233467789999999988899999999999999999999998763211000       00000011


Q ss_pred             HHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          299 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       299 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ........        .....+...+.++.+++.+||+.||.+|||+.++++.|+.
T Consensus       272 ~~~~~~~~--------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~  319 (326)
T 2w1i_A          272 LIELLKNN--------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ  319 (326)
T ss_dssp             HHHHHHTT--------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHhhcC--------CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            11111111        0111233345678999999999999999999999999875

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-42  Score=332.89  Aligned_cols=264  Identities=17%  Similarity=0.257  Sum_probs=198.5

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecC----
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS----  146 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----  146 (401)
                      ++...++|.+.+.||+|+||+||+|.+ .+|..||+|++......     ..+|+++++.++||||+++++++...    
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence            345677899999999999999999996 46899999998643222     23799999999999999999988443    


Q ss_pred             ----------------------------------CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 015734          147 ----------------------------------SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE  192 (401)
Q Consensus       147 ----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~  192 (401)
                                                        ...++||||++ ++|.+.+.........+++..++.++.|++.||+
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                              23789999998 5888888765445667999999999999999999


Q ss_pred             HHHhcCCCCeEEeCCCCCceEEc-CCCcEEEeecCCccccCCCCcceeccccCCcccccccccccC-CCCcccchhHHHH
Q 015734          193 YLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGI  270 (401)
Q Consensus       193 ~LH~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~  270 (401)
                      |||+.   +++||||||+||+++ .++.+||+|||+++.......  .....+|+.|+|||.+.+. .++.++|||||||
T Consensus       156 ~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  230 (383)
T 3eb0_A          156 FIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGC  230 (383)
T ss_dssp             HHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             HHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence            99998   999999999999997 689999999999986644322  2334679999999998765 4899999999999


Q ss_pred             HHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCc----------cchhccCcCCC------CCHHHHHHHHHHHHHc
Q 015734          271 TLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR----------LNDIVDRNLNT------YDSKEVETMVQVALLC  334 (401)
Q Consensus       271 ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~d~~~~~------~~~~~~~~l~~l~~~c  334 (401)
                      ++|||++|..||......+.    +...+. ......          .....-+....      .+...+.++.+++.+|
T Consensus       231 il~ell~g~~pf~~~~~~~~----~~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  305 (383)
T 3eb0_A          231 VFGELILGKPLFSGETSIDQ----LVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQI  305 (383)
T ss_dssp             HHHHHHHSSCSSCCSSHHHH----HHHHHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHH
T ss_pred             HHHHHHhCCCCCCCCChHHH----HHHHHH-HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHH
Confidence            99999999999986543221    111111 111000          00000000000      1223456788999999


Q ss_pred             ccCCCCCCCCHHHHHHH
Q 015734          335 TQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       335 l~~~p~~RPs~~~vl~~  351 (401)
                      |+.||.+|||+.|++++
T Consensus       306 L~~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          306 LRYEPDLRINPYEAMAH  322 (383)
T ss_dssp             CCSSGGGSCCHHHHHTS
T ss_pred             ccCChhhCCCHHHHhcC
Confidence            99999999999999763

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1e-43  Score=326.78  Aligned_cols=257  Identities=19%  Similarity=0.276  Sum_probs=190.2

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCcchHH-HHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEA-AFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~-~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      +..++|.+.+.||+|+||+||+|.. .+++.||+|++.......... .+.++...++.++||||+++++++...+..++
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l   83 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI   83 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence            3457899999999999999999996 468899999997543333333 34445555788899999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      ||||++ ++|.+++.........+++..++.++.|++.||+|||++.  +++|+||||+||+++.++.+||+|||++...
T Consensus        84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999997 5888887764444567999999999999999999999852  7999999999999999999999999999866


Q ss_pred             CCCCcceeccccCCccccccccc----ccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          232 DAKLTHVTTQIRGTMGHIAPEYL----STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      .....  .....||+.|+|||.+    .+..++.++||||||+++|+|++|..||........       ..........
T Consensus       161 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~  231 (290)
T 3fme_A          161 VDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-------QLKQVVEEPS  231 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-------HHHHHHHSCC
T ss_pred             ccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-------HHHHHhccCC
Confidence            44322  2233589999999996    456789999999999999999999999975332111       1111111110


Q ss_pred             cchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       308 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                       .       .......+.++.+++.+||+.||.+|||+.++++
T Consensus       232 -~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          232 -P-------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             -C-------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -C-------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence             0       0011223457889999999999999999999965

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=329.42  Aligned_cols=254  Identities=17%  Similarity=0.190  Sum_probs=203.8

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEE------ECCCCEEEEEEecccCCcchHHHHHHHHHHHHhcc---CCcccceeee
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGV------LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI---HKNLLQLIGY  142 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~  142 (401)
                      +++..++|.+.+.||+|+||+||+|.      ..+++.||+|++..    .....+..|.+++..+.   |+|+++++++
T Consensus        60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP----ANPWEFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS----CCHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC----CChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            34456789999999999999999994      44688999999864    23556778888887776   9999999999


Q ss_pred             eecCCeeEEEEecccCCcHHHHhhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC-----
Q 015734          143 CTTSSERILVYPFMQNLSVAYRLRDLKP-GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-----  216 (401)
Q Consensus       143 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-----  216 (401)
                      +...+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++   +++||||||+|||++.     
T Consensus       136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC
T ss_pred             eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCc
Confidence            9999999999999999999999985432 245699999999999999999999998   9999999999999998     


Q ss_pred             ------CCcEEEeecCCccccCC-CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchh
Q 015734          217 ------NFEAVLCDFGLAKLVDA-KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE  289 (401)
Q Consensus       217 ------~~~~kl~Dfgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~  289 (401)
                            ++.+||+|||+++.... ..........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  292 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE  292 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred             cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence                  89999999999975432 22333455679999999999999999999999999999999999999985322110


Q ss_pred             hhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHhcc
Q 015734          290 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDR-PPMAQVVKMLQG  354 (401)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~R-Ps~~~vl~~L~~  354 (401)
                      .                .    ........+  ....+.+++..|++.+|.+| |+++++.+.|+.
T Consensus       293 ~----------------~----~~~~~~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~  336 (365)
T 3e7e_A          293 C----------------K----PEGLFRRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK  336 (365)
T ss_dssp             E----------------E----ECSCCTTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred             e----------------e----echhccccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence            0                0    111111111  23456678889999999999 678888877765

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.6e-42  Score=324.96  Aligned_cols=260  Identities=19%  Similarity=0.269  Sum_probs=199.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCcccceeeeeec--CCeeEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTT--SSERIL  151 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~l  151 (401)
                      .++|.+.+.||+|+||+||+|.. .+++.||+|++..    .....+.+|+.++..+. ||||+++++++..  ....++
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l  110 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  110 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence            46789999999999999999986 4689999999864    33577899999999997 9999999999987  567899


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC-cEEEeecCCccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAKL  230 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfgl~~~  230 (401)
                      ||||+.+++|.+++..       ++...+..++.|++.||+|||++   +++||||||+|||++.++ .+||+|||++..
T Consensus       111 v~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~  180 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  180 (330)
T ss_dssp             EEECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence            9999999999988864       78899999999999999999999   999999999999999776 899999999986


Q ss_pred             cCCCCcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHH---------HHHH
Q 015734          231 VDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL---------DHIR  300 (401)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~---------~~~~  300 (401)
                      ......  .....+|+.|+|||.+.+ ..++.++|||||||++|+|++|..||..............         ++..
T Consensus       181 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~  258 (330)
T 3nsz_A          181 YHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  258 (330)
T ss_dssp             CCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             cCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence            644322  233468999999999877 6689999999999999999999999954332211111000         0000


Q ss_pred             HHhc--cCccchhccC--------cCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          301 KLLR--EDRLNDIVDR--------NLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       301 ~~~~--~~~~~~~~d~--------~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ....  ..........        ... ........++.+++.+||+.||.+|||+++++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0000  0000000000        000 0112245678999999999999999999999774

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=8.7e-43  Score=327.63  Aligned_cols=250  Identities=22%  Similarity=0.354  Sum_probs=206.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      .++|.+.+.||+|+||.||++.+. +++.||+|++....  .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467889999999999999999975 47899999986432  334567889999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||+++++|.+++...    ..+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++....
T Consensus       120 ~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          120 LELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             ECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            9999999999988762    4589999999999999999999999   99999999999999999999999999998664


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      .... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+        .........      
T Consensus       193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~------  257 (335)
T 2owb_A          193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--------TYLRIKKNE------  257 (335)
T ss_dssp             STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHTC------
T ss_pred             cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH--------HHHHHhcCC------
Confidence            3322 2234568999999999999889999999999999999999999997543221        111111100      


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                       .   ..+......+.+++.+||+.||.+|||+.+++++
T Consensus       258 -~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          258 -Y---SIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             -C---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             -C---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             0   0112233568889999999999999999999763

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.1e-43  Score=324.91  Aligned_cols=252  Identities=26%  Similarity=0.348  Sum_probs=198.7

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecC-CeeEEE
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-SERILV  152 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv  152 (401)
                      +..++|.+.+.||+|+||+||++.. +++.||+|.+...   ...+.+.+|+.+++.++||||+++++++... +..++|
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv   93 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   93 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             CChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch---hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence            3456889999999999999999988 5889999998642   3467889999999999999999999987554 478999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||+++++|.+++....  ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++....
T Consensus        94 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  168 (278)
T 1byg_A           94 TEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  168 (278)
T ss_dssp             ECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             EecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccc
Confidence            99999999999997532  12378899999999999999999999   99999999999999999999999999987554


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ...    ....+++.|+|||.+.+..++.++||||||+++|+|+| |..||.......     ...   .. ....    
T Consensus       169 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-----~~~---~~-~~~~----  231 (278)
T 1byg_A          169 STQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVP---RV-EKGY----  231 (278)
T ss_dssp             -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-----HHH---HH-TTTC----
T ss_pred             ccc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHH---HH-hcCC----
Confidence            321    22346889999999998899999999999999999998 999997543321     111   11 1110    


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                          ....+...+..+.+++..||+.||.+|||+.++++.|+..
T Consensus       232 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          232 ----KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence                0112233456788999999999999999999999998764

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.6e-42  Score=328.03  Aligned_cols=257  Identities=24%  Similarity=0.317  Sum_probs=205.2

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCc-------chHHHHHHHHHHHHhc-cCCcccceeee
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP-------GGEAAFQREVHLISVA-IHKNLLQLIGY  142 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l-~h~niv~~~~~  142 (401)
                      .....++|.+.+.||+|+||.||+|.+. +|+.||||++......       ...+.+.+|+.++.++ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            3445678999999999999999999975 6899999998743211       1245678999999999 79999999999


Q ss_pred             eecCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEE
Q 015734          143 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL  222 (401)
Q Consensus       143 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl  222 (401)
                      +...+..++||||+++++|.+++...    ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence            99999999999999999999999863    3589999999999999999999999   9999999999999999999999


Q ss_pred             eecCCccccCCCCcceeccccCCccccccccccc------CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHH
Q 015734          223 CDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST------GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL  296 (401)
Q Consensus       223 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~  296 (401)
                      +|||++.......  ......||+.|+|||++.+      ..++.++|||||||++|+|++|..||.......     ..
T Consensus       242 ~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-----~~  314 (365)
T 2y7j_A          242 SDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL-----ML  314 (365)
T ss_dssp             CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HH
T ss_pred             EecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH-----HH
Confidence            9999998665432  2234568999999999863      357889999999999999999999997533211     11


Q ss_pred             HHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          297 DHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       297 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..+..    ..... ..+.    ....+..+.+++.+||+.||.+|||+.+++++
T Consensus       315 ~~i~~----~~~~~-~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          315 RMIME----GQYQF-SSPE----WDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HHHHH----TCCCC-CHHH----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHh----CCCCC-CCcc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            11111    10000 0000    01123568899999999999999999999874

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=6.2e-43  Score=344.83  Aligned_cols=253  Identities=24%  Similarity=0.316  Sum_probs=206.6

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      ..++|.+.+.||+|+||.||+|... +++.||+|++....  .......+.+|+.++++++||||+++++++.+.+..++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            4567999999999999999999975 68999999986432  23457789999999999999999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEE---cCCCcEEEeecCCc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLA  228 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfgl~  228 (401)
                      ||||+.+++|.+.+..    ...+++..+..++.|++.||.|||++   +++||||||+|||+   +.++.+||+|||++
T Consensus       104 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  176 (484)
T 3nyv_A          104 VGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS  176 (484)
T ss_dssp             EECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred             EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence            9999999999998875    34589999999999999999999999   99999999999999   56789999999999


Q ss_pred             cccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      .......  ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.......     ....+..    ...
T Consensus       177 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i~~----~~~  244 (484)
T 3nyv_A          177 THFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-----ILKKVEK----GKY  244 (484)
T ss_dssp             HHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH----CCC
T ss_pred             EEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHc----CCC
Confidence            8665432  2234568999999999865 68999999999999999999999997644321     1111111    110


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..    .. ......+.++.+++.+||+.||.+|||+.+++++
T Consensus       245 ~~----~~-~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          245 TF----EL-PQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             CC----CS-GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CC----CC-cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            00    00 0112345678899999999999999999999864

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.6e-42  Score=321.38  Aligned_cols=252  Identities=20%  Similarity=0.313  Sum_probs=203.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ..++|.+.+.||+|+||.||++... +|+.||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc-ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            3467889999999999999999975 68999999997432 223467889999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEE---cCCCcEEEeecCCccc
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKL  230 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfgl~~~  230 (401)
                      ||+++++|.+++...    ..+++..+..++.|++.||.|||+.   +++|+||||+||++   +.++.+||+|||++..
T Consensus        86 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~  158 (304)
T 2jam_A           86 QLVSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM  158 (304)
T ss_dssp             CCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred             EcCCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence            999999999998763    3589999999999999999999999   99999999999999   7889999999999875


Q ss_pred             cCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccch
Q 015734          231 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND  310 (401)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ....   ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.......     ....+.   . ... .
T Consensus       159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~i~---~-~~~-~  225 (304)
T 2jam_A          159 EQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-----LFEKIK---E-GYY-E  225 (304)
T ss_dssp             CCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHH---H-CCC-C
T ss_pred             cCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHH---c-CCC-C
Confidence            4332   1233458999999999999999999999999999999999999997543211     111111   1 100 0


Q ss_pred             hccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       311 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      . .   .......+.++.+++.+||+.||.+|||+.+++++
T Consensus       226 ~-~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          226 F-E---SPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             C-C---TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             C-C---ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            0 0   01122344678899999999999999999999874

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.2e-42  Score=318.61  Aligned_cols=248  Identities=23%  Similarity=0.350  Sum_probs=202.3

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeec--------
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--------  145 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  145 (401)
                      ...+|...+.||+|+||.||+|.+. +++.||+|.+....     ..+.+|+++++.++||||+++++++..        
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            4567889999999999999999975 68999999986422     356789999999999999999998754        


Q ss_pred             --------CCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCC
Q 015734          146 --------SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN  217 (401)
Q Consensus       146 --------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~  217 (401)
                              ....++||||+++++|.+++....  ...+++..+..++.|++.||.|||++   +++|+||||+||+++.+
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT  158 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence                    345789999999999999997642  34689999999999999999999999   99999999999999999


Q ss_pred             CcEEEeecCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHH
Q 015734          218 FEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD  297 (401)
Q Consensus       218 ~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~  297 (401)
                      +.+||+|||++........  .....||+.|+|||.+.+..++.++||||||+++|+|++|..|+...      .    .
T Consensus       159 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------~----~  226 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET------S----K  226 (284)
T ss_dssp             TEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH------H----H
T ss_pred             CCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH------H----H
Confidence            9999999999986654322  23346899999999999989999999999999999999999886311      0    1


Q ss_pred             HHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 015734          298 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED  356 (401)
Q Consensus       298 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  356 (401)
                      ... .......           +...+..+.+++.+||+.||.+|||+.++++.|....
T Consensus       227 ~~~-~~~~~~~-----------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          227 FFT-DLRDGII-----------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             HHH-HHHTTCC-----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             HHH-Hhhcccc-----------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            111 1111111           1122346788999999999999999999999987533

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.4e-42  Score=342.99  Aligned_cols=253  Identities=21%  Similarity=0.295  Sum_probs=199.8

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      ..++|.+.+.||+|+||+||+|..+ ++..||+|++.... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3457999999999999999999975 68899999987432 334467889999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC---CCcEEEeecCCcc
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCDFGLAK  229 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Dfgl~~  229 (401)
                      |||+++|+|.+.+...    ..+++..+..++.|++.||+|||++   +++||||||+|||++.   ++.+||+|||++.
T Consensus       115 ~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          115 MECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            9999999999988763    3589999999999999999999999   9999999999999976   4559999999998


Q ss_pred             ccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccc
Q 015734          230 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN  309 (401)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ......  ......||+.|+|||++. ..++.++|||||||++|+|++|..||......+     ....+..    ....
T Consensus       188 ~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i~~----~~~~  255 (494)
T 3lij_A          188 VFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-----ILRKVEK----GKYT  255 (494)
T ss_dssp             ECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH----TCCC
T ss_pred             ECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHh----CCCC
Confidence            765432  233456999999999886 568999999999999999999999997644321     1111111    1100


Q ss_pred             hhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       310 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                       ...+    .....+..+.+++.+||+.||.+|||+.+++++
T Consensus       256 -~~~~----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          256 -FDSP----EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             -CCSG----GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             -CCch----hcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence             0000    012234578899999999999999999999764

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=5.2e-44  Score=341.37  Aligned_cols=245  Identities=15%  Similarity=0.097  Sum_probs=190.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEeccc--CCcchHHHHHHHH---HHHHhccCCccccee-------ee
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDY--YSPGGEAAFQREV---HLISVAIHKNLLQLI-------GY  142 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~  142 (401)
                      .++|.+.+.||+|+||+||+|.+ .+|+.||||++...  ......+.+.+|+   +.++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788899999999999999995 46899999999732  2344667899999   555666899999998       55


Q ss_pred             eecCC-----------------eeEEEEecccCCcHHHHhhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 015734          143 CTTSS-----------------ERILVYPFMQNLSVAYRLRDLKP---GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI  202 (401)
Q Consensus       143 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  202 (401)
                      +...+                 ..+++|||+ +|+|.+++.....   ....+++..+..++.|++.||+|||++   ++
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            55443                 278999999 6899999985321   112344688889999999999999999   99


Q ss_pred             EEeCCCCCceEEcCCCcEEEeecCCccccCCCCcceeccccCCcccccccccccC-----------CCCcccchhHHHHH
Q 015734          203 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-----------KSSEKTDVFGYGIT  271 (401)
Q Consensus       203 ~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDi~slG~l  271 (401)
                      +||||||+|||++.++.+||+|||+++....    ......| +.|+|||++.+.           .++.++|||||||+
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            9999999999999999999999999985432    2334567 999999999887           89999999999999


Q ss_pred             HHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          272 LLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       272 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      +|||++|+.||........                 ...... .    ....+.++.+++.+||+.||.+|||+.+++++
T Consensus       303 l~elltg~~Pf~~~~~~~~-----------------~~~~~~-~----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGG-----------------SEWIFR-S----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             HHHHHHSSCCC------CC-----------------SGGGGS-S----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred             HHHHHHCCCCCcccccccc-----------------hhhhhh-h----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence            9999999999964332110                 111111 0    11223578899999999999999999999763

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.1e-43  Score=328.53  Aligned_cols=266  Identities=26%  Similarity=0.368  Sum_probs=188.2

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeE
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI  150 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  150 (401)
                      +.+..++|.+.+.||+|+||.||+|... ++..||+|.+...........+.+|+.++..++||||+++++++...+..+
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            4556788999999999999999999954 688999998865433445677889999999999999999999999999999


Q ss_pred             EEEecccCCcHHHHhhhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecC
Q 015734          151 LVYPFMQNLSVAYRLRDLKP----GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG  226 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  226 (401)
                      +||||+++++|.+++.....    ....+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence            99999999999999875311    234589999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCc----ceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHH
Q 015734          227 LAKLVDAKLT----HVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK  301 (401)
Q Consensus       227 l~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~  301 (401)
                      ++........    .......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||........    .    ..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~----~~  238 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV----L----ML  238 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH----H----HH
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH----H----HH
Confidence            9876543211    11233468999999999876 5689999999999999999999999976433211    1    01


Q ss_pred             HhccCc--c-chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          302 LLREDR--L-NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       302 ~~~~~~--~-~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ......  . ....+..   .....+.++.+++.+||+.||.+|||+.+++++
T Consensus       239 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          239 TLQNDPPSLETGVQDKE---MLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             HHTSSCCCTTC-----C---CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HhccCCCccccccccch---hhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            111100  0 0001111   112234578899999999999999999999764

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.7e-42  Score=343.13  Aligned_cols=253  Identities=20%  Similarity=0.271  Sum_probs=202.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCc------------chHHHHHHHHHHHHhccCCcccceee
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP------------GGEAAFQREVHLISVAIHKNLLQLIG  141 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~e~~~l~~l~h~niv~~~~  141 (401)
                      ..++|.+.+.||+|+||+||+|..+ ++..||+|++......            ...+.+.+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4678999999999999999999975 5789999998743211            34578899999999999999999999


Q ss_pred             eeecCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC---
Q 015734          142 YCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF---  218 (401)
Q Consensus       142 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~---  218 (401)
                      ++.+....++||||+++|+|.+.+...    ..+++..+..++.|++.||+|||++   +++||||||+||+++.++   
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence            999999999999999999999988763    4589999999999999999999999   999999999999998776   


Q ss_pred             cEEEeecCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHH
Q 015734          219 EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH  298 (401)
Q Consensus       219 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~  298 (401)
                      .+||+|||++.......  ......||+.|+|||++. ..++.++|||||||++|+|++|..||.......     ....
T Consensus       187 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~  258 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-----IIKK  258 (504)
T ss_dssp             SEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHH
T ss_pred             cEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHH
Confidence            69999999998765432  233456999999999986 468999999999999999999999998644321     1111


Q ss_pred             HHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          299 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       299 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      +.   .........      .....+.++.+++..||+.||.+|||+.+++++
T Consensus       259 i~---~~~~~~~~~------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          259 VE---KGKYYFDFN------DWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             HH---HCCCCCCHH------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HH---cCCCCCCcc------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            11   111000000      001224578899999999999999999999764

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=8e-43  Score=338.92  Aligned_cols=200  Identities=24%  Similarity=0.358  Sum_probs=167.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecC-----Ce
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-----SE  148 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  148 (401)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++.... .......+.+|+.+++.++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            568999999999999999999965 57889999997533 334557889999999999999999999998766     56


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      .++||||+. ++|.+++..    ...+++..++.++.||+.||.|||+.   +++||||||+|||++.++.+||+|||++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            899999986 599998875    34699999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcc---------------------eeccccCCccccccccc-ccCCCCcccchhHHHHHHHHHHhCCCCCC
Q 015734          229 KLVDAKLTH---------------------VTTQIRGTMGHIAPEYL-STGKSSEKTDVFGYGITLLELVTGQRAID  283 (401)
Q Consensus       229 ~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~sDi~slG~ll~elltg~~p~~  283 (401)
                      +........                     ......||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            876443211                     23456789999999986 56669999999999999999998655543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.3e-42  Score=328.58  Aligned_cols=264  Identities=25%  Similarity=0.311  Sum_probs=200.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeec--------
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--------  145 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  145 (401)
                      .++|.+.+.||+|+||.||+|.. .+|+.||+|++.... .......+.+|+.+++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            35789999999999999999997 468999999986432 33345678899999999999999999999876        


Q ss_pred             CCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeec
Q 015734          146 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF  225 (401)
Q Consensus       146 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  225 (401)
                      .+..++||||+++ +|...+...   ...+++..++.++.|++.||+|||++   +++||||||+||+++.++.+||+||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence            3468999999975 777777653   34589999999999999999999999   9999999999999999999999999


Q ss_pred             CCccccCCCC---cceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHH
Q 015734          226 GLAKLVDAKL---THVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK  301 (401)
Q Consensus       226 gl~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~  301 (401)
                      |++.......   ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......     ....+..
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~i~~  243 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-----QLALISQ  243 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHH
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHH
Confidence            9998654322   122334568999999999876 457999999999999999999999998654321     1111111


Q ss_pred             Hhcc---CccchhccC----cC------CCCCHH------HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          302 LLRE---DRLNDIVDR----NL------NTYDSK------EVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       302 ~~~~---~~~~~~~d~----~~------~~~~~~------~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ....   .........    ..      ......      ....+.+++.+||+.||.+|||+.+++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            1111   101100000    00      000011      13457899999999999999999999774

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.1e-42  Score=325.94  Aligned_cols=262  Identities=20%  Similarity=0.218  Sum_probs=206.3

Q ss_pred             HHHHHHHhcCCCCC-CeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhcc-CCcccceeeeee
Q 015734           69 CRELQLATDNFSES-NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAI-HKNLLQLIGYCT  144 (401)
Q Consensus        69 ~~~~~~~~~~~~~~-~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~  144 (401)
                      +...+...+.|.+. +.||+|+||.||+|... +++.||+|++... ........+.+|+.++..+. ||||+++++++.
T Consensus        20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~   99 (327)
T 3lm5_A           20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE   99 (327)
T ss_dssp             SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            33445566778877 89999999999999975 5899999998743 33445678999999999985 699999999999


Q ss_pred             cCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC---CCcEE
Q 015734          145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAV  221 (401)
Q Consensus       145 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~k  221 (401)
                      ..+..++||||+++++|.+++...  ....+++..++.++.|++.||+|||++   +++||||||+||+++.   ++.+|
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~k  174 (327)
T 3lm5_A          100 NTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIK  174 (327)
T ss_dssp             CSSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEE
T ss_pred             eCCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEE
Confidence            999999999999999999888642  235689999999999999999999999   9999999999999998   78999


Q ss_pred             EeecCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHH
Q 015734          222 LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK  301 (401)
Q Consensus       222 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~  301 (401)
                      |+|||++.......  ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......     ....+..
T Consensus       175 L~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i~~  247 (327)
T 3lm5_A          175 IVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-----TYLNISQ  247 (327)
T ss_dssp             ECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH
T ss_pred             EeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHHHHh
Confidence            99999998664432  2233568999999999999999999999999999999999999997543321     1111111


Q ss_pred             HhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          302 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       302 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .  ....       ...........+.+++.+||+.||.+|||+++++++
T Consensus       248 ~--~~~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          248 V--NVDY-------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             T--CCCC-------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             c--cccc-------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            0  0000       001122344578899999999999999999999764

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.3e-42  Score=327.36  Aligned_cols=262  Identities=20%  Similarity=0.318  Sum_probs=203.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecC-----Cee
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-----SER  149 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  149 (401)
                      .++|.+.+.||+|+||.||+|... ++..||+|++...........+.+|++++.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            457999999999999999999965 67889999997655555567899999999999999999999998655     367


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ++|+||+. ++|.+++..     ..+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.
T Consensus       106 ~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence            99999997 589988875     3489999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcce--eccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC
Q 015734          230 LVDAKLTHV--TTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED  306 (401)
Q Consensus       230 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (401)
                      .........  .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+..     ..+.......
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-----~~i~~~~~~~  251 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL-----NHILGILGSP  251 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHH-----HHHHHHHCSC
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHH-----HHHHHHhCCC
Confidence            665432221  234578999999998754 45899999999999999999999999765432211     1111111100


Q ss_pred             ccc---------------hhccCcCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          307 RLN---------------DIVDRNLNT---YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       307 ~~~---------------~~~d~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ...               .........   ..+....++.+++.+||+.||.+|||+.+++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000               000000000   112234578899999999999999999999874

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=7e-42  Score=315.33  Aligned_cols=254  Identities=21%  Similarity=0.319  Sum_probs=199.2

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      ++|.....||+|+||.||+|.+. ++..||+|.+... .....+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  100 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ  100 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC-CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC-chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence            44556669999999999999964 6889999998753 334567899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC-CCcEEEeecCCccccCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Dfgl~~~~~~~  234 (401)
                      +++++|.+++.... ....+++..+..++.|++.||.|||++   +++|+||||+||+++. ++.+||+|||++......
T Consensus       101 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A          101 VPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             CSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred             CCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence            99999999998632 234567889999999999999999999   9999999999999987 899999999999865432


Q ss_pred             CcceeccccCCcccccccccccCC--CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      .. ......||+.|+|||++.+..  ++.++||||||+++|+|++|..||........   ..   ......        
T Consensus       177 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~---~~~~~~--------  241 (295)
T 2clq_A          177 NP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---AM---FKVGMF--------  241 (295)
T ss_dssp             -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---HH---HHHHHH--------
T ss_pred             CC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH---HH---Hhhccc--------
Confidence            21 223456899999999987654  78999999999999999999999964322110   00   000000        


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                       ......+...+.++.+++.+||+.||++|||+.+++++
T Consensus       242 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          242 -KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             -CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             -cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             00011223344678899999999999999999999763

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.7e-42  Score=327.28  Aligned_cols=270  Identities=21%  Similarity=0.248  Sum_probs=193.9

Q ss_pred             HHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCe
Q 015734           70 RELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE  148 (401)
Q Consensus        70 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  148 (401)
                      .+.....++|.+.+.||+|+||.||+|.+. ++..||||++...  ......+.++++.+..++||||+++++++...+.
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD--PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC--TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC--ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            456677889999999999999999999975 6899999998642  2233456778888899999999999999865443


Q ss_pred             -------eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEEeCCCCCceEEcC-CC
Q 015734          149 -------RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH--EQCNPKIIHRDLKAANILLDD-NF  218 (401)
Q Consensus       149 -------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~i~H~dlkp~Nill~~-~~  218 (401)
                             .++||||+++ +|...+.........+++..+..++.|++.||.|||  +.   +++||||||+|||++. ++
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred             ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence                   7899999986 555555543334567899999999999999999999  77   9999999999999996 89


Q ss_pred             cEEEeecCCccccCCCCcceeccccCCcccccccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHH
Q 015734          219 EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD  297 (401)
Q Consensus       219 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~  297 (401)
                      .+||+|||++........  .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||........    +..
T Consensus       170 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~----~~~  243 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ----LHE  243 (360)
T ss_dssp             EEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHH
T ss_pred             cEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH----HHH
Confidence            999999999986654322  23346899999999986654 89999999999999999999999986543221    111


Q ss_pred             HHHHH-----------hccCccchhccC-------cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          298 HIRKL-----------LREDRLNDIVDR-------NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       298 ~~~~~-----------~~~~~~~~~~d~-------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .....           ..........+.       .........+.++.+++.+||+.||.+|||+.+++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            11110           000000000000       0111222346789999999999999999999999764

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.6e-43  Score=355.13  Aligned_cols=261  Identities=20%  Similarity=0.323  Sum_probs=208.4

Q ss_pred             HHHHHhcCCCCCCeeeecCcEEEEEEEECC----CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecC
Q 015734           71 ELQLATDNFSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS  146 (401)
Q Consensus        71 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  146 (401)
                      +..+..++|.+.+.||+|+||.||+|.+..    +..||+|.+.........+.+.+|+.++++++||||+++++++. .
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~  462 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E  462 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence            344556778889999999999999998642    45799999876555556688999999999999999999999985 4


Q ss_pred             CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecC
Q 015734          147 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG  226 (401)
Q Consensus       147 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  226 (401)
                      +..++||||+++|+|.+++...   ...+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG  536 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG  536 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecC
Confidence            5689999999999999999862   34589999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhcc
Q 015734          227 LAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLRE  305 (401)
Q Consensus       227 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (401)
                      +++..............+|+.|+|||++.+..++.++|||||||++|||++ |..||......+     ....+.   ..
T Consensus       537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-----~~~~i~---~~  608 (656)
T 2j0j_A          537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VIGRIE---NG  608 (656)
T ss_dssp             CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHH---HT
T ss_pred             CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHHH---cC
Confidence            998765543333344457889999999998899999999999999999997 999997543321     111111   11


Q ss_pred             CccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          306 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       306 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                      .         ....+...+..+.+++.+||+.||.+|||+.++++.|+..
T Consensus       609 ~---------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          609 E---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C---------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            1         0112233456788999999999999999999999998753

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.3e-42  Score=353.94  Aligned_cols=252  Identities=22%  Similarity=0.292  Sum_probs=205.6

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCe
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSE  148 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  148 (401)
                      ....++|.+.++||+|+||.||+|..+ +++.||||++...  ........+..|..++..+ +||||+++++++.+.+.
T Consensus       337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~  416 (674)
T 3pfq_A          337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR  416 (674)
T ss_dssp             ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred             cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence            345678999999999999999999965 5789999999742  1233456788899999887 69999999999999999


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      .++||||+++|+|..++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++++||+|||++
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla  489 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC  489 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred             EEEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeeccee
Confidence            99999999999999999863    3589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      +...... .......||+.|+|||++.+..++.++|||||||++|||++|..||...+..+        .........  
T Consensus       490 ~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~--------~~~~i~~~~--  558 (674)
T 3pfq_A          490 KENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--------LFQSIMEHN--  558 (674)
T ss_dssp             EECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHSSC--
T ss_pred             eccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH--------HHHHHHhCC--
Confidence            8543322 23445679999999999999999999999999999999999999998644321        112221111  


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM-----AQVVK  350 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~~vl~  350 (401)
                              ..++...+.++.+|+..||+.||.+||++     +++++
T Consensus       559 --------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          559 --------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             --------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                    11223345678899999999999999997     66654

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5e-42  Score=326.91  Aligned_cols=264  Identities=19%  Similarity=0.274  Sum_probs=193.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCC------
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------  147 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  147 (401)
                      .++|.+.+.||+|+||.||+|... +++.||+|++.... .......+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            467999999999999999999965 68899999997432 3345567889999999999999999999987665      


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCC
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL  227 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl  227 (401)
                      ..++||||+++ +|.+.+..      .+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence            67999999975 78777752      388999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhH------------
Q 015734          228 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL------------  295 (401)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~------------  295 (401)
                      +.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.........            
T Consensus       174 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  251 (371)
T 2xrw_A          174 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  251 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred             cccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            98654321  2234568999999999999899999999999999999999999997654321100000            


Q ss_pred             --HHHHHHHhccC-c-----cchhccCcC-CC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          296 --LDHIRKLLRED-R-----LNDIVDRNL-NT---YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       296 --~~~~~~~~~~~-~-----~~~~~d~~~-~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                        ........... .     +........ +.   .......++.+|+.+||+.||.+|||+++++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence              00000000000 0     000000000 00   112336788999999999999999999999774

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=6.5e-43  Score=321.61  Aligned_cols=260  Identities=28%  Similarity=0.361  Sum_probs=198.8

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC--CCC--EEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCe
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS--DNT--KVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE  148 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~--~~~--~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  148 (401)
                      ..++|.+.+.||+|+||+||+|.+.  ++.  .||+|.+....  .....+.+.+|+++++.++||||+++++++.... 
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence            3467899999999999999999853  233  68999886432  3445678999999999999999999999998765 


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      .++|+||+++++|.+++...   ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~  168 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLM  168 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccc
Confidence            88999999999999999863   23588999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcc--eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhcc
Q 015734          229 KLVDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLRE  305 (401)
Q Consensus       229 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (401)
                      .........  ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.......        ........
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~  240 (291)
T 1u46_A          169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--------ILHKIDKE  240 (291)
T ss_dssp             EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTS
T ss_pred             ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH--------HHHHHHcc
Confidence            876544322  1233457889999999988889999999999999999999 999997543211        11111111


Q ss_pred             CccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCc
Q 015734          306 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDL  357 (401)
Q Consensus       306 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  357 (401)
                      ..        ....+...+.++.+++.+||+.||.+|||+.++++.|+....
T Consensus       241 ~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          241 GE--------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             CC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             CC--------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            10        011123345678899999999999999999999999876443

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.6e-43  Score=329.24  Aligned_cols=258  Identities=24%  Similarity=0.293  Sum_probs=188.3

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCcccceeeeee------
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCT------  144 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~------  144 (401)
                      ++...+|.+.+.||+|+||.||+|.+. +++.||+|++... .......+.+|+.++.++. ||||+++++++.      
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~  102 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES  102 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred             eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence            445568999999999999999999964 6899999998643 3445678899999999996 999999999983      


Q ss_pred             --cCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEeCCCCCceEEcCCCcE
Q 015734          145 --TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK--IIHRDLKAANILLDDNFEA  220 (401)
Q Consensus       145 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlkp~Nill~~~~~~  220 (401)
                        .....++++||+. |+|.+++..... ...+++..++.++.|++.||+|||+.   +  ++|+||||+|||++.++.+
T Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A          103 DTGQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             TTSSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCE
T ss_pred             ccCCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCE
Confidence              3445789999995 799988876433 34699999999999999999999998   7  9999999999999999999


Q ss_pred             EEeecCCccccCCCCcce-----------eccccCCccccccccc---ccCCCCcccchhHHHHHHHHHHhCCCCCCCCc
Q 015734          221 VLCDFGLAKLVDAKLTHV-----------TTQIRGTMGHIAPEYL---STGKSSEKTDVFGYGITLLELVTGQRAIDFSR  286 (401)
Q Consensus       221 kl~Dfgl~~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~sDi~slG~ll~elltg~~p~~~~~  286 (401)
                      ||+|||++..........           .....||+.|+|||++   .+..++.++|||||||++|+|++|..||....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            999999998665432211           1134589999999998   56678999999999999999999999996432


Q ss_pred             chhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 015734          287 LEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED  356 (401)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  356 (401)
                      ...        .....     ..    .   .........+.+++..||+.||.+|||+.++++.|+...
T Consensus       258 ~~~--------~~~~~-----~~----~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~  307 (337)
T 3ll6_A          258 KLR--------IVNGK-----YS----I---PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA  307 (337)
T ss_dssp             ---------------------CC----C---CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHH--------hhcCc-----cc----C---CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            110        00000     00    0   001111235778999999999999999999999987643

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=6e-42  Score=328.97  Aligned_cols=265  Identities=22%  Similarity=0.277  Sum_probs=203.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhcc--------CCcccceeeeee--
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI--------HKNLLQLIGYCT--  144 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~--  144 (401)
                      .++|.+.+.||+|+||+||+|... +++.||+|++..  .....+.+.+|+.+++.+.        |+||+++++++.  
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS--AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec--CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            578999999999999999999964 588999999864  3445678899999999886        788999999987  


Q ss_pred             --cCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC----
Q 015734          145 --TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF----  218 (401)
Q Consensus       145 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----  218 (401)
                        .....++||||+ +++|.+.+...  ....+++..++.++.|++.||+|||+++  +++||||||+|||++.++    
T Consensus       114 ~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          114 GVNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             ETTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHH
T ss_pred             CCCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhh
Confidence              556789999999 56666666542  2346899999999999999999999853  799999999999999775    


Q ss_pred             ---------------------------------------------cEEEeecCCccccCCCCcceeccccCCcccccccc
Q 015734          219 ---------------------------------------------EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY  253 (401)
Q Consensus       219 ---------------------------------------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~  253 (401)
                                                                   .+||+|||++......    .....||+.|+|||+
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence                                                         7999999999866433    233468999999999


Q ss_pred             cccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhh-hhhHHHHHHHHhccC--------c-cchhccC---------
Q 015734          254 LSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE-DVLLLDHIRKLLRED--------R-LNDIVDR---------  314 (401)
Q Consensus       254 ~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~--------~-~~~~~d~---------  314 (401)
                      +.+..++.++|||||||++|||+||..||......... .......+.......        . .......         
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            99999999999999999999999999999754432111 111111111111100        0 0000000         


Q ss_pred             -----------cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          315 -----------NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       315 -----------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                                 .....+......+.+|+.+||+.||.+|||+.+++++
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence                       0012356677889999999999999999999999764

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.5e-42  Score=332.96  Aligned_cols=260  Identities=21%  Similarity=0.306  Sum_probs=195.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCe------e
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE------R  149 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------~  149 (401)
                      ..+|...+.||+|+||+||+|....+..||+|++......     ..+|+++++.++||||+++++++...+.      .
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            4568999999999999999999877777999988643221     2379999999999999999999855443      7


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEc-CCCcEEEeecCCc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLA  228 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~~kl~Dfgl~  228 (401)
                      ++||||++++ +...+.........+++..++.++.|++.||+|||++   +++||||||+|||++ .++.+||+|||++
T Consensus       114 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a  189 (394)
T 4e7w_A          114 NLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA  189 (394)
T ss_dssp             EEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence            8999999875 4444433222345699999999999999999999999   999999999999999 8999999999999


Q ss_pred             cccCCCCcceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      +.......  .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+.    +..... ......
T Consensus       190 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~----l~~i~~-~~g~p~  262 (394)
T 4e7w_A          190 KILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ----LVEIIK-VLGTPS  262 (394)
T ss_dssp             EECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHH-HHCCCC
T ss_pred             ccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHH-HhCCCC
Confidence            86644322  2334689999999998765 589999999999999999999999986543221    111111 100000


Q ss_pred             c-------chhccCcCC---C------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          308 L-------NDIVDRNLN---T------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       308 ~-------~~~~d~~~~---~------~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .       ........+   .      .....+.++.+++.+||+.||.+|||+.+++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            0       000000000   0      122244678999999999999999999999875

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.2e-42  Score=318.28  Aligned_cols=253  Identities=23%  Similarity=0.306  Sum_probs=200.5

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      ...++|.+.+.||+|+||.||+|... +|+.||+|.+...   .....+.+|+.++..++||||+++++++...+..++|
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  102 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE---SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV  102 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT---SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch---HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            35678999999999999999999975 5899999998752   2346789999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||+++++|.+++...   ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++....
T Consensus       103 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  176 (314)
T 3com_A          103 MEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLT  176 (314)
T ss_dssp             EECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred             eecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence            9999999999998742   34689999999999999999999999   99999999999999999999999999997664


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      .... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.......        ....... .....  
T Consensus       177 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~-~~~~~--  244 (314)
T 3com_A          177 DTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--------AIFMIPT-NPPPT--  244 (314)
T ss_dssp             TTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHH-SCCCC--
T ss_pred             hhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHhc-CCCcc--
Confidence            4322 2233568999999999999899999999999999999999999997543211        0111100 00000  


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                          ...+...+..+.+++.+||+.||.+|||+.+++++
T Consensus       245 ----~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          245 ----FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             ----CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ----cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                00122234578899999999999999999999763

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=8.2e-42  Score=316.49  Aligned_cols=252  Identities=23%  Similarity=0.315  Sum_probs=199.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC---CcchHHHHHHHHHHHHhccCCcccceeeeee--cCCee
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY---SPGGEAAFQREVHLISVAIHKNLLQLIGYCT--TSSER  149 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~  149 (401)
                      .++|.+.+.||+|+||.||++... ++..||+|++....   .......+.+|+.+++.++||||+++++++.  +.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999964 68899999986421   2345678999999999999999999999984  45578


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ++||||++++ |.+.+....  ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++.
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence            9999999876 767776533  35689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCC-cceeccccCCcccccccccccCC--CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC
Q 015734          230 LVDAKL-THVTTQIRGTMGHIAPEYLSTGK--SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED  306 (401)
Q Consensus       230 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (401)
                      ...... ........||+.|+|||++.+..  .+.++||||||+++|+|++|..||.......     ....+.    ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~i~----~~  228 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK-----LFENIG----KG  228 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHH----HC
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH-----HHHHHh----cC
Confidence            664322 22233456899999999987654  3789999999999999999999997543211     111111    11


Q ss_pred             ccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       307 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .         ...+......+.+++.+||+.||.+|||+.+++++
T Consensus       229 ~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          229 S---------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             C---------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             C---------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0         01122334578899999999999999999999874

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=4.9e-42  Score=332.09  Aligned_cols=260  Identities=23%  Similarity=0.290  Sum_probs=195.5

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecC------Cee
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------SER  149 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~  149 (401)
                      .+|...+.||+|+||.||+|.+. +++.||||++.....     ...+|+++++.++||||+++++++...      ...
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            46888999999999999999975 589999999864322     234799999999999999999988532      235


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCC-CcEEEeecCCc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-FEAVLCDFGLA  228 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-~~~kl~Dfgl~  228 (401)
                      ++||||+++ ++...+.........+++..++.++.|++.||+|||++   +++||||||+|||++.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhh
Confidence            789999976 66666654433456799999999999999999999998   99999999999999955 67899999999


Q ss_pred             cccCCCCcceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhc---
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR---  304 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---  304 (401)
                      +.......  .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+    .+...+...-.   
T Consensus       205 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~----~l~~i~~~lg~p~~  278 (420)
T 1j1b_A          205 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD----QLVEIIKVLGTPTR  278 (420)
T ss_dssp             EECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCSCCH
T ss_pred             hhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCCH
Confidence            86543322  2335689999999998765 68999999999999999999999998654321    11111111000   


Q ss_pred             ------cCccchhccCcCCC------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          305 ------EDRLNDIVDRNLNT------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       305 ------~~~~~~~~d~~~~~------~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                            .........+.+..      +......++.+|+.+||+.||.+|||+.+++++
T Consensus       279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence                  00001110111111      112334678999999999999999999999864

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=9.4e-42  Score=318.77  Aligned_cols=254  Identities=22%  Similarity=0.316  Sum_probs=197.1

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-------CcchHHHHHHHHHHHHhccCCcccceeeeeecC
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-------SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS  146 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  146 (401)
                      ..++|.+.+.||+|+||.||+|... +++.||||.+....       .......+.+|+++++.++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            4567999999999999999999975 57899999986421       112234588999999999999999999998765


Q ss_pred             CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCc---EEEe
Q 015734          147 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE---AVLC  223 (401)
Q Consensus       147 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl~  223 (401)
                      + .++||||+++++|.+++..    ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++.   +||+
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~  159 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT  159 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred             c-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence            5 8999999999999988875    34689999999999999999999999   9999999999999987665   9999


Q ss_pred             ecCCccccCCCCcceeccccCCcccccccccc---cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHH
Q 015734          224 DFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR  300 (401)
Q Consensus       224 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~  300 (401)
                      |||++.......  ......||+.|+|||++.   ...++.++|||||||++|+|++|..||.......    .+...+.
T Consensus       160 Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~  233 (322)
T 2ycf_A          160 DFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV----SLKDQIT  233 (322)
T ss_dssp             CCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS----CHHHHHH
T ss_pred             cCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH----HHHHHHH
Confidence            999998664322  223346899999999974   4668999999999999999999999997543221    1111111


Q ss_pred             HHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          301 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       301 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .    ..... . +   ......+.++.+++.+||+.||.+|||+.+++++
T Consensus       234 ~----~~~~~-~-~---~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          234 S----GKYNF-I-P---EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             H----TCCCC-C-H---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             h----Ccccc-C-c---hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            1    10000 0 0   0011224578899999999999999999999774

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=323.93  Aligned_cols=259  Identities=24%  Similarity=0.338  Sum_probs=199.4

Q ss_pred             HHHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeeec-
Q 015734           69 CRELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTT-  145 (401)
Q Consensus        69 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-  145 (401)
                      +.++....++|.+.+.||+|+||.||+|.+. +++.||+|++...  ......+.+|+.++.++ +||||+++++++.. 
T Consensus        16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC--cccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            3344446788999999999999999999974 6899999998642  23457789999999998 79999999999876 


Q ss_pred             -----CCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcE
Q 015734          146 -----SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA  220 (401)
Q Consensus       146 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~  220 (401)
                           .+..++||||+++++|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCE
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCE
Confidence                 457899999999999999998642  34689999999999999999999999   99999999999999999999


Q ss_pred             EEeecCCccccCCCCcceeccccCCcccccccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhH
Q 015734          221 VLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL  295 (401)
Q Consensus       221 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~  295 (401)
                      ||+|||++........ ......||+.|+|||++.     +..++.++|||||||++|+|++|..||.......    . 
T Consensus       169 kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~-  242 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----A-  242 (326)
T ss_dssp             EECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH----H-
T ss_pred             EEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH----H-
Confidence            9999999886543221 223346899999999986     5568999999999999999999999997543211    0 


Q ss_pred             HHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          296 LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       296 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                         ...... ......       .....+..+.+++.+||+.||.+|||+.+++++
T Consensus       243 ---~~~~~~-~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          243 ---LFLIPR-NPAPRL-------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             ---HHHHHH-SCCCCC-------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ---HHHhhc-CccccC-------CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence               111111 111111       112224578899999999999999999999874

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=6.6e-42  Score=331.96  Aligned_cols=201  Identities=21%  Similarity=0.299  Sum_probs=173.7

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhc------cCCcccceeeeeecCC
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA------IHKNLLQLIGYCTTSS  147 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~  147 (401)
                      ...+|.+.+.||+|+||+||+|... +++.||||++..  .......+.+|+.++..+      +|+||+++++++...+
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN--EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC--ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            3457999999999999999999865 588999999964  234456778888888876      5779999999999999


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCc--EEEeec
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE--AVLCDF  225 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~--~kl~Df  225 (401)
                      ..++||||+. ++|.+++....  ...+++..++.++.|++.||+|||++   +++||||||+|||++.++.  +||+||
T Consensus       173 ~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DF  246 (429)
T 3kvw_A          173 HICMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDF  246 (429)
T ss_dssp             EEEEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred             eEEEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeec
Confidence            9999999996 68998888633  24589999999999999999999999   9999999999999999987  999999


Q ss_pred             CCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcc
Q 015734          226 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL  287 (401)
Q Consensus       226 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~  287 (401)
                      |++......    .....||+.|+|||++.+..++.++|||||||++|||+||..||.....
T Consensus       247 G~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          247 GSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             TTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            999755432    2335689999999999999999999999999999999999999986543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.9e-42  Score=326.87  Aligned_cols=260  Identities=20%  Similarity=0.272  Sum_probs=204.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCC--c--------------chHHHHHHHHHHHHhccCCcccce
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS--P--------------GGEAAFQREVHLISVAIHKNLLQL  139 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~--------------~~~~~~~~e~~~l~~l~h~niv~~  139 (401)
                      .++|.+.+.||+|+||.||+|.. +++.||+|.+.....  .              .....+.+|+.+++.++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 899999999863211  1              112789999999999999999999


Q ss_pred             eeeeecCCeeEEEEecccCCcHHHH------hhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCce
Q 015734          140 IGYCTTSSERILVYPFMQNLSVAYR------LRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANI  212 (401)
Q Consensus       140 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Ni  212 (401)
                      ++++.+.+..++||||+++++|.++      +..  .....+++..++.++.|++.||.|||+ .   +++|+||||+||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni  183 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI  183 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence            9999999999999999999999988      432  124679999999999999999999999 7   999999999999


Q ss_pred             EEcCCCcEEEeecCCccccCCCCcceeccccCCcccccccccccC-CCCc-ccchhHHHHHHHHHHhCCCCCCCCcchhh
Q 015734          213 LLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSE-KTDVFGYGITLLELVTGQRAIDFSRLEEE  290 (401)
Q Consensus       213 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDi~slG~ll~elltg~~p~~~~~~~~~  290 (401)
                      +++.++.+||+|||++......   ......||+.|+|||.+.+. .++. ++||||||+++|+|++|..||....... 
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-  259 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-  259 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-
T ss_pred             EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-
Confidence            9999999999999999865433   33445689999999999877 5666 9999999999999999999997544311 


Q ss_pred             hhhhHHHHHHHHhccC-ccch----hccC----cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          291 EDVLLLDHIRKLLRED-RLND----IVDR----NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       291 ~~~~~~~~~~~~~~~~-~~~~----~~d~----~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                            +......... ....    ...+    .........+.++.+++.+||+.||.+|||+.+++++
T Consensus       260 ------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          260 ------ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             ------HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ------HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                  1111111110 0000    0000    0000113345678899999999999999999999874

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.1e-42  Score=318.05  Aligned_cols=254  Identities=24%  Similarity=0.334  Sum_probs=200.4

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ..++|.+.+.||+|+||.||+|... ++..||+|.+... .......+.+|+.++..++||||+++++++...+..++||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC-CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            4568899999999999999999975 5889999998643 3445678999999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++++|.+++...   ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.....
T Consensus        96 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (302)
T 2j7t_A           96 EFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK  169 (302)
T ss_dssp             ECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred             EeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence            999999999988763   34589999999999999999999999   999999999999999999999999998753322


Q ss_pred             CCcceeccccCCccccccccc-----ccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYL-----STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      .. .......||+.|+|||.+     .+..++.++||||||+++|+|++|..||.......        .......... 
T Consensus       170 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~-  239 (302)
T 2j7t_A          170 TL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--------VLLKIAKSDP-  239 (302)
T ss_dssp             HH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSCC-
T ss_pred             cc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH--------HHHHHhccCC-
Confidence            11 112334689999999998     35678999999999999999999999997543211        1111111110 


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..      ...+...+..+.+++.+||+.||.+|||+.+++++
T Consensus       240 ~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          240 PT------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             CC------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             cc------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            00      01123334578899999999999999999999774

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4e-42  Score=325.27  Aligned_cols=262  Identities=20%  Similarity=0.304  Sum_probs=201.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecC-----Cee
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-----SER  149 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  149 (401)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++...........+.+|+.+++.++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468899999999999999999975 68899999997554555567888999999999999999999988654     678


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ++||||+. ++|.+++..     ..+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++.
T Consensus        90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            99999997 589888875     3589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcc---------eeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHH
Q 015734          230 LVDAKLTH---------VTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI  299 (401)
Q Consensus       230 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~  299 (401)
                      ........         ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........    + ..+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~-~~~  235 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ----L-LLI  235 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----H-HHH
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH----H-HHH
Confidence            66432211         1223468999999998754 6789999999999999999999999986543211    1 111


Q ss_pred             HHHhccCcc------------chhccC--cCC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          300 RKLLREDRL------------NDIVDR--NLN-----TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       300 ~~~~~~~~~------------~~~~d~--~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .........            .+....  ...     ...+..+.++.+++.+||+.||.+|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            111110000            000000  000     0112334678899999999999999999999774

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=6.7e-43  Score=333.01  Aligned_cols=254  Identities=8%  Similarity=-0.002  Sum_probs=181.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhc--cCCccccee-------eee
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVA--IHKNLLQLI-------GYC  143 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l--~h~niv~~~-------~~~  143 (401)
                      ..+|...+.||+|+||.||+|.+. +++.||+|++....  .....+.+.+|+.++..+  +|||+++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345888999999999999999965 68899999998543  223456677885544444  699988755       333


Q ss_pred             ecC-----------------CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCC
Q 015734          144 TTS-----------------SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTR------KRVAFGTAYGLEYLHEQCNP  200 (401)
Q Consensus       144 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~  200 (401)
                      ...                 ...++||||++ ++|.+++....   ..+++..+      ..++.|++.||+|||++   
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---  213 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSK---  213 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence            222                 34799999998 89999998642   22444555      67789999999999999   


Q ss_pred             CeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcceeccccCCccccccccccc--CCCCcccchhHHHHHHHHHHhC
Q 015734          201 KIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTG  278 (401)
Q Consensus       201 ~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDi~slG~ll~elltg  278 (401)
                      +++||||||+|||++.++.+||+|||+++.....    .....+|+.|+|||++.+  ..++.++|||||||++|||+||
T Consensus       214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             CCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            9999999999999999999999999999865432    213456799999999987  6799999999999999999999


Q ss_pred             CCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          279 QRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       279 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                      +.||..........          ............... ......+..+.+++.+||+.||++|||+.++++
T Consensus       290 ~~Pf~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          290 FLPFGLVTPGIKGS----------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             SCSTTBCCTTCTTC----------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCCcCcccccc----------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            99998653321100          000000000000000 112234567889999999999999999999954

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2e-41  Score=331.95  Aligned_cols=262  Identities=18%  Similarity=0.242  Sum_probs=205.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCcchHHHHHHHHHHHHhccC-CcccceeeeeecCCeeEEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH-KNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~  153 (401)
                      .++|.+.+.||+|+||.||+|.+ .++..||||++.....   ...+..|++++..+.| +++..+..++...+..++||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            46899999999999999999996 4689999998864322   2347889999999987 55566666677778889999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEE---cCCCcEEEeecCCccc
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKL  230 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill---~~~~~~kl~Dfgl~~~  230 (401)
                      ||+ +++|.+++...   ...+++..++.++.||+.||.|||++   +++||||||+|||+   +.++.+||+|||+++.
T Consensus        83 e~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~  155 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK  155 (483)
T ss_dssp             ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             ECC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence            999 99999999853   34699999999999999999999999   99999999999999   6889999999999987


Q ss_pred             cCCCCcc------eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhc
Q 015734          231 VDAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR  304 (401)
Q Consensus       231 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (401)
                      .......      ......||+.|+|||.+.+..++.++|||||||++|||++|..||..........  ....+.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~--~~~~i~~~~~  233 (483)
T 3sv0_A          156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ--KYEKISEKKV  233 (483)
T ss_dssp             CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHH--HHHHHHHHHH
T ss_pred             ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHH--HHHHHhhccc
Confidence            6543321      1235678999999999999999999999999999999999999998644321111  1111111111


Q ss_pred             cCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCc
Q 015734          305 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDL  357 (401)
Q Consensus       305 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~  357 (401)
                      ......+.        ...+.++.+++..||+.+|.+||++.+|++.|+....
T Consensus       234 ~~~~~~l~--------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~  278 (483)
T 3sv0_A          234 ATSIEALC--------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI  278 (483)
T ss_dssp             HSCHHHHH--------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             cccHHHHh--------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            11111111        1123578899999999999999999999999886533

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1e-41  Score=318.93  Aligned_cols=264  Identities=24%  Similarity=0.348  Sum_probs=201.7

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEE--CCCCEEEEEEecccC-CcchHHHHHHHHHHHHhc---cCCcccceeeeee----
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVL--SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVA---IHKNLLQLIGYCT----  144 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~----  144 (401)
                      ..++|.+.+.||+|+||.||+|..  .+++.||+|++.... .......+.+|+.+++.+   .||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            456899999999999999999997  357899999986322 222233566777777665   8999999999987    


Q ss_pred             -cCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEe
Q 015734          145 -TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLC  223 (401)
Q Consensus       145 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~  223 (401)
                       .....++||||+. ++|.+++....  ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence             5567899999997 69999988643  34589999999999999999999999   99999999999999999999999


Q ss_pred             ecCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHh
Q 015734          224 DFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL  303 (401)
Q Consensus       224 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  303 (401)
                      |||++.......  ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......     ....+....
T Consensus       163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~i~~~~  235 (326)
T 1blx_A          163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-----QLGKILDVI  235 (326)
T ss_dssp             SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHH
T ss_pred             cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHHHHHc
Confidence            999998654322  2234568999999999999899999999999999999999999998644321     111111111


Q ss_pred             ccC---ccch-------hc----cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          304 RED---RLND-------IV----DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       304 ~~~---~~~~-------~~----d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ...   .+..       ..    ...........+..+.+++.+||+.||.+|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            110   0000       00    000111223345678899999999999999999999764

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=324.03  Aligned_cols=266  Identities=24%  Similarity=0.388  Sum_probs=204.2

Q ss_pred             CHHHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecC
Q 015734           68 SCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS  146 (401)
Q Consensus        68 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  146 (401)
                      ...++.+..++|.+.+.||+|+||.||+|...+  .+|+|.+... ......+.+.+|+.++++++||||+++++++...
T Consensus        24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (319)
T 2y4i_B           24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP  101 (319)
T ss_dssp             CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred             ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            344556677899999999999999999999754  4999998632 2333445678899999999999999999999999


Q ss_pred             CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecC
Q 015734          147 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG  226 (401)
Q Consensus       147 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  226 (401)
                      +..+++|||+++++|.+++...   ...+++..+..++.|++.||+|||++   +++|+||||+||+++ ++.+||+|||
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg  174 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFG  174 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCS
T ss_pred             CceEEEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecC
Confidence            9999999999999999998752   34689999999999999999999999   999999999999998 6799999999


Q ss_pred             CccccCCCC----cceeccccCCccccccccccc---------CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhh
Q 015734          227 LAKLVDAKL----THVTTQIRGTMGHIAPEYLST---------GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV  293 (401)
Q Consensus       227 l~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~  293 (401)
                      ++.......    ........||+.|+|||.+.+         ..++.++||||||+++|+|++|..||.......    
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----  250 (319)
T 2y4i_B          175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA----  250 (319)
T ss_dssp             CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH----
T ss_pred             CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----
Confidence            987543211    112233458899999999864         347889999999999999999999997543221    


Q ss_pred             hHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCCch
Q 015734          294 LLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLA  358 (401)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~~~  358 (401)
                       .   .... .........       ....+.++.+++..||+.||.+|||+.++++.|+.....
T Consensus       251 -~---~~~~-~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          251 -I---IWQM-GTGMKPNLS-------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             -H---HHHH-HTTCCCCCC-------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             -H---HHHh-ccCCCCCCC-------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence             1   1111 111111111       111234688999999999999999999999999875543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.5e-41  Score=319.00  Aligned_cols=260  Identities=20%  Similarity=0.286  Sum_probs=204.7

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEE-C-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCc------ccceeeeeecC
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVL-S-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN------LLQLIGYCTTS  146 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~  146 (401)
                      ..++|.+.+.||+|+||+||+|.. . +++.||+|++..  .......+.+|+.++..++|+|      ++++++++...
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~   89 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN--VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH   89 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS--SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec--CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence            356899999999999999999986 3 578999999864  2345677889999999887665      99999999999


Q ss_pred             CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC----------
Q 015734          147 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD----------  216 (401)
Q Consensus       147 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~----------  216 (401)
                      +..++||||+ +++|.+++....  ..++++..+..++.|++.||+|||++   +++||||||+||+++.          
T Consensus        90 ~~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           90 GHICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             CcEEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCc
Confidence            9999999999 889999987632  34688999999999999999999999   9999999999999987          


Q ss_pred             ---------CCcEEEeecCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcc
Q 015734          217 ---------NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL  287 (401)
Q Consensus       217 ---------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~  287 (401)
                               ++.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             cccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                     678999999999865432    2335689999999999999999999999999999999999999986543


Q ss_pred             hhhhhhhHHHHHHHHhccC--------ccchhc---------------------c--CcCCCCCHHHHHHHHHHHHHccc
Q 015734          288 EEEEDVLLLDHIRKLLRED--------RLNDIV---------------------D--RNLNTYDSKEVETMVQVALLCTQ  336 (401)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~--------~~~~~~---------------------d--~~~~~~~~~~~~~l~~l~~~cl~  336 (401)
                      .+..     ..+.......        ......                     .  ............++.+++.+||+
T Consensus       240 ~~~~-----~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  314 (339)
T 1z57_A          240 KEHL-----AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE  314 (339)
T ss_dssp             HHHH-----HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred             HHHH-----HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence            2211     1111111000        000000                     0  00011234567889999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 015734          337 STPEDRPPMAQVVKM  351 (401)
Q Consensus       337 ~~p~~RPs~~~vl~~  351 (401)
                      .||.+|||+.+++++
T Consensus       315 ~dP~~Rpt~~ell~h  329 (339)
T 1z57_A          315 YDPAKRITLREALKH  329 (339)
T ss_dssp             SSTTTSCCHHHHTTS
T ss_pred             cCcccccCHHHHhcC
Confidence            999999999999654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.9e-42  Score=322.10  Aligned_cols=260  Identities=20%  Similarity=0.290  Sum_probs=200.2

Q ss_pred             CHHHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccc-CCcchHHHHHHHHHHHHhcc--CCcccceeeeee
Q 015734           68 SCRELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAI--HKNLLQLIGYCT  144 (401)
Q Consensus        68 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~  144 (401)
                      .+..+.+..++|.+.+.||+|+||.||++...+++.||+|++... ........+.+|+.++.++.  ||||+++++++.
T Consensus        19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~   98 (313)
T 3cek_A           19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI   98 (313)
T ss_dssp             -CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred             CeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence            333445566789999999999999999999888999999999643 33445678999999999997  599999999999


Q ss_pred             cCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEee
Q 015734          145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD  224 (401)
Q Consensus       145 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D  224 (401)
                      ..+..+++|| +.+++|.+++..    ...+++..+..++.|++.||.|||++   +++|+||||+||++++ +.+||+|
T Consensus        99 ~~~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~D  169 (313)
T 3cek_A           99 TDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLID  169 (313)
T ss_dssp             CSSEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECC
T ss_pred             cCCEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEee
Confidence            9999999999 568899999986    34689999999999999999999999   9999999999999965 8999999


Q ss_pred             cCCccccCCCCcc-eeccccCCccccccccccc-----------CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhh
Q 015734          225 FGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLST-----------GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEED  292 (401)
Q Consensus       225 fgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~  292 (401)
                      ||++......... ......||+.|+|||.+.+           ..++.++||||||+++|+|++|..||.......   
T Consensus       170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---  246 (313)
T 3cek_A          170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---  246 (313)
T ss_dssp             CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH---
T ss_pred             ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH---
Confidence            9999866443222 2234468999999999865           468889999999999999999999997432211   


Q ss_pred             hhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          293 VLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                          ............     .   ..+.....++.+++.+||+.||.+|||+.+++++
T Consensus       247 ----~~~~~~~~~~~~-----~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          247 ----SKLHAIIDPNHE-----I---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             ----HHHHHHHCTTSC-----C---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ----HHHHHHHhcccc-----c---CCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence                111111111100     0   1111224578899999999999999999999764

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.8e-42  Score=329.11  Aligned_cols=258  Identities=22%  Similarity=0.296  Sum_probs=184.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecC------C
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------S  147 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  147 (401)
                      .++|.+.+.||+|+||.||+|.+. +|+.||+|++... .+......+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            468999999999999999999964 6889999998643 2334567888999999999999999999998654      5


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCC
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL  227 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl  227 (401)
                      ..++++|++ +++|.+++..     ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred             eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence            579999999 7898887764     3589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC
Q 015734          228 AKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED  306 (401)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (401)
                      ++.....    .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+....     ...+.......
T Consensus       179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----l~~i~~~~g~p  249 (367)
T 2fst_X          179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-----LKLILRLVGTP  249 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----HHHHHHHHCSC
T ss_pred             ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHHhCCC
Confidence            9865432    234568999999999877 6789999999999999999999999976543211     11111111100


Q ss_pred             c-----------cchhcc--CcCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          307 R-----------LNDIVD--RNLNT-----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       307 ~-----------~~~~~d--~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .           ....+.  +..+.     ........+.+|+.+||+.||.+|||+.+++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            0           000000  00000     011224568899999999999999999999875

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.3e-41  Score=324.10  Aligned_cols=257  Identities=21%  Similarity=0.305  Sum_probs=196.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCee----
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER----  149 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~----  149 (401)
                      .++|...+.||+|+||.||+|.+. +|+.||+|++.... .......+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468899999999999999999965 68899999997433 334467889999999999999999999999877655    


Q ss_pred             --EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCC
Q 015734          150 --ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL  227 (401)
Q Consensus       150 --~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl  227 (401)
                        ++||||+. ++|.+.+..      .+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence              99999997 587776642      489999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC
Q 015734          228 AKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED  306 (401)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (401)
                      +......    .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+..    ..... .....
T Consensus       191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~----~~i~~-~~~~~  261 (371)
T 4exu_A          191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL----TQILK-VTGVP  261 (371)
T ss_dssp             C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHH-HHCCC
T ss_pred             ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHH----HHHHH-HhCCC
Confidence            9855432    234568999999999877 67899999999999999999999999865432111    11111 00000


Q ss_pred             c-----------c----chhccCcCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          307 R-----------L----NDIVDRNLN---TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       307 ~-----------~----~~~~d~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .           .    .........   ...+.....+.+++.+||+.||.+|||+.+++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            0           0    000000000   0112235678899999999999999999999764

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.7e-41  Score=313.34  Aligned_cols=253  Identities=21%  Similarity=0.267  Sum_probs=203.7

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCC--------cchHHHHHHHHHHHHhcc-CCcccceeeeee
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS--------PGGEAAFQREVHLISVAI-HKNLLQLIGYCT  144 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~  144 (401)
                      ..++|.+.+.||+|+||.||+|..+ +++.||+|++.....        ....+.+.+|+.+++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4578999999999999999999975 588999999864321        123457889999999995 999999999999


Q ss_pred             cCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEee
Q 015734          145 TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD  224 (401)
Q Consensus       145 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D  224 (401)
                      ..+..++||||+++++|.+++...    ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence            999999999999999999999863    4589999999999999999999999   999999999999999999999999


Q ss_pred             cCCccccCCCCcceeccccCCcccccccccc------cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHH
Q 015734          225 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS------TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH  298 (401)
Q Consensus       225 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~  298 (401)
                      ||++.......  ......+|+.|+|||++.      ...++.++||||||+++|+|++|..||.......     ....
T Consensus       168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~  240 (298)
T 1phk_A          168 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-----MLRM  240 (298)
T ss_dssp             CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHH
T ss_pred             ccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-----HHHH
Confidence            99998664432  223356899999999985      4567899999999999999999999997543211     1111


Q ss_pred             HHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          299 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       299 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                      +..   .. .. ..    .......+..+.+++.+||+.||.+|||+.++++
T Consensus       241 ~~~---~~-~~-~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          241 IMS---GN-YQ-FG----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHH---TC-CC-CC----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             Hhc---CC-cc-cC----cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            111   10 00 00    0111234567889999999999999999999965

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.6e-42  Score=330.41  Aligned_cols=268  Identities=22%  Similarity=0.290  Sum_probs=182.9

Q ss_pred             cCCCC-CCeeeecCcEEEEEEEEC---CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeee--cCCeeE
Q 015734           77 DNFSE-SNIIGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT--TSSERI  150 (401)
Q Consensus        77 ~~~~~-~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~  150 (401)
                      +.|.+ .++||+|+||+||+|..+   ++..||+|++...   .....+.+|+.+++.++||||+++++++.  .....+
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS---SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC---CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            34555 558999999999999965   4788999998643   22356889999999999999999999994  467889


Q ss_pred             EEEecccCCcHHHHhhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEE----cCCCcEE
Q 015734          151 LVYPFMQNLSVAYRLRDLK-----PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL----DDNFEAV  221 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill----~~~~~~k  221 (401)
                      +||||+. ++|.+.+....     .....+++..++.++.|++.||+|||++   +++||||||+|||+    +.++.+|
T Consensus        97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEE
Confidence            9999996 47777765321     1123589999999999999999999999   99999999999999    7789999


Q ss_pred             EeecCCccccCCCCc--ceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhh----hhh
Q 015734          222 LCDFGLAKLVDAKLT--HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEE----DVL  294 (401)
Q Consensus       222 l~Dfgl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~----~~~  294 (401)
                      |+|||+++.......  .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.........    ...
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  252 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  252 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence            999999987654322  223445789999999999874 5899999999999999999999999754321100    001


Q ss_pred             HHHHHHHHhccC---ccchhc-------------cCcCCCCC---------HHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 015734          295 LLDHIRKLLRED---RLNDIV-------------DRNLNTYD---------SKEVETMVQVALLCTQSTPEDRPPMAQVV  349 (401)
Q Consensus       295 ~~~~~~~~~~~~---~~~~~~-------------d~~~~~~~---------~~~~~~l~~l~~~cl~~~p~~RPs~~~vl  349 (401)
                      ....+.......   .+..+.             ........         .....++.+|+.+||+.||.+|||+.|++
T Consensus       253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L  332 (405)
T 3rgf_A          253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  332 (405)
T ss_dssp             HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            111111111100   000000             00000000         00134678999999999999999999998


Q ss_pred             HH
Q 015734          350 KM  351 (401)
Q Consensus       350 ~~  351 (401)
                      ++
T Consensus       333 ~h  334 (405)
T 3rgf_A          333 QD  334 (405)
T ss_dssp             TS
T ss_pred             cC
Confidence            85

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.6e-41  Score=311.97  Aligned_cols=255  Identities=22%  Similarity=0.277  Sum_probs=204.0

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeE
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI  150 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  150 (401)
                      ....++|.+.+.||+|+||.||+|... +++.||+|++... ........+.+|++++++++||||+++++++...+..+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            335678999999999999999999975 6899999998642 23445778999999999999999999999999999999


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCC---CcEEEeecCC
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN---FEAVLCDFGL  227 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~---~~~kl~Dfgl  227 (401)
                      +|+||+++++|.+.+...    ..+++..+..++.|++.||.|||++   +++|+||||+||+++.+   +.+||+|||+
T Consensus        98 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence            999999999999988763    3589999999999999999999999   99999999999999754   4699999999


Q ss_pred             ccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          228 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      +........  .....+|+.|+|||.+.+ .++.++||||||+++|+|++|..||.......     ....+.    ...
T Consensus       171 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~----~~~  238 (287)
T 2wei_A          171 STCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-----ILKRVE----TGK  238 (287)
T ss_dssp             GGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHH----HCC
T ss_pred             ceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-----HHHHHH----cCC
Confidence            886544322  223357899999999865 48999999999999999999999997543211     111111    111


Q ss_pred             cchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       308 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..... +    .....+.++.+++.+||+.||.+|||+.+++++
T Consensus       239 ~~~~~-~----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          239 YAFDL-P----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             CCCCS-G----GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             CCCCc-h----hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            10000 0    011234578899999999999999999999773

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-42  Score=319.19  Aligned_cols=248  Identities=21%  Similarity=0.320  Sum_probs=191.9

Q ss_pred             HHHHHhcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCc-----chHHHHHHHHHHHHhc----cCCccccee
Q 015734           71 ELQLATDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSP-----GGEAAFQREVHLISVA----IHKNLLQLI  140 (401)
Q Consensus        71 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l----~h~niv~~~  140 (401)
                      +.+...++|.+.+.||+|+||.||+|.. .+++.||+|++......     .....+.+|+.++.++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            3455678899999999999999999986 46889999998643221     1233456789999888    899999999


Q ss_pred             eeeecCCeeEEEEec-ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEc-CCC
Q 015734          141 GYCTTSSERILVYPF-MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNF  218 (401)
Q Consensus       141 ~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~  218 (401)
                      +++...+..++|+|+ +.+++|.+++...    ..+++..++.++.|++.||.|||++   +++|+||||+||+++ .++
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  177 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRG  177 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTT
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCC
Confidence            999999999999999 7899999999863    3589999999999999999999999   999999999999999 899


Q ss_pred             cEEEeecCCccccCCCCcceeccccCCcccccccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHH
Q 015734          219 EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD  297 (401)
Q Consensus       219 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~  297 (401)
                      .+||+|||++.......   .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.....          
T Consensus       178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------  244 (312)
T 2iwi_A          178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----------  244 (312)
T ss_dssp             EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------
T ss_pred             eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----------
Confidence            99999999998665432   233458999999999887766 4589999999999999999999964211          


Q ss_pred             HHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 015734          298 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKML  352 (401)
Q Consensus       298 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L  352 (401)
                       ...  ..           ...+.....++.+++.+||+.||++|||+.+++++-
T Consensus       245 -~~~--~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~  285 (312)
T 2iwi_A          245 -ILE--AE-----------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP  285 (312)
T ss_dssp             -HHH--TC-----------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred             -Hhh--hc-----------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence             000  00           011223345788999999999999999999998753

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.3e-41  Score=314.43  Aligned_cols=252  Identities=25%  Similarity=0.363  Sum_probs=192.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeec---------
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT---------  145 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---------  145 (401)
                      .++|.+.+.||+|+||.||+|... +++.||+|.+..  .......+.+|+.+++.++||||+++++++.+         
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE--EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec--cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            457889999999999999999964 689999999864  23456788999999999999999999998754         


Q ss_pred             ----CCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEE
Q 015734          146 ----SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAV  221 (401)
Q Consensus       146 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~k  221 (401)
                          .+..++||||+++++|.+++...   ...+++..++.++.|++.||+|||++   +++|+||||+||+++.++.+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence                35678999999999999999862   34578889999999999999999999   999999999999999999999


Q ss_pred             EeecCCccccCCCC-------------cceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcc
Q 015734          222 LCDFGLAKLVDAKL-------------THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRL  287 (401)
Q Consensus       222 l~Dfgl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~  287 (401)
                      |+|||++.......             ........||+.|+|||.+.+. .++.++|||||||++|+|++   ||.... 
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-  232 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-  232 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-
Confidence            99999998654321             1122334689999999999764 68999999999999999998   443211 


Q ss_pred             hhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          288 EEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                         .....   ...... ...  ...+   ......+..+.+++.+||+.||.+|||+.+++++
T Consensus       233 ---~~~~~---~~~~~~-~~~--~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          233 ---ERVNI---LKKLRS-VSI--EFPP---DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             ---HHHHH---HHHHHS-TTC--CCCT---TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ---hHHHH---HHhccc-ccc--ccCc---cccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence               11111   111111 000  0001   1233445678899999999999999999999875

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.8e-41  Score=318.74  Aligned_cols=257  Identities=23%  Similarity=0.328  Sum_probs=197.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCe-----
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE-----  148 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  148 (401)
                      .++|...+.||+|+||.||+|.+. +|+.||+|++.... .......+.+|+.+++.++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            357888999999999999999975 68999999997533 33345788999999999999999999999987654     


Q ss_pred             -eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCC
Q 015734          149 -RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL  227 (401)
Q Consensus       149 -~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl  227 (401)
                       .++||||+. ++|.+.+..      .+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence             499999997 587766542      489999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC
Q 015734          228 AKLVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED  306 (401)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (401)
                      +......    .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||......+.    + ..+.......
T Consensus       173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~----~-~~i~~~~~~~  243 (353)
T 3coi_A          173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ----L-TQILKVTGVP  243 (353)
T ss_dssp             TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH----H-HHHHHHHCBC
T ss_pred             ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----H-HHHHHHhCCC
Confidence            9765432    233468999999999876 6789999999999999999999999976543211    1 1111110000


Q ss_pred             ------------------ccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          307 ------------------RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       307 ------------------~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                                        .+............+..+.++.+++.+||+.||.+|||+.+++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             CHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                              000000111122233456788999999999999999999999764

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.6e-40  Score=317.79  Aligned_cols=203  Identities=24%  Similarity=0.285  Sum_probs=171.9

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhcc-CC-----cccceeeeeecCC
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HK-----NLLQLIGYCTTSS  147 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~  147 (401)
                      ..++|.+.+.||+|+||+||+|... +++.||||++..  .......+..|+.++..+. |+     +++++++++...+
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN--KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS--SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec--cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            4578999999999999999999965 578999999864  2334567788888888775 44     4999999999999


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEc--CCCcEEEeec
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD--DNFEAVLCDF  225 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~--~~~~~kl~Df  225 (401)
                      ..++||||+. ++|.+++....  ...+++..+..++.|++.||.|||++ ..+++||||||+|||++  .++.+||+||
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             ceEEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            9999999996 59999988643  24589999999999999999999952 12899999999999994  5788999999


Q ss_pred             CCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcc
Q 015734          226 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL  287 (401)
Q Consensus       226 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~  287 (401)
                      |+++.....    .....||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus       206 G~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          206 GSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             TTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999866432    2345689999999999999999999999999999999999999986543

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.4e-41  Score=327.59  Aligned_cols=253  Identities=23%  Similarity=0.284  Sum_probs=188.1

Q ss_pred             CCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCeeEEEEecc
Q 015734           78 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVYPFM  156 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  156 (401)
                      .|...+.||+|+||+||.+...+|+.||||++..    ...+.+.+|+.++.++ +||||+++++++.+.+..++||||+
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~----~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI----DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEG----GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcH----HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            3455688999999999877767899999999864    2345678999999876 8999999999999999999999999


Q ss_pred             cCCcHHHHhhhcCCCCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCC-------------CcE
Q 015734          157 QNLSVAYRLRDLKPGEKG---LDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDN-------------FEA  220 (401)
Q Consensus       157 ~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~-------------~~~  220 (401)
                      . |+|.+++.........   .++..+..++.|++.||+|||++   +++||||||+|||++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence            5 6999999864322111   12334578999999999999999   99999999999999754             489


Q ss_pred             EEeecCCccccCCCCcc---eeccccCCccccccccccc-------CCCCcccchhHHHHHHHHHHh-CCCCCCCCcchh
Q 015734          221 VLCDFGLAKLVDAKLTH---VTTQIRGTMGHIAPEYLST-------GKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEE  289 (401)
Q Consensus       221 kl~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~  289 (401)
                      ||+|||++.........   ......||+.|+|||++.+       ..++.++|||||||++|||+| |..||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            99999999876543322   1234569999999999865       568999999999999999999 999996433211


Q ss_pred             hhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          290 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                            ........   ....    .........+.++.+++.+||+.||.+|||+.+++++
T Consensus       248 ------~~i~~~~~---~~~~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          248 ------SNIIRGIF---SLDE----MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             ------HHHHHTCC---CCCC----CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------HHHhcCCC---Cccc----ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence                  01111000   0000    0011245667889999999999999999999999864

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=6.9e-41  Score=319.08  Aligned_cols=263  Identities=21%  Similarity=0.313  Sum_probs=200.7

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCcchHHHHHHHHHHHHhcc-----------CCcccceeeee
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-----------HKNLLQLIGYC  143 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~  143 (401)
                      .++|.+.+.||+|+||+||+|.. .+++.||+|++..  .......+.+|+.++.++.           ||||+++++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG--DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC--CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            46799999999999999999996 4688999999864  3345567889999998876           89999999998


Q ss_pred             ecCC----eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEc----
Q 015734          144 TTSS----ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD----  215 (401)
Q Consensus       144 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~----  215 (401)
                      ...+    ..+++||++ +++|.+++....  ...+++..+..++.|++.||+|||+++  +++||||||+|||++    
T Consensus        96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           96 NHKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             EEEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET
T ss_pred             hccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCC
Confidence            7654    679999999 899999998643  345899999999999999999999953  799999999999994    


Q ss_pred             --CCCcEEEeecCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhh--h
Q 015734          216 --DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE--E  291 (401)
Q Consensus       216 --~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~--~  291 (401)
                        .++.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|||+||..||........  .
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             CcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence              4458999999999866432    2334689999999999999999999999999999999999999975432111  1


Q ss_pred             hhhHHHHHHHHhccC------------------c-cc-----------hhccCcCCCCCHHHHHHHHHHHHHcccCCCCC
Q 015734          292 DVLLLDHIRKLLRED------------------R-LN-----------DIVDRNLNTYDSKEVETMVQVALLCTQSTPED  341 (401)
Q Consensus       292 ~~~~~~~~~~~~~~~------------------~-~~-----------~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~  341 (401)
                      ...+.... ......                  . ..           ..+. .....+.....++.+++.+||+.||.+
T Consensus       247 ~~~~~~~~-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~  324 (373)
T 1q8y_A          247 DDHIAQII-ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT-EKYKFSKDEAKEISDFLSPMLQLDPRK  324 (373)
T ss_dssp             HHHHHHHH-HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH-HTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             HHHHHHHH-HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh-hcccCCcchHHHHHHHHHHHhccCccc
Confidence            11111111 111000                  0 00           0000 011245677889999999999999999


Q ss_pred             CCCHHHHHHH
Q 015734          342 RPPMAQVVKM  351 (401)
Q Consensus       342 RPs~~~vl~~  351 (401)
                      |||+.+++++
T Consensus       325 Rpt~~ell~h  334 (373)
T 1q8y_A          325 RADAGGLVNH  334 (373)
T ss_dssp             CBCHHHHHTC
T ss_pred             cCCHHHHhhC
Confidence            9999999774

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.2e-41  Score=315.81  Aligned_cols=259  Identities=23%  Similarity=0.339  Sum_probs=181.9

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHH-HHHhccCCcccceeeeeecCCeeEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVH-LISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      ..++|...+.||+|+||.||+|..+ +++.||+|++...........+..|+. +++.++||||+++++++...+..++|
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv   99 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC   99 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence            4578999999999999999999975 688999999976544445556666666 67778999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          153 YPFMQNLSVAYRLRDLK-PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      |||+.+ +|.+++.... .....+++..+..++.|++.||.|||+..  +++|+||||+||+++.++.+||+|||++...
T Consensus       100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            999985 7777765321 12456899999999999999999999852  7999999999999999999999999999865


Q ss_pred             CCCCcceeccccCCccccccccc----ccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          232 DAKLTHVTTQIRGTMGHIAPEYL----STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      .....  .....||+.|+|||++    .+..++.++||||||+++|+|++|..||.......       +...... ...
T Consensus       177 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~-~~~  246 (327)
T 3aln_A          177 VDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-------DQLTQVV-KGD  246 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCC-CSC
T ss_pred             ccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-------HHHHHHh-cCC
Confidence            44322  2233589999999998    45668999999999999999999999997432110       0000000 000


Q ss_pred             cchhccCcCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          308 LNDIVDRNLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       308 ~~~~~d~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                           .+.+. .........+.+++..||+.||.+|||+.+++++
T Consensus       247 -----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          247 -----PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             -----CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             -----CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence                 00111 0112344678899999999999999999999663

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.3e-42  Score=321.59  Aligned_cols=248  Identities=21%  Similarity=0.369  Sum_probs=199.9

Q ss_pred             HHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCc-----chHHHHHHHHHHHHhcc--CCcccceee
Q 015734           70 RELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP-----GGEAAFQREVHLISVAI--HKNLLQLIG  141 (401)
Q Consensus        70 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~--h~niv~~~~  141 (401)
                      .+.....++|.+.+.||+|+||.||+|... +++.||+|.+......     .....+.+|+.+++++.  |||++++++
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~  115 (320)
T 3a99_A           36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD  115 (320)
T ss_dssp             ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence            344556778999999999999999999964 6889999999743211     12245678999999986  599999999


Q ss_pred             eeecCCeeEEEEecccC-CcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEc-CCCc
Q 015734          142 YCTTSSERILVYPFMQN-LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFE  219 (401)
Q Consensus       142 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~  219 (401)
                      ++...+..++++|++.+ ++|.+++..    ...+++..++.++.|++.||+|||+.   +++||||||+||+++ +++.
T Consensus       116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~  188 (320)
T 3a99_A          116 WFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGE  188 (320)
T ss_dssp             EEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTE
T ss_pred             EEecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCC
Confidence            99999999999999986 899999886    24589999999999999999999999   999999999999999 7899


Q ss_pred             EEEeecCCccccCCCCcceeccccCCcccccccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHH
Q 015734          220 AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDH  298 (401)
Q Consensus       220 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~  298 (401)
                      +||+|||++.......   .....||+.|+|||++.+..+ +.++||||||+++|||++|..||.....           
T Consensus       189 ~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----------  254 (320)
T 3a99_A          189 LKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----------  254 (320)
T ss_dssp             EEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------
T ss_pred             EEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----------
Confidence            9999999998665432   233468999999999987765 7889999999999999999999964211           


Q ss_pred             HHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          299 IRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       299 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                         ......          ......+.++.+++.+||+.||.+|||+.+++++
T Consensus       255 ---~~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          255 ---IIRGQV----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             ---HHHCCC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---hhcccc----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               000000          0112233578899999999999999999999874

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.1e-41  Score=316.30  Aligned_cols=254  Identities=21%  Similarity=0.271  Sum_probs=173.6

Q ss_pred             HhcCCCCC-CeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeec----CCe
Q 015734           75 ATDNFSES-NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT----SSE  148 (401)
Q Consensus        75 ~~~~~~~~-~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~  148 (401)
                      ..++|.+. ++||+|+||+||+|.+. +++.||+|++...  .   ....+....+..+.|||++++++++..    ...
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  100 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC  100 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence            45678885 46999999999999976 6899999998641  1   222223334566789999999999876    445


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC---CCcEEEeec
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCDF  225 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Df  225 (401)
                      .++||||+++|+|.+++....  ...+++..++.++.|++.||.|||++   +++||||||+||+++.   ++.+||+||
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Df  175 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDF  175 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             EEEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecc
Confidence            799999999999999998632  34699999999999999999999999   9999999999999976   455999999


Q ss_pred             CCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhcc
Q 015734          226 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE  305 (401)
Q Consensus       226 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (401)
                      |++......   ......+|+.|+|||++.+..++.++||||||+++|+|++|..||..........     ........
T Consensus       176 g~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-----~~~~~~~~  247 (336)
T 3fhr_A          176 GFAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP-----GMKRRIRL  247 (336)
T ss_dssp             TTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred             ccceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh-----hHHHhhhc
Confidence            999865432   2233467999999999988889999999999999999999999997543211100     00000000


Q ss_pred             CccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          306 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       306 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ... ...    .......+.++.+++..||+.||.+|||+.+++++
T Consensus       248 ~~~-~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          248 GQY-GFP----NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             ----CCC----TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ccc-ccC----chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            000 000    01112345678899999999999999999999884

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=310.79  Aligned_cols=261  Identities=20%  Similarity=0.284  Sum_probs=192.7

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeee----------
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT----------  144 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----------  144 (401)
                      .++|.+.+.||+|+||.||+|... +++.||+|++... +....+.+.+|+++++.++||||+++++++.          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            467889999999999999999976 4889999998642 3455678899999999999999999998873          


Q ss_pred             ----cCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEc-CCCc
Q 015734          145 ----TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD-DNFE  219 (401)
Q Consensus       145 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~-~~~~  219 (401)
                          ..+..++||||+. ++|.+++..     ..+++..++.++.|++.||+|||++   +++|+||||+||+++ +++.
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~  159 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLV  159 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTE
T ss_pred             ccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCe
Confidence                3467799999997 699988864     3588999999999999999999999   999999999999997 6779


Q ss_pred             EEEeecCCccccCCCCc--ceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHH
Q 015734          220 AVLCDFGLAKLVDAKLT--HVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL  296 (401)
Q Consensus       220 ~kl~Dfgl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~  296 (401)
                      +||+|||++........  .......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.........     
T Consensus       160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-----  234 (320)
T 2i6l_A          160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM-----  234 (320)
T ss_dssp             EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----
T ss_pred             EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH-----
Confidence            99999999986543221  12233457899999998865 67899999999999999999999999865432111     


Q ss_pred             HHHHHHhcc----------CccchhccCcC--C-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          297 DHIRKLLRE----------DRLNDIVDRNL--N-----TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       297 ~~~~~~~~~----------~~~~~~~d~~~--~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..+......          ...........  .     ...+..+.++.+++.+||+.||.+|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            111100000          00000000000  0     0112235678899999999999999999999763

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.1e-40  Score=311.32  Aligned_cols=260  Identities=20%  Similarity=0.273  Sum_probs=201.8

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CC-CEEEEEEecccCCcchHHHHHHHHHHHHhccCCc------ccceeeeeecC
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DN-TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN------LLQLIGYCTTS  146 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~  146 (401)
                      ..++|.+.+.||+|+||+||+|... ++ ..||+|++..  .......+.+|+.+++.+.|++      ++.+.+++...
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~   94 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN--VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH   94 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc--cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence            3578999999999999999999964 34 6899999864  3345677889999999988766      89999999999


Q ss_pred             CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEE------------
Q 015734          147 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL------------  214 (401)
Q Consensus       147 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill------------  214 (401)
                      +..++||||+ ++++.+++....  ...+++..+..++.|++.||+|||++   +++||||||+|||+            
T Consensus        95 ~~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           95 GHMCIAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred             CeEEEEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccc
Confidence            9999999999 667777776522  34689999999999999999999999   99999999999999            


Q ss_pred             -------cCCCcEEEeecCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcc
Q 015734          215 -------DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRL  287 (401)
Q Consensus       215 -------~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~  287 (401)
                             +.++.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence                   67889999999999864432    2335689999999999999999999999999999999999999986443


Q ss_pred             hhhhhhhHHHHHHHHhccC--------ccchhc-c----------------------CcCCCCCHHHHHHHHHHHHHccc
Q 015734          288 EEEEDVLLLDHIRKLLRED--------RLNDIV-D----------------------RNLNTYDSKEVETMVQVALLCTQ  336 (401)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~--------~~~~~~-d----------------------~~~~~~~~~~~~~l~~l~~~cl~  336 (401)
                      ...     ...+.......        ...... .                      .........+..++.+++.+||+
T Consensus       245 ~~~-----~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  319 (355)
T 2eu9_A          245 REH-----LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE  319 (355)
T ss_dssp             HHH-----HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred             HHH-----HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence            211     11111111000        000000 0                      00011234456789999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 015734          337 STPEDRPPMAQVVKM  351 (401)
Q Consensus       337 ~~p~~RPs~~~vl~~  351 (401)
                      .||.+|||+.+++++
T Consensus       320 ~dP~~Rpt~~e~l~h  334 (355)
T 2eu9_A          320 FDPAQRITLAEALLH  334 (355)
T ss_dssp             SSTTTSCCHHHHTTS
T ss_pred             CChhhCcCHHHHhcC
Confidence            999999999999653

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5e-40  Score=306.22  Aligned_cols=254  Identities=20%  Similarity=0.307  Sum_probs=180.7

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHH-HHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEA-AFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~-~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      ..++|...+.||+|+||.||+|.+. +++.||+|++.......... .+.++..+++.++||||+++++++...+..++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            3467888999999999999999975 68999999997544333333 344455567888999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      |||+ ++.+.......   ...+++..+..++.|++.||.|||+ .   +++|+||||+||+++.++.+||+|||++...
T Consensus       103 ~e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             ECCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             Eecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            9999 55555544432   3458999999999999999999998 5   7999999999999999999999999999765


Q ss_pred             CCCCcceeccccCCcccccccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC
Q 015734          232 DAKLTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED  306 (401)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (401)
                      ....  ......+|+.|+|||.+.     ...++.++||||||+++|+|++|..||.......       ..........
T Consensus       176 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~  246 (318)
T 2dyl_A          176 VDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-------EVLTKVLQEE  246 (318)
T ss_dssp             -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-------HHHHHHHHSC
T ss_pred             cCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-------HHHHHHhccC
Confidence            4332  223346899999999984     4568899999999999999999999997532211       1111111111


Q ss_pred             ccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       307 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      . .     ..+ .....+.++.+++.+||+.||.+|||+.+++++
T Consensus       247 ~-~-----~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          247 P-P-----LLP-GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             C-C-----CCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             C-C-----CCC-ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            0 0     000 111234578899999999999999999999763

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-40  Score=321.08  Aligned_cols=251  Identities=24%  Similarity=0.303  Sum_probs=187.6

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCeeEEEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ...+|...++||+|+||+||.....+++.||||++.....    ..+.+|+++++.+ +||||+++++++.+....++||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~   97 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI   97 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence            3456888899999999997665566899999999864222    2356899999998 7999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC-----CCcEEEeecCCc
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-----NFEAVLCDFGLA  228 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-----~~~~kl~Dfgl~  228 (401)
                      ||+. |+|.+++....   .......+..++.|++.||.|||++   +++||||||+|||++.     ...+||+|||++
T Consensus        98 E~~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a  170 (432)
T 3p23_A           98 ELCA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC  170 (432)
T ss_dssp             ECCS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred             ECCC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence            9996 59999987632   2344455678999999999999999   9999999999999943     346889999999


Q ss_pred             cccCCCCc--ceeccccCCcccccccccc---cCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHH
Q 015734          229 KLVDAKLT--HVTTQIRGTMGHIAPEYLS---TGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKL  302 (401)
Q Consensus       229 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  302 (401)
                      +.......  .......||+.|+|||++.   ...++.++|||||||++|||+| |..||.......         ....
T Consensus       171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~---------~~~~  241 (432)
T 3p23_A          171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ---------ANIL  241 (432)
T ss_dssp             ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH---------HHHH
T ss_pred             eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH---------HHHH
Confidence            86653321  2234456999999999997   4567889999999999999999 889985432210         1111


Q ss_pred             hccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          303 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       303 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ......      ............+.+++.+||+.||.+|||+.+++++
T Consensus       242 ~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          242 LGACSL------DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             TTCCCC------TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hccCCc------cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence            111100      0011123445668899999999999999999999864

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=5.6e-41  Score=336.24  Aligned_cols=267  Identities=21%  Similarity=0.261  Sum_probs=201.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeec------CCe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT------SSE  148 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  148 (401)
                      .++|.+.+.||+|+||+||+|.+. +|+.||+|++.........+.+.+|+++++.++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            478999999999999999999964 6899999998765566667889999999999999999999998765      667


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCc---EEEeec
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFE---AVLCDF  225 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~---~kl~Df  225 (401)
                      .++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.   +||+||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence            7999999999999999986432 34588999999999999999999998   9999999999999997665   999999


Q ss_pred             CCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHH-HHHHHHhc
Q 015734          226 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL-DHIRKLLR  304 (401)
Q Consensus       226 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~~  304 (401)
                      |++.......  ......||+.|+|||.+.+..++.++||||||+++|+|++|..||........-..... ........
T Consensus       169 G~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          169 GYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             CCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred             cccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence            9998765432  22345689999999999999999999999999999999999999975322110000000 00000000


Q ss_pred             cCccchh--ccCc---CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 015734          305 EDRLNDI--VDRN---LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQV  348 (401)
Q Consensus       305 ~~~~~~~--~d~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~v  348 (401)
                      .......  ....   ........+..+.+++..||+.||.+|||+.++
T Consensus       247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence            0000000  0011   112345577889999999999999999999774

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6e-40  Score=336.04  Aligned_cols=239  Identities=19%  Similarity=0.283  Sum_probs=193.7

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC--CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCe----
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS--DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE----  148 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----  148 (401)
                      ..++|.+.+.||+|+||+||+|.+.  +++.||||++...........+.+|+.++.+++||||+++++++...+.    
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            4578999999999999999999975  5889999998765455566788999999999999999999999987665    


Q ss_pred             -eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCC
Q 015734          149 -RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL  227 (401)
Q Consensus       149 -~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl  227 (401)
                       .++||||+++++|.+++..      .+++..+..++.|++.||.|||++   +|+||||||+|||++.+ .+||+|||+
T Consensus       158 ~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             EEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             eeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence             6999999999999876643      589999999999999999999999   99999999999999986 899999999


Q ss_pred             ccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          228 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      ++.....     ....||+.|+|||++.+.. +.++|||||||++|+|++|..||........                 
T Consensus       228 a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-----------------  284 (681)
T 2pzi_A          228 VSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----------------  284 (681)
T ss_dssp             CEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------------
T ss_pred             chhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-----------------
Confidence            9866443     3456899999999987654 8899999999999999999988764221100                 


Q ss_pred             cchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHhc
Q 015734          308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-MAQVVKMLQ  353 (401)
Q Consensus       308 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~~vl~~L~  353 (401)
                       .    .  ..........+.+++.+||+.||.+||+ ++++.+.|.
T Consensus       285 -~----~--~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          285 -P----E--DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             -C----T--TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             -c----c--cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence             0    0  0001123357889999999999999995 555555553

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.6e-38  Score=291.77  Aligned_cols=230  Identities=10%  Similarity=0.025  Sum_probs=183.6

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCC--cchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      ..++|.+.+.||+|+||.||+|.+. +++.||+|++.....  ......+.+|+..+.+++||||+++++++...+..++
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            3467999999999999999999975 489999999975433  3345789999999999999999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      ||||+++++|.+++..     . .....+..++.|++.||+|||++   +++||||||+||+++.++.+||+++|     
T Consensus       109 v~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-----  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-----  174 (286)
T ss_dssp             EEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred             EEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----
Confidence            9999999999999854     1 34557888999999999999999   99999999999999999999997443     


Q ss_pred             CCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                                      |++|       ++.++|||||||++|||+||+.||...........              ....
T Consensus       175 ----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~--------------~~~~  217 (286)
T 3uqc_A          175 ----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP--------------AERD  217 (286)
T ss_dssp             ----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE--------------CCBC
T ss_pred             ----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH--------------HHHH
Confidence                            3333       68899999999999999999999986443210000              0000


Q ss_pred             ccCcCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 015734          312 VDRNLN---TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED  356 (401)
Q Consensus       312 ~d~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  356 (401)
                      ......   ......+.++.+++.+||+.||.+| |+.++++.|+...
T Consensus       218 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~  264 (286)
T 3uqc_A          218 TAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT  264 (286)
T ss_dssp             TTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred             hccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence            000000   0112334578899999999999999 9999999997643

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.9e-38  Score=291.19  Aligned_cols=228  Identities=20%  Similarity=0.277  Sum_probs=178.5

Q ss_pred             hcCCCCC-CeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHH-HhccCCcccceeeeeec----CCe
Q 015734           76 TDNFSES-NIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLI-SVAIHKNLLQLIGYCTT----SSE  148 (401)
Q Consensus        76 ~~~~~~~-~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~  148 (401)
                      .++|.+. +.||+|+||.||+|... ++..||+|++..      ...+.+|+.++ +..+||||+++++++..    ...
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            3566666 78999999999999974 688999999864      24567888887 56689999999999876    667


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC---CCcEEEeec
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCDF  225 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Df  225 (401)
                      .++||||+++++|.+++....  ...+++..++.++.|++.||.|||++   +++|+||||+||+++.   ++.+||+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecc
Confidence            899999999999999998732  34699999999999999999999999   9999999999999998   789999999


Q ss_pred             CCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhcc
Q 015734          226 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE  305 (401)
Q Consensus       226 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (401)
                      |++....                       +..++.++|||||||++|+|++|..||.........             .
T Consensus       165 g~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-------------~  208 (299)
T 3m2w_A          165 GFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------------P  208 (299)
T ss_dssp             TTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------------C
T ss_pred             ccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-------------H
Confidence            9986432                       234678999999999999999999999643321100             0


Q ss_pred             CccchhccCcCCCCC----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          306 DRLNDIVDRNLNTYD----SKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       306 ~~~~~~~d~~~~~~~----~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..... ........+    ...+.++.+++..||+.||.+|||+.+++++
T Consensus       209 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          209 GMKTR-IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             CSCCS-SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHH-HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            00000 000000111    1235678899999999999999999999874

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-39  Score=313.88  Aligned_cols=244  Identities=16%  Similarity=0.083  Sum_probs=181.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCC--cchHHHHHHHHHHHHhccC-Cccccee---------ee
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYS--PGGEAAFQREVHLISVAIH-KNLLQLI---------GY  142 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h-~niv~~~---------~~  142 (401)
                      ..+|...+.||+|+||+||+|.+ .+|+.||||++.....  ....+.+.+|+.+++.+.| +|...+.         ..
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            34567788999999999999995 4689999999873222  2335778999999999987 3221111         11


Q ss_pred             ------------eec-----CCeeEEEEecccCCcHHHHhhhc---CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 015734          143 ------------CTT-----SSERILVYPFMQNLSVAYRLRDL---KPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI  202 (401)
Q Consensus       143 ------------~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  202 (401)
                                  +..     ....+++|+++ +++|.+++...   ......+++..+..++.|++.||+|||++   ++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence                        111     12346666665 67999888532   22345578889999999999999999999   99


Q ss_pred             EEeCCCCCceEEcCCCcEEEeecCCccccCCCCcceeccccCCccccccccc----------ccCCCCcccchhHHHHHH
Q 015734          203 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL----------STGKSSEKTDVFGYGITL  272 (401)
Q Consensus       203 ~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDi~slG~ll  272 (401)
                      +||||||+|||++.++.+||+|||+++.....    .....| +.|+|||++          .+..++.++|||||||++
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            99999999999999999999999998865433    344567 999999999          555688899999999999


Q ss_pred             HHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          273 LELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       273 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                      |||+||+.||........                 ....+.. .    ...+.++.+++..||+.||.+||++.++++
T Consensus       308 ~elltg~~Pf~~~~~~~~-----------------~~~~~~~-~----~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGG-----------------SEWIFRS-C----KNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSC-----------------SGGGGSS-C----CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHCCCCCCCcchhhh-----------------HHHHHhh-c----ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            999999999975432111                 1111111 0    112357889999999999999999999865

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.6e-38  Score=298.63  Aligned_cols=244  Identities=14%  Similarity=0.132  Sum_probs=184.7

Q ss_pred             HhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccC-------CcchHHHHHHHHHHHHhcc---------CCcccc
Q 015734           75 ATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-------SPGGEAAFQREVHLISVAI---------HKNLLQ  138 (401)
Q Consensus        75 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~---------h~niv~  138 (401)
                      ..++|.+.+.||+|+||+||+|.+ +|+.||||++....       .....+.+.+|+.+++.++         |||+++
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            456789999999999999999998 78999999997432       2334578899999998886         666666


Q ss_pred             eeee-----------------eec-------------CCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHH
Q 015734          139 LIGY-----------------CTT-------------SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA  188 (401)
Q Consensus       139 ~~~~-----------------~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~  188 (401)
                      +.+.                 +..             .+..++||||+++|++.+.+..     ..+++..++.++.|++
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT  171 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence            5554                 332             6788999999999977666643     3589999999999999


Q ss_pred             HHHHHHH-hcCCCCeEEeCCCCCceEEcCCC--------------------cEEEeecCCccccCCCCcceeccccCCcc
Q 015734          189 YGLEYLH-EQCNPKIIHRDLKAANILLDDNF--------------------EAVLCDFGLAKLVDAKLTHVTTQIRGTMG  247 (401)
Q Consensus       189 ~~l~~LH-~~~~~~i~H~dlkp~Nill~~~~--------------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~  247 (401)
                      .||+||| ++   +++||||||+|||++.++                    .+||+|||+++.....      ...||+.
T Consensus       172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~  242 (336)
T 2vuw_A          172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV  242 (336)
T ss_dssp             HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred             HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence            9999999 88   999999999999999887                    8999999999866432      2368999


Q ss_pred             cccccccccCCCCcccchhHHHHH-HHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHH
Q 015734          248 HIAPEYLSTGKSSEKTDVFGYGIT-LLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVET  326 (401)
Q Consensus       248 y~aPE~~~~~~~~~~sDi~slG~l-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  326 (401)
                      |+|||++.+.. +.++||||++++ .+++++|..||.....    ....   ............   ..........+.+
T Consensus       243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~----~~~~---~~~~~~~~~~~~---~~~~~~~~~~s~~  311 (336)
T 2vuw_A          243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW----LHYL---TDKMLKQMTFKT---KCNTPAMKQIKRK  311 (336)
T ss_dssp             TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH----HHHH---HHHHHHTCCCSS---CCCSHHHHHHHHH
T ss_pred             ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh----hhHH---HHhhhhhhccCc---ccchhhhhhcCHH
Confidence            99999998766 899999998777 7778889988742100    0001   111111100000   0001123457788


Q ss_pred             HHHHHHHcccCCCCCCCCHHHHH
Q 015734          327 MVQVALLCTQSTPEDRPPMAQVV  349 (401)
Q Consensus       327 l~~l~~~cl~~~p~~RPs~~~vl  349 (401)
                      +.+|+.+||+.|     |+.|++
T Consensus       312 ~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          312 IQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHHhccC-----CHHHHH
Confidence            999999999976     999987

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=1e-31  Score=268.27  Aligned_cols=185  Identities=13%  Similarity=0.049  Sum_probs=129.2

Q ss_pred             eeecCcEEEEEEE-ECCCCEEEEEEecccC---------CcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCeeEEEE
Q 015734           85 IGQGGFGKVYKGV-LSDNTKVAVKRLQDYY---------SPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        85 lG~G~~g~V~~~~-~~~~~~vavK~~~~~~---------~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      .+.|++|.+..+. .-.|+.+++|.+....         ++...++|.+|+++|+++ .|+||+++++++.+.+..|+||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            3455555555443 2247789999996431         123346799999999999 6999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||++|++|.+.+..    ..+++..   +|+.||+.||+|+|++   ||+||||||+|||++++|++||+|||+++....
T Consensus       322 Eyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          322 EKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             ECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             ecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            99999999999986    3446543   5889999999999999   999999999999999999999999999986654


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCC
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRA  281 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p  281 (401)
                      ... .....+||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus       392 ~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             --C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            332 2344679999999999865 467789999999998887666544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=2.8e-28  Score=242.11  Aligned_cols=186  Identities=15%  Similarity=0.191  Sum_probs=146.9

Q ss_pred             CCCCeeeecCcEEEEEEEECCCCEEEEEEecccCC-cc------hHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           80 SESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS-PG------GEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        80 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      ...+.||+|+||.||+|.. .+..+++|+...... ..      ..+.+.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3467899999999999954 678899998753221 11      134589999999999999999766677777888999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||+++++|.+++..            +..++.|++.||.|||++   +++||||||+|||++.  .+||+|||+++...
T Consensus       418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            999999999998875            458899999999999999   9999999999999999  99999999999775


Q ss_pred             CCCcce------eccccCCccccccccccc--CCCCcccchhHHHHHHHHHHhCCCCCC
Q 015734          233 AKLTHV------TTQIRGTMGHIAPEYLST--GKSSEKTDVFGYGITLLELVTGQRAID  283 (401)
Q Consensus       233 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~sDi~slG~ll~elltg~~p~~  283 (401)
                      ......      .....||+.|+|||++..  ..|+..+|+|+..+-..+-..++.+|.
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            532221      235679999999999987  568888999999999888888777663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=4.3e-25  Score=201.54  Aligned_cols=153  Identities=13%  Similarity=0.053  Sum_probs=121.1

Q ss_pred             HHHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCc-----------------chHHHHHHHHHHHHhcc
Q 015734           70 RELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP-----------------GGEAAFQREVHLISVAI  132 (401)
Q Consensus        70 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~l~  132 (401)
                      ..+......|.+.+.||+|+||.||+|.+.+|+.||+|.++.....                 .....+.+|+.++++++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            3344455566777999999999999999977999999998632211                 13567899999999998


Q ss_pred             CCcccceeeeeecCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCce
Q 015734          133 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANI  212 (401)
Q Consensus       133 h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Ni  212 (401)
                        | +++.+++. .+..++||||+++++|.+ +..          .....++.|++.||.|||+.   +++||||||+||
T Consensus       163 --~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NI  224 (282)
T 1zar_A          163 --G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNV  224 (282)
T ss_dssp             --T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSE
T ss_pred             --C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHE
Confidence              4 56655443 355699999999999987 421          12457999999999999999   999999999999


Q ss_pred             EEcCCCcEEEeecCCccccCCCCcceeccccCCcccccccccc
Q 015734          213 LLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS  255 (401)
Q Consensus       213 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~  255 (401)
                      |++ ++.+||+|||+++              .+..+.|||++.
T Consensus       225 Ll~-~~~vkl~DFG~a~--------------~~~~~~a~e~l~  252 (282)
T 1zar_A          225 LVS-EEGIWIIDFPQSV--------------EVGEEGWREILE  252 (282)
T ss_dssp             EEE-TTEEEECCCTTCE--------------ETTSTTHHHHHH
T ss_pred             EEE-CCcEEEEECCCCe--------------ECCCCCHHHHHH
Confidence            999 9999999999986              244578899874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.83  E-value=1.5e-20  Score=169.38  Aligned_cols=137  Identities=20%  Similarity=0.171  Sum_probs=105.9

Q ss_pred             CCCCCeeeecCcEEEEEEEE-CCCCE--EEEEEecccCCc-----------------------chHHHHHHHHHHHHhcc
Q 015734           79 FSESNIIGQGGFGKVYKGVL-SDNTK--VAVKRLQDYYSP-----------------------GGEAAFQREVHLISVAI  132 (401)
Q Consensus        79 ~~~~~~lG~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~-----------------------~~~~~~~~e~~~l~~l~  132 (401)
                      |.+.+.||+|+||.||+|.. .+|+.  ||||+++.....                       .....+.+|+..+..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56788999999999999997 67888  999987532111                       01236889999999999


Q ss_pred             CCcc--cceeeeeecCCeeEEEEecccC-C----cHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEE
Q 015734          133 HKNL--LQLIGYCTTSSERILVYPFMQN-L----SVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH-EQCNPKIIH  204 (401)
Q Consensus       133 h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~i~H  204 (401)
                      |+++  ..++++    +..++||||+.+ |    +|.+....       .++.....++.|++.||.||| +.   +++|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH  194 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH  194 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence            8864  333332    356899999942 4    56554432       224467789999999999999 87   9999


Q ss_pred             eCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          205 RDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       205 ~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      |||||+|||++.  .++|+|||++...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.74  E-value=1.5e-18  Score=162.69  Aligned_cols=141  Identities=13%  Similarity=0.140  Sum_probs=98.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCC-------------cchHHHHH--------HHHHHHHhccCC
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYS-------------PGGEAAFQ--------REVHLISVAIHK  134 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~--------~e~~~l~~l~h~  134 (401)
                      ..-|.+.+.||+|+||.||+|...+|+.||||+++....             ........        +|...|.++.+.
T Consensus        94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            334889999999999999999998999999998753110             11122222        344445444333


Q ss_pred             cccceeeeeecCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEE
Q 015734          135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILL  214 (401)
Q Consensus       135 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill  214 (401)
                      ++.-..-+.  ....++||||++|++|.....        .  .....++.|++.+|.+||+.   +++||||||.|||+
T Consensus       174 gv~vp~p~~--~~~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl  238 (397)
T 4gyi_A          174 GFPVPEPIA--QSRHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKH---GLIHGDFNEFNILI  238 (397)
T ss_dssp             TCSCCCEEE--EETTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred             CCCCCeeee--ccCceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEE
Confidence            321111111  122379999999988754322        1  23456889999999999998   99999999999999


Q ss_pred             cCCC----------cEEEeecCCcccc
Q 015734          215 DDNF----------EAVLCDFGLAKLV  231 (401)
Q Consensus       215 ~~~~----------~~kl~Dfgl~~~~  231 (401)
                      ++++          .+.|+||+-+...
T Consensus       239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          239 REEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             eCCCCcccccccccceEEEEeCCcccC
Confidence            8877          3899999977543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.35  E-value=5.2e-12  Score=113.49  Aligned_cols=146  Identities=16%  Similarity=0.134  Sum_probs=112.2

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCcccceeeeeecCCeeEE
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l  151 (401)
                      ....+.|.....++.|+.+.||++.. +++.+++|....... .....+.+|+.+++.+. +.++.++++++...+..++
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            33446788888888899999999886 468999999864221 12235888999998885 6778889999988888999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC---------------------------------  198 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------  198 (401)
                      |||+++|.+|.+.+..         ......++.+++.+|+.||+..                                 
T Consensus        88 v~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           88 LMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             EEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            9999999998765321         1123467889999999999810                                 


Q ss_pred             -----------------------CCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          199 -----------------------NPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       199 -----------------------~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                                             .+.++|+|++|.||+++++..+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                   1359999999999999876666799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.24  E-value=1.2e-11  Score=110.81  Aligned_cols=128  Identities=14%  Similarity=0.042  Sum_probs=95.5

Q ss_pred             eecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCc--ccceeeeeecCCeeEEEEecccCCcHHH
Q 015734           86 GQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN--LLQLIGYCTTSSERILVYPFMQNLSVAY  163 (401)
Q Consensus        86 G~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~  163 (401)
                      +.|..+.||++...+|..+++|.....    ....+..|+.+++.+.+.+  +.+++++....+..++||||++|.++. 
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence            455669999998767888999987542    2245778999998886545  455888888777889999999998873 


Q ss_pred             HhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------------
Q 015734          164 RLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC---------------------------------------------  198 (401)
Q Consensus       164 ~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------------  198 (401)
                       ...       .+   ...++.+++..|+.||+..                                             
T Consensus       104 -~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (264)
T 1nd4_A          104 -SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  172 (264)
T ss_dssp             -TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             -cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence             211       11   2356677778888888642                                             


Q ss_pred             ----------CCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          199 ----------NPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       199 ----------~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                                ...++|+|++|.||++++++.+.|+|||.+.
T Consensus       173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                      1139999999999999887667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.17  E-value=1e-10  Score=110.02  Aligned_cols=143  Identities=13%  Similarity=0.165  Sum_probs=105.3

Q ss_pred             CCCeeeecCcEEEEEEEECCCCEEEEEEec--ccCCcchHHHHHHHHHHHHhcc--CCcccceeeeeecC---CeeEEEE
Q 015734           81 ESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ--DYYSPGGEAAFQREVHLISVAI--HKNLLQLIGYCTTS---SERILVY  153 (401)
Q Consensus        81 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~  153 (401)
                      ..+.|+.|.++.||+.... +..+++|+..  ..........+.+|+.+++.+.  +.++.+++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            3567899999999998874 4678888765  3222223456788999999887  45678888888766   4478999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC-----------------------------------  198 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----------------------------------  198 (401)
                      ||++|..+.+..      -..++......++.+++..|+.||+..                                   
T Consensus       121 e~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          121 EFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             ECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            999987764311      123677888899999999999999731                                   


Q ss_pred             --------------------CCCeEEeCCCCCceEEcCCCc--EEEeecCCccc
Q 015734          199 --------------------NPKIIHRDLKAANILLDDNFE--AVLCDFGLAKL  230 (401)
Q Consensus       199 --------------------~~~i~H~dlkp~Nill~~~~~--~kl~Dfgl~~~  230 (401)
                                          ...++|+|+++.||+++.++.  +.|.||+.+..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                247999999999999997753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.06  E-value=2.3e-10  Score=105.10  Aligned_cols=183  Identities=19%  Similarity=0.202  Sum_probs=120.3

Q ss_pred             CCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCc--ccceeeeeecCC---eeEEEEec
Q 015734           82 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKN--LLQLIGYCTTSS---ERILVYPF  155 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~  155 (401)
                      .+.++.|....||+..    ..+++|....   ......+.+|..+++.+. +..  +.+++......+   ..++||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~---~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH---SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS---HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC---cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            4568999999999763    4588887543   234567889999998874 332  344555443333   34789999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ--------------------------------------  197 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------------------------------------  197 (401)
                      ++|.++......      .++......++.+++..++.||+.                                      
T Consensus        98 i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           98 IKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             CCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             cCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            999887653322      256677778888888888888861                                      


Q ss_pred             -----------------CCCCeEEeCCCCCceEEcC--CCcEEEeecCCccccCCCCcceeccccCCccc---ccccccc
Q 015734          198 -----------------CNPKIIHRDLKAANILLDD--NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH---IAPEYLS  255 (401)
Q Consensus       198 -----------------~~~~i~H~dlkp~Nill~~--~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y---~aPE~~~  255 (401)
                                       ..+.++|+|++|.||++++  +..+.|.||+.+...... ....    ....+   ..|+...
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~----~~~~~~~~~~~~~~~  246 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFI----SLMEDDEEYGMEFVS  246 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHH----TTCCTTTSCCHHHHH
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHH----HHHhhccccCHHHHH
Confidence                             1135899999999999998  556789999988643221 0000    00001   1222111


Q ss_pred             c-----CC---------CCcccchhHHHHHHHHHHhCCCCC
Q 015734          256 T-----GK---------SSEKTDVFGYGITLLELVTGQRAI  282 (401)
Q Consensus       256 ~-----~~---------~~~~sDi~slG~ll~elltg~~p~  282 (401)
                      .     +.         .....+.|+++.++|.+.+|..+|
T Consensus       247 ~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          247 KILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            0     00         122358999999999999998765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.55  E-value=1.1e-06  Score=78.81  Aligned_cols=133  Identities=14%  Similarity=0.122  Sum_probs=93.3

Q ss_pred             eeecCcE-EEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCcccceeeeeecCCeeEEEEecccCCcH
Q 015734           85 IGQGGFG-KVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSERILVYPFMQNLSV  161 (401)
Q Consensus        85 lG~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL  161 (401)
                      +..|..| .||+.... ++..+++|+-..    .....+.+|...|+.+. +-.+.++++++.+.+..++||++++|.++
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            4445554 68988754 456789997643    24567888999988774 33467788898888899999999999887


Q ss_pred             HHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 015734          162 AYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC-------------------------------------------  198 (401)
Q Consensus       162 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------------  198 (401)
                      .+.....        ......+..+++..|+-||+..                                           
T Consensus       108 ~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          108 FQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             HHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             cccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            6654321        1122344555555555555321                                           


Q ss_pred             ------------CCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          199 ------------NPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       199 ------------~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                                  .+.++|+|+.+.||++++++.+-|.||+.+.
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                        1237999999999999988777899999875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.49  E-value=1.8e-06  Score=78.97  Aligned_cols=136  Identities=19%  Similarity=0.205  Sum_probs=91.4

Q ss_pred             CCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCC---cccceeeeee-cCCeeEEEEeccc
Q 015734           82 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK---NLLQLIGYCT-TSSERILVYPFMQ  157 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~  157 (401)
                      .+.++.|....||+.    +..+++|+-.   .......+.+|..++..+.+.   .+.+++.++. ..+..+++|++++
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~---~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK---SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES---SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC---CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            456788999999987    5678888743   233456889999999998753   3556666664 4455789999999


Q ss_pred             CCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 015734          158 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ----------------------------------------  197 (401)
Q Consensus       158 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------------------------------------  197 (401)
                      |.++......      .++......++.+++..|+.||+.                                        
T Consensus        97 G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~  170 (306)
T 3tdw_A           97 GQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD  170 (306)
T ss_dssp             SEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred             CeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence            9887653211      123334444444444444444431                                        


Q ss_pred             -----------------CCCCeEEeCCCCCceEEcC---CCc-EEEeecCCccc
Q 015734          198 -----------------CNPKIIHRDLKAANILLDD---NFE-AVLCDFGLAKL  230 (401)
Q Consensus       198 -----------------~~~~i~H~dlkp~Nill~~---~~~-~kl~Dfgl~~~  230 (401)
                                       ..+.++|+|++|.||+++.   ++. +.|.||+.+..
T Consensus       171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                             2335799999999999987   455 48999998763

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.23  E-value=2.5e-06  Score=79.71  Aligned_cols=80  Identities=6%  Similarity=-0.021  Sum_probs=53.2

Q ss_pred             Cee-eecCcEEEEEEEEC-------CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccC---CcccceeeeeecC---
Q 015734           83 NII-GQGGFGKVYKGVLS-------DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIH---KNLLQLIGYCTTS---  146 (401)
Q Consensus        83 ~~l-G~G~~g~V~~~~~~-------~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~---  146 (401)
                      +.| +.|..+.+|+....       ++..+++|......  .......+.+|+.+++.+..   -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            456 78888999988764       26678888764321  00012356788888877742   3467788777655   


Q ss_pred             CeeEEEEecccCCcHH
Q 015734          147 SERILVYPFMQNLSVA  162 (401)
Q Consensus       147 ~~~~lv~e~~~~gsL~  162 (401)
                      +..++|||+++|.++.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3468999999886643

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.11  E-value=2.4e-05  Score=72.33  Aligned_cols=141  Identities=18%  Similarity=0.238  Sum_probs=77.8

Q ss_pred             CeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccC--Ccccceee------eeecCCeeEEEEe
Q 015734           83 NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH--KNLLQLIG------YCTTSSERILVYP  154 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~------~~~~~~~~~lv~e  154 (401)
                      +.|+.|..+.||++...++ .+++|+...  .   ...+..|..++..+..  -.+.+++.      +....+..+++++
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~--~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR--P---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECS--C---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCC--C---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            3455577899999987544 588998764  2   2333445555544431  12333332      1123556789999


Q ss_pred             cccCCcHH--------------HHhhhcCCCC----------CCCCHHHH------------------------------
Q 015734          155 FMQNLSVA--------------YRLRDLKPGE----------KGLDWPTR------------------------------  180 (401)
Q Consensus       155 ~~~~gsL~--------------~~l~~~~~~~----------~~l~~~~~------------------------------  180 (401)
                      |++|.++.              -.++......          ....|...                              
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986432              1122111100          01122211                              


Q ss_pred             -HHHHHHHHHHHHHHHh----------cCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          181 -KRVAFGTAYGLEYLHE----------QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       181 -~~i~~~i~~~l~~LH~----------~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                       ..+...+..++.+|+.          .....++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence             0111223445666653          123479999999999999888889999999764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.04  E-value=3e-05  Score=73.53  Aligned_cols=76  Identities=14%  Similarity=0.147  Sum_probs=49.1

Q ss_pred             CCeeeecCcEEEEEEEEC-CCCEEEEEEecccCC------cchHHHHHHHHHHHHhccC--Cccc-ceeeeeecCCeeEE
Q 015734           82 SNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYS------PGGEAAFQREVHLISVAIH--KNLL-QLIGYCTTSSERIL  151 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~e~~~l~~l~h--~niv-~~~~~~~~~~~~~l  151 (401)
                      .+.||.|.++.||++... +++.+++|.......      ......+..|.+++..+..  +..+ +++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            457899999999999754 468899998653211      1123456778888887642  3433 45543  3445689


Q ss_pred             EEecccCC
Q 015734          152 VYPFMQNL  159 (401)
Q Consensus       152 v~e~~~~g  159 (401)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.93  E-value=7.1e-05  Score=68.37  Aligned_cols=139  Identities=14%  Similarity=0.175  Sum_probs=91.7

Q ss_pred             CCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhcc---CCcccceeeeeecCCeeEEEEecccC
Q 015734           82 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI---HKNLLQLIGYCTTSSERILVYPFMQN  158 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~  158 (401)
                      .+.|+.|....+|+... ++..+++|+...    .....+..|...|+.+.   ...+.++++++...+..++|||++++
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~----~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINER----SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEG----GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCc----ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            45689999999999886 567888997653    23567889999888774   35688888888888889999999998


Q ss_pred             CcHH--------H---HhhhcCC-CC-----------------CCCCHHHHH---HHH----------------HHHHHH
Q 015734          159 LSVA--------Y---RLRDLKP-GE-----------------KGLDWPTRK---RVA----------------FGTAYG  190 (401)
Q Consensus       159 gsL~--------~---~l~~~~~-~~-----------------~~l~~~~~~---~i~----------------~~i~~~  190 (401)
                      ..+.        .   .|+.... ..                 ..-+|....   ++.                ..++..
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            7532        1   2333221 00                 011343321   111                111111


Q ss_pred             -HHHHHh-cCCCCeEEeCCCCCceEEcCCCcEEEeecC
Q 015734          191 -LEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFG  226 (401)
Q Consensus       191 -l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  226 (401)
                       ...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             123422 2246899999999999999887 8888974

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.82  E-value=0.00017  Score=65.00  Aligned_cols=78  Identities=21%  Similarity=0.255  Sum_probs=55.5

Q ss_pred             CCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCC---cccceeeeeecCCeeEEEEe
Q 015734           78 NFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK---NLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~lv~e  154 (401)
                      .....+.+|.|..+.||+....+|+.|++|+-... .......|..|...|+.+...   .+.+++++.    ..+++||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~-~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e   90 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDD-APALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME   90 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTT-CCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCC-CcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence            34446778999999999999989999999986532 222345678899988877422   244455442    3478999


Q ss_pred             cccCCc
Q 015734          155 FMQNLS  160 (401)
Q Consensus       155 ~~~~gs  160 (401)
                      |++++.
T Consensus        91 ~l~~~~   96 (288)
T 3f7w_A           91 WVDERP   96 (288)
T ss_dssp             CCCCCC
T ss_pred             eecccC
Confidence            998754

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.66  E-value=0.00041  Score=66.22  Aligned_cols=77  Identities=12%  Similarity=0.119  Sum_probs=46.7

Q ss_pred             CCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcceeccc-cCCcccccccccccC---CCCcccchhHHHHHHHHH
Q 015734          200 PKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQI-RGTMGHIAPEYLSTG---KSSEKTDVFGYGITLLEL  275 (401)
Q Consensus       200 ~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~~~~sDi~slG~ll~el  275 (401)
                      +.++|+|++|.||+++.++ +.+.||+.+........ ..... .-...|.+|+.....   ......++.+....+|+.
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            4799999999999999876 99999998874321110 00000 002345666554311   112234556777777777


Q ss_pred             HhC
Q 015734          276 VTG  278 (401)
Q Consensus       276 ltg  278 (401)
                      +++
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.50  E-value=0.004  Score=56.81  Aligned_cols=159  Identities=14%  Similarity=0.122  Sum_probs=85.3

Q ss_pred             cCHHHHHHHhcCCCCC-----CeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCc--ccce
Q 015734           67 FSCRELQLATDNFSES-----NIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN--LLQL  139 (401)
Q Consensus        67 ~~~~~~~~~~~~~~~~-----~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~  139 (401)
                      ++.+++......|...     +.|+.|....+|+....++ .+++|......+.   ..+..|..++..+...+  +.++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~---~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCH---HHHHHHHHHHHHHHHCCCCCCcc
Confidence            4455555555556552     3456688899999987555 6788987642222   34456777766654222  2333


Q ss_pred             eee------eecCCeeEEEEecccCCcHHH--------------HhhhcCCC-CCC----C---CHHHHHH---------
Q 015734          140 IGY------CTTSSERILVYPFMQNLSVAY--------------RLRDLKPG-EKG----L---DWPTRKR---------  182 (401)
Q Consensus       140 ~~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~-~~~----l---~~~~~~~---------  182 (401)
                      +..      ....+..+++++|++|..+..              .++..... ..+    .   .|.....         
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            321      112345689999998754211              12221110 000    1   1221100         


Q ss_pred             ---HHHHHHHHHHHHHhc----CCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          183 ---VAFGTAYGLEYLHEQ----CNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       183 ---i~~~i~~~l~~LH~~----~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                         +...+...++.+...    ....++|+|+.+.||+++++..+.+.||+.+.
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence               001134445555532    13479999999999999987666899998765

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.47  E-value=0.00058  Score=62.85  Aligned_cols=31  Identities=35%  Similarity=0.412  Sum_probs=27.0

Q ss_pred             CCeEEeCCCCCceEEcCC----CcEEEeecCCccc
Q 015734          200 PKIIHRDLKAANILLDDN----FEAVLCDFGLAKL  230 (401)
Q Consensus       200 ~~i~H~dlkp~Nill~~~----~~~kl~Dfgl~~~  230 (401)
                      ..++|+|+.+.||+++.+    +.+.|.||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            479999999999999875    6899999998763

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.47  E-value=0.00056  Score=62.02  Aligned_cols=71  Identities=7%  Similarity=-0.002  Sum_probs=43.5

Q ss_pred             CCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcc-cceeeeeecCCeeEEEEecc-cCC
Q 015734           82 SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL-LQLIGYCTTSSERILVYPFM-QNL  159 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~g  159 (401)
                      .+.|+.|....+|+.     ..+++|+......  ......+|..+++.+...++ .+++++.  ....+++++|+ ++.
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~--~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE--EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCcc--ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence            677889999999998     4688887754211  11123467777776653333 3555443  33457899999 554


Q ss_pred             cH
Q 015734          160 SV  161 (401)
Q Consensus       160 sL  161 (401)
                      ++
T Consensus        94 ~l   95 (301)
T 3dxq_A           94 TM   95 (301)
T ss_dssp             EC
T ss_pred             cC
Confidence            43

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.35  E-value=0.0027  Score=58.08  Aligned_cols=160  Identities=11%  Similarity=0.077  Sum_probs=87.1

Q ss_pred             cccCHHHHHHHhcCCCC-----CCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCc--cc
Q 015734           65 RRFSCRELQLATDNFSE-----SNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN--LL  137 (401)
Q Consensus        65 ~~~~~~~~~~~~~~~~~-----~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv  137 (401)
                      ..++.+.+....+.|.+     ...++ |....||+....+|+.+++|......  .....+..|..++..+....  +.
T Consensus         9 ~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~~~g~~vp   85 (328)
T 1zyl_A            9 QTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVA   85 (328)
T ss_dssp             CCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBC
T ss_pred             CCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHHHcCCeec
Confidence            34444444444344432     23466 88889998877667789999886321  13456667888777664222  33


Q ss_pred             ceeee-----eecCCeeEEEEecccCCcHH-----------HH---hhhcCC-----CCCCCCHHHH----HHH------
Q 015734          138 QLIGY-----CTTSSERILVYPFMQNLSVA-----------YR---LRDLKP-----GEKGLDWPTR----KRV------  183 (401)
Q Consensus       138 ~~~~~-----~~~~~~~~lv~e~~~~gsL~-----------~~---l~~~~~-----~~~~l~~~~~----~~i------  183 (401)
                      +++..     ....+..++++++++|..+.           ..   ++....     .....++...    ..+      
T Consensus        86 ~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  165 (328)
T 1zyl_A           86 APVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATL  165 (328)
T ss_dssp             CCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSS
T ss_pred             ceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCc
Confidence            44432     11234557899999875421           11   121110     0111222211    001      


Q ss_pred             ---------HHHHHHHHHHHHhc----CCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          184 ---------AFGTAYGLEYLHEQ----CNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       184 ---------~~~i~~~l~~LH~~----~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                               ...+...++.+...    ....++|+|+++.||+++ + .+.+.||+.+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          166 IPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             SCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence                     11111223333221    234689999999999999 4 89999998765

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.34  E-value=0.00087  Score=64.08  Aligned_cols=72  Identities=15%  Similarity=0.154  Sum_probs=48.8

Q ss_pred             CCeeeecCcEEEEEEEECC--------CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcc-cceeeeeecCCeeEEE
Q 015734           82 SNIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL-LQLIGYCTTSSERILV  152 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv  152 (401)
                      .+.|+.|....+|++...+        +..+++|+....   .....+.+|..++..+...++ .++++.+.+    .+|
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v  150 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  150 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence            4567888889999998753        578999987431   122456689888888754444 556665542    389


Q ss_pred             EecccCCc
Q 015734          153 YPFMQNLS  160 (401)
Q Consensus       153 ~e~~~~gs  160 (401)
                      ++|++|.+
T Consensus       151 ~e~l~G~~  158 (429)
T 1nw1_A          151 EEYIPSRP  158 (429)
T ss_dssp             ECCCCEEE
T ss_pred             EEEeCCcc
Confidence            99998644

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.12  E-value=0.0027  Score=53.87  Aligned_cols=104  Identities=16%  Similarity=0.075  Sum_probs=67.9

Q ss_pred             CCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcc
Q 015734          158 NLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH  237 (401)
Q Consensus       158 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  237 (401)
                      ..||.+.|..+   +.++++.++|.++.|.+.+|.-+-.... . ..+=+.|..|++..+|.|...+ +.+.        
T Consensus        32 ~vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------   97 (229)
T 2yle_A           32 ALSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD--------   97 (229)
T ss_dssp             EEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred             cccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc--------
Confidence            34788988874   5689999999999999999877632111 1 1233456899999999887763 1110        


Q ss_pred             eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCC
Q 015734          238 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRA  281 (401)
Q Consensus       238 ~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p  281 (401)
                           .....+.|||... ...+.+.-|||||+++|..+--..|
T Consensus        98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                 1123467888763 4456788999999999999874443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.07  E-value=0.003  Score=59.18  Aligned_cols=142  Identities=15%  Similarity=0.156  Sum_probs=82.1

Q ss_pred             CCeeeecCcEEEEEEEEC--------CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCc-ccceeeeeecCCeeEEE
Q 015734           82 SNIIGQGGFGKVYKGVLS--------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN-LLQLIGYCTTSSERILV  152 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv  152 (401)
                      .+.|..|-...+|++...        ++..+++|+.-.  .......+.+|..+++.+.-.+ ..++++++.+    .+|
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~--~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v  128 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA--ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL  128 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC--ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence            345667888889998864        247899987532  1223556678999888775333 3556666543    289


Q ss_pred             EecccCCcHHH--------------H---hhhcCC-CCCCCC--HHHHHHHHHHHHH-------------------HHHH
Q 015734          153 YPFMQNLSVAY--------------R---LRDLKP-GEKGLD--WPTRKRVAFGTAY-------------------GLEY  193 (401)
Q Consensus       153 ~e~~~~gsL~~--------------~---l~~~~~-~~~~l~--~~~~~~i~~~i~~-------------------~l~~  193 (401)
                      +||++|.++..              .   |+.... ......  +.++.++..++..                   .+..
T Consensus       129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  208 (379)
T 3feg_A          129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN  208 (379)
T ss_dssp             EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred             EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence            99999865431              1   122111 111222  3445555443321                   2233


Q ss_pred             HH----hc-CCCCeEEeCCCCCceEEcCC----CcEEEeecCCcc
Q 015734          194 LH----EQ-CNPKIIHRDLKAANILLDDN----FEAVLCDFGLAK  229 (401)
Q Consensus       194 LH----~~-~~~~i~H~dlkp~Nill~~~----~~~kl~Dfgl~~  229 (401)
                      |.    .. ....++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            32    21 12368999999999999876    789999998875

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.86  E-value=0.0021  Score=60.03  Aligned_cols=72  Identities=11%  Similarity=0.033  Sum_probs=42.0

Q ss_pred             CeeeecCcEEEEEEEECC---------CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcc-cceeeeeecCCeeEEE
Q 015734           83 NIIGQGGFGKVYKGVLSD---------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL-LQLIGYCTTSSERILV  152 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv  152 (401)
                      +.++.|....+|++...+         +..+++|+....  .........|..++..+...++ .++++..  .  ..+|
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH--VDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT--GGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC--ccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            456778889999998654         268888876432  1111123577777777753343 3555443  2  3689


Q ss_pred             EecccCCc
Q 015734          153 YPFMQNLS  160 (401)
Q Consensus       153 ~e~~~~gs  160 (401)
                      ++|++|.+
T Consensus       113 ~e~i~G~~  120 (369)
T 3c5i_A          113 EEWLYGDP  120 (369)
T ss_dssp             EECCCSEE
T ss_pred             EEEecCCc
Confidence            99998754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.77  E-value=0.0068  Score=58.29  Aligned_cols=74  Identities=16%  Similarity=0.121  Sum_probs=46.6

Q ss_pred             CCeeeecCcEEEEEEEECC-CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcc-cceeeeeecCCeeEEEEecccCC
Q 015734           82 SNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL-LQLIGYCTTSSERILVYPFMQNL  159 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g  159 (401)
                      .+.|+.|-...+|++...+ +..+++|+..... .. .....+|..++..+...++ .++++.+.  +  ..|++|++|.
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~  186 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY  186 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence            3467788889999998754 4788888764321 11 1112578888888865555 45666653  2  2599999875


Q ss_pred             cH
Q 015734          160 SV  161 (401)
Q Consensus       160 sL  161 (401)
                      ++
T Consensus       187 ~l  188 (458)
T 2qg7_A          187 AL  188 (458)
T ss_dssp             EC
T ss_pred             cC
Confidence            43

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.62  E-value=0.015  Score=53.63  Aligned_cols=30  Identities=20%  Similarity=0.337  Sum_probs=27.0

Q ss_pred             CCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          200 PKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       200 ~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ..++|+|+.+.||+++.++.+.+.||+.+.
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~  235 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM  235 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence            479999999999999988889999998765

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.18  E-value=0.068  Score=50.68  Aligned_cols=141  Identities=11%  Similarity=0.113  Sum_probs=81.9

Q ss_pred             CCeeeecCcEEEEEEEECC--------CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcc-cceeeeeecCCeeEEE
Q 015734           82 SNIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL-LQLIGYCTTSSERILV  152 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv  152 (401)
                      .+.+..|-...+|+....+        +..+++|+.....  .......+|..+++.+...++ .++++.+.    -.+|
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I  148 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRI  148 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEE
Confidence            3466778889999998753        5789998864321  111223578888877753333 44554332    3789


Q ss_pred             EecccCCcHHH--------------H---hhhc-------CC--CCCCCCHHHHHHHHHHH-------------------
Q 015734          153 YPFMQNLSVAY--------------R---LRDL-------KP--GEKGLDWPTRKRVAFGT-------------------  187 (401)
Q Consensus       153 ~e~~~~gsL~~--------------~---l~~~-------~~--~~~~l~~~~~~~i~~~i-------------------  187 (401)
                      ++|++|.+|..              .   ++..       ..  ...+.-+..+.++..++                   
T Consensus       149 ~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l  228 (424)
T 3mes_A          149 EEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKI  228 (424)
T ss_dssp             EECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHH
T ss_pred             EEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHH
Confidence            99999865321              1   1111       10  11222244444443322                   


Q ss_pred             HHHHHHHHh---------------------cCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          188 AYGLEYLHE---------------------QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       188 ~~~l~~LH~---------------------~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ...+..|.+                     .....++|+|+.+.||+ +.++.+.++||..+.
T Consensus       229 ~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~  290 (424)
T 3mes_A          229 LEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA  290 (424)
T ss_dssp             HHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             HHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence            122333321                     11235899999999999 888899999998875

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=92.87  E-value=0.37  Score=40.74  Aligned_cols=116  Identities=10%  Similarity=0.064  Sum_probs=79.2

Q ss_pred             cCCcccceeeeeecCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCc
Q 015734          132 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN  211 (401)
Q Consensus       132 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N  211 (401)
                      .||+.++. .+..+.+.+.+.++.-+.+.-...+..       ++...+++++.+|+....++++     -+|--|.|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~-------~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS-------FTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG-------SCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh-------cCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence            57888876 455666666666666553332222443       7788999999999887766554     4788999999


Q ss_pred             eEEcCCCcEEEeecCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCC
Q 015734          212 ILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID  283 (401)
Q Consensus       212 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~  283 (401)
                      ++++.++.+++.=.|+-..                  ++|.     ..+...=.-.+=|++..+++++..|.
T Consensus       110 L~f~~~~~p~i~~RGik~~------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNV------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EEECTTSCEEESCCEETTT------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEEcCCCCEEEEEccCccC------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999986665321                  2222     11222233467889999999988774

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.16  E-value=0.99  Score=42.27  Aligned_cols=29  Identities=31%  Similarity=0.501  Sum_probs=24.6

Q ss_pred             CeEEeCCCCCceEE------cCCCcEEEeecCCcc
Q 015734          201 KIIHRDLKAANILL------DDNFEAVLCDFGLAK  229 (401)
Q Consensus       201 ~i~H~dlkp~Nill------~~~~~~kl~Dfgl~~  229 (401)
                      .++|+|+.+.||++      +++..+.++||..+.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            36799999999999      456779999998875

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=91.95  E-value=0.078  Score=32.23  Aligned_cols=17  Identities=12%  Similarity=0.231  Sum_probs=7.6

Q ss_pred             EeehhHHHHHHHHHHHH
Q 015734           15 VVASASCGAFVLLSLGA   31 (401)
Q Consensus        15 ~~~~~~~~~~~~~~~~~   31 (401)
                      |.+++++|+++++++++
T Consensus        13 IA~gVVgGv~~~~ii~~   29 (44)
T 2ks1_B           13 IATGMVGALLLLLVVAL   29 (44)
T ss_dssp             STHHHHHHHHHHHHHHH
T ss_pred             EEeehhHHHHHHHHHHH
Confidence            44444444555444443

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=91.88  E-value=0.038  Score=33.46  Aligned_cols=6  Identities=17%  Similarity=0.479  Sum_probs=2.3

Q ss_pred             HHHHHH
Q 015734           20 SCGAFV   25 (401)
Q Consensus        20 ~~~~~~   25 (401)
                      ++|+++
T Consensus        18 vVGvll   23 (44)
T 2jwa_A           18 VVGILL   23 (44)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            333333

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=91.16  E-value=0.08  Score=32.09  Aligned_cols=16  Identities=31%  Similarity=0.630  Sum_probs=7.0

Q ss_pred             EeehhHHHHHHHHHHH
Q 015734           15 VVASASCGAFVLLSLG   30 (401)
Q Consensus        15 ~~~~~~~~~~~~~~~~   30 (401)
                      |.+++++|++++++++
T Consensus        12 IA~gVVgGv~~v~ii~   27 (44)
T 2l2t_A           12 IAAGVIGGLFILVIVG   27 (44)
T ss_dssp             HHHHHHHHHHHHHHHH
T ss_pred             EEEeehHHHHHHHHHH
Confidence            3444444444444333

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=90.34  E-value=1  Score=38.15  Aligned_cols=115  Identities=13%  Similarity=0.159  Sum_probs=77.5

Q ss_pred             cCCcccceeeeeecCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEEeCCCCC
Q 015734          132 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE-YLHEQCNPKIIHRDLKAA  210 (401)
Q Consensus       132 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~~~~i~H~dlkp~  210 (401)
                      .||++  -.....+.+.+.+.++.-+++.-...+..       ++...+++++.+++.... +++     .-+|--|.|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-------~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-------TTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-------SCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-------cCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCc
Confidence            57777  33455667777777776655443334443       678899999988887666 554     3578889999


Q ss_pred             ceEEcCCCcEEEeecCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCC
Q 015734          211 NILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID  283 (401)
Q Consensus       211 Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~  283 (401)
                      |++++.++.+++.-.|+-.                  -++|..+     +..-=.-.+=|++..++.++..|+
T Consensus       114 NL~f~~~~~p~i~hRGi~~------------------~lpP~e~-----~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKE------------------SLPPDEW-----DDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             GEEECTTCCEEESCCEETT------------------TBSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             eEEEeCCCcEEEEEcCCcc------------------cCCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999998666532                  2333321     111223367788888888877664

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=86.62  E-value=0.065  Score=51.53  Aligned_cols=62  Identities=8%  Similarity=0.022  Sum_probs=18.2

Q ss_pred             CCCCeeeecCcEEEEEEEECC-CCEEEE------EEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeee
Q 015734           80 SESNIIGQGGFGKVYKGVLSD-NTKVAV------KRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCT  144 (401)
Q Consensus        80 ~~~~~lG~G~~g~V~~~~~~~-~~~vav------K~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  144 (401)
                      .+.+.||   ||.||+|.+.. ..+||+      |..+.. .+.+....+.+|..++..++|||+++.+++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            3456676   99999999754 467888      766542 23344567888999999999999999987653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	401
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-63
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-63
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-62
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	9e-62
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-61
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-60
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-60
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-60
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-59
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-59
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	8e-58
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-57
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-56
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-56
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-56
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-56
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-56
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-55
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	8e-55
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-54
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-54
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-53
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-53
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-51
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-50
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-50
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-48
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-48
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-48
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-48
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	9e-46
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-44
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-43
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-41
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-41
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-41
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-41
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-41
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	9e-41
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-40
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-40
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-40
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-40
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-39
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-39
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-39
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-39
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-38
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-38
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-36
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-36
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-35
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-34
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-33
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	9e-33
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-32
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-29
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-28
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-28
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-28
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-27
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-19

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 2e-63
 Identities = 74/277 (26%), Positives = 126/277 (45%), Gaps = 24/277 (8%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 136
           +       +G G FG+V+ G  + +TKVAVK L+         AF  E +L+    H+ L
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRL 70

Query: 137 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 196
           ++L    T      ++  +M+N S+   L+   P    L       +A   A G+ ++ E
Sbjct: 71  VRLYAVVT-QEPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 197 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST 256
           +     IHRDL+AANIL+ D     + DFGLA+L++          +  +   APE ++ 
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 257 GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 316
           G  + K+DV+ +GI L E+VT  R         E    ++ ++ +  R  R ++  +   
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----VIQNLERGYRMVRPDNCPEE-- 238

Query: 317 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                     + Q+  LC +  PEDRP    +  +L+
Sbjct: 239 ----------LYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 4e-63
 Identities = 74/282 (26%), Positives = 127/282 (45%), Gaps = 26/282 (9%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKN 135
              +    IG G FG VYKG       VAVK L     +P    AF+ EV ++    H N
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
           +L  +GY T + +  +V  + +  S+ + L  ++      +      +A  TA G++YLH
Sbjct: 66  ILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLH 121

Query: 196 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD-AKLTHVTTQIRGTMGHIAPEYL 254
            +    IIHRDLK+ NI L ++    + DFGLA +      +H   Q+ G++  +APE +
Sbjct: 122 AKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 255 STGKS---SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 311
                   S ++DV+ +GI L EL+TGQ               ++  + +      L+ +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS----NINNRDQIIFMVGRGYLSPDLSKV 234

Query: 312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                    S   + M ++   C +   ++RP   Q++  ++
Sbjct: 235 --------RSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 6e-62
 Identities = 69/277 (24%), Positives = 116/277 (41%), Gaps = 24/277 (8%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 136
           ++      +GQG FG+V+ G  +  T+VA+K L+         AF +E  ++    H+ L
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKL 74

Query: 137 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 196
           +QL    +      +V  +M   S            K L  P    +A   A G+ Y+  
Sbjct: 75  VQLYAVVSEE-PIYIVTEYMSKGS--LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131

Query: 197 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST 256
                 +HRDL+AANIL+ +N    + DFGLA+L++          +  +   APE    
Sbjct: 132 MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188

Query: 257 GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 316
           G+ + K+DV+ +GI L EL T  R      +  E    +LD + +  R     +  +   
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQVERGYRMPCPPECPES-- 242

Query: 317 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                     +  +   C +  PE+RP    +   L+
Sbjct: 243 ----------LHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 9e-62
 Identities = 71/284 (25%), Positives = 123/284 (43%), Gaps = 28/284 (9%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 136
              +    IG G FG V+ G   +  KVA+K +++      E  F  E  ++    H  L
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKL 62

Query: 137 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRKRVAFGTAYGLEYLH 195
           +QL G C   +   LV+ FM++      L D    ++GL    T   +      G+ YL 
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGC----LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118

Query: 196 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 255
           E C   +IHRDL A N L+ +N    + DFG+ + V       +T  +  +   +PE  S
Sbjct: 119 EAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175

Query: 256 TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 315
             + S K+DV+ +G+ + E+ +  +    +R   E    +++ I    R  +        
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE----VVEDISTGFRLYKPRLASTH- 230

Query: 316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAE 359
                      + Q+   C +  PEDRP  +++++ L   ++AE
Sbjct: 231 -----------VYQIMNHCWKERPEDRPAFSRLLRQL--AEIAE 261

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  196 bits (499), Expect = 9e-61
 Identities = 72/304 (23%), Positives = 126/304 (41%), Gaps = 39/304 (12%)

Query: 67  FSCRELQLATDNFSES---------NIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYY 113
           F+  +   A   F++           +IG G FG+V  G L    K    VA+K L+  Y
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 114 SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEK 173
           +      F  E  ++    H N++ L G  T S+  +++  FM+N S+   LR     + 
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDG 123

Query: 174 GLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA 233
                    +  G A G++YL +      +HRDL A NIL++ N    + DFGL++ ++ 
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 234 KLTHVTT----QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE 289
             +  T       +  +   APE +   K +  +DV+ YGI + E+++      +  +  
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP-YWDMTN 239

Query: 290 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 349
           ++   +++ I +  R     D                + Q+ L C Q     RP   Q+V
Sbjct: 240 QD---VINAIEQDYRLPPPMDCPSA------------LHQLMLDCWQKDRNHRPKFGQIV 284

Query: 350 KMLQ 353
             L 
Sbjct: 285 NTLD 288

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 1e-60
 Identities = 70/289 (24%), Positives = 128/289 (44%), Gaps = 29/289 (10%)

Query: 73  QLATDNFSESNIIGQGGFGKVYKGVLSDNT-----KVAVKRLQDYYSPGGEAAFQREVHL 127
           ++     +   +IG G FG+VYKG+L  ++      VA+K L+  Y+      F  E  +
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62

Query: 128 ISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGT 187
           +    H N+++L G  +     +++  +M+N ++   LR+    +          +  G 
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGI 119

Query: 188 AYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIRGT 245
           A G++YL    N   +HRDL A NIL++ N    + DFGL++++  D + T+ T+  +  
Sbjct: 120 AAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176

Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 305
           +   APE +S  K +  +DV+ +GI + E++T      +     E    ++  I    R 
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----VMKAINDGFRL 232

Query: 306 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 354
               D                + Q+ + C Q     RP  A +V +L  
Sbjct: 233 PTPMDCPSA------------IYQLMMQCWQQERARRPKFADIVSILDK 269

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 3e-60
 Identities = 63/306 (20%), Positives = 113/306 (36%), Gaps = 36/306 (11%)

Query: 72  LQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISV 130
           ++L  D+F + + +G G  G V+K         +A K +     P       RE+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 131 AIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG 190
                ++   G   +  E  +    M   S    L  +      +      +V+     G
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGS----LDQVLKKAGRIPEQILGKVSIAVIKG 116

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
           L YL E+   KI+HRD+K +NIL++   E  LCDFG++  +      +     GT  +++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMS 171

Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 310
           PE L     S ++D++  G++L+E+  G+  I     +E E +                 
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231

Query: 311 IVDRNLNTYDSKEVETMVQVALL--------------------------CTQSTPEDRPP 344
              R L++Y       M    LL                          C    P +R  
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291

Query: 345 MAQVVK 350
           + Q++ 
Sbjct: 292 LKQLMV 297

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  195 bits (495), Expect = 5e-60
 Identities = 71/310 (22%), Positives = 123/310 (39%), Gaps = 46/310 (14%)

Query: 71  ELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQRE 124
            L+   +N      IG+G FG+V++            T VAVK L++  S   +A FQRE
Sbjct: 7   SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 66

Query: 125 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLK--------------- 169
             L++   + N+++L+G C       L++ +M    +   LR +                
Sbjct: 67  AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126

Query: 170 -----PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD 224
                PG   L    +  +A   A G+ YL E+   K +HRDL   N L+ +N    + D
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIAD 183

Query: 225 FGLAKLV-DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAID 283
           FGL++ +  A            +  + PE +   + + ++DV+ YG+ L E+ +      
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243

Query: 284 FSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP 343
           +    EE                 +  + D N+          +  +  LC    P DRP
Sbjct: 244 YGMAHEE----------------VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRP 287

Query: 344 PMAQVVKMLQ 353
               + ++LQ
Sbjct: 288 SFCSIHRILQ 297

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 3e-59
 Identities = 58/277 (20%), Positives = 108/277 (38%), Gaps = 24/277 (8%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 136
            + +    +G G FG V  G       VA+K +++      E  F  E  ++    H+ L
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKL 61

Query: 137 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 196
           +QL G CT      ++  +M N  +   L  L+             +       +EYL  
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCL---LNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118

Query: 197 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLST 256
           +     +HRDL A N L++D     + DFGL++ V       +   +  +    PE L  
Sbjct: 119 KQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175

Query: 257 GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNL 316
            K S K+D++ +G+ + E+ +  +   + R    E     +HI + LR  R +   ++  
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMP-YERFTNSE---TAEHIAQGLRLYRPHLASEK-- 229

Query: 317 NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                     +  +   C     ++RP    ++  + 
Sbjct: 230 ----------VYTIMYSCWHEKADERPTFKILLSNIL 256

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 6e-59
 Identities = 64/290 (22%), Positives = 121/290 (41%), Gaps = 29/290 (10%)

Query: 70  RELQLATDNFSESNI-IGQGGFGKVYKGVL---SDNTKVAVKRLQDYYSPGGEAAFQREV 125
           ++L L  DN   ++I +G G FG V +GV         VA+K L+            RE 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 126 HLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAF 185
            ++    +  +++LIG C      +LV        +   L   +   + +       +  
Sbjct: 61  QIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLH 116

Query: 186 GTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV--DAKLTHVTTQIR 243
             + G++YL E+     +HRDL A N+LL +   A + DFGL+K +  D       +  +
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173

Query: 244 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 303
             +   APE ++  K S ++DV+ YG+T+ E ++  +   + +++  E   ++  I +  
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP-YKKMKGPE---VMAFIEQGK 229

Query: 304 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
           R +   +                +  +   C     EDRP    V + ++
Sbjct: 230 RMECPPECPPE------------LYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 8e-58
 Identities = 78/285 (27%), Positives = 120/285 (42%), Gaps = 34/285 (11%)

Query: 78  NFSESNIIGQGGFGKVYKGVLSDNTK----VAVKRLQDYYSPGGEAAFQREVHLISVAIH 133
           +F+E  +IG+G FG VY G L DN       AVK L      G  + F  E  ++    H
Sbjct: 30  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 134 KNLLQLIGYCT-TSSERILVYPFMQNLSVAYRLRDLKPGEKG-LDWPTRKRVAFGTAYGL 191
            N+L L+G C  +    ++V P+M++      LR+    E                A G+
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGD----LRNFIRNETHNPTVKDLIGFGLQVAKGM 143

Query: 192 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV---DAKLTHVTTQIRGTMGH 248
                  + K +HRDL A N +LD+ F   + DFGLA+ +   +    H  T  +  +  
Sbjct: 144 ---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200

Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 308
           +A E L T K + K+DV+ +G+ L EL+T              DV   D    LL+  RL
Sbjct: 201 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-------PDVNTFDITVYLLQGRRL 253

Query: 309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                           + + +V L C     E RP  +++V  + 
Sbjct: 254 LQ---------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  187 bits (475), Expect = 3e-57
 Identities = 71/306 (23%), Positives = 134/306 (43%), Gaps = 26/306 (8%)

Query: 65  RRFSCRELQLATDNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDYYSPGGEAAFQR 123
              +  + ++   + +  + +G G +G+VY+GV    +  VAVK L++         F +
Sbjct: 5   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLK 62

Query: 124 EVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRV 183
           E  ++    H NL+QL+G CT      ++  FM   ++   LR+    E  +       +
Sbjct: 63  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYM 120

Query: 184 AFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIR 243
           A   +  +EYL +      IHRDL A N L+ +N    + DFGL++L+           +
Sbjct: 121 ATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177

Query: 244 GTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL 303
             +   APE L+  K S K+DV+ +G+ L E+ T   +        +    + + + K  
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYELLEKDY 233

Query: 304 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAE 363
           R +R     ++            + ++   C Q  P DRP  A++ +    E + +  + 
Sbjct: 234 RMERPEGCPEK------------VYELMRACWQWNPSDRPSFAEIHQAF--ETMFQESSI 279

Query: 364 WEELEE 369
            +E+E+
Sbjct: 280 SDEVEK 285

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 1e-56
 Identities = 67/301 (22%), Positives = 115/301 (38%), Gaps = 40/301 (13%)

Query: 77  DNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLIS- 129
           +  S    +G G FGKV +              VAVK L+         A   E+ ++S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRD--------------LKPGEKGL 175
           +  H N++ L+G CT     +++  +     +   LR               ++  E  L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 176 DWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 235
           D       ++  A G+ +L  +     IHRDL A NILL       +CDFGLA+ +    
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 236 TH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 294
            + V    R  +  +APE +     + ++DV+ YGI L EL +   +       + +   
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256

Query: 295 LLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG 354
               I++  R                      M  +   C  + P  RP   Q+V++++ 
Sbjct: 257 FYKMIKEGFRML------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

Query: 355 E 355
           +
Sbjct: 305 Q 305

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 1e-56
 Identities = 67/293 (22%), Positives = 124/293 (42%), Gaps = 37/293 (12%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSDN---TKVAVKRLQDYYSPGGEAAFQREVHLIS-VAI 132
           ++    ++IG+G FG+V K  +  +      A+KR+++Y S      F  E+ ++  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 133 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGE------------KGLDWPTR 180
           H N++ L+G C       L   +  + ++   LR  +  E              L     
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 181 KRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTT 240
              A   A G++YL +    + IHRDL A NIL+ +N+ A + DFGL++  +  +    T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184

Query: 241 QIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 300
             R  +  +A E L+    +  +DV+ YG+ L E+V+            E    L + + 
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----LYEKLP 240

Query: 301 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
           +  R ++  +  D             +  +   C +  P +RP  AQ++  L 
Sbjct: 241 QGYRLEKPLNCDDE------------VYDLMRQCWREKPYERPSFAQILVSLN 281

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 1e-56
 Identities = 66/278 (23%), Positives = 108/278 (38%), Gaps = 30/278 (10%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL 136
                   IG+G FG V  G      KVAVK +++        AF  E  +++   H NL
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNL 62

Query: 137 LQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
           +QL+G        + +V  +M   S+   LR    G   L      + +      +EYL 
Sbjct: 63  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLE 120

Query: 196 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 255
                  +HRDL A N+L+ ++  A + DFGL K   +         +  +   APE L 
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG----KLPVKWTAPEALR 173

Query: 256 TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 315
             K S K+DV+ +GI L E+ +  R        ++    ++  + K  + D  +      
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRVEKGYKMDAPDGCPPA- 228

Query: 316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                      + +V   C       RP   Q+ + L+
Sbjct: 229 -----------VYEVMKNCWHLDAAMRPSFLQLREQLE 255

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 3e-56
 Identities = 65/306 (21%), Positives = 117/306 (38%), Gaps = 45/306 (14%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTK------VAVKRLQDYYSPGGEAAFQREVHLIS- 129
           +N     ++G G FGKV        +K      VAVK L++        A   E+ +++ 
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 130 VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKP------------------- 170
           +  H+N++ L+G CT S    L++ +     +   LR  +                    
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 171 GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL 230
               L +      A+  A G+E+L  +     +HRDL A N+L+       +CDFGLA+ 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 231 VDAKLTHVT-TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEE 289
           + +   +V     R  +  +APE L  G  + K+DV+ YGI L E+ +      +  +  
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-YPGIPV 272

Query: 290 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVV 349
           + +      I+   + D+     +             +  +   C       RP    + 
Sbjct: 273 DAN--FYKLIQNGFKMDQPFYATEE------------IYIIMQSCWAFDSRKRPSFPNLT 318

Query: 350 KMLQGE 355
             L  +
Sbjct: 319 SFLGCQ 324

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 5e-56
 Identities = 63/291 (21%), Positives = 114/291 (39%), Gaps = 30/291 (10%)

Query: 85  IGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT 144
           IG+G FG+V++G      +VAVK              + E++   +  H+N+L  I    
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSS--REERSWFREAEIYQTVMLRHENILGFIAADN 67

Query: 145 ----TSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC-- 198
               T ++  LV  + ++ S+   L         +      ++A  TA GL +LH +   
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVG 122

Query: 199 ---NPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK---LTHVTTQIRGTMGHIAPE 252
               P I HRDLK+ NIL+  N    + D GLA   D+    +        GT  ++APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182

Query: 253 YLST------GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE--EDVLLLDHIRKLLR 304
            L         +S ++ D++  G+   E+             +    D++  D   + +R
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242

Query: 305 EDRLNDIVDRNL--NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
           +      +  N+       + +  M ++   C  +    R    ++ K L 
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 3e-55
 Identities = 55/280 (19%), Positives = 106/280 (37%), Gaps = 24/280 (8%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 134
           +++     IG G +G+  K    SD   +  K L     +   +     EV+L+    H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 135 NLLQLIGYCTTSSERIL--VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 192
           N+++        +   L  V  + +   +A  +       + LD     RV       L+
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 193 YLHEQ--CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
             H +      ++HRDLK AN+ LD      L DFGLA++++   T       GT  +++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMS 182

Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 310
           PE ++    +EK+D++  G  L EL        F+   ++E                   
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPP--FTAFSQKE---------------LAGK 225

Query: 311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
           I +        +  + + ++           RP + ++++
Sbjct: 226 IREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 8e-55
 Identities = 57/275 (20%), Positives = 107/275 (38%), Gaps = 31/275 (11%)

Query: 83  NIIGQGGFGKVYKGVLSD-NTKVAVKRLQD-YYSPGGEAAFQREVHLISVAIHKNLLQLI 140
             IG+G F  VYKG+ ++   +VA   LQD   +      F+ E  ++    H N+++  
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 141 GYCTTSSER----ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 196
               ++ +     +LV   M + +    L+      K +     +        GL++LH 
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGT----LKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 197 QCNPKIIHRDLKAANILLDD-NFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 255
           +  P IIHRDLK  NI +        + D GLA L           + GT   +APE   
Sbjct: 131 R-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMYE 186

Query: 256 TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN 315
             K  E  DV+ +G+ +LE+ T +        E +    +   +   ++    + +    
Sbjct: 187 -EKYDESVDVYAFGMCMLEMATSEYPYS----ECQNAAQIYRRVTSGVKPASFDKVAIPE 241

Query: 316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
           +            ++   C +   ++R  +  ++ 
Sbjct: 242 V-----------KEIIEGCIRQNKDERYSIKDLLN 265

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 1e-54
 Identities = 56/277 (20%), Positives = 107/277 (38%), Gaps = 25/277 (9%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           +++     +G+G +G+V   V       VAVK +    +       ++E+ +  +  H+N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
           +++  G+    + + L   +     +  R+      + G+  P  +R       G+ YLH
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLH 120

Query: 196 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA-KLTHVTTQIRGTMGHIAPEYL 254
                 I HRD+K  N+LLD+     + DFGLA +        +  ++ GT+ ++APE L
Sbjct: 121 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177

Query: 255 STGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 313
              +  +E  DV+  GI L  ++ G+   D      +      D   K    +    I  
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQ---PSDSCQEYSDWKEKKTYLNPWKKI-- 232

Query: 314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
                        ++          P  R  +  + K
Sbjct: 233 -------DSAPLALLH---KILVENPSARITIPDIKK 259

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 2e-54
 Identities = 64/279 (22%), Positives = 109/279 (39%), Gaps = 30/279 (10%)

Query: 81  ESNIIGQGGFGKVYKGVLSD---NTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKNL 136
           E   +G G FG V KG          VAVK L+ +   P  +     E +++    +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 137 LQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE 196
           +++IG C   S  +LV    +       L       + +       +    + G++YL E
Sbjct: 71  VRMIGICEAES-WMLVMEMAELGP----LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 125

Query: 197 QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQ--IRGTMGHIAPEYL 254
                 +HRDL A N+LL     A + DFGL+K + A   +   Q   +  +   APE +
Sbjct: 126 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182

Query: 255 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 314
           +  K S K+DV+ +G+ + E  +  +   +  ++  E   +   + K  R          
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSE---VTAMLEKGERMGCPAGCPRE 238

Query: 315 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                       M  +  LC     E+RP  A V   L+
Sbjct: 239 ------------MYDLMNLCWTYDVENRPGFAAVELRLR 265

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (446), Expect = 3e-53
 Identities = 63/277 (22%), Positives = 108/277 (38%), Gaps = 31/277 (11%)

Query: 77  DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIH 133
           ++F     +G+G FG VY          +A+K L        G E   +REV + S   H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
            N+L+L GY   ++   L+  +    +V   L+ L       D           A  L Y
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSY 121

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
            H +   ++IHRD+K  N+LL    E  + DFG +    +        + GT+ ++ PE 
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEM 175

Query: 254 LSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 313
           +      EK D++  G+   E + G+   + +  +E         I ++  E    D V 
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-----TYKRISRV--EFTFPDFVT 228

Query: 314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
                      E    +     +  P  RP + +V++
Sbjct: 229 -----------EGARDLISRLLKHNPSQRPMLREVLE 254

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 6e-53
 Identities = 63/298 (21%), Positives = 128/298 (42%), Gaps = 32/298 (10%)

Query: 71  ELQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQRE 124
           E ++A +  + S  +GQG FG VY+GV          T+VA+K + +  S      F  E
Sbjct: 14  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73

Query: 125 VHLISVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG------LDWP 178
             ++      ++++L+G  +     +++   M    +   LR L+P              
Sbjct: 74  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133

Query: 179 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV-DAKLTH 237
              ++A   A G+ YL+     K +HRDL A N ++ ++F   + DFG+ + + +     
Sbjct: 134 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190

Query: 238 VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD 297
              +    +  ++PE L  G  +  +DV+ +G+ L E+ T      +  L  E+   +L 
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQ---VLR 246

Query: 298 HIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE 355
            + +    D+ ++  D             + ++  +C Q  P+ RP   +++  ++ E
Sbjct: 247 FVMEGGLLDKPDNCPDM------------LFELMRMCWQYNPKMRPSFLEIISSIKEE 292

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 3e-51
 Identities = 57/283 (20%), Positives = 116/283 (40%), Gaps = 29/283 (10%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSDN-----TKVAVKRLQDYYSPGGEAAFQREVHLISVA 131
             F +  ++G G FG VYKG+           VA+K L++  SP        E ++++  
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 132 IHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGL 191
            + ++ +L+G C TS+ +++             L  ++  +  +            A G+
Sbjct: 69  DNPHVCRLLGICLTSTVQLITQLMPFG----CLLDYVREHKDNIGSQYLLNWCVQIAKGM 124

Query: 192 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA-KLTHVTTQIRGTMGHIA 250
            YL ++   +++HRDL A N+L+       + DFGLAKL+ A +  +     +  +  +A
Sbjct: 125 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181

Query: 251 PEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND 310
            E +     + ++DV+ YG+T+ EL+T      +  +   E   +   + K  R  +   
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP-YDGIPASE---ISSILEKGERLPQPPI 237

Query: 311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                           +  + + C     + RP   +++    
Sbjct: 238 CTID------------VYMIMVKCWMIDADSRPKFRELIIEFS 268

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  170 bits (432), Expect = 1e-50
 Identities = 72/281 (25%), Positives = 101/281 (35%), Gaps = 34/281 (12%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAI 132
              FS+   IG G FG VY    + ++  VA+K++      S        +EV  +    
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 133 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 192
           H N +Q  G         LV  +    +        KP    L       V  G   GL 
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLA 129

Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 252
           YLH      +IHRD+KA NILL +     L DFG A ++            GT   +APE
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPE 181

Query: 253 YLST---GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 309
            +     G+   K DV+  GIT +EL   +       L     +  L HI +       +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPP-----LFNMNAMSALYHIAQNESPALQS 236

Query: 310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
                          E        C Q  P+DRP    ++K
Sbjct: 237 GHWS-----------EYFRNFVDSCLQKIPQDRPTSEVLLK 266

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 4e-50
 Identities = 73/286 (25%), Positives = 107/286 (37%), Gaps = 32/286 (11%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTK----VAVKRL--QDYYSPGGEAAFQREVHLISV 130
            +      +G G FG V +G     +     VAVK L       P     F REV+ +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 131 AIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG-LDWPTRKRVAFGTAY 189
             H+NL++L G   T   ++ V       S    L D     +G     T  R A   A 
Sbjct: 68  LDHRNLIRLYGVVLTPPMKM-VTELAPLGS----LLDRLRKHQGHFLLGTLSRYAVQVAE 122

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH--VTTQIRGTMG 247
           G+ YL  +     IHRDL A N+LL       + DFGL + +     H  +    +    
Sbjct: 123 GMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179

Query: 248 HIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR 307
             APE L T   S  +D + +G+TL E+ T  +   +  L   +  +L    ++  R  R
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-WIGLNGSQ--ILHKIDKEGERLPR 236

Query: 308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
             D                +  V + C    PEDRP    +   L 
Sbjct: 237 PEDCPQD------------IYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 1e-48
 Identities = 54/282 (19%), Positives = 109/282 (38%), Gaps = 29/282 (10%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAI 132
           +       IG+G FG V++G+          VA+K  ++  S      F +E   +    
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 133 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKG-LDWPTRKRVAFGTAYGL 191
           H ++++LIG  T  +   ++            LR      K  LD  +    A+  +  L
Sbjct: 67  HPHIVKLIGVIT-ENPVWIIMELCTLGE----LRSFLQVRKYSLDLASLILYAYQLSTAL 121

Query: 192 EYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAP 251
            YL  +   + +HRD+ A N+L+  N    L DFGL++ ++    +  ++ +  +  +AP
Sbjct: 122 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 252 EYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI 311
           E ++  + +  +DV+ +G+ + E++             +    ++  I    R     + 
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIGRIENGERLPMPPNC 234

Query: 312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
                         T+  +   C    P  RP   ++   L 
Sbjct: 235 ------------PPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 3e-48
 Identities = 63/281 (22%), Positives = 111/281 (39%), Gaps = 29/281 (10%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 134
            D +     +G G FGKVYK      +   A K + D  S      +  E+ +++   H 
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI-DTKSEEELEDYMVEIDILASCDHP 69

Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           N+++L+      +   ++  F    +V   + +L+   + L     + V   T   L YL
Sbjct: 70  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYL 126

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 254
           H+    KIIHRDLKA NIL   + +  L DFG++      +    +   GT   +APE +
Sbjct: 127 HDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVV 182

Query: 255 STGKS-----SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 309
               S       K DV+  GITL+E+   +       L           + K+ + +   
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPP--HHELNPMR------VLLKIAKSEPPT 234

Query: 310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
                      S   +  ++    C +   + R   +Q+++
Sbjct: 235 LAQPSRW----SSNFKDFLK---KCLEKNVDARWTTSQLLQ 268

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 4e-48
 Identities = 69/299 (23%), Positives = 123/299 (41%), Gaps = 41/299 (13%)

Query: 77  DNFSESNIIGQGGFGKVYKGVL--------SDNTKVAVKRLQDYYSPGGEAAFQREVHLI 128
           D       +G+G FG+V             +  TKVAVK L+   +    +    E+ ++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 129 S-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPG------------EKGL 175
             +  HKN++ L+G CT      ++  +    ++   L+  +P             E+ L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 176 DWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL 235
                   A+  A G+EYL      K IHRDL A N+L+ ++    + DFGLA+ +    
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 236 THVTTQ-IRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVL 294
            +  T   R  +  +APE L     + ++DV+ +G+ L E+ T   +       EE    
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 245

Query: 295 LLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
           L   +++  R D+ ++  +             +  +   C  + P  RP   Q+V+ L 
Sbjct: 246 LFKLLKEGHRMDKPSNCTNE------------LYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 6e-48
 Identities = 70/298 (23%), Positives = 123/298 (41%), Gaps = 39/298 (13%)

Query: 77  DNFSESNIIGQGGFGKVYKGV------LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISV 130
           D       +G+G FG+V +         +    VAVK L++  +     A   E+ ++  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 131 AIH-KNLLQLIGYCTTSSERI-LVYPFMQNLSVAYRLRDLKP------------GEKGLD 176
             H  N++ L+G CT     + ++  F +  +++  LR  +              +  L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 177 WPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT 236
                  +F  A G+E+L  +   K IHRDL A NILL +     +CDFGLA+ +     
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 237 HV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL 295
           +V     R  +  +APE +     + ++DV+ +G+ L E+ +   +           V +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-------PGVKI 242

Query: 296 LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
            +   + L+E       D     Y + E   M Q  L C    P  RP  +++V+ L 
Sbjct: 243 DEEFCRRLKEGTRMRAPD-----YTTPE---MYQTMLDCWHGEPSQRPTFSELVEHLG 292

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 9e-46
 Identities = 52/276 (18%), Positives = 108/276 (39%), Gaps = 26/276 (9%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 134
              ++    IGQG  G VY  + ++   +VA++++ +      +     E+ ++    + 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNP 77

Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           N++  +       E  +V  ++   S+   +      E  +D      V       LE+L
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFL 132

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 254
           H     ++IHRD+K+ NILL  +    L DFG    +  + +  +T + GT   +APE +
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVV 188

Query: 255 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 314
           +      K D++  GI  +E++ G+             ++  +   +L   ++L      
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL------ 242

Query: 315 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
                 S      +     C     E R    ++++
Sbjct: 243 ------SAIFRDFLN---RCLDMDVEKRGSAKELLQ 269

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 1e-44
 Identities = 60/300 (20%), Positives = 107/300 (35%), Gaps = 34/300 (11%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIH 133
           ++F    I+G+G F  V     L+ + + A+K L  +            RE  ++S   H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
              ++L        +      + +N      L          D    +         LEY
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALEY 123

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPE 252
           LH +    IIHRDLK  NILL+++    + DFG AK++  +          GT  +++PE
Sbjct: 124 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180

Query: 253 YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 312
            L+   + + +D++  G  + +LV G             + L+   I KL          
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPP-----FRAGNEYLIFQKIIKL---------- 225

Query: 313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERW---AEWEELEE 369
           + +       +   +V+            R    ++     G   A  +     WE L +
Sbjct: 226 EYDFPEKFFPKARDLVE---KLLVLDATKRLGCEEMEGY--GPLKAHPFFESVTWENLHQ 280

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  152 bits (386), Expect = 1e-43
 Identities = 56/277 (20%), Positives = 104/277 (37%), Gaps = 26/277 (9%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           D++     +G G FG V++    +     A K +        +   ++E+  +SV  H  
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPT 84

Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
           L+ L       +E +++Y FM    +  ++ D       +              GL ++H
Sbjct: 85  LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMH 141

Query: 196 EQCNPKIIHRDLKAANILL--DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           E      +H DLK  NI+     + E  L DFGL   +D K +   T   GT    APE 
Sbjct: 142 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEV 196

Query: 254 LSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 313
                    TD++  G+    L++G           E D   L +++           +D
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSP-----FGGENDDETLRNVKSCDWN------MD 245

Query: 314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
            +  +  S++ +  ++       + P  R  + Q ++
Sbjct: 246 DSAFSGISEDGKDFIR---KLLLADPNTRMTIHQALE 279

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 2e-41
 Identities = 66/305 (21%), Positives = 115/305 (37%), Gaps = 36/305 (11%)

Query: 68  SCRELQLATDNFSESNIIGQGGFGKVYKG--VLSDNTKVAVKRL-QDYYSPGGEAAFQRE 124
            CR    A   +     IG+G +GKV+K   + +    VA+KR+       G   +  RE
Sbjct: 2   LCR----ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE 57

Query: 125 VHL---ISVAIHKNLLQLIGYCTTSS--ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPT 179
           V +   +    H N+++L   CT S       +    +++         K  E G+   T
Sbjct: 58  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 117

Query: 180 RKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT 239
            K + F    GL++LH     +++HRDLK  NIL+  + +  L DFGLA++   ++    
Sbjct: 118 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-- 172

Query: 240 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI 299
           T +  T+ + APE L     +   D++  G    E+   +            DV  L  I
Sbjct: 173 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL-----FRGSSDVDQLGKI 227

Query: 300 RKLLR--------------EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPM 345
             ++                   +    + +  + +   E    + L C    P  R   
Sbjct: 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287

Query: 346 AQVVK 350
              + 
Sbjct: 288 YSALS 292

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  145 bits (366), Expect = 2e-41
 Identities = 58/290 (20%), Positives = 110/290 (37%), Gaps = 39/290 (13%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--------QDYYSPGGEAAFQREVHL 127
           +N+    I+G+G    V + +      + AVK +                  A  +EV +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 128 IS-VAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFG 186
           +  V+ H N++QL     T++   LV+  M+   +   L +    +  L     +++   
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRA 118

Query: 187 TAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
               +  LH+     I+HRDLK  NILLDD+    L DFG +  +D        ++ GT 
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTP 173

Query: 247 GHIAPEYLSTG------KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR 300
            ++APE +            ++ D++  G+ +  L+ G            + +L+L  I 
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-----FWHRKQMLMLRMIM 228

Query: 301 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
                 +       +     S  V+ +V          P+ R    + + 
Sbjct: 229 S--GNYQFGSPEWDDY----SDTVKDLVS---RFLVVQPQKRYTAEEALA 269

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  145 bits (368), Expect = 2e-41
 Identities = 62/310 (20%), Positives = 125/310 (40%), Gaps = 29/310 (9%)

Query: 70  RELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLI 128
           ++ +   D +   +++G G F +V           VA+K +      G E + + E+ ++
Sbjct: 2   KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61

Query: 129 SVAIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 188
               H N++ L     +     L+   +    +  R+ +              R+ F   
Sbjct: 62  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF----YTERDASRLIFQVL 117

Query: 189 YGLEYLHEQCNPKIIHRDLKAANILL---DDNFEAVLCDFGLAKLVDAKLTHVTTQIRGT 245
             ++YLH+     I+HRDLK  N+L    D++ + ++ DFGL+K+ D     V +   GT
Sbjct: 118 DAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGT 172

Query: 246 MGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE 305
            G++APE L+    S+  D +  G+    L+ G          +E D  L + I K   E
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP-----FYDENDAKLFEQILK--AE 225

Query: 306 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM--LQGEDLAERWAE 363
              +     ++    S   +  ++      +  PE R    Q ++   + G+   ++   
Sbjct: 226 YEFDSPYWDDI----SDSAKDFIR---HLMEKDPEKRFTCEQALQHPWIAGDTALDKNIH 278

Query: 364 WEELEEVRQQ 373
               E++++ 
Sbjct: 279 QSVSEQIKKN 288

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  147 bits (371), Expect = 3e-41
 Identities = 50/277 (18%), Positives = 99/277 (35%), Gaps = 26/277 (9%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           D +     +G G FG V++ V  +       K +     P  +   + E+ +++   H  
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-YPLDKYTVKNEISIMNQLHHPK 87

Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
           L+ L        E +L+  F+    +  R+         +              GL+++H
Sbjct: 88  LINLHDAFEDKYEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMH 144

Query: 196 EQCNPKIIHRDLKAANILLD--DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           E     I+H D+K  NI+ +        + DFGLA  ++     +      T    APE 
Sbjct: 145 EH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTTATAEFAAPEI 199

Query: 254 LSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 313
           +        TD++  G+    L++G     F+  ++ E +  +        ED  + +  
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSP--FAGEDDLETLQNVKRCDWEFDEDAFSSV-- 255

Query: 314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
                  S E +  ++      Q  P  R  +   ++
Sbjct: 256 -------SPEAKDFIK---NLLQKEPRKRLTVHDALE 282

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  145 bits (365), Expect = 4e-41
 Identities = 61/288 (21%), Positives = 116/288 (40%), Gaps = 23/288 (7%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHKN 135
           + +     IG+G +G VYK   +     A+K+++ +    G  +   RE+ ++    H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
           +++L     T    +LV+  +         + L   E GL+  T K        G+ Y H
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 196 EQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLS 255
           ++   +++HRDLK  N+L++   E  + DFGLA+     +   T +I           + 
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 256 TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV--- 312
           + K S   D++  G    E+V G     F  + E + ++ +  I          ++    
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPL--FPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232

Query: 313 --DRNLNTYDSKEVETMVQ------VALL--CTQSTPEDRPPMAQVVK 350
             D N   Y+    E+ ++      + LL    +  P  R    Q ++
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  146 bits (368), Expect = 9e-41
 Identities = 63/278 (22%), Positives = 108/278 (38%), Gaps = 32/278 (11%)

Query: 77  DNFSESNIIGQGGFGKVYKGVLSD-NTKVAVKRL--QDYYSPGGEAAFQREVHLISV--- 130
           ++FS   IIG+GGFG+VY    +D     A+K L  +      GE     E  ++S+   
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 131 AIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG 190
                ++ +     T  +   +   M    + Y L               +  A     G
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF----SEADMRFYAAEIILG 119

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIA 250
           LE++H +    +++RDLK ANILLD++    + D GLA     K  H +    GT G++A
Sbjct: 120 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMA 173

Query: 251 PEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN 309
           PE L  G +     D F  G  L +L+ G       + +++ ++  +     +   D   
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF- 232

Query: 310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQ 347
                      S E+ ++++      Q     R     
Sbjct: 233 -----------SPELRSLLE---GLLQRDVNRRLGCLG 256

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 1e-40
 Identities = 58/287 (20%), Positives = 103/287 (35%), Gaps = 19/287 (6%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 134
           +NF +   IG+G +G VYK         VA+K+++ D  + G  +   RE+ L+    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           N+++L+    T ++  LV+ F+      +          G+  P  K   F    GL + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL---TGIPLPLIKSYLFQLLQGLAFC 118

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 254
           H      ++HRDLK  N+L++      L DFGLA+     +   T ++           L
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175

Query: 255 STGKSSEKTDVFGYGITLLELVTGQRAID-----------FSRLEEEEDVLLLDHIRKLL 303
                S   D++  G    E+VT +               F  L   ++V+         
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235

Query: 304 REDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
            +        ++ +       E    +        P  R      + 
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  143 bits (362), Expect = 2e-40
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 14/207 (6%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIH 133
            +F     +G G FG+V+      +    A+K L  +             E  ++S+  H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
             ++++ G    + +  ++  +++       L  L    +    P  K  A      LEY
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH +    II+RDLK  NILLD N    + DFG AK V      VT  + GT  +IAPE 
Sbjct: 120 LHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEV 172

Query: 254 LSTGKSSEKTDVFGYGITLLELVTGQR 280
           +ST   ++  D + +GI + E++ G  
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 3e-40
 Identities = 75/324 (23%), Positives = 124/324 (38%), Gaps = 41/324 (12%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAI- 132
           ++F    ++G+G FGKV+       N   A+K L                E  ++S+A  
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 133 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 192
           H  L  +     T      V  ++    + Y ++         D       A     GL+
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQ 117

Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 252
           +LH +    I++RDLK  NILLD +    + DFG+ K          T   GT  +IAPE
Sbjct: 118 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPE 173

Query: 253 YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 312
            L   K +   D + +G+ L E++ GQ    F   +EEE   L   IR            
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSP--FHGQDEEE---LFHSIRM----------D 218

Query: 313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM---LQGEDLAERWAEWEELEE 369
           +     +  KE + ++          PE R  +   ++     +  +       WEELE 
Sbjct: 219 NPFYPRWLEKEAKDLLV---KLFVREPEKRLGVRGDIRQHPLFREIN-------WEELER 268

Query: 370 VRQQEVSLLPHQFAWGEDSSIDQE 393
            ++ +    P   +  + S+ D+E
Sbjct: 269 -KEIDPPFRPKVKSPFDCSNFDKE 291

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 8e-40
 Identities = 53/326 (16%), Positives = 118/326 (36%), Gaps = 36/326 (11%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
           + +  +  +G+G FG V++ V  S       K ++       +   ++E+ ++++A H+N
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHRN 62

Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
           +L L     +  E ++++ F+  L +  R+         L+              L++LH
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLH 119

Query: 196 EQCNPKIIHRDLKAANILLDDNFEAV--LCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
                 I H D++  NI+      +   + +FG A+ +          +     + APE 
Sbjct: 120 SH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--GDNFRLLFTAPEYYAPEV 174

Query: 254 LSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 313
                 S  TD++  G  +  L++G     F     ++ +  + +      E+   +I  
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINP--FLAETNQQIIENIMNAEYTFDEEAFKEI-- 230

Query: 314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAERWAEWEELEEVRQQ 373
                  S E    V           + R   ++         L   W + +++E V  +
Sbjct: 231 -------SIEAMDFVD---RLLVKERKSRMTASEA--------LQHPWLK-QKIERVSTK 271

Query: 374 EVSLLPHQFAWGEDSSIDQEAIQLSN 399
            +  L H+  +      D   +  + 
Sbjct: 272 VIRTLKHRRYYHTLIKKDLNMVVSAA 297

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  140 bits (353), Expect = 2e-39
 Identities = 57/284 (20%), Positives = 109/284 (38%), Gaps = 30/284 (10%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAI 132
           +D +    I+G GG  +V+    L  +  VAVK L       P     F+RE    +   
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 133 HKNLLQLIGYCTTSSERI----LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 188
           H  ++ +       +       +V  ++  +++   +    P    +       V     
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADAC 121

Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHV--TTQIRGTM 246
             L + H+     IIHRD+K ANI++       + DFG+A+ +      V  T  + GT 
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 306
            +++PE         ++DV+  G  L E++TG+         +    +   H+R+     
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT----GDSPVSVAYQHVRE----- 229

Query: 307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
             + I     +   S +++ +V          PE+R   A  ++
Sbjct: 230 --DPIPPSARHEGLSADLDAVVL---KALAKNPENRYQTAAEMR 268

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  140 bits (353), Expect = 3e-39
 Identities = 50/294 (17%), Positives = 93/294 (31%), Gaps = 32/294 (10%)

Query: 71  ELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS 129
           EL++  + +     IG G FG +Y G  ++   +VA+K                E  +  
Sbjct: 2   ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC---VKTKHPQLHIESKIYK 57

Query: 130 VAIHKNLLQLIGYCTTSSER-ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 188
           +      +  I +C    +  ++V   +            +         T   +A    
Sbjct: 58  MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMI 113

Query: 189 YGLEYLHEQCNPKIIHRDLKAANIL---LDDNFEAVLCDFGLAKLVDAKLTHV------T 239
             +EY+H +     IHRD+K  N L           + DFGLAK      TH        
Sbjct: 114 SRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170

Query: 240 TQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHI 299
             + GT  + +       + S + D+   G  L+    G       +   +         
Sbjct: 171 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230

Query: 300 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ 353
           +K+             L      E  T +     C     +D+P  + + ++ +
Sbjct: 231 KKM-------STPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 4e-39
 Identities = 53/295 (17%), Positives = 110/295 (37%), Gaps = 27/295 (9%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHK 134
              ++  + IG+G +G V       +  +VA+K++  +          RE+ ++    H+
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           N++ +       +   +   ++    +   L  L    + L         +    GL+Y+
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLKYI 125

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVT--TQIRGTMGHIAPE 252
           H      ++HRDLK +N+LL+   +  +CDFGLA++ D    H    T+   T  + APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 253 YLSTG-KSSEKTDVFGYGITLLELVTGQ----------------RAIDFSRLEEEEDVLL 295
            +      ++  D++  G  L E+++ +                  +     E+   ++ 
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 296 LDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
           L     LL     N +    L      +   ++          P  R  + Q + 
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQALA 294

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 6e-39
 Identities = 70/285 (24%), Positives = 108/285 (37%), Gaps = 24/285 (8%)

Query: 83  NIIGQGGFGKVYKGV-LSDNTKVAVKRL----QDYYSPGGEAAFQREVHLISVAIHKNLL 137
           + +G+G F  VYK    + N  VA+K++    +     G      RE+ L+    H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 138 QLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
            L+      S   LV+ FM+          +K     L     K     T  GLEYLH+ 
Sbjct: 64  GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119

Query: 198 CNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTG 257
               I+HRDLK  N+LLD+N    L DFGLAK   +     T Q+  T  + APE L   
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175

Query: 258 KS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLL----------LDHIRKLLRED 306
           +      D++  G  L EL+     +      ++   +              +  L    
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM 351
                    L+   S   + ++ +        P  R    Q +KM
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 2e-38
 Identities = 66/298 (22%), Positives = 107/298 (35%), Gaps = 39/298 (13%)

Query: 77  DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKN 135
            +++++ +IG G FG VY+  L      VA+K++        +    RE+ ++    H N
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCN 74

Query: 136 LLQLIGYCTTSSER------ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAY 189
           +++L  +  +S E+       LV  ++         R     ++ L     K   +    
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFR 133

Query: 190 GLEYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 248
            L Y+H      I HRD+K  N+LLD D     LCDFG AK +        + I      
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYR 189

Query: 249 IAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL 308
                      +   DV+  G  L EL+ GQ    F      +    L  I K+L     
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVD---QLVEIIKVLGTPTR 244

Query: 309 NDIVDRNLNTYDSKEVETMVQ--------------VALL--CTQSTPEDRPPMAQVVK 350
             I + N N  + K  +                  +AL     + TP  R    +   
Sbjct: 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  136 bits (342), Expect = 8e-38
 Identities = 44/288 (15%), Positives = 93/288 (32%), Gaps = 33/288 (11%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYC 143
           IG+G FG +++G  L +N +VA+K              + E     +      +  + Y 
Sbjct: 13  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 144 TTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKII 203
                  ++   +   S+   L       +     T    A      ++ +HE+    ++
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLV 123

Query: 204 HRDLKAANILLDDNFEAV-----LCDFGLAKLVDAKLTHV------TTQIRGTMGHIAPE 252
           +RD+K  N L+            + DFG+ K     +T           + GT  +++  
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183

Query: 253 YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 312
                + S + D+   G   +  + G     +  L+   +    + I +  +   L    
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSL--PWQGLKAATNKQKYERIGEKKQSTPL---- 237

Query: 313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGEDLAER 360
            R L     +E    +           +  P    +  +     + ER
Sbjct: 238 -RELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLF--SKVLER 279

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 5e-37
 Identities = 56/284 (19%), Positives = 97/284 (34%), Gaps = 33/284 (11%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVK-----RLQDYYSPGGEAAFQREVHLISV 130
           D +     +G G F  V K    S   + A K     R +           +REV ++  
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 131 AIHKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYG 190
             H N++ L       ++ IL+   +        L D    ++ L              G
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNG 125

Query: 191 LEYLHEQCNPKIIHRDLKAANILLDDN----FEAVLCDFGLAKLVDAKLTHVTTQIRGTM 246
           + YLH      I H DLK  NI+L D         + DFGLA  +D    +    I GT 
Sbjct: 126 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFKNIFGTP 180

Query: 247 GHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 306
             +APE ++      + D++  G+    L++G         +E      L ++  +  E 
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----TLANVSAVNYEF 235

Query: 307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
                      +  S   +  ++         P+ R  +   ++
Sbjct: 236 E------DEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 2e-36
 Identities = 56/277 (20%), Positives = 98/277 (35%), Gaps = 43/277 (15%)

Query: 84  IIGQGGFGKVYKGV-LSDNTKVAVKRL-----QDYYSPGGEAAFQREVHLIS--VAIHKN 135
           ++G GGFG VY G+ +SDN  VA+K +      D+           EV L+    +    
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 136 LLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLH 195
           +++L+ +       +L+    + +     L D       L     +   +     + + H
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELARSFFWQVLEAVRHCH 127

Query: 196 EQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 254
                 ++HRD+K  NIL+D +  E  L DFG   L+      V T   GT  +  PE++
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWI 181

Query: 255 STGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD 313
              +       V+  GI L ++V G    +         V     +    +      ++ 
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ-----HLIR 236

Query: 314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
                               C    P DRP   ++  
Sbjct: 237 W-------------------CLALRPSDRPTFEEIQN 254

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 4e-36
 Identities = 52/276 (18%), Positives = 103/276 (37%), Gaps = 32/276 (11%)

Query: 84  IIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIG 141
           ++G G  GKV +        K A+K LQD          +REV L   A    ++++++ 
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVD 72

Query: 142 YCTTSSER----ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ 197
                       ++V   +    +  R++    G++         +       ++YLH  
Sbjct: 73  VYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLHSI 130

Query: 198 CNPKIIHRDLKAANILLDDNFE---AVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 254
               I HRD+K  N+L           L DFG AK   +  +  T     T  ++APE L
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVL 185

Query: 255 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 314
              K  +  D++  G+ +  L+ G              + +   ++  +R  +       
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFY-----SNHGLAISPGMKTRIRMGQYE--FPN 238

Query: 315 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
              +  S+EV+ +++      ++ P  R  + + + 
Sbjct: 239 PEWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 2e-35
 Identities = 54/288 (18%), Positives = 103/288 (35%), Gaps = 21/288 (7%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQ-DYYSPGGEAAFQREVHLISVAIHK 134
             + +   IG+G +G V+K      +  VA+KR++ D    G  ++  RE+ L+    HK
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           N+++L     +  +  LV+ F          +        LD    K   F    GL + 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 254
           H +    ++HRDLK  N+L++ N E  L +FGLA+     +   + ++            
Sbjct: 118 HSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174

Query: 255 STGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR 314
                S   D++  G    EL    R +      +++   +   +     E   +     
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234

Query: 315 NLNTYDSKEVETMVQVALL------------CTQSTPEDRPPMAQVVK 350
           +   Y      T +   +               +  P  R    + ++
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 4e-34
 Identities = 45/207 (21%), Positives = 80/207 (38%), Gaps = 11/207 (5%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIH 133
           ++F    ++G+G FGKV      +     A+K L  +   +    A    E  ++    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
             L  L     T      V  +     + + L   +         T +R  F  A  +  
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-------FTEERARFYGAEIVSA 117

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           L    +  +++RD+K  N++LD +    + DFGL K   +          GT  ++APE 
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEV 176

Query: 254 LSTGKSSEKTDVFGYGITLLELVTGQR 280
           L         D +G G+ + E++ G+ 
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  124 bits (313), Expect = 4e-33
 Identities = 45/207 (21%), Positives = 75/207 (36%), Gaps = 14/207 (6%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL--QDYYSPGGEAAFQREVHLISVAIH 133
           D F     +G G FG+V            A+K L  Q             E  ++     
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
             L++L      +S   +V  ++        +            P  +  A       EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAG----GEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           LH      +I+RDLK  N+L+D      + DFG AK    ++   T  + GT   +APE 
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEI 209

Query: 254 LSTGKSSEKTDVFGYGITLLELVTGQR 280
           + +   ++  D +  G+ + E+  G  
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYP 236

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 9e-33
 Identities = 67/310 (21%), Positives = 109/310 (35%), Gaps = 39/310 (12%)

Query: 69  CRELQLATDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVH 126
           C E+      + +   IGQG FG+V+K        KVA+K++  +    G      RE+ 
Sbjct: 6   CDEV----SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK 61

Query: 127 LISVAIHKNLLQLIGYCTTSSERI--------LVYPFMQNLSVAYRLRDLKPGEKGLDWP 178
           ++ +  H+N++ LI  C T +           LV+ F ++         L          
Sbjct: 62  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLS 117

Query: 179 TRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-- 236
             KRV       L  L+     KI+HRD+KAAN+L+  +    L DFGLA+         
Sbjct: 118 EIKRVMQML---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 174

Query: 237 -HVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQ------------RAI 282
            +  T    T+ +  PE L   +      D++G G  + E+ T                I
Sbjct: 175 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234

Query: 283 DFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALL--CTQSTPE 340
                    +V       +L  +  L     R +       V     + L+       P 
Sbjct: 235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 294

Query: 341 DRPPMAQVVK 350
            R      + 
Sbjct: 295 QRIDSDDALN 304

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 3e-32
 Identities = 51/289 (17%), Positives = 103/289 (35%), Gaps = 21/289 (7%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHK 134
             + +   +G G +G V   V      KVA+K+L + + S        RE+ L+    H+
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           N++ L+   T          F   +             + L     + + +    GL Y+
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137

Query: 195 HEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYL 254
           H        HRDLK  N+ ++++ E  + DFGLA+  D+++   T  +           L
Sbjct: 138 HAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEVIL 191

Query: 255 STGKSSEKTDVFGYGITLLELVTG-------------QRAIDFSRLEEEEDVLLLDHIRK 301
           +  + ++  D++  G  + E++TG             +  +  +     E V  L     
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251

Query: 302 LLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK 350
                 L ++  ++  +  +      V +         E R    + + 
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  114 bits (287), Expect = 1e-29
 Identities = 48/250 (19%), Positives = 97/250 (38%), Gaps = 22/250 (8%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-VAIHK 134
           D++     +G+G + +V++ + +++N KV VK L     P  +   +RE+ ++  +    
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL----KPVKKKKIKREIKILENLRGGP 90

Query: 135 NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYL 194
           N++ L         R     F           D K   + L     +   +     L+Y 
Sbjct: 91  NIITLADIVKDPVSRTPALVFEH-----VNNTDFKQLYQTLTDYDIRFYMYEILKALDYC 145

Query: 195 HEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE- 252
           H      I+HRD+K  N+++D ++ +  L D+GLA+       +       +     PE 
Sbjct: 146 HSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPEL 200

Query: 253 YLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV 312
            +         D++  G  L  ++  +           ++   L  I K+L  + L D +
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFF----HGHDNYDQLVRIAKVLGTEDLYDYI 256

Query: 313 DRNLNTYDSK 322
           D+     D +
Sbjct: 257 DKYNIELDPR 266

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 2e-28
 Identities = 43/206 (20%), Positives = 85/206 (41%), Gaps = 8/206 (3%)

Query: 76  TDNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIH 133
            + +   + +G G +G V          +VAVK+L + + S        RE+ L+    H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
           +N++ L+   T +              +     +     + L     + + +    GL+Y
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEY 253
           +H        HRDLK +N+ ++++ E  + DFGLA+  D     +T  +           
Sbjct: 137 IHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIM 190

Query: 254 LSTGKSSEKTDVFGYGITLLELVTGQ 279
           L+    ++  D++  G  + EL+TG+
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 5e-28
 Identities = 57/281 (20%), Positives = 97/281 (34%), Gaps = 31/281 (11%)

Query: 77  DNFSESNIIGQGGFGKVYKGVL----SDNTKVAVKRL---QDYYSPGGEAAFQREVHLIS 129
           +NF    ++G G +GKV+              A+K L               + E  ++ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 130 VAIHK-NLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTA 188
                  L+ L     T ++  L+  ++    +   L   +         T   V     
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-------FTEHEVQIYVG 136

Query: 189 YGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGH 248
             +  L       II+RD+K  NILLD N   VL DFGL+K   A  T       GT+ +
Sbjct: 137 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196

Query: 249 IAPEYLSTGKS--SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED 306
           +AP+ +  G S   +  D +  G+ + EL+TG     F+   E+     +          
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEISRRILKSEPP 254

Query: 307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQ 347
              ++         S   + ++Q         P+ R     
Sbjct: 255 YPQEM---------SALAKDLIQ---RLLMKDPKKRLGCGP 283

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  110 bits (275), Expect = 9e-28
 Identities = 48/235 (20%), Positives = 89/235 (37%), Gaps = 21/235 (8%)

Query: 85  IGQGGFGKVYKGV-LSDNTKVAVKRLQDYYSPGGEAAFQREVHLIS-----------VAI 132
           +G G F  V+    + +NT VA+K ++         A + E+ L+               
Sbjct: 21  LGWGHFSTVWLAKDMVNNTHVAMKIVRG--DKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 133 HKNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGL-DWPTRKRVAFGTAYGL 191
             ++L+L+ +        +    +  +     L  +K  E         K+++     GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 192 EYLHEQCNPKIIHRDLKAANILLD-DNFEAVLCDFGLAKLVDAKLTHVTTQ-IRGTMGHI 249
           +Y+H +C   IIH D+K  N+L++  +    L    +A L +A            T  + 
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 250 APEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR 304
           +PE L         D++     + EL+TG     F   E        DHI +++ 
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL--FEPDEGHSYTKDDDHIAQIIE 249

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 3e-27
 Identities = 48/207 (23%), Positives = 84/207 (40%), Gaps = 12/207 (5%)

Query: 77  DNFSESNIIGQGGFGKVYKGV-LSDNTKVAVKRL-QDYYSPGGEAAFQREVHLISVAIHK 134
             +     IG G  G V        +  VA+K+L + + +        RE+ L+    HK
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 135 NLLQLIGYCTTSS--ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLE 192
           N++ L+   T     E       +  L  A   + ++     LD      + +    G++
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIK 133

Query: 193 YLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPE 252
           +LH       IHRDLK +NI++  +    + DFGLA+      + + T    T  + APE
Sbjct: 134 HLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPE 188

Query: 253 YLSTGKSSEKTDVFGYGITLLELVTGQ 279
            +      E  D++  G  + E+V  +
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHK 215

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 83.7 bits (206), Expect = 2e-19
 Identities = 20/159 (12%), Positives = 42/159 (26%), Gaps = 20/159 (12%)

Query: 83  NIIGQGGFGKVYKGVLSDNTKVAVK---------RLQDYYSPGGEAAFQREVHLISVAIH 133
            ++G+G    V+        +  VK         +        G+  F       +    
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 134 KNLLQLIGYCTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEY 193
           + L +L G             +    +              +       V       +  
Sbjct: 66  RALQKLQGLAV-------PKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118

Query: 194 LHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD 232
            + +    I+H DL   N+L+ +     + DF  +  V 
Sbjct: 119 FYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVG 153

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	401
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.5
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.15
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.65
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.28
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.28
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.58

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-56  Score=403.01  Aligned_cols=261  Identities=29%  Similarity=0.445  Sum_probs=205.6

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      ++..++|.+.+.||+|+||+||+|..+  ..||||+++.. .+....+.|.+|+.++++++||||+++++++.+ +..++
T Consensus         4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l   80 (276)
T d1uwha_           4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI   80 (276)
T ss_dssp             BCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             ccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence            345678999999999999999999864  36999999733 345567889999999999999999999998765 56899


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      ||||+++|+|.+++...   ...+++..+..++.|+++||+|||++   +++||||||+|||++.++.+||+|||+++..
T Consensus        81 v~Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~  154 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVK  154 (276)
T ss_dssp             EEECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred             EEecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeec
Confidence            99999999999999753   34699999999999999999999998   9999999999999999999999999999866


Q ss_pred             CCCCc-ceeccccCCccccccccccc---CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          232 DAKLT-HVTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       232 ~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      ..... .......||+.|+|||++.+   ..++.++|||||||++|||+||+.||.......    .....+.....   
T Consensus       155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~----~~~~~~~~~~~---  227 (276)
T d1uwha_         155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD----QIIFMVGRGYL---  227 (276)
T ss_dssp             -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HHHHHHHHTSC---
T ss_pred             cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH----HHHHHHhcCCC---
Confidence            54322 23345679999999999864   347899999999999999999999997543321    11111111111   


Q ss_pred             cchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          308 LNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       308 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                           .+.....+...+.++.+++.+||+.||.+|||++++++.|+.
T Consensus       228 -----~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~  269 (276)
T d1uwha_         228 -----SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL  269 (276)
T ss_dssp             -----CCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----CCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                 111111233445678899999999999999999999999864

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-56  Score=399.10  Aligned_cols=254  Identities=25%  Similarity=0.370  Sum_probs=199.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      .++|.+.+.||+|+||+||+|.+.+++.||||++...  ....+.|.+|++++++++||||++++++|...+..++||||
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~   81 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   81 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC--cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence            3578889999999999999999988889999998753  33457899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +++|+|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+|||+++++.+||+|||+++......
T Consensus        82 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          82 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             CTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred             cCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCC
Confidence            9999999988753   35689999999999999999999999   99999999999999999999999999998776554


Q ss_pred             cceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhC-CCCCCCCcchhhhhhhHHHHHHHHhccCccchhccC
Q 015734          236 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG-QRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR  314 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  314 (401)
                      ........||+.|+|||++.+..++.++|||||||++|||+|+ .+||......     .....+...   ..       
T Consensus       156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~-----~~~~~i~~~---~~-------  220 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDISTG---FR-------  220 (263)
T ss_dssp             ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH-----HHHHHHHHT---CC-------
T ss_pred             ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHhc---CC-------
Confidence            4444456789999999999999999999999999999999995 5555432221     111222211   10       


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          315 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       315 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                        ...+...+.++.+++..||+.||++|||+++++++|+.
T Consensus       221 --~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~  258 (263)
T d1sm2a_         221 --LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE  258 (263)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence              01122334578899999999999999999999999875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-55  Score=391.92  Aligned_cols=254  Identities=22%  Similarity=0.348  Sum_probs=214.7

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      .++|++.++||+|+||+||+|++++++.||||+++..  ....+.|.+|+.++++++||||++++|++.+.+..++||||
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~--~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey   80 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY   80 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS--SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC--cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence            4689999999999999999999988889999999753  33457899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +++|+|..++...   ...+++..+.+++.|+++||+|||++   +++||||||+||++++++.+||+|||+++......
T Consensus        81 ~~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          81 MANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             CTTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred             cCCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence            9999999887653   34588999999999999999999998   99999999999999999999999999998766554


Q ss_pred             cceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccC
Q 015734          236 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDR  314 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  314 (401)
                      ........||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+     +...+.   ...+       
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-----~~~~i~---~~~~-------  219 (258)
T d1k2pa_         155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-----TAEHIA---QGLR-------  219 (258)
T ss_dssp             CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-----HHHHHH---TTCC-------
T ss_pred             ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-----HHHHHH---hCCC-------
Confidence            444445678999999999999999999999999999999998 899997654321     111111   1111       


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          315 NLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       315 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                        ...+...++++.+++.+||+.||++|||+++++++|.+
T Consensus       220 --~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         220 --LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             --CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             --CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence              11123334678999999999999999999999999865

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-56  Score=400.74  Aligned_cols=258  Identities=28%  Similarity=0.414  Sum_probs=211.0

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      +++..++|.+.+.||+|+||+||+|.+++++.||||++...  ....+.|.+|++++++++||||+++++++.+ +..++
T Consensus         8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i   84 (272)
T d1qpca_           8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG--SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (272)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC--cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence            34456788899999999999999999988899999999753  3346789999999999999999999998865 56799


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      ||||+++|+|.+++....  ...+++..+..++.||+.||.|||++   +++||||||+|||+++++.+||+|||+++..
T Consensus        85 v~Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~  159 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (272)
T ss_dssp             EEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEeCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEc
Confidence            999999999998776432  23589999999999999999999998   9999999999999999999999999999987


Q ss_pred             CCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCC-CCCcchhhhhhhHHHHHHHHhccCccch
Q 015734          232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAI-DFSRLEEEEDVLLLDHIRKLLREDRLND  310 (401)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ............||+.|+|||++.+..++.++|||||||++|||+||..|+ ......     .....+.   ....   
T Consensus       160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-----~~~~~i~---~~~~---  228 (272)
T d1qpca_         160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQNLE---RGYR---  228 (272)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHHH---TTCC---
T ss_pred             cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-----HHHHHHH---hcCC---
Confidence            665544555567899999999999999999999999999999999966554 332211     1111111   1110   


Q ss_pred             hccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       311 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                            ...+...+.++.+++.+||+.||++|||+++|++.|+.
T Consensus       229 ------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         229 ------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence                  11123344678899999999999999999999998874

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-55  Score=402.04  Aligned_cols=264  Identities=25%  Similarity=0.352  Sum_probs=217.9

Q ss_pred             HHHHHHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCe
Q 015734           70 RELQLATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSE  148 (401)
Q Consensus        70 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  148 (401)
                      +++++..++|++.+.||+|+||+||+|.++ +++.||||+++..  ....+.|.+|++++++++||||+++++++.+.+.
T Consensus        10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (287)
T d1opja_          10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   87 (287)
T ss_dssp             CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT--CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc--cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence            445566778999999999999999999975 5889999998753  3456789999999999999999999999999999


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      .++||||+++|+|.+++....  ...+++..+..++.|++.||+|||++   +++||||||+|||+++++.+||+|||++
T Consensus        88 ~~iv~E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a  162 (287)
T d1opja_          88 FYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS  162 (287)
T ss_dssp             CEEEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred             eEEEeecccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccce
Confidence            999999999999999997632  45689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      +..............||+.|+|||++.+..++.++|||||||++|||++|..|+......    ..+.+.+.    .+. 
T Consensus       163 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~----~~~~~~i~----~~~-  233 (287)
T d1opja_         163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVYELLE----KDY-  233 (287)
T ss_dssp             TTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HHHHHHHH----TTC-
T ss_pred             eecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH----HHHHHHHh----cCC-
Confidence            977665555555566899999999999999999999999999999999977665422211    11111111    110 


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccCC
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGED  356 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~~  356 (401)
                             ....+...+.++.+|+.+||+.||++|||++++++.|+...
T Consensus       234 -------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         234 -------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             -------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                   01122334567889999999999999999999999887653

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-56  Score=400.30  Aligned_cols=258  Identities=21%  Similarity=0.294  Sum_probs=198.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeec--CCeeEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--SSERIL  151 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l  151 (401)
                      .++|++.+.||+|+||+||+|..+ +|+.||+|.+... .++...+.+.+|++++++++||||+++++++.+  .+..++
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            367999999999999999999965 6899999999743 344556789999999999999999999998865  456799


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC--NPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ||||+++|+|.+++.........+++..++.++.|++.||.|||++.  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            99999999999998765444567999999999999999999999862  1249999999999999999999999999998


Q ss_pred             ccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccc
Q 015734          230 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN  309 (401)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ....... ......||+.|+|||++.+..++.++|||||||++|||+||..||...+..+     +...+.    ...  
T Consensus       163 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-----~~~~i~----~~~--  230 (269)
T d2java1         163 ILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-----LAGKIR----EGK--  230 (269)
T ss_dssp             HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHH----HTC--
T ss_pred             ecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-----HHHHHH----cCC--
Confidence            7654322 2344679999999999999999999999999999999999999997543321     111111    111  


Q ss_pred             hhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       310 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                            ....+...+.++.+++.+||+.||.+|||++|++++
T Consensus       231 ------~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         231 ------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                  111223345678899999999999999999999753

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-55  Score=396.72  Aligned_cols=252  Identities=22%  Similarity=0.317  Sum_probs=203.4

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      ++|++.+.||+|+||+||+|.++ +|+.||||++.........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            57899999999999999999975 68999999997544444556789999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +++|+|.+++..    ...+++..++.++.|++.||+|||++   +++||||||+|||+++++.+||+|||+++......
T Consensus        85 ~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          85 CSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            999999998864    34699999999999999999999999   99999999999999999999999999998764432


Q ss_pred             c-ceeccccCCcccccccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          236 T-HVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       236 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      . .......||+.|+|||++.+..+ +.++|||||||++|||+||+.||.........   .    .........     
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~---~----~~~~~~~~~-----  225 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---Y----SDWKEKKTY-----  225 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH---H----HHHHTTCTT-----
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH---H----HHHhcCCCC-----
Confidence            2 23445679999999999988776 67899999999999999999999754332111   1    011111100     


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                         .......+.++.+|+.+||+.||++|||++|+++
T Consensus       226 ---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         226 ---LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ---STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               0111233457788999999999999999999955

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8e-55  Score=399.66  Aligned_cols=256  Identities=27%  Similarity=0.390  Sum_probs=201.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC-C---CEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSD-N---TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      .++|.+.++||+|+||+||+|.++. +   ..||||.+....+....+.|.+|++++++++||||+++++++...+..++
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            3567778999999999999999753 2   36899998766666677889999999999999999999999999999999


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      ||||+++|+|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+|||++.++++||+|||+++..
T Consensus       105 v~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             EEECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence            99999999999988752   34689999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCcce----eccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccC
Q 015734          232 DAKLTHV----TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLRED  306 (401)
Q Consensus       232 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (401)
                      .......    .....||+.|+|||.+.+..++.++|||||||++|||+| |..||......     .+...+.   ...
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-----~~~~~i~---~~~  250 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-----DVINAIE---QDY  250 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHH---TTC
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH-----HHHHHHH---cCC
Confidence            5432221    122457899999999999999999999999999999998 89999754321     1111111   111


Q ss_pred             ccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       307 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      +         ...+...+.++.+++.+||+.||.+|||+.+|++.|+.
T Consensus       251 ~---------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~  289 (299)
T d1jpaa_         251 R---------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK  289 (299)
T ss_dssp             C---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             C---------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            1         11233445678899999999999999999999999864

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-55  Score=391.74  Aligned_cols=246  Identities=25%  Similarity=0.397  Sum_probs=206.8

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ++|.+.+.||+|+||+||+|.++ +++.||+|++...  ........+.+|+++++.++||||+++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57889999999999999999975 6889999998632  12344678899999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++.....
T Consensus        86 Ey~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          86 EYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             eecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            999999999999863    4589999999999999999999999   999999999999999999999999999986544


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      ..   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+...     .   ........       
T Consensus       159 ~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-----~---~~~i~~~~-------  220 (263)
T d2j4za1         159 SR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-----T---YKRISRVE-------  220 (263)
T ss_dssp             CC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----H---HHHHHTTC-------
T ss_pred             Cc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-----H---HHHHHcCC-------
Confidence            32   234569999999999999999999999999999999999999997544321     1   11111111       


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                      .   ..+...++++.+++.+||+.||.+|||++|+++
T Consensus       221 ~---~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         221 F---TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            0   112233457889999999999999999999975

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-54  Score=392.49  Aligned_cols=255  Identities=25%  Similarity=0.379  Sum_probs=208.4

Q ss_pred             hcCCCCCCe-eeecCcEEEEEEEEC---CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           76 TDNFSESNI-IGQGGFGKVYKGVLS---DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        76 ~~~~~~~~~-lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      .++|.+.+. ||+|+||+||+|.++   ++..||||+++........+.|.+|++++++++||||+++++++.. +..++
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence            345666664 999999999999864   3457999999866666677889999999999999999999999865 56899


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      ||||+++|+|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++..
T Consensus        86 vmE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcc
Confidence            99999999999987652   34699999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcc--eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          232 DAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       232 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ......  ......||+.|+|||++.+..++.++|||||||++|||+| |..||......+     +...+.    .+. 
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-----~~~~i~----~~~-  229 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----VMAFIE----QGK-  229 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-----HHHHHH----TTC-
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH-----HHHHHH----cCC-
Confidence            544332  2233468999999999999999999999999999999998 899997543221     111111    111 


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                             ....+...+.++.+++.+||+.||++|||+.+|++.|+.
T Consensus       230 -------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         230 -------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             -------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                   111233445678899999999999999999999998864

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-53  Score=387.33  Aligned_cols=250  Identities=20%  Similarity=0.288  Sum_probs=207.5

Q ss_pred             cCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           77 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      ++|.+.+.||+|+||+||+|.+ .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc-ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            4799999999999999999996 468999999987432 23467899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +++|+|.+++..     ..+++..++.++.|++.||+|||++   +++||||||+|||++.++++||+|||+++......
T Consensus        99 ~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~  170 (293)
T d1yhwa1          99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (293)
T ss_dssp             CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             cCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence            999999988765     3589999999999999999999999   99999999999999999999999999998765433


Q ss_pred             cceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCc
Q 015734          236 THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN  315 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  315 (401)
                      . ......||+.|+|||++.+..++.++|||||||++|+|+||..||.......    .+    ........ ..     
T Consensus       171 ~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~----~~~~~~~~-~~-----  235 (293)
T d1yhwa1         171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----AL----YLIATNGT-PE-----  235 (293)
T ss_dssp             C-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HH----HHHHHHCS-CC-----
T ss_pred             c-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH----HH----HHHHhCCC-CC-----
Confidence            2 2344579999999999999999999999999999999999999997543211    11    11111110 00     


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       316 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                       ...+...+.++.+++.+||+.||.+|||+.|++++
T Consensus       236 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         236 -LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             -CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             -CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             01123345678899999999999999999999753

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-55  Score=404.97  Aligned_cols=269  Identities=22%  Similarity=0.298  Sum_probs=209.4

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      +..++|.+.+.||+|+||+||+|.+. +|+.||+|+++....+.....+.+|+.++++++||||+++++++.+.+..++|
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV   82 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   82 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            34678999999999999999999975 68999999998655666678899999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||+++|+|.+++...    ..+++..++.++.|++.||.|||+++  +|+||||||+|||++.++++||+|||+|+...
T Consensus        83 mEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  156 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  156 (322)
T ss_dssp             EECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             EEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence            9999999999999863    35899999999999999999999731  79999999999999999999999999998654


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHh---------
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLL---------  303 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------  303 (401)
                      ..   ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....................         
T Consensus       157 ~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (322)
T d1s9ja_         157 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  233 (322)
T ss_dssp             HH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred             CC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence            32   223457999999999999999999999999999999999999999764432211100000000000         


Q ss_pred             ------------ccCccchh----ccCcCCCC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          304 ------------REDRLNDI----VDRNLNTY-DSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       304 ------------~~~~~~~~----~d~~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                                  ......+.    .....+.. ....+.++.+++.+||+.||.+|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                        00000000    00000000 11124578899999999999999999999764

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=388.75  Aligned_cols=257  Identities=25%  Similarity=0.397  Sum_probs=203.0

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCC-----CEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSDN-----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERI  150 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  150 (401)
                      .+.|+..++||+|+||+||+|.++++     ..||||++....++.....|.+|++++++++||||+++++++.+.+..+
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            35678889999999999999986532     3799999986666666778999999999999999999999999999999


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      +||||+.++++.+.+...   ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++.
T Consensus        86 ~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          86 IITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             EEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence            999999999999887763   35699999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCcc--eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          231 VDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       231 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      .......  ......||+.|+|||++.+..++.++|||||||++|||+||..|+......    ..+...+.    .+  
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~----~~~~~~i~----~~--  229 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HEVMKAIN----DG--  229 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHH----TT--
T ss_pred             ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH----HHHHHHHh----cc--
Confidence            6443222  223346899999999999999999999999999999999976665432211    11111111    11  


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                            .....+...+.++.+++.+||+.||++||||.+|++.|+.
T Consensus       230 ------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~  269 (283)
T d1mqba_         230 ------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK  269 (283)
T ss_dssp             ------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence                  1112233345678999999999999999999999998864

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-54  Score=389.89  Aligned_cols=253  Identities=25%  Similarity=0.315  Sum_probs=206.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      .+.|++.+.||+|+||+||+|.+. ++..||+|++... +....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence            356888999999999999999975 6889999998743 34556788999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++|+|.+++...   ..++++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++......
T Consensus        90 y~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          90 FCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             CCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred             cCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence            99999999988753   34699999999999999999999999   9999999999999999999999999999755432


Q ss_pred             CcceeccccCCcccccccccc-----cCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccc
Q 015734          235 LTHVTTQIRGTMGHIAPEYLS-----TGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN  309 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      . .......||+.|+|||++.     +..++.++|||||||++|||+||..||......+    .+. .+.   ... . 
T Consensus       164 ~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~----~~~-~i~---~~~-~-  232 (288)
T d2jfla1         164 I-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR----VLL-KIA---KSE-P-  232 (288)
T ss_dssp             H-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----HHH-HHH---HSC-C-
T ss_pred             c-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH----HHH-HHH---cCC-C-
Confidence            1 1233457999999999984     4557899999999999999999999997544321    111 111   111 0 


Q ss_pred             hhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       310 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                           .....+...+.++.+|+.+||+.||.+|||++|++++
T Consensus       233 -----~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         233 -----PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             -----CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             -----CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 0011223445678899999999999999999999763

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-54  Score=399.32  Aligned_cols=263  Identities=25%  Similarity=0.387  Sum_probs=209.8

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEECC-C-----CEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeee
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVLSD-N-----TKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT  144 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  144 (401)
                      +++..++|.+.++||+|+||+||+|++.. +     ..||+|.+...........+.+|+.++.++ +||||+++++++.
T Consensus        32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~  111 (325)
T d1rjba_          32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  111 (325)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence            34566789999999999999999998643 2     369999987655555667899999999998 8999999999999


Q ss_pred             cCCeeEEEEecccCCcHHHHhhhcCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 015734          145 TSSERILVYPFMQNLSVAYRLRDLKP-------------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHR  205 (401)
Q Consensus       145 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~  205 (401)
                      +.+..++||||+++|+|.+++.....                   ....+++..++.++.|++.||+|||++   +|+||
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHR  188 (325)
T d1rjba_         112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR  188 (325)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred             eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence            99999999999999999999976432                   124589999999999999999999999   99999


Q ss_pred             CCCCCceEEcCCCcEEEeecCCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCC
Q 015734          206 DLKAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAID  283 (401)
Q Consensus       206 dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~  283 (401)
                      ||||+|||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |..||.
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence            99999999999999999999999866544332 3344568999999999999999999999999999999998 899997


Q ss_pred             CCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 015734          284 FSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQ  353 (401)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~  353 (401)
                      ......    .+...+.    .+.     .   ...+...+.++.+|+.+||+.||++|||+++|+++|.
T Consensus       269 ~~~~~~----~~~~~~~----~~~-----~---~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         269 GIPVDA----NFYKLIQ----NGF-----K---MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             TCCCSH----HHHHHHH----TTC-----C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCHHH----HHHHHHh----cCC-----C---CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            543321    1111111    110     0   1122334567889999999999999999999999985

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-53  Score=385.24  Aligned_cols=247  Identities=25%  Similarity=0.354  Sum_probs=199.2

Q ss_pred             CeeeecCcEEEEEEEECC---CCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecccC
Q 015734           83 NIIGQGGFGKVYKGVLSD---NTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFMQN  158 (401)
Q Consensus        83 ~~lG~G~~g~V~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  158 (401)
                      ++||+|+||+||+|.+++   ++.||||+++.. .++...+.|.+|++++++++||||++++++|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            469999999999998542   468999999743 334456789999999999999999999999865 457899999999


Q ss_pred             CcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCcc-
Q 015734          159 LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLTH-  237 (401)
Q Consensus       159 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-  237 (401)
                      |+|.+++..    ...+++..+..++.||+.||+|||++   +++||||||+|||++.++.+||+|||+++........ 
T Consensus        92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            999999886    34699999999999999999999998   9999999999999999999999999999876544332 


Q ss_pred             -eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhccCc
Q 015734          238 -VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRN  315 (401)
Q Consensus       238 -~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  315 (401)
                       ......||+.|+|||.+.+..++.++|||||||++|||+| |..||......+     +...+.    .+.        
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-----~~~~i~----~~~--------  227 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----VTAMLE----KGE--------  227 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHHH----TTC--------
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-----HHHHHH----cCC--------
Confidence             2234568999999999999999999999999999999998 899997543211     111111    111        


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          316 LNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       316 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ....+...+.++.+++.+||+.||.+|||+++|++.|+.
T Consensus       228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            111233345678899999999999999999999988864

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-54  Score=390.42  Aligned_cols=260  Identities=27%  Similarity=0.402  Sum_probs=205.0

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      +++..++|++.+.||+|+||+||+|.++++..||||++...  ....+.|.+|+.++++++||||+++++++.+ +..++
T Consensus        12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~l   88 (285)
T d1fmka3          12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI   88 (285)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             eEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc--cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEE
Confidence            33456789999999999999999999988889999999743  3345789999999999999999999999854 56899


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      ||||+++|+|..++....  ...+++..+..++.||+.||+|||++   +++||||||+|||+++++++||+|||+++..
T Consensus        89 v~Ey~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~  163 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI  163 (285)
T ss_dssp             EECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             EEEecCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhc
Confidence            999999999998887532  24589999999999999999999999   9999999999999999999999999999877


Q ss_pred             CCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ............||+.|+|||++.+..++.++|||||||++|||+||+.|+......    ......+.   ....    
T Consensus       164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~----~~~~~~i~---~~~~----  232 (285)
T d1fmka3         164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REVLDQVE---RGYR----  232 (285)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHH---TTCC----
T ss_pred             cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH----HHHHHHHH---hcCC----
Confidence            555444445567899999999999999999999999999999999977665432221    11111111   1110    


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                           ...+...++++.+++.+||+.||++|||+++|++.|+..
T Consensus       233 -----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~  271 (285)
T d1fmka3         233 -----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  271 (285)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             -----CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence                 112333456788999999999999999999999988763

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=389.23  Aligned_cols=249  Identities=20%  Similarity=0.295  Sum_probs=204.8

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ++|++.+.||+|+||+||+|..+ +|+.||||++...  ......+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            67999999999999999999974 6899999998632  12345678999999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+++|+|.+++...    ..+++..++.++.|++.||+|||++   +++||||||+|||+++++.+||+|||+++....
T Consensus        88 Ey~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence            999999999988863    4599999999999999999999999   999999999999999999999999999987654


Q ss_pred             CC-cceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          234 KL-THVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       234 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      .. ........||+.|+|||++.+..++.++|||||||++|||+||..||...+...     +   ........      
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-----~---~~~i~~~~------  226 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-----I---FQKIIKLE------  226 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----H---HHHHHTTC------
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-----H---HHHHHcCC------
Confidence            32 223345679999999999999999999999999999999999999998543211     1   11111111      


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                       .   ..+...+.++.+|+.+||+.||.+|||++|+++
T Consensus       227 -~---~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         227 -Y---DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             -C---CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             -C---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence             0   112233457889999999999999999998744

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=378.99  Aligned_cols=246  Identities=24%  Similarity=0.366  Sum_probs=196.7

Q ss_pred             CCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeec----CCeeEEEE
Q 015734           80 SESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT----SSERILVY  153 (401)
Q Consensus        80 ~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~  153 (401)
                      ...+.||+|+||+||+|.++ ++..||+|.+... ......+.+.+|++++++++||||+++++++.+    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45668999999999999975 5889999998743 344556789999999999999999999999864    34578999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEeCCCCCceEEc-CCCcEEEeecCCccc
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPK--IIHRDLKAANILLD-DNFEAVLCDFGLAKL  230 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlkp~Nill~-~~~~~kl~Dfgl~~~  230 (401)
                      ||+++|+|.+++...    ..+++..++.++.|++.||+|||++   +  ++||||||+|||++ +++.+||+|||+++.
T Consensus        92 E~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             eCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            999999999999863    4589999999999999999999998   6  99999999999996 588999999999986


Q ss_pred             cCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccch
Q 015734          231 VDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND  310 (401)
Q Consensus       231 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ....   ......||+.|+|||++.+ +++.++|||||||++|||++|+.||.......    .+   .... .......
T Consensus       165 ~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~----~~---~~~i-~~~~~~~  232 (270)
T d1t4ha_         165 KRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA----QI---YRRV-TSGVKPA  232 (270)
T ss_dssp             CCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH----HH---HHHH-TTTCCCG
T ss_pred             ccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH----HH---HHHH-HcCCCCc
Confidence            4432   2334679999999999865 69999999999999999999999997433211    11   1111 1111111


Q ss_pred             hccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       311 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..       +...++++.+++.+||+.||++|||++|++++
T Consensus       233 ~~-------~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         233 SF-------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             GG-------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cc-------CccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence            11       11223468899999999999999999999763

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-53  Score=386.88  Aligned_cols=257  Identities=20%  Similarity=0.327  Sum_probs=200.7

Q ss_pred             HHhcCCCCCCeeeecCcEEEEEEEECC----CCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCee
Q 015734           74 LATDNFSESNIIGQGGFGKVYKGVLSD----NTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        74 ~~~~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  149 (401)
                      +..++|.+.+.||+|+||.||+|.+..    +..||||.+.........+.|.+|++++++++||||+++++++. .+..
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~   82 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   82 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence            345789999999999999999998643    34689999876556666788999999999999999999999986 4678


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ++||||+++|+|.+++...   ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++
T Consensus        83 ~iv~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~  156 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR  156 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             EEEEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhe
Confidence            9999999999999987752   34689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          230 LVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ..............||+.|+|||++.+..++.++|||||||++|||+| |.+||......+     +...+.   ...  
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-----~~~~i~---~~~--  226 (273)
T d1mp8a_         157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VIGRIE---NGE--  226 (273)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HHHHHH---TTC--
T ss_pred             eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-----HHHHHH---cCC--
Confidence            766554444555668999999999999999999999999999999998 889987654321     111111   111  


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                             ....++..+.++.+++.+||+.||++|||+.+|++.|+.
T Consensus       227 -------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~  265 (273)
T d1mp8a_         227 -------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  265 (273)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                   111233445678999999999999999999999999864

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.2e-53  Score=388.59  Aligned_cols=253  Identities=22%  Similarity=0.331  Sum_probs=192.6

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      .+.|.+.+.||+|+||+||+|.++ +++.||||++...........+.+|++++++++||||+++++++.+.+..++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            467899999999999999999975 6899999999754444445678899999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEc---CCCcEEEeecCCcccc
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---DNFEAVLCDFGLAKLV  231 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfgl~~~~  231 (401)
                      |+++|+|.+++..    ...+++..+..++.|++.||+|||++   +++||||||+||++.   +++.+||+|||+++..
T Consensus        88 ~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          88 LVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             ccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            9999999999975    34699999999999999999999999   999999999999994   5789999999999865


Q ss_pred             CCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchh
Q 015734          232 DAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDI  311 (401)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|..||.......     .   ..........   
T Consensus       161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-----~---~~~i~~~~~~---  227 (307)
T d1a06a_         161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-----L---FEQILKAEYE---  227 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----H---HHHHHTTCCC---
T ss_pred             cCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-----H---HHHHhccCCC---
Confidence            4332  2334579999999999999999999999999999999999999997543211     1   1111111100   


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .+   .......++++.+++.+||+.||.+|||++|++++
T Consensus       228 ~~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         228 FD---SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             CC---TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CC---CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            00   01123345678899999999999999999999985

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.9e-53  Score=390.30  Aligned_cols=267  Identities=26%  Similarity=0.406  Sum_probs=217.2

Q ss_pred             HHHHHHHhcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeee
Q 015734           69 CRELQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGY  142 (401)
Q Consensus        69 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~  142 (401)
                      +.+++.+.++|.+.+.||+|+||+||+|+.+      +++.||||++.........+.|.+|+.++++++|||+++++++
T Consensus         5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~   84 (301)
T d1lufa_           5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV   84 (301)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence            4456667889999999999999999999863      3578999999865566667889999999999999999999999


Q ss_pred             eecCCeeEEEEecccCCcHHHHhhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 015734          143 CTTSSERILVYPFMQNLSVAYRLRDLKP--------------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKI  202 (401)
Q Consensus       143 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  202 (401)
                      +...+..+++|||+++|+|.+++.....                    ....+++..+..++.|++.||+|||++   ++
T Consensus        85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i  161 (301)
T d1lufa_          85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF  161 (301)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred             eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence            9999999999999999999999875321                    123589999999999999999999999   99


Q ss_pred             EEeCCCCCceEEcCCCcEEEeecCCccccCCCCc-ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCC-C
Q 015734          203 IHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ-R  280 (401)
Q Consensus       203 ~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~-~  280 (401)
                      +||||||+|||++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++|. +
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~  241 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  241 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence            9999999999999999999999999986544322 2334456889999999999999999999999999999999986 5


Q ss_pred             CCCCCcchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          281 AIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       281 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                      ||......+     ....+    ..+.        ....+...+.++.+|+.+||+.+|++||||.+|++.|+.+
T Consensus       242 p~~~~~~~e-----~~~~v----~~~~--------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         242 PYYGMAHEE-----VIYYV----RDGN--------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             TTTTSCHHH-----HHHHH----HTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCCCCHHH-----HHHHH----HcCC--------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            676443221     11111    1111        1122333446788999999999999999999999999764

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.6e-53  Score=388.45  Aligned_cols=247  Identities=27%  Similarity=0.345  Sum_probs=201.9

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      +.|+..+.||+|+||+||+|... +++.||||++....  .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            35888999999999999999964 68899999987432  2334567899999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      |||.+|+|..++..    ..++++..++.++.||+.||.|||++   +++||||||+|||++.++.+||+|||++.....
T Consensus        95 E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             ECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            99999998766654    35699999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCcceeccccCCccccccccccc---CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccch
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLST---GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLND  310 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      .     ....||+.|+|||++.+   ..++.++|||||||++|||++|..||.......        ........ ....
T Consensus       168 ~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~--------~~~~i~~~-~~~~  233 (309)
T d1u5ra_         168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQN-ESPA  233 (309)
T ss_dssp             B-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHS-CCCC
T ss_pred             C-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhC-CCCC
Confidence            2     33569999999999864   458999999999999999999999997543211        11111111 1111


Q ss_pred             hccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          311 IVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       311 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .       .....++++.+|+.+||+.||.+|||+++++++
T Consensus       234 ~-------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         234 L-------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             C-------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             C-------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence            1       112234578899999999999999999999873

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-51  Score=373.51  Aligned_cols=252  Identities=21%  Similarity=0.240  Sum_probs=206.9

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-----CcchHHHHHHHHHHHHhccCCcccceeeeeecCCee
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-----SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  149 (401)
                      .++|.+.+.||+|+||+||+|..+ +|+.||||++....     .....+.+.+|++++++++||||+++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            467999999999999999999974 68999999986322     223467899999999999999999999999999999


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC----cEEEeec
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF----EAVLCDF  225 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~----~~kl~Df  225 (401)
                      ++||||+++|+|.+++...    ..+++..++.++.|++.||+|||++   +++||||||+||+++.++    .+||+||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence            9999999999999999863    4599999999999999999999999   999999999999998776    4999999


Q ss_pred             CCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhcc
Q 015734          226 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE  305 (401)
Q Consensus       226 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (401)
                      |++.......  ......||+.|+|||++.+..++.++|||||||++|||+||..||...+..+     .   .......
T Consensus       162 G~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-----~---~~~i~~~  231 (293)
T d1jksa_         162 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----T---LANVSAV  231 (293)
T ss_dssp             TTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----H---HHHHHTT
T ss_pred             hhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-----H---HHHHHhc
Confidence            9998765432  2334568999999999999999999999999999999999999998544321     1   1111111


Q ss_pred             C-ccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          306 D-RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       306 ~-~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      . ......       ....+.++.+|+.+||+.||.+|||++|++++
T Consensus       232 ~~~~~~~~-------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         232 NYEFEDEY-------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             CCCCCHHH-------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCCCCchh-------cCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0 111101       11234578899999999999999999999764

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-52  Score=383.25  Aligned_cols=254  Identities=24%  Similarity=0.378  Sum_probs=202.9

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCC----EEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNT----KVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERIL  151 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  151 (401)
                      ++|++.++||+|+||+||+|.+. +|+    +||+|++....+....+.|.+|++++++++||||++++++|.+. ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46889999999999999999964 343    68999987666667788999999999999999999999999865 5678


Q ss_pred             EEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcccc
Q 015734          152 VYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLV  231 (401)
Q Consensus       152 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~  231 (401)
                      +++++.+++|.+.+...   ...+++..+..++.||+.||+|||++   +++||||||+|||++.++.+||+|||+++..
T Consensus        88 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             EEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence            88999999999888763   45699999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccc
Q 015734          232 DAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLN  309 (401)
Q Consensus       232 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ...... ......||+.|+|||++.++.++.++|||||||++|||+| |..||+......     +...+...   .   
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-----~~~~i~~~---~---  230 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISSILEKG---E---  230 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-----HHHHHHHT---C---
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-----HHHHHHcC---C---
Confidence            544332 2334568999999999999999999999999999999999 788887544321     22222211   1   


Q ss_pred             hhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          310 DIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       310 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                            ....+...+.++.+++.+||+.||.+|||+.+++++|+.
T Consensus       231 ------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~  269 (317)
T d1xkka_         231 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK  269 (317)
T ss_dssp             ------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence                  011233445678899999999999999999999998754

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2e-51  Score=384.36  Aligned_cols=253  Identities=22%  Similarity=0.281  Sum_probs=208.1

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      -++|.+.+.||+|+||+||+|..+ +|+.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE  103 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  103 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc-chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            358999999999999999999974 6899999998643 33456788999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEc--CCCcEEEeecCCccccC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD--DNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~--~~~~~kl~Dfgl~~~~~  232 (401)
                      |+++|+|.+++...   ...+++..+..++.||+.||.|||++   +++||||||+|||++  .++.+||+|||+++...
T Consensus       104 ~~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~  177 (350)
T d1koaa2         104 FMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  177 (350)
T ss_dssp             CCCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred             cCCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence            99999999988642   34699999999999999999999999   999999999999995  46889999999998765


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ....  .....||+.|+|||++.+..++.++|||||||++|||+||..||...+..+     ....+...  ......  
T Consensus       178 ~~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-----~~~~i~~~--~~~~~~--  246 (350)
T d1koaa2         178 PKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-----TLRNVKSC--DWNMDD--  246 (350)
T ss_dssp             TTSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHT--CCCSCC--
T ss_pred             cccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH-----HHHHHHhC--CCCCCc--
Confidence            4332  334568999999999999999999999999999999999999997543221     11111111  000000  


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                           ......++++.+|+.+||+.||.+|||++|++++
T Consensus       247 -----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         247 -----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             -----GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             -----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 0112334578899999999999999999999985

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-51  Score=382.12  Aligned_cols=250  Identities=21%  Similarity=0.263  Sum_probs=208.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      -++|.+.+.||+|+||.||+|..+ +|+.||+|++...  ........+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            457899999999999999999964 6899999999642  1234567889999999999999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||+++|+|.+++..    ...+++..++.++.|++.||+|||++   +++||||||+|||++.+|.+||+|||+++...
T Consensus        84 ~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             eeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence            999999999999887    34589999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      .... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+...     +   ....... .     
T Consensus       157 ~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-----~---~~~i~~~-~-----  221 (337)
T d1o6la_         157 SDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----L---FELILME-E-----  221 (337)
T ss_dssp             CTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----H---HHHHHHC-C-----
T ss_pred             cCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-----H---HHHHhcC-C-----
Confidence            3322 3344679999999999999999999999999999999999999998654321     1   1111111 0     


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVKM  351 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~~  351 (401)
                          ..++...+.++.+|+.+||+.||.+||+     +++++++
T Consensus       222 ----~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         222 ----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ----CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence                0122334457889999999999999995     7787653

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.8e-51  Score=381.50  Aligned_cols=253  Identities=19%  Similarity=0.252  Sum_probs=208.4

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      .++|++.+.||+|+||+||+|... +|+.||||++.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE  106 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  106 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            467999999999999999999964 68999999987532 3345678899999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEc--CCCcEEEeecCCccccC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD--DNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~--~~~~~kl~Dfgl~~~~~  232 (401)
                      |+++|+|.+.+..   ...++++..++.++.||+.||+|||++   +++||||||+|||++  .++.+||+|||++....
T Consensus       107 ~~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         107 FLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  180 (352)
T ss_dssp             CCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             cCCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecC
Confidence            9999999887764   234699999999999999999999999   999999999999997  67899999999998775


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ...  ......||+.|+|||++.+..++.++|||||||++|+|+||..||.......     ....+...  .....   
T Consensus       181 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-----~~~~i~~~--~~~~~---  248 (352)
T d1koba_         181 PDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-----TLQNVKRC--DWEFD---  248 (352)
T ss_dssp             TTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----HHHHHHHC--CCCCC---
T ss_pred             CCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhC--CCCCC---
Confidence            533  2334568999999999999999999999999999999999999997543321     11111110  00000   


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                       .   ......+.++.+|+.+||+.||.+|||+.|++++
T Consensus       249 -~---~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         249 -E---DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             -S---STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -c---ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             0   1123345678899999999999999999999885

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.3e-51  Score=376.61  Aligned_cols=246  Identities=25%  Similarity=0.312  Sum_probs=206.2

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ++|.+.+.||+|+||+||+|..+ +|+.||||++...  ......+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            56889999999999999999974 6899999998632  12345678999999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||++||+|...+..    ...+++..++.++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++....
T Consensus        84 E~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          84 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence            99999999998886    44588899999999999999999999   999999999999999999999999999987654


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      .    .....||+.|+|||++.+..++.++|||||||++|||+||+.||...+..+     .   ........       
T Consensus       157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~---~~~i~~~~-------  217 (316)
T d1fota_         157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-----T---YEKILNAE-------  217 (316)
T ss_dssp             C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----H---HHHHHHCC-------
T ss_pred             c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH-----H---HHHHHcCC-------
Confidence            3    234679999999999999999999999999999999999999997644321     1   11111111       


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVKM  351 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~~  351 (401)
                         ...++..+.++.+++.+||+.||.+||     |+++++++
T Consensus       218 ---~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         218 ---LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ---CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence               011223345788999999999999996     89999764

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-52  Score=375.85  Aligned_cols=250  Identities=26%  Similarity=0.349  Sum_probs=197.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeec-CCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e  154 (401)
                      .++|.+.+.||+|+||.||+|.+ .|..||||+++.   +...+.+.+|++++++++||||++++|+|.+ .+..++|||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e   81 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   81 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCC---CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECc---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence            45678889999999999999998 578999999864   3345789999999999999999999999865 456899999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+++|+|.+++....  ...+++..++.++.||+.||.|||+.   +++||||||+||+++.++.+||+|||+++.....
T Consensus        82 y~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          82 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             CCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             ccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC
Confidence            999999999997532  23589999999999999999999998   9999999999999999999999999999865432


Q ss_pred             CcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                          .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||.......     ....+.    ...      
T Consensus       157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~-----~~~~i~----~~~------  217 (262)
T d1byga_         157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPRVE----KGY------  217 (262)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-----HHHHHT----TTC------
T ss_pred             ----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH-----HHHHHH----cCC------
Confidence                223457889999999999999999999999999999998 677776543321     222221    111      


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                        .+..+...+.++.+++.+||+.||.+||||.+++++|+..
T Consensus       218 --~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         218 --KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence              1112233446788999999999999999999999998754

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-51  Score=377.88  Aligned_cols=269  Identities=24%  Similarity=0.358  Sum_probs=204.8

Q ss_pred             CHHHHHHHhcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCccccee
Q 015734           68 SCRELQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLI  140 (401)
Q Consensus        68 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~  140 (401)
                      ...++++..++|.+.+.||+|+||.||+|.+.      +++.||||+++........+.+.+|...+.++ +|+||+.++
T Consensus         4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            34556667789999999999999999999853      24689999998655666677888888888776 689999999


Q ss_pred             eeeecC-CeeEEEEecccCCcHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCC
Q 015734          141 GYCTTS-SERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDL  207 (401)
Q Consensus       141 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl  207 (401)
                      +++... ...++||||+++|+|.+++.....            ....+++..+..++.|++.||+|||++   +++||||
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDl  160 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL  160 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcC
Confidence            988665 468999999999999999975321            124589999999999999999999999   9999999


Q ss_pred             CCCceEEcCCCcEEEeecCCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCC-CCCCCC
Q 015734          208 KAANILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ-RAIDFS  285 (401)
Q Consensus       208 kp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~-~p~~~~  285 (401)
                      ||+|||+++++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+||. .||...
T Consensus       161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~  240 (299)
T d1ywna1         161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  240 (299)
T ss_dssp             CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999866543332 334467999999999999999999999999999999999975 577643


Q ss_pred             cchhhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          286 RLEEEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                      ....    .+...+.    .+..        ...+...+.++.+++.+||+.||.+|||+++++++|+..
T Consensus       241 ~~~~----~~~~~~~----~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         241 KIDE----EFCRRLK----EGTR--------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             CCSH----HHHHHHH----HTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CHHH----HHHHHHh----cCCC--------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            3221    1111111    1111        112223345788999999999999999999999998753

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=379.81  Aligned_cols=265  Identities=23%  Similarity=0.370  Sum_probs=216.1

Q ss_pred             HHHHHhcCCCCCCeeeecCcEEEEEEEEC------CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeee
Q 015734           71 ELQLATDNFSESNIIGQGGFGKVYKGVLS------DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCT  144 (401)
Q Consensus        71 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  144 (401)
                      ++++..++|.+.+.||+|+||+||+|.+.      +++.||||+++..........|.+|++++++++||||+++++++.
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence            34556688999999999999999999863      257899999986556666678999999999999999999999999


Q ss_pred             cCCeeEEEEecccCCcHHHHhhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC
Q 015734          145 TSSERILVYPFMQNLSVAYRLRDLK------PGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF  218 (401)
Q Consensus       145 ~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~  218 (401)
                      ..+..++||||+++|+|.+++....      .....+++..+..++.|+++||.|||++   +++||||||+|||+++++
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCc
Confidence            9999999999999999999886432      1234578999999999999999999998   999999999999999999


Q ss_pred             cEEEeecCCccccCCCCcce-eccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCC-CCCCCCcchhhhhhhHH
Q 015734          219 EAVLCDFGLAKLVDAKLTHV-TTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQ-RAIDFSRLEEEEDVLLL  296 (401)
Q Consensus       219 ~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~-~p~~~~~~~~~~~~~~~  296 (401)
                      ++||+|||+++......... .....||+.|+|||.+.+..++.++|||||||++|||+||. .||......        
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~--------  242 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--------  242 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--------
T ss_pred             eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH--------
Confidence            99999999998665443322 33346899999999999999999999999999999999985 666543321        


Q ss_pred             HHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccC
Q 015734          297 DHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQGE  355 (401)
Q Consensus       297 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~~  355 (401)
                      +....... +        .....+...+..+.+++.+||+.+|++|||+.+|++.|+..
T Consensus       243 ~~~~~i~~-~--------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         243 QVLRFVME-G--------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             HHHHHHHT-T--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             HHHHHHHh-C--------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            11111111 1        11122333456799999999999999999999999999764

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=372.22  Aligned_cols=251  Identities=29%  Similarity=0.412  Sum_probs=201.8

Q ss_pred             CCeeeecCcEEEEEEEECCC----CEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeec-CCeeEEEEecc
Q 015734           82 SNIIGQGGFGKVYKGVLSDN----TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT-SSERILVYPFM  156 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~  156 (401)
                      .++||+|+||+||+|.+.++    ..||||++....+......|.+|++++++++||||++++|++.. .+..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999996432    26899999765666677889999999999999999999999865 46789999999


Q ss_pred             cCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCc
Q 015734          157 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT  236 (401)
Q Consensus       157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  236 (401)
                      ++|+|.+++...   ...+++..+..++.|++.||.|||+.   +++||||||+|||+++++.+||+|||+++.......
T Consensus       112 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         112 KHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             TTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             ecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            999999988753   34578889999999999999999999   999999999999999999999999999987654322


Q ss_pred             c---eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          237 H---VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       237 ~---~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      .   ......||+.|+|||.+.+..++.++||||||+++|||+||+.||......    .   +.........+      
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~----~---~~~~~i~~g~~------  252 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----F---DITVYLLQGRR------  252 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHTTCC------
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH----H---HHHHHHHcCCC------
Confidence            2   223356899999999999999999999999999999999988887542211    0   11111111111      


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                         ...+...+.++.+++.+||+.||++|||+.||+++|+.
T Consensus       253 ---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~  290 (311)
T d1r0pa_         253 ---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA  290 (311)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence               11122334578899999999999999999999999865

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.2e-50  Score=364.96  Aligned_cols=257  Identities=21%  Similarity=0.287  Sum_probs=200.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCC----e
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS----E  148 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~  148 (401)
                      .++|.+.+.||+|+||+||+|.+ .+|+.||||+++...  +......+.+|+++++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46799999999999999999996 468999999997433  3344568999999999999999999999987654    3


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      .++||||+++++|.+++...    ..+++..+..++.|++.||+|||++   +++||||||+|||++.++..+++|||.+
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             EEEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence            78999999999999988763    4599999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCCc--ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC
Q 015734          229 KLVDAKLT--HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED  306 (401)
Q Consensus       229 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (401)
                      ........  .......||+.|+|||++.+..++.++|||||||++|||+||..||......+        .........
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~~~~~~~~  230 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--------VAYQHVRED  230 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHCC
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH--------HHHHHHhcC
Confidence            75543322  23344679999999999999999999999999999999999999997544321        111122221


Q ss_pred             ccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhc
Q 015734          307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRP-PMAQVVKMLQ  353 (401)
Q Consensus       307 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~~vl~~L~  353 (401)
                      .....      ......+.++.+++.+||+.||.+|| |++++++.|.
T Consensus       231 ~~~~~------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         231 PIPPS------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             CCCGG------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             CCCCc------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence            11110      01122345788999999999999999 8999987764

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-51  Score=375.42  Aligned_cols=256  Identities=26%  Similarity=0.387  Sum_probs=203.7

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECC-CC--EEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeeecCCeeEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLSD-NT--KVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  152 (401)
                      ++|++.++||+|+||+||+|.+++ |.  .||||++.........+.|.+|++++.++ +||||+++++++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            678889999999999999999653 43  57888887655555677899999999998 799999999999999999999


Q ss_pred             EecccCCcHHHHhhhc------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcE
Q 015734          153 YPFMQNLSVAYRLRDL------------KPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEA  220 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~------------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~  220 (401)
                      |||+++|+|.++++..            ......+++..+..++.||+.||.|||++   +++||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence            9999999999998753            12245699999999999999999999999   99999999999999999999


Q ss_pred             EEeecCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCC-CCCCCcchhhhhhhHHHHH
Q 015734          221 VLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQR-AIDFSRLEEEEDVLLLDHI  299 (401)
Q Consensus       221 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~-p~~~~~~~~~~~~~~~~~~  299 (401)
                      ||+|||+++.......  .....||..|+|||.+.+..++.++|||||||++|||++|.. ||......+     +   .
T Consensus       167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-----~---~  236 (309)
T d1fvra_         167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----L---Y  236 (309)
T ss_dssp             EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----H---H
T ss_pred             EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH-----H---H
Confidence            9999999975543322  233458999999999999999999999999999999999765 665433211     1   1


Q ss_pred             HHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          300 RKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       300 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      .......         ....+...+.++.+|+.+||+.||++||||++|++.|+.
T Consensus       237 ~~i~~~~---------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~  282 (309)
T d1fvra_         237 EKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  282 (309)
T ss_dssp             HHGGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHhcC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            1111111         111233445688999999999999999999999998864

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-51  Score=369.06  Aligned_cols=256  Identities=28%  Similarity=0.366  Sum_probs=197.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEECC--C--CEEEEEEecccC--CcchHHHHHHHHHHHHhccCCcccceeeeeecCCee
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLSD--N--TKVAVKRLQDYY--SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~~--~--~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  149 (401)
                      .++|++.+.||+|+||.||+|.+..  +  ..||||++....  .+...+.|.+|+.++++++||||+++++++.+ +..
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            3568889999999999999998532  2  378999886432  34456789999999999999999999999976 467


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ++||||+++|++.+.+...   ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++
T Consensus        86 ~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~  159 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR  159 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             heeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhh
Confidence            8999999999999887753   34599999999999999999999998   99999999999999999999999999999


Q ss_pred             ccCCCCcc--eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchhhhhhhHHHHHHHHhccC
Q 015734          230 LVDAKLTH--VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEEEEDVLLLDHIRKLLRED  306 (401)
Q Consensus       230 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (401)
                      ........  ......||..|+|||.+.+..++.++|||||||++|||+| |..||......+        ........+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--------~~~~i~~~~  231 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--------ILHKIDKEG  231 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTSC
T ss_pred             hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--------HHHHHHhCC
Confidence            76554332  2233457889999999999999999999999999999998 899997543321        112222221


Q ss_pred             ccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       307 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      ..        ...+...+.++.+++.+||+.||++||||++|++.|+.
T Consensus       232 ~~--------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         232 ER--------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CC--------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            11        11123334578899999999999999999999988864

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-51  Score=375.09  Aligned_cols=264  Identities=25%  Similarity=0.383  Sum_probs=214.6

Q ss_pred             HHHHhcCCCCCCeeeecCcEEEEEEEE------CCCCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeeee
Q 015734           72 LQLATDNFSESNIIGQGGFGKVYKGVL------SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYCT  144 (401)
Q Consensus        72 ~~~~~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  144 (401)
                      +++..++|.+.++||+|+||.||+|++      .++..||||+++..........+.+|+.++.++ +||||+++++++.
T Consensus        18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~   97 (311)
T d1t46a_          18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (311)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence            455678899999999999999999985      235689999998666666677899999999998 6999999999999


Q ss_pred             cCCeeEEEEecccCCcHHHHhhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCC
Q 015734          145 TSSERILVYPFMQNLSVAYRLRDLKP--------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAA  210 (401)
Q Consensus       145 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~  210 (401)
                      +.+..+++|||+++|+|.+++.....              ....+++..+..++.||+.||+|||++   +++||||||+
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~  174 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR  174 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccc
Confidence            99999999999999999999976432              234689999999999999999999999   9999999999


Q ss_pred             ceEEcCCCcEEEeecCCccccCCCCc-ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhC-CCCCCCCcch
Q 015734          211 NILLDDNFEAVLCDFGLAKLVDAKLT-HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTG-QRAIDFSRLE  288 (401)
Q Consensus       211 Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg-~~p~~~~~~~  288 (401)
                      ||+++.++.+|++|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+|+ .+|+......
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987655433 333456789999999999999999999999999999999995 5555433221


Q ss_pred             hhhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          289 EEEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      +    .+...+....+            ...+...+.++.+|+.+||+.||.+||||+++++.|+.
T Consensus       255 ~----~~~~~i~~~~~------------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~  304 (311)
T d1t46a_         255 S----KFYKMIKEGFR------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (311)
T ss_dssp             H----HHHHHHHHTCC------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             H----HHHHHHhcCCC------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            1    11111211100            01122334678899999999999999999999999874

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6.2e-50  Score=362.60  Aligned_cols=252  Identities=21%  Similarity=0.284  Sum_probs=204.7

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCc--------chHHHHHHHHHHHHhcc-CCcccceeeeeecC
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP--------GGEAAFQREVHLISVAI-HKNLLQLIGYCTTS  146 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~  146 (401)
                      ++|.+.+.||+|+||+||+|+.. +|+.||||++......        ...+.+.+|+.++++++ ||||+++++++.+.
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            68899999999999999999964 6889999998643211        12346889999999997 99999999999999


Q ss_pred             CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecC
Q 015734          147 SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFG  226 (401)
Q Consensus       147 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfg  226 (401)
                      +..++||||+++|+|.+++..    ..++++..++.++.||+.||+|||++   +++||||||+||+++.++.+||+|||
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence            999999999999999999976    34699999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCcceeccccCCccccccccccc------CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHH
Q 015734          227 LAKLVDAKLTHVTTQIRGTMGHIAPEYLST------GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIR  300 (401)
Q Consensus       227 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~  300 (401)
                      +++......  ......||+.|+|||.+.+      ..++.++||||+||++|||+||..||.......     ..   .
T Consensus       156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-----~~---~  225 (277)
T d1phka_         156 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-----ML---R  225 (277)
T ss_dssp             TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HH---H
T ss_pred             heeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-----HH---H
Confidence            998765432  2344579999999999853      346889999999999999999999998654321     11   1


Q ss_pred             HHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          301 KLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       301 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ...... .. ..    .......++++.+++.+||+.||.+|||++|++++
T Consensus       226 ~i~~~~-~~-~~----~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         226 MIMSGN-YQ-FG----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HHHHTC-CC-CC----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHhCC-CC-CC----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            111111 00 00    01123445688899999999999999999999654

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.3e-50  Score=377.38  Aligned_cols=245  Identities=21%  Similarity=0.259  Sum_probs=205.7

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc--CCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY--YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  153 (401)
                      ++|.+.+.||+|+||.||+|.++ +|+.||||++...  ......+.+.+|+++++.++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57899999999999999999975 6899999998632  12345678899999999999999999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCC
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDA  233 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  233 (401)
                      ||+.+|+|..++...    ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       121 e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            999999999999863    3589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc
Q 015734          234 KLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD  313 (401)
Q Consensus       234 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  313 (401)
                      .    .....||+.|+|||++.+..++.++|||||||++|||+||..||.......     ....+.   ...       
T Consensus       194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~~i~---~~~-------  254 (350)
T d1rdqe_         194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-----IYEKIV---SGK-------  254 (350)
T ss_dssp             C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHH---HCC-------
T ss_pred             c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH-----HHHHHh---cCC-------
Confidence            3    234569999999999999999999999999999999999999997543211     111111   110       


Q ss_pred             CcCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 015734          314 RNLNTYDSKEVETMVQVALLCTQSTPEDRP-----PMAQVVK  350 (401)
Q Consensus       314 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~~vl~  350 (401)
                         ...+...+.++.+++.+||+.||.+|+     |++++++
T Consensus       255 ---~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         255 ---VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence               011233445788999999999999994     8899865

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-51  Score=374.01  Aligned_cols=262  Identities=27%  Similarity=0.387  Sum_probs=209.3

Q ss_pred             HHHhcCCCCCCeeeecCcEEEEEEEECC--------CCEEEEEEecccCCcchHHHHHHHHHHHHhc-cCCcccceeeee
Q 015734           73 QLATDNFSESNIIGQGGFGKVYKGVLSD--------NTKVAVKRLQDYYSPGGEAAFQREVHLISVA-IHKNLLQLIGYC  143 (401)
Q Consensus        73 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  143 (401)
                      .+..++|.+.+.||+|+||.||+|+...        +..||||+++..........+.+|...+.++ +||||++++++|
T Consensus         9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~   88 (299)
T d1fgka_           9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   88 (299)
T ss_dssp             BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence            3456789999999999999999998532        2479999998766666678899999999888 799999999999


Q ss_pred             ecCCeeEEEEecccCCcHHHHhhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCc
Q 015734          144 TTSSERILVYPFMQNLSVAYRLRDLKP------------GEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAAN  211 (401)
Q Consensus       144 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N  211 (401)
                      .+.+..++||||+++|+|.+++.....            ....+++.++..++.|++.||+|||+.   +++||||||+|
T Consensus        89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~N  165 (299)
T d1fgka_          89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  165 (299)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccc
Confidence            999999999999999999999975431            135689999999999999999999999   99999999999


Q ss_pred             eEEcCCCcEEEeecCCccccCCCCcc-eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHh-CCCCCCCCcchh
Q 015734          212 ILLDDNFEAVLCDFGLAKLVDAKLTH-VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVT-GQRAIDFSRLEE  289 (401)
Q Consensus       212 ill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~ellt-g~~p~~~~~~~~  289 (401)
                      ||++.++.+||+|||+++........ ......+|+.|+|||.+.++.++.++|||||||++|||++ |..||...... 
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~-  244 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-  244 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred             eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH-
Confidence            99999999999999999876544332 3344568999999999999999999999999999999998 68888643321 


Q ss_pred             hhhhhHHHHHHHHhccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          290 EEDVLLLDHIRKLLREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                          .+...+    ..+..        ...+...+.++.+|+.+||+.||++|||+.||++.|+.
T Consensus       245 ----~~~~~i----~~~~~--------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~  293 (299)
T d1fgka_         245 ----ELFKLL----KEGHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  293 (299)
T ss_dssp             ----HHHHHH----HTTCC--------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----HHHHHH----HcCCC--------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence                111111    11111        11222334578899999999999999999999999864

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-50  Score=368.76  Aligned_cols=266  Identities=24%  Similarity=0.305  Sum_probs=199.5

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCC----eeEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS----ERILV  152 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv  152 (401)
                      ++|.+.+.||+|+||+||+|++ +|+.||||++...  .........|+..+..++||||++++++|...+    ..++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~--~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc--chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            4577788999999999999997 6889999998642  222222334555556789999999999997654    57899


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEeCCCCCceEEcCCCcEEEeecCC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQ-----CNPKIIHRDLKAANILLDDNFEAVLCDFGL  227 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl  227 (401)
                      |||+++|+|.++++.     ..++|..+..++.|++.||+|||+.     ..++|+||||||+|||++.++.+||+|||+
T Consensus        80 ~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl  154 (303)
T d1vjya_          80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence            999999999999986     2489999999999999999999973     123899999999999999999999999999


Q ss_pred             ccccCCCCcc---eeccccCCcccccccccccCC------CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhh-----
Q 015734          228 AKLVDAKLTH---VTTQIRGTMGHIAPEYLSTGK------SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDV-----  293 (401)
Q Consensus       228 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~-----  293 (401)
                      ++........   ......||+.|+|||++.+..      ++.++|||||||++|||+||..|+...........     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~  234 (303)
T d1vjya_         155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence            9876543322   234467999999999987643      57789999999999999999988754322111100     


Q ss_pred             -hHHHHHHHHhccCccchhccCcCCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          294 -LLLDHIRKLLREDRLNDIVDRNLNT--YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       294 -~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                       ...............    ++.++.  ........+.+++.+||+.||.+|||+.||++.|+.
T Consensus       235 ~~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~  294 (303)
T d1vjya_         235 DPSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             SCCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             cchHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence             011222222222211    122221  134466779999999999999999999999999864

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.5e-50  Score=377.34  Aligned_cols=251  Identities=24%  Similarity=0.277  Sum_probs=199.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHH---HHHHHhccCCcccceeeeeecCCee
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQRE---VHLISVAIHKNLLQLIGYCTTSSER  149 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e---~~~l~~l~h~niv~~~~~~~~~~~~  149 (401)
                      -++|.+.++||+|+||.||+|... +|+.||||++....  .......+.+|   +.+++.++||||+++++++.+.+..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            367999999999999999999975 68999999985311  11222334444   6667778899999999999999999


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ++||||+++|+|.+++...    ..+++..++.++.||+.||+|||++   +++||||||+|||++.++.+||+|||+++
T Consensus        83 ~ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~  155 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC  155 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred             EEEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceee
Confidence            9999999999999999863    4588999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCcc
Q 015734          230 LVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRL  308 (401)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ......   .....||+.|+|||++.. ..++.++|||||||++|||+||+.||.........     ........    
T Consensus       156 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-----~~~~~~~~----  223 (364)
T d1omwa3         156 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----EIDRMTLT----  223 (364)
T ss_dssp             ECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH-----HHHHHSSS----
T ss_pred             ecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHhccc----
Confidence            765432   334569999999999875 46899999999999999999999999764432211     11111100    


Q ss_pred             chhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 015734          309 NDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVKM  351 (401)
Q Consensus       309 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~~  351 (401)
                            .....+...+.++.+++.+||+.||.+|||     +++++++
T Consensus       224 ------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         224 ------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             ------CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             ------CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence                  001122234457889999999999999999     6888654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-49  Score=365.72  Aligned_cols=251  Identities=16%  Similarity=0.244  Sum_probs=205.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      .++|.+.+.||+|+||+||+|.++ +++.||+|.++..  ......+.+|+++|+.++||||+++++++.+.+..++|||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            468999999999999999999975 6889999999752  3345678899999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC--CCcEEEeecCCccccC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD--NFEAVLCDFGLAKLVD  232 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~--~~~~kl~Dfgl~~~~~  232 (401)
                      |+++|+|.+++...   ...+++..++.++.||+.||.|||++   +++||||||+|||++.  ...+||+|||+++...
T Consensus        82 ~~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          82 FISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             CCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             cCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccc
Confidence            99999999998752   34689999999999999999999999   9999999999999985  4589999999998764


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC-ccchh
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED-RLNDI  311 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  311 (401)
                      ...  ......+|+.|+|||.+.+..++.++|||||||++|+|++|..||......+     .   ........ .....
T Consensus       156 ~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-----~---~~~i~~~~~~~~~~  225 (321)
T d1tkia_         156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-----I---IENIMNAEYTFDEE  225 (321)
T ss_dssp             TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----H---HHHHHHTCCCCCHH
T ss_pred             cCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-----H---HHHHHhCCCCCChh
Confidence            432  2334568999999999999999999999999999999999999998654321     1   11111111 11110


Q ss_pred             ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          312 VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       312 ~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .       ....+.++.+|+.+||+.||.+|||++|++++
T Consensus       226 ~-------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         226 A-------FKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             H-------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             h-------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0       01224568899999999999999999999874

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-50  Score=373.10  Aligned_cols=248  Identities=25%  Similarity=0.345  Sum_probs=203.2

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC--CcchHHHHHHHHHHHH-hccCCcccceeeeeecCCeeEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY--SPGGEAAFQREVHLIS-VAIHKNLLQLIGYCTTSSERILV  152 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv  152 (401)
                      ++|.+.+.||+|+||+||+|.++ +|+.||||++....  .....+.+..|..++. .++||||+++++++.+.+..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57899999999999999999975 68999999996321  2334566677777665 68999999999999999999999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccC
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVD  232 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~  232 (401)
                      |||+++|+|.+++...    ..+++..++.++.||+.||+|||++   +++||||||+|||+++++++||+|||+++...
T Consensus        82 mEy~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence            9999999999999863    3589999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhc
Q 015734          233 AKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIV  312 (401)
Q Consensus       233 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      .... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...+...     +...+.   ...      
T Consensus       155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-----~~~~i~---~~~------  219 (320)
T d1xjda_         155 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-----LFHSIR---MDN------  219 (320)
T ss_dssp             CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHH---HCC------
T ss_pred             cccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-----HHHHHH---cCC------
Confidence            4322 3344579999999999999999999999999999999999999998654321     111111   110      


Q ss_pred             cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 015734          313 DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMA-QVVK  350 (401)
Q Consensus       313 d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-~vl~  350 (401)
                       +   ..+...+.++.+|+.+||+.||.+|||+. ++++
T Consensus       220 -~---~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         220 -P---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             -C---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             -C---CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence             1   11223345788999999999999999985 6754

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-49  Score=369.61  Aligned_cols=252  Identities=21%  Similarity=0.261  Sum_probs=198.3

Q ss_pred             hcCCCCCC-eeeecCcEEEEEEEE-CCCCEEEEEEecccCCcchHHHHHHHHHHHHh-ccCCcccceeeeeec----CCe
Q 015734           76 TDNFSESN-IIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISV-AIHKNLLQLIGYCTT----SSE  148 (401)
Q Consensus        76 ~~~~~~~~-~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~----~~~  148 (401)
                      .++|.+.+ +||+|+||+||+|.+ .+++.||||++..      ...+.+|+.++.+ .+||||+++++++.+    ...
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            45788764 699999999999996 4689999999864      2457789988765 489999999998865    456


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC---CCcEEEeec
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD---NFEAVLCDF  225 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~---~~~~kl~Df  225 (401)
                      .++|||||+||+|.+++...  +...+++..++.++.|++.||+|||++   +++||||||+|||+++   ++.+||+||
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             EEEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccc
Confidence            89999999999999999752  235699999999999999999999999   9999999999999985   567999999


Q ss_pred             CCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhcc
Q 015734          226 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE  305 (401)
Q Consensus       226 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (401)
                      |+++......  ......||+.|+|||++.+..++.++|||||||++|+|+||+.||........     ..........
T Consensus       159 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-----~~~~~~~i~~  231 (335)
T d2ozaa1         159 GFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----SPGMKTRIRM  231 (335)
T ss_dssp             TTCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------CCCS
T ss_pred             ceeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-----HHHHHHHHhc
Confidence            9998765432  23445799999999999999999999999999999999999999975432110     0001100000


Q ss_pred             CccchhccCcCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          306 DRLNDIVDRNLNT-YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       306 ~~~~~~~d~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..      ...+. .....+.++.+|+.+||+.||++|||+.|++++
T Consensus       232 ~~------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         232 GQ------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             CS------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CC------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            00      00111 112345789999999999999999999999884

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-49  Score=361.77  Aligned_cols=257  Identities=27%  Similarity=0.269  Sum_probs=195.8

Q ss_pred             CCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCc----chHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEecc
Q 015734           82 SNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSP----GGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPFM  156 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  156 (401)
                      .++||+|+||+||+|.++ +|+.||||++......    .....+.+|++++++++||||+++++++...+..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            468999999999999964 6899999998642221    12346889999999999999999999999999999999999


Q ss_pred             cCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCCc
Q 015734          157 QNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKLT  236 (401)
Q Consensus       157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  236 (401)
                      .++++......    ...+++..+..++.||+.||+|||++   +++||||||+|||++.++.+||+|||+++.......
T Consensus        83 ~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          83 ETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             SEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             cchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            98876655443    45688999999999999999999999   999999999999999999999999999986654432


Q ss_pred             ceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCccchhcc--
Q 015734          237 HVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDRLNDIVD--  313 (401)
Q Consensus       237 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--  313 (401)
                      . .....||+.|+|||++.+. .++.++|||||||++|||+||..||......+     ....+.............+  
T Consensus       156 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-----~l~~i~~~~~~~~~~~~~~~~  229 (299)
T d1ua2a_         156 A-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-----QLTRIFETLGTPTEEQWPDMC  229 (299)
T ss_dssp             C-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHHHCCCCTTTSSSTT
T ss_pred             c-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-----HHHHHHHhcCCCChhhccchh
Confidence            2 2335689999999998654 57999999999999999999999997654322     1111111111110000000  


Q ss_pred             --------CcCCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          314 --------RNLNTY-----DSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       314 --------~~~~~~-----~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                              ...+..     .+...+++.+|+.+||+.||++|||++|++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence                    000111     11234678899999999999999999999763

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-49  Score=364.10  Aligned_cols=264  Identities=24%  Similarity=0.307  Sum_probs=200.7

Q ss_pred             cCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           77 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      ++|.+.+.||+|+||+||+|.+ .+|+.||||++.... .+.....+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5889999999999999999996 468999999996322 23345788999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      |+.++.+. .+...  ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~~~~~~-~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          82 FLHQDLKK-FMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             CCSEEHHH-HHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             ecCCchhh-hhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence            99765444 44321  245699999999999999999999999   9999999999999999999999999999866543


Q ss_pred             CcceeccccCCcccccccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhc--cCccchh
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR--EDRLNDI  311 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  311 (401)
                      .. ......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+..+    .+.........  .......
T Consensus       156 ~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~  230 (298)
T d1gz8a_         156 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID----QLFRIFRTLGTPDEVVWPGV  230 (298)
T ss_dssp             SB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCTTTSTTG
T ss_pred             cc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH----HHHHHHHhcCCCchhhcccc
Confidence            22 233456899999999977665 5889999999999999999999998654321    11111111100  0000000


Q ss_pred             c---c--CcCCC--------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          312 V---D--RNLNT--------YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       312 ~---d--~~~~~--------~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .   +  .....        .....+.++.+|+.+||+.||.+|||++|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            0   0  00000        011234678899999999999999999999775

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.2e-49  Score=360.88  Aligned_cols=261  Identities=23%  Similarity=0.327  Sum_probs=201.9

Q ss_pred             cCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEec
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYPF  155 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  155 (401)
                      ++|.+.+.||+|+||+||+|.+++|+.||||++.... .+.....+.+|+.++++++||||+++++++...+..++++++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5789999999999999999999899999999996432 334467899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCCC
Q 015734          156 MQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAKL  235 (401)
Q Consensus       156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  235 (401)
                      +.++.+......    ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||.+.......
T Consensus        82 ~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          82 LDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             ehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            988776666553    45699999999999999999999998   99999999999999999999999999998765432


Q ss_pred             cceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC---ccchh
Q 015734          236 THVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED---RLNDI  311 (401)
Q Consensus       236 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  311 (401)
                      . ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+    .+..... .....   .....
T Consensus       155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~----~~~~i~~-~~~~~~~~~~~~~  228 (286)
T d1ob3a_         155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD----QLMRIFR-ILGTPNSKNWPNV  228 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHH-HHCCCCTTTSTTG
T ss_pred             c-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH----HHHHHHH-hhCCCChhhccch
Confidence            2 23334589999999998754 56899999999999999999999997544321    1111111 11110   00000


Q ss_pred             c-----cCcC--------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          312 V-----DRNL--------NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       312 ~-----d~~~--------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                      .     +...        .........++.+++.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0     0000        0012233467889999999999999999999975

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=360.77  Aligned_cols=242  Identities=22%  Similarity=0.367  Sum_probs=196.3

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-Cc----chHHHHHHHHHHHHhcc--CCcccceeeeeecCC
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SP----GGEAAFQREVHLISVAI--HKNLLQLIGYCTTSS  147 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~----~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~  147 (401)
                      .++|.+.+.||+|+||+||+|... +|+.||||++.... ..    .....+.+|+.++++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            357999999999999999999964 68999999986321 11    11234678999999986  899999999999999


Q ss_pred             eeEEEEecccC-CcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC-CCcEEEeec
Q 015734          148 ERILVYPFMQN-LSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-NFEAVLCDF  225 (401)
Q Consensus       148 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-~~~~kl~Df  225 (401)
                      ..++||||+.+ +++.+++..    ...+++..++.++.|++.||+|||++   +++||||||+|||++. ++.+||+||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcc
Confidence            99999999976 577777765    34589999999999999999999999   9999999999999985 579999999


Q ss_pred             CCccccCCCCcceeccccCCcccccccccccCCC-CcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhc
Q 015734          226 GLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKS-SEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR  304 (401)
Q Consensus       226 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (401)
                      |+++.....   ......||+.|+|||++.+..+ +.++|||||||++|||+||..||.....           +.   .
T Consensus       156 G~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----------i~---~  218 (273)
T d1xwsa_         156 GSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----------II---R  218 (273)
T ss_dssp             TTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------HH---H
T ss_pred             ccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----------Hh---h
Confidence            999865433   2334579999999999987765 5778999999999999999999974211           00   0


Q ss_pred             cCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          305 EDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       305 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..          ...+...+.++.+++.+||+.||.+|||++|++++
T Consensus       219 ~~----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         219 GQ----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             CC----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             cc----------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            00          00112234578899999999999999999999874

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-49  Score=362.06  Aligned_cols=263  Identities=24%  Similarity=0.341  Sum_probs=198.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-C-CCEEEEEEeccc-CCcchHHHHHHHHHHHHhc---cCCcccceeeeeec----
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-D-NTKVAVKRLQDY-YSPGGEAAFQREVHLISVA---IHKNLLQLIGYCTT----  145 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~-~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~----  145 (401)
                      .++|.+.+.||+|+||+||+|.+. + ++.||||+++.. ........+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999973 4 567999998632 2222334566777776655   79999999998853    


Q ss_pred             -CCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEee
Q 015734          146 -SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCD  224 (401)
Q Consensus       146 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~D  224 (401)
                       ....++++|++.++++......   ....+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence             3467899999998877654443   245689999999999999999999999   999999999999999999999999


Q ss_pred             cCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhc
Q 015734          225 FGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLR  304 (401)
Q Consensus       225 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  304 (401)
                      ||++.......  ......||+.|+|||++.+..++.++||||+||++|||+||+.||...+..+.    + ..+.....
T Consensus       160 fg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~----~-~~i~~~~~  232 (305)
T d1blxa_         160 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ----L-GKILDVIG  232 (305)
T ss_dssp             CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----H-HHHHHHHC
T ss_pred             hhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH----H-HHHHHhhC
Confidence            99988654332  33446799999999999999999999999999999999999999986543221    1 11111111


Q ss_pred             cCccch----------h----ccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          305 EDRLND----------I----VDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       305 ~~~~~~----------~----~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ......          .    .............+.+.+|+.+||+.||++|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            100000          0    0000111223344677889999999999999999999764

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-46  Score=347.50  Aligned_cols=264  Identities=23%  Similarity=0.274  Sum_probs=196.8

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeec--------
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT--------  145 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  145 (401)
                      .++|.+.+.||+|+||+||+|.+. +|+.||||++... ..+.....+.+|+++|++++|||++++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            368999999999999999999974 7899999998632 334456778999999999999999999998855        


Q ss_pred             CCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeec
Q 015734          146 SSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDF  225 (401)
Q Consensus       146 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Df  225 (401)
                      .+..+++|||+.++.+......    ...++...++.++.|++.||.|||++   +++||||||+|||++.++.+||+||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             CceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence            3457899999988776544433    45689999999999999999999999   9999999999999999999999999


Q ss_pred             CCccccCCCCcc---eeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHH
Q 015734          226 GLAKLVDAKLTH---VTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRK  301 (401)
Q Consensus       226 gl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~  301 (401)
                      |++.........   ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......     ....+..
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~-----~~~~i~~  236 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-----QLALISQ  236 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHH
T ss_pred             ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH-----HHHHHHH
Confidence            999766533221   22334689999999998765 58999999999999999999999997543211     1111111


Q ss_pred             Hhcc---Cccchhcc---------CcCCCCCH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          302 LLRE---DRLNDIVD---------RNLNTYDS-------KEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       302 ~~~~---~~~~~~~d---------~~~~~~~~-------~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ....   ........         ........       .....+.+|+.+||+.||++|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            1111   00000000         00000001       113456789999999999999999999764

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-46  Score=350.34  Aligned_cols=263  Identities=19%  Similarity=0.293  Sum_probs=198.5

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecCC----eeE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS----ERI  150 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~  150 (401)
                      .++|++.+.||+|+||+||+|.+ .+|+.||||++.........+.+.+|+.+|+.++|||++++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            35799999999999999999996 4799999999976555556678999999999999999999999986553    235


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKL  230 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~  230 (401)
                      ++++++.+|+|.+++..     ..+++..++.++.|++.||+|||++   +|+||||||+|||+++++.+||+|||++..
T Consensus        87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence            55566779999999875     2589999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCcc--eeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          231 VDAKLTH--VTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       231 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      .......  ......||+.|+|||++.. ..++.++||||+||++|+|++|+.||......+....     .........
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~-----~~~~~~~~~  233 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH-----ILGILGSPS  233 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-----HHHHHCSCC
T ss_pred             ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHH-----HhhhccCCC
Confidence            5443222  2344568999999999854 4578999999999999999999999976543221111     000000000


Q ss_pred             cc-----------hh--ccCcCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          308 LN-----------DI--VDRNLNT-----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       308 ~~-----------~~--~d~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ..           ..  ..+....     ..+....++.+|+.+||+.||.+|||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00           00  0000000     011223468899999999999999999999875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-47  Score=352.39  Aligned_cols=253  Identities=22%  Similarity=0.282  Sum_probs=204.0

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC----CCCEEEEEEecccC---CcchHHHHHHHHHHHHhccC-CcccceeeeeecCCe
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS----DNTKVAVKRLQDYY---SPGGEAAFQREVHLISVAIH-KNLLQLIGYCTTSSE  148 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~  148 (401)
                      ++|.+.+.||+|+||+||+|...    +|+.||||.++...   .....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            67999999999999999999852    47899999986321   22345678899999999977 899999999999999


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      .+++|||+.+|+|.+++...    ..++...+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence            99999999999999999874    3478889999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcceeccccCCcccccccccccC--CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLSTG--KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED  306 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  306 (401)
                      +..............|++.|+|||.+.+.  .++.++|||||||++|+|+||..||............    ....... 
T Consensus       177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i----~~~~~~~-  251 (322)
T d1vzoa_         177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI----SRRILKS-  251 (322)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH----HHHHHHC-
T ss_pred             hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HHhcccC-
Confidence            87765545445556799999999998765  4688999999999999999999999765443222111    1111110 


Q ss_pred             ccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 015734          307 RLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPP-----MAQVVK  350 (401)
Q Consensus       307 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~~vl~  350 (401)
                               ....+...+.++.+++.+||++||.+|||     ++|+++
T Consensus       252 ---------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 ---------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ---------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ---------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                     01122344568889999999999999995     788865

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-47  Score=353.98  Aligned_cols=259  Identities=22%  Similarity=0.314  Sum_probs=195.2

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeecCC------
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSS------  147 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  147 (401)
                      .++|.+.+.||+|+||+||+|.+. +|+.||||++... .+....+.+.+|+++|+.++|||++++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            468999999999999999999964 6899999999743 34445678899999999999999999999987654      


Q ss_pred             eeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCC
Q 015734          148 ERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGL  227 (401)
Q Consensus       148 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl  227 (401)
                      ..++||||+ +.+|......     ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+|++|||+
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence            469999999 6677776654     3599999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCcceeccccCCcccccccccccC-CCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhcc-
Q 015734          228 AKLVDAKLTHVTTQIRGTMGHIAPEYLSTG-KSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE-  305 (401)
Q Consensus       228 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  305 (401)
                      ++.....    .....||+.|+|||++.+. .++.++||||+||++|+|++|+.||...+.....    .......... 
T Consensus       168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~----~~~~~~~~~~~  239 (346)
T d1cm8a_         168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL----KEIMKVTGTPP  239 (346)
T ss_dssp             CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHHHCCCC
T ss_pred             eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHH----HHHHhccCCCc
Confidence            9866443    2345689999999998764 5689999999999999999999999765432111    1100000000 


Q ss_pred             ----------------CccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          306 ----------------DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       306 ----------------~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                                      ....................++.+|+.+||+.||.+|||++|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                            0000000001111122334567899999999999999999999885

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-46  Score=342.65  Aligned_cols=263  Identities=24%  Similarity=0.289  Sum_probs=205.7

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecCCeeEEEEe
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTSSERILVYP  154 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  154 (401)
                      ++|++.+.||+|+||+||+|++. +++.||||+++... .+.....+.+|+.+++.++||||+++++++......+++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57899999999999999999964 68899999997433 34556889999999999999999999999999999999999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCccccCCC
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLAKLVDAK  234 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  234 (401)
                      ++.++++..++..    ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||.++.....
T Consensus        82 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          82 FCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             ecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence            9999998887765    45688999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CcceeccccCCcccccccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccC---ccch
Q 015734          235 LTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRED---RLND  310 (401)
Q Consensus       235 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  310 (401)
                      ... .....+++.|+|||.+.... ++.++|||||||++|||++|+.||........    ....+.......   ....
T Consensus       155 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  229 (292)
T d1unla_         155 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD----QLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             CSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH----HHHHHHHHHCCCCTTTCTT
T ss_pred             Ccc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH----HHHHHHhhcCCCChhhhhh
Confidence            322 23345788999999987665 68999999999999999999999743222111    111122111110   0000


Q ss_pred             ---h--------c--cCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          311 ---I--------V--DRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       311 ---~--------~--d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                         .        .  ............+.+.+|+.+||+.||.+|||++|++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               0        0  001111223345678899999999999999999999663

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-46  Score=349.79  Aligned_cols=263  Identities=22%  Similarity=0.288  Sum_probs=193.3

Q ss_pred             CCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccceeeeeecC------CeeE
Q 015734           78 NFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS------SERI  150 (401)
Q Consensus        78 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~  150 (401)
                      +|+..++||+|+||+||+|.+. +|+.||||++.....     ...+|++++++++||||+++++++...      ...+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            5778889999999999999975 689999999975322     224799999999999999999998543      2468


Q ss_pred             EEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC-cEEEeecCCcc
Q 015734          151 LVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAK  229 (401)
Q Consensus       151 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfgl~~  229 (401)
                      +||||++++.+. .+.........+++..++.++.|++.||+|||++   +|+||||||+|||++.++ .+||+|||++.
T Consensus        96 lv~Ey~~~~~~~-~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          96 LVLDYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             EEEECCSEEHHH-HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             EEEeccCCccHH-HHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchh
Confidence            999999865443 3433223356799999999999999999999998   999999999999999775 89999999998


Q ss_pred             ccCCCCcceeccccCCccccccccccc-CCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHH-------HHHHH
Q 015734          230 LVDAKLTHVTTQIRGTMGHIAPEYLST-GKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL-------DHIRK  301 (401)
Q Consensus       230 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~-------~~~~~  301 (401)
                      .......  .....||+.|+|||.+.+ ..++.++||||+||++|||++|..||......+.......       .....
T Consensus       172 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         172 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             ECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             hccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            6654322  233568999999998765 5689999999999999999999999976543221111000       00010


Q ss_pred             Hhc---cCccchhccCcC-CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          302 LLR---EDRLNDIVDRNL-NTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       302 ~~~---~~~~~~~~d~~~-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      ...   ............ .........++.+|+.+||+.||.+|||+.|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000   000000000000 00122345678899999999999999999999764

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=9.1e-46  Score=344.55  Aligned_cols=258  Identities=19%  Similarity=0.262  Sum_probs=196.2

Q ss_pred             cCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCcccceeeeeecC--CeeEEE
Q 015734           77 DNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTS--SERILV  152 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv  152 (401)
                      ++|.+.++||+|+||+||+|++ .+|+.||||+++.    ...+.+.+|+++|..+. ||||+++++++...  ...++|
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~----~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH----HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            6799999999999999999997 4689999999864    23567899999999995 99999999998743  468999


Q ss_pred             EecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCC-cEEEeecCCcccc
Q 015734          153 YPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNF-EAVLCDFGLAKLV  231 (401)
Q Consensus       153 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~-~~kl~Dfgl~~~~  231 (401)
                      |||+.+++|.....       .+++..++.++.||+.||.|||++   +|+||||||+|||++.++ .+||+|||+++..
T Consensus       111 ~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~  180 (328)
T d3bqca1         111 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  180 (328)
T ss_dssp             EECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred             EeecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceec
Confidence            99999999865532       489999999999999999999999   999999999999998654 6999999999866


Q ss_pred             CCCCcceeccccCCcccccccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHH---------HHHH
Q 015734          232 DAKLTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLD---------HIRK  301 (401)
Q Consensus       232 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~---------~~~~  301 (401)
                      ....  ......+|+.|+|||.+.+.. ++.++||||+||++|+|++|+.||...............         +...
T Consensus       181 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         181 HPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             CTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             cCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence            5432  233456899999999987654 799999999999999999999999754432211111111         1110


Q ss_pred             Hhcc--CccchhccC--------cCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 015734          302 LLRE--DRLNDIVDR--------NLN-TYDSKEVETMVQVALLCTQSTPEDRPPMAQVVK  350 (401)
Q Consensus       302 ~~~~--~~~~~~~d~--------~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~  350 (401)
                      ....  .........        ... ........++.+|+.+||+.||.+|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000  000000000        000 011223467889999999999999999999976

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.6e-45  Score=336.95  Aligned_cols=259  Identities=15%  Similarity=0.205  Sum_probs=202.7

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccC-CcccceeeeeecCCeeEEEE
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH-KNLLQLIGYCTTSSERILVY  153 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~  153 (401)
                      .++|.+.+.||+|+||+||+|++. +|+.||||++.....   ...+.+|++.+..+.| +|++.+++++......++||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            468999999999999999999965 688999998864322   2346788888888875 89999999999999999999


Q ss_pred             ecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcC-----CCcEEEeecCCc
Q 015734          154 PFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDD-----NFEAVLCDFGLA  228 (401)
Q Consensus       154 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~-----~~~~kl~Dfgl~  228 (401)
                      ||+ +++|.+.+...   ...++..++..++.|++.||+|||++   +++||||||+|||++.     ++.+||+|||++
T Consensus        81 e~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a  153 (293)
T d1csna_          81 DLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  153 (293)
T ss_dssp             ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             Eec-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEccccee
Confidence            999 78999888763   34689999999999999999999999   9999999999999974     578999999999


Q ss_pred             cccCCCCc------ceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHH
Q 015734          229 KLVDAKLT------HVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKL  302 (401)
Q Consensus       229 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~  302 (401)
                      +.......      .......||+.|+|||.+.+..++.++|||||||++|||+||..||...........  ...+...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~--~~~i~~~  231 (293)
T d1csna_         154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK--YERIGEK  231 (293)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH--HHHHHHH
T ss_pred             EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHH--HHHHHhc
Confidence            87643322      123345799999999999999999999999999999999999999975443221111  1111111


Q ss_pred             hccCccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          303 LREDRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       303 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      .......++        ....++++.+++..|++.+|++||+++.+.+.|+.
T Consensus       232 ~~~~~~~~l--------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~  275 (293)
T d1csna_         232 KQSTPLREL--------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK  275 (293)
T ss_dssp             HHHSCHHHH--------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             cCCCChHHh--------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence            111111111        11223578889999999999999999988777643

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-45  Score=337.82  Aligned_cols=258  Identities=17%  Similarity=0.193  Sum_probs=194.8

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcccce-eeeeecCCeeEEEEe
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNLLQL-IGYCTTSSERILVYP  154 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~-~~~~~~~~~~~lv~e  154 (401)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++.....   ...+..|+++++.++|+|++.. .++..+.+..++|||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            57999999999999999999964 688999998875322   2357889999999987775555 455577778889999


Q ss_pred             cccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEc---CCCcEEEeecCCcccc
Q 015734          155 FMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLD---DNFEAVLCDFGLAKLV  231 (401)
Q Consensus       155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~---~~~~~kl~Dfgl~~~~  231 (401)
                      |+ ++++...+...   ...+++..+..++.|++.||+|||++   +++||||||+|||++   .+..+||+|||+++..
T Consensus        84 ~~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          84 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             Ec-CCchhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            99 55666655542   35699999999999999999999999   999999999999985   4567999999999876


Q ss_pred             CCCCcc------eeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhcc
Q 015734          232 DAKLTH------VTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLRE  305 (401)
Q Consensus       232 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  305 (401)
                      ......      ......||+.|+|||.+.+..++.++|||||||++|||+||..||............ ......... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~-~~~~~~~~~-  234 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-ERISEKKMS-  234 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------H-HHHHHHHHH-
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHH-HHhhcccCC-
Confidence            543221      234457999999999999999999999999999999999999999764432211111 111111000 


Q ss_pred             CccchhccCcCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 015734          306 DRLNDIVDRNLNTYDSKEVETMVQVALLCTQSTPEDRPPMAQVVKMLQG  354 (401)
Q Consensus       306 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~L~~  354 (401)
                      .....        .....+.++.+++..||+.+|++||++.++.+.|+.
T Consensus       235 ~~~~~--------~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  275 (299)
T d1ckia_         235 TPIEV--------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  275 (299)
T ss_dssp             SCHHH--------HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred             CChhH--------hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence            00000        011233578899999999999999999999887764

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-46  Score=348.55  Aligned_cols=263  Identities=20%  Similarity=0.256  Sum_probs=191.7

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEeccc-CCcchHHHHHHHHHHHHhccCCcccceeeeeec------CCe
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDY-YSPGGEAAFQREVHLISVAIHKNLLQLIGYCTT------SSE  148 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  148 (401)
                      ++|.+.++||+|+||+||+|.+. +|+.||||++... .+......+.+|+.++++++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57899999999999999999975 6999999999743 334455678999999999999999999999853      367


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      .++||||+.++.+ ..+.      ..+++..++.++.|++.||+|||++   |++||||||+|||++.++.+|++|||++
T Consensus        97 ~~iv~Ey~~~~l~-~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEECCSEEHH-HHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             eEEEEeccchHHH-Hhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence            8999999976544 3332      2488999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHH------------
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLL------------  296 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~------------  296 (401)
                      +......  ......+|+.|+|||++.+..++.++||||+||++|+|++|+.||...+..........            
T Consensus       167 ~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             hcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence            8654432  33445689999999999999999999999999999999999999975543211110000            


Q ss_pred             --HHHHHHhccC------ccchhccCcCCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          297 --DHIRKLLRED------RLNDIVDRNLNT----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       297 --~~~~~~~~~~------~~~~~~d~~~~~----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                        ..........      ............    .....+.++.+|+.+||+.||++|||++|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence              0000000000      001111111111    123456788999999999999999999999764

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-45  Score=343.25  Aligned_cols=259  Identities=21%  Similarity=0.286  Sum_probs=195.7

Q ss_pred             hcCCCCCCeeeecCcEEEEEEEE-CCCCEEEEEEecccC-CcchHHHHHHHHHHHHhccCCcccceeeeeecC-----Ce
Q 015734           76 TDNFSESNIIGQGGFGKVYKGVL-SDNTKVAVKRLQDYY-SPGGEAAFQREVHLISVAIHKNLLQLIGYCTTS-----SE  148 (401)
Q Consensus        76 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  148 (401)
                      .++|.+.+.||+|+||+||+|.+ .+|+.||||++.... +....+.+.+|+++++.++|||++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            56899999999999999999996 469999999997432 334556789999999999999999999988643     33


Q ss_pred             eEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEEeecCCc
Q 015734          149 RILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVLCDFGLA  228 (401)
Q Consensus       149 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~  228 (401)
                      .+++++++.+|+|.+++..     ..+++..++.++.||+.||+|||++   +++||||||+|||++.++.+|++|||++
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence            4677788889999998854     3599999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCcceeccccCCcccccccccccCC-CCcccchhHHHHHHHHHHhCCCCCCCCcchhhhhhhHHHHHHHHhccCc
Q 015734          229 KLVDAKLTHVTTQIRGTMGHIAPEYLSTGK-SSEKTDVFGYGITLLELVTGQRAIDFSRLEEEEDVLLLDHIRKLLREDR  307 (401)
Q Consensus       229 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDi~slG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      ......    .....||+.|+|||.+.+.. ++.++|||||||++|+|++|..||...+.....     ..+........
T Consensus       169 ~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~-----~~i~~~~~~~~  239 (348)
T d2gfsa1         169 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL-----KLILRLVGTPG  239 (348)
T ss_dssp             -CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-----HHHHHHHCCCC
T ss_pred             cccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHH-----HHHHHhcCCCC
Confidence            755332    23456899999999876654 689999999999999999999999765432111     11111110000


Q ss_pred             c-----------chhcc--CcCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 015734          308 L-----------NDIVD--RNLNT-----YDSKEVETMVQVALLCTQSTPEDRPPMAQVVKM  351 (401)
Q Consensus       308 ~-----------~~~~d--~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~~vl~~  351 (401)
                      .           .....  .....     .......++.+|+.+||+.||.+|||++|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence            0           00000  00000     011234567899999999999999999999874

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.2e-40  Score=309.75  Aligned_cols=264  Identities=20%  Similarity=0.226  Sum_probs=190.3

Q ss_pred             cCCCCCCeeeecCcEEEEEEEEC-CCCEEEEEEecccCCcchHHHHHHHHHHHHhcc-----------CCcccceeeeee
Q 015734           77 DNFSESNIIGQGGFGKVYKGVLS-DNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-----------HKNLLQLIGYCT  144 (401)
Q Consensus        77 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~  144 (401)
                      ++|.+.++||+|+||+||+|+.. +|+.||||+++.  .....+.+.+|+++++.++           |+||+++++++.
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~--~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG--DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEec--cccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence            35999999999999999999974 689999999974  2334567788998887775           578999988875


Q ss_pred             cC--CeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCceEEcCCC---
Q 015734          145 TS--SERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNF---  218 (401)
Q Consensus       145 ~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~---  218 (401)
                      ..  ...++++.++..+.......... ....+++..++.++.|++.||+|||+ .   +|+||||||+|||++.++   
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          91 HKGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTT
T ss_pred             eccccceeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccc
Confidence            43  45566666665554333332222 24568999999999999999999998 5   899999999999998665   


Q ss_pred             ---cEEEeecCCccccCCCCcceeccccCCcccccccccccCCCCcccchhHHHHHHHHHHhCCCCCCCCcchhh--hhh
Q 015734          219 ---EAVLCDFGLAKLVDAKLTHVTTQIRGTMGHIAPEYLSTGKSSEKTDVFGYGITLLELVTGQRAIDFSRLEEE--EDV  293 (401)
Q Consensus       219 ---~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDi~slG~ll~elltg~~p~~~~~~~~~--~~~  293 (401)
                         .++++|||.+......    .....||+.|+|||++.+..++.++||||+||++++|++|+.||........  ...
T Consensus       167 ~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             ccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence               3999999999755432    2345689999999999999999999999999999999999999975432111  111


Q ss_pred             hHHHHHHHHhccC---------ccchhcc--------------------CcCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 015734          294 LLLDHIRKLLRED---------RLNDIVD--------------------RNLNTYDSKEVETMVQVALLCTQSTPEDRPP  344 (401)
Q Consensus       294 ~~~~~~~~~~~~~---------~~~~~~d--------------------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  344 (401)
                      .+...+. .+...         ......+                    ............++.+|+.+||+.||.+|||
T Consensus       243 ~~~~~~~-~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt  321 (362)
T d1q8ya_         243 HIAQIIE-LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  321 (362)
T ss_dssp             HHHHHHH-HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHH-HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence            1111111 10000         0000000                    0011235677888999999999999999999


Q ss_pred             HHHHHHH
Q 015734          345 MAQVVKM  351 (401)
Q Consensus       345 ~~~vl~~  351 (401)
                      ++|++++
T Consensus       322 a~e~L~H  328 (362)
T d1q8ya_         322 AGGLVNH  328 (362)
T ss_dssp             HHHHHTC
T ss_pred             HHHHhcC
Confidence            9999754

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=7.7e-25  Score=186.25  Aligned_cols=164  Identities=11%  Similarity=0.071  Sum_probs=120.2

Q ss_pred             CCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCc-----------------chHHHHHHHHHHHHhccCCcccceeee
Q 015734           80 SESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSP-----------------GGEAAFQREVHLISVAIHKNLLQLIGY  142 (401)
Q Consensus        80 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~l~h~niv~~~~~  142 (401)
                      .+.+.||+|+||+||+|.+.+|+.||||+++.....                 .......+|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            457889999999999999888999999987532110                 012345568888999999999988765


Q ss_pred             eecCCeeEEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEeCCCCCceEEcCCCcEEE
Q 015734          143 CTTSSERILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQCNPKIIHRDLKAANILLDDNFEAVL  222 (401)
Q Consensus       143 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nill~~~~~~kl  222 (401)
                      .    ..+++|||+++..+..           ++......++.|++.+++|||++   +++||||||+|||++++ .++|
T Consensus        83 ~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred             c----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence            3    2379999998765422           33344678899999999999999   99999999999999976 5899


Q ss_pred             eecCCccccCCCCcceeccccCCcccccc------cccccCCCCcccchhHHHHHH
Q 015734          223 CDFGLAKLVDAKLTHVTTQIRGTMGHIAP------EYLSTGKSSEKTDVFGYGITL  272 (401)
Q Consensus       223 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~sDi~slG~ll  272 (401)
                      +|||++.....+...         .|...      +. -..+++.++|+||..--+
T Consensus       144 iDFG~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         144 IDFPQSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCCTTCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             EECCCcccCCCCCcH---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence            999998755432211         11111      11 135678899999976443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.50  E-value=5.5e-07  Score=78.17  Aligned_cols=148  Identities=17%  Similarity=0.150  Sum_probs=95.9

Q ss_pred             HHHHHhcCCCCCCeeeecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhcc-CCcccceeeeeecCCee
Q 015734           71 ELQLATDNFSESNIIGQGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAI-HKNLLQLIGYCTTSSER  149 (401)
Q Consensus        71 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~  149 (401)
                      ++....+.|+..+..+.++.+.||+... +++.+.+|+...... .....+.+|...+..+. +-.+.+++.++...+..
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcc-cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            4555556776665544455578998875 566778887753221 12334677888877664 43467778888888888


Q ss_pred             EEEEecccCCcHHHHhhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------
Q 015734          150 ILVYPFMQNLSVAYRLRDLKPGEKGLDWPTRKRVAFGTAYGLEYLHEQC-------------------------------  198 (401)
Q Consensus       150 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------------  198 (401)
                      ++||++++|.++.......      .   ....++.+++..++.||+..                               
T Consensus        86 ~lv~~~l~G~~~~~~~~~~------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred             EEEEEeccccccccccccc------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence            9999999998775443210      0   11223344444444444311                               


Q ss_pred             -------------------------CCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          199 -------------------------NPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       199 -------------------------~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                                               .+.++|+|+.|.||++++++.+-|.||+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                     1237999999999999987767799998875

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.15  E-value=3.5e-06  Score=72.50  Aligned_cols=72  Identities=13%  Similarity=0.005  Sum_probs=50.6

Q ss_pred             eecC-cEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccC--CcccceeeeeecCCeeEEEEecccCCcH
Q 015734           86 GQGG-FGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIH--KNLLQLIGYCTTSSERILVYPFMQNLSV  161 (401)
Q Consensus        86 G~G~-~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL  161 (401)
                      ..|. .+.||+...+++..+++|......    ...+..|...++.+..  -.+.++++++.+.+..++||++++|.++
T Consensus        19 ~~G~s~~~v~r~~~~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          19 TIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             SCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             CCcccCCeEEEEEeCCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            3444 367999988778888889765432    2345677777776643  3356678888888888999999988654

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.65  E-value=0.00015  Score=66.21  Aligned_cols=77  Identities=14%  Similarity=0.121  Sum_probs=47.4

Q ss_pred             CCeeeecCcEEEEEEEECC-CCEEEEEEeccc------CCcchHHHHHHHHHHHHhcc-C-C-cccceeeeeecCCeeEE
Q 015734           82 SNIIGQGGFGKVYKGVLSD-NTKVAVKRLQDY------YSPGGEAAFQREVHLISVAI-H-K-NLLQLIGYCTTSSERIL  151 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~------~~~~~~~~~~~e~~~l~~l~-h-~-niv~~~~~~~~~~~~~l  151 (401)
                      .+.||.|....||++...+ ++.+++|.-...      ..+........|.+.++.+. + | .+.+++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            3468999999999998644 678999965421      01122334556777776553 2 2 34555544  3455688


Q ss_pred             EEecccCCc
Q 015734          152 VYPFMQNLS  160 (401)
Q Consensus       152 v~e~~~~gs  160 (401)
                      |||++.+..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.28  E-value=0.0008  Score=59.57  Aligned_cols=138  Identities=14%  Similarity=0.101  Sum_probs=77.0

Q ss_pred             cCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcc--cceee-----eeecCCeeEEEEecccCCc
Q 015734           88 GGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL--LQLIG-----YCTTSSERILVYPFMQNLS  160 (401)
Q Consensus        88 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~-----~~~~~~~~~lv~e~~~~gs  160 (401)
                      +.-..||++..++|..|++|+.+....  ..+++..|...+..+...++  +..+.     .....+..+.++++++|..
T Consensus        33 s~EN~vy~v~~~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          33 SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             cccceeEEEEcCCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            345789999998999999998865322  35667788888877653322  11111     1223445678899887643


Q ss_pred             HH-----------H---Hhhh----cCC-CCCCCCHH-------------------HHHHHHHHHHHHHHHHHh----cC
Q 015734          161 VA-----------Y---RLRD----LKP-GEKGLDWP-------------------TRKRVAFGTAYGLEYLHE----QC  198 (401)
Q Consensus       161 L~-----------~---~l~~----~~~-~~~~l~~~-------------------~~~~i~~~i~~~l~~LH~----~~  198 (401)
                      +.           .   .++.    ... .....++.                   ....+...+...++.+..    ..
T Consensus       111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~  190 (325)
T d1zyla1         111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF  190 (325)
T ss_dssp             CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred             CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence            11           0   1111    100 01111111                   111122222223333322    22


Q ss_pred             CCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          199 NPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       199 ~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                      ..+++|+|+.+.|||++++  ..+.||+-+.
T Consensus       191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         191 TVLRLHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             CCEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             CceeecCCCCcccEEEeCC--ceEEechhcc
Confidence            3478999999999999754  4588999876

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.28  E-value=0.0027  Score=55.67  Aligned_cols=159  Identities=13%  Similarity=0.073  Sum_probs=81.2

Q ss_pred             cCHHHHHHHhcCCCCCCeee-----ecCcEEEEEEEECCCCEEEEEEecccCCcchHHHHHHHHHHHHhccCCcc--cce
Q 015734           67 FSCRELQLATDNFSESNIIG-----QGGFGKVYKGVLSDNTKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL--LQL  139 (401)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~lG-----~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~  139 (401)
                      ++.++++....+|.+++...     .|---+.|+...++| .+++|+.....+.   ..+..|++++..+...++  ...
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~~---~~l~~~~~~l~~L~~~g~pvp~p   78 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLP   78 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCCH---HHHHHHHHHHHhhhhcccccccc
Confidence            56677888888898866543     565688899987655 5888987643333   234455666655543221  111


Q ss_pred             ee------eeecCCeeEEEEecccCCcHH--------------HHhhhcCCC---C--CCCCHH----------------
Q 015734          140 IG------YCTTSSERILVYPFMQNLSVA--------------YRLRDLKPG---E--KGLDWP----------------  178 (401)
Q Consensus       140 ~~------~~~~~~~~~lv~e~~~~gsL~--------------~~l~~~~~~---~--~~l~~~----------------  178 (401)
                      +.      +.........++.+..+....              ..++.....   .  ......                
T Consensus        79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (316)
T d2ppqa1          79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  158 (316)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence            11      112233445566666553211              011100000   0  000000                


Q ss_pred             --HHHHHHHHHHHHHHHHHh-cCCCCeEEeCCCCCceEEcCCCcEEEeecCCcc
Q 015734          179 --TRKRVAFGTAYGLEYLHE-QCNPKIIHRDLKAANILLDDNFEAVLCDFGLAK  229 (401)
Q Consensus       179 --~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nill~~~~~~kl~Dfgl~~  229 (401)
                        .....+......+.-.+. ....+++|+|+.++||+++.+...-+.||+.+.
T Consensus       159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence              011112222222222221 123479999999999999998777899999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.58  E-value=0.0064  Score=55.04  Aligned_cols=73  Identities=15%  Similarity=0.170  Sum_probs=48.4

Q ss_pred             CCeeeecCcEEEEEEEECCC--------CEEEEEEecccCCcchHHHHHHHHHHHHhccCCcc-cceeeeeecCCeeEEE
Q 015734           82 SNIIGQGGFGKVYKGVLSDN--------TKVAVKRLQDYYSPGGEAAFQREVHLISVAIHKNL-LQLIGYCTTSSERILV  152 (401)
Q Consensus        82 ~~~lG~G~~g~V~~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv  152 (401)
                      .+.|+.|-.-.+|++..+++        ..|.+++.-.  . .......+|..+++.+.-.++ .++++++.+    .+|
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I  119 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  119 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence            45688889999999986542        4566666532  2 223456688888887754444 466666643    678


Q ss_pred             EecccCCcH
Q 015734          153 YPFMQNLSV  161 (401)
Q Consensus       153 ~e~~~~gsL  161 (401)
                      ++|++|.++
T Consensus       120 ~efi~g~~l  128 (395)
T d1nw1a_         120 EEYIPSRPL  128 (395)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeccccC
Confidence            999987543